PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Beyea, J				Beyea, Jan			The Smart Electricity Grid and Scientific Research	SCIENCE			English	Editorial Material							SCIENCE; CANCER		Consulting Publ Interest, Lambertville, NJ 08530 USA		Beyea, J (corresponding author), Consulting Publ Interest, Lambertville, NJ 08530 USA.	jbeyea@cipi.com	Beyea, Jan/E-6505-2016	Beyea, Jan/0000-0002-0547-880X				*CEN, WORKSH DAT PROT PRIV; CERN, WORLDW LHC COMP GRID; Drenker S, 1999, IEEE COMPUT APPL POW, V12, P47, DOI 10.1109/67.795138; ELMAHRSI MK, 2009, P 3 INT C RES CHALL; Enfield KB, 2008, RESP CARE, V53, P1330; Faruqui A, 2009, ELECT J, V22, P55, DOI [10.1016/j.tej.2009.06.012, DOI 10.1016/J.TEJ.2009.06.012]; Gammon MD, 2002, BREAST CANCER RES TR, V74, P235, DOI 10.1023/A:1016387020854; Hey AJG, 2003, GRID COMPUTING MAKIN, P809, DOI DOI 10.1002/0470867167.CH36; Jones Douglas N., 2001, ENERGY L J, V22, P41; KING M, 2007, ELECT J, V20, P38; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; LERNER JI, 2008, STANFORD TECHNOL LAW, P3; Lisovich M.A., 2008, CLEMS POW SYST C 200, V1, P1; Meyers RJ, 2010, ENERG BUILDINGS, V42, P563, DOI 10.1016/j.enbuild.2009.10.026; Mezei G, 2008, EPIDEMIOLOGY, V19, P424, DOI 10.1097/EDE.0b013e3181690715; Newborough M, 1999, IEE P-GENER TRANSM D, V146, P283, DOI 10.1049/ip-gtd:19990318; *OFF SCI TECHN POL, CONS INT SMART GRID; Pringle H, 2010, SCIENCE, V327, P1322, DOI 10.1126/science.327.5971.1322; Prudenzi A, 2002, 2002 IEEE POWER ENGINEERING SOCIETY WINTER MEETING, VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P941, DOI 10.1109/PESW.2002.985144; Rice TW, 2008, RESP CARE, V53, P1325; Roberts S, 2008, ENERG POLICY, V36, P4552, DOI 10.1016/j.enpol.2008.09.012; Strbac G, 2008, ENERG POLICY, V36, P4419, DOI 10.1016/j.enpol.2008.09.030; SULTANEM F, 1991, IEEE T POWER DELIVER, V6, P1380, DOI 10.1109/61.97667; *US NIST, 2009, 7628 US NIST NISTIR; Venables Mark, 2009, Engineering & Technology, V4, P10, DOI 10.1049/et.2009.1800	25	21	21	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2010	328	5981					979	980		10.1126/science.1189229	http://dx.doi.org/10.1126/science.1189229			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	598YW	20489008				2022-12-24	WOS:000277877100023
J	Fryxell, JM; Packer, C; McCann, K; Solberg, EJ; Saether, BE				Fryxell, John M.; Packer, Craig; McCann, Kevin; Solberg, Erling J.; Saether, Bernt-Erik			Resource Management Cycles and the Sustainability of Harvested Wildlife Populations	SCIENCE			English	Article							DENSITY-DEPENDENCE; MARINE RESERVES; CONSEQUENCES; FLUCTUATIONS; CONSERVATION	Constant harvest policies for fish and wildlife populations can lead to population collapse in the face of stochastic variation in population growth rates. Here, we show that weak compensatory response by resource users or managers to changing levels of resource abundance can readily induce harvest cycles that accentuate the risk of catastrophic population collapse. Dynamic system models incorporating this mix of feedback predict that cycles or quasi-cycles with decadal periodicity should commonly occur in harvested wildlife populations, with effort and quotas lagging far behind resources, whereas harvests should exhibit lags of intermediate length. Empirical data gathered from three hunted populations of white-tailed deer and moose were consistent with these predictions of both underlying behavioral causes and dynamical consequences.	[Fryxell, John M.; McCann, Kevin] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Packer, Craig] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Solberg, Erling J.] Norwegian Inst Nat Res, N-7485 Trondheim, Norway; [Saether, Bernt-Erik] NTNU, Dept Biol, Ctr Conservat Biol, N-7491 Trondheim, Norway	University of Guelph; University of Minnesota System; University of Minnesota Twin Cities; Norwegian Institute Nature Research; Norwegian University of Science & Technology (NTNU)	Fryxell, JM (corresponding author), Univ Guelph, Dept Integrat Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	jfryxell@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada; NSF; Directorate for Nature Management; Norwegian Research Council [196304/V40]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSF(National Science Foundation (NSF)); Directorate for Nature Management; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by Discovery Grants to J.M.F. and K.M. from the Natural Sciences and Engineering Research Council of Canada, and NSF Grants for Long-Term Research in Environmental Biology and Biocomplexity to C.P. The contributions by B.E.S. and E.J.S. were funded by the Directorate for Nature Management and the Norwegian Research Council (Changing Landscapes, Lanskap i Endring, and project 196304/V40). We thank A. Fryxell, T. Avgar, M. Anderson, T. Nudds, and two anonymous reviewers for helpful suggestions. Details of the dynamical stability analysis are available on request from the senior author.	Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Beckerman AP, 2002, TRENDS ECOL EVOL, V17, P263, DOI 10.1016/S0169-5347(02)02469-2; BEDDINGTON JR, 1977, SCIENCE, V197, P463, DOI 10.1126/science.197.4302.463; BELL G, 1977, J FISH RES BOARD CAN, V34, P942, DOI 10.1139/f77-147; BERRYMAN AA, 1991, OIKOS, V62, P106, DOI 10.2307/3545457; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; Clark C.W., 1990, MATH BIOECONOMICS OP; Coulson T, 2008, ECOLOGY, V89, P1661, DOI 10.1890/07-1099.1; Coulson T, 2004, ECOLOGY, V85, P411, DOI 10.1890/03-0009; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; FRYXELL JM, 1991, J WILDLIFE MANAGE, V55, P377, DOI 10.2307/3808963; Hastings A, 1999, SCIENCE, V284, P1537, DOI 10.1126/science.284.5419.1537; Hastings A., 1997, POPULATION BIOL CONC; Lande R, 1997, ECOLOGY, V78, P1341; Lande R., 2003, OXFORD SERIES ECOLOG; Mangel M, 1998, ECOL LETT, V1, P87; MCGARVEY R, 1994, CAN J FISH AQUAT SCI, V51, P900, DOI 10.1139/f94-089; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; Neubert MG, 2003, ECOL LETT, V6, P843, DOI 10.1046/j.1461-0248.2003.00493.x; Nisbet RM, 1982, MODELLING FLUCTUATIN; Otto SP, 2007, BIOL GUIDE MATH MODE; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Schaefer MB., 1954, INT AM TROPICAL TUNA, V1, P23; Solberg EJ, 1999, J ANIM ECOL, V68, P186, DOI 10.1046/j.1365-2656.1999.00275.x; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	29	83	87	0	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					903	906		10.1126/science.1185802	http://dx.doi.org/10.1126/science.1185802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466934				2022-12-24	WOS:000277618800052
J	Nudds, RL; Dyke, GJ				Nudds, Robert L.; Dyke, Gareth J.			Narrow Primary Feather Rachises in Confuciusornis and Archaeopteryx Suggest Poor Flight Ability	SCIENCE			English	Article							EVOLUTION; FOSSIL; ORIGIN	The fossil birds Archaeopteryx and Confuciusornis had feathered wings resembling those of living birds, but their flight capabilities remain uncertain. Analysis of the rachises of their primary feathers shows that the rachises were much thinner and weaker than those of modern birds, and thus the birds were not capable of flight. Only if the primary feather rachises were solid in cross-section (the strongest structural configuration), and not hollow as in living birds, would flight have been possible. Hence, if Archaeopteryx and Confuciusornis were flapping flyers, they must have had a feather structure that was fundamentally different from that of living birds. Alternatively, if they were only gliders, then the flapping wing stroke must have appeared after the divergence of Confuciusornis, likely within the enantiornithine or ornithurine radiations.	[Nudds, Robert L.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Dyke, Gareth J.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 4, Ireland	University of Manchester; University College Dublin	Nudds, RL (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	robert.nudds@manchester.ac.uk	Dyke, Gareth/AAJ-9320-2020	Dyke, Gareth/0000-0002-8390-7817				Burgers P, 1999, NATURE, V399, P60, DOI 10.1038/19967; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Chiappe Luis M, 2008, Biol Lett, V4, P719, DOI 10.1098/rsbl.2008.0409; Corning WR, 1998, J EXP BIOL, V201, P3057; Elzanowski Andrzej, 2002, P129; Fountaine TMR, 2005, P ROY SOC B-BIOL SCI, V272, P289, DOI 10.1098/rspb.2004.2923; Hou LH, 2004, NATURWISSENSCHAFTEN, V91, P22, DOI 10.1007/s00114-003-0489-1; Norberg R.A., 1985, P303; Norberg U., 1990, VERTEBRATE FLIGHT ME; NORBERG UM, 1985, AM NAT, V126, P303, DOI 10.1086/284419; Nudds RL, 2007, J AVIAN BIOL, V38, P515, DOI 10.1111/j.0908-8857.2007.03913.x; Nudds RL, 2009, EVOLUTION, V63, P994, DOI 10.1111/j.1558-5646.2009.00613.x; OLSON SL, 1979, NATURE, V278, P247, DOI 10.1038/278247a0; OSTROM JH, 1974, Q REV BIOL, V49, P27, DOI 10.1086/407902; Rietschel S., 1985, P251; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; SPEAKMAN JR, 1994, NATURE, V370, P514, DOI 10.1038/370514a0; VAZQUEZ RJ, 1992, J MORPHOL, V211, P259, DOI 10.1002/jmor.1052110303; Wellnhofer P, 2004, LIFE O PAST, P282; Worcester SE, 1996, J ZOOL, V239, P609, DOI 10.1111/j.1469-7998.1996.tb05947.x; YALDEN DW, 1971, IBIS, V113, P349, DOI 10.1111/j.1474-919X.1971.tb05165.x; Zhou Zhong-He, 2004, Acta Zoologica Sinica, V50, P913	22	73	76	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					887	889		10.1126/science.1188895	http://dx.doi.org/10.1126/science.1188895			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466930				2022-12-24	WOS:000277618800047
J	Phelps, J; Webb, EL; Agrawal, A				Phelps, Jacob; Webb, Edward L.; Agrawal, Arun			LAND USE Does REDD plus Threaten to Recentralize Forest Governance?	SCIENCE			English	Editorial Material							DEFORESTATION; NEPAL		[Phelps, Jacob; Webb, Edward L.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Agrawal, Arun] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	National University of Singapore; University of Michigan System; University of Michigan	Webb, EL (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	ted.webb@nus.edu.sg	Agrawal, Arun/A-4257-2009; Webb, Edward L/E-8343-2011	Agrawal, Arun/0000-0001-6796-2958; Webb, Edward L/0000-0001-5554-9955; Phelps, Jacob/0000-0001-6489-1103				Agrawal A., 2008, DECENTRALIZATION FOR, P44; Agrawal A, 2008, SCIENCE, V320, P1460, DOI 10.1126/science.1155369; ANGELSEN A., 2008, MOVING AHEAD REDD IS, P11, DOI [10.17528/cifor/002601, DOI 10.17528/CIFOR/002601]; Brockington Dan, 2002, FORTRESS CONSERVATIO; Cacho OJ, 2005, ENVIRON DEV ECON, V10, P597, DOI 10.1017/S1355770X05002056; Capistrano D, 2005, Politics of Decentralization: Forests, People and Power, P296; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Davis C., 2009, REV 25 READINESS PLA; Griffiths Tom, 2007, SEEING RED AVOIDED D; Malla YB, 2001, ENVIRON HIST, V6, P287, DOI 10.2307/3985088; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; *MIN FIN REP IND, 2009, BUDG STAT 2008 2009; Minang P.A., 2010, REDD COPENHAGEN WAY; Nagendra H, 2002, ENVIRON CONSERV, V29, P530, DOI 10.1017/S0376892902000383; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Niles JO, 2002, PHILOS T ROY SOC A, V360, P1621, DOI 10.1098/rsta.2002.1023; Oestreicher JS, 2009, GLOBAL ENVIRON CHANG, V19, P279, DOI 10.1016/j.gloenvcha.2009.01.003; Ostrom E, 2006, P NATL ACAD SCI USA, V103, P19224, DOI 10.1073/pnas.0607962103; Peluso NL, 2001, J ASIAN STUD, V60, P761, DOI 10.2307/2700109; Ribot JC, 2006, WORLD DEV, V34, P1864, DOI 10.1016/j.worlddev.2005.11.020; Somanathan E, 2009, P NATL ACAD SCI USA, V106, P4143, DOI 10.1073/pnas.0810049106; Sutherland WJ, 2010, TRENDS ECOL EVOL, V25, P1, DOI 10.1016/j.tree.2009.10.003; Wardell DA, 2006, WORLD DEV, V34, P1887, DOI 10.1016/j.worlddev.2005.11.021; Webb EL, 2008, DECENTRALIZATION FOR; WERTZKANOUNNIKO.S, 2009, 46 CTR INT FOR; 2010, M DEFORESTATION BOOS	28	367	374	5	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					312	313		10.1126/science.1187774	http://dx.doi.org/10.1126/science.1187774			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	583NR	20395498				2022-12-24	WOS:000276685000022
J	Horton, R				Horton, Richard			Offline: The grey zone situation	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 10	2010	375	9722					1238	1238		10.1016/S0140-6736(10)60521-1	http://dx.doi.org/10.1016/S0140-6736(10)60521-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	585VN	20382314				2022-12-24	WOS:000276858400011
J	Bernards, R				Bernards, Rene			It's Diagnostics, Stupid	CELL			English	Article							METASTATIC COLORECTAL-CANCER; BREAST-CANCER; GENE-EXPRESSION; LUNG-CANCER; THERAPY; DETERMINANT; RESISTANCE; SIGNATURES; DISCOVERY; CETUXIMAB		[Bernards, Rene] Netherlands Canc Inst, Ctr Biomed Genet, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; [Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Ctr Biomed Genet, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl		Bernards, Rene/0000-0001-8677-3423	Centre of Biomedical Genetics; Cancer Genomics Centre; Netherlands Organisation for Scientific Research (NWO); Dutch Cancer Society	Centre of Biomedical Genetics; Cancer Genomics Centre; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding)	I thank P. Borst and members of my laboratory for helpful discussions and comments on the manuscript. The work of the author was supported by grants from the Centre of Biomedical Genetics, the Cancer Genomics Centre, the Netherlands Organisation for Scientific Research (NWO), and the Dutch Cancer Society.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; EARLE CC, 2008, DEVITA HELLMAN ROSEN, P369; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fojo T, 2009, JNCI-J NATL CANCER I, V101, P1044, DOI 10.1093/jnci/djp177; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Pinkel D, 2005, ANNU REV GENOM HUM G, V6, P331, DOI 10.1146/annurev.genom.6.080604.162140; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tomasello G, 2008, EXPERT REV ANTICANC, V8, P1883, DOI 10.1586/14737140.8.12.1883; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558	28	36	37	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2010	141	1					13	17		10.1016/j.cell.2010.03.018	http://dx.doi.org/10.1016/j.cell.2010.03.018			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371338	Bronze			2022-12-24	WOS:000276211100005
J	Jones, C; Hill, J; Chapple, C				Jones, Clare; Hill, Jennifer; Chapple, Christopher		Guideline Dev Grp	Management of lower urinary tract symptoms in men: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chapple, Christopher] Royal Coll Physicians, Natl Clin Guideline Ctr Acute & Chron Condit, Guideline Dev Grp, London NW1 4LE, England; [Chapple, Christopher] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Dept Urol, Guideline Dev Grp, Sheffield S10 2JF, S Yorkshire, England	Royal College of Physicians; University of Sheffield	Chapple, C (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr Acute & Chron Condit, Guideline Dev Grp, London NW1 4LE, England.	c.r.chapple@sheffield.ac.uk		Chapple, Christopher/0000-0002-2960-9931	Nation Clinical Excellence	Nation Clinical Excellence	The National Clinical Guideline Centre for Acute and Chronic Conditions was commissioned and funded by the Nation Clinical Excellence to write this summary.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Chapple CR, 2009, URODYNAMICS MADE EAS; CHAPPLE CR, 1999, EUR UROL, V36; MEBUST WK, 1991, INT CONS BEN PROST H, P51; *NAT I HLTH CLIN E, 2010, MAN LOW UR TRACT SYM, V97; *NAT I HLTH CLIN E, 2006, CLIN GUID NAT I HLTH, V40	7	56	57	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2010	340								c2354	10.1136/bmj.c2354	http://dx.doi.org/10.1136/bmj.c2354			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601LU	20484350	Green Submitted			2022-12-24	WOS:000278061800002
J	Ji, YH; Resch, W; Corbett, E; Yamane, A; Casellas, R; Schatz, DG				Ji, Yanhong; Resch, Wolfgang; Corbett, Elizabeth; Yamane, Arito; Casellas, Rafael; Schatz, David G.			The In Vivo Pattern of Binding of RAG1 and RAG2 to Antigen Receptor Loci	CELL			English	Article							HEAVY-CHAIN LOCUS; V(D)J RECOMBINATION; CHROMOSOMAL TRANSLOCATIONS; HISTONE H3; SYNAPTIC COMPLEX; ACTIVE-SITE; DNA BREAKS; CLEAVAGE; REPAIR; ACCESSIBILITY	The critical initial step in V(D)J recombination, binding of RAG1 and RAG2 to recombination signal sequences flanking antigen receptor V, D, and J gene segments, has not previously been characterized in vivo. Here, we demonstrate that RAG protein binding occurs in a highly focal manner to a small region of active chromatin encompassing Ig kappa and Tcr alpha J gene segments and Igh and Tcr beta J and J-proximal D gene segments. Formation of these small RAG-bound regions, which we refer to as recombination centers, occurs in a developmental stage- and lineage-specific manner. Each RAG protein is independently capable of specific binding within recombination centers. While RAG1 binding was detected only at regions containing recombination signal sequences, RAG2 binds at thousands of sites in the genome containing histone 3 trimethylated at lysine 4. We propose that recombination centers coordinate V(D)J recombination by providing discrete sites within which gene segments are captured for recombination.	[Resch, Wolfgang; Yamane, Arito; Casellas, Rafael] NIAMSD, NIH, Bethesda, MD 20892 USA; [Ji, Yanhong; Corbett, Elizabeth; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Casellas, Rafael] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Corbett, Elizabeth; Schatz, David G.] Howard Hughes Med Inst, Chevy Chase, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Yale University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute	Casellas, R (corresponding author), NIAMSD, NIH, Bethesda, MD 20892 USA.	casellar@mail.nih.gov; david.schatz@yale.edu	Schatz, David/A-6748-2013; Yamane, Arito/A-2959-2013	Schatz, David/0000-0002-5669-1176; Resch, Wolfgang/0000-0001-7594-5963	Public Health Service [AI32524]; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032524, R01AI032524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank S. Desiderio, R. Sen, and R. Subrahmanyam for lentiviral vectors expressing WT and W453A RAG2, M. Nussenzweig for providing the HG BAC, B. Sleckman and A. Bredemeyer for providing cell lines and technical advice, S. Zhou for help with the analysis of mice, J. Duke for analysis of genome-wide H3K4me3 data, the Yale Transgenic Mouse Service for generating transgenic mice, members of the Schatz lab for helpful discussions, the Yale Immunobiology Cell Sorting Facility for cell sorting, and M. Krangel, M. Schlissel, and B. Sleckman for critical reading of the manuscript. This work was supported in part by Public Health Service grant AI32524 to D. G. S. and in part by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health. D.G.S. is an investigator of the Howard Hughes Medical Institute.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bassing CH, 2008, EUR J IMMUNOL, V38, P2564, DOI 10.1002/eji.200838347; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Cobb RM, 2006, ADV IMMUNOL, V91, P45, DOI 10.1016/S0065-2776(06)91002-5; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Cui XP, 2007, P NATL ACAD SCI USA, V104, P17046, DOI 10.1073/pnas.0610928104; Curry JD, 2005, NAT IMMUNOL, V6, P1272, DOI 10.1038/ni1270; De P, 2004, IMMUNOL REV, V200, P70, DOI 10.1111/j.0105-2896.2004.00154.x; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712; Grazini U, 2010, MOL CELL, V37, P282, DOI 10.1016/j.molcel.2009.12.035; Hawwari A, 2007, P NATL ACAD SCI USA, V104, P903, DOI 10.1073/pnas.0608248104; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jiang H, 2005, MOL CELL, V18, P699, DOI 10.1016/j.molcel.2005.05.011; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Krangel MS, 2007, NAT IMMUNOL, V8, P686, DOI 10.1038/ni1484; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; Landree MA, 1999, GENE DEV, V13, P3059, DOI 10.1101/gad.13.23.3059; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; LEU TMJ, 1995, MOL CELL BIOL, V15, P5657; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Marculescu R, 2006, DNA REPAIR, V5, P1246, DOI 10.1016/j.dnarep.2006.05.015; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Matthews AGW, 2009, NAT IMMUNOL, V10, P817, DOI 10.1038/ni.1776; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Mundy CL, 2002, MOL CELL BIOL, V22, P69, DOI 10.1128/MCB.22.1.69-77.2002; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Ranganath S, 2008, J IMMUNOL, V180, P2339, DOI 10.4049/jimmunol.180.4.2339; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Rval P, 2008, NUCLEIC ACIDS RES, V36, P2060, DOI 10.1093/nar/gkn049; Shimazaki N, 2009, MOL CELL, V34, P535, DOI 10.1016/j.molcel.2009.05.011; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; VICTOR KD, 1994, J IMMUNOL, V152, P3467; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; Wu C, 2007, P NATL ACAD SCI USA, V104, P4002, DOI 10.1073/pnas.0700081104; Ye J, 2004, IMMUNOGENETICS, V56, P399, DOI 10.1007/s00251-004-0712-z; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080	50	210	212	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					419	431		10.1016/j.cell.2010.03.010	http://dx.doi.org/10.1016/j.cell.2010.03.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20398922	Bronze, Green Accepted			2022-12-24	WOS:000277180800014
J	Lohmann, KJ				Lohmann, Kenneth J.			Q&A ANIMAL BEHAVIOUR Magnetic-field perception	NATURE			English	Editorial Material							MAGNETORECEPTION; ORIENTATION; DESIGN; BIRDS		Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Lohmann, KJ (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	klohmann@email.unc.edu						Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Johnsen S, 2008, PHYS TODAY, V61, P29, DOI 10.1063/1.2897947; Kirschvink JL, 2010, J R SOC INTERFACE, V7, pS179, DOI 10.1098/rsif.2009.0491.focus; Lohmann KJ, 2007, J EXP BIOL, V210, P3697, DOI 10.1242/jeb.001313; Ritz T, 2010, J R SOC INTERFACE, V7, pS135, DOI 10.1098/rsif.2009.0456.focus; Rodgers CT, 2009, P NATL ACAD SCI USA, V106, P353, DOI 10.1073/pnas.0711968106; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7	7	107	115	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2010	464	7292					1140	1142		10.1038/4641140a	http://dx.doi.org/10.1038/4641140a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20414302				2022-12-24	WOS:000276891100026
J	Scharfmann, R; Polak, M				Scharfmann, Raphael; Polak, Michel			Transcribing Neonatal Diabetes Mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IN-VIVO; CELLS		[Scharfmann, Raphael; Polak, Michel] Univ Paris 05, INSERM, U845, Hop Necker,Growth & Signaling Res Ctr, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Scharfmann, R (corresponding author), Univ Paris 05, INSERM, U845, Hop Necker,Growth & Signaling Res Ctr, Paris, France.		scharfmann, raphael/L-3296-2017	Scharfmann, Raphael/0000-0001-7619-337X				Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	5	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2010	362	16					1538	1539		10.1056/NEJMcibr1001845	http://dx.doi.org/10.1056/NEJMcibr1001845			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586GP	20410520				2022-12-24	WOS:000276894700017
J	Miller, S; Tavshanjian, B; Oleksy, A; Perisic, O; Houseman, BT; Shokat, KM; Williams, RL				Miller, Simon; Tavshanjian, Brandon; Oleksy, Arkadiusz; Perisic, Olga; Houseman, Benjamin T.; Shokat, Kevan M.; Williams, Roger L.			Shaping Development of Autophagy Inhibitors with the Structure of the Lipid Kinase Vps34	SCIENCE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; PHOSPHOINOSITIDE 3-KINASE; SACCHAROMYCES-CEREVISIAE; REGULATES AUTOPHAGY; PROTEIN-KINASE; BECLIN 1; UVRAG; ACTIVATION; ENDOSOME; HVPS34	Phosphoinositide 3-kinases (PI3Ks) are lipid kinases with diverse roles in health and disease. The primordial PI3K, Vps34, is present in all eukaryotes and has essential roles in autophagy, membrane trafficking, and cell signaling. We solved the crystal structure of Vps34 at 2.9 angstrom resolution, which revealed a constricted adenine-binding pocket, suggesting the reason that specific inhibitors of this class of PI3K have proven elusive. Both the phosphoinositide-binding loop and the carboxyl-terminal helix of Vps34 mediate catalysis on membranes and suppress futile adenosine triphosphatase cycles. Vps34 appears to alternate between a closed cytosolic form and an open form on the membrane. Structures of Vps34 complexes with a series of inhibitors reveal the reason that an autophagy inhibitor preferentially inhibits Vps34 and underpin the development of new potent and specific Vps34 inhibitors.	[Miller, Simon; Oleksy, Arkadiusz; Perisic, Olga; Williams, Roger L.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Tavshanjian, Brandon; Houseman, Benjamin T.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Tavshanjian, Brandon; Houseman, Benjamin T.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	MRC Laboratory Molecular Biology; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Williams, RL (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	rlw@mrc-lmb.cam.ac.uk		Williams, Roger/0000-0001-7754-4207; Perisic, Olga/0000-0002-3842-2896	Mount Zion Health Fund; Achievement Rewards for College Scientists Fellowship at UCSF; Waxman Foundation; MRC [MC_U105184308] Funding Source: UKRI; Medical Research Council [MC_U105184308] Funding Source: researchfish	Mount Zion Health Fund; Achievement Rewards for College Scientists Fellowship at UCSF; Waxman Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank European Synchrotron Radiation Facility beamline scientists for ID14-4, ID23-1, and ID29. We are grateful to Y. Ohashi and A. Gillingham for help with yeast experiments, C. Sachse for electron microscopy, M. Allen for help with x-ray data collection, A. Berndt for advice and discussions, S. Munro for critically reading the manuscript, B. Gonz~lez for a clone of HsVps34, and G. Ducker for help in optimizing Vps34 inhibitor assays. B. T. H. is supported by the Mount Zion Health Fund, B. T. is supported by the Achievement Rewards for College Scientists Fellowship at UCSF, and K. M. S. thanks the Waxman Foundation for support. The coordinates have been deposited in the Protein Data Bank, with the following identification numbers (PDB IDs): 2X6H (apo), 2X6I (PIK-90), 2X6J (PIK-93), 2X6K (PI-103), and 2X6F (3-MA).	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Berndt A, 2010, NAT CHEM BIOL, V6, P117, DOI [10.1038/nchembio.293, 10.1038/NCHEMBIO.293]; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Budovskaya YV, 2002, J BIOL CHEM, V277, P287, DOI 10.1074/jbc.M109263200; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Murray JT, 2005, METHOD ENZYMOL, V403, P789, DOI 10.1016/S0076-6879(05)03068-5; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Panaretou C, 1997, J BIOL CHEM, V272, P2477; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Yan Y, 2009, BIOCHEM J, V417, P747, DOI 10.1042/BJ20081865	27	169	182	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1638	1642		10.1126/science.1184429	http://dx.doi.org/10.1126/science.1184429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339072	Green Accepted, Green Published			2022-12-24	WOS:000275970600042
J	McCormick, J; Mehta, G; Olesen, HV; Viviani, L; Macek, M; Mehta, A				McCormick, Jonathan; Mehta, Gita; Olesen, Hanne V.; Viviani, Laura; Macek, Milan, Jr.; Mehta, Anil		European Registry Working Grp	Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis	LANCET			English	Article							MORTALITY; AGE; OUTCOMES	Background Country-specific patients' registries are rarely used to make international comparisons because of protocol discrepancies in data collation. We present data from a European cystic fibrosis registry that is dedicated to collection of demographic data, and assess whether the resources available in countries with and without European Union (EU) membership affects care and survival of patients. Methods Data for demographic indicators age, age at diagnosis, sex, and genotype for patients with cystic fibrosis from 35 European countries were combined, and used to establish the differences in demographic indicators between EU and non-EU countries. EU membership status in 2003 was used to divide countries. We modelled demographic indicators of EU countries on non-EU countries to estimate the size of the cystic fibrosis population if non-EU countries had had the same resources available for patients as did EU countries. Findings Data were gathered for 29 025 patients, who had a median age of 16.3 years (IQR 8.9-24.8), with a difference of 4.9 years (95% CI 4.4-5.1; p<0.0001) between EU (median 17.0 years, IQR 9.5-25.6) and non-EU countries (12.1 years, 6.0-19.2). The proportion of patients older than 40 years was higher in EU countries (1205 [5%]) than in non-EU countries (76 [2%]), with an odds ratio of 2.4 (95% CI 1.9-3.0, p<0.0001). We estimated that the cystic fibrosis population in non-EU countries would increase by 84% if patients had a demographic profile comparable to that of patients in EU countries. Interpretation Future studies need to establish the reasons for the lower proportion of patients with cystic fibrosis in non-EU countries than in EU countries, such as underdiagnosis and premature childhood mortality.	[McCormick, Jonathan] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Acad Clin Practice, Div Clin Populat Sci & Educ, Dundee DD1 9SY, Scotland; [Mehta, Gita; Mehta, Anil] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Coll Med Dent & Nursing, Dundee DD1 9SY, Scotland; [Olesen, Hanne V.] Aarhus Univ Hosp, Cyst Fibrosis Ctr Aarhus, DK-8000 Aarhus N, Denmark; [Viviani, Laura] Univ Milan, Dipartimento Med Lavoro, Clin Lavoro Luigi Devoto, Sez Stat Med & Biometria GA Maccacaro, Milan, Italy; [Macek, Milan, Jr.] Charles Univ Prague, Dept Biol & Med Genet, Fac Med 2, Prague, Czech Republic; [Macek, Milan, Jr.] Univ Hosp Motol, Prague, Czech Republic	University of Dundee; University of Dundee; Aarhus University; University of Milan; Charles University Prague; Motol University Hospital	McCormick, J (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Ctr Acad Clin Practice, Div Clin Populat Sci & Educ, MACHS Bldg, Dundee DD1 9SY, Scotland.	jonathan.mccormick@nhs.net	Viviani, Laura/A-4787-2010; Kahre, Tiina/D-6198-2012; Sciuca, Svetlana/AAF-7239-2020	Viviani, Laura/0000-0003-2419-8472; Sciuca, Svetlana/0000-0003-1091-9419; mei-zahav, meir/0000-0002-6683-0264; Cinek, Ondrej/0000-0002-0526-8714	European Community [LSHM-CT-2005-018932]; Czech Ministry of Health [MZOFNM2005, 9448/3]	European Community(European Commission); Czech Ministry of Health(Ministry of Health, Czech Republic)	EuroCareCF was supported by the European Community's Sixth Framework Programme for Research, priority one Life Sciences, Genomics and Biotechnology for Health (contract number LSHM-CT-2005-018932) which supported GM and Margaret Fraser; we thank Margaret Fraser for expert data validation. MM was supported by grants from the Czech Ministry of Health (local grant number MZOFNM2005, and Internal Grant Agency [IGA] number 9448/3). We thank David Sheppard, Scientific Coordinator of EuroCareCF; and all the cystic fibrosis patient groups, the legal and ethics experts of EuroCareCF, and the US Cystic Fibrosis Foundation for their support.	Bellis G, 2007, J CYST FIBROS, V6, P179, DOI 10.1016/j.jcf.2006.07.001; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; Cystic Fibrosis Foundation, 2008, PAT REG ANN DAT REP; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Farrell PM, 2008, J CYST FIBROS, V7, P450, DOI 10.1016/j.jcf.2008.03.007; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Fogarty A, 2000, CHEST, V117, P1656, DOI 10.1378/chest.117.6.1656; Koch C, 1997, PEDIATR PULM, V24, P147, DOI 10.1002/(SICI)1099-0496(199708)24:2<147::AID-PPUL15>3.3.CO;2-Y; Mastella G, 2000, EUR RESPIR J, V16, P464, DOI 10.1034/j.1399-3003.2000.016003464.x; McCormick Jonathan, 2005, J Cyst Fibros, V4, P115, DOI 10.1016/j.jcf.2005.01.001; McKone EF, 2006, CHEST, V130, P1441, DOI 10.1378/chest.130.5.1441; Mehta G, 2004, J ROY SOC MED, V97, P60; O'Connor GT, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e333; OLESEN HV, EUROPEAN CYSTIC FIBR; OLESEN HV, EUROPEAN REGISTRY CY; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; Sims EJ, 2005, J PEDIATR-US, V147, P306, DOI 10.1016/j.jpeds.2005.05.034; Sims EJ, 2007, LANCET, V369, P1187, DOI 10.1016/S0140-6736(07)60565-0; Sims EJ, 2007, PEDIATRICS, V119, P19, DOI 10.1542/peds.2006-1498; STERN M, 2009, QUALITATSSICHERUNG M; STERN M, 2007, ECFS REG DEF CONS M; *UN DEP EC SOC AFF, 2008, STAT YB, P171	23	98	100	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2010	375	9719					1007	1013		10.1016/S0140-6736(09)62161-9	http://dx.doi.org/10.1016/S0140-6736(09)62161-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575YU	20304245				2022-12-24	WOS:000276110700033
J	Greenberger, S; Boscolo, E; Adini, I; Mulliken, JB; Bischoff, J				Greenberger, Shoshana; Boscolo, Elisa; Adini, Irit; Mulliken, John B.; Bischoff, Joyce			Corticosteroid Suppression of VEGF-A in Infantile Hemangioma-Derived Stem Cells.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR MALFORMATIONS; PROGENITOR CELLS; EXPRESSION; DEXAMETHASONE; APOPTOSIS; GLUCOCORTICOIDS; INHIBITION; ACTIVATION; CHILDREN	Background: Corticosteroids are commonly used to treat infantile hemangioma, but the mechanism of action of this therapy is unknown. We investigated the effect of corticosteroids in a previously described in vivo model of infantile hemangioma and in cultured hemangioma-derived cells. Methods: We tested hemangioma-derived stem cells for vasculogenic activity in vivo after implantation into immune-deficient (nude) mice. We studied dexamethasone treatment of both the cells before implantation and the mice after implantation. We also tested hemangioma-derived stem cells for expression of vascular endothelial growth factor A (VEGF-A) in vitro and studied the inhibition of VEGF-A expression, using short hairpin RNA (shRNA) in vivo and in vitro. Results: Systemic treatment with dexamethasone led to dose-dependent inhibition of tumor vasculogenesis in the murine model. Pretreatment of hemangioma-derived stem cells in vitro before implantation also inhibited vasculogenesis. Dexamethasone suppressed VEGF-A production by hemangioma-derived stem cells in vitro but not by hemangioma-derived endothelial cells or human umbilical-vein endothelial cells. Silencing VEGF-A in hemangioma-derived stem cells reduced vasculogenesis in vivo. VEGF-A was detected in hemangioma specimens in the proliferating phase but not in the involuting phase and was shown by immunostaining to reside outside of vessels. Corticosteroid treatment suppressed other proangiogenic factors in hemangioma-derived stem cells, including urokinase plasminogen activator receptor, interleukin-6, monocyte chemoattractant protein 1, and matrix metalloproteinase 1. Conclusions: In a murine model, dexamethasone inhibited the vasculogenic potential of stem cells derived from human infantile hemangioma. The corticosteroid also inhibited the expression of VEGF-A by hemangioma-derived stem cells, and silencing of VEGF-A expression in these cells inhibited vasculogenesis in vivo. N Engl J Med 2010;362:1005-13.	[Bischoff, Joyce] Harvard Univ, Vasc Biol Program, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA; [Greenberger, Shoshana; Boscolo, Elisa; Adini, Irit; Bischoff, Joyce] Childrens Hosp Boston, Dept Surg, Boston, MA 02115 USA; [Mulliken, John B.] Childrens Hosp Boston, Dept Plast Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Bischoff, J (corresponding author), Harvard Univ, Vasc Biol Program, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA.	joyce.bischoff@childrens.harvard.edu	Boscolo, Elisa/F-9483-2019; BISCHOFF, JOYCE/K-3354-2019	Boscolo, Elisa/0000-0002-6996-0419; BISCHOFF, JOYCE/0000-0002-6367-1974	National Institutes of Health [P01-AR48564, R01-HL096384]; Translational Research Program at Children's Hospital Boston; Harvard Skin Diseases Pilot Study Grant; Sheba Medical Center, Israel; John Butler Mulliken Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR048564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Translational Research Program at Children's Hospital Boston; Harvard Skin Diseases Pilot Study Grant; Sheba Medical Center, Israel; John Butler Mulliken Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by the National Institutes of Health (P01-AR48564 and R01-HL096384); the Translational Research Program at Children's Hospital Boston; a Harvard Skin Diseases Pilot Study Grant (to Dr. Greenberger); the Talpiot Medical Leadership Program, Sheba Medical Center, Israel (to Dr. Greenberger); and the John Butler Mulliken Foundation.	Boye E, 2001, J CLIN INVEST, V107, P745, DOI 10.1172/JCI11432; Chang J, 1999, PLAST RECONSTR SURG, V103, P1, DOI 10.1097/00006534-199901000-00001; Cifone MG, 1999, BLOOD, V93, P2282, DOI 10.1182/blood.V93.7.2282.407a23_2282_2296; Claesson-Welsh L, 2008, NAT MED, V14, P1147, DOI 10.1038/nm1108-1147; Drolet BA, 1999, NEW ENGL J MED, V341, P173, DOI 10.1056/NEJM199907153410307; Drolet BA, 2008, J PEDIATR, V153, P712, DOI 10.1016/j.jpeds.2008.05.043; EDGERTON MT, 1976, ANN SURG, V183, P517, DOI 10.1097/00000658-197605000-00009; Enjolras O, 1997, Adv Dermatol, V13, P375; GAILLARD RC, 1985, J CLIN ENDOCR METAB, V61, P1009, DOI 10.1210/jcem-61-6-1009; Hasan Q, 2003, CLIN EXP PHARMACOL P, V30, P140, DOI 10.1046/j.1440-1681.2003.03815.x; Hata Y, 2008, BRIT J OPHTHALMOL, V92, P1540, DOI 10.1136/bjo.2008.141002; Isik FF, 1996, J SURG RES, V61, P71, DOI 10.1006/jsre.1996.0083; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Khan ZA, 2008, J CLIN INVEST, V118, P2592, DOI 10.1172/JCI33493; Khan ZA, 2006, BLOOD, V108, P915, DOI 10.1182/blood-2006-03-006478; Kleinman ME, 2007, ARTERIOSCL THROM VAS, V27, P2664, DOI 10.1161/ATVBAHA.107.150284; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002; Mulliken JB, 2000, CURR PROB SURG, V37, P521; Nauck M, 1998, EUR J PHARMACOL, V341, P309, DOI 10.1016/S0014-2999(97)01464-7; Oh HY, 2006, CELL DEATH DIFFER, V13, P512, DOI 10.1038/sj.cdd.4401771; Ritter MR, 2002, P NATL ACAD SCI USA, V99, P7455, DOI 10.1073/pnas.102185799; Short SM, 2005, J CELL BIOL, V169, P541, DOI 10.1083/jcb.200407060042805c; Short SM, 2005, J CELL BIOL, V168, P643, DOI 10.1083/jcb.200407060; SMOLLER BR, 1993, J CUTAN PATHOL, V20, P330, DOI 10.1111/j.1600-0560.1993.tb01271.x; TAKAHASHI K, 1994, J CLIN INVEST, V93, P2357, DOI 10.1172/JCI117241; Wilson C, 2008, BRIT J CANCER, V99, P2054, DOI 10.1038/sj.bjc.6604804; Wu WS, 2006, J INVEST DERMATOL, V126, P1264, DOI 10.1038/sj.jid.5700274; Yamamoto M, 1998, HEPATOLOGY, V27, P959, DOI 10.1002/hep.510270410; Yu Y, 2004, BLOOD, V103, P1373, DOI 10.1182/blood-2003-08-2859; Yu Y, 2001, AM J PATHOL, V159, P2271, DOI 10.1016/S0002-9440(10)63077-5; ZACHARCHUK CM, 1990, J IMMUNOL, V145, P4037; Zhang L, 2005, PLAST RECONSTR SURG, V116, P200, DOI 10.1097/01.PRS.0000170804.80834.5F; Zins K, 2007, CANCER RES, V67, P1038, DOI 10.1158/0008-5472.CAN-06-2295	34	173	193	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11					1005	1013		10.1056/NEJMoa0903036	http://dx.doi.org/10.1056/NEJMoa0903036			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570CY	20237346	Green Accepted, Bronze			2022-12-24	WOS:000275650400011
J	Hui, D; Elsayem, A; De La Cruz, M; Berger, A; Zhukovsky, DS; Palla, S; Evans, A; Fadul, N; Palmer, JL; Bruera, E				Hui, David; Elsayem, Ahmed; De La Cruz, Maxine; Berger, Ann; Zhukovsky, Donna S.; Palla, Shana; Evans, Avery; Fadul, Nada; Palmer, J. Lynn; Bruera, Eduardo			Availability and Integration of Palliative Care at US Cancer Centers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; SUPPORTIVE CARE; MEDICAL-CARE; DATA-BASE; LIFE; ONCOLOGY; QUALITY; END; HOSPITALS; SOCIETY	Context The current state of palliative care in cancer centers is not known. Objectives To determine the availability and degree of integration of palliative care services and to compare between National Cancer Institute (NCI) and non-NCI cancer centers in the United States. Design, Setting, and Participants A survey of 71 NCI-designated cancer centers and a random sample of 71 non-NCI cancer centers of both executives and palliative care clinical program leaders, where applicable, regarding their palliative care services between June and October 2009. Survey questions were generated after a comprehensive literature search, review of guidelines from the National Quality Forum, and discussions among 7 physicians with research interest in palliative oncology. Executives were also asked about their attitudes toward palliative care. Main Outcome Measure Availability of palliative care services in the cancer center, defined as the presence of at least 1 palliative care physician. Results A total of 142 and 120 surveys were sent to executives and program leaders, with response rates of 71% and 82%, respectively. National Cancer Institute cancer centers were significantly more likely to have a palliative care program (50/51 [98%] vs 39/50 [78%]; P=.002), at least 1 palliative care physician (46/50 [92%] vs 28/38 [74%]; P=.04), an inpatient palliative care consultation team (47/51 [92%] vs 28/50 [56%]; P<.001), and an outpatient palliative care clinic (30/51 [59%] vs 11/50 [22%]; P<.001). Few centers had dedicated palliative care beds (23/101 [23%]) or an institution-operated hospice (37/101 [37%]). The median (interquartile range) reported durations from referral to death were 7 (4-16), 7 (5-10), and 90 (30-120) days for inpatient consultation teams, inpatient units, and outpatient clinics, respectively. Research programs, palliative care fellowships, and mandatory rotations for oncology fellows were uncommon. Executives were supportive of stronger integration and increasing palliative care resources. Conclusion Most cancer centers reported a palliative care program, although the scope of services and the degree of integration varied widely. JAMA. 2010; 303(11): 1054-1061	[Hui, David; Elsayem, Ahmed; De La Cruz, Maxine; Zhukovsky, Donna S.; Evans, Avery; Fadul, Nada; Bruera, Eduardo] Univ Texas MD Anderson Canc Ctr, Dept Palliat Care & Rehabil Med, Houston, TX 77030 USA; [Palla, Shana; Palmer, J. Lynn] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Berger, Ann] NCI, Dept Palliat Care, Ctr Clin Canc, Bethesda, MD 20892 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Elsayem, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Palliat Care & Rehabil Med, Unit 1414,1515 Holcombe Blvd, Houston, TX 77030 USA.	aelsayem@mdanderson.org	Bruera, Eduardo/AAA-1550-2022		National Institutes of Health [RO1NR010162-01A1, RO1CA122292-01, RO1CA124481-01]; National Cancer Institute [CA16672]; Royal College of Physicians and Surgeons of Canada; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA124481, R01CA122292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010162] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL000785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Royal College of Physicians and Surgeons of Canada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); CLINICAL CENTER	Funding/Support: This work was supported in part by grants RO1NR010162-01A1, RO1CA122292-01, and RO1CA124481-01 from the National Institutes of Health (Dr Bruera); grant CA16672 from the National Cancer Institute (Patient- Reported Outcomes, Survey and Population Research Shared Resources); and the Clinician Investigator Program, Royal College of Physicians and Surgeons of Canada (Dr Hui).	[Anonymous], 2006, NAT FRAM PREF PRACT; Baker JN, 2008, PEDIATR CLIN N AM, V55, P223, DOI 10.1016/j.pcl.2007.10.011; Bilimoria KY, 2008, ANN SURG ONCOL, V15, P683, DOI 10.1245/s10434-007-9747-3; Bilimoria KY, 2009, J CLIN ONCOL, V27, P4177, DOI 10.1200/JCO.2008.21.7018; Billings J A, 2001, J Palliat Med, V4, P309, DOI 10.1089/109662101753123913; Byock I, 2000, CA-CANCER J CLIN, V50, P123, DOI 10.3322/canjclin.50.2.123; Cheng Wen-Wu, 2005, J Palliat Med, V8, P1025, DOI 10.1089/jpm.2005.8.1025; Cherny NI, 2003, CANCER-AM CANCER SOC, V98, P2502, DOI 10.1002/cncr.11815; COLUZZI PH, 1995, J CLIN ONCOL, V13, P756, DOI 10.1200/JCO.1995.13.3.756; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; El Osta B, 2008, J PALLIAT MED, V11, P51, DOI 10.1089/jpm.2007.0103; Elsayem A, 2004, J CLIN ONCOL, V22, P2008, DOI 10.1200/JCO.2004.11.003; Ferrell B, 2008, J CLIN ONCOL, V26, P3824, DOI 10.1200/JCO.2007.15.7552; Ferris FD, 2009, J CLIN ONCOL, V27, P3052, DOI 10.1200/JCO.2008.20.1558; Goldsmith B, 2008, J PALLIAT MED, V11, P1094, DOI 10.1089/jpm.2008.0053; Higginson IJ, 2003, J PAIN SYMPTOM MANAG, V25, P150, DOI 10.1016/S0885-3924(02)00599-7; Hui D, 2010, J PALLIAT MED, V13, P49, DOI 10.1089/jpm.2009.0166; INGHAM J, 1998, PRINCIPLES PRACTICE, P749; *IOM NAT CANC POL, 2001, IMPR PALL CAR CANC; Johnson CE, 2008, PALLIATIVE MED, V22, P51, DOI 10.1177/0269216307085181; Lagman R, 2005, SEMIN ONCOL, V32, P134, DOI 10.1053/j.seminoncol.2004.11.015; LENEXA KS, 2009, STANDARD DEFINITIONS; Levy MH, 2009, J NATL COMPR CANC NE, V7, P436, DOI 10.6004/jnccn.2009.0031; Meyers FJ, 2004, J PAIN SYMPTOM MANAG, V28, P548, DOI 10.1016/j.jpainsymman.2004.03.002; Meyers FJ, 2003, J CLIN ONCOL, V21, P1412, DOI 10.1200/JCO.2003.01.104; Morita T, 2005, J CLIN ONCOL, V23, P2637, DOI 10.1200/JCO.2005.12.107; Morrison RS, 2005, J PALLIAT MED, V8, P1127, DOI 10.1089/jpm.2005.8.1127; Pan C X, 2001, J Palliat Med, V4, P315, DOI 10.1089/109662101753123922; Schnipper L, 1998, J CLIN ONCOL, V16, P1986; Temel JS, 2007, J CLIN ONCOL, V25, P2377, DOI 10.1200/JCO.2006.09.2627; World Health Organization, 2002, NAT CANC CONTR PROGR, V2nd, P83; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	33	349	353	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1054	1061		10.1001/jama.2010.258	http://dx.doi.org/10.1001/jama.2010.258			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233823	Green Accepted			2022-12-24	WOS:000275594100018
J	Nestle, M				Nestle, Marion			Health Care Reform in Action -- Calorie Labeling Goes National.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, Dept Nutr Food Studies & Publ Hlth, New York, NY 10012 USA	New York University	Nestle, M (corresponding author), NYU, Dept Nutr Food Studies & Publ Hlth, New York, NY 10012 USA.							Center for Science in the Public Interest, 2003, AN GUESS NEED NUTR L; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; Farley TA, 2009, HEALTH AFFAIR, V28, pW1098, DOI 10.1377/hlthaff.28.6.w1098; Larson N, 2009, MENU LABELING DOES P; Urban LE, 2010, J AM DIET ASSOC, V110, P116, DOI 10.1016/j.jada.2009.10.003	5	34	34	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2010	362	25					2343	2345		10.1056/NEJMp1003814	http://dx.doi.org/10.1056/NEJMp1003814			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614GO	20375399				2022-12-24	WOS:000279043800002
J	Asselin-Labat, ML; Vaillant, F; Sheridan, JM; Pal, B; Wu, D; Simpson, ER; Yasuda, H; Smyth, GK; Martin, TJ; Lindeman, GJ; Visvader, JE				Asselin-Labat, Marie-Liesse; Vaillant, Francois; Sheridan, Julie M.; Pal, Bhupinder; Wu, Di; Simpson, Evan R.; Yasuda, Hisataka; Smyth, Gordon K.; Martin, T. John; Lindeman, Geoffrey J.; Visvader, Jane E.			Control of mammary stem cell function by steroid hormone signalling	NATURE			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; PROGESTERONE-RECEPTOR; GLAND MORPHOGENESIS; MICE LACKING; PROLIFERATION; LIGAND; RISK; DIFFERENTIATION; ACTIVATOR	The ovarian hormones oestrogen and progesterone profoundly influence breast cancer risk(1-3), underpinning the benefit of endocrine therapies in the treatment of breast cancer(4). Modulation of their effects through ovarian ablation or chemoprevention strategies also significantly decreases breast cancer incidence(5,6). Conversely, there is an increased risk of breast cancer associated with pregnancy in the short term(7). The cellular mechanisms underlying these observations, however, are poorly defined. Here we demonstrate that mouse mammary stem cells (MaSCs)(8,9) are highly responsive to steroid hormone signalling, despite lacking the oestrogen and progesterone receptors(10). Ovariectomy markedly diminished MaSC number and outgrowth potential in vivo, whereas MaSC activity increased in mice treated with oestrogen plus progesterone. Notably, even three weeks of treatment with the aromatase inhibitor letrozole was sufficient to reduce the MaSC pool. In contrast, pregnancy led to a transient 11-fold increase in MaSC numbers, probably mediated through paracrine signalling from RANK ligand. The augmented MaSC pool indicates a cellular basis for the short-term increase in breast cancer incidence that accompanies pregnancy. These findings further indicate that breast cancer chemoprevention may be achieved, in part, through suppression of MaSC function.	[Asselin-Labat, Marie-Liesse; Vaillant, Francois; Sheridan, Julie M.; Pal, Bhupinder; Wu, Di; Smyth, Gordon K.; Lindeman, Geoffrey J.; Visvader, Jane E.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Wu, Di; Smyth, Gordon K.; Visvader, Jane E.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Simpson, Evan R.] Monash Med Ctr, Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia; [Yasuda, Hisataka] Oriental Yeast Co, Nagahama Inst Biochem Sci, Shiga 5260804, Japan; [Martin, T. John] St Vincents Inst, Fitzroy, Vic 3065, Australia; [Lindeman, Geoffrey J.] Royal Melbourne Hosp, Dept Med Oncol, Parkville, Vic 3050, Australia; [Lindeman, Geoffrey J.] Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne; Monash University; Prince Henry's Institute of Medical Research; Oriental Yeast Co., Ltd.; St. Vincent's Institute of Medical Research; Royal Melbourne Hospital; University of Melbourne	Lindeman, GJ (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	lindeman@wehi.edu.au; visvader@wehi.edu.au	Pal, Bhupinder/AAF-4011-2020; Smyth, Gordon/B-5276-2008; Wu, Di/AAB-7566-2021	Smyth, Gordon/0000-0001-9221-2892; Wu, Di/0000-0001-8331-2357; Pal, Bhupinder/0000-0002-3684-4331; Sheridan, Julie/0000-0002-1478-3662; Lindeman, Geoffrey/0000-0001-9386-2416	Australian Research Council; Victorian Breast Cancer Research Consortium; National Health and Medical Research Council (Australia); Susan G. Komen Foundation; National Breast Cancer Foundation; Australian Cancer Research Foundation	Australian Research Council(Australian Research Council); Victorian Breast Cancer Research Consortium; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); National Breast Cancer Foundation; Australian Cancer Research Foundation	We are grateful to A. Morcom and T. Ward for technical assistance, T. Bouras for advice, S. Mihajlovic for histology and F. Battye for FACS support. We thank C. Clarke for providing the hPRa7 antibody, A. Burgess for AG1478, A. Parlow for prolactin, and the Australian Genome Research Facility for RNA bioanalyses. M.-L. A.-L. is supported by an Australian Research Council Postdoctoral Fellowship. This work was supported by the Victorian Breast Cancer Research Consortium (J.E.V. and G.J.L.), the National Health and Medical Research Council (Australia), the Susan G. Komen Foundation, the National Breast Cancer Foundation and the Australian Cancer Research Foundation.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Anderson E, 2004, J MAMMARY GLAND BIOL, V9, P3, DOI 10.1023/B:JOMG.0000023584.01750.16; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fernandez-Valdivia R, 2008, ENDOCRINOLOGY, V149, P6236, DOI 10.1210/en.2008-0768; Fernandez-Valdivia R, 2009, DEV BIOL, V328, P127, DOI 10.1016/j.ydbio.2009.01.019; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez-Suarez E, 2007, MOL CELL BIOL, V27, P1442, DOI 10.1128/MCB.01298-06; Hankinson SE, 2004, BREAST CANCER RES, V6, P213, DOI 10.1186/bcr921; Howell A, 2008, BEST PRACT RES CL EN, V22, P615, DOI 10.1016/j.beem.2008.09.002; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Kim NS, 2006, MOL CELL BIOL, V26, P1002, DOI 10.1128/MCB.26.3.1002-1013.2006; LAMBE M, 1994, NEW ENGL J MED, V331, P5, DOI 10.1056/NEJM199407073310102; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Lydon JP, 2000, J MAMMARY GLAND BIOL, V5, P325, DOI 10.1023/A:1009555013246; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Mueller SO, 2002, ENDOCRINOLOGY, V143, P2357, DOI 10.1210/en.143.6.2357; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; Parker WH, 2009, OBSTET GYNECOL, V113, P1027, DOI 10.1097/AOG.0b013e3181a11c64; PIKE MC, 1993, EPIDEMIOL REV, V15, P17, DOI 10.1093/oxfordjournals.epirev.a036102; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Srivastava S, 2003, J BIOL CHEM, V278, P46171, DOI 10.1074/jbc.M308545200; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Visvanathan K, 2009, J CLIN ONCOL, V27, P3235, DOI 10.1200/JCO.2008.20.5179; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6	37	513	530	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					798	802		10.1038/nature09027	http://dx.doi.org/10.1038/nature09027			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20383121				2022-12-24	WOS:000278551800049
J	MacLennan, CA; Gilchrist, JJ; Gordon, MA; Cunningham, AF; Cobbold, M; Goodall, M; Kingsley, RA; van Oosterhout, JJG; Msefula, CL; Mandala, WL; Leyton, DL; Marshall, JL; Gondwe, EN; Bobat, S; Lopez-Macias, C; Doffinger, R; Henderson, IR; Zijlstra, EE; Dougan, G; Drayson, MT; MacLennan, ICM; Molyneux, ME				MacLennan, Calman A.; Gilchrist, James J.; Gordon, Melita A.; Cunningham, Adam F.; Cobbold, Mark; Goodall, Margaret; Kingsley, Robert A.; van Oosterhout, Joep J. G.; Msefula, Chisomo L.; Mandala, Wilson L.; Leyton, Denisse L.; Marshall, Jennifer L.; Gondwe, Esther N.; Bobat, Saeeda; Lopez-Macias, Constantino; Doffinger, Rainer; Henderson, Ian R.; Zijlstra, Eduard E.; Dougan, Gordon; Drayson, Mark T.; MacLennan, Ian C. M.; Molyneux, Malcolm E.			Dysregulated Humoral Immunity to Nontyphoidal Salmonella in HIV-Infected African Adults	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; PNEUMOCOCCAL VACCINATION; AIDS PATIENTS; BACTEREMIA; TYPHIMURIUM; ACTIVATION; ANTIBODIES; RESISTANCE; CHILDREN; KEY	Nontyphoidal Salmonellae are a major cause of life-threatening bacteremia among HIV-infected individuals. Although cell-mediated immunity controls intracellular infection, antibodies protect against Salmonella bacteremia. We report that high-titer antibodies specific for Salmonella lipopolysaccharide (LPS) are associated with a lack of Salmonella-killing in HIV-infected African adults. Killing was restored by genetically shortening LPS from the target Salmonella or removing LPS-specific antibodies from serum. Complement-mediated killing of Salmonella by healthy serum is shown to be induced specifically by antibodies against outer membrane proteins. This killing is lost when excess antibody against Salmonella LPS is added. Thus, our study indicates that impaired immunity against nontyphoidal Salmonella bacteremia in HIV infection results from excess inhibitory antibodies against Salmonella LPS, whereas serum killing of Salmonella is induced by antibodies against outer membrane proteins.	[MacLennan, Calman A.; Gilchrist, James J.; Cunningham, Adam F.; Cobbold, Mark; Goodall, Margaret; Marshall, Jennifer L.; Gondwe, Esther N.; Bobat, Saeeda; Drayson, Mark T.; MacLennan, Ian C. M.] Univ Birmingham, MRC, Ctr Immune Regulat & Clin Immunol Serv, Inst Biomed Res,Sch Immun & Infect, Birmingham, W Midlands, England; [MacLennan, Calman A.; Gilchrist, James J.; Gordon, Melita A.; van Oosterhout, Joep J. G.; Msefula, Chisomo L.; Mandala, Wilson L.; Gondwe, Esther N.; Molyneux, Malcolm E.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Program, Blantyre, Malawi; [MacLennan, Calman A.] Univ Liverpool, Div Med Microbiol, Liverpool L69 3BX, Merseyside, England; [MacLennan, Calman A.; Msefula, Chisomo L.] Univ Malawi, Coll Med, Dept Microbiol, Blantyre, Malawi; [Gilchrist, James J.] Univ Oxford, John Radcliffe Hosp, Div Med Sci, Clin Acad Grad Sch, Oxford OX3 9DU, England; [Gordon, Melita A.] Univ Liverpool, Gastroenterol Unit, Liverpool L69 3BX, Merseyside, England; [Gordon, Melita A.; van Oosterhout, Joep J. G.; Zijlstra, Eduard E.; Molyneux, Malcolm E.] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [Kingsley, Robert A.; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England; [Msefula, Chisomo L.; Mandala, Wilson L.; Gondwe, Esther N.; Molyneux, Malcolm E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Mandala, Wilson L.] Univ Malawi, Coll Med, Dept Biochem, Blantyre, Malawi; [Leyton, Denisse L.; Henderson, Ian R.] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England; [Lopez-Macias, Constantino] Specialties Hosp, Natl Med Ctr Siglo XXI, Mexican Inst Social Secur, Med Res Unit Immunochem, Mexico City, DF, Mexico; [Doffinger, Rainer] Addenbrookes Hosp, Dept Clin Biochem & Immunol, Cambridge, England	University of Birmingham; University of Malawi; University of Liverpool; University of Malawi; University of Oxford; University of Liverpool; University of Malawi; Wellcome Trust Sanger Institute; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of Birmingham; Instituto Mexicano del Seguro Social; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	MacLennan, CA (corresponding author), Univ Birmingham, MRC, Ctr Immune Regulat & Clin Immunol Serv, Inst Biomed Res,Sch Immun & Infect, Birmingham, W Midlands, England.	c.maclennan@bham.ac.uk	Henderson, Ian/AAD-5369-2019; Msefula, Chisomo/AAY-9107-2020; Leyton, Denisse L/A-6915-2015; MacLennan, Calman A/L-9343-2014; López Macías, Constatino III Roberto/ABG-3414-2021; Gordon, Melita/F-5563-2012	Leyton, Denisse L/0000-0003-4808-9289; MacLennan, Calman A/0000-0001-9694-0846; López Macías, Constatino III Roberto/0000-0003-0530-492X; Lopez-Macias, Constantino III Roberto/0000-0002-7756-8468; Gilchrist, James J/0000-0003-2045-6788; Gordon, Melita/0000-0002-0629-0884; Drayson, Mark/0000-0002-1528-7564; Mandala, Wilson/0000-0001-9386-9239; Henderson, Ian/0000-0002-9954-4977; Cunningham, Adam/0000-0003-0248-964X; Marshall, Jennifer/0000-0002-1727-8290; Msefula, Chisomo/0000-0003-2304-886X; Kingsley, Robert/0000-0002-0194-6485	GlaxoSmithKline; Wellcome Trust; University of Birmingham; Medical Research Council, UK; UK Biotechnology and Biological Sciences Research Council, UK; National Institute for Health Research Cambridge Biomedical Research Center; National Council for Science and Technology (CONACyT) Mexico [SALUD-2007-C01-69779]; BBSRC [BB/F022778/1] Funding Source: UKRI; MRC [G8402371, G0701275, G9818340, G108/574] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F022778/1] Funding Source: researchfish; Medical Research Council [G108/574, G8402371, G9818340, G9818340B, G0701275] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); Wellcome Trust(Wellcome TrustEuropean Commission); University of Birmingham; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research Cambridge Biomedical Research Center(National Institute for Health Research (NIHR)); National Council for Science and Technology (CONACyT) Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the individuals who participated in this study and the staff at the Malawi-Liverpool-Wellcome Trust Clinical Research Programme and Queen Elizabeth Central Hospital, Blantyre, Malawi, for their support. We are grateful to T. Plant, K. Stephens, A. Seeley, and the Clinical Immunology Service, Birmingham, UK, for technical assistance and to F. Gotch and P. Kelleher for helpful discussions. This work was supported by a Clinical Research Fellowship from GlaxoSmithKline (C. A. M.); Tropical Research Fellowships from the Wellcome Trust (C. A. M. and M. A. G.); a Programme Grant from the Wellcome Trust (M. E. M.); a Scientific Projects Committee Research Grant from the University of Birmingham (C. A. M.); the Medical Research Council and UK Biotechnology and Biological Sciences Research Council, UK (A. F. C., D. L. L., and I. R. H.); National Institute for Health Research Cambridge Biomedical Research Center (R. D.); and the National Council for Science and Technology (CONACyT) Mexico, grant number SALUD-2007-C01-69779 (C. L.-M.).	ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; AMMANN AJ, 1984, JAMA-J AM MED ASSOC, V251, P1447, DOI 10.1001/jama.251.11.1447; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; BLANDEN RV, 1966, J EXP MED, V124, P585, DOI 10.1084/jem.124.4.585; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Bustarnante J, 2008, CURR OPIN IMMUNOL, V20, P39, DOI 10.1016/j.coi.2007.10.005; CHART H, 1994, METHODS PRACTICAL LA, P11; CLUMECK N, 1983, LANCET, V1, P642; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Fierer J, 2001, J CLIN INVEST, V107, P775, DOI 10.1172/JCI12561; French N, 1998, AIDS, V12, P1683, DOI 10.1097/00002030-199813000-00017; Gil-Cruz C, 2009, P NATL ACAD SCI USA, V106, P9803, DOI 10.1073/pnas.0812431106; Gilks CF, 1998, BRIT MED BULL, V54, P383, DOI 10.1093/oxfordjournals.bmb.a011695; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; GRANT MD, 1990, J IMMUNOL, V144, P1241; GRUENEWALD R, 1994, CLIN INFECT DIS, V18, P358, DOI 10.1093/clinids/18.3.358; Huber M, 2006, EUR J IMMUNOL, V36, P701, DOI 10.1002/eji.200535593; JACOBS JL, 1985, ANN INTERN MED, V102, P186, DOI 10.7326/0003-4819-102-2-186; JOINER KA, 1982, J EXP MED, V155, P809, DOI 10.1084/jem.155.3.809; Kassa-Kelembho E, 2003, ACTA TROP, V89, P67, DOI 10.1016/j.actatropica.2003.09.004; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; LEVINE WC, 1991, J INFECT DIS, V164, P81, DOI 10.1093/infdis/164.1.81; MacLennan C, 2004, J INFECT DIS, V190, P1755, DOI 10.1086/425021; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; NORMANN B, 1972, ACTA PATH MICRO IM B, VB 80, P891; OPRAVIL M, 1991, CLIN EXP IMMUNOL, V84, P185, DOI 10.1111/j.1365-2249.1991.tb08146.x; SHIRAI A, 1992, J CLIN INVEST, V89, P561, DOI 10.1172/JCI115621; Tejiokem MC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001260; VUGIA DJ, 1993, J INFECT DIS, V168, P564, DOI 10.1093/infdis/168.3.564	33	122	122	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2010	328	5977					508	512		10.1126/science.1180346	http://dx.doi.org/10.1126/science.1180346			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413503	Green Accepted			2022-12-24	WOS:000276952400045
J	Rogelj, J; Nabel, J; Chen, C; Hare, W; Markmann, K; Meinshausen, M; Schaeffer, M; Macey, K; Hohne, N				Rogelj, Joeri; Nabel, Julia; Chen, Claudine; Hare, William; Markmann, Kathleen; Meinshausen, Malte; Schaeffer, Michiel; Macey, Kirsten; Hoehne, Niklas			Copenhagen Accord pledges are paltry	NATURE			English	Editorial Material									[Rogelj, Joeri; Nabel, Julia; Chen, Claudine; Hare, William; Markmann, Kathleen; Meinshausen, Malte] Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany; [Schaeffer, Michiel; Macey, Kirsten] Climate Analyt, D-14467 Potsdam, Germany; [Hoehne, Niklas] Ecofys, D-50829 Cologne, Germany	Potsdam Institut fur Klimafolgenforschung	Rogelj, J (corresponding author), Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany.	malte.meinshausen@pik-potsdam.de	Höhne, Niklas/AAZ-2422-2020; Meinshausen, Malte/A-7037-2011; Hare, Bill/A-8527-2013; Meinshausen, Malte/AAG-6505-2019; Höhne, Niklas/L-8971-2013; Rogelj, Joeri/I-7108-2012	Höhne, Niklas/0000-0001-9246-8759; Meinshausen, Malte/0000-0003-4048-3521; Hare, Bill/0000-0003-1242-8250; Meinshausen, Malte/0000-0003-4048-3521; Rogelj, Joeri/0000-0003-2056-9061				Bowen A., 2009, MITIGATING CLIMATE C; Houghton R. A, 2008, TRENDS COMPENDIUM DA; ICAO, 2009, HIGH LEV M INT AV CL; *ICS, 2009, SHIPP WORLD TRAD RED; LEVIN K, 2010, COMP ANNEX I EMISSIO; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; *POTSD I CLIM IMP, 2009, PRIMAP4 BAS REF; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Stern N., 2009, DECIDING OUR FUTURE; UNEP, 2010, CLOS AR WE 2 DEGR LI	10	151	152	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2010	464	7292					1126	1128		10.1038/4641126a	http://dx.doi.org/10.1038/4641126a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586FR	20414291				2022-12-24	WOS:000276891100016
J	Lamont, T; Watts, F; Stanley, J; Scarpello, J; Panesar, S				Lamont, Tara; Watts, Frances; Stanley, John; Scarpello, John; Panesar, Sukhmeet			Safety Alerts Reducing risks of tourniquets left on after finger and toe surgery: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lamont, Tara; Watts, Frances; Scarpello, John; Panesar, Sukhmeet] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England; [Stanley, John] Wrightington Hosp Upper Limb Unit, Wigan WN6 9EP, England		Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk						de Boer HL, 2007, EUR J PLAST SURG, V30, P91, DOI 10.1007/s00238-007-0144-8; Haas F, 1999, CHIRURG, V70, P608, DOI 10.1007/s001040050696; King C., 2008, TXB PEDIAT EMERGENCY; Medicines and Healthcare Products Regulatory Agency, 2010, MED DEV AL MDA 2010; Smith IM, 2002, J HAND SURG-BRIT EUR, V27B, P363, DOI 10.1054/jhsb.2002.0781; Tucker S, 2002, INJURY, V33, P76, DOI 10.1016/S0020-1383(01)00095-X	6	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2010	340								c1981	10.1136/bmj.c1981	http://dx.doi.org/10.1136/bmj.c1981			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589HN	20410165				2022-12-24	WOS:000277137900003
J	Niparko, JK; Tobey, EA; Thal, DJ; Eisenberg, LS; Wang, NY; Quittner, AL; Fink, NE				Niparko, John K.; Tobey, Emily A.; Thal, Donna J.; Eisenberg, Laurie S.; Wang, Nae-Yuh; Quittner, Alexandra L.; Fink, Nancy E.		CDaCI Investigative Team	Spoken Language Development in Children Following Cochlear Implantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRELINGUALLY DEAF-CHILDREN; CHILDHOOD DEVELOPMENT; SPEECH RECOGNITION; INFANTS; OUTCOMES; COMMUNICATION; SCHOOL; AGE	Context Cochlear implantation is a surgical alternative to traditional amplification (hearing aids) that can facilitate spoken language development in young children with severe to profound sensorineural hearing loss (SNHL). Objective To prospectively assess spoken language acquisition following cochlear implantation in young children. Design, Setting, and Participants Prospective, longitudinal, and multidimensional assessment of spoken language development over a 3-year period in children who underwent cochlear implantation before 5 years of age (n=188) from 6 US centers and hearing children of similar ages (n=97) from 2 preschools recruited between November 2002 and December 2004. Follow-up completed between November 2005 and May 2008. Main Outcome Measures Performance on measures of spoken language comprehension and expression (Reynell Developmental Language Scales). Results Children undergoing cochlear implantation showed greater improvement in spoken language performance (10.4; 95% confidence interval [CI], 9.6-11.2 points per year in comprehension; 8.4; 95% CI, 7.8-9.0 in expression) than would be predicted by their preimplantation baseline scores (5.4; 95% CI, 4.1-6.7, comprehension; 5.8; 95% CI, 4.6-7.0, expression), although mean scores were not restored to age-appropriate levels after 3 years. Younger age at cochlear implantation was associated with significantly steeper rate increases in comprehension (1.1; 95% CI, 0.5-1.7 points per year younger) and expression (1.0; 95% CI, 0.6-1.5 points per year younger). Similarly, each 1-year shorter history of hearing deficit was associated with steeper rate increases in comprehension (0.8; 95% CI, 0.2-1.2 points per year shorter) and expression (0.6; 95% CI, 0.2-1.0 points per year shorter). In multivariable analyses, greater residual hearing prior to cochlear implantation, higher ratings of parent-child interactions, and higher socioeconomic status were associated with greater rates of improvement in comprehension and expression. Conclusion The use of cochlear implants in young children was associated with better spoken language learning than would be predicted from their preimplantation scores. JAMA. 2010;303(15):1498-1506 www.jama.com	[Niparko, John K.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol, Baltimore, MD 21205 USA; [Wang, Nae-Yuh] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Tobey, Emily A.] Univ Texas Dallas, Callier Ctr Commun Disorders, Dallas, TX 75235 USA; [Thal, Donna J.] Univ Calif San Diego, Sch Speech Language & Hearing Sci, San Diego, CA 92103 USA; [Eisenberg, Laurie S.] House Ear Res Inst, Los Angeles, CA USA; [Quittner, Alexandra L.] Univ Miami, Dept Psychol, Miami, FL USA; [Niparko, John K.; Fink, Nancy E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Wang, Nae-Yuh] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Dallas; University of California System; University of California San Diego; House Research Institute; University of Miami; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Niparko, JK (corresponding author), Johns Hopkins Univ Hosp, 601 N Caroline St,JHOC-6161A, Baltimore, MD 21287 USA.	jnipark1@jhmi.edu	lee, yujun/P-6069-2014; Clark, James/AAB-5996-2021	lee, yujun/0000-0002-5821-7355; Wang, Nae-Yuh/0000-0001-6513-9730	National Institute on Deafness and Other Communication Disorders [R01 DC004797]; CityBridge Foundation; Sidgmore Family Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004797] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); CityBridge Foundation; Sidgmore Family Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The CDaCl was supported by grant R01 DC004797 from the National Institute on Deafness and Other Communication Disorders, the CityBridge Foundation, and the Sidgmore Family Foundation. Warranties on the implant devices used by children with implants in this study were discounted by 50% by the Advanced Bionics Corporation, Cochlear Corporation, and the MedEl Corporation.	Barker DH, 2009, DEV PSYCHOPATHOL, V21, P373, DOI 10.1017/S0954579409000212; Bayley N, 1993, BAYLEY SCALES INFANT; Bradham T, 2008, INT J PEDIATR OTORHI, V72, P1023, DOI 10.1016/j.ijporl.2008.03.005; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Dettman SJ, 2007, EAR HEARING, V28, p11S, DOI 10.1097/AUD.0b013e31803153f8; Eisenberg LS, 2006, AUDIOL NEURO-OTOL, V11, P259, DOI 10.1159/000093302; Estes KG, 2007, PSYCHOL SCI, V18, P254, DOI 10.1111/j.1467-9280.2007.01885.x; Fink Nancy E, 2007, Cochlear Implants Int, V8, P92, DOI 10.1002/cii.333; Francis HW, 2008, OTOL NEUROTOL, V29, P502, DOI 10.1097/MAO.0b013e318170b60b; Geers A, 2008, INT J AUDIOL, V47, pS21, DOI 10.1080/14992020802339167; Holt RF, 2008, EAR HEARING, V29, P492, DOI 10.1097/AUD.0b013e31816c409f; Kuhl PK, 2007, DEVELOPMENTAL SCI, V10, P110, DOI 10.1111/j.1467-7687.2007.00572.x; KUHL PK, 1994, CURR OPIN NEUROBIOL, V4, P812, DOI 10.1016/0959-4388(94)90128-7; Lin FR, 2008, OTOL NEUROTOL, V29, P208, DOI 10.1097/MAO.0b013e31812f6fa6; Marschark M, 2007, J DEAF STUD DEAF EDU, V12, P269, DOI 10.1093/deafed/enm013; Moeller MP, 2006, CHILD DEV, V77, P751, DOI 10.1111/j.1467-8624.2006.00901.x; Nicholas JG, 2007, J SPEECH LANG HEAR R, V50, P1048, DOI 10.1044/1092-4388(2007/073); Nikolopoulos TP, 2004, ARCH OTOLARYNGOL, V130, P629, DOI 10.1001/archotol.130.5.629; Niparko John K, 2004, JAMA, V291, P2378, DOI 10.1001/jama.291.19.2378; Quittner AL, 2004, ARCH OTOLARYNGOL, V130, P547, DOI 10.1001/archotol.130.5.547; REYNELL J, 1985, REYNELL DEV LANGUAGE; Reynell J. K., 1990, REYNELL DEV LANGUAGE; ROBBINS AM, 1991, AM J OTOL, V12, P144; Roid G.H., 2002, LEITER INT PERFORMAN; SAFFRAN JR, 1996, SCIENCE, V274, P5294; Sharma A, 2004, ARCH OTOLARYNGOL, V130, P511, DOI 10.1001/archotol.130.5.511; Spencer PE, 1996, CHILD DEV, V67, P3176, DOI 10.2307/1131773; STREETER LA, 1976, NATURE, V259, P39, DOI 10.1038/259041a0; Svirsky MA, 2000, PSYCHOL SCI, V11, P153, DOI 10.1111/1467-9280.00231; Svirsky MA, 2000, ANN OTO RHINOL LARYN, V109, P123, DOI 10.1177/0003489400109S1254; Tobey EA, 2003, EAR HEARING, V24, p36S, DOI 10.1097/01.AUD.0000051688.48224.A6; WALKER D, 1994, CHILD DEV, V65, P606, DOI 10.2307/1131404; Wang NY, 2008, OTOL NEUROTOL, V29, P240, DOI 10.1097/MAO.0b013e3181627a37; Werker JF, 2003, J PEDIATR-US, V143, pS62, DOI 10.1067/S0022-3476(03)00403-7; Zimmerman-Phillips S, 2000, ANN OTO RHINOL LARYN, V109, P42, DOI 10.1177/0003489400109S1217	35	632	658	9	162	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2010	303	15					1498	1506		10.1001/jama.2010.451	http://dx.doi.org/10.1001/jama.2010.451			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	585SJ	20407059	Green Accepted, Bronze			2022-12-24	WOS:000276849000026
J	Kaufmann, K; Wellmer, F; Muino, JM; Ferrier, T; Wuest, SE; Kumar, V; Serrano-Mislata, A; Madueno, F; Krajewski, P; Meyerowitz, EM; Angenent, GC; Riechmann, JL				Kaufmann, Kerstin; Wellmer, Frank; Muino, Jose M.; Ferrier, Thilia; Wuest, Samuel E.; Kumar, Vijaya; Serrano-Mislata, Antonio; Madueno, Francisco; Krajewski, Pawel; Meyerowitz, Elliot M.; Angenent, Gerco C.; Riechmann, Jose Luis			Orchestration of Floral Initiation by APETALA1	SCIENCE			English	Article							TRANSCRIPTION FACTORS; MERISTEM IDENTITY; FLOWERING TIME; EXPRESSION; ACTIVATION; INDUCTION; FRUITFULL; MICRORNA; PATHWAY; LEAFY	The MADS-domain transcription factor APETALA1 (AP1) is a key regulator of Arabidopsis flower development. To understand the molecular mechanisms underlying AP1 function, we identified its target genes during floral initiation using a combination of gene expression profiling and genome-wide binding studies. Many of its targets encode transcriptional regulators, including known floral repressors. The latter genes are down-regulated by AP1, suggesting that it initiates floral development by abrogating the inhibitory effects of these genes. Although AP1 acts predominantly as a transcriptional repressor during the earliest stages of flower development, at more advanced stages it also activates regulatory genes required for floral organ formation, indicating a dynamic mode of action. Our results further imply that AP1 orchestrates floral initiation by integrating growth, patterning, and hormonal pathways.	[Ferrier, Thilia; Riechmann, Jose Luis] CRAG, Barcelona 08034, Spain; [Kaufmann, Kerstin; Angenent, Gerco C.] Plant Res Int, Business Unit Biosci, NL-6700 AA Wageningen, Netherlands; [Kaufmann, Kerstin] Wageningen Univ, Mol Biol Lab, NL-6700 AP Wageningen, Netherlands; [Wellmer, Frank; Wuest, Samuel E.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Muino, Jose M.] Plant Res Int, Appl Bioinformat, NL-6700 AA Wageningen, Netherlands; [Kumar, Vijaya; Meyerowitz, Elliot M.; Riechmann, Jose Luis] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Serrano-Mislata, Antonio; Madueno, Francisco] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain; [Krajewski, Pawel] Polish Acad Sci, Inst Plant Genet, PL-60479 Poznan, Poland; [Angenent, Gerco C.] CBSG, NL-6700 AB Wageningen, Netherlands; [Riechmann, Jose Luis] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); University of Barcelona; Wageningen University & Research; Trinity College Dublin; California Institute of Technology; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; Centre for BioSystems Genomics; ICREA	Riechmann, JL (corresponding author), CRAG, Barcelona 08034, Spain.	jriechma@caltech.edu	Meyerowitz, Elliot M/A-7118-2009; Riechmann, José Luis/M-7005-2018; Kaufmann, Kerstin/A-2662-2012; Angenent, Gerco C./A-5993-2011; Kaufmann, Kerstin/GXF-3402-2022; Madueño, Francisco/L-5167-2014; Ding, Cheng-Qiang/B-6287-2011; Serrano-Mislata, Antonio/M-3254-2015	Riechmann, José Luis/0000-0003-1108-1945; Kaufmann, Kerstin/0000-0001-7960-6256; Kaufmann, Kerstin/0000-0001-7960-6256; Madueño, Francisco/0000-0001-7598-3003; Serrano-Mislata, Antonio/0000-0002-8828-1809; Wellmer, Frank/0000-0002-2095-0981; Wuest, Samuel/0000-0003-3982-0770; Muino, Jose M/0000-0002-6403-7262	Science Foundation Ireland [06/IN.1/B851]; European Union (EU) [Transistor-MRTNCT-2004-512285, IRG-224864]; NSF [2010-0520193]; Spanish Ministerio de Ciencia e Innovacion [BFU2008-04251, BIO2006-10994, BIO2009-10876]; Millard and Muriel Jacobs Laboratory at Caltech; Netherlands Proteomics Centre; CBSG; Horizon [93519020]; CRAG; ICREA Funding Source: Custom	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Union (EU)(CGIAREuropean Commission); NSF(National Science Foundation (NSF)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Millard and Muriel Jacobs Laboratory at Caltech; Netherlands Proteomics Centre; CBSG; Horizon; CRAG; ICREA(ICREA)	We are grateful to T. Mastro for help with microarray hybridizations, S. Kushnir for generating AP1 antibodies, Y. Hanzawa and D. Bradley for providing transferred DNA (T-DNA) insertion lines, and E. Graciet for help with AP1-GR detection in nuclear extracts. This work was supported by grants from Science Foundation Ireland (06/IN.1/B851 to F. W.), European Union (EU)-Marie Curie program (Transistor-MRTNCT-2004-512285 to G. C. A. and IRG-224864 to J.L.R.), NSF (2010-0520193 to J.L.R. and E. M. M.), Spanish Ministerio de Ciencia e Innovacion (BFU2008-04251 to J.L.R. and BIO2006-10994 and BIO2009-10876 to F. M.), and by the Millard and Muriel Jacobs Laboratory at Caltech. G. C. A. was also supported by the Netherlands Proteomics Centre and CBSG, which are part of the Netherlands Genomic Initiative. K. K. and J.M.M. were supported by fellowships from the EU-Marie Curie program; J.M.M. was also supported by CBSG and a Horizon grant (#93519020). T. F. was supported by a fellowship from CRAG. Microarray data have been deposited with the National Center for Biotechnology Information Gene Expression Omnibus under accession numbers GSE20184 and GSE20138 and the sequencing data under accession number GSE20176.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Achard P, 2009, CURR BIOL, V19, P1188, DOI 10.1016/j.cub.2009.05.059; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Chuck G, 2005, CURR OPIN PLANT BIOL, V8, P67, DOI 10.1016/j.pbi.2004.11.002; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Gomez-Mena C, 2005, DEVELOPMENT, V132, P429, DOI 10.1242/dev.01600; Gomez-Mena C, 2008, PLANT CELL, V20, P2059, DOI 10.1105/tpc.108.059188; Gregis V, 2008, PLANT J, V56, P891, DOI 10.1111/j.1365-313X.2008.03648.x; Gregis V, 2009, PLANT J, V60, P626, DOI 10.1111/j.1365-313X.2009.03985.x; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liljegren SJ, 1999, PLANT CELL, V11, P1007, DOI 10.1105/tpc.11.6.1007; Liu C, 2007, DEVELOPMENT, V134, P1901, DOI 10.1242/dev.003103; Liu C, 2009, DEV CELL, V16, P711, DOI 10.1016/j.devcel.2009.03.011; Longabaugh WJR, 2005, DEV BIOL, V283, P1, DOI 10.1016/j.ydbio.2005.04.023; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Ng M, 2001, PLANT CELL, V13, P739, DOI 10.1105/tpc.13.4.739; Riechmann JL, 1996, NUCLEIC ACIDS RES, V24, P3134, DOI 10.1093/nar/24.16.3134; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Sridhar VV, 2006, DEVELOPMENT, V133, P3159, DOI 10.1242/dev.02498; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wellmer F, 2006, PLOS GENET, V2, P1012, DOI 10.1371/journal.pgen.0020117; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007	28	365	387	3	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					85	89		10.1126/science.1185244	http://dx.doi.org/10.1126/science.1185244			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360106	Green Submitted			2022-12-24	WOS:000276202200040
J	Van de Veire, S; Stalmans, I; Heindryckx, F; Oura, H; Tijeras-Raballand, A; Schmidt, T; Loges, S; Albrecht, I; Jonckx, B; Vinckier, S; Van Steenkiste, C; Tugues, S; Rolny, C; De Mol, M; Dettori, D; Hainaud, P; Coenegrachts, L; Contreres, JO; Van Bergen, T; Cuervo, H; Xiao, WH; Le Henaff, C; Buysschaert, I; Masouleh, BK; Geerts, A; Schomber, T; Bonnin, P; Lambert, V; Haustraete, J; Zacchigna, S; Rakic, JM; Jimenez, W; Noel, A; Giacca, M; Colle, I; Foidart, JM; Tobelem, G; Morales-Ruiz, M; Vilar, J; Maxwell, P; Vinores, SA; Carmeliet, G; Dewerchin, M; Claesson-Welsh, L; Dupuy, E; Van Vlierberghe, H; Christofori, G; Mazzone, M; Detmar, M; Collen, D; Carmeliet, P				Van de Veire, Sara; Stalmans, Ingeborg; Heindryckx, Femke; Oura, Hajimu; Tijeras-Raballand, Annemilai; Schmidt, Thomas; Loges, Sonja; Albrecht, Imke; Jonckx, Bart; Vinckier, Stefan; Van Steenkiste, Christophe; Tugues, Sonia; Rolny, Charlotte; De Mol, Maria; Dettori, Daniela; Hainaud, Patricia; Coenegrachts, Lieve; Contreres, Jean-Olivier; Van Bergen, Tine; Cuervo, Henar; Xiao, Wei-Hong; Le Henaff, Carole; Buysschaert, Ian; Masouleh, Behzad Kharabi; Geerts, Anja; Schomber, Tibor; Bonnin, Philippe; Lambert, Vincent; Haustraete, Jurgen; Zacchigna, Serena; Rakic, Jean-Marie; Jimenez, Wladimiro; Noel, Agnes; Giacca, Mauro; Colle, Isabelle; Foidart, Jean-Michel; Tobelem, Gerard; Morales-Ruiz, Manuel; Vilar, Jose; Maxwell, Patrick; Vinores, Stanley A.; Carmeliet, Geert; Dewerchin, Mieke; Claesson-Welsh, Lena; Dupuy, Evelyne; Van Vlierberghe, Hans; Christofori, Gerhard; Mazzone, Massimiliano; Detmar, Michael; Collen, Desire; Carmeliet, Peter			Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease	CELL			English	Article							PLACENTA GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; PATHOLOGICAL CONDITIONS; MOUSE MODEL; METASTASIS; ANGIOGENESIS; MICE; PROGRESSION; HYPOXIA; LUNG	Our findings that PlGF is a cancer target and anti-PlGF is useful for anticancer treatment have been challenged by Bais et al. Here we take advantage of carcinogen-induced and transgenic tumor models as well as ocular neovascularization to report further evidence in support of our original findings of PlGF as a promising target for anticancer therapies. We present evidence for the efficacy of additional anti-PlGF antibodies and their ability to phenocopy genetic deficiency or silencing of PlGF in cancer and ocular disease but also show that not all anti-PlGF antibodies are effective. We also provide additional evidence for the specificity of our anti-PlGF antibody and experiments to suggest that anti-PlGF treatment will not be effective for all tumors and why. Further, we show that PlGF blockage inhibits vessel abnormalization rather than density in certain tumors while enhancing VEGF-targeted inhibition in ocular disease. Our findings warrant further testing of anti-PlGF therapies.	[Van de Veire, Sara; Schmidt, Thomas; Loges, Sonja; Vinckier, Stefan; De Mol, Maria; Dettori, Daniela; Cuervo, Henar; Buysschaert, Ian; Masouleh, Behzad Kharabi; Vinores, Stanley A.; Dewerchin, Mieke; Mazzone, Massimiliano; Carmeliet, Peter] Katholieke Univ Leuven, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Van de Veire, Sara; Schmidt, Thomas; Loges, Sonja; Jonckx, Bart; Vinckier, Stefan; De Mol, Maria; Dettori, Daniela; Cuervo, Henar; Buysschaert, Ian; Masouleh, Behzad Kharabi; Vinores, Stanley A.; Dewerchin, Mieke; Mazzone, Massimiliano; Collen, Desire; Carmeliet, Peter] VIB, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Van de Veire, Sara; Stalmans, Ingeborg; Van Bergen, Tine] Katholieke Univ Leuven, Lab Ophthalmol, B-3000 Louvain, Belgium; [Heindryckx, Femke; Van Steenkiste, Christophe; Geerts, Anja; Colle, Isabelle; Van Vlierberghe, Hans] Ghent Univ Hosp, Dept Gastroenterol & Hepatol, B-9000 Ghent, Belgium; [Oura, Hajimu; Detmar, Michael] ETH, Inst Pharmaceut Sci, CH-8057 Zurich, Switzerland; [Tijeras-Raballand, Annemilai; Hainaud, Patricia; Contreres, Jean-Olivier; Le Henaff, Carole; Bonnin, Philippe; Tobelem, Gerard; Dupuy, Evelyne] INSERM, U965, Inst Vaisseaux & Sang Angiogenese & Rech Translat, Paris, France; [Albrecht, Imke; Schomber, Tibor; Christofori, Gerhard] Univ Basel, Inst Biochem & Genet, CH-4051 Basel, Switzerland; [Tugues, Sonia; Jimenez, Wladimiro; Morales-Ruiz, Manuel] Univ Barcelona, Biochem & Mol Genet Serv, IDIBAPS, Hosp Clin Barcelona,CIBEREHD, E-08036 Barcelona, Spain; [Tugues, Sonia; Rolny, Charlotte; Claesson-Welsh, Lena] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden; [Coenegrachts, Lieve; Carmeliet, Geert] Katholieke Univ Leuven, Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium; [Xiao, Wei-Hong; Vinores, Stanley A.] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA; [Lambert, Vincent; Rakic, Jean-Marie; Noel, Agnes; Foidart, Jean-Michel] Univ Liege, Lab Tumour & Dev Biol, GIGA Canc, B-4000 Liege, Belgium; [Haustraete, Jurgen] VIB, Prot Serv Facil, B-9052 Ghent, Belgium; [Zacchigna, Serena; Giacca, Mauro] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy; [Jimenez, Wladimiro] Univ Barcelona, Dept Physiol, Barcelona 08036, Spain; [Vilar, Jose] Univ Paris 05, INSERM, U970, Hop Europeen Georges Pompidou,Cardiovasc Res Ctr, F-75270 Paris 06, France; [Maxwell, Patrick] UCL, Rayne Inst, Div Med, London WC1E 6JF, England	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Ghent University; Ghent University Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Basel; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Uppsala University; KU Leuven; Johns Hopkins University; Johns Hopkins Medicine; University of Liege; Flanders Institute for Biotechnology (VIB); International Center for Genetic Engineering & Biotechnology (ICGEB); University of Barcelona; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; King's College London; University College London	Carmeliet, P (corresponding author), Katholieke Univ Leuven, Vesalius Res Ctr, B-3000 Louvain, Belgium.	peter.carmeliet@vib-kuleuven.be	Morales-Ruiz, Manuel/AAM-1487-2020; Carmeliet, Peter/AAQ-5140-2020; Morales-Ruiz, Manuel/Z-2332-2019; Cuervo, Henar/AAF-4152-2019; Giacca, Mauro/J-9287-2016; Maxwell, Patrick H/C-5557-2008; Morales-Ruiz, Manuel/L-1031-2014; Bonnin, Philippe/Y-5872-2019; Schmidt, Thomas/Y-8431-2019; Loges, Sonja/ABE-9868-2021; Rolny, Charlotte/AET-0493-2022; ZACCHIGNA, SERENA/E-9496-2017	Carmeliet, Peter/0000-0001-7961-1821; Morales-Ruiz, Manuel/0000-0002-9074-2272; Cuervo, Henar/0000-0001-8293-9377; Giacca, Mauro/0000-0003-2927-7225; Maxwell, Patrick H/0000-0002-0338-2679; Morales-Ruiz, Manuel/0000-0002-9074-2272; Bonnin, Philippe/0000-0003-3184-3740; Schmidt, Thomas/0000-0002-7166-3675; Loges, Sonja/0000-0002-7650-8527; Heindryckx, Femke/0000-0002-1987-7676; Van Vlierberghe, Hans/0000-0003-0647-9238; Jimenez, Wladimiro/0000-0002-9376-0214; Vilar, Jose/0000-0002-9136-7726; geerts, anja/0000-0002-2218-9081; Noel, Agnes/0000-0002-7670-6179; ZACCHIGNA, SERENA/0000-0001-6705-3076; Rolny, Charlotte/0000-0003-4979-9266	TG; Methusalem funding; NCCR Molecular Oncology; Swiss Science Foundation; FWO [G. 0229.04, G. 0500.08, SCIE2006-3, OT/08/ 37]; NIH [CA69184, EY017164]; Swiss Science Foundation [3100A0108207]; DFG; DKH;  [IUAP06/30];  [GOA2006/11];  [LSHG-CT-2004-503573];  [LSHC-CT-2005-518178];  [SAF 2007-63069];  [2009 SGR 1496]; NATIONAL CANCER INSTITUTE [R01CA069184] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017164] Funding Source: NIH RePORTER	TG; Methusalem funding; NCCR Molecular Oncology(Swiss National Science Foundation (SNSF)); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); FWO(FWO); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); DFG(German Research Foundation (DFG)); DKH; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	ThromboGenics (TG) NV and BioInvent AB developed PlGF inhibitors for antiangiogenic treatment under a license from VIB and K. U. Leuven. D. C. was the Founder and is Chairman of the Board of TG (indirectly holding 1% equity share); his participation relates to his scientific directorship of the VIB department (until October 2008) when most studies were ongoing. The research on anti-PlGF conducted in the lab of P. C. has been financed in small part by TG. This work was supported by K. U. Leuven, IUAP06/30, GOA2006/11, and Methusalem funding to P. C.; by LSHG-CT-2004-503573 to P. C., L. C.-W., and G. Christofori; by NCCR Molecular Oncology, Swiss Science Foundation to G. Christofori; by FWO G. 0229.04 and G. 0500.08, SCIE2006-3, and OT/08/ 37 to G. Carmeliet; by NIH grant CA69184, Swiss Science Foundation 3100A0108207, and LSHC-CT-2005-518178 to M. Detmar; by NIH EY017164 to S. A. V.; by SAF 2007-63069 and 2009 SGR 1496 to M. M.-R.; by DFG fellowship to T. S.; and by DKH fellowship to S. L.	Bais C, 2010, CELL, V141, P166, DOI 10.1016/j.cell.2010.01.033; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Davidoff AM, 2002, CANCER RES, V62, P3077; Dawson MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006525; Dupuy E, 2003, J HEPATOL, V38, P793, DOI 10.1016/S0168-8278(03)00086-2; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Gerber HP, 2007, P NATL ACAD SCI USA, V104, P3478, DOI 10.1073/pnas.0611492104; Gordon MS, 2001, J CLIN ONCOL, V19, P843, DOI 10.1200/JCO.2001.19.3.843; Hawighorst T, 2001, EMBO J, V20, P2631, DOI 10.1093/emboj/20.11.2631; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Ho MC, 2007, CANCER LETT, V250, P237, DOI 10.1016/j.canlet.2006.10.005; Johnson SJ, 1998, J GASTROEN HEPATOL, V13, P145, DOI 10.1111/j.1440-1746.1998.tb00629.x; Landgren E, 1998, ONCOGENE, V16, P359, DOI 10.1038/sj.onc.1201545; Lassen U, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-A111; Xu L, 2007, MOL CANCER RES, V5, P873, DOI 10.1158/1541-7786.MCR-06-0141; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Luttun A, 2002, BIOCHEM BIOPH RES CO, V295, P428, DOI 10.1016/S0006-291X(02)00677-0; Luttun A., 2002, NAT MED, V1, P1; Marcellini M, 2006, AM J PATHOL, V169, P643, DOI 10.2353/ajpath.2006.051041; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Oura H, 2003, BLOOD, V101, P560, DOI 10.1182/blood-2002-05-1516; Paternostro C, 2010, WORLD J GASTROENTERO, V16, P281, DOI 10.3748/wjg.v16.i3.281; Riisbro R, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-A3; Roncal C, 2010, CARDIOVASC RES, V86, P29, DOI 10.1093/cvr/cvp380; Taylor AP, 2007, MOL CANCER THER, V6, P524, DOI 10.1158/1535-7163.MCT-06-0461; Van Steenkiste C, 2009, GASTROENTEROLOGY, V137, P2112, DOI 10.1053/j.gastro.2009.08.068; Willett CG, 2005, J CLIN ONCOL, V23, P8136, DOI 10.1200/JCO.2005.02.5635; Wittko IM, 2009, J NEUROSCI, V29, P8704, DOI 10.1523/JNEUROSCI.5527-08.2009; Wu XZ, 2007, J GASTROEN HEPATOL, V22, P1178, DOI 10.1111/j.1440-1746.2007.04997.x	33	213	217	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					178	190		10.1016/j.cell.2010.02.039	http://dx.doi.org/10.1016/j.cell.2010.02.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371353	Green Submitted, Bronze			2022-12-24	WOS:000276211100022
J	Shuman, EK				Shuman, Emily K.			Global Climate Change and Infectious Diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Michigan, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Shuman, EK (corresponding author), Univ Michigan, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA.							*ENV PROT AG, 2009, CLIM CHANG; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P161, DOI 10.1056/NEJM199407213310304; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P1035; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; [No title captured]	6	132	140	2	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1061	1063		10.1056/NEJMp0912931	http://dx.doi.org/10.1056/NEJMp0912931			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335580				2022-12-24	WOS:000275894600001
J	Checkley, W; West, KP; Wise, RA; Baldwin, MR; Wu, L; LeClerq, SC; Christian, P; Katz, J; Tielsch, JM; Khatry, S; Sommer, A				Checkley, William; West, Keith P., Jr.; Wise, Robert A.; Baldwin, Matthew R.; Wu, Lee; LeClerq, Steven C.; Christian, Parul; Katz, Joanne; Tielsch, James M.; Khatry, Subarna; Sommer, Alfred			Maternal Vitamin A Supplementation and Lung Function in Offspring	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-CAROTENE SUPPLEMENTATION; EARLY INFANT-MORTALITY; LOW-BIRTH-WEIGHT; NIGHT BLINDNESS; PULMONARY-FUNCTION; RANDOMIZED-TRIAL; RETINOIC ACID; RISK; PREGNANCY; WOMEN	BACKGROUND Vitamin A is important in regulating early lung development and alveolar formation. Maternal vitamin A status may be an important determinant of embryonic alveolar formation, and vitamin A deficiency in a mother during pregnancy could have lasting adverse effects on the lung health of her offspring. We tested this hypothesis by examining the long-term effects of supplementation with vitamin A or beta carotene in women before, during, and after pregnancy on the lung function of their offspring, in a population with chronic vitamin A deficiency. METHODS We examined a cohort of rural Nepali children 9 to 13 years of age whose mothers had participated in a placebo-controlled, double-blind, cluster-randomized trial of vitamin A or beta-carotene supplementation between 1994 and 1997. RESULTS Of 1894 children who were alive at the end of the original trial, 1658 (88%) were eligible to participate in the follow-up trial. We performed spirometry in 1371 of the children (83% of those eligible) between October 2006 and March 2008. Children whose mothers had received vitamin A had a forced expiratory volume in 1 second (FEV1) and a forced vital capacity (FVC) that were significantly higher than those of children whose mothers had received placebo (FEV1, 46 ml higher with vitamin A; 95% confidence interval [CI], 6 to 86; FVC, 46 ml higher with vitamin A; 95% CI, 8 to 84), after adjustment for height, age, sex, body-mass index, calendar month, caste, and individual spirometer used. Children whose mothers had received beta carotene had adjusted FEV1 and FVC values that were similar to those of children whose mothers had received placebo (FEV1, 14 ml higher with beta carotene; 95% CI, -24 to 54; FVC, 17 ml higher with beta carotene, 95% CI, -21 to 55). CONCLUSIONS In a chronically undernourished population, maternal repletion with vitamin A at recommended dietary levels before, during, and after pregnancy improved lung function in offspring. This public health benefit was apparent in the preadolescent years.	[Checkley, William; Wise, Robert A.; Baldwin, Matthew R.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care, Baltimore, MD 21205 USA; [Checkley, William; Katz, Joanne; Tielsch, James M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Program Global Dis Epidemiol & Control, Baltimore, MD 21205 USA; [West, Keith P., Jr.; Wu, Lee; LeClerq, Steven C.; Christian, Parul; Katz, Joanne; Tielsch, James M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Human Nutr, Baltimore, MD 21205 USA; [Sommer, Alfred] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Sommer, Alfred] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [LeClerq, Steven C.; Khatry, Subarna] Natl Soc Prevent Blindness, Nepal Nutr Intervent Project Sarlahi, Kathmandu, Nepal	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Checkley, W (corresponding author), Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care, 1830 Monument St,5th Fl, Baltimore, MD 21205 USA.	wcheckl1@jhmi.edu	Baldwin, Matthew/GQY-7234-2022	Tielsch, James/0000-0002-1151-060X; Wise, Robert/0000-0002-8353-2349; Katz, Joanne/0000-0002-5997-7823; Checkley, William/0000-0003-1106-8812	Bill and Melinda Gates Foundation [614]; Sight and Life Research Institute, Baltimore; Johns Hopkins University [HRN-A-0097-00015-00]; Office of Health, Infectious Diseases and Nutrition of the U.S. Agency for International Development [HRN-A-0097-00015-00]; Task Force Sight and Life, Basel, Switzerland; National Heart, Lung, and Blood Institute, National Institutes of Health [K99HL096955]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL096955] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Sight and Life Research Institute, Baltimore; Johns Hopkins University(Johns Hopkins University); Office of Health, Infectious Diseases and Nutrition of the U.S. Agency for International Development(United States Agency for International Development (USAID)); Task Force Sight and Life, Basel, Switzerland; National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a grant (no. 614) from the Bill and Melinda Gates Foundation and by a grant from the Sight and Life Research Institute, Baltimore. The original maternal vitamin A or beta-carotene supplementation trial (1994-1997) was conducted under the Vitamin A for Health Cooperative Agreement (HRN-A-0097-00015-00) between Johns Hopkins University and the Office of Health, Infectious Diseases and Nutrition of the U.S. Agency for International Development, with additional support from Task Force Sight and Life, Basel, Switzerland. Dr. Checkley is the recipient of a Clinician Scientist Award from Johns Hopkins University and a K99/R00 Pathway to Independence Award (K99HL096955) from the National Heart, Lung, and Blood Institute, National Institutes of Health.	Aird FK, 2006, J CYST FIBROS, V5, P129, DOI 10.1016/j.jcf.2005.11.007; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 2009, WHO GLOBAL DATABASE; Barua AB, 2003, INT J VITAM NUTR RES, V73, P267, DOI 10.1024/0300-9831.73.4.267; BEATY TH, 1982, AM J EPIDEMIOL, V116, P102, DOI 10.1093/oxfordjournals.aje.a113385; BIESALSKI HK, 1992, ANN NY ACAD SCI, V669, P325; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; BRILLIANT LB, 1985, B WORLD HEALTH ORGAN, V63, P375; Christian P, 2000, AM J EPIDEMIOL, V152, P542, DOI 10.1093/aje/152.6.542; Christian P, 2001, J NUTR, V131, P1510, DOI 10.1093/jn/131.5.1510; Christian P, 1998, INT J EPIDEMIOL, V27, P231, DOI 10.1093/ije/27.2.231; Chytil F, 1996, FASEB J, V10, P986, DOI 10.1096/fasebj.10.9.8801181; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; Congdon NG, 2000, AM J CLIN NUTR, V72, P1004; Cook DG, 1998, THORAX, V53, P884, DOI 10.1136/thx.53.10.884; Dimenstein R, 1996, BIOL NEONATE, V70, P248; Dimenstein R, 1996, BIOL NEONATE, V69, P230, DOI 10.1159/000244315; Dirami G, 2004, AM J PHYSIOL-LUNG C, V286, pL249, DOI 10.1152/ajplung.00140.2003; Galambos C, 2008, PATHOLOGY, V40, P124, DOI 10.1080/00313020701818981; Gilliland FD, 2003, AM J EPIDEMIOL, V158, P576, DOI 10.1093/aje/kwg181; Gorstein J, 2003, ASIA PAC J CLIN NUTR, V12, P96; Grievink L, 1998, THORAX, V53, P166, DOI 10.1136/thx.53.3.166; Grievink L, 1999, EUR J CLIN NUTR, V53, P813, DOI 10.1038/sj.ejcn.1600854; HAYES RJ, 2008, CLUSTER RANDOMISED T, P149; Hickenbottom SJ, 2002, AM J CLIN NUTR, V75, P900, DOI 10.1093/ajcn/75.5.900; Hole DJ, 1996, BRIT MED J, V313, P711; Humphrey JH, 1996, J PEDIATR-US, V128, P489, DOI 10.1016/S0022-3476(96)70359-1; Katz J, 2000, AM J CLIN NUTR, V71, P1570; Klemm RDW, 2008, PEDIATRICS, V122, pE242, DOI 10.1542/peds.2007-3448; Massaro GD, 1996, AM J PHYSIOL-LUNG C, V270, pL305, DOI 10.1152/ajplung.1996.270.2.L305; Massaro GD, 2000, AM J PHYSIOL-LUNG C, V278, pL955, DOI 10.1152/ajplung.2000.278.5.L955; McCollum EV, 1913, J BIOL CHEM, V15, P167; *MIN HLTH CHILD HL, 1998, NEP MICR STAT SURV 1, P54; MORABIA A, 1990, AM J EPIDEMIOL, V132, P77, DOI 10.1093/oxfordjournals.aje.a115645; Mori S, 1922, B JOHNS HOPKINS HOSP, V33, P357; PEARSON E, 1992, J PEDIATR-US, V121, P420, DOI 10.1016/S0022-3476(05)81800-1; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rahmathullah L, 2003, BMJ-BRIT MED J, V327, P254, DOI 10.1136/bmj.327.7409.254; RICE AI, 2004, COMP QUANTIFICATION, V1, P211; RODRIGUEZ BL, 1994, AM J EPIDEMIOL, V140, P398, DOI 10.1093/oxfordjournals.aje.a117262; Saunders C, 2004, J HEALTH POPUL NUTR, V22, P348; Semba RD, 2003, EUR J CLIN NUTR, V57, P1627, DOI 10.1038/sj.ejcn.1601734; SHARMA HS, 1987, Z ERNAHRUNGSWISS, V26, P116, DOI 10.1007/BF02019607; SHARMA HS, 1986, BIOL NEONATE, V50, P345, DOI 10.1159/000242619; SHENAI JP, 1987, J PEDIATR-US, V111, P269, DOI 10.1016/S0022-3476(87)80086-0; Sommer A., 1996, VITAMIN A DEFICIENCY, P19; Tielsch JM, 2008, J NUTR, V138, P787, DOI 10.1093/jn/138.4.787; Tielsch JM, 2007, J NUTR, V137, P2470, DOI 10.1093/jn/137.11.2470; UPADHYAY MP, 1985, AM J EPIDEMIOL, V121, P71, DOI 10.1093/oxfordjournals.aje.a113985; Wang XD, 1998, SUB CELL BIOCHEM, V30, P159; West KP, 1999, BMJ-BRIT MED J, V318, P570, DOI 10.1136/bmj.318.7183.570; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; ZACHMAN RD, 1995, J NUTR, V125, pS1634; Zile MH, 2001, J NUTR, V131, P705, DOI 10.1093/jn/131.3.705	55	126	129	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2010	362	19					1784	1794		10.1056/NEJMoa0907441	http://dx.doi.org/10.1056/NEJMoa0907441			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594RQ	20463338	Bronze			2022-12-24	WOS:000277555500005
J	Muraki, N; Nomata, J; Ebata, K; Mizoguchi, T; Shiba, T; Tamiaki, H; Kurisu, G; Fujita, Y				Muraki, Norifumi; Nomata, Jiro; Ebata, Kozue; Mizoguchi, Tadashi; Shiba, Tomoo; Tamiaki, Hitoshi; Kurisu, Genji; Fujita, Yuichi			X-ray crystal structure of the light-independent protochlorophyllide reductase	NATURE			English	Article							PYROCOCCUS-FURIOSUS; BCHN-BCHB; L-PROTEIN; IN-VITRO; OXIDOREDUCTASE; BIOSYNTHESIS; LIGAND; ENZYME; IDENTIFICATION; FERREDOXIN	Photosynthetic organisms adopt two different strategies for the reduction of the C17=C18 double bond of protochlorophyllide (Pchlide) to form chlorophyllide a, the direct precursor of chlorophyll a (refs 1-4). The first involves the activity of the light-dependent Pchlide oxidoreductase(5-9), and the second involves the light-independent (dark-operative) Pchlide oxidoreductase(10) (DPOR). DPOR is a nitrogenase-like enzyme consisting of two components, L-protein (a BchL dimer) and NB-protein (a BchN-BchB heterotetramer), which are structurally related to nitrogenase Fe protein and MoFe protein, respectively(10,11). Here we report the crystal structure of the NB-protein of DPOR from Rhodobacter capsulatus at a resolution of 2.3 angstrom. As expected, the overall structure is similar to that of nitrogenase MoFe protein: each catalytic BchN-BchB unit contains one Pchlide and one iron-sulphur cluster (NB-cluster) coordinated uniquely by one aspartate and three cysteines. Unique aspartate ligation is not necessarily needed for the cluster assembly but is essential for the catalytic activity. Specific Pchlide-binding accompanies the partial unwinding of an a-helix that belongs to the next catalytic BchN-BchB unit. We propose a unique trans-specific reduction mechanism in which the distorted C17-propionate of Pchlide and an aspartate from BchB serve as proton donors for C18 and C17 of Pchlide, respectively. Intriguingly, the spatial arrangement of the NB-cluster and Pchlide is almost identical to that of the P-cluster and FeMo-cofactor in nitrogenase MoFe-protein, illustrating that a common architecture exists to reduce chemically stable multibonds of porphyrin and dinitrogen.	[Muraki, Norifumi; Kurisu, Genji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Muraki, Norifumi; Shiba, Tomoo] Univ Tokyo, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Nomata, Jiro; Ebata, Kozue; Fujita, Yuichi] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Mizoguchi, Tadashi; Tamiaki, Hitoshi] Ritsumeikan Univ, Dept Biosci & Biotechnol, Shiga 5258577, Japan; [Fujita, Yuichi] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Osaka University; University of Tokyo; Nagoya University; Ritsumeikan University; Japan Science & Technology Agency (JST)	Kurisu, G (corresponding author), Osaka Univ, Inst Prot Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	gkurisu@protein.osaka-u.ac.jp; fujita@agr.nagoya-u.ac.jp	Muraki, Norifumi/AAW-2540-2020; KURISU, GENJI/AAD-7109-2022; KURISU, GENJI/ABA-5960-2020; Fujita, Yuichi/G-8908-2013; Nomata, Jiro/D-1813-2015	Muraki, Norifumi/0000-0003-4112-2955; KURISU, GENJI/0000-0002-5354-0807; KURISU, GENJI/0000-0002-5354-0807; Nomata, Jiro/0000-0001-9849-2426	Japan Society for the Promotion of Science (JSPS) [17687008, 18054308, 19570036, 20200063, 19750148, 19350088, 19010733, 2110614]; Japan Science and Technology Agency (JST); Kato Memorial Science Foundation; Toyoaki Scholarship Foundation; Japan Securities Scholarship Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Kato Memorial Science Foundation; Toyoaki Scholarship Foundation(Toyoaki Scholarship Foundation); Japan Securities Scholarship Foundation	We thank K. Fukuyama, T. Omata and K. Terauchi for discussions; J. Peters and R. Cogdell for a critical reading of the manuscript; H. Yamamoto for establishing the functional overexpression system in E. coli; J. Harimoto for technical help in the sequence confirmation of a series of expression vectors; C. E. Bauer for donating the broad host-range vector pBBR1MSC2 and the triparental mating system for R. capsulatus; and the staff at the Photon Factory, KEK, Japan, for support during data collection. This work was supported by Grants-in-Aid for Scientific Research numbers 17687008 and 18054308 (G. K.), 19570036, 14COEA2 and 20200063 (Y. F.), 19750148 (T. M.) and 19350088 (H. T.) from the Japan Society for the Promotion of Science (JSPS), Precursory Research for Embryonic Science and Technology of the Japan Science and Technology Agency (JST) (Y. F.), the Kato Memorial Science Foundation (G. K.), the Toyoaki Scholarship Foundation and the Japan Securities Scholarship Foundation (Y. F.). N. M and J. N. grateful for fellowships from the JSPS for Japanese Junior Scientists (numbers 19010733 and 2110614).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; Buhr F, 2008, P NATL ACAD SCI USA, V105, P12629, DOI 10.1073/pnas.0803950105; CALZOLAI L, 1995, BIOCHEMISTRY-US, V34, P11373, DOI 10.1021/bi00036a010; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; Fujita Y., 2003, PORPHYRIN HDB CHLORO, P109, DOI DOI 10.1016/B978-0-08-092387-1.50010-2; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Imai T, 2001, J BIOCHEM, V130, P649, DOI 10.1093/oxfordjournals.jbchem.a003030; KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; Lebedev N, 1999, P NATL ACAD SCI USA, V96, P9954, DOI 10.1073/pnas.96.17.9954; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Masuda T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1131, DOI 10.1039/b807210h; Mizoguchi T, 2009, ORG BIOMOL CHEM, V7, P2120, DOI 10.1039/b900802k; Nomata J, 2005, BBA-BIOENERGETICS, V1708, P229, DOI 10.1016/j.bbabio.2005.02.002; Nomata J, 2008, FEBS LETT, V582, P1346, DOI 10.1016/j.febslet.2008.03.018; Nomata J, 2006, FEBS LETT, V580, P6151, DOI 10.1016/j.febslet.2006.10.014; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Reinbothe S, 1996, CELL, V86, P703, DOI 10.1016/S0092-8674(00)80144-0; Ruediger Wolfhart, 2006, V25, P189; Sarma R, 2008, BIOCHEMISTRY-US, V47, P13004, DOI 10.1021/bi801058r; Schmid B, 2002, SCIENCE, V296, P352, DOI 10.1126/science.1070010; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; VON WETTSTEIN D, 1995, PLANT CELL, V7, P1039, DOI 10.1105/tpc.7.7.1039; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WILKS HM, 1995, P NATL ACAD SCI USA, V92, P724, DOI 10.1073/pnas.92.3.724; Yamamoto H, 2008, PHOTOCH PHOTOBIO SCI, V7, P1238, DOI 10.1039/b802427h	33	139	146	1	73	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					110	U124		10.1038/nature08950	http://dx.doi.org/10.1038/nature08950			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20400946				2022-12-24	WOS:000277311900041
J	Walensky, RP				Walensky, Rochelle P.			Disclosure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rwalensky@partners.org		Walensky, Rochelle P./0000-0002-8795-379X					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2010	303	17					1676	1677		10.1001/jama.2010.535	http://dx.doi.org/10.1001/jama.2010.535			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591CR	20442376				2022-12-24	WOS:000277276600001
J	Cui, J; Zhu, L; Xia, XJ; Wang, HY; Legras, X; Hong, J; Ji, JB; Shen, PP; Zheng, S; Chen, ZJJ; Wang, RF				Cui, Jun; Zhu, Liang; Xia, Xiaojun; Wang, Helen Y.; Legras, Xavier; Hong, Jun; Ji, Jiabing; Shen, Pingping; Zheng, Shu; Chen, Zhijian J.; Wang, Rong-Fu			NLRC5 Negatively Regulates the NF-kappa B and Type I Interferon Signaling Pathways	CELL			English	Article							PATTERN-RECOGNITION RECEPTORS; RIG-I; TOLL-LIKE; INNATE IMMUNITY; T-CELLS; INFLAMMATORY DISEASE; NALP3 INFLAMMASOME; UBIQUITIN LIGASE; KINASE COMPLEX; RNA	Stringent control of the NF-kappa B and type I interferon signaling pathways is critical to effective host immune responses, yet the molecular mechanisms that negatively regulate these pathways are poorly understood. Here, we show that NLRC5, a member of the highly conserved NOD-like protein family, can inhibit the IKK complex and RIG-I/MDA5 function. NLRC5 inhibited NF-kappa B-dependent responses by interacting with IKK alpha and IKK beta and blocking their phosphorylation. It also interacted with RIG-I and MDA5, but not with MAVS, to inhibit RLR-mediated type I interferon responses. Consistent with these observations, NLRC5-specific siRNA knockdown not only enhanced the activation of NF-kappa B and its responsive genes, TNF-alpha and IL-6, but also promoted type I interferon signaling and antiviral immunity. Our findings identify NLRC5 as a negative regulator that blocks two central components of the NF-kappa B and type I interferon signaling pathways and suggest an important role for NLRC5 in homeostatic control of innate immunity.	[Cui, Jun; Zhu, Liang; Xia, Xiaojun; Wang, Helen Y.; Legras, Xavier; Hong, Jun; Ji, Jiabing; Wang, Rong-Fu] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Cui, Jun; Zhu, Liang; Xia, Xiaojun; Wang, Helen Y.; Legras, Xavier; Hong, Jun; Ji, Jiabing; Wang, Rong-Fu] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Cui, Jun; Shen, Pingping] Nanjing Univ, Coll Life Sci, Nanjing 210008, Peoples R China; [Zhu, Liang; Zheng, Shu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Howard Hughes Med Inst, Dallas, TX 75390 USA	Baylor College of Medicine; Baylor College of Medicine; Nanjing University; Zhejiang University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wang, RF (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	rongfuw@bcm.edu	Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251	National Cancer Institute [P01CA094237, P50CA126752, R01CA09327, R01CA101795, R01CA116408, R01CA121191]; NIH; Cancer Research Institute; China Scholarship Council;  [NCET-06-0445]; NATIONAL CANCER INSTITUTE [P50CA126752, R01CA121191, R01CA116408, R01CA101795, P01CA094237, R01CA090327] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; China Scholarship Council(China Scholarship Council); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Drs. Michael Karin and Bing Su for IKK alpha, IKK beta, NEMO, and p38 constructs; Yinling Hu and Feng Zhu for constitutively active IKK alpha/beta (EE) mutants and GST-I kappa B (1-54) constructs; Jae U. Jung for RIG-I construct; Hongbin Shu for TRAF6; Kate Fitzgerald for TBK1 and IKKi constructs; and John Hiscott for pISRE-luc construct. We would also like to thank Drs Shao-Cong Sun, Xin Lin, and John Gilbert for their critical reading of this manuscript. This work was supported in part by grants (P01CA094237, P50CA126752, R01CA09327, R01CA101795, R01CA116408, and R01CA121191) from National Cancer Institute, NIH, and Cancer Research Institute ( to R. F. W). J.C. and L.Z. were partially supported by NCET-06-0445 and the China Scholarship Council. Z.J.C. is an investigator of Howard Hughes Medical Institute.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dowds TA, 2003, BIOCHEM BIOPH RES CO, V302, P575, DOI 10.1016/S0006-291X(03)00221-3; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Opitz B, 2006, J BIOL CHEM, V281, P36173, DOI 10.1074/jbc.M604638200; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	38	309	341	5	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					483	496		10.1016/j.cell.2010.03.040	http://dx.doi.org/10.1016/j.cell.2010.03.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434986	Green Accepted, Bronze			2022-12-24	WOS:000277180800019
J	Charron, S; Koechlin, E				Charron, Sylvain; Koechlin, Etienne			Divided Representation of Concurrent Goals in the Human Frontal Lobes	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; HUMAN PREFRONTAL CORTEX; DECISION-MAKING; REWARD; BRAIN; MOTIVATION; SELECTION; TASK	The anterior prefrontal cortex (APC) confers on humans the ability to simultaneously pursue several goals. How does the brain's motivational system, including the medial frontal cortex (MFC), drive the pursuit of concurrent goals? Using brain imaging, we observed that the left and right MFC, which jointly drive single-task performance according to expected rewards, divide under dual-task conditions: While the left MFC encodes the rewards driving one task, the right MFC concurrently encodes those driving the other task. The same dichotomy was observed in the lateral frontal cortex, whereas the APC combined the rewards driving both tasks. The two frontal lobes thus divide for representing simultaneously two concurrent goals coordinated by the APC. The human frontal function seems limited to driving the pursuit of two concurrent goals simultaneously.	[Charron, Sylvain; Koechlin, Etienne] INSERM, F-75654 Paris 13, France; [Charron, Sylvain] Ecole Polytech, F-91128 Palaiseau, France; [Koechlin, Etienne] Ecole Normale Super, F-75230 Paris 05, France; [Koechlin, Etienne] Univ Paris 06, CENIR, F-75651 Paris 13, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Sorbonne Universite	Koechlin, E (corresponding author), INSERM, F-75654 Paris 13, France.	etienne.koechlin@upmc.fr	Koechlin, Etienne/E-5061-2016; Koechlin, Etienne/AAF-5717-2021	Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311; Charron, Sylvain/0000-0001-9511-9693	Bettencourt-Schueller Foundation; EURYI	Bettencourt-Schueller Foundation; EURYI(European Science Foundation (ESF))	Supported by the Bettencourt-Schueller Foundation and a EURYI award to E. K. We thank L. Sabarly for his help in conducting the behavioral experiment.	Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Pandya DN, 1996, RES PER NEUROSCI, P13; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Ramnani N, 2003, CEREB CORTEX, V13, P318, DOI 10.1093/cercor/13.3.318; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025	21	100	107	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					360	363		10.1126/science.1183614	http://dx.doi.org/10.1126/science.1183614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395509				2022-12-24	WOS:000276685000039
J	Snow, RW; Marsh, K				Snow, Robert W.; Marsh, Kevin			Malaria in Africa: progress and prospects in the decade since the Abuja Declaration	LANCET			English	Editorial Material							TRANSMISSION; MORTALITY		[Snow, Robert W.; Marsh, Kevin] Ctr Geog Med, Wellcome Trust Collaborat Programme, Kenya Med Res Inst, Nairobi, Kenya; [Snow, Robert W.; Marsh, Kevin] Ctr Geog Med, Wellcome Trust Collaborat Programme, Kenya Med Res Inst, Kilifi, Kenya; [Snow, Robert W.; Marsh, Kevin] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, CCVTM, Oxford, England	Kenya Medical Research Institute; Kenya Medical Research Institute; University of Oxford	Snow, RW (corresponding author), KEMRI Univ Oxford Wellcome Trust Collaborat Progr, Kenyatta Natl Hosp Grounds, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med, POB 43640-00100, Nairobi, Kenya.	rsnow@nairobi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088	Wellcome Trust [079080, 077092] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], GLOB MAL ACT PLAN MA; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Feachem RGA, 2006, LANCET, V368, P537, DOI 10.1016/S0140-6736(06)69163-0; *GLOB FUND FIGHT A, 2009, TUB MAL COMM DISB; Kidson Chev, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P635; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Molineaux L, 1997, ANN TROP MED PARASIT, V91, P811, DOI 10.1080/00034989760572; Narasimhan V, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-8; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Teklehaimanot A, 2007, AM J TROP MED HYG, V77, P138, DOI 10.4269/ajtmh.2007.77.138; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; *WHO, WORLD MAL REP 2009; WHO, 2000, AB DECL PLAN ACT EXT; Zanzibar Malaria Control Program, 2009, MAL EL ZANZ FEAS ASS	20	69	69	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 10	2010	376	9735					137	139		10.1016/S0140-6736(10)60577-6	http://dx.doi.org/10.1016/S0140-6736(10)60577-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	626CJ	20417552	Green Accepted			2022-12-24	WOS:000279943200029
J	Chapman, S; Freeman, B				Chapman, Simon; Freeman, Becky			Personal View The cancer emperor's new clothes: Australia's historic legislation for plain tobacco packaging	BRITISH MEDICAL JOURNAL			English	Editorial Material							BRAND IMAGE; PERCEPTIONS		[Chapman, Simon; Freeman, Becky] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	simon.chapman@sydney.edu.au	Chapman, Simon/D-4114-2009					BARBER K, MORGAN CONSUMER REV; BERKOVIC N, 2010, AUSTRALIAN      0430; Chapman S, 2008, TOB CONTROL, V17, P25, DOI 10.1136/tc.2007.021386; EINDHOVEN G, 1999, WORLD TOBACCO, V170, P16; Freeman B, 2008, ADDICTION, V103, P580, DOI 10.1111/j.1360-0443.2008.02145.x; Germain D, 2010, J ADOLESCENT HEALTH, V46, P385, DOI 10.1016/j.jadohealth.2009.08.009; *TOB WORK GROUP PR, TOB CONTR AUSTR MAK; Wakefield MA, 2008, TOB CONTROL, V17, P416, DOI 10.1136/tc.2008.026732; P MORRIS DOCUMENT CO; BRIT AM TOBACCO DOCU	10	10	10	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2010	340								c2436	10.1136/bmj.c2436	http://dx.doi.org/10.1136/bmj.c2436			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	594XC	20444830				2022-12-24	WOS:000277572500014
J	Klass, P				Klass, Perri			Disconnected.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, New York, NY 10016 USA	New York University	Klass, P (corresponding author), NYU, New York, NY 10016 USA.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 15	2010	362	15					1358	1361		10.1056/NEJMp0911193	http://dx.doi.org/10.1056/NEJMp0911193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	582XY	20393174				2022-12-24	WOS:000276635300003
J	Bennett, WL; Gilson, MM; Jamshidi, R; Burke, AE; Segal, JB; Steele, KE; Makary, MA; Clark, JM				Bennett, Wendy L.; Gilson, Marta M.; Jamshidi, Roxanne; Burke, Anne E.; Segal, Jodi B.; Steele, Kimberley E.; Makary, Martin A.; Clark, Jeanne M.			Impact of bariatric surgery on hypertensive disorders in pregnancy: retrospective analysis of insurance claims data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MATERNAL OBESITY; UNITED-STATES; RISK; PREECLAMPSIA; OVERWEIGHT; DIAGNOSES; ACCURACY; WEIGHT	Objective To determine whether women who had a delivery after bariatric surgery have lower rates of hypertensive disorders in pregnancy compared with women who had a delivery before bariatric surgery. Design Retrospective cohort study. Setting Claims data for 2002-6 from seven insurance plans in the United States. Participants 585 women aged 16-45 who had undergone bariatric surgery, had at least one pregnancy and delivery, and had continuous insurance coverage during pregnancy plus two weeks after delivery. Main outcome measure Hypertensive disorders in pregnancy defined with ICD-9 codes. The independent variable was the timing of delivery in relation to bariatric surgery, classified as deliveries before and after surgery. We used logistic regression to calculate odds ratios and confidence intervals for each type of hypertensive disorder in pregnancy. Results Among the 585 women who had undergone bariatric surgery and had a delivery, 269 delivered before surgery and 316 delivered after surgery. Gastric bypass was the surgery in 82% (477) of all women. Women who delivered before surgery were younger at the time of delivery (mean age 31.3 v 32.5) but had higher rates of pre-existing diabetes and gestational diabetes mellitus. Compared with women who delivered before surgery, women who delivered after surgery had substantially lower rates of pre-eclampsia and eclampsia (odds ratio 0.20, 95% confidence interval 0.09 to 0.44), chronic hypertension complicating pregnancy (0.39, 0.20 to 0.74), and gestational hypertension (0.16, 0.07 to 0.37), even after adjustment for age at delivery, multiple pregnancy (that is, twins or more), surgical procedure, pre-existing diabetes, and insurance plan. Conclusion In this retrospective analysis of US women, bariatric surgery was associated with lower rates of hypertensive disorders in subsequent pregnancy.	[Bennett, Wendy L.; Segal, Jodi B.; Clark, Jeanne M.] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Dept Med, Baltimore, MD 21205 USA; [Gilson, Marta M.; Steele, Kimberley E.; Makary, Martin A.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Jamshidi, Roxanne; Burke, Anne E.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Bennett, WL (corresponding author), Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Dept Med, 2024 E Monument St,Room 2-611, Baltimore, MD 21205 USA.	wbennet5@jhmi.edu	Burke, Anne/AHE-9713-2022; Clark, Jeanne/AGG-8199-2022	Clark, Jeanne/0000-0003-1194-0092; Bennett, Wendy/0000-0001-9828-0706	Ethicon Endo-Surgery; Pfizer; GlaxoSmithKline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	Ethicon Endo-Surgery; Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The dataset used in this study was created for a research project on the patterns of obesity care within selected BlueCross BlueShield plans. The original development of the dataset was funded by unrestricted research grants from Ethicon Endo-Surgery, Pfizer, and GlaxoSmithKline. Data and database development support were provided by the BlueCross BlueShield Association (Tennessee, Hawaii, Michigan, North Carolina), Highmark (Pennsylvania), Independence BlueCross (Pennsylvania), and Wellmark BlueCross BlueShield (Iowa and South Dakota). The BlueCross BlueShield plans were invited to review the manuscript but they did not have any direct role in the design and conduct of the study, data management or analysis, interpretation of the data, or preparation of the manuscript.	ACOG, 2009, OBSTET GYNECOL, V113, P1405, DOI [10.1097/AOG.0b013e3181ac0544, DOI 10.1097/AOG.0B013E3181AC0544]; [Anonymous], 2001, OBSTET GYNECOL, V98, P177; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Bodnar LM, 2005, ANN EPIDEMIOL, V15, P475, DOI 10.1016/j.annepidem.2004.12.008; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; BURKE AE, J AM COLL S IN PRESS; CALLAWAY LK, 2009, HYPERTENS PREGNANCY, V4, P1; Chang Jeani, 2003, MMWR Surveill Summ, V52, P1; Chu SY, 2007, OBES REV, V8, P385, DOI 10.1111/j.1467-789X.2007.00397.x; Chu SY, 2008, NEW ENGL J MED, V358, P1444, DOI 10.1056/NEJMoa0706786; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Eerdekens A, 2010, EUR J PEDIATR, V169, P191, DOI 10.1007/s00431-009-1005-1; Fortner RT, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.021; Freedman DS, 2002, JAMA-J AM MED ASSOC, V288, P1758, DOI 10.1001/jama.288.14.1758; Geller SE, 2004, AM J OBSTET GYNECOL, V190, P1629, DOI 10.1016/j.ajog.2004.03.061; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; GRUNDY SM, 1991, ANN INTERN MED, V115, P956; Klemmensen AK, 2007, AM J EPIDEMIOL, V166, P117, DOI 10.1093/aje/kwm139; Lydon-Rochelle MT, 2005, AM J OBSTET GYNECOL, V193, P125, DOI 10.1016/j.ajog.2005.02.096; Lynch CS, 2007, J GEN INTERN MED, V22, P908, DOI 10.1007/s11606-007-0218-0; Maggard MA, 2008, JAMA-J AM MED ASSOC, V300, P2286, DOI 10.1001/jama.2008.641; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; RICHARDS DS, 1987, J REPROD MED, V32, P172; Roberts CL, 2008, HYPERTENS PREGNANCY, V27, P285, DOI 10.1080/10641950701826695; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Samuels-Kalow ME, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.043; Segal JB, 2009, OBES SURG, V19, P1646, DOI 10.1007/s11695-009-9960-1; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Stotland NE, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2450; Vikse BE, 2008, NEW ENGL J MED, V359, P800, DOI 10.1056/NEJMoa0706790; Weintraub AY, 2008, INT J GYNECOL OBSTET, V103, P246, DOI 10.1016/j.ijgo.2008.07.008; *WHO, 2006, 311 WHO; Yasmeen S, 2006, AM J OBSTET GYNECOL, V194, P992, DOI 10.1016/j.ajog.2005.08.058; Zhang J, 2003, HYPERTENS PREGNANCY, V22, P203, DOI 10.1081/PRG-120021066	35	65	65	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2010	340								c1662	10.1136/bmj.c1662	http://dx.doi.org/10.1136/bmj.c1662			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586JZ	20388692	Green Published, hybrid			2022-12-24	WOS:000276904800002
J	McDaniell, R; Lee, BK; Song, L; Liu, Z; Boyle, AP; Erdos, MR; Scott, LJ; Morken, MA; Kucera, KS; Battenhouse, A; Keefe, D; Collins, FS; Willard, HF; Lieb, JD; Furey, TS; Crawford, GE; Iyer, VR; Birney, E				McDaniell, Ryan; Lee, Bum-Kyu; Song, Lingyun; Liu, Zheng; Boyle, Alan P.; Erdos, Michael R.; Scott, Laura J.; Morken, Mario A.; Kucera, Katerina S.; Battenhouse, Anna; Keefe, Damian; Collins, Francis S.; Willard, Huntington F.; Lieb, Jason D.; Furey, Terrence S.; Crawford, Gregory E.; Iyer, Vishwanath R.; Birney, Ewan			Heritable Individual-Specific and Allele-Specific Chromatin Signatures in Humans	SCIENCE			English	Article							GENE-EXPRESSION; SITES	The extent to which variation in chromatin structure and transcription factor binding may influence gene expression, and thus underlie or contribute to variation in phenotype, is unknown. To address this question, we cataloged both individual-to-individual variation and differences between homologous chromosomes within the same individual (allele-specific variation) in chromatin structure and transcription factor binding in lymphoblastoid cells derived from individuals of geographically diverse ancestry. Ten percent of active chromatin sites were individual-specific; a similar proportion were allele-specific. Both individual-specific and allele-specific sites were commonly transmitted from parent to child, which suggests that they are heritable features of the human genome. Our study shows that heritable chromatin status and transcription factor binding differ as a result of genetic variation and may underlie phenotypic variation in humans.	[Song, Lingyun; Boyle, Alan P.; Kucera, Katerina S.; Willard, Huntington F.; Furey, Terrence S.; Crawford, Gregory E.] Duke Univ, IGSP, Durham, NC 27708 USA; [McDaniell, Ryan; Lee, Bum-Kyu; Liu, Zheng; Battenhouse, Anna; Iyer, Vishwanath R.] Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Song, Lingyun; Crawford, Gregory E.] Duke Univ, Dept Pediat, Div Med Genet, Durham, NC 27708 USA; [Erdos, Michael R.; Scott, Laura J.; Morken, Mario A.; Collins, Francis S.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Scott, Laura J.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Keefe, Damian; Birney, Ewan] European Bioinformat Inst, Cambridge CB10 1RQ, England; [Lieb, Jason D.] Univ N Carolina, Dept Biol, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Lieb, Jason D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Duke University; University of Texas System; University of Texas Austin; Duke University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan; European Molecular Biology Laboratory (EMBL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Crawford, GE (corresponding author), Duke Univ, IGSP, Durham, NC 27708 USA.	greg.crawford@duke.edu; vishy@mail.utexas.edu; birney@ebi.ac.uk	Boyle, Alan/I-1848-2014; Liu, Zheng/G-2612-2011	Boyle, Alan/0000-0002-2081-1105; Kucera, Katerina/0000-0003-4148-6599; Lee, Bum Kyu/0000-0001-7835-419X; Battenhouse, Anna/0000-0002-7455-9064; Furey, Terry/0000-0001-5546-9672; Birney, Ewan/0000-0001-8314-8497	National Human Genome Research Institute (NHGRI) ENCODE Consortium [U54 HG004563-03]; NHGRI [HG000024]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000024, ZIAHG000024, U54HG004563] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI) ENCODE Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank T. Severson, F. Ye, and L. Bukovnik at the Duke IGSP Sequencing Core Facility and K. Moon and S. Luo at Illumina for sequencing; S. Tenenbaum and S. Chittur at the State University of New York, Albany, for expression data; J. Lucas and Z. Zhang at Duke for gene expression analysis; the Texas Advanced Computing Center for computational infrastructure; and the 1000 Genomes Project for genotypes. E. B. has been a paid consultant to EagleGenomics, UK. Supported by National Human Genome Research Institute (NHGRI) ENCODE Consortium grant U54 HG004563-03 and NHGRI grant Z01 HG000024. Raw data from this paper are available at Gene Expression Omnibus (GSE15805 and GSE19622) and at the University of California, Santa Cruz (UCSC) Genome Browser.	Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hachwell E, 2007, TRENDS GENET, V23, P588, DOI 10.1016/j.tig.2007.08.010; Kadota M, 2007, PLOS GENET, V3, P768, DOI 10.1371/journal.pgen.0030081; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Lewis A, 2006, CYTOGENET GENOME RES, V113, P81, DOI 10.1159/000090818; Lewis A, 2004, CURR BIOL, V14, pR284, DOI 10.1016/j.cub.2004.03.026; Mohlke KL, 2002, P NATL ACAD SCI USA, V99, P16928, DOI 10.1073/pnas.262661399; Montgomery SB, 2009, HUM MOL GENET, V18, pR211, DOI 10.1093/hmg/ddp400; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Plagnol V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002966; WU C, 1979, CELL, V16, P797, DOI 10.1016/0092-8674(79)90095-3; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357	16	238	248	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					235	239		10.1126/science.1184655	http://dx.doi.org/10.1126/science.1184655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20299549	Green Accepted, Green Submitted, Green Published			2022-12-24	WOS:000276459600044
J	Locksley, RM				Locksley, Richard M.			Asthma and Allergic Inflammation	CELL			English	Article							LUNG DENDRITIC CELLS; CLASS-II EXPRESSION; IMMUNE-RESPONSES; T-CELLS; IN-VIVO; AIRWAY; INNATE; IL-4; BASOPHILS; RECEPTOR	Studies of the initiation and maintenance of asthma and allergic inflammation implicate dysregulated interactions between mucosal epithelia and innate immune cells as the underlying cause of these disorders. The similarities of these responses with mucosal responses to parasitic intestinal worms may reveal pathways relevant to the perplexing rise of these chronic inflammatory disorders.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu			Howard Hughes Medical Institute; National Institutes of Health; UCSF Strategic Asthma Basic Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439, R37AI026918, R01AI030663] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Strategic Asthma Basic Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	I gratefully acknowledge helpful discussions with faculty and members of my laboratory at UCSF and support from the Howard Hughes Medical Institute, the National Institutes of Health, and the UCSF Strategic Asthma Basic Research Center.	Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013; Aspock H, 1996, PARASITOL TODAY, V12, P255, DOI 10.1016/0169-4758(96)30008-2; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Barrett NA, 2009, IMMUNITY, V31, P425, DOI 10.1016/j.immuni.2009.08.014; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Cortez-Retamozo V, 2008, J CLIN INVEST, V118, P4058, DOI 10.1172/JCI36335; de Lange EE, 2009, RADIOLOGY, V250, P567, DOI 10.1148/radiol.2502080188; Delmotte P, 2006, AM J RESP CELL MOL, V35, P110, DOI 10.1165/rcmb.2005-0417OC; Demehri S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000067; Eller LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003919; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Kambayashi T, 2009, J IMMUNOL, V182, P4686, DOI 10.4049/jimmunol.0803180; Kepley CL, 2001, AM J RESP CRIT CARE, V164, P1053, DOI 10.1164/ajrccm.164.6.2102025; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Moorman Jeanne E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Muller S, 2009, PEDIAT ALLERG IMM-UK, V20, P358, DOI 10.1111/j.1399-3038.2008.00808.x; Niu N, 2009, J IMMUNOL, V183, P1523, DOI 10.4049/jimmunol.0901349; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Parkinson J, 2004, NAT GENET, V36, P1259, DOI 10.1038/ng1472; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Porter P, 2009, MUCOSAL IMMUNOL, V2, P504, DOI 10.1038/mi.2009.102; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rogers AJ, 2009, AM J RESP CRIT CARE, V179, P1084, DOI 10.1164/rccm.200812-1860OC; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Seibold MA, 2009, J BIOL CHEM, V284, P19650, DOI 10.1074/jbc.M109.012443; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tzeng YS, 2009, J APPL PHYSIOL, V106, P813, DOI 10.1152/japplphysiol.01133.2007; van Panhuys N, 2008, P NATL ACAD SCI USA, V105, P12423, DOI 10.1073/pnas.0806372105; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Wang HB, 2007, J IMMUNOL, V179, P7585, DOI 10.4049/jimmunol.179.11.7585; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737	51	274	288	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6					777	783		10.1016/j.cell.2010.03.004	http://dx.doi.org/10.1016/j.cell.2010.03.004			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303868	Green Accepted, Bronze			2022-12-24	WOS:000275746600002
J	Cristofanilli, M; Braun, S				Cristofanilli, Massimo; Braun, Stephan			Circulating Tumor Cells Revisited	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							METASTATIC BREAST-CANCER; SURVIVAL; PROGRESSION		[Cristofanilli, Massimo] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; [Braun, Stephan] Med Univ Innsbruck, Dept Gynecol, Innsbruck, Austria	Fox Chase Cancer Center; Medical University of Innsbruck	Cristofanilli, M (corresponding author), Fox Chase Canc Ctr, Dept Med Oncol, 333 Cottman Ave, Philadelphia, PA 19111 USA.	massimo.cristofanilli@fccc.edu						Alix-Panabieres C, 2005, J IMMUNOL METHODS, V299, P177, DOI 10.1016/j.jim.2005.02.007; Ashworth T. R, 1869, AUST MED J, V14, P146, DOI DOI 10.1038/SJ.BJC.6604218; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; De Giorgi U, 2009, J CLIN ONCOL, V27, P3303, DOI 10.1200/JCO.2008.19.4423; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44	10	36	47	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1092	1093		10.1001/jama.2010.292	http://dx.doi.org/10.1001/jama.2010.292			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233831				2022-12-24	WOS:000275594100026
J	Cifuentes, D; Xue, HL; Taylor, DW; Patnode, H; Mishima, Y; Cheloufi, S; Ma, EB; Mane, S; Hannon, GJ; Lawson, ND; Wolfe, SA; Giraldez, AJ				Cifuentes, Daniel; Xue, Huiling; Taylor, David W.; Patnode, Heather; Mishima, Yuichiro; Cheloufi, Sihem; Ma, Enbo; Mane, Shrikant; Hannon, Gregory J.; Lawson, Nathan D.; Wolfe, Scot A.; Giraldez, Antonio J.			A Novel miRNA Processing Pathway Independent of Dicer Requires Argonaute2 Catalytic Activity	SCIENCE			English	Article							ZINC-FINGER NUCLEASES; PASSENGER-STRAND; RNA CLEAVAGE; ZEBRAFISH; SIRNAS; DROSOPHILA; SHRNAS; SLICER	Dicer is a central enzyme in microRNA (miRNA) processing. We identified a Dicer-independent miRNA biogenesis pathway that uses Argonaute2 (Ago2) slicer catalytic activity. In contrast to other miRNAs, miR-451 levels were refractory to dicer loss of function but were reduced in MZago2 (maternal-zygotic) mutants. We found that pre-miR-451 processing requires Ago2 catalytic activity in vivo. MZago2 mutants showed delayed erythropoiesis that could be rescued by wild-type Ago2 or miR-451-duplex but not by catalytically dead Ago2. Changing the secondary structure of Dicer-dependent miRNAs to mimic that of pre-miR-451 restored miRNA function and rescued developmental defects in MZdicer mutants, indicating that the pre-miRNA secondary structure determines the processing pathway in vivo. We propose that Ago2-mediated cleavage of pre-miRNAs, followed by uridylation and trimming, generates functional miRNAs independently of Dicer.	[Cifuentes, Daniel; Xue, Huiling; Patnode, Heather; Mishima, Yuichiro; Giraldez, Antonio J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Taylor, David W.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Mishima, Yuichiro] Kobe Univ, Grad Sch Sci, Dept Biol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Cheloufi, Sihem; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Cheloufi, Sihem] SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA; [Ma, Enbo] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Mane, Shrikant] Yale Ctr Genome Anal, Orange, CT 06477 USA; [Lawson, Nathan D.; Wolfe, Scot A.] Univ Massachusetts, Program Gene Funct & Express, Sch Med, Worcester, MA 01605 USA; [Wolfe, Scot A.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Giraldez, Antonio J.] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA	Yale University; Yale University; Kobe University; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Berkeley; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Yale University	Giraldez, AJ (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	antonio.giraldez@yale.edu	Hannon, Gregory/AAB-3568-2019; Mishima, Yuichiro/I-3881-2019	Mishima, Yuichiro/0000-0002-1075-9454; Taylor, David/0000-0002-6198-1194; Lawson, Nathan/0000-0001-7788-9619; Cifuentes Buira, Daniel/0000-0001-5442-4843; Giraldez, Antonio/0000-0002-6823-137X	Fundacion Ramon Areces; Human Frontier Science Program fellowship; NIH [R01GM081602-03/03S1, R01HL093766]; Yale Scholar program; Pew Scholars Program in the Biomedical Sciences; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081602, R01GM101108] Funding Source: NIH RePORTER	Fundacion Ramon Areces; Human Frontier Science Program fellowship(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Scholar program; Pew Scholars Program in the Biomedical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Doudna, D. O'Carroll, L. Zon, S. Lacadie, G. Lieschke, D. Krausse, and S. Halene for reagents and protocols; A. Enright, C. Abreu-Goodger, and J. Brennecke for initial small RNA analysis; and B. Schachter, C. Takacs, V. Greco, and D. Cazalla for discussions and manuscript editing. Supported by Fundacion Ramon Areces (D. C.), a Human Frontier Science Program fellowship (H. X.), NIH grants R01GM081602-03/03S1 (A. J. G.) and R01HL093766 (N.D.L. and S. A. W.), the Yale Scholar program, and the Pew Scholars Program in the Biomedical Sciences (A.J.G.). Contributions: D. C. and A.J.G. designed and performed experiments; H. X. performed computational analysis; D. C. and D. W. T. performed in vitro assays; H. P. performed in situ hybridizations; Y.M., G.J.H., and S. C. helped with initial small RNA library sequencing and discussion; E. M. provided recombinant Ago2; S. M. provided small RNA Normalized growth Growth density (au) sequencing; S. A. W. and N.L. designed the zinc finger nucleases; and A.J.G. wrote the manuscript. Sequencing data are deposited in Gene Expression Omnibus (accession number GSE21503). Normalized growth Growth density (au)	Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812; Qian F, 2007, PLOS BIOL, V5, P1110, DOI 10.1371/journal.pbio.0050132; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tan GS, 2009, NUCLEIC ACIDS RES, V37, P7533, DOI 10.1093/nar/gkp812; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Weinstein BM, 1996, DEVELOPMENT, V123, P303; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251	29	597	643	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1694	1698		10.1126/science.1190809	http://dx.doi.org/10.1126/science.1190809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20448148	Green Accepted			2022-12-24	WOS:000279107400043
J	Deer, B				Deer, Brian			Autism Research Wakefield's "autistic enterocolitis" under the microscope	BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS; PATTERNS; DISORDER; CHILDREN; COLON											BARR R, 1996, PROPOSED PROTOCOL CO; BARTRAM CI, 1994, BAILLIERE CLIN GAST, V8, P108; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; BUNTING C, 2004, INDEPENDENT     0221; Carpenter HA, 2000, AM J GASTROENTEROL, V95, P878; DEER B, 2009, SUNDAY TIMES    0208; DEER B, 2004, SUNDAY TIMES    0222; Fernell E, 2007, ACTA PAEDIATR, V96, P1076, DOI 10.1111/j.1651-2227.2007.00298.x; General Medical Council, 2010, FITN PRACT PAN HEAR; Jenkins D, 1997, J CLIN PATHOL, V50, P93, DOI 10.1136/jcp.50.2.93; JEPSON B, C PRESENTATIONS; LEVINE DS, 1989, AM J SURG PATHOL, V13, P966, DOI 10.1097/00000478-198911000-00008; MACDONALD TT, 2007, IMMUNOLOGY DIS GUT; MOLAVI DM, 2008, PRACTICE SURG PATHOL, P65; Montgommery EA, 2005, BIOPSY INTERPRETATIO, P213; Murch S, 1998, LANCET, V351, P908, DOI 10.1016/S0140-6736(05)70323-8; Murch SH, 2004, LANCET, V363, P750, DOI 10.1016/S0140-6736(04)15715-2; *ROYAL FREE HAMP N, 1996, ETH PRACT SUBC PROT; Sandhu B, 2009, ARCH DIS CHILD, V94, P497, DOI 10.1136/adc.2008.148866; WAKEFIELD A, COMPLAINT PRESS COMP; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Walker-Smith JA, 1983, PRACTICAL PAEDIAT GA; [No title captured]	23	11	11	0	21	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 15	2010	340								c1127	10.1136/bmj.c1127	http://dx.doi.org/10.1136/bmj.c1127			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	586KC	20395277	Bronze			2022-12-24	WOS:000276905500001
J	Hansen, SG; Powers, CJ; Richards, R; Ventura, AB; Ford, JC; Siess, D; Axthelm, MK; Nelson, JA; Jarvis, MA; Picker, LJ; Fruh, K				Hansen, Scott G.; Powers, Colin J.; Richards, Rebecca; Ventura, Abigail B.; Ford, Julia C.; Siess, Don; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Picker, Louis J.; Frueh, Klaus			Evasion of CD8(+) T Cells Is Critical for Superinfection by Cytomegalovirus	SCIENCE			English	Article							CLASS-I MOLECULES; GENE; INFECTION; IMMUNITY; MEMORY; VIRUS; CHALLENGE; PRODUCTS; PROTECTS; STRAINS	Cytomegalovirus (CMV) can superinfect persistently infected hosts despite CMV-specific humoral and cellular immunity; however, how it does so remains undefined. We have demonstrated that superinfection of rhesus CMV-infected rhesus macaques (RM) requires evasion of CD8(+) T cell immunity by virally encoded inhibitors of major histocompatibility complex class I (MHC-I) antigen presentation, particularly the homologs of human CMV US2, 3, 6, and 11. In contrast, MHC-I interference was dispensable for primary infection of RM, or for the establishment of a persistent secondary infection in CMV-infected RM transiently depleted of CD8(+) lymphocytes. These findings demonstrate that US2-11 glycoproteins promote evasion of CD8(+) T cells in vivo, thus supporting viral replication and dissemination during superinfection, a process that complicates the development of preventive CMV vaccines but that can be exploited for CMV-based vector development.	[Hansen, Scott G.; Powers, Colin J.; Richards, Rebecca; Ventura, Abigail B.; Ford, Julia C.; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Picker, Louis J.; Frueh, Klaus] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Siess, Don; Axthelm, Michael K.; Nelson, Jay A.; Picker, Louis J.; Frueh, Klaus] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center	Picker, LJ (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, 505 NW 185th Ave, Beaverton, OR 97006 USA.	pickerl@ohsu.edu; fruehk@ohsu.edu		Jarvis, Michael A/0000-0002-0124-4061; Frueh, Klaus/0000-0001-8014-3877	Centocor, Inc [AI040101, RR016001]; National Institutes of Health [RO1 AI059457, RO1 AI060392]; International AIDS Vaccine Initiative; National Center for Research Resources [RR016025, RR18107, RR00163]; Ruth L. Kirschstein National Research Service [T32 AI007472, T32 HL007781]; OHSU Tartar Trust fellowship; Achievement Reward for College Scientists; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR018107, P51RR000163, R24RR016001, U42RR016025, K01RR000163] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059457, R01AI060392, R01AI021640, R01AI040101, T32AI007472] Funding Source: NIH RePORTER	Centocor, Inc(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OHSU Tartar Trust fellowship; Achievement Reward for College Scientists; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to P. Barry for providing the RhCMV-GFP and RhCMV-BAC and M. Messerle for plasmid ori6k-F5. The NIH Nonhuman Primate Reagent Resource Program provided the CD8a-specific antibody cM-T807 used in this work (contracts AI040101 and RR016001), which was originally obtained from Centocor, Inc. We thank A. Townsend for help with the graphics. We thank D. Drummond, L. Coyne-Johnson, M. Spooner Lewis, C. Hughes, N. Whizin, M. Giday, J. Clock, J. Cook, J. Edgar, J. Dewane, and A. Legasse for technical assistance. This research was supported by the National Institutes of Health (RO1 AI059457 to K. F. and RO1 AI060392 to L. J. P.), the International AIDS Vaccine Initiative (to L. J. P.), the National Center for Research Resources (RR016025 and RR18107 to M. K. A.; RR00163 supporting the Oregon National Primate Research Center), the Ruth L. Kirschstein National Research Service Awards T32 AI007472 (to C. J. P.) and T32 HL007781 (to R. R.), the OHSU Tartar Trust fellowship (to C. J. P.), and the Achievement Reward for College Scientists (to R. R.). The CMV vector technology has been patented by Oregon Health and Science University (US2008/0199493A1) with L. J. P., J. A. N., and M. A. J. as coinventors. This patent has been licensed to the International AIDS Vaccine Initiative. The comparative genome sequencing data shown in fig. S5 were deposited in the Gene Expression Omnibus database (accession number GSE20308).	ADLER SP, 1995, J INFECT DIS, V171, P26, DOI 10.1093/infdis/171.1.26; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; Furman MH, 2002, J VIROL, V76, P11753, DOI 10.1128/JVI.76.22.11753-11756.2002; Gorman S, 2006, J GEN VIROL, V87, P1123, DOI 10.1099/vir.0.81583-0; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hewitt EW, 2001, EMBO J, V20, P387, DOI 10.1093/emboj/20.3.387; Krmpotic A, 1999, J EXP MED, V190, P1285, DOI 10.1084/jem.190.9.1285; Liu Z, 2009, INT J BIOCHEM CELL B, V41, P503, DOI 10.1016/j.biocel.2008.10.012; Meyer-Konig U, 1998, LANCET, V352, P1280, DOI 10.1016/S0140-6736(05)70487-6; Pande NT, 2005, J VIROL, V79, P5786, DOI 10.1128/JVI.79.9.5786-5798.2005; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Pinto AK, 2005, VIRAL IMMUNOL, V18, P434, DOI 10.1089/vim.2005.18.434; PLOTKIN SA, 1989, J INFECT DIS, V159, P860, DOI 10.1093/infdis/159.5.860; Powers C, 2008, CURR TOP MICROBIOL, V325, P333; Powers CJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000150; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tirabassi RS, 2002, J VIROL, V76, P6832, DOI 10.1128/JVI.76.13.6832-6835.2002; van der Wal FJ, 2002, CURR TOP MICROBIOL, V269, P37; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603	20	199	222	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	2010	328	5974					102	106		10.1126/science.1185350	http://dx.doi.org/10.1126/science.1185350			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360110	Green Accepted			2022-12-24	WOS:000276202200045
J	Yang, WY; Lu, JM; Weng, JP; Jia, WP; Ji, LN; Xiao, JZ; Shan, ZY; Liu, J; Tian, HM; Ji, QH; Zhu, DL; Ge, JP; Lin, LX; Chen, L; Guo, XH; Zhao, ZG; Li, Q; Zhou, ZG; Shan, GL; He, J				Yang, Wenying; Lu, Juming; Weng, Jianping; Jia, Weiping; Ji, Linong; Xiao, Jianzhong; Shan, Zhongyan; Liu, Jie; Tian, Haoming; Ji, Qiuhe; Zhu, Dalong; Ge, Jiapu; Lin, Lixiang; Chen, Li; Guo, Xiaohui; Zhao, Zhigang; Li, Qiang; Zhou, Zhiguang; Shan, Guangliang; He, Jiang		China Natl Diabet Metab Disorders	Prevalence of Diabetes among Men and Women in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPAIRED FASTING GLUCOSE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; ADULT-POPULATION; EDUCATION; MELLITUS; OBESITY	BACKGROUND Because of the rapid change in lifestyle in China, there is concern that diabetes may become epidemic. We conducted a national study from June 2007 through May 2008 to estimate the prevalence of diabetes among Chinese adults. METHODS A nationally representative sample of 46,239 adults, 20 years of age or older, from 14 provinces and municipalities participated in the study. After an overnight fast, participants underwent an oral glucose-tolerance test, and fasting and 2-hour glucose levels were measured to identify undiagnosed diabetes and prediabetes (i.e., impaired fasting glucose or impaired glucose tolerance). Previously diagnosed diabetes was determined on the basis of self-report. RESULTS The age-standardized prevalences of total diabetes ( which included both previously diagnosed diabetes and previously undiagnosed diabetes) and prediabetes were 9.7% (10.6% among men and 8.8% among women) and 15.5% (16.1% among men and 14.9% among women), respectively, accounting for 92.4 million adults with diabetes (50.2 million men and 42.2 million women) and 148.2 million adults with prediabetes (76.1 million men and 72.1 million women). The prevalence of diabetes increased with increasing age (3.2%, 11.5%, and 20.4% among persons who were 20 to 39, 40 to 59, and >= 60 years of age, respectively) and with increasing weight (4.5%, 7.6%, 12.8%, and 18.5% among persons with a body-mass index [ the weight in kilograms divided by the square of the height in meters] of <18.5, 18.5 to 24.9, 25.0 to 29.9, and >= 30.0, respectively). The prevalence of diabetes was higher among urban residents than among rural residents (11.4% vs. 8.2%). The prevalence of isolated impaired glucose tolerance was higher than that of isolated impaired fasting glucose (11.0% vs. 3.2% among men and 10.9% vs. 2.2% among women). CONCLUSIONS These results indicate that diabetes has become a major public health problem in China and that strategies aimed at the prevention and treatment of diabetes are needed.	[Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China; [Lu, Juming] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Ji, Linong] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; [Shan, Zhongyan] Chinese Med Univ, Affiliated Hosp 1, Liaoling, Peoples R China; [Liu, Jie] Shanxi Prov Peoples Hosp, Taiyuan, Shanxi, Peoples R China; [Tian, Haoming] Sichuan Univ, W China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Ji, Qiuhe] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Zhu, Dalong] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Ge, Jiapu] Xinjiang Uygur Autonomous Reg Hosp, Urumqi, Xinjiang, Peoples R China; [Lin, Lixiang] Fujian Prov Hosp, Fuzhou, Fujiang, Peoples R China; [Chen, Li] Shandong Univ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Guo, Xiaohui] Peking Univ, Hosp 1, Beijing 100871, Peoples R China; [Zhao, Zhigang] Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China; [Li, Qiang] Harbin Med Univ, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Zhou, Zhiguang] Xiangya Second Hosp, Changsha, Hunan, Peoples R China; [Shan, Guangliang] Peking Union Med Coll, Beijing 100021, Peoples R China; [He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA	China-Japan Friendship Hospital; Chinese People's Liberation Army General Hospital; Sun Yat Sen University; Shanghai Jiao Tong University; Peking University; China Medical University; Shanxi People's Hospital; Sichuan University; Air Force Military Medical University; Nanjing University; Fujian Provincial Hospital; Shandong University; Peking University; Zhengzhou University; Harbin Medical University; Central South University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tulane University	Yang, WY (corresponding author), China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China.	ywy_1010@yahoo.com.cn	Li, Hongliang/AAV-1697-2020; Shi, Zumin/A-1093-2009; Linong, Ji/AAB-6543-2020; He, Jiang/AAF-5303-2020	Shi, Zumin/0000-0002-3099-3299; He, Jiang/0000-0002-8286-9652; Yang, Wenying/0000-0002-7997-9404; Zhou, Zhiguang/0000-0002-0374-1838; Weng, Jianping/0000-0002-7889-1697	Chinese Medical Association Foundation; Chinese Diabetes Society	Chinese Medical Association Foundation; Chinese Diabetes Society	Supported by grants from the Chinese Medical Association Foundation and Chinese Diabetes Society.	[Anonymous], 1981, Zhonghua Nei Ke Za Zhi, V20, P678; Borrell LN, 2006, AM J PUBLIC HEALTH, V96, P1637, DOI 10.2105/AJPH.2005.072884; Brancati FL, 1997, JAMA-J AM MED ASSOC, V278, P2069, DOI 10.1001/jama.278.23.2069; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; *DEP NONC DIS SURV, 1999, DEF DIAGN CLASS DIAB; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; *INT DIAB FED, 2008, DIAB ATL; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Ko GTC, 2001, EUR J EPIDEMIOL, V17, P289, DOI 10.1023/A:1017935707807; Leeder S, 2004, RACE TIME CHALLENGE; Levitzky YS, 2008, J AM COLL CARDIOL, V51, P264, DOI 10.1016/j.jacc.2007.09.038; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li GW, 1996, CHINESE MED J-PEKING, V109, P599; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Luepker R. V., 2004, Cardiovascular survey methods; Muntner P, 2005, AM J PUBLIC HEALTH, V95, P1631, DOI 10.2105/AJPH.2004.044743; *NAT BUR STAT CHIN, 2006, CHIN STAT YB 2006; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; *PLAN OP 3 NAT HLT, 1994, VITAL HLTH STAT, V32, P1; Qiao Q, 2000, DIABETOLOGIA, V43, P1470, DOI 10.1007/s001250051557; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Schramm TK, 2008, CIRCULATION, V117, P1945, DOI 10.1161/CIRCULATIONAHA.107.720847; Seeman T, 2008, SOC SCI MED, V66, P72, DOI 10.1016/j.socscimed.2007.08.027; Singh RB, 1998, INT J CARDIOL, V66, P65, DOI 10.1016/S0167-5273(98)00141-7; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yan LJL, 2006, JAMA-J AM MED ASSOC, V295, P1793, DOI 10.1001/jama.295.15.1793; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5	33	2348	3757	26	782	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1090	1101		10.1056/NEJMoa0908292	http://dx.doi.org/10.1056/NEJMoa0908292			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335585	Bronze			2022-12-24	WOS:000275894600006
J	Detering, KM; Hancock, AD; Reade, MC; Silvester, W				Detering, Karen M.; Hancock, Andrew D.; Reade, Michael C.; Silvester, William			The impact of advance care planning on end of life care in elderly patients: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DECISION-MAKING; FAMILY-MEMBERS; MEDICAL-CARE; EVENT SCALE; DISCUSSIONS; DIRECTIVES; DEATH; DEPRESSION; SYMPTOMS; AUTONOMY	Objective To investigate the impact of advance care planning on end of life care in elderly patients. Design Prospective randomised controlled trial. Setting Single centre study in a university hospital in Melbourne, Australia. Participants 309 legally competent medical inpatients aged 80 or more and followed for six months or until death. Interventions Participants were randomised to receive usual care or usual care plus facilitated advance care planning. Advance care planning aimed to assist patients to reflect on their goals, values, and beliefs; to consider future medical treatment preferences; to appoint a surrogate; and to document their wishes. Main outcome measures The primary outcome was whether a patient's end of life wishes were known and respected. Other outcomes included patient and family satisfaction with hospital stay and levels of stress, anxiety, and depression in relatives of patients who died. Results 154 of the 309 patients were randomised to advance care planning, 125 (81%) received advance care planning, and 108 (84%) expressed wishes or appointed a surrogate, or both. Of the 56 patients who died by six months, end of life wishes were much more likely to be known and followed in the intervention group (25/29, 86%) compared with the control group (8/27, 30%; P<0.001). In the intervention group, family members of patients who died had significantly less stress (intervention 5, control 15; P<0.001), anxiety (intervention 0, control 3; P=0.02), and depression (intervention 0, control 5; P=0.002) than those of the control patients. Patient and family satisfaction was higher in the intervention group. Conclusions Advance care planning improves end of life care and patient and family satisfaction and reduces stress, anxiety, and depression in surviving relatives. Trial registration Australian New Zealand clinical trials registry ACTRN12608000539336.	[Detering, Karen M.; Hancock, Andrew D.; Silvester, William] Austin Hlth, Respecting Patient Choices Program, Heidelberg, Vic 3084, Australia; [Reade, Michael C.] Austin Hlth, Intens Care Unit, Heidelberg, Vic 3084, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Detering, KM (corresponding author), Austin Hlth, Respecting Patient Choices Program, POB 555, Heidelberg, Vic 3084, Australia.	Karen.detering@austin.org.au	Reade, Michael/G-7035-2012	Reade, Michael/0000-0003-1570-0707	Australian Commonwealth; Victorian state governments	Australian Commonwealth; Victorian state governments	Funding: This study was carried out using staff employed in the Respecting Patient Choices programme, which receives public funding from the Australian Commonwealth and the Victorian state governments. No external funding was utilised.	Adams DH, 2006, J AM OSTEOPATH ASSOC, V106, P402; *AUSTR MED ASS, 1998, OP 2 225 OPT US ORD; *AUSTR MED ASS, 2006, AMA BACKS ADV CAR PL; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Briggs LA, 2004, J PROF NURS, V20, P47, DOI 10.1016/j.profnurs.2003.12.001; Briggs Linda, 2004, J Palliat Med, V7, P341, DOI 10.1089/109662104773709503; *BRIT MED ASS, 2007, END OF LIF DEC; Cartwright Colleen M, 2004, Aust Fam Physician, V33, P815; Drazen JM, 2009, NEW ENGL J MED, V360, P444, DOI 10.1056/NEJMp0809496; EMANUEL LL, 1991, NEW ENGL J MED, V324, P889, DOI 10.1056/NEJM199103283241305; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Gillick MR, 2004, NEW ENGL J MED, V350, P7, DOI 10.1056/NEJMp038202; Grimaldo DA, 2001, ANESTHESIOLOGY, V95, P43, DOI 10.1097/00000542-200107000-00012; Hammes BJ, 1998, ARCH INTERN MED, V158, P383, DOI 10.1001/archinte.158.4.383; HAMMES BJ, 1999, LESSONS RESPECTING Y; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Keay Timothy J, 2003, J Palliat Med, V6, P205, DOI 10.1089/109662103764978452; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Levinsky NG, 1996, NEW ENGL J MED, V335, P741, DOI 10.1056/NEJM199609053351012; Medical Research Council, 2008, DEV EV COMPL INT NEW; MORRISON RS, 1994, ARCH INTERN MED, V154, P2311, DOI 10.1001/archinte.154.20.2311; Pearlman RA, 2005, ARCH INTERN MED, V165, P667, DOI 10.1001/archinte.165.6.667; Perkins HS, 2007, ANN INTERN MED, V147, P51, DOI 10.7326/0003-4819-147-1-200707030-00008; Pochard F, 2001, CRIT CARE MED, V29, P1893, DOI 10.1097/00003246-200110000-00007; Prendergast TJ, 2001, CRIT CARE MED, V29, pN34, DOI 10.1097/00003246-200102001-00007; Ramsaroop SD, 2007, J AM GERIATR SOC, V55, P277, DOI 10.1111/j.1532-5415.2007.01065.x; Romer Anna L, 2004, J Palliat Med, V7, P335, DOI 10.1089/109662104773709495; Schwartz Carolyn, 2003, J Palliat Med, V6, P593, DOI 10.1089/109662103768253704; Schwartz CE, 2002, ARCH INTERN MED, V162, P1611, DOI 10.1001/archinte.162.14.1611; Singer PA, 1998, ARCH INTERN MED, V158, P879, DOI 10.1001/archinte.158.8.879; Singer PA, 1996, CAN MED ASSOC J, V155, P1689; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Skene L., 2008, LAW MED PRACTICE RIG, V3rd, P346; Song MK, 2005, MED CARE, V43, P1049, DOI 10.1097/01.mlr.0000178192.10283.b4; Song MK, 2004, NURS OUTLOOK, V52, P118, DOI 10.1016/j.outlook.2003.10.014; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Sundin EC, 2003, PSYCHOSOM MED, V65, P870, DOI 10.1097/01.PSY.0000084835.46074.F0; *SUPPORT PRINC INV, 1996, JAMA-J AM MED ASSOC, V275, P1232, DOI DOI 10.1001/JAMA.1995.03530200027032; Tierney WM, 2001, J GEN INTERN MED, V16, P32, DOI 10.1111/j.1525-1497.2001.00215.x; Tilden VP, 2001, NURS RES, V50, P105, DOI 10.1097/00006199-200103000-00006; Tolle SW, 1998, J AM GERIATR SOC, V46, P1097, DOI 10.1111/j.1532-5415.1998.tb06647.x; Tulsky JA, 2005, JAMA-J AM MED ASSOC, V294, P359, DOI 10.1001/jama.294.3.359; Volandes AE, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2159; Winzelberg GS, 2005, J AM GERIATR SOC, V53, P1046, DOI 10.1111/j.1532-5415.2005.53317.x; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	46	1407	1426	3	62	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2010	340								c1345	10.1136/bmj.c1345	http://dx.doi.org/10.1136/bmj.c1345			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	576PO	20332506	Green Published, Green Submitted, hybrid			2022-12-24	WOS:000276157600005
J	Kitamura, T; Iwami, T; Kawamura, T; Nagao, K; Tanaka, H; Hiraide, A				Kitamura, Tetsuhisa; Iwami, Taku; Kawamura, Takashi; Nagao, Ken; Tanaka, Hideharu; Hiraide, Atsushi		All-Japan Utstein Registry Fire	Nationwide Public-Access Defibrillation in Japan.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; HOSPITAL CARDIAC-ARREST; AUTOMATED EXTERNAL DEFIBRILLATOR; EUROPEAN-RESUSCITATION-COUNCIL; CARDIOPULMONARY-RESUSCITATION; STROKE-FOUNDATION; TASK-FORCE; STATEMENT; SURVIVAL; CARE	Background: It is unclear whether dissemination of automated external defibrillators (AEDs) in public places can improve the rate of survival among patients who have had an out-of-hospital cardiac arrest. Methods: From January 1, 2005, through December 31, 2007, we conducted a prospective, population-based, observational study involving consecutive patients across Japan who had an out-of-hospital cardiac arrest and in whom resuscitation was attempted by emergency responders. We evaluated the effect of nationwide dissemination of public-access AEDs on the rate of survival after an out-of-hospital cardiac arrest. The primary outcome measure was the 1-month rate of survival with minimal neurologic impairment. A multivariate logistic-regression analysis was performed to assess factors associated with a good neurologic outcome. Results: A total of 312,319 adults who had an out-of-hospital cardiac arrest were included in the study; 12,631 of these patients had ventricular fibrillation and had an arrest that was of cardiac origin and that was witnessed by bystanders. In 462 of these patients (3.7%), shocks were administered by laypersons with the use of public-access AEDs, and the proportion increased, from 1.2% to 6.2%, as the number of public-access AEDs increased (P<0.001 for trend). Among all patients who had a bystander-witnessed arrest of cardiac origin and who had ventricular fibrillation, 14.4% were alive at 1 month with minimal neurologic impairment; among patients who received shocks from public-access AEDs, 31.6% were alive at 1 month with minimal neurologic impairment. Early defibrillation, regardless of the type of provider (bystander or emergency-medical-services personnel), was associated with a good neurologic outcome after a cardiac arrest with ventricular fibrillation (adjusted odds ratio per 1-minute increase in the time to administration of shock, 0.91; 95% confidence interval, 0.89 to 0.92; P<0.001). The mean time to shock was reduced from 3.7 to 2.2 minutes, and the annual number of patients per 10 million population who survived with minimal neurologic impairment increased from 2.4 to 8.9 as the number of public-access AEDs increased from fewer than 1 per square kilometer of inhabited area to 4 or more. Conclusions: Nationwide dissemination of public-access AEDs in Japan resulted in earlier administration of shocks by laypersons and in an increase in the 1-month rate of survival with minimal neurologic impairment after an out-of-hospital cardiac arrest. N Engl J Med 2010;362:994-1004.	[Iwami, Taku] Kyoto Univ, Hlth Serv, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan; [Hiraide, Atsushi] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Kyoto 6068501, Japan; [Nagao, Ken] Surugadai Nihon Univ Hosp, Dept Cardiol Cardiopulm Resuscitat & Emergency Ca, Tokyo, Japan; [Tanaka, Hideharu] Kokushikan Univ, Grad Sch Sport Syst, Tokyo, Japan	Kyoto University; Kyoto University; Nihon University	Iwami, T (corresponding author), Kyoto Univ, Hlth Serv, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	iwamit@e-mail.jp	Kitamura, Tetsuhisa/AAA-2555-2020; IWAMI, Taku/HCH-0599-2022	Kitamura, Tetsuhisa/0000-0003-0107-0580; IWAMI, Taku/0000-0002-4150-7065	Fire and Disaster Management Agency; Ministry of Education, Culture, Sports, Science and Technology [19390458]	Fire and Disaster Management Agency; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by grants from the Fire and Disaster Management Agency (to Dr. Hiraide, on behalf of the study group concerning strategy for applying the results of Utstein report for improvement of emergency service) and the Ministry of Education, Culture, Sports, Science and Technology (19390458).	[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; [Anonymous], 2007, JAP GUID EM CAR CARD; Bardy GH, 2008, NEW ENGL J MED, V358, P1793, DOI 10.1056/NEJMoa0801651; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; Capucci A, 2002, CIRCULATION, V106, P1065, DOI 10.1161/01.CIR.0000028148.62305.69; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Hazinski MF, 2005, CIRCULATION, V111, P3336, DOI 10.1161/CIRCULATIONAHA.105.165674; *HLTH WELF STAT AS, 2007, VIT STAT JAP 2005; Holzer M, 2002, NEW ENGL J MED, V346, P549; Iwami T, 2009, CIRCULATION, V119, P728, DOI 10.1161/CIRCULATIONAHA.108.802058; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; *JAP STAT ASS, 2005, SOC IND PREF 2005; *JAP STAT ASS, 2006, 2005 POP CENS JAP; Kuramoto N, 2008, RESUSCITATION, V79, P475, DOI 10.1016/j.resuscitation.2008.07.005; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; MacDonald RD, 2001, ANN EMERG MED, V38, P262, DOI 10.1067/mem.2001.117953; *MIN INT AFF COMM, AMB SERV PLANN OFF F; Mitamura H, 2008, NAT CLIN PRACT CARD, V5, P690, DOI 10.1038/ncpcardio1330; Nichol G, 2009, ANN EMERG MED, V54, P226, DOI 10.1016/j.annemergmed.2009.01.021; Nishiyama C, 2008, RESUSCITATION, V79, P90, DOI 10.1016/j.resuscitation.2008.05.009; Page RL, 2000, NEW ENGL J MED, V343, P1210, DOI 10.1056/NEJM200010263431702; Rea TD, 2003, CIRCULATION, V107, P2780, DOI 10.1161/01.CIR.0000070950.17208.2A; Rea TD, 2006, CIRCULATION, V114, P2760, DOI 10.1161/CIRCULATIONAHA.106.654715; Sayre MR, 2008, CIRCULATION, V117, P2162, DOI 10.1161/CIRCULATIONAHA.107.189380; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; van Alem AP, 2003, BMJ-BRIT MED J, V327, P1312, DOI 10.1136/bmj.327.7427.1312; White RD, 2005, RESUSCITATION, V65, P279, DOI 10.1016/j.resuscitation.2004.10.018; REPORT STUDY SOCIAL; JAPAN FDN EMERGENCY	32	401	406	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11					994	1004		10.1056/NEJMoa0906644	http://dx.doi.org/10.1056/NEJMoa0906644			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570CY	20237345	Bronze, Green Published			2022-12-24	WOS:000275650400010
J	Hawkes, N				Hawkes, Nigel			Medicine and the Media Prostate screening: is the tide turning against the test?	BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER					nigel.hawkes1@btinternet.com						ABLIN R, 2010, NY TIMES        0309; Roehr B, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1293; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084	3	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 17	2010	340								c1497	10.1136/bmj.c1497	http://dx.doi.org/10.1136/bmj.c1497			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	573RG	20236997				2022-12-24	WOS:000275931700006
J	Oshima, K; Shin, K; Diensthuber, M; Peng, AW; Ricci, AJ; Heller, S				Oshima, Kazuo; Shin, Kunyoo; Diensthuber, Marc; Peng, Anthony W.; Ricci, Anthony J.; Heller, Stefan			Mechanosensitive Hair Cell-like Cells from Embryonic and Induced Pluripotent Stem Cells	CELL			English	Article							OTIC PLACODE INDUCTION; INNER-EAR DEVELOPMENT; DEVELOPMENTAL ACQUISITION; SENSORY TRANSDUCTION; PAX-2 EXPRESSION; ACTIN-FILAMENTS; HEAD INDUCTION; MOUSE COCHLEA; TIP-LINK; IN-VITRO	Mechanosensitive sensory hair cells are the linchpin of our senses of hearing and balance. The inability of the mammalian inner ear to regenerate lost hair cells is the major reason for the permanence of hearing loss and certain balance disorders. Here, we present a step-wise guidance protocol starting with mouse embryonic stem and induced pluripotent stem cells, which were directed toward becoming ectoderm capable of responding to otic-inducing growth factors. The resulting otic progenitor cells were subjected to varying differentiation conditions, one of which promoted the organization of the cells into epithelial clusters displaying hair cell-like cells with stereociliary bundles. Bundle-bearing cells in these clusters responded to mechanical stimulation with currents that were reminiscent of immature hair cell transduction currents.	[Oshima, Kazuo; Shin, Kunyoo; Diensthuber, Marc; Peng, Anthony W.; Ricci, Anthony J.; Heller, Stefan] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Oshima, Kazuo; Shin, Kunyoo; Diensthuber, Marc; Peng, Anthony W.; Ricci, Anthony J.; Heller, Stefan] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Heller, S (corresponding author), Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA.	hellers@stanford.edu		Peng, Anthony/0000-0002-2208-6779; Shin, Kunyoo/0000-0002-1519-9839; ricci, anthony/0000-0002-1706-8904	National Institutes of Health [DC006167, P30DC010363]; California Institute for Regenerative Medicine [RC1-00119-1]; McKnight Endowment Fund for Neuroscience; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006167, R21DC010042, R01DC003896, P30DC010363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); McKnight Endowment Fund for Neuroscience; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank H. Zeng (Stanford Transgenic Research Center) for help with ESC line derivation; J. Johnson (UT Southwestern) for Math1/nGFP mice; U. Mueller (Scripps) for cadherin 23 antibody; G. Richardson for hair cell antigen antibody; F. Salles (National Institute on Deafness and Other Communication Disorders) for advice in electron microscopy sample preparation; L. Joubert (Stanford EM core facility) for expert assistance; M. Yazawa, R. Dolmetsch, and A. Ootani for help with teratoma assays; and K. Masaki, V. Starlinger, E. Corrales, M. Herget, Z. Guo, T. Jan, and S. Sinkkonen for fruitful discussions; M. D. is a fellow of the Alexander-von-Humboldt Foundation. This work was supported by National Institutes of Health grants DC006167 and P30DC010363, by the California Institute for Regenerative Medicine (grant RC1-00119-1), and by a Neuroscience of Brain Disorders Award from the McKnight Endowment Fund for Neuroscience.	Alsina B, 2004, DEV BIOL, V267, P119, DOI 10.1016/j.ydbio.2003.11.012; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Brigande JV, 2009, NAT NEUROSCI, V12, P679, DOI 10.1038/nn.2311; Brown ST, 2005, J COMP NEUROL, V483, P48, DOI 10.1002/cne.20418; Chen P, 1999, DEVELOPMENT, V126, P1581; Diensthuber M, 2009, JARO-J ASSOC RES OTO, V10, P173, DOI 10.1007/s10162-009-0161-3; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; Freter S, 2008, DEVELOPMENT, V135, P3415, DOI 10.1242/dev.026674; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Geleoc GSG, 2004, J NEUROSCI, V24, P11148, DOI 10.1523/JNEUROSCI.2662-04.2004; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Hans S, 2004, DEVELOPMENT, V131, P5091, DOI 10.1242/dev.01346; Heller N, 1999, DEV GENET, V24, P208, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<208::AID-DVG4>3.0.CO;2-J; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Hu ZQ, 2007, P NATL ACAD SCI USA, V104, P16675, DOI 10.1073/pnas.0704576104; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Lelli A, 2009, J NEUROPHYSIOL, V101, P2961, DOI 10.1152/jn.00136.2009; Li HW, 2004, J NEUROBIOL, V60, P61, DOI 10.1002/neu.20013; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; Lin HW, 2005, CURR OPIN CELL BIOL, V17, P55, DOI 10.1016/j.ceb.2004.12.005; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Marcotti W, 1999, PFLUG ARCH EUR J PHY, V439, P113, DOI 10.1007/s004240051134; Martin K, 2006, DEVELOPMENT, V133, P877, DOI 10.1242/dev.02267; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Michalski N, 2009, PFLUG ARCH EUR J PHY, V459, P115, DOI 10.1007/s00424-009-0711-x; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Oliver D, 1997, PFLUG ARCH EUR J PHY, V434, P772, DOI 10.1007/s004240050464; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pera EM, 2001, DEV CELL, V1, P655, DOI 10.1016/S1534-5807(01)00069-7; Phillips BT, 2004, DEVELOPMENT, V131, P923, DOI 10.1242/dev.00978; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Ricci A, 2002, J NEUROPHYSIOL, V87, P1738, DOI 10.1152/jn.00574.2001; ROWITCH DH, 1995, MECH DEVELOP, V52, P3, DOI 10.1016/0925-4773(95)00380-J; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TILNEY LG, 1983, J CELL BIOL, V96, P822, DOI 10.1083/jcb.96.3.822; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Vendrell V, 2000, DEVELOPMENT, V127, P2011; Waguespack J, 2007, J NEUROSCI, V27, P13890, DOI 10.1523/JNEUROSCI.2159-07.2007; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev.00555; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8; Zou D, 2004, DEVELOPMENT, V131, P5561, DOI 10.1242/dev.01437	61	208	237	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					704	716		10.1016/j.cell.2010.03.035	http://dx.doi.org/10.1016/j.cell.2010.03.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478259	Bronze, Green Accepted			2022-12-24	WOS:000277623600022
J	Lichtenstein, AH; Ludwig, DS				Lichtenstein, Alice H.; Ludwig, David S.			Bring Back Home Economics Education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BODY-MASS INDEX; FOOD; CHILDREN; US		[Lichtenstein, Alice H.] Tufts Univ, Cardiovasc Res Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Ludwig, David S.] Childrens Hosp, Dept Med, Optimal Weight Life Program, Boston, MA 02115 USA	Tufts University; United States Department of Agriculture (USDA); Harvard University; Boston Children's Hospital	Lichtenstein, AH (corresponding author), Tufts Univ, Cardiovasc Res Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, 711 Washington St, Boston, MA 02111 USA.	alice.lichtenstein@tufts.edu		Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24DK082730, K24 DK082730] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		DOLNICK S, 2010, NY TIMES        0312; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Larson NI, 2006, J AM DIET ASSOC, V106, P2001, DOI 10.1016/j.jada.2006.09.008; Nielsen SJ, 2002, OBES RES, V10, P370, DOI 10.1038/oby.2002.51; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; SEVERSON K, 2010, NY TIMES        0316; Taveras EM, 2005, PEDIATRICS, V116, pE518, DOI 10.1542/peds.2004-2732; Thompson OM, 2004, INT J OBESITY, V28, P282, DOI 10.1038/sj.ijo.0802538	10	151	152	1	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2010	303	18					1857	1858		10.1001/jama.2010.592	http://dx.doi.org/10.1001/jama.2010.592			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594DK	20460625	Green Accepted, Green Submitted			2022-12-24	WOS:000277513900027
J	Hsiang, MS; Abeyasinghe, R; Whittaker, M; Feachem, RGA				Hsiang, Michelle S.; Abeyasinghe, Rabindra; Whittaker, Maxine; Feachem, Richard G. A.			Malaria elimination in Asia-Pacific: an under-told story	LANCET			English	Editorial Material							ERADICATION		[Hsiang, Michelle S.; Feachem, Richard G. A.] UCSF Global Hlth Sci, Global Hlth Grp, San Francisco, CA 94105 USA; [Abeyasinghe, Rabindra] Sri Lanka Natl Malaria Control Program, Colombo, Sri Lanka; [Whittaker, Maxine] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	University of California System; University of California San Francisco; University of Queensland	Hsiang, MS (corresponding author), UCSF Global Hlth Sci, Global Hlth Grp, San Francisco, CA 94105 USA.	hsiangm@peds.ucsf.edu	Whittaker, Maxine/H-1990-2011	Whittaker, Maxine/0000-0002-1677-2991				[Anonymous], 2008 MDG MAL SUMM WO; [Anonymous], 2008, GLOB MAL CONTR EL RE; *APMEN, APMEN 2 M P; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dysoley L, 2008, ACTA TROP, V106, P207, DOI 10.1016/j.actatropica.2007.01.007; Feachem RGA, 2009, SHRINKING MALARIA MA; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; *IRIN, 2008, 6 PROV DECL MAL FREE; Kaneko A, 2000, LANCET, V356, P1560, DOI 10.1016/S0140-6736(00)03127-5; Park J, 2009, IND HEALTH, V47, P50, DOI 10.2486/indhealth.47.50; Pinikahana Jayaratne, 1993, Indian Journal of Malariology, V30, P51; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; *WHO, 2008, MAL SIT SRI LANK; *WHO, 2009, LAUNCH M STRAT CONT; *WHO, WORLD MAL REP 2009; *WHO MEK MAL PROGR, 2009, STRAT PLAN STRENGTH; Yip Ka-che, 2009, DIS COLONIALISM STAT; Zhou YH, 2007, J RARE EARTH, V25, P41; 2009, HINDU           0128	19	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 8	2010	375	9726					1586	1587		10.1016/S0140-6736(10)60350-9	http://dx.doi.org/10.1016/S0140-6736(10)60350-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597CX	20452505				2022-12-24	WOS:000277734700007
J	Baker, M				Baker, M.			RNA interference Micrornas as biomarkers	NATURE			English	Editorial Material																			0	15	16	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2010	464	7292					1227	1227						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20414310	Bronze			2022-12-24	WOS:000276891100047
J	Baker, M				Baker, Monya			RNA interference From tools to therapies	NATURE			English	Editorial Material																			0	0	0	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2010	464	7292					1225	1225						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20414309	Bronze			2022-12-24	WOS:000276891100046
J	Nicoli, S; Standley, C; Walker, P; Hurlstone, A; Fogarty, KE; Lawson, ND				Nicoli, Stefania; Standley, Clive; Walker, Paul; Hurlstone, Adam; Fogarty, Kevin E.; Lawson, Nathan D.			MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis	NATURE			English	Article							DEVELOPING ZEBRAFISH; TIP CELLS; FORCES; EXPRESSION	Within the circulatory system, blood flow regulates vascular remodelling(1), stimulates blood stem cell formation(2), and has a role in the pathology of vascular disease(3). During vertebrate embryogenesis, vascular patterning is initially guided by conserved genetic pathways that act before circulation(4). Subsequently, endothelial cells must incorporate the mechanosensory stimulus of blood flow with these early signals to shape the embryonic vascular system(4). However, few details are known about how these signals are integrated during development. To investigate this process, we focused on the aortic arch (AA) blood vessels, which are known to remodel in response to blood flow(1). By using two-photon imaging of live zebrafish embryos, we observe that flow is essential for angiogenesis during AA development. We further find that angiogenic sprouting of AA vessels requires a flow-induced genetic pathway in which the mechano-sensitive zinc finger transcription factor klf2a(5-7) induces expression of an endothelial-specific microRNA, mir-126, to activate Vegf signalling. Taken together, our work describes a novel genetic mechanism in which a microRNA facilitates integration of a physiological stimulus with growth factor signalling in endothelial cells to guide angiogenesis.	[Nicoli, Stefania; Lawson, Nathan D.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Standley, Clive; Fogarty, Kevin E.] Univ Massachusetts, Sch Med, Program Mol Med, Biomed Imaging Grp, Worcester, MA 01605 USA; [Walker, Paul; Hurlstone, Adam] Univ Manchester, Fac Life Sci, Mol Canc Studies Grp, Manchester M13 9PT, Lancs, England	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Manchester	Lawson, ND (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	nathan.lawson@umassmed.edu	Nicoli, Stefania/P-8627-2019	Walker, Paul/0000-0002-7840-9709; Lawson, Nathan/0000-0001-7788-9619; Hurlstone, Adam/0000-0001-5260-9457	National Heart, Lung, and Blood Institute and National Cancer Institute; National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes Endocrinology Research Center (DERC) [DK32520]; NATIONAL CANCER INSTITUTE [R01CA107454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute and National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes Endocrinology Research Center (DERC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank B. Roman, V. Ambros and C. Sagerstrom for critical review of the manuscript. We thank J.-N. Chen for providing the Tg(kdrl:egfp)<SUP>la116</SUP> zebrafish line. We appreciate the assistance of T. Stork and M. Freeman for help in performing laser assisted microsurgery. We also thank C. Grabher for the gift of gata1 morpholino. We are grateful to M. Beltrame for providing the cdh5 plasmid and T. Smith and S. Sheppard for technical assistance. We thank M. Green and N. Wajapeyee for the Ras-transformed NIH3T3 cell line. This work was supported in part by grants from the National Heart, Lung, and Blood Institute and National Cancer Institute (N. D. L.). The Bioimaging Group (C. S. and K. E. F.) is a core resource supported by a Diabetes Endocrinology Research Center (DERC) grant DK32520 from the National Institute of Diabetes and Digestive and Kidney Diseases. N. D. L and K. E. F are members of the UMass DERC (DK32520). We apologize to researchers whose work we were unable to cite due to space constraints.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Anderson MJ, 2008, DEV BIOL, V318, P258, DOI 10.1016/j.ydbio.2008.03.022; Covassin LD, 2009, DEV BIOL, V329, P212, DOI 10.1016/j.ydbio.2009.02.031; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; le Noble F, 2008, CARDIOVASC RES, V78, P232, DOI 10.1093/cvr/cvn058; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Meadows SM, 2009, DEVELOPMENT, V136, P1115, DOI 10.1242/dev.029538; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Roman BL, 2002, DEVELOPMENT, V129, P3009; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Serluca FC, 2002, CURR BIOL, V12, P492, DOI 10.1016/S0960-9822(02)00694-2; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Westerfield M, 1993, ZEBRAFISH BOOK; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yashiro K, 2007, NATURE, V450, P285, DOI 10.1038/nature06254	30	341	365	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1196	U118		10.1038/nature08889	http://dx.doi.org/10.1038/nature08889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20364122	Green Accepted, Green Submitted			2022-12-24	WOS:000276891100038
J	Dheda, K; Shean, K; Zumla, A; Badri, M; Streicher, EM; Page-Shipp, L; Willcox, P; John, MA; Reubenson, G; Govindasamy, D; Wong, M; Padanilam, X; Dziwiecki, A; van Helden, PD; Siwendu, S; Jarand, J; Menezes, CN; Burns, A; Victor, T; Warren, R; Grobusch, MP; van der Walt, M; Kvasnovsky, C				Dheda, Keertan; Shean, Karen; Zumla, Alimuddin; Badri, Motasim; Streicher, Elizabeth M.; Page-Shipp, Liesl; Willcox, Paul; John, Melanie-Anne; Reubenson, Gary; Govindasamy, Darshini; Wong, Michelle; Padanilam, Xavier; Dziwiecki, Alicia; van Helden, Paul D.; Siwendu, Sweetness; Jarand, Julie; Menezes, Colin N.; Burns, Avril; Victor, Thomas; Warren, Robin; Grobusch, Martin P.; van der Walt, Martie; Kvasnovsky, Charlotte			Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study	LANCET			English	Article							SUB-SAHARAN AFRICA; MULTIDRUG-RESISTANT; MYCOBACTERIUM-TUBERCULOSIS; XDR-TB; DIAGNOSIS; STRAIN; SUSCEPTIBILITY; MANAGEMENT; MODEL	Background Data from Kwazulu Natal, South Africa, suggest that almost all patients with extensively drug-resistant (XDR) tuberculosis are HIV-positive, with a fatal outcome. Since, there are few data for the treatment-related outcomes of XDR tuberculosis in settings with a high HIV prevalence, we investigated the associations of these diseases in such settings to formulate recommendations for control programmes. Methods In a retrospective cohort study, we analysed the case records of patients (>16 years old) with XDR tuberculosis (culture-proven at diagnosis) between August, 2002, and February, 2008, at four designated provincial treatment facilities in South Africa. We used Cox proportional hazards regression models to assess risk factors associated with the outcomes mortality and culture conversion. Findings 195 of 227 patients were analysed. 21 died before initiation of any treatment, and 174 patients (82 with HIV infection) were treated. 62 (36%) of these patients died during follow-up. The number of deaths was not significantly different in patients with or without HIV infection: 34 (41%) of 82 versus 28 (30%) of 92 (p=0.13). Treatment with moxifloxacin (hazard ratio 0.11, 95% CI 0.01-0.82; p=0.03), previous culture-proven multidrug-resistant tuberculosis (5.21, 1.93-14.1; p=0.001), and number of drugs used in a regimen (0.59, 0.45-0.78, p<0.0001) were independent predictors of death. Fewer deaths occurred in patients with HIV infection given highly active antiretroviral therapy than in those who were not (0.38, 0.18-0.80; p=0.01). 33 (19%) of 174 patients showed culture conversion, of which 23 (70%) converted within 6 months of initiation of treatment. Interpretation In South Africa, patients with XDR tuberculosis, a substantial proportion of whom are not infected with HIV, have poor management outcomes. Nevertheless, survival in patients with HIV infection is better than previously reported. The priorities for the country are still prevention of XDR tuberculosis, and early detection and management of multidrug-resistant and XDR tuberculosis through strengthened programmes and laboratory capacity.	[Dheda, Keertan; Shean, Karen; Badri, Motasim; Willcox, Paul; Govindasamy, Darshini] Univ Cape Town, Dept Med, Lung Inst, ZA-7925 Cape Town, South Africa; [Dheda, Keertan; Shean, Karen; Badri, Motasim; Willcox, Paul; Govindasamy, Darshini] Div Pulmonol, Lung Infect & Immun Unit, Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Dheda, Keertan; Zumla, Alimuddin] UCL, Dept Infect, Ctr Infect Dis & Int Hlth, London, England; [Padanilam, Xavier; Dziwiecki, Alicia; Grobusch, Martin P.] Sizwe Trop Dis Hosp, Johannesburg, South Africa; [John, Melanie-Anne; Menezes, Colin N.; Grobusch, Martin P.] Univ Witwatersrand, Natl Hlth Lab Serv, Johannesburg, South Africa; [John, Melanie-Anne; Menezes, Colin N.; Grobusch, Martin P.] Univ Witwatersrand, Div Clin Microbiol & Infect Dis, Johannesburg, South Africa; [John, Melanie-Anne; Menezes, Colin N.; Grobusch, Martin P.] Univ Witwatersrand, Fac Hlth Sci, Div Infect Dis, Johannesburg, South Africa; [Reubenson, Gary] Univ Witwatersrand, Dept Paediat, Johannesburg, South Africa; [Menezes, Colin N.] Univ Witwatersrand, Dept Med, ZA-2001 Johannesburg, South Africa; [Wong, Michelle] Univ Witwatersrand, Chris Hani Baragwanath Hosp, Johannesburg, South Africa; [Streicher, Elizabeth M.; van Helden, Paul D.; Victor, Thomas; Warren, Robin] Univ Stellenbosch, Dept Sci & Technol, Natl Res Fdn Ctr Excellence Biomed TB Res,Fac Hlt, Med Res Council Ctr Mol & Cellular Biol,Div Mol B, ZA-7505 Tygerberg, South Africa; [Siwendu, Sweetness; Burns, Avril] Brooklyn TB Chest Hosp, Cape Town, South Africa; [Page-Shipp, Liesl] Right Care, Johannesburg, South Africa; [Jarand, Julie] Univ Calgary, Calgary, AB, Canada; [van der Walt, Martie; Kvasnovsky, Charlotte] Med Res Council Pretoria, TB Epidemiol & Intervent Res Unit, Pretoria, South Africa; [Kvasnovsky, Charlotte] Emory Sch Med, Atlanta, GA USA; [Kvasnovsky, Charlotte] Rollins Sch Publ Hlth, Atlanta, GA USA	University of Cape Town; University of Cape Town; University of London; University College London; National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; National Research Foundation - South Africa; Stellenbosch University; University of Calgary; Emory University; Emory University; Rollins School Public Health	Dheda, K (corresponding author), Groote Schuur Hosp, Dept Med, H Floor,Old Main Bldg, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	ZUMLA, Alimuddin/ABA-8208-2020; Streicher, Elizabeth M/I-7780-2018; Streicher, Elizabeth/O-9597-2019; van der Walt, Martie/CAH-0101-2022; Badri, Motasim/E-1141-2013	ZUMLA, Alimuddin/0000-0002-5111-5735; Streicher, Elizabeth M/0000-0003-3901-1981; Streicher, Elizabeth/0000-0003-3901-1981; van der Walt, Martie/0000-0001-9987-3167; Warren, Robin/0000-0001-5741-7358; Badri, Motasim/0000-0002-5268-6492; Menezes, Colin/0000-0003-3838-5359	South African Research Chair Initiative; South African Medical Research Council; EU; European Developing Countries Clinical Trials Partnership (EDCTP); UK University College London Hospital National Health Service-Comprehensive Biomedical Research Centre; EuropeAID	South African Research Chair Initiative; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); European Developing Countries Clinical Trials Partnership (EDCTP); UK University College London Hospital National Health Service-Comprehensive Biomedical Research Centre; EuropeAID	KD and this work was supported by a South African Research Chair Initiative award, a South African Medical Research Council Career Development Fellowship, the EU (FW7-TBsusgent) and the European Developing Countries Clinical Trials Partnership (EDCTP). AZ acknowledges support from the UK University College London Hospital National Health Service-Comprehensive Biomedical Research Centre, EU(FW7-TBsusgent and TrDNA), EDCTP, and EuropeAID. We thank the management and staff of the following provincial tuberculosis facilities where the data was obtained: Brooklyn Chest Hospital (Cape Town, Western Cape), Josie Pearson Hospital (Port Elizabeth, Eastern Cape), Sizwe Hospital (Johannesburg, Gauteng), and Gordonia Hospital (Upington, Northern Cape). We are grateful for the assistance of the staff of the national and provincial tuberculosis programme, including Marlein Bosman, Gerrit Coetzee, Lindiwe Mvusi, Krish Vallabhjee, Jimmy Ledwaba, John Simpson, and Phyllis Baitiswe; and Gary Maartens for his helpful suggestions about the report.	Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Bonilla Cesar A, 2008, PLoS One, V3, pe2957, DOI 10.1371/journal.pone.0002957; Chan ED, 2008, NEW ENGL J MED, V359, P657, DOI 10.1056/NEJMc0706556; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Gandhi NR, 2009, JAIDS-J ACQ IMM DEF, V50, P37, DOI 10.1097/QAI.0b013e31818ce6c4; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Isenberg HD, 2004, CLIN MICROBIOLOGY PR; Jones KDJ, 2008, T ROY SOC TROP MED H, V102, P219, DOI 10.1016/j.trstmh.2007.11.014; Jugheli L, 2009, ANTIMICROB AGENTS CH, V53, P5064, DOI 10.1128/AAC.00851-09; Kam KM, 2006, MICROB DRUG RESIST, V12, P7, DOI 10.1089/mdr.2006.12.7; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Kwon YS, 2008, CLIN INFECT DIS, V47, P496, DOI 10.1086/590005; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; LoBue P, 2009, CURR OPIN INFECT DIS, V22, P167, DOI 10.1097/QCO.0b013e3283229fab; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Migliori GB, 2008, EUR RESPIR J, V31, P1155, DOI 10.1183/09031936.00028708; Migliori GB, 2008, EUR RESPIR J, V31, P904, DOI 10.1183/09031936.00159807; Migliori GB, 2007, EUR RESPIR J, V30, P623, DOI 10.1183/09031936.00077307; Migliori GB, 2008, CAN J INFECT DIS MED, V19, P169, DOI 10.1155/2008/857901; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; Padayatchi N, 2008, INT J TUBERC LUNG D, V12, P978; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Rook GAW, 2005, NAT REV IMMUNOL, V5, P661, DOI 10.1038/nri1666; Rook GAW, 2007, J INFECT DIS, V196, P191, DOI 10.1086/518937; Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; van Rie A, 1999, J INFECT DIS, V180, P1608, DOI 10.1086/315054; Via LE, 2010, J CLIN MICROBIOL, V48, P402, DOI 10.1128/JCM.01476-09; Warren R, 2006, J CLIN MICROBIOL, V44, P254, DOI 10.1128/JCM.44.1.254-256.2006; WHO, 2004, INT POL COLL TB HIV	41	188	194	1	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2010	375	9728					1798	1807		10.1016/S0140-6736(10)60492-8	http://dx.doi.org/10.1016/S0140-6736(10)60492-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603NY	20488525	Green Accepted			2022-12-24	WOS:000278216500031
J	Bayard, D				Bayard, Dominique			Haiti Earthquake Relief, Phase Two - Long-Term Needs and Local Resources	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Brennan RJ, 2006, NEW ENGL J MED, V354, P1769, DOI 10.1056/NEJMp068017; *PAN AM HLTH ORG, 2010, HAIT HLTH CLUST B EA; *UN OFF COORD HUM, 30 UN OFF COORD HUM; *UNICEF, HAIT EM RESP UPD MAR	4	21	21	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2010	362	20					1858	1861		10.1056/NEJMp1003839	http://dx.doi.org/10.1056/NEJMp1003839			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	598EI	20393163				2022-12-24	WOS:000277815600003
J	Ren, DJ				Ren, Dejian			Sperm and the Proton Channel	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FERTILITY; MOTILITY		Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Ren, DJ (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.							Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044	5	4	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2010	362	20					1934	1935		10.1056/NEJMcibr1001843	http://dx.doi.org/10.1056/NEJMcibr1001843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598EI	20484401				2022-12-24	WOS:000277815600016
J	Dispenzieri, A; Katzmann, JA; Kyle, RA; Larson, DR; Melton, LJ; Colby, CL; Therneau, TM; Clark, R; Kumar, SK; Bradwell, A; Fonseca, R; Jelinek, DF; Rajkumar, SV				Dispenzieri, Angela; Katzmann, Jerry A.; Kyle, Robert A.; Larson, Dirk R.; Melton, L. Joseph, III; Colby, Colin L.; Therneau, Terry M.; Clark, Raynell; Kumar, Shaji K.; Bradwell, Arthur; Fonseca, Rafael; Jelinek, D. F.; Rajkumar, S. Vincent			Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study	LANCET			English	Article							PRECEDES MULTIPLE-MYELOMA; LONG-TERM; SIGNIFICANCE MGUS; SERUM	Background Monoclonal gammopathy of undetermined significance (MGUS) is defined by expression of heavy-chain immunoglobulin (IgH) and is the precursor lesion for 80% of cases of multiple myeloma. The remaining 20% are characterised by absence of IgH expression; we aimed to assess prevalence of a corresponding precursor entity, light-chain MGUS. Methods We used a population-based cohort, previously assembled to estimate MGUS prevalence, of 21 463 residents of Olmsted County, MN, USA, aged 50 years and older. We did a serum free light-chain assay on all samples with sufficient serum remaining, and immunofixation electrophoresis was done for all samples with an abnormal free light-chain ratio or abnormal protein electrophoresis results from the original study. Light-chain MGUS was defined as an abnormal free light-chain ratio with no IgH expression, plus increased concentration of the involved light chain. We calculated age-specific and sex-specific prevalence and rates of progression to lymphoproliferative disorders for light-chain and conventional MGUS and assessed incidence of renal disorders in patients with light-chain MGUS. Findings 610 (3.3%) of 18 357 people tested had an abnormal free light-chain ratio, of whom 213 had IgH expression that was diagnostic of conventional MGUS. 146 of the remaining 397 individuals had an increase of at least one free light chain and met criteria for light-chain MGUS. Prevalence of light-chain MGUS was 0.8% (95% CI 0.7-0.9), contributing to an overall MGUS prevalence of 4.2% (3.9-4.5). Risk of progression to multiple myeloma in patients with light-chain MGUS was 0.3% (0.1-0.8) per 100 person-years. 30 (23%) of 129 patients with light-chain MGUS were diagnosed with renal disease. Interpretation We define a clinical entity representing the light-chain equivalent of conventional MGUS and posing a risk of progression to light-chain multiple myeloma and related disorders.	[Dispenzieri, Angela; Katzmann, Jerry A.; Kyle, Robert A.; Larson, Dirk R.; Melton, L. Joseph, III; Colby, Colin L.; Therneau, Terry M.; Clark, Raynell; Kumar, Shaji K.; Jelinek, D. F.; Rajkumar, S. Vincent] Mayo Clin, Rochester, MN 55905 USA; [Bradwell, Arthur] Univ Birmingham, Birmingham, W Midlands, England; [Fonseca, Rafael] Mayo Clin, Scottsdale, AZ USA	Mayo Clinic; University of Birmingham; Mayo Clinic; Mayo Clinic Phoenix	Dispenzieri, A (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	dispenzieri.angela@mayo.edu	Kumar, Shaji K/A-9853-2008; Rajkumar, S. Vincent/AAV-1834-2021	Kumar, Shaji K/0000-0001-5392-9284; Rajkumar, S. Vincent/0000-0002-5862-1833; Dispenzieri, Angela/0000-0001-8780-9512; Fonseca, Rafael/0000-0002-5938-3769; Bradwell, Arthur/0000-0002-1562-1606	US National Cancer Institute [CA 125614, CA062242, CA107476, CA150831, CA93842, CA83724, CA100080, CA100707]; Robert A Kyle Hematologic Malignancies Fund; NATIONAL CANCER INSTITUTE [R01CA107476, P50CA100707, R01CA100080, R01CA093842, R01CA083724, R01CA125614, P01CA062242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Robert A Kyle Hematologic Malignancies Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Investigators were supported in part by the US National Cancer Institute (grant numbers CA 125614, CA062242, CA107476, CA150831, CA93842, CA83724, CA100080, and CA100707). Support was also provided by the Robert A Kyle Hematologic Malignancies Fund. We thank The Binding Site, UK, for providing reagents and Tara Phelps and Carol Shipman for their work maintaining the samples and the Dysproteinemia database, respectively.	Ayliffe MJ, 2007, HAEMATOLOGICA, V92, P1135, DOI 10.3324/haematol.11133; Bida JP, 2009, MAYO CLIN PROC, V84, P685, DOI 10.1016/S0025-6196(11)60518-1; Bradwell AR, 2001, CLIN CHEM, V47, P673; Bradwell AR, 2003, LANCET, V361, P489, DOI 10.1016/S0140-6736(03)12457-9; Drayson M, 2001, BLOOD, V97, P2900, DOI 10.1182/blood.V97.9.2900; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hutchison CA, 2008, CLIN J AM SOC NEPHRO, V3, P1684, DOI 10.2215/CJN.02290508; Katzmann JA, 2002, CLIN CHEM, V48, P1437; Katzmann JA, 2006, MAYO CLIN PROC, V81, P1575, DOI 10.4065/81.12.1575; Katzmann JA, 2009, CLIN CHEM, V55, P1517, DOI 10.1373/clinchem.2009.126664; Kyle RA, 2004, CANCER-AM CANCER SOC, V101, P2667, DOI 10.1002/cncr.20652; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; KYLE RA, 1978, AM J MED, V64, P814, DOI 10.1016/0002-9343(78)90522-3; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; KYLE RA, 1982, NEW ENGL J MED, V306, P564, DOI 10.1056/NEJM198203113061002; Landgren O, 2006, BLOOD, V107, P904, DOI 10.1182/blood-2005-08-3449; Landgren O, 2009, BLOOD, V113, P5412, DOI 10.1182/blood-2008-12-194241; Magrangeas F, 2004, BLOOD, V103, P3869, DOI 10.1182/blood-2003-07-2501; Mead G P, 2003, Clin Lab, V49, P25; Melton LJ, 1998, OSTEOPOROSIS INT, V8, P68; Rajkumar SV, 2006, BLOOD, V108, p354B; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; Therneau TM, 2000, MODELING SURVIVAL DA; Tsai HT, 2009, BLOOD, V114, P4928, DOI 10.1182/blood-2009-08-237651; Weiss BM, 2009, BLOOD, V113, P5418, DOI 10.1182/blood-2008-12-195008	28	238	245	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2010	375	9727					1721	1728		10.1016/S0140-6736(10)60482-5	http://dx.doi.org/10.1016/S0140-6736(10)60482-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599DK	20472173	Green Accepted			2022-12-24	WOS:000277890200033
J	Stadtfeld, M; Apostolou, E; Akutsu, H; Fukuda, A; Follett, P; Natesan, S; Kono, T; Shioda, T; Hochedlinger, K				Stadtfeld, Matthias; Apostolou, Effie; Akutsu, Hidenori; Fukuda, Atsushi; Follett, Patricia; Natesan, Sridaran; Kono, Tomohiro; Shioda, Toshi; Hochedlinger, Konrad			Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells	NATURE			English	Article							NUCLEAR TRANSFER; ES CELLS; EXPRESSION; MICE; METHYLATION; GENERATION; CLUSTER; DIFFERENTIATION; FIBROBLASTS; CLONING	Induced pluripotent stem cells (iPSCs) have been generated by enforced expression of defined sets of transcription factors in somatic cells. It remains controversial whether iPSCs are molecularly and functionally equivalent to blastocyst-derived embryonic stem (ES) cells. By comparing genetically identical mouse ES cells and iPSCs, we show here that their overall messenger RNA and microRNA expression patterns are indistinguishable with the exception of a few transcripts encoded within the imprinted Dlk1-Dio3 gene cluster on chromosome 12qF1, which were aberrantly silenced in most of the iPSC clones. Consistent with a developmental role of the Dlk1-Dio3 gene cluster, these iPSC clones contributed poorly to chimaeras and failed to support the development of entirely iPSC-derived animals ('all-iPSC mice'). In contrast, iPSC clones with normal expression of the Dlk1-Dio3 cluster contributed to high-grade chimaeras and generated viable all-iPSC mice. Notably, treatment of an iPSC clone that had silenced Dlk1-Dio3 with a histone deacetylase inhibitor reactivated the locus and rescued its ability to support full-term development of all-iPSC mice. Thus, the expression state of a single imprinted gene cluster seems to distinguish most murine iPSCs from ES cells and allows for the prospective identification of iPSC clones that have the full development potential of ES cells.	[Stadtfeld, Matthias; Apostolou, Effie; Follett, Patricia; Hochedlinger, Konrad] Massachusetts Gen Hosp, Howard Hughes Med Inst, Ctr Regenerat Med, Harvard Stem Cell Inst, Boston, MA 02114 USA; [Stadtfeld, Matthias; Apostolou, Effie; Shioda, Toshi; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Stadtfeld, Matthias; Apostolou, Effie; Shioda, Toshi; Hochedlinger, Konrad] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Stadtfeld, Matthias; Apostolou, Effie; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Stadtfeld, Matthias; Apostolou, Effie; Hochedlinger, Konrad] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Akutsu, Hidenori] Natl Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo 1578535, Japan; [Fukuda, Atsushi; Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Tokyo 1568502, Japan; [Natesan, Sridaran] Sanofi Aventis, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; National Center for Child Health & Development - Japan; Tokyo University of Agriculture; Sanofi-Aventis	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Ctr Regenerat Med, Harvard Stem Cell Inst, 185 Cambridge St, Boston, MA 02114 USA.	khochedlinger@helix.mgh.harvard.edu	Apostolou, Effie/AAG-1559-2020	Stadtfeld, Matthias/0000-0002-5852-9906	Schering Foundation; Jane Coffin Childs postdoctoral fellowship; NIH; Harvard Stem Cell Institute; MGH; HHMI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	Schering Foundation; Jane Coffin Childs postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; MGH; HHMI(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to H. Arnold for assistance with GeneSifter analysis; K. Coser, K. Claycomb and P. August for technical support on Affymetrix expression profiling; S. Sato and M. Machida for technical assistance; V. Greco for advice on keratinocyte isolation; and S. Schubert for advice on miRNA isolation. We thank members of the Hochedlinger laboratory for helpful suggestions and A. Umezawa for discussions and support. M. S. was supported by a postdoctoral fellowship from the Schering Foundation, E. A. was supported by a Jane Coffin Childs postdoctoral fellowship and K. H. was supported by a NIH Director's Innovator Award and by funds provided by the Harvard Stem Cell Institute, MGH and HHMI.	Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Carr MS, 2007, GENOMICS, V89, P280, DOI 10.1016/j.ygeno.2006.10.005; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Coser KR, 2003, P NATL ACAD SCI USA, V100, P13994, DOI 10.1073/pnas.2235866100; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Dean W, 1998, DEVELOPMENT, V125, P2273; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Lin SP, 2007, DEVELOPMENT, V134, P417, DOI 10.1242/dev.02726; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; NAGY A, 1990, DEVELOPMENT, V110, P815; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ono Y, 2006, BIOL REPROD, V75, P210, DOI 10.1095/biolreprod.105.049171; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Schmidt JV, 2000, GENE DEV, V14, P1997; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Steshina EY, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-44; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi N, 2009, HUM MOL GENET, V18, P1879, DOI 10.1093/hmg/ddp108; Tevendale M, 2006, CYTOGENET GENOME RES, V113, P215, DOI 10.1159/000090835; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	50	611	649	0	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					175	U55		10.1038/nature09017	http://dx.doi.org/10.1038/nature09017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20418860	Green Accepted			2022-12-24	WOS:000277558500026
J	Theobald, DL				Theobald, Douglas L.			A formal test of the theory of universal common ancestry	NATURE			English	Article							GENETIC CODE; EVOLUTION; HYPOTHESES; LIKELIHOOD; SELECTION; PROTEINS; HOMOLOGY; ORIGIN; LIFE	Universal common ancestry (UCA) is a central pillar of modern evolutionary theory(1). As first suggested by Darwin(2), the theory of UCA posits that all extant terrestrial organisms share a common genetic heritage, each being the genealogical descendant of a single species from the distant past(3-6). The classic evidence for UCA, although massive, is largely restricted to 'local' common ancestry-for example, of specific phyla rather than the entirety of life-and has yet to fully integrate the recent advances from modern phylogenetics and probability theory. Although UCA is widely assumed, it has rarely been subjected to formal quantitative testing(7-10), and this has led to critical commentary emphasizing the intrinsic technical difficulties in empirically evaluating a theory of such broad scope(1,5,8,9,11-15). Furthermore, several researchers have proposed that early life was characterized by rampant horizontal gene transfer, leading some to question the monophyly of life(11,14,15). Here I provide the first, to my knowledge, formal, fundamental test of UCA, without assuming that sequence similarity implies genetic kinship. I test UCA by applying model selection theory(5,16,17) to molecular phylogenies, focusing on a set of ubiquitously conserved proteins that are proposed to be orthologous. Among a wide range of biological models involving the independent ancestry of major taxonomic groups, the model selection tests are found to overwhelmingly support UCA irrespective of the presence of horizontal gene transfer and symbiotic fusion events. These results provide powerful statistical evidence corroborating the monophyly of all known life.	Brandeis Univ, Dept Biochem, Waltham, MA 01778 USA	Brandeis University	Theobald, DL (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 01778 USA.	dtheobald@brandeis.edu	Theobald, Douglas L/F-3514-2013	Theobald, Douglas L/0000-0002-2695-8343				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Burnham K. P., 1998, MODEL SELECTION INFE; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; CRICK FHC, 1963, PROGR NUCL ACID RES, P163; DARWIN C, 1859, ORIGIN SPECIES NATUR, pCH14; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Doolittle WF, 2009, PHILOS T R SOC B, V364, P2221, DOI 10.1098/rstb.2009.0032; Doolittle WF, 2000, CURR OPIN STRUC BIOL, V10, P355, DOI 10.1016/S0959-440X(00)00096-8; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harlow LL., 1997, WHAT THERE WERE NO S; HINEGARDNER RT, 1963, SCIENCE, V142, P1083, DOI 10.1126/science.142.3595.1083; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; HUXLEY JS, 1943, EVOLUTION MODERN SYN, P397; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Mindell DP, 2001, TRENDS ECOL EVOL, V16, P434, DOI 10.1016/S0169-5347(01)02206-6; Murzin AG, 1998, CURR OPIN STRUC BIOL, V8, P380, DOI 10.1016/S0959-440X(98)80073-0; Penny D, 2003, J THEOR BIOL, V223, P377, DOI 10.1016/S0022-5193(03)00099-7; PENNY D, 1982, NATURE, V297, P197, DOI 10.1038/297197a0; Poole AM, 2007, BIOESSAYS, V29, P74, DOI 10.1002/bies.20516; Popper Karl., 1976, UNENDED QUEST INTELL; RAUP DM, 1983, P NATL ACAD SCI-BIOL, V80, P2981, DOI 10.1073/pnas.80.10.2981; REECK GR, 1987, CELL, V50, P667, DOI 10.1016/0092-8674(87)90322-9; Sober E, 2002, J THEOR BIOL, V218, P395, DOI 10.1006/jtbi.2002.3086; SOBER E, 2008, EVIDENCE EVOLUTION, pCH4; Syvanen M, 2002, J MOL EVOL, V54, P258, DOI 10.1007/s0023901-0007-z; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; ZUCKERKANDL EMILE, 1965, P97; 1981, NATURE, V290, P75	36	131	134	3	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					219	U104		10.1038/nature09014	http://dx.doi.org/10.1038/nature09014			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463738				2022-12-24	WOS:000277558500035
J	Okamoto, K; Iwai, Y; Oh-hora, M; Yamamoto, M; Morio, T; Aoki, K; Ohya, K; Jetten, AM; Akira, S; Muta, T; Takayanagi, H				Okamoto, Kazuo; Iwai, Yoshiko; Oh-hora, Masatsugu; Yamamoto, Masahiro; Morio, Tomohiro; Aoki, Kazuhiro; Ohya, Keiichi; Jetten, Anton M.; Akira, Shizuo; Muta, Tatsushi; Takayanagi, Hiroshi			I kappa B zeta regulates T(H)17 development by cooperating with ROR nuclear receptors	NATURE			English	Article							TARGETED DISRUPTION; GAMMA-T; DIFFERENTIATION; TRANSCRIPTION; INDUCTION; PROTEIN; CELLS; EXPRESSION; APOPTOSIS; ROLES	Interleukin (IL)-17-producing helper T (T(H)17) cells are a distinct T-cell subset characterized by its pathological role in autoimmune diseases(1-3). IL-6 and transforming growth factor-beta (TGF-beta) induce TH17 development, in which the orphan nuclear receptors, ROR gamma t and ROR alpha, have an indispensable role(4-6). However, in the absence of IL-6 and TGF-beta, the ectopic expression of ROR gamma t or ROR alpha leads to only a modest IL-17 production(5,7,8). Here we identify a nuclear I kappa B family member, I kappa B zeta (encoded by the Nfkbiz gene), as a transcription factor required for TH17 development in mice. The ectopic expression of I kappa B zeta in naive CD4(+) T cells together with ROR gamma t or ROR alpha potently induces T(H)17 development, even in the absence of IL-6 and TGF-beta. Notably, Nfkbiz(-/-) mice have a defect in T(H)17 development and a resistance to experimental autoimmune encephalomyelitis (EAE). The T-cell-intrinsic function of I kappa B zeta was clearly demonstrated by the resistance to EAE of the Rag2(-/-) mice into which Nfkbiz(-/-) CD4(+) T cells were transferred. In cooperation with ROR gamma t and RORa, I kappa B zeta enhances Il17a expression by binding directly to the regulatory region of the Il17a gene. This study provides evidence for the transcriptional mechanisms underlying T(H)17 development and points to a molecular basis for a novel therapeutic strategy against autoimmune disease.	[Okamoto, Kazuo; Oh-hora, Masatsugu; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Bunkyo Ku, Tokyo 1138549, Japan; [Okamoto, Kazuo; Oh-hora, Masatsugu; Takayanagi, Hiroshi] Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence Program, Bunkyo Ku, Tokyo 1138549, Japan; [Okamoto, Kazuo; Takayanagi, Hiroshi] Japan Sci & Technol Agcy, ERATO, Takayanagi Osteonetwork Project, Bunkyo Ku, Tokyo 1138549, Japan; [Iwai, Yoshiko] Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Bunkyo Ku, Tokyo 1138510, Japan; [Yamamoto, Masahiro] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Immune Regulat, Suita, Osaka 5650871, Japan; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan; [Morio, Tomohiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pediat & Dev Biol, Bunkyo Ku, Tokyo 1138519, Japan; [Aoki, Kazuhiro; Ohya, Keiichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hard Tissue Engn Pharmacol, Bunkyo Ku, Tokyo 1138549, Japan; [Jetten, Anton M.] NIEHS, Cell Biol Sect, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Muta, Tatsushi] Tohoku Univ, Grad Sch Life Sci, Lab Cell Recognit & Response, Aoba Ku, Sendai, Miyagi 9808578, Japan	Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); Osaka University; Osaka University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Tohoku University	Takayanagi, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138549, Japan.	taka.csi@tmd.ac.jp	Akira, Shizuo/C-3134-2009; AOKI, Kazuhiro/GRO-6475-2022; Jetten, Anton/C-3736-2019	AOKI, Kazuhiro/0000-0001-6643-6315; Jetten, Anton/0000-0003-0954-4445; Morio, Tomohiro/0000-0002-9259-1025	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); ERATO; JST; NIEHS [Z01-ES-101586]; Takeda Life Science Foundation; Yokoyama Foundation; Ichiro Kanehara; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101586, ZIAES101586] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ERATO(Japan Science & Technology Agency (JST)); JST(Japan Science & Technology Agency (JST)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Takeda Life Science Foundation; Yokoyama Foundation; Ichiro Kanehara; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We are grateful to Y. Iwakura and T. Kitamura for providing Il17a<SUP>-/-</SUP> mice and retrovirus vectors, respectively. We also thank M. Shinohara, T. Negishi-Koga, M. Asagiri, T. Nakashima, N. Komatsu, M. Ohba, Y. Kunisawa, Y. Suzuki, S. Miyakoshi and T. Kunigami for discussion and assistance. This work was supported in part by Grant-in-Aid for Creative Scientific Research from the Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Challenging Exploratory Research from JSPS, Grant-in-Aid for JSPS Fellows, Grants-in-Aid for GCOE Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and ERATO, Takayanagi Osteonetwork Project from JST. It was also supported by grants from the Intramural Research Program of the NIEHS (Z01-ES-101586) (to A. M. J.), Takeda Life Science Foundation and Yokoyama Foundation for Clinical Pharmacology and the Ichiro Kanehara	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Huber M, 2008, P NATL ACAD SCI USA, V105, P20846, DOI 10.1073/pnas.0809077106; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jetten AM, 2006, AD DEV BIOL, V16, P313, DOI 10.1016/S1574-3349(06)16010-X; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Muta T, 2006, VITAM HORM, V74, P301, DOI 10.1016/S0083-6729(06)74012-2; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; O'Shea JJ, 2009, MICROBES INFECT, V11, P599, DOI 10.1016/j.micinf.2009.04.007; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shiina T, 2004, J BIOL CHEM, V279, P55493, DOI 10.1074/jbc.M409770200; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Takeda K, 1998, J IMMUNOL, V161, P4652; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamamoto Masahiro, 2008, Journal of Infection and Chemotherapy, V14, P265, DOI 10.1007/s10156-008-0619-y; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663	35	194	204	3	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1381	U13		10.1038/nature08922	http://dx.doi.org/10.1038/nature08922			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20383124				2022-12-24	WOS:000277149000053
J	Doebeli, M; Ispolatov, I				Doebeli, Michael; Ispolatov, Iaroslav			Complexity and Diversity	SCIENCE			English	Article							NATURAL-POPULATIONS; GENETIC-VARIABILITY; GENIC HETEROZYGOSITY; POLYGENIC CHARACTER; MAINTENANCE; EVOLUTION; MUTATION; DIFFERENTIATION; ALLELES; MODEL	The mechanisms for the origin and maintenance of biological diversity are not fully understood. It is known that frequency-dependent selection, generating advantages for rare types, can maintain genetic variation and lead to speciation, but in models with simple phenotypes (that is, low-dimensional phenotype spaces), frequency dependence needs to be strong to generate diversity. However, we show that if the ecological properties of an organism are determined by multiple traits with complex interactions, the conditions needed for frequency-dependent selection to generate diversity are relaxed to the point where they are easily satisfied in high-dimensional phenotype spaces. Mathematically, this phenomenon is reflected in properties of eigenvalues of quadratic forms. Because all living organisms have at least hundreds of phenotypes, this casts the potential importance of frequency dependence for the origin and maintenance of diversity in a new light.	[Doebeli, Michael] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Doebeli, M (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	doebeli@zoology.ubc.ca; slava@math.ubc.ca	Doebeli, Michael/D-5391-2012; Ispolatov, Yaroslav/E-8544-2010	Ispolatov, Yaroslav/0000-0002-0201-3396	Natural Sciences and Engineering Research Council (Canada); European Union	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Union(European Commission)	The order of authors is alphabetical. We thank K. Schneider for improving some of the mathematical arguments and D. Weigel, H. Metz, and S. Otto for discussions and comments. This research was supported by the Natural Sciences and Engineering Research Council (Canada) and by the Human Frontier Science Program (European Union).	Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Burger R, 2009, THEOR POPUL BIOL, V76, P214, DOI 10.1016/j.tpb.2009.07.002; BURGER R, 1986, J MATH BIOL, V24, P341, DOI 10.1007/BF00275642; CHRISTIANSEN FB, 1987, THEOR POPUL BIOL, V31, P33, DOI 10.1016/0040-5809(87)90021-9; CLARKE BC, 1979, PROC R SOC SER B-BIO, V205, P453, DOI 10.1098/rspb.1979.0079; Coyne JA, 2004, SPECIATION, V37; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dieckmann U., 2004, ADAPTIVE SPECIATION; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Doebeli M, 2007, P ROY SOC B-BIOL SCI, V274, P347, DOI 10.1098/rspb.2006.3725; Durinx M, 2008, J MATH BIOL, V56, P673, DOI 10.1007/s00285-007-0134-2; Frantz A, 2009, BIOL J LINN SOC, V97, P718, DOI 10.1111/j.1095-8312.2009.01221.x; Gavrilets S, 2004, FITNESS LANDSCAPES O; Gyllenberg M, 2005, J MATH BIOL, V50, P133, DOI 10.1007/s00285-004-0283-5; Hernandez-Garcia E, 2009, PHILOS T R SOC A, V367, P3183, DOI 10.1098/rsta.2009.0086; HERNANDEZGARCIA E, 2009, THEOR ECOL, DOI DOI 10.1007/S12080-009-0056-2; HUBBY JL, 1966, GENETICS, V54, P577; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; KIMURA M, 1965, P NATL ACAD SCI USA, V54, P731, DOI 10.1073/pnas.54.3.731; Kimura MA, 1985, NEUTRAL THEORY MOL E; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; LANDE R, 1975, GENET RES, V26, P221, DOI 10.1017/S0016672300016037; Le Gac M, 2008, GENETICS, V178, P1049, DOI 10.1534/genetics.107.082040; LEWONTIN RC, 1966, GENETICS, V54, P595; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Maharjan R, 2006, SCIENCE, V313, P514, DOI 10.1126/science.1129865; Matessi C, 2009, THEOR POPUL BIOL, V76, P1, DOI 10.1016/j.tpb.2009.02.007; Phillips PC, 2007, GENET RES, V89, P371, DOI 10.1017/S0016672308009567; Roughgarden J., 1979, THEORY POPULATION GE; Singer MC, 2010, EVOLUTION, V64, P921, DOI 10.1111/j.1558-5646.2009.00866.x; TAPER ML, 1985, ECOLOGY, V66, P355, DOI 10.2307/1940385; TURELLI M, 1984, THEOR POPUL BIOL, V25, P138, DOI 10.1016/0040-5809(84)90017-0; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	35	92	94	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2010	328	5977					494	497		10.1126/science.1187468	http://dx.doi.org/10.1126/science.1187468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413499				2022-12-24	WOS:000276952400041
J	Stechmann, B; Bai, SK; Gobbo, E; Lopez, R; Merer, G; Pinchard, S; Panigai, L; Tenza, D; Raposo, G; Beaumelle, B; Sauvaire, D; Gillet, D; Johannes, L; Barbier, J				Stechmann, Bahne; Bai, Siau-Kun; Gobbo, Emilie; Lopez, Roman; Merer, Goulven; Pinchard, Suzy; Panigai, Laetitia; Tenza, Daniele; Raposo, Graca; Beaumelle, Bruno; Sauvaire, Didier; Gillet, Daniel; Johannes, Ludger; Barbier, Julien			Inhibition of Retrograde Transport Protects Mice from Lethal Ricin Challenge	CELL			English	Article							GOLGI NETWORK; EARLY/RECYCLING ENDOSOMES; SNARE COMPLEX; RECEPTOR; TOXIN; CELLS; IDENTIFICATION; TRAFFICKING; MEMBRANE; SYNTAXIN-5	Bacterial Shiga-like toxins are virulence factors that constitute a significant public health threat worldwide, and the plant toxin ricin is a potential bioterror weapon. To gain access to their cytosolic target, ribosomal RNA, these toxins follow the retrograde transport route from the plasma membrane to the endoplasmic reticulum, via endosomes and the Golgi apparatus. Here, we used high-throughput screening to identify small molecule inhibitors that protect cells from ricin and Shiga-like toxins. We identified two compounds that selectively block retrograde toxin trafficking at the early endosome-TGN interface, without affecting compartment morphology, endogenous retrograde cargos, or other trafficking steps, demonstrating an unexpected degree of selectivity and lack of toxicity. In mice, one compound clearly protects from lethal nasal exposure to ricin. Our work discovers the first small molecule that shows efficacy against ricin in animal experiments and identifies the retrograde route as a potential therapeutic target.	[Gobbo, Emilie; Gillet, Daniel; Barbier, Julien] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol & Technol Saclay, Serv Ingn Mol Prot,Lab Toxinol Mol & Biotechnol, F-91191 Gif Sur Yvette, France; [Stechmann, Bahne; Bai, Siau-Kun; Johannes, Ludger] Inst Curie, Ctr Rech, Traff Signaling & Delivery Lab, F-75248 Paris 05, France; [Tenza, Daniele; Raposo, Graca] Inst Curie, Ctr Rech, Struct & Membrane Compartments Lab, F-75248 Paris 05, France; [Tenza, Daniele; Raposo, Graca] Inst Curie, Ctr Rech, Cell & Tissue Imaging Facil Infrastruct Biol Sant, F-75248 Paris 05, France; [Stechmann, Bahne; Bai, Siau-Kun; Tenza, Daniele; Raposo, Graca; Johannes, Ludger] CNRS, UMR 144, F-75700 Paris, France; [Lopez, Roman; Merer, Goulven] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol & Technol Saclay, Lab Chim Bioorgan,Serv Chim Bioorgan & Marquage, F-91191 Gif Sur Yvette, France; [Pinchard, Suzy; Panigai, Laetitia; Sauvaire, Didier] French Hlth Prod Safety Agcy, Afssaps French Official Med Control Lab, Direct Labs & Controles, Unite Controles Bioact & Radioanal, F-34740 Vendargues, France; [Beaumelle, Bruno] Univ Montpellier 2, CNRS, Ctr Etud Agents Pathogenes & Biotechnol Sante, UMR 5236, F-34095 Montpellier, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Gillet, D (corresponding author), Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol & Technol Saclay, Serv Ingn Mol Prot,Lab Toxinol Mol & Biotechnol, F-91191 Gif Sur Yvette, France.	daniel.gillet@cea.fr; ludger.johannes@curie.fr	Johannes, Ludger/M-9778-2017; Gillet, Daniel/C-5592-2008; Johannes, Ludger/W-8593-2019	Johannes, Ludger/0000-0002-2168-0004; Gillet, Daniel/0000-0003-0477-3599; Johannes, Ludger/0000-0002-2168-0004; Beaumelle, Bruno/0000-0002-4912-9134; barbier, julien/0000-0003-2187-4973; Stechmann, Bahne/0000-0003-2759-5924; Raposo, graca/0000-0001-9590-1298; Stechmann, Bahne/0000-0003-1440-1545	European Union; Commissariat a l'Energie Atomique et aux Energies Alternatives; Association pour la Recherche sur le Cancer	European Union(European Commission); Commissariat a l'Energie Atomique et aux Energies Alternatives; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by grants from the European Union (Cancerimmunotherapy), Project ToxScreen, and the Commissariat a l'Energie Atomique et aux Energies Alternatives. B. S. was supported by Association pour la Recherche sur le Cancer. We are grateful to Francois Becher, Elodie Duriez and Eric Ezan for measurement of the enzymatic activity of ricin, Annie El Zaouk, Philippe Chabert, and Emmanuel Intsaby for technical help with mouse experiments, Anne Bonhoure for help with ricin purification, Severine Hebbe for chemical synthesis of Retro-2, and Jennifer Martinez and Michel Petitjean for technical help. The following colleagues kindly provided us with reagents ( further details are in the Extended Experimental Procedures): Georges Bismuth, Juan Bonifacino, Michel Bornens, Frances Brodsky, Paul Gleeson, Jennifer Hirst, Bernard Hoflack, Wanjin Hong, Michael Marks, Kazuhisa Nakayama, Andrew Peden, Franck Perez, Suzanne Pfeffer, Lynne Roberts, and Harald Stenmark.	Amessou M, 2006, CURR PROTOC CELL BIO, P15, DOI [10.1002/0471143030.cb1510s32, DOI 10.1002/0471143030.CB1510S32]; Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; BEAUMELLE B, 1993, J BIOL CHEM, V268, P23661; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Cook DL, 2006, TOXICOLOGY, V223, P61, DOI 10.1016/j.tox.2006.03.010; DONTA ST, 1995, J INFECT DIS, V171, P721, DOI 10.1093/infdis/171.3.721; Feng Y, 2004, EMBO REP, V5, P596, DOI 10.1038/sj.embor.7400152; Fraser T R, 1872, Br Med J, V2, P457; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; GLICKMAN JN, 1989, EMBO J, V8, P1041, DOI 10.1002/j.1460-2075.1989.tb03471.x; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; HOLMGREN J, 1973, INFECT IMMUN, V8, P208, DOI 10.1128/IAI.8.2.208-214.1973; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Liger D, 1997, FEBS LETT, V406, P157, DOI 10.1016/S0014-5793(97)00243-3; Lord Michael J., 2003, Toxicological Reviews, V22, P53, DOI 10.2165/00139709-200322010-00006; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Nishimoto-Morita K, 2009, J BIOL CHEM, V284, P10583, DOI 10.1074/jbc.M900847200; Ponnambalam S, 1996, J CELL SCI, V109, P675; Pratt TS, 2007, EXP LUNG RES, V33, P459, DOI 10.1080/01902140701731805; Saenz JB, 2007, INFECT IMMUN, V75, P4552, DOI 10.1128/IAI.00442-07; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Sandvig K, 2004, INT J MED MICROBIOL, V293, P483, DOI 10.1078/1438-4221-00294; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; SNIDER MD, 1985, J CELL BIOL, V100, P826, DOI 10.1083/jcb.100.3.826; Spillsberg B, 2003, TRAFFIC, V4, P544, DOI 10.1034/j.1600-0854.2003.00111.x; Tai GH, 2004, MOL BIOL CELL, V15, P4011, DOI 10.1091/mbc.E03-12-0876; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133; Zhang T, 2001, J BIOL CHEM, V276, P27480, DOI 10.1074/jbc.M102786200	38	213	227	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					231	242		10.1016/j.cell.2010.01.043	http://dx.doi.org/10.1016/j.cell.2010.01.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403321	Bronze			2022-12-24	WOS:000276738400014
J	Davis, ME; Zuckerman, JE; Choi, CHJ; Seligson, D; Tolcher, A; Alabi, CA; Yen, Y; Heidel, JD; Ribas, A				Davis, Mark E.; Zuckerman, Jonathan E.; Choi, Chung Hang J.; Seligson, David; Tolcher, Anthony; Alabi, Christopher A.; Yen, Yun; Heidel, Jeremy D.; Ribas, Antoni			Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles	NATURE			English	Article							RIBONUCLEOTIDE REDUCTASE; GENE-EXPRESSION; IN-VIVO; INTERFERENCE; POTENT; MICE; CELL; PHARMACOKINETICS; THERAPEUTICS; INHIBITION	Therapeutics that are designed to engage RNA interference (RNAi) pathways have the potential to provide new, major ways of imparting therapy to patients(1,2). Long, double-stranded RNAs were first shown to mediate RNAi in Caenorhabditis elegans(3), and the potential use of RNAi for human therapy has been demonstrated by the finding that small interfering RNAs (siRNAs; approximately 21-base-pair double-stranded RNA) can elicit RNAi in mammalian cells without producing an interferon response(4). We are at present conducting the first in-human phase I clinical trial involving the systemic administration of siRNA to patients with solid cancers using a targeted, nanoparticle delivery system. Here we provide evidence of inducing an RNAi mechanism of action in a human from the delivered siRNA. Tumour biopsies from melanoma patients obtained after treatment show the presence of intracellularly localized nanoparticles in amounts that correlate with dose levels of the nanoparticles administered (this is, to our knowledge, a first for systemically delivered nanoparticles of any kind). Furthermore, a reduction was found in both the specific messenger RNA (M2 subunit of ribonucleotide reductase (RRM2)) and the protein (RRM2) levels when compared to pre-dosing tissue. Most notably, we detect the presence of an mRNA fragment that demonstrates that siRNA-mediated mRNA cleavage occurs specifically at the site predicted for an RNAi mechanism from a patient who received the highest dose of the nanoparticles. Together, these data demonstrate that siRNA administered systemically to a human can produce a specific gene inhibition (reduction in mRNA and protein) by an RNAi mechanism of action.	[Davis, Mark E.; Zuckerman, Jonathan E.; Choi, Chung Hang J.; Alabi, Christopher A.] CALTECH, Pasadena, CA 91125 USA; [Seligson, David; Ribas, Antoni] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Seligson, David] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Ribas, Antoni] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Tolcher, Anthony] START LLC, San Antonio, TX 78229 USA; [Yen, Yun] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA; [Heidel, Jeremy D.] Calando Pharmaceut, Pasadena, CA 91101 USA	California Institute of Technology; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; City of Hope	Davis, ME (corresponding author), CALTECH, Pasadena, CA 91125 USA.	mdavis@cheme.caltech.edu		Choi, Chung Hang Jonathan/0000-0003-2935-7217	National Cancer Institute [CA U54 119347]; Daljit S. & Elaine Sarkaria Biomarker Laboratory Fund; NATIONAL CANCER INSTITUTE [U54CA119347] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Daljit S. & Elaine Sarkaria Biomarker Laboratory Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. Sazegar, E. Seja, A. Villanueva and the G-CRC nursing staff at University of California, Los Angeles (UCLA), and L. Kalinoski, J. Peterkin, S. Rele, Y. Liang and J. Y. C. Liu for their assistance in conducting the clinical trial. We thank J. S. Economou for performing the tumour biopsies, and B. Chmielowski and Z. Wainberg for patient referrals. Histotechnology support at the UCLA Biomarker Innovations Laboratory was provided by C. Savina and J. Reiss. We also thank J. Rossi for discussions on RACE analyses. This work was supported in part by the National Cancer Institute Grant CA U54 119347 and the Daljit S. & Elaine Sarkaria Biomarker Laboratory Fund.	Alvarez R, 2009, ANTIMICROB AGENTS CH, V53, P3952, DOI 10.1128/AAC.00014-09; Bartlett DW, 2008, BIOTECHNOL BIOENG, V99, P975, DOI 10.1002/bit.21668; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Bartlett DW, 2006, NUCLEIC ACIDS RES, V34, P322, DOI 10.1093/nar/gkj439; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Cerqueira NMFSA, 2005, CURR MED CHEM, V12, P1283, DOI 10.2174/0929867054020981; Davis ME, 2009, MOL PHARMACEUT, V6, P659, DOI 10.1021/mp900015y; DeVincenzo J, 2008, ANTIVIR RES, V77, P225, DOI 10.1016/j.antiviral.2007.11.009; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Heidel JD, 2007, P NATL ACAD SCI USA, V104, P5715, DOI 10.1073/pnas.0701458104; Heidel JD, 2007, CLIN CANCER RES, V13, P2207, DOI 10.1158/1078-0432.CCR-06-2218; Juhasz A, 2006, ONCOL REP, V15, P1299; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Koldehoff M, 2007, CLIN EXP MED, V7, P47, DOI 10.1007/s10238-007-0125-z; Leachman SA, 2010, MOL THER, V18, P442, DOI 10.1038/mt.2009.273; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; MCCLARTY GA, 1987, BIOCHEMISTRY-US, V26, P8004, DOI 10.1021/bi00398a068; RIEHL R, 1984, J CANCER RES CLIN, V107, P21, DOI 10.1007/BF00395486; Schluep T, 2009, P NATL ACAD SCI USA, V106, P11394, DOI 10.1073/pnas.0905487106; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121	25	1934	2068	16	942	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 15	2010	464	7291					1067	U140		10.1038/nature08956	http://dx.doi.org/10.1038/nature08956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20305636	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000276635000044
J	Gill, TM; Gahbauer, EA; Han, L; Allore, HG				Gill, Thomas M.; Gahbauer, Evelyne A.; Han, Ling; Allore, Heather G.			Trajectories of Disability in the Last Year of Life.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OLDER PERSONS; FUNCTIONAL DECLINE; SAS PROCEDURE; HEALTH; MORBIDITY; FRAILTY; STATES	Background: Despite the importance of functional status to older persons and their families, little is known about the course of disability at the end of life. Methods: We evaluated data on 383 decedents from a longitudinal study involving 754 community-dwelling older persons. None of the subjects had disability in essential activities of daily living at the beginning of the study, and the level of disability was ascertained during monthly interviews for more than 10 years. Information on the conditions leading to death was obtained from death certificates and comprehensive assessments that were completed at 18-month intervals after the baseline assessment. Results: In the last year of life, five distinct trajectories were identified, from no disability to the most severe disability: 65 subjects had no disability (17.0%), 76 had catastrophic disability (19.8%), 67 had accelerated disability (17.5%), 91 had progressive disability (23.8%), and 84 had persistently severe disability (21.9%). The most common condition leading to death was frailty (in 107 subjects [27.9%]), followed by organ failure (in 82 subjects [21.4%]), cancer (in 74 subjects [19.3%]), other causes (in 57 subjects [14.9%]), advanced dementia (in 53 subjects [13.8%]), and sudden death (in 10 subjects [2.6%]). When the distribution of the disability trajectories was evaluated according to the conditions leading to death, a predominant trajectory was observed only for subjects who died from advanced dementia (67.9% of these subjects had a trajectory of persistently severe disability) and sudden death (50.0% of these subjects had no disability). For the four other conditions leading to death, no more than 34% of the subjects had any of the disability trajectories. The distribution of disability trajectories was particularly heterogeneous among the subjects with organ failure (from 12.2 to 32.9% of the subjects followed a specific trajectory) and frailty (from 14.0 to 27.1% of the subjects followed a specific trajectory). Conclusions: In most of the decedents, the course of disability in the last year of life did not follow a predictable pattern based on the condition leading to death. N Engl J Med 2010;362:1173-80.	[Gill, Thomas M.] Yale Univ, Sch Med, Adler Geriatr Ctr, Dept Internal Med, New Haven, CT 06510 USA	Yale University	Gill, TM (corresponding author), Yale Univ, Sch Med, Adler Geriatr Ctr, Dept Internal Med, 874 Howard Ave, New Haven, CT 06510 USA.	thomas.gill@yale.edu	Maier, Andrea B./Q-5548-2019; Gill, Thomas M./H-7043-2019	Gill, Thomas M./0000-0002-6450-0368; Allore, Heather/0000-0001-7685-8175	National Institute on Aging [R37AG17560, R01AG022993, K24AG021507]; Yale Claude D. Pepper Older Americans Independence Center [P30AG21342]; NATIONAL INSTITUTE ON AGING [P30AG021342, R01AG022993, R37AG017560, K24AG021507] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Yale Claude D. Pepper Older Americans Independence Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institute on Aging (R37AG17560 and R01AG022993) and the Yale Claude D. Pepper Older Americans Independence Center (P30AG21342) and by a Midcareer Investigator Award in Patient-Oriented Research from the National Institute on Aging (K24AG021507, to Dr. Gill).	Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Chen JH, 2007, J GERONTOL A-BIOL, V62, P531, DOI 10.1093/gerona/62.5.531; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gazelle G, 2007, NEW ENGL J MED, V357, P321, DOI 10.1056/NEJMp078067; Gill TM, 2008, J AM GERIATR SOC, V56, P436, DOI 10.1111/j.1532-5415.2007.01603.x; Gill TM, 2006, ARCH INTERN MED, V166, P418, DOI 10.1001/.418; Gill TM, 2002, J AM GERIATR SOC, V50, P1492, DOI 10.1046/j.1532-5415.2002.50403.x; Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007; GURALNIK JM, 1991, AM J PUBLIC HEALTH, V81, P443, DOI 10.2105/AJPH.81.4.443; Hardy SE, 2005, AM J EPIDEMIOL, V161, P575, DOI 10.1093/aje/kwi083; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; Ives DG, 2009, J AM GERIATR SOC, V57, P133, DOI 10.1111/j.1532-5415.2008.02056.x; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Liao YL, 1999, AM J EPIDEMIOL, V149, P1097; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Lunney JR, 2002, J AM GERIATR SOC, V50, P1108, DOI 10.1046/j.1532-5415.2002.50268.x; Manton KG, 2006, P NATL ACAD SCI USA, V103, P18374, DOI 10.1073/pnas.0608483103; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Tibshirani R., 1993, INTRO BOOTSTRAP, DOI 10.1007/978-1-4899-4541-9; Weiss CO, 2007, JAMA-J AM MED ASSOC, V298, P1160, DOI 10.1001/jama.298.10.1160-a	24	555	567	0	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13					1173	1180		10.1056/NEJMoa0909087	http://dx.doi.org/10.1056/NEJMoa0909087			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	577QQ	20357280	Bronze, Green Accepted			2022-12-24	WOS:000276239500007
J	Niederhuber, JE				Niederhuber, John E.			Translating Discovery to Patient Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TUMOR MICROENVIRONMENT; CANCER		NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Niederhuber, JE (corresponding author), NCI, 31 Ctr Dr,Room 11A48, Bethesda, MD 20892 USA.	niederj@mail.nih.gov						Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Caussinus Emmanuel, 2007, Prog Mol Subcell Biol, V45, P205; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Danish M, 2008, CANCER BIOL THER, V7, P331, DOI 10.4161/cbt.7.3.5761; Ischehko I, 2009, SURGERY, V146, P430, DOI 10.1016/j.surg.2009.05.003; Khalil I, 2010, GYNECOL ONCOL, V116, P282, DOI 10.1016/j.ygyno.2009.10.085; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Ross JS, 2004, AM J CLIN PATHOL, V122, P598, DOI 10.1309/5CWPU41AFR1VYM3F; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271	9	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1088	1089		10.1001/jama.2010.281	http://dx.doi.org/10.1001/jama.2010.281			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233829				2022-12-24	WOS:000275594100024
J	Janda, CY; Li, J; Oubridge, C; Hernandez, H; Robinson, CV; Nagai, K				Janda, Claudia Y.; Li, Jade; Oubridge, Chris; Hernandez, Helena; Robinson, Carol V.; Nagai, Kiyoshi			Recognition of a signal peptide by the signal recognition particle	NATURE			English	Article							ESCHERICHIA-COLI RIBONUCLEOPROTEIN; CRYSTAL-STRUCTURE; RIBOSOME; SEQUENCE; RNA; PROTEINS; TRANSLOCATION; CONTAINS; SUBUNIT; DOMAIN	Targeting of proteins to appropriate subcellular compartments is a crucial process in all living cells. Secretory and membrane proteins usually contain an amino-terminal signal peptide, which is recognized by the signal recognition particle (SRP) when nascent polypeptide chains emerge from the ribosome. The SRP-ribosome nascent chain complex is then targeted through its GTP-dependent interaction with SRP receptor to the protein-conducting channel on endoplasmic reticulum membrane in eukaryotes or plasma membrane in bacteria. A universally conserved component of SRP (refs 1, 2), SRP54 or its bacterial homologue, fifty-four homologue (Ffh), binds the signal peptides, which have a highly divergent sequence divisible into a positively charged n-region, an h-region commonly containing 8-20 hydrophobic residues and a polar c-region(3-5). No structure has been reported that exemplifies SRP54 binding of any signal sequence. Here we have produced a fusion protein between Sulfolobus solfataricus SRP54 (Ffh) and a signal peptide connected via a flexible linker. This fusion protein oligomerizes in solution through interaction between the SRP54 and signal peptide moieties belonging to different chains, and it is functional, as demonstrated by its ability to bind SRP RNA and SRP receptor FtsY. We present the crystal structure at 3.5 angstrom resolution of an SRP54-signal peptide complex in the dimer, which reveals how a signal sequence is recognized by SRP54.	[Janda, Claudia Y.; Li, Jade; Oubridge, Chris; Nagai, Kiyoshi] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Hernandez, Helena; Robinson, Carol V.] Univ Cambridge, Chem Labs, Cambridge CB2 1EW, England	MRC Laboratory Molecular Biology; University of Cambridge	Nagai, K (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	kn@mrc-lmb.cam.ac.uk		robinson, carol/0000-0001-7829-5505; Oubridge, Chris/0000-0001-8492-8305	Medical Research Council of the UK; HFSP; MRC [MC_U105184330] Funding Source: UKRI; Medical Research Council [MC_U105184330] Funding Source: researchfish	Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HFSP(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank members of the Nagai group for assisting with data collection, O. Daumke for help with the GTP binding and GTPase assays, and J. Kavran for discussion. This project was supported by the Medical Research Council of the UK. C. Y. J. was supported by a HFSP grant.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CHOTHIA C, 1981, J MOL BIOL, V145, P215, DOI 10.1016/0022-2836(81)90341-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doudna JA, 2004, ANNU REV BIOCHEM, V73, P539, DOI 10.1146/annurev.biochem.73.011303.074048; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Freymann DM, 1997, NATURE, V385, P361, DOI 10.1038/385361a0; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; Gu SQ, 2003, RNA, V9, P566, DOI 10.1261/rna.2196403; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; KENDALL DA, 1986, NATURE, V321, P706, DOI 10.1038/321706a0; Kuglstatter A, 2002, NAT STRUCT BIOL, V9, P740, DOI 10.1038/nsb843; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LUIRINK J, 1992, NATURE, V359, P741, DOI 10.1038/359741a0; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; PORITZ MA, 1990, SCIENCE, V250, P1111, DOI 10.1126/science.1701272; Rosendal KR, 2003, P NATL ACAD SCI USA, V100, P14701, DOI 10.1073/pnas.2436132100; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	32	147	155	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					507	U139		10.1038/nature08870	http://dx.doi.org/10.1038/nature08870			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20364120	Green Accepted			2022-12-24	WOS:000278043700041
J	Scurr, LL; Pupo, GM; Becker, TM; Lai, K; Schrama, D; Haferkamp, S; Irvine, M; Scolyer, RA; Mann, GJ; Becker, JC; Kefford, RF; Rizos, H				Scurr, Lyndee L.; Pupo, Gulietta M.; Becker, Therese M.; Lai, Ken; Schrama, David; Haferkamp, Sebastian; Irvine, Mal; Scolyer, Richard A.; Mann, Graham J.; Becker, Juergen C.; Kefford, Richard F.; Rizos, Helen			IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence	CELL			English	Article							ONCOGENE-INDUCED SENESCENCE; CELLULAR SENESCENCE; COLORECTAL-CANCER; DOWN-REGULATION; PROTEIN; GROWTH; NEVI; GENE; EXPRESSION; MUTATIONS	Induction of senescence permanently restricts cellular proliferation after oncogenic stimulation thereby acting as a potent barrier to tumor development. The relevant effector proteins may therefore be fundamental to cancer development. A recent study identified IGFBP7 as a secreted factor mediating melanocyte senescence induced by oncogenic B-RAF, which is found commonly in cutaneous nevi. In contrast to the previous report, we demonstrate that B-RAF signaling does not induce IGFBP7 expression, nor the expression of the IGFBP7 targets, BNIP3L, SMARCB1, or PEA15, in human melanocytes or fibroblasts. We also found no correlation between B-RAF mutational status and IGFBP7 protein expression levels in 22 melanoma cell lines, 90 melanomas, and 46 benign nevi. Furthermore, using a lentiviral silencing strategy we show that B-RAF induces senescence in melanocytes and fibroblasts, irrespective of the presence of IGFBP7. Therefore, we conclude that the secreted protein IGFBP7 is dispensable for B-RAF (V600E)-induced senescence in human melanocytes.	[Scurr, Lyndee L.; Pupo, Gulietta M.; Becker, Therese M.; Haferkamp, Sebastian; Irvine, Mal; Mann, Graham J.; Kefford, Richard F.; Rizos, Helen] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; [Lai, Ken; Scolyer, Richard A.; Kefford, Richard F.] Melanoma Inst Australia, Sydney Melanoma Unit, Sydney, NSW 2050, Australia; [Schrama, David; Becker, Juergen C.] Univ Hosp Wurzburg, Dept Dermatol, D-97080 Wurzburg, Germany; [Lai, Ken; Scolyer, Richard A.] Royal Prince Alfred Hosp, Dept Anat Pathol, Sydney, NSW 2050, Australia; [Scolyer, Richard A.] Univ Sydney, Fac Med, Discipline Pathol, Sydney, NSW 2006, Australia	University of Sydney; Westmead Institute for Medical Research; Melanoma Institute Australia; University of Wurzburg; University of Sydney; University of Sydney	Scurr, LL (corresponding author), Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia.	lyndee_scurr@wmi.usyd.edu.au; helen_rizos@wmi.usyd.edu.au	Haferkamp, Sebastian/AAN-3649-2021; Mann, Graham J/G-4758-2014; Rizos, Helen/AAE-5010-2020; Scolyer, Richard/AAE-8511-2019; Haferkamp, Sebastian/ABD-7390-2021	Mann, Graham J/0000-0003-1301-405X; Rizos, Helen/0000-0002-2094-9198; Scolyer, Richard/0000-0002-8991-0013; Haferkamp, Sebastian/0000-0002-3894-8345; Schrama, David/0000-0002-6931-8194; Kefford, Richard/0000-0001-9251-9229; Becker, Therese/0000-0002-5636-9902	National Health and Medical Research Council of Australia (NHMRC) [402761]; Australian Cancer Research Foundation; Melanoma and Skin Cancer Research Institute, University of Sydney; Melanoma Foundation of the University of Sydney; Department of Anatomical Pathology at the Royal Prince Alfred Hospital	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; Melanoma and Skin Cancer Research Institute, University of Sydney(University of Sydney); Melanoma Foundation of the University of Sydney(University of Sydney); Department of Anatomical Pathology at the Royal Prince Alfred Hospital	This work is supported by Program Grant 402761, project grants of the National Health and Medical Research Council of Australia (NHMRC), and an infrastructure grant to Westmead Millennium Institute by the Health Department of NSW through Sydney West Area Health Service. Westmead Institute for Cancer Research is the recipient of capital grant funding from the Australian Cancer Research Foundation. L. L. S. is a Cameron Melanoma Research Fellow, supported by the Melanoma and Skin Cancer Research Institute, University of Sydney. H.R. is a Cancer Institute New South Wales Research Fellow. R.A.S. is a Cancer Institute New South Wales Clinical Research Fellow. We thank Eva-Maria Stuhl, Claudia Siedel, James Wilmott, Suzanah Philipsz, Branka Mijatov, Svetlana Pianova, and Jason Todd for excellent technical assistance and Dr. Hermann Kneitz for staining evaluation. The support of the Melanoma Foundation of the University of Sydney and colleagues from the Melanoma Institute Australia (incorporating the Sydney Melanoma Unit) and the Department of Anatomical Pathology at the Royal Prince Alfred Hospital are also gratefully acknowledged.	Acosta JC, 2008, CELL CYCLE, V7, P2956, DOI 10.4161/cc.7.19.6780; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bauer J, 2007, J INVEST DERMATOL, V127, P179, DOI 10.1038/sj.jid.5700490; Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; Bennett DC, 2008, PIGM CELL MELANOMA R, V21, P27, DOI 10.1111/j.1755-148X.2007.00433.x; Burger AM, 1998, ONCOGENE, V16, P2459, DOI 10.1038/sj.onc.1201772; Chen Y, 2007, J PATHOL, V211, P431, DOI 10.1002/path.2132; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Degeorges A, 1999, CANCER RES, V59, P2787; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Haferkamp S, 2009, AGING-US, V1, P542, DOI 10.18632/aging.100051; Haferkamp S, 2009, J INVEST DERMATOL, V129, P1983, DOI 10.1038/jid.2009.5; HALABAN R, 1986, J INVEST DERMATOL, V87, P95, DOI 10.1111/1523-1747.ep12523594; Harrison SL, 2008, CANCER EPIDEM BIOMAR, V17, P2318, DOI 10.1158/1055-9965.EPI-07-2801; Herlyn M, 2007, CANCER BIOL THER, V6, P467, DOI 10.4161/cbt.6.3.4118; Jiang W, 2008, NEOPLASIA, V10, P1335, DOI 10.1593/neo.08694; Kelly JW, 1997, MED J AUSTRALIA, V167, P191, DOI 10.5694/j.1326-5377.1997.tb138843.x; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Landberg G, 2001, ONCOGENE, V20, P3497, DOI 10.1038/sj.onc.1204471; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Papp T, 1999, J MED GENET, V36, P610; Pen A, 2008, ONCOGENE, V27, P6834, DOI 10.1038/onc.2008.287; Pen A, 2007, GLIA, V55, P559, DOI 10.1002/glia.20481; Platz A, 2008, MOL ONCOL, V1, P395, DOI 10.1016/j.molonc.2007.12.003; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Ruan WJ, 2007, CANCER BIOL THER, V6, P354, DOI 10.4161/cbt.6.3.3702; Schrama D, 2010, J INVEST DERMATOL, V130, P897, DOI 10.1038/jid.2009.304; Shao L, 2004, ENDOCR-RELAT CANCER, V11, P141, DOI 10.1677/erc.0.0110141; Suzuki H, 2010, CARCINOGENESIS, V31, P342, DOI 10.1093/carcin/bgp179; Sviderskaya EV, 2003, J NATL CANCER I, V95, P723, DOI 10.1093/jnci/95.10.723; SWISSHELM K, 1995, P NATL ACAD SCI USA, V92, P4472, DOI 10.1073/pnas.92.10.4472; Takeno A, 2008, BRIT J CANCER, V99, P1307, DOI 10.1038/sj.bjc.6604682; Thompson JF, 2005, LANCET, V365, P687, DOI 10.1016/S0140-6736(05)17951-3; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wajapeyee N, 2009, MOL CANCER THER, V8, P3009, DOI 10.1158/1535-7163.MCT-09-0470; Ye F, 2007, J CANCER RES CLIN, V133, P305, DOI 10.1007/s00432-006-0171-z; Yu H, 2009, AM J PATHOL, V174, P2367, DOI 10.2353/ajpath.2009.081057; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258	43	51	53	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					717	727		10.1016/j.cell.2010.04.021	http://dx.doi.org/10.1016/j.cell.2010.04.021			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478260	Bronze			2022-12-24	WOS:000277623600023
J	Lund, K; Manzo, AJ; Dabby, N; Michelotti, N; Johnson-Buck, A; Nangreave, J; Taylor, S; Pei, RJ; Stojanovic, MN; Walter, NG; Winfree, E; Yan, H				Lund, Kyle; Manzo, Anthony J.; Dabby, Nadine; Michelotti, Nicole; Johnson-Buck, Alexander; Nangreave, Jeanette; Taylor, Steven; Pei, Renjun; Stojanovic, Milan N.; Walter, Nils G.; Winfree, Erik; Yan, Hao			Molecular robots guided by prescriptive landscapes	NATURE			English	Article							DNA; ENZYME; DEOXYRIBOZYME; COMPUTATION; DEVICES; MOTORS	Traditional robots(1) rely for their function on computing, to store internal representations of their goals and environment and to coordinate sensing and any actuation of components required in response. Moving robotics to the single-molecule level is possible in principle, but requires facing the limited ability of individual molecules to store complex information and programs. One strategy to overcome this problem is to use systems that can obtain complex behaviour from the interaction of simple robots with their environment(2-4). A first step in this direction was the development of DNA walkers(5), which have developed from being non-autonomous(6,7) to being capable of directed but brief motion on one-dimensional tracks(8-11). Here we demonstrate that previously developed random walkers(12)-so-called molecular spiders that comprise a streptavidin molecule as an inert 'body' and three deoxyribozymes as catalytic 'legs'-show elementary robotic behaviour when interacting with a precisely defined environment. Single-molecule microscopy observations confirm that such walkers achieve directional movement by sensing and modifying tracks of substrate molecules laid out on a two-dimensional DNA origami landscape(13). When using appropriately designed DNA origami, the molecular spiders autonomously carry out sequences of actions such as 'start', 'follow', 'turn' and 'stop'. We anticipate that this strategy will result in more complex robotic behaviour at the molecular level if additional control mechanisms are incorporated. One example might be interactions between multiple molecular robots leading to collective behaviour(14,15); another might be the ability to read and transform secondary cues on the DNA origami landscape as a means of implementing Turing-universal algorithmic behaviour(2,16,17).	[Taylor, Steven; Pei, Renjun; Stojanovic, Milan N.] Columbia Univ, Dept Med, Div Expt Therapeut, New York, NY 10032 USA; [Lund, Kyle; Nangreave, Jeanette; Yan, Hao] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Lund, Kyle; Nangreave, Jeanette; Yan, Hao] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Manzo, Anthony J.; Michelotti, Nicole; Johnson-Buck, Alexander; Walter, Nils G.] Univ Michigan, Dept Chem, Single Mol Anal Grp, Ann Arbor, MI 48109 USA; [Dabby, Nadine; Winfree, Erik] CALTECH, Pasadena, CA 91125 USA; [Michelotti, Nicole] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Stojanovic, Milan N.] Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA	Columbia University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Michigan System; University of Michigan; California Institute of Technology; University of Michigan System; University of Michigan; Columbia University	Stojanovic, MN (corresponding author), Columbia Univ, Dept Med, Div Expt Therapeut, New York, NY 10032 USA.	mns18@columbia.edu; nwalter@umich.edu; winfree@caltech.edu; hao.yan@asu.edu	Walter, Nils/P-3163-2019; Winfree, Erik/L-4002-2013; Walter, Nils G/G-7504-2016	Walter, Nils/0000-0002-7301-1275; Winfree, Erik/0000-0002-5899-7523; Walter, Nils G/0000-0002-7301-1275; Johnson-Buck, Alexander/0000-0003-3748-6000	US National Science Foundation (NSF) EMT; US National Science Foundation (NSF) CBC; Kinship Foundation (Searle); Leukemia & Lymphoma Society; Juvenile Diabetes Research Foundation; NSF ITR; US Army Research Office; NSF; US Office of Naval Research; US National Institutes of Health; US Department of Energy; Sloan Research Fellowship; NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008270, R01GM062357] Funding Source: NIH RePORTER; Division of Computing and Communication Foundations [0829744] Funding Source: National Science Foundation	US National Science Foundation (NSF) EMT(National Science Foundation (NSF)); US National Science Foundation (NSF) CBC(National Science Foundation (NSF)); Kinship Foundation (Searle); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NSF ITR(National Science Foundation (NSF)); US Army Research Office; NSF(National Science Foundation (NSF)); US Office of Naval Research(Office of Naval Research); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); Sloan Research Fellowship(Alfred P. Sloan Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research was supported by the US National Science Foundation (NSF) EMT and CBC grants (all authors); fellowships and grants from the Kinship Foundation (Searle), the Leukemia & Lymphoma Society, the Juvenile Diabetes Research Foundation and NSF ITR (M.N.S.); awards from the US Army Research Office, the NSF, the US Office of Naval Research, the US National Institutes of Health, the US Department of Energy and a Sloan Research Fellowship (H.Y.); an NSF Graduate Fellowship (N.D.); and Molecular Biophysics and Microfluidics in Biomedical Sciences Training Fellowships from the NIH (A.J.-B. and N.M., respectively). M.N.S. is grateful to T. E. Mitchell and M. Olah for inspiration, discussions and help.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Antal T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021121; Bath J, 2005, ANGEW CHEM INT EDIT, V44, P4358, DOI 10.1002/anie.200501262; Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; BENNETT CH, 1982, INT J THEOR PHYS, V21, P905, DOI 10.1007/BF02084158; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Braitenberg V., 1984, VEHICLES EXPT SYNTHE; BROOKS RA, 1991, ARTIF INTELL, V47, P139, DOI 10.1016/0004-3702(91)90053-M; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Hess H, 2006, SCIENCE, V312, P860, DOI 10.1126/science.1126399; Ke YG, 2008, SCIENCE, V319, P180, DOI 10.1126/science.1150082; Li J, 2000, NUCLEIC ACIDS RES, V28, P481, DOI 10.1093/nar/28.2.481; Omabegho T, 2009, SCIENCE, V324, P67, DOI 10.1126/science.1170336; Pei R, 2006, J AM CHEM SOC, V128, P12693, DOI 10.1021/ja058394n; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rus D, 2002, COMMUN ACM, V45, P39, DOI 10.1145/504729.504752; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q; Shin JS, 2004, J AM CHEM SOC, V126, P10834, DOI 10.1021/ja047543j; Siegwart R., 2004, INTRO AUTONOMOUS MOB; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Tian Y, 2005, ANGEW CHEM INT EDIT, V44, P4355, DOI 10.1002/anie.200500703; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; von Neumann J., 1966, THEORY SELF REPROD A; Walter NG, 2008, NAT METHODS, V5, P475, DOI 10.1038/nmeth.1215; Yildiz A, 2005, ACCOUNTS CHEM RES, V38, P574, DOI 10.1021/ar040136s; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	30	673	698	15	669	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2010	465	7295					206	210		10.1038/nature09012	http://dx.doi.org/10.1038/nature09012			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463735	Green Accepted			2022-12-24	WOS:000277558500032
J	Germain, A; Dixon-Mueller, R				Germain, Adrienne; Dixon-Mueller, Ruth			HIV is the biggest killer of women-but is it?	LANCET			English	Editorial Material							REPRODUCTIVE HEALTH; HIV/AIDS		[Germain, Adrienne] Int Womens Hlth Coalit, New York, NY USA		Dixon-Mueller, R (corresponding author), Int Womens Hlth Coalit, New York, NY USA.	dixonmueller@yahoo.com						Germain A, 2009, B WORLD HEALTH ORGAN, V87, P840, DOI 10.2471/BLT.09.065425; Horton R, 2008, LANCET, V372, P421, DOI 10.1016/S0140-6736(08)60882-X; Horton R, 2006, LANCET, V368, P1549, DOI 10.1016/S0140-6736(06)69484-1; Knight Lindsay, 2008, UNAIDS 1 10 YEARS 19; *UNAIDS, 2009, WHO REP HLTH WOM AID; *WHO, DIS INJ REG EST 2004; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; World Health Organization, 2007, MAT MORT 2005 EST DE	8	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2010	375	9726					1592	1593		10.1016/S0140-6736(10)60312-1	http://dx.doi.org/10.1016/S0140-6736(10)60312-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	597CX	20452509				2022-12-24	WOS:000277734700011
J	Anderson, WF; Camargo, MC; Fraumeni, JF; Correa, P; Rosenberg, PS; Rabkin, CS				Anderson, William F.; Camargo, M. Constanza; Fraumeni, Joseph F., Jr.; Correa, Pelayo; Rosenberg, Philip S.; Rabkin, Charles S.			Age-Specific Trends in Incidence of Noncardia Gastric Cancer in US Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HELICOBACTER-PYLORI INFECTION; UNITED-STATES; TEMPORAL VARIATION; COHORT MODELS; RATES; PERIOD; EPIDEMIOLOGY; ESOPHAGEAL; RISK	Context For the last 50 years, overall age-standardized incidence rates for noncardia gastric cancer have steadily declined in most populations. However, overall rates are summary measures that may obscure important age-specific trends. Objective To examine effects of age at diagnosis on noncardia gastric cancer incidence trends in the United States. Design, Setting, and Participants Descriptive study with age-period-cohort analysis of cancer registration data from the National Cancer Institute's Surveillance, Epidemiology, and End Results Program, which covers approximately 26% of the US population. From 1977 through 2006, there were 83 225 adults with incident primary gastric cancer, including 39 003 noncardia cases. Main Outcome Measures Overall and age-specific incidence rates, adjusted for period and cohort effects using age-period-cohort models. Results were stratified by race, sex, and socioeconomic status. Results Overall age-standardized annual incidence per 100 000 population declined during the study period from 5.9 (95% confidence interval [CI], 5.7-6.1) to 4.0 (95% CI, 3.9-4.1) in whites, from 13.7 (95% CI, 12.5-14.9) to 9.5 (95% CI, 9.1-10.0) in blacks, and from 17.8 (95% CI, 16.1-19.4) to 11.7 (95% CI, 11.2-12.1) in other races. Age-specific trends among whites varied significantly between older and younger age groups (P < .001 for interaction by age): incidence per 100 000 declined significantly from 19.8 (95% CI, 19.0-20.6) to 12.8 (95% CI, 12.5-13.1) for ages 60 to 84 years and from 2.6 (95% CI, 2.4-2.8) to 2.0 (95% CI, 1.9-2.1) for ages 40 to 59 years but increased significantly from 0.27 (95% CI, 0.19-0.35) to 0.45 (95% CI, 0.39-0.50) for ages 25 to 39 years. Conversely, rates for all age groups declined or were stable among blacks and other races. Age-period-cohort analysis confirmed a significant increase in whites among younger cohorts born since 1952 (P < .001). Conclusions From 1977 through 2006, the incidence rate for noncardia gastric cancer declined among all race and age groups except for whites aged 25 to 39 years, for whom it increased. Additional surveillance and analytical studies are warranted to identify risk factors that may explain this unfavorable trend. JAMA. 2010;303(17):1723-1728 www.jama.com	[Rabkin, Charles S.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; [Camargo, M. Constanza] Univ Illinois, Div Epidemiol & Biostat, Chicago, IL USA; [Correa, Pelayo] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vanderbilt University	Rabkin, CS (corresponding author), NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, 6120 Execut Blvd,Ste 7082, Rockville, MD 20852 USA.	rabkinc@mail.nih.gov	Camargo, M. Constanza/R-9891-2016	Camargo, M. Constanza/0000-0002-1065-2198; Rosenberg, Philip/0000-0001-6349-9126	National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIACP010142, ZIACP010212, P01CA028842] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the Intramural Research Program of the National Cancer Institute, National Institutes of Health.	Abnet CC, 2008, EUR J CANCER, V44, P465, DOI 10.1016/j.ejca.2007.12.009; Anderson WF, 2008, JNCI-J NATL CANCER I, V100, P1804, DOI 10.1093/jnci/djn411; BANATVALA N, 1993, J INFECT DIS, V168, P219, DOI 10.1093/infdis/168.1.219; Blaser MJ, 2007, PLOS MED, V4, P53, DOI 10.1371/journal.pmed.0040007; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Blaser MJ, 2007, PLOS MED, V4, P397, DOI 10.1371/journal.pmed.0040100; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; CLAYTON D, 1987, STAT MED, V6, P469, DOI 10.1002/sim.4780060406; CORREA P, 1975, LANCET, V2, P58; Everhart JE, 2000, J INFECT DIS, V181, P1359, DOI 10.1086/315384; FORMAN D, 1993, LANCET, V341, P1359; Forman D, 2006, ASS FOOD NUTR PHYS A, P1; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; HOLFORD TR, 1983, BIOMETRICS, V39, P311, DOI 10.2307/2531004; International Agency for Research on Cancer, 1994, IARC MON EV CARC RIS, V61; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V83; Kim CC, 2000, ELECTROCHEM SOLID ST, V3, P335; Kuipers EJ, 1996, NEW ENGL J MED, V334, P1018, DOI 10.1056/NEJM199604183341603; Kuller LH, 1999, ANN EPIDEMIOL, V9, P91; Murphy G, 2009, GASTROENTEROLOGY, V137, P824, DOI 10.1053/j.gastro.2009.05.001; Parker S, 2005, HIST TODAY, V55, P2; Rosenberg PS, 2010, STAT MED, V29, P1228, DOI 10.1002/sim.3865; Singh GK, 2003, NCI CANC SURVEILLANC, V4; Singh GK, 2003, NIH PUBLICATION; Surveillance Epidemiology and End Results (SEER) Program, 1969, SURV EP END RES SEER; Tarone RE, 1996, AM J EPIDEMIOL, V143, P85; U.S. Food and Drug Administration, 2009, OR BOOK APPR DRUG PR; Wu XC, 2007, CANCER CAUSE CONTROL, V18, P585, DOI 10.1007/s10552-007-9000-1; ZIPPIN C, 1995, CANCER, V76, P2343, DOI 10.1002/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-#	31	304	316	2	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2010	303	17					1723	1728		10.1001/jama.2010.496	http://dx.doi.org/10.1001/jama.2010.496			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591CR	20442388	Green Accepted, Bronze			2022-12-24	WOS:000277276600025
J	Kahn, KL; Adams, JL; Weeks, JC; Chrischilles, EA; Schrag, D; Ayanian, JZ; Kiefe, CI; Ganz, PA; Bhoopalam, N; Potosky, AL; Harrington, DP; Fletcher, RH				Kahn, Katherine L.; Adams, John L.; Weeks, Jane C.; Chrischilles, Elizabeth A.; Schrag, Deborah; Ayanian, John Z.; Kiefe, Catarina I.; Ganz, Patricia A.; Bhoopalam, Nirmala; Potosky, Arnold L.; Harrington, David P.; Fletcher, Robert H.			Adjuvant Chemotherapy Use and Adverse Events Among Older Patients With Stage III Colon Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MARGINAL STRUCTURAL MODELS; CARE OUTCOMES RESEARCH; COLORECTAL-CANCER; ELDERLY-PATIENTS; CLINICAL-TRIALS; RANDOMIZED-TRIAL; POOLED ANALYSIS; OF-LIFE; FLUOROURACIL; LEUCOVORIN	Context Randomized trials suggest adjuvant chemotherapy is effective for older patients with stage III colon cancer. However, older patients are less likely to receive this therapy than younger patients, perhaps because of concern about adverse effects. Objective To evaluate adjuvant chemotherapy use and outcomes for older patients with stage III colon cancer from well-defined population-based settings and health care systems. Design Observational study of adjuvant chemotherapy use and outcomes by age using Poisson regression to estimate the number of adverse events adjusted for demographic and clinical factors, including comorbid illness and specific elements of chemotherapy regimens documented with clinically detailed medical record reviews and patient and surrogate surveys. Setting Five geographically defined regions (Alabama, Iowa, Los Angeles County, northern California, and North Carolina), 5 integrated health care delivery systems, and 15 Veterans Affairs hospitals. Patients Six hundred seventy-five patients diagnosed with stage III colon cancer from 2003 through 2005 who underwent surgical resection and were followed up for as long as 15 months postdiagnosis. Main Outcome Measures Chemotherapy regimen, dose, duration, and annualized mean number of adverse events stratified by age. Results Of 202 patients aged 75 years and older, 101 (50%) received adjuvant chemotherapy compared with 87% of 473 younger patients (difference, 37%; 95% confidence interval [CI], 30%-45%). Among patients who received adjuvant chemotherapy, 14 patients (14%) aged 75 years and older and 178 younger patients (44%) received a regimen containing oxaliplatin (difference, 30%; 95% CI, 21%-38%). Older patients were less likely to continue treatment, such that by 150 days, 99 patients (40%) aged 65 years and older and 68 younger patients (25%) had discontinued chemotherapy (difference, 15%; 95% CI, 7%-23%). Overall, 162 patients (24%) had at least 1 adverse clinical event, with more events among patients treated with vs without adjuvant chemotherapy (mean, 0.39 vs 0.16; difference, 0.23; 95% CI, 0.11-0.36; P<.001). Among patients receiving adjuvant chemotherapy, adjusted rates of late clinical adverse events were lower for patients 75 years and older (mean, 0.28) vs for younger patients (0.35 for ages 18-54 years, 0.52 for ages 55-64 years, and 0.45 for ages 65-74 years; P=.008 for any age effect). Conclusion Among patients with stage III colon cancer who underwent surgical resection and received adjuvant chemotherapy, older patients in the community received less-toxic and shorter chemotherapy regimens, and those treated had fewer adverse events than younger patients. JAMA. 2010; 303(11): 1037-1045	[Kahn, Katherine L.; Adams, John L.] RAND Corp, Santa Monica, CA 90401 USA; [Kahn, Katherine L.] Univ Calif Los Angeles, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Div Hematol & Med Oncol, Los Angeles, CA USA; [Kahn, Katherine L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA; [Weeks, Jane C.] Div Populat Sci, Boston, MA USA; [Harrington, David P.] Dept Biostat & Computat Biol, Boston, MA USA; [Schrag, Deborah] Dana Farber Canc Inst, Boston, MA 02115 USA; [Chrischilles, Elizabeth A.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA; [Ayanian, John Z.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Ayanian, John Z.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Fletcher, Robert H.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA; [Kiefe, Catarina I.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Bhoopalam, Nirmala] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Hines, IL 60141 USA; [Potosky, Arnold L.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Canc Control Program, Washington, DC 20007 USA; [Fletcher, Robert H.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Fletcher, Robert H.] Univ N Carolina, Dept Social Med, Chapel Hill, NC USA	RAND Corporation; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Harvard University; Dana-Farber Cancer Institute; University of Iowa; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kahn, KL (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA.	kahn@rand.org	Kahn, Katherine/AAE-2857-2020; Adams, John/ABE-6170-2021	Kahn, Katherine/0000-0002-6605-1455; 	National Cancer Institute (NCI) [U01 CA093344, U01 CA093348]; Harvard Medical School and Northern California Cancer Center [U01 CA093324]; Dana-Farber Cancer Institute and Cancer Research Network [U01 CA093332]; University of Alabama at Birmingham [U01 CA093329]; University of Iowa [U01 CA01013]; University of North Carolina [U01 CA093326]; Department of Veterans Affairs [U01 CDA093344 [MOU], HARQ 03-438MO-03]; NATIONAL CANCER INSTITUTE [U01CA093324, U01CA093348, U01CA093344, U01CA093332, U01CA093326, U01CA093329] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Harvard Medical School and Northern California Cancer Center; Dana-Farber Cancer Institute and Cancer Research Network; University of Alabama at Birmingham; University of Iowa; University of North Carolina; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding/Support: The Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium was supported by grants from the National Cancer Institute (NCI) to the statistical coordinating center at the Dana-Farber Cancer Institute (U01 CA093344) and the primary data collection and research centers at RAND Corporation and University of California, Los Angeles (U01 CA093348); Harvard Medical School and Northern California Cancer Center (U01 CA093324); Dana-Farber Cancer Institute and Cancer Research Network (U01 CA093332); University of Alabama at Birmingham (U01 CA093329); University of Iowa (U01 CA01013); and University of North Carolina (U01 CA093326) and by a Department of Veterans Affairs grant to the Durham VA Medical Center (U01 CDA093344 [MOU] and HARQ 03-438MO-03).	American Joint Committee on Cancer, 2006, AJCC CANC STAG ATL; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; [Anonymous], DEC MAK TOOLS HLTH C; Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; Ayanian JZ, 2004, J CLIN ONCOL, V22, P2992, DOI 10.1200/JCO.2004.06.020; Ayanian JZ, 2003, J CLIN ONCOL, V21, P1293, DOI 10.1200/JCO.2003.06.178; Dencausse Y, 2002, ONKOLOGIE, V25, P426, DOI 10.1159/000067436; Folprecht G, 2004, ANN ONCOL, V15, P1330, DOI 10.1093/annonc/mdh344; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Haller DG, 2005, J CLIN ONCOL, V23, P8671, DOI 10.1200/JCO.2004.00.5686; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Jessup JM, 2005, JAMA-J AM MED ASSOC, V294, P2703, DOI 10.1001/jama.294.21.2703; Kahn KL, 2008, J CLIN ONCOL, V26, P523, DOI 10.1200/JCO.2007.13.1870; Keating NL, 2008, J CLIN ONCOL, V26, P2532, DOI 10.1200/JCO.2007.15.9434; Keating NL, 2010, CANCER-AM CANCER SOC, V116, P998, DOI 10.1002/cncr.24761; Kohne CH, 2008, ONCOLOGIST, V13, P390, DOI 10.1634/theoncologist.2007-0043; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; LAURIE JA, 1989, J CLIN ONCOL, V7, P1447, DOI 10.1200/JCO.1989.7.10.1447; Malin JL, 2006, SUPPORT CARE CANCER, V14, P837, DOI 10.1007/s00520-005-0902-8; Minino AM, 2007, NATL VITAL STAT REP, V55, P1; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; National Cancer Institute, CANC THER EV PROGR C; Neugut AI, 2006, J CLIN ONCOL, V24, P2368, DOI 10.1200/JCO.2005.04.5005; O'Connell MJ, 1998, J CLIN ONCOL, V16, P295, DOI 10.1200/JCO.1998.16.1.295; Piccirillo AF, 2003, J REGISTRY MANAG, V30, P117; Piccirillo JF, 2004, ORL J OTO-RHINO-LARY, V66, P180, DOI 10.1159/000079875; Potosky AL, 2002, J CLIN ONCOL, V20, P1192, DOI 10.1200/JCO.20.5.1192; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sargent D, 2009, J CLIN ONCOL, V27, P872, DOI 10.1200/JCO.2008.19.5362; Sargent DJ, 2001, NEW ENGL J MED, V345, P1091, DOI 10.1056/NEJMoa010957; Schrag D, 2001, J NATL CANCER I, V93, P850, DOI 10.1093/jnci/93.11.850; StataCorp, 2005, STAT STAT SOFTW REL; Sundararajan V, 2002, ANN INTERN MED, V136, P349, DOI 10.7326/0003-4819-136-5-200203050-00007; Townsley CA, 2005, J CLIN ONCOL, V23, P3112, DOI 10.1200/JCO.2005.00.141; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Zaniboni A, 1998, CANCER, V82, P2135, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2135::AID-CNCR7>3.0.CO;2-U	38	114	119	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1037	1045		10.1001/jama.2010.272	http://dx.doi.org/10.1001/jama.2010.272			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233821	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000275594100016
J	Marais, BJ; Gupta, A; Starke, JR; El Sony, A				Marais, Ben J.; Gupta, Amita; Starke, Jeffrey R.; El Sony, Asma			Tuberculosis in women and children	LANCET			English	Editorial Material							EPIDEMIOLOGY; INFECTION; COMMUNITY; DISEASE; AGE		[Marais, Ben J.] Univ Stellenbosch, Fac Hlth Sci, Dept Paediat & Child Hlth, ZA-7505 Tygerberg, South Africa; [Gupta, Amita] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; [Starke, Jeffrey R.] Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA; [El Sony, Asma] Epidemiol Lab, Khartoum, Sudan	Stellenbosch University; Johns Hopkins University; Baylor College of Medicine	Marais, BJ (corresponding author), Univ Stellenbosch, Fac Hlth Sci, Dept Paediat & Child Hlth, ZA-7505 Tygerberg, South Africa.	bjmarais@sun.ac.za	El-Sony, Asma/G-9112-2019; Marais, Ben/AAX-2626-2021	El-Sony, Asma/0000-0002-6989-8862; Gupta, Amita/0000-0001-7036-2718				Adhikari M, 2009, SEMIN FETAL NEONAT M, V14, P234, DOI 10.1016/j.siny.2009.02.001; Allotey P, 2008, INT J TUBERC LUNG D, V12, P831; Bates L, 2004, LANCET INFECT DIS, V4, P368, DOI 10.1016/S1473-3099(04)01047-3; Burman WJ, 2008, PLOS MED, V5, P1168, DOI 10.1371/journal.pmed.0050176; DAS P, 2002, LANCET INFECT DIS, V2, P317; Gupta A, 2007, CLIN INFECT DIS, V45, P241, DOI 10.1086/518974; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Marais BJ, 2009, CLIN CHEST MED, V30, P827, DOI 10.1016/j.ccm.2009.08.012; Marais BJ, 2006, INT J TUBERC LUNG D, V10, P259; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Stop TB Partnership, GLOB DRUG FAC; Weiss MG, 2006, GENDER TUBERCULOSIS; *WHO, 2009, GLOB TUB CONTR SHORT	15	40	43	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 12	2010	375	9731					2057	2059		10.1016/S0140-6736(10)60579-X	http://dx.doi.org/10.1016/S0140-6736(10)60579-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614OK	20488522				2022-12-24	WOS:000279069300007
J	Stohr, K				Stoehr, Klaus			Vaccinate before the next pandemic?	NATURE			English	Editorial Material									[Stoehr, Klaus] Novartis Vaccines & Diagnost Cambridge, Cambridge, MA 02139 USA; [Stoehr, Klaus] WHO, Global Influenza Programme, CH-1211 Geneva, Switzerland	World Health Organization	Stohr, K (corresponding author), Novartis Vaccines & Diagnost Cambridge, Cambridge, MA 02139 USA.	klaus.stohr@novartis.com						Chan M., 2009, WORLD NOW START 2009; *EUR MED AG, 2010, 14 PAND PHARM UPD; Fidler DP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000247; Stephenson I, 2008, NEW ENGL J MED, V359, P1631, DOI 10.1056/NEJMc0805274	4	36	37	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2010	465	7295					161	161		10.1038/465161a	http://dx.doi.org/10.1038/465161a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	594SS	20463719	Bronze			2022-12-24	WOS:000277558500016
J	Jasanoff, S				Jasanoff, Sheila			Testing Time for Climate Science	SCIENCE			English	Editorial Material									Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University	Jasanoff, S (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.	sheila_jasanoff@harvard.edu						Brickman R., 1985, CONTROLLING CHEM POL; Broad W., 1983, BETRAYERS TRUTH FRAU; Gieryn T. F., 1999, CULTURAL BOUNDARIES; Jasanoff Sheila, 1990, 5 BRANCH SCI ADVISER; Jowit J, 2010, GUARDIAN, P9; Merton Robert, 1973, SOCIOL SCI; National Research Council, 1983, RISK ASS FED GOV MAN; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Revkin AC, 2009, NY TIMES        1120, pA1; REVKIN AC, 2010, NY TIMES        0414; Scientific Working Group for Forensic Anthropology, 2010, SESS 2009 10, P3; Shapin S., 1985, LEVIATHAN AIR PUMP H; Stern P. C., 1996, UNDERSTANDING RISK I	13	56	57	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					695	696		10.1126/science.1189420	http://dx.doi.org/10.1126/science.1189420			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	592DZ	20448170				2022-12-24	WOS:000277357100022
J	Niessing, J; Friedrich, RW				Niessing, Joern; Friedrich, Rainer W.			Olfactory pattern classification by discrete neuronal network states	NATURE			English	Article							BINARY ODOR MIXTURES; ANTENNAL LOBE; MITRAL CELLS; SENSORY INFORMATION; ATTRACTOR DYNAMICS; GLOMERULAR LAYER; BULB; REPRESENTATIONS; ZEBRAFISH; DISCRIMINATION	The categorial nature of sensory, cognitive and behavioural acts indicates that the brain classifies neuronal activity patterns into discrete representations. Pattern classification may be achieved by abrupt switching between discrete activity states of neuronal circuits, but few experimental studies have directly tested this. We gradually varied the concentration or molecular identity of odours and optically measured responses across output neurons of the olfactory bulb in zebrafish. Whereas population activity patterns were largely insensitive to changes in odour concentration, morphing of one odour into another resulted in abrupt transitions between odour representations. These transitions were mediated by coordinated response changes among small neuronal ensembles rather than by shifts in the global network state. The olfactory bulb therefore classifies odour-evoked input patterns into many discrete and defined output patterns, as proposed by attractor models. This computation is consistent with perceptual phenomena and may represent a general information processing strategy in the brain.	[Niessing, Joern; Friedrich, Rainer W.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Friedrich, RW (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	Rainer.Friedrich@fmi.ch		Friedrich, Rainer/0000-0001-9107-0482	Novartis Research Foundation; Max Planck Society; Deutsche Forschungsgemeinschaft [FOR 643]; Studienstiftung des deutschen Volkes	Novartis Research Foundation; Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	We thank A. Luthi, T. Oertner, G. Jacobson and M. Wiechert for comments on the manuscript, and members of the Friedrich laboratory for discussions. This work was funded by the Novartis Research Foundation, the Max Planck Society, the Deutsche Forschungsgemeinschaft (FOR 643) and a fellowship from the Studienstiftung des deutschen Volkes (J.N.).	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Barnes DC, 2008, NAT NEUROSCI, V11, P1378, DOI 10.1038/nn.2217; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Carlson GC, 2000, J NEUROSCI, V20, P2011; Carr W.E.S., 1988, P3; Cleland TA, 2007, P NATL ACAD SCI USA, V104, P1953, DOI 10.1073/pnas.0608564104; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; FREEMAN WJ, 1978, ELECTROEN CLIN NEURO, V44, P586, DOI 10.1016/0013-4694(78)90126-8; FREEMAN WJ, 1987, BIOL CYBERN, V56, P139, DOI 10.1007/BF00317988; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galan RF, 2004, NEURAL COMPUT, V16, P999, DOI 10.1162/089976604773135078; GROSSISSEROFF R, 1988, CHEM SENSES, V13, P191, DOI 10.1093/chemse/13.2.191; HASSELMO ME, 1990, COLD SPRING HARB SYM, V55, P599; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Khan AG, 2008, NEURON, V57, P571, DOI 10.1016/j.neuron.2008.01.008; Krone D, 2001, PHYTOTHER RES, V15, P135, DOI 10.1002/ptr.716; LAING DG, 1983, CHEM SENSES, V7, P249, DOI 10.1093/chemse/7.3-4.249; LAING DG, 1984, PHYSIOL BEHAV, V33, P309, DOI 10.1016/0031-9384(84)90118-5; Laing DG, 2003, CHEM SENSES, V28, P57, DOI 10.1093/chemse/28.1.57; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Li J, 2005, J NEUROSCI, V25, P5784, DOI 10.1523/JNEUROSCI.0922-05.2005; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; MATHIESON WB, 1988, J COMP PHYSIOL A, V163, P489, DOI 10.1007/BF00604903; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Meister M, 2001, J NEUROSCI, V21, P1351; MICHEL WC, 1995, J COMP PHYSIOL A, V177, P191; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MOZER MC, 2009, OXFORD COMPANION CON; Murphy GJ, 2004, J NEUROSCI, V24, P3023, DOI 10.1523/JNEUROSCI.5745-03.2004; Parker AJ, 2003, CURR OPIN NEUROBIOL, V13, P433, DOI 10.1016/S0959-4388(03)00099-0; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Sachse S, 2003, EUR J NEUROSCI, V18, P2119, DOI 10.1046/j.1460-9568.2003.02931.x; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Uchida N, 2008, FRONT SYST NEUROSCI, V1, DOI 10.3389/neuro.06.003.2007; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Valentincic T, 2000, J EXP BIOL, V203, P3307; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Wiltrout C, 2003, BEHAV NEUROSCI, V117, P236, DOI 10.1037/0735-7044.117.2.236; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Yaksi E, 2007, PLOS BIOL, V5, P1453, DOI 10.1371/journal.pbio.0050178; Yaksi E, 2009, NAT NEUROSCI, V12, P474, DOI 10.1038/nn.2288	54	122	123	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					47	U53		10.1038/nature08961	http://dx.doi.org/10.1038/nature08961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20393466				2022-12-24	WOS:000277311900028
J	Donald, PR; Marais, BJ; Barry, CE				Donald, Peter R.; Marais, Ben J.; Barry, Clifton E., III			Age and the epidemiology and pathogenesis of tuberculosis	LANCET			English	Editorial Material							CHILDHOOD TUBERCULOSIS; IMMUNITY; DEFECTS; CELLS		[Donald, Peter R.; Marais, Ben J.] Univ Stellenbosch, Fac Hlth Sci, Dept Paediat & Child Hlth, ZA-7505 Tygerberg, South Africa; [Barry, Clifton E., III] NIAID, TB Res Sect, NIH, Bethesda, MD 20892 USA	Stellenbosch University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Donald, PR (corresponding author), Univ Stellenbosch, Fac Hlth Sci, Dept Paediat & Child Hlth, ZA-7505 Tygerberg, South Africa.	prd@sun.ac.za	Barry, Clifton E/ABE-7992-2020; Barry, III, Clifton/H-3839-2012; Marais, Ben/AAX-2626-2021	Barry, Clifton E/0000-0002-2927-270X; Barry, III, Clifton/0000-0002-2927-270X; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001067] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Basu S, 2009, B MATH BIOL, V71, P1073, DOI 10.1007/s11538-009-9394-x; Bozza VV, 2007, SCAND J IMMUNOL, V66, P97, DOI 10.1111/j.1365-3083.2007.01952.x; Corsini E, 2002, J IMMUNOL, V168, P1753, DOI 10.4049/jimmunol.168.4.1753; Dannenberg AM, 2009, TUBERCULOSIS, V89, P243, DOI 10.1016/j.tube.2009.05.006; DEPERETTI E, 1978, J CLIN ENDOCR METAB, V47, P572, DOI 10.1210/jcem-47-3-572; Donald PR, 2004, INT J TUBERC LUNG D, V8, P627; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; GROTH-PETERSEN E., 1959, BULL WORLD HEALTH ORGAN, V21, P5; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Marais BJ, 2005, ANN TROP PAEDIATR, V25, P79, DOI 10.1179/146532805X45665; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Olsen NJ, 1996, ENDOCR REV, V17, P369, DOI 10.1210/edrv-17-4-369; Rich A., 1951, PATHOGENESIS TUBERCU, V2nd; Smith S, 1997, J PEDIATR-US, V131, P16, DOI 10.1016/S0022-3476(97)70120-3; Tsukamoto H, 2009, P NATL ACAD SCI USA, V106, P18333, DOI 10.1073/pnas.0910139106	15	113	118	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2010	375	9729					1852	1854		10.1016/S0140-6736(10)60580-6	http://dx.doi.org/10.1016/S0140-6736(10)60580-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609BC	20488519				2022-12-24	WOS:000278628800007
J	Zhang, X; Jin, L; Fang, Q; Hui, WH; Zhou, ZH				Zhang, Xing; Jin, Lei; Fang, Qin; Hui, Wong H.; Zhou, Z. Hong			3.3 angstrom Cryo-EM Structure of a Nonenveloped Virus Reveals a Priming Mechanism for Cell Entry	CELL			English	Article							GRASS CARP REOVIRUS; CAPSID PROTEIN MU-1; INFECTIOUS SUBVIRION PARTICLES; MEMBRANE-PENETRATION PROTEIN; ELECTRON CRYOMICROSCOPY; CRYOELECTRON MICROSCOPY; MAMMALIAN REOVIRUSES; PUTATIVE AUTOCLEAVAGE; IMAGE-RECONSTRUCTION; 3D RECONSTRUCTION	To achieve cell entry, many nonenveloped viruses must transform from a dormant to a primed state. In contrast to the membrane fusion mechanism of enveloped viruses (e.g., influenza virus), this membrane penetration mechanism is poorly understood. Here, using single-particle cryo-electron microscopy, we report a 3.3 angstrom structure of the primed, infectious subvirion particle of aquareovirus. The density map reveals side-chain densities of all types of amino acids (except glycine), enabling construction of a full-atom model of the viral particle. Our structure and biochemical results show that priming involves autocleavage of the membrane penetration protein and suggest that Lys84 and Glu76 may facilitate this autocleavage in a nucleophilic attack. We observe a myristoyl group, covalently linked to the N terminus of the penetration protein and embedded in a hydrophobic pocket. These results suggest a well-orchestrated process of nonenveloped virus entry involving autocleavage of the penetration protein prior to exposure of its membrane-insertion finger.	[Zhang, Xing; Jin, Lei; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Fang, Qin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China; [Hui, Wong H.; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; University of California System; University of California Los Angeles	Zhou, ZH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	hong.zhou@ucla.edu	fang, qin/GQA-8223-2022; Zhou, Z Hong/HDN-0747-2022		National Institutes of Health (NIH) [GM071940, AI069015, 1S10RR23057]; Abraxis BioScience; National Basic Research Program of China (973 Program) [2009CB118701]; National Natural Scientific Foundation of China [30671615, 30871940]; Chinese Academy of Sciences [KSCX2-YW-N-021]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abraxis BioScience; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Stan Schein for editing our manuscript, Xiaokang Zhang for assistance in programming, Xuekui Yu for advice in sample purification, Hongrong Liu and Lingpeng Cheng for assistance in film development, and Connie Huang for film digitization. This project is supported in part by grants from the National Institutes of Health (NIH; GM071940 and AI069015 to Z.H.Z.) and Abraxis BioScience. We acknowledge the use of the cryo-EM facility at the Electron Imaging Center for NanoMachines supported by the NIH (1S10RR23057 to Z.H.Z.). This project is also supported by the National Basic Research Program of China (973 Program, #2009CB118701 to Q.F.), the National Natural Scientific Foundation of China (# 30671615 and # 30871940 to Q.F.), and the Chinese Academy of Sciences (KSCX2-YW-N-021 to Q.F.).	Agosto MA, 2008, P NATL ACAD SCI USA, V105, P10571, DOI 10.1073/pnas.0802039105; Agosto MA, 2007, J VIROL, V81, P7400, DOI 10.1128/JVI.02720-06; Banerjee M, 2008, CURR PROTEIN PEPT SC, V9, P16; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chandran K, 2003, TRENDS MICROBIOL, V11, P374, DOI 10.1016/S0966-842X(03)00178-1; Chandran K, 2002, J VIROL, V76, P9920, DOI 10.1128/JVI.76.19.9920-9933.2002; Chandran K, 1998, J VIROL, V72, P467, DOI 10.1128/JVI.72.1.467-475.1998; Cheng LP, 2008, J MOL BIOL, V382, P213, DOI 10.1016/j.jmb.2008.06.075; Cheng LP, 2010, J MOL BIOL, V397, P852, DOI 10.1016/j.jmb.2009.12.027; Clarke P, 2005, CURR TOP MICROBIOL, V289, P1; Danthi P, 2008, J VIROL, V82, P161, DOI 10.1128/JVI.01739-07; DeLano WL, 2002, PYMOL USERS MANUAL; DOWELL LG, 1960, NATURE, V188, P1144, DOI 10.1038/1881144a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang Q, 2008, ARCH VIROL, V153, P675, DOI 10.1007/s00705-008-0048-3; Fang Q, 2005, SCI CHINA SER C, V48, P593, DOI 10.1360/062004-105; FritzWolf K, 1996, NATURE, V381, P341, DOI 10.1038/381341a0; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; Greenleaf WB, 2008, J VIROL, V82, P6017, DOI 10.1128/JVI.00387-08; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Ivanovic T, 2008, EMBO J, V27, P1289, DOI 10.1038/emboj.2008.60; Jiang W, 2008, NATURE, V451, P1130, DOI 10.1038/nature06665; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380; Liang YY, 2002, J STRUCT BIOL, V137, P292, DOI 10.1016/S1047-8477(02)00014-X; Liemann S, 2002, CELL, V108, P283, DOI 10.1016/S0092-8674(02)00612-8; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Middleton JK, 2007, VIROLOGY, V361, P412, DOI 10.1016/j.virol.2006.11.024; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nason EL, 2000, J VIROL, V74, P6546, DOI 10.1128/JVI.74.14.6546-6555.2000; Nibert ML, 2005, J MOL BIOL, V345, P461, DOI 10.1016/j.jmb.2004.10.026; NIBERT ML, 1991, J VIROL, V65, P1960, DOI 10.1128/JVI.65.4.1960-1967.1991; NIBERT ML, 1992, J VIROL, V66, P6408, DOI 10.1128/JVI.66.11.6408-6418.1992; Noad L, 2006, VIRUS RES, V116, P45, DOI 10.1016/j.virusres.2005.08.014; Odegard AL, 2004, J VIROL, V78, P8732, DOI 10.1128/JVI.78.16.8732-8745.2004; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REDDY V, 2004, NODAVIRUS ENDOPEPTID, V1; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Rivas C, 1998, AQUACULTURE, V160, P47, DOI 10.1016/S0044-8486(97)00239-1; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Shing M, 1996, VIRUS RES, V46, P19, DOI 10.1016/S0168-1702(96)01372-X; Taylor DJ, 2005, PROTEIN SCI, V14, P401, DOI 10.1110/ps.041054605; TILLOTSON L, 1992, J VIROL, V66, P2180, DOI 10.1128/JVI.66.4.2180-2186.1992; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893; Zhang L, 2006, J VIROL, V80, P12367, DOI 10.1128/JVI.01343-06; Zhang X, 2005, VIROLOGY, V343, P25, DOI 10.1016/j.virol.2005.08.002; Zhang X, 2005, STRUCTURE, V13, P1545, DOI 10.1016/j.str.2005.07.012; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105; Zhou ZH, 2008, CURR OPIN STRUC BIOL, V18, P218, DOI 10.1016/j.sbi.2008.03.004	58	237	266	0	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					472	482		10.1016/j.cell.2010.03.041	http://dx.doi.org/10.1016/j.cell.2010.03.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20398923	Green Accepted, Bronze			2022-12-24	WOS:000277180800018
J	Gruter, T; Carbon, CC				Grueter, Thomas; Carbon, Claus-Christian			Escaping attention. Some cognitive disorders can be overlooked	SCIENCE			English	Editorial Material							FACE RECOGNITION; PROSOPAGNOSIA; ABILITY		[Grueter, Thomas; Carbon, Claus-Christian] Otto Friedrich Univ Bamberg, Dept Gen Psychol & Methodol, D-96047 Bamberg, Germany	Otto Friedrich University Bamberg	Gruter, T (corresponding author), Otto Friedrich Univ Bamberg, Dept Gen Psychol & Methodol, Markuspl 3, D-96047 Bamberg, Germany.	tgrueter@comfood.com	Carbon, Claus-Christian/GLQ-6274-2022; Carbon, Claus-Christian/A-7494-2008	Carbon, Claus-Christian/0000-0002-3446-9347; Carbon, Claus-Christian/0000-0002-3446-9347; Gruter, Thomas/0000-0003-3529-9244				Anokhin AP, 2010, BEHAV GENET, V40, P178, DOI 10.1007/s10519-010-9337-1; Basso MR, 2002, CLIN NEUROPSYCHOL, V16, P57, DOI 10.1076/clin.16.1.57.8329; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Garrido L, 2009, NEUROPSYCHOLOGIA, V47, P123, DOI 10.1016/j.neuropsychologia.2008.08.003; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gruter T, 2008, J NEUROPSYCHOL, V2, P79, DOI 10.1348/174866407X231001; Hausknecht JP, 2007, J APPL PSYCHOL, V92, P373, DOI 10.1037/0021-9010.92.2.373; Kennerknecht I, 2006, AM J MED GENET A, V140A, P1617, DOI 10.1002/ajmg.a.31343; Nijboer TCW, 2007, NEUROPSYCHOLOGIA, V45, P1961, DOI 10.1016/j.neuropsychologia.2007.01.021; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; Wilmer JB, 2010, P NATL ACAD SCI USA, V107, P5238, DOI 10.1073/pnas.0913053107; Zhu Q, 2010, CURR BIOL, V20, P137, DOI 10.1016/j.cub.2009.11.067	15	14	14	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					435	436		10.1126/science.1190432	http://dx.doi.org/10.1126/science.1190432			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YR	20413479				2022-12-24	WOS:000276952400019
J	Trifiro, G; Gambassi, G; Sen, EF; Caputi, AP; Bagnardi, V; Brea, J; Sturkenboom, MCJM				Trifiro, Gianluca; Gambassi, Giovanni; Sen, Elif F.; Caputi, Achille P.; Bagnardi, Vincenzo; Brea, Jose; Sturkenboom, Miriam C. J. M.			Association of Community-Acquired Pneumonia With Antipsychotic Drug Use in Elderly Patients A Nested Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							OLDER-ADULTS; RISK; MORTALITY; AFFINITY; BINDING; EVENTS; RECORDS	Background: According to safety alerts from the U. S. Food and Drug Administration, pneumonia is one of the most frequently reported causes of death in elderly patients with dementia who are treated with antipsychotic drugs. However, epidemiologic evidence of the association between antipsychotic drug use and pneumonia is limited. Objective: To evaluate whether typical or atypical antipsychotic use is associated with fatal or nonfatal pneumonia in elderly persons. Design: Population-based, nested case-control study. Setting: Dutch Integrated Primary Care Information database. Patients: Cohort of persons who used an antipsychotic drug, were 65 years or older, and were registered in the IPCI database from 1996 to 2006. Case patients were all persons with incident community-acquired pneumonia. Up to 20 control participants were matched to each case patient on the basis of age, sex, and date of onset. Measurements: Risk for fatal or nonfatal community-acquired pneumonia with atypical and typical antipsychotic use. Antipsychotic exposure was categorized by type, timing, and daily dose, and the association with pneumonia was assessed by using conditional logistic regression. Results: 258 case patients with incident pneumonia were matched to 1686 control participants. Sixty-five (25%) of the case patients died in 30 days, and their disease was considered fatal. Current use of either atypical (odds ratio [OR], 2.61 [95% CI, 1.48 to 4.61]) or typical (OR, 1.76 [CI, 1.22 to 2.53]) antipsychotic drugs was associated with a dose-dependent increase in the risk for pneumonia compared with past use of antipsychotic drugs. Only atypical antipsychotic drugs were associated with an increase in the risk for fatal pneumonia (OR, 5.97 [CI, 1.49 to 23.98]). Limitations: Antipsychotic exposure was based on prescription files. Residual confounding due to unmeasured covariates or severity of disease was possible. Conclusion: The use of either atypical or typical antipsychotic drugs in elderly patients is associated in a dose-dependent manner with risk for community-acquired pneumonia.	[Trifiro, Gianluca] Erasmus Univ, Med Ctr, Dept Med Informat, NL-3800 DR Rotterdam, Netherlands; Univ Cattolica Sacro Cuore, I-00168 Rome, Italy; Univ Messina, I-98125 Messina, Italy; IRCCS, Ctr Neurolesi Bonino Pulejo, Messina, Italy; Univ Milano Bicocca, I-20126 Milan, Italy; European Inst Oncol, Milan, Italy; Univ Santiago Compostela, Santiago De Compostela 15782, Spain	Erasmus University Rotterdam; Erasmus MC; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Messina; IRCCS Bonino Pulejo; University of Milano-Bicocca; IRCCS European Institute of Oncology (IEO); Universidade de Santiago de Compostela	Trifiro, G (corresponding author), Erasmus Univ, Med Ctr, Dept Med Informat, POB 1738, NL-3800 DR Rotterdam, Netherlands.	g.trifiro@erasmusmc.nl	Brea, Jose/ABH-3260-2020; Trifiro, Gianluca/K-9744-2016	Trifiro, Gianluca/0000-0003-1147-7296; Brea, Jose/0000-0002-5523-1979				Alexopoulos GS, 2004, J CLIN PSYCHIAT, V65, P5; Alexopoulos GS, 2004, J CLIN PSYCHIAT, V65, P100; Barnett MJ, 2006, J CLIN PSYCHOPHARM, V26, P182, DOI 10.1097/01.jcp.0000203598.43314.34; BEAUMONT JJ, 1989, AM J EPIDEMIOL, V129, P212, DOI 10.1093/oxfordjournals.aje.a115111; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gill SS, 2007, ANN INTERN MED, V146, P775, DOI 10.7326/0003-4819-146-11-200706050-00006; GOLDS PR, 1980, BRIT J PHARMACOL, V68, P541, DOI 10.1111/j.1476-5381.1980.tb14570.x; HORWITZ RI, 1980, AM J MED, V68, P255, DOI 10.1016/0002-9343(80)90363-0; Jeste DV, 1999, AM J GERIAT PSYCHIAT, V7, P70; Knol W, 2008, J AM GERIATR SOC, V56, P661, DOI 10.1111/j.1532-5415.2007.01625.x; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; LAMBERTS H, 1992, FAM PRACT, V9, P330, DOI 10.1093/fampra/9.3.330; Marder SR, 2003, J CLIN PSYCHIAT, V64, P3; Marrie TJ, 2000, CLIN INFECT DIS, V31, P1066, DOI 10.1086/318124; MOORE KA, 2005, Patent No. 2005035511; PALACIOS JM, 1978, EUR J PHARMACOL, V50, P443, DOI 10.1016/0014-2999(78)90151-6; Pierre JM, 2005, DRUG SAFETY, V28, P191, DOI 10.2165/00002018-200528030-00002; Psaty BM, 1999, J AM GERIATR SOC, V47, P749, DOI 10.1111/j.1532-5415.1999.tb01603.x; Rochon PA, 2008, ARCH INTERN MED, V168, P1090, DOI 10.1001/archinte.168.10.1090; Schindler JS, 2002, LARYNGOSCOPE, V112, P589, DOI 10.1097/00005537-200204000-00001; Sekine Y, 1999, EUR J CLIN PHARMACOL, V55, P583, DOI 10.1007/s002280050676; Silvestre JS, 2005, METHOD FIND EXP CLIN, V27, P289, DOI 10.1358/mf.2005.27.5.908643; Trifiro G, 2005, EUR J CLIN PHARMACOL, V61, P47, DOI 10.1007/s00228-004-0868-3; Trifiro G, 2007, PHARMACOEPIDEM DR S, V16, P538, DOI 10.1002/pds.1334; U.S. Food and Drug Administration, 2005, PUBL HLTH ADV DEATHS; van der Steen JT, 2006, J CLIN EPIDEMIOL, V59, P970, DOI 10.1016/j.jclinepi.2005.12.005; VANDERLEI J, 1993, ANN INTERN MED, V119, P1036, DOI 10.7326/0003-4819-119-10-199311150-00011; Vlug AE, 1999, METHOD INFORM MED, V38, P339; Wada H, 2001, GERONTOLOGY, V47, P271, DOI 10.1159/000052811; Wang PS, 2007, J CLIN PSYCHOPHARM, V27, P707, DOI 10.1097/JCP.0b013e31815a882b; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827	31	109	111	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	2010	152	7					418	W140		10.7326/0003-4819-152-7-201004060-00006	http://dx.doi.org/10.7326/0003-4819-152-7-201004060-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579QI	20368647				2022-12-24	WOS:000276386900002
J	Gapstur, SM; Thun, MJ				Gapstur, Susan M.; Thun, Michael J.			Progress in the War on Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gapstur, Susan M.] Amer Canc Soc, Natl Home Off, Atlanta, GA 30303 USA	American Cancer Society	Gapstur, SM (corresponding author), Amer Canc Soc, Natl Home Off, 250 Williams St NW, Atlanta, GA 30303 USA.	susan.gapstur@cancer.org						American Cancer Society, 2009, CANC FACTS FIG 2009; American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Bailar JC, 1997, NEW ENGL J MED, V336, P1569, DOI 10.1056/NEJM199705293362206; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; LEAF C, WHY WERE LOSING WAR; *NAT CANC I, SEER CANC STAT 1975; *US BUR CENS, POP EST PROGR; *WHO, WORLD HLTH STAT 2007	8	14	15	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1084	1085		10.1001/jama.2010.284	http://dx.doi.org/10.1001/jama.2010.284			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233827				2022-12-24	WOS:000275594100022
J	Jennings, MD; Pavitt, GD				Jennings, Martin D.; Pavitt, Graham D.			eIF5 has GDI activity necessary for translational control by eIF2 phosphorylation	NATURE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; C-TERMINAL DOMAIN; EUKARYOTIC TRANSLATION; RIBOSOMAL-SUBUNIT; GTPASE ACTIVATION; GCN4 TRANSLATION; INITIATION; YEAST; COMPLEX; BINDING	In protein synthesis initiation, the eukaryotic translation initiation factor (eIF) 2 (a G protein) functions in its GTP-bound state to deliver initiator methionyl-tRNA (tRNA(i)(Met)) to the small ribosomal subunit and is necessary for protein synthesis in all cells(1,2). Phosphorylation of eIF2 [eIF2(alpha P)] is critical for translational control in diverse settings including nutrient deprivation, viral infection and memory formation(3-5). eIF5 functions in start site selection as a GTPase accelerating protein (GAP) for the eIF2.GTP.tRNA(i)(Met) ternary complex within the ribosome-bound pre-initiation complex(6-8). Here we define new regulatory functions of eIF5 in the recycling of eIF2 from its inactive eIF2.GDP state between successive rounds of translation initiation. First we show that eIF5 stabilizes the binding of GDP to eIF2 and is therefore a bi-functional protein that acts as a GDP dissociation inhibitor (GDI). We find that this activity is independent of the GAP function and identify conserved residues within eIF5 that are necessary for this role. Second we show that eIF5 is a critical component of the eIF2(alpha P) regulatory complex that inhibits the activity of the guanine-nucleotide exchange factor (GEF) eIF2B. Together our studies define a new step in the translation initiation pathway, one that is critical for normal translational controls.	[Jennings, Martin D.; Pavitt, Graham D.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Pavitt, GD (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	graham.pavitt@manchester.ac.uk	Pavitt, Graham D/A-1363-2010; Jennings, martin/E-5240-2010	Pavitt, Graham D/0000-0002-8593-2418; Jennings, Martin/0000-0001-6173-0988	BBSRC [BB/E002005/1, BB/H010599/1]; Biotechnology and Biological Sciences Research Council [BB/H010599/1, BB/E002005/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank K. Asano for plasmids and yeast strains, and discussions, and M. Ashe and members of the Pavitt and Ashe labs for discussions. This work was supported by grants BB/E002005/1 and BB/H010599/1 from the BBSRC to G. D. P.	Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Alone PV, 2006, J BIOL CHEM, V281, P12636, DOI 10.1074/jbc.M511700200; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Conte MR, 2006, BIOCHEMISTRY-US, V45, P4550, DOI 10.1021/bi052387u; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Das S, 2001, J BIOL CHEM, V276, P6720, DOI 10.1074/jbc.M008863200; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DEVER TE, 1995, MOL CELL BIOL, V15, P6351; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Mohammad-Qureshi SS, 2007, MOL CELL BIOL, V27, P5225, DOI 10.1128/MCB.00495-07; Mohr I, 2004, INT REV IMMUNOL, V23, P199, DOI 10.1080/08830180490265600; Paulin FEM, 2001, CURR BIOL, V11, P55, DOI 10.1016/S0960-9822(00)00025-7; Pavitt GD, 1997, MOL CELL BIOL, V17, P1298, DOI 10.1128/MCB.17.3.1298; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; RAMIREZ M, 1992, MOL CELL BIOL, V12, P5801, DOI 10.1128/MCB.12.12.5801; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Schmitt E, 2002, EMBO J, V21, P1821, DOI 10.1093/emboj/21.7.1821; Singh CR, 2006, EMBO J, V25, P4537, DOI 10.1038/sj.emboj.7601339; Singh CR, 2005, MOL CELL BIOL, V25, P5480, DOI 10.1128/MCB.25.13.5480-5491.2005; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Wei ZY, 2006, J MOL BIOL, V359, P1, DOI 10.1016/j.jmb.2006.03.037	29	77	78	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2010	465	7296					378	U142		10.1038/nature09003	http://dx.doi.org/10.1038/nature09003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485439	Green Accepted			2022-12-24	WOS:000277829200047
J	Larrea, AA; Lujan, SA; Kunkel, TA				Larrea, Andres A.; Lujan, Scott A.; Kunkel, Thomas A.			SnapShot: DNA Mismatch Repair	CELL			English	Editorial Material									[Larrea, Andres A.; Lujan, Scott A.; Kunkel, Thomas A.] NIEHS, NIH, DHHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Larrea, AA (corresponding author), NIEHS, NIH, DHHS, POB 12233, Res Triangle Pk, NC 27709 USA.		Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788; Lujan, Scott/0000-0003-2400-8325	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065089] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lin Z, 2007, NUCLEIC ACIDS RES, V35, P7591, DOI 10.1093/nar/gkm921	9	68	75	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4								10.1016/j.cell.2010.05.002	http://dx.doi.org/10.1016/j.cell.2010.05.002			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478261	Bronze			2022-12-24	WOS:000277623600025
J	Zhang, XW; Yan, XJ; Zhou, ZR; Yang, FF; Wu, ZY; Sun, HB; Liang, WX; Song, AX; Lallemand-Breitenbach, V; Jeanne, M; Zhang, QY; Yang, HY; Huang, QH; Zhou, GB; Tong, JH; Zhang, Y; Wu, JH; Hu, HY; de The, H; Chen, SJ; Chen, Z				Zhang, Xiao-Wei; Yan, Xiao-Jing; Zhou, Zi-Ren; Yang, Fei-Fei; Wu, Zi-Yu; Sun, Hong-Bin; Liang, Wen-Xue; Song, Ai-Xin; Lallemand-Breitenbach, Valerie; Jeanne, Marion; Zhang, Qun-Ye; Yang, Huai-Yu; Huang, Qiu-Hua; Zhou, Guang-Biao; Tong, Jian-Hua; Zhang, Yan; Wu, Ji-Hui; Hu, Hong-Yu; de The, Hugues; Chen, Sai-Juan; Chen, Zhu			Arsenic Trioxide Controls the Fate of the PML-RAR alpha Oncoprotein by Directly Binding PML	SCIENCE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; INITIATING CELLS; DEGRADATION; RECEPTOR; THERAPY; PROTEINS; EFFICACY; DOMAIN; AS2O3	Arsenic, an ancient drug used in traditional Chinese medicine, has attracted worldwide interest because it shows substantial anticancer activity in patients with acute promyelocytic leukemia (APL). Arsenic trioxide (As2O3) exerts its therapeutic effect by promoting degradation of an oncogenic protein that drives the growth of APL cells, PML-RAR alpha (a fusion protein containing sequences from the PML zinc finger protein and retinoic acid receptor alpha). PML and PML-RAR alpha degradation is triggered by their SUMOylation, but the mechanism by which As2O3 induces this posttranslational modification is unclear. Here we show that arsenic binds directly to cysteine residues in zinc fingers located within the RBCC domain of PML-RAR alpha and PML. Arsenic binding induces PML oligomerization, which increases its interaction with the small ubiquitin-like protein modifier (SUMO)-conjugating enzyme UBC9, resulting in enhanced SUMOylation and degradation. The identification of PML as a direct target of As2O3 provides new insights into the drug's mechanism of action and its specificity for APL.	[Zhang, Xiao-Wei; Yan, Xiao-Jing; Liang, Wen-Xue; Zhang, Qun-Ye; Huang, Qiu-Hua; Tong, Jian-Hua; Zhang, Yan; Chen, Sai-Juan; Chen, Zhu] Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Inst Hematol, State Key Lab Med Genom,Sch Med, Shanghai 200025, Peoples R China; [Zhou, Zi-Ren; Song, Ai-Xin; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Yang, Fei-Fei; Wu, Zi-Yu] Univ Sci & Technol China, Natl Synchrotron Radiat Lab, Beijing 10004, Peoples R China; [Yang, Fei-Fei; Wu, Zi-Yu] CAS, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing 10004, Peoples R China; [Sun, Hong-Bin; Wu, Ji-Hui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Sun, Hong-Bin; Wu, Ji-Hui] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Lallemand-Breitenbach, Valerie; Jeanne, Marion; de The, Hugues] Univ Paris 07, INSERM, CNRS,Hop St Louis, Equipe Labellisee Ligue Natl Canc 11,UMR 944 7151, F-75475 Paris 10, France; [Yang, Huai-Yu] CAS, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Zhou, Guang-Biao] CAS, Lab Mol Carcinogenesis & Targeted Therapy Canc, State Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China; [Zhou, Guang-Biao] CAS, Inst Zool, Key Lab Stem Cell Dev, Beijing, Peoples R China; [de The, Hugues; Chen, Sai-Juan; Chen, Zhu] Hop Rui Jin, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Zoology, CAS	Chen, SJ (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Inst Hematol, State Key Lab Med Genom,Sch Med, 197 Rui Jin Rd 2, Shanghai 200025, Peoples R China.	sjchen@stn.sh.cn; zchen@stn.sh.cn	Hu, Hong-Yu/AAQ-2633-2020; Zhou, Guang-Biao/ABG-5795-2021; Chou, Steven Ziren/M-1995-2014; Sun, Hongbin/C-9721-2015; Zhou, Guangbiao/J-6575-2017; Yang, Fang/AAF-3024-2019	Sun, Hongbin/0000-0002-7712-0655; Zhou, Guangbiao/0000-0002-6327-2316; Lallemand, Valerie/0000-0001-9852-204X; Jeanne, Marion/0000-0001-7334-3061; Zhou, Guang-Biao/0000-0001-6778-7133	863 Program [2006AA02A405]; 973 Project [2010CB529201, 2006CB910305]; National Natural Science Foundation of China [30801372, 30623010, 30772744, 30830119, 10734070]; Shanghai Municipal Commission for Science and Technology [07DZ05908, 08DZ2200100]; Samuel Waxman Cancer Research Foundation	863 Program(National High Technology Research and Development Program of China); 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology; Samuel Waxman Cancer Research Foundation	We thank E.-D. Wang, K.-K. Wang, J. Zhu, and X.-J. Sun for constructive comments on the work; Y.-Y. Shi, H.-L. Jiang, J.-H. Mao, C.-F. Wu, Y.-Y. Xie, Y.-G. Chang, Y.-J. Jiang, and W.-S. Chu for experimental assistance; X.-D. Xi, N. Kieffer, and J. Zhu for critical reading of the manuscript; and all members of Shanghai Institute of Hematology for their encouragement. This work was supported in part by 863 Program (2006AA02A405), 973 Project (2010CB529201, 2006CB910305), the National Natural Science Foundation of China (30801372, 30623010, 30772744, 30830119, 10734070), the Shanghai Municipal Commission for Science and Technology (07DZ05908 and 08DZ2200100), and the Samuel Waxman Cancer Research Foundation Co-Principal Investigator Program.	Benfatto M, 2003, J SYNCHROTRON RADIAT, V10, P51, DOI 10.1107/S0909049502018137; Bhattacharjee H, 1996, J BIOL CHEM, V271, P24465, DOI 10.1074/jbc.271.40.24465; Borden KLB, 1996, P NATL ACAD SCI USA, V93, P1601, DOI 10.1073/pnas.93.4.1601; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Chen GQ, 1997, BLOOD, V89, P3345; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Duprez E, 1999, J CELL SCI, V112, P381; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Jiang GF, 2003, CHEM RES TOXICOL, V16, P873, DOI 10.1021/tx034053g; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Spuches AM, 2005, INORG CHEM, V44, P2964, DOI 10.1021/ic048694q; Spuches AM, 2008, J AM CHEM SOC, V130, P8148, DOI 10.1021/ja802179p; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Zhang XY, 2007, CANCER LETT, V255, P95, DOI 10.1016/j.canlet.2007.03.025; Zhou GB, 2007, PHILOS T R SOC B, V362, P959, DOI 10.1098/rstb.2007.2026; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807; Zhu J, 2002, NAT REV CANCER, V2, P705, DOI 10.1038/nrc887; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	28	549	627	15	344	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					240	243		10.1126/science.1183424	http://dx.doi.org/10.1126/science.1183424			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20378816				2022-12-24	WOS:000276459600045
J	Raaijmakers, MHGP; Mukherjee, S; Guo, SQ; Zhang, SY; Kobayashi, T; Schoonmaker, JA; Ebert, BL; Al-Shahrour, F; Hasserjian, RP; Scadden, EO; Aung, Z; Matza, M; Merkenschlager, M; Lin, C; Rommens, JM; Scadden, DT				Raaijmakers, Marc H. G. P.; Mukherjee, Siddhartha; Guo, Shangqin; Zhang, Siyi; Kobayashi, Tatsuya; Schoonmaker, Jesse A.; Ebert, Benjamin L.; Al-Shahrour, Fatima; Hasserjian, Robert P.; Scadden, Edward O.; Aung, Zinmar; Matza, Marc; Merkenschlager, Matthias; Lin, Charles; Rommens, Johanna M.; Scadden, David. T.			Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia	NATURE			English	Article							STEM-CELL NICHE; HEMATOPOIETIC PROGENITORS; DIFFERENTIATION; MICROENVIRONMENT; IDENTIFICATION; EXPRESSION; HEDGEHOG; SBDS	Mesenchymal cells contribute to the 'stroma' of most normal and malignant tissues, with specific mesenchymal cells participating in the regulatory niches of stem cells. By examining how mesenchymal osteolineage cells modulate haematopoiesis, here we show that deletion of Dicer1 specifically in mouse osteoprogenitors, but not in mature osteoblasts, disrupts the integrity of haematopoiesis. Myelodysplasia resulted and acute myelogenous leukaemia emerged that had acquired several genetic abnormalities while having intact Dicer1. Examining gene expression altered in osteoprogenitors as a result of Dicer1 deletion showed reduced expression of Sbds, the gene mutated in Schwachman-Bodian-Diamond syndrome-a human bone marrow failure and leukaemia pre-disposition condition. Deletion of Sbds in mouse osteoprogenitors induced bone marrow dysfunction with myelodysplasia. Therefore, perturbation of specific mesenchymal subsets of stromal cells can disorder differentiation, proliferation and apoptosis of heterologous cells, and disrupt tissue homeostasis. Furthermore, primary stromal dysfunction can result in secondary neoplastic disease, supporting the concept of niche-induced oncogenesis.	[Raaijmakers, Marc H. G. P.; Mukherjee, Siddhartha; Guo, Shangqin; Zhang, Siyi; Schoonmaker, Jesse A.; Scadden, Edward O.; Aung, Zinmar; Matza, Marc; Scadden, David. T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Raaijmakers, Marc H. G. P.; Mukherjee, Siddhartha; Guo, Shangqin; Zhang, Siyi; Schoonmaker, Jesse A.; Scadden, Edward O.; Aung, Zinmar; Matza, Marc; Scadden, David. T.] Harvard Univ, Sch Med, CPZN, Boston, MA 02114 USA; [Mukherjee, Siddhartha; Scadden, David. T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Kobayashi, Tatsuya] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Hasserjian, Robert P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Lin, Charles] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Raaijmakers, Marc H. G. P.; Mukherjee, Siddhartha; Guo, Shangqin; Zhang, Siyi; Schoonmaker, Jesse A.; Scadden, Edward O.; Aung, Zinmar; Matza, Marc; Scadden, David. T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Raaijmakers, Marc H. G. P.; Mukherjee, Siddhartha; Guo, Shangqin; Zhang, Siyi; Schoonmaker, Jesse A.; Scadden, Edward O.; Aung, Zinmar; Matza, Marc; Scadden, David. T.] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA; [Ebert, Benjamin L.; Al-Shahrour, Fatima] Broad Inst, Cambridge, MA 02138 USA; [Ebert, Benjamin L.; Al-Shahrour, Fatima] Massachusetts Gen Hosp, Div Hematol, Boston, MA 02115 USA; [Merkenschlager, Matthias] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Lymphocyte Dev Grp, London W12 0NN, England; [Rommens, Johanna M.] Univ Toronto, Program Genet & Genome Biol, Hosp Sick Children, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Imperial College London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Raaijmakers, MHGP (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Room 4265A,185 Cambridge St, Boston, MA 02114 USA.	hraaijmakers@partners.org; dscadden@mgh.harvard.edu	Guo, Shangqin/AAL-7580-2020; Guo, Shangqin/Q-4088-2019; Rommens, Johanna/AAT-7465-2021	Guo, Shangqin/0000-0003-1157-0423; Merkenschlager, Matthias/0000-0003-2889-3288; Kobayashi, Tatsuya/0000-0003-4264-5117	Dutch Cancer Society; Leukemia & Lymphoma Society; National Institutes of Health; Harvard Stem Cell Institute; Ellison Medical Foundation; MRC [MC_U120027516] Funding Source: UKRI; Medical Research Council [MC_U120027516] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL081030, R01HL097794, R01HL044851, U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER	Dutch Cancer Society(KWF Kankerbestrijding); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Schipani, E. Attar and H. Kronenberg for advice and discussion, A. McMahon for providing the Osx-Cre mice, J. Fujisaki, D. Wilpitz, M. Ohishi, S. Vallet, M. Churchill and G. Frankl for technical assistance, the Histocore (Endocrine Unit), Flow Core at the Center for Regenerative Medicine, Massachusetts General Hospital (L. Pickett and K. Folz-Donahue), and F. Preffer and D. Dombrowski for assistance with histology and flow-cytometry. We thank D. Machon for help preparing the manuscript and the Cytogenetics Core at Brigham Women/Dana Farber (Y. Xiao and C. Lee) for performing CGH analyses. This work was supported by a Fellowship Award of the Dutch Cancer Society (KWF) and a Special Fellowship Award of The Leukemia & Lymphoma Society to M. H. G. P. R. and grants of the National Institutes of Health, the Harvard Stem Cell Institute and the Ellison Medical Foundation to D. T. S.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Dror Y, 1999, BLOOD, V94, P3048, DOI 10.1182/blood.V94.9.3048.421k24_3048_3054; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heaney ML, 1999, NEW ENGL J MED, V340, P1649, DOI 10.1056/NEJM199905273402107; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Korkolopoulou P, 2001, LEUKEMIA, V15, P1369, DOI 10.1038/sj.leu.2402220; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Mellibovsky L, 1996, BONE, V19, P401, DOI 10.1016/S8756-3282(96)00210-4; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Raaijmakers MHGP, 2002, EXP HEMATOL, V30, P481, DOI 10.1016/S0301-472X(02)00787-7; Rawls AS, 2007, BLOOD, V110, P2414, DOI 10.1182/blood-2006-03-007112; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Schilling T, 2008, J CELL BIOCHEM, V103, P413, DOI 10.1002/jcb.21415; Sneddon JB, 2007, CELL STEM CELL, V1, P607, DOI 10.1016/j.stem.2007.11.009; Sternberg A, 2005, BLOOD, V106, P2982, DOI 10.1182/blood-2005-04-1543; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; van de Loosdrecht AA, 2008, BLOOD, V111, P1067, DOI 10.1182/blood-2007-07-098764; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	39	760	798	7	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					852	U58		10.1038/nature08851	http://dx.doi.org/10.1038/nature08851			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20305640	Green Accepted, Green Submitted			2022-12-24	WOS:000276397300029
J	Moore, J; McKnight, AJ; Simmonds, MJ; Courtney, AE; Hanvesakul, R; Brand, OJ; Briggs, D; Ball, S; Cockwell, P; Patterson, CC; Maxwell, AP; Gough, SCL; Borrows, R				Moore, Jason; McKnight, Amy Jayne; Simmonds, Matthew J.; Courtney, Aisling E.; Hanvesakul, Rajesh; Brand, Oliver J.; Briggs, David; Ball, Simon; Cockwell, Paul; Patterson, Christopher C.; Maxwell, Alexander P.; Gough, Stephen C. L.; Borrows, Richard			Association of Caveolin-1 Gene Polymorphism With Kidney Transplant Fibrosis and Allograft Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CELLS	Context Caveolin-1 (CAV1) is an inhibitor of tissue fibrosis. Objective To study the association of CAV1 gene variation with kidney transplant outcome, using kidney transplantation as a model of accelerated fibrosis. Design, Setting, and Patients Candidate gene association and validation study. Genomic DNA from 785 white kidney transplant donors and their respective recipients (transplantations in Birmingham, England, between 1996 and 2006; median followup, 81 months) were analyzed for common variation in CAV1 using a single-nucleotide polymorphism (SNP) tagging approach. Validation of positive findings was sought in an independent kidney transplant donor-recipient cohort (transplantations in Belfast, Northern Ireland, between 1986 and 2005; n=697; median follow-up, 69 months). Association between genotype and allograft failure was initially assessed by Kaplan-Meier analysis, then in an adjusted Cox model. Main Outcome Measure Death-censored allograft failure, defined as a return to dialysis or retransplantation. Results The presence of donor AA genotype for the CAV1 rs4730751 SNP was associated with increased risk of allograft failure in the Birmingham group (donor AA vs non-AA genotype in adjusted Cox model, hazard ratio [HR], 1.97; 95% confidence interval [CI], 1.29-3.16; P=.002). No other tag SNPs showed a significant association. This finding was validated in the Belfast cohort (in adjusted Cox model, HR, 1.56; 95% CI, 1.07-2.27; P=.02). Overall graft failure rates were as follows: for the Birmingham cohort, donor genotype AA, 22 of 57 (38.6%); genotype CC, 96 of 431 (22.3%); and genotype AC, 66 of 297 (22.2%); and for the Belfast cohort, donor genotype AA, 32 of 48 (67%); genotype CC, 150 of 358 (42%); and genotype AC, 119 of 273 (44%). Conclusion Among kidney transplant donors, the CAV1 rs4730751 SNP was significantly associated with allograft failure in 2 independent cohorts. JAMA. 2010;303(13):1282-1287	[Moore, Jason; Hanvesakul, Rajesh; Ball, Simon; Cockwell, Paul; Borrows, Richard] Univ Hosp Birmingham, Renal Inst Birmingham, Dept Nephrol & Transplantat, Birmingham, W Midlands, England; [Simmonds, Matthew J.; Brand, Oliver J.; Gough, Stephen C. L.] Univ Birmingham, Inst Biomed Res, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Briggs, David] Natl Blood Serv, Birmingham, W Midlands, England; [McKnight, Amy Jayne; Courtney, Aisling E.; Patterson, Christopher C.; Maxwell, Alexander P.] Queens Univ Belfast, Nephrol Res Grp, Belfast, Antrim, North Ireland	University of Birmingham; University of Birmingham; Queens University Belfast	Borrows, R (corresponding author), Queen Elizabeth Hosp, Univ Hosp Birmingham, Dept Nephrol & Kidney Transplantat, Birmingham B15 2TH, W Midlands, England.	richard.borrows@uhb.nhs.uk	McKnight, Amy Jayne/ABF-4492-2020; McKnight, AJ/B-2450-2009	McKnight, Amy Jayne/0000-0002-7482-709X; Ball, Simon/0000-0001-7410-5268; Cockwell, Paul/0000-0003-1975-266X; Briggs, David/0000-0002-6796-7086; Maxwell, Alexander P./0000-0002-6110-7253; Simmonds, Matt/0000-0003-3154-3510	University Hospital Birmingham Charities; Novartis Pharmaceuticals; ESRC [ES/G007438/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Public Health Agency [STL/3714/07] Funding Source: researchfish	University Hospital Birmingham Charities; Novartis Pharmaceuticals(Novartis); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Public Health Agency	Funding was provided by the University Hospital Birmingham Charities. Dr Moore is funded by an unrestricted educational grant from Novartis Pharmaceuticals.	Clarke GM, 2007, AM J HUM GENET, V81, P995, DOI 10.1086/521952; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; El-Zoghby ZM, 2009, AM J TRANSPLANT, V9, P527, DOI 10.1111/j.1600-6143.2008.02519.x; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Park HC, 2010, AM J PHYSIOL-RENAL, V298, pF357, DOI 10.1152/ajprenal.00542.2009; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Rienstra H, 2009, AM J TRANSPLANT, V9, P463, DOI 10.1111/j.1600-6143.2008.02534.x; Saidi RF, 2007, AM J TRANSPLANT, V7, P2769, DOI 10.1111/j.1600-6143.2007.01993.x; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; Wang L, 2008, PROG CHEM, V20, P713	12	64	65	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1282	1287		10.1001/jama.2010.356	http://dx.doi.org/10.1001/jama.2010.356			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579FM	20371787	Bronze			2022-12-24	WOS:000276353700028
J	Smeitink, J				Smeitink, Jan			Metabolism, Gliomas, and IDH1	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Radboud Univ Nijmegen, Dept Pediat, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Smeitink, J (corresponding author), Radboud Univ Nijmegen, Dept Pediat, Med Ctr, NL-6525 ED Nijmegen, Netherlands.		Smeitink, Jan/C-1351-2013					Chalmers R A, 1980, J Inherit Metab Dis, V3, P11, DOI 10.1007/BF02312516; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Duran M, 1980, J Inherit Metab Dis, V3, P109, DOI 10.1007/BF02312543; KNAAP MS, 1999, J INHERIT METAB DIS, V22, P404; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3	5	14	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1144	1145		10.1056/NEJMcibr0912922	http://dx.doi.org/10.1056/NEJMcibr0912922			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335593	Green Published			2022-12-24	WOS:000275894600015
J	Elkin, EB; Bach, PB				Elkin, Elena B.; Bach, Peter B.			Cancer's Next Frontier Addressing High and Increasing Costs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							REIMBURSEMENT; MEDICARE		[Elkin, Elena B.; Bach, Peter B.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, 1275 York Ave,Box 44, New York, NY 10065 USA.	bachp@mskcc.org			NCI NIH HHS [K07 CA118189-04, K07 CA118189] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA118189] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brown ML, 2001, ANNU REV PUBL HEALTH, V22, P91, DOI 10.1146/annurev.publhealth.22.1.91; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Goldman DP, 2006, HEALTH AFFAIR, V25, P1319, DOI 10.1377/hlthaff.25.5.1319; Jacobson M, 2006, HEALTH AFFAIR, V25, P437, DOI 10.1377/hlthaff.25.2.437; National Heart Lung and Blood Institute, 2008, NHLBI FACT BOOK FISC; Neumann PJ, 2010, HEALTH AFFAIR, V29, P196, DOI 10.1377/hlthaff.2009.0077; The Kaiser Family Foundation, 2009, US TOD KAIS FAM FDN; Warren JL, 2008, J NATL CANCER I, V100, P888, DOI 10.1093/jnci/djn175; Weight CJ, 2008, CANCER-AM CANCER SOC, V112, P2195, DOI 10.1002/cncr.23421	9	110	114	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1086	1087		10.1001/jama.2010.283	http://dx.doi.org/10.1001/jama.2010.283			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	569KC	20233828	Green Accepted			2022-12-24	WOS:000275594100023
J	Van Roy, P; Orr, PJ; Botting, JP; Muir, LA; Vinther, J; Lefebvre, B; el Hariri, K; Briggs, DEG				Van Roy, Peter; Orr, Patrick J.; Botting, Joseph P.; Muir, Lucy A.; Vinther, Jakob; Lefebvre, Bertrand; el Hariri, Khadija; Briggs, Derek E. G.			Ordovician faunas of Burgess Shale type	NATURE			English	Article							DEVONIAN HUNSRUCK SLATE; PRESERVATION; LAGERSTATTE; ARTHROPOD; MOROCCO; BIOTAS	The renowned soft-bodied faunas of the Cambrian period, which include the Burgess Shale, disappear from the fossil record in the late Middle Cambrian, after which the Palaeozoic fauna(1) dominates. The disappearance of faunas of Burgess Shale type curtails the stratigraphic record of a number of iconic Cambrian taxa. One possible explanation for this loss is a major extinction(2,3), but more probably it reflects the absence of preservation of similar soft-bodied faunas in later periods(4). Here we report the discovery of numerous diverse soft-bodied assemblages in the Lower and Upper Fezouata Formations (Lower Ordovician) of Morocco, which include a range of remarkable stem-group morphologies normally considered characteristic of the Cambrian. It is clear that biotas of Burgess Shale type persisted after the Cambrian and are preserved where suitable facies occur. The Fezouata biota provides a link between the Burgess Shale communities and the early stages of the Great Ordovician Biodiversification Event.	[Van Roy, Peter; Vinther, Jakob; Briggs, Derek E. G.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Van Roy, Peter; Orr, Patrick J.] Univ Coll Dublin, Sch Geol Sci, Dublin 4, Ireland; [Botting, Joseph P.] Leeds Museum Discovery Ctr, Leeds LS10 1LB, W Yorkshire, England; [Lefebvre, Bertrand] Univ Lyon 1, CNRS, UMR PEPS 5125, F-69622 Villeurbanne, France; [el Hariri, Khadija] Univ Cadi Ayyad, Fac Sci & Tech Gueliz, Dept Sci Terre, Marrakech 40000, Morocco; [Briggs, Derek E. G.] Yale Univ, Yale Peabody Museum Nat Hist, New Haven, CT 06520 USA	Yale University; University College Dublin; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Cadi Ayyad University of Marrakech; Yale University	Van Roy, P (corresponding author), Yale Univ, Dept Geol & Geophys, POB 208109, New Haven, CT 06520 USA.	peter.vanroy@yale.edu; derek.briggs@yale.edu		Orr, Patrick/0000-0002-6740-1656; Vinther, Jakob/0000-0002-3584-9616; Van Roy, Peter/0000-0001-5330-8402	Agency for Innovation, Science and Technology (IWT); Irish Research Council for Science, Engineering and Technology (IRCSET); National Geographic Society	Agency for Innovation, Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Irish Research Council for Science, Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); National Geographic Society(National Geographic Society)	S. Butts (Yale Peabody Museum of Natural History), A. Prieur (Lyon1 University), D. Berthet (Natural History Museum of Lyon), A. Medard-Blondel and S. Pichard (Natural History Museum of Marseille), G. Fleury (Natural History Museum of Toulouse), the National Museums of Scotland and the Sedgwick Museum provided access to specimens. M. Ben Said Ben Moula, W. and D. De Winter, B. MacGabhann, R. and V. Reboul-Baron, C. Upton, B. Van Bocxlaer, and D. and K. Van Damme assisted with fieldwork, and B. Tahiri arranged logistical support. E. Champion helped with the preparation of figures. J. De Grave and B. Van Bocxlaer (Ghent University) provided photographic equipment, and the Palaeontology and Petrology Research Units of Ghent University allowed use of their imaging facilities. P. and O. Van Roy-Lassaut financially aided fieldwork. This research was funded by an Agency for Innovation by Science and Technology (IWT) doctoral fellowship and by an Irish Research Council for Science, Engineering and Technology (IRCSET) - EMPOWER postdoctoral fellowship awarded to P. V. R. Fieldwork was supported by a National Geographic Society Research and Exploration grant.	Aldridge R.J., 2001, P340, DOI 10.1002/9780470999295.ch79; Alessandrello Anna, 2003, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V144, P337; ALLISON PA, 1993, GEOLOGY, V21, P527, DOI 10.1130/0091-7613(1993)021<0527:EFRDOS>2.3.CO;2; ALLISON PA, 1993, LETHAIA, V26, P184, DOI 10.1111/j.1502-3931.1993.tb01813.x; ALLISON PA, 1991, TAPHONOMY RELEASING, P25; Bambach RK, 2007, PALAEONTOLOGY, V50, P1, DOI 10.1111/j.1475-4983.2006.00611.x; Bambach RK, 2004, PALEOBIOLOGY, V30, P522, DOI 10.1666/0094-8373(2004)030<0522:OEAMDO>2.0.CO;2; Botting JP, 2007, GEOBIOS-LYON, V40, P737, DOI 10.1016/j.geobios.2007.02.006; BUTTERFIELD NJ, 1995, LETHAIA, V28, P1, DOI 10.1111/j.1502-3931.1995.tb01587.x; Caron JB, 2004, J PALEONTOL, V78, P1138, DOI 10.1666/0022-3360(2004)078<1138:ANLSPN>2.0.CO;2; Clausen S, 2010, PALAEOGEOGR PALAEOCL, V294, P133, DOI 10.1016/j.palaeo.2010.01.001; Destombes J., 1985, LOWER PALAEOZOIC ROC, V4, P91; Droser ML, 2003, INTEGR COMP BIOL, V43, P178, DOI 10.1093/icb/43.1.178; Farrell UC, 2009, GEOLOGY, V37, P907, DOI 10.1130/G30177A.1; Friend D., 2002, PALEONTOL J, V36, P20; Gabbott SE, 2004, GEOLOGY, V32, P901, DOI 10.1130/G20640.1; Harper DAT, 2006, PALAEOGEOGR PALAEOCL, V232, P148, DOI 10.1016/j.palaeo.2005.07.010; Kuhl G, 2009, SCIENCE, V323, P771, DOI 10.1126/science.1166586; Kuhl G, 2008, PALAEONTOGR ABT A, V286, P123; Liu HPB, 2006, GEOLOGY, V34, P969, DOI 10.1130/G22911A.1; MORRIS SC, 1989, T RSE EARTH, V80, P271; MORRIS SC, 1985, PHILOS T ROY SOC B, V311, P49, DOI 10.1098/rstb.1985.0138; Orr PJ, 2003, GEOLOGY, V31, P769, DOI 10.1130/G19193.1; SEPKOSKI JJ, 1979, PALEOBIOLOGY, V5, P222, DOI 10.1017/S0094837300006539; Van Roy P, 2006, T ROY SOC EDIN-EARTH, V96, P327; Vandenbroucke TRA, 2009, J MICROPALAEONTOL, V28, P53, DOI 10.1144/jm.28.1.53; Vinther J, 2008, NATURE, V451, P185, DOI 10.1038/nature06474; Webby B.D., 2004, GREAT ORDOVICIAN BIO, DOI DOI 10.7312/WEBB12678; Young GA, 2007, GEOLOGY, V35, P883, DOI 10.1130/G23947A.1; Zhang XG, 2007, TERRA NOVA, V19, P407, DOI 10.1111/j.1365-3121.2007.00765.x	30	230	233	3	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					215	218		10.1038/nature09038	http://dx.doi.org/10.1038/nature09038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463737				2022-12-24	WOS:000277558500034
J	Gao, ZH; Liu, HL; Daxinger, L; Pontes, O; He, XJ; Qian, WQ; Lin, HX; Xie, MT; Lorkovic, ZJ; Zhang, SD; Miki, D; Zhan, XQ; Pontier, D; Lagrange, T; Jin, HL; Matzke, AJM; Matzke, M; Pikaard, CS; Zhu, JK				Gao, Zhihuan; Liu, Hai-Liang; Daxinger, Lucia; Pontes, Olga; He, Xinjian; Qian, Weiqiang; Lin, Huixin; Xie, Mingtang; Lorkovic, Zdravko J.; Zhang, Shoudong; Miki, Daisuke; Zhan, Xiangqiang; Pontier, Dominique; Lagrange, Thierry; Jin, Hailing; Matzke, Antonius J. M.; Matzke, Marjori; Pikaard, Craig S.; Zhu, Jian-Kang			An RNA polymerase II- and AGO4-associated protein acts in RNA-directed DNA methylation	NATURE			English	Article							ARABIDOPSIS-THALIANA; PROCESSING CENTER; BINDING PROTEIN; ARGONAUTE4; GLYCOSYLASE/LYASE; TRANSCRIPTION; RESOLUTION; PATHWAYS; PATTERNS; BODIES	DNA methylation is an important epigenetic mark in many eukaryotes(1-5). In plants, 24-nucleotide small interfering RNAs (siRNAs) bound to the effector protein, Argonaute 4 (AGO4), can direct de novo DNA methylation by the methyltransferase DRM2 (refs 2, 4-6). Here we report a new regulator of RNA-directed DNA methylation (RdDM) in Arabidopsis: RDM1. Loss-of-function mutations in the RDM1 gene impair the accumulation of 24-nucleotide siRNAs, reduce DNA methylation, and release transcriptional gene silencing at RdDM target loci. RDM1 encodes a small protein that seems to bind single-stranded methyl DNA, and associates and co-localizes with RNA polymerase II (Pol II, also known as NRPB), AGO4 and DRM2 in the nucleus. Our results indicate that RDM1 is a component of the RdDM effector complex and may have a role in linking siRNA production with pre-existing or de novo cytosine methylation. Our results also indicate that, although RDM1 and Pol V (also known as NRPE) may function together at some RdDM target sites in the peri-nucleolar siRNA processing centre, Pol II rather than Pol Vis associated with the RdDM effector complex at target sites in the nucleoplasm.	[Gao, Zhihuan; Liu, Hai-Liang; He, Xinjian; Qian, Weiqiang; Lin, Huixin; Xie, Mingtang; Zhang, Shoudong; Miki, Daisuke; Zhan, Xiangqiang; Jin, Hailing; Zhu, Jian-Kang] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Gao, Zhihuan; Liu, Hai-Liang; He, Xinjian; Qian, Weiqiang; Lin, Huixin; Xie, Mingtang; Zhang, Shoudong; Miki, Daisuke; Zhan, Xiangqiang; Zhu, Jian-Kang] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Liu, Hai-Liang] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Daxinger, Lucia; Matzke, Antonius J. M.; Matzke, Marjori] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, A-1030 Vienna, Austria; [Pontes, Olga] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [He, Xinjian; Zhang, Shoudong; Zhan, Xiangqiang; Zhu, Jian-Kang] 4700 King Abdullah Univ Sci & Technol, Ctr Plant Stress Genom & Technol, Thuwal 239556900, Saudi Arabia; [Lorkovic, Zdravko J.] Med Univ Vienna, Max F Perutz Lab, A-1030 Vienna, Austria; [Pontier, Dominique; Lagrange, Thierry] Univ Perpignan, CNRS, IRD, LGDP,UMR 5096, F-66806 Perpignan, France; [Jin, Hailing] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Pikaard, Craig S.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Pikaard, Craig S.] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; Tongji University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Washington University (WUSTL); King Abdullah University of Science & Technology; Medical University of Vienna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut de Recherche pour le Developpement (IRD); Universite Perpignan Via Domitia; University of California System; University of California Riverside; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Zhu, JK (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	jian-kang.zhu@ucr.edu	Daxinger, Lucia/A-6840-2013; Matzke, Antonius/H-8698-2015; Pontes, Olga MF/F-9768-2011; Zhan, Xiangqiang/B-6073-2018; Zhang, Shoudong/ABC-5471-2021; Zhu, Jian-Kang/F-7658-2011; Jin, Hailing/Z-1168-2019; Pikaard, Craig S/K-8772-2012	Pontes, Olga MF/0000-0003-3316-1145; Zhang, Shoudong/0000-0001-7332-7627; Zhu, Jian-Kang/0000-0001-5134-731X; Jin, Hailing/0000-0001-5778-5193; Pikaard, Craig S/0000-0001-8204-7459; Miki, Daisuke/0000-0001-6066-3357; Pontier, Dominique/0000-0001-9032-4620; Lorkovic, Zdravko/0000-0002-3074-7258; Daxinger, Lucia/0000-0001-6557-6201; Zhan, Xiangqiang/0000-0003-2682-5310; Lagrange, Thierry/0000-0003-3090-0918; Xie, Mingtang/0000-0002-2797-0598	National Institutes of Health; Austrian Fonds zur Forderung der wissenschaftlichen Forschung; National Science Foundation Career Award; Edward Mallinckrodt Foundation Award; Agence Nationale de la Recherche; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093008, R01GM059138, R01GM070795, R01GM077590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); National Science Foundation Career Award(National Science Foundation (NSF)); Edward Mallinckrodt Foundation Award; Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants (J.-K.Z.), Austrian Fonds zur Forderung der wissenschaftlichen Forschung ( M. M. and Z.J.L.), National Science Foundation Career Award (H.J.), Edward Mallinckrodt Foundation Award (O.P.), and Agence Nationale de la Recherche ( T. L.). We thank E. Richards for his gift of methylated DNA oligonucleotides, B. Stevenson for technical assistance and T. Kanno for discussions.	Allard STM, 2005, ACTA CRYSTALLOGR F, V61, P647, DOI 10.1107/S1744309105019743; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; He XJ, 2009, CELL, V137, P498, DOI 10.1016/j.cell.2009.04.028; He XJ, 2009, GENE DEV, V23, P318, DOI 10.1101/gad.1765209; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Jasencakova Z, 2000, PLANT CELL, V12, P2087, DOI 10.1105/tpc.12.11.2087; Kapoor A, 2005, CURR BIOL, V15, P1912, DOI 10.1016/j.cub.2005.09.013; LAW JA, CURR BIOL IN PRESS; Li CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040027; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; MARTIENSSEN RA, 1995, CURR OPIN GENET DEV, V5, P234, DOI 10.1016/0959-437X(95)80014-X; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007; Zheng BL, 2009, GENE DEV, V23, P2850, DOI 10.1101/gad.1868009; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	30	183	194	9	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 6	2010	465	7294					106	U118		10.1038/nature09025	http://dx.doi.org/10.1038/nature09025			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20410883	Green Accepted, Green Submitted			2022-12-24	WOS:000277311900040
J	Tsuchimatsu, T; Suwabe, K; Shimizu-Inatsugi, R; Isokawa, S; Pavlidis, P; Stadler, T; Suzuki, G; Takayama, S; Watanabe, M; Shimizu, KK				Tsuchimatsu, Takashi; Suwabe, Keita; Shimizu-Inatsugi, Rie; Isokawa, Sachiyo; Pavlidis, Pavlos; Staedler, Thomas; Suzuki, Go; Takayama, Seiji; Watanabe, Masao; Shimizu, Kentaro K.			Evolution of self-compatibility in Arabidopsis by a mutation in the male specificity gene	NATURE			English	Article							S-LOCUS GENES; BRASSICA-NAPUS; INCOMPATIBILITY; THALIANA; HAPLOTYPES; TRANSITION; BREAKDOWN; DISTANCE; RNA	Ever since Darwin's pioneering research, the evolution of self-fertilisation (selfing) has been regarded as one of the most prevalent evolutionary transitions in flowering plants(1,2). A major mechanism to prevent selfing is the self-incompatibility (SI) recognition system, which consists of male and female specificity genes at the S-locus and SI modifier genes(2-4). Under conditions that favour selfing, mutations disabling the male recognition component are predicted to enjoy a relative advantage over those disabling the female component, because male mutations would increase through both pollen and seeds whereas female mutations would increase only through seeds(5,6). Despite many studies on the genetic basis of loss of SI in the predominantly selfing plant Arabidopsis thaliana(7-15), it remains unknown whether selfing arose through mutations in the female specificity gene (S-receptor kinase, SRK), male specificity gene (S-locus cysteine-rich protein, SCR; also known as S-locus protein 11, SP11) or modifier genes, and whether any of them rose to high frequency across large geographic regions. Here we report that a disruptive 213-base-pair (bp) inversion in the SCR gene (or its derivative haplotypes with deletions encompassing the entire SCR-A and a large portion of SRK-A) is found in 95% of European accessions, which contrasts with the genome-wide pattern of polymorphism in European A. thaliana(16,17). Importantly, interspecific crossings using Arabidopsis halleri as a pollen donor reveal that some A. thaliana accessions, including Wei-1, retain the female SI reaction, suggesting that all female components including SRK are still functional. Moreover, when the 213-bp inversion in SCR was inverted and expressed in transgenic Wei-1 plants, the functional SCR restored the SI reaction. The inversion within SCR is the first mutation disrupting SI shown to be nearly fixed in geographically wide samples, and its prevalence is consistent with theoretical predictions regarding the evolutionary advantage of mutations in male components.	[Tsuchimatsu, Takashi; Shimizu-Inatsugi, Rie; Shimizu, Kentaro K.] Univ Zurich, Inst Plant Biol, Univ Res Prior Program Syst Biol, Funct Genom & Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; [Tsuchimatsu, Takashi] Univ Tokyo, Dept Gen Syst Studies, Meguro Ku, Tokyo 1538902, Japan; [Suwabe, Keita; Isokawa, Sachiyo; Watanabe, Masao] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808577, Japan; [Suwabe, Keita] Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan; [Isokawa, Sachiyo; Watanabe, Masao] Tohoku Univ, Fac Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Pavlidis, Pavlos] Univ Munich LMU, Bioctr, Sect Evolutionary Biol, D-82152 Planegg Martinsried, Germany; [Staedler, Thomas] ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland; [Suzuki, Go] Osaka Kyoiku Univ, Div Nat Sci, Kashiwara 5828582, Japan; [Takayama, Seiji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300101, Japan	University of Zurich; University of Tokyo; Tohoku University; Mie University; Tohoku University; University of Munich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Osaka University of Education; Nara Institute of Science & Technology	Shimizu, KK (corresponding author), Univ Zurich, Inst Plant Biol, Univ Res Prior Program Syst Biol, Funct Genom & Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland.	nabe@ige.tohoku.ac.jp; shimizu@botinst.uzh.ch	Watanabe, Masao/N-1465-2019; Tsuchimatsu, Takashi/A-9218-2017; Städler, Thomas/B-7286-2009; Watanabe, Masao/E-6300-2011; Tsuchimatsu, Takashi/T-7402-2019	Watanabe, Masao/0000-0002-9419-5149; Tsuchimatsu, Takashi/0000-0003-1241-9338; Städler, Thomas/0000-0003-4513-8583; Watanabe, Masao/0000-0002-9419-5149; Tsuchimatsu, Takashi/0000-0003-1241-9338; Shimizu, Kentaro K./0000-0002-6483-1781; Shimizu Inatsugi, Rie/0000-0002-9899-591X	University of Zurich; Swiss National Science Foundation (SNF); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Japan Society for the Promotion of Science (JSPS); Volkswagen Foundation; Deutscher Akademischer Austauschdienst (DAAD)	University of Zurich; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Volkswagen Foundation(Volkswagen); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	We thank P. Awadalla, C. Bustamante, A. Caicedo, G. Coop, U. Grossniklaus, T.-h. Kao, C. Mays, R. Moore, K. Olsen, M. Purugganan, J. Reininga, L. Rose, S. Ruzsa and W. Stephan for discussions or technical advice. This work was supported by grants from the University Research Priority Program in Systems Biology/Functional Genomics of the University of Zurich and from the Swiss National Science Foundation (SNF) to K. K. S., and by Grants-in-Aid for Special Research on Priority Areas to S. T., M. W. and K. K. S.; by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) and by a Grant-in-Aid for Creative Scientific Research to S. T.; by a Young Scientific Research (S) grant to M. W.; and by a grant from the Japan Society for the Promotion of Science (JSPS). P. P. is the recipient of a grant from the Volkswagen Foundation and a STIBET scholarship of the Deutscher Akademischer Austauschdienst (DAAD). T. T. and K. S. are recipients of a Research Fellowship for Young Scientists from JSPS.	ABBOTT RJ, 1989, HEREDITY, V62, P411, DOI 10.1038/hdy.1989.56; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Bechsgaard JS, 2006, MOL BIOL EVOL, V23, P1741, DOI 10.1093/molbev/msl042; Boggs NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000426; Busch JW, 2008, TRENDS PLANT SCI, V13, P128, DOI 10.1016/j.tplants.2008.01.002; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Darwin CR, 1876, EFFECTS CROSS SELF F; Fisher RA, 1941, ANN EUGENIC, V11, P53, DOI 10.1111/j.1469-1809.1941.tb02272.x; Francois O, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000075; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; GORING DR, 1993, PLANT CELL, V5, P531, DOI 10.1105/tpc.5.5.531; Guo YL, 2009, P NATL ACAD SCI USA, V106, P5246, DOI 10.1073/pnas.0808012106; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Igic B, 2008, INT J PLANT SCI, V169, P93, DOI 10.1086/523362; Karkkainen K, 1999, EVOLUTION, V53, P1354, DOI [10.2307/2640882, 10.1111/j.1558-5646.1999.tb05400.x]; Kusaba M, 2001, PLANT CELL, V13, P627, DOI 10.1105/tpc.13.3.627; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu P, 2007, CURR BIOL, V17, P734, DOI 10.1016/j.cub.2007.03.022; Mable BK, 2008, GENET RES, V90, P47, DOI 10.1017/S0016672307008907; Nasrallah ME, 2002, SCIENCE, V297, P247, DOI 10.1126/science.1072205; Nettancourt, 2001, INCOMPATIBILITY INCO; NOU IS, 1993, SEX PLANT REPROD, V6, P79, DOI 10.1007/BF00227652; Okamoto S, 2007, PLANT J, V50, P391, DOI 10.1111/j.1365-313X.2007.03058.x; Park JI, 2006, GENES GENET SYST, V81, P355, DOI 10.1266/ggs.81.355; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Sherman-Broyles S, 2007, PLANT CELL, V19, P94, DOI 10.1105/tpc.106.048199; SHIBA H, 1995, P JPN ACAD B-PHYS, V71, P81, DOI 10.2183/pjab.71.81; Shimizu KK, 2008, MOL ECOL, V17, P704, DOI 10.1111/j.1365-294X.2007.03605.x; Shimizu KK, 2002, POPUL ECOL, V44, P221, DOI 10.1007/s101440200025; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; Tang CL, 2007, SCIENCE, V317, P1070, DOI 10.1126/science.1143153; Uyenoyama MK, 2001, GENETICS, V157, P1805	37	98	106	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1342	1346		10.1038/nature08927	http://dx.doi.org/10.1038/nature08927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20400945	Green Accepted			2022-12-24	WOS:000277149000045
J	Roehr, B				Roehr, Bob			US Global Health Initiative takes shape	BRITISH MEDICAL JOURNAL			English	News Item																			0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2010	340								c2131	10.1136/bmj.c2131	http://dx.doi.org/10.1136/bmj.c2131			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589HK	20460316				2022-12-24	WOS:000277137500011
J	Chen, HC; Vermulst, M; Wang, YE; Chomyn, A; Prolla, TA; McCaffery, JM; Chan, DC				Chen, Hsiuchen; Vermulst, Marc; Wang, Yun E.; Chomyn, Anne; Prolla, Tomas A.; McCaffery, J. Michael; Chan, David C.			Mitochondrial Fusion Is Required for mtDNA Stability in Skeletal Muscle and Tolerance of mtDNA Mutations	CELL			English	Article							DOMINANT OPTIC ATROPHY; DYNAMIN-RELATED GTPASE; SUBSTANTIA-NIGRA NEURONS; DNA DELETIONS; FUNCTIONAL MITOCHONDRIA; MEMBRANE FUSION; MICE; DISEASE; FIBERS; OPA1	Mitochondria are highly mobile and dynamic organelles that continually fuse and divide. These processes allow mitochondria to exchange contents, including mitochondrial DNA (mtDNA). Here we examine the functions of mitochondrial fusion in differentiated skeletal muscle through conditional deletion of the mitofusins Mfn1 and Mfn2, mitochondrial GTPases essential for fusion. Loss of the mitofusins causes severe mitochondrial dysfunction, compensatory mitochondrial proliferation, and muscle atrophy. Mutant mice have severe mtDNA depletion in muscle that precedes physiological abnormalities. Moreover, the mitochondrial genomes of the mutant muscle rapidly accumulate point mutations and deletions. In a related experiment, we find that disruption of mitochondrial fusion strongly increases mitochondrial dysfunction and lethality in a mouse model with high levels of mtDNA mutations. With its dual function in safeguarding mtDNA integrity and preserving mtDNA function in the face of mutations, mitochondrial fusion is likely to be a protective factor in human disorders associated with mtDNA mutations.	[Chen, Hsiuchen; Vermulst, Marc; Wang, Yun E.; Chomyn, Anne; Chan, David C.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Chomyn, Anne; Chan, David C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Prolla, Tomas A.] Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA; [McCaffery, J. Michael] Johns Hopkins Univ, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University	Chan, DC (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	dchan@caltech.edu			Ellison Medical Foundation; NCRR [1 S10 RR023454-01];  [R01 GM062967]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062967] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. S. Burden and P. Soriano for generously providing the MLC-Cre and Meox2-Cre mouse strains. We are grateful to Igor Antoshechkin, director of the Caltech Genomics Facility, for help with analysis of Solexa sequence data. This work was supported by grants to D. C. C. (R01 grant GM062967 and an Ellison Medical Foundation Senior Scholar Award) and J.M.M. (NCRR grant 1 S10 RR023454-01).	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Duan S, 2003, J BIOL CHEM, V278, P1346, DOI 10.1074/jbc.M209269200; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Nakada K, 2001, BIOCHEM BIOPH RES CO, V288, P743, DOI 10.1006/bbrc.2001.5838; Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010; Ogata T, 1997, ANAT REC, V248, P214; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008; Villani G, 2001, METHOD CELL BIOL, V65, P119, DOI 10.1016/S0091-679X(01)65007-6; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	48	771	789	0	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 16	2010	141	2					280	289		10.1016/j.cell.2010.02.026	http://dx.doi.org/10.1016/j.cell.2010.02.026			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403324	Green Accepted, Bronze			2022-12-24	WOS:000276738400018
J	Iheanacho, I				Iheanacho, Ike			Rosiglitazone in the UK: down but not out	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2010	340								c1849	10.1136/bmj.c1849	http://dx.doi.org/10.1136/bmj.c1849			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582ZF	20375092				2022-12-24	WOS:000276639400007
J	Xu, M; Long, CZ; Chen, XZ; Huang, C; Chen, S; Zhu, B				Xu, Mo; Long, Chengzu; Chen, Xiuzhen; Huang, Chang; Chen, She; Zhu, Bing			Partitioning of Histone H3-H4 Tetramers During DNA Replication-Dependent Chromatin Assembly	SCIENCE			English	Article							NEWLY SYNTHESIZED HISTONES; HYBRID NUCLEOSOMES; H3; SEGREGATION; DEPOSITION; H4; METHYLATION; PATHWAYS	Semiconservative DNA replication ensures the faithful duplication of genetic information during cell divisions. However, how epigenetic information carried by histone modifications propagates through mitotic divisions remains elusive. To address this question, the DNA replication-dependent nucleosome partition pattern must be clarified. Here, we report significant amounts of H3.3-H4 tetramers split in vivo, whereas most H3.1-H4 tetramers remained intact. Inhibiting DNA replication-dependent deposition greatly reduced the level of splitting events, which suggests that (i) the replication-independent H3.3 deposition pathway proceeds largely by cooperatively incorporating two new H3.3-H4 dimers and (ii) the majority of splitting events occurred during replication-dependent deposition. Our results support the idea that "silent" histone modifications within large heterochromatic regions are maintained by copying modifications from neighboring preexisting histones without the need for H3-H4 splitting events.	[Xu, Mo; Long, Chengzu; Chen, Xiuzhen; Huang, Chang; Chen, She; Zhu, Bing] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Xu, Mo] Peking Union Med Coll, Grad Program, Beijing 100730, Peoples R China; [Xu, Mo] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Chen, Xiuzhen] Beijing Normal Univ, Life Sci Coll, Beijing 100875, Peoples R China; [Huang, Chang] China Agr Univ, Coll Biol Sci, Dept Biochem, Beijing 100094, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Beijing Normal University; China Agricultural University	Chen, S (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhong Guan Cun Life Sci Pk, Beijing 102206, Peoples R China.	chenshe@nibs.ac.cn; zhubing@nibs.ac.cn		Chen, Xiuzhen/0000-0002-3027-6441	Chinese Ministry of Science and Technology [2007AA02Z1A6, 2007AA02Z1A3]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	We thank X. Wang from the Howard Hughes Medical Institute/University of Texas Southwestern Medical Center for critical comments on the manuscript. We thank N. Yang and J. Ni for color illustration. We thank P. Mortensen from the University of Southern Denmark for developing and supporting the MSQuant software. This work was supported by the Chinese Ministry of Science and Technology 863 projects 2007AA02Z1A6 (to B. Z.) and 2007AA02Z1A3 (to S. C.).	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Allis C. D., 2006, EPIGENETICS; ANNUNZIATO AT, 1982, J BIOL CHEM, V257, P8507; Benson LJ, 2006, J BIOL CHEM, V281, P9287, DOI 10.1074/jbc.M512956200; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; JACKSON V, 1981, CELL, V23, P121, DOI 10.1016/0092-8674(81)90277-4; JACKSON V, 1988, BIOCHEMISTRY-US, V27, P2109, DOI 10.1021/bi00406a044; JACKSON V, 1990, BIOCHEMISTRY-US, V29, P719, DOI 10.1021/bi00455a019; JACKSON V, 1981, J BIOL CHEM, V256, P5095; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LEFFAK IM, 1977, CELL, V12, P837, DOI 10.1016/0092-8674(77)90282-3; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Nakatani Y, 2004, COLD SPRING HARB SYM, V69, P273, DOI 10.1101/sqb.2004.69.273; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; PRIOR CP, 1980, CELL, V20, P597, DOI 10.1016/0092-8674(80)90306-2; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; RUSSEV G, 1981, NUCLEIC ACIDS RES, V9, P4129, DOI 10.1093/nar/9.16.4129; SEALE RL, 1976, CELL, V9, P423, DOI 10.1016/0092-8674(76)90087-8; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; YAMASU K, 1990, J BIOCHEM-TOKYO, V107, P15, DOI 10.1093/oxfordjournals.jbchem.a122999	27	228	233	14	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					94	98		10.1126/science.1178994	http://dx.doi.org/10.1126/science.1178994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360108				2022-12-24	WOS:000276202200043
J	Kang, K; Pulver, SR; Panzano, VC; Chang, EC; Griffith, LC; Theobald, DL; Garrity, PA				Kang, Kyeongjin; Pulver, Stefan R.; Panzano, Vincent C.; Chang, Elaine C.; Griffith, Leslie C.; Theobald, Douglas L.; Garrity, Paul A.			Analysis of Drosophila TRPA1 reveals an ancient origin for human chemical nociception	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; COVALENT MODIFICATION; MAXIMUM-LIKELIHOOD; CHANNEL TRPA1; ION CHANNELS; PAINLESS; CHEMOSENSATION; ACTIVATION; EXPRESSION; RECEPTORS	Chemical nociception, the detection of tissue-damaging chemicals, is important for animal survival and causes human pain and inflammation, but its evolutionary origins are largely unknown. Reactive electrophiles are a class of noxious compounds humans find pungent and irritating, such as allyl isothiocyanate (in wasabi) and acrolein ( in cigarette smoke)(1-3). Diverse animals, from insects to humans, find reactive electrophiles aversive(1-3), but whether this reflects conservation of an ancient sensory modality has been unclear. Here we identify the molecular basis of reactive electrophile detection in flies. We demonstrate that Drosophila TRPA1 (Transient receptor potential A1), the Drosophila melanogaster orthologue of the human irritant sensor, acts in gustatory chemosensors to inhibit reactive electrophile ingestion. We show that fly and mosquito TRPA1 orthologues are molecular sensors of electrophiles, using a mechanism conserved with vertebrate TRPA1s. Phylogenetic analyses indicate that invertebrate and vertebrate TRPA1s share a common ancestor that possessed critical characteristics required for electrophile detection. These findings support emergence of TRPA1-based electrophile detection in a common bilaterian ancestor, with widespread conservation throughout vertebrate and invertebrate evolution. Such conservation contrasts with the evolutionary divergence of canonical olfactory and gustatory receptors and may relate to electrophile toxicity. We propose that human pain perception relies on an ancient chemical sensor conserved across similar to 500 million years of animal evolution.	[Kang, Kyeongjin; Pulver, Stefan R.; Panzano, Vincent C.; Chang, Elaine C.; Griffith, Leslie C.; Garrity, Paul A.] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Kang, Kyeongjin; Pulver, Stefan R.; Panzano, Vincent C.; Chang, Elaine C.; Griffith, Leslie C.; Garrity, Paul A.] Brandeis Univ, Volen Ctr Complex Syst, Dept Biol, Waltham, MA 02454 USA; [Theobald, Douglas L.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Brandeis University; Brandeis University; Brandeis University	Garrity, PA (corresponding author), Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA.	pgarrity@brandeis.edu	babakinejad, babak/G-2674-2012; Theobald, Douglas L/F-3514-2013	Theobald, Douglas L/0000-0002-2695-8343; Kang, KyeongJin/0000-0003-0446-469X; Garrity, Paul/0000-0002-8274-6564; Griffith, Leslie/0000-0003-3164-9876; Pulver, Stefan/0000-0001-5170-7522	NIMH [R21 MH080206, RO1 MH067284]; NINDS [PO1 NS044232]; Royal Society; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067284, R21MH080206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Royal Society(Royal Society of London); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Amrein, G. Boekh, K. Scott, D. Tracey and Bloomington Stock center for flies, C. Miller-Patterson and D. Zeiger for assistance, and members of the Garrity laboratory, J. P. Garrity, L. Huang, E. Marder, S. Nelson, G. Turrigiano and M. Rosbash for comments. This work was supported by grants from the NIMH (R21 MH080206, P. A. G.; RO1 MH067284, L. C. G.), NINDS (PO1 NS044232), and the Royal Society (Newton International Fellowship, S. R. P.).	Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Eisner T., 1970, CHEM ECOL, P157; Gendre N, 2004, DEVELOPMENT, V131, P83, DOI 10.1242/dev.00879; GOMES R, 2002, 43 WHO; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kindt KS, 2007, NAT NEUROSCI, V10, P568, DOI 10.1038/nn1886; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Talavera K, 2009, NAT NEUROSCI, V12, P1293, DOI 10.1038/nn.2379; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	38	225	229	3	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					597	U155		10.1038/nature08848	http://dx.doi.org/10.1038/nature08848			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20237474	Green Accepted			2022-12-24	WOS:000275974200049
J	Lin, HK; Chen, ZB; Wang, GC; Nardella, C; Lee, SW; Chan, CH; Yang, WL; Wang, J; Egia, A; Nakayama, KI; Cordon-Cardo, C; Teruya-Feldstein, J; Pandolfi, PP				Lin, Hui-Kuan; Chen, Zhenbang; Wang, Guocan; Nardella, Caterina; Lee, Szu-Wei; Chan, Chan-Hsin; Yang, Wei-Lei; Wang, Jing; Egia, Ainara; Nakayama, Keiichi I.; Cordon-Cardo, Carlos; Teruya-Feldstein, Julie; Pandolfi, Pier Paolo			Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence	NATURE			English	Article							ONCOGENE-INDUCED SENESCENCE; BOX PROTEIN SKP2; TUMOR SUPPRESSION; P53; PTEN; EXPRESSION; ACCUMULATION; RESTORATION; INHIBITOR; COMPLEX	Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19(Arf)-p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19(Arf)-p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)-p53 response is impaired, whereas a Skp2-SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy.	[Lin, Hui-Kuan; Chen, Zhenbang; Wang, Guocan; Nardella, Caterina; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; [Lin, Hui-Kuan; Chen, Zhenbang; Wang, Guocan; Nardella, Caterina; Cordon-Cardo, Carlos; Teruya-Feldstein, Julie; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; [Lin, Hui-Kuan; Lee, Szu-Wei; Chan, Chan-Hsin; Yang, Wei-Lei; Wang, Jing] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chen, Zhenbang; Wang, Guocan; Nardella, Caterina; Egia, Ainara] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Chen, Zhenbang; Wang, Guocan; Nardella, Caterina; Egia, Ainara] Beth Israel Deaconess Canc Ctr, Canc Genet Program, Boston, MA 02215 USA; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Kyushu University	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	ppandolf@bidmc.harvard.edu	Chan, Chia-Hsin/AAT-7782-2020; Chan, Chia-Hsin/F-2272-2011; Yang, Wei-Lei/E-2598-2012; Wang, Guocan/F-1530-2011	Nardella, Caterina/0000-0002-1901-7916; Chan, Chia-Hsin/0000-0001-8506-7500	NIH; Anderson Trust Scholar Award; DOD Prostate Cancer New Investigator Award; NATIONAL CANCER INSTITUTE [R01CA082328] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD004038] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anderson Trust Scholar Award; DOD Prostate Cancer New Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We are grateful to C. J. Sherr, S. W. Lowe and M. Oren for mice and reagents. We would also like to thank B. Carver, L. DiSantis, J. Clossey and S. Megan for editing and critical reading of the manuscript, J. A. Koutcher, C. Le, C. Matei and M. Lupa for MRI analysis, as well all the members of the Pandolfi laboratory for comments and discussion. We extend our thanks to M. Rolfe, P. G. Smith, and Millennium Pharmaceuticals for discussion and for providing the MLN4924 compound. This work was supported by NIH grants to P. P. P. and M. D. Anderson Trust Scholar Award and DOD Prostate Cancer New Investigator Award to H. K.	Agarwal A, 2008, BLOOD, V112, P1960, DOI 10.1182/blood-2007-09-113860; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chen ZB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000053; Chiarle R, 2002, AM J PATHOL, V160, P1457, DOI 10.1016/S0002-9440(10)62571-0; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; GOTTLIEB E, 1994, EMBO J, V13, P1368, DOI 10.1002/j.1460-2075.1994.tb06390.x; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kuo YL, 2006, EMBO J, V25, P1741, DOI 10.1038/sj.emboj.7601054; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2005, NATURE, V436, P636, DOI 10.1038/436636a; Shim EH, 2003, CANCER RES, V63, P1583; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324	41	311	336	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					374	U66		10.1038/nature08815	http://dx.doi.org/10.1038/nature08815			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20237562	Green Accepted			2022-12-24	WOS:000275657100038
J	Ray, WA; Murray, KT; Md, MRG; Chung, CP; Smalley, WE; Hall, K; Daugherty, JR; Kaltenbach, LA; Stein, CM				Ray, Wayne A.; Murray, Katherine T.; Md, Marie R. Griffin; Chung, Cecilia P.; Smalley, Walter E.; Hall, Kathi; Daugherty, James R.; Kaltenbach, Lisa A.; Stein, C. Michael			Outcomes With Concurrent Use of Clopidogrel and Proton-Pump Inhibitors A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CORONARY HEART-DISEASE; RISK; OMEPRAZOLE; PHARMACOEPIDEMIOLOGY; PHARMACOKINETICS; RESPONSIVENESS; LANSOPRAZOLE; PANTOPRAZOLE; POLYMORPHISM	Background: Proton-pump inhibitors (PPIs) and clopidogrel are frequently coprescribed, although the benefits and harms of their concurrent use are unclear. Objective: To examine the association between concurrent use of PPIs and clopidogrel and the risks for hospitalizations for gastroduodenal bleeding and serious cardiovascular disease. Design: Retrospective cohort study using automated data to identify patients who received clopidogrel between 1999 through 2005 after hospitalization for coronary heart disease. Setting: Tennessee Medicaid program. Patients: 20 596 patients (including 7593 concurrent users of clopidogrel and PPIs) hospitalized for myocardial infarction, coronary artery revascularization, or unstable angina pectoris. Measurements: Baseline and follow-up drug use was assessed from automated records of dispensed prescriptions. Primary outcomes were hospitalizations for gastroduodenal bleeding and serious cardiovascular disease ( fatal or nonfatal myocardial infarction or sudden cardiac death, stroke, or other cardiovascular death). Results: Pantoprazole and omeprazole accounted for 62% and 9% of concurrent PPI use, respectively. Adjusted incidence of hospitalization for gastroduodenal bleeding in concurrent PPI users was 50% lower than that in nonusers (hazard ratio, 0.50 [95% CI, 0.39 to 0.65]). For patients at highest risk for bleeding, PPI use was associated with an absolute reduction of 28.5 (CI, 11.7 to 36.9) hospitalizations for gastroduodenal bleeding per 1000 person-years. The hazard ratio associated with concurrent PPI use for risk for serious cardiovascular disease was 0.99 (CI, 0.82 to 1.19) for the entire cohort and 1.01 (CI, 0.76 to 1.34) for the subgroup of patients who had percutaneous coronary interventions with stenting during the qualifying hospitalization. Limitations: Unmeasured confounding and misclassification of exposure (no information on adherence or over-the-counter use of drugs) and end points (not confirmed by medical record review) were possible. Because many patients entered the cohort from hospitals with relatively few cohort members, the analysis relied on the assumption that after adjustment for observed covariates, PPI users from one such hospital could be compared with nonusers from a different hospital. Conclusion: In patients with serious coronary heart disease treated with clopidogrel, concurrent PPI use was associated with reduced incidence of hospitalizations for gastroduodenal bleeding. The corresponding point estimate for serious cardiovascular disease was not increased; however, the 95% CI included a clinically important increased risk.	Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Ray, WA (corresponding author), Dept Prevent Med, 1500 21st Ave S,Suite 2600, Nashville, TN 37212 USA.	Wayne.Ray@vanderbilt.edu	Chung, Cecilia P/ABE-2177-2021	Chung, Cecilia P/0000-0001-5908-9423	Agency for Healthcare Research and Quality [HS1-16974]; National Heart, Lung, and Blood Institute [HL081707]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081707, R01HL096844] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Agency for Healthcare Research and Quality and National Heart, Lung, and Blood Institute.; By the Agency for Healthcare Research and Quality Centers for Education and Research on Therapeutics cooperative agreement (HS1-16974) and the National Heart, Lung, and Blood Institute (HL081707).	Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; Arnason T, 2006, THROMB RES, V118, P253, DOI 10.1016/j.thromres.2005.06.015; Bhatt DL, 2008, CIRCULATION, V118, P1894, DOI 10.1161/CIRCULATIONAHA.108.191087; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; CHAE YK, 2009, JAMA-J AM MED ASSOC, V302, P31; Chae YK, 2009, JAMA-J AM MED ASSOC, V302, P29, DOI 10.1001/jama.2009.896; Chin MWS, 2007, AM J GASTROENTEROL, V102, P2411, DOI 10.1111/j.1572-0241.2007.01460.x; Choma NN, 2009, PHARMACOEPIDEM DR S, V18, P1064, DOI 10.1002/pds.1821; Cryer B, 2005, NEW ENGL J MED, V352, P287, DOI 10.1056/NEJMe048330; Eshaghian S, 2007, ANN INTERN MED, V146, P434, DOI 10.7326/0003-4819-146-6-200703200-00008; Freedman JE, 2009, NEW ENGL J MED, V360, P411, DOI 10.1056/NEJMe0810513; Gerson LB, 2001, EUR J GASTROEN HEPAT, V13, P611, DOI 10.1097/00042737-200105000-00025; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Gugler R, 1996, BRIT J CLIN PHARMACO, V42, P249, DOI 10.1046/j.1365-2125.1996.40619.x; Gurbel PA, 2008, J AM COLL CARDIOL, V51, P261, DOI 10.1016/j.jacc.2007.07.090; Hernandez-Diaz Sonia, 2001, American Journal of Medicine, V110, p20S; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; JOHNSON RE, 1991, J AM GERIATR SOC, V39, P1079, DOI 10.1111/j.1532-5415.1991.tb02872.x; JUURLINK DN, 2009, CAN MED ASSOC J, V180, P1; Kahrilas PJ, 2008, NEW ENGL J MED, V359, P1700, DOI 10.1056/NEJMcp0804684; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; LANDRY JA, 1988, GERONTOLOGIST, V28, P672, DOI 10.1093/geront/28.5.672; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; Ray WA, 2003, NEW ENGL J MED, V349, P1592, DOI 10.1056/NEJMp038145; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1; Ray WA, 2007, GASTROENTEROLOGY, V133, P790, DOI 10.1053/j.gastro.2007.06.058; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518; Schneider-Lindner V, 2009, JAMA-J AM MED ASSOC, V302, P29, DOI 10.1001/jama.2009.897; SCHNEIDERLINDNE.V, 2009, JAMA-J AM MED ASSOC, V302, P31, DOI DOI 10.1001/JAMA.2009.897; Shahi CN, 2001, AM HEART J, V142, P263, DOI 10.1067/mhj.2001.116477; Siller-Matula JM, 2009, AM HEART J, V157, P148, DOI 10.1016/j.ahj.2008.09.017; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Small DS, 2008, J CLIN PHARMACOL, V48, P475, DOI 10.1177/0091270008315310; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yu KS, 2001, CLIN PHARMACOL THER, V69, P266, DOI 10.1067/mcp.2001.114231	44	183	200	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6					337	+		10.7326/0003-4819-152-6-201003160-00003	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-00003			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231564	Green Accepted			2022-12-24	WOS:000275905200001
J	Calsbeek, R; Cox, RM				Calsbeek, Ryan; Cox, Robert M.			Experimentally assessing the relative importance of predation and competition as agents of selection	NATURE			English	Article							LIZARD ANOLIS-CAROLINENSIS; NATURAL-POPULATIONS; SEXUAL-DIMORPHISM; ADAPTIVE RADIATION; ISLAND LIZARDS; HABITAT USE; PERFORMANCE; MORPHOLOGY; EVOLUTION; BEHAVIOR	Field experiments that measure natural selection in response to manipulations of the selective regime are extremely rare(1), even in systems where the ecological basis of adaptation has been studied extensively. The adaptive radiation of Caribbean Anolis lizards has been studied for decades(2-5), leading to precise predictions about the influence of alternative agents of selection in the wild. Here we present experimental evidence for the relative importance of two putative agents of selection in shaping the adaptive landscape for a classic island radiation. We manipulated whole-island populations of the brown anole lizard, Anolis sagrei, to measure the relative importance of predation versus competition as agents of natural selection. We excluded or included bird and snake predators across six islands that ranged from low to high population densities of lizards, then measured subsequent differences in behaviour and natural selection in each population. Predators altered the lizards' perching behaviour and increased mortality, but predation treatments did not alter selection on phenotypic traits. By contrast, experimentally increasing population density dramatically increased the strength of viability selection favouring large body size, long relative limb length and high running stamina. Our results from A. sagrei are consistent with the hypothesis(6) that intraspecific competition is more important than predation in shaping the selective landscape for traits central to the adaptive radiation of Anolis ecomorphs.	[Calsbeek, Ryan; Cox, Robert M.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College	Calsbeek, R (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	ryan.calsbeek@dartmouth.edu		Calsbeek, Ryan/0000-0002-9236-4092	National Science Foundation; Dartmouth College	National Science Foundation(National Science Foundation (NSF)); Dartmouth College	We thank T. B. Smith for suggestions about experimental design, and B. Calsbeek and A. Gasc for help with predator manipulations. M. C. Duryea, S. Kuchta, M. Logan, M. Najarro and D. Urbach helped to clarify the manuscript. This research was conducted under permits from The Bahamas Ministry of Agriculture and approval from the Dartmouth College Institutional Animal Care and Use Committee. An award from the National Science Foundation to R. Calsbeek, and funding from Dartmouth College, provided financial support.	Anderson D.R., 2008, MODEL BASED INFERENC; Andrews R.M., 1979, BREVIORA, V454, P1; Butler MA, 2007, NATURE, V447, P202, DOI 10.1038/nature05774; Calsbeek R, 2008, EVOLUTION, V62, P478, DOI 10.1111/j.1558-5646.2007.00282.x; Calsbeek R, 2007, EVOLUTION, V61, P2493, DOI 10.1111/j.1558-5646.2007.00206.x; Calsbeek R, 2007, EVOLUTION, V61, P1052, DOI 10.1111/j.1558-5646.2007.00093.x; Calsbeek R, 2009, J ANIM ECOL, V78, P617, DOI 10.1111/j.1365-2656.2009.01527.x; COX RM, EVOLUTION IN PRESS; Cox RM, 2009, AM NAT, V173, P176, DOI 10.1086/595841; Irschick DJ, 1997, ECOLOGY, V78, P2191, DOI 10.2307/2265955; Irschick DJ, 2005, BIOL J LINN SOC, V85, P223, DOI 10.1111/j.1095-8312.2005.00487.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Lailvaux SP, 2004, P ROY SOC B-BIOL SCI, V271, P2501, DOI 10.1098/rspb.2004.2891; Langerhans RB, 2006, EVOLUTION, V60, P362; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 2004, NATURE, V432, P505, DOI 10.1038/nature03039; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Losos JB, 2006, SCIENCE, V314, P1111, DOI 10.1126/science.1133584; MAC ARTHUR ROBERT H., 1967; Perry G, 2004, ANIM BEHAV, V67, P37, DOI 10.1016/j.anbehav.2003.02.003; RAND A. STANLEY, 1967, PROC U S NAT MUS, V122, P1; Reznick DN, 2005, INTEGR COMP BIOL, V45, P456, DOI 10.1093/icb/45.3.456; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; SCHOENER TW, 1967, SCIENCE, V155, P474, DOI 10.1126/science.155.3761.474; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; SCHOENER TW, 1979, ECOLOGY, V60, P1110, DOI 10.2307/1936958; STAMPS JA, 1994, ANIM BEHAV, V47, P1375, DOI 10.1006/anbe.1994.1185; Williams E.E., 1983, P326	30	104	108	4	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 3	2010	465	7298					613	616		10.1038/nature09020	http://dx.doi.org/10.1038/nature09020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20453837				2022-12-24	WOS:000278249000041
J	Ghebreyesus, TA; Kazatchkine, M; Sidibe, M; Nakatani, H				Ghebreyesus, Tedros Adhanom; Kazatchkine, Michel; Sidibe, Michel; Nakatani, Hiroki			Tuberculosis and HIV: time for an intensified response	LANCET			English	Editorial Material									[Ghebreyesus, Tedros Adhanom] Minist Hlth, Addis Ababa, Ethiopia; [Kazatchkine, Michel] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Sidibe, Michel] Joint UN Programme HIV AIDS, Geneva, Switzerland; [Nakatani, Hiroki] WHO, CH-1211 Geneva, Switzerland	World Health Organization	Ghebreyesus, TA (corresponding author), Minist Hlth, Addis Ababa, Ethiopia.	moh.vmo@ethionet.et						Assefa Y, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000056; *GLOB FUND FIGHT A, 2008, BUILD SUST RESP HALV; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; UNAIDS, 2009, JOINT ACT RES UNAIDS; *WHO, JOINT TB HIV INT; *WHO, 2009, GLOB TUB CONTR SHORT	7	11	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 22	2010	375	9728					1757	1758		10.1016/S0140-6736(10)60595-8	http://dx.doi.org/10.1016/S0140-6736(10)60595-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603NY	20488527				2022-12-24	WOS:000278216500005
J	Yu, YTN; Yuan, X; Velicer, GJ				Yu, Yuen-Tsu N.; Yuan, Xi; Velicer, Gregory J.			Adaptive Evolution of an sRNA That Controls Myxococcus Development	SCIENCE			English	Article									[Yu, Yuen-Tsu N.; Yuan, Xi; Velicer, Gregory J.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Velicer, GJ (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	gvelicer@indiana.edu			NIH [GM079690]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Sogaard-Andersen and H.-C. T. Tsui for helpful discussion and C. Fuqua for manuscript suggestions. This work was supported by NIH grant GM079690 to G.J.V.	Fiegna F, 2006, NATURE, V441, P310, DOI 10.1038/nature04677; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Harris BZ, 1998, GENE DEV, V12, P1022, DOI 10.1101/gad.12.7.1022; Shimkets L.J., 2006, PROKARYOTES, P31, DOI [10.1007/0-387-30747-8_3, DOI 10.1007/0-387-30747-8_3]; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347	5	31	32	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					993	993		10.1126/science.1187200	http://dx.doi.org/10.1126/science.1187200			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20489016	Green Accepted			2022-12-24	WOS:000277877100031
J	Del Romero, J; Castilla, J; Hernando, V; Rodriguez, C; Garcia, S				Del Romero, Jorge; Castilla, Jesus; Hernando, Victoria; Rodriguez, Carmen; Garcia, Soledad			Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VIRAL LOAD; SEXUAL TRANSMISSION; COITAL ACT; THERAPY; INFECTION; VIREMIA; PROBABILITY; PLASMA; RAKAI; RISK	Objective To estimate the risk and probability of heterosexual transmission of HIV-1 from infected people taking combined antiretroviral treatment. Design Cross sectional and prospective cohort studies. Setting HIV clinic in Madrid, Spain. Participants Stable heterosexual couples with one partner with HIV-1 infection (index partner) and the other reporting this sexual relationship as the only risk exposure. Main outcome measures HIV seroprevalence in non-index partners at enrolment and seroconversions in follow-up according to antiretroviral treatment taken by the index partner. Results In 476 couples in which the index partner was not taking antiretroviral treatment, HIV seroprevalence at enrolment in non-index partners was 9.2% (n=44), whereas in 149 couples in which the index partner was taking combined antiretroviral therapy no partner was infected (P<0.001). During follow-up, the 341 serodiscordant couples in which the index partner was not taking antiretroviral treatment had about 11 000 acts of intercourse without condoms, 50 natural pregnancies, and five HIV seroconversions (0.0004 per unprotected intercourse; 95% confidence interval 0.0001 to 0.0010); 294 of these couples always used condoms, accounting for about 42 000 acts of intercourse, 136 risk exposures from condom failure, and one HIV seroconversion. The relative risk associated with condom use was 0.07 (0.01 to 0.58). In 144 couples the index partner was taking combined antiretroviral treatment; they accounted for over 7000 unprotected acts of intercourse and 47 natural pregnancies but no HIV seroconversion (0 to 0.0005 per unprotected intercourse). Conclusions The heterosexual infectivity of HIV-1 in individuals taking effective antiretroviral treatment is low. Avoidance of unprotected intercourse and receipt of antiretroviral treatment by the infected partner in accordance with protocols are complementary measures to prevent HIV transmission.	[Del Romero, Jorge; Rodriguez, Carmen; Garcia, Soledad] Ctr Sanitario Sandoval, Comunidad De Madrid, Spain; [Castilla, Jesus] CIBER Epidemiol & Salud Publ, Inst Salud Publ Navarra, Pamplona, Spain; [Hernando, Victoria] CIBER Epidemiol & Salud Publ, Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Public Health Institute of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE)	Del Romero, J (corresponding author), Ctr Sanitario Sandoval, Comunidad De Madrid, Spain.	jorgedelromero@gmail.com	Castilla, Jesus/B-9048-2008; Hernando, Victoria/E-1740-2015	Castilla, Jesus/0000-0002-6396-7265; Hernando, Victoria/0000-0003-2762-4924	FIPSE [24324/02]; Instituto de Salud Carlos III	FIPSE; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	Funding: This study was supported by a grant from FIPSE (foundation formed by the Spanish Ministry of Health and Consumer Affairs, Abbott Laboratories, Boehringer Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Merck Sharp and Dohme, and Roche; No 24324/02) and by the Spanish Network for Research on AIDS (RIS), which is funded by the Instituto de Salud Carlos III. The authors affirm the independence of the researchers from the funders.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Carpenter CCJ, 1998, JAMA-J AM MED ASSOC, V280, P78, DOI 10.1001/jama.280.1.78; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; De Cock KM, 2009, LANCET, V373, P7, DOI 10.1016/S0140-6736(08)61732-8; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; Di Mascio M, 2003, J VIROL, V77, P12165, DOI 10.1128/JVI.77.22.12165-12172.2003; Downs AM, 1996, J ACQ IMMUN DEF SYND, V11, P388, DOI 10.1097/00042560-199604010-00010; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454; Neely MN, 2007, JAIDS-J ACQ IMM DEF, V44, P38, DOI 10.1097/01.qai.0000248352.18007.1f; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Pedraza MA, 1999, J ACQ IMMUN DEF SYND, V21, P120; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Sadiq ST, 2002, AIDS, V16, P219, DOI 10.1097/00002030-200201250-00011; SARACCO A, 1993, J ACQ IMMUN DEF SYND, V6, P497; Shiboski SC, 1998, J ACQ IMMUN DEF SYND, V19, P527, DOI 10.1097/00042560-199812150-00013; Sturmer M, 2008, ANTIVIR THER, V13, P729; van Sighem A, 2008, JAIDS-J ACQ IMM DEF, V48, P104, DOI 10.1097/QAI.0b013e31816a1d4f; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	30	127	128	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2010	340								c2205	10.1136/bmj.c2205	http://dx.doi.org/10.1136/bmj.c2205			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598HS	20472675	Green Published, hybrid			2022-12-24	WOS:000277826600002
J	Gu, HZ; Chao, J; Xiao, SJ; Seeman, NC				Gu, Hongzhou; Chao, Jie; Xiao, Shou-Jun; Seeman, Nadrian C.			A proximity-based programmable DNA nanoscale assembly line	NATURE			English	Article							NANOTECHNOLOGY; CHEMISTRY; SUBSTRATE; COHESION; MACHINE; DEVICE; MOTOR; TILES; WILL	Our ability to synthesize nanometre-scale chemical species, such as nanoparticles with desired shapes and compositions, offers the exciting prospect of generating new functional materials and devices by combining them in a controlled fashion into larger structures. Self-assembly can achieve this task efficiently, but may be subject to thermodynamic and kinetic limitations: reactants, intermediates and products may collide with each other throughout the assembly time course to produce non-target species instead of target species. An alternative approach to nanoscale assembly uses information-containing molecules such as DNA(1) to control interactions and thereby minimize unwanted cross-talk between different components. In principle, this method should allow the stepwise and programmed construction of target products by linking individually selected nanoscale components-much as an automobile is built on an assembly line. Here we demonstrate that a nanoscale assembly line can be realized by the judicious combination of three known DNA-based modules: a DNA origami(2) tile that provides a framework and track for the assembly process, cassettes containing three independently controlled two-state DNA machines that serve as programmable cargo-donating devices(3,4) and are attached(4,5) in series to the tile, and a DNA walker that can move on the track from device to device and collect cargo. As the walker traverses the pathway prescribed by the origami tile track, it sequentially encounters the three DNA devices, each of which can be independently switched between an 'ON' state, allowing its cargo to be transferred to the walker, and an 'OFF' state, in which no transfer occurs. We use three different types of gold nanoparticle species as cargo and show that the experimental system does indeed allow the controlled fabrication of the eight different products that can be obtained with three two-state devices.	[Gu, Hongzhou; Seeman, Nadrian C.] NYU, Dept Chem, New York, NY 10003 USA; [Chao, Jie; Xiao, Shou-Jun] Nanjing Univ, State Key Lab Coordinat Chem, Sch Chem & Chem Engn, Nanjing Natl Lab Microstruct, Nanjing 210093, Peoples R China	New York University; Nanjing University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	ned.seeman@nyu.edu	Chao, Jie/G-3157-2017; Xiao, Shou-Jun/K-7718-2012; Gu, Hongzhou/H-5308-2011	Chao, Jie/0000-0003-1030-9944; Gu, Hongzhou/0000-0001-5058-4815	US National Institute of General Medical Sciences [GM-29544]; US National Science Foundation [CTS-0608889, CCF-0726378]; US Army Research Office [48681-EL, W911NF-07-1-0439]; US Office of Naval Research [N000140910181, N000140911118]; W. M. Keck Foundation; National Basic Research Program of China [2007CB925101]; National Natural Science Foundation of China [20721002]; New York University; Chinese Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029554] Funding Source: NIH RePORTER	US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Science Foundation(National Science Foundation (NSF)); US Army Research Office; US Office of Naval Research(Office of Naval Research); W. M. Keck Foundation(W.M. Keck Foundation); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New York University; Chinese Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Canary, H. Yan, C. Mao and R. Sha for comments on this manuscript. This research has been supported by the following grants: GM-29544 from the US National Institute of General Medical Sciences, CTS-0608889 and CCF-0726378 from the US National Science Foundation, 48681-EL and W911NF-07-1-0439 from the US Army Research Office, N000140910181 and N000140911118 from the US Office of Naval Research and a grant from the W. M. Keck Foundation (to N.C.S.); and 2007CB925101 from the National Basic Research Program of China and 20721002 from the National Natural Science Foundation of China (to S.-J.X.). H. G. thanks New York University for a Dissertation Fellowship and J. C. thanks the Chinese Scholarship Council for a research fellowship.	Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Bath J, 2009, SMALL, V5, P1513, DOI 10.1002/smll.200900078; CARUTHERS MH, 1985, SCIENCE, V230, P281, DOI 10.1126/science.3863253; Constantinou PE, 2006, ORG BIOMOL CHEM, V4, P3414, DOI 10.1039/b605212f; Ding B, 2006, SCIENCE, V314, P1583, DOI 10.1126/science.1131372; Ding BQ, 2004, J AM CHEM SOC, V126, P10230, DOI 10.1021/ja047486u; Drexler KE, 2001, SCI AM, V285, P74, DOI 10.1038/scientificamerican0901-74; Gartner ZJ, 2002, J AM CHEM SOC, V124, P10304, DOI 10.1021/ja027307d; Gu HZ, 2009, NAT NANOTECHNOL, V4, P245, DOI [10.1038/nnano.2009.5, 10.1038/NNANO.2009.5]; Ke YG, 2008, SCIENCE, V319, P180, DOI 10.1126/science.1150082; Liu D, 2004, J AM CHEM SOC, V126, P2324, DOI 10.1021/ja031754r; Omabegho T, 2009, SCIENCE, V324, P67, DOI 10.1126/science.1170336; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; Seeman NC, 2005, REP PROG PHYS, V68, P237, DOI 10.1088/0034-4885/68/1/R05; Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q; Shin JS, 2004, J AM CHEM SOC, V126, P10834, DOI 10.1021/ja047543j; Smalley RE, 2001, SCI AM, V285, P76, DOI 10.1038/scientificamerican0901-76; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c	21	584	601	12	548	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2010	465	7295					202	U86		10.1038/nature09026	http://dx.doi.org/10.1038/nature09026			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463734	Green Accepted			2022-12-24	WOS:000277558500031
J	Hoffman, J; Earle, S				Hoffman, Jascha; Earle, Sylvia			Q&A: Sylvia Earle on protecting our seas	NATURE			English	Editorial Material												jascha@jaschahoffman.com							0	1	1	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2010	465	7295					165	165		10.1038/465165a	http://dx.doi.org/10.1038/465165a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	594SS	20463723	Bronze			2022-12-24	WOS:000277558500019
J	Chapple, A; Ziebland, S				Chapple, A.; Ziebland, S.			Viewing the body after bereavement due to a traumatic death: qualitative study in the UK	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACCIDENT; DISASTER	Objective Whether bereaved relatives should be encouraged to view the body after a traumatic death is uncertain. This analysis of narrative interviews interprets people's accounts of why and how they decided whether to view the body and their emotional reactions to this, immediately and at a later stage. Design In depth interviews with qualitative analysis. Participants A maximum variation sample of 80 people bereaved because of suicide or other traumatic death. Setting Most people were interviewed in their homes. Results For those who had the option, decisions about seeing the body varied. Some wanted someone else to identify the body, because they feared how it might look or preferred to remember their relative as they had been in life. Those who had wanted to see the body gave various reasons beyond the need to check identity. Some felt they ought to see the body. Others felt that the body had not lost its social identity, so wanted to make sure the loved one was "being cared for" or to say goodbye. Some people wanted to touch the body, in privacy, but the coroner sometimes allowed this only after the postmortem examination, which made relatives feel that the body had become police property. Seeing the body brought home the reality of death; it could be shocking or distressing, but, in this sample, few who did so said they regretted it. Conclusions Even after a traumatic death, relatives should have the opportunity to view the body, and time to decide which family member, if any, should identify remains. Officials should prepare relatives for what they might see, and explain any legal reasons why the body cannot be touched. Guidelines for professional practice must be sensitive to the needs and preferences of people bereaved by traumatic death. The way that relatives refer to the body can be a strong indication for professionals about whether the person who died retains a social identity for the bereaved.	[Chapple, A.; Ziebland, S.] Univ Oxford, Dept Primary Hlth Care, Headington OX3 7LF, England	University of Oxford	Chapple, A (corresponding author), Univ Oxford, Dept Primary Hlth Care, Headington OX3 7LF, England.	Alison.chapple@dphpc.ox.ac.uk		Ziebland, Sue/0000-0002-6496-4859	The Department of Health	The Department of Health	The Department of Health funded the work. The views expressed do not necessarily reflect those of the funder.	[Anonymous], 1991, GRIEF COUNSELING GRI; AWOONORRENNER S, 1992, BRIT MED J, V304, P1566, DOI 10.1136/bmj.304.6841.1566-a; Baglow J. S., 2007, MORTALITY, V12, P223; Blumer H., 1969, SYMB INTERACT; Bogard W., 2008, MORTALITY, V13, P187; COOKE MW, 1992, BRIT MED J, V304, P1207, DOI 10.1136/bmj.304.6836.1207; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Dix P, 1998, LANCET, V352, P1061, DOI 10.1016/S0140-6736(98)06491-5; Douglas Mary, 1966, PURITY DANGER ANAL C, DOI 10.4324/9780203361832; Foltyn J.L., 2008, MORTALITY, V13, P99, DOI [DOI 10.1080/13576270801954351, 10.1080/13576270801954351]; Glaser B, 1978, DISCOV GROUNDED THEO; Green J., 2018, QUALITATIVE METHODS, VFourth; Hallam E., 1999, BODY DEATH SOCIAL ID; Hallam E., 2001, DEATH MEMORY MAT CUL; Herxheimer A, 2004, NARRATIVE RES HLTH I, P115; Hodgkinson P., 1995, BEREAVEMENT CARE, V14, P2, DOI DOI 10.1080/02682629508657347; HODGKINSON PE, 1993, MED SCI LAW, V33, P197, DOI 10.1177/002580249303300303; Howarth G., 2007, DEATH DYING SOCIOLOG; HOWARTH G, 2000, MORTALITY, V2, P127; MACHIN L, 1982, COMMUNITY CARE, V20, P14; Mowll J, 2007, BEREAVE CARE, V26, P3, DOI 10.1080/02682620708657676; PAUL R, 2001, COMPLICATED GRIEVING; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; SILVERMAN D, 1994, INTERPRETING QUALITA; Silverman P.R., 1996, CONTINUING BONDS NEW; SINGH B, 1981, J NERV MENT DIS, V169, P203, DOI 10.1097/00005053-198104000-00001; Stroebe M., 1996, CONTINUING BONDS NEW, P31; Turner Bryan S, 2008, BODY SOC; TYE C, 1993, J ADV NURS, V18, P948, DOI 10.1046/j.1365-2648.1993.18060948.x; Valentine C, 2008, BEREAVEMENT NARRATIV; Walter T., 1996, MORTALITY, V1, P7, DOI [10.1080/713685822, DOI 10.1080/713685822]	31	43	43	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2010	340								c2032	10.1136/bmj.c2032	http://dx.doi.org/10.1136/bmj.c2032			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	591PP	20435644	Green Published, hybrid			2022-12-24	WOS:000277314400001
J	Qi, SQ; Pang, YX; Hu, Q; Liu, Q; Li, H; Zhou, YL; He, TX; Liang, QL; Liu, YX; Yuan, XQ; Luo, GA; Li, HL; Wang, JW; Yan, N; Shi, YG				Qi, Shiqian; Pang, Yuxuan; Hu, Qi; Liu, Qun; Li, Hua; Zhou, Yulian; He, Tianxi; Liang, Qionglin; Liu, Yexing; Yuan, Xiaoqiu; Luo, Guoan; Li, Huilin; Wang, Jiawei; Yan, Nieng; Shi, Yigong			Crystal Structure of the Caenorhabditis elegans Apoptosome Reveals an Octameric Assembly of CED-4	CELL			English	Article							PROGRAMMED CELL-DEATH; NB-ARC DOMAIN; DISEASE RESISTANCE; CYTOCHROME-C; MEDIATED OLIGOMERIZATION; 3-DIMENSIONAL STRUCTURE; CED-4-CED-9 COMPLEX; NUCLEOTIDE EXCHANGE; DROSOPHILA HOMOLOG; CASPASE ACTIVATION	The CED-4 homo-oligomer or apoptosome is required for initiation of programmed cell death in Caenorhabditis elegans by facilitating autocatalytic activation of the CED-3 caspase zymogen. How the CED-4 apoptosome assembles and activates CED-3 remains enigmatic. Here we report the crystal structure of the complete CED-4 apoptosome and show that it consists of eight CED-4 molecules, organized as a tetramer of an asymmetric dimer via a previously unreported interface among AAA(+) ATPases. These eight CED-4 molecules form a funnel-shaped structure. The mature CED-3 protease is monomeric in solution and forms an active holoenzyme with the CED-4 apoptosome, within which the protease activity of CED-3 is markedly stimulated. Unexpectedly, the octameric CED-4 apoptosome appears to bind only two, not eight, molecules of mature CED-3. The structure of the CED-4 apoptosome reveals shared principles for the NB-ARC family of AAA(+) ATPases and suggests a mechanism for the activation of CED-3.	[Pang, Yuxuan; Hu, Qi; Yuan, Xiaoqiu; Wang, Jiawei; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane, Beijing 100084, Peoples R China; [Pang, Yuxuan; Hu, Qi; Yuan, Xiaoqiu; Wang, Jiawei; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Qi, Shiqian; Zhou, Yulian; Liu, Yexing; Shi, Yigong] Tsinghua Univ, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China; [Liu, Qun] Brookhaven Natl Lab, New York Struct Biol Ctr, Upton, NY 11973 USA; [Li, Hua; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [He, Tianxi; Liang, Qionglin; Luo, Guoan] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory; Tsinghua University	Yan, N (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn; shi-lab@tsinghua.edu.cn	Liang, Qionglin/A-2407-2011; Liu, Qun/A-8757-2011; Qi, Shiqian/P-9177-2014; Wang, Jiawei/D-1144-2010; Li, Hua/N-6658-2017	Liang, Qionglin/0000-0002-6750-038X; Liu, Qun/0000-0002-1179-290X; Wang, Jiawei/0000-0001-9893-8539; Li, Hua/0000-0002-8786-4295; Qi, Shiqian/0000-0002-7589-8877; Li, Huilin/0000-0001-8085-8928; Shi, Yigong/0000-0003-2030-168X	Ministry of Science and Technology [2009CB918801, 2009CB918802]; National Natural Science Foundation of China [30888001]; Beijing Municipal Commissions of Education and Science and Technology; Yuyuan Foundation; Li's Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074985] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commissions of Education and Science and Technology; Yuyuan Foundation; Li's Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Huang and J. He at Shanghai Synchrotron Radiation Facility (SSRF) and N. Shimizu, S. Baba, and T. Kumasaka at the Spring-8 beamline BL41XU for assistance. This work was supported by funds from the Ministry of Science and Technology (grant # 2009CB918801 and 2009CB918802), Tsinghua University 985 Phase II funds, Project 30888001 supported by National Natural Science Foundation of China, and Beijing Municipal Commissions of Education and Science and Technology. N.Y. acknowledges support from the Yuyuan Foundation and Li's Foundation.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Bao Q, 2007, MOL CELL, V25, P181, DOI 10.1016/j.molcel.2006.12.013; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Chao Y, 2005, PLOS BIOL, V3, P1079, DOI 10.1371/journal.pbio.0030183; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; del Peso L, 1998, J BIOL CHEM, V273, P33495, DOI 10.1074/jbc.273.50.33495; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diemand AV, 2006, J STRUCT BIOL, V156, P230, DOI 10.1016/j.jsb.2006.04.011; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Horvitz HR, 2003, CHEMBIOCHEM, V4, P697, DOI 10.1002/cbic.200300614; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; James C, 1997, CURR BIOL, V7, P246, DOI 10.1016/S0960-9822(06)00120-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; Moffett P, 2002, EMBO J, V21, P4511, DOI 10.1093/emboj/cdf453; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Neuwald AF, 1999, GENOME RES, V9, P27; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Seshagiri S, 1997, CURR BIOL, V7, P455, DOI 10.1016/S0960-9822(06)00216-8; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Spector MS, 1997, NATURE, V385, P653, DOI 10.1038/385653a0; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Wu DY, 1997, SCIENCE, V275, P1126, DOI 10.1126/science.275.5303.1126; Yan N, 2006, J BIOL CHEM, V281, P8667, DOI 10.1074/jbc.M513232200; Yan N, 2006, CELL CYCLE, V5, P31, DOI 10.4161/cc.5.1.2263; Yan N, 2005, ANNU REV CELL DEV BI, V21, P35, DOI 10.1146/annurev.cellbio.21.012704.131040; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; Yan NG, 2004, MOL CELL, V15, P999, DOI 10.1016/j.molcel.2004.08.022; Yang XL, 1998, SCIENCE, V281, P1355, DOI 10.1126/science.281.5381.1355; Yin Q, 2006, MOL CELL, V22, P259, DOI 10.1016/j.molcel.2006.03.030; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Yu XC, 2006, J MOL BIOL, V355, P577, DOI 10.1016/j.jmb.2005.10.040; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Zhou L, 1999, MOL CELL, V4, P745, DOI 10.1016/S1097-2765(00)80385-8; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	68	121	130	2	175	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					446	457		10.1016/j.cell.2010.03.017	http://dx.doi.org/10.1016/j.cell.2010.03.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434985	Bronze			2022-12-24	WOS:000277180800016
J	Ehrenreich, IM; Torabi, N; Jia, Y; Kent, J; Martis, S; Shapiro, JA; Gresham, D; Caudy, AA; Kruglyak, L				Ehrenreich, Ian M.; Torabi, Noorossadat; Jia, Yue; Kent, Jonathan; Martis, Stephen; Shapiro, Joshua A.; Gresham, David; Caudy, Amy A.; Kruglyak, Leonid			Dissection of genetically complex traits with extremely large pools of yeast segregants	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; LOCI; IDENTIFICATION; ARCHITECTURE; MICROARRAYS; MUTATION; DISEASES	Most heritable traits, including many human diseases(1), are caused by multiple loci. Studies in both humans and model organisms, such as yeast, have failed to detect a large fraction of the loci that underlie such complex traits(2,3). A lack of statistical power to identify multiple loci with small effects is undoubtedly one of the primary reasons for this problem. We have developed a method in yeast that allows the use of much larger sample sizes than previously possible and hence permits the detection of multiple loci with small effects. The method involves generating very large numbers of progeny from a cross between two Saccharomyces cerevisiae strains and then phenotyping and genotyping pools of these offspring. We applied the method to 17 chemical resistance traits and mitochondrial function, and identified loci for each of these phenotypes. We show that the level of genetic complexity underlying these quantitative traits is highly variable, with some traits influenced by one major locus and others by at least 20 loci. Our results provide an empirical demonstration of the genetic complexity of a number of traits and show that it is possible to identify many of the underlying factors using straightforward techniques. Our method should have broad applications in yeast and can be extended to other organisms.	[Ehrenreich, Ian M.; Torabi, Noorossadat; Jia, Yue; Kent, Jonathan; Martis, Stephen; Shapiro, Joshua A.; Gresham, David; Caudy, Amy A.; Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08540 USA; [Ehrenreich, Ian M.; Shapiro, Joshua A.; Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; [Ehrenreich, Ian M.; Jia, Yue; Shapiro, Joshua A.; Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08540 USA; [Torabi, Noorossadat] Princeton Univ, Dept Mol Biol, Princeton, NJ 08540 USA	Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University; Princeton University	Kruglyak, L (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08540 USA.	leonid@genomics.princeton.edu	Shapiro, Joshua/B-5948-2008	Shapiro, Joshua/0000-0002-6224-0347; Caudy, Amy/0000-0001-6307-8137	NIH [R37 MH59520, F32 HG51762, P50 GM071508]; James S. McDonnell Centennial Fellowship; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG005176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Centennial Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors are grateful to members of the Kruglyak laboratory for comments on this manuscript; D. Botstein, J. Gerke, G. Lang and E. Perlstein for input regarding experiments; J. Bloom, L. Parsons, D. Sangurdekar and J. Storey for advice regarding analyses; and E. Alani for sharing the EAY1467 strain. This work was supported by NIH grant R37 MH59520, a James S. McDonnell Centennial Fellowship, and the Howard Hughes Medical Institute (L. K.), a NIH postdoctoral fellowship F32 HG51762 (I. M. E.), and NIH grant P50 GM071508 to the Center for Quantitative Biology at the Lewis-Sigler Institute of Princeton University.	Brauer MJ, 2006, GENETICS, V173, P1813, DOI 10.1534/genetics.106.057927; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Demogines A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000123; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490; Gresham D, 2010, P NATL ACAD SCI USA, V107, P1482, DOI 10.1073/pnas.0913883107; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kim HS, 2009, GENETICS, V183, P1141, DOI 10.1534/genetics.109.108068; Lai CQ, 2007, NAT METHODS, V4, P839, DOI 10.1038/NMETH1084; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mackay TFC, 2005, PHILOS T R SOC B, V360, P1513, DOI 10.1098/rstb.2005.1672; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Segre AV, 2006, PLOS BIOL, V4, P1372, DOI 10.1371/journal.pbio.0040256; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Wolyn DJ, 2004, GENETICS, V167, P907, DOI 10.1534/genetics.103.024810; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	29	293	300	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1039	U101		10.1038/nature08923	http://dx.doi.org/10.1038/nature08923			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393561	Green Submitted, Green Accepted			2022-12-24	WOS:000276635000038
J	Carr, BG; Addyson, DK; Kahn, JM				Carr, Brendan G.; Addyson, Daniel K.; Kahn, Jeremy M.			Variation in Critical Care Beds Per Capita in the United States: Implications for Pandemic and Disaster Planning	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							2009 INFLUENZA A(H1N1); SERVICES		[Carr, Brendan G.] Univ Penn, Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA; [Addyson, Daniel K.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kahn, Jeremy M.] Univ Penn, Sch Med, Div Pulm Allergy & Crit Care, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Carr, BG (corresponding author), Univ Penn, Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA.	jmkahn@mail.med.upenn.edu		Kahn, Jeremy/0000-0001-9688-5576	AHRQ HHS [K08HS017960, K08 HS017960] Funding Source: Medline; NHLBI NIH HHS [K23 HL082650, K23HL082650] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS017960] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL082650] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barnato AE, 2007, CRIT CARE MED, V35, P1003, DOI 10.1097/01.CCM.0000259535.06205.B4; Farmer JC, 2006, CRIT CARE MED, V34, pS56, DOI 10.1097/01.CCM.0000199989.44467.2E; Institute of Medicine, 2007, HOSP BAS EM CAR BREA; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; White DB, 2009, JAMA-J AM MED ASSOC, V302, P1905, DOI 10.1001/jama.2009.1539; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8	6	52	53	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2010	303	14					1371	1372		10.1001/jama.2010.394	http://dx.doi.org/10.1001/jama.2010.394			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582KX	20388892	Green Accepted			2022-12-24	WOS:000276597300021
J	Akil, H; Brenner, S; Kandel, E; Kendler, KS; King, MC; Scolnick, E; Watson, JD; Zoghbi, HY				Akil, Huda; Brenner, Sydney; Kandel, Eric; Kendler, Kenneth S.; King, Mary-Claire; Scolnick, Edward; Watson, James D.; Zoghbi, Huda Y.			The Future of Psychiatric Research: Genomes and Neural Circuits	SCIENCE			English	Editorial Material							SCHIZOPHRENIA; STIMULATION; DISORDER; BRAIN; TWIN		[Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Brenner, Sydney] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Kandel, Eric] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Kandel, Eric] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Kendler, Kenneth S.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA; [King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Scolnick, Edward] Broad Inst, Cambridge, MA 02142 USA; [Watson, James D.] Cold Spring Harbor Labs, Cold Spring Harbor, NY 11724 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Virginia Commonwealth University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cold Spring Harbor Laboratory; Baylor College of Medicine; Howard Hughes Medical Institute	Akil, H (corresponding author), Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.	akil@umich.edu	Kendler, Kenneth/AAF-2876-2019	King, Mary-Claire/0000-0001-9426-1743; Zoghbi, Huda/0000-0002-0700-3349	Howard Hughes Medical Institute Funding Source: Medline; NIDA NIH HHS [P01 DA021633, P01 DA021633-01A2] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA021633] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; Bernard R, 2009, J NEUROSCI METH, V178, P46, DOI 10.1016/j.jneumeth.2008.11.012; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Eaton WW, 2008, EPIDEMIOL REV, V30, P1, DOI 10.1093/epirev/mxn011; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Gartlehner G, 2008, ANN INTERN MED, V149, P734, DOI 10.7326/0003-4819-149-10-200811180-00008; Gottesman I.I., 1991, SCHIZOPHRENIA GENESI; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; Messias EL, 2007, PSYCHIAT CLIN N AM, V30, P323, DOI 10.1016/j.psc.2007.04.007; Shah SG, 2009, J PSYCHIATR NEUROSCI, V34; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367	20	123	129	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1580	1581		10.1126/science.1188654	http://dx.doi.org/10.1126/science.1188654			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339051	Green Accepted			2022-12-24	WOS:000275970600019
J	Nissen, SE				Nissen, Steven E.			Setting the RECORD Straight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ROSIGLITAZONE		Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland Clin, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Nissen, SE (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland Clin, 9500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org						Fontanarosa PB, 2005, JAMA-J AM MED ASSOC, V294, P110, DOI 10.1001/jama.294.1.110; HARRIS GA, 2010, NY TIMES        0222; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Nathan DM, 2007, NEW ENGL J MED, V357, P64, DOI 10.1056/NEJMe078117; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Psaty BM, 2010, JAMA-J AM MED ASSOC, V303, P734, DOI 10.1001/jama.2010.97; Psaty BM, 2009, JAMA-J AM MED ASSOC, V302, P1698, DOI 10.1001/jama.2009.1497; STILES S, 2009, AVANDIA RECORD NO OV; *US SEN, STAFF REP GLAXOSMITH; *US SEN, 2007, INT J BUS DIAB DRUG	12	31	32	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2010	303	12					1194	1195		10.1001/jama.2010.333	http://dx.doi.org/10.1001/jama.2010.333			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573AC	20332408				2022-12-24	WOS:000275879600027
J	Bach, PB				Bach, Peter B.			Gardasil: from bench, to bedside, to blunder	LANCET			English	Editorial Material							UNITED-STATES; VACCINATION; HEALTH		Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA.	bachp@mskcc.org						Akers Aletha Y, 2007, Curr Probl Cancer, V31, P157, DOI 10.1016/j.currproblcancer.2007.01.001; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P997; Horner MJ, 2009, SEER CANC STAT REV 1; Kim JJ, 2008, NEW ENGL J MED, V359, P821, DOI 10.1056/NEJMsa0707052; *NAT AC SCI I MED, 2002, UN TREATM CONFR RAC; Rothman SM, 2009, JAMA-J AM MED ASSOC, V302, P781, DOI 10.1001/jama.2009.1179; *US BUR CENS, 2008, 2 YEAR AV MED HOUS I	7	38	39	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 20	2010	375	9719					963	964		10.1016/S0140-6736(09)62029-8	http://dx.doi.org/10.1016/S0140-6736(09)62029-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575YU	20304226				2022-12-24	WOS:000276110700007
J	Percec, V; Wilson, DA; Leowanawat, P; Wilson, CJ; Hughes, AD; Kaucher, MS; Hammer, DA; Levine, DH; Kim, AJ; Bates, FS; Davis, KP; Lodge, TP; Klein, ML; DeVane, RH; Aqad, E; Rosen, BM; Argintaru, AO; Sienkowska, MJ; Rissanen, K; Nummelin, S; Ropponen, J				Percec, Virgil; Wilson, Daniela A.; Leowanawat, Pawaret; Wilson, Christopher J.; Hughes, Andrew D.; Kaucher, Mark S.; Hammer, Daniel A.; Levine, Dalia H.; Kim, Anthony J.; Bates, Frank S.; Davis, Kevin P.; Lodge, Timothy P.; Klein, Michael L.; DeVane, Russell H.; Aqad, Emad; Rosen, Brad M.; Argintaru, Andreea O.; Sienkowska, Monika J.; Rissanen, Kari; Nummelin, Sami; Ropponen, Jarmo			Self-Assembly of Janus Dendrimers into Uniform Dendrimersomes and Other Complex Architectures	SCIENCE			English	Article							BLOCK-COPOLYMER VESICLES; DRUG-DELIVERY; LIPOSOMES; TRANSITION; MEMBRANES; DYNAMICS; ORIGINS; SYSTEMS; MODELS; PORES	Self-assembled nanostructures obtained from natural and synthetic amphiphiles serve as mimics of biological membranes and enable the delivery of drugs, proteins, genes, and imaging agents. Yet the precise molecular arrangements demanded by these functions are difficult to achieve. Libraries of amphiphilic Janus dendrimers, prepared by facile coupling of tailored hydrophilic and hydrophobic branched segments, have been screened by cryogenic transmission electron microscopy, revealing a rich palette of morphologies in water, including vesicles, denoted dendrimersomes, cubosomes, disks, tubular vesicles, and helical ribbons. Dendrimersomes marry the stability and mechanical strength obtainable from polymersomes with the biological function of stabilized phospholipid liposomes, plus superior uniformity of size, ease of formation, and chemical functionalization. This modular synthesis strategy provides access to systematic tuning of molecular structure and of self-assembled architecture.	[Percec, Virgil; Wilson, Daniela A.; Leowanawat, Pawaret; Wilson, Christopher J.; Hughes, Andrew D.; Kaucher, Mark S.; Aqad, Emad; Rosen, Brad M.; Argintaru, Andreea O.; Sienkowska, Monika J.] Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA; [Hammer, Daniel A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Hammer, Daniel A.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; [Hammer, Daniel A.; Levine, Dalia H.; Kim, Anthony J.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Bates, Frank S.; Davis, Kevin P.; Lodge, Timothy P.] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Lodge, Timothy P.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Klein, Michael L.; DeVane, Russell H.] Temple Univ, Inst Computat Mol Sci, Philadelphia, PA 19122 USA; [Rissanen, Kari; Nummelin, Sami; Ropponen, Jarmo] Univ Jyvaskyla, Dept Chem, Nanosci Ctr, Jyu 40014, Finland; [Nummelin, Sami] Aalto Univ, Dept Appl Phys, Sch Sci & Technol, FI-02150 Espoo, Finland	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Jyvaskyla; Aalto University	Percec, V (corresponding author), Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA.	percec@sas.upenn.edu	Wilson, Daniela A./A-8119-2010; Sienkowska, Monika/GLR-1518-2022; Rosen, Brad/A-5174-2008; Wilson, Christopher/T-5925-2019; Wilson, Christopher J/C-9390-2009; Nummelin, Sami J/O-5741-2015; Kim, Anthony/A-1681-2012; Rissanen, Kari T/B-5688-2008; Nummelin, Sami/P-4185-2019; Wilson, Christopher/ABC-5819-2020; Percec, Virgil/H-6316-2014	Wilson, Daniela A./0000-0002-8796-2274; Wilson, Christopher/0000-0003-0760-3421; Wilson, Christopher J/0000-0003-0760-3421; Nummelin, Sami J/0000-0003-2195-4818; Rissanen, Kari T/0000-0002-7282-8419; Nummelin, Sami/0000-0003-2195-4818; Wilson, Christopher/0000-0003-0760-3421; Percec, Virgil/0000-0001-5926-0489; Bates, Frank/0000-0003-3977-1278; Lodge, Timothy/0000-0001-5916-8834; Aqad, Emad/0000-0002-8907-7391	NSF [DMR-0548559]; Academy of Finland; P. Roy Vagelos Chair at the University of Pennsylvania; Finnish Cultural Foundation	NSF(National Science Foundation (NSF)); Academy of Finland(Academy of Finland); P. Roy Vagelos Chair at the University of Pennsylvania; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	We thank the NSF (grant DMR-0548559), NSF-funded Materials Research Science and Engineering Centers at the University of Pennsylvania and at the University of Minnesota, the Academy of Finland, and the P. Roy Vagelos Chair at the University of Pennsylvania for financial support. We also thank T. Tuttila, N. Kuuloja, and M. Lahtinen from the University of Jyvaskyla for contributions on the synthesis and analysis of some Janus dendrimers from library 1. Additional funding was provided by the Finnish Cultural Foundation.	Almgren M, 2000, COLLOID SURFACE A, V174, P3, DOI 10.1016/S0927-7757(00)00516-1; [Anonymous], 1992, INTERMOLECULAR SURFA; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; Barenholz Y, 2001, CURR OPIN COLLOID IN, V6, P66, DOI 10.1016/S1359-0294(00)00090-X; Bridson RH, 2006, J PHARM PHARMACOL, V58, P775, DOI 10.1211/jpp.58.6.0008; CHIRUVOLU S, 1994, SCIENCE, V266, P1222, DOI 10.1126/science.7973704; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; Dobereiner HG, 2000, CURR OPIN COLLOID IN, V5, P256, DOI 10.1016/S1359-0294(00)00064-9; Dubois M, 2001, NATURE, V411, P672, DOI 10.1038/35079541; Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; GHADIRI MR, 1994, NATURE, V369, P301, DOI 10.1038/369301a0; Guo X, 2003, ACCOUNTS CHEM RES, V36, P335, DOI 10.1021/ar9703241; Haluska CK, 2006, P NATL ACAD SCI USA, V103, P15841, DOI 10.1073/pnas.0602766103; Hanczyc MM, 2004, CURR OPIN CHEM BIOL, V8, P660, DOI 10.1016/j.cbpa.2004.10.002; Jung HT, 2001, P NATL ACAD SCI USA, V98, P1353, DOI 10.1073/pnas.041420998; Kita-Tokarczyk K, 2008, CHIMIA, V62, P820, DOI 10.2533/chimia.2008.820; Klein ML, 2008, SCIENCE, V321, P798, DOI 10.1126/science.1157834; Krafft MP, 2001, ADV DRUG DELIVER REV, V47, P209, DOI 10.1016/S0169-409X(01)00107-7; LASIC DD, 1995, SCIENCE, V267, P1275, DOI 10.1126/science.7871422; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; Matsen MW, 1996, MACROMOLECULES, V29, P7641, DOI 10.1021/ma960744q; Percec V, 2004, NATURE, V430, P764, DOI 10.1038/nature02770; Rank A, 2009, LANGMUIR, V25, P1337, DOI 10.1021/la802709v; RINGSDORF H, 1988, ANGEW CHEM INT EDIT, V27, P113, DOI 10.1002/anie.198801131; Rosen BM, 2009, J AM CHEM SOC, V131, P17500, DOI 10.1021/ja907882n; Rosen BM, 2009, CHEM REV, V109, P6275, DOI 10.1021/cr900157q; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Thiele J, 2010, LANGMUIR, V26, P6860, DOI 10.1021/la904163v; THOMAS JL, 1992, ACCOUNTS CHEM RES, V25, P336, DOI 10.1021/ar00020a003; van Dongen SFM, 2009, CHEM REV, V109, P6212, DOI 10.1021/cr900072y; WALTER A, 1991, BIOPHYS J, V60, P1315, DOI 10.1016/S0006-3495(91)82169-5; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Zhu TF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005009	35	555	564	18	853	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					1009	1014		10.1126/science.1185547	http://dx.doi.org/10.1126/science.1185547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	598YW	20489021				2022-12-24	WOS:000277877100036
J	Holloway, RG; Quill, TE				Holloway, Robert G.; Quill, Timothy E.			Treatment Decisions after Brain Injury - Tensions among Quality, Preference, and Cost	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OF-LIFE CARE		[Holloway, Robert G.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Holloway, Robert G.; Quill, Timothy E.] Univ Rochester, Med Ctr, Palliat Care Program, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Holloway, RG (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.							Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Carlet J, 2004, INTENS CARE MED, V30, P770, DOI 10.1007/s00134-004-2241-5; Epstein RM, 2009, JAMA-J AM MED ASSOC, V302, P195, DOI 10.1001/jama.2009.984; Loggers ET, 2009, J CLIN ONCOL, V27, P5559, DOI 10.1200/JCO.2009.22.4733; O'Connor AM, 2007, HEALTH AFFAIR, V26, P716, DOI 10.1377/hlthaff.26.3.716	5	33	33	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2010	362	19					1757	1759		10.1056/NEJMp0907808	http://dx.doi.org/10.1056/NEJMp0907808			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	594RQ	20463337				2022-12-24	WOS:000277555500002
J	Mbulaiteye, SM; Talisuna, AO; Ogwang, MD; McKenzie, FE; Ziegler, JL; Parkin, DM				Mbulaiteye, Sam M.; Talisuna, Ambrose O.; Ogwang, Martin D.; McKenzie, F. Ellis; Ziegler, John L.; Parkin, Donald M.			African Burkitt's lymphoma: could collaboration with HIV-1 and malaria programmes reduce the high mortality rate?	LANCET			English	Editorial Material							CHILDREN; UGANDA; INFECTION; PEPFAR; BURDEN; MALAWI		[Talisuna, Ambrose O.] Uganda Malaria Surveillance Programme, Kampala, Uganda; [Ogwang, Martin D.] St Marys Hosp, Dept Surg, Lacor, Gulu, Uganda; [McKenzie, F. Ellis] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Ziegler, John L.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Parkin, Donald M.] Univ Oxford, Clin Trial Serv Unit, Oxford, England	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of California System; University of California San Francisco; University of Oxford	Mbulaiteye, SM (corresponding author), 2302 Cranberry Terrace, Silver Spring, MD 20906 USA.	sammwiidu@hotmail.com	Mbulaiteye, Sam/O-3056-2019	Mbulaiteye, Sam/0000-0002-8273-9831				Bristol N, 2008, LANCET, V372, P277, DOI 10.1016/S0140-6736(08)61093-4; BURKITT D, 1965, CANCER-AM CANCER SOC, V18, P399, DOI 10.1002/1097-0142(196504)18:4<399::AID-CNCR2820180402>3.0.CO;2-G; BURKITT D, 1958, BRIT J SURG, V46, P218, DOI 10.1002/bjs.18004619704; Hesseling PB, 2008, LANCET ONCOL, V9, P512, DOI 10.1016/S1470-2045(08)70139-6; Kamwi R, 2006, LANCET, V367, P1978, DOI 10.1016/S0140-6736(06)68879-X; Klein G, 2009, SEMIN CANCER BIOL, V19, P347, DOI 10.1016/j.semcancer.2009.07.001; Molyneux E, 2003, LANCET, V362, P2117, DOI 10.1016/S0140-6736(03)15116-1; Ogwang MD, 2008, INT J CANCER, V123, P2658, DOI 10.1002/ijc.23800; OLWENY CL, 1985, IARC SCI PUBL, V60, P375; Orem J, 2009, PEDIATR BLOOD CANCER, V52, P455, DOI 10.1002/pbc.21769; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Patte C, 2001, BLOOD, V97, P3370, DOI 10.1182/blood.V97.11.3370; Phillips JA, 2006, LANCET, V368, P2251, DOI 10.1016/S0140-6736(06)69898-X; Ribeiro RC, 2008, LANCET ONCOL, V9, P721, DOI 10.1016/S1470-2045(08)70194-3; Ribeiro RC, 2008, PEDIATR BLOOD CANCER, V50, P1125, DOI 10.1002/pbc.21528; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; *UG MIN HLTH, 2008, ANN HLTH SECT PERF R; Wakabi W, 2008, LANCET ONCOL, V9, P319, DOI 10.1016/S1470-2045(08)70088-3; Wolitz R, 2009, LANCET, V374, P847, DOI 10.1016/S0140-6736(09)60320-2; ZIEGLER JL, 1981, NEW ENGL J MED, V305, P735, DOI 10.1056/NEJM198109243051305; ZIEGLER JL, 1979, LANCET, V2, P936; 2006, LANCET, V368, P1	22	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 8	2010	375	9726					1661	1663		10.1016/S0140-6736(10)60134-1	http://dx.doi.org/10.1016/S0140-6736(10)60134-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597CX	20452522				2022-12-24	WOS:000277734700032
J	Lee, HK; Yang, Y; Su, ZL; Hyeon, C; Lee, TS; Lee, HW; Kweon, DH; Shin, YK; Yoon, TY				Lee, Han-Ki; Yang, Yoosoo; Su, Zengliu; Hyeon, Changbong; Lee, Tae-Sun; Lee, Hong-Won; Kweon, Dae-Hyuk; Shin, Yeon-Kyun; Yoon, Tae-Young			Dynamic Ca2+-Dependent Stimulation of Vesicle Fusion by Membrane-Anchored Synaptotagmin 1	SCIENCE			English	Article							NEUROTRANSMITTER RELEASE; PHOSPHOLIPIDS; PENETRATION; MACHINERY; CALCIUM; BINDING; SNARES; DOMAIN; CA2+	In neurons, synaptotagmin 1 (Syt1) is thought to mediate the fusion of synaptic vesicles with the plasma membrane when presynaptic Ca2+ levels rise. However, in vitro reconstitution experiments have failed to recapitulate key characteristics of Ca2+-triggered membrane fusion. Using an in vitro single-vesicle fusion assay, we found that membrane-anchored Syt1 enhanced Ca2+ sensitivity and fusion speed. This stimulatory activity of membrane-anchored Syt1 dropped as the Ca2+ level rose beyond physiological levels. Thus, Syt1 requires the membrane anchor to stimulate vesicle fusion at physiological Ca2+ levels and may function as a dynamic presynaptic Ca2+ sensor to control the probability of neurotransmitter release.	[Su, Zengliu; Shin, Yeon-Kyun] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Lee, Han-Ki; Lee, Tae-Sun; Lee, Hong-Won; Yoon, Tae-Young] Korea Adv Inst Sci & Technol, Dept Phys, Taejon 305701, South Korea; [Yoon, Tae-Young] Korea Adv Inst Sci & Technol, Inst BioCentury, Taejon 305701, South Korea; [Yang, Yoosoo; Kweon, Dae-Hyuk] Sungkyunkwan Univ, Dept Genet Engn, Suwon 4400746, Gyeonggi Do, South Korea; [Hyeon, Changbong] Korea Inst Adv Study, Sch Computat Sci, Seoul 130722, South Korea; [Shin, Yeon-Kyun] POSTECH, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea	Iowa State University; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Sungkyunkwan University (SKKU); Korea Institute for Advanced Study (KIAS); Pohang University of Science & Technology (POSTECH)	Shin, YK (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, 4152 Mol Biol Bldg, Ames, IA 50011 USA.	colishin@iastate.edu; tyyoon@kaist.ac.kr	Yoon, Tae-Young/C-1687-2011; Hyeon, Changbong/H-3295-2011; Su, Zengliu/E-3156-2010; Hyeon, Changbong/AAU-7862-2021	Yoon, Tae-Young/0000-0002-5184-7725; Hyeon, Changbong/0000-0002-4844-7237; Lee, Hong-won/0000-0003-0627-9850; Lee, Hanki/0000-0002-3479-1651	Korea Research Foundation [KRF-2008-313-C00365, KRF-C00142, KRF-C00180]; Korean government [2009-0087691, R01-2008-00010920-0, 2007-D00243]; National Institutes of Health [R01 GM051290]; World Class University program in Korea [R31-2008-000-10105-0, R33-10163]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051290] Funding Source: NIH RePORTER	Korea Research Foundation(National Research Foundation of Korea); Korean government(Korean Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class University program in Korea; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T.-Y. Y. thanks W. Bae and J. Ryu for writing analysis programs, K. Kim for help with the supporting movie, and T. Ha and W. Jones for critical reading of the manuscript. This work was supported by Korea Research Foundation grants (KRF-2008-313-C00365 to T.-Y. Y.; KRF-C00142 and KRF-C00180 to C. H.), and National Research Foundation of Korea grants funded by the Korean government (2009-0087691 to T.-Y. Y.; R01-2008-00010920-0 to C. H.; 2007-D00243 to D.-H. K.). This work was also supported by a National Institutes of Health grant (R01 GM051290 to Y.-K. S.) and the World Class University program in Korea (R31-2008-000-10105-0 to Y.-K. S. and R33-10163 to T.-Y. Y.).	Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brunger AT, 2009, ANNU REV BIOCHEM, V78, P903, DOI 10.1146/annurev.biochem.77.070306.103621; Chan YHM, 2009, P NATL ACAD SCI USA, V106, P979, DOI 10.1073/pnas.0812356106; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Craxton M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-259; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Holt M, 2008, CURR BIOL, V18, P715, DOI 10.1016/j.cub.2008.04.069; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Mahal LK, 2002, J CELL BIOL, V158, P273, DOI 10.1083/jcb.200203135; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508; Yoon TY, 2008, NAT STRUCT MOL BIOL, V15, P707, DOI 10.1038/nsmb.1446; Yoon TY, 2006, P NATL ACAD SCI USA, V103, P19731, DOI 10.1073/pnas.0606032103; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	29	101	101	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					760	763		10.1126/science.1187722	http://dx.doi.org/10.1126/science.1187722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448186	Green Accepted			2022-12-24	WOS:000277357100042
J	McGill, BJ				McGill, Brian J.			Matters of Scale	SCIENCE			English	Editorial Material									Univ Arizona, Sch Nat Resources, Tucson, AZ 85721 USA	University of Arizona	McGill, BJ (corresponding author), Univ Arizona, Sch Nat Resources, Tucson, AZ 85721 USA.	mcgillb@u.arizona.edu	McGill, Brian/A-3476-2008	McGill, Brian/0000-0002-0850-1913				CAUGHLEY G, 1987, J ANIM ECOL, V56, P751, DOI 10.2307/4946; Gotelli NJ, 2010, P NATL ACAD SCI USA, V107, P5030, DOI 10.1073/pnas.0914089107; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; MacArthur R.H., 1972, pvii; McGill BJ, 2008, AM NAT, V172, P88, DOI 10.1086/588044; Newton I, 1687, PHILOS NATURALIS PRI; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; ROOT T, 1988, J BIOGEOGR, V15, P489, DOI 10.2307/2845278; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Russell R, 2006, AM NAT, V167, pE158, DOI 10.1086/504603; Schneider DC, 2001, BIOSCIENCE, V51, P545, DOI 10.1641/0006-3568(2001)051[0545:TROTCO]2.0.CO;2; SHMIDA A, 1984, VEGETATIO, V58, P29; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; Veech JA, 2006, J BIOGEOGR, V33, P2145, DOI 10.1111/j.1365-2699.2006.01571.x; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612	16	254	259	8	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2010	328	5978					575	576		10.1126/science.1188528	http://dx.doi.org/10.1126/science.1188528			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431001				2022-12-24	WOS:000277159800026
J	Fazzari, P; Paternain, AV; Valiente, M; Pla, R; Lujan, R; Lloyd, K; Lerma, J; Marin, O; Rico, B				Fazzari, Pietro; Paternain, Ana V.; Valiente, Manuel; Pla, Ramon; Lujan, Rafael; Lloyd, Kent; Lerma, Juan; Marin, Oscar; Rico, Beatriz			Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling	NATURE			English	Article							GABAERGIC INTERNEURONS; NEUREGULIN-1; NEURONS; RAT; SCHIZOPHRENIA; RECEPTORS; SUSCEPTIBILITY; ORIGIN; CELLS; CAT	Schizophrenia is a complex disorder that interferes with the function of several brain systems required for cognition and normal social behaviour. Although the most notable clinical aspects of the disease only become apparent during late adolescence or early adulthood, many lines of evidence suggest that schizophrenia is a neurodevelopmental disorder with a strong genetic component(1,2). Several independent studies have identified neuregulin 1 (NRG1) and its receptor ERBB4 as important risk genes for schizophrenia(3,4), although their precise role in the disease process remains unknown. Here we show that Nrg1 and ErbB4 signalling controls the development of inhibitory circuitries in the mammalian cerebral cortex by cell-autonomously regulating the connectivity of specific GABA (gamma-aminobutyric acid)-containing interneurons. In contrast to the prevalent view, which supports a role for these genes in the formation and function of excitatory synapses between pyramidal cells, we found that ErbB4 expression in the mouse neocortex and hippocampus is largely confined to certain classes of interneurons. In particular, ErbB4 is expressed by many parvalbumin-expressing chandelier and basket cells, where it localizes to axon terminals and postsynaptic densities receiving glutamatergic input. Gain- and loss-of-function experiments, both in vitro and in vivo, demonstrate that ErbB4 cell-autonomously promotes the formation of axo-axonic inhibitory synapses over pyramidal cells, and that this function is probably mediated by Nrg1. In addition, ErbB4 expression in GABA-containing interneurons regulates the formation of excitatory synapses onto the dendrites of these cells. By contrast, ErbB4 is dispensable for excitatory transmission between pyramidal neurons. Altogether, our results indicate that Nrg1 and ErbB4 signalling is required for the wiring of GABA-mediated circuits in the postnatal cortex, providing a new perspective to the involvement of these genes in the aetiology of schizophrenia.	[Fazzari, Pietro; Paternain, Ana V.; Valiente, Manuel; Pla, Ramon; Lerma, Juan; Marin, Oscar; Rico, Beatriz] CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain; [Fazzari, Pietro; Paternain, Ana V.; Valiente, Manuel; Pla, Ramon; Lerma, Juan; Marin, Oscar; Rico, Beatriz] Univ Miguel Hernandez, Sant Joan dAlacant 03550, Spain; [Lujan, Rafael] Univ Castilla La Mancha, Fac Med, Dept Ciencias Med, Albacete 02006, Spain; [Lloyd, Kent] Univ Calif Davis, Dept Internal Med, Calif Natl Primate Res Ctr, Davis, CA 95616 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche; Universidad de Castilla-La Mancha; University of California System; University of California Davis	Marin, O (corresponding author), CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain.	o.marin@umh.es; brico@umh.es	Marin, Oscar/F-3856-2012; Ferriz, Ramon Pla/ABF-5635-2020; Fazzari, Pietro/ABE-9368-2020; Valiente, Manuel/J-9523-2014; Lujan, Rafael/G-2555-2015; Lerma, Juan/G-7907-2015; Pla, Ramon/AAA-9243-2020	Marin, Oscar/0000-0001-6264-7027; Fazzari, Pietro/0000-0003-3457-9201; Valiente, Manuel/0000-0002-0647-7542; Lerma, Juan/0000-0001-7838-5199; Pla, Ramon/0000-0003-4115-149X; Rico, Beatriz/0000-0002-0581-851X; Lujan Miras, Rafael/0000-0003-2001-9545	Spanish Ministry of Science and Innovation [SAF2008-00770, SAF2007-61904, BFU2006-07138, CSD2007-00023]; Consejeria de Educacion y Ciencia de la Junta de Comunidades de Castilla-La Mancha [PAI08-0174-6967]; fundacio la Caixa; EURYI; Marie Curie Intra-European Fellowship	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Educacion y Ciencia de la Junta de Comunidades de Castilla-La Mancha; fundacio la Caixa(La Caixa FoundationEuropean Commission); EURYI(European Science Foundation (ESF)); Marie Curie Intra-European Fellowship(European Commission)	We thank G. Fernandez for technical assistance, T. Gil and A. Casillas for general laboratory support, C. Lai for antibodies and plasmids, F. H. Gage for retroviral vectors, and K. Campbell (Dlx5/6-Cre-IRES-GFP), M. Gassmann (HER4<SUP>heart</SUP> and Erbb4<SUP>-</SUP>), S. Goebbels and K.-A. Nave (Nex Cre), and G. Szabo (GAD65-GFP) for mouse strains. We are grateful to L. Menendez de la Prida and P. Aivar for help with electrophysiological experiments, M. Maravall for critical reading of the manuscript, and members of the Borrell, Marin and Rico laboratories for stimulating discussions and ideas. This work was supported by grants from Spanish Ministry of Science and Innovation SAF2008-00770 (to O. M.), SAF2007-61904 (to B. R.), BFU2006-07138 (to J.L.), and CONSOLIDER CSD2007-00023 (to J. L., O. M. and B. R.), Consejeria de Educacion y Ciencia de la Junta de Comunidades de Castilla-La Mancha PAI08-0174-6967 (to R. L.), fundacio la Caixa (to B. R.) and the EURYI (see http://www.esf.org/euryi) scheme award (to O. M). P. F. is the recipient of a Marie Curie Intra-European Fellowship.	Addington AM, 2007, MOL PSYCHIATR, V12, P195, DOI 10.1038/sj.mp.4001906; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Barros CS, 2009, P NATL ACAD SCI USA, V106, P4507, DOI 10.1073/pnas.0900355106; Bjarnadottir M, 2007, J NEUROSCI, V27, P4519, DOI 10.1523/JNEUROSCI.4314-06.2007; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Christensen JK, 2004, J NEUROSCI, V24, P8986, DOI 10.1523/JNEUROSCI.2156-04.2004; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Golub MS, 2004, BEHAV BRAIN RES, V153, P159, DOI 10.1016/j.bbr.2003.11.010; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hall J, 2006, NAT NEUROSCI, V9, P1477, DOI 10.1038/nn1795; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Krivosheya D, 2008, J BIOL CHEM, V283, P32944, DOI 10.1074/jbc.M800073200; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Longart M, 2007, BRAIN RES BULL, V73, P210, DOI 10.1016/j.brainresbull.2007.02.014; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Owen MJ, 2004, MOL PSYCHIATR, V9, P14, DOI 10.1038/sj.mp.4001444; Pla R, 2006, J NEUROSCI, V26, P6924, DOI 10.1523/JNEUROSCI.0245-06.2006; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; SOMOGYI P, 1982, NEUROSCIENCE, V7, P2577, DOI 10.1016/0306-4522(82)90086-0; Spencer KM, 2003, J NEUROSCI, V23, P7407; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stenman J, 2003, J NEUROSCI, V23, P167; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Vullhorst D, 2009, J NEUROSCI, V29, P12255, DOI 10.1523/JNEUROSCI.2454-09.2009; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Woo TU, 1998, P NATL ACAD SCI USA, V95, P5341, DOI 10.1073/pnas.95.9.5341; ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x	42	335	339	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1376	U11		10.1038/nature08928	http://dx.doi.org/10.1038/nature08928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20393464				2022-12-24	WOS:000277149000052
J	Gracheva, EO; Ingolia, NT; Kelly, YM; Cordero-Morales, JF; Hollopeter, G; Chesler, AT; Sanchez, EE; Perez, JC; Weissman, JS; Julius, D				Gracheva, Elena O.; Ingolia, Nicholas T.; Kelly, Yvonne M.; Cordero-Morales, Julio F.; Hollopeter, Gunther; Chesler, Alexander T.; Sanchez, Elda E.; Perez, John C.; Weissman, Jonathan S.; Julius, David			Molecular basis of infrared detection by snakes	NATURE			English	Article							TRIGEMINAL SYSTEM; ION CHANNELS; TRPA1; NEURONS; PIT; CROTALINE; PROJECTIONS; RECEPTORS; NUCLEUS; THERMOSENSATION	Snakes possess a unique sensory system for detecting infrared radiation, enabling them to generate a 'thermal image' of predators or prey. Infrared signals are initially received by the pit organ, a highly specialized facial structure that is innervated by nerve fibres of the somatosensory system. How this organ detects and transduces infrared signals into nerve impulses is not known. Here we use an unbiased transcriptional profiling approach to identify TRPA1 channels as infrared receptors on sensory nerve fibres that innervate the pit organ. TRPA1 orthologues from pit-bearing snakes (vipers, pythons and boas) are the most heat-sensitive vertebrate ion channels thus far identified, consistent with their role as primary transducers of infrared stimuli. Thus, snakes detect infrared signals through a mechanism involving radiant heating of the pit organ, rather than photochemical transduction. These findings illustrate the broad evolutionary tuning of transient receptor potential (TRP) channels as thermosensors in the vertebrate nervous system.	[Gracheva, Elena O.; Kelly, Yvonne M.; Cordero-Morales, Julio F.; Hollopeter, Gunther; Chesler, Alexander T.; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.; Julius, David] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Sanchez, Elda E.; Perez, John C.] Texas A&M Univ, Nat Toxins Res Ctr, Kingsville, TX 78363 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Texas A&M University System; Texas A&M University Kingsville	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	julius@cmp.ucsf.edu	Chesler, Alexander/V-2748-2019; Kelly, Yvonne/AAR-3856-2020	Chesler, Alexander/0000-0002-3131-0728; Kelly, Yvonne/0000-0002-1494-0429; Cordero Morales, Julio/0000-0002-6505-5403; Gracheva, Elena O/0000-0002-0846-3427; Sanchez, Elda E./0000-0001-5222-8873; Weissman, Jonathan/0000-0003-2445-670X	Ruth L. Kirschstein National Research Service Award [GM080853]; NIH; Howard Hughes Medical Institute; National Institutes of Health, including NCRR [P40 RR018300-06, P01 AG010770, NS047723, NS055299]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047723, R01NS055299, R01NS047723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health, including NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Priel for advice and assistance with calcium imaging and electrophysiology, C. Chu for help with sequencing, J. Poblete for technical assistance, and the staff of the Natural Toxins Research Center serpentarium for animal husbandry. We thank P. Garrity for providing the dTrpA1 cDNA. This work was supported by a Ruth L. Kirschstein National Research Service Award (GM080853) (N.T.I.), a NIH Institutional Research Service Award in Molecular and Cellular Basis of Cardiovascular Disease (A. T. C.), the Howard Hughes Medical Institute (J. S. W.), and grants from the National Institutes of Health, including NCRR Viper grant P40 RR018300-06 (E. E. S. and J. C. P.), P01 AG010770 (J. S. W.) and NS047723 and NS055299 (D. J.).	Amemiya F, 1996, ANAT RECORD, V246, P135; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Barrett R., 1970, BIOL REPTILIA, P227; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; BLEICHMAR H, 1962, Z ZELLFORSCH MIK ANA, V56, P748, DOI 10.1007/BF00336332; BULLOCK TH, 1952, SCIENCE, V115, P541, DOI 10.1126/science.115.2994.541-a; BUNING TD, 1981, CELL MOL NEUROBIOL, V1, P271, DOI 10.1007/BF00710682; Campbell AL, 2002, MICRON, V33, P211, DOI 10.1016/S0968-4328(01)00010-5; Caspani O, 2009, J GEN PHYSIOL, V133, P245, DOI 10.1085/jgp.200810136; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; DeCoursey TE, 1998, J GEN PHYSIOL, V112, P503, DOI 10.1085/jgp.112.4.503; Dong S, 2005, J MOL EVOL, V61, P12, DOI 10.1007/s00239-004-0190-9; Ebert J, 2007, THESIS RHEINISCHE F; Ebert Jill, 2006, P215; Eng SR, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-3; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HARTLINE PH, 1978, SCIENCE, V199, P1225, DOI 10.1126/science.628839; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KISHIDA R, 1983, BRAIN RES, V263, P132, DOI 10.1016/0006-8993(83)91209-X; KISHIDA R, 1980, BRAIN RES, V195, P271, DOI 10.1016/0006-8993(80)90064-5; KISHIDA R, 1984, BRAIN RES, V322, P351, DOI 10.1016/0006-8993(84)90132-X; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Krochmal AR, 2004, J EXP BIOL, V207, P4231, DOI 10.1242/jeb.01278; Liman ER, 2006, PFLUG ARCH EUR J PHY, V453, P125, DOI 10.1007/s00424-006-0120-3; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Matsuura H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-228; MOLENAAR GJ, 1978, J COMP NEUROL, V179, P137, DOI 10.1002/cne.901790109; MOLENAAR GJ, 1974, BRAIN RES, V78, P340, DOI 10.1016/0006-8993(74)90560-5; Myers BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005741; NEWMAN EA, 1981, SCIENCE, V213, P789, DOI 10.1126/science.7256281; NOBLE G. K., 1937, PROC AMER PHIL SOC, V77, P263; Pappas TC, 2004, AM J PHYSIOL-CELL PH, V287, pC1219, DOI 10.1152/ajpcell.00040.2004; Prober DA, 2008, J NEUROSCI, V28, P10102, DOI 10.1523/JNEUROSCI.2740-08.2008; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Safer AB, 2004, BEHAV BRAIN RES, V154, P55, DOI 10.1016/j.bbr.2004.01.020; SCHROEDER DM, 1976, J COMP NEUROL, V169, P1, DOI 10.1002/cne.901690102; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TERASHIMA S, 1991, J NEUROPHYSIOL, V66, P623, DOI 10.1152/jn.1991.66.2.623; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x; WARREN JW, 1968, SCIENCE, V159, P439, DOI 10.1126/science.159.3813.439; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016	48	261	267	11	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1006	U66		10.1038/nature08943	http://dx.doi.org/10.1038/nature08943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20228791	Green Accepted, Green Submitted			2022-12-24	WOS:000276635000031
J	Deyo, RA; Mirza, SK; Martin, BI; Kreuter, W; Goodman, DC; Jarvik, JG				Deyo, Richard A.; Mirza, Sohail K.; Martin, Brook I.; Kreuter, William; Goodman, David C.; Jarvik, Jeffrey G.			Trends, Major Medical Complications, and Charges Associated With Surgery for Lumbar Spinal Stenosis in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-BACK-PAIN; UNITED-STATES TRENDS; RANDOMIZED CONTROLLED-TRIAL; FUSION SURGERY; REGIONAL-VARIATIONS; ARTHRODESIS; SPONDYLOLISTHESIS; DECOMPRESSION; OUTCOMES; INSTRUMENTATION	Context In recent decades, the fastest growth in lumbar surgery occurred in older patients with spinal stenosis. Trials indicate that for selected patients, decompressive surgery offers an advantage over nonoperative treatment, but surgeons often recommend more invasive fusion procedures. Comorbidity is common in older patients, so benefits and risks must be carefully weighed in the choice of surgical procedure. Objective To examine trends in use of different types of stenosis operations and the association of complications and resource use with surgical complexity. Design, Setting, and Patients Retrospective cohort analysis of Medicare claims for 2002-2007, focusing on 2007 to assess complications and resource use in US hospitals. Operations for Medicare recipients undergoing surgery for lumbar stenosis (n=32 152 in the first 11 months of 2007) were grouped into 3 gradations of invasiveness: decompression alone, simple fusion (1 or 2 disk levels, single surgical approach), or complex fusion (more than 2 disk levels or combined anterior and posterior approach). Main Outcome Measures Rates of the 3 types of surgery, major complications, postoperative mortality, and resource use. Results Overall, surgical rates declined slightly from 2002-2007, but the rate of complex fusion procedures increased 15-fold, from 1.3 to 19.9 per 100 000 beneficiaries. Life-threatening complications increased with increasing surgical invasiveness, from 2.3% among patients having decompression alone to 5.6% among those having complex fusions. After adjustment for age, comorbidity, previous spine surgery, and other features, the odds ratio (OR) of life-threatening complications for complex fusion compared with decompression alone was 2.95 (95% confidence interval [CI], 2.50-3.49). A similar pattern was observed for rehospitalization within 30 days, which occurred for 7.8% of patients undergoing decompression and 13.0% having a complex fusion (adjusted OR, 1.94; 95% CI, 1.74-2.17). Adjusted mean hospital charges for complex fusion procedures were US $80 888 compared with US $23 724 for decompression alone. Conclusions Among Medicare recipients, between 2002 and 2007, the frequency of complex fusion procedures for spinal stenosis increased while the frequency of decompression surgery and simple fusions decreased. In 2007, compared with decompression, simple fusion and complex fusion were associated with increased risk of major complications, 30-day mortality, and resource use. JAMA. 2010; 303(13): 1259-1265	[Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97239 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA; [Deyo, Richard A.] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Mirza, Sohail K.; Martin, Brook I.] Dartmouth Med Sch, Dept Orthopaed, Hanover, NH USA; [Kreuter, William] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Jarvik, Jeffrey G.] Univ Washington, Dept Radiol & Neurol Surg, Seattle, WA 98195 USA; [Goodman, David C.] Dartmouth Inst Hlth Policy & Clin Practice, Ctr Hlth Policy Res, Lebanon, NH USA	Oregon Health & Science University; Oregon Health & Science University; Kaiser Permanente; Dartmouth College; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Dartmouth College	Deyo, RA (corresponding author), Oregon Hlth & Sci Univ, Dept Family Med, Mail Code FM,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	deyor@ohsu.edu	Goodman, David/AAG-7497-2020; Martin, Brook/L-4698-2019; Jarvik, Jeffrey/AAL-4292-2021		National Institute of Arthritis, Musculoskeletal and Skin Diseases [1R01AR054912-01A2]; National Institute on Aging [1RC1AG036268-01]; National Center for Research Resources [1UL1RR024140-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC1AG036268, P01AG019783] Funding Source: NIH RePORTER	National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding/Support: This study was supported in part by grants 1R01AR054912-01A2 from the National Institute of Arthritis, Musculoskeletal and Skin Diseases; 1RC1AG036268-01 from the National Institute on Aging; and 1UL1RR024140-01 from the National Center for Research Resources.	Abdu WA, 2009, SPINE, V34, P2351, DOI 10.1097/BRS.0b013e3181b8a829; BJARKE CF, 2002, SPINE, V27, P1269; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Carreon LY, 2003, J BONE JOINT SURG AM, V85A, P2089, DOI 10.2106/00004623-200311000-00004; CHERKIN DC, 1993, SPINE, V18, P1728, DOI 10.1097/00007632-199310000-00003; Chou R, 2005, ANN INTERN MED, V142, P1090, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00009; Ciol MA, 1996, J AM GERIATR SOC, V44, P285, DOI 10.1111/j.1532-5415.1996.tb00915.x; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; DEYO RA, 1993, SPINE, V18, P1463; Deyo RA, 2004, NEW ENGL J MED, V350, P722, DOI 10.1056/NEJMsb031771; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Deyo RA, 2006, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000198726.62514.75; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; ESSES SI, 1993, SPINE, V18, P2231, DOI 10.1097/00007632-199311000-00015; Fischgrund JS, 1997, SPINE, V22, P2807, DOI 10.1097/00007632-199712150-00003; Fritzell P, 2001, SPINE, V26, P2521, DOI 10.1097/00007632-200112010-00002; Fritzell P, 2003, EUR SPINE J, V12, P178, DOI 10.1007/s00586-002-0493-8; Glassman SD, 2007, SPINE J, V7, P547, DOI 10.1016/j.spinee.2006.11.003; Glick H, 2007, EC EVALUATION CLIN T; GROB D, 1995, J BONE JOINT SURG AM, V77A, P1036, DOI 10.2106/00004623-199507000-00009; HERKOWITZ HN, 1991, J BONE JOINT SURG AM, V73A, P802, DOI 10.2106/00004623-199173060-00002; Irwin ZN, 2005, SPINE, V30, P2208, DOI 10.1097/01.brs.0000181057.60012.08; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Katz JN, 1997, SPINE, V22, P1123, DOI 10.1097/00007632-199705150-00012; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Malmivaara A, 2007, SPINE, V32, P1, DOI 10.1097/01.brs.0000251014.81875.6d; Mirza SK, 2008, SPINE, V33, P2651, DOI 10.1097/BRS.0b013e31818dad07; Moller H, 2000, SPINE, V25, P1716, DOI 10.1097/00007632-200007010-00017; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Schermerhorn ML, 2008, NEW ENGL J MED, V358, P464, DOI 10.1056/NEJMoa0707348; TAYLOR VM, 1994, SPINE, V19, P1207, DOI 10.1097/00007632-199405310-00002; Thomsen K, 1997, SPINE, V22, P2813, DOI 10.1097/00007632-199712150-00004; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136; Weinstein JN, 2006, SPINE, V31, P2707, DOI 10.1097/01.brs.0000248132.15231.fe	35	933	972	3	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1259	1265		10.1001/jama.2010.338	http://dx.doi.org/10.1001/jama.2010.338			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579FM	20371784	Green Accepted, Bronze			2022-12-24	WOS:000276353700025
J	Liu, JG				Liu, Jianguo			China's Road to Sustainability	SCIENCE			English	Editorial Material									Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48823 USA	Michigan State University	Liu, JG (corresponding author), Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48823 USA.	jliu@panda.msu.edu	Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087				*CAEP, 2006, CHIN GREEN NAT ACC S; Cao SX, 2008, ENVIRON SCI TECHNOL, V42, P1826, DOI 10.1021/es0870597; *CHIN POP DEV RES, 2010, 1949 1998 TOT POP CH; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; *MEP, 2009, B NAT ENV STAT 2008; National Development and Reform Commission, 2019, CHIN NAT CLIM CHANG; PAN Y, 2007, THOUGHTS CHINAS ENV; Shapiro Judith, 2001, MAOS WAR NATURE; TANG Q, 2009, J HUNAN ADM I, P9; *XINH NEWS AG, CHIN ANN TARG CARB E; Zhao J, 2007, LANDSCAPE RES, V32, P171, DOI 10.1080/01426390701231564; 2005 ENV SUSTAINABIL	15	116	126	3	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	2010	328	5974					50	50		10.1126/science.1186234	http://dx.doi.org/10.1126/science.1186234			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	577DR	20360095				2022-12-24	WOS:000276202200026
J	Zenewicz, LA; Abraham, C; Flavell, RA; Cho, JH				Zenewicz, Lauren A.; Abraham, Clara; Flavell, Richard A.; Cho, Judy H.			Unraveling the Genetics of Autoimmunity	CELL			English	Article							GENOME-WIDE ASSOCIATION; LYMPHOID TYROSINE PHOSPHATASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; RISK LOCUS; SUSCEPTIBILITY LOCI; VARIANTS; DISEASE; REGION	The chronic autoimmune diseases include multiple complex genetic disorders. Recently, genome-wide association studies (GWAS) have identified a large number of major loci, with many associations shared between various autoimmune diseases. These associations highlight key roles for lymphocyte activation and prioritize specific cytokine pathways and mechanisms of host-microbe recognition. Despite success in identifying loci, comprehensive models of disease pathogenesis are currently lacking. Future efforts comparing association patterns between autoimmune diseases may be particularly illustrative. New genomic technologies applied to classic genetic studies involving twins, early onset cases, and phenotypic extremes may provide key insights into developmental and gene-environment interactions in autoimmunity.	[Abraham, Clara; Cho, Judy H.] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Zenewicz, Lauren A.; Flavell, Richard A.] Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA; [Cho, Judy H.] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Cho, JH (corresponding author), Yale Univ, Dept Med, New Haven, CT 06520 USA.	judy.cho@yale.edu		Zenewicz, Lauren/0000-0002-8787-5955	National Institutes of Health [DK P30-34989, U19AI082713, R01DK077905, R01DK077903, U01 DK62429, U01 DK062422, UL1 RR024139, RCDK086800]; Bohmfalk Funds for Medical Research; Crohn's and Colitis Foundation of America; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077903, P30DK034989, R01DK077905, U01DK062422, RC1DK086800, U01DK062429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bohmfalk Funds for Medical Research; Crohn's and Colitis Foundation of America; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health: DK P30-34989 (J.H.C. and C.A.), U19AI082713 (J.H.C. and C.A.), R01DK077905 (C.A.), R01DK077903, U01 DK62429, U01 DK062422, UL1 RR024139, RCDK086800 (J.H.C.); the Bohmfalk Funds for Medical Research (J.H.C.); and the Crohn's and Colitis Foundation of America (J.H.C. and C.A.).	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Broadley SA, 2000, BRAIN, V123, P1102, DOI 10.1093/brain/123.6.1102; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Festen EAM, 2009, GUT, V58, P799, DOI 10.1136/gut.2008.166918; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Lin JP, 1998, HUM GENET, V103, P475, DOI 10.1007/s004390050853; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; ROSENTHAL M, 2009, NAT IMMUNOL, V10, P1000; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JCI33194, 10.1172/JC133194]; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zenewicz LA, 2008, EUR J IMMUNOL, V38, P3265, DOI 10.1002/eji.200838655; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhernakova A, 2007, AM J HUM GENET, V81, P1284, DOI 10.1086/522037	59	97	101	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6					791	797		10.1016/j.cell.2010.03.003	http://dx.doi.org/10.1016/j.cell.2010.03.003			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303870	Green Accepted, Bronze			2022-12-24	WOS:000275746600004
J	Manning, KD				Manning, Kimberly D.			Do Something	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												kdmanni@emory.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1018	1018		10.1001/jama.2010.82	http://dx.doi.org/10.1001/jama.2010.82			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233812				2022-12-24	WOS:000275594100001
J	Sasaki, J; Kofuji, S; Itoh, R; Momiyama, T; Takayama, K; Murakami, H; Chida, S; Tsuya, Y; Takasuga, S; Eguchi, S; Asanuma, K; Horie, Y; Miura, K; Davies, EM; Mitchell, C; Yamazaki, M; Hirai, H; Takenawa, T; Suzuki, A; Sasaki, T				Sasaki, Junko; Kofuji, Satoshi; Itoh, Reietsu; Momiyama, Toshihiko; Takayama, Kiyohiko; Murakami, Haruka; Chida, Shinsuke; Tsuya, Yuko; Takasuga, Shunsuke; Eguchi, Satoshi; Asanuma, Ken; Horie, Yasuo; Miura, Kouichi; Davies, Elizabeth Michele; Mitchell, Christina; Yamazaki, Masakazu; Hirai, Hirokazu; Takenawa, Tadaomi; Suzuki, Akira; Sasaki, Takehiko			The PtdIns(3,4)P-2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death	NATURE			English	Article							INOSITOL POLYPHOSPHATE 4-PHOSPHATASE; HUNTINGTONS-DISEASE; LENTIVIRAL VECTORS; NMDA RECEPTORS; PURKINJE-CELL; IN-VIVO; SYSTEM; PTEN; MICE; PHOSPHOINOSITIDES	Phosphorylated derivatives of phosphatidylinositol, collectively referred to as phosphoinositides, occur in the cytoplasmic leaflet of cellular membranes and regulate activities such as vesicle transport, cytoskeletal reorganization and signal transduction(1,2). Recent studies have indicated an important role for phosphoinositide metabolism in the aetiology of diseases such as cancer, diabetes, myopathy and inflammation(3-5). Although the biological functions of the phosphatases that regulate phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P-3)have been well characterized, little is known about the functions of the phosphatases regulating the closely related molecule phosphatidylinositol-3,4-bisphosphate (PtdIns(3,4)P-2). Here we show that inositol polyphosphate phosphatase 4A (INPP4A), a PtdIns(3,4)P2 phosphatase, is a suppressor of glutamate excitotoxicity in the central nervous system. Targeted disruption of the Inpp4a gene in mice leads to neurodegeneration in the striatum, the input nucleus of the basal ganglia that has a central role inmotor and cognitive behaviours. Notably, Inpp4a(-/-) mice show severe involuntary movement disorders. In vitro, Inpp4a gene silencing via short hairpin RNA renders cultured primary striatal neurons vulnerable to cell death mediated by N-methyl-D-aspartatetype glutamate receptors (NMDARs). Mechanistically, INPP4A is found at the postsynaptic density and regulates synaptic NMDAR localization and NMDAR-mediated excitatory postsynaptic current. Thus, INPP4A protects neurons from excitotoxic cell death and thereby maintains the functional integrity of the brain. Our study demonstrates that PtdIns(3,4)P-2, PtdIns(3,4,5)P-3 and the phosphatases acting on them can have distinct regulatory roles, and provides insight into the unique aspects and physiological significance of PtdIns(3,4)P-2 metabolism. INPP4A represents, to our knowledge, the first signalling protein with a function in neurons to suppress excitotoxic cell death. The discovery of a direct link between PtdIns(3,4)P-2 metabolism and the regulation of neurodegeneration and involuntary movements may aid the development of new approaches for the treatment of neurodegenerative disorders.	[Sasaki, Junko; Kofuji, Satoshi; Itoh, Reietsu; Murakami, Haruka; Chida, Shinsuke; Tsuya, Yuko; Takasuga, Shunsuke; Eguchi, Satoshi; Asanuma, Ken; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Dept Med Biol, Akita 0108543, Japan; [Sasaki, Junko; Kofuji, Satoshi; Itoh, Reietsu; Takayama, Kiyohiko; Murakami, Haruka; Chida, Shinsuke; Tsuya, Yuko; Takasuga, Shunsuke; Eguchi, Satoshi; Asanuma, Ken; Yamazaki, Masakazu; Hirai, Hirokazu; Suzuki, Akira; Sasaki, Takehiko] Gunma Univ, Global COE Program, Gunma 3718511, Japan; [Sasaki, Junko; Kofuji, Satoshi; Itoh, Reietsu; Takayama, Kiyohiko; Murakami, Haruka; Chida, Shinsuke; Tsuya, Yuko; Takasuga, Shunsuke; Eguchi, Satoshi; Asanuma, Ken; Yamazaki, Masakazu; Hirai, Hirokazu; Suzuki, Akira; Sasaki, Takehiko] Akita Univ, Gunma 3718511, Japan; [Momiyama, Toshihiko] Jikei Univ, Sch Med, Dept Pharmacol, Tokyo 1058461, Japan; [Takayama, Kiyohiko; Hirai, Hirokazu] Gunma Univ, Dept Neurophysiol, Grad Sch Med, Gunma 3718511, Japan; [Horie, Yasuo; Miura, Kouichi] Akita Univ, Grad Sch Med, Dept Gastroenterol & Neurol, Akita 0108543, Japan; [Davies, Elizabeth Michele; Mitchell, Christina] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Takenawa, Tadaomi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Lipid Biochem, Kobe, Hyogo 6500017, Japan; [Takenawa, Tadaomi] Kobe Univ, Grad Sch Med, Global COE Program, Kobe, Hyogo 6500017, Japan; [Suzuki, Akira] Kyushu Univ, Med Inst Bioregulat, Div Embryon & Genet Engn, Fukuoka 8128582, Japan	Akita University; Gunma University; Akita University; Jikei University; Gunma University; Akita University; Monash University; Kobe University; Kobe University; Kyushu University	Sasaki, J (corresponding author), Akita Univ, Grad Sch Med, Dept Med Biol, Akita 0108543, Japan.	sasakij@med.akita-u.ac.jp; tsasaki@med.akita-u.ac.jp	Suzuki, Akira/GYD-6697-2022; Hirai, Hirokazu/ABP-1143-2022	Suzuki, Akira/0000-0002-5950-8808; Mitchell, Christina A/0000-0001-9372-3192; Hirai, Hirokazu/0000-0002-0721-4293; Sasaki, Takehiko/0000-0003-1837-3748	Ministry of Education, Culture, Sports and Technology of Japan (MEXT); Japan Society for the Promotion of Science (JSPS); Japan Science and Technology Corporation (JST); Naito Foundation; Toray Science Foundation; MEXT	Ministry of Education, Culture, Sports and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)); Naito Foundation(Naito Memorial Foundation); Toray Science Foundation(Toray Industries, Inc.); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank R. Shigemoto, T. Iwatsubo, I. Kanazawa, T. Shimizu, H. Ichijo, K. Yamada, Y. Imai, K. Kawamura, Y. Kanaho and T. Itoh for discussions; and H. Takahashi, K. Sasaki, Y. Sugihara, S. Kumagai, A. Kato, C. Horie, M. Nishio, S. Sato, T. Sugawara, R. Nakamura and K. Mizoi for technical support. Anti-Met-enkephalin antibody was provided by T. Kaneko and T. Furuta, and anti-NR2C antibody was provided by B. S. Chen and W. Roche. This work was supported by research grants from the Ministry of Education, Culture, Sports and Technology of Japan (MEXT); the Japan Society for the Promotion of Science (JSPS); the Japan Science and Technology Corporation (JST); the Naito Foundation; and the Toray Science Foundation. H. H., T. T., A. S. and T. S. are supported by the Global Centers of Excellence Program of MEXT. T. T. and T. S. are supported by a Grant-in-Aid for Creative Scientific Research from MEXT.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen BS, 2009, NEURON, V62, P471, DOI 10.1016/j.neuron.2009.04.015; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Furuta T, 2002, NEUROSCIENCE, V114, P611, DOI 10.1016/S0306-4522(02)00312-3; Gantois I, 2007, P NATL ACAD SCI USA, V104, P4182, DOI 10.1073/pnas.0611625104; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; Inagaki S, 2001, J BIOL CHEM, V276, P9174, DOI 10.1074/jbc.M009051200; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Lipton Stuart A., 2005, Current Alzheimer Research, V2, P155, DOI 10.2174/1567205053585846; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; NORRIS FA, 1995, J BIOL CHEM, V270, P16128, DOI 10.1074/jbc.270.27.16128; Nystuen A, 2001, NEURON, V32, P203, DOI 10.1016/S0896-6273(01)00468-8; Oda M, 2007, STROKE, V38, P2157, DOI 10.1161/STROKEAHA.106.477026; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sanchez AME, 2008, ARCH MED RES, V39, P265, DOI 10.1016/j.arcmed.2007.11.011; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; SASAKI T, 2009, J LIPID RES, V48, P307; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Suzuki A, 2008, CANCER SCI, V99, P209, DOI 10.1111/j.1349-7006.2007.00670.x; Takayama K, 2008, NEUROSCI LETT, V443, P7, DOI 10.1016/j.neulet.2008.07.058; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Torashima T, 2006, BRAIN RES, V1082, P11, DOI 10.1016/j.brainres.2006.01.104; Torashima T, 2006, EUR J NEUROSCI, V24, P371, DOI 10.1111/j.1460-9568.2006.04927.x; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wolf JA, 2005, J NEUROSCI, V25, P9080, DOI 10.1523/JNEUROSCI.2220-05.2005; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yamazaki M, 2002, J BIOL CHEM, V277, P17226, DOI 10.1074/jbc.M109795200; Zhang S, 2008, J NEUROSCI, V28, P415, DOI 10.1523/JNEUROSCI.1900-07.2008	40	73	76	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					497	U127		10.1038/nature09023	http://dx.doi.org/10.1038/nature09023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20463662				2022-12-24	WOS:000278043700039
J	Wohri, AB; Katona, G; Johansson, LC; Fritz, E; Malmerberg, E; Andersson, M; Vincent, J; Eklund, M; Cammarata, M; Wulff, M; Davidsson, J; Groenhof, G; Neutze, R				Wohri, Annemarie B.; Katona, Gergely; Johansson, Linda C.; Fritz, Emelie; Malmerberg, Erik; Andersson, Magnus; Vincent, Jonathan; Eklund, Mattias; Cammarata, Marco; Wulff, Michael; Davidsson, Jan; Groenhof, Gerrit; Neutze, Richard			Light-Induced Structural Changes in a Photosynthetic Reaction Center Caught by Laue Diffraction	SCIENCE			English	Article							TIME-RESOLVED CRYSTALLOGRAPHY; VIRIDIS REACTION CENTERS; RHODOPSEUDOMONAS-VIRIDIS; RHODOBACTER-SPHAEROIDES; ELECTRON-TRANSFER; SPECIAL PAIR; PROTEIN; CYTOCHROME; SPECTROSCOPY; TEMPERATURE		[Katona, Gergely; Johansson, Linda C.; Fritz, Emelie; Malmerberg, Erik; Neutze, Richard] Univ Gothenburg, Dept Chem Biochem & Biophys, SE-40530 Gothenburg, Sweden; [Wohri, Annemarie B.; Andersson, Magnus] Chalmers, Dept Biol & Chem Engn, SE-40530 Gothenburg, Sweden; [Vincent, Jonathan; Eklund, Mattias; Davidsson, Jan] Uppsala Univ, Dept Photochem & Mol Sci, SE-75120 Uppsala, Sweden; [Cammarata, Marco; Wulff, Michael] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Groenhof, Gerrit] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, Computat Biomol Chem Grp, D-37077 Gottingen, Germany	University of Gothenburg; Chalmers University of Technology; Uppsala University; European Synchrotron Radiation Facility (ESRF); Max Planck Society	Neutze, R (corresponding author), Univ Gothenburg, Dept Chem Biochem & Biophys, Box 462, SE-40530 Gothenburg, Sweden.	Richard.Neutze@chem.gu.se	Johansson, Linda/B-1240-2011; Neutze, Richard/A-7573-2010; Cammarata, Marco/C-2322-2008; Katona, Gergely/B-3491-2008; Malmerberg, Erik/A-1114-2010; Johansson, Linda/O-6893-2019; Vincent, Jonathan/HHY-9994-2022	Johansson, Linda/0000-0003-4776-5142; Neutze, Richard/0000-0003-0986-6153; Cammarata, Marco/0000-0003-3013-1186; Katona, Gergely/0000-0002-2031-8716; Johansson, Linda/0000-0003-4776-5142; Johansson, Linda/0000-0002-8931-0683; Groenhof, Gerrit/0000-0001-8148-5334; Andersson, Magnus/0000-0002-3364-6647	Swedish Science Research Council; European Commission; European Molecular Biology Organization (EMBO); Human Frontier Science Program (HFSP); University of Gothenburg	Swedish Science Research Council; European Commission(European CommissionEuropean Commission Joint Research Centre); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); University of Gothenburg	Refined crystallographic coordinates and structure factor amplitudes are deposited within the Protein Data Bank (PDB) with codes 2x5u (dark state) and 2x5v (photoactivated state). We thank L. Hammarstrom for valuable discussions and acknowledge financial support from the Swedish Science Research Council (Vetenskapsradet), European Commission [Research Training Network (RTN) "Fast light-actuated structural changes" (FLASH), and Integrated Project, the European Membrane Protein Consortium (EMEP)], European Molecular Biology Organization (EMBO), Human Frontier Science Program (HFSP), and the University of Gothenburg Quantitative Biology Platform.	Allen JF, 2007, NATURE, V445, P610, DOI 10.1038/445610a; Andresson U, 2003, PHOTOSYNTH RES, V75, P223, DOI 10.1023/A:1023944605460; BARRY BA, 1987, P NATL ACAD SCI USA, V84, P7099, DOI 10.1073/pnas.84.20.7099; Baxter RHG, 2004, P NATL ACAD SCI USA, V101, P5982, DOI 10.1073/pnas.0306840101; BUCHANAN S, 1992, BIOCHEMISTRY-US, V31, P1314, DOI 10.1021/bi00120a006; CARTLING B, 1992, CHEM PHYS LETT, V196, P128, DOI 10.1016/0009-2614(92)85941-3; DEBUS RJ, 1988, BIOCHEMISTRY-US, V27, P9071, DOI 10.1021/bi00426a001; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; DOHSE B, 1995, BIOCHEMISTRY-US, V34, P11335, DOI 10.1021/bi00036a006; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Genick UK, 1997, SCIENCE, V275, P1471, DOI 10.1126/science.275.5305.1471; Gong XM, 2003, BIOCHEMISTRY-US, V42, P14492, DOI 10.1021/bi035603c; Hammarstrom L, 2008, PHILOS T R SOC B, V363, P1283, DOI 10.1098/rstb.2007.2225; Katona G, 2005, NAT STRUCT MOL BIOL, V12, P630, DOI 10.1038/nsmb948; LEONHARD M, 1993, BIOCHEMISTRY-US, V32, P4532, DOI 10.1021/bi00068a007; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; McMahon BH, 1998, BIOPHYS J, V74, P2567, DOI 10.1016/S0006-3495(98)77964-0; Narvaez AJ, 2004, BIOCHEMISTRY-US, V43, P14379, DOI 10.1021/bi048691p; Ohtsuka Y, 2001, J COMPUT CHEM, V22, P521, DOI 10.1002/1096-987X(20010415)22:5<521::AID-JCC1023>3.0.CO;2-J; Ortega JM, 1998, BIOPHYS J, V74, P1135, DOI 10.1016/S0006-3495(98)77831-2; PERMAN B, 1946, SCIENCE, V279, P1998; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; SEBBAN P, 1989, BIOCHIM BIOPHYS ACTA, V974, P54, DOI 10.1016/S0005-2728(89)80165-3; Srajer V, 1996, SCIENCE, V274, P1726, DOI 10.1126/science.274.5293.1726; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; van Mourik F, 2001, BBA-BIOENERGETICS, V1504, P311, DOI 10.1016/S0005-2728(00)00259-0; WACHTVEITL J, 1993, BIOCHEMISTRY-US, V32, P10894, DOI 10.1021/bi00091a045; Wohri AB, 2009, BIOCHEMISTRY-US, V48, P9831, DOI 10.1021/bi900545e	28	76	77	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					630	633		10.1126/science.1186159	http://dx.doi.org/10.1126/science.1186159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431017	Green Published			2022-12-24	WOS:000277159800046
J	Castera, L; Pinzani, M				Castera, Laurent; Pinzani, Massimo			Non-invasive assessment of liver fibrosis: are we ready?	LANCET			English	Editorial Material							CHRONIC HEPATITIS-C; TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; GENERAL-POPULATION; FIBROTEST; CIRRHOSIS		[Castera, Laurent] Ctr Hosp Univ Bordeaux, Hop Haut Leveque, Serv Hepatogastroenterol, F-33604 Bordeaux, France; [Castera, Laurent] Ctr Hosp Univ Bordeaux, Hop St Andre, F-33604 Bordeaux, France; [Pinzani, Massimo] Univ Florence, Dipartimento Med Interna, Florence, Italy; [Pinzani, Massimo] Univ Florence, Ctr Res High Educ & Transfer DENOThe, Florence, Italy	CHU Bordeaux; CHU Bordeaux; University of Florence; University of Florence	Castera, L (corresponding author), Ctr Hosp Univ Bordeaux, Hop Haut Leveque, Serv Hepatogastroenterol, F-33604 Bordeaux, France.	laurent.castera@chu-bordeaux.fr		Castera, laurent/0000-0002-6715-8588				Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Hezode C, 2009, J HEPATOL, V50, pS226, DOI 10.1016/S0168-8278(09)60617-6; Pinzani M, 2008, NAT CLIN PRACT GASTR, V5, P95, DOI 10.1038/ncpgasthep1025; Poynard T, 2009, J HEPATOL, V50, pS369, DOI 10.1016/S0168-8278(09)61023-0; Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40; Roulot D, 2009, J HEPATOL, V50, pS89, DOI 10.1016/S0168-8278(09)60221-X; Shaheen AAM, 2007, HEPATOLOGY, V46, P912, DOI 10.1002/hep.21835; Vizzutti F, 2007, HEPATOLOGY, V45, P1290, DOI 10.1002/hep.21665; *WHO, MORT DAT 2006, P92502	12	90	95	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 24	2010	375	9724					1419	1420		10.1016/S0140-6736(09)62195-4	http://dx.doi.org/10.1016/S0140-6736(09)62195-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590FL	20417845				2022-12-24	WOS:000277210000010
J	Benson, RBJ; Barrett, PM; Rich, TH; Vickers-Rich, P				Benson, Roger B. J.; Barrett, Paul M.; Rich, Tom H.; Vickers-Rich, Pat			A Southern Tyrant Reptile	SCIENCE			English	Article							DINOSAUR		[Benson, Roger B. J.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Barrett, Paul M.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Rich, Tom H.; Vickers-Rich, Pat] Museum Victoria, Dept Paleontol, Melbourne, Vic 3000, Australia; [Rich, Tom H.; Vickers-Rich, Pat] Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia	University of Cambridge; Natural History Museum London; Museum Victoria; Monash University	Benson, RBJ (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	rbb27@cam.ac.uk	Barrett, Paul M/A-2648-2010; Benson, Roger/A-1252-2011	Barrett, Paul M/0000-0003-0412-3000; Benson, Roger/0000-0001-8244-6177				Norell Mark A., 1997, American Museum Novitates, V3215, P1; Rauhut OWM, 2010, ZOOL J LINN SOC-LOND, V158, P155, DOI 10.1111/j.1096-3642.2009.00591.x; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Sereno PC, 2009, SCIENCE, V326, P418, DOI 10.1126/science.1177428; WAGSTAFF BE, 1989, NATL GEOGR RES, V5, P54; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511	6	39	44	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1613	1613		10.1126/science.1187456	http://dx.doi.org/10.1126/science.1187456			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339066				2022-12-24	WOS:000275970600034
J	Stenestrand, U; Wijkman, M; Fredrikson, M; Nystrom, FH				Stenestrand, Ulf; Wijkman, Magnus; Fredrikson, Mats; Nystrom, Fredrik H.			Association Between Admission Supine Systolic Blood Pressure and 1-Year Mortality in Patients Admitted to the Intensive Care Unit for Acute Chest Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOCARDIAL-INFARCTION; HEART-FAILURE; RISK-FACTORS; HYPERTENSION; DISEASE; POPULATION; OUTCOMES	Context High resting blood pressure (BP) is among the best studied and established risk factors for cardiovascular disease. However, little is known about the relationship between BP under acute stress, such as in acute chest pain, and subsequent mortality. Objective To study long-term mortality related to supine BP in patients admitted to the medical intensive care unit (ICU) for acute chest pain. Design, Setting, and Participants Data from the RIKS-HIA (Registry of Information and Knowledge About Swedish Heart Intensive Care Admissions) was used to analyze the mortality in relation to supine admission systolic BP in 119 151 participants who were treated at the ICU for the symptom of chest pain from 1997 through 2007. Results from this prospective cohort study were presented according to systolic BP quartiles: Q1, less than 128 mm Hg; Q2, from 128 to 144 mm Hg; Q3, from 145 to 162 mm Hg; and Q4, at or above 163 mm Hg. Main Outcome Measure Total mortality. Results Mean (SD) follow-up time was 2.47 (1.5) years (range, 1-10 years). One-year mortality rate by Cox proportional hazard model (adjusted for age, sex, smoking, diastolic BP, use of antihypertensive medication at admission and discharge, and use of lipid-lowering and antiplatelet medication at discharge) showed that participants in Q4 had the best prognosis (hazard ratio [HR], 0.76; 95% confidence interval [CI], 0.72-0.80, Q4 compared with Q2; corresponding risks for Q1 were HR, 1.46; 95% CI, 1.39-1.52, and for Q3, HR, 0.83; 95% CI, 0.79-0.87). Patients in Q4 had a 21.7% lower absolute risk compared with Q2, patients in Q3 had a 15.2% lower risk than in Q2, and patients in Q1 had a 40.3% higher risk for mortality than in Q2. The worse prognosis in Q2 compared with Q4 was independent of body mass index and previous diagnoses and similar when analysis was restricted to patients with a final diagnosis of angina or myocardial infarction (HR, 0.75; 95% CI, 0.71-0.80, Q4 compared with Q2). Conclusion Among patients admitted to the ICU for chest pain, there is an inverse association between admission supine systolic BP and 1-year mortality rate. JAMA. 2010; 303(12): 1167-1172	[Stenestrand, Ulf; Wijkman, Magnus; Nystrom, Fredrik H.] Linkoping Univ, Dept Med & Hlth Sci, Fac Hlth Sci, SE-58185 Linkoping, Sweden; [Wijkman, Magnus; Nystrom, Fredrik H.] Linkoping Univ, Diabet Res Ctr, Fac Hlth Sci, SE-58185 Linkoping, Sweden; [Fredrikson, Mats] Linkoping Univ, Dept Clin & Expt Med, Fac Hlth Sci, SE-58185 Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University	Nystrom, FH (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Fac Hlth Sci, SE-58185 Linkoping, Sweden.	fredrik.nystrom@lio.se		Nystrom, Fredrik/0000-0002-1680-1000				Amar J, 2002, HEART, V88, P587, DOI 10.1136/heart.88.6.587; Boggia J, 2007, LANCET, V370, P1219, DOI 10.1016/S0140-6736(07)61538-4; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; FOLKOW B, 1982, PHYSIOL REV, V62, P347, DOI 10.1152/physrev.1982.62.2.347; Franklin SS, 2001, CIRCULATION, V103, P1245; Franklin SS, 1997, CIRCULATION, V96, P308; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Mundal R, 1996, HYPERTENSION, V27, P324, DOI 10.1161/01.HYP.27.3.324; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Staessen JA, 2003, LANCET, V361, P1629, DOI 10.1016/S0140-6736(03)13302-8; Stenestrand U, 2006, JAMA-J AM MED ASSOC, V296, P1749, DOI 10.1001/jama.296.14.1749; Tabrizi F, 2007, EUR HEART J, V28, P2449, DOI 10.1093/eurheartj/ehm262; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	16	28	31	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2010	303	12					1167	1172		10.1001/jama.2010.314	http://dx.doi.org/10.1001/jama.2010.314			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573AC	20332402				2022-12-24	WOS:000275879600021
J	Bawa, KS; Koh, LP; Lee, TM; Liu, JG; Ramakrishnan, PS; Yu, DW; Zhang, YP; Raven, PH				Bawa, Kamaljit S.; Koh, Lian Pin; Lee, Tien Ming; Liu, Jianguo; Ramakrishnan, P. S.; Yu, Douglas W.; Zhang, Ya-ping; Raven, Peter H.			China, India, and the Environment	SCIENCE			English	Editorial Material							BIODIVERSITY; CLIMATE; WATER		[Raven, Peter H.] Missouri Bot Garden, St Louis, MO 63166 USA; [Bawa, Kamaljit S.] Univ Massachusetts, Boston, MA 02125 USA; [Bawa, Kamaljit S.] Harvard Univ, Sustainabil Sci Program, Cambridge, MA 02138 USA; [Bawa, Kamaljit S.] Ashoka Trust Res Ecol & Environm, Bangalore 560024, Karnataka, India; [Lee, Tien Ming] Univ Calif San Diego, La Jolla, CA 92093 USA; [Lee, Tien Ming] Yale Univ, New Haven, CT 06520 USA; [Liu, Jianguo] Michigan State Univ, E Lansing, MI 48824 USA; [Ramakrishnan, P. S.] Jawaharlal Nehru Univ, New Delhi 110067, India; [Yu, Douglas W.; Zhang, Ya-ping] Kunming Inst Zool, Yunnan 650223, Peoples R China; [Yu, Douglas W.] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Koh, Lian Pin] ETH, Inst Terr Ecosyst, CH-8092 Zurich, Switzerland	Missouri Botanical Gardens; University of Massachusetts System; University of Massachusetts Boston; Harvard University; University of California System; University of California San Diego; Yale University; Michigan State University; Jawaharlal Nehru University, New Delhi; Chinese Academy of Sciences; Kunming Institute of Zoology; University of East Anglia; Swiss Federal Institutes of Technology Domain; ETH Zurich	Raven, PH (corresponding author), Missouri Bot Garden, St Louis, MO 63166 USA.	peter.raven@mobot.org	Liu, Jianguo/G-5211-2015; Koh, Lian Pin/A-5794-2010; Yu, Douglas W./D-2536-2009	Liu, Jianguo/0000-0001-6344-0087; Koh, Lian Pin/0000-0001-8152-3871; Yu, Douglas W./0000-0001-8551-5609; Bawa, Kamal/0000-0001-6174-9777				Ali S. H, 2007, PEACE PARKS CONSERVA; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Bawa KS, 2007, AGR ECOSYST ENVIRON, V121, P287, DOI 10.1016/j.agee.2006.12.023; Briscoe J., 2006, INDIAS WATER EC BRAC; HAND E, 2010, NATURE, V463, P282; Johnson Todd M., 1997, CLEAR WATER BLUE SKI; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; MOORE M, 2008, TELEGRAPH       1014; Pomeranz K, 2009, NEW LEFT REV, P5; VANGELDER JW, 2008, NEW TRENDS FINANCING; World Bank, 2010, GLOB EC PROSP 2010 C; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x; 2009, EC TIMES        1021; 2003, NATL NATURAL SCI FDN; CONFUCIUS I	16	72	75	6	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1457	1459		10.1126/science.1185164	http://dx.doi.org/10.1126/science.1185164			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	570YQ	20299578				2022-12-24	WOS:000275715200029
J	Jensen, LMR; Sanishvili, R; Davidson, VL; Wilmot, CM				Jensen, Lyndal M. R.; Sanishvili, Ruslan; Davidson, Victor L.; Wilmot, Carrie M.			In Crystallo Posttranslational Modification Within a MauG/Pre-Methylamine Dehydrogenase Complex	SCIENCE			English	Article							TRYPTOPHAN TRYPTOPHYLQUINONE; OXYGEN ACTIVATION; COFACTOR; MECHANISM	MauG is a diheme enzyme responsible for the posttranslational modification of two tryptophan residues to form the tryptophan tryptophylquinone (TTQ) cofactor of methylamine dehydrogenase (MADH). MauG converts preMADH, containing monohydroxylated beta Trp(57), to fully functional MADH by catalyzing the insertion of a second oxygen atom into the indole ring and covalently linking beta Trp(57) to beta Trp(108). We have solved the x-ray crystal structure of MauG complexed with preMADH to 2.1 angstroms. The c-type heme irons and the nascent TTQ site are separated by long distances over which electron transfer must occur to achieve catalysis. In addition, one of the hemes has an atypical His-Tyr axial ligation. The crystalline protein complex is catalytically competent; upon addition of hydrogen peroxide, MauG-dependent TTQ synthesis occurs.	[Jensen, Lyndal M. R.; Wilmot, Carrie M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Sanishvili, Ruslan] Argonne Natl Lab, Biosci Div, Collaborat Access Team, Gen Med Inst, Argonne, IL 60439 USA; [Sanishvili, Ruslan] Argonne Natl Lab, Biosci Div, Collaborat Access Team, Inst Canc, Argonne, IL 60439 USA; [Davidson, Victor L.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Mississippi; University of Mississippi Medical Center	Wilmot, CM (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	wilmo004@umn.edu		Davidson, Victor/0000-0002-1966-7302; Wilmot, Carrie/0000-0002-8706-0000	NIH [GM66569, GM41574]; Minnesota Partnership for Biotechnology and Medical Genomics [SPAP-05-0013-P-FY06]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066569, R01GM041574, R37GM041574] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Partnership for Biotechnology and Medical Genomics; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants GM66569 (C. M. W.) and GM41574 (V. L. D.) and Minnesota Partnership for Biotechnology and Medical Genomics grant SPAP-05-0013-P-FY06. Computer resources were provided by the Basic Sciences Computing Laboratory of the University of Minnesota Supercomputing Institute, and we thank C. Ergenekan for his support. X-ray data were collected at the Kahlert Structural Biology Laboratory (KSBL) at the University of Minnesota and GM/CA-CAT at the Advanced Photon Source (APS), Argonne National Laboratory, Argonne, IL. GM/CA-CAT is funded by National Cancer Institute grant Y1-CO-1020 and National Institute of General Medical Sciences grant Y1-GM-1104. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract DE-AC02-06CH11357. We thank E. Hoeffner for KSBL support and the staff at Sector 23, APS, for their support, especially M. Becker, S. Corcoran, V. Nagarajan, and D. Yoder. We thank S. Shin for performing the experiment shown in fig. S4. Coordinates and structure factors have been deposited in the Protein Data Bank with acquisition codes 3L4M (MauG-preMADH complex) and 3L4O (MauG-preMADH complex treated with H<INF>2</INF>O<INF>2</INF>).	Chen LY, 1998, J MOL BIOL, V276, P131, DOI 10.1006/jmbi.1997.1511; Davidson VL, 2007, BIOCHEMISTRY-US, V46, P5283, DOI 10.1021/bi700468t; Davidson VL, 2001, ADV PROTEIN CHEM, V58, P95; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Fulop V, 2001, ADV INORG CHEM, V51, P163; Hersleth HP, 2006, J INORG BIOCHEM, V100, P460, DOI 10.1016/j.jinorgbio.2006.01.018; Kovaleva EG, 2007, ACCOUNTS CHEM RES, V40, P475, DOI 10.1021/ar700052v; Lee SY, 2009, BIOCHEMISTRY-US, V48, P2442, DOI 10.1021/bi802166c; Li XH, 2006, BIOCHEMISTRY-US, V45, P821, DOI 10.1021/bi052000n; Li XH, 2008, P NATL ACAD SCI USA, V105, P8597, DOI 10.1073/pnas.0801643105; Li XH, 2006, BIOCHEMISTRY-US, V45, P13276, DOI 10.1021/bi061497d; Makris TM, 2002, DRUG METAB REV, V34, P691, DOI 10.1081/DMR-120015691; MCINTIRE WS, 1991, SCIENCE, V252, P817, DOI 10.1126/science.2028257; Pearson AR, 2004, BIOCHEMISTRY-US, V43, P5494, DOI 10.1021/bi049863l; Pearson AR, 2006, J AM CHEM SOC, V128, P12416, DOI 10.1021/ja064466e; Pettigrew GW, 2006, J INORG BIOCHEM, V100, P551, DOI 10.1016/j.jinorgbio.2005.12.008; RAAG R, 1991, BIOCHEMISTRY-US, V30, P2674, DOI 10.1021/bi00224a016; Wang YT, 2005, J AM CHEM SOC, V127, P8258, DOI 10.1021/ja051734k; Wang YT, 2003, BIOCHEMISTRY-US, V42, P7318, DOI 10.1021/bi034243q	19	100	101	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1392	1394		10.1126/science.1182492	http://dx.doi.org/10.1126/science.1182492			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223990	Green Accepted			2022-12-24	WOS:000275418700045
J	Iezzoni, LI; Ronan, LJ				Iezzoni, Lisa I.; Ronan, Laurence J.			Disability Legacy of the Haitian Earthquake	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AMPUTATION		[Iezzoni, Lisa I.] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Iezzoni, LI (corresponding author), Massachusetts Gen Hosp, Mongan Inst Hlth Policy, 50 Staniford St,Room 901B, Boston, MA 02114 USA.	liezzoni@partners.org						Bigelow J, 2004, DISABIL REHABIL, V26, P246, DOI 10.1080/09638280310001644915; Collins Diane M., 2006, Critical Reviews in Biomedical Engineering, V34, P379, DOI 10.1615/CritRevBiomedEng.v34.i5.20; Cummings D, 1996, PROSTHET ORTHOT INT, V20, P51; Cummings Donald R, 2006, Phys Med Rehabil Clin N Am, V17, P15, DOI 10.1016/j.pmr.2005.10.002; Esquenazi A, 2004, DISABIL REHABIL, V26, P831, DOI 10.1080/09638280410001708850; Iezzoni LI, 2008, JAMA-J AM MED ASSOC, V299, P332, DOI 10.1001/jama.299.3.332; Kirschner KL, 2007, JAMA-J AM MED ASSOC, V297, P1121, DOI 10.1001/jama.297.10.1121; Sontag Deborah, 2010, NY TIMES, pA1; Sullivan SR, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1000976; *UN OFF COORD HUM, 2010, 25 UN OFF COORD HUM; United Nations Office for the Coordination of Humanitarian Affairs, 2010, 24 UN OFF COORD HUM; Ustun TB, 2003, HEALTH CARE FINANC R, V24, P77; *WHO, 2010, REV UN HUM AFF GLOB; WHO, 2001, WHO INT CLASS FUNCT	14	27	27	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12					812	814		10.7326/0003-4819-152-12-201006150-00234	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-00234			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611OP	20231547				2022-12-24	WOS:000278827700008
J	Oren-Suissa, M; Hall, DH; Treinin, M; Shemer, G; Podbilewicz, B				Oren-Suissa, Meital; Hall, David H.; Treinin, Millet; Shemer, Gidi; Podbilewicz, Benjamin			The Fusogen EFF-1 Controls Sculpting of Mechanosensory Dendrites	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; HOMOTYPIC FUSION; NERVOUS-SYSTEM; GENE; CELL; EXPRESSION; RECEPTORS; MEMBRANES; REQUIRES	The mechanisms controlling the formation and maintenance of neuronal trees are poorly understood. We examined the dynamic development of two arborized mechanoreceptor neurons (PVDs) required for reception of strong mechanical stimuli in Caenorhabditis elegans. The PVDs elaborated dendritic trees comprising structural units we call "menorahs." We studied how the number, structure, and function of menorahs were maintained. EFF-1, an essential protein mediating cell fusion, acted autonomously in the PVDs to trim developing menorahs. eff-1 mutants displayed hyperbranched, disorganized menorahs. Overexpression of EFF-1 in the PVD reduced branching. Neuronal pruning appeared to involve EFF-1-dependent branch retraction and neurite-neurite autofusion. Thus, EFF-1 activities may act as a quality control mechanism during the sculpting of dendritic trees.	[Oren-Suissa, Meital; Shemer, Gidi; Podbilewicz, Benjamin] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Hall, David H.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Ctr C Elegans Anat, New York, NY 10461 USA; [Treinin, Millet] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91120 Jerusalem, Israel	Technion Israel Institute of Technology; Yeshiva University; Hebrew University of Jerusalem	Shemer, G (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	bishemer@email.unc.edu; podbilew@tx.technion.ac.il	Oren-Suissa, Meital/GXG-0736-2022; Podbilewicz, Benjamin/N-4825-2014	Oren-Suissa, Meital/0000-0001-9937-8326; Podbilewicz, Benjamin/0000-0002-0411-4182	Israel Science Foundation (ISF) [1542/07, 493/01-16.6]; NIH [RR12596]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR012596] Funding Source: NIH RePORTER	Israel Science Foundation (ISF)(Israel Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank A. Fire for vectors; N. Assaf and T. Gattegno for eff-1 alleles; E. Shmukler for preliminary phenotypic characterization of the PVD in eff-1(hy21ts); T. Stiernagle and the CGC for nematode strains; J. White and J. Hodgkin for donation of the MRC/LMB archival prints to DHH; C. Crocker for TEM cartoon; and O. Avinoam, D. Cassel, M. Kozlov, A. Sapir, and I. Yanai for critically reading the manuscript. Supported by grants from the FIRST program of the Israel Science Foundation (ISF 1542/07 to B.P.), ISF 493/01-16.6 to M.T., and NIH RR12596 (WormImage Web site) to D.H.H.	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Chen JH, 1999, BRAIN RES, V846, P243, DOI 10.1016/S0006-8993(99)01883-1; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; Grueber WB, 2004, CURR OPIN NEUROBIOL, V14, P74, DOI 10.1016/j.conb.2004.01.001; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Mohler WA, 2002, DEV CELL, V2, P355, DOI 10.1016/S1534-5807(02)00129-6; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Sapir A, 2007, DEV CELL, V12, P683, DOI 10.1016/j.devcel.2007.03.003; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Tobin DM, 2004, J NEUROBIOL, V61, P161, DOI 10.1002/neu.20082; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	17	108	111	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2010	328	5983					1285	1288		10.1126/science.1189095	http://dx.doi.org/10.1126/science.1189095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20448153	Green Accepted			2022-12-24	WOS:000278318600037
J	Hartley, J; Harnden, A; Kelly, D				Hartley, Jane; Harnden, Anthony; Kelly, Deirdre			Easily Missed? Biliary atresia	BRITISH MEDICAL JOURNAL			English	Editorial Material							KASAI OPERATION; MANAGEMENT; JAUNDICE		[Hartley, Jane; Kelly, Deirdre] Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England; [Harnden, Anthony] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Birmingham; University of Oxford	Hartley, J (corresponding author), Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England.	Jane.Hartley@bch.nhs.uk						Crofts DJ, 1999, ACTA PAEDIATR, V88, P969, DOI 10.1080/08035259950168478; Davenport M, 2004, J PEDIATR SURG, V39, P575, DOI 10.1016/j.jpedsurg.2003.12.014; Davenport M, 2004, LANCET, V363, P1354, DOI 10.1016/S0140-6736(04)16045-5; Davenport M, 2006, J PEDIATR-US, V149, P393, DOI 10.1016/j.jpeds.2006.05.030; Hannam S, 2000, ACTA PAEDIATR, V89, P694, DOI 10.1080/080352500750044025; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; LAWRENCE M, 2001, J PERINATOLOGY, V21, pS25; Livesey E, 2009, ARCH DIS CHILD-FETAL, V94, pF451, DOI 10.1136/adc.2009.159780; McKiernan PJ, 2009, J PEDIATR GASTR NUTR, V48, P78, DOI 10.1097/MPG.0b013e31817d80de; National Institute for Health and Clinical Excellence, 2010, CLIN GUID NAT I HLTH, V98; Serinet MO, 2009, PEDIATRICS, V123, P1280, DOI 10.1542/peds.2008-1949; Shinkai M, 2009, J PEDIATR GASTR NUTR, V48, P443, DOI 10.1097/MPG.0b013e318189f2d5	12	25	27	1	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2010	340								c2383	10.1136/bmj.c2383	http://dx.doi.org/10.1136/bmj.c2383			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601LU	20484362				2022-12-24	WOS:000278061800003
J	Poon, EG; Keohane, CA; Yoon, CS; Ditmore, M; Bane, A; Levtzion-Korach, O; Moniz, T; Rothschild, JM; Kachalia, AB; Hayes, J; Churchill, WW; Lipsitz, S; Whittemore, AD; Bates, DW; Gandhi, TK				Poon, Eric G.; Keohane, Carol A.; Yoon, Catherine S.; Ditmore, Matthew; Bane, Anne; Levtzion-Korach, Osnat; Moniz, Thomas; Rothschild, Jeffrey M.; Kachalia, Allen B.; Hayes, Judy; Churchill, William W.; Lipsitz, Stuart; Whittemore, Anthony D.; Bates, David W.; Gandhi, Tejal K.			Effect of Bar-Code Technology on the Safety of Medication Administration.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADVERSE DRUG EVENTS; PHYSICIAN ORDER ENTRY; PATIENT SAFETY; INFORMATION-TECHNOLOGY; ERRORS; PREVENTION; SYSTEMS; CARE; HOSPITALS; IMPACT	Background: Serious medication errors are common in hospitals and often occur during order transcription or administration of medication. To help prevent such errors, technology has been developed to verify medications by incorporating bar-code verification technology within an electronic medication-administration system (bar-code eMAR). Methods: We conducted a before-and-after, quasi-experimental study in an academic medical center that was implementing the bar-code eMAR. We assessed rates of errors in order transcription and medication administration on units before and after implementation of the bar-code eMAR. Errors that involved early or late administration of medications were classified as timing errors and all others as nontiming errors. Two clinicians reviewed the errors to determine their potential to harm patients and classified those that could be harmful as potential adverse drug events. Results: We observed 14,041 medication administrations and reviewed 3082 order transcriptions. Observers noted 776 nontiming errors in medication administration on units that did not use the bar-code eMAR (an 11.5% error rate) versus 495 such errors on units that did use it (a 6.8% error rate) -- a 41.4% relative reduction in errors (P<0.001). The rate of potential adverse drug events (other than those associated with timing errors) fell from 3.1% without the use of the bar-code eMAR to 1.6% with its use, representing a 50.8% relative reduction (P<0.001). The rate of timing errors in medication administration fell by 27.3% (P<0.001), but the rate of potential adverse drug events associated with timing errors did not change significantly. Transcription errors occurred at a rate of 6.1% on units that did not use the bar-code eMAR but were completely eliminated on units that did use it. Conclusions: Use of the bar-code eMAR substantially reduced the rate of errors in order transcription and in medication administration as well as potential adverse drug events, although it did not eliminate such errors. Our data show that the bar-code eMAR is an important intervention to improve medication safety. (ClinicalTrials.gov number, NCT00243373.) N Engl J Med 2010;362:1698-707.	[Poon, Eric G.] Brigham & Womens Hosp, Div Gen Med Primary Care, Boston, MA 02120 USA; [Poon, Eric G.; Rothschild, Jeffrey M.; Kachalia, Allen B.; Whittemore, Anthony D.; Bates, David W.; Gandhi, Tejal K.] Harvard Univ, Sch Med, Boston, MA USA; [Poon, Eric G.; Bates, David W.] Partners Informat Syst, Boston, MA USA; [Hayes, Judy] Faulkner Hosp, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Poon, EG (corresponding author), Brigham & Womens Hosp, Div Gen Med Primary Care, 3-F,1620 Tremont St, Boston, MA 02120 USA.	epoon@partners.org	Bates, David/AAE-7283-2019	Poon, Eric/0000-0002-7251-5842	Healthcare Research and Quality [HS14053-02]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS014053] Funding Source: NIH RePORTER	Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Supported by a grant (HS14053-02) from the Agency for Healthcare Research and Quality.	Barker KN, 2002, ARCH INTERN MED, V162, P1897, DOI 10.1001/archinte.162.16.1897; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bates DW, 2000, BRIT MED J, V320, P788, DOI 10.1136/bmj.320.7237.788; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Cochran GL, 2007, JT COMM J QUAL PATIE, V33, P293, DOI 10.1016/S1553-7250(07)33034-1; DiConsiglio John, 2008, Mater Manag Health Care, V17, P26; FLYNN EA, 1999, MED ERRORS CAUSES PR; FOLLI HL, 1987, PEDIATRICS, V79, P718; Franklin BD, 2007, QUAL SAF HEALTH CARE, V16, P279, DOI 10.1136/qshc.2006.019497; Greenberg CC, 2008, ANN SURG, V247, P612, DOI 10.1097/SLA.0b013e3181656cd5; *HLTH IT POL COMM, 2009, FIN MEAN US OBJ MEAS; JOHNSON CL, 2003, J HEALTHC INF MANAG, V16, P46; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Koppel R, 2008, J AM MED INFORM ASSN, V15, P408, DOI 10.1197/jamia.M2616; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Mahoney CD, 2007, AM J HEALTH-SYST PH, V64, P1969, DOI 10.2146/ajhp060617; McDonald CJ, 2006, ANN INTERN MED, V145, P235, DOI 10.7326/0003-4819-145-3-200608010-00022; Neuenschwander M, 2003, AM J HEALTH-SYST PH, V60, P1219; Paoletti RD, 2007, AM J HEALTH-SYST PH, V64, P536, DOI 10.2146/ajhp060140; Patterson ES, 2002, J AM MED INFORM ASSN, V9, P540, DOI 10.1197/jamia.M1061; Poon EG, 2006, ANN INTERN MED, V145, P426, DOI 10.7326/0003-4819-145-6-200609190-00006; Poon EG, 2008, J NURS ADMIN, V38, P541, DOI 10.1097/NNA.0b013e31818ebf1c; PUCKETT F, 1995, AM J HEALTH-SYST PH, V52, P1305, DOI 10.1093/ajhp/52.12.1305; RAO JNK, 1987, ANN STAT, V15, P385, DOI 10.1214/aos/1176350273; Woods D. D., 2007, HDB HUMAN FACTORS ER, P459; Wright AA, 2005, NEW ENGL J MED, V353, P329, DOI 10.1056/NEJMp058101; Yang M, 2002, IMPACT INFORM TECHNO, P37; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	31	326	343	2	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					1698	1707		10.1056/NEJMsa0907115	http://dx.doi.org/10.1056/NEJMsa0907115			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591OQ	20445181				2022-12-24	WOS:000277311200007
J	Dinan, MA; Curtis, LH; Hammill, BG; Patz, EF; Abernethy, AP; Shea, AM; Schulman, KA				Dinan, Michaela A.; Curtis, Lesley H.; Hammill, Bradley G.; Patz, Edward F., Jr.; Abernethy, Amy P.; Shea, Alisa M.; Schulman, Kevin A.			Changes in the Use and Costs of Diagnostic Imaging Among Medicare Beneficiaries With Cancer, 1999-2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TRENDS; TECHNOLOGY; ACCURACY; ICD-9-CM; PATIENT; ISSUES	Context Emerging technologies, changing diagnostic and treatment patterns, and changes in Medicare reimbursement are contributing to increasing use of imaging in cancer. Imaging is the fastest growing expense for Medicare but has not been examined among beneficiaries with cancer. Objective To examine changes in the use of imaging and how those changes contribute to the overall cost of cancer care. Design, Setting, and Patients Analysis of a nationally representative 5% sample of claims from the US Centers for Medicare & Medicaid Services from 1999 through 2008. Patients were Medicare beneficiaries with incident breast cancer, colorectal cancer, leukemia, lung cancer, non-Hodgkin lymphoma, or prostate cancer. Main Outcome Measures Use and cost of imaging by modality, year, and cancer type. Results There were 100 954 incident cases of breast cancer, colorectal cancer, leukemia, lung cancer, non-Hodgkin lymphoma, and prostate cancer from 1999 through 2006. Significant mean annual increases in imaging use occurred among all cancer types for positron emission tomography (35.9%-53.6%), bone density studies (6.3%-20.0%), echocardiograms (5.0%-7.8%), magnetic resonance imaging (4.4%-11.5%), and ultrasound (0.7%-7.4%). Conventional radiograph rates decreased or stayed the same. As of 2006, beneficiaries with lung cancer and beneficiaries with lymphoma incurred the largest overall imaging costs, exceeding a mean of $3000 per beneficiary within 2 years of diagnosis. By 2005, one-third of beneficiaries with breast cancer underwent bone scans and half of beneficiaries with lung cancer or lymphoma underwent positron emission tomography scans. Mean 2-year imaging costs per beneficiary increased at a rate greater than the increase in mean total costs per beneficiary for all cancer types. Conclusion Imaging costs among Medicare beneficiaries with cancer increased from 1999 through 2006, outpacing the rate of increase in total costs among Medicare beneficiaries with cancer. JAMA. 2010;303(16):1625-1631 www.jama.com	[Dinan, Michaela A.; Curtis, Lesley H.; Hammill, Bradley G.; Shea, Alisa M.; Schulman, Kevin A.] Duke Univ, Sch Med, Ctr Clin & Genet Econ, Duke Clin Res Inst, Durham, NC 27715 USA; [Curtis, Lesley H.; Schulman, Kevin A.] Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA; [Patz, Edward F., Jr.] Duke Univ, Sch Med, Dept Radiol, Durham, NC 27715 USA; [Patz, Edward F., Jr.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27715 USA; [Patz, Edward F., Jr.; Abernethy, Amy P.] Duke Univ, Sch Med, Duke Comprehens Canc Ctr, Durham, NC 27715 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Schulman, KA (corresponding author), Duke Univ, Sch Med, Ctr Clin & Genet Econ, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	kevin.schulman@duke.edu		Patz, Edward/0000-0003-3374-1596	Allergan; Eli Lilly and Company; GlaxoSmithKline; Medtronic; Merck Co; Johnson & Johnson (Ortho Biotech); Novartis; OSI Eyetech; Sanofi-Aventis; Actelion Pharmaceuticals; Amgen; Arthritis Foundation; Astellas Pharma; Bristol-Myers Squibb; The Duke Endowment; Genentech; Inspire Pharmaceuticals; Kureha Corporation; Nabi Biopharmaceuticals; National Patient Advocate Foundation; Nova-Cardia; Pfizer; Scios; Tengion; Theravance; Thomson Healthcare; Vertex Pharmaceuticals	Allergan(AbbVieAllergan); Eli Lilly and Company(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Medtronic(Medtronic); Merck Co(Merck & Company); Johnson & Johnson (Ortho Biotech)(Johnson & JohnsonJohnson & Johnson USA); Novartis(Novartis); OSI Eyetech; Sanofi-Aventis(Sanofi-Aventis); Actelion Pharmaceuticals; Amgen(Amgen); Arthritis Foundation; Astellas Pharma(Astellas Pharmaceuticals); Bristol-Myers Squibb(Bristol-Myers Squibb); The Duke Endowment; Genentech(Roche HoldingGenentech); Inspire Pharmaceuticals; Kureha Corporation; Nabi Biopharmaceuticals; National Patient Advocate Foundation; Nova-Cardia; Pfizer(Pfizer); Scios; Tengion; Theravance; Thomson Healthcare; Vertex Pharmaceuticals(Vertex Pharmaceuticals)	Dr Curtis reported receiving research support from Allergan, Eli Lilly and Company, GlaxoSmithKline, Medtronic, Merck & Co, Johnson & Johnson (Ortho Biotech), Novartis, OSI Eyetech, and Sanofi-Aventis. Dr Curtis has made available online a detailed listing of financial disclosures (http://www.dcri.duke.edu/research/coi.jsp). Dr Schulman reported receiving research support from Actelion Pharmaceuticals, Allergan, Amgen, Arthritis Foundation, Astellas Pharma, Bristol-Myers Squibb, The Duke Endowment, Genentech, Inspire Pharmaceuticals, Johnson & Johnson, Kureha Corporation, Medtronic, Merck & Co, Nabi Biopharmaceuticals, National Patient Advocate Foundation, Nova-Cardia, Novartis, OSI Eyetech, Pfizer, Sanofi-Aventis, Scios, Tengion, Theravance, Thomson Healthcare, and Vertex Pharmaceuticals; receiving personal income for consulting from McKinsey & Company and the National Pharmaceutical Council; having equity in Alnylam Pharmaceuticals; having equity in and serving on the board of directors of Cancer Consultants Inc; and having equity in and serving on the executive board of Faculty Connection LLC. Dr Schulman has made available online a detailed listing of financial disclosures (http: // www. dcri. duke. edu/ research/ coi. jsp). No other disclosures were reported.	American Cancer Society, CANC FACTS FIG 2009; Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; Baker L, 2003, HLTH AFF MILLWOOD S; Baker LC, 2008, HEALTH AFFAIR, V27, P1467, DOI 10.1377/hlthaff.27.6.1467; BERENSON A, 2007, NY TIMES        0612, pC6; Bhargavan M, 2005, RADIOLOGY, V234, P824, DOI 10.1148/radiol.2343031536; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Centers for Medicare & Medicaid Services, CMS MAN SYST PUB 100; Feldmon MD, 2008, J GEN INTERN MED, V23, P57, DOI 10.1007/s11606-007-0275-4; Flanagan FL, 1998, SEMIN NUCL MED, V28, P290, DOI 10.1016/S0001-2998(98)80034-2; GINSBURG PB, 2005, HLTH AFF MILLWOOD S; Golub RM, 2004, J CLIN ONCOL, V22, P2430, DOI 10.1200/jco.2004.06.154; Herrmann K, 2009, SEMIN NUCL MED, V39, P210, DOI 10.1053/j.semnuclmed.2008.12.001; Iglehart JK, 2006, NEW ENGL J MED, V354, P2822, DOI 10.1056/NEJMhpr061219; Kaa K, 2007, J MANAGE CARE PHARM, V13, pS19; Knuuti J, 2008, HEART, V94, P360, DOI 10.1136/hrt.2007.118992; Maitino AJ, 2003, RADIOLOGY, V227, P113, DOI 10.1148/radiol.2272020617; Medicare Payment Advisory Commission, REP C MED PAYM POL; Meropol NJ, 2007, J CLIN ONCOL, V25, P180, DOI 10.1200/JCO.2006.09.6081; Miletich RS, 2009, NEUROL CLIN, V27, P61, DOI 10.1016/j.ncl.2008.09.004; Mitchell JM, 2008, MED CARE, V46, P460, DOI 10.1097/MLR.0b013e31815dc5ae; National Cancer Institute, CANC TRENDS PROGR RE; PODOLOFF A, 2007, J NATL COMPR CANC S1, V5, pS1; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Shea AM, 2008, JAMA-J AM MED ASSOC, V300, P189, DOI 10.1001/jama.300.2.189; Sistrom Christopher Lee, 2005, J Am Coll Radiol, V2, P511, DOI 10.1016/j.jacr.2004.09.013; TYNAN A, 2008, ISSUE BRIEF CENT STU, P1; *US DEP HHS, MED REIMB PRESCR DRU; *US DEP HHS, EX MED PAYM PRESCR D; *US GOV ACC OFF, 2001, PUB US GOV ACC OFF	31	169	170	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2010	303	16					1625	1631		10.1001/jama.2010.460	http://dx.doi.org/10.1001/jama.2010.460			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588PQ	20424253	Bronze			2022-12-24	WOS:000277085200026
J	Welsh, JA; Sharma, A; Abramson, JL; Vaccarino, V; Gillespie, C; Vos, MB				Welsh, Jean A.; Sharma, Andrea; Abramson, Jerome L.; Vaccarino, Viola; Gillespie, Cathleen; Vos, Miriam B.			Caloric Sweetener Consumption and Dyslipidemia Among US Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUGARS; BEVERAGES; FOODS; DIET; NUTRIENTS; NUTRITION; FRUCTOSE; CHILDREN; HEALTH; LIPIDS	Context Dietary carbohydrates have been associated with dyslipidemia, a lipid profile known to increase cardiovascular disease risk. Added sugars (caloric sweeteners used as ingredients in processed or prepared foods) are an increasing and potentially modifiable component in the US diet. No known studies have examined the association between the consumption of added sugars and lipid measures. Objective To assess the association between consumption of added sugars and blood lipid levels in US adults. Design, Setting, and Participants Cross-sectional study among US adults (n=6113) from the National Health and Nutrition Examination Survey (NHANES) 1999-2006. Respondents were grouped by intake of added sugars using limits specified in dietary recommendations (<5% [reference group], 5%-<10%, 10%-<17.5%, 17.5%-<25%, and >= 25% of total calories). Linear regression was used to estimate adjusted mean lipid levels. Logistic regression was used to determine adjusted odds ratios of dyslipidemia. Interactions between added sugars and sex were evaluated. Main Outcome Measures Adjusted mean high-density lipoprotein cholesterol (HDL-C), geometric mean triglycerides, and mean low-density lipoprotein cholesterol (LDL-C) levels and adjusted odds ratios of dyslipidemia, including low HDL-C levels (<40 mg/dL for men; <50 mg/dL for women), high triglyceride levels (>= 150 mg/dL), high LDL-C levels (>130 mg/dL), or high ratio of triglycerides to HDL-C (>3.8). Results were weighted to be representative of the US population. Results A mean of 15.8% of consumed calories was from added sugars. Among participants consuming less than 5%, 5% to less than 17.5%, 17.5% to less than 25%, and 25% or greater of total energy as added sugars, adjusted mean HDL-C levels were, respectively, 58.7, 57.5, 53.7, 51.0, and 47.7 mg/dL (P<.001 for linear trend), geometric mean triglyceride levels were 105, 102, 111, 113, and 114 mg/dL (P<.001 for linear trend), and LDL-C levels modified by sex were 116, 115, 118, 121, and 123 mg/dL among women (P=.047 for linear trend). There were no significant trends in LDL-C levels among men. Among higher consumers (>= 10% added sugars) the odds of low HDL-C levels were 50% to more than 300% greater compared with the reference group (<5% added sugars). Conclusion In this study, there was a statistically significant correlation between dietary added sugars and blood lipid levels among US adults. JAMA. 2010; 303(15): 1490-1497	[Welsh, Jean A.; Sharma, Andrea; Vaccarino, Viola; Vos, Miriam B.] Emory Univ, Nutr & Hlth Sci Program, Grad Div Biol & Biomed Sci, Atlanta, GA 30322 USA; [Abramson, Jerome L.; Vaccarino, Viola] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Vaccarino, Viola] Emory Univ, Div Cardiol, Sch Med, Atlanta, GA 30322 USA; [Vos, Miriam B.] Emory Univ, Dept Pediat Gastroenterol Hepatol & Nutr, Sch Med, Atlanta, GA 30322 USA; [Welsh, Jean A.; Vos, Miriam B.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Sharma, Andrea] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Atlanta, GA USA; [Gillespie, Cathleen] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Atlanta, GA USA	Emory University; Emory University; Rollins School Public Health; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Vos, MB (corresponding author), Emory Univ, Nutr & Hlth Sci Program, Grad Div Biol & Biomed Sci, 2015 Uppergate Dr NE, Atlanta, GA 30322 USA.	mvos@emory.edu	, Viola/AAW-5600-2020	Sharma, Andrea/0000-0003-0385-0011	National Institute of Diabetes and Digestive and Kidney Diseases [K23DK080953]; Children's Digestive Health and Nutrition Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK080953] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Children's Digestive Health and Nutrition Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr Vos reported that she is the author of and receives royalties from a book about childhood obesity and that she is supported in part by a career award from the National Institute of Diabetes and Digestive and Kidney Diseases (K23DK080953) and from the Children's Digestive Health and Nutrition Foundation. No other authors reported disclosures.	[Anonymous], 2005, DIETARY REFERENCE IN; BALLINGER RA, 1978, 382 USDA; CARLETON RA, 1991, CIRCULATION, V83, P2154, DOI 10.1161/01.CIR.83.6.2154; Centers for Disease Control and Prevention, NCHS RES ETH REV BOA; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, KEY CONC NHANES SURV; Cleveland LE, 1997, AM J CLIN NUTR, V65, P1254; Cooney MT, 2009, J AM COLL CARDIOL, V54, P1209, DOI 10.1016/j.jacc.2009.07.020; Couillard B, 1999, ARTERIOSCL THROM VAS, V19, P2448; Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011; *EUFIC, SUG OUR DIET; Frary CD, 2004, J ADOLESCENT HEALTH, V34, P56, DOI 10.1016/S1054-139X(03)00248-9; GLINSMANN WH, 1986, J NUTR, V116, pS1, DOI 10.1093/jn/116.suppl_11.S1; Grundy S. M., 1982, CIRCULATION, V65, P839, DOI DOI 10.1161/01.CIR.65.5.839; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HALEY S, SUGAR BACKGROUNDER; Hanak V, 2004, AM J CARDIOL, V94, P219, DOI 10.1016/j.amjcard.2004.03.069; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Johnson RK, 2001, J NUTR, V131, p2766S, DOI 10.1093/jn/131.10.2766S; Krebs-Smith SM, 2000, EUR J CLIN NUTR, V54, P281, DOI 10.1038/sj.ejcn.1600936; Krebs-Smith SM, 2001, J NUTR, V131, p527S, DOI 10.1093/jn/131.2.527S; Marshall TA, 2007, J AM DENT ASSOC, V138, P39, DOI 10.14219/jada.archive.2007.0019; Montonen J, 2007, J NUTR, V137, P1447, DOI 10.1093/jn/137.6.1447; *NCHS, LAB PROC MAN; Nishida C, 2004, PUBLIC HEALTH NUTR, V7, P245, DOI 10.1079/PHN2003592; Obarzanek E, 2001, AM J CLIN NUTR, V74, P80; Stanhope KL, 2009, J NUTR, V139, pS1236, DOI 10.3945/jn.109.106641; Thompson FE, 2009, J AM DIET ASSOC, V109, P1376, DOI 10.1016/j.jada.2009.05.002; US Department of Health and Human Services and US Department of Agriculture, 2005, DIET GUID AM; *USDA, NAT AGR LIB NAT NUTR; *USDA, 2006, MYPYRAMID EQ DAT USD; *USDA AGR RES SERV, 2005, USDA DAT ADD SUG CON; *USDA EC RES SERV, NAT AGR LIB NAT NUTR; VANHORN LV, 1991, AM J EPIDEMIOL, V133, P9, DOI 10.1093/oxfordjournals.aje.a115807; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Wells H.F., 2008, EC INFORM B; Willett W., 2012, NUTR EPIDEMIOLOGY	37	178	184	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2010	303	15					1490	1497		10.1001/jama.2010.449	http://dx.doi.org/10.1001/jama.2010.449			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585SJ	20407058	Green Accepted, Bronze			2022-12-24	WOS:000276849000025
J	Gething, PW; Smith, DL; Patil, AP; Tatem, AJ; Snow, RW; Hay, SI				Gething, Peter W.; Smith, David L.; Patil, Anand P.; Tatem, Andrew J.; Snow, Robert W.; Hay, Simon I.			Climate change and the global malaria recession	NATURE			English	Article							INSECTICIDE-TREATED NETS; COMBINATION THERAPY; INOCULATION RATE; TRANSMISSION; IMPACT; POPULATIONS; ELIMINATION; INFECTION; AFRICA; BURDEN	The current and potential future impact of climate change on malaria is of major public health interest(1,2). The proposed effects of rising global temperatures on the future spread and intensification of the disease(3-5), and on existing malaria morbidity and mortality rates(3), substantively influence global health policy(6,7). The contemporary spatial limits of Plasmodium falciparum malaria and its endemicity within this range(8), when compared with comparable historical maps, offer unique insights into the changing global epidemiology of malaria over the last century. It has long been known that the range of malaria has contracted through a century of economic development and disease control(9). Here, for the first time, we quantify this contraction and the global decreases in malaria endemicity since approximately 1900. We compare the magnitude of these changes to the size of effects on malaria endemicity proposed under future climate scenarios and associated with widely used public health interventions. Our findings have two key and often ignored implications with respect to climate change and malaria. First, widespread claims that rising mean temperatures have already led to increases in worldwide malaria morbidity and mortality are largely at odds with observed decreasing global trends in both its endemicity and geographic extent. Second, the proposed future effects of rising temperatures on endemicity are at least one order of magnitude smaller than changes observed since about 1900 and up to two orders of magnitude smaller than those that can be achieved by the effective scale-up of key control measures. Predictions of an intensification of malaria in a warmer world, based on extrapolated empirical relationships or biological mechanisms, must be set against a context of a century of warming that has seen marked global declines in the disease and a substantial weakening of the global correlation between malaria endemicity and climate.	[Gething, Peter W.; Patil, Anand P.; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Smith, David L.; Tatem, Andrew J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Smith, David L.] Univ Florida, Dept Biol, Gainesville, FL 32610 USA; [Tatem, Andrew J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Snow, Robert W.] KEMRI Univ Oxford Wellcome Trust Collaborat Progr, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med, Nairobi, Kenya; [Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, CCVTM, Oxford OX3 7LJ, England	University of Oxford; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Oxford	Hay, SI (corresponding author), Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Tinbergen Bldg,S Parks Rd, Oxford OX1 3PS, England.	peter.gething@zoo.ox.ac.uk; simon.hay@zoo.ox.ac.uk	Smith, David L/L-8850-2013; Snow, Robert William/AFR-1436-2022; Hay, Simon Iain/F-8967-2015; Gething, Peter/GQR-1884-2022; Gething, Peter/ABD-2110-2020	Smith, David L/0000-0003-4367-3849; Snow, Robert William/0000-0003-3725-6088; Hay, Simon Iain/0000-0002-0611-7272; Gething, Peter/0000-0001-6759-5449; Tatem, Andrew/0000-0002-7270-941X	Wellcome Trust [079091, 079080]; Bill and Melinda Gates Foundation [49446]; Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Wellcome Trust, UK	Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust, UK(Wellcome Trust)	We thank A. Bibby, H. C. J. Godfray, G. D. Shanks and G. R. W. Wint for comments on the manuscript. S. I. H. is funded by a Senior Research Fellowship from the Wellcome Trust (#079091) that also supports P. W. G. and previously A. J. T. R. W. S. is funded by a Principal Research Fellowship from the Wellcome Trust (#079080) that also supports A. P. P. D. L. S. and A. J. T. are supported by a grant from the Bill and Melinda Gates Foundation (#49446). D. L. S. and S. I. H. also acknowledge funding support from the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. This work forms part of the output of the Malaria Atlas Project (MAP, http://www.map.ox.ac.uk), principally funded by the Wellcome Trust, UK.	[Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2004, BIODIVERSITE PALUDIS; Antosiewicz H.A., 1964, HDB MATH FUNCTIONS, P435; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; DAVIS GM, 1964, HDB MATH FUNCTION, P253; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Killeen GF, 2006, AM J TROP MED HYG, V75, P38, DOI 10.4269/ajtmh.2006.75.2_suppl.0750038; Killeen GF, 2000, AM J TROP MED HYG, V62, P545, DOI 10.4269/ajtmh.2000.62.545; Kleinschmidt I, 2006, AM J TROP MED HYG, V74, P972, DOI 10.4269/ajtmh.2006.74.972; Kouznetsov R L, 1977, Trop Doct, V7, P81; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; Lysenko A.J., 1968, MEDICINSKAJA GEOGRAF, P25; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; Martens WJM, 1997, CLIMATIC CHANGE, V35, P145, DOI 10.1023/A:1005365413932; McMichael A., 2004, COMP QUANTIFICATION, V2, P1543; Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226; Parry M. L., 2007, CLIMATE CHANGE 2007; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Reiter P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S3; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Small J, 2003, P NATL ACAD SCI USA, V100, P15341, DOI 10.1073/pnas.2236969100; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002; Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Stein ML, 2005, J AM STAT ASSOC, V100, P310, DOI 10.1198/016214504000000854; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; van Lieshout M, 2004, GLOBAL ENVIRON CHANG, V14, P87, DOI 10.1016/j.gloenvcha.2003.10.009	38	231	235	6	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2010	465	7296					342	U94		10.1038/nature09098	http://dx.doi.org/10.1038/nature09098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485434	Green Accepted			2022-12-24	WOS:000277829200039
J	Stott, PA; Thorne, PW				Stott, Peter A.; Thorne, Peter W.			How best to log local temperatures?	NATURE			English	Editorial Material									[Stott, Peter A.] Met Off, Hadley Ctr, Climate Monitoring & Attribut Grp, Exeter EX1 3PB, Devon, England; [Thorne, Peter W.] Cooperat Inst Climate & Satellites, Asheville, NC 28801 USA	Met Office - UK; Hadley Centre	Stott, PA (corresponding author), Met Off, Hadley Ctr, Climate Monitoring & Attribut Grp, Exeter EX1 3PB, Devon, England.	peter.stott@metoffice.gov.uk	Thorne, Peter/F-2225-2014; Thorne, Peter W/R-6823-2017; Scott, Peter/GYA-5335-2022; Stott, Peter/N-1228-2016	Thorne, Peter/0000-0003-0485-9798; Thorne, Peter W/0000-0003-0485-9798; Stott, Peter/0000-0003-4853-7686				KENNEDY JJ, 2010, B AM METEOR IN PRESS, V91; Titchner HA, 2009, J CLIMATE, V22, P465, DOI 10.1175/2008JCLI2419.1	2	13	13	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2010	465	7295					158	159		10.1038/465158a	http://dx.doi.org/10.1038/465158a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463718	Green Accepted			2022-12-24	WOS:000277558500015
J	Malleshaiah, MK; Shahrezaei, V; Swain, PS; Michnick, SW				Malleshaiah, Mohan K.; Shahrezaei, Vahid; Swain, Peter S.; Michnick, Stephen W.			The scaffold protein Ste5 directly controls a switch-like mating decision in yeast	NATURE			English	Article							MAP KINASE; MULTISITE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; PATHWAY; MECHANISM; DYNAMICS	Evolution has resulted in numerous innovations that allow organisms to increase their fitness by choosing particular mating partners, including secondary sexual characteristics, behavioural patterns, chemical attractants and corresponding sensory mechanisms(1). The haploid yeast Saccharomyces cerevisiae selects mating partners by interpreting the concentration gradient of pheromone secreted by potential mates through a network of mitogen-activated protein kinase (MAPK) signalling proteins(2,3). The mating decision in yeast is an all-or-none, or switch-like, response that allows cells to filter weak pheromone signals, thus avoiding inappropriate commitment to mating by responding only at or above critical concentrations when a mate is sufficiently close(4). The molecular mechanisms that govern the switch-like mating decision are poorly understood. Here we show that the switching mechanism arises from competition between the MAPK Fus3 and a phosphatase Ptc1 for control of the phosphorylation state of four sites on the scaffold protein Ste5. This competition results in a switch-like dissociation of Fus3 from Ste5 that is necessary to generate the switch-like mating response. Thus, the decision to mate is made at an early stage in the pheromone pathway and occurs rapidly, perhaps to prevent the loss of the potential mate to competitors. We argue that the architecture of the Fus3Ste5- Ptc1 circuit generates a novel ultrasensitivity mechanism, which is robust to variations in the concentrations of these proteins. This robustness helps assure that mating can occur despite stochastic or genetic variation between individuals. The role of Ste5 as a direct modulator of a cell-fate decision expands the functional repertoire of scaffold proteins beyond providing specificity and efficiency of information processing(5,6). Similar mechanisms may govern cellular decisions in higher organisms and be disrupted in cancer.	[Malleshaiah, Mohan K.; Michnick, Stephen W.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Michnick, Stephen W.] Univ Montreal, Ctr Robert Cedergren Bioinformat & Genom, Montreal, PQ H3C 3J7, Canada; [Shahrezaei, Vahid] Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2AZ, England; [Swain, Peter S.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Swain, Peter S.] Univ Edinburgh, Ctr Syst Biol, Edinburgh EH9 3JD, Midlothian, Scotland	Universite de Montreal; Universite de Montreal; Imperial College London; McGill University; University of Edinburgh	Michnick, SW (corresponding author), Univ Montreal, Dept Biochim, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	peter.swain@ed.ac.uk; stephen.michnick@umontreal.ca	Swain, Peter S/AAW-3265-2020	Shahrezaei, Vahid/0000-0002-4013-5458; Swain, Peter/0000-0001-7489-8587; Malleshaiah, Mohan/0000-0003-2896-8585	Canadian Institutes of Health Research [MOP-GMX-152556]; Canada Research Chair in Integrative Genomics; Canada Research Chair in Systems Biology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Integrative Genomics; Canada Research Chair in Systems Biology	We thank J. Ferrell Jr, W. Lim, M. Babu, E. Stefan, C. Landry, F.-X. Campbell-Valois and E. Levy for comments on the manuscript; W. Lim and J. Vogel for providing plasmids and yeast strains; N. Paquin for assistance with the in vitro kinase assay; and J. Ollivier, O. Dushek and our laboratory members for discussions. This work was supported by grants from the Canadian Institutes of Health Research (MOP-GMX-152556) and a Canada Research Chair in Integrative Genomics to S. W. M. P. S. S. was supported by a Canada Research Chair in Systems Biology and currently holds a Scottish Universities Life Sciences Alliance Professorship, also in systems biology.	Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Darwin G., 1871, P423; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; Erdman S, 2001, GENETICS, V159, P919; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; JACKSON CL, 1990, CELL, V63, P1039, DOI 10.1016/0092-8674(90)90507-B; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lenz P, 2006, CURR BIOL, V16, P2150, DOI 10.1016/j.cub.2006.09.013; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PETER M, 1994, SCIENCE, V265, P1228, DOI 10.1126/science.8066461; Salazar C, 2007, FEBS J, V274, P1046, DOI 10.1111/j.1742-4658.2007.05653.x; Serber Z, 2007, CELL, V128, P441, DOI 10.1016/j.cell.2007.01.018; Siso-Nadal F, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-36; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Swain PS, 2002, BIOPHYS J, V82, P2928, DOI 10.1016/S0006-3495(02)75633-6; van Drogen F, 2001, NAT CELL BIOL, V3, P1051, DOI 10.1038/ncb1201-1051; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001	30	133	139	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					101	105		10.1038/nature08946	http://dx.doi.org/10.1038/nature08946			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20400943				2022-12-24	WOS:000277311900039
J	Gornall, J				Gornall, Jonathan			Stem cell treatment Stem cell renegades or pioneers?	BRITISH MEDICAL JOURNAL			English	Editorial Material							LATERAL-SCLEROSIS PATIENTS; 1-YEAR FOLLOW-UP; TRANSPLANTATION					jgornall@mac.com						[Anonymous], 2010, ECONOMIST       0114; Deda H, 2008, CYTOTHERAPY, V10, P565, DOI 10.1080/14653240802241797; Deda H, 2009, CYTOTHERAPY, V11, P18, DOI 10.1080/14653240802549470; *DEP HLTH, 2008, WARN UNPR STEM CELL; Dyer C, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2009; Hawkes N, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2069; *INT SOC STEM CELL, 2008, ISSCR REL NEW GUID S; Martinez HR, 2009, CYTOTHERAPY, V11, P26, DOI 10.1080/14653240802644651; *NAT I HLTH CLIN E, 2001, GUID US RIL RIL TREA; *NAT I HLTH CLIN E, GUID US RIL RIL TREA; *NAT STEM CELL NET, STEN CELL TOUR POS S; *NHS DIR, 2008, WARN FREE ONL STEM C; Rowley E., 2009, BARRIERS COMMERCIALI; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; *U MICH, 2009, 1 STEM CELL TRIAL AL; WATERS R, 2008, ROGUE STEM CELL CLIN	16	6	6	1	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2010	340								c2041	10.1136/bmj.c2041	http://dx.doi.org/10.1136/bmj.c2041			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594XC	20444823				2022-12-24	WOS:000277572500004
J	Wolf, B; Zheng, XH; Brueggemann, N; Chen, WW; Dannenmann, M; Han, XG; Sutton, MA; Wu, HH; Yao, ZS; Butterbach-Bahl, K				Wolf, Benjamin; Zheng, Xunhua; Brueggemann, Nicolas; Chen, Weiwei; Dannenmann, Michael; Han, Xingguo; Sutton, Mark A.; Wu, Honghui; Yao, Zhisheng; Butterbach-Bahl, Klaus			Grazing-induced reduction of natural nitrous oxide release from continental steppe	NATURE			English	Article							CARBON-DIOXIDE; SOIL-WATER; N2O; EMISSIONS; FLUXES; METHANE; GRASSLAND	Atmospheric concentrations of the greenhouse gas nitrous oxide (N2O) have increased significantly since pre-industrial times owing to anthropogenic perturbation of the global nitrogen cycle(1,2), with animal production being one of the main contributors(3). Grasslands cover about 20 per cent of the temperate land surface of the Earth and are widely used as pasture. It has been suggested that high animal stocking rates and the resulting elevated nitrogen input increase N2O emissions(4-7). Internationally agreed methods to upscale the effect of increased livestock numbers on N2O emissions are based directly on per capita nitrogen inputs(8). However, measurements of grassland N2O fluxes are often performed over short time periods(9), with low time resolution and mostly during the growing season. In consequence, our understanding of the daily and seasonal dynamics of grassland N2O fluxes remains limited. Here we report year-round N2O flux measurements with high and low temporal resolution at ten steppe grassland sites in Inner Mongolia, China. We show that short-lived pulses of N2O emission during spring thaw dominate the annual N2O budget at our study sites. The N2O emission pulses are highest in ungrazed steppe and decrease with increasing stocking rate, suggesting that grazing decreases rather than increases N2O emissions. Our results show that the stimulatory effect of higher stocking rates on nitrogen cycling(4,7) and, hence, on N2O emission is more than offset by the effects of a parallel reduction in microbial biomass, inorganic nitrogen production and wintertime water retention. By neglecting these freeze-thaw interactions, existing approaches may have systematically overestimated N2O emissions over the last century for semi-arid, cool temperate grasslands by up to 72 per cent.	[Wolf, Benjamin; Brueggemann, Nicolas; Dannenmann, Michael; Butterbach-Bahl, Klaus] Karlsruhe Inst Technol, Inst Meteorol & Climate Res, D-82467 Garmisch Partenkirchen, Germany; [Zheng, Xunhua; Chen, Weiwei; Yao, Zhisheng] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Atmospher Boundary Layer Phys & Atm, Beijing 100029, Peoples R China; [Han, Xingguo; Wu, Honghui] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China; [Sutton, Mark A.] Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland	Helmholtz Association; Karlsruhe Institute of Technology; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; UK Centre for Ecology & Hydrology (UKCEH)	Butterbach-Bahl, K (corresponding author), Karlsruhe Inst Technol, Inst Meteorol & Climate Res, Kreuzeckbahnstr 19, D-82467 Garmisch Partenkirchen, Germany.	klaus.butterbach-bahl@kit.edu	Han, Xingguo/B-3980-2012; Yao, Zhisheng/A-5749-2015; Han, Xingguo/K-7552-2016; Butterbach-Bahl, Klaus/A-8081-2013; Zheng, Xunhua/D-3048-2017; Wu, Honghui/AAF-5696-2019; Zheng, Xunhua/AAH-8172-2019; LAPC, IAP/AAI-6991-2020; Brueggemann, Nicolas/C-4263-2014; Sutton, Mark/K-2700-2012; Dannenmann, Michael/A-7278-2013	Yao, Zhisheng/0000-0001-6242-2426; Han, Xingguo/0000-0002-1836-975X; Butterbach-Bahl, Klaus/0000-0001-9499-6598; Zheng, Xunhua/0000-0002-4138-7470; Zheng, Xunhua/0000-0002-4138-7470; LAPC, IAP/0000-0002-0025-3484; Brueggemann, Nicolas/0000-0003-3851-2418; Sutton, Mark/0000-0002-1342-2072; Dannenmann, Michael/0000-0001-5924-7612	German Research Foundation (DFG) [536]; National Natural Science Foundation of China [40805061]; European Commission; Natural Environment Research Council [ceh010023] Funding Source: researchfish	German Research Foundation (DFG)(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work has been supported by the German Research Foundation (DFG research group 536, 'Matter fluxes in grasslands of Inner Mongolia as influenced by stocking rate') and the National Natural Science Foundation of China (grant number 40805061), with co-funding from the NitroEurope Integrated Project of the European Commission. We thank K. K. Goldewijk for providing livestock data for the years before 1961, and Z. Yu, K. Muller, L. Lin, P. Schoenbach, G. Willibald, R. Kiese, C. Werner and C. Liu for support with field measurements.	Brooks PD, 1998, BIOGEOCHEMISTRY, V43, P1, DOI 10.1023/A:1005947511910; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; Dannenmann M, 2006, PLANT SOIL, V287, P279, DOI 10.1007/s11104-006-9077-4; Davidson EA, 2009, NAT GEOSCI, V2, P659, DOI 10.1038/NGEO608; Eggleston H.S., 2006, 2006 IPCC GUIDELINES; Essery R, 2004, J HYDROMETEOROL, V5, P735, DOI 10.1175/1525-7541(2004)005<0735:VATCOW>2.0.CO;2; *FERTISTAT, 2007, FERT US CROP STAT; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Groffman PM, 2006, GLOBAL CHANGE BIOL, V12, P1748, DOI 10.1111/j.1365-2486.2006.01194.x; Hoffmann C, 2008, J ARID ENVIRON, V72, P792, DOI 10.1016/j.jaridenv.2007.09.004; Koponen HT, 2004, NUTR CYCL AGROECOSYS, V69, P213, DOI 10.1023/B:FRES.0000035172.37839.24; Ma XZ, 2006, NEW ZEAL J AGR RES, V49, P285, DOI 10.1080/00288233.2006.9513719; Matzner E, 2008, EUR J SOIL SCI, V59, P274, DOI 10.1111/j.1365-2389.2007.00992.x; Mitchell B.R., 1995, INT HIST STAT AFRICA; MITCHELL BR, 1992, INT HIST STAT EUROPE, P325; Mitchell Brian R, 1993, INT HIST STAT AM 175; Mosier A, 1998, NUTR CYCL AGROECOSYS, V52, P225, DOI 10.1023/A:1009740530221; Mosier AR, 1997, GLOBAL BIOGEOCHEM CY, V11, P29, DOI 10.1029/96GB03612; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Oenema O, 1997, SOIL USE MANAGE, V13, P288, DOI 10.1111/j.1475-2743.1997.tb00600.x; Papen H, 1999, J GEOPHYS RES-ATMOS, V104, P18487, DOI 10.1029/1999JD900293; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Rivkina EM, 2000, APPL ENVIRON MICROB, V66, P3230, DOI 10.1128/AEM.66.8.3230-3233.2000; Rover M, 1998, SOIL BIOL BIOCHEM, V30, P1859, DOI 10.1016/S0038-0717(98)00080-7; Saggar S, 2007, AGR ECOSYST ENVIRON, V122, P357, DOI 10.1016/j.agee.2007.02.006; Sharma S, 2006, APPL ENVIRON MICROB, V72, P2148, DOI 10.1128/AEM.72.3.2148-2154.2006; Teepe R, 2004, EUR J SOIL SCI, V55, P357, DOI 10.1111/j.1365-2389.2004.00602.x; Yamulki S, 1998, SOIL BIOL BIOCHEM, V30, P491, DOI 10.1016/S0038-0717(97)00145-4	28	216	237	23	477	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					881	884		10.1038/nature08931	http://dx.doi.org/10.1038/nature08931			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20376147				2022-12-24	WOS:000276397300035
J	Judd, O; Colvin, IB				Judd, O.; Colvin, I. B.			10 Minute Consultation Hoarse voice	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Judd, O.] Derbyshire Royal Infirm, Dept Otolaryngol, Derby DE1 2QY, England; [Colvin, I. B.] Elizabeth Ave Grp Practice, London N1 3BX, England		Judd, O (corresponding author), Derbyshire Royal Infirm, Dept Otolaryngol, Derby DE1 2QY, England.	owenjudd@doctors.org.uk		Judd, Owen/0000-0003-3112-931X					0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2010	340								c522	10.1136/bmj.c522	http://dx.doi.org/10.1136/bmj.c522			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582ZF	20375088				2022-12-24	WOS:000276639400014
J	Storlazzi, A; Gargano, S; Ruprich-Robert, G; Falque, M; David, M; Kleckner, N; Zickler, D				Storlazzi, Aurora; Gargano, Silvana; Ruprich-Robert, Gwenael; Falque, Matthieu; David, Michelle; Kleckner, Nancy; Zickler, Denise			Recombination Proteins Mediate Meiotic Spatial Chromosome Organization and Pairing	CELL			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE MER3; CROSSING-OVER; CROSSOVER CONTROL; MEIOSIS; ARABIDOPSIS; INITIATION; PROPHASE; TRANSITION	Meiotic chromosome pairing involves not only recognition of homology but also juxtaposition of entire chromosomes in a topologically regular way. Analysis of filamentous fungus Sordaria macrospora reveals that recombination proteins Mer3, Msh4, and Mlh1 play direct roles in all of these aspects, in advance of their known roles in recombination. Absence of Mer3 helicase results in interwoven chromosomes, thereby revealing the existence of features that specifically ensure "entanglement avoidance." Entanglements that remain at zygotene, i.e., "interlockings," require Mlh1 for resolution, likely to eliminate constraining recombinational connections. Patterns of Mer3 and Msh4 foci along aligned chromosomes show that the double-strand breaks mediating homologous alignment have spatially separated ends, one localized to each partner axis, and that pairing involves interference among developing interhomolog interactions. We propose that Mer3, Msh4, and Mlh1 execute all of these roles during pairing by modulating the state of nascent double-strand break/partner DNA contacts within axis-associated recombination complexes.	[Storlazzi, Aurora; Ruprich-Robert, Gwenael; David, Michelle; Zickler, Denise] Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Storlazzi, Aurora; Gargano, Silvana] CNR, Ist Genet & Biofis A Buzzati Traverso, I-80131 Naples, Italy; [Falque, Matthieu] UMR Genet Vegetale Moulon, F-91190 Gif Sur Yvette, France; [Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02139 USA	UDICE-French Research Universities; Universite Paris Saclay; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); Harvard University	Zickler, D (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France.	denise.zickler@igmors.u-psud.fr		Falque, Matthieu/0000-0002-6444-858X; Ruprich-Robert, Gwenael/0000-0003-3679-428X	Centre National de la Recherche Scientifique [UMR 8621]; National Institutes of Health [GM025326, GM044794]; Regione campania Legge [28/03/2002 n.5]; CNR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044794, R37GM025326, R01GM025326] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regione campania Legge(Regione Campania); CNR(Consiglio Nazionale delle Ricerche (CNR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Stefanie Poggeler for the recombinant ku70 plasmid and Olivier Martin for his advice in the statistical analyses. D. Z., A. S. and G. R.-R. were supported by grants from the Centre National de la Recherche Scientifique (UMR 8621), and from the National Institutes of Health (GM025326 and GM044794) to N. K. S. G. was supported by Regione campania Legge 28/03/2002 n.5, and together with A. S. by CNR.	ALBINI SM, 1987, CHROMOSOMA, V95, P324, DOI 10.1007/BF00293179; Anderson LK, 2005, CYTOGENET GENOME RES, V109, P198, DOI 10.1159/000082400; Argueso JL, 2003, MOL CELL BIOL, V23, P873, DOI 10.1128/MCB.23.3.873-886.2003; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; de Boer E, 2006, P NATL ACAD SCI USA, V103, P9607, DOI 10.1073/pnas.0600418103; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Franklin FCH, 2006, BIOCHEM SOC T, V34, P542, DOI 10.1042/BST0340542; Guillon H, 2005, MOL CELL, V20, P563, DOI 10.1016/j.molcel.2005.09.021; Henderson KA, 2005, BIOESSAYS, V27, P995, DOI 10.1002/bies.20310; Higgins JD, 2004, GENE DEV, V18, P2557, DOI 10.1101/gad.317504; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Jackson N, 2006, EMBO J, V25, P1315, DOI 10.1038/sj.emboj.7600992; KLECKNER N, 1993, COLD SPRING HARB SYM, V58, P553, DOI 10.1101/SQB.1993.058.01.062; Koszul R, 2008, CELL, V133, P1188, DOI 10.1016/j.cell.2008.04.050; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Mazina OM, 2004, CELL, V117, P47, DOI 10.1016/S0092-8674(04)00294-6; Moens PB, 2007, J CELL SCI, V120, P1017, DOI 10.1242/jcs.03394; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Nakagawa T, 2002, MOL CELL BIOL, V22, P3281, DOI 10.1128/MCB.22.10.3281-3291.2002; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Oliver-Bonet M, 2007, MOL HUM REPROD, V13, P837, DOI 10.1093/molehr/gam076; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Robine N, 2007, MOL CELL BIOL, V27, P1868, DOI 10.1128/MCB.02063-06; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Storlazzi A, 2003, GENE DEV, V17, P2675, DOI 10.1101/gad.275203; Storlazzi A, 2008, GENE DEV, V22, P796, DOI 10.1101/gad.459308; Tesse S, 2003, P NATL ACAD SCI USA, V100, P12865, DOI 10.1073/pnas.2034282100; van Heemst D, 1999, CELL, V98, P261, DOI 10.1016/S0092-8674(00)81020-X; VONWETTSTEIN D, 1984, ANNU REV GENET, V18, P331, DOI 10.1146/annurev.ge.18.120184.001555; Wang CJR, 2009, GENETICS, V183, P905, DOI 10.1534/genetics.109.108688; Wang KJ, 2009, J CELL SCI, V122, P2055, DOI 10.1242/jcs.049080; WU TC, 1995, GENETICS, V140, P55; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; ZICKLER D, 1992, GENETICS, V132, P135	38	110	110	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					94	106		10.1016/j.cell.2010.02.041	http://dx.doi.org/10.1016/j.cell.2010.02.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371348	Bronze, Green Accepted			2022-12-24	WOS:000276211100015
J	Livesley, B				Livesley, Brian			Personal View Assisted suicide: a substitute for a caring doctor?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Livesley, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	brian.livesley@doctors.org.uk						Gale J, 1974, Age Ageing, V3, P49, DOI 10.1093/ageing/3.1.49; KAMISAR Y, 1958, MINN LAW REV, V42, P969; The Crown Prosecution Service, POL PROS RESP CAS EN	3	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2010	340								c1590	10.1136/bmj.c1590	http://dx.doi.org/10.1136/bmj.c1590			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	576PO	20332309				2022-12-24	WOS:000276157600001
J	Talcott, JA; Rossi, C; Shipley, WU; Clark, JA; Slater, JD; Niemierko, A; Zietman, AL				Talcott, James A.; Rossi, Carl; Shipley, William U.; Clark, Jack A.; Slater, Jerry D.; Niemierko, Andrzej; Zietman, Anthony L.			Patient-Reported Long-term Outcomes After Conventional and High-Dose Combined Proton and Photon Radiation for Early Prostate Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; OF-LIFE OUTCOMES; CONFORMAL RADIOTHERAPY; PATIENTS PERCEPTIONS; THERAPY; ADENOCARCINOMA; IRRADIATION; CARCINOMA; SEQUELAE; ESCALATION	Context Increased radiation doses improve prostate cancer control but also increase toxicity to adjacent normal tissue. Proton radiation may attenuate adverse effects. Objective To determine long-term, patient-reported, dose-related toxicity. Design, Setting, and Patients We performed a post hoc cross-sectional survey of surviving participants in the Proton Radiation Oncology Group (PROG) 9509-a randomized trial comparing 70.2 Gy vs 79.2 Gy of combined photon and proton radiation for 393 men with clinically localized prostate cancer (stage T1b-T2b, prostate-specific antigen <15 ng/mL, and no radiographic evidence of metastasis). The estimated 10-year biochemical progression rate for patients receiving standard dose was 32% (95% confidence interval, 26%-39%) compared with 17% (95% confidence interval, 11%-23%) for patients receiving high dose (P<.001). We surveyed 280 of the surviving 337 patients (83%) from April 2007 to September 2008. Main Outcome Measures Prostate Cancer Symptom Indices, a validated measure of urinary incontinence, urinary obstruction and irritation, bowel problems, and sexual dysfunction, and related quality-of-life instruments. Results At a median of 9.4 years after treatment (range, 7.4-12.1 years), participants' demographic and clinical characteristics were similar. Patient-reported outcomes were reported as mean (SD) scale score for standard dose vs high dose: urinary obstruction/irritation (23.3 [13.7] vs 24.6 [14.0]; P=.36), urinary incontinence (10.6 [17.7] vs 9.7 [15.8]; P=.99), bowel problems (7.7 [7.8] vs 7.9 [9.1]; P=.70), sexual dysfunction (68.2 [34.6] vs 65.9 [34.7]; P=.65), and most other outcomes were also similar, although patients receiving standard dose whose cancers had more often progressed expressed less confidence that their cancers were under control (mean [SD] scale score for standard dose, 76.0 [25.4] vs high dose, 86.2 [17.9]; P<.001). Many patients characterized their urinary and bowel function as normal despite reporting symptoms that, for other prostate cancer patients before and early after cancer treatment, caused substantial distress. Conclusion Among men with clinically localized prostate cancer, treatment with higher-dose radiation compared with standard dose was not associated with an increase in patient-reported prostate cancer symptoms after a median of 9.4 years. JAMA. 2010; 303(11): 1046-1053	[Talcott, James A.] Massachusetts Gen Hosp, MGH Canc Ctr, Ctr Outcomes Res, Boston, MA 02114 USA; [Rossi, Carl; Slater, Jerry D.] Loma Linda Univ, Med Ctr, Loma Linda, CA USA; [Shipley, William U.; Niemierko, Andrzej; Zietman, Anthony L.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Clark, Jack A.] Edith Nourse Rogers Mem Vet Adm Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA 01730 USA; [Clark, Jack A.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Talcott, James A.; Shipley, William U.; Niemierko, Andrzej; Zietman, Anthony L.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Loma Linda University; Harvard University; Massachusetts General Hospital; Boston University; Harvard University; Harvard Medical School	Talcott, JA (corresponding author), Ctr Outcomes Res, Charlestown Navy Yard,Bldg 120,6th St,2nd Floor, Charlestown, MA 02129 USA.	jtalcott@partners.org	Niemierko, Andrzej/GSV-8546-2022; Niemierko, Andrzej/AAJ-2313-2020; Talcott, James/CAG-8759-2022	Niemierko, Andrzej/0000-0002-8895-5500; Clark, Jack/0000-0002-7424-1670	Massachusetts General Hospital, Boston, MA	Massachusetts General Hospital, Boston, MA	Funding/Support: This research was supported by the Bertucci Genitourinary Cancer Research Fund, Massachusetts General Hospital, Boston, MA.	BENK VA, 1993, INT J RADIAT ONCOL, V26, P551, DOI 10.1016/0360-3016(93)90978-5; Chen RC, 2009, J CLIN ONCOL, V27, P3916, DOI 10.1200/JCO.2008.18.6486; Clark JA, 2003, MED CARE, V41, P923, DOI 10.1097/00005650-200308000-00006; Clark JA, 2001, MED CARE, V39, P1118, DOI 10.1097/00005650-200110000-00009; Clark JA, 2006, J CLIN ONCOL, V24, P4457, DOI 10.1200/JCO.2006.06.2893; Dearnaley DP, 1999, LANCET, V353, P267, DOI 10.1016/S0140-6736(98)05180-0; Do YK, 2010, CANCER CAUSE CONTROL, V21, P31, DOI 10.1007/s10552-009-9431-y; Gardner BG, 2002, J UROLOGY, V167, P123, DOI 10.1016/S0022-5347(05)65395-5; Garg AK, 2006, INT J RADIAT ONCOL, V66, P1294, DOI 10.1016/j.ijrobp.2006.07.1386; Hanks GE, 1998, INT J RADIAT ONCOL, V41, P501, DOI 10.1016/S0360-3016(98)00089-3; Jacob R, 2004, CANCER-AM CANCER SOC, V100, P538, DOI 10.1002/cncr.11927; Jayadevappa R, 2007, CANCER-AM CANCER SOC, V109, P2229, DOI 10.1002/cncr.22675; Korfage IJ, 2006, SOC SCI MED, V63, P911, DOI 10.1016/j.socscimed.2006.01.027; LAWTON CA, 1991, INT J RADIAT ONCOL, V21, P935, DOI 10.1016/0360-3016(91)90732-J; Little DJ, 2003, UROLOGY, V62, P707, DOI 10.1016/S0090-4295(03)00504-1; LITWIN MS, 1995, JAMA-J AM MED ASSOC, V273, P129, DOI 10.1001/jama.273.2.129; Loeffler JS, 1997, SEMIN ONCOL, V24, P686; Mangar SA, 2006, RADIOTHER ONCOL, V80, P355, DOI 10.1016/j.radonc.2006.07.037; Papoulis A., 1991, PROBABILITY RANDOM V; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; SHIPLEY WU, 1995, INT J RADIAT ONCOL, V32, P3, DOI 10.1016/0360-3016(95)00063-5; STEWART A, 1992, MEASURING FUNCTION S; Talcott JA, 2003, J CLIN ONCOL, V21, P3979, DOI 10.1200/JCO.2003.01.199; Talcott JA, 2006, J UROLOGY, V176, P1558, DOI 10.1016/j.juro.2006.06.067; Wachter S, 2001, RADIOTHER ONCOL, V59, P65, DOI 10.1016/S0167-8140(01)00281-X; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Yeoh EE, 2006, INT J RADIAT ONCOL, V66, P1072, DOI 10.1016/j.ijrobp.2006.06.005; Yonemoto LT, 1997, INT J RADIAT ONCOL, V37, P21, DOI 10.1016/S0360-3016(96)00311-2; YU CL, 2003, QUAL LIFE RES, V12, P41; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233; Zietman AL, 2010, J CLIN ONCOL, V28, P1106, DOI 10.1200/JCO.2009.25.8475	31	75	76	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1046	1053		10.1001/jama.2010.287	http://dx.doi.org/10.1001/jama.2010.287			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233822	Bronze			2022-12-24	WOS:000275594100017
J	Wu, XW; Nguyen, BC; Dziunycz, P; Chang, S; Brooks, Y; Lefort, K; Hofbauer, GFL; Dotto, GP				Wu, Xunwei; Nguyen, Bach-Cuc; Dziunycz, Piotr; Chang, Sungeun; Brooks, Yang; Lefort, Karine; Hofbauer, Guenther F. L.; Dotto, G. Paolo			Opposing roles for calcineurin and ATF3 in squamous skin cancer	NATURE			English	Article							TRANSFORMED PHENOTYPE; CELLULAR SENESCENCE; TUMOR SUPPRESSION; C-MYC; CELLS; GROWTH; P63; TRANSCRIPTION; INHIBITOR; NFAT	Calcineurin inhibitors such as cyclosporin A (CsA) are the mainstay of immunosuppressive treatment for organ transplant recipients. Squamous cell carcinoma (SCC) of the skin is a major complication of treatment with these drugs, with a 65 to 100-fold higher risk than in the normal population(1). By contrast, the incidence of basal cell carcinoma (BCC), the other major keratinocyte-derived tumour of the skin, of melanoma and of internal malignancies increases to a significantly lesser extent(1). Here we report that genetic and pharmacological suppression of calcineurin/nuclear factor of activated T cells (NFAT) function promotes tumour formation in mouse skin and in xenografts, in immune compromised mice, of H-ras(V12) (also known as Hras1)-expressing primary human keratinocytes or keratinocyte-derived SCC cells. Calcineurin/NFAT inhibition counteracts p53 (also known as TRP53)-dependent cancer cell senescence, thereby increasing tumorigenic potential. ATF3, a member of the 'enlarged' AP-1 family, is selectively induced by calcineurin/NFAT inhibition, both under experimental conditions and in clinically occurring tumours, and increased ATF3 expression accounts for suppression of p53-dependent senescence and enhanced tumorigenic potential. Thus, intact calcineurin/NFAT signalling is critically required for p53 and senescence-associated mechanisms that protect against skin squamous cancer development.	[Wu, Xunwei; Nguyen, Bach-Cuc; Chang, Sungeun; Brooks, Yang; Dotto, G. Paolo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Dziunycz, Piotr; Hofbauer, Guenther F. L.] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Lefort, Karine; Dotto, G. Paolo] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Harvard University; Massachusetts General Hospital; University of Zurich; University Zurich Hospital; University of Lausanne	Dotto, GP (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	gian-paolo.dotto@unil.ch	chang, sungeun/AAH-1247-2020; Wu, Xunwei/J-9014-2018; Hofbauer, Gunther/B-2671-2010	Wu, Xunwei/0000-0002-0822-1700; Hofbauer, Gunther/0000-0003-0542-7989	NIH [AR054856, AR39190]; Swiss National Foundation [311003A-122281/1]; Oncosuisse [OCS-02361-02-2009]; European Union [LSHB-CT-2005-019067]; Korean Government Foundation [KRF-2007-013-E00044]; Olga-Mayenfisch-Stiftung; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR059471, R01AR054856, R01AR039190] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Oncosuisse; European Union(European Commission); Korean Government Foundation; Olga-Mayenfisch-Stiftung; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank P. Khavari, S. Kitajima, N. Clipstone and G. Crabtree for gift of retroviruses, W. Austen for human skin material, C. Brisken and C. Missero for careful reading of the manuscript, and E. Castillo for sequencing of the ras and p53 genes. This work was supported by grants from NIH (AR054856 and AR39190), the Swiss National Foundation (311003A-122281/1), Oncosuisse (OCS-02361-02-2009), the European Union (Epistem, Sixth Framework Program, LSHB-CT-2005-019067) and, in part, by a grant to S. C. by the Korean Government Foundation (KRF-2007-013-E00044) and to G. F. L. H. by the Olga-Mayenfisch-Stiftung.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; BURNS JE, 1993, BRIT J CANCER, V67, P1274, DOI 10.1038/bjc.1993.238; Cano E, 2005, J BIOL CHEM, V280, P29435, DOI 10.1074/jbc.M506205200; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DOTTO GP, 1988, P NATL ACAD SCI USA, V85, P6389, DOI 10.1073/pnas.85.17.6389; DOTTO GP, 1989, J CELL BIOL, V109, P3115, DOI 10.1083/jcb.109.6.3115; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Krizhanovsky V, 2008, COLD SH Q B, V73, P513, DOI 10.1101/sqb.2008.73.048; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Li A, 2004, METH MOL B, V289, P87; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Prince MEP, 2008, J CLIN ONCOL, V26, P2871, DOI 10.1200/JCO.2007.15.1613; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Wang AJ, 2007, MOL CARCINOGEN, V46, P476, DOI 10.1002/mc.20298; Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x	37	212	214	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2010	465	7296					368	U130		10.1038/nature08996	http://dx.doi.org/10.1038/nature08996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485437	Green Accepted			2022-12-24	WOS:000277829200045
J	Hedayati, SS; Minhajuddin, AT; Afshar, M; Toto, RD; Trivedi, MH; Rush, AJ				Hedayati, S. Susan; Minhajuddin, Abu T.; Afshar, Masoud; Toto, Robert D.; Trivedi, Madhukar H.; Rush, A. John			Association Between Major Depressive Episodes in Patients With Chronic Kidney Disease and Initiation of Dialysis, Hospitalization, or Death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEUROPSYCHIATRIC INTERVIEW MINI; CORONARY-HEART-DISEASE; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; MYOCARDIAL-INFARCTION; PSYCHOSOCIAL FACTORS; UNITED-STATES; MORTALITY; SURVIVAL; SYMPTOMS	Context Patients with chronic kidney disease (CKD) experience increased rates of hospitalization and death. Depressive disorders are associated with morbidity and mortality. Whether depression contributes to poor outcomes in patients with CKD not receiving dialysis is unknown. Objective To determine whether the presence of a current major depressive episode (MDE) is associated with poorer outcomes in patients with CKD. Design, Setting, and Patients Prospective cohort study of 267 consecutively recruited outpatients with CKD (stages 2-5 and who were not receiving dialysis) at a VA medical center between May 2005 and November 2006 and followed up for 1 year. An MDE was diagnosed by blinded personnel using the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) criteria. Main Outcome Measures The primary outcome was event-free survival defined as the composite of death, dialysis initiation, or hospitalization. Secondary outcomes included each of these events assessed separately. Results Among 267 patients, 56 had a current MDE (21%) and 211 did not (79%). There were 127 composite events, 116 hospitalizations, 38 dialysis initiations, and 18 deaths. Events occurred more often in patients with an MDE compared with those without an MDE (61% vs 44%, respectively, P=.03). Four patients with missing dates of hospitalization were excluded from survival analyses. The mean (SD) time to the composite event was 206.5 (19.8) days (95% CI, 167.7-245.3 days) for those with an MDE compared with 273.3 (8.5) days (95% CI, 256.6-290.0 days) for those without an MDE (P=.003). The adjusted hazard ratio (HR) for the composite event for patients with an MDE was 1.86 (95% CI, 1.23-2.84). An MDE at baseline independently predicted progression to dialysis (HR, 3.51; 95% CI, 1.77-6.97) and hospitalization (HR, 1.90; 95% CI, 1.23-2.95). Conclusion The presence of an MDE was associated with an increased risk of poor outcomes in CKD patients who were not receiving dialysis, independent of comorbidities and kidney disease severity. JAMA. 2010; 303(19): 1946-1953	[Hedayati, S. Susan] VA N Texas Hlth Care Syst, Nephrol Sect, Div Nephrol, Dept Med, Dallas, TX 75216 USA; [Minhajuddin, Abu T.] Univ Texas SW Med Ctr Dallas, Div Biostat, Dept Clin Sci, Dallas, TX 75390 USA; [Hedayati, S. Susan; Afshar, Masoud; Toto, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Med, Div Nephrol, Dallas, TX 75390 USA; [Trivedi, Madhukar H.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Rush, A. John] Duke NUS, Div Clin Sci, Singapore, Singapore	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National University of Singapore	Hedayati, SS (corresponding author), VA N Texas Hlth Care Syst, Nephrol Sect, Div Nephrol, Dept Med, MC 111G1,4500 S Lancaster Rd, Dallas, TX 75216 USA.	susan.hedayati@utsouthwestern.edu	Trivedi, Madhukar/A-9029-2013	Trivedi, Madhukar/0000-0002-2983-1110; Rush, Augustus/0000-0003-2004-2382; Hedayati, S Susan/0000-0001-8850-4729	Advanced Neuromodulation Systems; AstraZeneca; Best Practice Project Management; Bristol-Myers Squibb/Otsuka; Cyberonics Inc; Forest Pharmaceuticals; Gerson Lehrman Group; GlaxoSmithKline; Jazz Pharmaceuticals; Magellan Health Services; Merck Company; Neuronetics; Novartis Pharmaceuticals; Ono Pharmaceuticals; Organon; Otsuka Pharmaceuticals; Pamlab; Pfizer; Transcept Pharmaceuticals; Urban Institute; Wyeth Ayerst; Forest Laboratories; National Institute of Mental Health; Stanley Medical Research Institute; Veterans Integrated Systems Network 17; VA North Texas Health Care System Research Corporation; National Institutes of Health [2K24DK002818-0]; Rosewood Corporation Chair in Biomedical Science;  [P30DK079328]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002818, P30DK079328] Funding Source: NIH RePORTER	Advanced Neuromodulation Systems; AstraZeneca(AstraZeneca); Best Practice Project Management; Bristol-Myers Squibb/Otsuka(Otsuka PharmaceuticalBristol-Myers Squibb); Cyberonics Inc; Forest Pharmaceuticals; Gerson Lehrman Group; GlaxoSmithKline(GlaxoSmithKline); Jazz Pharmaceuticals(Jazz Pharmaceuticals); Magellan Health Services; Merck Company(Merck & Company); Neuronetics; Novartis Pharmaceuticals(Novartis); Ono Pharmaceuticals; Organon; Otsuka Pharmaceuticals(Otsuka Pharmaceutical); Pamlab; Pfizer(Pfizer); Transcept Pharmaceuticals; Urban Institute; Wyeth Ayerst; Forest Laboratories; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stanley Medical Research Institute; Veterans Integrated Systems Network 17; VA North Texas Health Care System Research Corporation(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosewood Corporation Chair in Biomedical Science; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Financial Disclosure: Dr Rush reported receiving consulting fees from Advanced Neuromodulation Systems, AstraZeneca, Best Practice Project Management, Bristol-Myers Squibb/Otsuka, Cyberonics, Forest Pharmaceuticals, Gerson Lehrman Group, GlaxoSmithKline, Jazz Pharmaceuticals, Magellan Health Services, Merck & Company, Neuronetics, Novartis Pharmaceuticals, Ono Pharmaceuticals, Organon, Otsuka Pharmaceuticals, Pamlab, Pfizer, Transcept Pharmaceuticals, Urban Institute, and Wyeth Ayerst; speaking fees from Cyberonics Inc, Forest Laboratories, GlaxoSmithKline, and Otsuka; royalties from Guilford Publications and Healthcare Technology Systems; and research support from the National Institute of Mental Health and the Stanley Medical Research Institute. He also reported owning shares of stock in Pfizer.; Funding/Support: This work was supported by grants from the Veterans Integrated Systems Network 17 and the VA North Texas Health Care System Research Corporation, which were used for the design and conduct of the study and collection, management, and analysis of data; and grant P30DK079328 to the University of Texas Southwestern Medical Center O'Brien Kidney Research Core Center (pilot and feasibility awarded to Susan Hedayati, MD), which was used for the analysis and interpretation of data and preparation of the manuscript. This work also was supported by National Institutes of Health grant 2K24DK002818-0 (awarded to Robert Toto, MD), which was used for the preparation and review of the manuscript. Support for Dr Rush was provided by the Rosewood Corporation Chair in Biomedical Science.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Ariyo AA, 2000, CIRCULATION, V102, P1773; Barefoot John C, 2003, J Cardiopulm Rehabil, V23, P404, DOI 10.1097/00008483-200311000-00002; Bonnet F, 2005, ATHEROSCLEROSIS, V178, P339, DOI 10.1016/j.atherosclerosis.2004.08.035; Boulware LE, 2006, CLIN J AM SOC NEPHRO, V1, P496, DOI 10.2215/CJN.00030505; BURTON HJ, 1986, PSYCHOSOM MED, V48, P261, DOI 10.1097/00006842-198603000-00011; CHRISTENSEN AJ, 1994, HEALTH PSYCHOL, V13, P521, DOI 10.1037/0278-6133.13.6.521; DEVINS GM, 1990, J NERV MENT DIS, V178, P127, DOI 10.1097/00005053-199002000-00008; Drayer RA, 2006, GEN HOSP PSYCHIAT, V28, P306, DOI 10.1016/j.genhosppsych.2006.03.008; Einwohner R, 2004, PERITON DIALYSIS INT, V24, P256; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Empana JP, 2005, CIRCULATION, V111, P2299, DOI 10.1161/01.CIR.0000164203.54111.AE; EVERETT KD, 1995, BEHAV MED, V21, P25, DOI 10.1080/08964289.1995.9933739; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; Friend R, 1997, ADV PERIT D, V13, P155; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751; Hedayati SS, 2008, KIDNEY INT, V74, P930, DOI 10.1038/ki.2008.311; Hedayati SS, 2009, AM J KIDNEY DIS, V54, P741, DOI 10.1053/j.ajkd.2009.05.003; Hedayati SS, 2009, AM J KIDNEY DIS, V54, P433, DOI 10.1053/j.ajkd.2009.03.016; Hedayati SS, 2009, AM J KIDNEY DIS, V54, P424, DOI 10.1053/j.ajkd.2009.03.017; Hedayati SS, 2006, KIDNEY INT, V69, P1662, DOI 10.1038/sj.ki.5000308; Hedayati SS, 2005, AM J KIDNEY DIS, V46, P642, DOI 10.1053/j.ajkd.2005.07.002; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Kimmel PL, 2000, KIDNEY INT, V57, P2093, DOI 10.1046/j.1523-1755.2000.00059.x; Kimmel PL, 2005, SEMIN DIALYSIS, V18, P91, DOI 10.1111/j.1525-139X.2005.18209.x; Kimmel PL, 1998, KIDNEY INT, V54, P245, DOI 10.1046/j.1523-1755.1998.00989.x; Koo JR, 2003, AM J KIDNEY DIS, V41, P1037, DOI 10.1016/S0272-6386(03)00201-4; Larkin M, 2002, LANCET, V359, P1836, DOI 10.1016/S0140-6736(02)08731-7; Lesperance F, 2002, CIRCULATION, V105, P1049, DOI 10.1161/hc0902.104707; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lopes AA, 2002, KIDNEY INT, V62, P199, DOI 10.1046/j.1523-1755.2002.00411.x; National Kidney Foundation,, FACTS CHRON KIDN DIS; Owen WF, 2003, J AM SOC NEPHROL, V14, pS76, DOI 10.1097/01.ASN.0000070145.00225.EC; *REN PHYS ASS, 2002, CLIN PRACT GUID, V3, P4; Safdar Nilofer, 1995, JPMA (Journal of the Pakistan Medical Association), V45, P293; Sensky T, 1996, PSYCHOTHER PSYCHOSOM, V65, P36, DOI 10.1159/000289029; Serebruany VL, 2003, CIRCULATION, V108, P939, DOI 10.1161/01.CIR.0000085163.21752.0A; Serebruany VL, 2003, BLOOD COAGUL FIBRIN, V14, P563, DOI 10.1097/00001721-200309000-00008; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SHULMAN R, 1989, PSYCHOL MED, V19, P945, DOI 10.1017/S0033291700005663; Soucie JM, 1996, J AM SOC NEPHROL, V7, P2169; Troidle L, 2003, AM J KIDNEY DIS, V42, P350, DOI 10.1016/S0272-6386(03)00661-9; *US REN DAT SYST, 2009, USRDS 2009 ANN REP A; WAI L, 1981, LANCET, V2, P1155; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818; Zimmermann PR, 2006, INT J PSYCHIAT MED, V36, P457, DOI 10.2190/H8L6-0016-U636-8512; [No title captured]	51	150	156	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2010	303	19					1946	1953		10.1001/jama.2010.619	http://dx.doi.org/10.1001/jama.2010.619			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597NJ	20483971	Green Accepted, Bronze			2022-12-24	WOS:000277764500021
J	Rennie, J; Burman-Roy, S; Murphy, S				Rennie, Janet; Burman-Roy, Shona; Murphy, Stephen			Neonatal jaundice: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPERBILIRUBINEMIA; UK		[Rennie, Janet] Univ Coll London NHS Fdn Trust London, Elizabeth Garrett Anderson Inst Womens Hlth, London NW1 2BU, England; [Burman-Roy, Shona; Murphy, Stephen] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England		Rennie, J (corresponding author), Univ Coll London NHS Fdn Trust London, Elizabeth Garrett Anderson Inst Womens Hlth, London NW1 2BU, England.	janet.rennie@uclh.nhs.uk		Cullen, Katherine/0000-0002-3704-4598	National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	The National Collaborating Centre for Women's and Children's Health was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.	Bhutani VK, 2009, J PERINATOL, V29, pS20, DOI 10.1038/jp.2008.212; Bhutani VK, 1999, PEDIATRICS, V103, P6, DOI 10.1542/peds.103.1.6; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; Maisels MJ, 2000, MG CLIN PED, P139; Manning D, 2007, ARCH DIS CHILD-FETAL, V92, P342, DOI 10.1136/adc.2006.105361; *NAT I HLTH CLIN E, 2006, CLIN GUID NAT I HLTH, V37; National Institute for Health and Clinical Excellence, 2010, CLIN GUID NAT I HLTH, V98; Newman TB, 2000, ARCH PEDIAT ADOL MED, V154, P1140, DOI 10.1001/archpedi.154.11.1140; Rennie JM, 2009, ARCH DIS CHILD-FETAL, V94, pF323, DOI 10.1136/adc.2008.147686	9	73	77	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2010	340								c2409	10.1136/bmj.c2409	http://dx.doi.org/10.1136/bmj.c2409			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601LU	20484363				2022-12-24	WOS:000278061800004
J	Black, DM; Kelly, MP; Genant, HK; Palermo, L; Eastell, R; Bucci-Rechtweg, C; Cauley, J; Leung, PC; Boonen, S; Santora, A; de Papp, A; Bauer, DC				Black, Dennis M.; Kelly, Michael P.; Genant, Harry K.; Palermo, Lisa; Eastell, Richard; Bucci-Rechtweg, Christina; Cauley, Jane; Leung, Ping Chung; Boonen, Steven; Santora, Arthur; de Papp, Anne; Bauer, Douglas C.		Fracture Intervention Trial Comm; HORIZON Pivotal Fracture Trial Ste	Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUPPRESSED BONE TURNOVER; FEMORAL-SHAFT FRACTURES; LONG-TERM ALENDRONATE; INTERVENTION TRIAL; VERTEBRAL FRACTURES; RANDOMIZED-TRIAL; THERAPY; WOMEN; OSTEOPOROSIS; RISK	BACKGROUND A number of recent case reports and series have identified a subgroup of atypical fractures of the femoral shaft associated with bisphosphonate use. A population-based study did not support this association. Such a relationship has not been examined in randomized trials. METHODS We performed secondary analyses using the results of three large, randomized bisphosphonate trials: the Fracture Intervention Trial (FIT), the FIT Long-Term Extension (FLEX) trial, and the Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly (HORIZON) Pivotal Fracture Trial (PFT). We reviewed fracture records and radiographs (when available) from all hip and femur fractures to identify those below the lesser trochanter and above the distal metaphyseal flare (subtrochanteric and diaphyseal femur fractures) and to assess atypical features. We calculated the relative hazards for subtrochanteric and diaphyseal fractures for each study. RESULTS We reviewed 284 records for hip or femur fractures among 14,195 women in these trials. A total of 12 fractures in 10 patients were classified as occurring in the subtrochanteric or diaphyseal femur, a combined rate of 2.3 per 10,000 patient-years. As compared with placebo, the relative hazard was 1.03 (95% confidence interval [CI], 0.06 to 16.46) for alendronate use in the FIT trial, 1.50 (95% CI, 0.25 to 9.00) for zoledronic acid use in the HORIZON-PFT trial, and 1.33 (95% CI, 0.12 to 14.67) for continued alendronate use in the FLEX trial. Although increases in risk were not significant, confidence intervals were wide. CONCLUSIONS The occurrence of fracture of the subtrochanteric or diaphyseal femur was very rare, even among women who had been treated with bisphosphonates for as long as 10 years. There was no significant increase in risk associated with bisphosphonate use, but the study was underpowered for definitive conclusions.	[Black, Dennis M.; Kelly, Michael P.; Genant, Harry K.; Palermo, Lisa; Bauer, Douglas C.] Univ Calif San Francisco, San Francisco, CA 94107 USA; [Eastell, Richard] Univ Sheffield, Sheffield, S Yorkshire, England; [Bucci-Rechtweg, Christina] Novartis Pharmaceut, E Hanover, NJ USA; [Cauley, Jane] Univ Pittsburgh, Pittsburgh, PA USA; [Leung, Ping Chung] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Boonen, Steven] Katholieke Univ Leuven, Leuven, Belgium; [Santora, Arthur; de Papp, Anne] Merck Res Labs, Rahway, NJ USA	University of California System; University of California San Francisco; University of Sheffield; Novartis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese University of Hong Kong; KU Leuven; Merck & Company	Black, DM (corresponding author), Univ Calif San Francisco, 185 Berry St,Suite 5700, San Francisco, CA 94107 USA.	dblack@psg.ucsf.edu	Kelly, Michael P/CAE-8607-2022; Eastell, Richard/G-5851-2011	Kelly, Michael P/0000-0001-6221-7406; Eastell, Richard/0000-0002-0323-3366; Cauley, Jane A/0000-0003-0752-4408	Merck; Novartis; Amgen; Roche; AstraZeneca; GlaxoSmithKline; Medtronics; Nastech; Nestle; Fonterra Brands; Ono Pharma; Osteologix; Pfizer; Lilly; Sanofi-Aventis; Tethys; Unilever; Unipath; Inverness Medical; Ortho Clinical Diagnostics; OSI Prosidion; Takeda; National Osteoporosis Foundation; Procter Gamble	Merck(Merck & Company); Novartis(Novartis); Amgen(Amgen); Roche(Roche Holding); AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Medtronics; Nastech; Nestle(Nestle SA); Fonterra Brands(Fonterra); Ono Pharma; Osteologix; Pfizer(Pfizer); Lilly(Eli Lilly); Sanofi-Aventis(Sanofi-Aventis); Tethys; Unilever(Unilever); Unipath; Inverness Medical; Ortho Clinical Diagnostics; OSI Prosidion; Takeda(Takeda Pharmaceutical Company Ltd); National Osteoporosis Foundation; Procter Gamble(Procter & Gamble)	Supported by Merck and Novartis.; Dr. Black reports receiving grants (to UCSF) from Merck, Novartis, Amgen, and Roche and travel reimbursements from Merck and Novartis; Dr. Genant, receiving consulting and lecture fees and grant support from Merck and Novartis; Ms. Palermo, receiving support from Nycomed for data analysis; Dr. Eastell, serving on advisory boards for Procter & Gamble and the Medical Research Council and receiving consulting fees from Amgen, AstraZeneca, GlaxoSmithKline, Medtronics, Nastech, Nestle, Fonterra Brands, Novartis, Ono Pharma, Osteologix, Pfizer, Lilly, Sanofi-Aventis, Tethys, Unilever, Unipath, Inverness Medical, Ortho Clinical Diagnostics, OSI Prosidion, and Roche, lecture fees from Takeda, Lilly, Amgen, National Osteoporosis Foundation, Procter & Gamble, and GlaxoSmithKline Nutrition, and travel expenses from Novartis; Dr. Bucci-Rechwig, being a full-time employee of and having an equity interest in Novartis; Dr. Cauley, receiving consulting fees from Novartis; Drs. Santora and de Papp, being full-time employees of and having equity interests in Merck; and Dr. Bauer, receiving consulting fees from Amgen and lecture fees from Merck. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	Abrahamsen B, 2009, J BONE MINER RES, V24, P1095, DOI [10.1359/JBMR.081247, 10.1359/jbmr.081247]; Armamento-Villareal R, 2006, NEW ENGL J MED, V355, P2048, DOI 10.1056/NEJMc062268; Armamento-Villareal R, 2009, CALCIFIED TISSUE INT, V85, P37, DOI 10.1007/s00223-009-9263-5; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; BLACK DM, 1993, OSTEOPOROSIS INT, V3, pS29; Black DM, 2000, J CLIN ENDOCR METAB, V85, P4118, DOI 10.1210/jc.85.11.4118; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Capeci CM, 2009, J BONE JOINT SURG AM, V91A, P2556, DOI 10.2106/JBJS.H.01774; Cheung Ralph K. H., 2007, Hong Kong Medical Journal, V13, P485; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Glover SJ, 2009, J BONE MINER RES, V24, P389, DOI [10.1359/jbmr.080703, 10.1359/JBMR.080703]; Goh SK, 2007, J BONE JOINT SURG BR, V89B, P349, DOI 10.1302/0301-620X.89B3.18146; Ing-Lorenzini K, 2009, DRUG SAFETY, V32, P775, DOI 10.2165/00002018-200932090-00002; Kwek EBK, 2008, INJURY, V39, P224, DOI 10.1016/j.injury.2007.08.036; Lenart BA, 2009, OSTEOPOROSIS INT, V20, P1353, DOI 10.1007/s00198-008-0805-x; Lenart BA, 2008, NEW ENGL J MED, V358, P1304, DOI 10.1056/NEJMc0707493; Neviaser AS, 2008, J ORTHOP TRAUMA, V22, P346, DOI 10.1097/BOT.0b013e318172841c; Nieves JW, 2010, OSTEOPOROSIS INT, V21, P399, DOI 10.1007/s00198-009-0962-6; Odvina C, 2009, CLIN ENDOCRINOL 0319; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Salminen S, 1997, J TRAUMA, V43, P117, DOI 10.1097/00005373-199707000-00027; Somford MP, 2009, J BONE MINER RES, V24, P1736, DOI [10.1359/JBMR.090408, 10.1359/jbmr.090408]; Visekruna M, 2008, J CLIN ENDOCR METAB, V93, P2948, DOI 10.1210/jc.2007-2803; Walker AM, 1996, EPIDEMIOLOGY, V7, P335	25	351	366	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2010	362	19					1761	1771		10.1056/NEJMoa1001086	http://dx.doi.org/10.1056/NEJMoa1001086			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594RQ	20335571				2022-12-24	WOS:000277555500003
J	Kartal, B; Kuenen, JG; van Loosdrecht, MCM				Kartal, B.; Kuenen, J. G.; van Loosdrecht, M. C. M.			Sewage Treatment with Anammox	SCIENCE			English	Editorial Material							AMMONIUM OXIDATION; WASTE-WATER; REACTOR; BACTERIA; REMOVAL; SYSTEM		[Kartal, B.] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Kuenen, J. G.; van Loosdrecht, M. C. M.] Delft Univ Technol, NL-2628 BC Delft, Netherlands	Radboud University Nijmegen; Delft University of Technology	Kartal, B (corresponding author), Radboud Univ Nijmegen, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	j.g.kuenen@tudelft.nl	van Loosdrecht, Mark C.M./B-2738-2009; Kartal, Boran/D-2488-2014; van Loosdrecht, Mark/AAA-9997-2019; Kartal, Boran/ABD-5400-2021	van Loosdrecht, Mark C.M./0000-0003-0658-4775; Kartal, Boran/0000-0003-4199-952X				Abma WR, 2010, WATER SCI TECHNOL, V61, P1715, DOI 10.2166/wst.2010.977; Arrigo KR, 2005, NATURE, V438, P122, DOI 10.1038/nature04265; Damste JSS, 2002, NATURE, V419, P708, DOI 10.1038/nature01128; de Kreuk MK, 2005, WATER RES, V39, P4476, DOI 10.1016/j.watres.2005.08.031; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Jetten MSM, 1997, WATER SCI TECHNOL, V35, P171, DOI 10.2166/wst.1997.0341; Kuenen JG, 2008, NAT REV MICROBIOL, V6, P320, DOI 10.1038/nrmicro1857; LETTINGA G, 1991, WATER SCI TECHNOL, V24, P87, DOI 10.2166/wst.1991.0220; LETTINGA G, 1980, BIOTECHNOL BIOENG, V22, P699, DOI 10.1002/bit.260220402; MULDER A, 1995, FEMS MICROBIOL ECOL, V16, P177, DOI 10.1016/0168-6496(94)00081-7; Siegrist H, 2008, WATER SCI TECHNOL, V57, P383, DOI 10.2166/wst.2008.048; Third KA, 2001, SYST APPL MICROBIOL, V24, P588, DOI 10.1078/0723-2020-00077; van der Star WRL, 2007, WATER RES, V41, P4149, DOI 10.1016/j.watres.2007.03.044; Wett B, 2007, WATER SCI TECHNOL, V56, P81, DOI 10.2166/wst.2007.611	14	799	933	50	1010	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					702	703		10.1126/science.1185941	http://dx.doi.org/10.1126/science.1185941			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448175				2022-12-24	WOS:000277357100027
J	Brownstein, JS; Freifeld, CC; Chan, EH; Keller, M; Sonricker, AL; Mekaru, SR; Buckeridge, DL				Brownstein, John S.; Freifeld, Clark C.; Chan, Emily H.; Keller, Mikaela; Sonricker, Amy L.; Mekaru, Sumiko R.; Buckeridge, David L.			Information Technology and Global Surveillance of Cases of 2009 H1N1 Influenza.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH		[Brownstein, John S.; Keller, Mikaela] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Pediat, Boston, MA 02215 USA; [Brownstein, John S.; Freifeld, Clark C.; Chan, Emily H.; Keller, Mikaela; Sonricker, Amy L.; Mekaru, Sumiko R.] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Computat Epidemiol Grp, Childrens Hosp Informat Program, Boston, MA USA; [Mekaru, Sumiko R.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Freifeld, Clark C.] MIT, Media Lab, Cambridge, MA 02139 USA; [Brownstein, John S.; Buckeridge, David L.] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Buckeridge, David L.] Direct Sante Publ Montreal, Montreal, PQ, Canada	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Boston University; Massachusetts Institute of Technology (MIT); McGill University	Brownstein, JS (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Pediat, 1 Autumn St,Rm 451, Boston, MA 02215 USA.	john_brownstein@harvard.edu	Tao, Youyou/D-2367-2014; Brownstein, John S/A-1438-2011	Mekaru, Sumiko/0000-0002-9782-3833	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073591] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [G08LM009776] Funding Source: NIH RePORTER; CIHR Funding Source: Medline; NIAID NIH HHS [R21 AI073591-02, R21 AI073591] Funding Source: Medline; NLM NIH HHS [G08LM009776-01A2, G08 LM009776-01A2, G08 LM009776] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); CIHR(Canadian Institutes of Health Research (CIHR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Diamond CC, 2009, HEALTH AFFAIR, V28, P454, DOI 10.1377/hlthaff.28.2.454; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Hartley Dm, 2010, Emerg Health Threats J, V3, pe3, DOI 10.3134/ehtj.10.003; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Mandl KD, 2008, NEW ENGL J MED, V358, P1732, DOI 10.1056/NEJMsb0800220; *NOV SWIN OR INFL, 2009, NEW ENGL J MED, V361, P102	10	72	74	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					1731	1735		10.1056/NEJMsr1002707	http://dx.doi.org/10.1056/NEJMsr1002707			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	591OQ	20445186	Green Accepted			2022-12-24	WOS:000277311200013
J	Roberts, SA; Strande, N; Burkhalter, MD; Strom, C; Havener, JM; Hasty, P; Ramsden, DA				Roberts, Steven A.; Strande, Natasha; Burkhalter, Martin D.; Strom, Christina; Havener, Jody M.; Hasty, Paul; Ramsden, Dale A.			Ku is a 5 '-dRP/AP lyase that excises nucleotide damage near broken ends	NATURE			English	Article							DOUBLE-STRAND BREAKS; DNA-POLYMERASE-BETA; REPAIR IN-VITRO; PHOSPHATE LYASE; URACIL EXCISION; PROTEIN-KINASE; CELLS; IDENTIFICATION; DEPENDENCE; ROLES	Mammalian cells require non-homologous end joining (NHEJ) for the efficient repair of chromosomal DNA double-strand breaks(1). A key feature of biological sources of strand breaks is associated nucleotide damage, including base loss (abasic or apurinic/apyrimidinic (AP) sites)(2). At single-strand breaks, 5'-terminal abasic sites are excised by the 5'-deoxyribose-5-phosphate (5'-dRP) lyase activity of DNA polymerase beta (pol beta)(3-6): here we show, in vitro and in cells, that accurate and efficient repair by NHEJ of double-strand breaks with such damage similarly requires 5'-dRP/AP lyase activity. Classically defined NHEJ is moreover uniquely effective at coupling this end-cleaning step to joining in cells, helping to distinguish this pathway from otherwise robust alternative NHEJ pathways. The NHEJ factor Ku can be identified as an effective 5'-dRP/AP lyase. In a similar manner to other lyases(7), Ku nicks DNA 3' of an abasic site by a mechanism involving a Schiff-base covalent intermediate with the abasic site. We show by using cell extracts that Ku is essential for the efficient removal of AP sites near double-strand breaks and, consistent with this result, that joining of such breaks is specifically decreased in cells complemented with a lyase-attenuated Ku mutant. Ku had previously been presumed only to recognize ends and recruit other factors that process ends; our data support an unexpected direct role for Ku in end-processing steps as well.	[Roberts, Steven A.; Strande, Natasha; Burkhalter, Martin D.; Strom, Christina; Havener, Jody M.; Ramsden, Dale A.] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Roberts, Steven A.; Strande, Natasha; Burkhalter, Martin D.; Strom, Christina; Havener, Jody M.; Ramsden, Dale A.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Hasty, Paul] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78245 USA; [Hasty, Paul] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78245 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Ramsden, DA (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	dale_ramsden@med.unc.edu	Strande, Natasha T./H-9894-2019	Strande, Natasha T./0000-0001-5148-9772; Hasty, Paul/0000-0003-3046-0131; Burkhalter, Martin/0000-0002-8646-3131; Ramsden, Dale/0000-0003-1575-4748	Public Health Service (PHS) [CA 84442, R01 CA76317-05A1, P01 AG17242]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA084442, R01CA076317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	Public Health Service (PHS)(United States Department of Health & Human ServicesUnited States Public Health Service); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Gellert, T. Kunkel, M. Garcia-Diaz, T. Traut, L. Harrison and K. Meek for helpful comments. This work was supported by Public Health Service (PHS) grant CA 84442 and a Leukemia and Lymphoma Society scholar award to D. A. R., and by PHS grants R01 CA76317-05A1 and P01 AG17242 to P. H.	AHNSTROM G, 1982, INT J RADIAT BIOL, V41, P671, DOI 10.1080/09553008214550761; Allinson SL, 2001, EMBO J, V20, P6919, DOI 10.1093/emboj/20.23.6919; Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; Bebenek K, 2005, J BIOL CHEM, V280, P20051, DOI 10.1074/jbc.M501981200; Daley JM, 2008, DNA REPAIR, V7, P67, DOI 10.1016/j.dnarep.2007.07.018; Davis BJ, 2008, NUCLEIC ACIDS RES, V36, P3085, DOI 10.1093/nar/gkn164; Di Noia JM, 2007, J EXP MED, V204, P3209, DOI 10.1084/jem.20071768; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Garcia-Diaz M, 2001, J BIOL CHEM, V276, P34659, DOI 10.1074/jbc.M106336200; Guirouilh-Barbat J, 2007, P NATL ACAD SCI USA, V104, P20902, DOI 10.1073/pnas.0708541104; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Ilina ES, 2008, BBA-PROTEINS PROTEOM, V1784, P1777, DOI 10.1016/j.bbapap.2008.08.001; JEGGO PA, 1990, MUTAT RES, V239, P1, DOI 10.1016/0165-1110(90)90028-A; Kabotyanski EB, 1998, NUCLEIC ACIDS RES, V26, P5333, DOI 10.1093/nar/26.23.5333; Li H, 2009, ONCOGENE, V28, P1875, DOI 10.1038/onc.2009.57; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i; Prasad R, 1998, J BIOL CHEM, V273, P11121, DOI 10.1074/jbc.273.18.11121; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Prasad R, 2009, NUCLEIC ACIDS RES, V37, P1868, DOI 10.1093/nar/gkp035; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Schulte-Uentrop L, 2008, NUCLEIC ACIDS RES, V36, P2561, DOI 10.1093/nar/gkn094; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Stewart RD, 2001, RADIAT RES, V156, P365, DOI 10.1667/0033-7587(2001)156[0365:TLKMOD]2.0.CO;2; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; Yang N, 2004, DNA REPAIR, V3, P1323, DOI 10.1016/j.dnarep.2004.04.014	31	141	147	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1214	U139		10.1038/nature08926	http://dx.doi.org/10.1038/nature08926			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20383123	Green Accepted, Green Submitted			2022-12-24	WOS:000276891100042
J	Duval, X; Iung, B; Klein, I; Brochet, E; Thabut, G; Arnoult, F; Lepage, L; Laissy, JP; Wolff, M; Leport, C				Duval, Xavier; Iung, Bernard; Klein, Isabelle; Brochet, Eric; Thabut, Gabriel; Arnoult, Florence; Lepage, Laurent; Laissy, Jean-Pierre; Wolff, Michel; Leport, Catherine		IMAGE Resonance Magnetic Imaging	Effect of Early Cerebral Magnetic Resonance Imaging on Clinical Decisions in Infective Endocarditis A Prospective Study	ANNALS OF INTERNAL MEDICINE			English	Article							CEREBROVASCULAR COMPLICATIONS; PROGNOSTIC VALUE; MICROBLEEDS; ECHOCARDIOGRAPHY; DIAGNOSIS; EMBOLISM; DEATH; RISK	Background: Neurologic complications of endocarditis can influence diagnosis, therapeutic plans, and prognosis. Objective: To describe how early cerebral magnetic resonance imaging (MRI) affects the diagnosis and management of endocarditis in hospitalized adults. Design: Single-center prospective study between June 2005 and October 2008. (ClinicalTrials.govregistration number: NCT00144885) Setting: Tertiary care university hospital in France. Patients: 130 patients with endocarditis. Intervention: Cerebral MRI with angiography performed up to 7 days after admission and before any surgical intervention. Measurements: 2 experts jointly established the endocarditis diagnostic classification ( according to Duke-modified criteria) and therapeutic plans just before and after MRI and then compared them. Results: Endocarditis was initially classified as definite in 77 patients and possible in 50 and was excluded in 3. Sixteen patients (12%) had acute neurologic symptoms. Cerebral lesions were detected by MRI in 106 patients (82% [95% CI, 75% to 89%]), including ischemic lesions in 68, microhemorrhages in 74, and silent aneurysms in 10. Solely on the basis of MRI results and excluding microhemorrhages, diagnostic classification of 17 of 53 (32%) cases of nondefinite endocarditis was upgraded to either definite ( 14 patients) or possible ( 3 patients). Endocarditis therapeutic plans were modified for 24 (18%) of the 130 patients, including surgical plan modifications for 18 (14%). Overall, early MRI led to modifications of diagnosis or therapeutic plan in 36 patients (28% [CI, 20% to 36%]). Limitation: Investigators did not assess whether the MRI-related changes in diagnosis and therapeutic plans improved patient outcomes or led to unnecessary procedures and increased costs. Conclusion: Cerebral lesions were identified by MRI in many patients with endocarditis but no neurologic symptoms. The MRI findings affected both diagnostic classifications and clinical management plans.	Univ Paris 07, Bichat Univ Hosp, AP HP, Sch Med, Paris, France; INSERM, CIC 007, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Duval, X (corresponding author), Hop Bichat Claude Bernard, Ctr Invest Clin, 46 Rue Henri Huchard, F-75877 Paris 18, France.	xavier.duval@bch.aphp.fr	Ruimy, Raymond/P-6068-2016; Essig, Marie/Q-5770-2016; Iung, Bernard/AAQ-9004-2020	Essig, Marie/0000-0002-2030-5616; Iung, Bernard/0000-0002-9127-348X; Ravaud, Philippe/0000-0001-8264-9206; MOURVILLIER, BRUNO/0000-0001-5227-1468; Vrtovsnik, Francois/0000-0003-1554-314X; patrick, nataf/0000-0002-8412-6182	French Ministry of Health	French Ministry of Health	Primary Funding Source: French Ministry of Health.	Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Bannay A, 2009, EUR HEART J; Chu VH, 2004, CIRCULATION, V109, P1745, DOI 10.1161/01.CIR.0000124719.61827.7F; Cooper HA, 2009, CIRCULATION, V120, P585, DOI 10.1161/CIRCULATIONAHA.108.834432; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; Di Salvo G, 2001, J AM COLL CARDIOL, V37, P1069, DOI 10.1016/S0735-1097(00)01206-7; Dixon AK, 1997, LANCET, V350, P509, DOI 10.1016/S0140-6736(97)06100-X; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Heiro M, 2000, ARCH INTERN MED, V160, P2781, DOI 10.1001/archinte.160.18.2781; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Imaizumi T, 2004, J NEUROIMAGING, V14, P251, DOI 10.1177/1051228404265714; Klein I, 2007, NEUROLOGY, V68, P2043, DOI 10.1212/01.wnl.0000266965.04112.bc; Klein I, 2009, STROKE, V40, P3461, DOI 10.1161/STROKEAHA.109.562546; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; PANKEY GA, 1961, ANN INTERN MED, V55, P550, DOI 10.7326/0003-4819-55-4-550; Provenchere S, 2003, ANESTH ANALG, V96, P1258, DOI 10.1213/01.ANE.0000055803.92191.69; PRUITT AA, 1978, MEDICINE, V57, P329, DOI 10.1097/00005792-197807000-00004; Snygg-Martin U, 2008, CLIN INFECT DIS, V47, P23, DOI 10.1086/588663; STECKELBERG JM, 1991, ANN INTERN MED, V114, P635, DOI 10.7326/0003-4819-114-8-635; Subramaniam S, 2006, NEUROLOGY, V67, P1697, DOI 10.1212/01.wnl.0000229143.28230.ce; Thuny F, 2005, CIRCULATION, V112, P69, DOI 10.1161/CIRCULATIONAHA.104.493155; Thuny F, 2007, EUR HEART J, V28, P1155, DOI 10.1093/eurheartj/ehm005	24	177	181	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2010	152	8					497	U40		10.7326/0003-4819-152-8-201004200-00006	http://dx.doi.org/10.7326/0003-4819-152-8-201004200-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588FV	20404380				2022-12-24	WOS:000277054400003
J	Uemura, S; Aitken, CE; Korlach, J; Flusberg, BA; Turner, SW; Puglisi, JD				Uemura, Sotaro; Aitken, Colin Echeverria; Korlach, Jonas; Flusberg, Benjamin A.; Turner, Stephen W.; Puglisi, Joseph D.			Real-time tRNA transit on single translating ribosomes at codon resolution	NATURE			English	Article							ALLOSTERIC 3-SITE MODEL; ELONGATION-FACTOR G; L1 STALK; POLYMERASE MOLECULES; ANTIBIOTICS; MECHANISMS; SELECTION; MOVEMENT; DYNAMICS; GUIDES	Translation by the ribosome occurs by a complex mechanism involving the coordinated interaction of multiple nucleic acid and protein ligands. Here we use zero-mode waveguides (ZMWs) and sophisticated detection instrumentation to allow real-time observation of translation at physiologically relevant micromolar ligand concentrations. Translation at each codon is monitored by stable binding of transfer RNAs (tRNAs)-labelled with distinct fluorophores-to translating ribosomes, which allows direct detection of the identity of tRNA molecules bound to the ribosome and therefore the underlying messenger RNA (mRNA) sequence. We observe the transit of tRNAs on single translating ribosomes and determine the number of tRNA molecules simultaneously bound to the ribosome, at each codon of an mRNA molecule. Our results show that ribosomes are only briefly occupied by two tRNA molecules and that release of deacylated tRNA from the exit (E) site is uncoupled from binding of aminoacyl-tRNA site (A-site) tRNA and occurs rapidly after translocation. The methods outlined here have broad application to the study of mRNA sequences, and the mechanism and regulation of translation.	[Uemura, Sotaro; Aitken, Colin Echeverria; Puglisi, Joseph D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Uemura, Sotaro] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Aitken, Colin Echeverria; Puglisi, Joseph D.] Stanford Univ, Sch Med, Biophys Program, Stanford, CA 94305 USA; [Korlach, Jonas; Flusberg, Benjamin A.; Turner, Stephen W.] Pacific Biosci Inc, Menlo Pk, CA 94025 USA	Stanford University; Japan Science & Technology Agency (JST); Stanford University	Puglisi, JD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	puglisi@stanford.edu	Turner, Stephen/GXM-4654-2022		National Institutes of Health [GM51266]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM51266 (to J. D. P.). We thank T. Funatsu, A. Tsai and A. Petrov for encouragement and discussions. We thank J. Gray for performing ellipsometry experiments.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; AITKEN CE, NAT STRUCT IN PRESS; Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; BODLEY JW, 1972, BIOCHEM BIOPH RES CO, V46, P871, DOI 10.1016/S0006-291X(72)80222-5; Chan V, 1995, BIOPHYS J, V69, P2243, DOI 10.1016/S0006-3495(95)80095-0; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Fei JY, 2009, P NATL ACAD SCI USA, V106, P15702, DOI 10.1073/pnas.0908077106; Foquet M, 2008, J APPL PHYS, V103, DOI 10.1063/1.2831366; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; HAUSNER TP, 1988, J BIOL CHEM, V263, P13103; Korlach J, 2008, P NATL ACAD SCI USA, V105, P1176, DOI 10.1073/pnas.0710982105; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; LILL R, 1987, J MOL BIOL, V196, P137, DOI 10.1016/0022-2836(87)90516-X; Lundquist PM, 2008, OPT LETT, V33, P1026, DOI 10.1364/OL.33.001026; Marshall RA, 2008, ANNU REV BIOCHEM, V77, P177, DOI 10.1146/annurev.biochem.77.070606.101431; Marshall RA, 2009, MOL CELL, V35, P37, DOI 10.1016/j.molcel.2009.06.008; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Sanders CL, 2007, RNA, V13, P1483, DOI 10.1261/rna.638707; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; Semenkov YP, 1996, P NATL ACAD SCI USA, V93, P12183, DOI 10.1073/pnas.93.22.12183; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; Underwood KA, 2005, BIOTECHNOL BIOENG, V91, P425, DOI 10.1002/bit.20529	28	273	282	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1012	U73		10.1038/nature08925	http://dx.doi.org/10.1038/nature08925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393556	Green Accepted			2022-12-24	WOS:000276635000032
J	Hagberg, CE; Falkevall, A; Wang, X; Larsson, E; Huusko, J; Nilsson, I; van Meeteren, LA; Samen, E; Lu, L; Vanwildemeersch, M; Klar, J; Genove, G; Pietras, K; Stone-Elander, S; Claesson-Welsh, L; Yla-Herttuala, S; Lindahl, P; Eriksson, U				Hagberg, Carolina E.; Falkevall, Annelie; Wang, Xun; Larsson, Erik; Huusko, Jenni; Nilsson, Ingrid; van Meeteren, Laurens A.; Samen, Erik; Lu, Li; Vanwildemeersch, Maarten; Klar, Joakim; Genove, Guillem; Pietras, Kristian; Stone-Elander, Sharon; Claesson-Welsh, Lena; Yla-Herttuala, Seppo; Lindahl, Per; Eriksson, Ulf			Vascular endothelial growth factor B controls endothelial fatty acid uptake	NATURE			English	Article							VEGF-B; LIPID-METABOLISM; TRANSPORT; ANGIOGENESIS; MOUSE; LACKING; FLT-1; PERMEABILITY; RECEPTOR-1; LETHALITY	The vascular endothelial growth factors (VEGFs) are major angiogenic regulators and are involved in several aspects of endothelial cell physiology(1). However, the detailed role of VEGF-B in blood vessel function has remained unclear(2,3). Here we show that VEGF-B has an unexpected role in endothelial targeting of lipids to peripheral tissues. Dietary lipids present in circulation have to be transported through the vascular endothelium to be metabolized by tissue cells, a mechanism that is poorly understood(4). Bioinformatic analysis showed that Vegfb was tightly co-expressed with nuclear-encoded mitochondrial genes across a large variety of physiological conditions in mice, pointing to a role for VEGF-B in metabolism. VEGF-B specifically controlled endothelial uptake of fatty acids via transcriptional regulation of vascular fatty acid transport proteins. As a consequence, Vegfb(-/-) mice showed less uptake and accumulation of lipids in muscle, heart and brown adipose tissue, and instead shunted lipids to white adipose tissue. This regulation was mediated by VEGF receptor 1 and neuropilin 1 expressed by the endothelium. The co-expression of VEGF-B and mitochondrial proteins introduces a novel regulatory mechanism, whereby endothelial lipid uptake and mitochondrial lipid use are tightly coordinated. The involvement of VEGF-B in lipid uptake may open up the possibility for novel strategies to modulate pathological lipid accumulation in diabetes, obesity and cardiovascular diseases.	[Hagberg, Carolina E.; Falkevall, Annelie; Wang, Xun; Nilsson, Ingrid; Vanwildemeersch, Maarten; Pietras, Kristian; Eriksson, Ulf] Karolinska Inst, Tissue Biol Grp, Div Matrix Biol, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Hagberg, Carolina E.; Falkevall, Annelie; Wang, Xun; Vanwildemeersch, Maarten; Klar, Joakim; Pietras, Kristian; Eriksson, Ulf] Ludwig Inst Canc Res Ltd, Stockholm Branch, Karolinska Inst, SE-17177 Stockholm, Sweden; [Larsson, Erik; Lindahl, Per] Univ Gothenburg, Inst Biomed, SE-40530 Gothenburg, Sweden; [Huusko, Jenni; Yla-Herttuala, Seppo] Univ Kuopio, AI Virtanen Inst, Dept Biotechnol & Mol Med, FIN-70211 Kuopio, Finland; [van Meeteren, Laurens A.; Klar, Joakim; Claesson-Welsh, Lena] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; [Samen, Erik; Stone-Elander, Sharon] Karolinska Pharm, Karolinska Univ Hosp, SE-17176 Stockholm, Sweden; [Samen, Erik; Lu, Li; Stone-Elander, Sharon] Karolinska Inst, SE-17176 Stockholm, Sweden; [Genove, Guillem] Karolinska Inst, Lab Vasc Biol, Div Matrix Biol, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Lindahl, Per] Sahlgrens Univ Hosp, Wallenberg Lab Cardiovasc Res, SE-41345 Gothenburg, Sweden	Karolinska Institutet; Karolinska Institutet; Ludwig Institute for Cancer Research; University of Gothenburg; University of Eastern Finland; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Sahlgrenska University Hospital	Eriksson, U (corresponding author), Karolinska Inst, Tissue Biol Grp, Div Matrix Biol, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden.	ulf.pe.eriksson@ki.se	Pietras, Kristian/ABG-2097-2021; Larsson Lekholm, Erik/AHE-0932-2022; Larsson Lekholm, Erik/HDM-8032-2022; van Meeteren, Laurens/A-9890-2008; Van Meeteren, Laurens A./AGQ-6139-2022; Klar, Joakim/H-2900-2019; Pietras, Kristian/ABE-8727-2020; Genove, Guillem/F-1158-2011	Pietras, Kristian/0000-0001-6738-4705; Larsson Lekholm, Erik/0000-0003-1400-0119; Larsson Lekholm, Erik/0000-0003-1400-0119; van Meeteren, Laurens/0000-0001-9885-0668; Klar, Joakim/0000-0003-4185-7409; Genove, Guillem/0000-0002-8558-3107; Yla-Herttuala, Seppo/0000-0001-7593-2708; Hagberg, Carolina/0000-0002-5497-2855	Wilhelm och Else Stockmanns Stiftelse; Frans Wilhelm och Waldemar von Frenckells fond; European Commission [LSHG-CT-2004-503573]; Dutch Cancer Society; Novo Nordisk Foundation; Swedish Cancer Foundation; Swedish Research Council; Dr. Peter Wallenbergs Foundation for Economics and Technology; LeDucq Foundation; Swedish Brain Foundation and Hallstens Forskningsstiftelse; Karolinska Institutet	Wilhelm och Else Stockmanns Stiftelse; Frans Wilhelm och Waldemar von Frenckells fond; European Commission(European CommissionEuropean Commission Joint Research Centre); Dutch Cancer Society(KWF Kankerbestrijding); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Dr. Peter Wallenbergs Foundation for Economics and Technology; LeDucq Foundation(Leducq Foundation); Swedish Brain Foundation and Hallstens Forskningsstiftelse; Karolinska Institutet(Karolinska Institutet)	We thank S. Rezian for technical assistance; W. C. Claycomb for the gift of the HL-1 cardiomyocytes; M. McMahon for the TIME cells; A. Nash for the 2H10 anti-VEGF-B monoclonal antibody; K. Plate and M. Shibuya for Flt1-TK<SUP>-/-</SUP> mouse organs; and D. Cheresh for the EC-SCL-Cre-ER<SUP>T</SUP> Nrp1<SUP>fl/fl</SUP> mice. C. E. H. was supported by Wilhelm och Else Stockmanns Stiftelse, and by Frans Wilhelm och Waldemar von Frenckells fond. E. L. was supported by Lymphangiogenomics, an Integrated Project funded by the European Commission within its FP6 Programme, under the thematic area 'Life sciences, genomics and biotechnology for health', contract number LSHG-CT-2004-503573. L. A. v. M. was supported by The Dutch Cancer Society. This study was supported by The Novo Nordisk Foundation, The Swedish Cancer Foundation, The Swedish Research Council, Dr. Peter Wallenbergs Foundation for Economics and Technology, The LeDucq Foundation, The Swedish Brain Foundation and Hallstens Forskningsstiftelse, and the Karolinska Institutet.	Aase K, 2001, CIRCULATION, V104, P358, DOI 10.1161/01.CIR.104.3.358; Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; BREIER G, 1995, DEV DYNAM, V204, P228, DOI 10.1002/aja.1002040303; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; Faldt J, 2004, ENDOCRINOLOGY, V145, P2680, DOI 10.1210/en.2003-1319; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Garcia MC, 2006, DIABETES, V55, P1205, DOI 10.2337/db05-1304; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Jia ZZ, 2007, J MOL NEUROSCI, V33, P25, DOI 10.1007/s12031-007-0038-z; Karpanen T, 2008, CIRC RES, V103, P1018, DOI 10.1161/CIRCRESAHA.108.178459; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Leppanen P, 2005, CIRCULATION, V112, P1347, DOI 10.1161/CIRCULATIONAHA.105.534107; Li X, 2008, ARTERIOSCL THROM VAS, V28, P1614, DOI 10.1161/ATVBAHA.107.158725; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Migdal M, 1998, J BIOL CHEM, V273, P22272, DOI 10.1074/jbc.273.35.22272; Muoio D. M., 2007, NOVART FDN SYMP, V286, P196; Muoio Deborah M, 2007, Novartis Found Symp, V286, P24; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Olofsson B, 1996, J BIOL CHEM, V271, P19310, DOI 10.1074/jbc.271.32.19310; Olofsson B, 1998, P NATL ACAD SCI USA, V95, P11709, DOI 10.1073/pnas.95.20.11709; Petersen KF, 2002, J ROY SOC MED, V95, P8; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rohrer L, 2006, BBA-MOL CELL BIOL L, V1761, P186, DOI 10.1016/j.bbalip.2006.01.009; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Scotney PD, 2002, CLIN EXP PHARMACOL P, V29, P1024, DOI 10.1046/j.1440-1681.2002.03769.x; Springer ML, 2005, AM J PHYSIOL-HEART C, V289, pH1307, DOI 10.1152/ajpheart.00164.2005; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; van der Vusse GJ, 2000, CARDIOVASC RES, V45, P279, DOI 10.1016/S0008-6363(99)00263-1; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005	38	333	355	4	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					917	U136		10.1038/nature08945	http://dx.doi.org/10.1038/nature08945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20228789				2022-12-24	WOS:000276397300043
J	Nadjm, B; Amos, B; Mtove, G; Ostermann, J; Chonya, S; Wangai, H; Kimera, J; Msuya, W; Mtei, F; Dekker, D; Malahiyo, R; Olomi, R; Crump, JA; Whitty, CJM; Reyburn, H				Nadjm, Behzad; Amos, Ben; Mtove, George; Ostermann, Jan; Chonya, Semkini; Wangai, Hannah; Kimera, Juma; Msuya, Walii; Mtei, Frank; Dekker, Denise; Malahiyo, Rajabu; Olomi, Raimos; Crump, John A.; Whitty, Christopher J. M.; Reyburn, Hugh			WHO guidelines for antimicrobial treatment in children admitted to hospital in an area of intense Plasmodium falciparum transmission: prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-STREAM INFECTIONS; COMMUNITY-ACQUIRED BACTEREMIA; MALAWIAN CHILDREN; SEVERE MALARIA; SALMONELLA INFECTIONS; AFRICAN CHILDREN; CASE DEFINITIONS; FEBRILE ILLNESS; KENYAN CHILDREN; TANZANIA	Objectives To assess the performance of WHO's "Guidelines for care at the first-referral level in developing countries" in an area of intense malaria transmission and identify bacterial infections in children with and without malaria. Design Prospective study. Setting District hospital in Muheza, northeast Tanzania. Participants Children aged 2 months to 13 years admitted to hospital for febrile illness. Main outcome measures Sensitivity and specificity of WHO guidelines in diagnosing invasive bacterial disease; susceptibility of isolated organisms to recommended antimicrobials. Results Over one year, 3639 children were enrolled and 184 (5.1%) died; 2195 (60.3%) were blood slide positive for Plasmodium falciparum, 341 (9.4%) had invasive bacterial disease, and 142 (3.9%) were seropositive for HIV. The prevalence of invasive bacterial disease was lower in slide positive children (100/2195, 4.6%) than in slide negative children (241/1444, 16.7%). Non-typhi Salmonella was the most frequently isolated organism (52/100 (52%) of organisms in slide positive children and 108/241 (45%) in slide negative children). Mortality among children with invasive bacterial disease was significantly higher (58/341, 17%) than in children without invasive bacterial disease (126/3298, 3.8%) (P<0.001), and this was true regardless of the presence of P falciparum parasitaemia. The sensitivity and specificity of WHO criteria in identifying invasive bacterial disease in slide positive children were 60.0% (95% confidence interval 58.0% to 62.1%) and 53.5% (51.4% to 55.6%), compared with 70.5% (68.2% to 72.9%) and 48.1% (45.6% to 50.7%) in slide negative children. In children with WHO criteria for invasive bacterial disease, only 99/211(47%) of isolated organisms were susceptible to the first recommended antimicrobial agent. Conclusions In an area exposed to high transmission of malaria, current WHO guidelines failed to identify almost a third of children with invasive bacterial disease, and more than half of the organisms isolated were not susceptible to currently recommended antimicrobials. Improved diagnosis and treatment of invasive bacterial disease are needed to reduce childhood mortality.	[Nadjm, Behzad; Whitty, Christopher J. M.; Reyburn, Hugh] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Amos, Ben; Kimera, Juma; Msuya, Walii; Malahiyo, Rajabu] Hosp Teule, Muheza, Tanga, Tanzania; [Ostermann, Jan] Duke Univ, Ctr Hlth Policy, Durham, NC 27705 USA; [Chonya, Semkini; Wangai, Hannah; Mtei, Frank; Dekker, Denise; Olomi, Raimos] Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania; [Crump, John A.] Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Durham, NC 27710 USA	University of London; London School of Hygiene & Tropical Medicine; Duke University; Kilimanjaro Christian Medical Centre; Duke University	Reyburn, H (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Hugh.reyburn@lshtm.ac.uk	Amos, Ben/AAG-6934-2022; Crump, John A./AAZ-6412-2020; Whitty, Christopher/C-7740-2012; Crump, John A./AAZ-6289-2020; Amos, Ben/AFL-6820-2022; Ostermann, Jan/GQB-4743-2022	Amos, Ben/0000-0002-8569-1650; Crump, John A./0000-0002-4529-102X; Crump, John A./0000-0002-4529-102X; Amos, Ben/0000-0002-8569-1650; Nadjm, Behzad/0000-0002-7704-3629; Mtove, George/0000-0001-5173-0829; Whitty, Christopher/0000-0002-6076-5027; Ostermann, Jan/0000-0002-8236-9500	European Commission [SANTE/2004/078-607]; Berkeley Fellowship; Sir Halley Stewart Trust; Pfizer Pharmaceuticals; Netspear; National Institute for Health Research [CL-2008-20-001] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Berkeley Fellowship; Sir Halley Stewart Trust; Pfizer Pharmaceuticals(Pfizer); Netspear; National Institute for Health Research(National Institute for Health Research (NIHR))	Funding: Core funding for the study was provided by European Commission (Europaid) grant code SANTE/2004/078-607. BN was supported by grants from the Berkeley Fellowship, Sir Halley Stewart Trust, and Pfizer Pharmaceuticals. Pfizer Pharmaceuticals provided equipment and consumables for microbiology. Abbott Pharmaceuticals provided reagents for HIV testing. Netspear (www.netspear.org) funded the E-tests, which were performed at the KEMRI/Wellcome Trust Centre for Geographic Medicine (Coast), Kilifi, Kenya. None of the funders had a role in the design, analysis, or interpretation of results.	Archibald LK, 2003, J INFECT DIS, V188, P202, DOI 10.1086/376507; Bahwere P, 2001, Int J Infect Dis, V5, P180, DOI 10.1016/S1201-9712(01)90067-0; Bassat Q, 2009, TROP MED INT HEALTH, V14, P1011, DOI 10.1111/j.1365-3156.2009.02326.x; Bejon P, 2005, J ANTIMICROB CHEMOTH, V56, P232, DOI 10.1093/jac/dki145; Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2004, PEDIATRICS, V114, P1737, DOI 10.1542/peds.2004-1263; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Chandler CIR, 2006, TROP MED INT HEALTH, V11, P1178, DOI 10.1111/j.1365-3156.2006.01672.x; Clinical and Laboratory Standards Institute, 2009, M100S19 CLIN LAB STA, V29; Cockerill FR, 2004, CLIN INFECT DIS, V38, P1724, DOI 10.1086/421087; Edmonds S, 2009, HIV MED, V10, P26; English M, 1996, T ROY SOC TROP MED H, V90, P658, DOI 10.1016/S0035-9203(96)90423-X; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; FIERER J, 1990, ANTIMICROB AGENTS CH, V34, P343, DOI 10.1128/AAC.34.2.343; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; Graham SM, 2000, T ROY SOC TROP MED H, V94, P227, DOI 10.1016/S0035-9203(00)90286-4; Graham SM, 2009, LANCET, V373, P267, DOI 10.1016/S0140-6736(09)60073-8; KIHLSTROM E, 1985, J ANTIMICROB CHEMOTH, V15, P723, DOI 10.1093/jac/15.6.723; Lee A, 2007, J CLIN MICROBIOL, V45, P3546, DOI 10.1128/JCM.01555-07; LEPAGE P, 1987, LANCET, V1, P1458; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; Mayhood MK, 2008, J CLIN MICROBIOL, V46, P3946, DOI 10.1128/JCM.01045-08; ONWUBALILI JK, 1983, J INFECTION, V7, P2, DOI 10.1016/S0163-4453(83)90863-0; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2008, B WORLD HEALTH ORGAN, V86, P132, DOI 10.2471/BLT.07.041723; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; ROUX CM, 2010, INFECT IMMUN; Scott JAG, 2005, ANTIMICROB AGENTS CH, V49, P3021, DOI 10.1128/AAC.49.7.3021-3024.2005; Shaw AV, 2008, 46 ANN M INF DIS SOC; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010; WHO, 2006, GUID TREATM MAL; World Health Organization, 2000, MAN CHILD SER INF SE; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	47	115	115	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2010	340								c1350	10.1136/bmj.c1350	http://dx.doi.org/10.1136/bmj.c1350			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579VJ	20354024	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000276404100004
J	Gostin, LO; Connors, EE				Gostin, Lawrence O.; Connors, Elenora E.			Health Care Reform in Transition Incremental Insurance Reform Without an Individual Mandate	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.; Connors, Elenora E.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], 2010, INCOME POVERTY HLTH; CLAXTON G, 2008, PRIVATE HLTH COVERAG; Glied SA, 2008, NEW ENGL J MED, V358, P1540, DOI 10.1056/NEJMp0802027; JOST TS, 2010, HLTH AFFAIRS BL 0202; JOST TS, HLTH INSURANCE EXCHA; Pear Robert, 2010, N Y TIMES; SCHWARTZ TK, 2010, KAISER COMMISSION ME	7	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2010	303	12					1188	1189		10.1001/jama/2010.375	http://dx.doi.org/10.1001/jama/2010.375			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573AC	20332405				2022-12-24	WOS:000275879600024
J	Partridge, E; Fouad, M				Partridge, Edward; Fouad, Mona			Community-Driven Approaches for Reducing Health Disparities in Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRENDS; MORTALITY		[Partridge, Edward] Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Gynecol Oncol, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Fouad, Mona] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Partridge, E (corresponding author), Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Gynecol Oncol, Ctr Comprehens Canc, 1802 6th Ave S,NP 2555, Birmingham, AL 35294 USA.	eep3840@uab.edu			NATIONAL CANCER INSTITUTE [U54CA118638] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA118638] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		DeLancey JOL, 2008, CANCER EPIDEM BIOMAR, V17, P2908, DOI 10.1158/1055-9965.EPI-08-0131; FOUAD MN, 2006, J CANC ED S, pS91; FREMONT A, 2003, 290000012 AG HEALTHC; Glied S, 2008, DEMOGRAPHY, V45, P741; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Kinsey T, 2008, JNCI-J NATL CANCER I, V100, P1003, DOI 10.1093/jnci/djn207; Lurie N, 2007, JAMA-J AM MED ASSOC, V297, P1118, DOI 10.1001/jama.297.10.1118; Partridge EE, 2005, FAM COMMUNITY HEALTH, V28, P6, DOI 10.1097/00003727-200501000-00004; Theory at a Glance, 2005, NIH PUBL; World Health Organization, SOC DET HLTH	10	12	12	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1090	1091		10.1001/jama.2010.282	http://dx.doi.org/10.1001/jama.2010.282			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	569KC	20233830				2022-12-24	WOS:000275594100025
J	Zhang, X; Rashid, R; Wang, K; Shan, SO				Zhang, Xin; Rashid, Rumana; Wang, Kai; Shan, Shu-ou			Sequential Checkpoints Govern Substrate Selection During Cotranslational Protein Targeting	SCIENCE			English	Article							SIGNAL-RECOGNITION PARTICLE; ESCHERICHIA-COLI; TRIGGER FACTOR; ENDOPLASMIC-RETICULUM; RIBOSOME; RECEPTOR; SRP; RNA; TRANSLOCATION; SEQUENCES	Proper protein localization is essential for all cells. However, the precise mechanism by which high fidelity is achieved is not well understood for any protein-targeting pathway. To address this fundamental question, we investigated the signal recognition particle (SRP) pathway in Escherichia coli, which delivers proteins to the bacterial inner membrane through recognition of signal sequences on cargo proteins. Fidelity was thought to arise from the inability of SRP to bind strongly to incorrect cargos. Using biophysical assays, we found that incorrect cargos were also rejected through a series of checkpoints during subsequent steps of targeting. Thus, high fidelity of substrate selection is achieved through the cumulative effect of multiple checkpoints; this principle may be generally applicable to other pathways involving selective signal recognition.	[Zhang, Xin; Rashid, Rumana; Wang, Kai; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	sshan@caltech.edu	Zhang, Xin/B-2185-2016	Zhang, Xin/0000-0001-6686-1645	NIH [GM078024]; Burroughs Wellcome Foundation; Henry and Camille Dreyfus Foundation; Arnold and Mabel Beckman Foundation; Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078024] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Henry and Camille Dreyfus Foundation; Arnold and Mabel Beckman Foundation; Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Schaffitzel and N. Ban for help with the purification of RNCs and Trigger factor; J. Luirink for plasmids encoding the phoA signal sequence variants; L. Randall for the plasmid encoding luciferase; B. Bukau and E. Deuerling for the plasmid encoding Trigger factor; F. Nataro for the plasmid encoding EspP; H. D. Bernstein for the strain HDB51; and R. J. Deshaies, A. Varshavsky, W. Zhong, N. Pierce, and the Shan laboratory for comments on the manuscript. This work was supported by NIH grant GM078024, and career awards from the Burroughs Wellcome Foundation, the Henry and Camille Dreyfus Foundation, the Arnold and Mabel Beckman Foundation, and the Packard Foundation to S.	Bornemann T, 2008, NAT STRUCT MOL BIOL, V15, P494, DOI 10.1038/nsmb.1402; Buskiewicz I, 2004, P NATL ACAD SCI USA, V101, P7902, DOI 10.1073/pnas.0402231101; CONNOLLY T, 1989, CELL, V57, P599, DOI 10.1016/0092-8674(89)90129-3; DeGier JWL, 1997, FEBS LETT, V408, P1, DOI 10.1016/S0014-5793(97)00402-X; DOUD SK, 1993, BIOCHEMISTRY-US, V32, P1251, DOI 10.1021/bi00056a008; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; JENSEN CG, 1994, J BACTERIOL, V176, P7148, DOI 10.1128/JB.176.23.7148-7154.1994; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; MILLER JD, 1994, NATURE, V367, P657, DOI 10.1038/367657a0; Peterson JH, 2006, J BIOL CHEM, V281, P9038, DOI 10.1074/jbc.M508681200; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Schaffitzel C, 2007, J STRUCT BIOL, V158, P463, DOI 10.1016/j.jsb.2007.01.005; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Shan SO, 2007, J CELL BIOL, V178, P611, DOI 10.1083/jcb.200702018; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106; Zheng N, 1996, CELL, V86, P849, DOI 10.1016/S0092-8674(00)80159-2	28	86	87	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					757	760		10.1126/science.1186743	http://dx.doi.org/10.1126/science.1186743			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448185	Green Accepted			2022-12-24	WOS:000277357100041
J	Matsuda, K; Miura, E; Miyazaki, T; Kakegawa, W; Emi, K; Narumi, S; Fukazawa, Y; Ito-Ishida, A; Kondo, T; Shigemoto, R; Watanabe, M; Yuzaki, M				Matsuda, Keiko; Miura, Eriko; Miyazaki, Taisuke; Kakegawa, Wataru; Emi, Kyoichi; Narumi, Sakae; Fukazawa, Yugo; Ito-Ishida, Aya; Kondo, Tetsuro; Shigemoto, Ryuichi; Watanabe, Masahiko; Yuzaki, Michisuke			Cbln1 Is a Ligand for an Orphan Glutamate Receptor delta 2, a Bidirectional Synapse Organizer	SCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; EXCITATORY SYNAPSES; TERMINAL DOMAIN; IN-VIVO; GLUR-DELTA-2; FAMILY; PLASTICITY; DIFFERENTIATION; SYNAPTOGENESIS; EXPRESSION	Cbln1, secreted from cerebellar granule cells, and the orphan glutamate receptor delta 2 (GluD2), expressed by Purkinje cells, are essential for synapse integrity between these neurons in adult mice. Nevertheless, no endogenous binding partners for these molecules have been identified. We found that Cbln1 binds directly to the N-terminal domain of GluD2. GluD2 expression by postsynaptic cells, combined with exogenously applied Cbln1, was necessary and sufficient to induce new synapses in vitro and in the adult cerebellum in vivo. Further, beads coated with recombinant Cbln1 directly induced presynaptic differentiation and indirectly caused clustering of postsynaptic molecules via GluD2. These results indicate that the Cbln1-GluD2 complex is a unique synapse organizer that acts bidirectionally on both pre- and postsynaptic components.	[Matsuda, Keiko; Miura, Eriko; Kakegawa, Wataru; Emi, Kyoichi; Narumi, Sakae; Ito-Ishida, Aya; Kondo, Tetsuro; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Miyazaki, Taisuke; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Fukazawa, Yugo; Shigemoto, Ryuichi] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448787, Japan; [Ito-Ishida, Aya] Univ Tokyo, Grad Sch Med, Dept Cellular Neurobiol, Tokyo 1130033, Japan; [Kondo, Tetsuro] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058566, Japan	Keio University; Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Yuzaki, M (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan.	myuzaki@a5.keio.jp	Watanabe, Masahiko/S-3614-2019; Yuzaki, Michisuke/K-5328-2013; Ito-Ishida, Aya/AEP-0189-2022; Kakegawa, Wataru/G-5569-2016; Shigemoto, Ryuichi/E-3628-2013; Kakegawa, Wataru/L-4900-2013; Miyazaki, Taisuke/C-8685-2012; Kondo, Tetsuro/L-7044-2018; WATANABE, Masahiko/A-4055-2012; Matsuda, Keiko/L-5778-2013; Fukazawa, Yugo/H-9899-2012	Watanabe, Masahiko/0000-0001-5037-7138; Yuzaki, Michisuke/0000-0002-5750-3544; Shigemoto, Ryuichi/0000-0001-8761-9444; Kondo, Tetsuro/0000-0002-0055-3292; WATANABE, Masahiko/0000-0001-5037-7138; Fukazawa, Yugo/0000-0001-7436-8797; Ito-Ishida, Aya/0000-0001-5531-2480	Japanese Government Ministry of Education, Culture, Sports, Science and Technology (MEXT); Takeda Science Foundation; Naito Memorial Grant for Female Researchers; Core Research for Evolutional Science and Technology from the Japanese Science and Technology Agency	Japanese Government Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Memorial Grant for Female Researchers; Core Research for Evolutional Science and Technology from the Japanese Science and Technology Agency	We thank J. Motohashi for excellent technical support. This work was supported by a grant-in-aid from Japanese Government Ministry of Education, Culture, Sports, Science and Technology (MEXT) (M.Y.), the Takeda Science Foundation (M.Y.), the Naito Memorial Grant for Female Researchers (K. M.), and the Core Research for Evolutional Science and Technology from the Japanese Science and Technology Agency (M.Y.).	Bao DS, 2005, J NEUROCHEM, V95, P618, DOI 10.1111/j.1471-4159.2005.03385.x; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Iijima T, 2009, J NEUROSCI, V29, P5425, DOI 10.1523/JNEUROSCI.4473-08.2009; Ito-Ishida A, 2008, J NEUROSCI, V28, P5920, DOI 10.1523/JNEUROSCI.1030-08.2008; Kakegawa W, 2008, J NEUROSCI, V28, P1460, DOI 10.1523/JNEUROSCI.2553-07.2008; Kakegawa W, 2009, J NEUROSCI, V29, P5738, DOI 10.1523/JNEUROSCI.6013-08.2009; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Kuroyanagi T, 2009, P NATL ACAD SCI USA, V106, P4912, DOI 10.1073/pnas.0900892106; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; Masugi-Tokita M, 2007, J NEUROSCI, V27, P2135, DOI 10.1523/JNEUROSCI.2861-06.2007; Miura E, 2006, EUR J NEUROSCI, V24, P750, DOI 10.1111/j.1460-9568.2006.04950.x; Miura E, 2009, EUR J NEUROSCI, V29, P693, DOI 10.1111/j.1460-9568.2009.06632.x; Roche KW, 1999, J NEUROSCI, V19, P3926; Takeuchi T, 2005, J NEUROSCI, V25, P2146, DOI 10.1523/JNEUROSCI.4740-04.2005; Uemura T, 2004, MOL CELL NEUROSCI, V26, P330, DOI 10.1016/j.mcn.2004.02.007; Uemura T, 2008, BIOCHEM BIOPH RES CO, V377, P1315, DOI 10.1016/j.bbrc.2008.10.170; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Wei P, 2009, MOL CELL NEUROSCI, V41, P258, DOI 10.1016/j.mcn.2009.03.005; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Yuzaki M, 2008, CELL MOL LIFE SCI, V65, P1698, DOI 10.1007/s00018-008-7550-3; Yuzaki M, 2009, NEUROSCIENCE, V162, P633, DOI 10.1016/j.neuroscience.2008.12.002	24	236	241	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					363	368		10.1126/science.1185152	http://dx.doi.org/10.1126/science.1185152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395510				2022-12-24	WOS:000276685000040
J	Meyer, G; Roy, PM; Gilberg, S; Perrier, A				Meyer, Guy; Roy, Pierre-Marie; Gilberg, Serge; Perrier, Arnaud			Easily Missed? Pulmonary embolism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VENOUS THROMBOEMBOLISM; DIAGNOSIS; MANAGEMENT		[Meyer, Guy; Gilberg, Serge] Univ Paris 05, Paris, France; [Meyer, Guy] Hop Europeen Georges Pompidou, Serv Pneumol & Soins Intensifs, APHP, Paris, France; [Meyer, Guy] INSERM, U765, Paris, France; [Roy, Pierre-Marie] Univ Angers, IFR 132, Angers, France; [Roy, Pierre-Marie] Ctr Hosp Univ, Serv Accueil & Traitement Urgences, Angers, France; [Perrier, Arnaud] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; University of Geneva	Meyer, G (corresponding author), Hop Europeen Georges Pompidou, Serv Pneumol, 20 Rue Leblanc, F-75015 Paris, France.	guy.meyer@egp.aphp.fr	Perrier, Arnaud/M-2263-2014; Roy, Pierre-Marie/AAA-7737-2022					Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Le Gal G, 2005, BRIT MED J, V330, P452, DOI 10.1136/bmj.38331.602384.8F; Meyer G, 2008, CURR OPIN HEMATOL, V15, P499, DOI 10.1097/MOH.0b013e3283063a51; Nordstrom M, 1998, APMIS, V106, P378, DOI 10.1111/j.1699-0463.1998.tb01360.x; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Pineda LA, 2001, CHEST, V120, P791, DOI 10.1378/chest.120.3.791; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Roy PM, 2006, ANN INTERN MED, V144, P157, DOI 10.7326/0003-4819-144-3-200602070-00003; Roy PM, 2005, BMJ-BRIT MED J, V331, P259, DOI 10.1136/bmj.331.7511.259; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172	13	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2010	340								c1421	10.1136/bmj.c1421	http://dx.doi.org/10.1136/bmj.c1421			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586JZ	20388676				2022-12-24	WOS:000276904800001
J	Chang, VW; Asch, DA; Werner, RM				Chang, Virginia W.; Asch, David A.; Werner, Rachel M.			Quality of Care Among Obese Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER; MEDICARE BENEFICIARIES; PREVENTIVE SERVICES; BODY-WEIGHT; HEALTH-CARE; CLAIMS DATA; SELF-REPORT; US ADULTS; WOMEN; MAMMOGRAPHY	Context Clinicians often have negative attitudes toward obesity and express dissatisfaction in caring for obese patients. Moreover, obese patients often feel that clinicians are biased or disrespectful because of their weight. These observations raise the concern that obese patients may receive lower quality of care. Objective To determine whether performance on common outpatient quality measures differs by patient weight status. Design, Setting, and Participants Eight different performance measures were examined in 2 national-level patient populations: (1) Medicare beneficiaries (n=36 122) using data from the Medicare Beneficiary Survey (1994-2006); and (2) recipients of care from the Veterans Health Administration (VHA) (n=33 550) using data from an ongoing performance-evaluation program (2003-2004). Main Outcome Measures Performance measures among eligible patients for diabetes care (eye examination, glycated hemoglobin [HbA(1c)] testing, and lipid screening), pneumococcal vaccination, influenza vaccination, screening mammography, colorectal cancer screening, and cervical cancer screening. Measures were based on a combination of administrative claims, survey, and chart review data. Results We found no evidence that obese or overweight patients were less likely to receive recommended care relative to normal-weight patients. Moreover, success rates were marginally higher for obese and/or overweight patients on several measures. The most notable differentials were observed for recommended diabetes care among Medicare beneficiaries: comparing obese vs normal-weight patients with diabetes, obese patients were more likely to receive recommended care on lipid screening (72% vs 65%; odds ratio, 1.37 [95% confidence interval, 1.09-1.73]) and HbA(1c) testing (74% vs 62%; odds ratio, 1.73 [95% confidence interval, 1.41-2.11]). All analyses were adjusted for sociodemographic factors, health status, clinical complexity, and visit frequency. Conclusions Among samples of patients from the Medicare and VHA populations, there was no evidence across 8 performance measures that obese or overweight patients received inferior care when compared with normal-weight patients. Being obese or overweight was associated with a marginally higher rate of recommended care on several measures. JAMA. 2010;303(13):1274-1281	[Chang, Virginia W.; Asch, David A.; Werner, Rachel M.] Univ Penn, Sch Med, Dept Med, Ctr Hlth Equ Res & Promot,Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA; [Chang, Virginia W.; Asch, David A.; Werner, Rachel M.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Chang, Virginia W.] Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; University of Pennsylvania	Chang, VW (corresponding author), Univ Penn, Sch Med, Dept Med, Ctr Hlth Equ Res & Promot,Philadelphia VA Med Ctr, 1233 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	vwchang@mail.med.upenn.edu		Asch, David/0000-0002-7970-286X; Werner, Rachel/0000-0003-3435-4221	Veterans Administration Health Services [IIR 06-096]; Robert Wood Johnson Foundation	Veterans Administration Health Services; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This work was supported by a Veterans Administration Health Services Research and Development Merit Award (IIR 06-096); the Robert Wood Johnson Foundation Physician Faculty Scholars Program; and a Veterans Administration Health Services Research and Development Career Development Award (to Dr Werner).	[Anonymous], 1991, MMWR Recomm Rep, V40, P1; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; Arday DR, 2002, DIABETES CARE, V25, P2230, DOI 10.2337/diacare.25.12.2230; Asch SM, 2000, JAMA-J AM MED ASSOC, V284, P2325, DOI 10.1001/jama.284.18.2325; Baier M, 2000, CANCER EPIDEM BIOMAR, V9, P229; Chao A, 2004, AM J PUBLIC HEALTH, V94, P1775, DOI 10.2105/AJPH.94.10.1775; Cohen SS, 2008, CANCER-AM CANCER SOC, V112, P1892, DOI 10.1002/cncr.23408; Das SR, 2005, AM J PREV MED, V28, P291, DOI 10.1016/j.amepre.2004.12.007; Doshi JA, 2007, HEALTH AFFAIR, V26, P1111, DOI 10.1377/hlthaff.26.4.1111; Ellis RP, 1996, HEALTH CARE FINANC R, V17, P101; Ferrante JM, 2006, CANCER DETECT PREV, V30, P459, DOI 10.1016/j.cdp.2006.09.003; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; Fontaine KR, 1998, ARCH FAM MED, V7, P381, DOI 10.1001/archfami.7.4.381; Freeman JL, 2002, MED CARE, V40, P36; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Hebert P L, 1999, Am J Med Qual, V14, P270, DOI 10.1177/106286069901400607; Higashi T, 2007, NEW ENGL J MED, V356, P2496, DOI 10.1056/NEJMsa066253; Holt K, 2006, MED CARE, V44, P513, DOI 10.1097/01.mlr.0000215884.81143.da; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; KLEIN D, 1982, J FAM PRACTICE, V14, P881; LUBITZ RM, 1995, AM J MED, V98, P491, DOI 10.1016/S0002-9343(99)80350-7; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; NHLBI Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Obesity in Adults (US), 1998, CLIN GUID ID EV TREA; *OFF QUAL PERF, 2004, FY 2004 TECHN MAN VH; Ostbye T, 2005, AM J PUBLIC HEALTH, V95, P1623, DOI 10.2105/AJPH.2004.047803; Peytremann-Bridevaux I, 2007, J GEN INTERN MED, V22, P923, DOI 10.1007/s11606-007-0181-9; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Puhl RM, 2006, OBESITY, V14, P1802, DOI 10.1038/oby.2006.208; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rosen AB, 2004, J GEN INTERN MED, V19, P332, DOI 10.1111/j.1525-1497.2004.30339.x; Smith-Bindman R, 2006, MED CARE, V44, P463, DOI 10.1097/01.mlr.0000207436.07513.79; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Thompson BL, 2001, HEALTH SERV RES, V36, P813; US Preventive Services Task Force. Screening for Cervical Cancer: Recommendations and Rationale. Agency for Healthcare Research and Quality, 2003, SCREEN CERV CANC REC; Wee CC, 2000, ANN INTERN MED, V132, P697, DOI 10.7326/0003-4819-132-9-200005020-00003; Werner RM, 2008, J GEN INTERN MED, V23, P1729, DOI 10.1007/s11606-008-0734-6	40	64	65	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1274	1281		10.1001/jama.2010.339	http://dx.doi.org/10.1001/jama.2010.339			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579FM	20371786	Bronze			2022-12-24	WOS:000276353700027
J	Bais, C; Wu, XM; Yao, J; Yang, SY; Crawford, Y; McCutcheon, K; Tan, C; Kolumam, G; Vernes, JM; Eastham-Anderson, J; Haughney, P; Kowanetz, M; Hagenbeek, T; Kasman, I; Reslan, HB; Ross, J; Van Bruggen, N; Carano, RAD; Meng, YJG; Hongo, JA; Stephan, JP; Shibuya, M; Ferrara, N				Bais, Carlos; Wu, Xiumin; Yao, Jenny; Yang, Suya; Crawford, Yongping; McCutcheon, Krista; Tan, Christine; Kolumam, Ganesh; Vernes, Jean-Michel; Eastham-Anderson, Jeffrey; Haughney, Peter; Kowanetz, Marcin; Hagenbeek, Thijs; Kasman, Ian; Reslan, Hani Bou; Ross, Jed; Van Bruggen, Nick; Carano, Richard A. D.; Meng, Yu-Ju Gloria; Hongo, Jo-Anne; Stephan, Jean-Philippe; Shibuya, Masabumi; Ferrara, Napoleone			PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth	CELL			English	Article							VEGFR1-ACTIVITY-INDEPENDENT METASTASIS FORMATION; HIGH-AFFINITY BINDING; FACTOR RECEPTOR-1; TYROSINE KINASE; IN-VIVO; VEGF; FLT-1; ANTIBODY; TARGETS; CANCER	It has been recently reported that treatment with an anti-placenta growth factor (PlGF) antibody inhibits metastasis and primary tumor growth. Here we show that, although anti-PlGF treatment inhibited wound healing, extravasation of B16F10 cells, and growth of a tumor engineered to overexpress the PlGF receptor (VEGFR-1), neutralization of PlGF using four novel blocking antibodies had no significant effect on tumor angiogenesis in 15 models. Also, genetic ablation of the tyrosine kinase domain of VEGFR-1 in the host did not result in growth inhibition of the anti-VEGF-A sensitive or resistant tumors tested. Furthermore, combination of anti-PlGF with anti-VEGF-A antibodies did not result in greater antitumor efficacy than anti-VEGF-A monotherapy. In conclusion, our data argue against an important role of PlGF during primary tumor growth in most models and suggest that clinical evaluation of anti-PlGF antibodies may be challenging.	[Bais, Carlos; Wu, Xiumin; Yao, Jenny; Yang, Suya; Crawford, Yongping; McCutcheon, Krista; Tan, Christine; Kolumam, Ganesh; Vernes, Jean-Michel; Eastham-Anderson, Jeffrey; Haughney, Peter; Kowanetz, Marcin; Hagenbeek, Thijs; Kasman, Ian; Reslan, Hani Bou; Ross, Jed; Van Bruggen, Nick; Carano, Richard A. D.; Meng, Yu-Ju Gloria; Hongo, Jo-Anne; Stephan, Jean-Philippe; Shibuya, Masabumi; Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA; [Shibuya, Masabumi] Tokyo Med & Dent Univ, Grad Sch Med & Dent, Dept Mol Oncol, Tokyo 1138510, Japan	Roche Holding; Genentech; Tokyo Medical & Dental University (TMDU)	Bais, C (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	bais@gene.com; nf@gene.com						Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Cao YH, 1996, J BIOL CHEM, V271, P3154, DOI 10.1074/jbc.271.6.3154; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cianfarani F, 2006, AM J PATHOL, V169, P1167, DOI 10.2353/ajpath.2006.051314; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; DavisSmyth T, 1996, EMBO J, V15, P4919, DOI 10.1002/j.1460-2075.1996.tb00872.x; Dawson MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006525; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4; Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2010, CYTOKINE GROWTH F R, V21, P21, DOI 10.1016/j.cytogfr.2009.11.003; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gerber HP, 2000, CANCER RES, V60, P6253; Gluzman-Poltorak Z, 2000, J BIOL CHEM, V275, P29922; HATTORI K, 2002, NAT MED, V1, P1; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hiratsuka S, 2001, CANCER RES, V61, P1207; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kaplan RN, 2009, NATURE, V461, pE5, DOI 10.1038/nature08261; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kerber M, 2008, CANCER RES, V68, P7342, DOI 10.1158/0008-5472.CAN-07-6241; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Luttun A., 2002, NAT MED, V1, P1; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Marcellini M, 2006, AM J PATHOL, V169, P643, DOI 10.2353/ajpath.2006.051041; Murakami M, 2006, BLOOD, V108, P1849, DOI 10.1182/blood-2006-04-016030; Odorisio T, 2002, J CELL SCI, V115, P2559; Oflazoglu E, 2007, BLOOD, V110, P4370, DOI 10.1182/blood-2007-06-097014; PARK JE, 1994, J BIOL CHEM, V269, P25646; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Schomber T, 2007, CANCER RES, V67, P10840, DOI 10.1158/0008-5472.CAN-07-1034; Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Wu Y, 2006, CLIN CANCER RES, V12, P6573, DOI 10.1158/1078-0432.CCR-06-0831; Wu Y, 2006, INT J CANCER, V119, P1519, DOI 10.1002/ijc.21865; Ziche M, 1997, LAB INVEST, V76, P517	49	124	131	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2010	141	1					166	177		10.1016/j.cell.2010.01.033	http://dx.doi.org/10.1016/j.cell.2010.01.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371352	Bronze			2022-12-24	WOS:000276211100021
J	Ross, JS; Normand, SLT; Wang, Y; Ko, DT; Chen, J; Drye, EE; Keenan, PS; Lichtman, JH; Bueno, H; Schreiner, GC; Krumholz, HM				Ross, Joseph S.; Normand, Sharon-Lise T.; Wang, Yun; Ko, Dennis T.; Chen, Jersey; Drye, Elizabeth E.; Keenan, Patricia S.; Lichtman, Judith H.; Bueno, Hector; Schreiner, Geoffrey C.; Krumholz, Harlan M.			Hospital Volume and 30-Day Mortality for Three Common Medical Conditions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-CARE; QUALITY; RATES	BACKGROUND The association between hospital volume and the death rate for patients who are hospitalized for acute myocardial infarction, heart failure, or pneumonia remains unclear. It is also not known whether a volume threshold for such an association exists. METHODS We conducted cross-sectional analyses of data from Medicare administrative claims for all fee-for-service beneficiaries who were hospitalized between 2004 and 2006 in acute care hospitals in the United States for acute myocardial infarction, heart failure, or pneumonia. Using hierarchical logistic-regression models for each condition, we estimated the change in the odds of death within 30 days associated with an increase of 100 patients in the annual hospital volume. Analyses were adjusted for patients' risk factors and hospital characteristics. Bootstrapping procedures were used to estimate 95% confidence intervals to identify the condition-specific volume thresholds above which an increased volume was not associated with reduced mortality. RESULTS There were 734,972 hospitalizations for acute myocardial infarction in 4128 hospitals, 1,324,287 for heart failure in 4679 hospitals, and 1,418,252 for pneumonia in 4673 hospitals. An increased hospital volume was associated with reduced 30-day mortality for all conditions (P<0.001 for all comparisons). For each condition, the association between volume and outcome was attenuated as the hospital's volume increased. For acute myocardial infarction, once the annual volume reached 610 patients ( 95% confidence interval [CI], 539 to 679), an increase in the hospital volume by 100 patients was no longer significantly associated with reduced odds of death. The volume threshold was 500 patients ( 95% CI, 433 to 566) for heart failure and 210 patients ( 95% CI, 142 to 284) for pneumonia. CONCLUSIONS Admission to higher-volume hospitals was associated with a reduction in mortality for acute myocardial infarction, heart failure, and pneumonia, although there was a volume threshold above which an increased condition-specific hospital volume was no longer significantly associated with reduced mortality.	[Ross, Joseph S.] Mt Sinai Sch Med, New York, NY 10029 USA; [Ross, Joseph S.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Boston, MA USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Wang, Yun; Chen, Jersey; Drye, Elizabeth E.; Schreiner, Geoffrey C.; Krumholz, Harlan M.] Yale New Haven Med Ctr, New Haven, CT 06504 USA; [Wang, Yun; Chen, Jersey; Lichtman, Judith H.; Krumholz, Harlan M.] Yale Univ, Sch Med, New Haven, CT USA; [Ko, Dennis T.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Ko, Dennis T.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Bueno, Hector] Hosp Gen Univ Gregorio Maranon, Madrid, Spain	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Yale University; Yale University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; General University Gregorio Maranon Hospital	Ross, JS (corresponding author), Mt Sinai Sch Med, 1 Gustave L Levy Pl,Box 1070, New York, NY 10029 USA.	joseph.ross@mssm.edu	Bueno, Hector/I-3910-2015; , Harlan/AAI-2875-2020	Bueno, Hector/0000-0003-0277-7596; Ko, Dennis/0000-0001-6840-8051; Ross, Joseph/0000-0002-9218-3320; Normand, Sharon-Lise/0000-0001-7027-4769	CMS [HHSM-500-2005-CO001C]; National Institute on Aging [K08 AG032886]; American Federation for Aging Research; Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Madrid [BA08/90010]; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	CMS; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Madrid(Instituto de Salud Carlos III); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a contract (HHSM-500-2005-CO001C) with the CMS, by a grant (K08 AG032886, to Dr. Ross) from the National Institute on Aging, by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program, and by a grant (BA08/90010, to Dr. Bueno) from the Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Madrid.	*AM HOSP ASS, 2004, ANN SURV HOSP DAT DO; Auerbach AD, 2009, ANN INTERN MED, V150, P696, DOI 10.7326/0003-4819-150-10-200905190-00007; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Casale PN, 1998, J AM COLL CARDIOL, V32, P885, DOI 10.1016/S0735-1097(98)00325-8; FARLEY DE, 1992, MED CARE, V30, P77, DOI 10.1097/00005650-199201000-00009; Glance LG, 2007, INT J QUAL HEALTH C, V19, P195, DOI 10.1093/intqhc/mzm020; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Homboe ES, 2006, MED CARE, V44, P1073, DOI 10.1097/01.mlr.0000233685.22497.cf; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; KRUMHOLZ HM, 2006, RISK ADJUSTMENT ME S, V1; KRUMHOLZ HM, 2005, RISK ADJUSTMENT MODE; Lindenauer PK, 2006, ANN INTERN MED, V144, P262, DOI 10.7326/0003-4819-144-4-200602210-00008; MERRILL CT, 2005, AHRQ PUBLICATION; *NAT QUAL FOR, 2007, NAT VOL CONS STAND H; *NAT QUAL FOR, 2006, NAT VOL CONS STAND H; Normand SLT, 2007, HEALTH SERV OUTCOME, V7, P79, DOI 10.1007/s10742-006-0018-8; Normand SLT, 2002, STAT MED, V21, P331, DOI 10.1002/sim.1020; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106	22	237	241	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1110	1118		10.1056/NEJMsa0907130	http://dx.doi.org/10.1056/NEJMsa0907130			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335587	Green Accepted			2022-12-24	WOS:000275894600008
J	Yu, XJ; McGourty, K; Liu, M; Unsworth, KE; Holden, DW				Yu, Xiu-Jun; McGourty, Kieran; Liu, Mei; Unsworth, Kate E.; Holden, David W.			pH Sensing by Intracellular Salmonella Induces Effector Translocation	SCIENCE			English	Article							III SECRETION SYSTEM; PATHOGENICITY ISLAND 2; YERSINIA-PESTIS; APPARATUS	Salmonella enterica is an important intracellular bacterial pathogen of humans and animals. It replicates within host-cell vacuoles by delivering virulence (effector) proteins through a vacuolar membrane pore made by the Salmonella pathogenicity island 2 (SPI-2) type III secretion system (T3SS). T3SS assembly follows vacuole acidification, but when bacteria are grown at low pH, effector secretion is negligible. We found that effector secretion was activated at low pH from mutant strains lacking a complex of SPI-2-encoded proteins SsaM, SpiC, and SsaL. Exposure of wild-type bacteria to pH 7.2 after growth at pH 5.0 caused dissociation and degradation of SsaM/SpiC/SsaL complexes and effector secretion. In infected cells, loss of the pH 7.2 signal through acidification of host-cell cytosol prevented complex degradation and effector translocation. Thus, intravacuolar Salmonella senses host cytosolic pH, resulting in the degradation of regulatory complex proteins and effector translocation.	[Yu, Xiu-Jun; McGourty, Kieran; Liu, Mei; Unsworth, Kate E.; Holden, David W.] Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London	Holden, DW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, Ctr Mol Microbiol & Infect, Armstrong Rd, London SW7 2AZ, England.	d.holden@imperial.ac.uk		Liu, Mei/0000-0002-4319-3063	Medical Research Council [G0800148, 074553/Z/04/Z]; Wellcome Trust; MRC [G0800148] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Mota, C. Tang, and members of the Holden laboratory for comments on the manuscript. This research was supported by grants G0800148 and 074553/Z/04/Z to D. W. H. from the Medical Research Council and Wellcome Trust.	Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Rappl C, 2003, FEMS MICROBIOL LETT, V226, P363, DOI 10.1016/S0378-1097(03)00638-4; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Yu XJ, 2004, MOL MICROBIOL, V54, P604, DOI 10.1111/j.1365-2958.2004.04297.x	12	134	138	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					1040	1043		10.1126/science.1189000	http://dx.doi.org/10.1126/science.1189000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20395475	Green Submitted, Green Accepted			2022-12-24	WOS:000277877100044
J	Wei, L; Struthers, AD; Fahey, T; Watson, AD; MacDonald, TM				Wei, Li; Struthers, Allan D.; Fahey, Tom; Watson, Alexander D.; MacDonald, Thomas M.			Spironolactone use and renal toxicity: population based longitudinal analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONGESTIVE-HEART-FAILURE; ALDOSTERONE ANTAGONISTS; RENIN RATIO; HYPERKALEMIA; HYPERTENSION; THERAPY; EVENTS	Objective To determine the safety of spironolactone prescribing in the setting of the UK National Health Service. Design Population based longitudinal analysis using a record linkage database. Setting Tayside, Scotland. Population All patients who received one or more dispensed prescriptions for spironolactone between 1994 and 2007. Main outcome measures Rates of prescribing for spironolactone, hospital admissions for hyperkalaemia, and hyperkalaemia and renal function without admission, before and after the publication of results from the Randomised Aldactone Evaluation Study (RALES). Results Prescriptions for spironolactone and measurements of serum creatinine and serum potassium all increased in parallel in Tayside after the release of the RALES results in 1999 ( from 2847, 5345, and 5246 in the first half of 1999 to 6582, 10 753, and 10 534 by the second half of 2001, and to 8619, 17 844, and 17 649 by 2007). These increases occurred in patients with and without heart failure. Few hospital admissions for hyperkalaemia occurred over this time: three in the first quarter of 1995, two in the last quarter of 2001, and three in 2007. Among patients who were taking angiotensin converting enzyme inhibitors and who had recently been admitted to hospital for heart failure, the rate of spironolactone use was 19.8 per 100 patients in early 1999 rising to 70.1 per 100 patients by late 2001 (P<0.01) and 61.3 by 2007. The rate of outpatient measured hyperkalaemia ( serum K+>6 mmol/l) did not increase over time (9.9 per 100 patients in early 1999, 6.9 per 100 patients in late 2001, and 2.9 per 100 patients in 2007) despite the increased use of spironolactone. Conclusions Despite a marked increased in the use of spironolactone in patients with and without heart failure, no increase was seen in hospital admissions for hyperkalaemia and outpatient hyperkalaemia actually fell. Careful monitoring of patients prescribed spironolactone seems to have been associated with no increase in risk of hyperkalaemia.	[Wei, Li; MacDonald, Thomas M.] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Med Monitoring Unit MEMO, Dundee DD1 9SY, Scotland; [Fahey, Tom] Royal Coll Surgeons Ireland, Mercers Med Ctr, Dept Gen Practice, Dublin 2, Ireland; [Watson, Alexander D.] Westgate Hlth Ctr, Dundee DD2 4AD, Scotland	University of Dundee; Royal College of Surgeons - Ireland; University of Dundee	MacDonald, TM (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Med Monitoring Unit MEMO, Dundee DD1 9SY, Scotland.	t.m.macdonald@dundee.ac.uk	Fahey, Tom/C-9367-2012	Fahey, Tom/0000-0002-5896-5783; Struthers, Allan/0000-0002-2926-2528; MacDonald, Thomas/0000-0001-5189-6669	TENOVUS Scotland [T06/44]; UK Medical Research Council [G106/1249]; Pfizer; Servier; Novartis; Wyeth; Kaiser Permanante; Takeda; Recordati; NiCox; Quintiles; Speedel; MRC [G106/1249] Funding Source: UKRI; Medical Research Council [G106/1249] Funding Source: researchfish	TENOVUS Scotland; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer(Pfizer); Servier(Servier); Novartis(Novartis); Wyeth(Wyeth); Kaiser Permanante; Takeda(Takeda Pharmaceutical Company Ltd); Recordati; NiCox; Quintiles; Speedel; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the TENOVUS Scotland (T06/44). LW holds a special training fellowship in health services and health of the public research award from the UK Medical Research Council (G106/1249). The funding body did not have any role in study design, data analysis, result interpretations, or report submission.; (All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf ( available on request from the corresponding author) and declare ( 1) no financial support from any commercial company for the submitted work; ( 2) TMM received consultancy fees, honoraria, and travel expenses in the past three years from Pfizer, Servier, Novartis, Wyeth, Kaiser Permanante, Takeda, Recordati, NiCox, Quintiles, and Speedel; ADS received consultancy fees, honoraria, and travel expenses from Pfizer in the past three years; ADW received consultancy fees, honoraria, and travel expenses from Servier and Pfizer in the past three years; ( 3) no spouses, partners, or children with relationships with commercial entities that might have an interest in the submitted work; and ( 4) no non-financial interests that may be relevant to the submitted work.	Albert NM, 2009, JAMA-J AM MED ASSOC, V302, P1658, DOI 10.1001/jama.2009.1493; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Calhoun DA, 2006, PROG CARDIOVASC DIS, V48, P387, DOI 10.1016/j.pcad.2006.02.002; Chapman N, 2007, HYPERTENSION, V49, P839, DOI 10.1161/01.HYP.0000259805.18468.8c; GISSI Prevenzione Investigators, 2000, ITAL HEART J, V1, P810; Glasziou P, 2005, BMJ-BRIT MED J, V330, P644, DOI 10.1136/bmj.330.7492.644; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Lim PO, 1999, LANCET, V353, P40, DOI 10.1016/S0140-6736(05)74868-6; Lim PO, 2002, J HYPERTENS, V20, P11, DOI 10.1097/00004872-200201000-00003; Lim PO, 2002, J HUM HYPERTENS, V16, P153, DOI 10.1038/sj.jhh.1001320; Lim PO, 2001, J HYPERTENS, V19, P353, DOI 10.1097/00004872-200103000-00001; Lim PO, 1999, BRIT J CLIN PHARMACO, V48, P756; Masoudi FA, 2005, CIRCULATION, V112, P39, DOI 10.1161/CIRCULATIONAHA.104.527549; Obialo CI, 2002, AM J CARDIOL, V90, P663, DOI 10.1016/S0002-9149(02)02581-X; Ouzan J, 2002, AM J HYPERTENS, V15, P333, DOI 10.1016/S0895-7061(01)02342-1; PEDERSEN TR, 1994, LANCET, V344, P1383; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schepkens H, 2001, AM J MED, V110, P438, DOI 10.1016/S0002-9343(01)00642-8; Svensson M, 2003, BRIT MED J, V327, P1141, DOI 10.1136/bmj.327.7424.1141; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Vasan RS, 2004, NEW ENGL J MED, V351, P33, DOI 10.1056/NEJMoa033263; Verhamme KMC, 2006, BMJ-BRIT MED J, V333, P330, DOI 10.1136/bmj.38883.479549.2F; Wei L, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P323; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634	25	72	72	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2010	340								c1768	10.1136/bmj.c1768	http://dx.doi.org/10.1136/bmj.c1768			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601LR	20483947	Green Submitted, hybrid			2022-12-24	WOS:000278061500003
J	Tseng, HF; Slezak, JM; Quinn, VP; Sy, LS; Van Den Eeden, SK; Jacobsen, SJ				Tseng, Hung Fu; Slezak, Jeffrey M.; Quinn, Virginia P.; Sy, Lina S.; Van Den Eeden, Stephen K.; Jacobsen, Steven J.			Pneumococcal Vaccination and Risk of Acute Myocardial Infarction and Stroke in Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; INFLUENZA VACCINATION; PREVENTION; HEALTH	Context Multiple studies have shown that preventing influenza by vaccination reduces the risk of vascular events. However, the effect of pneumococcal polysaccharide vaccine on vascular events remains controversial. Objective To examine the association between pneumococcal vaccination and risk of acute myocardial infarction (MI) and stroke among men. Design, Setting, and Participants A prospective cohort study of Kaiser Permanente Northern and Southern California health plans with 84 170 participants aged 45 to 69 years from the California Men's Health Study who were recruited between January 2002 and December 2003, and followed up until December 31, 2007. The cohort was similar to the population of health plan members and men who responded to a general health survey in California on important demographic and clinical characteristics. Demographic and detailed lifestyle characteristics were collected from surveys. Vaccination records were obtained from the Kaiser Immunization Tracking System. Main Outcome Measure Incidence of acute MI and stroke during the follow-up period in men who had no history of such conditions. Results During follow-up, there were 1211 first MIs in 112 837 vaccinated personyears (10.73 per 1000 person-years) compared with 1494 first MI events in 246 170 unvaccinated person-years (6.07 per 1000 person-years). For stroke, there were 651 events in 122 821 vaccinated person-years (5.30 per 1000 person-years) compared with 483 events in 254 541 unvaccinated person-years (1.90 per 1000 person-years). With propensity score adjustment, we found no evidence for an association between pneumococcal vaccination and reduced risk of acute MI (adjusted hazard ratio [HR], 1.09; 95% confidence interval [CI], 0.98-1.21) or stroke (adjusted HR, 1.14; 95% CI, 1.00-1.31). An inverse association was also not found in men of different age and risk groups. The results appeared to be consistent, because using more specific International Classification of Diseases, Ninth Revision codes for the outcome definition did not change the estimations. Conclusion Among a cohort of men aged 45 years or older, receipt of pneumococcal vaccine was not associated with subsequent reduced risk of acute MI and stroke. JAMA. 2010;303(17):1699-1706 www.jama.com	[Tseng, Hung Fu; Slezak, Jeffrey M.; Quinn, Virginia P.; Sy, Lina S.; Jacobsen, Steven J.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA USA; [Van Den Eeden, Stephen K.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA	Kaiser Permanente; Kaiser Permanente	Tseng, HF (corresponding author), Kaiser Permanente, So Calif Permanente Med Grp, Dept Res & Evaluat, 100 S Los Robles Ave,2nd Floor, Pasadena, CA 91101 USA.	hung-fu.x.tseng@kp.org	Sy, Lina/AFM-9458-2022	Sy, Lina/0000-0003-2762-9266; Jacobsen, Steven/0000-0002-8174-8533	California Cancer Research Program; Kaiser Permanente	California Cancer Research Program; Kaiser Permanente	This study was funded by California Cancer Research Program and Kaiser Permanente.	[Anonymous], 1997, MMWR Recomm Rep, V46, P1; Chao C, 2008, CANCER EPIDEM BIOMAR, V17, P2692, DOI 10.1158/1055-9965.EPI-08-0410; Davis MM, 2006, J AM COLL CARDIOL, V48, P1498, DOI 10.1016/j.jacc.2006.09.004; Enger SM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-172; Grau AJ, 2005, STROKE, V36, P1501, DOI 10.1161/01.STR.0000170674.45136.80; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Lamontagne F, 2008, CAN MED ASSOC J, V179, P773, DOI 10.1503/cmaj.070221; Madjid M, 2005, EXPERT OPIN BIOL TH, V5, P91, DOI 10.1517/14712598.5.1.91; Madjid M, 2008, CAN MED ASSOC J, V179, P749, DOI 10.1503/cmaj.081302; Meyers David G., 2004, HeartDrug, V4, P96, DOI 10.1159/000077705; Meyers David G, 2003, Curr Atheroscler Rep, V5, P146, DOI 10.1007/s11883-003-0087-x; Moberley SA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub2; Rosa EM, 2009, CAN MED ASSOC J, V180, P319, DOI 10.1503/cmaj.1080119; Skowronski DM, 2009, CAN MED ASSOC J, V180, P319, DOI 10.1503/cmaj.1080120; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747	15	53	55	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2010	303	17					1699	1706		10.1001/jama.2010.529	http://dx.doi.org/10.1001/jama.2010.529			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591CR	20442385	Bronze			2022-12-24	WOS:000277276600022
J	Burmann, BM; Schweimer, K; Luo, X; Wahl, MC; Stitt, BL; Gottesman, ME; Rosch, P				Burmann, Bjoern M.; Schweimer, Kristian; Luo, Xiao; Wahl, Markus C.; Stitt, Barbara L.; Gottesman, Max E.; Roesch, Paul			A NusE:NusG Complex Links Transcription and Translation	SCIENCE			English	Article							ESCHERICHIA-COLI; ANTITERMINATION COMPLEX; RNA-TRANSCRIPTION; PHAGE-LAMBDA; FACTOR-NUSG; N-PROTEIN; BOXA RNA; ELONGATION; TERMINATION; RHO	Bacterial NusG is a highly conserved transcription factor that is required for most Rho activity in vivo. We show by nuclear magnetic resonance spectroscopy that Escherichia coli NusG carboxy-terminal domain forms a complex alternatively with Rho or with transcription factor NusE, a protein identical to 30S ribosomal protein S10. Because NusG amino-terminal domain contacts RNA polymerase and the NusG carboxyl-terminal domain interaction site of NusE is accessible in the ribosomal 30S subunit, NusG may act as a link between transcription and translation. Uncoupling of transcription and translation at the ends of bacterial operons enables transcription termination by Rho factor, and competition between ribosomal NusE and Rho for NusG helps to explain why Rho cannot terminate translated transcripts.	[Burmann, Bjoern M.; Schweimer, Kristian; Roesch, Paul] Univ Bayreuth, Lehrstuhl Biopolymere, D-95447 Bayreuth, Germany; [Burmann, Bjoern M.; Schweimer, Kristian; Roesch, Paul] Univ Bayreuth, Forschungszentrum BioMakromol, D-95447 Bayreuth, Germany; [Luo, Xiao; Wahl, Markus C.] Free Univ Berlin, Fachbereich Biol Chem Pharm, Inst Chem & Biochem, AG Strukturbiochem, D-14195 Berlin, Germany; [Stitt, Barbara L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Stitt, Barbara L.] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; [Gottesman, Max E.] Columbia Univ, Dept Microbiol, Med Ctr, New York, NY 10032 USA; [Gottesman, Max E.] Columbia Univ, Inst Canc Res, Med Ctr, New York, NY 10032 USA	University of Bayreuth; University of Bayreuth; Free University of Berlin; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Columbia University; Columbia University	Rosch, P (corresponding author), Univ Bayreuth, Lehrstuhl Biopolymere, Univ Str 30, D-95447 Bayreuth, Germany.	roesch@unibt.de	Wahl, Markus C./D-6365-2017; Burmann, Björn/M-8913-2015; Rösch, Paul/I-5445-2014; Burmann, Björn M./AAI-7760-2021; Burmann, Björn M./AAR-7399-2020	Wahl, Markus C./0000-0002-2811-5307; Burmann, Björn/0000-0002-3135-7964; Rösch, Paul/0000-0003-3330-2446; Burmann, Björn M./0000-0002-3135-7964; Schweimer, Kristian/0000-0002-3837-8442	Deutsche Forschungsgemeinschaft [Ro617/16-1, Wa1126/3-1, NSF MCB-0744422]; NIH [GM037219]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037219, R56GM037219] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Heissmann for excellent technical assistance. Financial support by the Deutsche Forschungsgemeinschaft to P. R. (Ro617/16-1), M. C. W. (Wa1126/3-1), and B. L. S. (NSF MCB-0744422) as well as by the NIH to M. E. G. (GM037219) is gratefully acknowledged.	ADHYA S, 1978, ANNU REV BIOCHEM, V47, P967, DOI 10.1146/annurev.bi.47.070178.004535; Belogurov GA, 2009, EMBO J, V28, P112, DOI 10.1038/emboj.2008.268; Burmann BM, 2010, NUCLEIC ACIDS RES, V38, P314, DOI 10.1093/nar/gkp736; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; DAS A, 1985, P NATL ACAD SCI USA, V82, P4070, DOI 10.1073/pnas.82.12.4070; DOWNING WL, 1990, J BACTERIOL, V172, P1621, DOI 10.1128/jb.172.3.1621-1627.1990; GREENBLATT J, 1993, NATURE, V364, P401, DOI 10.1038/364401a0; Greive SJ, 2005, J BIOL CHEM, V280, P36397, DOI 10.1074/jbc.M507146200; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; KELLER EB, 1979, P NATL ACAD SCI USA, V76, P6186, DOI 10.1073/pnas.76.12.6186; Knowlton JR, 2003, BIOCHEMISTRY-US, V42, P2275, DOI 10.1021/bi0272508; Kyrpides NC, 1996, TRENDS BIOCHEM SCI, V21, P425, DOI 10.1016/S0968-0004(96)30036-4; Kyrpides NC, 1999, P NATL ACAD SCI USA, V96, P8545, DOI 10.1073/pnas.96.15.8545; Luo X, 2008, MOL CELL, V32, P791, DOI 10.1016/j.molcel.2008.10.028; MASON SW, 1991, GENE DEV, V5, P1504, DOI 10.1101/gad.5.8.1504; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Mooney RA, 2009, J MOL BIOL, V391, P341, DOI 10.1016/j.jmb.2009.05.078; Pasman Z, 2000, BIOCHEMISTRY-US, V39, P5573, DOI 10.1021/bi992658z; Peters JM, 2009, P NATL ACAD SCI USA, V106, P15406, DOI 10.1073/pnas.0903846106; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Squires CL, 2000, ANNU REV MICROBIOL, V54, P775, DOI 10.1146/annurev.micro.54.1.775; Steiner T, 2002, EMBO J, V21, P4641, DOI 10.1093/emboj/cdf455; SULLIVAN SL, 1992, J BACTERIOL, V174, P1339, DOI 10.1128/jb.174.4.1339-1344.1992; SULLIVAN SL, 1992, CELL, V68, P989, DOI 10.1016/0092-8674(92)90041-A; Torres M, 2001, EMBO J, V20, P3811, DOI 10.1093/emboj/20.14.3811; VOGEL U, 1994, J BIOL CHEM, V269, P16236; Zellars M, 1999, MOL MICROBIOL, V32, P1296, DOI 10.1046/j.1365-2958.1999.01442.x; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	28	235	237	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					501	504		10.1126/science.1184953	http://dx.doi.org/10.1126/science.1184953			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413501				2022-12-24	WOS:000276952400043
J	Lyratzopoulos, G; Barbiere, JM; Greenberg, DC; Wright, KA; Neal, DE				Lyratzopoulos, Georgios; Barbiere, Josephine M.; Greenberg, David C.; Wright, Karen A.; Neal, David E.			Population based time trends and socioeconomic variation in use of radiotherapy and radical surgery for prostate cancer in a UK region: continuous survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOCIAL-CLASS; SURVIVAL; MORTALITY; CARE; DEPRIVATION; DIAGNOSIS; PATTERNS; QUALITY; ENGLAND; RACE/ETHNICITY	Objective To examine variation in the management of prostate cancer in patients with different socioeconomic status. Design Survey using UK regional cancer registry data. Setting Regional population based cancer registry. Participants 35 171 patients aged >= 51 with a diagnosis of prostate cancer, 1995-2006. Main outcome measures Use of radiotherapy and radical surgery. Socioeconomic status according to fifths of small area deprivation index. Results Over nine years of the study, information on stage at diagnosis was available for 15 916 of 27 970 patients (57%). During the study period, the proportion of patients treated with radiotherapy remained at about 25%, while use of radical surgery increased significantly (from 2.9% (212/7201) during 1995-7 to 8.4% (854/10 211) during 2004-6, P<0.001). Both treatments were more commonly used in least deprived compared with most deprived patients (28.5% v 21.0% for radiotherapy and 8.4% v 4.0% for surgery). In multivariable analysis, increasing deprivation remained strongly associated with lower odds of radiotherapy or surgery (odds ratio 0.92 (95% confidence interval 0.90 to 0.94), P<0.001, and 0.91 (0.87 to 0.94), P<0.001, respectively, per incremental deprivation group). There were consistently concordant findings with multilevel models for clustering of observations by hospital of diagnosis, with restriction of the analysis to patients with information on stage, and with sequential restriction of the analysis to different age, stage, diagnosis period, and morphology groups. Conclusions After a diagnosis of prostate cancer, men from lower socioeconomic groups were substantially less likely to be treated with radical surgery or radiotherapy. The causes and impact on survival of such differences remain uncertain.	[Lyratzopoulos, Georgios; Barbiere, Josephine M.] Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England; [Greenberg, David C.; Wright, Karen A.] Eastern Canc Registrat & Informat Ctr, Cambridge CB22 3AD, England; [Neal, David E.] Addenbrookes Hosp, Univ Dept Oncol, Cambridge CB2 OQQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital	Lyratzopoulos, G (corresponding author), Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England.	gl290@medschl.cam.ac.uk	Lyratzopoulos, Georgios/B-6301-2012; Lyratzopoulos, Georgios/O-8260-2019	Lyratzopoulos, Georgios/0000-0002-2873-7421; Neal, David/0000-0002-6033-5086	MRC [G0900871] Funding Source: UKRI; Medical Research Council [G0900871] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Albain KS, 2009, JNCI-J NATL CANCER I, V101, P984, DOI 10.1093/jnci/djp175; [Anonymous], 1997, J CLIN PATHOL; Bentley R, 2008, CANCER CAUSE CONTROL, V19, P183, DOI 10.1007/s10552-007-9084-7; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Bott SRJ, 2005, BJU INT, V95, P34, DOI 10.1111/j.1464-410X.2005.05245.x; *BRIT ASS UR SURG, 2007, AN MIN DAT SET UR CA; CARSTAIRS V, 1989, COMMUNITY MED, V11, P210, DOI 10.1093/oxfordjournals.pubmed.a042469; Clarke NW, 2008, BRIT J CANCER, V99, pS78, DOI 10.1038/sj.bjc.6604596; *COMM LOC GOV, IND DEPR 2004; Davison BJ, 2004, BJU INT, V93, P47, DOI 10.1111/j.1464-410X.2004.04553.x; Fairley L, 2009, BRIT J CANCER, V101, P1839, DOI 10.1038/sj.bjc.6605424; Hall SE, 2005, BJU INT, V95, P51, DOI 10.1111/j.1464-410X.2005.05248.x; Harlan LC, 2001, J NATL CANCER I, V93, P1864, DOI 10.1093/jnci/93.24.1864; Hayen A, 2008, AUST NZ J PUBL HEAL, V32, P417, DOI 10.1111/j.1753-6405.2008.00272.x; Hoffman RM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-27; Jeffreys M, 2009, CANCER EPIDEM BIOMAR, V18, P915, DOI 10.1158/1055-9965.EPI-08-0685; Kim SP, 2001, CANCER INVEST, V19, P684, DOI 10.1081/CNV-100106143; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Krupski TL, 2005, J CLIN ONCOL, V23, P7881, DOI 10.1200/JCO.2005.08.755; LIBERATOS P, 1988, EPIDEMIOL REV, V10, P87, DOI 10.1093/oxfordjournals.epirev.a036030; Lyratzopoulos G, 2008, J CLIN EPIDEMIOL, V61, P261, DOI 10.1016/j.jclinepi.2007.05.020; Marsa K, 2008, EUR J CANCER, V44, P2018, DOI 10.1016/j.ejca.2008.06.012; Melia J, 2004, BJU INT, V94, P51, DOI 10.1111/j.1464-4096.2004.04832.x; *NAT CANC INT NETW, 2002, ENGL CANC INC SURV M; *NAT CANC INT NETW, 1995, CANC INC DEPR ENGL; National Institute for Health and Clinical Excellence, 2008, PROST CANC DIAGN TRE; *NHS CONN HLTH, 2010, OPCS 4 INT CLASS; *OFF NAT STAT, 2010, EST POP EST ETHN GRO; Oliver SE, 2003, BJU INT, V91, P331, DOI 10.1046/j.1464-410X.2003.04083.x; Penson DF, 2005, J CLIN ONCOL, V23, P7783, DOI 10.1200/JCO.2005.03.0353; Quinn M, 2002, BJU INT, V90, P162, DOI 10.1046/j.1464-410X.2002.2822.x; Quinn MJ, 2001, STUDIES MED POPULATI; Rachet B, 2009, LANCET ONCOL, V10, P351, DOI 10.1016/S1470-2045(09)70028-2; Rapiti E, 2009, CANCER-AM CANCER SOC, V115, P5556, DOI 10.1002/cncr.24607; Richstone L, 2008, BJU INT, V101, P541, DOI 10.1111/j.1464-410X.2007.07410.x; ROWAN S, 2008, BR J CANC S1, V99, P75; Shavers VL, 2004, MED CARE, V42, P239, DOI 10.1097/01.mlr.0000117361.61444.71; Shavers VL, 2004, J GEN INTERN MED, V19, P146, DOI 10.1111/j.1525-1497.2004.30209.x; Shohaimi S, 2004, EUR RESPIR J, V24, P157, DOI 10.1183/09031936.04.00088303; Sloggett A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-20; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Smith JA, 2007, J UROLOGY, V178, P2385, DOI 10.1016/j.juro.2007.08.008; SWORDS K, 2008, UROL ONCOL      1211; *U BRIST, 2009, PROTECT STUD PROST T; Wilt TJ, 2008, J UROLOGY, V180, P820, DOI 10.1016/j.juro.2008.05.010; Woods LM, 2005, BRIT J CANCER, V92, P1279, DOI 10.1038/sj.bjc.6602506	48	38	38	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2010	340								c1928	10.1136/bmj.c1928	http://dx.doi.org/10.1136/bmj.c1928			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589HO	20413566	hybrid, Green Published			2022-12-24	WOS:000277138000001
J	Wojcicki, JM; Heyman, MB				Wojcicki, Janet M.; Heyman, Melvin B.			Let's Move - Childhood Obesity Prevention from Pregnancy and Infancy Onward	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wojcicki, Janet M.; Heyman, Melvin B.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Wojcicki, JM (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.				NIDDK NIH HHS [T32 DK007762, K24 DK060617, K24 DK060617-08] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007762, K24DK060617] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Horta BL, 2007, EVIDENCE LONG TERM E; Skinner AC, 2010, PEDIATRICS      0301; Sullivan EL, 2010, FORUM NUTR, V63, P186, DOI 10.1159/000264406; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub2, 10.1002/14651858.CD001871.pub4]; Wrotniak BH, 2008, AM J CLIN NUTR, V87, P1818, DOI 10.1093/ajcn/87.6.1818	5	69	71	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2010	362	16					1457	1459		10.1056/NEJMp1001857	http://dx.doi.org/10.1056/NEJMp1001857			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	586GP	20393165	Green Accepted			2022-12-24	WOS:000276894700002
J	Mooney, KA; Halitschke, R; Kessler, A; Agrawal, AA				Mooney, Kailen A.; Halitschke, Rayko; Kessler, Andre; Agrawal, Anurag A.			Evolutionary Trade-Offs in Plants Mediate the Strength of Trophic Cascades	SCIENCE			English	Article							HERBIVORES; METAANALYSIS; DEFENSE; PREY; PRODUCTIVITY; TERRESTRIAL; STRATEGIES; PREDATION; GROWTH	Predators determine herbivore and plant biomass via so-called trophic cascades, and the strength of such effects is influenced by ecosystem productivity. To determine whether evolutionary trade-offs among plant traits influence patterns of trophic control, we manipulated predators and soil fertility and measured impacts of a major herbivore ( the aphid Aphis nerii) on 16 milkweed species (Asclepias spp.) in a phylogenetic field experiment. Herbivore density was determined by variation in predation and trade-offs between herbivore resistance and plant growth strategy. Neither herbivore density nor predator effects on herbivores predicted the cascading effects of predators on plant biomass. Instead, cascade strength was strongly and positively associated with milkweed response to soil fertility. Accordingly, contemporary patterns of trophic control are driven by evolutionary convergent trade-offs faced by plants.	[Mooney, Kailen A.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Halitschke, Rayko; Kessler, Andre; Agrawal, Anurag A.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Agrawal, Anurag A.] Cornell Ctr Sustainable Future, Ithaca, NY 14853 USA	University of California System; University of California Irvine; Cornell University	Mooney, KA (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	mooneyk@uci.edu	Kessler, Andre/C-7810-2014; Halitschke, Rayko/AAY-2365-2020; Agrawal, Anurag A/Y-2497-2019	Halitschke, Rayko/0000-0002-1109-8782; Agrawal, Anurag A/0000-0003-0095-1220; Kessler, Andre/0000-0002-1797-7518	NSF; Cornell Center for a Sustainable Future; University of California Irvine School of Biological Sciences	NSF(National Science Foundation (NSF)); Cornell Center for a Sustainable Future; University of California Irvine School of Biological Sciences	We thank R. A. Smith and J. Goldstein for field assistance; S. Rasmann for contributing cardenolide data; M. Fishbein for providing phylogenetic information; and the University of California Berkeley Botanical Garden, S. Malcolm, A. Rapini, and M. Fishbein for providing plant material. The manuscript was improved by comments from A. Flecker, S. Rasmann, D. Raboski, and D. Gruner and supported by NSF, the Cornell Center for a Sustainable Future, and the University of California Irvine School of Biological Sciences.	Agrawal AA, 2004, AM NAT, V164, P113, DOI 10.1086/420980; Agrawal AA, 2008, P NATL ACAD SCI USA, V105, P10057, DOI 10.1073/pnas.0802368105; Borer ET, 2006, ECOLOGY, V87, P2813, DOI 10.1890/0012-9658(2006)87[2813:AICREO]2.0.CO;2; Brett MT, 1996, P NATL ACAD SCI USA, V93, P7723, DOI 10.1073/pnas.93.15.7723; CLANCY KM, 1987, ECOLOGY, V68, P733, DOI 10.2307/1938479; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Craine JM., 2009, RESOURCE STRATEGIES; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Forkner RE, 2000, ECOLOGY, V81, P1588, DOI 10.1890/0012-9658(2000)081[1588:WGUMCD]2.0.CO;2; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2; Helms SE, 2004, ECOL ENTOMOL, V29, P44, DOI 10.1111/j.0307-6946.2004.00566.x; Lill JT, 2002, NATURE, V417, P170, DOI 10.1038/417170a; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Sipura M, 1999, OECOLOGIA, V121, P537, DOI 10.1007/s004420050960; van der Stap I, 2007, ECOLOGY, V88, P2474, DOI 10.1890/07-1731.1; Vance-Chalcraft HD, 2007, ECOLOGY, V88, P2689, DOI 10.1890/06-1869.1	27	96	125	6	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2010	327	5973					1642	1644		10.1126/science.1184814	http://dx.doi.org/10.1126/science.1184814			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339073				2022-12-24	WOS:000275970600043
J	Wang, YZ; Krivtsov, AV; Sinha, AU; North, TE; Goessling, W; Feng, ZH; Zon, LI; Armstrong, SA				Wang, Yingzi; Krivtsov, Andrei V.; Sinha, Amit U.; North, Trista E.; Goessling, Wolfram; Feng, Zhaohui; Zon, Leonard I.; Armstrong, Scott A.			The Wnt/beta-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML	SCIENCE			English	Article							ACUTE MYELOID-LEUKEMIA; BETA-CATENIN; COLON-CANCER; HEMATOPOIETIC-CELLS; SIGNALING PATHWAY; IN-VIVO; PROGENITORS; EXPRESSION; EXPANSION; RENEWAL	Leukemia stem cells (LSCs) are capable of limitless self-renewal and are responsible for the maintenance of leukemia. Because selective eradication of LSCs could offer substantial therapeutic benefit, there is interest in identifying the signaling pathways that control their development. We studied LSCs in mouse models of acute myelogenous leukemia (AML) induced either by coexpression of the Hoxa9 and Meis1a oncogenes or by the fusion oncoprotein MLL-AF9. We show that the Wnt/beta-catenin signaling pathway is required for self-renewal of LSCs that are derived from either hematopoietic stem cells (HSC) or more differentiated granulocyte-macrophage progenitors (GMP). Because the Wnt/beta-catenin pathway is normally active in HSCs but not in GMP, these results suggest that reactivation of beta-catenin signaling is required for the transformation of progenitor cells by certain oncogenes. beta-catenin is not absolutely required for self-renewal of adult HSCs; thus, targeting the Wnt/beta-catenin pathway may represent a new therapeutic opportunity in AML.	[Wang, Yingzi; Krivtsov, Andrei V.; Sinha, Amit U.; Feng, Zhaohui; Zon, Leonard I.; Armstrong, Scott A.] Harvard Univ, Childrens Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA; [Sinha, Amit U.; Feng, Zhaohui; Armstrong, Scott A.] Harvard Univ, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA; [North, Trista E.] Harvard Univ, Sch Med, Beth Israel Deaconess Hosp, Dept Pathol, Boston, MA 02115 USA; [North, Trista E.; Goessling, Wolfram; Zon, Leonard I.; Armstrong, Scott A.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Goessling, Wolfram] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Goessling, Wolfram] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Zon, Leonard I.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Armstrong, SA (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA.	scott.armstrong@childrens.harvard.edu	Wang, Jenny Y./ABD-2091-2020; North, Trista/ABG-4789-2020; Krivtsov, Andrei/AAJ-9966-2021	North, Trista/0000-0003-1249-563X; Goessling, Wolfram/0000-0001-9972-1569	NIH [5P01CA66996, 5R01HL048801]; American Cancer Society [RSG-09-068-01]; Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE [P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank D. Fisher, X. He, and H. Widlund for plasmid pcDNA3.1-beta cat-*-Flag; D. Williams for helpful discussion and advice; and M. Smith for administrative assistance. This work was supported by the NIH grants 5P01CA66996 ( to S. A. A.) and 5R01HL048801 ( to L.I.Z.), the American Cancer Society (RSG-09-068-01), and the Harvard Stem Cell Institute. S. A. A. is a Leukemia and Lymphoma Society Scholar. Microarray data was submitted to the National Center for Biotechnology Information Gene Expression Omnibus (GEO) GSE20377. L.I.Z. is a founding member of and stockholder in Fate Therapeutics, a biotechnology company that is developing stem cell therapeutics and that has acquired a patent covering the use of prostaglandin E2 in hematopoietic stem cell modulation and tissue regeneration. W. G. and T.E.N. are paid consultants for Fate Therapeutics.	Abramovich C, 2005, ANN NY ACAD SCI, V1044, P109, DOI 10.1196/annals.1349.014; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brault V, 2001, DEVELOPMENT, V128, P1253; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Eisinger AL, 2007, PROSTAG OTH LIPID M, V82, P147, DOI 10.1016/j.prostaglandins.2006.05.026; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Orido T, 2008, J PHARMACOL SCI, V108, P389, DOI 10.1254/jphs.08167SC; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Ysebaert L, 2006, LEUKEMIA, V20, P1211, DOI 10.1038/sj.leu.2404239; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	25	551	585	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1650	1653		10.1126/science.1186624	http://dx.doi.org/10.1126/science.1186624			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339075	Green Accepted			2022-12-24	WOS:000275970600046
J	Wong, WCW; Fairley, CK				Wong, William C. W.; Fairley, Christopher K.			10-Minute Consultation Sexual health consultation for men who have sex with men	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wong, William C. W.] Dept Gen Practice, Carlton, Vic 3053, Australia; [Fairley, Christopher K.] Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Fairley, Christopher K.] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic 3010, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne	Wong, WCW (corresponding author), Dept Gen Practice, Carlton, Vic 3053, Australia.	w.wong@unimelb.edu.au	Wong, William Chi Wai/B-3417-2011	Christopher, Fairley/0000-0001-9081-1664					0	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 22	2010	340								c958	10.1136/bmj.c958	http://dx.doi.org/10.1136/bmj.c958			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576PN	20308182				2022-12-24	WOS:000276157500009
J	Carnall, JMA; Waudby, CA; Belenguer, AM; Stuart, MCA; Peyralans, JJP; Otto, S				Carnall, Jacqui M. A.; Waudby, Christopher A.; Belenguer, Ana M.; Stuart, Marc C. A.; Peyralans, Jerome J. -P.; Otto, Sijbren			Mechanosensitive Self-Replication Driven by Self-Organization	SCIENCE			English	Article							MECHANICAL FORCE; CONGO RED; PEPTIDE; HEXADEOXYNUCLEOTIDE; CONFORMATION; EMERGENCE; CHEMISTRY; BINDING; SYSTEM; GROWTH	Self-replicating molecules are likely to have played an important role in the origin of life, and a small number of fully synthetic self-replicators have already been described. Yet it remains an open question which factors most effectively bias the replication toward the far-from-equilibrium distributions characterizing even simple organisms. We report here two self-replicating peptide-derived macrocycles that emerge from a small dynamic combinatorial library and compete for a common feedstock. Replication is driven by nanostructure formation, resulting from the assembly of the peptides into fibers held together by beta sheets. Which of the two replicators becomes dominant is influenced by whether the sample is shaken or stirred. These results establish that mechanical forces can act as a selection pressure in the competition between replicators and can determine the outcome of a covalent synthesis.	[Stuart, Marc C. A.; Peyralans, Jerome J. -P.; Otto, Sijbren] Univ Groningen, Stratingh Inst, Ctr Syst Chem, NL-9747 AG Groningen, Netherlands; [Carnall, Jacqui M. A.; Waudby, Christopher A.; Belenguer, Ana M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Waudby, Christopher A.] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England; [Stuart, Marc C. A.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Cambridge; University of London; University College London; University of Groningen	Otto, S (corresponding author), Univ Groningen, Stratingh Inst, Ctr Syst Chem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	s.otto@rug.nl	Otto, Sijbren/E-9568-2014; Waudby, Christopher/AAT-1736-2021; Stuart, Marc/B-6274-2008	Waudby, Christopher/0000-0001-7810-3753; Stuart, Marc/0000-0003-0667-6338; Otto, Sijbren/0000-0003-0259-5637	Engineering and Physical Sciences Research Council; Royal Society; Dynamic Combinatorial Chemistry Marie-Curie Research Training Network; Cooperation in Science and Technology (COST) [CM0703]; Engineering and Physical Sciences Research Council [EP/F035888/1] Funding Source: researchfish; EPSRC [EP/F035888/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); Dynamic Combinatorial Chemistry Marie-Curie Research Training Network; Cooperation in Science and Technology (COST)(European Cooperation in Science and Technology (COST)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank J. K. M. Sanders and J. B. F. N. Engberts for critical reading of the manuscript and C. M. Dobson for useful discussions. This research has been supported by the Engineering and Physical Sciences Research Council, the Royal Society, the Dynamic Combinatorial Chemistry Marie-Curie Research Training Network, and Cooperation in Science and Technology (COST) CM0703.	Brunsveld L, 2001, CHEM REV, V101, P4071, DOI 10.1021/cr990125q; Corbett PT, 2006, CHEM REV, V106, P3652, DOI 10.1021/cr020452p; Davis DA, 2009, NATURE, V459, P68, DOI 10.1038/nature07970; DEGRADO WF, 1985, J AM CHEM SOC, V107, P7684, DOI 10.1021/ja00311a076; Dwyer-Joyce RS, 2003, P ROY SOC A-MATH PHY, V459, P957, DOI 10.1098/rspa.2002.1018; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hickenboth CR, 2007, NATURE, V446, P423, DOI 10.1038/nature05681; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Krishnan-Ghosh Y, 2003, ANGEW CHEM INT EDIT, V42, P2171, DOI 10.1002/anie.200250551; Lee DH, 1996, NATURE, V382, P525, DOI 10.1038/382525a0; Lee DH, 1997, NATURE, V390, P591, DOI 10.1038/37569; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Nguyen R, 2009, ANGEW CHEM INT EDIT, V48, P1093, DOI 10.1002/anie.200804602; ORGEL LE, 1992, NATURE, V358, P203, DOI 10.1038/358203a0; ORGEL LE, 1995, ACCOUNTS CHEM RES, V28, P109, DOI 10.1021/ar00051a004; Otto S, 2000, J AM CHEM SOC, V122, P12063, DOI 10.1021/ja005507o; Paul N, 2002, P NATL ACAD SCI USA, V99, P12733, DOI 10.1073/pnas.202471099; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Piermattei A, 2009, NAT CHEM, V1, P133, DOI [10.1038/NCHEM.167, 10.1038/nchem.167]; PIETERS RJ, 1994, ANGEW CHEM INT EDIT, V33, P1579, DOI 10.1002/anie.199415791; Pross A, 2003, J THEOR BIOL, V220, P393, DOI 10.1006/jtbi.2003.3178; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; ROTELLO V, 1991, J AM CHEM SOC, V113, P9422, DOI 10.1021/ja00024a089; Sadownik JW, 2008, ANGEW CHEM INT EDIT, V47, P9965, DOI 10.1002/anie.200804223; Szathmary E, 1997, J THEOR BIOL, V187, P555, DOI 10.1006/jtbi.1996.0389; TJIVIKUA T, 1990, J AM CHEM SOC, V112, P1249, DOI 10.1021/ja00159a057; Vidonne A., 2009, EUR J ORG CHEM, V2009, P593; VONKIEDROWSKI G, 1991, ANGEW CHEM INT EDIT, V30, P423, DOI 10.1002/anie.199104231; VONKIEDROWSKI G, 1986, ANGEW CHEM INT EDIT, V25, P932, DOI 10.1002/anie.198609322; Wang B, 1997, CHEM COMMUN, P1495, DOI 10.1039/a701573i; Williams RJ, 2009, NAT NANOTECHNOL, V4, P19, DOI [10.1038/nnano.2008.378, 10.1038/NNANO.2008.378]; Xu S, 2008, J AM CHEM SOC, V130, P1826, DOI 10.1021/ja710248q; Yao S, 1997, J AM CHEM SOC, V119, P10559, DOI 10.1021/ja9710619	34	374	379	9	297	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1502	1506		10.1126/science.1182767	http://dx.doi.org/10.1126/science.1182767			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299594				2022-12-24	WOS:000275715200046
J	Flothmann, S; von Kistowski, K; Dolan, E; Lee, E; Meere, F; Album, G				Flothmann, Stefan; von Kistowski, Kristin; Dolan, Emily; Lee, Elsa; Meere, Frank; Album, Gunnar			Closing Loopholes: Getting Illegal Fishing Under Control	SCIENCE			English	Editorial Material							GLOBAL FISHERIES; WORLD FISHERIES; IMPACTS; TRENDS		[Flothmann, Stefan; von Kistowski, Kristin; Lee, Elsa; Meere, Frank] Int Ocean Governance, Pew Environm Grp, Pew Charitable Trusts, Washington, DC 20004 USA; [Dolan, Emily] Univ Ghent, Dept Biol, Marine Biol Sect, B-9000 Ghent, Belgium; [Album, Gunnar] Trygg Mat Fdn, Barents Sea Offi, N-8285 Leines, Norway	Ghent University	von Kistowski, K (corresponding author), Int Ocean Governance, Pew Environm Grp, Pew Charitable Trusts, Washington, DC 20004 USA.	kristin@kistowski.de						Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; [Anonymous], 2006, CLOS NET STOPP ILL F; Barnes CT, 2004, FISH PIRACY COMBATIN; CULLISSUZUKI S, MAR POLICY; Delgado CL, 2003, OUTLOOK FISH 2020 M; FAO, 2007, MODEL SCHEME PORT ST; FAO, 2009, STAT WORLD FISH AQ 2; *FAO, 1993, AGR PROM COMPL INT C; FAO, 2009, AGR PORT STAT MEAS P; Gianni Matthew, 2005, CHANGING NATURE HIGH; Gupta A, 2008, GLOBAL ENVIRON POLIT, V8, P1, DOI 10.1162/glep.2008.8.2.1; Hilborn R, 2003, ANNU REV ENV RESOUR, V28, P359, DOI 10.1146/annurev.energy.28.050302.105509; Langley Paul, 2001, GLOBAL SOC, V15, P73, DOI DOI 10.1080/13600820123590; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; Pitcher T, 2009, NATURE, V457, P658, DOI 10.1038/457658a; Sumaila UR, 2006, MAR POLICY, V30, P696, DOI 10.1016/j.marpol.2005.11.001; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zeller D, 2005, FISH FISH, V6, P156, DOI 10.1111/j.1467-2979.2005.00177.x	22	43	44	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1235	1236		10.1126/science.1190245	http://dx.doi.org/10.1126/science.1190245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	605AC	20488991				2022-12-24	WOS:000278318600018
J	Ercan-Sencicek, AG; Stillman, AA; Ghosh, AK; Bilguvar, K; O'Roak, BJ; Mason, CE; Abbott, T; Gupta, A; King, RA; Pauls, DL; Tischfield, JA; Heiman, GA; Singer, HS; Gilbert, DL; Hoekstra, PJ; Morgan, TM; Loring, E; Yasuno, K; Fernandez, T; Sanders, S; Louvi, A; Cho, JH; Mane, S; Colangelo, CM; Biederer, T; Lifton, RP; Gunel, M; State, MW				Ercan-Sencicek, A. Gulhan; Stillman, Althea A.; Ghosh, Ananda K.; Bilguvar, Kaya; O'Roak, Brian J.; Mason, Christopher E.; Abbott, Thomas; Gupta, Abha; King, Robert A.; Pauls, David L.; Tischfield, Jay A.; Heiman, Gary A.; Singer, Harvey S.; Gilbert, Donald L.; Hoekstra, Pieter J.; Morgan, Thomas M.; Loring, Erin; Yasuno, Katsuhito; Fernandez, Thomas; Sanders, Stephan; Louvi, Angeliki; Cho, Judy H.; Mane, Shrikant; Colangelo, Christopher M.; Biederer, Thomas; Lifton, Richard P.; Gunel, Murat; State, Matthew W.			L-Histidine Decarboxylase and Tourette's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HISTAMINE; MICE; SCHIZOPHRENIA; COGNITION; EFFICACY; GENOME	Tourette's syndrome is a common developmental neuropsychiatric disorder characterized by chronic motor and vocal tics. Despite a strong genetic contribution, inheritance is complex, and risk alleles have proven difficult to identify. Here, we describe an analysis of linkage in a two-generation pedigree leading to the identification of a rare functional mutation in the HDC gene encoding l-histidine decarboxylase, the rate-limiting enzyme in histamine biosynthesis. Our findings, together with previously published data from model systems, point to a role for histaminergic neurotransmission in the mechanism and modulation of Tourette's syndrome and tics.	[State, Matthew W.] Yale Univ, Sch Med, Program Neurogenet, Dept Child Psychiat, New Haven, CT 06520 USA; [Ghosh, Ananda K.; Mason, Christopher E.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [O'Roak, Brian J.] Univ Washington, Seattle, WA 98195 USA; [Pauls, David L.] Harvard Univ, Boston, MA 02115 USA; [Tischfield, Jay A.; Heiman, Gary A.] New Jersey Ctr Tourette Syndrome & Associated Dis, Somerville, NJ USA; [Tischfield, Jay A.; Heiman, Gary A.] Rutgers State Univ, Piscataway, NJ USA; [Singer, Harvey S.] Johns Hopkins Univ, Baltimore, MD USA; [Gilbert, Donald L.] Univ Cincinnati, Sch Med, Cincinnati, OH USA; [Gilbert, Donald L.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Hoekstra, Pieter J.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Morgan, Thomas M.] Vanderbilt Univ, Med Ctr, Nashville, TN USA	Yale University; Cornell University; University of Washington; University of Washington Seattle; Harvard University; Rutgers State University New Brunswick; Johns Hopkins University; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Groningen; Vanderbilt University	State, MW (corresponding author), Yale Univ, Sch Med, Program Neurogenet, Dept Child Psychiat, 230 S Frontage Rd, New Haven, CT 06520 USA.	matthew.state@yale.edu	Morgan, Tom/C-3478-2012; Mason, Christopher/HCH-3977-2022; State, Matthew/W-2256-2019; Hoekstra, Pieter/O-4396-2014; Sanders, Stephan/S-8645-2019; Sandor, Paul/I-7211-2016; Heiman, Gary A/K-2366-2018; Sander-Effron, Samuel/AAX-2231-2020; Fernandez, Thomas V/D-4295-2009; Yasuno, Katsuhito/E-1960-2012; Gilbert, Donald L./D-6443-2016; Resource Center, NINDS Human Genetics/AGF-2474-2022; Biederer, Thomas/AAZ-6133-2021	Sandor, Paul/0000-0003-2397-0758; Heiman, Gary A/0000-0001-5859-0259; Fernandez, Thomas V/0000-0003-0830-022X; Yasuno, Katsuhito/0000-0002-3606-532X; Gilbert, Donald L./0000-0002-9245-6878; Biederer, Thomas/0000-0003-0912-1514; Sanders, Stephan/0000-0001-9112-5148; State, Matthew/0000-0003-1624-8302; Colangelo, Christopher/0000-0002-0438-1395; Tischfield, Jay/0000-0003-3217-8287; O'Roak, Brian/0000-0002-4141-0095	National Institute of Neurological Disorders and Stroke, grants [R01 NS43520, NS016648, NS040024]; National Institutes of Health [U24 NS051869-02S1, UL1 RR024139, NCRR UL1 RR024139]; National Institute of Mental Health [U24 MH068457]; Lawrence Family; Overlook International Foundation; Shepherd Fund; New Jersey Center for Tourette Syndrome and Associated Disorders [08-1827-FS-N-0]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026707, UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH068457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS051869, R01NS040024, R01NS016648, U01NS040024, R01NS043520] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lawrence Family; Overlook International Foundation; Shepherd Fund; New Jersey Center for Tourette Syndrome and Associated Disorders; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants (R01 NS43520, to Drs. State and Louvi; and NS016648 and NS040024, to Dr. Pauls) from the National Institute of Neurological Disorders and Stroke, grants (Neuroscience Micro-array Consortium U24 NS051869-02S1 and UL1 RR024139, to Dr. Mane; and NCRR UL1 RR024139, to Mr. Abbott and Dr. Colangelo) from the National Institutes of Health, and a grant (U24 MH068457, to Drs. Tischfield and Heiman) from the National Institute of Mental Health; additional funding from the Lawrence Family (to Dr. State), the Overlook International Foundation (to Dr. State), and the Shepherd Fund (to Dr. State); and a grant (08-1827-FS-N-0) from the New Jersey Center for Tourette Syndrome and Associated Disorders (through the New Jersey Department of Health and Senior Services).	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Acevedoa SF, 2006, BEHAV BRAIN RES, V168, P92, DOI 10.1016/j.bbr.2005.10.016; Dere E, 2004, EUR J NEUROSCI, V20, P1051, DOI 10.1111/j.1460-9568.2004.03546.x; Fleming JV, 2003, J BIOL CHEM, V278, P686, DOI 10.1074/jbc.M210718200; Fox GB, 2005, INFLAMM RES, V54, pS23, DOI 10.1007/s00011-004-0410-1; Fox GB, 2005, J PHARMACOL EXP THER, V313, P176, DOI 10.1124/jpet.104.078402; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jeffries KJ, 2002, NEUROPSYCHOPHARMACOL, V27, P92, DOI 10.1016/S0893-133X(01)00428-6; KATAYAMA KYK, 2008, MOL PSYCHIATR, V15, P177; Kubota Y, 2002, J NEUROCHEM, V83, P837, DOI 10.1046/j.1471-4159.2002.01189.x; Leckman JF, 2006, J CHILD NEUROL, V21, P642, DOI 10.1177/08830738060210081001; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Ligneau X, 2007, BIOCHEM PHARMACOL, V73, P1215, DOI 10.1016/j.bcp.2007.01.023; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Ohtsu H, 2003, BIOCHEM BIOPH RES CO, V305, P443, DOI 10.1016/S0006-291X(03)00696-X; PRICE RA, 1985, ARCH GEN PSYCHIAT, V42, P815; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saka E, 2003, BRAIN DEV-JPN, V25, pS15, DOI 10.1016/S0387-7604(03)90002-7; TSIRKA S, 1992, J BIOL CHEM, V267, P23057	20	217	220	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2010	362	20					1901	1908		10.1056/NEJMoa0907006	http://dx.doi.org/10.1056/NEJMoa0907006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598EI	20445167	Green Accepted			2022-12-24	WOS:000277815600008
J	Ito, K; Elkin, EB; Girotra, M; Morris, MJ				Ito, Kouta; Elkin, Elena B.; Girotra, Monica; Morris, Michael J.			Cost-Effectiveness of Fracture Prevention in Men Who Receive Androgen Deprivation Therapy for Localized Prostate Cancer	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	45th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2009	Orlando, FL	Amer Soc Clin Oncol			BONE-MINERAL DENSITY; CLINICAL-PRACTICE GUIDELINE; RANDOMIZED CONTROLLED-TRIAL; ZOLEDRONIC ACID; HIP FRACTURE; VERTEBRAL FRACTURES; HORMONE AGONISTS; AMERICAN-COLLEGE; UNITED-STATES; OSTEOPOROSIS	Background: Androgen deprivation therapy (ADT) increases the risk for fractures in patients with prostate cancer. Objective: To assess the cost-effectiveness of measuring bone mineral density (BMD) before initiating ADT followed by alendronate therapy in men with localized prostate cancer. Design: Markov state-transition model simulating the progression of prostate cancer and the incidence of hip fracture. Data Sources: Published literature. Target Population: A hypothetical cohort of men aged 70 years with locally advanced or high-risk localized prostate cancer starting a 2-year course of ADT after radiation therapy. Time Horizon: Lifetime. Perspective: Societal. Intervention: No BMD test or alendronate therapy, a BMD test followed by selective alendronate therapy for patients with osteoporosis, or universal alendronate therapy without a BMD test. Outcome Measures: Incremental cost-effectiveness ratio (ICER), measured by cost per quality-adjusted life-year (QALY) gained. Results of Base-Case Analysis: The ICERs for the strategy of a BMD test and selective alendronate therapy for patients with osteoporosis and universal alendronate therapy without a BMD test were $66 800 per QALY gained and $178 700 per QALY gained, respectively. Results of Sensitivity Analyses: The ICER for universal alendronate therapy without a BMD test decreased to $100 000 per QALY gained, assuming older age, a history of fractures, lower mean BMD before ADT, or a lower cost of alendronate. Limitations: No evidence shows that alendronate reduces actual fracture rates in patients with prostate cancer who receive ADT. The model predicted fracture rates by using data on the surrogate BMD end point. Conclusion: In patients starting adjuvant ADT for locally advanced or high-risk localized prostate cancer, a BMD test followed by selective alendronate for those with osteoporosis is a cost-effective use of resources. Routine use of alendronate without a BMD test is justifiable in patients at higher risk for hip fractures.	[Ito, Kouta; Elkin, Elena B.; Girotra, Monica; Morris, Michael J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Ito, K (corresponding author), 1275 York Ave, New York, NY 10065 USA.	itok1@mskcc.org		Morris, Michael J./0000-0002-9454-0096	NCI NIH HHS [P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alibhai SMH, 2006, UROLOGY, V68, P126, DOI 10.1016/j.urology.2006.01.054; Allain TJ, 2006, GERONTOLOGY, V52, P107, DOI 10.1159/000090956; American Urological Association, 2007, GUID MAN CLIN LOC PR; Arias E, 2007, NATL VITAL STAT REPO, V56; Berruti A, 2002, J UROLOGY, V167, P2361, DOI 10.1016/S0022-5347(05)64985-3; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Cadarette SM, 2009, OSTEOPOROSIS INT, V20, P1735, DOI 10.1007/s00198-009-0871-8; *CTR MED MED SERV, PHYS SCHED SEARCH 20; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Daniell HW, 2000, J UROLOGY, V163, P181, DOI 10.1016/S0022-5347(05)68000-7; Dawson-Hughes B, 2008, OSTEOPOROSIS INT, V19, P449, DOI 10.1007/s00198-008-0559-5; DeLaet CEDH, 1997, BRIT MED J, V315, P221, DOI 10.1136/bmj.315.7102.221; DESHARNAIS CL, 2001, SUPPORT CARE CANCER, V9, P545; Diamond TH, 2004, CANCER-AM CANCER SOC, V100, P892, DOI 10.1002/cncr.20056; Eastham JA, 2007, J UROLOGY, V177, P17, DOI 10.1016/j.juro.2006.08.089; Edwards BJ, 2008, LANCET ONCOL, V9, P1166, DOI 10.1016/S1470-2045(08)70305-X; *END SOC, 2009, POS STAT MED COV DXA; Gabriel SE, 2002, OSTEOPOROSIS INT, V13, P323, DOI 10.1007/s001980200033; Gold MR, 1996, COST EFFECTIVENESS H; Greenspan SL, 2008, J CLIN ONCOL, V26, P4426, DOI 10.1200/JCO.2007.15.1233; Greenspan SL, 2008, J CLIN ENDOCR METAB, V93, P2, DOI 10.1210/jc.2007-1402; Greenspan SL, 2007, ANN INTERN MED, V146, P416, DOI 10.7326/0003-4819-146-6-200703200-00006; Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710; Horwitz EM, 2008, J CLIN ONCOL, V26, P2497, DOI 10.1200/JCO.2007.14.9021; Hummel S, 2003, Health Technol Assess, V7, pix; Hummel S, 2003, HEALTH TECHNOL ASSES, V7, pix; Israeli RS, 2007, CLIN GENITOURIN CANC, V5, P271, DOI 10.3816/CGC.2007.n.003; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P20, DOI 10.1007/s00198-003-1463-7; Kanis JA, 2002, J BONE MINER RES, V17, pS146; Kattan MW, 1997, J GEN INTERN MED, V12, P299, DOI 10.1046/j.1525-1497.1997.012005299.x; Kiratli BJ, 2001, UROLOGY, V57, P127, DOI 10.1016/S0090-4295(00)00895-5; Kothawala P, 2007, MAYO CLIN PROC, V82, P1493, DOI 10.4065/82.12.1493; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Lu-Yao GL, 2008, JAMA-J AM MED ASSOC, V300, P173, DOI 10.1001/jama.300.2.173; Maillefert JF, 1999, J UROLOGY, V161, P1219, DOI 10.1016/S0022-5347(01)61639-2; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Michaelson MD, 2007, J CLIN ONCOL, V25, P1038, DOI 10.1200/JCO.2006.07.3361; Miksad RA, 2007, J CLIN ONCOL, V25; National Osteoporosis Foundation, 2013, CLIN GUID PREV TREAT; NCCN, 2010, NCCN CLIN PRACT GUID; *NY STAT DEP HLTH, PRESCR DRUG PRIC NEW; Orwoll E, 2000, NEW ENGL J MED, V343, P604, DOI 10.1056/NEJM200008313430902; Polascik TJ, 2008, PROSTATE CANCER P D, V11, P13, DOI 10.1038/sj.pcan.4501019; Qaseem A, 2008, ANN INTERN MED, V149, P404, DOI 10.7326/0003-4819-149-6-200809160-00007; Qaseem A, 2008, ANN INTERN MED, V148, P680, DOI 10.7326/0003-4819-148-9-200805060-00008; Ringe JD, 2006, RHEUMATOL INT, V26, P427, DOI 10.1007/s00296-005-0004-4; Ross JR, 2003, BMJ-BRIT MED J, V327, P469, DOI 10.1136/bmj.327.7413.469; Ryan CW, 2006, J UROLOGY, V176, P972, DOI 10.1016/j.juro.2006.04.078; Saad F, 2008, J CLIN ONCOL, V26, P5465, DOI 10.1200/JCO.2008.18.4184; Scher HI, 2000, UROLOGY, V55, P323, DOI 10.1016/S0090-4295(99)00471-9; Schousboe JT, 2007, JAMA-J AM MED ASSOC, V298, P629, DOI 10.1001/jama.298.6.629; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Simonelli C, 2002, MAYO CLIN PROC, V77, P334, DOI 10.4065/77.4.334; Smith MR, 2008, J UROLOGY, V179, P152, DOI 10.1016/j.juro.2007.08.137; Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003; Smith MR, 2006, J UROLOGY, V175, P136, DOI 10.1016/S0022-5347(05)00033-9; Smith MR, 2005, J CLIN ONCOL, V23, P7897, DOI 10.1200/JCO.2004.00.6908; Smith MR, 2005, J CLIN ONCOL, V23, P2918, DOI 10.1200/JCO.2005.01.529; Smith MR, 2003, J UROLOGY, V169, P2008, DOI 10.1097/01.ju.0000063820.94994.95; Smith MR, 2004, J CLIN ENDOCR METAB, V89, P3841, DOI 10.1210/jc.2003-032058; Tanvetyanon T, 2005, CANCER-AM CANCER SOC, V103, P237, DOI 10.1002/cncr.20766; Tosteson ANA, 2008, OSTEOPOROSIS INT, V19, P437, DOI 10.1007/s00198-007-0550-6; TOSTESON ANA, 1990, ANN INTERN MED, V113, P594, DOI 10.7326/0003-4819-113-8-594; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; *US DEP LAB, US CONS PRIC IND MED; US Office of Technology Assessment, 1995, EFF COSTS OST SCREEN, VII; Wilcox A, 2006, ANN PHARMACOTHER, V40, P2107, DOI 10.1345/aph.1H209; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209; Winstead NS, 2007, ALIMENT PHARM THERAP, V26, P1371, DOI 10.1111/j.1365-2036.2007.03516.x; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009; Yee EFT, 2007, J GEN INTERN MED, V22, P1305, DOI 10.1007/s11606-007-0291-4; [No title captured]	75	39	41	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 18	2010	152	10					621	+		10.7326/0003-4819-152-10-201005180-00002	http://dx.doi.org/10.7326/0003-4819-152-10-201005180-00002			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	598RJ	20479027	Green Accepted			2022-12-24	WOS:000277855500001
J	Halpin, LJL; Anderson, CL; Corriette, N				Halpin, Laura J. L.; Anderson, Claire L.; Corriette, Nicole			10-Minute Consultation Stridor in children	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Halpin, Laura J. L.] Medway Maritime Hosp, Gillingham ME7 5NY, England; [Anderson, Claire L.] Royal Brompton Hosp, London SW3 6NP, England	Medway Maritime Hospital; Royal Brompton Hospital	Halpin, LJL (corresponding author), Medway Maritime Hosp, Gillingham ME7 5NY, England.	laurajhalpin@doctors.org.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 4	2010	340								c2193	10.1136/bmj.c2193	http://dx.doi.org/10.1136/bmj.c2193			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594XB	20442228				2022-12-24	WOS:000277572400005
J	Iwabu, M; Yamauchi, T; Okada-Iwabu, M; Sato, K; Nakagawa, T; Funata, M; Yamaguchi, M; Namiki, S; Nakayama, R; Tabata, M; Ogata, H; Kubota, N; Takamoto, I; Hayashi, YK; Yamauchi, N; Waki, H; Fukayama, M; Nishino, I; Tokuyama, K; Ueki, K; Oike, Y; Ishii, S; Hirose, K; Shimizu, T; Touhara, K; Kadowaki, T				Iwabu, Masato; Yamauchi, Toshimasa; Okada-Iwabu, Miki; Sato, Koji; Nakagawa, Tatsuro; Funata, Masaaki; Yamaguchi, Mamiko; Namiki, Shigeyuki; Nakayama, Ryo; Tabata, Mitsuhisa; Ogata, Hitomi; Kubota, Naoto; Takamoto, Iseki; Hayashi, Yukiko K.; Yamauchi, Naoko; Waki, Hironori; Fukayama, Masashi; Nishino, Ichizo; Tokuyama, Kumpei; Ueki, Kohjiro; Oike, Yuichi; Ishii, Satoshi; Hirose, Kenzo; Shimizu, Takao; Touhara, Kazushige; Kadowaki, Takashi			Adiponectin and AdipoR1 regulate PGC-1 alpha and mitochondria by Ca2+ and AMPK/SIRT1	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; MUSCLE FIBER-TYPE; SKELETAL-MUSCLE; INSULIN-RESISTANCE; RECEPTOR ACTIVATION; PHOSPHORYLATION; CLONING; DISEASE; OBESITY	Adiponectin is an anti-diabetic adipokine. Its receptors possess a seven-transmembrane topology with the amino terminus located intracellularly, which is the opposite of G-protein-coupled receptors. Here we provide evidence that adiponectin induces extracellular Ca2+ influx by adiponectin receptor 1 (AdipoR1), which was necessary for subsequent activation of Ca2+/calmodulin-dependent protein kinase kinase beta (CaMKK beta), AMPK and SIRT1, increased expression and decreased acetylation of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha), and increased mitochondria in myocytes. Moreover, muscle-specific disruption of AdipoR1 suppressed the adiponectin-mediated increase in intracellular Ca2+ concentration, and decreased the activation of CaMKK, AMPK and SIRT1 by adiponectin. Suppression of AdipoR1 also resulted in decreased PGC-1 alpha expression and deacetylation, decreased mitochondrial content and enzymes, decreased oxidative type I myofibres, and decreased oxidative stress-detoxifying enzymes in skeletal muscle, which were associated with insulin resistance and decreased exercise endurance. Decreased levels of adiponectin and AdipoR1 in obesity may have causal roles in mitochondrial dysfunction and insulin resistance seen in diabetes.	[Iwabu, Masato; Yamauchi, Toshimasa; Okada-Iwabu, Miki; Funata, Masaaki; Yamaguchi, Mamiko; Nakayama, Ryo; Kubota, Naoto; Takamoto, Iseki; Waki, Hironori; Ueki, Kohjiro; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1130033, Japan; [Iwabu, Masato; Yamauchi, Toshimasa; Okada-Iwabu, Miki] Univ Tokyo, Dept Integrated Mol Sci Metab Dis, Century Med & Res Ctr 22, Tokyo 1130033, Japan; [Namiki, Shigeyuki; Hirose, Kenzo] Univ Tokyo, Grad Sch Med, Dept Neurobiol, Tokyo 1130033, Japan; [Yamauchi, Naoko; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1130033, Japan; [Ishii, Satoshi; Shimizu, Takao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 1130033, Japan; [Sato, Koji; Touhara, Kazushige] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Nakagawa, Tatsuro; Touhara, Kazushige] Univ Tokyo, Dept Integrated Biosci, Chiba 2778562, Japan; [Tabata, Mitsuhisa] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto 8600811, Japan; [Ogata, Hitomi; Tokuyama, Kumpei] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Hayashi, Yukiko K.; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 1878502, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Kumamoto University; University of Tsukuba; National Center for Neurology & Psychiatry - Japan	Yamauchi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1130033, Japan.	tyamau-tky@umin.net; kadowaki-3im@h.u-tokyo.ac.jp	Namiki, Shigeyuki/AAF-6157-2019; Waki, Hironori/AAE-3942-2020; Nishino, Ichizo/G-2676-2010; Shimizu, Takao/AAV-7052-2021; Kubota, Naoto/N-7892-2015	Namiki, Shigeyuki/0000-0003-1520-8261; Waki, Hironori/0000-0002-5302-9793; Nishino, Ichizo/0000-0001-9452-112X; xing zhi, zuo teng/0000-0001-6198-6406	Ministry of Education, Culture, Sports, Science and Technology of Japan [20229008, 20390254]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank B. M. Spiegelman for critical discussions and reading of the manuscript; T. Yokomizo for discussion and support; A. Tsuchida, K. Hara, Y. Hada, Y. Nio, T. Maki, T. Takazawa, Y. Iwata, M. Kobayashi, S. Kawamoto, K. Kobayashi, K. Hirota, Y. Shiomi, T. Mitsumatsu, L. Hirose, Y. Sea, M. Nakamura and K. Take for technical help and support; and S. Suzuki, K. Miyata, C. Ueda, A. Itoh and A. Okano for technical assistance. This work was supported by Grant-in-aid for Scientific Research (S) (20229008) (to T. K.), (B) (20390254) (to T. Y.), Targeted Proteins Research Program (to T. K.), the Global COE Research Program (to T. K.) and Translational Systems Biology and Medicine Initiative (to T. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Scheer A, 1996, EMBO J, V15, P3566, DOI 10.1002/j.1460-2075.1996.tb00726.x; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shkryl VM, 2006, J BIOL CHEM, V281, P1547, DOI 10.1074/jbc.M505024200; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Toth A, 1998, AM J PHYSIOL-HEART C, V275, pH1652, DOI 10.1152/ajpheart.1998.275.5.H1652; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang CH, 2007, J BIOL CHEM, V282, P7991, DOI 10.1074/jbc.M700098200; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	45	689	725	3	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 29	2010	464	7293					1313	1319		10.1038/nature08991	http://dx.doi.org/10.1038/nature08991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20357764				2022-12-24	WOS:000277149000038
J	Chamnan, P; Simmons, RK; Khaw, KT; Wareham, NJ; Griffin, SJ				Chamnan, Parinya; Simmons, Rebecca K.; Khaw, Kay-Tee; Wareham, Nicholas J.; Griffin, Simon J.			Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; PRIMARY PREVENTION; EPIC-NORFOLK; PRIMARY-CARE; MYOCARDIAL-INFARCTION; VEGETABLE INTAKE; NON-ATTENDANCE; DIABETES RISK; MEN; MORTALITY	Objective To estimate the potential population impact of different screening strategies for identifying and treating people at high risk of cardiovascular disease, including strategies using routine data for cardiovascular risk stratification, in light of the UK government's recommended national strategy to screen all adults aged 40-74 for cardiovascular risk. Design Modelling study using data from a prospective cohort, EPIC-Norfolk (European Prospective Investigation of Cancer-Norfolk). Setting An English county. Participants 16 970 men and women aged 40-74 and free from cardiovascular disease and diabetes at baseline. Main outcome measures The main outcomes were the population attributable fraction, the number needed to screen to prevent one new case of cardiovascular disease, the number needed to treat to prevent one new case of cardiovascular disease, and the number of new cardiovascular events that could be prevented. Relative risk reductions for estimated treatment effects were derived from meta-analyses of clinical trials or guidelines from the National Institute for Health and Clinical Excellence. Results 1362 cardiovascular events occurred over 183 586 person years of follow-up. Compared with the recommended government strategy, a stepwise screening approach using a simple risk score incorporating routine data could prevent a similar number (lower to upper estimates) of new cardiovascular events annually in the United Kingdom (26 789, 20 778 to 36 239) and 25 134 (19 450 to 34 134), respectively) but requiring only 60% of the population to be invited to attend a vascular risk assessment. A similar number of cardiovascular events (25 016, 19 563 to 33 372) could also be prevented by inviting everyone aged 50-74 for a vascular assessment. Using a participant completed Finnish diabetes risk score questionnaire or anthropometric cut-off points for risk prestratification was less effective. Conclusions Compared with the UK government's recommended national strategy to screen all adults aged 40-74 for cardiovascular risk, an approach using routine data for cardiovascular risk stratification before inviting people at high risk for a vascular risk assessment may be similarly effective at preventing new cases of cardiovascular disease, with potential cost savings.	[Khaw, Kay-Tee; Griffin, Simon J.] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England; [Chamnan, Parinya; Simmons, Rebecca K.; Wareham, Nicholas J.; Griffin, Simon J.] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Griffin, SJ (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England.	simon.griffin@mrc-epid.cam.ac.uk	Griffin, Simon J/K-3106-2013; Khaw, Kay-Tee/AAZ-3209-2021; Chamnan, Parinya/J-6712-2017	Griffin, Simon J/0000-0002-2157-4797; Chamnan, Parinya/0000-0002-5202-4149; Simmons, Rebecca/0000-0002-7726-8529	Medical Research Council [G950223]; Cancer Research UK [C8648A3883]; European Union; Royal Thai Government; National Institute for Health [RP-PG-0606-1259]; MRC [MC_U106179474] Funding Source: UKRI; Medical Research Council [MC_U106179471, MC_U106179474, G0401527] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1259] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); European Union(European Commission); Royal Thai Government; National Institute for Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the Medical Research Council (grant No G950223), Cancer Research UK (grant No C8648A3883), and European Union (Europe Against Cancer Programme No 6438). PC is supported by a Royal Thai Government scholarship. SJG receives support from the National Institute for Health Research programme grant funding scheme (RP-PG-0606-1259). The views expressed in this publication are those of the authors and not necessarily those of the NHS, National Institute for Health Research, or Department of Health. The sponsors did not participate in the design or conduct of this study; in the collection, management, analysis, or interpretation of data; in the writing of the manuscript; or in the preparation, review, approval, or decision to submit this manuscript for publication.	Baillargeon J, 2001, OCCUP MED-STATE ART, V16, P359; Bingham S, 2008, INT J EPIDEMIOL, V37, P978, DOI 10.1093/ije/dyn111; Boekholdt MS, 2004, AM J MED, V117, P390, DOI 10.1016/j.amjmed.2004.04.010; *BRIT HEART FDN, 2008, HLTH CAR EC COSTS CV; Capewell Simon, 2008, BMJ, V337, pa1395, DOI 10.1136/bmj.a1395; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; DAVIES G, 1994, BRIT MED J, V309, P1553, DOI 10.1136/bmj.309.6968.1553; Day N, 1999, BRIT J CANCER, V80, P95; Department of Health, 2008, EC MOD VASC CHECKS; Department of Health, 2008, PUTT PREV 1 VASC CHE; Echouffo-Tcheugui JB, 2008, DIABETIC MED, V25, P1433, DOI 10.1111/j.1464-5491.2008.02600.x; Gemmell I, 2006, QUAL SAF HEALTH CARE, V15, P339, DOI 10.1136/qshc.2005.017061; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Heller RF, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-7; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Jackson Rod, 2008, BMJ, V337, pa1371, DOI 10.1136/bmj.a1371; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; Kahn R, 2008, CIRCULATION, V118, P576, DOI 10.1161/CIRCULATIONAHA.108.190186; Khaw KT, 2006, INT J EPIDEMIOL, V35, P1034, DOI 10.1093/ije/dyl079; Knops-Dullens T, 2007, EUR J CANCER PREV, V16, P436, DOI 10.1097/01.cej.0000236250.71113.7c; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; Marshall T, 2002, BMJ-BRIT MED J, V325, P197, DOI 10.1136/bmj.325.7357.197; National Collaborating Centre for Chronic Conditions, 2006, HYP MAN HYP AD PRIM; National Institute for Health and Clinical Excellence, 2006, STAT PREV CARD EV PA; *OFF NAT STAT, DEATHS HLTH AR US RE; Office for National Statistics, 2008, MID 2007 UK ENGL WAL; PETERSON S, 2005, CORONARY HEART DIS S; Pignone M, 2006, ANN INTERN MED, V144, P326, DOI 10.7326/0003-4819-144-5-200603070-00007; Shaw C, 1999, SOC SCI MED, V49, P1571, DOI 10.1016/S0277-9536(99)00244-0; Simmons RK, 2007, DIABETIC MED, V24, P830, DOI 10.1111/j.1464-5491.2007.02173.x; Sliventoinen K, 2005, EUR J CARDIOV PREV R, V12, P451, DOI 10.1097/01.hjr.0000174793.31812.21; Spanjersberg MQI, 2007, FOOD CHEM TOXICOL, V45, P49, DOI 10.1016/j.fct.2006.07.018; Spijkerman A, 2002, J MED SCREEN, V9, P187, DOI 10.1136/jms.9.4.187; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Thomas MC, 2002, J PUBLIC HEALTH MED, V24, P285, DOI 10.1093/pubmed/24.4.285; *UK NAT SCREEN COM, 2008, HDB VASC RISK ASS RI; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; WOOD PD, 1991, NEW ENGL J MED, V325, P461, DOI 10.1056/NEJM199108153250703	44	64	67	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2010	340								c1693	10.1136/bmj.c1693	http://dx.doi.org/10.1136/bmj.c1693			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589HS	20418545	Green Published, hybrid			2022-12-24	WOS:000277138400002
J	Parkhurst, J; Weller, I; Kemp, J				Parkhurst, Justin; Weller, Ian; Kemp, Julia			Getting research into policy, or out of practice, in HIV?	LANCET			English	Editorial Material							COUNTRIES		[Parkhurst, Justin] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Weller, Ian] UCL, Sch Med, Ctr Sexual Hlth & HIV Res, London W1N 8AA, England; [Weller, Ian] Camden Provider Serv, London, England; [Kemp, Julia] British Embassy, Dept Int Dev, Yangon, Myanmar	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Medical School	Parkhurst, J (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.	justin.parkhurst@lshtm.ac.uk	Parkhurst, Justin/AAP-3615-2021					Ainsworth M, 2000, LANCET, V356, P55, DOI 10.1016/S0140-6736(00)02440-5; Alliance for Health Policy and Systems Research, 2007, SOUND CHOIC ENH CAP; [Anonymous], 2003, EVIDENCE BASED HLTH; Bonell C, 2001, BRIT MED BULL, V58, P155, DOI 10.1093/bmb/58.1.155; Garner P, 1998, BRIT MED J, V317, P531; Global Health Council, GETT RES POL PRACT G; Harries AD, 2002, B WORLD HEALTH ORGAN, V80, P464; Pawson R., 2006, EVIDENCE BASED POLIC, DOI DOI 10.4135/9781849209120; UNAIDS, 1999, SEX BEH CHANG HIV HA; Walley J, 2007, B WORLD HEALTH ORGAN, V85, P424, DOI 10.2471/BLT.07.042531; World Health Organization, 2007, TASK SHIFT TACKL HLT; World Health Organization, 2004, WORLD HLTH REP 2004	12	14	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 24	2010	375	9724					1414	1415		10.1016/S0140-6736(10)60585-5	http://dx.doi.org/10.1016/S0140-6736(10)60585-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	590FL	20417842				2022-12-24	WOS:000277210000007
J	Allen, C; Pepper, J				Allen, Camilla; Pepper, John			A Patient's Journey External aortic support for people with Marfan's syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Pepper, John] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, London SW3 6NP, England	Imperial College London; Royal Brompton Hospital		allen@vilberie.wanadoo.co.uk							0	5	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2010	340								c1692	10.1136/bmj.c1692	http://dx.doi.org/10.1136/bmj.c1692			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601LR	20483926				2022-12-24	WOS:000278061500002
J	Tcherkezian, J; Brittis, PA; Thomas, F; Roux, PP; Flanagan, JG				Tcherkezian, Joseph; Brittis, Perry A.; Thomas, Franziska; Roux, Philippe P.; Flanagan, John G.			Transmembrane Receptor DCC Associates with Protein Synthesis Machinery and Regulates Translation	CELL			English	Article							MESSENGER-RNA LOCALIZATION; PEPTIDYL-TRANSFER-RNA; COLORECTAL-CANCER; GROWTH CONES; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; NETRIN RECEPTOR; GUIDANCE; ACTIN; RIBOSOME	Extracellular signals regulate protein translation in many cell functions. A key advantage of control at the translational level is the opportunity to regulate protein synthesis within specific cellular subregions. However, little is known about mechanisms that may link extracellular cues to translation with spatial precision. Here, we show that a transmembrane receptor, DCC, forms a binding complex containing multiple translation components, including eukaryotic initiation factors, ribosomal large and small subunits, and monosomes. In neuronal axons and dendrites DCC colocalizes in particles with translation machinery, and newly synthesized protein. The extracellular ligand netrin promoted DCC-mediated translation and disassociation of translation components. The functional and physical association of a cell surface receptor with the translation machinery leads to a generalizable model for localization and extracellular regulation of protein synthesis, based on a transmembrane translation regulation complex.	[Tcherkezian, Joseph; Brittis, Perry A.; Flanagan, John G.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Thomas, Franziska] Dana Farber Canc Inst, Boston, MA 02115 USA; [Roux, Philippe P.] Univ Montreal, Fac Med, Inst Res Immunol & Canc, Montreal, PQ H3T 1J4, Canada; [Roux, Philippe P.] Univ Montreal, Fac Med, Dept Pathol & Cell Biol, Montreal, PQ H3T 1J4, Canada	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Universite de Montreal; Universite de Montreal	Brittis, PA (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	perry_brittis@hms.harvard.edu; flanagan@hms.harvard.edu	Roux, Philippe P./J-3996-2012; Flanagan, John/AAM-2995-2020	Roux, Philippe P./0000-0002-5962-0250; 	NIH; NCIC; HHMI; CIHR; Canada Research Chair; HFSP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD029417] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040043] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); HHMI(Howard Hughes Medical Institute); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); HFSP(Human Frontier Science Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Marc Kirschner, Dietmar Schmucker, Melissa Hancock, Marc Tessier-Lavigne, Nancy Kadersha, Steven Gygi, Ross Tomaino, Tom Walz, Maria Ericsson, Natalie Farny, Pam Silver, Joachim Hauber, Taka-Aki Sato, Nathalie Lamarche-Vane, John Blenis, Davie Van Vactor, Judy Glaven, Yao Chen, Dan Nowakowski, Miriam Osterfield, and Nicolas Preitner, for help, reagents, advice, and comments on the manuscript. This work was supported by grants from the NIH (J.G.F.) and NCIC (P.P.R.), an HHMI fellowship (P.A.B.), a CIHR fellowship (J.T.), and a Canada Research Chair and HFSP Career Development Award (P.P.R.).	Amrani N, 2008, NATURE, V453, P1276, DOI 10.1038/nature06974; Beatty KE, 2008, BIOORG MED CHEM LETT, V18, P5995, DOI 10.1016/j.bmcl.2008.08.046; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Drees F, 2008, CURR OPIN NEUROBIOL, V18, P53, DOI 10.1016/j.conb.2008.05.007; FABIJANSKI S, 1981, MOL GEN GENET, V184, P551, DOI 10.1007/BF00352539; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Finger JH, 2002, J NEUROSCI, V22, P10346; FLANAGAN J, 1978, NATURE, V273, P278, DOI 10.1038/273278a0; Garbe DS, 2004, CRIT REV BIOCHEM MOL, V39, P319, DOI 10.1080/10409230490906797; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; HESKETH JE, 1991, BIOCHEM J, V277, P1; Kebache S, 2002, P NATL ACAD SCI USA, V99, P5406, DOI 10.1073/pnas.082483399; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Koenig E, 1996, J NEUROSCI, V16, P1400; Kruger M, 2001, MOL CELL BIOL, V21, P8357, DOI 10.1128/MCB.21.24.8357-8364.2001; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; LENK R, 1977, CELL, V10, P67, DOI 10.1016/0092-8674(77)90141-6; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Meskauskas A, 2001, RNA, V7, P1084, DOI 10.1017/S1355838201001480; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Parent AT, 2005, J NEUROSCI, V25, P1540, DOI 10.1523/JNEUROSCI.3850-04.2005; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pfeifer I, 2008, P NATL ACAD SCI USA, V105, P4173, DOI 10.1073/pnas.0711222105; RAMAIAH KVA, 1992, P NATL ACAD SCI USA, V89, P12063, DOI 10.1073/pnas.89.24.12063; Roche FK, 2009, J NEUROSCI, V29, P638, DOI 10.1523/JNEUROSCI.3845-08.2009; RODBELL M, 1980, NATURE, V284, P17, DOI 10.1038/284017a0; Rodriguez AJ, 2008, CURR OPIN CELL BIOL, V20, P144, DOI 10.1016/j.ceb.2008.02.004; Rodriguez AJ, 2006, J CELL BIOL, V175, P67, DOI 10.1083/jcb.200512137; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Takahashi Y, 2005, J BIOCHEM, V138, P41, DOI 10.1093/jb/mvi096; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9	51	181	182	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					632	644		10.1016/j.cell.2010.04.008	http://dx.doi.org/10.1016/j.cell.2010.04.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20434207	Green Accepted, Bronze			2022-12-24	WOS:000277623600016
J	McPherson, R				McPherson, Ruth			Chromosome 9p21 and Coronary Artery Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RISK		Univ Ottawa, Inst Heart, Atherogenom Lab, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute	McPherson, R (corresponding author), Univ Ottawa, Inst Heart, Atherogenom Lab, Ottawa, ON, Canada.							Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Holdt LM, 2010, ARTERIOSCL THROM VAS, V30, P620, DOI 10.1161/ATVBAHA.109.196832; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801	5	55	54	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					1736	1737		10.1056/NEJMcibr1002359	http://dx.doi.org/10.1056/NEJMcibr1002359			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591OQ	20445187				2022-12-24	WOS:000277311200014
J	Sauter, D; Specht, A; Kirchhoff, F				Sauter, Daniel; Specht, Anke; Kirchhoff, Frank			Tetherin: Holding On and Letting Go	CELL			English	Article							PLASMACYTOID DENDRITIC CELLS; INHIBITS HIV-1; INTERFERON-PRODUCTION; VPU PROTEIN; VIRUS; RELEASE; RESTRICTION; NEF; SURFACE; SIV		[Sauter, Daniel; Specht, Anke; Kirchhoff, Frank] Univ Clin Ulm, Inst Mol Virol, D-89081 Ulm, Germany	Ulm University	Kirchhoff, F (corresponding author), Univ Clin Ulm, Inst Mol Virol, Meyerhofstr 1, D-89081 Ulm, Germany.	frank.kirchhoff@uni-ulm.de	Kirchhoff, Frank/O-8367-2018	Kirchhoff, Frank/0000-0002-7052-2360	Deutsche Forschungsgemeinschaft; National Institutes of Health	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Beatrice H. Hahn and Guido Silvestri for helpful comments. The authors are supported by Deutsche Forschungsgemeinschaft and the National Institutes of Health.	Alexander L, 1999, J VIROL, V73, P5814, DOI 10.1128/JVI.73.7.5814-5825.1999; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; GOTTLINGER HG, 1993, P NATL ACAD SCI USA, V90, P7381, DOI 10.1073/pnas.90.15.7381; Gummuluru S, 2000, J VIROL, V74, P10882, DOI 10.1128/JVI.74.23.10882-10891.2000; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Haupt S, 2008, J VIROL, V82, P8900, DOI 10.1128/JVI.00196-08; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; HINZ A, 2010, CELL HOST MICROBE, DOI DOI 10.1016/J.CHOM2010.03.005; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; JIA B, 2009, PLOS PATHOG, V5, P429; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kirchhoff F, 1999, J VIROL, V73, P8371, DOI 10.1128/JVI.73.10.8371-8383.1999; Kirchhoff F, 2009, NAT REV MICROBIOL, V7, P467, DOI 10.1038/nrmicro2111; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Mauclere P, 1997, AIDS, V11, P445, DOI 10.1097/00002030-199704000-00007; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Miyakawa K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000700; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Pais-Correia AM, 2010, NAT MED, V16, P83, DOI 10.1038/nm.2065; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schindler M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-1; SCHUBERT U, 1994, J VIROL, V68, P2260, DOI 10.1128/JVI.68.4.2260-2271.1994; STREBEL K, 1989, J VIROL, V63, P3784, DOI 10.1128/JVI.63.9.3784-3791.1989; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Van Heuverswyn Fran, 2007, Curr Infect Dis Rep, V9, P338, DOI 10.1007/s11908-007-0052-x; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; Vendrame D, 2009, J VIROL, V83, P10527, DOI 10.1128/JVI.01235-09; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	56	68	70	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					392	398		10.1016/j.cell.2010.04.022	http://dx.doi.org/10.1016/j.cell.2010.04.022			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434978	Bronze			2022-12-24	WOS:000277180800008
J	Campins, H; Hargrove, K; Pinilla-Alonso, N; Howell, ES; Kelley, MS; Licandro, J; Mothe-Diniz, T; Fernandez, Y; Ziffer, J				Campins, Humberto; Hargrove, Kelsey; Pinilla-Alonso, Noemi; Howell, Ellen S.; Kelley, Michael S.; Licandro, Javier; Mothe-Diniz, T.; Fernandez, Y.; Ziffer, Julie			Water ice and organics on the surface of the asteroid 24 Themis	NATURE			English	Article								It has been suggested(1-3) that Earth's current supply of water was delivered by asteroids, some time after the collision that produced the Moon (which would have vaporized any of the pre-existing water). So far, no measurements of water ice on asteroids(4,5) have been made, but its presence has been inferred from the comet-like activity of several small asteroids, including two members of the Themis dynamical family(6). Here we report infrared spectra of the asteroid 24 Themis which show that ice and organic compounds are not only present on its surface but also prevalent. Infrared spectral differences between it and other asteroids make 24 Themis unique so far, and our identification of ice and organics agrees with independent results(7) that rule out other compounds as possible sources of the observed spectral structure. The widespread presence of surface ice on 24 Themis is somewhat unexpected because of the relatively short lifetime of exposed ice at this distance (similar to 3.2 AU) from the Sun. Nevertheless, there are several plausible sources, such as a subsurface reservoir that brings water to the surface through 'impact gardening' and/or sublimation.	[Campins, Humberto; Hargrove, Kelsey; Fernandez, Y.] Univ Cent Florida, Orlando, FL 32816 USA; [Pinilla-Alonso, Noemi] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Howell, Ellen S.] NAIC Arecibo Observ, Arecibo, PR 00612 USA; [Kelley, Michael S.] Univ Maryland, College Pk, MD 20742 USA; [Licandro, Javier] Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Spain; [Mothe-Diniz, T.] Univ Fed Rio de Janeiro, BR-20080090 Rio De Janeiro, RJ, Brazil; [Licandro, Javier] Univ La Laguna, Dept Astrophys, E-38205 San Cristobal la Laguna, Spain; [Ziffer, Julie] Univ So Maine, Dept Phys, Portland, ME 04104 USA	State University System of Florida; University of Central Florida; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University System of Maryland; University of Maryland College Park; Instituto de Astrofisica de Canarias; Universidade Federal do Rio de Janeiro; Universidad de la Laguna; University of Maine System; University of Southern Maine	Campins, H (corresponding author), Univ Cent Florida, POB 162385, Orlando, FL 32816 USA.	campins@physics.ucf.edu	Licandro, Javier/L-7667-2014; Mothe-Diniz, Thais/B-8987-2011; Pinilla-Alonso, Noemi/K-4361-2017	Licandro, Javier/0000-0002-9214-337X; Pinilla-Alonso, Noemi/0000-0002-2770-7896; Fernandez, Yanga/0000-0003-1156-9721; Mothe-Diniz, Thais/0000-0002-2707-5534; Kelley, Michael/0000-0002-6702-7676	NASA; US National Science Foundation; Spanish 'Ministerio de Ciencia e Innovacion'; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro	NASA(National Aeronautics & Space Administration (NASA)); US National Science Foundation(National Science Foundation (NSF)); Spanish 'Ministerio de Ciencia e Innovacion'(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	H. C. and K. H. are visiting astronomers at the Infrared Telescope Facility (IRTF), which is operated by the University of Hawaii under cooperative agreement no. NCC 5-538 with NASA. All the observations used in this publication were obtained at the IRTF. H. C. acknowledges support from NASA's Planetary Astronomy programme and from the US National Science Foundation. H. C. was a visiting Fulbright Scholar at the "Instituto de Astrofisica de Canarias'' in Tenerife, Spain, and a visiting astronomer at Observatoire de la Cote d'Azur, Nice, France. J.L. acknowledges support from the Spanish 'Ministerio de Ciencia e Innovacion'. T.M.-D. was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and by the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro. We benefited from discussions with D. Cruikshank, M. Delbo, P. Michel, A. Morbidelli and T. Roush.	Baldridge AM, 2009, REMOTE SENS ENVIRON, V113, P711, DOI 10.1016/j.rse.2008.11.007; Blanco C, 1998, ASTRON ASTROPHYS SUP, V131, P385, DOI 10.1051/aas:1998277; CLARK RN, 2007, DIGITAL DATA SER US, V231; DRAKE MJ, 2006, ASTEROIDS COMETS MET, P381; HEIKEN GH, 1991, LUNAR SOURCEBOOK USE, P736; Hsieh HH, 2006, SCIENCE, V312, P561, DOI 10.1126/science.1125150; KHARE BN, 1993, ICARUS, V103, P290, DOI 10.1006/icar.1993.1071; LEBOFSKY LA, 1975, ICARUS, V25, P205, DOI 10.1016/0019-1035(75)90020-2; LICANDRO J, 2007, B AM ASTRON SOC, V39, P470; McKinnon W. B., 2008, SOLAR SYSTEM NEPTUNE, P213; Milliken RE, 2009, NAT GEOSCI, V2, P258, DOI 10.1038/NGEO478; Morbidelli A, 2000, METEORIT PLANET SCI, V35, P1309, DOI 10.1111/j.1945-5100.2000.tb01518.x; Mottl MJ, 2007, CHEM ERDE-GEOCHEM, V67, P253, DOI 10.1016/j.chemer.2007.09.002; Nesvorny D, 2008, ASTROPHYS J LETT, V679, pL143, DOI 10.1086/588841; Pieters C., 2004, I SC, V35, P1720; Pinilla-Alonso N, 2009, ASTRON ASTROPHYS, V496, P547, DOI 10.1051/0004-6361/200809733; Rivkin A.S., 2002, ASTEROIDS, VIII, P235, DOI DOI 10.1038/NATURE09028; RIVKIN AS, 2008, ASTEROIDS COMETS MET; Schorghofer N, 2008, ASTROPHYS J, V682, P697, DOI 10.1086/588633; Sunshine JM, 2006, SCIENCE, V311, P1453, DOI 10.1126/science.1123632; Thomas PC, 2005, NATURE, V437, P224, DOI 10.1038/nature03938	21	248	249	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1320	1321		10.1038/nature09029	http://dx.doi.org/10.1038/nature09029			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428164				2022-12-24	WOS:000277149000039
J	Baker, M				Baker, Monya			Homing in on delivery	NATURE			English	Editorial Material							RNA											Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105	6	54	56	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2010	464	7292					1225	1230		10.1038/4641225a	http://dx.doi.org/10.1038/4641225a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20414308	Bronze			2022-12-24	WOS:000276891100044
J	Lu, Y; Cross, FR				Lu, Ying; Cross, Frederick R.			Periodic Cyclin-Cdk Activity Entrains an Autonomous Cdc14 Release Oscillator	CELL			English	Article							POLO KINASE CDC5; CELL-CYCLE; MITOTIC EXIT; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; PHOSPHATASE CDC14; GENE-EXPRESSION; PROTEIN-KINASE; MITOSIS; LOCALIZATION	One oscillation of Cyclin-dependent kinase (Cdk) activity, largely driven by periodic synthesis and destruction of cyclins, is tightly coupled to a single complete eukaryotic cell division cycle. Tight linkage of different steps in diverse cell-cycle processes to Cdk activity has been proposed to explain this coupling. Here, we demonstrate an intrinsically oscillatory module controlling nucleolar release and resequestration of the Cdc14 phosphatase, which is essential for mitotic exit in budding yeast. We find that this Cdc14 release oscillator functions at constant and physiological cyclin-Cdk levels, and is therefore independent of the Cdk oscillator. However, the frequency of the release oscillator is regulated by cyclin-Cdk activity. This observation together with its mechanism suggests that the intrinsically autonomous Cdc14 release cycles are locked at once-per-cell-cycle through entrainment by the Cdk oscillator in wild-type cells. This concept may have broad implications for the structure and evolution of eukaryotic cell-cycle control.	[Lu, Ying; Cross, Frederick R.] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Cross, FR (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	fcross@rockefeller.edu	Lu, Ying/B-4925-2011		National Institutes of Health [GM078153, GM47238]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047238, R01GM078153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Special thanks go to B. Drapkin for developing and characterizing the quantitative Clb2kd-GFP-loading method and for communicating results before publication. We thank A. Amon, B. Drapkin, A. Geoghegan, K. Lee, D. Morgan, K. Nasmyth, J. Robbins, E. Schiebel, J. Skotheim, and R. Visintin for providing strains and plasmids. We thank L. Bai, N. Buchler, B. Drapkin, H. Funabiki, J. Robbins, W. Shou, E. Siggia, and J. Skotheim for comments on the manuscript. We thank R. Visintin for sharing unpublished data. We also thank E. Siggia for extended discussion. This work was supported by grants from the National Institutes of Health GM078153 and GM47238 to F. C.	Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Brede M, 2008, PHYS LETT A, V372, P5305, DOI 10.1016/j.physleta.2008.06.017; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Darwin C., 1859, ORIGIN SPECIES MEANS; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Drapkin BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.78; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fesquet D, 1999, EMBO J, V18, P2424, DOI 10.1093/emboj/18.9.2424; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Haase SB, 1999, NATURE, V401, P394, DOI 10.1038/43930; Haase SB, 2001, NAT CELL BIOL, V3, P38, DOI 10.1038/35050543; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HARTWELL LH, 1974, BACTERIOL REV, V38, P164, DOI 10.1128/MMBR.38.2.164-198.1974; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jensen S, 2002, J CELL SCI, V115, P4977, DOI 10.1242/jcs.00189; Kearsey SE, 2003, MOL CELL, V12, P1067, DOI 10.1016/S1097-2765(03)00441-6; Krylov DM, 2003, CURR BIOL, V13, P173, DOI 10.1016/S0960-9822(03)00008-3; Kuramoto, 1975, LECT NOTE PHYS, V30, P420, DOI DOI 10.1007/BFB0013365; Lu Y, 2009, MOL BIOL CELL, V20, P1576, DOI 10.1091/mbc.E08-10-1042; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; McCleland ML, 2008, CURR BIOL, V18, P245, DOI 10.1016/j.cub.2008.01.041; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; NASMYTH K, 1995, PHILOS T ROY SOC B, V349, P271, DOI 10.1098/rstb.1995.0113; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Pfleger CM, 2000, GENE DEV, V14, P655; PRINGLE JR, 1981, MOL BIOL YEAST SACCH, P97; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Sendina-Nadal I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002644; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; SLUDER G, 1990, J CELL BIOL, V110, P2025, DOI 10.1083/jcb.110.6.2025; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Stern B, 1996, TRENDS GENET, V12, P345; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Toyn JH, 1997, GENETICS, V145, P85; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Visintin C, 2008, GENE DEV, V22, P79, DOI 10.1101/gad.1601308; Visintin R, 2003, MOL BIOL CELL, V14, P4486, DOI 10.1091/mbc.E03-02-0095; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606; WITTENBERG C, 1990, CELL, V62, P225, DOI 10.1016/0092-8674(90)90361-H; Xu SC, 2000, CURR BIOL, V10, P329, DOI 10.1016/S0960-9822(00)00382-1; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Yoshida S, 2001, GENES GENET SYST, V76, P141, DOI 10.1266/ggs.76.141	63	70	71	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					268	279		10.1016/j.cell.2010.03.021	http://dx.doi.org/10.1016/j.cell.2010.03.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403323	Green Accepted, Bronze			2022-12-24	WOS:000276738400017
J	Cooke, M				Cooke, Molly			Cost Consciousness in Patient Care -- What is Medical Education's Responsibility?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH-CARE		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Cooke, M (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							Abbo ED, 2006, AM J BIOETHICS, V6, P33, DOI 10.1080/15265160600755540; Beach MC, 2005, ANN FAM MED, V3, P53, DOI 10.1370/afm.257; Blumenthal D, 2001, NEW ENGL J MED, V344, P766, DOI 10.1056/NEJM200103083441012; HIATT HH, 1975, NEW ENGL J MED, V293, P235, DOI 10.1056/NEJM197507312930506; Shortell SM, 1998, JAMA-J AM MED ASSOC, V280, P1102, DOI 10.1001/jama.280.12.1102	5	118	119	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2010	362	14					1253	1255		10.1056/NEJMp0911502	http://dx.doi.org/10.1056/NEJMp0911502			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579SN	20357275				2022-12-24	WOS:000276393700001
J	Ballard, JO				Ballard, J. O.			To Bed With Dad	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jballard@psu.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2010	303	12					1125	1126		10.1001/jama.2010.318	http://dx.doi.org/10.1001/jama.2010.318			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573AC	20332391				2022-12-24	WOS:000275879600001
J	Blumberg, HM; Migliori, GB; Ponomarenko, O; Heldal, E				Blumberg, Henry M.; Migliori, Giovanni B.; Ponomarenko, Oksana; Heldal, Einar			Tuberculosis on the move	LANCET			English	Editorial Material							MIGRANTS; COUNTRIES; EPIDEMIOLOGY; IMPACT		[Blumberg, Henry M.] Emory Univ, Div Infect Dis, Atlanta, GA 30303 USA; [Migliori, Giovanni B.] WHO, Collaborating Ctr TB & Lung Dis, Fdn S Maugeri, Care & Res Inst, Tradate, Italy; [Ponomarenko, Oksana] Partners Hlth, Representat Off Russian Federat, Moscow, Russia; [Heldal, Einar] Norwegian Inst Publ Hlth, Oslo, Norway	Emory University; Istituti Clinici Scientifici Maugeri IRCCS; World Health Organization; Norwegian Institute of Public Health (NIPH)	Blumberg, HM (corresponding author), Emory Univ, Div Infect Dis, Atlanta, GA 30303 USA.	hblumbe@emory.edu	Migliori, Giovanni Battista/AAB-8589-2020; Blumberg, Henry/W-2156-2019	Migliori, Giovanni Battista/0000-0002-2597-574X; Blumberg, Henry/0000-0002-3110-2443	FIC NIH HHS [D43 TW007124] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW007124] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Chin DP, 1998, AM J RESP CRIT CARE, V158, P1797, DOI 10.1164/ajrccm.158.6.9804029; Coker R, 2006, EUR RESPIR J, V27, P801, DOI 10.1183/09031936.06.00104305; Dahle UR, 2007, AM J RESP CRIT CARE, V176, P930, DOI 10.1164/rccm.200702-187OC; European Centre for Disease Prevention and Control (ECDC), 2009, MIGR HLTH BACKGR NOT; Hargreaves S, 2009, LANCET INFECT DIS, V9, P139, DOI 10.1016/S1473-3099(09)70026-X; Heldal E, 2008, INT J TUBERC LUNG D, V12, P878; International_Union_Against_Tuberculosis_and_Lung_Disease, 2008, REC ENS DIAGN TREATM; Schwartzman K, 2005, NEW ENGL J MED, V353, P1008, DOI 10.1056/NEJMsa043194; Stop TB Partnership, GLOB PLAN STOP TB; *UN DEV PROGR, HUM DEV REP 2009 OV; United Nations High Commission for Refugees, 2009, 2008 GLOB TRENDS REF; World Health Organization Stop TB Partnership, 2006, STOP TB STRAT BUILD; Zhang LX, 2006, INT J TUBERC LUNG D, V10, P959; 2008, 61 WORLD HLTH ASS HL	14	22	23	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 19	2010	375	9732					2127	2129		10.1016/S0140-6736(10)60574-0	http://dx.doi.org/10.1016/S0140-6736(10)60574-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	617BF	20488513				2022-12-24	WOS:000279255100007
J	McCracken, CB				McCracken, Clinton B.			Intellectualization of Drug Abuse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												clinton.mccracken1@gmail.com						ANNITTO WJ, 1991, DUAL DIAGNOSIS SUBST, P289; Bryson EO, 2008, ANESTHESIOLOGY, V109, P905, DOI 10.1097/ALN.0b013e3181895bc1; Griffith J, 1999, Nurs Forum, V34, P19, DOI 10.1111/j.1744-6198.1999.tb01167.x; McLellan AT, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2038; WHITE RK, 1998, MD MED J, V37, P183	5	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2010	303	19					1894	1895		10.1001/jama.2010.581	http://dx.doi.org/10.1001/jama.2010.581			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597NJ	20483960				2022-12-24	WOS:000277764500001
J	Crawley, J; Chu, C; Mtove, G; Nosten, F				Crawley, Jane; Chu, Cindy; Mtove, George; Nosten, Francois			Malaria in children	LANCET			English	Article							INTERMITTENT PREVENTIVE TREATMENT; SEVERE FALCIPARUM-MALARIA; TUMOR-NECROSIS-FACTOR; CHILDHOOD CEREBRAL MALARIA; SULFADOXINE-PYRIMETHAMINE; AFRICAN CHILDREN; UNCOMPLICATED MALARIA; VIVAX MALARIA; COST-EFFECTIVENESS; CLINICAL-FEATURES	The past decade has seen an unprecedented surge in political commitment and international funding for malaria control. Coverage with existing control methods (ie, vector control and artemisinin-based combination therapy) is increasing, and, in some Asian and African countries, childhood morbidity and mortality from malaria caused by Plasmodium falciparum are starting to decline. Consequently, there is now renewed interest in the possibility of malaria elimination. But the ability of the parasite to develop resistance to antimalarial drugs and increasing insecticide resistance of the vector threaten to reduce and even reverse current gains. Plasmodium vivax, with its dormant liver stage, will be particularly difficult to eliminate, and access to effective and affordable treatment at community level is a key challenge. New drugs and insecticides are needed urgently, while use of an effective vaccine as part of national malaria control programmes remains an elusive goal. This Seminar, which is aimed at clinicians who manage children with malaria, especially in resource-poor settings, discusses present knowledge and controversies in relation to the epidemiology, pathophysiology, diagnosis, treatment, and prevention of malaria in children.	[Chu, Cindy; Nosten, Francois] Mahidol Oxford Univ, Trop Med Res Programme, Shoklo Malaria Res Unit, Mae Sot 63110, Thailand; [Crawley, Jane] MRC, Clin Trials Unit, London, England; [Chu, Cindy; Nosten, Francois] Churchill Hosp, Ctr Vaccinol & Trop Med, Oxford OX3 7LJ, England; [Mtove, George] Amani Ctr, Natl Inst Med Res Tanzania, Tanga, Tanzania	Mahidol University; Medical Research Council Clinical Trials Unit; University of Oxford; National Institute of Medical Research	Nosten, F (corresponding author), Mahidol Oxford Univ, Trop Med Res Programme, Shoklo Malaria Res Unit, 68-30 Ban Tung Rd, Mae Sot 63110, Thailand.	SMRU@tropmedres.ac	Chu, Cindy S/E-3135-2014; Nosten, Francois/AAC-5509-2019	Chu, Cindy S/0000-0001-9465-8214; Nosten, Francois/0000-0002-7951-0745; Mtove, George/0000-0001-5173-0829	Wellcome Trust, UK	Wellcome Trust, UK(Wellcome Trust)	CC and FN are supported by the Wellcome Trust, UK.	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; ACHOKI R, 2009, J TROP PEDIATRICS, DOI DOI 10.1093/TROPEJ/FRNP109; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Angulo I, 2002, CLIN DIAGN LAB IMMUN, V9, P1145, DOI 10.1128/CDLI.9.6.1145-1152.2002; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], 2007, INS TREAT MOSQ NETS; [Anonymous], 2006, IND RES SPRAYING US; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Armah H, 2005, ANN TROP MED PARASIT, V99, P629, DOI 10.1179/136485905X51508; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; Barnes KI, 2008, TRENDS PARASITOL, V24, P127, DOI 10.1016/j.pt.2007.11.008; Barnes KI, 2006, CLIN PHARMACOL THER, V80, P582, DOI 10.1016/j.clpt.2006.08.016; Bassat Q, 2009, TROP MED INT HEALTH, V14, P1011, DOI 10.1111/j.1365-3156.2009.02326.x; Bate R, 2009, LANCET INFECT DIS, V9, P396, DOI 10.1016/S1473-3099(09)70158-6; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Beare NAV, 2006, AM J TROP MED HYG, V75, P790, DOI 10.4269/ajtmh.2006.75.790; Beare NAV, 2009, J INFECT DIS, V199, P263, DOI 10.1086/595735; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Buffet PA, 2009, CURR OPIN HEMATOL, V16, P157, DOI 10.1097/MOH.0b013e32832a1d4b; Butler D, 2009, NATURE, V462, P19, DOI 10.1038/462017a; Carrara VI, 2006, PLOS MED, V3, P856, DOI 10.1371/journal.pmed.0030183; Carter JA, 2005, J NEUROL NEUROSUR PS, V76, P476, DOI 10.1136/jnnp.2004.043893; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Cisse B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007164; Clark IA, 2003, PHARMACOL THERAPEUT, V99, P221, DOI 10.1016/S0163-7258(03)00060-3; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; Clark IA, 2009, TRENDS PARASITOL, V25, P314, DOI 10.1016/j.pt.2009.04.003; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Cole-Tobian JL, 2009, INFECT IMMUN, V77, P4009, DOI 10.1128/IAI.00158-09; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Crawley J, 2000, LANCET, V355, P701, DOI 10.1016/S0140-6736(99)07148-2; Crawley J, 2001, ARCH DIS CHILD, V84, P247, DOI 10.1136/adc.84.3.247; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Dinglasan RR, 2008, TRENDS PARASITOL, V24, P364, DOI 10.1016/j.pt.2008.05.002; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Dondorp AM, 2004, ACTA TROP, V89, P309, DOI 10.1016/j.actatropica.2003.10.004; Dondorp AM, 2002, T ROY SOC TROP MED H, V96, P282, DOI 10.1016/S0035-9203(02)90100-8; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; EISENHUT M, 2005, COCHRANE DB SYST REV, V1; English M, 1996, AM J TROP MED HYG, V55, P525, DOI 10.4269/ajtmh.1996.55.525; English M, 1997, QJM-INT J MED, V90, P263, DOI 10.1093/qjmed/90.4.263; English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; English M, 2000, T ROY SOC TROP MED H, V94, P585, DOI 10.1016/S0035-9203(00)90197-4; Enwere G, 2005, TROP MED INT HEALTH, V10, P1171, DOI 10.1111/j.1365-3156.2005.01505.x; Faiz MA, 2005, LANCET, V366, P717; Falade C, 2007, TROP MED INT HEALTH, V12, P1279, DOI 10.1111/j.1365-3156.2007.01931.x; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; Gasasira AF, 2008, CLIN INFECT DIS, V46, P985, DOI 10.1086/529192; German P, 2007, CLIN INFECT DIS, V44, P889, DOI 10.1086/511882; Gimenez F, 2003, CELL MOL LIFE SCI, V60, P1623, DOI 10.1007/s00018-003-2347-x; *GLOB FUND FIGHT A, AFF MED FAC MAL AMFM; Gomes MF, 2009, LANCET, V373, P557, DOI 10.1016/S0140-6736(08)61734-1; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Graham SM, 2009, LANCET, V373, P267, DOI 10.1016/S0140-6736(09)60073-8; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; Greenwood B, 2004, AM J TROP MED HYG, V70, P1; Greenwood B, 2009, PARASITE IMMUNOL, V31, P582, DOI 10.1111/j.1365-3024.2009.01140.x; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Iannotti LL, 2006, AM J CLIN NUTR, V84, P1261, DOI 10.1093/ajcn/84.6.1261; Idro R, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-57; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; Jurado RL, 1997, CLIN INFECT DIS, V25, P888, DOI 10.1086/515549; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; KARUNAWEERA ND, 1992, P NATL ACAD SCI USA, V89, P3200, DOI 10.1073/pnas.89.8.3200; Kitchen AD, 2006, VOX SANG, V90, P77, DOI 10.1111/j.1423-0410.2006.00733.x; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; KRISHNA S, 1994, T ROY SOC TROP MED H, V88, P67, DOI 10.1016/0035-9203(94)90504-5; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Lubell Y, 2009, TROP MED INT HEALTH, V14, P332, DOI 10.1111/j.1365-3156.2009.02227.x; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; Magowan C, 2000, BBA-MOL BASIS DIS, V1502, P461, DOI 10.1016/S0925-4439(00)00069-7; Maitland K, 2005, BRIT J HAEMATOL, V128, P393, DOI 10.1111/j.1365-2141.2004.05312.x; Maitland K, 2006, TRENDS PARASITOL, V22, P457, DOI 10.1016/j.pt.2006.07.006; Maitland Kathryn, 2003, Pediatr Crit Care Med, V4, P426, DOI 10.1097/01.PCC.0000090293.32810.4E; *MAL VACC IN, LIF CYCL MAL PAR MAN; Marchiafava E., 1894, SUMMER AUTUMNAL FEVE; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; McGready R, 2009, LANCET, V374, P1478, DOI 10.1016/S0140-6736(09)61629-9; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Meremikwu M, 2002, COCHRANE DB SYST REV; Meremikwu M, 2000, COCHRANE DB SYST REV, V2; Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23; Mithwani S, 2004, BRIT J CLIN PHARMACO, V57, P146, DOI 10.1046/j.1365-2125.2003.01986.x; Molyneux EM, 2005, NEW ENGL J MED, V353, P941, DOI 10.1056/NEJMe058135; Moxon CA, 2009, MOL BIOCHEM PARASIT, V166, P99, DOI 10.1016/j.molbiopara.2009.03.006; Namutangula B, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-138; Newton PN, 2008, PLOS MED, V5, P209, DOI 10.1371/journal.pmed.0050032; Ngoungou EB, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01752.x; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; OJUKWU JU, 2009, COCHRANE DB SYST REV, V3; Pagnoni F, 2009, TRENDS PARASITOL, V25, P115, DOI 10.1016/j.pt.2008.12.003; PASVOL G, 1991, AM J TROP MED HYG, V45, P702, DOI 10.4269/ajtmh.1991.45.702; Planche T, 2005, TRENDS PARASITOL, V21, P562, DOI 10.1016/j.pt.2005.09.010; Planche T, 2005, CURR OPIN INFECT DIS, V18, P369, DOI 10.1097/01.qco.0000180161.38530.81; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Price RN, 2007, ANTIMICROB AGENTS CH, V51, P4090, DOI 10.1128/AAC.00486-07; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Rivers EP, 2008, CRIT CARE CLIN, V24, pS1, DOI 10.1016/j.ccc.2008.04.002; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; SABOT O, DISTRIBUTION ARTEMIS; Saul A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000850; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; SINCLAIR D, 2009, COCHRANE DB SYST REV, V3; Snow RW, 2006, AM J TROP MED HYG, V74, P189, DOI 10.4269/ajtmh.2006.74.189; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; Stoltzfus R, 2004, COMP QUANTIFICATION; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Waltz E, 2007, NAT MED, V13, P6, DOI 10.1038/nm0107-6a; White NJ, 2010, TRENDS PARASITOL, V26, P11, DOI 10.1016/j.pt.2009.10.007; WHITE NJ, 1992, ADV PARASIT, V31, P83, DOI 10.1016/S0065-308X(08)60021-4; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; WHITE NJ, 1987, LANCET, V1, P708; White VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004317; *WHO, 2009, REP TECHN CONS INT P; WHO, 2010, GUID TREATM MAL, V2nd; *WHO, 2009, WORLD MAL REP; *WHO FIND DIAGN, 2008, MAL RAP DIAGN TEST P; World Health Organization, 2000, MAN CHILD SER INF SE; World Health Organization, 1998, GUID US IR SUPPL PRE; World Health Organization, 2008, WORLD MAL REP; World Health Organization, 2006, WHO EXP CONS COTR PR; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636	147	65	66	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2010	375	9724					1468	1481		10.1016/S0140-6736(10)60447-3	http://dx.doi.org/10.1016/S0140-6736(10)60447-3			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590FL	20417858				2022-12-24	WOS:000277210000033
J	Hoffmann, DE; Weber, E				Hoffmann, Diane E.; Weber, Ellen			Medical Marijuana and the Law	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hoffmann, Diane E.; Weber, Ellen] Univ Maryland, Sch Law, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Hoffmann, DE (corresponding author), Univ Maryland, Sch Law, Baltimore, MD 21201 USA.		Weber, Ellen/GRR-9967-2022					*AM MED ASS, 2009, US CANN MED PURP REP; Degenhardt L, 2008, CAN MED ASSOC J, V178, P1685, DOI 10.1503/cmaj.080585; *PROCON ORG, 14 LEG MED MAR STAT; Taylor T., 2008, SUPPORTING RES THERA	4	76	80	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2010	362	16					1453	1457		10.1056/NEJMp1000695	http://dx.doi.org/10.1056/NEJMp1000695			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	586GP	20410512				2022-12-24	WOS:000276894700001
J	Zanin-Zhorov, A; Ding, Y; Kumari, S; Attur, M; Hippen, KL; Brown, M; Blazar, BR; Abramson, SB; Lafaille, JJ; Dustin, ML				Zanin-Zhorov, Alexandra; Ding, Yi; Kumari, Sudha; Attur, Mukundan; Hippen, Keli L.; Brown, Maryanne; Blazar, Bruce R.; Abramson, Steven B.; Lafaille, Juan J.; Dustin, Michael L.			Protein Kinase C-theta Mediates Negative Feedback on Regulatory T Cell Function	SCIENCE			English	Article							PKC-THETA; KAPPA-B; ACTIVATION; MECHANISMS; THERAPY; POTENT; FOXP3; BETA	T cell receptor (TCR)-dependent regulatory T cell (T-reg) activity controls effector T cell (T-eff) function and is inhibited by the inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha). Protein kinase C-theta (PKC-theta) recruitment to the immunological synapse is required for full T-eff activation. In contrast, PKC-theta was sequestered away from the T-reg immunological synapse. Furthermore, PKC-theta blockade enhanced T-reg function, demonstrating PKC-theta inhibits T-reg-mediated suppression. Inhibition of PKC-theta protected T-reg from inactivation by TNF-alpha, restored activity of defective T-reg from rheumatoid arthritis patients, and enhanced protection of mice from inflammatory colitis. T-reg freed of PKC-theta-mediated inhibition can function in the presence of inflammatory cytokines and thus have therapeutic potential in control of inflammatory diseases.	[Zanin-Zhorov, Alexandra; Ding, Yi; Kumari, Sudha; Lafaille, Juan J.; Dustin, Michael L.] NYU, Sch Med, Mol Pathogenesis Program,Dept Pathol, Helen & Martin Kimmel Ctr Biol & Med,Skirball Ins, New York, NY 10016 USA; [Attur, Mukundan; Abramson, Steven B.] NYU, Sch Med, Div Rheumatol, New York, NY 10003 USA; [Attur, Mukundan; Abramson, Steven B.] NYU, Hosp Joint Dis, New York, NY 10003 USA; [Hippen, Keli L.; Blazar, Bruce R.] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA; [Hippen, Keli L.; Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Bone Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; [Brown, Maryanne] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA	New York University; New York University; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Boehringer Ingelheim	Dustin, ML (corresponding author), NYU, Sch Med, Mol Pathogenesis Program,Dept Pathol, Helen & Martin Kimmel Ctr Biol & Med,Skirball Ins, New York, NY 10016 USA.	michael.dustin@med.nyu.edu	Attur, Mukundan/O-1578-2019; Dustin, Michael/AAM-4611-2020	Attur, Mukundan/0000-0001-7080-8118; Abramson, Steven/0000-0002-0668-6344; Dustin, Michael/0000-0003-4983-6389	NIH [PN2 EY016586, R01 AI43542]; Leukemia and Lymphoma Translational Research [6098-09]; Osaka University Immunology Frontier Research Center; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043542, R01AI055037, R01AI043542, P01AI056299] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Translational Research; Osaka University Immunology Frontier Research Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH through the NIH Roadmap for Medical Research PN2 EY016586 and R01 AI43542 to M. L. D.; a Leukemia and Lymphoma Translational Research grant 6098-09 to B. B. S. K. was supported by the Osaka University Immunology Frontier Research Center. B. Blazer is an ad hoc advisor to Becton Dickinson. Becton Dickinson has purchased licensing rights for the use of T<INF>reg</INF> cells to prevent alloresponses and autoimmunity. An MTA agreement is required for use of compound 20. M. D. and A.Z.-Z. have applied for patents for the use of compound 20 and RNA interference against PKC theta in adoptive immunotherapy (patent application nos. 61173237 and 61286871).	Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Dustin ML, 2006, CURR OPIN IMMUNOL, V18, P512, DOI 10.1016/j.coi.2006.05.017; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Flores-Borja F, 2008, EUR J IMMUNOL, V38, P934, DOI 10.1002/eji.200738107; Godfrey WR, 2005, BLOOD, V105, P750, DOI 10.1182/blood-2004-06-2467; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Shaffer MH, 2009, J IMMUNOL, V182, P1021, DOI 10.4049/jimmunol.182.2.1021; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Srivastava KK, 2004, J BIOL CHEM, V279, P29911, DOI 10.1074/jbc.M401997200; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tran DQ, 2009, J IMMUNOL, V182, P2929, DOI 10.4049/jimmunol.0803827; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	29	219	230	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					372	376		10.1126/science.1186068	http://dx.doi.org/10.1126/science.1186068			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20339032	Green Accepted			2022-12-24	WOS:000276685000042
J	Walker, AS; Ford, D; Gilks, CF; Munderi, P; Ssali, F; Reid, A; Katabira, E; Grosskurth, H; Mugyenyi, P; Hakim, J; Darbyshire, JH; Gibb, DM; Babiker, AG				Walker, A. S.; Ford, D.; Gilks, C. F.; Munderi, P.; Ssali, F.; Reid, A.; Katabira, E.; Grosskurth, H.; Mugyenyi, P.; Hakim, J.; Darbyshire, J. H.; Gibb, D. M.; Babiker, A. G.			Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort	LANCET			English	Article							TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS; PNEUMOCYSTIS-CARINII PNEUMONIA; IMMUNE ACTIVATION; EARLY MORTALITY; HIV-1-INFECTED PATIENTS; SECONDARY PROPHYLAXIS; RANDOMIZED-TRIAL; COTE-DIVOIRE; TUBERCULOSIS; DISCONTINUATION	Background Co-trimoxazole prophylaxis can reduce mortality from untreated HIV infection in Africa; whether benefits occur alongside combination antiretroviral therapy (ART) is unclear. We estimated the effect of prophylaxis after ART initiation in adults. Methods Participants in our observational analysis were from the DART randomised trial of management strategies in HIV-infected, symptomatic, previously untreated African adults starting triple-drug ART with CD4 counts lower than 200 cells per mu L. Co-trimoxazole prophylaxis was not routinely used or randomly allocated, but was variably prescribed by clinicians We estimated effects on clinical outcomes, CD4 cell count, and body-mass index (BMI) using marginal structural models to adjust for time-dependent confounding by indication. DART was registered, number ISRCTN13968779. Findings 3179 participants contributed 14 214 years of follow-up (8128 [57%] person-years on co-trimoxazole). Time-dependent predictors of co-trimoxazole use were current CD4 cell count, haemoglobin concentration, BMI, and previous WHO stage 3 or 4 events on ART. Present prophylaxis significantly reduced mortality (odds ratio 0.65, 95% CI 0.50-0.85; p=0.001). Mortality risk reduction on ART was substantial to 12 weeks (0.41, 0.27-0.65), sustained from 12-72 weeks (0.56, 0.37-0.86), but not evident subsequently (0-96, 0.63-1-45; heterogeneity p=0.02). Variation in mortality reduction was not accounted for by time on co-trimoxazole or current CD4 cell count. Prophylaxis reduced frequency of malaria (0.74, 0.63-0.88; p=0.0005), an effect that was maintained with time, but we observed no effect on new WHO stage 4 events (0.86, 0.69-1.07; p=0.17), CD4 cell count (difference vs non-users, 3 cells per mu L [-12 to 6]; p=0.50), or BMI (difference vs non-users, 0.04 kg/m(2) [-0-20 to 0.13); p=0.681. Interpretation Our results reinforce WHO guidelines and provide strong motivation for provision of co-trimoxazole prophylaxis for at least 72 weeks for all adults starting combination ART in Africa.	[Walker, A. S.; Ford, D.; Darbyshire, J. H.; Gibb, D. M.; Babiker, A. G.] MRC, Clin Trials Unit, London NW1 2DA, England; [Gilks, C. F.] Univ London Imperial Coll Sci Technol & Med, London, England; [Munderi, P.; Grosskurth, H.] MRC UVRI, Uganda Res Unit AIDS, Entebbe, Uganda; [Ssali, F.; Mugyenyi, P.] Joint Clin Res Ctr, Kampala, Uganda; [Reid, A.; Hakim, J.] Univ Zimbabwe, Harare, Zimbabwe; [Katabira, E.] Makerere Univ, Infect Dis Inst, Mulago, Uganda	Medical Research Council Clinical Trials Unit; Imperial College London; Joint Clinic Research Center - United Arab Emirates; University of Zimbabwe; Makerere University	Walker, AS (corresponding author), MRC, Clin Trials Unit, 222 Euston Rd, London NW1 2DA, England.	asw@ctu.mrc.ac.uk	Gilks, Charles/B-4184-2012; Walker, Sarah/HDM-8717-2022; Franzeck, Fabian C/B-5055-2011	Gilks, Charles/0000-0002-8953-3123; Gibb, Diana/0000-0002-9738-5490; Grosskurth, Heiner/0000-0001-9960-7280	UK Medical Research Council; UK Department for International Development; Rockefeller Foundation; GlaxoSmithKline; Gilead Sciences; Boehringer-Ingelheim; Abbott Laboratories; MRC [G0600344, MC_U950080931, MC_U122886352] Funding Source: UKRI; Medical Research Council [G0600344, MC_U950080931, MC_U122886352] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; Rockefeller Foundation; GlaxoSmithKline(GlaxoSmithKline); Gilead Sciences(Gilead Sciences); Boehringer-Ingelheim(Boehringer Ingelheim); Abbott Laboratories(Abbott Laboratories); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK Medical Research Council, the UK Department for International Development, the Rockefeller Foundation, GlaxoSmithKline, Gilead Sciences, Boehringer-Ingelheim, and Abbott Laboratories.	Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Badri M, 2001, AIDS, V15, P1143, DOI 10.1097/00002030-200106150-00009; Baker CAR, 2007, AIDS RES HUM RETROV, V23, P900, DOI 10.1089/aid.2006.0309; BLOLAND PB, 1991, LANCET, V337, P518, DOI 10.1016/0140-6736(91)91299-A; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; CAMPBELL J, 2009, C RETR OPP INF 2009; CARR A, 1992, ANN INTERN MED, V117, P106, DOI 10.7326/0003-4819-117-2-106; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; de Quiros JCLB, 2001, NEW ENGL J MED, V344, P159, DOI 10.1056/NEJM200101183440301; Division of AIDS, 1992, DIV AIDS GRAD SEV AD; Forgacs P, 2009, ANTIMICROB AGENTS CH, V53, P4789, DOI 10.1128/AAC.01658-08; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS131, DOI 10.1002/cyto.b.20391; Grimwade K, 2005, AIDS, V19, P163, DOI 10.1097/00002030-200501280-00008; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; HESS KR, 1994, STAT MED, V13, P1045, DOI 10.1002/sim.4780131007; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Jones J L, 1999, MMWR CDC Surveill Summ, V48, P1; Koblavi-Deme S, 2003, AIDS, V17, pS17, DOI 10.1097/00002030-200317003-00003; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Ledergerber B, 2001, NEW ENGL J MED, V344, P168, DOI 10.1056/NEJM200101183440302; Lowrance D, 2007, JAIDS-J ACQ IMM DEF, V46, P56; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Mulenga V, 2007, AIDS, V21, P77, DOI 10.1097/QAD.0b013e3280114ed7; Nunn AJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a257; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Walker AS, 2008, AIDS, V22, P237, DOI 10.1097/QAD.0b013e3282f2d760; *WHO, 2006, WHO CAS DEF SURV REV; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; World Health Organization, 2003, SCAL ANT THER RES LT; World Health Organization (WHO), 2006, GUID COTR PROPH HIV; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	34	85	88	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 10	2010	375	9722					1278	1286		10.1016/S0140-6736(10)60057-8	http://dx.doi.org/10.1016/S0140-6736(10)60057-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VN	20347483	Green Published, Green Accepted			2022-12-24	WOS:000276858400030
J	Kirak, O; Frickel, EM; Grotenbreg, GM; Suh, H; Jaenisch, R; Ploegh, HL				Kirak, Oktay; Frickel, Eva-Maria; Grotenbreg, Gijsbert M.; Suh, Heikyung; Jaenisch, Rudolf; Ploegh, Hidde L.			Transnuclear Mice with Predefined T Cell Receptor Specificities Against Toxoplasma gondii Obtained via SCNT	SCIENCE			English	Article							MOUSE CLONING; NEGATIVE SELECTION; NUCLEAR TRANSFER; TCR EXPRESSION; TRICHOSTATIN-A; IMMUNITY; RESPONSES; GENES	Mice that are transgenic for rearranged antigen-specific T cell receptors (TCRs) are essential tools to study T cell development and function. Such TCRs are usually isolated from the relevant T cells after long-term culture, often after repeated antigen stimulation, which unavoidably skews the T cell population used. Random genomic integration of the TCR alpha and beta chain and expression from nonendogenous promoters represent additional drawbacks of transgenics. Using epigenetic reprogramming via somatic cell nuclear transfer, we demonstrated that T cells with predefined specificities against Toxoplasma gondii can be used to generate mouse models that express the TCR from their endogenous loci, without experimentally introduced genetic modification. The relative ease and speed with which such transnuclear models can be obtained holds promise for the construction of other disease models.	[Kirak, Oktay; Frickel, Eva-Maria; Grotenbreg, Gijsbert M.; Suh, Heikyung; Jaenisch, Rudolf; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Jaenisch, Rudolf; Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Kirak, O (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	kirak@wi.mit.edu; jaenisch@wi.mit.edu; ploegh@wi.mit.edu	Kirak, Oktay/H-6347-2013	Kirak, Oktay/0000-0002-6524-4685	Human Frontiers Science Program; NIH [RO1-HD045022, R37-CA084198]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062502] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are thankful to H. Eisen, M. J. Gubbels, K. van Grinsven, E. Guillen, A. Drake, V. Mahajan, Q. Gao, and G. Yap for fruitful discussions and reagents; J. Dausman, R. Flannery, and J. Jackson for assistance with the management of the mouse colony; P. Wisniewski for FACSorting; and J. Saeij and K. Jensen for the Pru PA7 and assistance with the in vivo imaging. E. M. F. was supported by the Human Frontiers Science Program. R. J. was supported by NIH grants RO1-HD045022 and R37-CA084198. H. L. P. was supported by grants from NIH. We thank L. Clay for financial support. The Whitehead Institute has filed a patent related to the generation of mice with defined antigen receptor specificity using epigenetic reprogramming (international patent application PCT/US2009/049596). The sequences have been submitted to the European Molecular Biology Laboratory Nucleotide Sequence Database, accession number FN601337-FN601346.	Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; Chen JZ, 2003, MICROBES INFECT, V5, P233, DOI 10.1016/S1286-4579(03)00016-9; Dzierszinski FS, 2008, PARASITE IMMUNOL, V30, P235, DOI 10.1111/j.1365-3024.2007.01016.x; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Frickel EM, 2008, J INFECT DIS, V198, P1625, DOI 10.1086/593019; Gredmark S, 2007, J VIROL, V81, P10300, DOI 10.1128/JVI.01149-07; Harrington LE, 2002, J VIROL, V76, P3329, DOI 10.1128/JVI.76.7.3329-3337.2002; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Inoue K, 2005, CURR BIOL, V15, P1114, DOI 10.1016/j.cub.2005.05.021; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Kishigami S, 2007, J REPROD DEVELOP, V53, P165, DOI 10.1262/jrd.18098; Koralov SB, 2005, J EXP MED, V201, P341, DOI 10.1084/jem.20041577; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; MAMALAKI C, 1993, DEV IMMUNOL, V3, P159, DOI 10.1155/1993/98015; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Serwold T, 2007, J IMMUNOL, V179, P928, DOI 10.4049/jimmunol.179.2.928; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SUZUKI Y, 1990, J IMMUNOL, V144, P1954; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Wang XCL, 2003, J IMMUNOL METHODS, V280, P25, DOI 10.1016/S0022-1759(03)00079-6; Wilson DC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000815; Wong P, 2003, ANNU REV IMMUNOL, V21, P29, DOI 10.1146/annurev.immunol.21.120601.141114	27	45	46	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					243	248		10.1126/science.1178590	http://dx.doi.org/10.1126/science.1178590			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20378817	Green Submitted, Green Accepted			2022-12-24	WOS:000276459600046
J	Foti, JJ; Walker, GC				Foti, James J.; Walker, Graham C.			SnapShot: DNA Polymerases I Prokaryotes	CELL			English	Editorial Material									[Foti, James J.; Walker, Graham C.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Foti, JJ (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			/0000-0001-7243-8261	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Kornberg A., 1992, DNA REPLICATION; Lamers MH, 2006, CELL, V126, P881, DOI 10.1016/j.cell.2006.07.028; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; Rattray AJ, 2003, ANNU REV GENET, V37, P31, DOI 10.1146/annurev.genet.37.042203.132748; SIMMONS LA, 2008, ECOSAL ESCHERICHIA C; Yang W, 2005, FEBS LETT, V579, P868, DOI 10.1016/j.febslet.2004.11.047	6	3	3	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2010	141	1					192	E1		10.1016/j.cell.2010.03.024	http://dx.doi.org/10.1016/j.cell.2010.03.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371354	Green Published, Bronze			2022-12-24	WOS:000276211100024
J	Saumitou-Laprade, P; Vernet, P; Vassiliadis, C; Hoareau, Y; de Magny, G; Dommee, B; Lepart, J				Saumitou-Laprade, Pierre; Vernet, Philippe; Vassiliadis, Christine; Hoareau, Yves; de Magny, Guillaume; Dommee, Bertrand; Lepart, Jacques			A Self-Incompatibility System Explains High Male Frequencies in an Androdioecious Plant	SCIENCE			English	Article							PHILLYREA-ANGUSTIFOLIA OLEACEAE; SEX ALLOCATION; EVOLUTION; MAINTENANCE; GYNODIOECY; DIOECY; MODEL; HERMAPHRODITES; FEMALES; SUCCESS	Androdioecy is a sexual system in which males co-occur with hermaphrodites, which have both male and female function. Stable androdioecy is rare in nature, and theory suggests that it requires that males sire more than twice as many offspring as hermaphrodites. In several members of the olive family (Oleaceae), androdioecy occurs with higher frequencies of males than predicted by theory. In Phillyrea angustifolia L., we found that high male frequencies can be maintained in natural populations because hermaphrodites belong exclusively to one of two self-incompatibility groups, and thus, each can fertilize only half of all pollen recipients. In contrast, males can pollinate all hermaphrodites. Thus, in this species, the reproductive disadvantage that males face due to the loss of female function is offset by the fact that all males are fully compatible with all pollen recipients.	[Saumitou-Laprade, Pierre; Vernet, Philippe; Vassiliadis, Christine; Hoareau, Yves; de Magny, Guillaume] Univ Sci & Technol Lille Lille 1, Lab Genet & Evolut Populat Vegetales, CNRS, UMR 8016, F-59655 Villeneuve Dascq, France; [Dommee, Bertrand; Lepart, Jacques] CEFE, CNRS, UMR 5175, F-34293 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Saumitou-Laprade, P (corresponding author), Univ Sci & Technol Lille Lille 1, Lab Genet & Evolut Populat Vegetales, CNRS, UMR 8016, F-59655 Villeneuve Dascq, France.	pierre.saumitou@univ-lille1.fr	Constantin de Magny, Guillaume/L-6706-2017; Saumitou-Laprade, Pierre/A-2499-2009	Hoareau, Yves/0000-0002-2807-2247; Saumitou-Laprade, Pierre/0000-0001-7413-3090				ATLAN A, 1992, J EVOLUTION BIOL, V5, P189, DOI 10.1046/j.1420-9101.1992.5020189.x; BEACH JH, 1980, EVOLUTION, V34, P1138, DOI [10.2307/2408294, 10.1111/j.1558-5646.1980.tb04055.x]; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; CHARLESWORTH D, 1984, BIOL J LINN SOC, V22, P333, DOI 10.1111/j.1095-8312.1984.tb01683.x; CHARLESWORTH D, 1979, AM NAT, V114, P467, DOI 10.1086/283496; CHARLESWORTH D, 1981, HEREDITY, V46, P27, DOI 10.1038/hdy.1981.3; Delph LF, 2005, NEW PHYTOL, V166, P119, DOI 10.1111/j.1469-8137.2005.01339.x; Delph LF, 2009, CURR BIOL, V19, pR249, DOI 10.1016/j.cub.2009.01.048; Dommee B, 1999, NEW PHYTOL, V143, P419, DOI 10.1046/j.1469-8137.1999.00442.x; Hurst LD, 1996, Q REV BIOL, V71, P317, DOI 10.1086/419442; Ishida K, 1998, INT J PLANT SCI, V159, P941, DOI 10.1086/314088; Keller SR, 2006, J EVOLUTION BIOL, V19, P1128, DOI 10.1111/j.1420-9101.2006.01101.x; Kurian V, 1997, HEREDITY, V78, P383, DOI 10.1038/hdy.1997.61; LEPART J, 1992, BOT J LINN SOC, V108, P375, DOI 10.1111/j.1095-8339.1992.tb00252.x; Lewis D, 1942, BIOL REV CAMB PHILOS, V17, P46, DOI 10.1111/j.1469-185X.1942.tb00431.x; Lloyd D.G, 1992, EVOLUTION FUNCTION H, P151; LLOYD DG, 1975, GENETICA, V45, P325, DOI 10.1007/BF01508307; Pannell JR, 2006, EVOLUTION, V60, P660, DOI 10.1554/05-481.1; Pannell JR, 2000, ECOL LETT, V3, P495, DOI 10.1046/j.1461-0248.2000.00173.x; Pannell JR, 2002, ANNU REV ECOL SYST, V33, P397, DOI 10.1146/annurev.ecolsys.33.010802.150419; Pannell JR, 2002, FUNCT ECOL, V16, P862, DOI 10.1046/j.1365-2435.2002.06893.x; Poot P, 1997, AM J BOT, V84, P1256, DOI 10.2307/2446050; Sakai AK, 1997, EVOLUTION, V51, P724, DOI 10.1111/j.1558-5646.1997.tb03656.x; Saumitou-Laprade P, 2000, MOL ECOL, V9, P112, DOI 10.1046/j.1365-294x.2000.00764-4.x; SAUMITOULAPRADE P, 1994, TRENDS ECOL EVOL, V9, P431, DOI 10.1016/0169-5347(94)90126-0; Tantikanjana T, 2009, PLANT CELL, V21, P2642, DOI 10.1105/tpc.109.067801; TAYLOR HERBERT, 1945, BRITTONIA, V5, P337, DOI 10.2307/2804889; Van Etten ML, 2008, INT J PLANT SCI, V169, P271, DOI 10.1086/524109; Vassiliadis C, 2000, INT J PLANT SCI, V161, P393, DOI 10.1086/314263; Vassiliadis C, 2002, EVOLUTION, V56, P1362, DOI 10.1111/j.0014-3820.2002.tb01450.x; Vassiliadis C, 2000, HEREDITY, V85, P413, DOI 10.1046/j.1365-2540.2000.00755.x; Wallander E, 2000, AM J BOT, V87, P1827, DOI 10.2307/2656836; Weeks SC, 2006, INVERTEBR REPROD DEV, V49, P113, DOI 10.1080/07924259.2006.9652200	33	55	56	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2010	327	5973					1648	1650		10.1126/science.1186687	http://dx.doi.org/10.1126/science.1186687			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339074				2022-12-24	WOS:000275970600045
J	Kreiss, Y; Merin, O; Peleg, K; Levy, G; Vinker, S; Sagi, R; Abargel, A; Bartal, C; Lin, G; Bar, A; Bar-On, E; Schwaber, MJ; Ash, N				Kreiss, Yitshak; Merin, Ofer; Peleg, Kobi; Levy, Gad; Vinker, Shlomo; Sagi, Ram; Abargel, Avi; Bartal, Carmi; Lin, Guy; Bar, Ariel; Bar-On, Elhanan; Schwaber, Mitchell J.; Ash, Nachman			Early Disaster Response in Haiti: The Israeli Field Hospital Experience	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EARTHQUAKE	The earthquake that struck Haiti in January 2010 caused an estimated 230 000 deaths and injured approximately 250 000 people. The Israel Defense Forces Medical Corps Field Hospital was fully operational on site only 89 hours after the earthquake struck and was capable of providing sophisticated medical care. During the 10 days the hospital was operational, its staff treated 1111 patients, hospitalized 737 patients, and performed 244 operations on 203 patients. The field hospital also served as a referral center for medical teams from other countries that were deployed in the surrounding areas. The key factor that enabled rapid response during the early phase of the disaster from a distance of 6000 miles was a well-prepared and trained medical unit maintained on continuous alert. The prompt deployment of advanced-capability field hospitals is essential in disaster relief, especially in countries with minimal medical infrastructure. The changing medical requirements of people in an earthquake zone dictate that field hospitals be designed to operate with maximum flexibility and versatility regarding triage, staff positioning, treatment priorities, and hospitalization policies. Early coordination with local administrative bodies is indispensable.	Hebrew Univ Jerusalem, Shaare Zedek Med Ctr, Jerusalem, Israel; Israel Natl Ctr Trauma & Emergency Med Res, Gertner Inst Epidemiol & Hlth Policy Reasearch, Tel Hashomer, Israel; Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Assaf Harofeh Med Ctr, Sch Publ Hlth, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Assaf Harofeh Med Ctr, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Israel Minist Hlth, Natl Ctr Infect Control, Tel Aviv, Israel; Soroka Univ Med Ctr, Beer Sheva, Israel; Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; Western Galilee Hosp, Nahariyya, Israel; Schneider Childrens Med Ctr, Petah Tiqwa, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Chaim Sheba Medical Center; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Western Galilee Hospital	Kreiss, Y (corresponding author), 182 Kedem St,POB 1773, Shoham, Israel.	ykreiss@gmail.com	Schwaber, Mitchell/AAI-2486-2019; Ash, Nachman/ABC-2961-2020	bartal, carmi/0000-0003-0894-5466				Adler J, 2001, Harefuah, V140, P877; ADLER J, 2001, HAREFUAH, V140, P893; Amital Howard, 2003, Prehosp Disaster Med, V18, P301; Aoki Noriaki, 2004, Prehosp Emerg Care, V8, P217, DOI 10.1016/j.prehos.2003.12.019; Bar-Dayan Y, 2000, DISASTERS, V24, P262, DOI 10.1111/1467-7717.00147; Bar-Dayan Y, 2005, PREHOSP DISASTER MED, V20, P103, DOI 10.1017/S1049023X00002272; HEYMAN SN, 1988, PREHOSP DISASTER MED, V13, P21; Medecins Sans Frontieres, 2010, HAIT ON EM NEXT; Merin O, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1001693; NOJI EK, 1990, ANN EMERG MED, V19, P891, DOI 10.1016/S0196-0644(05)81563-X; Schultz CH, 1996, NEW ENGL J MED, V334, P438, DOI 10.1056/NEJM199602153340706; SHENG ZY, 1987, J TRAUMA, V27, P1130; Tanaka K, 1996, Eur J Emerg Med, V3, P263, DOI 10.1097/00063110-199612000-00009; World Medical Association, 2006, STAT MED ETH EV DIS	14	75	77	4	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 6	2010	153	1					45	48		10.7326/0003-4819-153-1-201007060-00253	http://dx.doi.org/10.7326/0003-4819-153-1-201007060-00253			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620GS	20442270				2022-12-24	WOS:000279487700007
J	Karunadasa, HI; Chang, CJ; Long, JR				Karunadasa, Hemamala I.; Chang, Christopher J.; Long, Jeffrey R.			A molecular molybdenum-oxo catalyst for generating hydrogen from water	NATURE			English	Article							TRANSITION-METAL-COMPLEXES; ACTIVE-SITE; OXIDATIVE ADDITION; LOW OVERPOTENTIALS; EVOLUTION; CHEMISTRY; ENZYMES; MODELS; H-2	A growing awareness of issues related to anthropogenic climate change and an increase in global energy demand have made the search for viable carbon-neutral sources of renewable energy one of the most important challenges in science today(1). The chemical community is therefore seeking efficient and inexpensive catalysts that can produce large quantities of hydrogen gas from water(1-7). Here we identify a molybdenum-oxo complex that can catalytically generate gaseous hydrogen either from water at neutral pH or from sea water. This work shows that high-valency metal-oxo species can be used to create reduction catalysts that are robust and functional in water, a concept that has broad implications for the design of 'green' and sustainable chemistry cycles.	[Karunadasa, Hemamala I.; Chang, Christopher J.; Long, Jeffrey R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Karunadasa, Hemamala I.; Chang, Christopher J.; Long, Jeffrey R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Chang, CJ (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	chrischang@berkeley.edu; jrlong@berkeley.edu	Karunadasa, Hemamala I./ABE-6223-2020		NSF [CHE-0617063]; Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-AC02-05CH11231]; Tyco Electronics	NSF(National Science Foundation (NSF)); Office of Science, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); Tyco Electronics	We acknowledge the NSF (grant number CHE-0617063) for research funding in the initial stages of this project. For the later stages, we acknowledge the Helios Solar Energy Research Center, which is supported by the Office of Science, Office of Basic Energy Sciences of the US Department of Energy under contract number DE-AC02-05CH11231. C. J. C. is an Investigator with the Howard Hughes Medical Institute. We thank Tyco Electronics for the partial support of H. I. K. We also thank M. Majda for discussions, D. M. Jenkins and P. Dechambenoit for experimental assistance, A. T. Iavarone for obtaining the mass spectra, and J. D. Breen for fabrication of the electrochemical cells.	Appel AM, 2005, J AM CHEM SOC, V127, P12717, DOI 10.1021/ja054034o; Armstrong FA, 2004, CURR OPIN CHEM BIOL, V8, P133, DOI 10.1016/j.cbpa.2004.02.004; Armstrong FA, 2009, CHEM SOC REV, V38, P36, DOI 10.1039/b801144n; Baffert C, 2007, INORG CHEM, V46, P1817, DOI 10.1021/ic061625m; Bernhardt PV, 1999, INORG CHEM, V38, P5086, DOI 10.1021/ic981425d; Blum O, 2002, J AM CHEM SOC, V124, P11456, DOI 10.1021/ja012611c; COLLIN JP, 1988, INORG CHEM, V27, P1986, DOI 10.1021/ic00284a030; Dance I, 2005, J AM CHEM SOC, V127, P10925, DOI 10.1021/ja0504946; Darensbourg MY, 2003, P NATL ACAD SCI USA, V100, P3683, DOI 10.1073/pnas.0536955100; Du PW, 2008, J AM CHEM SOC, V130, P12576, DOI 10.1021/ja804650g; Esswein AJ, 2007, CHEM REV, V107, P4022, DOI 10.1021/cr050193e; Evans DJ, 2003, CHEM SOC REV, V32, P268, DOI 10.1039/b201317g; Felton GAN, 2007, J AM CHEM SOC, V129, P12521, DOI 10.1021/ja073886g; Fihri A, 2008, ANGEW CHEM INT EDIT, V47, P564, DOI 10.1002/anie.200702953; Frey M, 2002, CHEMBIOCHEM, V3, P153, DOI 10.1002/1439-7633(20020301)3:2/3<153::AID-CBIC153>3.0.CO;2-B; Gebbink RJMK, 2002, INORG CHEM, V41, P4633, DOI 10.1021/ic025617r; Gloaguen F, 2009, CHEM SOC REV, V38, P100, DOI 10.1039/b801796b; Goldsmith JI, 2005, J AM CHEM SOC, V127, P7502, DOI 10.1021/ja0427101; Hinnemann B, 2005, J AM CHEM SOC, V127, P5308, DOI 10.1021/ja0504690; Hu XL, 2007, J AM CHEM SOC, V129, P8988, DOI 10.1021/ja067876b; JAKSIC MM, 1966, ELECTROCHEM TECHNOL, V4, P49; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Kohl SW, 2009, SCIENCE, V324, P74, DOI 10.1126/science.1168600; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Ozerov OV, 2009, CHEM SOC REV, V38, P83, DOI 10.1039/b802420k; Sun LC, 2005, COORDIN CHEM REV, V249, P1653, DOI 10.1016/j.ccr.2005.01.013; Tard C, 2005, NATURE, V433, P610, DOI 10.1038/nature03298; Turner JA, 2004, SCIENCE, V305, P972, DOI 10.1126/science.1103197; Wilson AD, 2006, J AM CHEM SOC, V128, P358, DOI 10.1021/ja056442y; Yoon M, 1997, CHEM COMMUN, P639, DOI 10.1039/a700087a	30	560	562	7	329	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1329	1333		10.1038/nature08969	http://dx.doi.org/10.1038/nature08969			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428167				2022-12-24	WOS:000277149000042
J	Carr, DB; Ott, BR				Carr, David B.; Ott, Brian R.			The Older Adult Driver With Cognitive Impairment: "It's a Very Frustrating Life"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MOTOR-VEHICLE CRASHES; QUALITY STANDARDS SUBCOMMITTEE; EARLY ALZHEIMER-DISEASE; DRIVING PERFORMANCE; AMERICAN ASSOCIATION; GERIATRIC PSYCHIATRY; CONSENSUS CONFERENCE; PRACTICE PARAMETER; DEMENTIA; RISK		[Carr, David B.] Washington Univ, Dept Med, St Louis, MO 63017 USA; [Carr, David B.] Washington Univ, Dept Neurol, St Louis, MO 63017 USA; [Carr, David B.] Rehabil Inst St Louis, St Louis, MO USA; [Ott, Brian R.] Brown Univ, Dept Neurol, Warren Alpert Med Sch, Providence, RI 02912 USA	Washington University (WUSTL); Washington University (WUSTL); Brown University	Carr, DB (corresponding author), Washington Univ, Dept Med, 4488 Forest Pk Ave, St Louis, MO 63017 USA.	dcarr@im.wustl.edu		Carr, David/0000-0003-2641-3850	Washington University Alzheimer's Disease Research Center [P50AG05681]; Healthy Aging and Senile Dementia [P01AG03991, AG16335]; The SCAN Foundation; NATIONAL INSTITUTE ON AGING [R01AG016335, P01AG003991, P50AG005681] Funding Source: NIH RePORTER	Washington University Alzheimer's Disease Research Center; Healthy Aging and Senile Dementia; The SCAN Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	and serving as a paid speaker for Forrest. Funding/Support: This work was supported in part by the Washington University Alzheimer's Disease Research Center (P50AG05681, J. Morris, principal investigator [PI]), the program project, Healthy Aging and Senile Dementia (P01AG03991, J. Morris, PI), and grant AG16335 (B. Ott, PI) from the NIA. The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	*ALZH ASS, 2001, POS STAT DRIV; *AM MED ASS, 2010, AM MED ASS PHYS GUID; *AM MED ASS COD ME, OP 2 24 IMP DRIV THE; [Anonymous], 1997, Am J Psychiatry, V154, P1; Arbesman M, 2007, DRIVING COMMUNITY MO; Ball KK, 2006, J AM GERIATR SOC, V54, P77, DOI 10.1111/j.1532-5415.2005.00568.x; Bedard M, 1998, ALZ DIS ASSOC DIS, V12, P135; Bedard M, 2008, TRAFFIC INJ PREV, V9, P336, DOI 10.1080/15389580802117184; Berndt A, 2008, AUSTRALAS J AGEING, V27, P157, DOI 10.1111/j.1741-6612.2008.00300.x; Brown LB, 2005, ARCH CLIN NEUROPSYCH, V20, P209, DOI 10.1016/j.acn.2004.06.003; Byszewski AM, 2003, J AM GERIATR SOC, V51, P1484, DOI 10.1046/j.1532-5415.2003.51483.x; Canadian Medical Association, 2006, CMA DRIVERS GUIDE DE; Carr DB, 2000, J AM GERIATR SOC, V48, P18, DOI 10.1111/j.1532-5415.2000.tb03023.x; Charlton JL., 2004, MONASH U ACCIDENT RE, P482; Cox D J, 1998, J Am Board Fam Pract, V11, P264; Croston J, 2009, TOP GERIATR REHABIL, V25, P154; DAIELLO LA, J CLIN PSYC IN PRESS; Dawson JD, 2009, NEUROLOGY, V72, P521, DOI 10.1212/01.wnl.0000341931.35870.49; de Simone V, 2007, DEMENT GERIATR COGN, V23, P1, DOI 10.1159/000096317; DOBBS BM, MED CONDITIONS REV L; DOBBS BM, 2002, NHTSA PUBLICATION; DRACHMAN DA, 1993, NEUROLOGY, V43, P2448, DOI 10.1212/WNL.43.12.2448; Dubinsky RM, 2000, NEUROLOGY, V54, P2205, DOI 10.1212/WNL.54.12.2205; DUBINSKY RM, 1992, J AM GERIATR SOC, V40, P1112, DOI 10.1111/j.1532-5415.1992.tb01799.x; Duchek JM, 2003, J AM GERIATR SOC, V51, P1342, DOI 10.1046/j.1532-5415.2003.51481.x; Edwards JD, 2005, AGING MENT HEALTH, V9, P262, DOI 10.1080/13607860412331336788; FITTEN LJ, 1995, JAMA-J AM MED ASSOC, V273, P1360, DOI 10.1001/jama.273.17.1360; Foley DJ, 2000, J AM GERIATR SOC, V48, P928, DOI 10.1111/j.1532-5415.2000.tb06889.x; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Fonda SJ, 2001, J GERONTOL B-PSYCHOL, V56, pS343, DOI 10.1093/geronb/56.6.S343; Freeman EE, 2006, AM J PUBLIC HEALTH, V96, P1254, DOI 10.2105/AJPH.2005.069146; Freund B, 2002, J AM GERIATR SOC, V50, P1309, DOI 10.1046/j.1532-5415.2002.50325.x; FRIEDLAND RP, 1988, ANN NEUROL, V24, P782, DOI 10.1002/ana.410240613; Frittelli C, 2009, INT J GERIATR PSYCH, V24, P232, DOI 10.1002/gps.2095; Grace J, 2005, J INT NEUROPSYCH SOC, V11, P766, DOI 10.1017/S135561770505848; HUNT L, 1993, J AM GERIATR SOC, V41, P747, DOI 10.1111/j.1532-5415.1993.tb07465.x; Johansson K, 1997, ALZ DIS ASSOC DIS, V11, P62, DOI 10.1097/00002093-199706001-00013; Kelly R, 1999, POSTGRAD MED J, V75, P537, DOI 10.1136/pgmj.75.887.537; Korner-Bitensky N, 2006, AM J OCCUP THER, V60, P428, DOI 10.5014/ajot.60.4.428; Langford J, 2008, ACCIDENT ANAL PREV, V40, P1913, DOI 10.1016/j.aap.2008.08.010; Leproust S, 2008, J GEN INTERN MED, V23, P1796, DOI 10.1007/s11606-008-0777-8; Lesikar Sandra E, 2002, J Am Board Fam Pract, V15, P11; Lincoln NB, 2010, INT J GERIATR PSYCH, V25, P489, DOI 10.1002/gps.2367; LOCOCO K, 2008, MED RELATED IMPAIRED; Lyketsos CG, 2006, AM J GERIAT PSYCHIAT, V14, P561, DOI 10.1097/01.JGP.0000221334.65330.55; Marmeleira JF, 2009, ACCIDENT ANAL PREV, V41, P90, DOI 10.1016/j.aap.2008.09.008; Marottoli RA, 2000, J GERONTOL B-PSYCHOL, V55, pS334, DOI 10.1093/geronb/55.6.S334; Martin AJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006222.pub2; McCarthy DP, 2006, TOP GERIATR REHABIL, V22, P139; Meuser TM, 2006, GERONTOLOGIST, V46, P680, DOI 10.1093/geront/46.5.680; Meuser TM, 2009, ACCIDENT ANAL PREV, V41, P246, DOI 10.1016/j.aap.2008.11.003; Mezuk B, 2008, J GERONTOL B-PSYCHOL, V63, pS298, DOI 10.1093/geronb/63.5.S298; Molnar FJ, 2006, J AM GERIATR SOC, V54, P1809, DOI 10.1111/j.1532-5415.2006.00967.x; Nasvadi GC, 2009, GERONTOLOGIST, V49, P474, DOI 10.1093/geront/gnp039; Odenheimer G L, 1993, Clin Geriatr Med, V9, P349; Ott BR, 2000, DEMENT GERIATR COGN, V11, P153, DOI 10.1159/000017229; Ott BR, 2005, J AM GERIATR SOC, V53, P829, DOI 10.1111/j.1532-5415.2005.53265.x; Ott BR, 2008, J GERIATR PSYCH NEUR, V21, P18, DOI 10.1177/0891988707311031; Patterson CJS, 1999, CAN MED ASSOC J, V160, P1738; Perkinson MA, 2005, GERONTOLOGIST, V45, P676, DOI 10.1093/geront/45.5.676; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Rapoport MJ, 2007, CAN MED ASSOC J, V177, P599, DOI 10.1503/cmaj.070342; Reger MA, 2004, NEUROPSYCHOLOGY, V18, P85, DOI 10.1037/0894-4105.18.1.85; Rizzo M, 2001, ALZ DIS ASSOC DIS, V15, P10, DOI 10.1097/00002093-200101000-00002; Silverstein NM, 2008, GERONTOL GERIATR EDU, V29, P305, DOI 10.1080/02701960802497795; Small GW, 1997, JAMA-J AM MED ASSOC, V278, P1363, DOI 10.1001/jama.278.16.1363; Snellgrove C, 2005, COGNITIVE SCREENING; Staplin L, 2003, J SAFETY RES, V34, P389, DOI 10.1016/j.jsr.2003.09.002; Stutts JC, 1998, ACCIDENT ANAL PREV, V30, P337, DOI 10.1016/S0001-4575(97)00108-5; Taylor BD, 2001, ACCIDENT ANAL PREV, V33, P519, DOI 10.1016/S0001-4575(00)00065-8; Trobe JD, 1996, ARCH NEUROL-CHICAGO, V53, P411, DOI 10.1001/archneur.1996.00550050033021; TUOKKO H, 1995, J GERONTOL B-PSYCHOL, V50, pS173, DOI 10.1093/geronb/50B.3.S173; Uc EY, 2008, CURR NEUROL NEUROSCI, V8, P377, DOI 10.1007/s11910-008-0059-1; Uc EY, 2004, NEUROLOGY, V63, P832, DOI 10.1212/01.WNL.0000139301.01177.35; Wadley VG, 2009, J GERIATR PSYCH NEUR, V22, P87, DOI 10.1177/0891988708328215; Wang CC, 2004, J AM GERIATR SOC, V52, P143, DOI 10.1111/j.1532-5415.2004.52025.x; Whelihan WM, 2005, ARCH CLIN NEUROPSYCH, V20, P217, DOI 10.1016/j.acn.2004.07.002; Zuin D, 2002, EUR J NEUROL, V9, P29, DOI 10.1046/j.1468-1331.2002.00296.x	78	117	118	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2010	303	16					1632	1641		10.1001/jama.2010.481	http://dx.doi.org/10.1001/jama.2010.481			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	588PQ	20424254	Green Accepted			2022-12-24	WOS:000277085200027
J	Purshouse, RC; Meier, PS; Brennan, A; Taylor, KB; Rafia, R				Purshouse, Robin C.; Meier, Petra S.; Brennan, Alan; Taylor, Karl B.; Rafia, Rachid			Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model	LANCET			English	Article							GLOBAL BURDEN; DRINKING; METAANALYSIS; CONSUMPTION; PREVENTION; BENEFITS; DISEASE	Background Although pricing policies for alcohol are known to be effective, little is known about how specific interventions affect health-care costs and health-related quality-of-life outcomes for different types of drinkers. We assessed effects of alcohol pricing and promotion policy options in various population subgroups. Methods We built an epidemiological mathematical model to appraise 18 pricing policies, with English data from the Expenditure and Food Survey and the General Household Survey for average and peak alcohol consumption. We used results from econometric analyses (256 own-price and cross-price elasticity estimates) to estimate effects of policies on alcohol consumption. We applied risk functions from systemic reviews and meta-analyses, or derived from attributable fractions, to model the effect of consumption changes on mortality and disease prevalence for 47 illnesses. Findings General price increases were effective for reduction of consumption, health-care costs, and health-related quality of life losses in all population subgroups. Minimum pricing policies can maintain this level of effectiveness for harmful drinkers while reducing effects on consumer spending for moderate drinkers. Total bans of supermarket and off-license discounting are effective but banning only large discounts has little effect. Young adult drinkers aged 18-24 years are especially affected by policies that raise prices in pubs and bars. Interpretation Minimum pricing policies and discounting restrictions might warrant further consideration because both strategies are estimated to reduce alcohol consumption, and related health harms and costs, with drinker spending increases targeting those who incur most harm.	[Purshouse, Robin C.] Univ Sheffield, Dept Automat Control & Syst Engn, Sheffield S1 3JD, S Yorkshire, England; [Meier, Petra S.; Brennan, Alan; Rafia, Rachid] Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 3JD, S Yorkshire, England; [Taylor, Karl B.] Univ Sheffield, Dept Econ, Sheffield S1 3JD, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Purshouse, RC (corresponding author), Univ Sheffield, Dept Automat Control & Syst Engn, Mappin St, Sheffield S1 3JD, S Yorkshire, England.	r.purshouse@sheffield.ac.uk	Meier, Petra/P-7504-2019; Meier, Petra S/L-7387-2017; Stockwell, Tim/B-6662-2012	Meier, Petra/0000-0001-5354-1933; Meier, Petra S/0000-0001-5354-1933; Brennan, Alan/0000-0002-1025-312X; Taylor, Karl/0000-0002-6525-0815; Purshouse, Robin/0000-0001-5880-1925	Policy Research Programme, UK Department of Health	Policy Research Programme, UK Department of Health	Policy Research Programme, UK Department of Health.; We thank Yang Meng for his work on the sensitivity analyses and the three anonymous reviewers for their valuable comments and suggestions. The original data creators, depositors, or copyright holders, the finders of the Data Collections (where different), and the UK Data Archive bear no responsibility for the analysis and interpretation of the General Household Survey and Expenditure and Food Survey data. This article shows results of independent research commissioned and funded by the Policy Research Programme in the UK Department of Health. The views expressed are those of the authors and not necessarily those of the Department.	Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; [Anonymous], 2008, PURCHASING POWER PAR; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Booth A, 2008, INDEPENDENT REV EF A; Brennan A, 2008, INDEPENDENT REV EF B; *CARD RES CONS, HLTH OUTC DAT REP; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; CLEMENS S, 2008, DRUG USE SMOKING DRI; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; *DEP HLTH SAF SENS, 2007, NEXT STEPS NAT ALC S; Department of Health, 2008, COST ALC HARM NHS EN; Department of Health, 2004, POL APPR HLTH; Doran C., 2008, IDENTIFYING COSTEFFE; English D.R., 1995, QUANTIFICATION DRUG; Gallet CA, 2007, AUST J AGR RESOUR EC, V51, P121, DOI 10.1111/j.1467-8489.2007.00365.x; GUNNINGSCHEPERS L, 1989, HEALTH POLICY, V12, P1; Gutjahr E, 2001, EUR ADDICT RES, V7, P117, DOI 10.1159/000050729; Hollingworth W, 2006, J STUD ALCOHOL, V67, P300, DOI 10.15288/jsa.2006.67.300; Kenkel DS, 2005, AM ECON REV, V95, P273, DOI 10.1257/000282805774670284; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Mortimer D, 2006, ALCOHOL ALCOHOLISM, V41, P92, DOI 10.1093/alcalc/agh224; *NIELS CO, ALC RET SAL DA UNPUB; Norstrom T, 2001, ADDICTION, V96, pS5, DOI 10.1080/09652140020021143; [North West Public Health Observatory Department of Health], 2008, HOSP ADM ALC REL HAR; *OFF NAT STAT, 2006, POP DAT 2006; *OFF NAT STAT DEP, 2008, EXP FOOD SURV 2006 C; *OFF NAT STAT SOC, 2006, GEN HOUS SURV 2006; Peele S, 2000, DRUG ALCOHOL DEPEN, V60, P221, DOI 10.1016/S0376-8716(00)00112-5; Rehm J, 2004, COMP QUANTIFICATION, P959; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Ridolfo B, 2001, QUANTIFICATION DRUG; Single E., 1996, COST SUBSTANCE ABUSE; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; Young DJ, 2002, NATL TAX J, V55, P57, DOI 10.17310/ntj.2002.1.04	36	171	171	0	43	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2010	375	9723					1355	1364		10.1016/S0140-6736(10)60058-X	http://dx.doi.org/10.1016/S0140-6736(10)60058-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	588GW	20338629				2022-12-24	WOS:000277057800026
J	Sedgwick, P				Sedgwick, Philip			Statistical Question Per protocol analysis	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Ctr Med & Healthcare Educ, London WC1E 7HU, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London WC1E 7HU, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Johansson K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4609; Sedgwick P, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1705	2	7	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2010	340								c1825	10.1136/bmj.c1825	http://dx.doi.org/10.1136/bmj.c1825			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	582ZF	20375086				2022-12-24	WOS:000276639400005
J	Wang, HP; Spencer, D; Fellous, JM; Sejnowski, TJ				Wang, Hsi-Ping; Spencer, Donald; Fellous, Jean-Marc; Sejnowski, Terrence J.			Synchrony of Thalamocortical Inputs Maximizes Cortical Reliability	SCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; PRIMARY VISUAL-CORTEX; NEOCORTICAL NEURONS; SPIKE TRAINS; FIRING RATE; INFORMATION; CAT; CELLS; INNERVATION; VARIABILITY	Thalamic inputs strongly drive neurons in the primary visual cortex, even though these neurons constitute only similar to 5% of the synapses on layer 4 spiny stellate simple cells. We modeled the feedforward excitatory and inhibitory inputs to these cells based on in vivo recordings in cats, and we found that the reliability of spike transmission increased steeply between 20 and 40 synchronous thalamic inputs in a time window of 5 milliseconds, when the reliability per spike was most energetically efficient. The optimal range of synchronous inputs was influenced by the balance of background excitation and inhibition in the cortex, which could gate the flow of information into the cortex. Ensuring reliable transmission by spike synchrony in small populations of neurons may be a general principle of cortical function.	[Wang, Hsi-Ping; Spencer, Donald; Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA; [Wang, Hsi-Ping; Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Fellous, Jean-Marc] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; [Fellous, Jean-Marc] Univ Arizona, Program Appl Math, Tucson, AZ 85721 USA	Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of Arizona; University of Arizona	Wang, HP (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA.	ping@salk.edu	Sejnowski, Terrence/AAV-5558-2021; Fellous, Jean-Marc/AAP-3117-2021		Howard Hughes Medical Institute; NSF Science of Learning Center [SBE-0542013]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF Science of Learning Center(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank P. Kara, P. Reinagel, and R. C. Reid for sharing in vivo recordings of simultaneously recorded retinal, thalamic, and cortical neurons. K. Martin provided invaluable anatomical data on thalamocortical connectivity. This research was supported by the Howard Hughes Medical Institute and the NSF Science of Learning Center SBE-0542013.	AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Chatterjee S, 2007, VISUAL NEUROSCI, V24, P827, DOI 10.1017/S0952523807070757; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; FREUND TF, 1985, J COMP NEUROL, V242, P263, DOI 10.1002/cne.902420208; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Kara P, 2003, J NEUROSCI, V23, P8547; Kumbhani RD, 2007, J NEUROPHYSIOL, V98, P2647, DOI 10.1152/jn.00900.2006; Lesica NA, 2007, NEURON, V55, P479, DOI 10.1016/j.neuron.2007.07.013; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; Reich DS, 2000, J NEUROSCI, V20, P1964; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schreiber S, 2003, NEUROCOMPUTING, V52-4, P925, DOI 10.1016/S0925-2312(02)00838-X; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Usrey WM, 2002, PHILOS T ROY SOC B, V357, P1729, DOI 10.1098/rstb.2002.1157; Usrey WM, 2002, CURR OPIN NEUROBIOL, V12, P411, DOI 10.1016/S0959-4388(02)00339-2; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; White E.L., 1989, CORTICAL CIRCUITS SY	30	101	101	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	2010	328	5974					106	109		10.1126/science.1183108	http://dx.doi.org/10.1126/science.1183108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360111	Green Accepted			2022-12-24	WOS:000276202200046
J	Kolokotrones, T; Savage, V; Deeds, EJ; Fontana, W				Kolokotrones, Tom; Savage, Van; Deeds, Eric J.; Fontana, Walter			Curvature in metabolic scaling	NATURE			English	Article							BODY-SIZE; ENERGY-METABOLISM; TEMPERATURE; POWER	For more than three-quarters of a century it has been assumed(1) that basal metabolic rate increases as body mass raised to some power p. However, there is no broad consensus regarding the value of p: whereas many studies have asserted that p is 3/4 (refs 1-4; 'Kleiber's law'), some have argued that it is 2/3 (refs 5-7), and others have found that it varies depending on factors like environment and taxonomy(6,8-16). Here we show that the relationship between mass and metabolic rate has convex curvature on a logarithmic scale, and is therefore not a pure power law, even after accounting for body temperature. This finding has several consequences. First, it provides an explanation for the puzzling variability in estimates of p, settling a long-standing debate. Second, it constitutes a stringent test for theories of metabolic scaling. A widely debated model(17) based on vascular system architecture fails this test, and we suggest modifications that could bring it into compliance with the observed curvature. Third, it raises the intriguing question of whether the scaling relation limits body size.	[Kolokotrones, Tom; Deeds, Eric J.; Fontana, Walter] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Savage, Van] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA	Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fontana, W (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	walter@hms.harvard.edu			NATIONAL INSTITUTE ON AGING [R01AG034994] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alberts B, 2002, MOL BIOL CELL; BARTELS H, 1982, EXP BIOL MED, V7, P1; Bokma F, 2004, FUNCT ECOL, V18, P184, DOI 10.1111/j.0269-8463.2004.00817.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Calder WAI., 1996, SIZE FUNCTION LIFE H; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; FELDMAN HA, 1983, RESP PHYSIOL, V52, P149, DOI 10.1016/0034-5687(83)90002-6; Gillooly JF, 2007, BIOL LETTERS, V3, P99, DOI 10.1098/rsbl.2006.0576; GLAZIER DS, 2009, BIOL REV CAMB PHIL S, V85, P111; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; HEUSNER AA, 1982, RESP PHYSIOL, V48, P1, DOI 10.1016/0034-5687(82)90046-9; HEUSNER AA, 1991, J EXP BIOL, V160, P25; HEUSNER AA, 1982, RESP PHYSIOL, V48, P13, DOI 10.1016/0034-5687(82)90047-0; KLEIBER MAX, 1932, HILGARDIA, V6, P315; LINDSTEDT SL, 1981, Q REV BIOL, V56, P1, DOI 10.1086/412080; Lovegrove BG, 2003, J COMP PHYSIOL B, V173, P87, DOI 10.1007/s00360-002-0309-5; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; McMahon T.A., 1983, SIZE LIFE; MCNAB BK, 1988, Q REV BIOL, V63, P25, DOI 10.1086/415715; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; ROBINSON WR, 1983, CAN J ZOOL, V61, P281, DOI 10.1139/z83-037; Savage VM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000171; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; SCHMIDTNIELSEN K, 1983, SCALING WHY IS ANIMA; Sieg AE, 2009, AM NAT, V174, P720, DOI 10.1086/606023; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378; White CR, 2009, EVOLUTION, V63, P2658, DOI 10.1111/j.1558-5646.2009.00747.x	30	247	252	1	118	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					753	756		10.1038/nature08920	http://dx.doi.org/10.1038/nature08920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20360740				2022-12-24	WOS:000276205000044
J	Petersen, KF; Dufour, S; Hariri, A; Nelson-Williams, C; Foo, JN; Zhang, XM; Dziura, J; Lifton, RP; Shulman, GI				Petersen, Kitt Falk; Dufour, Sylvie; Hariri, Ali; Nelson-Williams, Carol; Foo, Jia Nee; Zhang, Xian-Man; Dziura, James; Lifton, Richard P.; Shulman, Gerald I.			Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATIC INSULIN-RESISTANCE; DENSITY-LIPOPROTEIN RECEPTOR; CORONARY-ARTERY-DISEASE; METABOLIC SYNDROME; STEATOSIS; POLYMORPHISMS; BINDING; CIII; HYPERTRIGLYCERIDEMIA; CHYLOMICRONS	BACKGROUND Nonalcoholic fatty liver disease is associated with hepatic insulin resistance and type 2 diabetes mellitus. Whether this association has a genetic basis is unknown. METHODS In 95 healthy Asian Indian men, a group known to have a high prevalence of nonalcoholic fatty liver disease, we genotyped two single-nucleotide polymorphisms (SNPs) in the gene encoding apolipoprotein C3 (APOC3) that are known to be associated with hypertriglyceridemia (rs2854116 [T-455C] and rs2854117 [C-482T]). Plasma apolipoprotein C3 concentrations, insulin sensitivity, and hepatic triglyceride content were measured. We also measured plasma triglyceride concentrations and retinyl fatty acid ester absorption as well as plasma triglyceride clearance after oral and intravenous fat-tolerance tests. Liver triglyceride content and APOC3 genotypes were also assessed in a group of 163 healthy non-Asian Indian men. RESULTS Carriers of the APOC3 variant alleles (C-482T, T-455C, or both) had a 30% increase in the fasting plasma apolipoprotein C3 concentration, as compared with the wildtype homozygotes. They also had a 60% increase in the fasting plasma triglyceride concentration, an increase by a factor of approximately two in the plasma triglyceride and retinyl fatty acid ester concentrations after an oral fat-tolerance test, and a 46% reduction in plasma triglyceride clearance. The prevalence of nonalcoholic fatty liver disease was 38% among variant-allele carriers and 0% among wild-type homozygotes (P<0.001). The subjects with nonalcoholic fatty liver disease had marked insulin resistance. A validation study involving non-Asian Indian men confirmed the association between APOC3 variant alleles and nonalcoholic fatty liver disease. CONCLUSIONS The polymorphisms C-482T and T-455C in APOC3 are associated with nonalcoholic fatty liver disease and insulin resistance.	[Dufour, Sylvie; Lifton, Richard P.; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Petersen, Kitt Falk; Hariri, Ali; Zhang, Xian-Man; Dziura, James; Lifton, Richard P.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Nelson-Williams, Carol; Foo, Jia Nee; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University	Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, TAC S-269,POB 9812, New Haven, CT 06520 USA.	gerald.shulman@yale.edu	Volti, Giovanni Li/A-2435-2008; Valenti, Luca/B-3695-2009; Nobili, Valerio/K-8670-2018; Galvano, Fabio/F-8122-2010; Foo, Jia Nee/D-6069-2014; RICHART, CRISTOBAL C/S-9158-2017; Adiels, Martin/C-9278-2011; Shulman, Gerald I./P-7176-2019	Volti, Giovanni Li/0000-0002-8678-2183; Valenti, Luca/0000-0001-8909-0345; Galvano, Fabio/0000-0003-0644-0755; Foo, Jia Nee/0000-0001-9899-2308; RICHART, CRISTOBAL C/0000-0003-0852-6739; Shulman, Gerald I./0000-0003-1529-5668	U.S. Public Health Service [R01 AG-23686, R01 DK-49230, P01 DK-068229, P30 DK-45735, UL1 RR-024139]; American Diabetes Association; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049230, P01DK068229, R01DK040936, P30DK045735, R24DK085638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023686] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the U.S. Public Health Service (R01 AG-23686, R01 DK-49230, P01 DK-068229, P30 DK-45735, and UL1 RR-024139) and by Distinguished Clinical Scientist Awards from the American Diabetes Association ( to Dr. Petersen and Dr. Shulman).	BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Browning JD, 2006, HEPATOLOGY, V44, P466, DOI 10.1002/hep.21248; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; COOPER AD, 1985, GASTROENTEROLOGY, V88, P192, DOI 10.1016/S0016-5085(85)80155-4; Guettier JM, 2005, J CLIN ENDOCR METAB, V90, P1705, DOI 10.1210/jc.2004-1338; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; Li WW, 1995, J CLIN INVEST, V96, P2601, DOI 10.1172/JCI118324; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Miller M, 2007, ARCH MED RES, V38, P444, DOI 10.1016/j.arcmed.2006.10.013; NAGATA Y, 1988, J BIOL CHEM, V263, P15151; Olivieri O, 2003, J LIPID RES, V44, P2374, DOI 10.1194/jlr.M300253-JLR200; Olivieri O, 2002, J LIPID RES, V43, P1450, DOI 10.1194/jlr.M200145-JLR200; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; SHERRILL BC, 1978, J BIOL CHEM, V253, P1859; van Dijk KW, 2004, CURR OPIN LIPIDOL, V15, P239, DOI [10.1097/01.mol.00001300096.77252.1f, 10.1097/00041433-200406000-00002]; WEINTRAUB MS, 1987, J CLIN INVEST, V79, P1110, DOI 10.1172/JCI112926; WINDLER EET, 1988, BIOCHEM J, V252, P553, DOI 10.1042/bj2520553; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104	27	306	324	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1082	1089		10.1056/NEJMoa0907295	http://dx.doi.org/10.1056/NEJMoa0907295			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335584	Green Accepted			2022-12-24	WOS:000275894600005
J	Volkow, ND; Montaner, J				Volkow, Nora D.; Montaner, Julio			Enhanced HIV Testing, Treatment, and Support for HIV-Infected Substance Users	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACTIVE ANTIRETROVIRAL THERAPY; INJECTION-DRUG USERS; EPIDEMIC; CARE		[Volkow, Nora D.] NIDA, NIH, Bethesda, MD 20892 USA; [Montaner, Julio] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Montaner, Julio] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Montaner, Julio] Int AIDS Soc, Geneva, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); B.C. Centre for Excellence in HIV/AIDS; University of British Columbia	Volkow, ND (corresponding author), 6001 Execut Blvd,Room 5274,MSC 9581, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov	Montaner, Julio/K-7621-2012		NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182] Funding Source: NIH RePORTER; CIHR Funding Source: Medline; NIDA NIH HHS [DP1 DA026182] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); CIHR(Canadian Institutes of Health Research (CIHR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Bruce RD, 2007, INFECT DIS CLIN N AM, V21, P149, DOI 10.1016/j.idc.2007.03.009; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Lert F, 2007, INT J DRUG POLICY, V18, P255, DOI 10.1016/j.drugpo.2007.05.002; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; *SUBST AB MENT HLT, RES 2008 NAT SURV DR; Wood E, 2005, AIDS, V19, P1189, DOI 10.1097/01.aids.0000176219.48484.f1; Wood E, 2008, JAMA-J AM MED ASSOC, V300, P550, DOI 10.1001/jama.300.5.550; Wood E, 2006, DRUG ALCOHOL REV, V25, P451, DOI 10.1080/09595230600883313; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649	10	50	50	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2010	303	14					1423	1424		10.1001/jama.2010.421	http://dx.doi.org/10.1001/jama.2010.421			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582KX	20388900	Green Accepted			2022-12-24	WOS:000276597300029
J	Silveira, MJ; Kim, SYH; Langa, KM				Silveira, Maria J.; Kim, Scott Y. H.; Langa, Kenneth M.			Advance Directives and Outcomes of Surrogate Decision Making before Death.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OF-LIFE CARE; CRITICALLY-ILL; LIVING WILL; END; HEALTH; PLACE	Background: Recent discussions about health care reform have raised questions regarding the value of advance directives. Methods: We used data from survey proxies in the Health and Retirement Study involving adults 60 years of age or older who had died between 2000 and 2006 to determine the prevalence of the need for decision making and lost decision-making capacity and to test the association between preferences documented in advance directives and outcomes of surrogate decision making. Results: Of 3746 subjects, 42.5% required decision making, of whom 70.3% lacked decision-making capacity and 67.6% of those subjects, in turn, had advance directives. Subjects who had living wills were more likely to want limited care (92.7%) or comfort care (96.2%) than all care possible (1.9%); 83.2% of subjects who requested limited care and 97.1% of subjects who requested comfort care received care consistent with their preferences. Among the 10 subjects who requested all care possible, only 5 received it; however, subjects who requested all care possible were far more likely to receive aggressive care as compared with those who did not request it (adjusted odds ratio, 22.62; 95% confidence interval [CI], 4.45 to 115.00). Subjects with living wills were less likely to receive all care possible (adjusted odds ratio, 0.33; 95% CI, 0.19 to 0.56) than were subjects without living wills. Subjects who had assigned a durable power of attorney for health care were less likely to die in a hospital (adjusted odds ratio, 0.72; 95% CI, 0.55 to 0.93) or receive all care possible (adjusted odds ratio, 0.54; 95% CI, 0.34 to 0.86) than were subjects who had not assigned a durable power of attorney for health care. Conclusions: Between 2000 and 2006, many elderly Americans needed decision making near the end of life at a time when most lacked the capacity to make decisions. Patients who had prepared advance directives received care that was strongly associated with their preferences. These findings support the continued use of advance directives. N Engl J Med 2010;362:1211-8.	[Silveira, Maria J.; Langa, Kenneth M.] Univ Michigan, Vet Affairs Ctr Clin Management Res, Ann Arbor, MI 48109 USA; [Silveira, Maria J.; Langa, Kenneth M.] Univ Michigan, Div Gen Med, Ann Arbor, MI 48109 USA; [Silveira, Maria J.; Kim, Scott Y. H.] Univ Michigan, Bioeth Program, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Kim, Scott Y. H.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Kim, Scott Y. H.] Univ Michigan, Ctr Behav & Decis Sci Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Silveira, MJ (corresponding author), 300 N Ingalls Bldg,Rm 7C27,Box 5429, Ann Arbor, MI 48901 USA.	mariajs@umich.edu		Silveira, Maria/0000-0002-6600-8633; Langa, Kenneth/0000-0002-2798-1836	Ann Arbor Veterans Affairs Center for Clinical Management Research; Division of General Medicine at the University of Michigan; National Institute on Aging [R01 AG027010, U01 AG09740]; Greenwall Faculty Scholarship in Bioethics; NATIONAL INSTITUTE ON AGING [U01AG009740, R01AG027010] Funding Source: NIH RePORTER	Ann Arbor Veterans Affairs Center for Clinical Management Research; Division of General Medicine at the University of Michigan; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Greenwall Faculty Scholarship in Bioethics; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by core funds from the Ann Arbor Veterans Affairs Center for Clinical Management Research and the Division of General Medicine at the University of Michigan (to Dr. Silveira); a grant (R01 AG027010) from the National Institute on Aging and a Paul Beeson Physician Faculty Scholars in Aging Research award (to Dr. Langa); a grant (U01 AG09740) from the National Institute on Aging for the Health and Retirement Study, which was performed at the Survey Research Center, Institute for Social Research, University of Michigan; and a Greenwall Faculty Scholarship in Bioethics (to Dr. Kim).	Brown Barbara A, 2003, J Gerontol Nurs, V29, P4; DANIS M, 1991, NEW ENGL J MED, V324, P882, DOI 10.1056/NEJM199103283241304; Degenholtz HB, 2004, ANN INTERN MED, V141, P113, DOI 10.7326/0003-4819-141-2-200407200-00009; EDINGER W, 1992, J FAM PRACTICE, V35, P650; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Goodman MD, 1998, CRIT CARE MED, V26, P701, DOI 10.1097/00003246-199804000-00018; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; LO B, 1985, ARCH INTERN MED, V145, P1115, DOI 10.1001/archinte.145.6.1115; O'Brien M, 2009, HILL            0813; SCHNEIDERMAN LJ, 1992, ANN INTERN MED, V117, P599, DOI 10.7326/0003-4819-117-7-599; SEHGAL A, 1992, JAMA-J AM MED ASSOC, V267, P59, DOI 10.1001/jama.267.1.59; SMEDIRA NG, 1990, NEW ENGL J MED, V322, P309, DOI 10.1056/NEJM199002013220506; Smucker W D, 1993, J Am Board Fam Pract, V6, P473; Soldo BJ, 1997, J GERONTOL B-PSYCHOL, V52, P1, DOI 10.1093/geronb/52B.Special_Issue.1; Steinhauser KE, 2001, J PAIN SYMPTOM MANAG, V22, P727, DOI 10.1016/S0885-3924(01)00334-7; TENO JM, 1994, J CLIN ETHIC, V5, P23; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno JM, 2007, J AM GERIATR SOC, V55, P189, DOI 10.1111/j.1532-5415.2007.01045.x	18	841	859	3	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13					1211	1218		10.1056/NEJMsa0907901	http://dx.doi.org/10.1056/NEJMsa0907901			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	577QQ	20357283	Green Accepted			2022-12-24	WOS:000276239500011
J	Gotzsche, PC; Berg, S				Gotzsche, Peter C.; Berg, Soren			A Patient's Journey Sleep apnoea: from person to patient, and back again	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADULTS		[Berg, Soren] ScanSleep, DK-1364 Copenhagen, Denmark			pcg@cochrane.dk						Blennerhassett M., 2008, NOTHING PERSONAL DIS; Elshaug AG, 2008, BMJ-BRIT MED J, V336, P44, DOI 10.1136/bmj.39381.509213.AE; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; Sundaram S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001004.pub2; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2010	340								c360	10.1136/bmj.c360	http://dx.doi.org/10.1136/bmj.c360			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579VJ	20354019				2022-12-24	WOS:000276404100024
J	Povolotskaya, IS; Kondrashov, FA				Povolotskaya, Inna S.; Kondrashov, Fyodor A.			Sequence space and the ongoing expansion of the protein universe	NATURE			English	Article							AMINO-ACID GAIN; COMMON ANCESTOR; MAXIMUM-LIKELIHOOD; GENOME EVOLUTION; SELECTION; PERSPECTIVE; PROKARYOTES; TOLERANCE; EPISTASIS; ALIGNMENT	The need to maintain the structural and functional integrity of an evolving protein severely restricts the repertoire of acceptable amino-acid substitutions(1-4). However, it is not known whether these restrictions impose a global limit on how far homologous protein sequences can diverge from each other. Here we explore the limits of protein evolution using sequence divergence data. We formulate a computational approach to study the rate of divergence of distant protein sequences and measure this rate for ancient proteins, those that were present in the last universal common ancestor. We show that ancient proteins are still diverging from each other, indicating an ongoing expansion of the protein sequence universe. The slow rate of this divergence is imposed by the sparseness of functional protein sequences in sequence space and the ruggedness of the protein fitness landscape: similar to 98 per cent of sites cannot accept an amino-acid substitution at any given moment but a vast majority of all sites may eventually be permitted to evolve when other, compensatory, changes occur. Thus, similar to 3.5 x 10(9) yr has not been enough to reach the limit of divergent evolution of proteins, and for most proteins the limit of sequence similarity imposed by common function may not exceed that of random sequences.	[Povolotskaya, Inna S.; Kondrashov, Fyodor A.] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Kondrashov, FA (corresponding author), Ctr Genom Regulat, Bioinformat & Genom Programme, Calle Dr Aiguader 88,Barcelona Biomed Res Pk Bldg, Barcelona 08003, Spain.	fyodor.kondrashov@crg.es	Kondrashov, Fyodor Alexeevich/H-6331-2015	Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694; Povolotskaya, Inna/0000-0001-6621-232X				Aravind L, 2002, CURR OPIN STRUC BIOL, V12, P392, DOI 10.1016/S0959-440X(02)00334-2; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Camps M, 2007, CRIT REV BIOCHEM MOL, V42, P313, DOI 10.1080/10409230701597642; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P14132, DOI 10.1073/pnas.202497999; Doolittle WF, 2000, CURR OPIN STRUC BIOL, V10, P355, DOI 10.1016/S0959-440X(00)00096-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GOLDING B, 1990, J MOL EVOL, V31, P511, DOI 10.1007/BF02102078; Goldstein RA, 2006, MOL BIOL EVOL, V23, P1444, DOI 10.1093/molbev/msl010; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Guzzo L, 2008, NATURE, V451, P541, DOI 10.1038/nature06555; Heger A, 2000, PROG BIOPHYS MOL BIO, V73, P321, DOI 10.1016/S0079-6107(00)00013-4; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; Hubble E, 1929, P NATL ACAD SCI USA, V15, P168, DOI 10.1073/pnas.15.3.168; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; Kondrashov AS, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-5; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Kondrashov FA, 2001, P NATL ACAD SCI USA, V98, P12089, DOI 10.1073/pnas.211214298; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; Mirkin BG, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-2; Novichkov PS, 2009, NUCLEIC ACIDS RES, V37, pD448, DOI 10.1093/nar/gkn684; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Ranea JAG, 2006, J MOL EVOL, V63, P513, DOI 10.1007/s00239-005-0289-7; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Taylor SV, 2001, P NATL ACAD SCI USA, V98, P10596, DOI 10.1073/pnas.191159298; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	36	141	144	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					922	U7		10.1038/nature09105	http://dx.doi.org/10.1038/nature09105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20485343				2022-12-24	WOS:000278804500037
J	McGrew, WC				McGrew, William C.			Chimpanzee Technology	SCIENCE			English	Editorial Material							SAVANNA CHIMPANZEES; TOOLS		Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England	University of Cambridge	McGrew, WC (corresponding author), Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England.	wcm21@cam.ac.uk						Boesch C, 2009, J HUM EVOL, V56, P560, DOI 10.1016/j.jhevol.2009.04.001; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; Carvalho S, 2009, ANIM COGN, V12, pS103, DOI 10.1007/s10071-009-0271-7; Fowler A, 2007, INT J PRIMATOL, V28, P997, DOI 10.1007/s10764-007-9166-0; GOODALL J, 1964, NATURE, V201, P1264, DOI 10.1038/2011264a0; Haslam M, 2009, NATURE, V460, P339, DOI 10.1038/nature08188; Hernandez-Aguilar RA, 2007, P NATL ACAD SCI USA, V104, P19210, DOI 10.1073/pnas.0707929104; Koops K, 2010, PRIMATES, V51, P175, DOI 10.1007/s10329-009-0178-6; Matsuzawa T, 2009, ANIM COGN, V12, pS1, DOI 10.1007/s10071-009-0277-1; McGrew William, 2004, CULTURED CHIMPANZEE; Mercader J, 2007, P NATL ACAD SCI USA, V104, P3043, DOI 10.1073/pnas.0607909104; Nishida T, 2009, PRIMATES, V50, P23, DOI 10.1007/s10329-008-0109-y; PETERSON D, 2006, J GOODALL WOMAN REDE, P212; Pruetz JD, 2007, CURR BIOL, V17, P412, DOI 10.1016/j.cub.2006.12.042; Sanz CM, 2007, J HUM EVOL, V52, P420, DOI 10.1016/j.jhevol.2006.11.001; Sousa C, 2009, ANIM COGN, V12, pS115, DOI 10.1007/s10071-009-0278-0; Stewart FA, 2007, AM J PRIMATOL, V69, P930, DOI 10.1002/ajp.20432; Watts DP, 2008, INT J PRIMATOL, V29, P83, DOI 10.1007/s10764-007-9227-4	18	65	67	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					579	580		10.1126/science.1187921	http://dx.doi.org/10.1126/science.1187921			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431004				2022-12-24	WOS:000277159800029
J	Frost, PJ; Leadbeatter, S; Wise, MP				Frost, Paul J.; Leadbeatter, Stephen; Wise, Matt P.			The Competent Novice Managing sudden death in hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LIFE CARE; CERTIFICATION; MEDICINE; AUDIT; NEWS; END; BAD		[Frost, Paul J.; Wise, Matt P.] Univ Wales Hosp, Crit Care Directorate, Cardiff CF14 4XW, Wales; [Frost, Paul J.] Cardiff Univ, Schoool Med, Univ Wales Hosp, Cardiff, Wales; [Leadbeatter, Stephen] Univ Wales Hosp, Dept Med Genet Pathol & Haematol, Cardiff CF14 4XW, Wales	Cardiff University; Cardiff University; Cardiff University	Frost, PJ (corresponding author), Univ Wales Hosp, Crit Care Directorate, Cardiff CF14 4XW, Wales.	Paul.Frost@CardiffandVale.Wales.nhs.uk		Wise, Matt/0000-0002-2763-4316				Academy of Medical Royal Colleges, 2008, COD PRACT DIAGN CONF; AWOONORRENNER S, 1991, BRIT MED J, V302, P356, DOI 10.1136/bmj.302.6772.356; Baker JN, 2007, J PALLIAT MED, V10, P420, DOI 10.1089/jpm.2006.0135; Cave J, 2008, BRIT MED J, V336, P326, DOI 10.1136/bmj.39455.639340.AD; Department of Health, 2005, PAT DIES ADV DEV BER; Edmonds P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5048; Ellershaw J, 2007, PALLIATIVE MED, V21, P365, DOI 10.1177/0269216307081117; Fallowfield L, 2004, LANCET, V363, P312, DOI 10.1016/S0140-6736(03)15392-5; *HOSP EP STAT, 2009, HEADL FIG 2008 9; Iversen A, 2009, BMJ-BRIT MED J, V338, P1139; JAMES DS, 1995, J ROY COLL PHYS LOND, V29, P424; Jurkovich GJ, 2000, J TRAUMA, V48, P865, DOI 10.1097/00005373-200005000-00009; LEADBEATTER S, 1986, J ROY COLL PHYS LOND, V20, P273; LEADBEATTER S, 1986, J ROY COLL PHYS LOND, V20, P129; LEASH RM, 1994, DEATH NOTIFICATION; Lserson KV, 2000, ANN EMERG MED, V36, P75, DOI 10.1067/mem.2000.107664; *M CUR PALL CAR I, LIV LIV CAR PATHW 20; Moores TS, 2007, MED EDUC, V41, P942, DOI 10.1111/j.1365-2923.2007.02836.x; National Council for Hospice and Specialist Palliative Care Services, 2003, BREAK BAD NEWS REG G; NEVILLE RG, 1987, J ROY COLL GEN PRACT, V37, P496; Office for National Statistics, MORT STAT DEATHS REG; Redinbaugh EM, 2003, BMJ-BRIT MED J, V327, P185, DOI 10.1136/bmj.327.7408.185; Selinger CP, 2007, POSTGRAD MED J, V83, P285, DOI 10.1136/pgmj.2006.054833; Swift B, 2002, J CLIN PATHOL, V55, P275, DOI 10.1136/jcp.55.4.275; Treloar AJ, 2008, BRIT MED J, V336, P905, DOI 10.1136/bmj.39556.400370.80; *UK TRANSPL, 2003, UK HOSP POL ORG TISS	26	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2010	340								c962	10.1136/bmj.c962	http://dx.doi.org/10.1136/bmj.c962			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586JZ	20388691				2022-12-24	WOS:000276904800021
J	Nathan, C; Ding, AH				Nathan, Carl; Ding, Aihao			SnapShot: Reactive Oxygen Intermediates (ROI)	CELL			English	Editorial Material									[Nathan, Carl; Ding, Aihao] Weill Cornell Med Coll, New York, NY 10065 USA	Cornell University	Nathan, C (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.							Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016	6	158	169	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6							952.e1	10.1016/j.cell.2010.03.008	http://dx.doi.org/10.1016/j.cell.2010.03.008			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303882	Bronze			2022-12-24	WOS:000275746600016
J	Levesque, LE; Hanley, JA; Kezouh, A; Suissa, S				Levesque, Linda E.; Hanley, James A.; Kezouh, Abbas; Suissa, Samy			Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes	BRITISH MEDICAL JOURNAL			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MYOCARDIAL-INFARCTION; ELDERLY PATIENTS; INHALED CORTICOSTEROIDS; RISK; MORTALITY; INHIBITORS; ADHERENCE; SURVIVAL; USERS		[Levesque, Linda E.; Hanley, James A.; Suissa, Samy] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Levesque, Linda E.] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada; [Levesque, Linda E.] Kingston Frontenac Lennox & Addington Publ Hlth, Kingston, ON, Canada; [Hanley, James A.; Kezouh, Abbas; Suissa, Samy] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada	McGill University; Queens University - Canada; McGill University	Levesque, LE (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	linda.levesque@queensu.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Breslow NL, 1987, STAT METHODS CANC RE, VII, P178; COX DR, 1972, J R STAT SOC B, V187, P220; Downey W, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P295; Ellis JJ, 2004, J GEN INTERN MED, V19, P638, DOI 10.1111/j.1525-1497.2004.30516.x; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jackevicius CA, 2008, CIRCULATION, V117, P1028, DOI 10.1161/CIRCULATIONAHA.107.706820; KLEINBAUM DG, 1998, APPL REGRESSION ANAL, P687; Levesque LE, 2005, ANN INTERN MED, V142, P481, DOI 10.7326/0003-4819-142-7-200504050-00113; Levesque LE, 2006, CAN MED ASSOC J, V174, P1563, DOI 10.1503/cmaj.051679; LIDDELL FDK, 1977, J R STAT SOC A STAT, V140, P469, DOI 10.2307/2345280; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Rothman K., 1998, MODERN EPIDEMIOLOGY, P79; Schade R, 2007, NEW ENGL J MED, V356, P29, DOI 10.1056/NEJMoa062222; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Sheehy O, 2008, CAN MED ASSOC J, V178, P413, DOI 10.1503/cmaj.070586; Sin DD, 2002, AM J MED, V113, P650, DOI 10.1016/S0002-9343(02)01346-3; Sin DD, 2001, AM J RESP CRIT CARE, V164, P580, DOI 10.1164/ajrccm.164.4.2009033; Soriano JB, 2002, EUR RESPIR J, V20, P819, DOI 10.1183/09031936.02.00301302; Strom BL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P17; Suissa S, 2004, EUR RESPIR J, V23, P391, DOI 10.1183/09031936.04.00062504; Suissa S, 2003, AM J RESP CRIT CARE, V168, P49, DOI 10.1164/rccm.200210-1231OC; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Suissa S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P811; Suissa S, 2007, PHARMACOEPIDEM DR S, V16, P241, DOI 10.1002/pds.1357; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G; Yee A, 2004, DIABETIC MED, V21, P962, DOI 10.1111/j.1464-5491.2004.01263.x; Zhou Z, 2005, AM J EPIDEMIOL, V162, P1016, DOI 10.1093/aje/kwi307; 2004, DIABETES CARE S1, V27, pS15	31	579	579	1	32	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 12	2010	340								b5087	10.1136/bmj.b5087	http://dx.doi.org/10.1136/bmj.b5087			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570FF	20228141				2022-12-24	WOS:000275657000001
J	Akugizibwe, P; Ramakant, B				Akugizibwe, Paula; Ramakant, Bobby			Challenges for community role in tuberculosis response	LANCET			English	Editorial Material									[Akugizibwe, Paula] AIDS & Rights Alliance So Africa, Cape Town, South Africa; [Ramakant, Bobby] Stop TB Citizen News Serv, Lucknow, Uttar Pradesh, India		Akugizibwe, P (corresponding author), AIDS & Rights Alliance So Africa, Cape Town, South Africa.	paula@arasa.info						DONNELLY J, 2009, AIRBORNE JOURNEY CHA; Garner P, 2007, B WORLD HEALTH ORGAN, V85, P404, DOI 10.2471/BLT.06.035568; Geffen N, 2008, S AFR J HIV MED, P12; Hadley M, 2000, INT J TUBERC LUNG D, V4, P401; *HEALTHDEV NET, 2009, NEW DELH NEW IN IMPR; *STOP TB DEP, 2003, COMM PART TB CAR PRA; *STOP TB PARTN, 2008, TB HIV COMM MOB TB H; Tuberculosis Coalition for Technical Assistance, 2006, INT STAND TUB CAR; *WORLD CAR COUNC, 2010, PATIENTS CHARTER TUB; World Health Organization, 2006, STOP TB STRAT BUILD; World Health Organization, 2009, GLOB TUB CONTR EP ST	11	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 12	2010	375	9731					2059	2061		10.1016/S0140-6736(10)60581-8	http://dx.doi.org/10.1016/S0140-6736(10)60581-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614OK	20488520				2022-12-24	WOS:000279069300008
J	Schmidt, BH; Burgin, AB; Deweese, JE; Osheroff, N; Berger, JM				Schmidt, Bryan H.; Burgin, Alex B.; Deweese, Joseph E.; Osheroff, Neil; Berger, James M.			A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases	NATURE			English	Article							SINGLE-STRANDED-DNA; CRYSTAL-STRUCTURE; ACTIVE-SITE; RELIGATION REACTION; PURIFICATION; SUBSTRATE; DOMAIN; COMPLEXES; CATALYSIS; TRANSPORT	Type II topoisomerases are required for the management of DNA tangles and supercoils(1), and are targets of clinical antibiotics and anticancer agents(2). These enzymes catalyse the ATP-dependent passage of one DNA duplex (the transport or T-segment) through a transient, double-stranded break in another (the gate or G-segment), navigating DNA through the protein using a set of dissociable internal interfaces, or 'gates'(3,4). For more than 20 years, it has been established that a pair of dimer-related tyrosines, together with divalent cations, catalyse G-segment cleavage(5-7). Recent efforts have proposed that strand scission relies on a 'two-metal mechanism'(8-10), a ubiquitous biochemical strategy that supports vital cellular processes ranging from DNA synthesis to RNA self-splicing(11,12). Here we present the structure of the DNA-binding and cleavage core of Saccharomyces cerevisiae topoisomerase II covalently linked to DNA through its active-site tyrosine at 2.5 angstrom resolution, revealing for the first time the organization of a cleavage-competent type II topoisomerase configuration. Unexpectedly, metal-soaking experiments indicate that cleavage is catalysed by a novel variation of the classic two-metal approach. Comparative analyses extend this scheme to explain how distantly-related type IA topoisomerases cleave single-stranded DNA, unifying the cleavage mechanisms for these two essential enzyme families. The structure also highlights a hitherto undiscovered allosteric relay that actuates a molecular 'trapdoor' to prevent subunit dissociation during cleavage. This connection illustrates how an indispensable chromosome-disentangling machine auto-regulates DNA breakage to prevent the aberrant formation of mutagenic and cytotoxic genomic lesions.	[Schmidt, Bryan H.; Berger, James M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Burgin, Alex B.] Emerald BioStruct, Bainbridge Isl, WA 98110 USA; [Deweese, Joseph E.; Osheroff, Neil] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Osheroff, Neil] Vanderbilt Univ, Dept Med Hematol Oncol, Sch Med, Nashville, TN 37232 USA	University of California System; University of California Berkeley; Vanderbilt University; Vanderbilt University	Berger, JM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	jmberger@berkeley.edu		Thurtle-Schmidt, Bryan/0000-0002-0509-0987; Deweese, Joseph/0000-0001-9683-6723	NIH [GM033944, GM053960, T32CA09592, GM08295, CA077373]; NATIONAL CANCER INSTITUTE [R01CA077373, T32CA009592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008295, R01GM033944] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported the NIH (GM033944 and GM053960 for N.O.; T32CA09592 for J.E.D.; GM08295 for B. H. S. and CA077373 for J.M.B.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Berger JM, 1998, P NATL ACAD SCI USA, V95, P7876, DOI 10.1073/pnas.95.14.7876; BURGIN AB, 1995, NUCLEIC ACIDS RES, V23, P2973, DOI 10.1093/nar/23.15.2973; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Cheng BK, 2009, J MOL BIOL, V385, P558, DOI 10.1016/j.jmb.2008.10.073; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deweese JE, 2008, BIOCHEMISTRY-US, V47, P4129, DOI 10.1021/bi702194x; Deweese JE, 2009, BIOCHEMISTRY-US, V48, P8940, DOI 10.1021/bi900875c; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; DOMANICO PL, 1991, J INORG BIOCHEM, V42, P87, DOI 10.1016/0162-0134(91)80035-G; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fass D, 1999, NAT STRUCT BIOL, V6, P322; GOTO T, 1984, J BIOL CHEM, V259, P422; GOTO T, 1982, J BIOL CHEM, V257, P5866; Liu QY, 1998, J BIOL CHEM, V273, P20252, DOI 10.1074/jbc.273.32.20252; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; Noble CG, 2002, J MOL BIOL, V318, P361, DOI 10.1016/S0022-2836(02)00049-9; Nowotny M, 2006, EMBO J, V25, P1924, DOI 10.1038/sj.emboj.7601076; Okada Y, 2000, J BIOL CHEM, V275, P24630, DOI 10.1074/jbc.M003243200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Sabbagh G, 2004, NUCLEIC ACIDS RES, V32, P495, DOI 10.1093/nar/gkh189; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Strahs D, 2006, NUCLEIC ACIDS RES, V34, P1785, DOI 10.1093/nar/gkl109; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Wang J, 1996, BIOCHEMISTRY-US, V35, P8110, DOI 10.1021/bi960178r; West KL, 2000, BIOCHEMISTRY-US, V39, P1223, DOI 10.1021/bi991328b; WORLAND ST, 1989, J BIOL CHEM, V264, P4412; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; ZECHIEDRICH EL, 1989, BIOCHEMISTRY-US, V28, P6229, DOI 10.1021/bi00441a014	41	117	119	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					641	U139		10.1038/nature08974	http://dx.doi.org/10.1038/nature08974			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20485342	Green Accepted			2022-12-24	WOS:000278249000047
J	Marteyn, B; West, NP; Browning, DF; Cole, JA; Shaw, JG; Palm, F; Mounier, J; Prevost, MC; Sansonetti, P; Tang, CM				Marteyn, Benoit; West, Nicholas P.; Browning, Douglas F.; Cole, Jeffery A.; Shaw, Jonathan G.; Palm, Fredrik; Mounier, Joelle; Prevost, Marie-Christine; Sansonetti, Philippe; Tang, Christoph M.			Modulation of Shigella virulence in response to available oxygen in vivo	NATURE			English	Article							III SECRETION MACHINERY; ESCHERICHIA-COLI K-12; CHROMOSOMAL GENES; FLEXNERI; PROTEINS; EXPRESSION; INVASION; CELLS; IPAC; CONSTRUCTION	Bacteria coordinate expression of virulence determinants in response to localized microenvironments in their hosts. Here we show that Shigella flexneri, which causes dysentery, encounters varying oxygen concentrations in the gastrointestinal tract, which govern activity of its type three secretion system (T3SS). The T3SS is essential for cell invasion and virulence(1). In anaerobic environments (for example, the gastrointestinal tract lumen), Shigella is primed for invasion and expresses extended T3SS needles while reducing Ipa (invasion plasmid antigen) effector secretion. This is mediated by FNR (fumarate and nitrate reduction), a regulator of anaerobic metabolism that represses transcription of spa32 and spa33, virulence genes that regulate secretion through the T3SS. We demonstrate there is a zone of relative oxygenation adjacent to the gastrointestinal tract mucosa, caused by diffusion from the capillary network at the tips of villi. This would reverse the anaerobic block of Ipa secretion, allowing T3SS activation at its precise site of action, enhancing invasion and virulence.	[Marteyn, Benoit; West, Nicholas P.; Tang, Christoph M.] Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Browning, Douglas F.; Cole, Jeffery A.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Shaw, Jonathan G.] Univ Sheffield, Sch Med, Div Genom Med, Sheffield S10 2RX, S Yorkshire, England; [Palm, Fredrik] Uppsala Univ, Biomed Ctr, Dept Med Cell Biol, S-75123 Uppsala, Sweden; [Mounier, Joelle; Sansonetti, Philippe] Inst Pasteur, INSERM, U786, F-75724 Paris 15, France; [Mounier, Joelle; Sansonetti, Philippe] Inst Pasteur, Unite Pathogenie Microbienne Mol, F-75724 Paris 15, France; [Sansonetti, Philippe] Coll France, F-75231 Paris 05, France	Imperial College London; University of Birmingham; University of Sheffield; Uppsala University; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France	Tang, CM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, Ctr Mol Microbiol & Infect, Flowers Bldg, London SW7 2AZ, England.	psanson@pasteur.fr; c.tang@imperial.ac.uk	Marteyn, Benoit S/M-3763-2017; West, Nicholas P/C-3119-2008	West, Nicholas P/0000-0003-0955-9890; Marteyn, Benoit/0000-0001-5638-702X; Browning, Douglas/0000-0003-4672-3514	Fondation pour la Recherche Medicale; Royal Society; ERC; European Union [QLRT-1999-00938]; Wellcome Trust; Medical Research Council	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Royal Society(Royal Society of London); ERC(European Research Council (ERC)European Commission); European Union(European Commission); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Fondation pour la Recherche Medicale, the Royal Society, an ERC Advanced Grant (HOMEOEPITH), and the European Union (QLRT-1999-00938). Work in CMT's laboratory is supported by the Wellcome Trust and The Medical Research Council, and PJS is a Howard Hughes Medical Institute scholar. Imaging was performed at the PFID station (Institut Pasteur). We are grateful to J. Green for the anti-FNR pAbs and advice. R. Exley, D. Holden and K. Ray provided suggestions and reviewed the manuscript; we thank M.-A. Nicola for technical help.	Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; Becker S, 1996, J BACTERIOL, V178, P4515, DOI 10.1128/jb.178.15.4515-4521.1996; Browning DF, 2002, MOL MICROBIOL, V43, P687, DOI 10.1046/j.1365-2958.2002.02776.x; d'Hauteville H, 2002, J IMMUNOL, V168, P5240, DOI 10.4049/jimmunol.168.10.5240; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Exley RM, 2005, J EXP MED, V201, P1637, DOI 10.1084/jem.20041548; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; GHISLA S, 1978, P NATL ACAD SCI USA, V75, P5860, DOI 10.1073/pnas.75.12.5860; Hansen MC, 2001, MICROBIOL-SGM, V147, P1383, DOI 10.1099/00221287-147-5-1383; HOITINK CWG, 1990, GENE, V90, P15, DOI 10.1016/0378-1119(90)90434-S; Jaumouille V, 2008, EMBO J, V27, P447, DOI 10.1038/sj.emboj.7601976; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Liss P, 1997, PFLUG ARCH EUR J PHY, V434, P705, DOI 10.1007/s004240050455; Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002; Marti MA, 2006, J INORG BIOCHEM, V100, P761, DOI 10.1016/j.jinorgbio.2005.12.009; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Melican K, 2008, CELL MICROBIOL, V10, P1987, DOI 10.1111/j.1462-5822.2008.01182.x; MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7; Miller JH., 1972, EXPT MOL GENETICS; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; PHALIPON A, 1992, INFECT IMMUN, V60, P1919, DOI 10.1128/IAI.60.5.1919-1926.1992; Phalipon A, 2007, IMMUNOL CELL BIOL, V85, P119, DOI 10.1038/sj.icb7100025; PODKOVYROV SM, 1995, GENE, V156, P151, DOI 10.1016/0378-1119(95)00053-9; SANSONETTI PJ, 1983, INFECT IMMUN, V39, P1392, DOI 10.1128/IAI.39.3.1392-1402.1983; SASAKAWA C, 1993, J BACTERIOL, V175, P2334, DOI 10.1128/JB.175.8.2334-2346.1993; Schuch R, 2001, INFECT IMMUN, V69, P2180, DOI 10.1128/IAI.69.4.2180-2189.2001; Takahashi E, 2006, AM J PHYSIOL-CELL PH, V291, pC781, DOI 10.1152/ajpcell.00067.2006; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002; Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876; TOBE T, 1991, MOL MICROBIOL, V5, P887, DOI 10.1111/j.1365-2958.1991.tb00762.x; TORRES IP, 1994, P NATL ACAD SCI USA, V91, P2081, DOI 10.1073/pnas.91.6.2081; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472	35	232	236	0	56	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2010	465	7296					355	U113		10.1038/nature08970	http://dx.doi.org/10.1038/nature08970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20436458	Green Accepted			2022-12-24	WOS:000277829200042
J	Matyas, C				Matyas, Csaba			Forecasts needed for retreating forests	NATURE			English	Editorial Material									[Matyas, Csaba] Univ W Hungary, Focus Res Ctr Nonboreal Eastern Europe, Inst Environm & Earth Sci, H-9401 Sopron, Hungary; [Matyas, Csaba] Univ W Hungary, Focus Res Ctr Nonboreal Eastern Europe, No Eurasian Earth Sci Partnership Initiat, H-9401 Sopron, Hungary	University of West Hungary; University of West Hungary	Matyas, C (corresponding author), Univ W Hungary, Focus Res Ctr Nonboreal Eastern Europe, Inst Environm & Earth Sci, H-9401 Sopron, Hungary.	cm@emk.nyme.hu							0	82	87	3	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 29	2010	464	7293					1271	1271		10.1038/4641271a	http://dx.doi.org/10.1038/4641271a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428144	Bronze			2022-12-24	WOS:000277149000018
J	Yeh, JM; Nekhlyudov, L; Goldie, SJ; Mertens, AC; Diller, L				Yeh, Jennifer M.; Nekhlyudov, Larissa; Goldie, Sue J.; Mertens, Ann C.; Diller, Lisa			A Model-Based Estimate of Cumulative Excess Mortality in Survivors of Childhood Cancer	ANNALS OF INTERNAL MEDICINE			English	Article							LONG-TERM SURVIVORS; 5-YEAR SURVIVORS; ADOLESCENT CANCER; DEATH; OUTCOMES; COHORT	Background: Although childhood cancer survival rates have dramatically increased, survivors face elevated risk for life-threatening late effects, including secondary cancer. Objective: To estimate the cumulative effect of disease-and treatment-related mortality risks on survivor life expectancy. Design: State-transition model to simulate the lifetime clinical course of childhood cancer survivors. Setting: Childhood Cancer Survivor Study. Patients: Five-year survivors of childhood cancer. Measurements: Probabilities of risk for death from the original cancer diagnosis, excess mortality from subsequent cancer and cardiac, pulmonary, external, and other complications, and background mortality (age-specific mortality rates for the general population) were estimated over the lifetime of survivors of childhood cancer. Results: For a cohort of 5-year survivors aged 15 years who received a diagnosis of cancer at age 10 years, the average lifetime probability was 0.10 for late-recurrence mortality; 0.15 for treatment-related subsequent cancer and death from cardiac, pulmonary, and external causes; and 0.05 for death from other excess risks. Life expectancy for the cohort of persons aged 15 years was 50.6 years, a loss of 10.4 years (17.1%) compared with the general population. Reduction in life expectancy varied by diagnosis, ranging from 4.0 years (6.0%) for kidney tumor survivors to more than 17.8 years (>= 28.0%) for brain and bone tumor survivors, and was sensitive to late-recurrence mortality risk and duration of excess mortality risk. Limitation: Estimates are based on data for survivors who received treatment 20 to 40 years ago; patients who received treatment more recently may have more favorable outcomes. Conclusion: Childhood cancer survivors face considerable mortality during adulthood, with excess risks reducing life expectancy by as much as 28%. Monitoring the health of current survivors and carefully evaluating therapies with known late toxicities in patients with newly diagnosed cancer are needed.	[Yeh, Jennifer M.] Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, Med Sch,Harvard Pilgrim Hlth Care Inst, Boston, MA 02115 USA; Harvard Vanguard Med Associates, Dana Farber Canc Inst, Boston, MA USA; Childrens Hosp, Boston, MA 02115 USA; Emory Univ, Atlanta, GA 30322 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard Vanguard Medical Associates; Harvard University; Boston Children's Hospital; Emory University	Yeh, JM (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, Med Sch,Harvard Pilgrim Hlth Care Inst, 718 Huntington Ave,2nd Floor, Boston, MA 02115 USA.	jyeh@hsph.harvard.edu			National Cancer Institute [R25-CA057711]; NATIONAL CANCER INSTITUTE [R25CA057711, K07CA143044] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: By the National Cancer Institute (R25-CA057711; Dr. Yeh).	Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; Cardous-Ubbink MC, 2004, PEDIATR BLOOD CANCER, V42, P563, DOI 10.1002/pbc.20028; *CDCP, 2009, SER CDCP, V20; *CHILDR ONC GROUP, 2006, LONG TERM FOLL UP GU; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Green DM, 1999, J CLIN ONCOL, V17, P3207, DOI 10.1200/JCO.1999.17.10.3207; Inskip PD, 2007, INT J CANCER, V121, P2233, DOI 10.1002/ijc.22827; Kadan-Lottick NS, 2003, JAMA-J AM MED ASSOC, V290, P2008, DOI 10.1001/jama.290.15.2008; KIRCHER T, 1987, JAMA-J AM MED ASSOC, V258, P349, DOI 10.1001/jama.258.3.349; KUNTZ KM, 1995, MED DECIS MAKING, V15, P158, DOI 10.1177/0272989X9501500209; Lawless SCW, 2007, PEDIATR BLOOD CANCER, V48, P333, DOI 10.1002/pbc.20723; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; MacArthur AC, 2007, PEDIATR BLOOD CANCER, V48, P460, DOI 10.1002/pbc.20922; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Moller TR, 2001, J CLIN ONCOL, V19, P3173; MULROONEY DA, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B4606; *NAT CANC I, 2008, SNAPSH PED CANC; Nathan PC, 2008, J CLIN ONCOL, V26, P4401, DOI 10.1200/JCO.2008.16.9607; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Park ER, 2005, J CLIN ONCOL, V23, P9187, DOI 10.1200/JCO.2005.01.7418; RIES LA, 1999, NIH PUBLICATION; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Simone J.V., 2003, CHILDHOOD CANC SURVI; Simone JV, 2001, J CLIN ONCOL, V19, P3161, DOI 10.1200/JCO.2001.19.13.3161; SIRKEN MG, 1987, AM J PUBLIC HEALTH, V77, P137, DOI 10.2105/AJPH.77.2.137; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Twombly R, 2007, J NATL CANCER I, V99, P1574, DOI 10.1093/jnci/djm218; *US CANC STAT WORK, 2007, US CANC STAT 1999 20, V2008	29	63	63	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	2010	152	7					409	W138		10.7326/0003-4819-152-7-201004060-00005	http://dx.doi.org/10.7326/0003-4819-152-7-201004060-00005			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579QI	20368646	Green Accepted			2022-12-24	WOS:000276386900001
J	Nakagawa, T; Sharma, M; Nabeshima, Y; Braun, RE; Yoshida, S				Nakagawa, Toshinori; Sharma, Manju; Nabeshima, Yo-ichi; Braun, Robert E.; Yoshida, Shosei			Functional Hierarchy and Reversibility Within the Murine Spermatogenic Stem Cell Compartment	SCIENCE			English	Article							UNDIFFERENTIATED SPERMATOGONIA; SELF-RENEWAL; GERM-CELLS; PROLIFERATION; LESSONS; MAINTENANCE; EXPANSION; PLZF	Stem cells support tissue maintenance by balancing self-renewal and differentiation. In mice, it is believed that a homogeneous stem cell population of single spermatogonia supports spermatogenesis, and that differentiation, which is accompanied by the formation of connected cells (cysts) of increasing length, is linear and nonreversible. We evaluated this model with the use of lineage analysis and live imaging, and found that this putative stem cell population is not homogeneous. Instead, the stem cell pool that supports steady-state spermatogenesis is contained within a subpopulation of single spermatogonia. We also found that cysts are not committed to differentiation and appear to recover stem cell potential by fragmentation, and that the fate of individual spermatogonial populations was markedly altered during regeneration after damage. Thus, there are multiple and reversible paths from stem cells to differentiation, and these may also occur in other systems.	[Nakagawa, Toshinori; Nabeshima, Yo-ichi; Yoshida, Shosei] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan; [Sharma, Manju; Braun, Robert E.] Jackson Lab, Bar Harbor, ME 04609 USA; [Yoshida, Shosei] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Germ Cell Biol, Okazaki, Aichi 4448787, Japan; [Yoshida, Shosei] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan	Kyoto University; Jackson Laboratory; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Yoshida, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan.	shosei@nibb.ac.jp		Yoshida, Shosei/0000-0001-8861-1866; Nakagawa, Toshinori/0000-0001-7620-1720	NICHD/NIH Contraceptive Development Research Centers [U54 HD4254]; Uehara Memorial Foundation; Naito Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD042454] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20116004] Funding Source: KAKEN	NICHD/NIH Contraceptive Development Research Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Miyazaki, T. Noce, and A. Imura for materials; T. Ogawa, R. Sugimoto, Y. Kitadate, K. Hara, and H. Mizuguchi-Takase for comments; T. Fujimori for discussion and technical advice; and M. Sukeno for technical assistance. Supported by a Grant-in-Aid for Scientific Research (KAKENHI) on Innovative Areas, "Regulatory Mechanism of Gamete Stem Cells" (S.Y.), NICHD/NIH Contraceptive Development Research Centers Program grant U54 HD4254 (R.E.B.), the Uehara Memorial Foundation, and the Naito Foundation.	Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; De Rooij DG, 1998, INT J EXP PATHOL, V79, P67, DOI 10.1046/j.1365-2613.1998.00057.x; De Rooij DG, 2000, J ANDROL, V21, P776; Ehmcke J, 2005, BIOL REPROD, V72, P293, DOI 10.1095/biolreprod.104.033092; Ehmcke J, 2006, REPRODUCTION, V132, P673, DOI 10.1530/rep.1.01081; ERICKSON BH, 1981, RADIAT RES, V86, P34, DOI 10.2307/3575597; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006; HUCKINS C, 1971, ANAT REC, V169, P533, DOI 10.1002/ar.1091690306; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; OAKBERG EF, 1971, ANAT REC, V169, P515, DOI 10.1002/ar.1091690305; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Suzuki H, 2009, DEV BIOL, V336, P222, DOI 10.1016/j.ydbio.2009.10.002; Tokuda M, 2007, BIOL REPROD, V76, P130, DOI 10.1095/biolreprod.106.053181; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Yoshida S, 2008, COLD SH Q B, V73, P25, DOI 10.1101/sqb.2008.73.046; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38	34	328	346	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					62	67		10.1126/science.1182868	http://dx.doi.org/10.1126/science.1182868			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20299552	Green Accepted			2022-12-24	WOS:000276202200034
J	Taylor, C; Munro, AJ; Glynne-Jones, R; Griffith, C; Trevatt, P; Richards, M; Ramirez, AJ				Taylor, Cath; Munro, Alastair J.; Glynne-Jones, Rob; Griffith, Clive; Trevatt, Paul; Richards, Michael; Ramirez, Amanda J.			Multidisciplinary team working in cancer: what is the evidence?	BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST-CANCER; TREATMENT PLAN; IMPACT; MANAGEMENT; OUTCOMES; SURVIVAL; DISEASE; CARE		[Munro, Alastair J.] Univ Dundee, Ninewells Hosp, Dundee DD1 9SY, Scotland; [Glynne-Jones, Rob] Mt Vernon Canc Ctr, Northwood HA6 2RN, Middx, England; [Griffith, Clive] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Trevatt, Paul] NE London Canc Network, London E1 1BB, England; [Richards, Michael] St Thomas Hosp, Natl Canc Act Team, London SE1 7EH, England; [Ramirez, Amanda J.] St Thomas Hosp, Adamson Ctr, Canc Res UK Promoting Early Presentat Grp, London SE1 7EH, England	University of Dundee; Mount Vernon Cancer Centre; Newcastle University - UK; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust		cath.taylor@kcl.ac.uk			Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Aradhana G, 2022, P 2022 IEEE INT C CO, P25; Birchall M, 2004, BRIT J CANCER, V91, P1477, DOI 10.1038/sj.bjc.6602118; Blazeby JM, 2006, ANN ONCOL, V17, P457, DOI 10.1093/annonc/mdj102; Burton S, 2006, BRIT J CANCER, V94, P351, DOI 10.1038/sj.bjc.6602947; Butow P, 2007, CANCER-AM CANCER SOC, V110, P1937, DOI 10.1002/cncr.23007; Chang JH, 2001, CANCER-AM CANCER SOC, V91, P1231, DOI 10.1002/1097-0142(20010401)91:7<1231::AID-CNCR1123>3.0.CO;2-K; Choy ET, 2007, BREAST, V16, P178, DOI 10.1016/j.breast.2006.10.002; *CLIN OUTC GROUP C, 1996, IMPR OUTC BREAST CAN; Coory M, 2008, LUNG CANCER, V60, P14, DOI 10.1016/j.lungcan.2008.01.008; Davies AR, 2006, DIS ESOPHAGUS, V19, P496, DOI 10.1111/j.1442-2050.2006.00629.x; *DEP HLTH, 2000, COR HEART DIS NAT SE; Department of Health, 2001, NAT SERV FRAM OLD PE; Department of Health, 1999, NAT SERV FRAM MENT H; Department of Health, 2001, NAT SERV FRAM DIAB S; Department of Health, 2004, MAN CANC SERV; Department of Health, 2007, CANC REF STRAT; Eaker S, 2005, CANCER EPIDEM BIOMAR, V14, P2914, DOI 10.1158/1055-9965.EPI-05-0317; Gabel M, 1997, CANCER, V79, P2380; Houssami N, 2006, EUR J CANCER, V42, P2480, DOI 10.1016/j.ejca.2006.05.023; Kagan AR, 2005, INT J RADIAT ONCOL, V61, P967, DOI 10.1016/j.ijrobp.2004.10.040; Kane B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-15; Morris E, 2006, BRIT J CANCER, V95, P979, DOI 10.1038/sj.bjc.6603372; National Cancer Action Team, 2008, NAT CANC PEER REV PR; National Institute for Health and Clinical Excellence, 2004, CHRON OBSTR PULM DIS; Picker Institute Europe, 2005, IS NHS GETT BETT WOR; Richards MA, 1994, PROVISION BREAST SER; Stephens MR, 2006, DIS ESOPHAGUS, V19, P164, DOI 10.1111/j.1442-2050.2006.00559.x; Taylor C., 2009, MULTIDISCIPLINARY TE; The Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales, 1995, POL FRAM COMM CANC S; Trevino LK, 2008, ACAD MANAGE REV, V33, P8, DOI 10.5465/AMR.2008.27744831; Wood JJ, 2008, COLORECTAL DIS, V10, P769, DOI 10.1111/j.1463-1318.2007.01464.x	31	244	254	0	32	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2010	340								c951	10.1136/bmj.c951	http://dx.doi.org/10.1136/bmj.c951			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	576PO	20332315				2022-12-24	WOS:000276157600011
J	Spence, D				Spence, Des			From the Frontline Men behaving madly: testosterone replacement therapy	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Martinez-Jabaloyas JM, 2007, EUR UROL, V52, P1760, DOI 10.1016/j.eururo.2007.05.021	1	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 18	2010	340								c1493	10.1136/bmj.c1493	http://dx.doi.org/10.1136/bmj.c1493			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573RI	20299394				2022-12-24	WOS:000275931900006
J	Lonnroth, K; Castro, KG; Chakaya, JM; Chauhan, LS; Floyd, K; Glaziou, P; Raviglione, MC				Loennroth, Knut; Castro, Kenneth G.; Chakaya, Jeremiah Muhwa; Chauhan, Lakhbir Singh; Floyd, Katherine; Glaziou, Philippe; Raviglione, Mario C.			Tuberculosis control and elimination 2010-50: cure, care, and social development	LANCET			English	Article							PULMONARY TUBERCULOSIS; COST-EFFECTIVENESS; DIABETES-MELLITUS; PUBLIC-HEALTH; GLOBAL HEALTH; ALCOHOL-USE; RISK-FACTOR; LOW-INCOME; TRENDS; IMPACT	Rapid expansion of the standardised approach to tuberculosis diagnosis and treatment that is recommended by WHO allowed more than 36 million people to be cured between 1995 and 2008, averting up to 6 million deaths. Yet tuberculosis remains a severe global public health threat. There are more than 9 million new cases every year worldwide, and the incidence rate is falling at less than 1% per year. Although the overall target related to the Millennium Development Goals of halting and beginning to reverse the epidemic might have already been reached in 2004, the more important long-term elimination target set for 2050 will not be met with present strategies and instruments. Several key challenges persist. Many vulnerable people do not have access to affordable services of sufficient quality. Technologies for diagnosis, treatment, and prevention are old and inadequate. Multidrug-resistant tuberculosis is a serious threat in many settings. HIV/AIDS continues to fuel the tuberculosis epidemic, especially in Africa. Furthermore, other risk factors and underlying social determinants help to maintain tuberculosis in the community. Acceleration of the decline towards elimination of this disease will need invigorated actions in four broad areas: continued scale-up of early diagnosis and proper treatment for all forms of tuberculosis in line with the Stop TB Strategy; development and enforcement of bold health-system policies; establishment of links with the broader development agenda; and promotion and intensification of research towards innovations.	[Loennroth, Knut; Floyd, Katherine; Glaziou, Philippe; Raviglione, Mario C.] WHO, Stop TB Dept, CH-1211 Geneva 27, GE, Switzerland; [Castro, Kenneth G.] Ctr Dis Control & Prevent, Div TB Eliminat Natl Ctr HIV Viral Hepatitis STD, Atlanta, GA USA; [Chakaya, Jeremiah Muhwa] Natl Leprosy & TB Programme, Nairobi, Kenya; [Chakaya, Jeremiah Muhwa] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Chauhan, Lakhbir Singh] Minist Hlth & Family Welf, New Delhi, India	World Health Organization; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute	Lonnroth, K (corresponding author), WHO, Stop TB Dept, 20 Ave Appia, CH-1211 Geneva 27, GE, Switzerland.	lonnrothk@who.int	Lönnroth, Knut/L-2339-2014; Castro, Kenneth G/P-1882-2018; Lonnroth, Knut/H-5470-2017	Lönnroth, Knut/0000-0001-5054-8240; Castro, Kenneth G/0000-0001-7964-6354; Lonnroth, Knut/0000-0001-6944-0256; RAVIGLIONE, Mario/0000-0002-9331-2067; Muhwa, Chakaya Jeremiah/0000-0002-3229-2429; Glaziou, Philippe/0000-0002-0649-1272				Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; ALUOCH JA, 1984, AM REV RESPIR DIS, V129, P915; [Anonymous], 1999, EPIDEMIOLOGIC BASIS; Atun R, 2010, LANCET, V375, P2169, DOI 10.1016/S0140-6736(10)60493-X; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Barboza Carlos Eduardo Galvão, 2008, J. bras. pneumol., V34, P959, DOI 10.1590/S1806-37132008001100012; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; BLAS E, 2010, PRIORITY PUBLIC HLTH; Bock NN, 2007, J INFECT DIS, V196, pS108, DOI 10.1086/518661; Boggio Andrea, 2008, Health Hum Rights, V10, P121; Borgdorff MW, 2004, EMERG INFECT DIS, V10, P1523, DOI 10.3201/eid1009.040349; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Camacho M, 2007, INT J TUBERC LUNG D, V11, P1246; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Chaisson RE, 2009, INT J TUBERC LUNG D, V13, P558; Chen XY, 2004, LANCET, V364, P417; Cheng MH, 2009, LANCET, V373, P1328, DOI 10.1016/S0140-6736(09)60757-1; Commission on Social Determinants of Health, 2007, ACH HLTH EQ ROOT CAU; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Davies RPO, 1999, INT J TUBERC LUNG D, V3, P1051; de Vries G, 2007, AM J RESP CRIT CARE, V176, P201, DOI 10.1164/rccm.200612-1877OC; DEMARCO JR, 2007, CONTROL TUBERCULOSIS; DIWAN V, 1998, 19983 NORD SCH PUBL; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dowdy DW, 2009, B WORLD HEALTH ORGAN, V87, P296, DOI 10.2471/BLT.08.054510; Dye C, 2008, LANCET INFECT DIS, V8, P233, DOI 10.1016/S1473-3099(07)70291-8; Dye C, 2007, INT J TUBERC LUNG D, V11, P1225; Dye C, 2006, INT J TUBERC LUNG D, V10, P460; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Dye C, 2000, INT J TUBERC LUNG D, V4, pS146; DYE C, 2004, BMJ-BRIT MED J, V330, P195; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; *GLOB FUND, 2009, GLOB FUND 2009 INN I; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Gonzalez E, 2007, INT J TUBERC LUNG D, V11, P405; Gonzalez-Ochoa E, 2009, TROP MED INT HEALTH, V14, P131, DOI 10.1111/j.1365-3156.2008.02201.x; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; HANSON C, 2006, TB COMPREHENSIVE INT, P1097; Harries A, 2004, TOMANS TUBERCULOSIS; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Harries AD, 2009, T ROY SOC TROP MED H, V103, P1, DOI 10.1016/j.trstmh.2008.08.008; Hassmiller K, 2007, IMPACT SMOKING POPUL; Havlir DV, 1999, NEW ENGL J MED, V340, P367, DOI 10.1056/NEJM199902043400507; Hirao S, 2007, TROP MED INT HEALTH, V12, P1459, DOI 10.1111/j.1365-3156.2007.01952.x; HOLT DF, 2008, LANCET, V372, P164; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; *IDF, 2010, INT DIAB FED DIAB AT; Islam MA, 2002, B WORLD HEALTH ORGAN, V80, P445; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jaramillo E, 2001, HEALTH POLICY PLANN, V16, P68, DOI 10.1093/heapol/16.1.68; Jaramillo E, 1999, SOC SCI MED, V49, P393, DOI 10.1016/S0277-9536(99)00114-8; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; John TJ, 2009, TROP MED INT HEALTH, V14, P1428, DOI 10.1111/j.1365-3156.2009.02392.x; Kjellstrom T., 2007, OUR CITIES OUR HLTH; Kobaidze Ketevan, 2009, Interdiscip Perspect Infect Dis, V2009, P513609, DOI 10.1155/2009/513609; Lagomarsino G., 2009, PUBLIC STEWARDSHIP P; Lawn SD, 2009, CURR OPIN HIV AIDS, V4, P325, DOI 10.1097/COH.0b013e32832c7d61; Laxminarayan R, 2009, HEALTH AFFAIR, V28, pW730, DOI 10.1377/hlthaff.28.4.w730; Lin HH, 2008, LANCET, V372, P1473, DOI 10.1016/S0140-6736(08)61345-8; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Lonnroth K, 2006, B WORLD HEALTH ORGAN, V84, P876; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; LONNROTH K, 2009, TUBERCULOSIS ESSENTI; LONNROTH K, 2006, TB COMPREHENSIVE INT; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Maher D, 2007, B WORLD HEALTH ORGAN, V85, P341, DOI 10.2471/BLT.06.037820; MCKEOWN T, 1962, POP STUD-J DEMOG, V16, P94, DOI 10.2307/2173119; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Miller TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005080; *MIN HLTH, 2002, NAT TB PREV SURV 200; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Murray CJL, 2004, BMJ-BRIT MED J, V329, P1096, DOI 10.1136/bmj.329.7474.1096; Nganda B, 2003, INT J TUBERC LUNG D, V7, pS14; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Obermeyer Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001721; Oxlade O, 2009, INT J TUBERC LUNG D, V13, P1238; Pai M, 2008, PLOS MED, V5, P1043, DOI 10.1371/journal.pmed.0050156; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Sanchez-Perez HJ, 2002, ANN EPIDEMIOL, V12, P166, DOI 10.1016/S1047-2797(01)00308-8; Shilova MV, 2001, PHILOS T R SOC B, V356, P1069, DOI 10.1098/rstb.2001.0895; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; *STOP TB PARTN, 2006, WHOHTMST13200635 STO; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; STYBLO K, 1991, TUBERCULOSIS CAN BE; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; Subramani R, 2007, INT J EPIDEMIOL, V36, P387, DOI 10.1093/ije/dyl216; *TB ALL, 2007, PATHW PAT CHART DYN; *TDR, 2006, TDR REP SER, V3; *TEATM ACT GROUP, 2009, 2009 REP TUB RES FUN; Thomas Aleyamma, 2008, Indian J Tuberc, V55, P77; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; *UNAIDS, 2008, UNAIDS0825EJC1510E; United Nations High Commissioner for Refugees, 2017, DESP JOURN REF MIGR; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; USA-Department of Agriculture, 2008, RIS FOOD PRIC INT FO; van der Werf MJ, 2007, B WORLD HEALTH ORGAN, V85, P370, DOI 10.2471/BLT.06.039941; Van Leth F, 2008, B WORLD HEALTH ORGAN, V86, P20, DOI 10.2471/BLT.06.037804; VOLMINK J, 2006, COCHRANE DB SYST REV, V2; Vree M, 2007, EMERG INFECT DIS, V13, P796, DOI 10.3201/eid1305.060904; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P943, DOI 10.1017/S0950268807008552; Vynnycky E, 1999, INT J EPIDEMIOL, V28, P327, DOI 10.1093/ije/28.2.327; W.H. Organization, 2009, WORLD HLTH STAT 2009; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; WATT C, 2009, TUBERCULOSIS; WHO, 2008, GLOBAL TUBERCULOSIS; *WHO, 2007, WHOHTMTB2007379; WHO, 2004, GLOB STAT REP ALC 20; *WHO, 2008, TOB ATL; WHO, 2009, TREATM TUB GUID; *WHO, 2006, WHOHTMTB2006373; *WHO, 1974, WHO TECHN SER, V552; *WHO, 2009, WH0HTMTB2009426; *WHO, 2008, WHOTB2007390; *WHO, 2008, REV CAS DEF SPUT SME; World Health Organization, 1998, WHOTB98250; World Health Organization, 2005, WHOHTMTB2005352; World Health Organization, 2008, WHOHTMTB2008400; World Health Organization, 2006, WHO HOUS EN DAT; World Health Organization, 2008, WHOHTMTB2008401; World Health Organization, 2008, WHOHTMTB2008404; World Health Organization, 2009, GLOB TUB CONTR EP ST; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Xu L, 2008, T ROY SOC TROP MED H, V102, P797, DOI 10.1016/j.trstmh.2008.04.027; ZUÑIGA G. MANUEL, 2002, Rev. chil. enferm. respir., V18, P55	138	533	554	3	121	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2010	375	9728					1814	1829		10.1016/S0140-6736(10)60483-7	http://dx.doi.org/10.1016/S0140-6736(10)60483-7			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603NY	20488524				2022-12-24	WOS:000278216500033
J	Bombardier, CH; Fann, JR; Temkin, NR; Esselman, PC; Barber, J; Dikmen, SS				Bombardier, Charles H.; Fann, Jesse R.; Temkin, Nancy R.; Esselman, Peter C.; Barber, Jason; Dikmen, Sureyya S.			Rates of Major Depressive Disorder and Clinical Outcomes Following Traumatic Brain Injury	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SCHEDULED TELEPHONE INTERVENTION; COMORBIDITY SURVEY REPLICATION; PSYCHIATRIC-DISORDERS; PRIMARY-CARE; MENTAL-DISORDERS; SELF-REPORT; 1ST YEAR; SEVERITY; ALCOHOL; REHABILITATION	Context Uncertainties exist about the rates, predictors, and outcomes of major depressive disorder (MDD) among individuals with traumatic brain injury (TBI). Objective To describe MDD-related rates, predictors, outcomes, and treatment during the first year after TBI. Design Cohort from June 2001 through March 2005 followed up by structured telephone interviews at months 1 through 6, 8, 10, and 12 (data collection ending February 2006). Setting Harborview Medical Center, a level I trauma center in Seattle, Washington. Participants Five hundred fifty-nine consecutively hospitalized adults with complicated mild to severe TBI. Main Outcome Measures The Patient Health Questionnaire (PHQ) depression and anxiety modules were administered at each assessment and the European Quality of Life measure was given at 12 months. Results Two hundred ninety-seven of 559 patients (53.1%) met criteria for MDD at least once in the follow-up period. Point prevalences ranged between 31% at 1 month and 21% at 6 months. In a multivariate model, risk of MDD after TBI was associated with MDD at the time of injury (risk ratio [RR], 1.62; 95% confidence interval [CI], 1.37-1.91), history of MDD prior to injury (but not at the time of injury) (RR, 1.54; 95% CI, 1.31-1.82), age (RR, 0.61; 95% CI, 0.44-0.83 for >60 years vs 18-29 years), and lifetime alcohol dependence (RR, 1.34; 95% CI, 1.14-1.57). Those with MDD were more likely to report comorbid anxiety disorders after TBI than those without MDD (60% vs 7%; RR, 8.77; 95% CI, 5.56-13.83). Only 44% of those with MDD received antidepressants or counseling. After adjusting for predictors of MDD, persons with MDD reported lower quality of life at 1 year compared with the nondepressed group. Conclusions Among a cohort of patients hospitalized for TBI, 53.1% met criteria for MDD during the first year after TBI. Major depressive disorder was associated with history of MDD and was an independent predictor of poorer health-related quality of life. JAMA. 2010; 303(19): 1938-1945	[Bombardier, Charles H.; Fann, Jesse R.; Temkin, Nancy R.; Esselman, Peter C.; Dikmen, Sureyya S.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98104 USA; [Fann, Jesse R.; Dikmen, Sureyya S.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Temkin, Nancy R.; Barber, Jason; Dikmen, Sureyya S.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98104 USA; [Fann, Jesse R.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bombardier, CH (corresponding author), Univ Washington, Sch Med, Dept Rehabil Med, Box 359612,325 Ninth Ave, Seattle, WA 98104 USA.	chb@uw.edu	Bombardier, Charles H./AAZ-3260-2021	Bombardier, Charles H./0000-0003-4758-6283	National Center for Medical Rehabilitation Research; National Institute of Child Health and Human Development; National Institutes of Health [R01 HD39415]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039415] Funding Source: NIH RePORTER	National Center for Medical Rehabilitation Research; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding/Support: This work was supported by the National Center for Medical Rehabilitation Research, the National Institute of Child Health and Human Development, and National Institutes of Health grant R01 HD39415 to Drs Bombardier and Fann (co-principal investigators). Pfizer supplied masked sertraline and placebo for the controlled trial.	Agency for Healthcare Research and Quality, CALC US POP BAS EQ 5; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Dobrez D, 2010, ARCH PHYS MED REHAB, V91, P184, DOI 10.1016/j.apmr.2009.10.020; Donker T, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1134; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Fann JR, 2009, J HEAD TRAUMA REHAB, V24, P272, DOI 10.1097/HTR.0b013e3181a66342; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Fava M, 2000, NEURON, V28, P335, DOI 10.1016/S0896-6273(00)00112-4; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; First M. B., 2001, USERS GUIDE STRUCTUR; GENTILELLO LM, 1995, JAMA-J AM MED ASSOC, V274, P1043, DOI 10.1001/jama.274.13.1043; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gorlyn M, 2008, J NEURAL TRANSM, V115, P1213, DOI 10.1007/s00702-008-0084-x; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huddleston Mary, 2004, J Healthc Qual, V26, P12; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Novack TA, 2009, J NEUROTRAUM, V26, P1921, DOI 10.1089/neu.2009.0895; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Rush AJ, 2009, CNS DRUGS, V23, P627, DOI 10.2165/00023210-200923080-00001; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simon GE, 2001, ARCH GEN PSYCHIAT, V58, P395, DOI 10.1001/archpsyc.58.4.395; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Turner-Stokes L, 2002, CLIN REHABIL, V16, P261, DOI 10.1191/0269215502cr489oa; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	49	432	438	1	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2010	303	19					1938	1945		10.1001/jama.2010.599	http://dx.doi.org/10.1001/jama.2010.599			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597NJ	20483970	Green Accepted, Bronze			2022-12-24	WOS:000277764500020
J	Sarewitz, D				Sarewitz, Daniel			Brick by brick	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA.	dsarewitz@gmail.com							0	2	2	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 6	2010	465	7294					29	29		10.1038/465029a	http://dx.doi.org/10.1038/465029a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	591OW	20445605	Bronze			2022-12-24	WOS:000277311900012
J	Xu, X; Zheng, XT; You, HL				Xu, Xing; Zheng, Xiaoting; You, Hailu			Exceptional dinosaur fossils show ontogenetic development of early feathers	NATURE			English	Article							EVOLUTIONARY ORIGIN; CHINA; DIVERSIFICATION; MORPHOGENESIS; THEROPOD; BIRDS	Recent discoveries of feathered dinosaur specimens have greatly improved our understanding of the origin and early evolution of feathers, but little information is available on the ontogenetic development of early feathers(1-7). Here we describe an early-juvenile specimen and a late-juvenile specimen, both referable to the oviraptorosaur Similicaudipteryx(8), recovered from the Lower Cretaceous Yixian Formation of western Liaoning, China(9). The two specimens have strikingly different remiges and rectrices, suggesting that a radical morphological change occurred during feather development, as is the case for modern feathers(10). However, both the remiges and the rectrices are proximally ribbon-like in the younger specimen but fully pennaceous in the older specimen, a pattern not known in any modern bird(10). In combination with the wide distribution of proximally ribbon-like pennaceous feathers and elongate broad filamentous feathers among extinct theropods, this find suggests that early feathers were developmentally more diverse than modern ones and that some developmental features, and the resultant morphotypes, have been lost in feather evolution.	[Xu, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Zheng, Xiaoting] Shandong Tianyu Museum Nat, Pingyi 273300, Shandong, Peoples R China; [You, Hailu] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Geological Sciences	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, 142 Xiwai St, Beijing 100044, Peoples R China.	xingxu@vip.sina.com; ty4291666@163.com		You, Hai-Lu/0000-0003-2203-6461	Chinese Academy of Sciences; National Natural Science Foundation of China; Special Funds For Major State Basic Research Projects of China	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funds For Major State Basic Research Projects of China	The authors thank P.-J. Chen, L.-H. Hou and Z.-M. Dong for coordinating the project, M. Kundrat and F. C. Zhang for discussions, and M. Kundrat and C. Sullivan for commenting on and editing the manuscript. This work was supported by grants from the Chinese Academy of Sciences, the National Natural Science Foundation of China and Special Funds For Major State Basic Research Projects of China, presented to X.X.	BRUSH AH, 1972, BIOCHEM GENET, V7, P87, DOI 10.1007/BF00487012; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Chuong CM, 2003, J EXP ZOOL PART B, V298B, P42, DOI 10.1002/jez.b.00025; Harris MP, 2005, P NATL ACAD SCI USA, V102, P11734, DOI 10.1073/pnas.0500781102; Harris MP, 2002, J EXP ZOOL, V294, P160, DOI 10.1002/jez.10157; He Tao, 2008, Vertebrata Palasiatica, V46, P178; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Lingham-Soliar T, 2010, J ORNITHOL, V151, P193, DOI 10.1007/s10336-009-0446-7; Lucas A. M., 1972, AVIAN ANATOMY INTEGU, P197; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Osmolska H, 2004, DINOSAURIA, 2ND EDITION, P165; Prum RO, 1999, J EXP ZOOL, V285, P291; Prum RO, 2005, J EXP ZOOL PART B, V304B, P570, DOI 10.1002/jez.b.21073; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Raff R. A., 1996, SHAPE LIFE GENES DEV; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Widelitz RB, 2003, J EXP ZOOL PART B, V298B, P109, DOI 10.1002/jez.b.00029; Witmer LM, 2009, NATURE, V458, P293, DOI 10.1038/458293a; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311; Xu X, 2009, P NATL ACAD SCI USA, V106, P832, DOI 10.1073/pnas.0810055106; Yu MK, 2002, NATURE, V420, P308, DOI 10.1038/nature01196; Zhang FC, 2000, SCIENCE, V290, P1955, DOI 10.1126/science.290.5498.1955; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zhang FC, 2006, GEOL J, V41, P395, DOI 10.1002/gj.1057; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740; ZHENG XT, 2009, ORIGIN BIRDS, P1; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P455, DOI 10.1007/s00114-004-0570-4; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P241	29	99	111	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1338	1341		10.1038/nature08965	http://dx.doi.org/10.1038/nature08965			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428169				2022-12-24	WOS:000277149000044
J	Polonsky, TS; McClelland, RL; Jorgensen, NW; Bild, DE; Burke, GL; Guerci, AD; Greenland, P				Polonsky, Tamar S.; McClelland, Robyn L.; Jorgensen, Neal W.; Bild, Diane E.; Burke, Gregory L.; Guerci, Alan D.; Greenland, Philip			Coronary Artery Calcium Score and Risk Classification for Coronary Heart Disease Prediction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INCIDENT CARDIOVASCULAR EVENTS; ATHEROSCLEROSIS; CALCIFICATION; IMPROVE	Context The coronary artery calcium score (CACS) has been shown to predict future coronary heart disease (CHD) events. However, the extent to which adding CACS to traditional CHD risk factors improves classification of risk is unclear. Objective To determine whether adding CACS to a prediction model based on traditional risk factors improves classification of risk. Design, Setting, and Participants CACS was measured by computed tomography in 6814 participants from the Multi-Ethnic Study of Atherosclerosis (MESA), a population-based cohort without known cardiovascular disease. Recruitment spanned July 2000 to September 2002; follow-up extended through May 2008. Participants with diabetes were excluded from the primary analysis. Five-year risk estimates for incident CHD were categorized as 0% to less than 3%, 3% to less than 10%, and 10% or more using Cox proportional hazards models. Model 1 used age, sex, tobacco use, systolic blood pressure, antihypertensive medication use, total and high-density lipoprotein cholesterol, and race/ethnicity. Model 2 used these risk factors plus CACS. We calculated the net reclassification improvement and compared the distribution of risk using model 2 vs model 1. Main Outcome Measures Incident CHD events. Results During a median of 5.8 years of follow-up among a final cohort of 5878, 209 CHD events occurred, of which 122 were myocardial infarction, death from CHD, or resuscitated cardiac arrest. Model 2 resulted in significant improvements in risk prediction compared with model 1 (net reclassification improvement=0.25; 95% confidence interval, 0.16-0.34; P<.001). In model 1, 69% of the cohort was classified in the highest or lowest risk categories compared with 77% in model 2. An additional 23% of those who experienced events were reclassified as high risk, and an additional 13% without events were reclassified as low risk using model 2. Conclusion In this multi-ethnic cohort, addition of CACS to a prediction model based on traditional risk factors significantly improved the classification of risk and placed more individuals in the most extreme risk categories. JAMA. 2010; 303(16): 1610-1616	[Greenland, Philip] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [McClelland, Robyn L.; Jorgensen, Neal W.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Bild, Diane E.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Burke, Gregory L.] Wake Forest Univ, Div Publ Hlth Sci, Sch Med, Winston Salem, NC 27109 USA; [Guerci, Alan D.] St Francis Hosp, Ctr Heart, Roslyn, NY USA	Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Wake Forest University	Greenland, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 750 N Lake Shore Dr,11th Floor, Chicago, IL 60611 USA.		Greenland, Philip/ABD-5528-2021		Pfizer; National Heart, Lung, and Blood Institute (NHLBI) [N01-HC-95159, N01-HC-95169, 5T32HL069771]; National Center for Research Resources [1UL1RR025741]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095167, N01HC095165, N01HC095166, N01HC095160, N01HC095159, N01HC095168, N01HC095169, N01HC095162, N01HC095163, N01HC095161, N01HC095164] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL095169, R43HL095169, T32HL069771] Funding Source: NIH RePORTER	Pfizer(Pfizer); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Financial Disclosures: Dr Guerci reports that he has received grant suppot from Pfizer. Dr Greenland reports that he has served as a consultant to Pfizer and GE/Toshiba. No other disclosures were reported.; Funding/Support: MESA was supported by contracts N01-HC-95159 through N01-HC-95169 from the National Heart, Lung, and Blood Institute (NHLBI). Dr Polonsky is supported by an NHLBI training grant in cardiovascular epidemiology and prevention (grant 5T32HL069771). Dr Greenland is supported by a grant from the National Center for Research Resources (grant number 1UL1RR025741).	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cleves MA, 2002, STATA J, V2, P301, DOI 10.1177/1536867X0200200307; Cooney MT, 2009, J AM COLL CARDIOL, V54, P1209, DOI 10.1016/j.jacc.2009.07.020; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Diamond GA, 2007, AM J CARDIOL, V99, P1013, DOI 10.1016/j.amjcard.2006.10.070; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Kim KP, 2009, ARCH INTERN MED, V169, P1188, DOI 10.1001/archinternmed.2009.162; May S, 1998, LIFETIME DATA ANAL, V4, P109, DOI 10.1023/A:1009612305785; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Raggi P, 2008, J AM COLL CARDIOL, V52, P17, DOI 10.1016/j.jacc.2008.04.004; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Simmons RK, 2008, ARCH INTERN MED, V168, P1209, DOI 10.1001/archinte.168.11.1209; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801	24	773	800	0	61	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2010	303	16					1610	1616		10.1001/jama.2010.461	http://dx.doi.org/10.1001/jama.2010.461			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588PQ	20424251	Green Accepted, Bronze			2022-12-24	WOS:000277085200024
J	Aldrich, TK; Gustave, J; Hall, CB; Cohen, HW; Webber, MP; Zeig-Owens, R; Cosenza, K; Christodoulou, V; Glass, L; Al-Othman, F; Weiden, MD; Kelly, KJ; Prezant, DJ				Aldrich, Thomas K.; Gustave, Jackson; Hall, Charles B.; Cohen, Hillel W.; Webber, Mayris P.; Zeig-Owens, Rachel; Cosenza, Kaitlyn; Christodoulou, Vasilios; Glass, Lara; Al-Othman, Fairouz; Weiden, Michael D.; Kelly, Kerry J.; Prezant, David J.			Lung Function in Rescue Workers at the World Trade Center after 7 Years.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY-FUNCTION; CENTER DUST; FOLLOW-UP; RESPIRATORY SYMPTOMS; CENTER DISASTER; FIRE FIGHTERS; FIREFIGHTERS; EXPOSURE; SPIROMETRY; SMOKE	Background: The terrorist attacks on the World Trade Center on September 11, 2001, exposed thousands of Fire Department of New York City (FDNY) rescue workers to dust, leading to substantial declines in lung function in the first year. We sought to determine the longer-term effects of exposure. Methods: Using linear mixed models, we analyzed the forced expiratory volume in 1 second (FEV(sub 1)) of both active and retired FDNY rescue workers on the basis of spirometry routinely performed at intervals of 12 to 18 months from March 12, 2000, to September 11, 2008. Results: Of the 13,954 FDNY workers who were present at the World Trade Center between September 11, 2001, and September 24, 2001, a total of 12,781 (91.6%) participated in this study, contributing 61,746 quality-screened spirometric measurements. The median follow-up was 6.1 years for firefighters and 6.4 years for emergency-medical-services (EMS) workers. In the first year, the mean FEV(sub 1) decreased significantly for all workers, more for firefighters who had never smoked (a reduction of 439 ml; 95% confidence interval [CI], 408 to 471) than for EMS workers who had never smoked (a reduction of 267 ml; 95% CI, 263 to 271) (P<0.001 for both comparisons). There was little or no recovery in FEV(sub 1) during the subsequent 6 years, with a mean annualized reduction in FEV(sub 1) of 25 ml per year for firefighters and 40 ml per year for EMS workers. The proportion of workers who had never smoked and who had an FEV(sub 1) below the lower limit of the normal range increased during the first year, from 3% to 18% for firefighters and from 12% to 22% for EMS workers, stabilizing at about 13% for firefighters and 22% for EMS workers during the subsequent 6 years. Conclusions: Exposure to World Trade Center dust led to large declines in FEV(sub 1) for FDNY rescue workers during the first year. Overall, these declines were persistent, without recovery over the next 6 years, leaving a substantial proportion of workers with abnormal lung function. N Engl J Med 2010;362:1263-72.	[Aldrich, Thomas K.; Zeig-Owens, Rachel; Al-Othman, Fairouz; Prezant, David J.] Montefiore Med Ctr, Dept Med, Div Pulm Med, Bronx, NY 10467 USA; [Hall, Charles B.; Cohen, Hillel W.] Albert Einstein Coll Med, Div Biostat, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Cohen, Hillel W.; Webber, Mayris P.] Albert Einstein Coll Med, Div Epidemiol, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Gustave, Jackson; Webber, Mayris P.; Zeig-Owens, Rachel; Cosenza, Kaitlyn; Christodoulou, Vasilios; Glass, Lara; Weiden, Michael D.; Kelly, Kerry J.; Prezant, David J.] Bur Hlth Serv, Brooklyn, NY USA; [Prezant, David J.] New York City Fire Dept, WTC Med Monitoring Program, Off Med Affairs, Brooklyn, NY 11201 USA; [Weiden, Michael D.] NYU, Dept Med, Div Pulm Med, New York, NY 10016 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; New York University	Prezant, DJ (corresponding author), New York City Fire Dept, WTC Med Monitoring Program, Off Med Affairs, 9 Metrotech Ctr,Rm 4W-1, Brooklyn, NY 11201 USA.	prezand@fdny.nyc.gov	Hall, Charles B./AAX-8216-2020; Zeig-Owens, Rachel/HIA-8364-2022	Cohen, Hillel/0000-0002-4524-0898; Hall, Charles/0000-0001-9982-8120	National Institute of Occupational Safety and Health [U10-OH008243, U10-OH008242, R01-OH07350]; National Institutes of Health [M01 00096, K23HL084191, K24A1080298, R01HL057879]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057879, K23HL084191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U10OH008242, U10OH008243] Funding Source: NIH RePORTER	National Institute of Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	Supported by grants (U10-OH008243, U10-OH008242, and R01-OH07350) from the National Institute of Occupational Safety and Health and grants (M01 00096, K23HL084191, K24A1080298, and R01HL057879) from the National Institutes of Health.	Banauch GI, 2003, AM J RESP CRIT CARE, V168, P54, DOI 10.1164/rccm.200211-1329OC; Banauch GI, 2006, AM J RESP CRIT CARE, V174, P312, DOI 10.1164/rccm.200511-1736OC; Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Buyantseva LV, 2007, J OCCUP ENVIRON MED, V49, P310, DOI 10.1097/JOM.0b013e318032256e; Feldman DM, 2004, CHEST, V125, P1256, DOI 10.1378/chest.125.4.1256; Fireman EM, 2004, ENVIRON HEALTH PERSP, V112, P1564, DOI 10.1289/ehp.7233; Gaughan DM, 2008, J OCCUP ENVIRON MED, V50, P1019, DOI 10.1097/JOM.0b013e3181754161; GIBBS L, 2008, WORLD TRADE CTR MED; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Herbert R, 2006, ENVIRON HEALTH PERSP, V114, P1853, DOI 10.1289/ehp.9592; Kerstjens HAM, 1997, THORAX, V52, P820, DOI 10.1136/thx.52.9.820; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LARGE AA, 1990, CHEST, V97, P806, DOI 10.1378/chest.97.4.806; Lebowitz MD, 1996, AM J RESP CRIT CARE, V154, pS273, DOI 10.1164/ajrccm/154.6_Pt_2.S273; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MUSK AW, 1977, AM J PUBLIC HEALTH, V67, P630, DOI 10.2105/AJPH.67.7.630; MUSK AW, 1979, BRIT J IND MED, V36, P29; MUSK AW, 1977, AM J PUBLIC HEALTH, V67, P626, DOI 10.2105/AJPH.67.7.626; Reibman J, 2009, J OCCUP ENVIRON MED, V51, P534, DOI 10.1097/JOM.0b013e3181a0365b; Schouten JP, 1996, AM J RESP CRIT CARE, V154, pS278, DOI 10.1164/ajrccm/154.6_Pt_2.S278; Skloot G, 2004, CHEST, V125, P1248, DOI 10.1378/chest.125.4.1248; Skloot GS, 2009, CHEST, V135, P492, DOI 10.1378/chest.08-1391; SMITH TJ, 1978, INT ARCH OCC ENV HEA, V41, P139, DOI 10.1007/BF00381798; TASHKIN DP, 1977, CHEST, V71, P445, DOI 10.1378/chest.71.4.445; Webber MP, 2009, ENVIRON HEALTH PERSP, V117, P975, DOI 10.1289/ehp.0800291; Weiden MD, 2010, CHEST, V137, P566, DOI 10.1378/chest.09-1580	27	145	145	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2010	362	14					1263	1272		10.1056/NEJMoa0910087	http://dx.doi.org/10.1056/NEJMoa0910087			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579SN	20375403	Bronze, Green Accepted			2022-12-24	WOS:000276393700005
J	Harris, KM; Henry, JT; Rohman, E; Haas, TS; Maron, BJ				Harris, Kevin M.; Henry, Jason T.; Rohman, Eric; Haas, Tammy S.; Maron, Barry J.			Sudden Death During the Triathlon	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Harris, Kevin M.; Henry, Jason T.; Rohman, Eric; Haas, Tammy S.; Maron, Barry J.] Abbott NW Hosp, Minneapolis Heart Inst Fdn, Minneapolis, MN 55407 USA	Minneapolis Heart Institute Foundation	Harris, KM (corresponding author), Abbott NW Hosp, Minneapolis Heart Inst Fdn, Minneapolis, MN 55407 USA.	kharris@mplsheart.com						Dallam GM, 2005, SPORTS MED, V35, P143, DOI 10.2165/00007256-200535020-00004; Douglas PS, 1997, AM J CARDIOL, V80, P1384, DOI 10.1016/S0002-9149(97)00693-0; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Redelmeier DA, 2007, BRIT MED J, V335, P1275, DOI 10.1136/bmj.39384.551539.25; Rifai N, 1999, AM J CARDIOL, V83, P1085, DOI 10.1016/S0002-9149(99)00020-X	5	60	60	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1255	1257		10.1001/jama.2010.368	http://dx.doi.org/10.1001/jama.2010.368			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579FM	20371783				2022-12-24	WOS:000276353700019
J	Neely, GG; Kuba, K; Cammarato, A; Isobe, K; Amann, S; Zhang, LY; Murata, M; Elmen, L; Gupta, V; Arora, S; Sarangi, R; Dan, D; Fujisawa, S; Usami, T; Xia, CP; Keene, AC; Alayari, NN; Yamakawa, H; Elling, U; Berger, C; Novatchkova, M; Koglgruber, R; Fukuda, K; Nishina, H; Isobe, M; Pospisilik, JA; Imai, Y; Pfeufer, A; Hicks, AA; Pramstaller, PP; Subramaniam, S; Kimura, A; Ocorr, K; Bodmer, R; Penninger, JM				Neely, G. Gregory; Kuba, Keiji; Cammarato, Anthony; Isobe, Kazuya; Amann, Sabine; Zhang, Liyong; Murata, Mitsushige; Elmen, Lisa; Gupta, Vaijayanti; Arora, Suchir; Sarangi, Rinku; Dan, Debasis; Fujisawa, Susumu; Usami, Takako; Xia, Cui-ping; Keene, Alex C.; Alayari, Nakissa N.; Yamakawa, Hiroyuki; Elling, Ulrich; Berger, Christian; Novatchkova, Maria; Koglgruber, Rubina; Fukuda, Keiichi; Nishina, Hiroshi; Isobe, Mitsuaki; Pospisilik, J. Andrew; Imai, Yumiko; Pfeufer, Arne; Hicks, Andrew A.; Pramstaller, Peter P.; Subramaniam, Sai; Kimura, Akinori; Ocorr, Karen; Bodmer, Rolf; Penninger, Josef M.			A Global In Vivo Drosophila RNAi Screen Identifies NOT3 as a Conserved Regulator of Heart Function	CELL			English	Article							QT INTERVAL DURATION; CARDIAC-ARRHYTHMIAS; COMMON VARIANTS; MUTATIONS; COMPLEX; DYSFUNCTION; CHANNELS; DISEASE; MOUSE	Heart diseases are the most common causes of morbidity and death in humans. Using cardiac-specific RNAi-silencing in Drosophila, we knocked down 7061 evolutionarily conserved genes under conditions of stress. We present a first global road-map of pathways potentially playing conserved roles in the cardiovascular system. One critical pathway identified was the CCR4-Not complex implicated in transcriptional and posttranscriptional regulatory mechanisms. Silencing of CCR4-Not components in adult Drosophila resulted in myofibrillar disarray and dilated cardiomyopathy. Heterozygous not3 knockout mice showed spontaneous impairment of cardiac contractility and increased susceptibility to heart failure. These heart defects were reversed via inhibition of HDACs, suggesting a mechanistic link to epigenetic chromatin remodeling. In humans, we show that a common NOT3 SNP correlates with altered cardiac QT intervals, a known cause of potentially lethal ventricular tachyarrhythmias. Thus, our functional genome-wide screen in Drosophila can identify candidates that directly translate into conserved mammalian genes involved in heart function.	[Kuba, Keiji; Isobe, Kazuya; Fujisawa, Susumu; Imai, Yumiko] Akita Univ, Grad Sch Med, Dept Biol Informat & Expt Therapeut, Akita 0108543, Japan; [Neely, G. Gregory; Amann, Sabine; Xia, Cui-ping; Elling, Ulrich; Berger, Christian; Novatchkova, Maria; Koglgruber, Rubina; Pospisilik, J. Andrew; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol IMBA, A-1030 Vienna, Austria; [Cammarato, Anthony; Elmen, Lisa; Alayari, Nakissa N.; Ocorr, Karen; Bodmer, Rolf] Sanford Burnham Med Res Inst, Del E Webb Neurosci Aging & Stem Cell Res Ctr, Dev & Aging Program, La Jolla, CA 92037 USA; [Isobe, Kazuya; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiol, Bunkyo Ku, Tokyo 1138510, Japan; [Usami, Takako; Kimura, Akinori] Tokyo Med & Dent Univ, Dept Mol Pathogenesis, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Nishina, Hiroshi] Tokyo Med & Dent Univ, Dept Dev & Regenerat Biol, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Zhang, Liyong] Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, Div Cardiol, Toronto, ON M5S 1A1, Canada; [Murata, Mitsushige; Yamakawa, Hiroyuki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Regenerat Med & Adv Cardiac Therapeut, Tokyo 1608582, Japan; [Gupta, Vaijayanti; Arora, Suchir; Sarangi, Rinku; Dan, Debasis; Subramaniam, Sai] Strand Life Sci, Bangalore 560024, Karnataka, India; [Keene, Alex C.] NYU, Dept Biol, New York, NY 10003 USA; [Pfeufer, Arne] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Pfeufer, Arne] Helmholtz Ctr Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Hicks, Andrew A.; Pramstaller, Peter P.] European Acad Bozen Bolzano, Inst Med Genet, I-39100 Bolzano, Italy; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, I-39100 Bolzano, Italy; [Pramstaller, Peter P.] Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany	Akita University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Sanford Burnham Prebys Medical Discovery Institute; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Keio University; New York University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; European Academy of Bozen-Bolzano; Krankenhaus Bozen; University of Lubeck	Kuba, K (corresponding author), Akita Univ, Grad Sch Med, Dept Biol Informat & Expt Therapeut, 1-1-1 Hondo, Akita 0108543, Japan.	kuba@med.akita-u.ac.jp; rolf@burnham.org; josef.penninger@imba.oeaw.ac.at	Neely, Greg/AAB-4642-2020; Kimura, Akinori/I-5989-2018; Pramstaller, Peter P/C-2357-2008; Imai, Yumiko/GXW-1144-2022; neely, graham/A-6511-2011; Penninger, Josef M/I-6860-2013; Fukuda, Keiichi/L-3777-2013; Hicks, Andrew Anthony/E-9518-2017; YAMAKAWA, Hiroyuki/L-8582-2013; Pfeufer, Arne/B-6634-2013	Neely, Greg/0000-0002-1957-9732; Kimura, Akinori/0000-0002-4933-2132; Penninger, Josef M/0000-0002-8194-3777; Hicks, Andrew Anthony/0000-0001-6320-0411; YAMAKAWA, Hiroyuki/0000-0003-3100-5077; Pramstaller, Peter P/0000-0002-9831-8302	IMBA; Austrian Ministry of Science; European Research Council; EuGeneHeart; Japanese Ministry of Science [21659198]; Medical Top Track Program; Japan Heart Foundation; Marie Curie International; American Heart Association; German Federal Ministry of Research [01GR0803, 01EZ0874]; UK Foundation [FSID-261/2008]; Cyprus Cardiovascular Disease Educational and Research Trust [YGEIA/1104/17, ERYEX/0406/06]; Global Center of Excellence Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM086207] Funding Source: NIH RePORTER	IMBA; Austrian Ministry of Science; European Research Council(European Research Council (ERC)European Commission); EuGeneHeart; Japanese Ministry of Science; Medical Top Track Program; Japan Heart Foundation; Marie Curie International(European Commission); American Heart Association(American Heart Association); German Federal Ministry of Research; UK Foundation; Cyprus Cardiovascular Disease Educational and Research Trust; Global Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of our laboratories and the VDRC, the Bioscience Education Research Center (Akita University), and Vincent Chen for helpful discussions and excellent technical support. We thank Eric Olson for the Hand-Gal4 driver and Manfred Frasch for TinCD4-Gal4 driver stocks. We thank the members of the QTSCD consortium for valuable support and discussion. J.M.P. is supported by the IMBA, the Austrian Ministry of Science, a European Research Council Advanced Investigator grant, and EuGeneHeart. K. K. is supported by Kaken (21659198) from the Japanese Ministry of Science, the Medical Top Track Program, and the Japan Heart Foundation. G. G. N. was supported by a Marie Curie International Incoming Fellowship. A. C. was supported by a postdoctoral fellowship and K. O. by a Scientist Development Grant from the American Heart Association. R. B. was supported by grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health. A. P. is supported by grants 01GR0803 and 01EZ0874 from the German Federal Ministry of Research, FSID-261/2008 from the UK Foundation for the Study of Infant Deaths, and YGEIA/1104/17 and ERYEX/0406/06 from the Cyprus Cardiovascular Disease Educational and Research Trust. Y. I. is supported by the Global Center of Excellence Program.	Alayari NN, 2009, JOVE-J VIS EXP, pe1423, DOI DOI 10.3791/1423; Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; BODMER R, 1995, TRENDS CARDIOVAS MED, V5, P21, DOI 10.1016/1050-1738(94)00032-Q; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; DENIS CL, 1984, GENETICS, V108, P833; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; GORDON T, 1977, JAMA-J AM MED ASSOC, V238, P497, DOI 10.1001/jama.238.6.497; Han Z, 2005, DEVELOPMENT, V132, P3525, DOI 10.1242/dev.01899; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Jayne S, 2006, BIOCHEM J, V398, P461, DOI 10.1042/BJ20060406; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Laribee RN, 2007, P NATL ACAD SCI USA, V104, P5836, DOI 10.1073/pnas.0607996104; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lo PCH, 2001, MECH DEVELOP, V104, P49, DOI 10.1016/S0925-4773(01)00361-6; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; Moss AJ, 2005, J CLIN INVEST, V115, P2018, DOI 10.1172/JCI25537; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; Nerbonne JM, 2004, TRENDS CARDIOVAS MED, V14, P83, DOI 10.1016/j.tcm.2003.12.006; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Ocorr K, 2007, TRENDS CARDIOVAS MED, V17, P177, DOI 10.1016/j.tcm.2007.04.001; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Paternostro G, 2001, CIRC RES, V88, P1053, DOI 10.1161/hh1001.090857; Peng WM, 2008, GENETICS, V179, P277, DOI 10.1534/genetics.107.085068; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Qian L, 2009, HUM MOL GENET, V18, P3153, DOI 10.1093/hmg/ddp254; Qian L, 2008, P NATL ACAD SCI USA, V105, P19833, DOI 10.1073/pnas.0808705105; Ray VM, 2005, J NEUROGENET, V19, P39, DOI 10.1080/01677060590953066; Rusconi JC, 2007, INT J DEV BIOL, V51, P259, DOI 10.1387/ijdb.062233jr; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sanyal S, 2006, J COMP PHYSIOL B, V176, P253, DOI 10.1007/s00360-005-0046-7; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	37	162	164	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					142	153		10.1016/j.cell.2010.02.023	http://dx.doi.org/10.1016/j.cell.2010.02.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371351	Green Accepted, Bronze			2022-12-24	WOS:000276211100019
J	Yamey, G				Yamey, Gavin			Medicine in Developing Countries Do schools hold the key to controlling parasitic disease?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MALARIA; SCHOOLCHILDREN; EDUCATION; HEALTH		Univ Calif San Francisco, Global Hlth Grp, Evidence Policy Initiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Yamey, G (corresponding author), Univ Calif San Francisco, Global Hlth Grp, Evidence Policy Initiat, San Francisco, CA 94143 USA.	YameyG@globalhealth.ucsf.edu						[Anonymous], 2004, COCHRANE DB SYST REV; Brooker S, 2008, T ROY SOC TROP MED H, V102, P304, DOI 10.1016/j.trstmh.2008.01.010; Bundy DAP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000362; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; *CLIN TRIALS SERV, DEVTA; *DEP INT DEV, FACTS KEN; Gulani A, 2007, BMJ-BRIT MED J, V334, P1095, DOI 10.1136/bmj.39150.510475.AE; Lalloo DG, 2006, LANCET INFECT DIS, V6, P780, DOI 10.1016/S1473-3099(06)70655-7; Miguel E, 2004, ECONOMETRICA, V72, P159, DOI 10.1111/j.1468-0262.2004.00481.x; Mwandawiro Charles S, 2004, Afr J Health Sci, V11, pi; NOKES C, 1994, PARASITOL TODAY, V10, P14, DOI 10.1016/0169-4758(94)90348-4; Taylor-Robinson DC, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub3	12	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2010	340								c1565	10.1136/bmj.c1565	http://dx.doi.org/10.1136/bmj.c1565			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576PR	20348176				2022-12-24	WOS:000276157900005
J	Barrett-Connor, E; Nielson, CM; Orwoll, E; Bauer, DC; Cauley, JA				Barrett-Connor, Elizabeth; Nielson, Carrie M.; Orwoll, Eric; Bauer, Douglas C.; Cauley, Jane A.		Osteoporotic Fractures Men MrOS St	Epidemiology of rib fractures in older men: Osteoporotic Fractures in Men (MrOS) prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							HIGH-TRAUMA FRACTURES; BONE-MINERAL DENSITY; WOMEN	Objective To study the causes and consequences of radiologically confirmed rib fractures (seldom considered in the context of osteoporosis) in community dwelling older men. Design Prospective cohort study (Osteoporotic Fractures in Men (MrOS) Study). Setting and participants 5995 men aged 65 or over recruited in 2000-2 from six US sites; 99% answered mailed questionnaires about falls and fractures every four months for a mean 6.2 (SD 1.3) year follow-up. Main outcome measures New fractures validated by radiology reports; multivariate Cox proportional hazard ratios were used to evaluate factors independently associated with time to incident rib fracture; associations between baseline rib fracture and incident hip and wrist fracture were also evaluated. Results The incidence of rib fracture was 3.5/1000 person years, and 24% (126/522) of all incident non-spine fractures were rib fractures. Nearly half of new rib fractures (48%; n=61) followed falling from standing height or lower. Independent risk factors for an incident rib fracture were age 80 or above, low bone density, difficulty with instrumental activities of daily living, and a baseline history of rib/chest fracture. Men with a history of rib/chest fracture had at least a twofold increased risk of an incident rib fracture (adjusted hazard ratio 2.71, 95% confidence interval 1.86 to 3.95), hip fracture (2.05, 1.33 to 3.15), and wrist fracture (2.06, 1.14 to 3.70). Only 14/82 of men reported being treated with bone specific drugs after their incident rib fracture. Conclusions Rib fracture, the most common incident clinical fracture in men, was associated with classic risk markers for osteoporosis, including old age, low hip bone mineral density, and history of fracture. A history of rib fracture predicted a more than twofold increased risk of future fracture of the rib, hip, or wrist, independent of bone density and other covariates. Rib fractures should be considered to be osteoporotic fractures in the evaluation of older men for treatment to prevent future fracture.	[Barrett-Connor, Elizabeth] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Nielson, Carrie M.; Orwoll, Eric] Oregon Hlth & Sci Univ, Bone & Mineral Unit, Portland, OR 97201 USA; [Bauer, Douglas C.] Univ Calif San Francisco, San Francisco, CA 94107 USA; [Cauley, Jane A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15241 USA	University of California System; University of California San Diego; Oregon Health & Science University; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Barrett-Connor, E (corresponding author), Univ Calif San Diego, Dept Family & Prevent Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ebarrettconnor@ucsd.edu		Orwoll, Eric/0000-0002-8520-7355; Cauley, Jane A/0000-0003-0752-4408	National Institutes of Health [U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, UL1 RR024140]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute on Aging (NIA); National Center for Research Resources (NCRR)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The Osteoporotic Fractures in Men (MrOS) Study is supported by National Institutes of Health funding. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute on Aging (NIA), the National Center for Research Resources (NCRR), and NIH Roadmap for Medical Research provide support under the following grant numbers: U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, and UL1 RR024140.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Barnea Y, 2002, CAN J SURG, V45, P43; Blank JB, 2005, CONTEMP CLIN TRIALS, V26, P557, DOI 10.1016/j.cct.2005.05.005; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; COOPER C, 1992, TRENDS ENDOCRIN MET, V3, P224, DOI 10.1016/1043-2760(92)90032-V; Davie MWJ, 1996, J ORTHOP RHEUMATOL, V9, P41; HONKANEN R, 1995, J CLIN EPIDEMIOL, V48, P881, DOI 10.1016/0895-4356(94)00220-K; Ismail AA, 2006, OSTEOPOROSIS INT, V17, P41, DOI 10.1007/s00198-005-1887-3; JONES G, 1994, OSTEOPOROSIS INT, V4, P277, DOI 10.1007/BF01623352; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Mackey DC, 2007, JAMA-J AM MED ASSOC, V298, P2381, DOI 10.1001/jama.298.20.2381; Marcus R, 2008, OSTEOPOROSIS, VOLS I AND II, 3RD EDITION, P1; NEVITT M, 1992, P INT S FALLS ELD MA; NEVITT MC, 1992, AM J EPIDEMIOL, V135, P490, DOI 10.1093/oxfordjournals.aje.a116315; NEVITT MC, 1991, P INT S FALLS ELD MA; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Palvanen M, 2004, OSTEOPOROSIS INT, V15, P649, DOI 10.1007/s00198-003-1585-y; Sanders KM, 1998, J BONE MINER RES, V13, P1337, DOI 10.1359/jbmr.1998.13.8.1337; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4	20	47	47	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 15	2010	340								c1069	10.1136/bmj.c1069	http://dx.doi.org/10.1136/bmj.c1069			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573RA	20231246	hybrid, Green Submitted, Green Published			2022-12-24	WOS:000275931100001
J	Novarino, G; Weinert, S; Rickheit, G; Jentsch, TJ				Novarino, Gaia; Weinert, Stefanie; Rickheit, Gesa; Jentsch, Thomas J.			Endosomal Chloride-Proton Exchange Rather Than Chloride Conductance Is Crucial for Renal Endocytosis	SCIENCE			English	Article							DENTS-DISEASE; CLC PROTEINS; IMPAIRS ENDOCYTOSIS; PROXIMAL TUBULE; CHANNEL; MODEL; NEPHROLITHIASIS; ACIDIFICATION; ANTIPORTER; MOUSE	Loss of the endosomal anion transport protein ClC-5 impairs renal endocytosis and underlies human Dent's disease. ClC-5 is thought to promote endocytosis by facilitating endosomal acidification through the neutralization of proton pump currents. However, ClC-5 is a 2 chloride (Cl(-))/proton (H(+)) exchanger rather than a Cl(-) channel. We generated mice that carry the uncoupling E211A (unc) mutation that converts ClC-5 into a pure Cl(-) conductor. Adenosine triphosphate (ATP)-dependent acidification of renal endosomes was reduced in mice in which ClC-5 was knocked out, but normal in Clcn5(unc) mice. However, their proximal tubular endocytosis was also impaired. Thus, endosomal chloride concentration, which is raised by ClC-5 in exchange for protons accumulated by the H(+)-ATPase, may play a role in endocytosis.	[Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Jentsch, TJ (corresponding author), Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany.	jentsch@fmp-berlin.de	Weinert, Stefanie/AAR-1481-2021	Weinert, Stefanie/0000-0003-3036-1440; Jentsch, Thomas/0000-0002-3509-2553	Deutsche Forschungsgemeinschaft [Zd58/1, Je164/6, Je164/9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank R. Pareja-Alcaraz and S. Rode for technical assistance and P. Verroust, S. Bachmann, W. Blaner, and C. Wagner for antibodies against cubilin, megalin, retinol binding protein, and AE1, respectively. This work was supported by the Deutsche Forschungsgemeinschaft (grants Zd58/1, Je164/6, and Je164/9).	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; Christensen EI, 2003, P NATL ACAD SCI USA, V100, P8472, DOI 10.1073/pnas.1432873100; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Hryciw DH, 2006, J BIOL CHEM, V281, P16068, DOI 10.1074/jbc.M512559200; Hryciw DH, 2003, J BIOL CHEM, V278, P40169, DOI 10.1074/jbc.M307890200; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Reed AAC, 2010, AM J PHYSIOL-RENAL, V298, pF365, DOI 10.1152/ajprenal.00038.2009; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Scheinman SJ, 1998, KIDNEY INT, V53, P3, DOI 10.1046/j.1523-1755.1998.00718.x; Wang SS, 2000, HUM MOL GENET, V9, P2937, DOI 10.1093/hmg/9.20.2937; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	25	116	125	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1398	1401		10.1126/science.1188070	http://dx.doi.org/10.1126/science.1188070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20430975				2022-12-24	WOS:000278598400039
J	Schmidtko, A; Lotsch, J; Freynhagen, R; Geisslinger, G				Schmidtko, Achim; Loetsch, Joern; Freynhagen, Rainer; Geisslinger, Gerd			Ziconotide for treatment of severe chronic pain	LANCET			English	Article							CALCIUM-CHANNEL BLOCKER; COMBINED INTRATHECAL MORPHINE; ORAL ANALGESIC EFFICACY; N-TYPE; OMEGA-CONOTOXIN; OPEN-LABEL; NEUROPATHIC PAIN; CA2+ CHANNELS; DOUBLE-BLIND; T-TYPE	Pharmacological management of severe chronic pain is difficult to achieve with currently available analgesic drugs, and remains a large unmet therapeutic need. The synthetic peptide ziconotide has been approved by the US Food and Drug Administration and the European Medicines Agency for intrathecal treatment of patients with severe chronic pain that is refractory to other treatment modalities. Ziconotide is the first member in the new drug class of selective N-type voltage-sensitive calcium-channel blockers. The ziconotide-induced blockade of N-type calcium channels in the spinal cord inhibits release of pain-relevant neurotransmitters from central terminals of primary afferent neurons. By this mechanism, ziconotide can effectively reduce pain. However, ziconotide has a narrow therapeutic window because of substantial CNS side-effects, and thus treatment with ziconotide is appropriate for only a small subset of patients with severe chronic pain. We provide an overview of the benefits and limitations of intrathecal ziconotide treatment and review potential future developments in this new drug class.	[Schmidtko, Achim; Loetsch, Joern; Geisslinger, Gerd] Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Inst Klin Pharmakol, D-60590 Frankfurt, Germany; [Freynhagen, Rainer] Benedictus Krankenhaus, Zentrum Anasthesiol Intens Med Schmerztherapie, Schmerzzentrum Starnberger See, Tutzing, Germany	Goethe University Frankfurt	Geisslinger, G (corresponding author), Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Inst Klin Pharmakol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	geisslinger@em.uni-frankfurt.de	Schmidtko, Achim/AAB-2122-2019	Freynhagen, Rainer/0000-0002-3759-1508; Lotsch, Jorn/0000-0002-5818-6958; Schmidtko, Achim/0000-0001-7270-5075	Deutsche Forschungsgemeinschaft [DFG-SFB 815/A14, GE695]; LOEWE Lipid Signaling Forschungszentrum Frankfurt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE Lipid Signaling Forschungszentrum Frankfurt	Research work of AS, Jl, and GG is supported by the Deutsche Forschungsgemeinschaft (DFG-SFB 815/A14, GE695) and the LOEWE Lipid Signaling Forschungszentrum Frankfurt.	Alford DP, 2008, J GEN INTERN MED, V23, P841, DOI 10.1007/s11606-008-0570-8; Altier C, 2004, TRENDS PHARMACOL SCI, V25, P465, DOI 10.1016/j.tips.2004.07.004; [Anonymous], 2006, NATL PBM DRUG MONOGR; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; Bowersox SS, 1998, TOXICON, V36, P1651, DOI 10.1016/S0041-0101(98)00158-5; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Cizkova D, 2002, EXP BRAIN RES, V147, P456, DOI 10.1007/s00221-002-1217-3; Deer T, 2008, NEUROMODULATION, V11, P92, DOI 10.1111/j.1525-1403.2008.00148.x; Deer T, 2007, NEUROMODULATION, V10, P300, DOI 10.1111/j.1525-1403.2007.00128.x; *EMEA, 2005, SCI DISC ZIC; Feng ZP, 2003, J BIOL CHEM, V278, P20171, DOI 10.1074/jbc.M300581200; Field MJ, 2006, P NATL ACAD SCI USA, V103, P17537, DOI 10.1073/pnas.0409066103; GOHIL K, 1994, BRAIN RES, V653, P258, DOI 10.1016/0006-8993(94)90398-0; Heading Christine E, 2002, Curr Opin Investig Drugs, V3, P915; Hu LY, 1999, J MED CHEM, V42, P4239, DOI 10.1021/jm9902739; Jeon D, 2007, GENES BRAIN BEHAV, V6, P375, DOI 10.1111/j.1601-183X.2006.00267.x; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Kapural L, 2009, PAIN PRACT, V9, P296, DOI 10.1111/j.1533-2500.2009.00289.x; Klotz U, 2006, INT J CLIN PHARM TH, V44, P478; Koganei H, 2009, BIOL PHARM BULL, V32, P1695, DOI 10.1248/bpb.32.1695; Kroenke K, 2009, GEN HOSP PSYCHIAT, V31, P206, DOI 10.1016/j.genhosppsych.2008.12.006; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Lynch SS, 2006, ANN PHARMACOTHER, V40, P1293, DOI 10.1345/aph.1G584; McGivern JG, 2006, DRUG DISCOV TODAY, V11, P245, DOI 10.1016/S1359-6446(05)03662-7; McGuire D, 1997, J CARDIOVASC PHARM, V30, P400, DOI 10.1097/00005344-199709000-00019; Meng G, 2008, EUR J PHARMACOL, V586, P130, DOI 10.1016/j.ejphar.2008.02.066; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; MILJANICH GP, 1995, ANNU REV PHARMACOL, V35, P707, DOI 10.1146/annurev.pa.35.040195.003423; Motin L, 2008, NEUROPHARMACOLOGY, V55, P860, DOI 10.1016/j.neuropharm.2008.06.049; Newcomb R, 2000, PEPTIDES, V21, P491, DOI 10.1016/S0196-9781(00)00175-3; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Olivera BM, 2007, MOL INTERV, V7, P251, DOI 10.1124/mi.7.5.7; OLIVERA BM, 1987, BIOCHEMISTRY-US, V26, P2086, DOI 10.1021/bi00382a004; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; Rauck RL, 2009, PAIN PRACT, V9, P327, DOI 10.1111/j.1533-2500.2009.00303.x; Rauck RL, 2006, J PAIN SYMPTOM MANAG, V31, P393, DOI 10.1016/j.jpainsymman.2005.10.003; Schmidtko A, 2009, TRENDS NEUROSCI, V32, P339, DOI 10.1016/j.tins.2009.01.010; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Seko T, 2002, BIOORG MED CHEM LETT, V12, P2267, DOI 10.1016/S0960-894X(02)00456-0; Seko T, 2001, BIOORG MED CHEM LETT, V11, P2067, DOI 10.1016/S0960-894X(01)00414-0; Smith Howard S, 2009, Ther Clin Risk Manag, V5, P521; Snutch Terrance P, 2005, NeuroRx, V2, P662, DOI 10.1602/neurorx.2.4.662; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Stanton-Hicks M, 2006, J PAIN SYMPTOM MANAG, V32, P509, DOI 10.1016/j.jpainsymman.2006.08.002; Stix G, 2005, SCI AM, V292, P79; Taylor CP, 2009, PAIN, V142, P13, DOI 10.1016/j.pain.2008.11.019; Thompson James C, 2006, Pain Physician, V9, P147; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Wallace MS, 2008, PAIN MED, V9, P271, DOI 10.1111/j.1526-4637.2007.00355.x; Wallace MS, 2008, ANESTH ANALG, V106, P628, DOI 10.1213/ane.0b013e3181606fad; Wallace Mark S, 2006, Expert Rev Neurother, V6, P1423, DOI 10.1586/14737175.6.10.1423; Wallace MS, 2006, NEUROMODULATION, V9, P75, DOI 10.1111/j.1525-1403.2006.00055.x; Wang YX, 2000, PAIN, V84, P271, DOI 10.1016/S0304-3959(99)00214-6; Webster LR, 2008, PAIN MED, V9, P282, DOI 10.1111/j.1526-4637.2007.00356.x; Webster LR, 2009, J PAIN SYMPTOM MANAG, V37, P363, DOI 10.1016/j.jpainsymman.2008.02.016; Wermeling D, 2003, J CLIN PHARMACOL, V43, P624, DOI 10.1177/0091270003253349; Wermeling DR, 2005, PHARMACOTHERAPY, V25, P1084, DOI 10.1592/phco.2005.25.8.1084; Williams JA, 2008, EXPERT OPIN PHARMACO, V9, P1575, DOI 10.1517/14656566.9.9.1575 ; Yaksh TL, 2006, CNS DRUGS, V20, P339; Yamamoto T, 2006, BIOORG MED CHEM LETT, V16, P798, DOI 10.1016/j.bmcl.2005.11.021; Yamamoto T, 2006, BIOORGAN MED CHEM, V14, P5333, DOI 10.1016/j.bmc.2006.03.040; Yamamoto T, 2009, CURR TOP MED CHEM, V9, P377, DOI 10.2174/156802609788317838; Yokoyama K, 2003, ANESTHESIOLOGY, V99, P1364, DOI 10.1097/00000542-200312000-00019; Zamponi GW, 2009, BIOORG MED CHEM LETT, V19, P6467, DOI 10.1016/j.bmcl.2009.09.008	64	224	230	1	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2010	375	9725					1569	1577		10.1016/S0140-6736(10)60354-6	http://dx.doi.org/10.1016/S0140-6736(10)60354-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AH	20413151				2022-12-24	WOS:000277655100030
J	Yu, XR; Huang, YG; Qu, G; Xu, JY; Hui, SY				Yu, Xuerong; Huang, Yuguang; Qu, Ge; Xu, Jiaying; Hui, Shangyi			Safety and current status of blood transfusion in China	LANCET			English	Editorial Material									[Yu, Xuerong; Huang, Yuguang; Qu, Ge; Xu, Jiaying; Hui, Shangyi] Beijing Union Med Coll Hosp, Dept Anaesthesiol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Huang, YG (corresponding author), Beijing Union Med Coll Hosp, Dept Anaesthesiol, 1 Shuaifuyuan, Beijing 100730, Peoples R China.	pumchhyg@yahoo.com.cn	xu, jia/GSD-6347-2022					FENG Z, 2005, CHINA DAILY BEI 1201, P92502; JUAN S, 2007, CHINA DAILY BEI 0901, P92502; MINGYAN W, 2009, EVENING PAPER B 0122, P92502; MINYI C, 2007, NEWS NET CHINES 1204, P92502; QI B, BEIJING BUREAU HLTH, P92502; QI L, 1999, REGULATION BLOOD DON, P92502; The Ministry of Health of the People's Republic of China Joint United Nations Programme on HIV/AIDS and World Health Organization, 2006, 2005 UPD HIV AIDS EP; United States Department of Health and Human Services, 2007 NAT BLOOD COLL; YUGUI L, 2008, BEIJING EVENING 1006, P92502	9	25	28	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 24	2010	375	9724					1420	1421		10.1016/S0140-6736(10)60003-7	http://dx.doi.org/10.1016/S0140-6736(10)60003-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	590FL	20347128				2022-12-24	WOS:000277210000011
J	Ozaltin, E; Hill, K; Subramanian, SV				Ozaltin, Emre; Hill, Kenneth; Subramanian, S. V.			Association of Maternal Stature With Offspring Mortality, Underweight, and Stunting in Low- to Middle-Income Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPRODUCTIVE SUCCESS; BODY-SIZE; REGRESSION APPROACH; CHILD-MORTALITY; HEIGHT; DETERMINANTS; FERTILITY	Context Although maternal stature has been associated with offspring mortality and health, the extent to which this association is universal across developing countries is unclear. Objective To examine the association between maternal stature and offspring mortality, underweight, stunting, and wasting in infancy and early childhood in 54 low- to middle-income countries. Design, Setting, and Participants Analysis of 109 Demographic and Health Surveys in 54 countries conducted between 1991 and 2008. Study population consisted of a nationally representative cross-sectional sample of children aged 0 to 59 months born to mothers aged 15 to 49 years. Sample sizes were 2 661 519 (mortality), 587 096 (underweight), 558 347 (stunting), and 568 609 (wasting) children. Main Outcome Measures Likelihood of mortality, underweight, stunting, or wasting in children younger than 5 years. Results The mean response rate across surveys in the mortality data set was 92.8%. In adjusted models, a 1-cm increase in maternal height was associated with a decreased risk of child mortality (absolute risk difference [ARD], 0.0014; relative risk [RR], 0.988; 95% confidence interval [CI], 0.987-0.988), underweight (ARD, 0.0068; RR, 0.968; 95% CI, 0.968-0.969), stunting (ARD, 0.0126; RR, 0.968; 95% CI, 0.967-0.968), and wasting (ARD, 0.0005; RR, 0.994; 95% CI, 0.993-0.995). Absolute risk of dying among children born to the tallest mothers (>= 160 cm) was 0.073 (95% CI, 0.072-0.074) and to those born to the shortest mothers (< 145 cm) was 0.128 (95% CI, 0.126-0.130). Country-specific decrease in the risk for child mortality associated with a 1-cm increase in maternal height varied between 0.978 and 1.011, with the decreased risk being statistically significant in 46 of 54 countries (85%) (alpha =. 05). Conclusion Among 54 low- to middle-income countries, maternal stature was inversely associated with offspring mortality, underweight, and stunting in infancy and childhood. JAMA. 2010; 303(15): 1507-1516 www.jama.com	[Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Ozaltin, Emre; Hill, Kenneth] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Subramanian, SV (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	svsubram@hsph.harvard.edu			National Institutes of Health [NHLBI K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	No direct financial support or funding was obtained to conduct this study. Dr Subramanian is supported by a career development grant NHLBI K25 HL081275 from the National Institutes of Health.	Allal N, 2004, P ROY SOC B-BIOL SCI, V271, P465, DOI 10.1098/rspb.2003.2623; [Anonymous], 1995, Bull World Health Organ, V73 Suppl, P1; BAQUI AH, 1994, EUR J CLIN NUTR, V48, P349; Behrman JR, 2004, ECON HUM BIOL, V2, P335, DOI 10.1016/j.ehb.2004.10.002; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Boerma J T, 1993, World Health Stat Q, V46, P222; Cheung YB, 2007, AM J EPIDEMIOL, V166, P1337, DOI 10.1093/aje/kwm223; DEVI MR, 1985, ANN HUM BIOL, V12, P479, DOI 10.1080/03014468500008031; Ethiopia CSA, 2006, DEMOGRAPHIC HLTH SUR; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; FRISANCH.AR, 1973, AM J PHYS ANTHROPOL, V39, P255, DOI 10.1002/ajpa.1330390216; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; HART N, 1993, POP STUD-J DEMOG, V47, P27, DOI 10.1080/0032472031000146716; Hernandez-Diaz S, 1999, EUR J CLIN NUTR, V53, P938, DOI 10.1038/sj.ejcn.1600876; Johnson K., 2009, FIELDWORK RELATED FA; Kelly A, 1996, INT J GYNECOL OBSTET, V53, P219, DOI 10.1016/0020-7292(96)02652-5; Kirchengast S, 2000, COLLEGIUM ANTROPOL, V24, P121; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; LASKER GW, 1976, HUM BIOL, V48, P775; Macro International Inc, 1996, SAMPL MAN DHS 3; MARTORELL R, 1989, HUM ORGAN, V48, P15, DOI 10.17730/humo.48.1.x20u5450x51h5211; MARTORELL R, 1986, HUMAN GROWTH COMPREH, V3; Monden CWS, 2009, AM J HUM BIOL, V21, P305, DOI 10.1002/ajhb.20860; MUELLER WH, 1979, HUM BIOL, V51, P153; Pollet TV, 2008, AM J HUM BIOL, V20, P264, DOI 10.1002/ajhb.20708; Pullum TW, 2008, ASSESSMENT QUALITY D; Rush D, 2000, AM J CLIN NUTR, V72, p212S, DOI 10.1093/ajcn/72.1.212S; Rutstein SO, 2003, GUIDE DHS STAT; Rutstein SO, 2004, DHS WEALTH ASSET IND; Saleemi MA, 2001, ACTA PAEDIATR, V90, P1304, DOI 10.1080/080352501317130371; Sear R, 2004, RES ECON ANTHROPOL, V23, P203, DOI 10.1016/S0190-1281(04)23008-6; Sichieri R, 2000, J ADOLESCENT HEALTH, V26, P414, DOI 10.1016/S1054-139X(99)00004-X; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Stata Corp, 2008, STAT SOFTW REL 10SE; Steckel RH, 2008, J ECON PERSPECT, V22, P129, DOI 10.1257/jep.22.1.129; Strickland Simon S., 2002, Journal of Physiological Anthropology and Applied Human Science, V21, P1, DOI 10.2114/jpa.21.1; STRICKLAND SS, 1997, FORM FUNCTION STUDY; Subramanian SV, 2009, JAMA-J AM MED ASSOC, V301, P1691, DOI 10.1001/jama.2009.548; SULLIVAN JM, 1990, DEMOGRAPHIC HLTH SUR, V1, P113; VAESSEN M, 1996, DEMOGRAPHIC EVALUATI; VANROOSMALEN J, 1992, INT J GYNECOL OBSTET, V37, P169, DOI 10.1016/0020-7292(92)90377-U; WHO, 2006, WHO CHILD GROWTH STA; WRITH ME, 2006, MONITORING HLTH EQUI; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; DEMOGRAPHIC HLTH SUR	46	263	268	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2010	303	15					1507	1516		10.1001/jama.2010.450	http://dx.doi.org/10.1001/jama.2010.450			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	585SJ	20407060	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000276849000027
J	Shelton, JD				Shelton, James D.			A tale of two-component generalised HIV epidemics	LANCET			English	Editorial Material							CONCURRENT PARTNERSHIPS; INFECTION; RISK		US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA.	jshelton@usaid.gov						Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bunnell R, 2008, LANCET, V371, P2148, DOI 10.1016/S0140-6736(08)60929-0; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Gray RH, 2008, LANCET, V371, P2064, DOI 10.1016/S0140-6736(08)60896-X; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; *MIN HLTH KEN NAT, 2008, KEN AIDS IND SURV 20; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; PEPFAR, 2009, US PRES EM PLAN AIDS; Pinkerton SD, 2008, AIDS BEHAV, V12, P677, DOI 10.1007/s10461-007-9329-1; Sagar M, 2009, J INFECT DIS, V199, P580, DOI 10.1086/596557; Shelton JD, 2008, LANCET, V372, P273, DOI 10.1016/S0140-6736(08)61091-0; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148	16	25	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2010	375	9719					964	966		10.1016/S0140-6736(10)60416-3	http://dx.doi.org/10.1016/S0140-6736(10)60416-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	575YU	20304227				2022-12-24	WOS:000276110700008
J	Carel, H; Johnson, S; Gamble, L				Carel, Havi; Johnson, Simon; Gamble, Liz			A Patient's Journey Living with lymphangioleiomyomatosis	BRITISH MEDICAL JOURNAL			English	Editorial Material							TUBEROUS SCLEROSIS COMPLEX; SIROLIMUS		[Carel, Havi] Univ W England, Fac Humanities & Social Sci, Bristol BS16 1QY, Avon, England; [Johnson, Simon] Univ Nottingham, Queens Med Ctr, Div Therapeut & Mol Med, Nottingham NG7 2RD, England; [Gamble, Liz] Bristol Royal Infirm & Gen Hosp, Dept Resp Med, Bristol, Avon, England	University of West England; University of Nottingham; Bristol Royal Infirmary	Carel, H (corresponding author), Univ W England, Fac Humanities & Social Sci, Bristol BS16 1QY, Avon, England.	havi.Carel@uwe.ac.uk; simon.johnson@nottingham.ac.uk; liz.gamble@UHBristol.nhs.uk		Johnson, Simon/0000-0002-9837-2763; Carel, Havi/0000-0002-1260-2362				Avila NA, 2000, RADIOLOGY, V216, P147, DOI 10.1148/radiology.216.1.r00jl42147; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Davies DM, 2008, NEW ENGL J MED, V358, P200, DOI 10.1056/NEJMc072500; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Henske EP, 2003, GENE CHROMOSOME CANC, V38, P376, DOI 10.1002/gcc.10252; Johnson SR, 2010, EUR RESPIR J, V35, P14, DOI 10.1183/09031936.00076209; Johnson SR, 2004, THORAX, V59, P800, DOI 10.1136/thx.2004.023283; Johnson SR, 2006, EUR RESPIR J, V27, P1056, DOI 10.1183/09031936.06.00113303	8	3	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 12	2010	340								c848	10.1136/bmj.c848	http://dx.doi.org/10.1136/bmj.c848			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570FF	20228149				2022-12-24	WOS:000275657000011
J	Le Trong, I; Aprikian, P; Kidd, BA; Forero-Shelton, M; Tchesnokova, V; Rajagopal, P; Rodriguez, V; Interlandi, G; Klevit, R; Vogel, V; Stenkamp, RE; Sokurenko, EV; Thomas, WE				Le Trong, Isolde; Aprikian, Pavel; Kidd, Brian A.; Forero-Shelton, Manu; Tchesnokova, Veronika; Rajagopal, Ponni; Rodriguez, Victoria; Interlandi, Gianluca; Klevit, Rachel; Vogel, Viola; Stenkamp, Ronald E.; Sokurenko, Evgeni V.; Thomas, Wendy E.			Structural Basis for Mechanical Force Regulation of the Adhesin FimH via Finger Trap-like beta Sheet Twisting	CELL			English	Article							ESCHERICHIA-COLI; CATCH BONDS; MOLECULAR REPLACEMENT; BACTERIAL ADHESION; CRYSTAL-STRUCTURE; CELL-ADHESION; COMPLEX; BINDING; ALLOSTERY; SELECTIN	The Escherichia coli fimbrial adhesive protein, FimH, mediates shear-dependent binding to mannosylated surfaces via force-enhanced allosteric catch bonds, but the underlying structural mechanism was previously unknown. Here we present the crystal structure of FimH incorporated into the multiprotein fimbrial tip, where the anchoring ( pilin) domain of FimH interacts with the mannose-binding ( lectin) domain and causes a twist in the beta sandwich fold of the latter. This loosens the mannose-binding pocket on the opposite end of the lectin domain, resulting in an inactive low-affinity state of the adhesin. The autoinhibition effect of the pilin domain is removed by application of tensile force across the bond, which separates the domains and causes the lectin domain to untwist and clamp tightly around the ligand like a finger-trap toy. Thus, b sandwich domains, which are common in multidomain proteins exposed to tensile force in vivo, can undergo drastic allosteric changes and be subjected to mechanical regulation.	[Le Trong, Isolde; Stenkamp, Ronald E.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Aprikian, Pavel; Tchesnokova, Veronika; Sokurenko, Evgeni V.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Kidd, Brian A.; Rodriguez, Victoria; Interlandi, Gianluca; Thomas, Wendy E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Rajagopal, Ponni; Klevit, Rachel; Stenkamp, Ronald E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Stenkamp, Ronald E.] Univ Washington, Biomol Struct Ctr, Seattle, WA 98195 USA; [Forero-Shelton, Manu] Univ Los Andes, Dept Phys, Bogota, Colombia; [Forero-Shelton, Manu; Vogel, Viola] ETH, Lab Biol Oriented Mat, Dept Mat, Zurich, Switzerland	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Universidad de los Andes (Colombia); Swiss Federal Institutes of Technology Domain; ETH Zurich	Stenkamp, RE (corresponding author), Univ Washington, Dept Biol Struct, Box 357420, Seattle, WA 98195 USA.	stenkamp@u.washington.edu; evs@u.washington.edu; wendyt@u.washington.edu	Klevit, Rachel/AAI-7038-2021; Vogel, Viola/O-8025-2015	Klevit, Rachel/0000-0002-3476-969X; Vogel, Viola/0000-0003-2898-7671; Forero-Shelton, Manu/0000-0002-7989-0311; Kidd, Brian/0000-0003-2110-1145	NIH [1RO1 AI50940, 5R01 AI045820, 5T32 GM008268]; AHA [0820107Z]; Director, Office of Science, Office of Basic Energy Sciences, the U. S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045820, R01AI050940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Director, Office of Science, Office of Basic Energy Sciences, the U. S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank NIH (1RO1 AI50940, 5R01 AI045820, and 5T32 GM008268) and the AHA Postdoctoral Fellowship # 0820107Z for funding this work. We thank Eric Larson for helpful discussions and the Advanced Light Source for beamtime. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, the U. S. Department of Energy, under Contract No. DE-AC02-05CH11231.	Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Anderson BN, 2007, J BACTERIOL, V189, P1794, DOI 10.1128/JB.00899-06; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Bouckaert J, 2005, MOL MICROBIOL, V55, P441, DOI 10.1111/j.1365-2958.2004.04415.x; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Chen XH, 2007, P NATL ACAD SCI USA, V104, P15358, DOI 10.1073/pnas.0707406104; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Eidam O, 2008, FEBS LETT, V582, P651, DOI 10.1016/j.febslet.2008.01.030; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Gossert AD, 2008, J MOL BIOL, V375, P752, DOI 10.1016/j.jmb.2007.10.059; Hashimoto H, 2006, CELL MOL LIFE SCI, V63, P2954, DOI 10.1007/s00018-006-6195-3; Holmes KC, 2004, PHILOS T ROY SOC B, V359, P1819, DOI 10.1098/rstb.2004.1566; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nilsson LM, 2006, APPL ENVIRON MICROB, V72, P3005, DOI 10.1128/AEM.72.4.3005-3010.2006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Puorger C, 2008, STRUCTURE, V16, P631, DOI 10.1016/j.str.2008.01.013; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Shan WS, 1999, BIOPHYS CHEM, V82, P157, DOI 10.1016/S0301-4622(99)00115-5; Sokurenko EV, 2004, MOL BIOL EVOL, V21, P1373, DOI 10.1093/molbev/msh136; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; Tchesnokova V, 2008, J BIOL CHEM, V283, P7823, DOI 10.1074/jbc.M707804200; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Waldron TT, 2009, P NATL ACAD SCI USA, V106, P85, DOI 10.1073/pnas.0810620105; Wellens A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002040; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200; Zhu C, 2002, ANN BIOMED ENG, V30, P305, DOI 10.1114/1.1467923	51	197	200	1	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					645	655		10.1016/j.cell.2010.03.038	http://dx.doi.org/10.1016/j.cell.2010.03.038			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478255	Bronze, Green Accepted			2022-12-24	WOS:000277623600017
J	Kaminski, MF; Regula, J; Kraszewska, E; Polkowski, M; Wojciechowska, U; Didkowska, J; Zwierko, M; Rupinski, M; Nowacki, MP; Butruk, E				Kaminski, Michal F.; Regula, Jaroslaw; Kraszewska, Ewa; Polkowski, Marcin; Wojciechowska, Urszula; Didkowska, Joanna; Zwierko, Maria; Rupinski, Maciej; Nowacki, Marek P.; Butruk, Eugeniusz			Quality Indicators for Colonoscopy and the Risk of Interval Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOCIETY TASK-FORCE; COLORECTAL-CANCER; ADENOMA; SURVEILLANCE; PREVENTION; GUIDELINES; FAILURE	BACKGROUND Although rates of detection of adenomatous lesions (tumors or polyps) and cecal intubation are recommended for use as quality indicators for screening colonoscopy, these measurements have not been validated, and their importance remains uncertain. METHODS We used a multivariate Cox proportional-hazards regression model to evaluate the influence of quality indicators for colonoscopy on the risk of interval cancer. Data were collected from 186 endoscopists who were involved in a colonoscopy-based colorectal-cancer screening program involving 45,026 subjects. Interval cancer was defined as colorectal adenocarcinoma that was diagnosed between the time of screening colonoscopy and the scheduled time of surveillance colonoscopy. We derived data on quality indicators for colonoscopy from the screening program's database and data on interval cancers from cancer registries. The primary aim of the study was to assess the association between quality indicators for colonoscopy and the risk of interval cancer. RESULTS A total of 42 interval colorectal cancers were identified during a period of 188,788 person-years. The endoscopist's rate of detection of adenomas was significantly associated with the risk of interval colorectal cancer (P = 0.008), whereas the rate of cecal intubation was not significantly associated with this risk (P = 0.50). The hazard ratios for adenoma detection rates of less than 11.0%, 11.0 to 14.9%, and 15.0 to 19.9%, as compared with a rate of 20.0% or higher, were 10.94 (95% confidence interval [CI], 1.37 to 87.01), 10.75 (95% CI, 1.36 to 85.06), and 12.50 (95% CI, 1.51 to 103.43), respectively (P = 0.02 for all comparisons). CONCLUSIONS The adenoma detection rate is an independent predictor of the risk of interval colorectal cancer after screening colonoscopy.	[Regula, Jaroslaw] Maria Sklodowska Curie Mem Canc Ctr, Dept Gastroenterol, Inst Oncol, Warsaw, Poland; [Wojciechowska, Urszula; Didkowska, Joanna] Maria Sklodowska Curie Mem Canc Ctr, Natl Canc Registry Poland, Warsaw, Poland; [Zwierko, Maria] Maria Sklodowska Curie Mem Canc Ctr, Masovian Canc Registry, Warsaw, Poland; [Nowacki, Marek P.] Maria Sklodowska Curie Mem Canc Ctr, Dept Colorectal Canc, Warsaw, Poland; [Regula, Jaroslaw; Kraszewska, Ewa; Polkowski, Marcin; Rupinski, Maciej; Butruk, Eugeniusz] Med Ctr Postgrad Educ, Dept Gastroenterol & Hepatol, Warsaw, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Centre of Postgraduate Medical Education - Poland	Regula, J (corresponding author), Maria Sklodowska Curie Mem Canc Ctr, Dept Gastroenterol, Inst Oncol, Roentgen St 5, Warsaw, Poland.	jregula@coi.waw.pl	Didkowska, Joanna Aleksandra/ABG-8672-2020; Kaminski, Michal F./AFN-3411-2022; Polkowski, Marcin/K-8897-2012	Didkowska, Joanna Aleksandra/0000-0001-9160-9118; Polkowski, Marcin/0000-0003-4934-9759; Regula, Jaroslaw/0000-0001-7071-3151; Kaminski, Michal/0000-0002-9714-6457; Zwierko, Maria/0000-0001-7294-4164; Rupinski, Maciej/0000-0002-1041-1159	Polish Ministry of Health; Polish Foundation of Gastroenterology	Polish Ministry of Health; Polish Foundation of Gastroenterology	Supported by the Polish Ministry of Health and the Polish Foundation of Gastroenterology.	AALEN O, 1978, ANN STAT, V6, P701, DOI 10.1214/aos/1176344247; Ahmed RL, 2006, CANCER-AM CANCER SOC, V107, P28, DOI 10.1002/cncr.21950; Aronchick CA, 1999, AM J GASTROENTEROL, V94, P2667; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Day N, 1995, J Med Screen, V2, P180; DAY NE, 1989, BRIT J CANCER, V59, P954, DOI 10.1038/bjc.1989.203; Doria-Rose VP, 2004, GASTROENTEROLOGY, V127, P714, DOI 10.1053/j.gastro.2004.06.048; Farrar WD, 2006, CLIN GASTROENTEROL H, V4, P1259, DOI 10.1016/j.cgh.2006.07.012; Froehlich F, 2005, GASTROINTEST ENDOSC, V61, P378, DOI 10.1016/S0016-5107(04)02776-2; GIOVANNUCCI E, 1994, J NATL CANCER I, V86, P183, DOI 10.1093/jnci/86.3.183; Haseman JH, 1997, GASTROINTEST ENDOSC, V45, P451, DOI 10.1016/S0016-5107(97)70172-X; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman D, 2007, GASTROINTEST ENDOSC, V65, P757, DOI 10.1016/j.gie.2006.12.055; NELSON W, 1972, TECHNOMETRICS, V14, P945, DOI 10.2307/1267144; Pabby A, 2005, GASTROINTEST ENDOSC, V61, P385, DOI 10.1016/S0016-5107(04)02765-8; Percy C, 2000, INT CLASSIFICATION D; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 2006, GASTROINTEST ENDOSC, V63, pS16, DOI 10.1016/j.gie.2006.02.021; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; Rex DK, 2000, GASTROINTEST ENDOSC, V51, P33, DOI 10.1016/S0016-5107(00)70383-X; Rex DK, 2008, CLIN GASTROENTEROL H, V6, P506, DOI 10.1016/j.cgh.2008.02.025; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Sawhney MS, 2006, GASTROENTEROLOGY, V131, P1700, DOI 10.1053/j.gastro.2006.10.022; Sawhney MS, 2008, GASTROENTEROLOGY, V135, P1892, DOI 10.1053/j.gastro.2008.08.024; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Winawer SJ, 2006, CA-CANCER J CLIN, V56, P143, DOI 10.3322/canjclin.56.3.143; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Wojciechowska U, 2006, CANC POLAND 2004	33	1310	1353	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2010	362	19					1795	1803		10.1056/NEJMoa0907667	http://dx.doi.org/10.1056/NEJMoa0907667			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594RQ	20463339				2022-12-24	WOS:000277555500006
J	Foti, JJ; Walker, GC				Foti, James J.; Walker, Graham C.			SnapShot: DNA Polymerases II Mammals	CELL			English	Editorial Material							THETA		[Foti, James J.; Walker, Graham C.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Foti, JJ (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			/0000-0001-7243-8261	NATIONAL CANCER INSTITUTE [R01CA021615] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA021615] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arana ME, 2007, DNA REPAIR, V6, P213, DOI 10.1016/j.dnarep.2006.09.012; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Kawamura K, 2004, INT J CANCER, V109, P9, DOI 10.1002/ijc.11666; Kunkel TA, 2003, CANCER CELL, V3, P105, DOI 10.1016/S1535-6108(03)00027-8; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Prasad R, 2009, NUCLEIC ACIDS RES, V37, P1868, DOI 10.1093/nar/gkp035; Rattray AJ, 2003, ANNU REV GENET, V37, P31, DOI 10.1146/annurev.genet.37.042203.132748; Seki M, 2005, EMBO REP, V6, P1143, DOI 10.1038/sj.embor.7400582; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08	9	3	3	6	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 16	2010	141	2					370	U185		10.1016/j.cell.2010.04.005	http://dx.doi.org/10.1016/j.cell.2010.04.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403330	Green Published, Bronze			2022-12-24	WOS:000276738400027
J	Say, RF; Fuchs, G				Say, Rafael F.; Fuchs, Georg			Fructose 1,6-bisphosphate aldolase/phosphatase may be an ancestral gluconeogenic enzyme	NATURE			English	Article							CARBON-DIOXIDE ASSIMILATION; THERMOCOCCUS-KODAKARAENSIS; PURIFICATION; EVOLUTION; ALDOLASE; METABOLISM; EXPRESSION; CLONING; GENOME; REDUCTASE	Most archaeal groups and deeply branching bacterial lineages harbour thermophilic organisms with a chemolithoautotrophic metabolism. They live at high temperatures in volcanic habitats at the expense of inorganic substances, often under anoxic conditions(1). These autotrophic organisms use diverse carbon dioxide fixation mechanisms generating acetyl-coenzyme A, from which gluconeogenesis must start(2-4). Here we show that virtually all archaeal groups as well as the deeply branching bacterial lineages contain a bifunctional fructose 1,6-bisphosphate (FBP) aldolase/phosphatase with both FBP aldolase and FBP phosphatase activity. This enzyme is missing inmost other Bacteria and in Eukaryota, and is heat-stabile even in mesophilic marine Crenarchaeota. Its bifunctionality ensures that heat-labile triosephosphates are quickly removed and trapped in stabile fructose 6-phosphate, rendering gluconeogenesis unidirectional. We propose that this highly conserved, heat-stabile and bifunctional FBP aldolase/phosphatase represents the pacemaking ancestral gluconeogenic enzyme, and that in evolution gluconeogenesis preceded glycolysis(5).	[Say, Rafael F.; Fuchs, Georg] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany	University of Freiburg	Fuchs, G (corresponding author), Univ Freiburg, Fak Biol, Schanzlestr 1, D-79104 Freiburg, Germany.	georg.fuchs@biologie.uni-freiburg.de			Deutsche Forschungsgemeinschaft; Evonik-Degussa	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Evonik-Degussa	We thank R. Thauer, S. Ragsdale, H. Atomi and H. Huber for the supply of strains; F. Drepper for help with bioinformatic approaches; W. Haehnel and B. Knapp for MS analysis; N. Gad'on and C. Ebenau-Jehle for growing cells and maintaining the laboratory running; the DOE Joint Genome Institute for early release of archaeal genomic sequence data; and the Deutsche Forschungsgemeinschaft and Evonik-Degussa for financial support. We also thank M. Ziemski and I. Berg for help with data base analysis as the basis of Fig. 1a, and H. Teeling and F. O. Glockner for providing Fig. 1b.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; BABUL J, 1983, ARCH BIOCHEM BIOPHYS, V225, P944, DOI 10.1016/0003-9861(83)90109-1; BERG IA, NATURE REV IN PRESS; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Chong PK, 2007, J PROTEOME RES, V6, P1430, DOI 10.1021/pr060575g; Dagan T, 2008, P NATL ACAD SCI USA, V105, P10039, DOI 10.1073/pnas.0800679105; Dawson Rex M.C., 1986, DATA BIOCH RES; DeMontigny C, 1996, EUR J BIOCHEM, V241, P243; Donahue JL, 2000, J BACTERIOL, V182, P5624, DOI 10.1128/JB.182.19.5624-5627.2000; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Ferry JG, 2006, MOL BIOL EVOL, V23, P1286, DOI 10.1093/molbev/msk014; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; FUCHS G, 1983, ARCH MICROBIOL, V136, P160, DOI 10.1007/BF00404793; FUJITA Y, 1979, J BIOL CHEM, V254, P5340; Gascuel O, 2006, MOL BIOL EVOL, V23, P1997, DOI 10.1093/molbev/msl072; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Grochowski LL, 2008, ANN NY ACAD SCI, V1125, P190, DOI 10.1196/annals.1419.001; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Huber H, 2000, INT J SYST EVOL MICR, V50, P2093, DOI 10.1099/00207713-50-6-2093; Huber H, 2008, P NATL ACAD SCI USA, V105, P7851, DOI 10.1073/pnas.0801043105; Imanaka H, 2002, J BIOSCI BIOENG, V94, P237, DOI 10.1263/jbb.94.237; Jahn U, 2007, J BACTERIOL, V189, P4108, DOI 10.1128/JB.00047-07; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lorentzen E, 2004, BIOCHEM SOC T, V32, P259, DOI 10.1042/BST0320259; Ludwig W, 2005, BERGEYS MANUAL SYSTE, V2, P49, DOI DOI 10.1007/978-0-387-21609-6_8; Makarova KS, 2003, TRENDS GENET, V19, P172, DOI 10.1016/S0168-9525(03)00047-7; Martin W, 2008, NAT REV MICROBIOL, V6, P805, DOI 10.1038/nrmicro1991; Nishimasu H, 2004, STRUCTURE, V12, P949, DOI 10.1016/j.str.2004.03.026; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; Poele EMT, 2008, ANTON LEEUW INT J G, V94, P127, DOI 10.1007/s10482-008-9255-x; Ramos-Vera WH, 2009, J BACTERIOL, V191, P4286, DOI 10.1128/JB.00145-09; Rashid N, 2002, J BIOL CHEM, V277, P30649, DOI 10.1074/jbc.M202868200; Ronimus Ron S., 2003, Archaea, V1, P199, DOI 10.1155/2003/162593; Sato T, 2004, J BACTERIOL, V186, P5799, DOI 10.1128/JB.186.17.5799-5807.2004; Sauve V, 2001, PROTEIN EXPRES PURIF, V21, P293, DOI 10.1006/prep.2000.1380; Sauve V, 2001, ACTA CRYSTALLOGR D, V57, P310, DOI 10.1107/S0907444900019727; SCAMUFFA MD, 1980, BIOCHIM BIOPHYS ACTA, V614, P583, DOI 10.1016/0005-2744(80)90247-8; SCHAFER S, 1986, ARCH MICROBIOL, V146, P301, DOI 10.1007/BF00403234; Schofield LR, 2004, PROTEIN EXPRES PURIF, V34, P17, DOI 10.1016/j.pep.2003.11.008; Schopfer P, 2008, PLANT PHYSIOL, V147, P864, DOI 10.1104/pp.108.118745; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Stec B, 2000, NAT STRUCT BIOL, V7, P1046, DOI 10.1038/80968; Stetter KO, 2006, PHILOS T R SOC B, V361, P1837, DOI 10.1098/rstb.2006.1907; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teeling H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-66; Teufel R, 2009, J BACTERIOL, V191, P4572, DOI 10.1128/JB.00068-09; Wachtershauser G, 2007, CHEM BIODIVERS, V4, P584, DOI 10.1002/cbdv.200790052; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; White RH, 2004, BIOCHEMISTRY-US, V43, P7618, DOI 10.1021/bi0495127; WITKE C, 1993, J BACTERIOL, V175, P7495, DOI 10.1128/JB.175.22.7495-7499.1993; Zhaxybayeva O, 2009, P NATL ACAD SCI USA, V106, P5865, DOI 10.1073/pnas.0901260106	58	133	151	1	50	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1077	U156		10.1038/nature08884	http://dx.doi.org/10.1038/nature08884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20348906				2022-12-24	WOS:000276635000046
J	Zhang, L; Ren, XY; Alt, E; Bai, XW; Huang, SY; Xu, ZM; Lynch, PM; Moyer, MP; Wen, XF; Wu, XW				Zhang, Ling; Ren, Xiaoyang; Alt, Eckhard; Bai, Xiaowen; Huang, Shaoyi; Xu, Zhengming; Lynch, Patrick M.; Moyer, Mary P.; Wen, Xian-Feng; Wu, Xiangwei			Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis	NATURE			English	Article							MULTIPLE INTESTINAL NEOPLASIA; STEM-CELLS; C-MYC; TRAIL; GENE; MUTATION; LIGAND; MOUSE; IDENTIFICATION; SENSITIVITY	Cancer chemoprevention uses natural, synthetic, or biological substances to reverse, suppress, or prevent either the initial phase of carcinogenesis or the progression of neoplastic cells to cancer(1). It holds promise for overcoming problems associated with the treatment of late-stage cancers. However, the broad application of chemoprevention is compromised at present by limited effectiveness and potential toxicity. To overcome these challenges, here we developed a new chemoprevention approach that specifically targets premalignant tumour cells for apoptosis. We show that a deficiency in the adenomatous polyposis coli (APC) gene and subsequent activation of beta-catenin lead to the repression of cellular caspase-8 inhibitor c-FLIP (also known as CFLAR) expression through activation of c-Myc, and that all-trans-retinyl acetate (RAc) independently upregulates tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptors and suppresses decoy receptors. Thus, the combination of TRAIL and RAc induces apoptosis in APC-deficient premalignant cells without affecting normal cells in vitro. In addition, we show that short-term and non-continuous TRAIL and RAc treatment induce apoptosis specifically in intestinal polyps, strongly inhibit tumour growth, and prolong survival in multiple intestinal neoplasms C57BL/6J-Apc(Min)/J (Apc(Min)) mice. With our approach, we further demonstrate that TRAIL and RAc induce significant cell death in human colon polyps, providing a potentially selective approach for colorectal cancer chemoprevention by targeting APC-deficient cells for apoptosis.	[Zhang, Ling; Ren, Xiaoyang; Huang, Shaoyi; Xu, Zhengming; Wen, Xian-Feng; Wu, Xiangwei] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Alt, Eckhard; Bai, Xiaowen] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Lynch, Patrick M.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Wu, Xiangwei] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Moyer, Mary P.] INCELL Corp, San Antonio, TX 78249 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wu, XW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, 1515 Holcombe Blvd, Houston, TX 77030 USA.	xwwu@mdanderson.org	ren, xianyan/J-3165-2018		NIH [AI063063]; M. D. Anderson Cancer Center; Alliance of Cardiovascular Researchers [543102]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063063] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. D. Anderson Cancer Center; Alliance of Cardiovascular Researchers; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Yang for technical support, R. Lotan for the BW1799 cells, and W. El-Deiry for DR5 expression plasmid; and M. Chambers, J. Yate, L. Ingram, D. Chow and G. Reyes for their involvement in IRB approval and human tissue acquisition. We also thank J. Vykoukal, A. E. Kadala and D. Malone for their help in editing the manuscript. This work was supported by NIH grant AI063063 and Institutional Funds from M. D. Anderson Cancer Center (to X. W.), and in part by Alliance of Cardiovascular Researchers grant 543102 (to E. A.).	Altucci L, 2001, NAT MED, V7, P680, DOI 10.1038/89050; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bai XW, 2007, AM J PHYSIOL-CELL PH, V293, pC1539, DOI 10.1152/ajpcell.00089.2007; Bai XW, 2007, FEBS LETT, V581, P4681, DOI 10.1016/j.febslet.2007.08.063; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Chen DH, 2003, CANCER RES, V63, P6626; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; EVANS GS, 1992, J CELL SCI, V101, P219; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Hasson E, 2005, J GENE MED, V7, P926, DOI 10.1002/jgm.740; Jin FS, 2005, CANCER RES, V65, P6354, DOI 10.1158/0008-5472.CAN-04-4061; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nieminen AI, 2007, EMBO J, V26, P1055, DOI 10.1038/sj.emboj.7601551; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Ren XY, 2007, CANCER BIOL THER, V6, P1031, DOI 10.4161/cbt.6.7.4206; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; SPORN MB, 1976, FED PROC, V35, P1332; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Sun SY, 2000, CANCER RES, V60, P7149; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; WILLSON JKV, 1987, CANCER RES, V47, P2704; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Yang K, 1997, J EXP ZOOL, V277, P245, DOI 10.1002/(SICI)1097-010X(19970215)277:3<245::AID-JEZ5>3.3.CO;2-N	27	110	112	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1058	U128		10.1038/nature08871	http://dx.doi.org/10.1038/nature08871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20348907	Green Accepted			2022-12-24	WOS:000276635000042
J	Moynihan, R				Moynihan, Ray			Drug Regulation Rosiglitazone, marketing, and medical science	BRITISH MEDICAL JOURNAL			English	Editorial Material							MYOCARDIAL-INFARCTION; RISK		Univ Newcastle, Newcastle, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Newcastle, NSW 2308, Australia.	ray.moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					DeAngelis CD, 2010, JAMA-J AM MED ASSOC, V303, P1196, DOI 10.1001/jama.2010.337; *GLAXOSMITHKLINE L, GLAXOSMITHKLINE DIAB; *GSK, 2008, GRANTS CHAR CONTR US; *GSK, 2009, GRANTS CHAR CONTR US; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; MANNUCCI E, 2009, INT J CARDIOL   0326; MARBAUCUS M, 2010, COMMUNICATION   0218; Moynihan R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1714; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Psaty BM, 2007, NEW ENGL J MED, V357, P67, DOI 10.1056/NEJMe078116; *US DEP HHS, PFIZ FACT SHEET PFIZ; US Senate Committee on Finance, 2010, STAFF REP GLAXOSMITH; Wang AT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1344; 2010, GUARDIAN        0305	15	10	10	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2010	340								c1848	10.1136/bmj.c1848	http://dx.doi.org/10.1136/bmj.c1848			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582ZF	20375091				2022-12-24	WOS:000276639400006
J	Religa, TL; Sprangers, R; Kay, LE				Religa, Tomasz L.; Sprangers, Remco; Kay, Lewis E.			Dynamic Regulation of Archaeal Proteasome Gate Opening As Studied by TROSY NMR	SCIENCE			English	Article							20S PROTEASOME; PROTEIN-DEGRADATION; STRUCTURAL BASIS; RELAXATION; TERMINI	The proteasome catalyzes the majority of protein degradation in the cell and plays an integral role in cellular homeostasis. Control over proteolysis by the 20S core-particle (CP) proteasome is achieved by gated access of substrate; thus, an understanding of the molecular mechanism by which these gates regulate substrate entry is critical. We used methyl-transverse relaxation optimized nuclear magnetic resonance spectroscopy to show that the amino-terminal residues that compose the gates of the a subunits of the Thermoplasma acidophilum proteasome are highly dynamic over a broad spectrum of time scales and that gating termini are in conformations that extend either well inside (closed gate) or outside (open gate) of the antechamber. Interconversion between these conformers on a time scale of seconds leads to a dynamic regulation of 20S CP proteolysis activity.	[Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada; [Sprangers, Remco] Max Planck Inst Dev Biol, Tubingen, Germany	University of Toronto; University of Toronto; University of Toronto; Max Planck Society	Kay, LE (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	kay@pound.med.utoronto.ca			European Molecular Biology Organization [ALTF 827-2006]; Canadian Institutes of Health Research (CIHR)	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We thank J. Forman-Kay for providing laboratory space and for valuable discussions, R. Muhandiram for NMR support, X. Li and A. Shimmer for assistance with the plate reader, and F. Hansen and D. Korzhnev for discussions. T. L. R. acknowledges the European Molecular Biology Organization (ALTF 827-2006) and the Canadian Institutes of Health Research (CIHR) for postdoctoral fellowships. L. E. K. holds a Canada Research Chair in Biochemistry. This work was supported by a grant from the CIHR. The structural ensembles of WT alpha<INF>7</INF> and Y8G/D9G a7 have been deposited in the Protein Data Bank (PDB) with accession codes 2ku1 and 2ku2, respectively.	Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Cheng YF, 2009, CURR OPIN STRUC BIOL, V19, P203, DOI 10.1016/j.sbi.2009.02.004; Clore GM, 2008, MOL BIOSYST, V4, P1058, DOI 10.1039/b810232e; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Forster A, 2003, EMBO J, V22, P4356, DOI 10.1093/emboj/cdg436; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Mittermaier A, 1999, J BIOMOL NMR, V13, P181, DOI 10.1023/A:1008387715167; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Ruepp A, 2001, J STRUCT BIOL, V135, P126, DOI 10.1006/jsbi.2001.4402; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Sprangers R, 2008, BIOCHEMISTRY-US, V47, P6727, DOI 10.1021/bi8005913; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Tsvetkov P, 2009, J BIOL CHEM, V284, P26234, DOI 10.1074/jbc.M109.040493; Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s; Tugarinov V, 2007, J AM CHEM SOC, V129, P1743, DOI 10.1021/ja067827z; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382	29	177	179	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					98	102		10.1126/science.1184991	http://dx.doi.org/10.1126/science.1184991			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360109				2022-12-24	WOS:000276202200044
J	Paczolt, KA; Jones, AG				Paczolt, Kimberly A.; Jones, Adam G.			Post-copulatory sexual selection and sexual conflict in the evolution of male pregnancy	NATURE			English	Article							PIPEFISH SPECIES SYNGNATHIDAE; ROLE-REVERSED PIPEFISH; MATE CHOICE; DIFFERENTIAL-ALLOCATION; GULF PIPEFISH; BROOD POUCH; SEAHORSES; COMPETITION; INVESTMENT; HYPOTHESIS	Male pregnancy in seahorses, pipefishes and sea dragons ( family Syngnathidae) represents a striking reproductive adaptation that has shaped the evolution of behaviour and morphology in this group of fishes(1-4). In many syngnathid species, males brood their offspring in a specialized pouch, which presumably evolved to facilitate male parental care(5,6). However, an unexplored possibility is that brood pouch evolution was partly shaped by parent-offspring or sexual conflict, processes that would result in trade-offs between current and future pregnancies. Here we report a controlled breeding experiment using the sexually dimorphic Gulf pipefish, Syngnathus scovelli, to test for post-copulatory sexual selection within broods and for trade-offs between successive male pregnancies as functions of female attractiveness. Offspring survivorship within a pregnancy was affected by the size of a male's mate, the number of eggs transferred and the male's sexual responsiveness. Significantly, we also found that embryo survivorship in a current pregnancy was negatively related to survivorship in the prior pregnancy, clearly demonstrating fitness trade-offs between broods. Overall, our data indicate that post-copulatory sexual selection and sexual conflict occur in Gulf pipefishes. The conflict seems to be mediated by a strategy of cryptic choice in which males increase rates of offspring abortion in pregnancies from unattractive mothers to retain resources for future reproductive opportunities. Hence, the male brood pouch of syngnathid fishes, which nurtures offspring(7-9), also seems to have an important role as an arbiter of conflict between the sexes.	[Paczolt, Kimberly A.; Jones, Adam G.] Texas A&M Univ, Dept Biol, College Stn, TX 77845 USA	Texas A&M University System; Texas A&M University College Station	Paczolt, KA (corresponding author), Texas A&M Univ, Dept Biol, 3258 TAMU, College Stn, TX 77845 USA.	kpaczolt@mail.bio.tamu.edu		Jones, Adam/0000-0003-0228-7124	US National Science Foundation [IOS-0455927]	US National Science Foundation(National Science Foundation (NSF))	This work was supported by grant IOS-0455927 from the US National Science Foundation. We thank S. Scobell and R. Carter for help with animal husbandry. We are also grateful to S. Arnold, A. Berglund, M. Giresi, N. Ratterman, E. Rose, G. Rosenthal, C. Small and D. Zeh for comments on the manuscript.	Ahnesjo I, 1996, BEHAV ECOL SOCIOBIOL, V38, P167, DOI 10.1007/s002650050229; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Arnqvist Goran, 2005, pUnpaginated; Berglund A, 2003, ADV STUD BEHAV, V32, P131, DOI 10.1016/S0065-3454(03)01003-9; BERGLUND A, 1986, MAR ECOL PROG SER, V29, P209, DOI 10.3354/meps029209; BERGLUND A, 1986, BEHAV ECOL SOCIOBIOL, V19, P301, DOI 10.1007/BF00300646; Brown JD, 1972, THESIS U FLORIDA; BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; Dawson C.E., 1985, INDOPACIFIC PIPEFISH; Harlin-Cognato A, 2006, P NATL ACAD SCI USA, V103, P19407, DOI 10.1073/pnas.0603000103; HERALD EARL S., 1959, PROC CALIFORNIA ACAD SCI, V29, P465; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; Jones AG, 2000, P ROY SOC B-BIOL SCI, V267, P677, DOI 10.1098/rspb.2000.1055; Jones AG, 1997, MOL ECOL, V6, P203, DOI 10.1046/j.1365-294X.1997.00173.x; Jones AG, 2001, P ROY SOC B-BIOL SCI, V268, P2531, DOI 10.1098/rspb.2001.1841; Parker GA, 2002, PHILOS T R SOC B, V357, P295, DOI 10.1098/rstb.2001.0950; Partridge C, 2007, COMP BIOCHEM PHYS A, V147, P556, DOI 10.1016/j.cbpa.2007.02.007; Partridge C, 2009, BEHAV ECOL SOCIOBIOL, V63, P345, DOI 10.1007/s00265-008-0668-3; Ripley JL, 2009, COMP BIOCHEM PHYS A, V154, P98, DOI 10.1016/j.cbpa.2009.05.003; Ripley JL, 2009, J COMP PHYSIOL B, V179, P325, DOI 10.1007/s00360-008-0316-2; Ripley JL, 2006, J EXP BIOL, V209, P1112, DOI 10.1242/jeb.02119; Sagebakken G, 2010, P ROY SOC B-BIOL SCI, V277, P971, DOI 10.1098/rspb.2009.1767; Scobell SK, 2009, ANIM BEHAV, V78, P747, DOI 10.1016/j.anbehav.2009.05.036; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Steiger J. H., 1980, P ANN SPRING M PSYCH; Stolting KN, 2007, BIOESSAYS, V29, P884, DOI 10.1002/bies.zm.uzh.ch; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; VINCENT A, 1992, TRENDS ECOL EVOL, V7, P237, DOI 10.1016/0169-5347(92)90052-D; Wilson AB, 2003, EVOLUTION, V57, P1374; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017; Zeh DW, 2000, BIOESSAYS, V22, P938, DOI 10.1002/1521-1878(200010)22:10<938::AID-BIES9>3.0.CO;2-9	31	62	62	3	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 18	2010	464	7287					401	U94		10.1038/nature08861	http://dx.doi.org/10.1038/nature08861			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20237568				2022-12-24	WOS:000275657100044
J	Wacholder, S; Hartge, P; Prentice, R; Garcia-Closas, M; Feigelson, HS; Diver, WR; Thun, MJ; Cox, DG; Hankinson, SE; Kraft, P; Rosner, B; Berg, CD; Brinton, LA; Lissowska, J; Sherman, ME; Chlebowski, R; Kooperberg, C; Jackson, RD; Buckman, DW; Hui, P; Pfeiffer, R; Jacobs, KB; Thomas, GD; Hoover, RN; Gail, MH; Chanock, SJ; Hunter, DJ				Wacholder, Sholom; Hartge, Patricia; Prentice, Ross; Garcia-Closas, Montserrat; Feigelson, Heather Spencer; Diver, W. Ryan; Thun, Michael J.; Cox, David G.; Hankinson, Susan E.; Kraft, Peter; Rosner, Bernard; Berg, Christine D.; Brinton, Louise A.; Lissowska, Jolanta; Sherman, Mark E.; Chlebowski, Rowan; Kooperberg, Charles; Jackson, Rebecca D.; Buckman, Dennis W.; Hui, Peter; Pfeiffer, Ruth; Jacobs, Kevin B.; Thomas, Gilles D.; Hoover, Robert N.; Gail, Mitchell H.; Chanock, Stephen J.; Hunter, David J.			Performance of Common Genetic Variants in Breast-Cancer Risk Models.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; POLYMORPHISMS; PREVENTION; ALLELES; MARKER	Background: Genomewide association studies have identified multiple genetic variants associated with breast cancer. The extent to which these variants add to existing risk-assessment models is unknown. Methods: We used information on traditional risk factors and 10 common genetic variants associated with breast cancer in 5590 case subjects and 5998 control subjects, 50 to 79 years of age, from four U.S. cohort studies and one case-control study from Poland to fit models of the absolute risk of breast cancer. With the use of receiver-operating-characteristic curve analysis, we calculated the area under the curve (AUC) as a measure of discrimination. By definition, random classification of case and control subjects provides an AUC of 50%; perfect classification provides an AUC of 100%. We calculated the fraction of case subjects in quintiles of estimated absolute risk after the addition of genetic variants to the traditional risk model. Results: The AUC for a risk model with age, study and entry year, and four traditional risk factors was 58.0%; with the addition of 10 genetic variants, the AUC was 61.8%. About half the case subjects (47.2%) were in the same quintile of risk as in a model without genetic variants; 32.5% were in a higher quintile, and 20.4% were in a lower quintile. Conclusions: The inclusion of newly discovered genetic factors modestly improved the performance of risk models for breast cancer. The level of predicted breast-cancer risk among most women changed little after the addition of currently available genetic information. N Engl J Med 2010;362:986-93.	[Wacholder, Sholom; Hartge, Patricia; Garcia-Closas, Montserrat; Brinton, Louise A.; Sherman, Mark E.; Pfeiffer, Ruth; Jacobs, Kevin B.; Thomas, Gilles D.; Hoover, Robert N.; Gail, Mitchell H.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Berg, Christine D.] NCI, Early Detect Res Grp, Canc Prevent Div, Bethesda, MD 20892 USA; [Prentice, Ross; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Feigelson, Heather Spencer; Diver, W. Ryan; Thun, Michael J.] Amer Canc Soc, Dept Epidemiol, Atlanta, GA 30329 USA; [Feigelson, Heather Spencer] Kaiser Permanente, Inst Hlth Res, Denver, CO USA; [Cox, David G.] INSERM, F-69008 Lyon, France; [Cox, David G.; Hankinson, Susan E.; Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rosner, Bernard] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Hankinson, Susan E.; Rosner, Bernard; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Hankinson, Susan E.; Rosner, Bernard; Hunter, David J.] Harvard Univ, Sch Med, Boston, MA USA; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Chlebowski, Rowan] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Hematol & Med Oncol, Torrance, CA 90509 USA; [Jackson, Rebecca D.] Ohio State Univ, Columbus, OH 43210 USA; [Buckman, Dennis W.; Hui, Peter] Informat Management Serv Inc, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center; American Cancer Society; Kaiser Permanente; Institut National de la Sante et de la Recherche Medicale (Inserm); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University System of Ohio; Ohio State University; Information Management Services, Inc.	Wacholder, S (corresponding author), NCI, Div Canc Epidemiol & Genet, 6120 Execut Blvd,EPS 5050,MSC 7244, Bethesda, MD 20892 USA.	wacholds@mail.nih.gov	Diver, Ryan/AAG-3469-2019; Garcia-Closas, Montserrat/AAZ-6930-2021; Lissowska, Jolanta/AAH-3252-2020; Cox, David/ABA-7454-2020; Garcia-Closas, Montserrat/F-3871-2015; Pfeiffer, Ruth M/F-4748-2011; Brinton, Louise A/G-7486-2015; Cox, David G/A-2023-2009	Diver, Ryan/0000-0002-5418-9000; Garcia-Closas, Montserrat/0000-0003-1033-2650; Lissowska, Jolanta/0000-0003-2695-5799; Garcia-Closas, Montserrat/0000-0003-1033-2650; Brinton, Louise A/0000-0003-3853-8562; Cox, David G/0000-0002-2152-9259; Cox, David/0000-0003-2047-4687; Jacobs, Kevin/0000-0002-4657-6473	Division of Cancer Epidemiology and Genetics of the National Cancer Institute; National Institutes of Health [N01WH22110, P01 CA87969, P01 CA53996, R01 CA49449, U01CA098233, U01CA098710]; NATIONAL CANCER INSTITUTE [P01CA053996, ZIACP010181, P01CA087969, U01CA098710, R01CA049449, U01CA098233] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005007] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH022110] Funding Source: NIH RePORTER	Division of Cancer Epidemiology and Genetics of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported in part by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute and by grants from the National Institutes of Health (N01WH22110, P01 CA87969, P01 CA53996, R01 CA49449, U01CA098233, and U01CA098710).	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; American College of Obstetricians and Gynecologists, 2009, OBSTET GYNECOL, V113, P957, DOI DOI 10.1097/AOG.0B013E3181A106D4; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; Chen JB, 2006, J NATL CANCER I, V98, P1215, DOI 10.1093/jnci/djj332; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829; Gail MH, 2000, J NATL CANCER I, V92, P758, DOI 10.1093/jnci/92.9.758; GAIL MH, 1994, J NATL CANCER I, V86, P573, DOI 10.1093/jnci/86.8.573; Gail MH, 2008, J NATL CANCER I, V100, P1037, DOI 10.1093/jnci/djn180; Gail MH, 2009, J NATL CANCER I, V101, P959, DOI 10.1093/jnci/djp130; Garcia-Closas M, 2006, HUM GENET, V119, P376, DOI 10.1007/s00439-006-0135-z; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Katki HA, 2009, LANCET ONCOL, V10, P1022, DOI 10.1016/S1470-2045(09)70253-0; Kraft P, 2009, NAT REV GENET, V10, P264, DOI 10.1038/nrg2516; Langer RD, 2003, ANN EPIDEMIOL, V13, pS107, DOI 10.1016/S1047-2797(03)00047-4; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; *M SKLOD MEM CANC, NUMB NEW CANC CAS SI; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; *SEER PROGR, 2007, SEER 17 INC MORT 200; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; TUKEY JW, 1949, BIOMETRICS, V5, P232, DOI 10.2307/3001938; WILLETT WC, 1987, NEW ENGL J MED, V316, P1174, DOI 10.1056/NEJM198705073161902	31	331	344	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11					986	993		10.1056/NEJMoa0907727	http://dx.doi.org/10.1056/NEJMoa0907727			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570CY	20237344	Green Accepted, Bronze			2022-12-24	WOS:000275650400009
J	Becker, V; Schilling, M; Bachmann, J; Baumann, U; Raue, A; Maiwald, T; Timmer, J; Klingmuller, U				Becker, Verena; Schilling, Marcel; Bachmann, Julie; Baumann, Ute; Raue, Andreas; Maiwald, Thomas; Timmer, Jens; Klingmueller, Ursula			Covering a Broad Dynamic Range: Information Processing at the Erythropoietin Receptor	SCIENCE			English	Article							EPIDERMAL-GROWTH-FACTOR; SIGNAL-TRANSDUCTION; SURFACE; INTERNALIZATION; ENDOCYTOSIS; GENERATION; ACTIVATION; EXPRESSION; CELLS	Cell surface receptors convert extracellular cues into receptor activation, thereby triggering intracellular signaling networks and controlling cellular decisions. A major unresolved issue is the identification of receptor properties that critically determine processing of ligand-encoded information. We show by mathematical modeling of quantitative data and experimental validation that rapid ligand depletion and replenishment of the cell surface receptor are characteristic features of the erythropoietin (Epo) receptor (EpoR). The amount of Epo-EpoR complexes and EpoR activation integrated over time corresponds linearly to ligand input; this process is carried out over a broad range of ligand concentrations. This relation depends solely on EpoR turnover independent of ligand binding, which suggests an essential role of large intracellular receptor pools. These receptor properties enable the system to cope with basal and acute demand in the hematopoietic system.	[Becker, Verena; Schilling, Marcel; Bachmann, Julie; Baumann, Ute; Klingmueller, Ursula] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Syst Biol Signal Transduct, D-69120 Heidelberg, Germany; [Becker, Verena; Klingmueller, Ursula] Univ Heidelberg, D-69120 Heidelberg, Germany; [Raue, Andreas; Maiwald, Thomas; Timmer, Jens] Univ Freiburg, Inst Phys, D-79104 Freiburg, Germany; [Timmer, Jens] Univ Freiburg, Freiburg Inst Adv Studies, D-79104 Freiburg, Germany; [Timmer, Jens] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Freiburg; University of Freiburg; University of Freiburg	Klingmuller, U (corresponding author), German Canc Res Ctr, DKFZ ZMBH Alliance, Div Syst Biol Signal Transduct, D-69120 Heidelberg, Germany.	u.klingmueller@dkfz-heidelberg.de	Schilling, Marcel/A-4426-2008; Klingmüller, Ursula/G-8477-2013	Schilling, Marcel/0000-0002-9517-5166; Klingmüller, Ursula/0000-0001-9845-3099	Helmholtz Alliance on Systems Biology (SBCancer); German Federal Ministry of Education and Research (BMBF); Excellence Initiative of the German Federal and State Governments [EXC 294]	Helmholtz Alliance on Systems Biology (SBCancer); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Excellence Initiative of the German Federal and State Governments	We thank R. Eils, U. Kummer, R. Meyer, A. C. Pfeifer, J. P. Schloder, C. Schultz, and V. Starkuviene for critically reading the manuscript; S. N. Constantinescu for HA-EpoR constructs; and S. Manthey and S. Lattermann for technical assistance. This work was supported by the Helmholtz Alliance on Systems Biology (SBCancer) (V.B., M.S., J.T., and U.K.), the German Federal Ministry of Education and Research (BMBF)-funded MedSys-Network LungSys (J.B., A.R., and U.K.), and the Excellence Initiative of the German Federal and State Governments (EXC 294) (J.T.).	BAJZER Z, 1989, J BIOL CHEM, V264, P13623; Beckman DL, 1999, BLOOD, V94, P2667, DOI 10.1182/blood.V94.8.2667.420k27_2667_2675; Belouzard S, 2004, J BIOL CHEM, V279, P28499, DOI 10.1074/jbc.M400508200; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Jelkmann W, 2004, INTERNAL MED, V43, P649, DOI 10.2169/internalmedicine.43.649; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Macdougall IC, 2006, LANCET, V368, P947, DOI 10.1016/S0140-6736(06)69120-4; Price KS, 2003, AM J RESP CELL MOL, V28, P420, DOI 10.1165/rcmb.2002-0155OC; RAUE A, 1923, BIOINFORMATICS, V25, P2009; Resat H, 2003, BIOPHYS J, V85, P730, DOI 10.1016/S0006-3495(03)74516-0; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Shankaran H, 2007, PLOS COMPUT BIOL, V3, P986, DOI 10.1371/journal.pcbi.0030101; WILEY HS, 1991, J BIOL CHEM, V266, P11083; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; YOSHIMURA A, 1990, P NATL ACAD SCI USA, V87, P4139, DOI 10.1073/pnas.87.11.4139; YOUSSOUFIAN H, 1993, BLOOD, V81, P2223	17	113	114	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1404	1408		10.1126/science.1184913	http://dx.doi.org/10.1126/science.1184913			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20488988				2022-12-24	WOS:000278598400041
J	Balasubramanian, R; Smith, SM; Rawat, S; Yatsunyk, LA; Stemmler, TL; Rosenzweig, AC				Balasubramanian, Ramakrishnan; Smith, Stephen M.; Rawat, Swati; Yatsunyk, Liliya A.; Stemmler, Timothy L.; Rosenzweig, Amy C.			Oxidation of methane by a biological dicopper centre	NATURE			English	Article							METHYLOCOCCUS-CAPSULATUS BATH; X-RAY-ABSORPTION; METAL CENTERS; ACTIVE-SITE; MONOOXYGENASE PMMO; COPPER; CLUSTER; CATALYSIS; PROTEINS	Vast world reserves of methane gas are underutilized as a feedstock for the production of liquid fuels and chemicals owing to the lack of economical and sustainable strategies for the selective oxidation of methane to methanol(1). Current processes to activate the strong C-H bond (104 kcal mol(-1)) in methane require high temperatures, are costly and inefficient, and produce waste(2). In nature, methanotrophic bacteria perform this reaction under ambient conditions using metalloenzymes called methane mono-oxygenases (MMOs). MMOs thus provide the optimal model for an efficient, environmentally sound catalyst(3). There are two types of MMO. Soluble MMO (sMMO) is expressed by several strains of methanotroph under copper-limited conditions and oxidizes methane with a well-characterized catalytic di-iron centre(4). Particulate MMO ( pMMO) is an integral membrane metalloenzyme produced by all methanotrophs and is composed of three subunits, pmoA, pmoB and pmoC, arranged in a trimeric alpha(3)beta(3)gamma(3) complex(5). Despite 20 years of research and the availability of two crystal structures, the metal composition and location of the pMMO metal active site are not known. Here we show that pMMO activity is dependent on copper, not iron, and that the copper active site is located in the soluble domains of the pmoB subunit rather than within the membrane. Recombinant soluble fragments of pmoB (spmoB) bind copper and have propylene and methane oxidation activities. Disruption of each copper centre in spmoB by mutagenesis indicates that the active site is a dicopper centre. These findings help resolve the pMMO controversy and provide a promising new approach to developing environmentally friendly C-H oxidation catalysts.	[Rawat, Swati; Stemmler, Timothy L.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Balasubramanian, Ramakrishnan; Smith, Stephen M.; Yatsunyk, Liliya A.; Rosenzweig, Amy C.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Balasubramanian, Ramakrishnan; Smith, Stephen M.; Yatsunyk, Liliya A.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Wayne State University; Northwestern University; Northwestern University	Stemmler, TL (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.	tstemmle@med.wayne.edu; amyr@northwestern.edu	Balasubramanian, Ramakrishnan/C-7620-2011	rawat, swati/0000-0003-3905-0446	US National Institutes of Health (NIH) [GM070473, DK068139]; Department of Energy, Office of Biological and Environmental Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070473] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health (NIH) grants GM070473 (A. C. R.) and DK068139 (T. L. S.). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL). The SSRL is a national user facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the NIH, National Center for Research Resources, Biomedical Technology Program.	Ankudinov AL, 1997, PHYS REV B, V56, pR1712, DOI 10.1103/PhysRevB.56.R1712; Arakawa H, 2001, CHEM REV, V101, P953, DOI 10.1021/cr000018s; Balasubramanian R, 2007, ACCOUNTS CHEM RES, V40, P573, DOI 10.1021/ar700004s; BATLIWALA H, 1995, BIOCHEM J, V307, P433, DOI 10.1042/bj3070433; Chan SI, 2008, ACCOUNTS CHEM RES, V41, P969, DOI 10.1021/ar700277n; Chan SI, 2007, ANGEW CHEM INT EDIT, V46, P1992, DOI 10.1002/anie.200604647; Chen KHC, 2004, J CHIN CHEM SOC-TAIP, V51, P1081, DOI 10.1002/jccs.200400162; Choi DW, 2003, J BACTERIOL, V185, P5755, DOI 10.1128/JB.185.19.5755-5764.2003; George G. N., 2001, EXAFSPAK; Hakemian AS, 2008, BIOCHEMISTRY-US, V47, P6793, DOI 10.1021/bi800598h; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; Hermans I, 2009, TOP CATAL, V52, P1162, DOI 10.1007/s11244-009-9268-3; KAU LS, 1987, J AM CHEM SOC, V109, P6433, DOI 10.1021/ja00255a032; Kitmitto A, 2005, BIOCHEMISTRY-US, V44, P10954, DOI 10.1021/bi050820u; Lieberman RL, 2006, INORG CHEM, V45, P8372, DOI 10.1021/ic060739v; Lieberman RL, 2003, P NATL ACAD SCI USA, V100, P3820, DOI 10.1073/pnas.0536703100; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; Martinho M, 2007, J AM CHEM SOC, V129, P15783, DOI 10.1021/ja077682b; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; MILLER KW, 1977, CHEM PHYS LIPIDS, V20, P229, DOI 10.1016/0009-3084(77)90039-1; Miyaji A, 2009, J MOL CATAL B-ENZYM, V57, P211, DOI 10.1016/j.molcatb.2008.09.005; Myronova N, 2006, BIOCHEMISTRY-US, V45, P11905, DOI 10.1021/bi061294p; Nguyen HHT, 1996, J AM CHEM SOC, V118, P12766, DOI 10.1021/ja961778g; PRIOR SD, 1985, FEMS MICROBIOL LETT, V29, P105; Que L, 2008, NATURE, V455, P333, DOI 10.1038/nature07371; RIGGSGELASCO PJ, 1995, COORDIN CHEM REV, V144, P245, DOI 10.1016/0010-8545(95)01144-E; Rosenzweig AC, 2008, BIOCHEM SOC T, V36, P1134, DOI 10.1042/BST0361134; Shiota Y, 2009, INORG CHEM, V48, P838, DOI 10.1021/ic8003933; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Woertink JS, 2009, P NATL ACAD SCI USA, V106, P18908, DOI 10.1073/pnas.0910461106; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200; Yu SSF, 2003, J BACTERIOL, V185, P5915, DOI 10.1128/JB.185.20.5915-5924.2003; Yu SSF, 2007, BIOCHEMISTRY-US, V46, P13762, DOI 10.1021/bi700883g; Zahn JA, 1996, J BACTERIOL, V178, P1018, DOI 10.1128/jb.178.4.1018-1029.1996	34	379	393	7	424	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 6	2010	465	7294					115	U131		10.1038/nature08992	http://dx.doi.org/10.1038/nature08992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20410881	Green Accepted, Green Submitted			2022-12-24	WOS:000277311900042
J	Jia, HB; Rochefort, NL; Chen, XW; Konnerth, A				Jia, Hongbo; Rochefort, Nathalie L.; Chen, Xiaowei; Konnerth, Arthur			Dendritic organization of sensory input to cortical neurons in vivo	NATURE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; MOUSE VISUAL-CORTEX; RECEPTIVE-FIELDS; CALCIUM DYNAMICS; FUNCTIONAL ARCHITECTURE; SYNAPTIC INTEGRATION; BASAL DENDRITES; CELLS; POTENTIALS; SPINES	In sensory cortex regions, neurons are tuned to specific stimulus features. For example, in the visual cortex, many neurons fire predominantly in response to moving objects of a preferred orientation. However, the characteristics of the synaptic input that cortical neurons receive to generate their output firing pattern remain unclear. Here we report a novel approach for the visualization and functional mapping of sensory inputs to the dendrites of cortical neurons in vivo. By combining high-speed two-photon imaging with electrophysiological recordings, we identify local subthreshold calcium signals that correspond to orientation-specific synaptic inputs. We find that even inputs that share the same orientation preference are widely distributed throughout the dendritic tree. At the same time, inputs of different orientation preference are interspersed, so that adjacent dendritic segments are tuned to distinct orientations. Thus, orientation-tuned neurons can compute their characteristic firing pattern by integrating spatially distributed synaptic inputs coding for multiple stimulus orientations.	[Konnerth, Arthur] Tech Univ Munich, Inst Neurosci, D-80802 Munich, Germany; Tech Univ Munich, Ctr Integrated Prot Sci, D-80802 Munich, Germany	Technical University of Munich; Technical University of Munich; University of Munich	Konnerth, A (corresponding author), Tech Univ Munich, Inst Neurosci, Biedersteinerstr 29, D-80802 Munich, Germany.	arthur.konnerth@lrz.tum.de	Jia, Hongbo/H-2476-2017	Jia, Hongbo/0000-0003-1585-2161; Rochefort, Nathalie/0000-0002-3498-6221	DFG [IRTG 1373]; Friedrich Schiedel Foundation	DFG(German Research Foundation (DFG)); Friedrich Schiedel Foundation	We are grateful to B. Sakmann for discussions and to Y. Kovalchuk for help in the initial experiments. This work was supported by grants from the DFG (to A. K.) and the Friedrich Schiedel Foundation. A. K. is a Carl von Linde Senior Fellow of the Institute for Advanced Study of the TUM. H.J., N.L.R. and X. C. were supported by the DFG (IRTG 1373).	Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Bannister AP, 2005, NEUROSCI RES, V53, P95, DOI 10.1016/j.neures.2005.06.019; Bloodgood BL, 2007, CURR OPIN NEUROBIOL, V17, P345, DOI 10.1016/j.conb.2007.04.003; Bollmann JH, 2009, NEURON, V61, P895, DOI 10.1016/j.neuron.2009.01.018; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Hirsch JA, 2006, CURR OPIN NEUROBIOL, V16, P377, DOI 10.1016/j.conb.2006.06.014; Holthoff K, 2004, J PHYSIOL-LONDON, V560, P27, DOI 10.1113/jphysiol.2004.072678; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; METIN C, 1988, EXP BRAIN RES, V69, P594; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	39	342	348	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1307	1312		10.1038/nature08947	http://dx.doi.org/10.1038/nature08947			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428163				2022-12-24	WOS:000277149000037
J	Cannarrozzi, G; Schraudolph, NN; Faty, M; von Rohr, P; Friberg, MT; Roth, AC; Gonnet, P; Gonnet, G; Barral, Y				Cannarrozzi, Gina; Schraudolph, Nicol N.; Faty, Mahamadou; von Rohr, Peter; Friberg, Markus T.; Roth, Alexander C.; Gonnet, Pedro; Gonnet, Gaston; Barral, Yves			A Role for Codon Order in Translation Dynamics	CELL			English	Article							AMINOACYL-TRANSFER-RNA; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; EXPRESSION PROFILES; GENE-EXPRESSION; CELL-CYCLE; USAGE; YEAST; BIAS; GENOME	The genetic code is degenerate. Each amino acid is encoded by up to six synonymous codons; the choice between these codons influences gene expression. Here, we show that in coding sequences, once a particular codon has been used, subsequent occurrences of the same amino acid do not use codons randomly, but favor codons that use the same tRNA. The effect is pronounced in rapidly induced genes, involves both frequent and rare codons and diminishes only slowly as a function of the distance between subsequent synonymous codons. Furthermore, we found that in S. cerevisiae codon correlation accelerates translation relative to the translation of synonymous yet anticorrelated sequences. The data suggest that tRNA diffusion away from the ribosome is slower than translation, and that some tRNA channeling takes place at the ribosome. They also establish that the dynamics of translation leave a significant signature at the level of the genome.	[Cannarrozzi, Gina; Schraudolph, Nicol N.; von Rohr, Peter; Friberg, Markus T.; Roth, Alexander C.; Gonnet, Pedro; Gonnet, Gaston] ETH, Inst Computat Sci, CH-8092 Zurich, Switzerland; [Faty, Mahamadou; Barral, Yves] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Cannarrozzi, Gina; Roth, Alexander C.; Gonnet, Gaston] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics	Gonnet, G (corresponding author), ETH, Inst Computat Sci, CH-8092 Zurich, Switzerland.	gonnet@inf.ethz.ch; yves.barral@bc.biol.ethz.ch	Cannarozzi, Gina/S-1595-2019; Gonnet, Pedro/A-6935-2008	Cannarozzi, Gina/0000-0002-0704-663X; Gonnet, Pedro/0000-0003-4509-7291; Barral, Yves/0000-0002-0989-3373	Swiss National Science Foundation [107782]; Origin and Function of Codon Bias; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Origin and Function of Codon Bias; ETH Zurich(ETH Zurich)	We acknowledge the Swiss National Science Foundation ( Project no. 107782, Origin and Function of Codon Bias) and the ETH Zurich for funding support.; We thank the Computational Biochemistry Research Group, Steven A. Benner, Ari Helenius, three anonymous reviewers and Lara Szewczak for helpful discussions.	Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Friberg MT, 2006, LECT NOTES COMPUT SC, V4175, P1; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gaucher EA, 2001, P NATL ACAD SCI USA, V98, P548, DOI 10.1073/pnas.98.2.548; Gonnet GH, 2000, BIOINFORMATICS, V16, P101, DOI 10.1093/bioinformatics/16.2.101; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; IRVIN JD, 1972, BIOCHEMISTRY-US, V11, P1915, DOI 10.1021/bi00760a028; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; Kulikova T, 2004, NUCLEIC ACIDS RES, V32, pD27, DOI 10.1093/nar/gkh120; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; NEGRUTSKII BS, 1991, P NATL ACAD SCI USA, V88, P4991, DOI 10.1073/pnas.88.11.4991; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Petrushenko ZM, 2002, EUR J BIOCHEM, V269, P4811, DOI 10.1046/j.1432-1033.2002.03178.x; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Roberts GG, 2006, MOL GENET GENOMICS, V276, P170, DOI 10.1007/s00438-006-0133-9; Schutze Norbert, 2005, Cell Commun Signal, V3, P5, DOI 10.1186/1478-811X-3-5; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHARP PM, 1993, BIOCHEM SOC T, V21, P835, DOI 10.1042/bst0210835; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; SPIRIN AS, 1999, RIBOSOMES, P243; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zouridis H, 2008, BIOPHYS J, V95, P1018, DOI 10.1529/biophysj.107.126128	36	246	257	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					355	367		10.1016/j.cell.2010.02.036	http://dx.doi.org/10.1016/j.cell.2010.02.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403329	Bronze			2022-12-24	WOS:000276738400024
J	Cheng, XP; Jin, J; Hu, L; Shen, DB; Dong, XP; Samie, MA; Knoff, J; Eisinger, B; Liu, ML; Huang, SM; Caterina, MJ; Dempsey, P; Michael, LE; Dlugosz, AA; Andrews, NC; Clapham, DE; Xu, HX				Cheng, Xiping; Jin, Jie; Hu, Lily; Shen, Dongbiao; Dong, Xian-ping; Samie, Mohammad A.; Knoff, Jayne; Eisinger, Brian; Liu, Mei-ling; Huang, Susan M.; Caterina, Michael J.; Dempsey, Peter; Michael, Lowell Evan; Dlugosz, Andrzej A.; Andrews, Nancy C.; Clapham, David E.; Xu, Haoxing			TRP Channel Regulates EGFR Signaling in Hair Morphogenesis and Skin Barrier Formation	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; MICE LACKING; FACTOR-ALPHA; WAVY HAIR; DIFFERENTIATION; EXPRESSION; KERATINOCYTES; MUTATION; TEMPERATURE	A plethora of growth factors regulate keratinocyte proliferation and differentiation that control hair morphogenesis and skin barrier formation. Wavy hair phenotypes in mice result from naturally occurring loss-of-function mutations in the genes for TGF-alpha and EGFR. Conversely, excessive activities of TGF-alpha/EGFR result in hairless phenotypes and skin cancers. Unexpectedly, we found that mice lacking the Trpv3 gene also exhibit wavy hair coat and curly whiskers. Here we show that keratinocyte TRPV3, a member of the transient receptor potential (TRP) family of Ca2+-permeant channels, forms a signaling complex with TGF-alpha/EGFR. Activation of EGFR leads to increased TRPV3 channel activity, which in turn stimulates TGF-alpha release. TRPV3 is also required for the formation of the skin barrier by regulating the activities of transglutaminases, a family of Ca2+-dependent crosslinking enzymes essential for keratinocyte cornification. Our results show that a TRP channel plays a role in regulating growth factor signaling by direct complex formation.	[Jin, Jie; Clapham, David E.; Xu, Haoxing] Childrens Hosp Boston, Manton Ctr Orphan Dis, Dept Cardiol, Boston, MA 02115 USA; [Cheng, Xiping; Hu, Lily; Shen, Dongbiao; Dong, Xian-ping; Samie, Mohammad A.; Knoff, Jayne; Eisinger, Brian; Liu, Mei-ling; Xu, Haoxing] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Jin, Jie; Andrews, Nancy C.] Childrens Hosp Boston, Div Hematol & Oncol, Boston, MA 02115 USA; [Huang, Susan M.; Caterina, Michael J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21025 USA; [Huang, Susan M.; Caterina, Michael J.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21025 USA; [Dempsey, Peter] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Dempsey, Peter] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Michael, Lowell Evan; Dlugosz, Andrzej A.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Michael, Lowell Evan; Dlugosz, Andrzej A.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Andrews, Nancy C.] Duke Univ, Sch Med, Dept Pediat, Durham, NC 27710 USA; [Andrews, Nancy C.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Harvard University; Boston Children's Hospital; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Johns Hopkins University; Johns Hopkins University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Duke University; Duke University	Clapham, DE (corresponding author), Childrens Hosp Boston, Manton Ctr Orphan Dis, Dept Cardiol, Enders 1350,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu; haoxingx@umich.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019; xu, hao/GWQ-7394-2022	Clapham, David/0000-0002-4459-9428; Andrews, Nancy/0000-0003-0243-4462; Bissonette, Jayne/0000-0001-8376-9242; Dong, Xianping/0000-0002-4496-7104	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062792] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAMS NIH HHS [R01 AR045973] Funding Source: Medline; NINDS NIH HHS [R01 NS062792-02, R01 NS062792] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Ballaro C, 2005, EMBO REP, V6, P755, DOI 10.1038/sj.embor.7400458; Byrne C, 2003, J ANAT, V202, P113, DOI 10.1046/j.1469-7580.2003.00142.x; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; COULOMBE PA, 1989, J CELL BIOL, V109, P2295, DOI 10.1083/jcb.109.5.2295; Denda M, 2007, J INVEST DERMATOL, V127, P654, DOI 10.1038/sj.jid.5700590; Denning MF, 2000, EXP DERMATOL, V9, P192, DOI 10.1034/j.1600-0625.2000.009003192.x; DLUGOSZ AA, 1994, CELL GROWTH DIFFER, V5, P1283; Du X, 2004, GENETICS, V166, P331, DOI 10.1534/genetics.166.1.331; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huang SM, 2008, J NEUROSCI, V28, P13727, DOI 10.1523/JNEUROSCI.5741-07.2008; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; PANDIELLA A, 1991, J BIOL CHEM, V266, P5769; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Peus D, 1997, J INVEST DERMATOL, V109, P751, DOI 10.1111/1523-1747.ep12340759; Ponec M, 1997, ARCH DERMATOL RES, V289, P317, DOI 10.1007/s004030050198; Raghunath M, 1998, ARCH DERMATOL RES, V290, P621, DOI 10.1007/s004030050362; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; SAKAI Y, 1994, CELL GROWTH DIFFER, V5, P527; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Sevilla LM, 2007, J CELL BIOL, V179, P1599, DOI 10.1083/jcb.200706187; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Wakita N, 1999, J BIOL CHEM, V274, P37285, DOI 10.1074/jbc.274.52.37285; Wang X, 2006, J CELL BIOL, V172, P409, DOI 10.1083/jcb.200510002; Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207	44	194	203	5	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					331	343		10.1016/j.cell.2010.03.013	http://dx.doi.org/10.1016/j.cell.2010.03.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403327	Green Accepted, Bronze			2022-12-24	WOS:000276738400022
J	Dirks, PHGM; Kibii, JM; Kuhn, BF; Steininger, C; Churchill, SE; Kramers, JD; Pickering, R; Farber, DL; Meriaux, AS; Herries, AIR; King, GCP; Berger, LR				Dirks, Paul H. G. M.; Kibii, Job M.; Kuhn, Brian F.; Steininger, Christine; Churchill, Steven E.; Kramers, Jan D.; Pickering, Robyn; Farber, Daniel L.; Meriaux, Anne-Sophie; Herries, Andy I. R.; King, Geoffrey C. P.; Berger, Lee R.			Geological Setting and Age of Australopithecus sediba from Southern Africa	SCIENCE			English	Article							STERKFONTEIN; PALEOENVIRONMENTS; GEOCHRONOLOGY; SURFACES; DESERT; SKULL; HOMO	We describe the geological, geochronological, geomorphological, and faunal context of the Malapa site and the fossils of Australopithecus sediba. The hominins occur with a macrofauna assemblage that existed in Africa between 2.36 and 1.50 million years ago (Ma). The fossils are encased in water-laid, clastic sediments that were deposited along the lower parts of what is now a deeply eroded cave system, immediately above a flowstone layer with a U-Pb date of 2.026 +/- 0.021 Ma. The flowstone has a reversed paleomagnetic signature and the overlying hominin-bearing sediments are of normal polarity, indicating deposition during the 1.95- to 1.78-Ma Olduvai Subchron. The two hominin specimens were buried together in a single debris flow that lithified soon after deposition in a phreatic environment inaccessible to scavengers.	[Dirks, Paul H. G. M.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Dirks, Paul H. G. M.; Steininger, Christine; Kramers, Jan D.; Berger, Lee R.] Univ Witwatersrand, Sch Geosci, ZA-2050 Johannesburg, South Africa; [Kibii, Job M.; Kuhn, Brian F.; Steininger, Christine; Churchill, Steven E.; Berger, Lee R.] Univ Witwatersrand, Inst Human Evolut, ZA-2050 Johannesburg, South Africa; [Churchill, Steven E.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Kramers, Jan D.] Univ Bern, Inst Geol Sci, CH-3012 Bern, Switzerland; [Kramers, Jan D.] Univ Johannesburg, Dept Geol, ZA-2006 Auckland Pk, South Africa; [Pickering, Robyn] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; [Farber, Daniel L.] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94550 USA; [Farber, Daniel L.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Meriaux, Anne-Sophie] Univ Newcastle, Sch Geog Polit & Sociol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Herries, Andy I. R.] Univ New S Wales, Sch Med Sci, UNSW Archaeomagnetism Lab, Sydney, NSW 2052, Australia; [Herries, Andy I. R.] Univ Liverpool, Dept Earth & Ocean Sci, Geomagnetism Lab, Liverpool L69 3BX, Merseyside, England; [King, Geoffrey C. P.] Inst Phys Globe Paris, Lab Tecton, F-75252 Paris, France	James Cook University; University of Witwatersrand; University of Witwatersrand; Duke University; University of Bern; University of Johannesburg; University of Melbourne; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Santa Cruz; Newcastle University - UK; University of New South Wales Sydney; University of Liverpool; UDICE-French Research Universities; Universite Paris Cite	Dirks, PHGM (corresponding author), James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia.	paul.dirks@jcu.edu.au	Meriaux, Anne-Sophie/G-1754-2010; Churchill, Steven/AAA-9386-2022; Berger, Lee Rogers/AAC-3484-2020; Farber, Daniel L/F-9237-2011	Meriaux, Anne-Sophie/0000-0002-5112-0948; Berger, Lee Rogers/0000-0002-0367-7629; Herries, Andy/0000-0002-2905-2002; Steininger, Christine/0000-0002-9082-0672	Palaeontological Scientific Trust (PAST); Institute for Human Evolution; University of the Witwatersrand; School of Geosciences, University of the Witwatersrand; AfricaArray; France-SA; Khure Africa project; LLNL GEO-CAMS; US-NSF [EAR-0345895]; Swiss National Science Foundation; UNSW Faculty of Medicine; ARC [DP0877603]; Liverpool University	Palaeontological Scientific Trust (PAST); Institute for Human Evolution; University of the Witwatersrand; School of Geosciences, University of the Witwatersrand; AfricaArray; France-SA; Khure Africa project; LLNL GEO-CAMS; US-NSF(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UNSW Faculty of Medicine; ARC(Australian Research Council); Liverpool University	We thank the South African Heritage Resource Agency for allowing work on the Malapa site; the Nash family for granting access to the Malapa site and continued support; the Palaeontological Scientific Trust (PAST), the Institute for Human Evolution, University of the Witwatersrand and the School of Geosciences, University of the Witwatersrand, for funding; and the University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology for support and facilities. Further support was provided by AfricaArray (P. H. G. M. D.), the France-SA, !Khure Africa project (G. C. P. K., D. L. F., A.-S.M.), and LLNL GEO-CAMS and the US-NSF EAR-0345895 (D. L. F.). R. P. is supported by a Swiss National Science Foundation Post-Doctoral Grant and gratefully acknowledges J. Woodhead, A. Grieg, and the team at Melbourne University. A. I. R. H. was funded through a UNSW Faculty of Medicine research grant and ARC Discovery Grant DP0877603 and acknowledges the support of the Liverpool University Geomagnetism Laboratory staff. Contributions to mapping and sample preparation by G. Charlesworth and Z. Jinnah are kindly acknowledged.	Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Berger LR, 2002, AM J PHYS ANTHROPOL, V119, P192, DOI 10.1002/ajpa.10156; Blatt H., 2006, PETROLOGY IGNEOUS SE; Brain C.K., 1995, PALAEOCLIMATE EVOLUT, P385; Brain C. K., 1981, HUNTERS HUNTED INTRO; BRAIN CK, 2004, SWARTKRANS CAVES CHR; BROOM R, 1949, NATURE, V164, P322, DOI 10.1038/164322a0; BROWN FH, 1985, ANCESTORS HARD EVIDE, P82; Brugal JP, 2003, CR PALEVOL, V2, P675, DOI 10.1016/j.crpv.2003.09.028; Clarke RJ, 1998, S AFR J SCI, V94, P460; Coussot P, 1996, EARTH-SCI REV, V40, P209, DOI 10.1016/0012-8252(95)00065-8; de Ruiter DJ, 2009, J HUM EVOL, V56, P497, DOI 10.1016/j.jhevol.2009.01.009; Eriksson K.A., 1974, T GEOL SOC S AFR, V77, P211; Eriksson P.G., 2006, GEOLOGY S AFRICA, P237; Hall SR, 2008, TECTONOPHYSICS, V459, P186, DOI 10.1016/j.tecto.2007.11.073; HUGHES AR, 1977, NATURE, V265, P310, DOI 10.1038/265310a0; Lanphere MA, 2002, GEOL SOC AM BULL, V114, P559, DOI 10.1130/0016-7606(2002)114<0559:RAFTOT>2.0.CO;2; Lewis ME, 2007, VERTEBR PALEOBIOL PA, P77, DOI 10.1007/978-1-4020-3098-7_4; Martin DM, 1998, J GEOL SOC LONDON, V155, P311, DOI 10.1144/gsjgs.155.2.0311; Matmon A, 2009, GEOL SOC AM BULL, V121, P688, DOI 10.1130/B26422.1; Nishiizumi K, 2005, EARTH PLANET SC LETT, V237, P499, DOI 10.1016/j.epsl.2005.05.032; OGG JG, 2004, GEOLOGIC TIME SCALE, P63, DOI [DOI 10.1017/CBO9780511536045.006, DOI 10.2277/0511074050]; PARTRIDGE TC, 1978, NATURE, V275, P282, DOI 10.1038/275282a0; Partridge TC, 2003, SCIENCE, V300, P607, DOI 10.1126/science.1081651; Partridge TC, 2000, OXFORD MGR GEOL GEOP, P100; Pickering R, 2007, J HUM EVOL, V53, P602, DOI 10.1016/j.jhevol.2007.02.005; Retallack G.J., 1990, SOILS INTRO PALAEOPE; Tucker M.E., 1991, SEDIMENTARY PETROLOG; Woodhead J, 2006, QUAT GEOCHRONOL, V1, P208, DOI 10.1016/j.quageo.2006.08.002	29	111	122	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					205	208		10.1126/science.1184950	http://dx.doi.org/10.1126/science.1184950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580OU	20378812	Green Submitted			2022-12-24	WOS:000276459600036
J	Nakamura, S; Kobayashi, K; Nishimura, T; Higashijima, S; Tanaka, M				Nakamura, Shuhei; Kobayashi, Kayo; Nishimura, Toshiya; Higashijima, Shin-ichi; Tanaka, Minoru			Identification of Germline Stem Cells in the Ovary of the Teleost Medaka	SCIENCE			English	Article							ORYZIAS-LATIPES; HEMATOPOIETIC STEM; EXPRESSION; SOX9; OOGENESIS; REVEALS; FISH; MICE	Germline stem cells continually produce sperm in vertebrate testes, whereas there is no direct evidence showing that germline stem cells are present in adult vertebrate ovaries. By using transgenic methods and clonal analysis, we identified germline stem cells that supported oogenesis and the production of offspring in the ovaries of adult medaka fish. Early-stage germ cells were localized in clusters along interwoven threadlike cords of sox9b-expressing somatic cells (termed germinal cradles) where the germ cells developed. Germline stem cells gave rise to germ cells that divided to produce cysts, which then underwent cell death or separated to form follicles. Our results provide insight into the germline stem cell biology of medaka and provide a model system for studying vertebrate stem cell niches.	[Nakamura, Shuhei; Kobayashi, Kayo; Nishimura, Toshiya; Tanaka, Minoru] Natl Inst Basic Biol, Lab Mol Genet Reprod, Okazaki, Aichi 4448787, Japan; [Nishimura, Toshiya; Tanaka, Minoru] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Higashijima, Shin-ichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan; [Higashijima, Shin-ichi] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan	Tanaka, M (corresponding author), Natl Inst Basic Biol, Lab Mol Genet Reprod, Okazaki, Aichi 4448787, Japan.	mtanaka@nibb.ac.jp	Nakamura, Shuhei/G-8571-2011; Shuhei, Nakamura/AGZ-2173-2022	Shuhei, Nakamura/0000-0002-1488-8317; Higashijima, Shin-ichi/0000-0001-6350-4992; TANAKA, MINORU/0000-0001-9100-1487	National BioResource Project Medaka; Daiko Foundation; Center for the Promotion of Integrated Science (CPIS) of SOKENDAI;  [21116509];  [21770072];  [21370101]	National BioResource Project Medaka(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Daiko Foundation(Daiko Foundation); Center for the Promotion of Integrated Science (CPIS) of SOKENDAI; ; ; 	We thank M. Yamashita and T. Iwai for anti-medaka SYCP antibodies, T. Czerny for plasmids containing the hs promoter region, and S. Yoshida for helpful discussions. We are grateful to Y. Ichikawa and C. Kinoshita for maintaining the fish colony. This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas, "Gamete Stem Cells" (grant 21116509) and for Young Scientists (B) (21770072) (to S.N.), and for Scientific Research on Priority Areas (B) (21370101); the National BioResource Project Medaka; and the Daiko Foundation and the Center for the Promotion of Integrated Science (CPIS) of SOKENDAI (to M. T.).	Aoki Y, 2008, DEV DYNAM, V237, P800, DOI 10.1002/dvdy.21448; Aoki Y, 2009, ZOOL SCI, V26, P112, DOI 10.2108/zsj.26.112; Eggan K, 2006, NATURE, V441, P1109, DOI 10.1038/nature04929; Iwai T, 2006, EXP CELL RES, V312, P2528, DOI 10.1016/j.yexcr.2006.04.015; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Kluver N, 2005, DEV GENES EVOL, V215, P297, DOI 10.1007/s00427-005-0477-x; KUMAR TCA, 1968, PROC R SOC SER B-BIO, V169, P167, DOI 10.1098/rspb.1968.0004; Kurokawa H, 2006, DEV GROWTH DIFFER, V48, P209, DOI 10.1111/j.1440-169x.2006.00858.x; Morinaga C, 2007, P NATL ACAD SCI USA, V104, P9691, DOI 10.1073/pnas.0611379104; Nakamura S, 2008, MOL REPROD DEV, V75, P472, DOI 10.1002/mrd.20764; Pacchiarotti J, 2010, DIFFERENTIATION, V79, P159, DOI 10.1016/j.diff.2010.01.001; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Stahl Y, 2005, INT J DEV BIOL, V49, P479, DOI 10.1387/ijdb.041929ys; Tanaka M, 2001, P NATL ACAD SCI USA, V98, P2544, DOI 10.1073/pnas.041315498; Tokarz R.R., 1978, P145; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WALLACE RA, 1990, J ELECTRON MICR TECH, V16, P175, DOI 10.1002/jemt.1060160302; Wong MD, 2005, ANNU REV GENET, V39, P173, DOI 10.1146/annurev.genet.39.073003.105855; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869	21	165	174	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1561	1563		10.1126/science.1185473	http://dx.doi.org/10.1126/science.1185473			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20488987				2022-12-24	WOS:000278859200047
J	Banci, L; Bertini, I; Ciofi-Baffoni, S; Kozyreva, T; Zovo, K; Palumaa, P				Banci, Lucia; Bertini, Ivano; Ciofi-Baffoni, Simone; Kozyreva, Tatiana; Zovo, Kairit; Palumaa, Peep			Affinity gradients drive copper to cellular destinations	NATURE			English	Article							CYTOCHROME-C-OXIDASE; MENKES-DISEASE PROTEIN; SUPEROXIDE-DISMUTASE; ZINC-BINDING; CHAPERONE; DOMAIN; COX17; MECHANISM; ATP7A; METALLOTHIONEIN	Copper is an essential trace element for eukaryotes and most prokaryotes(1). However, intracellular free copper must be strictly limited because of its toxic side effects. Complex systems for copper trafficking evolved to satisfy cellular requirements while minimizing toxicity(2). The factors driving the copper transfer between protein partners along cellular copper routes are, however, not fully rationalized. Until now, inconsistent, scattered and incomparable data on the copper-binding affinities of copper proteins have been reported. Here we determine, through a unified electrospray ionization mass spectrometry (ESI-MS)-based strategy, in an environment that mimics the cellular redox milieu, the apparent Cu(I)-binding affinities for a representative set of intracellular copper proteins involved in enzymatic redox catalysis, in copper trafficking to and within various cellular compartments, and in copper storage. The resulting thermodynamic data show that copper is drawn to the enzymes that require it by passing from one copper protein site to another, exploiting gradients of increasing copper-binding affinity. This result complements the finding that fast copper-transfer pathways require metal-mediated protein-protein interactions and therefore protein-protein specific recognition(3). Together with Cu, Zn-SOD1, metallothioneins have the highest affinity for copper(I), and may play special roles in the regulation of cellular copper distribution; however, for kinetic reasons they cannot demetallate copper enzymes. Our study provides the thermodynamic basis for the kinetic processes that lead to the distribution of cellular copper.	[Banci, Lucia; Bertini, Ivano; Ciofi-Baffoni, Simone; Kozyreva, Tatiana] Univ Florence, Magnet Resonance Ctr CERM, I-50019 Florence, Italy; [Banci, Lucia; Bertini, Ivano; Ciofi-Baffoni, Simone; Kozyreva, Tatiana] Univ Florence, Dept Chem, I-50019 Florence, Italy; [Zovo, Kairit; Palumaa, Peep] Tallinn Univ Technol, Dept Gene Technol, EE-12618 Tallinn, Estonia	University of Florence; University of Florence; Tallinn University of Technology	Bertini, I (corresponding author), Univ Florence, Magnet Resonance Ctr CERM, Via Luigi Sacconi 6, I-50019 Florence, Italy.	ivanobertini@cerm.unifi.it; peepp@staff.ttu.ee	Palumaa, Peep/AAF-7617-2020; Ciofi-Baffoni, Simone/AAH-9778-2021; Palumaa, Peep/B-4668-2019	Palumaa, Peep/0000-0002-3505-3466; Palumaa, Peep/0000-0002-3505-3466; BANCI, LUCIA/0000-0003-0562-5774; Zovo, Kairit/0000-0001-5834-5157; Ciofi Baffoni, Simone/0000-0002-2376-3321; Kozyreva, Tatiana/0000-0003-3104-0489	Estonian Science Foundation [7191]; Estonian Ministry of Education and Research [SF0140055s08]; SPINE-II-COMPLEXES [LSHG-CT-2006-031220]; FIRB PROTEOMICA MIUR [RBRN07BMCT]; World Federation of Scientists	Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); SPINE-II-COMPLEXES; FIRB PROTEOMICA MIUR(Ministry of Education, Universities and Research (MIUR)); World Federation of Scientists	This work was supported by grants from the Estonian Science Foundation project 7191, the Estonian Ministry of Education and Research (grant SF0140055s08), by the SPINE-II-COMPLEXES contract LSHG-CT-2006-031220, by the FIRB PROTEOMICA MIUR contract RBRN07BMCT and by a World Federation of Scientists scholarship to K.Z. We thank K. Saar for preparative work with rat mitochondrial fractions and for measuring the enzymatic activity of CcO, and C. Massagni for preparing the CCS expression plasmid.	Atkinson A, 2009, CHEM REV, V109, P4708, DOI 10.1021/cr900006y; Banci L, 2005, FEBS J, V272, P865, DOI 10.1111/j.1742-4658.2004.04526.x; Banci L, 2008, P NATL ACAD SCI USA, V105, P6803, DOI 10.1073/pnas.0800019105; Banci L, 2008, J BIOL CHEM, V283, P7912, DOI 10.1074/jbc.M708016200; Banci L, 2007, P NATL ACAD SCI USA, V104, P15, DOI 10.1073/pnas.0606189103; Banci L, 2006, J BIOL CHEM, V281, P29141, DOI 10.1074/jbc.M603176200; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Bertini I, 2010, COORDIN CHEM REV, V254, P506, DOI 10.1016/j.ccr.2009.07.024; Eriste E, 2003, PROTEIN EXPRES PURIF, V31, P161, DOI 10.1016/S1046-5928(03)00144-X; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; HALLEWELL RA, 1989, J BIOL CHEM, V264, P5260; Hitomi Y, 2001, J AM CHEM SOC, V123, P8614, DOI 10.1021/ja016146v; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Jensen PY, 1999, BBA-PROTEIN STRUCT M, V1434, P103, DOI 10.1016/S0167-4838(99)00161-2; KAGI JHR, 1993, METALLOTHIONEIN; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Krezel A, 2001, J INORG BIOCHEM, V84, P77, DOI 10.1016/S0162-0134(00)00212-9; Krezel A, 2008, J BIOL INORG CHEM, V13, P401, DOI 10.1007/s00775-007-0330-y; LAPPALAINEN P, 1993, J BIOL CHEM, V268, P26416; Leavesley HB, 2008, TOXICOL SCI, V101, P101, DOI 10.1093/toxsci/kfm254; Linz R, 2007, J BIOENERG BIOMEMBR, V39, P403, DOI 10.1007/s10863-007-9101-2; NIELSON KB, 1984, J BIOL CHEM, V259, P4941; Nose Y, 2006, TRENDS BIOCHEM SCI, V31, P604, DOI 10.1016/j.tibs.2006.09.003; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Palumaa P, 2004, BIOCHEM J, V382, P307, DOI 10.1042/BJ20040360; PRESTA A, 1995, EUR J BIOCHEM, V227, P226, DOI 10.1111/j.1432-1033.1995.tb20380.x; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rae TD, 2001, J BIOL CHEM, V276, P5166, DOI 10.1074/jbc.M008005200; SAKS VA, 1980, J BIOL CHEM, V255, P755; Slutter CE, 1996, BIOCHEMISTRY-US, V35, P3387, DOI 10.1021/bi9525839; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; VONWACHENFELDT C, 1994, FEBS LETT, V340, P109, DOI 10.1016/0014-5793(94)80182-7; Voronova A, 2007, PROTEIN EXPRES PURIF, V53, P138, DOI 10.1016/j.pep.2006.11.014; Voskoboinik I, 2002, J BIOENERG BIOMEMBR, V34, P363, DOI 10.1023/A:1021250003104; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200; YONETANI T, 1965, J BIOL CHEM, V240, P3392	37	331	335	4	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 3	2010	465	7298					645	U145		10.1038/nature09018	http://dx.doi.org/10.1038/nature09018			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20463663				2022-12-24	WOS:000278249000048
J	Cheloufi, S; Dos Santos, CO; Chong, MMW; Hannon, GJ				Cheloufi, Sihem; Dos Santos, Camila O.; Chong, Mark M. W.; Hannon, Gregory J.			A Dicer-independent miRNA biogenesis pathway that requires Ago catalysis	NATURE			English	Article							CRYSTAL-STRUCTURE; ARGONAUTE FAMILY; SMALL RNAS; SLICER; RISC; IDENTIFICATION; MICRORNAS; SIRNAS; GENE; RECRUITS	The nucleolytic activity of animal Argonaute proteins is deeply conserved, despite its having no obvious role in microRNA-directed gene regulation. In mice, Ago2 (also known as Eif2c2) is uniquely required for viability, and only this family member retains catalytic competence. To investigate the evolutionary pressure to conserve Argonaute enzymatic activity, we engineered a mouse with catalytically inactive Ago2 alleles. Homozygous mutants died shortly after birth with an obvious anaemia. Examination of microRNAs and their potential targets revealed a loss of miR-451, a small RNA important for erythropoiesis. Though this microRNA is processed by Drosha (also known as Rnasen), its maturation does not require Dicer. Instead, the pre-miRNA becomes loaded into Ago and is cleaved by the Ago catalytic centre to generate an intermediate 39 end, which is then further trimmed. Our findings link the conservation of Argonaute catalysis to a conserved mechanism of microRNA biogenesis that is important for vertebrate development.	[Cheloufi, Sihem; Dos Santos, Camila O.; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Cheloufi, Sihem] SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; [Chong, Mark M. W.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Chong, Mark M. W.] Walter & Eliza Hall Inst Med Res Parkville, Parkville, Vic 3052, Australia	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York University; Walter & Eliza Hall Institute	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Chong, Mark/H-6684-2016; Hannon, Gregory/AAB-3568-2019	Chong, Mark/0000-0002-3701-7397; Cheloufi, Sihem/0000-0002-1726-4796	NIH; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Mosquera, S. Y. Kim, D. Frendewey and A. Economides for help with generating mutants and caring for animals. A. Nagy, M. Shen, J. Murn, V. Vagin and A. Aravin provided discussion. N. Kim, D. Littman, I. Ibarra and E. Wagenblast provided critical reagents, and O. Tam, R. Sachidanandam, Z. Xuan, D. McCombie and M. Rooks provided support for generation and analysis of deep sequencing data. This work was supported by grants from the NIH and by a gift from K. W. Davis.	Alisch RS, 2007, PLOS GENET, V3, P2565, DOI 10.1371/journal.pgen.0030227; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Joshua-Tor L, 2006, COLD SPRING HARB SYM, V71, P67, DOI 10.1101/sqb.2006.71.048; Kaneda M, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-9; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Morita S, 2007, GENOMICS, V89, P687, DOI 10.1016/j.ygeno.2007.01.004; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Nagy A., 2003, MANIPULATING MOUSE E; NAGY A, 2000, GENE TARGETING PRACT, P189; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Papapetrou EP, 2010, STEM CELLS, V28, P287, DOI 10.1002/stem.257; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Rossant J., 2002, MOUSE DEV PATTERNING, P155; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	55	750	811	0	130	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					584	U76		10.1038/nature09092	http://dx.doi.org/10.1038/nature09092			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20424607	Green Accepted			2022-12-24	WOS:000278249000034
J	Gamo, FJ; Sanz, LM; Vidal, J; de Cozar, C; Alvarez, E; Lavandera, JL; Vanderwall, DE; Green, DVS; Kumar, V; Hasan, S; Brown, JR; Peishoff, CE; Cardon, LR; Garcia-Bustos, JF				Gamo, Francisco-Javier; Sanz, Laura M.; Vidal, Jaume; de Cozar, Cristina; Alvarez, Emilio; Lavandera, Jose-Luis; Vanderwall, Dana E.; Green, Darren V. S.; Kumar, Vinod; Hasan, Samiul; Brown, James R.; Peishoff, Catherine E.; Cardon, Lon R.; Garcia-Bustos, Jose F.			Thousands of chemical starting points for antimalarial lead identification	NATURE			English	Article							PLASMODIUM-FALCIPARUM; MALARIA; DRUGS; SENSITIVITY; DISCOVERY; EFFICACY; KINOME; GENOME	Malaria is a devastating infection caused by protozoa of the genus Plasmodium. Drug resistance is widespread, no new chemical class of antimalarials has been introduced into clinical practice since 1996 and there is a recent rise of parasite strains with reduced sensitivity to the newest drugs. We screened nearly 2 million compounds in GlaxoSmithKline's chemical library for inhibitors of P. falciparum, of which 13,533 were confirmed to inhibit parasite growth by at least 80% at 2 mu M concentration. More than 8,000 also showed potent activity against the multidrug resistant strain Dd2. Most (82%) compounds originate from internal company projects and are new to the malaria community. Analyses using historic assay data suggest several novel mechanisms of antimalarial action, such as inhibition of protein kinases and host-pathogen interaction related targets. Chemical structures and associated data are hereby made public to encourage additional drug lead identification efforts and further research into this disease.	[Gamo, Francisco-Javier; Sanz, Laura M.; Vidal, Jaume; de Cozar, Cristina; Alvarez, Emilio; Lavandera, Jose-Luis; Garcia-Bustos, Jose F.] GlaxoSmithKline, Tres Cantos 28760, Spain; [Vanderwall, Dana E.] GlaxoSmithKline, Computat & Struct Chem, Res Triangle Pk, NC 27709 USA; [Green, Darren V. S.] GlaxoSmithKline, Computat & Struct Chem, Med Res Ctr, Stevenage SG1 2NY, Herts, England; [Kumar, Vinod; Hasan, Samiul; Brown, James R.] GlaxoSmithKline, Quantitat Sci, Computat Biol, Collegeville, PA 19426 USA; [Peishoff, Catherine E.] GlaxoSmithKline, Computat & Struct Chem, Collegeville, PA 19426 USA; [Cardon, Lon R.] GlaxoSmithKline, Quantitat Sci, King Of Prussia, PA 19406 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Garcia-Bustos, JF (corresponding author), GlaxoSmithKline, Cantos Med Dev Campus,Severo Ochoa 2, Tres Cantos 28760, Spain.	jose.f.garcia-bustos@gsk.com	Lavandera, José Luis/J-6913-2019; Lavandera, Jose Luis L/K-3690-2014; Green, Darren/AAG-5754-2019	Lavandera, José Luis/0000-0003-0730-6865; Lavandera, Jose Luis L/0000-0003-0730-6865; Green, Darren/0000-0001-9063-2754; Garcia-Bustos, Jose/0000-0002-6310-796X; Vanderwall, Dana/0000-0003-1076-8788; Brown, James/0000-0002-9368-627X	Medicines for Malaria Venture	Medicines for Malaria Venture	We thank S. Peregrina and S. Prats for technical assistance, and D. Jimenez-Alfaro for supplying compounds pre-dispensed in microtitre plates. We thank P. Vallance and R. Keenan for organising support for this work, R. Macarron and J. Luengo for developing the IFI index and getting the chemistry data ready for publication, together with J. M. Fiandor, S. Chakravorty and members of GSK's Chemistry Council. J. Lewis, A. Clow, J. Overington and M. Davies were instrumental in the uploading and formatting of the data. We also thank N. Cammack, P. Sanseau and J. Burrows for critically commenting on the manuscript. The support and funding of Medicines for Malaria Venture is gratefully acknowledged.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; Andriantsoanirina V, 2009, ANTIMICROB AGENTS CH, V53, P4588, DOI 10.1128/AAC.00610-09; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; *AUR PHARM, 2004, AUR PHARM AURSCOPE D; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bemis GW, 1996, J MED CHEM, V39, P2887, DOI 10.1021/jm9602928; Bonnet M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-192; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; Davis AM, 2005, CURR TOP MED CHEM, V5, P421, DOI 10.2174/1568026053828411; Daylight Chemical Information Systems Inc., 2008, DAYL THEOR MAN; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Ekland EH, 2008, INT J PARASITOL, V38, P743, DOI 10.1016/j.ijpara.2008.03.004; FELSENTEIN J, PHYLIP PHYLOGENETIC; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Goodman CD, 2007, MOL BIOCHEM PARASIT, V152, P181, DOI 10.1016/j.molbiopara.2007.01.005; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; JOHNSON M, 1989, QSAR QUANTITATIVE ST, P167; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Leroy D, 2008, TRENDS PHARMACOL SCI, V29, P241, DOI 10.1016/j.tips.2008.02.005; Madeira L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001889; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; O'Brien PJ, 2006, ARCH TOXICOL, V80, P580, DOI 10.1007/s00204-006-0091-3; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Ramya TNC, 2007, ANTIMICROB AGENTS CH, V51, P307, DOI 10.1128/AAC.00808-06; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; *WHO, 2009, WORLD MAL REP; Wu YM, 2003, GENOME RES, V13, P601, DOI 10.1101/gr.913403; Xia M, 2008, ENVIRON HEALTH PERSP, V116, P284, DOI 10.1289/ehp.10727; Yuan J, 2009, NAT CHEM BIOL, V5, P765, DOI 10.1038/nchembio.215; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	39	723	747	3	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2010	465	7296					305	U56		10.1038/nature09107	http://dx.doi.org/10.1038/nature09107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	598IO	20485427				2022-12-24	WOS:000277829200031
J	Ding, L; Ellis, MJ; Li, SQ; Larson, DE; Chen, K; Wallis, J; Harris, CC; McLellan, MD; Fulton, RS; Fulton, LL; Abbott, RM; Hoog, J; Dooling, DJ; Koboldt, DC; Schmidt, H; Kalicki, J; Zhang, QY; Chen, L; Lin, L; Wendl, MC; McMichael, JF; Magrini, VJ; Cook, L; McGrath, SD; Vickery, TL; Appelbaum, E; DeSchryver, K; Davies, S; Guintoli, T; Lin, L; Crowder, R; Tao, Y; Snider, JE; Smith, SM; Dukes, AF; Sanderson, GE; Pohl, CS; Delehaunty, KD; Fronick, CC; Pape, KA; Reed, JS; Robinson, JS; Hodges, JS; Schierding, W; Dees, ND; Shen, D; Locke, DP; Wiechert, ME; Eldred, JM; Peck, JB; Oberkfell, BJ; Lolofie, JT; Du, FY; Hawkins, AE; O'Laughlin, MD; Bernard, KE; Cunningham, M; Elliott, G; Mason, MD; Thompson, DM; Ivanovich, JL; Goodfellow, PJ; Perou, CM; Weinstock, GM; Aft, R; Watson, M; Ley, TJ; Wilson, RK; Mardis, ER				Ding, Li; Ellis, Matthew J.; Li, Shunqiang; Larson, David E.; Chen, Ken; Wallis, Johnw.; Harris, Christopher C.; McLellan, Michael D.; Fulton, Robert S.; Fulton, Lucinda L.; Abbott, Rachel M.; Hoog, Jeremy; Dooling, David J.; Koboldt, Daniel C.; Schmidt, Heather; Kalicki, Joelle; Zhang, Qunyuan; Chen, Lei; Lin, Ling; Wendl, Michael C.; McMichael, Joshua F.; Magrini, Vincent J.; Cook, Lisa; McGrath, Sean D.; Vickery, Tammi L.; Appelbaum, Elizabeth; DeSchryver, Katherine; Davies, Sherri; Guintoli, Therese; Lin, Li; Crowder, Robert; Tao, Yu; Snider, Jacqueline E.; Smith, Scott M.; Dukes, Adam F.; Sanderson, Gabriel E.; Pohl, Craig S.; Delehaunty, Kim D.; Fronick, Catrina C.; Pape, Kimberley A.; Reed, Jerry S.; Robinson, Jody S.; Hodges, Jennifer S.; Schierding, William; Dees, Nathan D.; Shen, Dong; Locke, Devin P.; Wiechert, Madeline E.; Eldred, James M.; Peck, Josh B.; Oberkfell, Benjamin J.; Lolofie, Justin T.; Du, Feiyu; Hawkins, Amy E.; O'Laughlin, Michelle D.; Bernard, Kelly E.; Cunningham, Mark; Elliott, Glendoria; Mason, Mark D.; Thompson, Dominic M., Jr.; Ivanovich, Jennifer L.; Goodfellow, Paul J.; Perou, Charles M.; Weinstock, George M.; Aft, Rebecca; Watson, Mark; Ley, Timothy J.; Wilson, Richard K.; Mardis, Elaine R.			Genome remodelling in a basal-like breast cancer metastasis and xenograft	NATURE			English	Article							MYELOID-LEUKEMIA GENOME; COLORECTAL CANCERS; SOMATIC MUTATIONS; TUMOR-SUPPRESSOR; LUNG-CANCER; DIFFERENTIATION; RESOLUTION; SUBTYPES; TAZ	Massively parallel DNA sequencing technologies provide an unprecedented ability to screen entire genomes for genetic changes associated with tumour progression. Here we describe the genomic analyses of four DNA samples from an African-American patient with basal-like breast cancer: peripheral blood, the primary tumour, a brain metastasis and a xenograft derived from the primary tumour. The metastasis contained two de novo mutations and a large deletion not present in the primary tumour, and was significantly enriched for 20 shared mutations. The xenograft retained all primary tumour mutations and displayed a mutation enrichment pattern that resembled the metastasis. Two overlapping large deletions, encompassing CTNNA1, were present in all three tumour samples. The differential mutation frequencies and structural variation patterns in metastasis and xenograft compared with the primary tumour indicate that secondary tumours may arise from a minority of cells within the primary tumour.	[Ding, Li; Larson, David E.; Chen, Ken; Wallis, Johnw.; Harris, Christopher C.; McLellan, Michael D.; Fulton, Robert S.; Fulton, Lucinda L.; Abbott, Rachel M.; Dooling, David J.; Koboldt, Daniel C.; Schmidt, Heather; Kalicki, Joelle; Chen, Lei; Lin, Ling; Wendl, Michael C.; McMichael, Joshua F.; Magrini, Vincent J.; Cook, Lisa; McGrath, Sean D.; Vickery, Tammi L.; Appelbaum, Elizabeth; Smith, Scott M.; Dukes, Adam F.; Sanderson, Gabriel E.; Pohl, Craig S.; Delehaunty, Kim D.; Fronick, Catrina C.; Pape, Kimberley A.; Reed, Jerry S.; Robinson, Jody S.; Hodges, Jennifer S.; Schierding, William; Dees, Nathan D.; Shen, Dong; Locke, Devin P.; Wiechert, Madeline E.; Eldred, James M.; Peck, Josh B.; Oberkfell, Benjamin J.; Lolofie, Justin T.; Du, Feiyu; Hawkins, Amy E.; O'Laughlin, Michelle D.; Bernard, Kelly E.; Cunningham, Mark; Elliott, Glendoria; Mason, Mark D.; Weinstock, George M.; Ley, Timothy J.; Wilson, Richard K.; Mardis, Elaine R.] Washington Univ, Genome Ctr, Sch Med, St Louis, MO 63108 USA; [Ding, Li; Wallis, Johnw.; Fulton, Robert S.; Fulton, Lucinda L.; Dooling, David J.; Zhang, Qunyuan; Wendl, Michael C.; Magrini, Vincent J.; Weinstock, George M.; Ley, Timothy J.; Wilson, Richard K.; Mardis, Elaine R.] Washington Univ, Dept Genet, Sch Med, St Louis, MO 63108 USA; [Ellis, Matthew J.; Li, Shunqiang; Hoog, Jeremy; DeSchryver, Katherine; Davies, Sherri; Guintoli, Therese; Lin, Li; Crowder, Robert; Snider, Jacqueline E.; Ley, Timothy J.] Washington Univ, Dept Med, Sch Med, St Louis, MO 63108 USA; [Ellis, Matthew J.; Ley, Timothy J.; Wilson, Richard K.; Mardis, Elaine R.] Washington Univ, Siteman Canc Ctr, Sch Med, St Louis, MO 63108 USA; [Zhang, Qunyuan] Washington Univ, Div Stat Genom, Sch Med, St Louis, MO 63108 USA; [Tao, Yu] Washington Univ, Div Biostat, Sch Med, St Louis, MO 63108 USA; [Thompson, Dominic M., Jr.; Ivanovich, Jennifer L.; Goodfellow, Paul J.; Aft, Rebecca] Washington Univ, Dept Surg, Sch Med, St Louis, MO 63108 USA; [Thompson, Dominic M., Jr.; Ivanovich, Jennifer L.; Goodfellow, Paul J.; Aft, Rebecca] Washington Univ, Young Womens Breast Canc Program, Sch Med, St Louis, MO 63108 USA; [Watson, Mark] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63108 USA; [Perou, Charles M.] Univ N Carolina, Lineberger Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill	Wilson, RK (corresponding author), Washington Univ, Genome Ctr, Sch Med, St Louis, MO 63108 USA.	rwilson@wustl.edu	Magrini, Vincent/AAT-5830-2020; Chen, Ken/AAU-1432-2021; Weinstock, George M/C-6314-2013; Wilson, Richard K./AAF-4139-2019; Mardis, Elaine/W-2202-2019; Wendl, Michael C/A-2741-2008; Perou, Charles M/H-9934-2014; McGrath, Sean David/AAT-3540-2020; Chen, Ken/A-1074-2009	Magrini, Vincent/0000-0002-2019-4872; Chen, Ken/0000-0003-4013-5279; Weinstock, George M/0000-0002-2997-4592; Wilson, Richard K./0000-0002-1992-1358; Perou, Charles M/0000-0001-9827-2247; McGrath, Sean David/0000-0001-9064-8449; Schierding, William/0000-0001-5659-2701; Larson, David/0000-0001-7934-5906; Davies, Sherri/0000-0002-7141-8354; Locke, Devin/0000-0002-2527-0475; MCLELLAN, MICHAEL/0000-0002-2703-8784	Washington University in St Louis; National Human Genome Research Institute (NHGRI) [U54 HG003079]; National Cancer Institute (NCI) [1 U01 CA114722-01]; Susan G Komen Breast Cancer Foundation [BCTR0707808]; Fashion Footwear Charitable Foundation, Inc. [NCI U10 CA076001, NCI 3P50 CA68438]; Breast Cancer Research Foundation; Institute of Clinical and Translational Sciences at Washington University [UL1 RR024992]; Illumina, Inc.; NATIONAL CANCER INSTITUTE [U01CA114722, U10CA076001, P50CA068438] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	Washington University in St Louis; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Fashion Footwear Charitable Foundation, Inc.; Breast Cancer Research Foundation; Institute of Clinical and Translational Sciences at Washington University; Illumina, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the many members of The Genome Center and Siteman Cancer Center at Washington University in St Louis for support. This work was funded by grants to R. K. W. from Washington University in St Louis and the National Human Genome Research Institute (NHGRI U54 HG003079), and grants to M. J. E. from the National Cancer Institute (NCI 1 U01 CA114722-01), the Susan G Komen Breast Cancer Foundation (BCTR0707808), and the Fashion Footwear Charitable Foundation, Inc. NCI U10 CA076001 and a Breast Cancer Research Foundation grant awarded to the American College of Surgeons Oncology Group supported the acquisition of samples for recurrence testing. The tissue procurement core was supported by an NCI core grant to the Siteman Cancer Center (NCI 3P50 CA68438). The Human and Mouse Linked Evaluation of Tumors Core was supported by the Institute of Clinical and Translational Sciences at Washington University (CTSA grant UL1 RR024992). We also thank Illumina, Inc. for their support and role in the Washington University Cancer Genome Initiative.	BAIPAI S, 2009, J BIOL CHEM, V284, P18252; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Clark AM, 2004, GENE CHROMOSOME CANC, V41, P99, DOI 10.1002/gcc.20069; Gandara ML, 2003, MOL CELL BIOL, V23, P7377, DOI 10.1128/MCB.23.20.7377-7390.2003; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Kamal M, 2010, BREAST CANCER RES TR, V121, P555, DOI 10.1007/s10549-009-0500-4; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Plumb CL, 2009, AM J PATHOL, V175, P1662, DOI 10.2353/ajpath.2009.090007; Sacco F, 2009, J BIOL CHEM, V284, P22048, DOI 10.1074/jbc.M109.002758; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Toomes C, 2003, GENE CHROMOSOME CANC, V37, P132, DOI 10.1002/gcc.10191; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhang W, 2006, MOL CANCER RES, V4, P935, DOI 10.1158/1541-7786.MCR-06-0253	30	916	958	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					999	1005		10.1038/nature08989	http://dx.doi.org/10.1038/nature08989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393555	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000276635000030
J	Frearson, JA; Brand, S; McElroy, SP; Cleghorn, LAT; Smid, O; Stojanovski, L; Price, HP; Guther, MLS; Torrie, LS; Robinson, DA; Hallyburton, I; Mpamhanga, CP; Brannigan, JA; Wilkinson, AJ; Hodgkinson, M; Hui, R; Qiu, W; Raimi, OG; van Aalten, DMF; Brenk, R; Gilbert, IH; Read, KD; Fairlamb, AH; Ferguson, MAJ; Smith, DF; Wyatt, PG				Frearson, Julie A.; Brand, Stephen; McElroy, Stuart P.; Cleghorn, Laura A. T.; Smid, Ondrej; Stojanovski, Laste; Price, Helen P.; Guther, M. Lucia S.; Torrie, Leah S.; Robinson, David A.; Hallyburton, Irene; Mpamhanga, Chidochangu P.; Brannigan, James A.; Wilkinson, Anthony J.; Hodgkinson, Michael; Hui, Raymond; Qiu, Wei; Raimi, Olawale G.; van Aalten, Daan M. F.; Brenk, Ruth; Gilbert, Ian H.; Read, Kevin D.; Fairlamb, Alan H.; Ferguson, Michael A. J.; Smith, Deborah F.; Wyatt, Paul G.			N-myristoyltransferase inhibitors as new leads to treat sleeping sickness	NATURE			English	Article							VARIANT SURFACE GLYCOPROTEIN; TRYPANOSOMA-BRUCEI; AFRICAN TRYPANOSOMES; MYRISTOYL-COA; DRUG TARGET; SUBSTRATE PROTEINS; ENDOCYTOSIS; LEISHMANIA; TRAFFICKING; COMPLEXES	African sleeping sickness or human African trypanosomiasis, caused by Trypanosoma brucei spp., is responsible for similar to 30,000 deaths each year. Available treatments for this disease are poor, with unacceptable efficacy and safety profiles, particularly in the late stage of the disease when the parasite has infected the central nervous system. Here we report the validation of a molecular target and the discovery of associated lead compounds with the potential to address this lack of suitable treatments. Inhibition of this target-T. brucei N-myristoyltransferase-leads to rapid killing of trypanosomes both in vitro and in vivo and cures trypanosomiasis in mice. These high-affinity inhibitors bind into the peptide substrate pocket of the enzyme and inhibit protein N-myristoylation in trypanosomes. The compounds identified have promising pharmaceutical properties and represent an opportunity to develop oral drugs to treat this devastating disease. Our studies validate T. brucei N-myristoyltransferase as a promising therapeutic target for human African trypanosomiasis.	[Frearson, Julie A.; Brand, Stephen; McElroy, Stuart P.; Cleghorn, Laura A. T.; Smid, Ondrej; Stojanovski, Laste; Guther, M. Lucia S.; Torrie, Leah S.; Robinson, David A.; Hallyburton, Irene; Mpamhanga, Chidochangu P.; Brenk, Ruth; Gilbert, Ian H.; Read, Kevin D.; Fairlamb, Alan H.; Ferguson, Michael A. J.; Wyatt, Paul G.] Univ Dundee, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Coll Life Sci, Dundee DD1 5EH, Scotland; [Raimi, Olawale G.; van Aalten, Daan M. F.] Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dundee DD1 5EH, Scotland; [Price, Helen P.; Hodgkinson, Michael; Smith, Deborah F.] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5YW, N Yorkshire, England; [Brannigan, James A.; Wilkinson, Anthony J.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Price, Helen P.; Hodgkinson, Michael; Smith, Deborah F.] Univ York, Hull York Med Sch, York YO10 5YW, N Yorkshire, England; [Hui, Raymond; Qiu, Wei] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada	University of Dundee; University of Dundee; University of York - UK; University of York - UK; University of Hull; University of York - UK; University of Toronto; Structural Genomics Consortium	Wyatt, PG (corresponding author), Univ Dundee, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Coll Life Sci, Dundee DD1 5EH, Scotland.	p.g.wyatt@dundee.ac.uk	Ferguson, Michael A. J./F-7829-2010; Fairlamb, Alan/A-5272-2009	Ferguson, Michael A. J./0000-0003-1321-8714; Fairlamb, Alan/0000-0001-5134-0329; van Aalten, Daan/0000-0002-1499-6908; Brand, Stephen/0000-0002-7010-5348; Wyatt, Paul/0000-0002-0397-245X; Raimi, Olawale G./0000-0003-2782-7318; Brenk, Ruth/0000-0002-6204-5488; Cleghorn, Laura/0000-0001-6218-0092; Price, Helen/0000-0003-1537-4390; Hallyburton, Irene/0000-0003-4883-5560; Gilbert, Ian/0000-0002-5238-1314; Robinson, David/0000-0003-1979-5918; Wilkinson, Anthony/0000-0003-4577-9479	Wellcome Trust [WT077705, WT083481, WT077503, WT085622]; Scottish Funding Council [HR04013]; Translational Biology Theme of SULSA; European Regional Development Fund; Wolfson Foundation; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation and Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation, Merck; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Medical Research Council [G0900138] Funding Source: researchfish; MRC [G0900138] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Scottish Funding Council; Translational Biology Theme of SULSA; European Regional Development Fund(European Commission); Wolfson Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation and Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet(GlaxoSmithKline); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation, Merck; Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Wellcome Trust (WT077705, WT083481, WT077503 and WT085622), Scottish Funding Council (HR04013) and by the Translational Biology Theme of SULSA. We thank the European Regional Development Fund and the Wolfson Foundation for grants that provided relevant infrastructure for this work. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation and Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck, the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. Wewould like to thank all members of the Drug Discovery Unit for their technical assistance in this study, particularly B. Rao, I. Collie and D. James.	Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Armah DA, 1999, J BIOL CHEM, V274, P5931, DOI 10.1074/jbc.274.9.5931; Bhatnagar RS, 1999, BBA-MOL CELL BIOL L, V1441, P162, DOI 10.1016/S1388-1981(99)00155-9; Bowyer PW, 2008, CHEMMEDCHEM, V3, P402, DOI 10.1002/cmdc.200700301; Bowyer PW, 2007, BIOCHEM J, V408, P173, DOI 10.1042/BJ20070692; Brenk R, 2008, CHEMMEDCHEM, V3, P435, DOI 10.1002/cmdc.200700139; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; DOERING TL, 1991, SCIENCE, V252, P1851, DOI 10.1126/science.1829548; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Farazi TA, 2001, BIOCHEMISTRY-US, V40, P6335, DOI 10.1021/bi0101401; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; FERGUSON MAJ, 1984, J BIOL CHEM, V259, P3011; Georgopapadakou NH, 2002, EXPERT OPIN INV DRUG, V11, P1117, DOI 10.1517/13543784.11.8.1117; Giang DG, 1998, J BIOL CHEM, V273, P6595, DOI 10.1074/jbc.273.12.6595; Hall B, 2004, MOL BIOCHEM PARASIT, V138, P67, DOI 10.1016/j.molbiopara.2004.07.007; Hertz-Fowler C, 2001, MOL BIOCHEM PARASIT, V116, P25, DOI 10.1016/S0166-6851(01)00296-1; Hill BT, 2005, J VIROL, V79, P1133, DOI 10.1128/JVI.79.2.1133-1141.2005; Maurer-Stroh S, 2002, J MOL BIOL, V317, P541, DOI 10.1006/jmbi.2002.5426; Mills E, 2007, MOL BIOCHEM PARASIT, V152, P22, DOI 10.1016/j.molbiopara.2006.11.008; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overath P, 2004, MOL MICROBIOL, V53, P735, DOI 10.1111/j.1365-2958.2004.04224.x; Panethymitaki C, 2006, BIOCHEM J, V396, P277, DOI 10.1042/BJ20051886; Patterson S, 2009, CHEMMEDCHEM, V4, P1341, DOI 10.1002/cmdc.200900098; Price HP, 2007, MOL BIOL CELL, V18, P864, DOI 10.1091/mbc.E06-08-0736; Price HP, 2010, MOL BIOCHEM PARASIT, V169, P55, DOI 10.1016/j.molbiopara.2009.09.006; Price HP, 2005, J CELL SCI, V118, P831, DOI 10.1242/jcs.01624; Price HP, 2003, J BIOL CHEM, V278, P7206, DOI 10.1074/jbc.M211391200; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Selvakumar P, 2007, PROG LIPID RES, V46, P1, DOI 10.1016/j.plipres.2006.05.002; Sheng CQ, 2009, J COMPUT AID MOL DES, V23, P375, DOI 10.1007/s10822-009-9267-2; Sienkiewicz N, 2008, MOL MICROBIOL, V69, P520, DOI 10.1111/j.1365-2958.2008.06305.x; Thuita JK, 2008, ACTA TROP, V108, P6, DOI 10.1016/j.actatropica.2008.07.006; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wingard Jennifer N, 2008, J Biol Chem, V283, P23388, DOI 10.1074/jbc.M803178200	39	214	215	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	2010	464	7289					728	U100		10.1038/nature08893	http://dx.doi.org/10.1038/nature08893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	577EO	20360736	Green Accepted			2022-12-24	WOS:000276205000038
J	Shen, H; Sabaliauskas, N; Sherpa, A; Fenton, AA; Stelzer, A; Aoki, C; Smith, SS				Shen, Hui; Sabaliauskas, Nicole; Sherpa, Ang; Fenton, Andre A.; Stelzer, Armin; Aoki, Chiye; Smith, Sheryl S.			A Critical Role for alpha 4 beta delta GABA(A) Receptors in Shaping Learning Deficits at Puberty in Mice	SCIENCE			English	Article							LONG-TERM POTENTIATION; SPATIAL MEMORY; DELTA-SUBUNIT; HIPPOCAMPAL-NEURONS; WATER MAZE; STRESS; INHIBITION; ANXIETY; RAT; MATURATION	The onset of puberty defines a developmental stage when some learning processes are diminished, but the mechanism for this deficit remains unknown. We found that, at puberty, expression of inhibitory alpha 4 beta delta gamma-aminobutyric acid type A (GABA(A)) receptors (GABAR) increases perisynaptic to excitatory synapses in CA1 hippocampus. Shunting inhibition via these receptors reduced N-methyl-D-aspartate receptor activation, impairing induction of long-term potentiation (LTP). Pubertal mice also failed to learn a hippocampal, LTP-dependent spatial task that was easily acquired by delta-/- mice. However, the stress steroid THP (3 alpha OH-5 alpha[beta]-pregnan-20-one), which reduces tonic inhibition at puberty, facilitated learning. Thus, the emergence of alpha 4 beta delta GABARs at puberty impairs learning, an effect that can be reversed by a stress steroid.	[Shen, Hui; Sabaliauskas, Nicole; Sherpa, Ang; Fenton, Andre A.; Stelzer, Armin; Smith, Sheryl S.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Sabaliauskas, Nicole; Aoki, Chiye] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Sherpa, Ang; Fenton, Andre A.; Stelzer, Armin; Smith, Sheryl S.] Suny Downstate Med Ctr, Program Neural & Behav Sci, Brooklyn, NY 11203 USA; [Fenton, Andre A.; Stelzer, Armin; Smith, Sheryl S.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Smith, SS (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	sheryl.smith@downstate.edu	Aoki, Chiye/T-9405-2019	Aoki, Chiye/0000-0003-4010-9425; Smith, Sheryl/0000-0003-4308-3267; Fenton, Andre/0000-0002-5063-1156	NIH [DA09618, AA12958]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank D. Lovinger for a critical reading of the manuscript; W. Sieghart for his generous gift of the delta antibody; and A. Kuver, L. Silva, and J. Molla for technical assistance. This work was supported by NIH grants DA09618 and AA12958 to S. S. S.	Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Belelli D, 2002, NEUROPHARMACOLOGY, V43, P651, DOI 10.1016/S0028-3908(02)00172-7; Bianchi MT, 2002, NEUROPHARMACOLOGY, V43, P492, DOI 10.1016/S0028-3908(02)00163-6; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cheng VY, 2006, J NEUROSCI, V26, P3713, DOI 10.1523/JNEUROSCI.5024-05.2006; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Collinson N, 2006, PSYCHOPHARMACOLOGY, V188, P619, DOI 10.1007/s00213-006-0361-z; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; FRIEDMAN SB, 1967, PSYCHOSOM MED, V29, P323, DOI 10.1097/00006842-196707000-00003; Girdler SS, 2001, BIOL PSYCHIAT, V49, P788, DOI 10.1016/S0006-3223(00)01044-1; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; HASSLER M, 1991, INT J NEUROSCI, V58, P183, DOI 10.3109/00207459108985434; HERRON CE, 1986, NATURE, V322, P265, DOI 10.1038/322265a0; Hodes GE, 2005, HORM BEHAV, V48, P163, DOI 10.1016/j.yhbeh.2005.02.008; IZUMI Y, 1995, SYNAPSE, V20, P19, DOI 10.1002/syn.890200104; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; KRASNOFF A, 1976, DEV PSYCHOBIOL, V9, P261, DOI 10.1002/dev.420090310; Luine Victoria, 1996, Physiology and Behavior, V59, P27, DOI 10.1016/0031-9384(95)02016-0; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; Matthews DB, 2002, ALCOHOL CLIN EXP RES, V26, P1747, DOI 10.1097/01.ALC.0000037219.79257.17; McGivern RF, 2002, BRAIN COGNITION, V50, P73, DOI 10.1016/S0278-2626(02)00012-X; Meredith RM, 2003, J NEUROSCI, V23, P11142, DOI 10.1523/jneurosci.23-35-11142.2003; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; Sadowski RN, 2009, BEHAV BRAIN RES, V205, P19, DOI 10.1016/j.bbr.2009.06.027; Shen H, 2007, NAT NEUROSCI, V10, P469, DOI 10.1038/nn1868; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Subrahmanyam K., 1994, J APPL DEV PSYCHOL, V15, P13, DOI DOI 10.1016/0193-3973(94)90004-3; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0	35	124	127	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	2010	327	5972					1515	1518		10.1126/science.1184245	http://dx.doi.org/10.1126/science.1184245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299596	Green Accepted			2022-12-24	WOS:000275715200050
J	Yang, Q; Pando, BF; Dong, GG; Golden, SS; van Oudenaarden, A				Yang, Qiong; Pando, Bernardo F.; Dong, Guogang; Golden, Susan S.; van Oudenaarden, Alexander			Circadian Gating of the Cell Cycle Revealed in Single Cyanobacterial Cells	SCIENCE			English	Article							GENE-EXPRESSION; DIVISION; CLOCK; RHYTHMS; OSCILLATIONS; ZEBRAFISH; TIMES	Although major progress has been made in uncovering the machinery that underlies individual biological clocks, much less is known about how multiple clocks coordinate their oscillations. We simultaneously tracked cell division events and circadian phases of individual cells of the cyanobacterium Synechococcus elongatus and fit the data to a model to determine when cell cycle progression slows as a function of circadian and cell cycle phases. We infer that cell cycle progression in cyanobacteria slows during a specific circadian interval but is uniform across cell cycle phases. Our model is applicable to the quantification of the coupling between biological oscillators in other organisms.	[Yang, Qiong; Pando, Bernardo F.; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Dong, Guogang; Golden, Susan S.] Univ Calif San Diego, Ctr Chronobiol, La Jolla, CA 92093 USA; [Dong, Guogang; Golden, Susan S.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019; Yang, Qiong/G-9630-2016	Yang, Qiong/0000-0002-2442-2094	NSF [PHY-0548484]; NIH [R01-GM068957, R01-GM062419]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068957, R01GM062419] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Gore, P. Luitel, C. Engert, and S. Klemm for helpful discussions and/or experimental help. Supported by NSF grant PHY-0548484 and by NIH grants R01-GM068957 and R01-GM062419.	Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Charvin G, 2009, P NATL ACAD SCI USA, V106, P6632, DOI 10.1073/pnas.0809227106; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Dong GG, 2010, CELL, V140, P529, DOI 10.1016/j.cell.2009.12.042; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Goldbeter A, 2008, CURR BIOL, V18, pR751, DOI 10.1016/j.cub.2008.06.044; Hirayama J, 2005, P NATL ACAD SCI USA, V102, P10194, DOI 10.1073/pnas.0502610102; Imai K, 2004, J BIOL CHEM, V279, P36534, DOI 10.1074/jbc.M405861200; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Maroto M., 2008, CELLULAR OSCILLATORY; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Mori T, 2001, J BACTERIOL, V183, P2439, DOI 10.1128/JB.183.8.2439-2444.2001; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Salter MG, 2003, NATURE, V426, P680, DOI 10.1038/nature02174; Strogatz HS., 1994, NONLINEAR DYNAMICS C; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Zamborszky J, 2007, J BIOL RHYTHM, V22, P542, DOI 10.1177/0748730407307225	24	117	120	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1522	1526		10.1126/science.1181759	http://dx.doi.org/10.1126/science.1181759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299597	Green Submitted, Green Accepted			2022-12-24	WOS:000275715200052
J	Snippert, HJ; Haegebarth, A; Kasper, M; Jaks, V; van Es, JH; Barker, N; van de Wetering, M; van den Born, M; Begthel, H; Vries, RG; Stange, DE; Toftgard, R; Clevers, H				Snippert, Hugo J.; Haegebarth, Andrea; Kasper, Maria; Jaks, Viljar; van Es, Johan H.; Barker, Nick; van de Wetering, Marc; van den Born, Maaike; Begthel, Harry; Vries, Robert G.; Stange, Daniel E.; Toftgard, Rune; Clevers, Hans			Lgr6 Marks Stem Cells in the Hair Follicle That Generate All Cell Lineages of the Skin	SCIENCE			English	Article							LABEL-RETAINING CELLS; ADULT-MOUSE SKIN; POPULATION; EPIDERMIS; KERATINOCYTES; DISTINCT; BULGE; EXPRESSION; RENEWAL; DEFINES	Mammalian epidermis consists of three self-renewing compartments: the hair follicle, the sebaceous gland, and the interfollicular epidermis. We generated knock-in alleles of murine Lgr6, a close relative of the Lgr5 stem cell gene. Lgr6 was expressed in the earliest embryonic hair placodes. In adult hair follicles, Lgr6+ cells resided in a previously uncharacterized region directly above the follicle bulge. They expressed none of the known bulge stem cell markers. Prenatal Lgr6+ cells established the hair follicle, sebaceous gland, and interfollicular epidermis. Postnatally, Lgr6+ cells generated sebaceous gland and interfollicular epidermis, whereas contribution to hair lineages gradually diminished with age. Adult Lgr6+ cells executed long-term wound repair, including the formation of new hair follicles. We conclude that Lgr6 marks the most primitive epidermal stem cell.	[Snippert, Hugo J.; Haegebarth, Andrea; van Es, Johan H.; Barker, Nick; van de Wetering, Marc; van den Born, Maaike; Begthel, Harry; Vries, Robert G.; Stange, Daniel E.; Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Snippert, Hugo J.; Haegebarth, Andrea; van Es, Johan H.; Barker, Nick; van de Wetering, Marc; van den Born, Maaike; Begthel, Harry; Vries, Robert G.; Stange, Daniel E.; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Kasper, Maria; Jaks, Viljar; Toftgard, Rune] Karolinska Inst, Ctr Biosci, SE-14157 Huddinge, Sweden; [Kasper, Maria; Jaks, Viljar; Toftgard, Rune] Novum, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Karolinska Institutet; Karolinska Institutet	Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Stange, Daniel E/O-1837-2015; Jaks, Viljar/H-2467-2012; Kasper, Maria/Q-6318-2016; Barker, Nick/A-5535-2011; Barker, Nick/AAS-2774-2020; Barker, Nick/AAE-9833-2021; van+Es, Johan/ABD-5411-2021	Stange, Daniel E/0000-0003-4246-2230; Jaks, Viljar/0000-0002-2221-6262; Barker, Nick/0000-0003-3566-4475; Kasper, Maria/0000-0002-6117-2717	Koningin Wilhelmina Fonds; European Research Council; European Molecular Biology Organization; Swedish Cancer Society; Swedish Research Council	Koningin Wilhelmina Fonds; European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We acknowledge M. Cozijnsen, J. Korving, A. Bergstrom, A. Dackland, and Hubrecht Imaging Centre for technical help and support. This work was supported by the Koningin Wilhelmina Fonds and a European Research Council grant to H. C., a European Molecular Biology Organization Long-Term Fellowship to A. H., and by grants from the Swedish Cancer Society and the Swedish Research Council to R. T. A patent is pending on work with Lgr5 and Lgr6 (A. H., N. B., and H. C.). GEO microarray accession number is GSE20269.	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Iseki S, 1996, BIOCHEM BIOPH RES CO, V218, P688, DOI 10.1006/bbrc.1996.0123; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nijhof JGW, 2006, DEVELOPMENT, V133, P3027, DOI 10.1242/dev.02443; Pispa J, 2008, HUM MOL GENET, V17, P3380, DOI 10.1093/hmg/ddn232; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Van Loy T, 2008, GEN COMP ENDOCR, V155, P14, DOI 10.1016/j.ygcen.2007.06.022; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064	30	542	574	6	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1385	1389		10.1126/science.1184733	http://dx.doi.org/10.1126/science.1184733			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223988				2022-12-24	WOS:000275418700043
J	Zalzman, M; Falco, G; Sharova, LV; Nishiyama, A; Thomas, M; Lee, SL; Stagg, CA; Hoang, HG; Yang, HT; Indig, FE; Wersto, RP; Ko, MSH				Zalzman, Michal; Falco, Geppino; Sharova, Lioudmila V.; Nishiyama, Akira; Thomas, Marshall; Lee, Sung-Lim; Stagg, Carole A.; Hoang, Hien G.; Yang, Hsih-Te; Indig, Fred E.; Wersto, Robert P.; Ko, Minoru S. H.			Zscan4 regulates telomere elongation and genomic stability in ES cells	NATURE			English	Article							EMBRYONIC STEM-CELLS; DOUBLE-STRAND BREAKS; DNA; EXPRESSION; LENGTH; LINES; RECOMBINATION; MAINTENANCE; MICE; IDENTIFICATION	Exceptional genomic stability is one of the hallmarks of mouse embryonic stem (ES) cells. However, the genes contributing to this stability remain obscure. We previously identified Zscan4 as a specific marker for two-cell embryo and ES cells. Here we show that Zscan4 is involved in telomere maintenance and long-term genomic stability in ES cells. Only 5% of ES cells express Zscan4 at a given time, but nearly all ES cells activate Zscan4 at least once during nine passages. The transient Zscan4-positive state is associated with rapid telomere extension by telomere recombination and upregulation of meiosis-specific homologous recombination genes, which encode proteins that are colocalized with ZSCAN4 on telomeres. Furthermore, Zscan4 knockdown shortens telomeres, increases karyotype abnormalities and spontaneous sister chromatid exchange, and slows down cell proliferation until reaching crisis by passage eight. Together, our data show a unique mode of genome maintenance in ES cells.	[Zalzman, Michal; Falco, Geppino; Sharova, Lioudmila V.; Nishiyama, Akira; Thomas, Marshall; Lee, Sung-Lim; Stagg, Carole A.; Hoang, Hien G.; Yang, Hsih-Te; Ko, Minoru S. H.] NIA, Dev Genom & Aging Sect, Genet Lab, Baltimore, MD 21224 USA; [Indig, Fred E.; Wersto, Robert P.] NIA, Res Resources Branch, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Ko, MSH (corresponding author), NIA, Dev Genom & Aging Sect, Genet Lab, Baltimore, MD 21224 USA.	kom@mail.nih.gov	Ko, Minoru S. H./B-7969-2009; Zalzman, Michal/Z-2121-2019	Ko, Minoru S. H./0000-0002-3530-3015; falco, geppino/0000-0001-6193-7233; Zalzman, Michal/0000-0002-4689-2951; YANG, HSIH-TE/0000-0002-4851-1374	National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000662, ZICAG000615, ZICAG000618, ZIAAG000706, ZIAAG000700, ZIAAG000678, ZIAAG000655, ZIAAG000656] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank T. Hamatani, Y. Nakatake, M. Monti, L. Xin, B. Binder and A. A. Sharov for discussion; Y. Piao, C. Nguyen, D. Eckley, I. Goldberg, D. Dudekula and I. Stanghellini for technical assistance; P. Soriano for providing ROSA26-floxed LacZ cells; and H. Niwa for providing ROSA-tet-inducible system. This work was entirely supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health.	Aiba K, 2009, DNA RES, V16, P73, DOI 10.1093/dnares/dsn035; Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Bailey SM, 1996, MUTAGENESIS, V11, P139, DOI 10.1093/mutage/11.2.139; Blelloch RH, 2004, P NATL ACAD SCI USA, V101, P13985, DOI 10.1073/pnas.0405015101; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; De Boeck G, 2009, J PATHOL, V217, P327, DOI 10.1002/path.2500; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Dronkert MLG, 2000, MOL CELL BIOL, V20, P3147, DOI 10.1128/MCB.20.9.3147-3156.2000; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; GOODWIN E, 1993, CYTOGENET CELL GENET, V63, P126, DOI 10.1159/000133516; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 2003, MANIPULATING MOUSE E; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Olson LE, 2003, CANCER RES, V63, P6602; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O; Rebuzzini P, 2008, CYTOTECHNOLOGY, V58, P17, DOI 10.1007/s10616-008-9164-x; Reinholdt LG, 2005, CHROMOSOMA, V114, P127, DOI 10.1007/s00412-005-0346-4; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Storm MP, 2009, STEM CELLS, V27, P764, DOI 10.1002/stem.3; SUDA Y, 1987, J CELL PHYSIOL, V133, P197, DOI 10.1002/jcp.1041330127; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka TS, 2009, REPROD FERT DEVELOP, V21, P67, DOI 10.1071/RD08219; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Wang YS, 2005, P NATL ACAD SCI USA, V102, P10256, DOI 10.1073/pnas.0504635102; Yoshikawa T, 2006, GENE EXPR PATTERNS, V6, P213, DOI 10.1016/j.modgep.2005.06.003	52	283	296	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					858	U66		10.1038/nature08882	http://dx.doi.org/10.1038/nature08882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20336070	Green Accepted			2022-12-24	WOS:000276397300030
J	Kastner, DL; Aksentijevich, I; Goldbach-Mansky, R				Kastner, Daniel L.; Aksentijevich, Ivona; Goldbach-Mansky, Raphaela			Autoinflammatory Disease Reloaded: A Clinical Perspective	CELL			English	Article							FAMILIAL MEDITERRANEAN FEVER; NALP3 INFLAMMASOME; B30.2 DOMAIN; PYRIN; MUTATIONS; PROTEIN; INTERLEUKIN-1-BETA; CIAS1; INHIBITION; ACTIVATION	Our understanding of the etiology of autoinflammatory disease is growing rapidly. Recent advances offer new opportunities for therapeutic intervention and suggest that the definition of what constitutes an autoinflammatory disease should be reassessed.	[Kastner, Daniel L.; Aksentijevich, Ivona; Goldbach-Mansky, Raphaela] NIAMSD, Clin Invest Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Kastner, DL (corresponding author), NIAMSD, Clin Invest Lab, NIH, Bethesda, MD 20892 USA.	kastnerd@mail.nih.gov	Aksentijevich, Ivona/AAF-1335-2019; Goldbach-Mansky, Raphaela/N-5917-2017		National Institute of Arthritis and Musculoskeletal; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIDAR041180, ZIAAR041162, ZIAAR041139, Z01AR041176, ZIEAR041176, ZIAAR041138, Z01AR041139, Z01AR041153, ZIAAR041123, ZIAAR041083, ZIAAR041185, Z01AR041180, Z01AR041170, ZIAAR041153, ZIAAR041170] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 1999, AM J HUM GENET, V64, P949, DOI 10.1086/302327; Aksentijevich I, 1997, CELL, V90, P797; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Bernot A, 1997, NAT GENET, V17, P25; Booty MG, 2009, ARTHRITIS RHEUM-US, V60, P1851, DOI 10.1002/art.24569; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Choi HK, 2010, CURR OPIN RHEUMATOL, V22, P144, DOI 10.1097/BOR.0b013e32833645e8; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Feder HM, 2010, ACTA PAEDIATR, V99, P178, DOI 10.1111/j.1651-2227.2009.01554.x; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Galon J, 2000, CURR OPIN IMMUNOL, V12, P479, DOI 10.1016/S0952-7915(00)00124-2; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Gul Ahmet, 2005, Current Drug Targets - Inflammation and Allergy, V4, P81, DOI 10.2174/1568010053622894; Hoffman HM, 2008, ARTHRITIS RHEUM, V58, P2443, DOI 10.1002/art.23687; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hopkins Donald R., 1983, GREATEST KILLER SMAL; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lobito AA, 2006, BLOOD, V108, P1320, DOI 10.1182/blood-2005-11-006783; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Marek-Yagel D, 2009, ARTHRITIS RHEUM-US, V60, P1862, DOI 10.1002/art.24570; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; Ozen S, 2009, ARTHRITIS RHEUM, V60, P1575, DOI 10.1002/art.24565; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Suber T, 2009, ARTHRITIS RHEUM-US, V60, P2216, DOI 10.1002/art.24715; Sugiura T, 2008, MOD RHEUMATOL, V18, P57, DOI 10.1007/s10165-007-0003-2; Terkeltaub R, 2009, ANN RHEUM DIS, V68, P1613, DOI 10.1136/ard.2009.108936; Touitou I, 2007, ARTHRITIS RHEUM, V56, P1706, DOI 10.1002/art.22507; Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029	51	322	340	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6					784	790		10.1016/j.cell.2010.03.002	http://dx.doi.org/10.1016/j.cell.2010.03.002			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303869	Bronze, Green Accepted			2022-12-24	WOS:000275746600003
J	Zitvogel, L; Kepp, O; Kroemer, G				Zitvogel, Laurence; Kepp, Oliver; Kroemer, Guido			Decoding Cell Death Signals in Inflammation and Immunity	CELL			English	Article							TUMOR-CELLS; CALRETICULIN EXPOSURE; AUTOPHAGY; CLEARANCE; INDUCTION; RECEPTOR; SYSTEM; AUTOIMMUNITY; SENESCENCE; RELEASE	Dying cells release and expose at their surface molecules that signal to the immune system. We speculate that combinations of these molecules determine the route by which dying cells are engulfed and the nature of the immune response that their death elicits.	[Zitvogel, Laurence] Inst Gustave Roussy, INSERM, U805, F-94805 Villejuif, France; [Zitvogel, Laurence; Kepp, Oliver; Kroemer, Guido] Univ Paris 11, F-94805 Villejuif, France; [Kepp, Oliver; Kroemer, Guido] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Zitvogel, L (corresponding author), Inst Gustave Roussy, INSERM, U805, F-94805 Villejuif, France.	zitvogel@igr.fr; kroemer@orange.fr	Kroemer, Guido/AAY-9859-2020; Kepp, Oliver/GPX-8627-2022; KROEMER, Guido/B-4263-2013; Kepp, Oliver/N-2763-2017	KROEMER, Guido/0000-0002-9334-4405; Kepp, Oliver/0000-0002-6081-9558; ZITVOGEL, laurence/0000-0003-1596-0998	Ligue Nationale contre le Cancer (equipes labellisees); Fondation pour la Recherche Medicale; European Union; Canceropole Ile-de-France; Institut National du Cancer; Agence Nationale pour la Recherche	Ligue Nationale contre le Cancer (equipes labellisees); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Union(European Commission); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale pour la Recherche(French National Research Agency (ANR))	G.K. and L.Z. are supported by grants from the Ligue Nationale contre le Cancer (equipes labellisees), Fondation pour la Recherche Medicale, European Union, Canceropole Ile-de-France, Institut National du Cancer, and Agence Nationale pour la Recherche.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bartek J, 2008, NAT CELL BIOL, V10, P887, DOI 10.1038/ncb0808-887; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bournazou I, 2009, J CLIN INVEST, V119, P20, DOI 10.1172/JCI36226; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kepp O, 2010, EUR J IMMUNOL, V40, P627, DOI 10.1002/eji.200940160; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; METCHNIKOFF E, 1990, SCAND J IMMUNOL, V31, P1; Miles K, 2009, J IMMUNOL, V183, P2122, DOI 10.4049/jimmunol.0804187; Morselli E, 2009, AGING-US, V1, P961, DOI 10.18632/aging.100110; Munoz LE, 2010, AUTOIMMUN REV, V9, P425, DOI 10.1016/j.autrev.2009.11.016; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schulze C, 2008, AUTOIMMUN REV, V8, P5, DOI 10.1016/j.autrev.2008.07.049; Spisek R, 2007, BLOOD, V109, P4839, DOI 10.1182/blood-2006-10-054221; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Valle FM, 2008, AUTOIMMUN REV, V7, P359, DOI 10.1016/j.autrev.2008.02.002; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Wartha F, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe25; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651	42	412	436	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6					798	804		10.1016/j.cell.2010.02.015	http://dx.doi.org/10.1016/j.cell.2010.02.015			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303871	Bronze			2022-12-24	WOS:000275746600005
J	Joshi, PA; Jackson, HW; Beristain, AG; Di Grappa, MA; Mote, PA; Clarke, CL; Stingl, J; Waterhouse, PD; Khokha, R				Joshi, Purna A.; Jackson, Hartland W.; Beristain, Alexander G.; Di Grappa, Marco A.; Mote, Patricia A.; Clarke, Christine L.; Stingl, John; Waterhouse, Paul D.; Khokha, Rama			Progesterone induces adult mammary stem cell expansion	NATURE			English	Article							BREAST-CANCER; GLAND DEVELOPMENT; EPITHELIAL-CELLS; ESTROUS-CYCLE; RECEPTOR-B; DIFFERENTIATION; RISK; 17-BETA-ESTRADIOL; PROLIFERATION; MORPHOGENESIS	Reproductive history is the strongest risk factor for breast cancer after age, genetics and breast density(1,2). Increased breast cancer risk is entwined with a greater number of ovarian hormone-dependent reproductive cycles, yet the basis for this predisposition is unknown(3-5). Mammary stem cells (MaSCs) are located within a specialized niche in the basal epithelial compartment that is under local and systemic regulation(6). The emerging role of MaSCs in cancer initiation warrants the study of ovarian hormones in MaSC homeostasis. Here we show that the MaSC pool increases 14-fold during maximal progesterone levels at the luteal dioestrus phase of the mouse. Stem-cell-enriched CD49f(hi) cells amplify at dioestrus, or with exogenous progesterone, demonstrating a key role for progesterone in propelling this expansion. In aged mice, CD49f(hi) cells display stasis upon cessation of the reproductive cycle. Progesterone drives a series of events where luminal cells probably provide Wnt4 and RANKL signals to basal cells which in turn respond by upregulating their cognate receptors, transcriptional targets and cell cycle markers. Our findings uncover a dynamic role for progesterone in activating adult MaSCs within the mammary stem cell niche during the reproductive cycle, where MaSCs are putative targets for cell transformation events leading to breast cancer.	[Joshi, Purna A.; Jackson, Hartland W.; Beristain, Alexander G.; Di Grappa, Marco A.; Waterhouse, Paul D.; Khokha, Rama] Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Joshi, Purna A.; Jackson, Hartland W.; Beristain, Alexander G.; Di Grappa, Marco A.; Waterhouse, Paul D.; Khokha, Rama] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada; [Mote, Patricia A.; Clarke, Christine L.] Univ Sydney, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; [Stingl, John] Li Ka Shing Ctr, Cambridge Res Inst, Canc Res UK, Cambridge CB2 0RE, England	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Sydney; Westmead Institute for Medical Research; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Khokha, R (corresponding author), Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada.	rkhokha@uhnres.utoronto.ca	Jackson, Hartland/AAL-7751-2020	Jackson, Hartland/0000-0001-6423-2415; Waterhouse, Paul/0000-0001-8745-5224; Joshi, Purna/0000-0002-1628-9940; Beristain, Alexander/0000-0002-1117-6242; Clarke, Christine/0000-0001-7568-111X	Canadian Breast Cancer Research Alliance; National Cancer Institute of Canada; Canadian Breast Cancer Foundation, Ontario; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0300723B, G0800784B, G0800784] Funding Source: researchfish	Canadian Breast Cancer Research Alliance; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Breast Cancer Foundation, Ontario; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Canadian Breast Cancer Research Alliance. P.A.J. holds a Terry Fox Foundation studentship through an award from the National Cancer Institute of Canada; H.W.J. holds a studentship and A. G. B. a fellowship from the Canadian Breast Cancer Foundation, Ontario. The authors thank F. Tong and R. Nayyar of the OCI FACS facility for cell sorting, and M. Monroy and S. Yousef of the UHN Animal Resources Center for performing ovariectomies.	APTER D, 1989, INT J CANCER, V44, P783, DOI 10.1002/ijc.2910440506; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Bernstein L, 2002, J MAMMARY GLAND BIOL, V7, P3, DOI 10.1023/A:1015714305420; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Brisken C, 2000, GENE DEV, V14, P650; Brisken C, 2007, STEM CELL REV, V3, P147, DOI 10.1007/s12015-007-0019-1; Chepko G, 1999, J MAMMARY GLAND BIOL, V4, P35, DOI 10.1023/A:1018752519356; DANIEL CW, 1987, CANCER RES, V47, P6052; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; Graham JD, 2009, ENDOCRINOLOGY, V150, P3318, DOI 10.1210/en.2008-1630; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Harmes DC, 2009, J MAMMARY GLAND BIOL, V14, P19, DOI 10.1007/s10911-009-9111-2; HASLAM SZ, 1979, BIOCHEM J, V182, P127, DOI 10.1042/bj1820127; Kariagina A, 2007, ENDOCRINOLOGY, V148, P2723, DOI 10.1210/en.2006-1493; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Lydon JP, 1999, CANCER RES, V59, P4276; Mote PA, 2006, ENDOCRINOLOGY, V147, P5503, DOI 10.1210/en.2006-0040; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; TRICHOPOULOS D, 1972, JNCI-J NATL CANCER I, V48, P605; Veronesi U, 2005, LANCET, V365, P1727, DOI 10.1016/S0140-6736(05)66546-4	30	499	510	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					803	807		10.1038/nature09091	http://dx.doi.org/10.1038/nature09091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20445538				2022-12-24	WOS:000278551800050
J	Wang, YD; Nakayama, M; Pitulescu, ME; Schmidt, TS; Bochenek, ML; Sakakibara, A; Adams, S; Davy, A; Deutsch, U; Luthi, U; Barberis, A; Benjamin, LE; Makinen, T; Nobes, CD; Adams, RH				Wang, Yingdi; Nakayama, Masanori; Pitulescu, Mara E.; Schmidt, Tim S.; Bochenek, Magdalena L.; Sakakibara, Akira; Adams, Susanne; Davy, Alice; Deutsch, Urban; Luethi, Urs; Barberis, Alcide; Benjamin, Laura E.; Maekinen, Taija; Nobes, Catherine D.; Adams, Ralf H.			Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis	NATURE			English	Article							CARDIOVASCULAR DEVELOPMENT; MOLECULAR REGULATION; ENDOTHELIAL-CELLS; TRANSGENIC MOUSE; SMOOTH-MUSCLE; AXON GUIDANCE; EXPRESSION; ADULT; RECEPTORS; ARTERIAL	In development, tissue regeneration or certain diseases, angiogenic growth leads to the expansion of blood vessels and the lymphatic vasculature. This involves endothelial cell proliferation as well as angiogenic sprouting, in which a subset of cells, termed tip cells, acquires motile, invasive behaviour and extends filopodial protrusions(1-3). Although it is already appreciated that angiogenesis is triggered by tissue-derived signals, such as vascular endothelial growth factor (VEGF) family growth factors, the resulting signalling processes in endothelial cells are only partly understood. Here we show with genetic experiments in mouse and zebrafish that ephrin-B2, a transmembrane ligand for Eph receptor tyrosine kinases, promotes sprouting behaviour and motility in the angiogenic endothelium. We link this pro-angiogenic function to a crucial role of ephrin-B2 in the VEGF signalling pathway, which we have studied in detail for VEGFR3, the receptor for VEGF-C. In the absence of ephrin-B2, the internalization of VEGFR3 in cultured cells and mutant mice is defective, which compromises downstream signal transduction by the small GTPase Rac1, Akt and the mitogen-activated protein kinase Erk. Our results show that full VEGFR3 signalling is coupled to receptor internalization. Ephrin-B2 is a key regulator of this process and thereby controls angiogenic and lymphangiogenic growth.	[Wang, Yingdi; Schmidt, Tim S.; Sakakibara, Akira; Adams, Susanne; Adams, Ralf H.] Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England; [Nakayama, Masanori; Pitulescu, Mara E.; Bochenek, Magdalena L.; Adams, Susanne; Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Nakayama, Masanori; Pitulescu, Mara E.; Bochenek, Magdalena L.; Adams, Susanne; Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Bochenek, Magdalena L.; Nobes, Catherine D.] Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS6 6BS, Avon, England; [Bochenek, Magdalena L.; Nobes, Catherine D.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS6 6BS, Avon, England; [Davy, Alice] Univ Toulouse, CNRS, CBD UMR 5547, Ctr Dev Biol, F-31062 Toulouse 9, France; [Deutsch, Urban] Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland; [Luethi, Urs; Barberis, Alcide] Oncalis AG, Schlieren, Switzerland; [Benjamin, Laura E.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Maekinen, Taija] Canc Res UK London Res Inst, Lymphat Dev Lab, London WC2A 3PX, England	Cancer Research UK; University of Munster; Max Planck Society; University of Bristol; University of Bristol; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Bern; Harvard University; Beth Israel Deaconess Medical Center; Cancer Research UK	Adams, RH (corresponding author), Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England.	ralf.adams@mpi-muenster.mpg.de	Adams, Ralf H/AAE-9274-2019; Makinen, Taija/C-5765-2014; Wang, Yingdi/O-1807-2013; Makinen, Taija/CAI-2233-2022	Makinen, Taija/0000-0002-9338-1257; Makinen, Taija/0000-0002-9338-1257; Pitulescu, Mara E/0000-0001-5322-8146; Deutsch, Urban/0000-0003-4265-6262	Cancer Research UK; Max-Planck-Society; German Research Foundation [SFB 629, SPP 1190]; EMBO LTF	Cancer Research UK(Cancer Research UK); Max-Planck-Society(Max Planck Society); German Research Foundation(German Research Foundation (DFG)); EMBO LTF(European Molecular Biology Organization (EMBO))	We thank R. Benedito, I. Schmidt, S. Hoffmann, I. Rosewell, S. M. Kuijper, F. Gisler and N. Hostettler for their help, N. Copeland and A. Eichmann for information and reagents, P. Chambon for the CreERT2 cDNA, A. L. Bermange, J.D. Leslie and J. Lewis for help with zebrafish experiments, and A. Acker-Palmer for discussions and for reading the manuscript. Cancer Research UK, the Max-Planck-Society, the German Research Foundation (programmes SFB 629 and SPP 1190) and the EMBO LTF programme provided funding.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Davy A, 2007, DEV BIOL, V304, P182, DOI 10.1016/j.ydbio.2006.12.028; Deutsch U, 2008, EXP CELL RES, V314, P1202, DOI 10.1016/j.yexcr.2007.12.026; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Gerhardt H, 2005, EXP SUPPL, V94, P3; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Lamont RE, 2006, SCI STKE, DOI [10.1126/stke.3552006pe39, DOI 10.1126/STKE.3552006PE39]; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; McColl BK, 2004, APMIS, V112, P463, DOI 10.1111/j.1600-0463.2004.apm11207-0807.x; Morgan SM, 1999, BLOOD, V93, P165, DOI 10.1182/blood.V93.1.165.401k25_165_175; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Osoegawa K, 2000, GENOME RES, V10, P116; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Taylor AC, 2007, MICROCIRCULATION, V14, P253, DOI 10.1080/10739680601141829; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6; Zhu Z, 2002, SEMIN CELL DEV BIOL, V13, P121, DOI 10.1016/S1084-9521(02)00018-6	37	781	804	0	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					483	U108		10.1038/nature09002	http://dx.doi.org/10.1038/nature09002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20445537				2022-12-24	WOS:000278043700036
J	Tao, X; Lee, A; Limapichat, W; Dougherty, DA; MacKinnon, R				Tao, Xiao; Lee, Alice; Limapichat, Walrati; Dougherty, Dennis A.; MacKinnon, Roderick			A Gating Charge Transfer Center in Voltage Sensors	SCIENCE			English	Article							DEPENDENT K+ CHANNEL; SHAKER POTASSIUM CHANNEL; FOCUSED ELECTRIC-FIELD; TRANSMEMBRANE MOVEMENT; WILD-TYPE; ACTIVATION; PORE; S4; DISPLACEMENT; TRANSITIONS	Voltage sensors regulate the conformations of voltage-dependent ion channels and enzymes. Their nearly switchlike response as a function of membrane voltage comes from the movement of positively charged amino acids, arginine or lysine, across the membrane field. We used mutations with natural and unnatural amino acids, electrophysiological recordings, and x-ray crystallography to identify a charge transfer center in voltage sensors that facilitates this movement. This center consists of a rigid cyclic "cap" and two negatively charged amino acids to interact with a positive charge. Specific mutations induce a preference for lysine relative to arginine. By placing lysine at specific locations, the voltage sensor can be stabilized in different conformations, which enables a dissection of voltage sensor movements and their relation to ion channel opening.	[Tao, Xiao; Lee, Alice; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA; [Limapichat, Walrati; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Howard Hughes Medical Institute; Rockefeller University; California Institute of Technology	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu			NIH [GM43949, NS 34407]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034407, R01NS034407] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of D. Gadsby's laboratory (Rockefeller University) for assistance with oocyte preparation; members of the MacKinnon laboratory for assistance; the staff at beamline X29 (National Synchrotron Light Source, Brookhaven National Laboratory) for advice at the synchrotron; and A. Banerjee, J. A. Letts, G. von Heijne (Stockholm University), and J. Chen (Purdue University) for helpful discussions. R. M. is the Investigator in the Howard Hughes Medical Institute. D. A. D. is a George Grant Hoag Professor of Chemistry. Supported by NIH GM43949 to R. M and NS 34407 to D. A. D. The x-ray crystallographic coordinates and structure factor files have been deposited in the Protein Data Bank with accession ID 3LNM.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Banerjee A, 2008, J MOL BIOL, V381, P569, DOI 10.1016/j.jmb.2008.06.010; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Okamura Yasushi, 2006, Tanpakushitsu Kakusan Koso, V51, P18; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	30	350	359	0	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					67	73		10.1126/science.1185954	http://dx.doi.org/10.1126/science.1185954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360102	Green Accepted			2022-12-24	WOS:000276202200035
J	Boehm, A; Kaiser, M; Li, H; Spangler, C; Kasper, CA; Ackermann, M; Kaever, V; Sourjik, V; Roth, V; Jenal, U				Boehm, Alex; Kaiser, Matthias; Li, Hui; Spangler, Christian; Kasper, Christoph Alexander; Ackermann, Martin; Kaever, Volkhard; Sourjik, Victor; Roth, Volker; Jenal, Urs			Second Messenger-Mediated Adjustment of Bacterial Swimming Velocity	CELL			English	Article							C-DI-GMP; FLAGELLAR ROTARY MOTOR; ESCHERICHIA-COLI; PILZ DOMAIN; IN-VIVO; MOTILITY; CHEMOTAXIS; PROTEINS; TORQUE; PATHWAY	Bacteria swim by means of rotating flagella that are powered by ion influx through membrane-spanning motor complexes. Escherichia coli and related species harness a chemosensory and signal transduction machinery that governs the direction of flagellar rotation and allows them to navigate in chemical gradients. Here, we show that Escherichia coli can also fine-tune its swimming speed with the help of a molecular brake (YcgR) that, upon binding of the nucleotide second messenger cyclic di-GMP, interacts with the motor protein MotA to curb flagellar motor output. Swimming velocity is controlled by the synergistic action of at least five signaling proteins that adjust the cellular concentration of cyclic di-GMP. Activation of this network and the resulting deceleration coincide with nutrient depletion and might represent an adaptation to starvation. These experiments demonstrate that bacteria can modulate flagellar motor output and thus swimming velocity in response to environmental cues.	[Boehm, Alex; Kaiser, Matthias; Kasper, Christoph Alexander; Jenal, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Li, Hui; Sourjik, Victor] Univ Heidelberg, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany; [Spangler, Christian; Kaever, Volkhard] Hannover Med Sch, Inst Pharmacol, D-30625 Hannover, Germany; [Ackermann, Martin] ETH, Dept Environm Sci, CH-8092 Zurich, Switzerland; [Ackermann, Martin] EAWAG, Dept Environm Microbiol, CH-8092 Zurich, Switzerland; [Roth, Volker] Univ Basel, Dept Comp Sci, CH-4056 Basel, Switzerland	University of Basel; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Hannover Medical School; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Basel	Boehm, A (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	alexander.boehm@unibas.ch	Roth, Volker/Q-4025-2017; Ackermann, Martin/V-4554-2017; Kaever, Volkhard/G-3280-2013	Roth, Volker/0000-0003-0991-0273; Ackermann, Martin/0000-0003-0087-4819; 	Swiss National Science Foundation [3100A0-108186]; Baden-Wurttemberg; Deutsche Forschungsgemeinschaft [SO 421/7-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Baden-Wurttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank F. Hamburger for help with cloning, M. Durrenberger for microscopy support, M. Podvinec for IT service, A. Vaknin for pAV1, and S. Parkinson for FliC antibody and advice. This work was supported by Swiss National Science Foundation Fellowship 3100A0-108186 to U.J. H. L. was supported by the Bioquant Graduate Program of Baden-Wurttemberg, M. A. by a grant from the Swiss National Science Foundation, and V. S. by the grant SO 421/7-1 from the Deutsche Forschungsgemeinschaft.	Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; AMSLER CD, 1993, J BACTERIOL, V175, P6238, DOI 10.1128/JB.175.19.6238-6244.1993; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darnton NC, 2007, J BACTERIOL, V189, P1756, DOI 10.1128/JB.01501-06; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Gabel CV, 2003, P NATL ACAD SCI USA, V100, P8748, DOI 10.1073/pnas.1533395100; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kentner D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.77; Ko M, 2000, J MOL BIOL, V303, P371, DOI 10.1006/jmbi.2000.4147; Lemke JJ, 2009, MOL MICROBIOL, V74, P1368, DOI 10.1111/j.1365-2958.2009.06939.x; MEISTER M, 1987, CELL, V49, P643, DOI 10.1016/0092-8674(87)90540-X; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Pilizota T, 2009, P NATL ACAD SCI USA, V106, P11582, DOI 10.1073/pnas.0813164106; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; SLOCUM MK, 1985, J BACTERIOL, V163, P586, DOI 10.1128/JB.163.2.586-594.1985; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; van den Heuvel MGL, 2007, SCIENCE, V317, P333, DOI 10.1126/science.1139570; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; Wolfe AJ, 2008, J BACTERIOL, V190, P463, DOI 10.1128/JB.01418-07; Yuan JH, 2008, P NATL ACAD SCI USA, V105, P1182, DOI 10.1073/pnas.0711539105; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436	35	326	344	3	78	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2010	141	1					107	116		10.1016/j.cell.2010.01.018	http://dx.doi.org/10.1016/j.cell.2010.01.018			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20303158	Bronze			2022-12-24	WOS:000276211100016
J	Craddock, N; Hurles, ME; Cardin, N; Pearson, RD; Plagnol, V; Robson, S; Vukcevic, D; Barnes, C; Conrad, DF; Giannoulatou, E; Holmes, C; Marchini, JL; Stirrups, K; Tobin, MD; Wain, LV; Yau, C; Aerts, J; Ahmad, T; Andrews, TD; Arbury, H; Attwood, A; Auton, A; Ball, SG; Balmforth, AJ; Barrett, JC; Barroso, I; Barton, A; Bennett, AJ; Bhaskar, S; Blaszczyk, K; Bowes, J; Brand, OJ; Braund, PS; Bredin, F; Breen, G; Brown, MJ; Bruce, IN; Bull, J; Burren, OS; Burton, J; Byrnes, J; Caesar, S; Clee, CM; Coffey, AJ; Connell, JMC; Cooper, JD; Dominiczak, AF; Downes, K; Drummond, HE; Dudakia, D; Dunham, A; Ebbs, B; Eccles, D; Edkins, S; Edwards, C; Elliot, A; Emery, P; Evans, DM; Evans, G; Eyre, S; Farmer, A; Ferrier, IN; Feuk, L; Fitzgerald, T; Flynn, E; Forbes, A; Forty, L; Franklyn, JA; Freathy, RM; Gibbs, P; Gilbert, P; Gokumen, O; Gordon-Smith, K; Gray, E; Green, E; Groves, CJ; Grozeva, D; Gwilliam, R; Hall, A; Hammond, N; Hardy, M; Harrison, P; Hassanali, N; Hebaishi, H; Hines, S; Hinks, A; Hitman, GA; Hocking, L; Howard, E; Howard, P; Howson, JMM; Hughes, D; Hunt, S; Isaacs, JD; Jain, M; Jewell, DP; Johnson, T; Jolley, JD; Jones, IR; Jones, LA; Kirov, G; Langford, CF; Lango-Allen, H; Lathrop, GM; Lee, J; Lee, KL; Lees, C; Lewis, K; Lindgren, CM; Maisuria-Armer, M; Maller, J; Mansfield, J; Martin, P; Massey, DCO; McArdle, WL; McGuffin, P; McLay, KE; Mentzer, A; Mimmack, ML; Morgan, AE; Morris, AP; Mowat, C; Myers, S; Newman, W; Nimmo, ER; O'Donovan, MC; Onipinla, A; Onyiah, I; Ovington, NR; Owen, MJ; Palin, K; Parnell, K; Pernet, D; Perry, JRB; Phillips, A; Pinto, D; Prescott, NJ; Prokopenko, I; Quail, MA; Rafelt, S; Rayner, NW; Redon, R; Reid, DM; Renwick, A; Ring, SM; Robertson, N; Russell, E; St Clair, D; Sambrook, JG; Sanderson, JD; Schuilenburg, H; Scott, CE; Scott, R; Seal, S; Shaw-Hawkins, S; Shields, BM; Simmonds, MJ; Smyth, DJ; Somaskantharajah, E; Spanova, K; Steer, S; Stephens, J; Stevens, HE; Stone, MA; Su, Z; Symmons, DPM; Thompson, JR; Thomson, W; Travers, ME; Turnbull, C; Valsesia, A; Walker, M; Walker, NM; Wallace, C; Warren-Perry, M; Watkins, NA; Webster, J; Weedon, MN; Wilson, AG; Woodburn, M; Wordsworth, BP; Young, AH; Zeggini, E; Carter, NP; Frayling, TM; Lee, C; McVean, G; Munroe, PB; Palotie, A; Sawcer, SJ; Scherer, SW; Strachan, DP; Tyler-Smith, C; Brown, MA; Burton, PR; Caulfield, MJ; Compston, A; Farrall, M; Gough, SCL; Hall, AS; Hattersley, AT; Hill, AVS; Mathew, CG; Pembrey, M; Satsangi, J; Stratton, MR; Worthington, J; Deloukas, P; Duncanson, A; Kwiatkowski, DP; McCarthy, MI; Ouwehand, WH; Parkes, M; Rahman, N; Todd, JA; Samani, NJ; Donnelly, P				Craddock, Nick; Hurles, Matthew E.; Cardin, Niall; Pearson, Richard D.; Plagnol, Vincent; Robson, Samuel; Vukcevic, Damjan; Barnes, Chris; Conrad, Donald F.; Giannoulatou, Eleni; Holmes, Chris; Marchini, Jonathan L.; Stirrups, Kathy; Tobin, Martin D.; Wain, Louise V.; Yau, Chris; Aerts, Jan; Ahmad, Tariq; Andrews, T. Daniel; Arbury, Hazel; Attwood, Anthony; Auton, Adam; Ball, Stephen G.; Balmforth, Anthony J.; Barrett, Jeffrey C.; Barroso, Ines; Barton, Anne; Bennett, Amanda J.; Bhaskar, Sanjeev; Blaszczyk, Katarzyna; Bowes, John; Brand, Oliver J.; Braund, Peter S.; Bredin, Francesca; Breen, Gerome; Brown, Morris J.; Bruce, Ian N.; Bull, Jaswinder; Burren, Oliver S.; Burton, John; Byrnes, Jake; Caesar, Sian; Clee, Chris M.; Coffey, Alison J.; Connell, John M. C.; Cooper, Jason D.; Dominiczak, Anna F.; Downes, Kate; Drummond, Hazel E.; Dudakia, Darshna; Dunham, Andrew; Ebbs, Bernadette; Eccles, Diana; Edkins, Sarah; Edwards, Cathryn; Elliot, Anna; Emery, Paul; Evans, David M.; Evans, Gareth; Eyre, Steve; Farmer, Anne; Ferrier, I. Nicol; Feuk, Lars; Fitzgerald, Tomas; Flynn, Edward; Forbes, Alistair; Forty, Liz; Franklyn, Jayne A.; Freathy, Rachel M.; Gibbs, Polly; Gilbert, Paul; Gokumen, Omer; Gordon-Smith, Katherine; Gray, Emma; Green, Elaine; Groves, Chris J.; Grozeva, Detelina; Gwilliam, Rhian; Hall, Anita; Hammond, Naomi; Hardy, Matt; Harrison, Pile; Hassanali, Neelam; Hebaishi, Husam; Hines, Sarah; Hinks, Anne; Hitman, Graham A.; Hocking, Lynne; Howard, Eleanor; Howard, Philip; Howson, Joanna M. M.; Hughes, Debbie; Hunt, Sarah; Isaacs, John D.; Jain, Mahim; Jewell, Derek P.; Johnson, Toby; Jolley, Jennifer D.; Jones, Ian R.; Jones, Lisa A.; Kirov, George; Langford, Cordelia F.; Lango-Allen, Hana; Lathrop, G. Mark; Lee, James; Lee, Kate L.; Lees, Charlie; Lewis, Kevin; Lindgren, Cecilia M.; Maisuria-Armer, Meeta; Maller, Julian; Mansfield, John; Martin, Paul; Massey, Dunecan C. O.; McArdle, Wendy L.; McGuffin, Peter; McLay, Kirsten E.; Mentzer, Alex; Mimmack, Michael L.; Morgan, Ann E.; Morris, Andrew P.; Mowat, Craig; Myers, Simon; Newman, William; Nimmo, Elaine R.; O'Donovan, Michael C.; Onipinla, Abiodun; Onyiah, Ifejinelo; Ovington, Nigel R.; Owen, Michael J.; Palin, Kimmo; Parnell, Kirstie; Pernet, David; Perry, John R. B.; Phillips, Anne; Pinto, Dalila; Prescott, Natalie J.; Prokopenko, Inga; Quail, Michael A.; Rafelt, Suzanne; Rayner, Nigel W.; Redon, Richard; Reid, David M.; Renwick, Anthony; Ring, Susan M.; Robertson, Neil; Russell, Ellie; St Clair, David; Sambrook, Jennifer G.; Sanderson, Jeremy D.; Schuilenburg, Helen; Scott, Carol E.; Scott, Richard; Seal, Sheila; Shaw-Hawkins, Sue; Shields, Beverley M.; Simmonds, Matthew J.; Smyth, Debbie J.; Somaskantharajah, Elilan; Spanova, Katarina; Steer, Sophia; Stephens, Jonathan; Stevens, Helen E.; Stone, Millicent A.; Su, Zhan; Symmons, Deborah P. M.; Thompson, John R.; Thomson, Wendy; Travers, Mary E.; Turnbull, Clare; Valsesia, Armand; Walker, Mark; Walker, Neil M.; Wallace, Chris; Warren-Perry, Margaret; Watkins, Nicholas A.; Webster, John; Weedon, Michael N.; Wilson, Anthony G.; Woodburn, Matthew; Wordsworth, B. Paul; Young, Allan H.; Zeggini, Eleftheria; Carter, Nigel P.; Frayling, Timothy M.; Lee, Charles; McVean, Gil; Munroe, Patricia B.; Palotie, Aarno; Sawcer, Stephen J.; Scherer, Stephen W.; Strachan, David P.; Tyler-Smith, Chris; Brown, Matthew A.; Burton, Paul R.; Caulfield, Mark J.; Compston, Alastair; Farrall, Martin; Gough, Stephen C. L.; Hall, Alistair S.; Hattersley, Andrew T.; Hill, Adrian V. S.; Mathew, Christopher G.; Pembrey, Marcus; Satsangi, Jack; Stratton, Michael R.; Worthington, Jane; Deloukas, Panos; Duncanson, Audrey; Kwiatkowski, Dominic P.; McCarthy, Mark I.; Ouwehand, Willem H.; Parkes, Miles; Rahman, Nazneen; Todd, John A.; Samani, Nilesh J.; Donnelly, Peter		Wellcome Trust Case Control	Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls	NATURE			English	Article							COPY-NUMBER VARIATION; LARGE-SCALE; SUSCEPTIBILITY; POLYMORPHISMS; DELETION; HERITABILITY; HEALTH	Copy number variants (CNVs) account for a major proportion of human genetic polymorphism and have been predicted to have an important role in genetic susceptibility to common disease. To address this we undertook a large, direct genome-wide study of association between CNVs and eight common human diseases. Using a purpose-designed array we typed,19,000 individuals into distinct copy-number classes at 3,432 polymorphic CNVs, including an estimated similar to 50% of all common CNVs larger than 500 base pairs. We identified several biological artefacts that lead to false-positive associations, including systematic CNV differences between DNAs derived from blood and cell lines. Association testing and follow-up replication analyses confirmed three loci where CNVs were associated with disease-IRGM for Crohn's disease, HLA for Crohn's disease, rheumatoid arthritis and type 1 diabetes, and TSPAN8 for type 2 diabetes-although in each case the locus had previously been identified in single nucleotide polymorphism (SNP)-based studies, reflecting our observation that most common CNVs that are well-typed on our array are well tagged by SNPs and so have been indirectly explored through SNP studies. We conclude that common CNVs that can be typed on existing platforms are unlikely to contribute greatly to the genetic basis of common human diseases.	[Craddock, Nick; Forty, Liz; Green, Elaine; Grozeva, Detelina; Jones, Ian R.; Kirov, George; O'Donovan, Michael C.; Owen, Michael J.; Russell, Ellie] Cardiff Univ, MRC, Ctr Neuropsychiat Genet & Genom, Sch Med, Cardiff CF14 4XN, Wales; [Hurles, Matthew E.; Robson, Samuel; Barnes, Chris; Conrad, Donald F.; Stirrups, Kathy; Aerts, Jan; Andrews, T. Daniel; Arbury, Hazel; Attwood, Anthony; Barrett, Jeffrey C.; Barroso, Ines; Bhaskar, Sanjeev; Burton, John; Clee, Chris M.; Coffey, Alison J.; Dunham, Andrew; Edkins, Sarah; Fitzgerald, Tomas; Gray, Emma; Gwilliam, Rhian; Hammond, Naomi; Hebaishi, Husam; Howard, Eleanor; Hunt, Sarah; Langford, Cordelia F.; Lewis, Kevin; McLay, Kirsten E.; Mimmack, Michael L.; Onyiah, Ifejinelo; Palin, Kimmo; Quail, Michael A.; Redon, Richard; Scott, Carol E.; Somaskantharajah, Elilan; Valsesia, Armand; Zeggini, Eleftheria; Carter, Nigel P.; Palotie, Aarno; Tyler-Smith, Chris; Stratton, Michael R.; Deloukas, Panos; Kwiatkowski, Dominic P.; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Cardin, Niall; Giannoulatou, Eleni; Holmes, Chris; Marchini, Jonathan L.; Yau, Chris; Auton, Adam; Myers, Simon; Su, Zhan; McVean, Gil; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Pearson, Richard D.; Vukcevic, Damjan; Byrnes, Jake; Jain, Mahim; Lindgren, Cecilia M.; Maller, Julian; Morris, Andrew P.; Prokopenko, Inga; Rayner, Nigel W.; Robertson, Neil; Zeggini, Eleftheria; Hill, Adrian V. S.; Kwiatkowski, Dominic P.; McCarthy, Mark I.; Donnelly, Peter] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Plagnol, Vincent; Burren, Oliver S.; Cooper, Jason D.; Downes, Kate; Hardy, Matt; Howson, Joanna M. M.; Maisuria-Armer, Meeta; Ovington, Nigel R.; Schuilenburg, Helen; Smyth, Debbie J.; Stevens, Helen E.; Walker, Neil M.; Wallace, Chris; Woodburn, Matthew; Todd, John A.] Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab,Dept Med Ge, Cambridge CB2 0XY, England; [Tobin, Martin D.; Wain, Louise V.; Thompson, John R.; Burton, Paul R.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Tobin, Martin D.; Wain, Louise V.; Thompson, John R.; Burton, Paul R.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Ahmad, Tariq; Freathy, Rachel M.; Lango-Allen, Hana; Parnell, Kirstie; Perry, John R. B.; Shields, Beverley M.; Weedon, Michael N.; Frayling, Timothy M.; Hattersley, Andrew T.] Univ Exeter, Peninsula Coll Med & Dent, Exeter EX1 2LU, Devon, England; [Attwood, Anthony; Jolley, Jennifer D.; Sambrook, Jennifer G.; Stephens, Jonathan; Watkins, Nicholas A.; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge CB2 0PT, England; [Attwood, Anthony; Jolley, Jennifer D.; Sambrook, Jennifer G.; Stephens, Jonathan; Watkins, Nicholas A.; Ouwehand, Willem H.] Cambridge Ctr, Natl Hlth Serv Blood & Transplant, Cambridge CB2 0PT, England; [Ball, Stephen G.; Balmforth, Anthony J.; Hall, Alistair S.] Univ Leeds, LIGHT, MCRC, Leeds LS2 9JT, W Yorkshire, England; [Barton, Anne; Bowes, John; Bruce, Ian N.; Eyre, Steve; Flynn, Edward; Gilbert, Paul; Hinks, Anne; Martin, Paul; Symmons, Deborah P. M.; Thomson, Wendy; Worthington, Jane] Univ Manchester, Arc Epidemiol Unit, Manchester M13 9PT, Lancs, England; [Bennett, Amanda J.; Groves, Chris J.; Hassanali, Neelam; Lindgren, Cecilia M.; Prokopenko, Inga; Rayner, Nigel W.; Robertson, Neil; Travers, Mary E.; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Med, Oxford OX3 7LJ, England; [Blaszczyk, Katarzyna; Prescott, Natalie J.; Mathew, Christopher G.] Kings Coll London, Sch Med, Dept Med & Mol Genet, Guys Hosp, London SE1 9RT, England; [Brand, Oliver J.; Franklyn, Jayne A.; Simmonds, Matthew J.; Gough, Stephen C. L.] Univ Birmingham, Inst Biomed Res, Ctr Endocrinol Diabet & Metab, Birmingham B15 2TT, W Midlands, England; [Braund, Peter S.; Rafelt, Suzanne; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Bredin, Francesca; Lee, James; Massey, Dunecan C. O.; Parkes, Miles] Addenbrookes Hosp, IBD Genet Res Grp, Cambridge CB2 0QQ, England; [Breen, Gerome; St Clair, David] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Breen, Gerome; Farmer, Anne; McGuffin, Peter] Kings Coll London, Inst Psychiat, SGDP, London SE5 8AF, England; [Brown, Morris J.] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Bull, Jaswinder; Dudakia, Darshna; Ebbs, Bernadette; Elliot, Anna; Gibbs, Polly; Hall, Anita; Hines, Sarah; Hughes, Debbie; Pernet, David; Renwick, Anthony; Scott, Richard; Seal, Sheila; Spanova, Katarina; Turnbull, Clare; Warren-Perry, Margaret; Stratton, Michael R.; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Caesar, Sian; Gordon-Smith, Katherine; Jones, Lisa A.] Univ Birmingham, Natl Ctr Mental Hlth, Dept Psychiat, Birmingham B15 2FG, W Midlands, England; [Connell, John M. C.; Dominiczak, Anna F.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Drummond, Hazel E.; Lees, Charlie; Nimmo, Elaine R.; Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Gastrointestinal Unit, Div Med Sci,Sch Mol & Clin Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Eccles, Diana] Univ Southampton, Acad Unit Genet Med, Southampton SO16 5YA, Hants, England; [Edwards, Cathryn] Torbay Hosp, Endoscopy Reg Training Unit, Torquay TQ2 7AA, England; [Emery, Paul] Univ Leeds, Chapel Allerton Hosp, Acad Unit Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England; [Evans, David M.] Univ Bristol, MRC, Ctr Causal Analyses Translat Epidemiol, Dept Social Med, Bristol BS8 2BN, Avon, England; [Evans, Gareth; Newman, William] Univ Manchester, MAHSC, Dept Med Genet, Manchester M13 0JH, Lancs, England; [Ferrier, I. Nicol; Young, Allan H.] Royal Victoria Infirm, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Feuk, Lars; Pinto, Dalila; Scherer, Stephen W.] Hosp Sick Children, MaRS Ctr, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; [Feuk, Lars; Pinto, Dalila; Scherer, Stephen W.] Hosp Sick Children, MaRS Ctr, Program Genet & Genom Biol, Toronto, ON M5G 1L7, Canada; [Feuk, Lars] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden; [Forbes, Alistair] Univ Coll London Hosp Trust, Inst Digest Dis, London NW1 2BU, England; [Franklyn, Jayne A.; Gough, Stephen C. L.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham B15 2TT, W Midlands, England; [Gokumen, Omer; Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Gokumen, Omer; Lee, Charles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Harrison, Pile] Univ Oxford, Inst Musculoskeletal Sci, Botnar Res Ctr, Oxford OX3 7LD, England; [Hitman, Graham A.] Barts & London Royal London Hosp, Ctr Diabet & Metab Med, London E1 1BB, England; [Hocking, Lynne; Reid, David M.] Univ Aberdeen, Bone Res Grp, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland; [Howard, Philip; Johnson, Toby; Lee, Kate L.; Onipinla, Abiodun; Shaw-Hawkins, Sue; Munroe, Patricia B.; Caulfield, Mark J.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Barts & London Genome Ctr, London EC1M 6BQ, England; [Isaacs, John D.] Sch Med, Musculoskeletal Res Grp, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Jewell, Derek P.] Univ Oxford, Gastroenterol Unit, Radcliffe Infirm, Oxford OX2 6HE, England; [Lathrop, G. Mark] Ctr Natl Genotypage, F-91057 Paris, France; [Mansfield, John] Newcastle Univ, Royal Victoria Infirm, Dept Gastroenterol & Hepatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [McArdle, Wendy L.; Ring, Susan M.] Univ Bristol, Dept Social Med, ALSPAC Lab, Bristol BS8 2BN, Avon, England; [Mentzer, Alex; Sanderson, Jeremy D.] Kings Coll London, Sch Biomed & Hlth Sci, Div Nutr Sci, London SE1 9NH, England; [Morgan, Ann E.] Univ Leeds, Chapel Allerton Hosp, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds LS7 4SA, W Yorkshire, England; [Mowat, Craig; Phillips, Anne] Univ Dundee, Ninewells Hosp & Med Sch, Dept Gen Internal Med, Dundee DD1 9SY, Scotland; [Redon, Richard] INSERM, UMR915, Inst Thorax, F-44035 Nantes, France; [Steer, Sophia] Kings Coll Hosp Natl Hlth Serv Fdn Trust, London SE5 9RS, England; [Stone, Millicent A.] Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Stone, Millicent A.] Univ Bath, Bath BA2 7AY, Somerset, England; [Walker, Mark] Newcastle Univ, Diabet Res Grp, Sch Clin Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Webster, John] Aberdeen Royal Infirm, Aberdeen AB9 2ZB, Grampian, Scotland; [Wilson, Anthony G.] Univ Sheffield, Sch Med & Biomed Sci, Sheffield S10 2JF, S Yorkshire, England; [Wordsworth, B. Paul; Brown, Matthew A.] Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Young, Allan H.] Univ British Columbia, Inst Mental Hlth, Vancouver, BC V6T 1Z3, Canada; [Sawcer, Stephen J.; Compston, Alastair] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Strachan, David P.] Univ London, Div Community Hlth Sci, London SW17 0RE, England; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld 4102, Australia; [Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Hattersley, Andrew T.] Univ Exeter, Peninsula Coll Med & Dent, Exeter EX2 5DW, Devon, England; [Pembrey, Marcus] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 1EH, England; [Duncanson, Audrey] Wellcome Trust Res Labs, London NW1 2BE, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Samani, Nilesh J.] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England	Cardiff University; Wellcome Trust Sanger Institute; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge; University of Leicester; University of Leicester; University of Exeter; University of Plymouth; University of Cambridge; NHS Blood & Transplant (NHSBT); University of Leeds; University of Manchester; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Birmingham; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Aberdeen; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; Institute of Cancer Research - UK; University of Birmingham; University of Glasgow; University of Edinburgh; University of Southampton; Chapel Allerton Hospital; University of Leeds; University of Bristol; University of Manchester; Newcastle University - UK; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Uppsala University; University of London; University College London; University of Birmingham; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Oxford; Barts Health NHS Trust; Royal London Hospital; University of Aberdeen; University of London; Queen Mary University London; Newcastle University - UK; Radcliffe Infirmary; University of Oxford; CEA; Newcastle University - UK; University of Bristol; University of London; King's College London; Chapel Allerton Hospital; Leeds Biomedical Research Centre; University of Leeds; University of Dundee; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Bath; Newcastle University - UK; University of Aberdeen; University of Sheffield; Nuffield Orthopaedic Centre; University of Oxford; University of British Columbia; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Toronto; University of London; University of Queensland; University of Oxford; Wellcome Centre for Human Genetics; University of Exeter; University of Plymouth; University of London; University College London; University of Oxford; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Craddock, N (corresponding author), Cardiff Univ, MRC, Ctr Neuropsychiat Genet & Genom, Sch Med, Heath Pk, Cardiff CF14 4XN, Wales.		Turnbull, Clare/AAA-6596-2019; Scherer, Stephen W./B-3785-2013; McGuffin, Peter/A-1565-2012; Worthington, Jane/M-9770-2014; Brown, Matthew A/E-5749-2010; Pinto, Dalila/C-4218-2016; Evans, David M/H-6325-2013; Prokopenko, Inga/AAU-9895-2020; Yau, Christopher/G-2896-2012; Aerts, Jan/AAQ-6949-2020; Andrews, Dan/ABG-4815-2020; Hall, Alistair/K-1953-2019; St Clair, David/AAN-2412-2021; Pillay, Nischalan/F-9536-2012; Palin, Kimmo/ABG-5710-2020; Rahman, Nazneen/B-8890-2012; Myers, Simon R/A-6792-2015; Deloukas, Panos/B-2922-2013; Marchini, Jonathan/ABE-9024-2020; Eccles, Diana/K-6327-2019; O'Donovan, Michael C/P-7005-2018; Valsesia, Armand/F-1724-2010; Breen, Gerome D/A-5540-2010; Evans, D Gareth/AAB-4308-2022; Lee, James/ABD-5920-2020; Quail, michael/ABE-6131-2020; Burton, Paul R/H-7527-2016; Bowes, John/B-3472-2015; Breen, Gerome/Y-2706-2019; eyre, stephen/K-3776-2017; Jones, Ian R/B-4925-2009; Prescott, Natalie J/F-6490-2011; emery, paul/B-3560-2013; Prokopenko, Inga/H-3241-2014; Hinks, Anne/E-1853-2015; Plagnol, Vincent/A-5667-2011; Mowat, Craig/AAD-1851-2019; Redon, Richard/F-3303-2014; Mathew, Christopher G/G-3434-2015; Dominiczak, Anna F/P-9390-2017; Rahman, Nazneen/D-2802-2013; Holmes, Christopher/C-7108-2011; McCarthy, Mark/M-3763-2015; Barton, Anne/N-2053-2014; Todd, John/A-3542-2010	Scherer, Stephen W./0000-0002-8326-1999; McGuffin, Peter/0000-0002-9888-2907; Worthington, Jane/0000-0003-0544-042X; Brown, Matthew A/0000-0003-0538-8211; Pinto, Dalila/0000-0002-8769-0846; Evans, David M/0000-0003-0663-4621; Yau, Christopher/0000-0001-7615-8523; Aerts, Jan/0000-0002-6416-2717; Palin, Kimmo/0000-0002-4621-6128; Myers, Simon R/0000-0002-2585-9626; Deloukas, Panos/0000-0001-9251-070X; Marchini, Jonathan/0000-0003-0610-8322; Eccles, Diana/0000-0002-9935-3169; O'Donovan, Michael C/0000-0001-7073-2379; Breen, Gerome D/0000-0003-2053-1792; Evans, D Gareth/0000-0002-8482-5784; Lee, James/0000-0001-5711-9385; Bowes, John/0000-0003-4659-031X; Breen, Gerome/0000-0003-2053-1792; eyre, stephen/0000-0002-1251-6974; Jones, Ian R/0000-0001-5821-5889; Prescott, Natalie J/0000-0002-5901-7371; Prokopenko, Inga/0000-0003-1624-7457; Hinks, Anne/0000-0001-8843-3967; Mowat, Craig/0000-0002-5021-415X; Redon, Richard/0000-0001-7751-2280; Mathew, Christopher G/0000-0003-4178-1838; Dominiczak, Anna F/0000-0003-4913-3608; Donnelly, Peter/0000-0001-9495-3408; Hall, Alistair/0000-0003-0306-7887; Isaacs, John/0000-0002-6103-7056; bennett, amanda/0000-0003-2140-8710; Rahman, Nazneen/0000-0003-4376-0440; Walker, Neil/0000-0001-9796-7688; Holmes, Christopher/0000-0001-9021-3760; Symmons, Deborah/0000-0002-8625-1200; Hocking, Lynne J/0000-0002-2414-2826; Forbes, Alastair/0000-0001-7416-9843; Wain, Louise/0000-0003-4951-1867; Kirov, George/0000-0002-3427-3950; s, hema/0000-0002-3440-9475; Edkins, Sarah/0000-0003-0717-1972; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Wilson, Anthony Gerard/0000-0003-4855-3926; Vukcevic, Damjan/0000-0001-7780-9586; Hunt, Sarah/0000-0002-8350-1235; Munroe, Patricia/0000-0002-4176-2947; Weedon, Michael/0000-0002-6174-6135; Johnson, Toby/0000-0002-5998-3270; Caulfield, Mark/0000-0001-9295-3594; McCarthy, Mark/0000-0002-4393-0510; Grozeva, Detelina/0000-0003-3239-8415; Hattersley, Andrew/0000-0001-5620-473X; Lee, Kathryn/0000-0001-6848-4767; Barnes, Chris/0000-0002-9459-1395; Fitzgerald, Tomas/0000-0002-2370-8496; Martin, Paul/0000-0002-1016-6851; Wallace, Chris/0000-0001-9755-1703; Newman, William/0000-0002-6382-4678; Jones, Lisa/0000-0002-5122-8334; Thomson, Wendy/0000-0002-9022-5179; Palotie, Aarno/0000-0002-2527-5874; Simmonds, Matt/0000-0003-3154-3510; Bruce, Ian/0000-0003-3047-500X; Barton, Anne/0000-0003-3316-2527; Gordon-Smith, Katherine/0000-0003-4083-1143; Harrison, Pille/0000-0003-4117-6910; Burren, Oliver/0000-0002-3388-5760; Parkes, Miles/0000-0002-6467-0631; Lango Allen, Hana/0000-0002-7803-8688; Massey, Dunecan/0000-0002-7144-4579; Tobin, Martin/0000-0002-3596-7874; Mentzer, Alexander/0000-0002-4502-2209; Andrews, Dan/0000-0003-3922-6376; Valsesia, Armand/0000-0003-0746-9664; Young, Allan/0000-0003-2291-6952; Morgan, Ann/0000-0003-1109-624X; Howson, Joanna/0000-0001-7618-0050; Zeggini, Eleftheria/0000-0003-4238-659X; Maller, Julian/0000-0002-1565-9559; Todd, John/0000-0003-2740-8148; Plagnol, Vincent/0000-0002-5597-9215; Morris, Andrew/0000-0002-6805-6014; Lindgren, Cecilia/0000-0002-4903-9374; Turnbull, Clare/0000-0002-1734-5772; Giannoulatou, Eleni/0000-0002-7084-6736; Kwiatkowski, Dominic/0000-0002-5023-0176	Wellcome Trust; MRC [G0800675, G0701420, G0701810, G0800383, G0400874, G90/106, G0700491, G0501942, G0800759, G19/9, MC_UP_A390_1107, G0800509, G0600329, G0000934, G0701003, G0500115, G0600705, G9521010] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067, RG/09/012/28096] Funding Source: researchfish; Medical Research Council [G0000934, G9817803B, G0701003, G9521010, G0501942, G90/106, G0400874, G0600718B, G0500115, G0701420, G0800509, G0800759, G0801418B, G19/9, G0600329, G0701810, G0600705, G0800675, G0800383, MC_UP_A390_1107, G0700491] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10299, NF-SI-0508-10335] Funding Source: researchfish; Versus Arthritis [18475] Funding Source: researchfish; Chief Scientist Office [CZB/4/540] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); Chief Scientist Office	The principal funder of this project was the Wellcome Trust. Many individuals, groups, consortia, organizations and funding bodies have made important contributions to sample collections and coordination of the scientific analyses. Details are provided in Supplementary Information Section 11. We are indebted to all those who participated within the sample collections.	Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; CONRAD DF, 2009, NATURE          1007, DOI DOI 10.1038/NATURE08516; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Field SF, 2009, NAT MED, V15, P1115, DOI 10.1038/nm1009-1115; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Koch S, 2005, GENES IMMUN, V6, P445, DOI 10.1038/sj.gene.6364187; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Mamtani M, 2008, ANN RHEUM DIS, V67, P1076, DOI 10.1136/ard.2007.078048; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	33	599	625	0	118	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					713	U86		10.1038/nature08979	http://dx.doi.org/10.1038/nature08979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20360734	Green Submitted, Green Published, Green Accepted			2022-12-24	WOS:000276205000036
J	Henne, WM; Boucrot, E; Meinecke, M; Evergren, E; Vallis, Y; Mittal, R; McMahon, HT				Henne, William Mike; Boucrot, Emmanuel; Meinecke, Michael; Evergren, Emma; Vallis, Yvonne; Mittal, Rohit; McMahon, Harvey T.			FCHo Proteins Are Nucleators of Clathrin-Mediated Endocytosis	SCIENCE			English	Article							MEMBRANE INVAGINATION; BAR DOMAINS; CURVATURE; CARGO; CELLS	Clathrin-mediated endocytosis, the major pathway for ligand internalization into eukaryotic cells, is thought to be initiated by the clustering of clathrin and adaptors around receptors destined for internalization. However, here we report that the membrane-sculpting F-BAR domain-containing Fer/Cip4 homology domain-only proteins 1 and 2 (FCHo1/2) were required for plasma membrane clathrin-coated vesicle (CCV) budding and marked sites of CCV formation. Changes in FCHo1/2 expression levels correlated directly with numbers of CCV budding events, ligand endocytosis, and synaptic vesicle marker recycling. FCHo1/2 proteins bound specifically to the plasma membrane and recruited the scaffold proteins eps15 and intersectin, which in turn engaged the adaptor complex AP2. The FCHo F-BAR membrane-bending activity was required, leading to the proposal that FCHo1/2 sculpt the initial bud site and recruit the clathrin machinery for CCV formation.	[Henne, William Mike; Boucrot, Emmanuel; Meinecke, Michael; Evergren, Emma; Vallis, Yvonne; Mittal, Rohit; McMahon, Harvey T.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Boucrot, E (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	eboucrot@mrc-lmb.cam.ac.uk; hmm@mrc-lmb.cam.ac.uk	Evergren, Emma/X-3677-2019; Meinecke, Michael/C-4833-2013	Meinecke, Michael/0000-0003-1414-6951; Boucrot, Emmanuel/0000-0001-7312-6462; Evergren, Emma/0000-0002-0775-2921	MRC, UK; MRC-LMB Ph.D. scholarship; Human Frontiers Science Program Organization; European Molecular Biology Organization; Medical Research Council [MC_U105178795] Funding Source: researchfish; MRC [MC_U105178795] Funding Source: UKRI	MRC, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC-LMB Ph.D. scholarship; Human Frontiers Science Program Organization(Human Frontier Science Program); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S.-Y. Peak-Chew for mass spectrometry, M. Daly for cell sorting, G. Lingley for movie design, J. E. Tyrrell for summer assistance, and Perkin Elmer for support with spinning-disk microscopy. Support was provided to H.M.M. (MRC, UK), W.M.H. (MRC-LMB Ph.D. scholarship), E. B. (Human Frontiers Science Program Organization and MRC), and M.M. and E.E. (European Molecular Biology Organization fellowships). Core funding for this work was provided by MRC.	Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Boettner DR, 2009, CURR BIOL, V19, P1979, DOI 10.1016/j.cub.2009.10.062; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Grosse J, 2006, BLOOD, V107, P3350, DOI 10.1182/blood-2005-09-3556; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Stimpson HEM, 2009, MOL BIOL CELL, V20, P4640, DOI 10.1091/mbc.E09-05-0429; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Uezu A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703815200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	19	290	308	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1281	1284		10.1126/science.1188462	http://dx.doi.org/10.1126/science.1188462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20448150	Green Accepted			2022-12-24	WOS:000278318600036
J	Ormond, KE; Wheeler, MT; Hudgins, L; Klein, TE; Butte, AJ; Altman, RB; Ashley, EA; Greely, HT				Ormond, Kelly E.; Wheeler, Matthew T.; Hudgins, Louanne; Klein, Teri E.; Butte, Atul J.; Altman, Russ B.; Ashley, Euan A.; Greely, Henry T.			Challenges in the clinical application of whole-genome sequencing	LANCET			English	Editorial Material									[Wheeler, Matthew T.; Ashley, Euan A.] Stanford Univ, Sch Med, Ctr Inherited Cardiovasc Dis, Div Cardiovasc Med, Stanford, CA 94305 USA; [Altman, Russ B.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Altman, Russ B.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Hudgins, Louanne] Stanford Univ, Sch Med, Div Med Genet, Stanford, CA 94305 USA; [Butte, Atul J.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Ormond, Kelly E.; Klein, Teri E.; Altman, Russ B.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Greely, Henry T.] Stanford Univ, Sch Law, Ctr Law & Biosci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Greely, HT (corresponding author), Stanford Law Sch, 559 Nathan Abbott Way, Stanford, CA 94305 USA.	hgreely@stanford.edu	Ormond, Kelly E/I-5676-2019	Ormond, Kelly E/0000-0002-1033-0818; Wheeler, Matthew/0000-0001-8721-3022; Klein, Teri/0000-0001-5527-6475	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079719] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009719] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM079719-04] Funding Source: Medline; NLM NIH HHS [R01 LM009719, R01 LM009719-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Peters E, 2006, PSYCHOL SCI, V17, P407, DOI 10.1111/j.1467-9280.2006.01720.x	3	163	166	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2010	375	9727					1749	1751		10.1016/S0140-6736(10)60599-5	http://dx.doi.org/10.1016/S0140-6736(10)60599-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599DK	20434765				2022-12-24	WOS:000277890200036
J	Tehranchi, AK; Blankschien, MD; Zhang, Y; Halliday, JA; Srivatsan, A; Peng, J; Herman, C; Wang, JD				Tehranchi, Ashley K.; Blankschien, Matthew D.; Zhang, Yan; Halliday, Jennifer A.; Srivatsan, Anjana; Peng, Jia; Herman, Christophe; Wang, Jue D.			The Transcription Factor DksA Prevents Conflicts between DNA Replication and Transcription Machinery	CELL			English	Article							COLI RNA-POLYMERASE; HEAD-ON COLLISION; GUANOSINE TETRAPHOSPHATE; TERMINATION EFFICIENCY; BACILLUS-SUBTILIS; FORK PROGRESSION; BETA-SUBUNIT; PPGPP; INITIATION; GENE	Actively dividing cells perform robust and accurate DNA replication during fluctuating nutrient availability, yet factors that prevent disruption of replication remain largely unknown. Here we report that DksA, a nutrient-responsive transcription factor, ensures replication completion in Escherichia coli by removing transcription roadblocks. In the absence of DksA, replication is rapidly arrested upon amino acid starvation. This arrest requires active transcription and is alleviated by RNA polymerase mutants that compensate for DksA activity. This replication arrest occurs independently of exogenous DNA damage, yet it induces the DNA-damage response and recruits the main recombination protein RecA. This function of DksA is independent of its transcription initiation activity but requires its less-studied transcription elongation activity. Finally, GreA/B elongation factors also prevent replication arrest during nutrient stress. We conclude that transcription elongation factors alleviate fundamental conflicts between replication and transcription, thereby protecting replication fork progression and DNA integrity.	[Tehranchi, Ashley K.; Blankschien, Matthew D.; Halliday, Jennifer A.; Srivatsan, Anjana; Peng, Jia; Herman, Christophe; Wang, Jue D.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zhang, Yan; Wang, Jue D.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Herman, Christophe; Wang, Jue D.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Herman, C (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	herman@bcm.edu; jdwang@bcm.edu	Wang, Jue/GVU-0480-2022; Srivatsan, Anjana/Q-6312-2017; Srivatsan, Anjana/S-1518-2017	Srivatsan, Anjana/0000-0003-1645-7075; Srivatsan, Anjana/0000-0003-1645-7075; Wang, Jue/0000-0003-1503-170X	Human Frontier Science Program Young Investigator Grant [HFSP2006-0060]; Welch Research Grant [Q-1698]; NIH [1R01GM084]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084003] Funding Source: NIH RePORTER	Human Frontier Science Program Young Investigator Grant(Human Frontier Science Program); Welch Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michael Cashel, Marc Drolet, Patrick Piggot, Susan Rosenberg, and Steve Sandler for strains; Adam Breier, Michael Cashel, Herman Dierick, Tamas Gaal, Alasdair Gordon, Rick Gourse, Phil Hastings, Greg Ira, Allison Kriel, Bob Landick, Jeong Hyun Lee, Susan Rosenberg, Wilma Ross, Jonathan Weissman, Ivan Matic, and the anonymous reviewers for critical comments. C. H. is supported by Human Frontier Science Program Young Investigator Grant (HFSP2006-0060). J. D. W. is supported by a Welch Research Grant (Q-1698) and a Public Health Service grant (1R01GM084) from NIH.	Aberg A, 2008, MOL MICROBIOL, V67, P1223, DOI 10.1111/j.1365-2958.2008.06115.x; Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Artsimovitch I, 2000, J BACTERIOL, V182, P6027, DOI 10.1128/JB.182.21.6027-6035.2000; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Bidnenko V, 2002, EMBO J, V21, P3898, DOI 10.1093/emboj/cdf369; Bipatnath M, 1998, J BACTERIOL, V180, P265, DOI 10.1128/JB.180.2.265-273.1998; Blankschien MD, 2009, EMBO J, V28, P1720, DOI 10.1038/emboj.2009.126; Blankschien MD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000345; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Breier AM, 2005, P NATL ACAD SCI USA, V102, P3942, DOI 10.1073/pnas.0500812102; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; CARL PL, 1970, MOL GEN GENET, V109, P107, DOI 10.1007/BF00269647; CASHEL M, 1996, ESCHERICHIA COLI SAL; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Elias-Arnanz M, 1999, EMBO J, V18, P5675, DOI 10.1093/emboj/18.20.5675; Ferullo DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000300; FISHER RF, 1983, J BIOL CHEM, V258, P8146; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Gowrishankar J, 2004, MOL MICROBIOL, V54, P598, DOI 10.1111/j.1365-2958.2004.04289.x; Ishii Y, 2000, BIOSCI BIOTECH BIOCH, V64, P799, DOI 10.1271/bbb.64.799; Jin DJ, 2006, J STRUCT BIOL, V156, P284, DOI 10.1016/j.jsb.2006.07.005; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P9419, DOI 10.1073/pnas.97.17.9419; KINGSTON RE, 1981, J BIOL CHEM, V256, P2787; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Krohn M, 1996, J BIOL CHEM, V271, P23884, DOI 10.1074/jbc.271.39.23884; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; LANDICK R, 1990, GENE DEV, V4, P1623, DOI 10.1101/gad.4.9.1623; LEVINE A, 1991, J MOL BIOL, V219, P605, DOI 10.1016/0022-2836(91)90657-R; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MAALOE O, 1961, J MOL BIOL, V3, P144, DOI 10.1016/S0022-2836(61)80041-7; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Mahdi AA, 2006, GENE DEV, V20, P2135, DOI 10.1101/gad.382306; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; Michelsen O, 2003, MICROBIOL-SGM, V149, P1001, DOI 10.1099/mic.0.26058-0; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; Murphy H, 2003, METHOD ENZYMOL, V371, P596; Neuhard, 1987, ESCHERICHIA COLI SAL, V1, P445; Olavarrieta L, 2002, J MOL BIOL, V322, P1, DOI 10.1016/S0022-2836(02)00740-4; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Renzette N, 2005, MOL MICROBIOL, V57, P1074, DOI 10.1111/j.1365-2958.2005.04755.x; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Rutherford ST, 2009, GENE DEV, V23, P236, DOI 10.1101/gad.1745409; Schneider DA, 2003, METHOD ENZYMOL, V370, P606; SCHREIBER G, 1995, CURR MICROBIOL, V30, P27, DOI 10.1007/BF00294520; Srivatsan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000810; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; Torres JZ, 2004, MOL CELL BIOL, V24, P3198, DOI 10.1128/MCB.24.8.3198-3212.2004; TOSA T, 1971, J BACTERIOL, V106, P966, DOI 10.1128/JB.106.3.966-971.1971; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; VOGEL U, 1994, J BIOL CHEM, V269, P16236; Wang JD, 2007, CELL, V128, P865, DOI 10.1016/j.cell.2006.12.043; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; YAMANAKA K, 1994, MOL MICROBIOL, V13, P301, DOI 10.1111/j.1365-2958.1994.tb00424.x; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908	76	111	114	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					595	605		10.1016/j.cell.2010.03.036	http://dx.doi.org/10.1016/j.cell.2010.03.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478253	Bronze, Green Accepted			2022-12-24	WOS:000277623600013
J	Shanklin, J				Shanklin, Jonathan			Reflections on the ozone hole	NATURE			English	Editorial Material									British Antarctic Survey, Meteorol & Ozone Monitoring Unit, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Shanklin, J (corresponding author), British Antarctic Survey, Meteorol & Ozone Monitoring Unit, Cambridge CB3 0ET, England.	j.shanklin@bas.ac.uk			NERC [bas010011, bas0100023] Funding Source: UKRI; Natural Environment Research Council [bas010011, bas0100023] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; STOLARSKI RS, 1986, NATURE, V322, P808, DOI 10.1038/322808a0; Velders GJM, 2007, P NATL ACAD SCI USA, V104, P4814, DOI 10.1073/pnas.0610328104; *WORLD MET ORG, 2007, SCI ASS OZ DEPL 2006	4	19	19	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 6	2010	465	7294					34	35		10.1038/465034a	http://dx.doi.org/10.1038/465034a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	591OW	20445611				2022-12-24	WOS:000277311900018
J	Rule, AD; Amer, H; Cornell, LD; Taler, SJ; Cosio, FG; Kremers, WK; Textor, SC; Stegall, MD				Rule, Andrew D.; Amer, Hatem; Cornell, Lynn D.; Taler, Sandra J.; Cosio, Fernando G.; Kremers, Walter K.; Textor, Stephen C.; Stegall, Mark D.			The Association Between Age and Nephrosclerosis on Renal Biopsy Among Healthy Adults	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; ESTIMATED GFR; CLASSIFICATION; SENESCENCE; DAMAGE	Background: Chronic kidney disease is common with older age and is characterized on renal biopsy by global glomerulosclerosis, tubular atrophy, interstitial fibrosis, and arteriosclerosis. Objective: To see whether the prevalence of these histologic abnormalities in the kidney increases with age in healthy adults and whether histologic findings are explained by age-related differences in kidney function or chronic kidney disease risk factors. Design: Cross-sectional study. Setting: Mayo Clinic, Rochester, Minnesota, from 1999 to 2009. Patients: 1203 adult living kidney donors. Measurements: Core-needle biopsy of the renal cortex obtained during surgical implantation of the kidney, and medical record data of kidney function and risk factors obtained before donation. Results: The prevalence of nephrosclerosis (>= 2 chronic histologic abnormalities) was 2.7% (95% CI, 1.1% to 6.7%) for patients aged 18 to 29 years, 16% (CI, 12% to 20%) for patients aged 30 to 39 years, 28% (CI, 24% to 32%) for patients aged 40 to 49 years, 44% (CI, 38% to 50%) for patients aged 50 to 59 years, 58% (CI, 47% to 67%) for patients aged 60 to 69 years, and 73% (CI, 43% to 90%) for patients aged 70 to 77 years. Adjustment for kidney function and risk factor covariates did not explain the age-related increase in the prevalence of nephrosclerosis. Limitation: Kidney donors are selected for health and lack the spectrum or severity of renal pathologic findings in the general population. Conclusion: Kidney function and chronic kidney disease risk factors do not explain the strong association between age and nephrosclerosis in healthy adults.	[Rule, Andrew D.; Amer, Hatem; Cornell, Lynn D.; Taler, Sandra J.; Cosio, Fernando G.; Kremers, Walter K.; Textor, Stephen C.; Stegall, Mark D.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Rule, AD (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.		Amer, Hatem/AAN-2676-2020; Stegall, Mark/AAX-6496-2020	Amer, Hatem/0000-0002-9570-0506; Stegall, Mark/0000-0002-1392-0792	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [K23 DK078229]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK078229] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (grant K23 DK078229).	ALPERS CE, 2009, ROBINS COTRAN PATHOL; Bang H, 2007, ARCH INTERN MED, V167, P374, DOI 10.1001/archinte.167.4.374; Brantsma AH, 2006, J AM SOC NEPHROL, V17, P331, DOI 10.1681/ASN.2005111153; Choudhury D, 2007, BRENNER RECTORS KIDN, P681; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Couser WG, 2007, J AM SOC NEPHROL, V18, P2803, DOI 10.1681/ASN.2007080964; DARMADY EM, 1973, J PATHOL, V109, P195, DOI 10.1002/path.1711090304; Daugirdas JT, 2009, CLIN J AM SOC NEPHRO, V4, P1575, DOI 10.2215/CJN.05581008; de Jong PE, 2006, J AM SOC NEPHROL, V17, P2120, DOI 10.1681/ASN.2006010097; Eckardt KU, 2009, AM J KIDNEY DIS, V53, P915, DOI 10.1053/j.ajkd.2009.04.001; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eknoyan G, 2009, KIDNEY INT, V75, P1015, DOI 10.1038/ki.2009.53; Glassock Richard J, 2009, Trans Am Clin Climatol Assoc, V120, P419; Howie AJ, 2001, NEPHROL DIAL TRANSPL, V16, P1163, DOI 10.1093/ndt/16.6.1163; KAPLAN C, 1975, AM J PATHOL, V80, P227; KASISKE BL, 1987, KIDNEY INT, V31, P1153, DOI 10.1038/ki.1987.122; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Poggio ED, 2009, NEPHROL DIAL TRANSPL, V24, P698, DOI 10.1093/ndt/gfn704; Poggio ED, 2009, KIDNEY INT, V75, P1079, DOI 10.1038/ki.2009.11; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rule AD, 2004, AM J KIDNEY DIS, V43, P112, DOI 10.1053/j.ajkd.2003.09.026; Silva Fred G., 2005, International Urology and Nephrology, V37, P419, DOI 10.1007/s11255-004-0874-5; Silva Fred G., 2005, International Urology and Nephrology, V37, P185, DOI 10.1007/s11255-004-0873-6; Stevens LA, 2008, AM J KIDNEY DIS, V51, P353, DOI 10.1053/j.ajkd.2008.01.009; TAKAZAKURA E, 1972, KIDNEY INT, V2, P224, DOI 10.1038/ki.1972.98; Takebayashi S, 2001, CLIN NEPHROL, V55, P349; TAUCHI H, 1971, GERONTOLOGY, V17, P87, DOI 10.1159/000211811; Thomas SE, 1998, J AM SOC NEPHROL, V9, P231; TRACY RE, 1992, VIRCHOWS ARCH A, V420, P479, DOI 10.1007/BF01600252; Tracy RE, 2000, NEPHROL DIAL TRANSPL, V15, P1357, DOI 10.1093/ndt/15.9.1357; WALD HERBERT, 1937, ARCH PATH, V23, P493; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Winearls CG, 2009, KIDNEY INT, V75, P1009, DOI 10.1038/ki.2009.49	37	297	314	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 4	2010	152	9					561	+		10.7326/0003-4819-152-9-201005040-00006	http://dx.doi.org/10.7326/0003-4819-152-9-201005040-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595IN	20439574	Green Accepted			2022-12-24	WOS:000277604000003
J	Hellsten, U; Harland, RM; Gilchrist, MJ; Hendrix, D; Jurka, J; Kapitonov, V; Ovcharenko, I; Putnam, NH; Shu, SQ; Taher, L; Blitz, IL; Blumberg, B; Dichmann, DS; Dubchak, I; Amaya, E; Detter, JC; Fletcher, R; Gerhard, DS; Goodstein, D; Graves, T; Grigoriev, IV; Grimwood, J; Kawashima, T; Lindquist, E; Lucas, SM; Mead, PE; Mitros, T; Ogino, H; Ohta, Y; Poliakov, AV; Pollet, N; Robert, J; Salamov, A; Sater, AK; Schmutz, J; Terry, A; Vize, PD; Warren, WC; Wells, D; Wills, A; Wilson, RK; Zimmerman, LB; Zorn, AM; Grainger, R; Grammer, T; Khokha, MK; Richardson, PM; Rokhsar, DS				Hellsten, Uffe; Harland, Richard M.; Gilchrist, Michael J.; Hendrix, David; Jurka, Jerzy; Kapitonov, Vladimir; Ovcharenko, Ivan; Putnam, Nicholas H.; Shu, Shengqiang; Taher, Leila; Blitz, Ira L.; Blumberg, Bruce; Dichmann, Darwin S.; Dubchak, Inna; Amaya, Enrique; Detter, John C.; Fletcher, Russell; Gerhard, Daniela S.; Goodstein, David; Graves, Tina; Grigoriev, Igor V.; Grimwood, Jane; Kawashima, Takeshi; Lindquist, Erika; Lucas, Susan M.; Mead, Paul E.; Mitros, Therese; Ogino, Hajime; Ohta, Yuko; Poliakov, Alexander V.; Pollet, Nicolas; Robert, Jacques; Salamov, Asaf; Sater, Amy K.; Schmutz, Jeremy; Terry, Astrid; Vize, Peter D.; Warren, Wesley C.; Wells, Dan; Wills, Andrea; Wilson, Richard K.; Zimmerman, Lyle B.; Zorn, Aaron M.; Grainger, Robert; Grammer, Timothy; Khokha, Mustafa K.; Richardson, Paul M.; Rokhsar, Daniel S.			The Genome of the Western Clawed Frog Xenopus tropicalis	SCIENCE			English	Article							MOLECULAR PALEONTOLOGY; TRANSPOSABLE ELEMENTS; IMMUNE-SYSTEM; GENE; IGD	The western clawed frog Xenopus tropicalis is an important model for vertebrate development that combines experimental advantages of the African clawed frog Xenopus laevis with more tractable genetics. Here we present a draft genome sequence assembly of X. tropicalis. This genome encodes more than 20,000 protein-coding genes, including orthologs of at least 1700 human disease genes. Over 1 million expressed sequence tags validated the annotation. More than one-third of the genome consists of transposable elements, with unusually prevalent DNA transposons. Like that of other tetrapods, the genome of X. tropicalis contains gene deserts enriched for conserved noncoding elements. The genome exhibits substantial shared synteny with human and chicken over major parts of large chromosomes, broken by lineage-specific chromosome fusions and fissions, mainly in the mammalian lineage.	[Hellsten, Uffe; Shu, Shengqiang; Dubchak, Inna; Goodstein, David; Grigoriev, Igor V.; Grimwood, Jane; Lindquist, Erika; Lucas, Susan M.; Poliakov, Alexander V.; Salamov, Asaf; Schmutz, Jeremy; Terry, Astrid; Richardson, Paul M.; Rokhsar, Daniel S.] Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Harland, Richard M.; Hendrix, David; Dichmann, Darwin S.; Fletcher, Russell; Kawashima, Takeshi; Mitros, Therese; Wills, Andrea; Grammer, Timothy; Rokhsar, Daniel S.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Gilchrist, Michael J.] MRC Natl Inst Med Res, Div Syst Biol, London NW7 1AA, England; [Jurka, Jerzy; Kapitonov, Vladimir] Genet Informat Res Inst, Mountain View, CA 94043 USA; [Ovcharenko, Ivan; Taher, Leila] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Putnam, Nicholas H.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA; [Blitz, Ira L.; Blumberg, Bruce] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Amaya, Enrique] Univ Manchester, Healing Fdn Ctr, Manchester M13 9PT, Lancs, England; [Detter, John C.] Los Alamos Natl Lab, DOE Joint Genome Inst, Los Alamos, NM 87545 USA; [Gerhard, Daniela S.] NCI, Off Canc Genom, NIH, Dhhs Bethesda, MD 20892 USA; [Graves, Tina; Warren, Wesley C.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; [Grimwood, Jane; Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Joint Genome Inst, Huntsville, AL 35806 USA; [Kawashima, Takeshi] Okinawa Inst Sci & Technol, Okinawa 9042234, Japan; [Mead, Paul E.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Ogino, Hajime] Nara Inst Sci & Technol, Nara, Japan; [Ohta, Yuko] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Pollet, Nicolas] Univ Evry Val Essonne, CNRS, Programme Epigenom, F-91058 Evry, France; [Robert, Jacques] Univ Rochester, Dept Microbiol & Immunol, Med Ctr, Rochester, NY 14642 USA; [Sater, Amy K.; Wells, Dan] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Vize, Peter D.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Zorn, Aaron M.] Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Grainger, Robert] Dept Biol, Charlottesville, VA 22904 USA; [Khokha, Mustafa K.] Yale Univ, Sch Med, Dept Pediat & Genet, New Haven, CT 06520 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Rice University; University of California System; University of California Irvine; University of Manchester; United States Department of Energy (DOE); Los Alamos National Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Washington University (WUSTL); HudsonAlpha Institute for Biotechnology; United States Department of Energy (DOE); Joint Genome Institute - JGI; Okinawa Institute of Science & Technology Graduate University; St Jude Children's Research Hospital; Nara Institute of Science & Technology; University System of Maryland; University of Maryland Baltimore; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Rochester; University of Houston System; University of Houston; University of Calgary; Cincinnati Children's Hospital Medical Center; Yale University	Hellsten, U (corresponding author), Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA.	uhellsten@lbl.gov	Schmutz, Jeremy/N-3173-2013; Grimwood, Jane/ABD-5737-2021; Pollet, Nicolas/A-4746-2013; Ogino, Hajime/G-5279-2019; Kawashima, Takeshi/M-4510-2015; Putnam, Nicholas/B-9968-2008; Dichmann, Darwin/C-7239-2012; Terry, Astrid Y/A-2538-2011; /AAD-2181-2020; Wilson, Richard K./AAF-4139-2019; Robert, Jacques/B-2179-2008	Schmutz, Jeremy/0000-0001-8062-9172; Pollet, Nicolas/0000-0002-9975-9644; Ogino, Hajime/0000-0003-2707-2330; Putnam, Nicholas/0000-0002-1315-782X; Terry, Astrid Y/0000-0002-5234-1224; Wilson, Richard K./0000-0002-1992-1358; Robert, Jacques/0000-0003-4380-1476; Rokhsar, Daniel/0000-0002-8704-2224; Shu, Shengqiang/0000-0002-4336-8994; Goodstein, David/0000-0001-6287-2697; Grigoriev, Igor/0000-0002-3136-8903; Amaya, Enrique/0000-0002-1805-8548; Taher, Leila/0000-0002-2013-5426	U.S. Department of Energy's Office of Science; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; NIH, National Library of Medicine; National Human Genome Research Institute (NHGRI) [U01 HG02155]; National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P41HD064556] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045776, R01HD046661, R01HD042294, R21HD065713] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR015088] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018000] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG002155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027877, R24AI059830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086321, R01GM060572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079381] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200881] Funding Source: NIH RePORTER; MRC [MC_U117560482] Funding Source: UKRI; Medical Research Council [MC_U117560482] Funding Source: researchfish	U.S. Department of Energy's Office of Science(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); NIH, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was performed under the auspices of the U.S. Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory, under contract DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344, and Los Alamos National Laboratory under contract DE-AC02-06NA25396. This research was supported in part by the Intramural Research Program of the NIH, National Library of Medicine, and by a grant to R. K. W. from the National Human Genome Research Institute (NHGRI U01 HG02155) with supplemental funds provided by the National Institute of Child Health and Human Development. We thank R. Gibbs and S. Scherer of the Human Genome Sequencing Center, Baylor College of Medicine, for their contributions to identification and mapping of simple sequence length polymorphisms.	Abu-Daya A, 2009, DEV BIOL, V336, P20, DOI 10.1016/j.ydbio.2009.09.019; Brown DD, 2004, J BIOL CHEM, V279, P45291, DOI 10.1074/jbc.X400008200; CRAIG NL, 2002, MOBILE DNA, V2; DUPASQUIER L, 1989, ANNU REV IMMUNOL, V7, P251, DOI 10.1146/annurev.immunol.7.1.251; Garriock RJ, 2007, DEV DYNAM, V236, P1249, DOI 10.1002/dvdy.21156; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hogben L, 1930, J EXP BIOL, V7, P286; Kapitonov VV, 1999, GENETICA, V107, P27, DOI 10.1023/A:1004030922447; Kapitonov VV, 2004, DNA CELL BIOL, V23, P311, DOI 10.1089/104454904323090949; Kapitonov VV, 2003, P NATL ACAD SCI USA, V100, P6569, DOI 10.1073/pnas.0732024100; Kofron M, 1999, DEVELOPMENT, V126, P5759; Kreil G., 1996, BIOL XENOPUS, P263; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ohta Y, 2006, P NATL ACAD SCI USA, V103, P10723, DOI 10.1073/pnas.0601407103; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Robert J, 2009, DEV DYNAM, V238, P1249, DOI 10.1002/dvdy.21891; Rollins-Smith LA, 2005, INTEGR COMP BIOL, V45, P137, DOI 10.1093/icb/45.1.137; TYMOWSKA J, 1973, CYTOGENET CELL GENET, V12, P297, DOI 10.1159/000130468; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Zhao YF, 2006, P NATL ACAD SCI USA, V103, P12087, DOI 10.1073/pnas.0600291103	23	534	660	2	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2010	328	5978					633	636		10.1126/science.1183670	http://dx.doi.org/10.1126/science.1183670			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431018	Green Submitted, Green Accepted			2022-12-24	WOS:000277159800047
J	Duewell, P; Kono, H; Rayner, KJ; Sirois, CM; Vladimer, G; Bauernfeind, FG; Abela, GS; Franchi, L; Nunez, G; Schnurr, M; Espevik, T; Lien, E; Fitzgerald, KA; Rock, KL; Moore, KJ; Wright, SD; Hornung, V; Latz, E				Duewell, Peter; Kono, Hajime; Rayner, Katey J.; Sirois, Cherilyn M.; Vladimer, Gregory; Bauernfeind, Franz G.; Abela, George S.; Franchi, Luigi; Nunez, Gabriel; Schnurr, Max; Espevik, Terje; Lien, Egil; Fitzgerald, Katherine A.; Rock, Kenneth L.; Moore, Kathryn J.; Wright, Samuel D.; Hornung, Veit; Latz, Eicke			NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals	NATURE			English	Article							LOW-DENSITY-LIPOPROTEIN; NALP3 INFLAMMASOME; ATHEROSCLEROTIC LESIONS; MASSIVE XANTHOMATOSIS; HYPERLIPIDEMIC MICE; APOLIPOPROTEIN-E; ACAT INHIBITION; PROGRESSION; CELLS; HYPERCHOLESTEROLEMIA	The inflammatory nature of atherosclerosis is well established but the agent(s) that incite inflammation in the artery wall remain largely unknown. Germ-free animals are susceptible to atherosclerosis, suggesting that endogenous substances initiate the inflammation(1). Mature atherosclerotic lesions contain macroscopic deposits of cholesterol crystals in the necrotic core, but their appearance late in atherogenesis had been thought to disqualify them as primary inflammatory stimuli. However, using a new microscopic technique, we revealed that minute cholesterol crystals are present in early diet-induced atherosclerotic lesions and that their appearance in mice coincides with the first appearance of inflammatory cells. Other crystalline substances can induce inflammation by stimulating the caspase-1-activating NLRP3 (NALP3 or cryopyrin) inflammasome(2,3), which results in cleavage and secretion of interleukin (IL)-1 family cytokines. Here we show that cholesterol crystals activate the NLRP3 inflammasome in phagocytes in vitro in a process that involves phagolysosomal damage. Similarly, when injected intraperitoneally, cholesterol crystals induce acute inflammation, which is impaired in mice deficient in components of the NLRP3 inflammasome, cathepsin B, cathepsin L or IL-1 molecules. Moreover, when mice deficient in low-density lipoprotein receptor (LDLR) were bone-marrow transplanted with NLRP3-deficient, ASC (also known as PYCARD)-deficient or IL-1 alpha/beta-deficient bone marrow and fed on a high-cholesterol diet, they had markedly decreased early atherosclerosis and inflammasome-dependent IL-18 levels. Minimally modified LDL can lead to cholesterol crystallization concomitant with NLRP3 inflammasome priming and activation in macrophages. Although there is the possibility that oxidized LDL activates the NLRP3 inflammasome in vivo, our results demonstrate that crystalline cholesterol acts as an endogenous danger signal and its deposition in arteries or elsewhere is an early cause rather than a late consequence of inflammation. These findings provide new insights into the pathogenesis of atherosclerosis and indicate new potential molecular targets for the therapy of this disease.	[Duewell, Peter; Sirois, Cherilyn M.; Vladimer, Gregory; Lien, Egil; Fitzgerald, Katherine A.; Latz, Eicke] Univ Massachusetts, Sch Med, Dept Immunol & Infect Dis, Worcester, MA 01605 USA; [Kono, Hajime; Rock, Kenneth L.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Duewell, Peter; Schnurr, Max] Univ Munich, Div Gastroenterol, Dept Med, D-80336 Munich, Germany; [Rayner, Katey J.; Moore, Kathryn J.] NYU, Leon H Charney Div Cardiol, New York, NY 10016 USA; [Rayner, Katey J.; Moore, Kathryn J.; Hornung, Veit] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Lipid Metab Unit, Boston, MA 02114 USA; [Bauernfeind, Franz G.] Univ Bonn, Inst Clin Chem & Pharmacol, D-53127 Bonn, Germany; [Latz, Eicke] Univ Bonn, Univ Hosp, Inst Innate Immunol, D-53127 Bonn, Germany; [Abela, George S.] Michigan State Univ, Dept Med, Div Cardiol, E Lansing, MI 48824 USA; [Franchi, Luigi; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Espevik, Terje; Latz, Eicke] Norwegian Univ Sci & Technol, Inst Canc Res & Mol Med, N-7491 Trondheim, Norway; [Wright, Samuel D.] CSL Ltd, Cardiovasc Therapeut, Parkville, Vic 3052, Australia	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Munich; New York University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Bonn; University of Bonn; Michigan State University; University of Michigan System; University of Michigan; Norwegian University of Science & Technology (NTNU); CSL	Latz, E (corresponding author), Univ Massachusetts, Sch Med, Dept Immunol & Infect Dis, Worcester, MA 01605 USA.	eicke.latz@umassmed.edu	Moore, Kathryn/ABE-6416-2020; Duewell, Peter/C-4576-2014; Fitzgerald, Katherine/ABE-6317-2020; Bauernfeind, Franz-Georg/ABF-1148-2020; Hornung, Veit/C-3565-2012; Nuñez, Gabriel/A-7160-2014; Rayner, Katey/K-8914-2012; Latz, Eicke/H-3951-2014; Vladimer, Gregory/X-4547-2018	Moore, Kathryn/0000-0003-2505-2547; Hornung, Veit/0000-0002-4150-194X; Latz, Eicke/0000-0003-1488-5666; Duewell, Peter/0000-0003-0836-6448; Fitzgerald, Kate/0000-0003-3175-609X; Rayner, Katey/0000-0001-6230-426X; Vladimer, Gregory/0000-0003-4205-7585; Kono, Hajime/0000-0002-4578-8677; Sirois, Cherilyn M./0000-0002-5472-4288	National Institutes of Health; Deutsche Forschungsgemeinschaft [GK 1202]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075318, R01AI083713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (to E. L. and K. L. R.) and from the Deutsche Forschungsgemeinschaft (GK 1202, to M. S. and P. D.).	Abela GS, 2009, AM J CARDIOL, V103, P959, DOI 10.1016/j.amjcard.2008.12.019; Accad M, 2000, J CLIN INVEST, V105, P711, DOI 10.1172/JCI9021; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meuwese MC, 2009, JAMA-J AM MED ASSOC, V301, P1131, DOI 10.1001/jama.301.11.1131; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; SMALL DM, 1988, ARTERIOSCLEROSIS, V8, P103, DOI 10.1161/01.ATV.8.2.103; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Wright SD, 2000, J EXP MED, V191, P1437, DOI 10.1084/jem.191.8.1437; Yuan XM, 1997, ATHEROSCLEROSIS, V133, P153, DOI 10.1016/S0021-9150(97)00094-4; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	28	2460	2592	18	403	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1357	U7		10.1038/nature08938	http://dx.doi.org/10.1038/nature08938			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428172	Green Accepted			2022-12-24	WOS:000277149000048
J	Zeng, WW; Sun, LJ; Jiang, XM; Chen, X; Hou, FJ; Adhikari, A; Xu, M; Chen, ZJJ				Zeng, Wenwen; Sun, Lijun; Jiang, Xiaomo; Chen, Xiang; Hou, Fajian; Adhikari, Anirban; Xu, Ming; Chen, Zhijian J.			Reconstitution of the RIG-I Pathway Reveals a Signaling Role of Unanchored Polyubiquitin Chains in Innate Immunity	CELL			English	Article							TUMOR-SUPPRESSOR CYLD; DOUBLE-STRANDED-RNA; ANTIVIRAL RESPONSES; ADAPTER PROTEIN; UBIQUITIN; ACTIVATION; DOMAIN; RECOGNITION; KINASES; SENSOR	RIG-I detects invading viral RNA and activates the transcription factors NF-kappa B and IRF3 through the mitochondrial protein MAVS. Here we show that RNA bearing 5'-triphosphate strongly activates the RIG-I-IRF3 signaling cascade in a reconstituted system composed of RIG-I, mitochondria, and cytosol. Activation of RIG-I requires not only RNA but also polyubiquitin chains linked through lysine 63 (K63) of ubiquitin. RIG-I binds specifically to K63-polyubiquitin chains through its tandem CARD domains in a manner that depends on RNA and ATP. Mutations in the CARD domains that abrogate ubiquitin binding also impair RIG-I activation. Remarkably, unanchored K63-ubiquitin chains, which are not conjugated to any target protein, potently activate RIG-I. These ubiquitin chains function as an endogenous ligand of RIG-I in human cells. Our results delineate the mechanism of RIG-I activation, identify CARD domains as a ubiquitin sensor, and demonstrate that unanchored K63-polyubiquitin chains are signaling molecules in antiviral innate immunity.	[Zeng, Wenwen; Sun, Lijun; Jiang, Xiaomo; Chen, Xiang; Hou, Fajian; Adhikari, Anirban; Xu, Ming; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Sun, Lijun; Chen, Xiang; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Sun, Lijun/ABD-4470-2021; xu, ming/E-5524-2012; Zeng, Wenwen/D-7276-2017; Chen, Zhijian/C-6039-2012	Zeng, Wenwen/0000-0001-8544-3318; Chen, Zhijian/0000-0002-8475-8251	NIH [RO1-AI09919, RO1-GM63692]; Welch Foundation [I-1389]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI009919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063692] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Francesco Melandri and Dr. Kal Lapan (Boston Biochem) for generously providing some of the ubiquitin chains and Dr. Jae Jung (University of Southern California) for the mammalian expression plasmids of GST-RIG-I(N), K172R, K172-only, and 6KR mutants. We also thank Brian Skaug for reading the manuscript. This work was supported by grants from NIH (RO1-AI09919 and RO1-GM63692) and the Welch Foundation (I-1389). Z.J.C. is an Investigator of Howard Hughes Medical Institute.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Fujita T, 2009, IMMUNITY, V31, P4, DOI 10.1016/j.immuni.2009.06.014; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; XU M, 2009, CELL, V36, P302; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2002, J INTERF CYTOK RES, V22, P73, DOI 10.1089/107999002753452674; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200	28	461	486	5	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					315	330		10.1016/j.cell.2010.03.029	http://dx.doi.org/10.1016/j.cell.2010.03.029			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403326	Green Accepted, Bronze			2022-12-24	WOS:000276738400021
J	Chen, MIC; Lee, VJM; Lim, WY; Barr, IG; Lin, RTP; Koh, GCH; Yap, J; Cui, L; Cook, AR; Laurie, K; Tan, LWL; Tan, BH; Loh, J; Shaw, R; Durrant, C; Chow, VTK; Kelso, A; Chia, KS; Leo, YS				Chen, Mark I. C.; Lee, Vernon J. M.; Lim, Wei-Yen; Barr, Ian G.; Lin, Raymond T. P.; Koh, Gerald C. H.; Yap, Jonathan; Cui, Lin; Cook, Alex R.; Laurie, Karen; Tan, Linda W. L.; Tan, Boon Huan; Loh, Jimmy; Shaw, Robert; Durrant, Chris; Chow, Vincent T. K.; Kelso, Anne; Chia, Kee Seng; Leo, Yee Sin			2009 Influenza A(H1N1) Seroconversion Rates and Risk Factors Among Distinct Adult Cohorts in Singapore	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROPHYLAXIS; HOUSEHOLDS	Context Singapore experienced a single epidemic wave of 2009 influenza A(H1N1) with epidemic activity starting in late June 2009 and peaking in early August before subsiding within a month. Objective To compare the risk and factors associated with H1N1 seroconversion in different adult cohorts. Design, Setting, and Participants A study with serial serological samples from 4 distinct cohorts: general population (n=838), military personnel (n=1213), staff from an acute care hospital (n=558), and staff as well as residents from long-term care facilities (n=300) from June 22, 2009, to October 15, 2009. Hemagglutination inhibition results of serum samples taken before, during, and after the epidemic and data from symptom questionnaires are presented. Main Outcome Measures A 4-fold or greater increase in titer between any of the 3 serological samples was defined as evidence of H1N1 seroconversion. Results Baseline titers of 40 or more were observed in 22 members (2.6%; 95% confidence interval [CI], 1.7%-3.9%) of the community, 114 military personnel (9.4%; 95% CI, 7.9%-11.2%), 37 hospital staff (6.6%; 95% CI, 4.8%-9.0%), and 20 participants from long-term care facilities (6.7%; 95% CI, 4.4%-10.1%). In participants with 1 or more follow-up serum samples, 312 military personnel (29.4%; 95% CI, 26.8%-32.2%) seroconverted compared with 98 community members (13.5%; 95% CI, 11.2%-16.2%), 35 hospital staff (6.5%; 95% CI, 4.7%-8.9%), and only 3 longterm care participants (1.2%; 95% CI, 0.4%-3.5%). Increased frequency of seroconversion was observed for community participants from households in which 1 other member seroconverted (adjusted odds ratio [OR], 3.32; 95% CI, 1.50-7.33), whereas older age was associated with reduced odds of seroconversion (adjusted OR, 0.77 per 10 years; 95% CI, 0.64-0.93). Higher baseline titers were associated with decreased frequency of seroconversion in community (adjusted OR for every doubling of baseline titer, 0.48; 95% CI, 0.27-0.85), military (adjusted OR, 0.71; 95% CI, 0.61-0.81), and hospital staff cohorts (adjusted OR, 0.50; 95% CI, 0.26-0.93). Conclusion Following the June-September 2009 wave of 2009 influenza A(H1N1), 13% of the community participants seroconverted, and most of the adult population likely remained susceptible. JAMA. 2010; 303(14): 1383-1391	[Chen, Mark I. C.] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore 308433, Singapore; [Chen, Mark I. C.; Lee, Vernon J. M.; Lim, Wei-Yen; Koh, Gerald C. H.; Chia, Kee Seng] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Chen, Mark I. C.] Duke NUS Grad Med Sch, Singapore, Singapore; [Lee, Vernon J. M.; Yap, Jonathan] Minist Def, Biodef Ctr, Singapore, Singapore; [Lee, Vernon J. M.] Australian Natl Univ, Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; [Lee, Vernon J. M.; Koh, Gerald C. H.] Natl Univ Singapore, Ctr Hlth Serv Res, Singapore 117548, Singapore; [Barr, Ian G.; Laurie, Karen; Shaw, Robert; Durrant, Chris; Kelso, Anne] World Hlth Org Collaborating Ctr Reference & Res, Melbourne, Vic, Australia; [Lin, Raymond T. P.; Cui, Lin] Minist Hlth, Natl Publ Hlth Lab, Singapore, Singapore; [Cook, Alex R.] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Loh, Jimmy] DSO Natl Labs, Detect & Diagnost Lab, Singapore, Singapore; [Chow, Vincent T. K.] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Leo, Yee Sin] Tan Tock Seng Hosp, Dept Infect Dis, Communicable Dis Ctr, Singapore 308433, Singapore	Tan Tock Seng Hospital; National University of Singapore; National University of Singapore; Australian National University; National University of Singapore; World Health Organization; Ministry of Health-Singapore; National University of Singapore; National University of Singapore; Tan Tock Seng Hospital	Chen, MIC (corresponding author), Tan Tock Seng Hosp, Dept Clin Epidemiol, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	mark_chen@ttsh.com.sg	Cook, Alex/B-5941-2011; Chen, Mark/AGC-5338-2022; Chen, Mark/CAG-2949-2022; Yap, Jonathan/AAJ-7266-2020; Cook, Alex/S-3576-2019; Tan, Boon Huan/ABB-8381-2021; CHIA, Kee Seng/C-5790-2011	Cook, Alex/0000-0002-6271-5832; Chen, Mark/0000-0001-9369-5830; Chen, Mark/0000-0001-9369-5830; Yap, Jonathan/0000-0002-5227-8536; Tan, Boon Huan/0000-0002-4976-7988; Kelso, Anne/0000-0002-3166-3267; Chow, Vincent/0000-0003-2634-6213; Laurie, Karen/0000-0001-5186-8342; Koh, Choon Huat Gerald/0000-0002-6453-6897; Barr, Ian/0000-0002-7351-418X	National University of Singapore; GlaxoSmithKline; National Medical Research Council of Singapore [NMRC/H1N1O/005/2009]; Australian Government Department of Health and Ageing; Ministry of Defence, Singapore	National University of Singapore(National University of Singapore); GlaxoSmithKline(GlaxoSmithKline); National Medical Research Council of Singapore(National Medical Research Council, Singapore); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Ministry of Defence, Singapore(Ministry of Defence, Singapore)	Dr Cook reported that he has received research funding from the National University of Singapore. Dr Lee reported that he has received unrelated research funding from GlaxoSmithKline. No other financial disclosures were reported.; Funding/Support: This project was funded by grant NMRC/H1N1O/005/2009 from the National Medical Research Council of Singapore. The Melbourne World Health Organization Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing; the Centre has collaborative projects with vaccine companies unrelated to this study. The military cohort study was funded by the Ministry of Defence, Singapore.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; CUTTER J, 2009, EPIDEMIOLOGICAL NEWS, V35, P39; Dan YY, 2009, EMERG INFECT DIS, V15, P1909, DOI 10.3201/eid1512.090902; DORAISINGHAM S, 1986, Annals Academy of Medicine Singapore, V15, P9; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hong CY, 2004, FAM PRACT, V21, P317, DOI 10.1093/fampra/cmh319; Kendal AP, 1982, CONCEPTS PROCEDURES; Leo YS, 2010, EMERG INFECT DIS, V16, P103, DOI 10.3201/eid1601.091164; Liang M, 2009, SINGAP MED J, V50, P581; LIM KA, 1957, LANCET, V2, P791; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Marchand-Austin A, 2009, EMERG INFECT DIS, V15, P2001, DOI 10.3201/eid1512.091022; MEDLOCK J, 2009, PLOS CURR INFLUENZA; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Monto AS, 2002, J INFECT DIS, V186, P1582, DOI 10.1086/345722; Mukherjee P, 2010, EMERG INFECT DIS, V16, P21, DOI 10.3201/eid1601.091376; Ong AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008453; ONG JBS, PLOS ONE IN PRESS; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; WHO, 2009, WKLY EPIDEMIOL REC, V84, P185; *WHO, WHO INFL LIK ILLN US; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	28	138	139	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2010	303	14					1383	1391		10.1001/jama.2010.404	http://dx.doi.org/10.1001/jama.2010.404			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582KX	20388894	Bronze			2022-12-24	WOS:000276597300023
J	Gradinaru, V; Zhang, F; Ramakrishnan, C; Mattis, J; Prakash, R; Diester, I; Goshen, I; Thompson, KR; Deisseroth, K				Gradinaru, Viviana; Zhang, Feng; Ramakrishnan, Charu; Mattis, Joanna; Prakash, Rohit; Diester, Ilka; Goshen, Inbal; Thompson, Kimberly R.; Deisseroth, Karl			Molecular and Cellular Approaches for Diversifying and Extending Optogenetics	CELL			English	Article							EXCITATORY CORTICAL-NEURONS; IN-VIVO CONTROL; OPTICAL CONTROL; MILLISECOND-TIMESCALE; ADENOASSOCIATED VIRUS; EXPRESSION; ACTIVATION; RHODOPSIN; PROTEINS; HALORHODOPSIN	Optogenetic technologies employ light to control biological processes within targeted cells in vivo with high temporal precision. Here, we show that application of molecular trafficking principles can expand the optogenetic repertoire along several long-sought dimensions. Subcellular and transcellular trafficking strategies now permit (1) optical regulation at the far-red/infrared border and extension of optogenetic control across the entire visible spectrum, (2) increased potency of optical inhibition without increased light power requirement (nanoampere-scale chloride-mediated photocurrents that maintain the light sensitivity and reversible, step-like kinetic stability of earlier tools), and (3) generalizable strategies for targeting cells based not only on genetic identity, but also on morphology and tissue topology, to allow versatile targeting when promoters are not known or in genetically intractable organisms. Together, these results illustrate use of cell-biological principles to enable expansion of the versatile fast optogenetic technologies suitable for intact-systems biology and behavior.	[Gradinaru, Viviana; Zhang, Feng; Ramakrishnan, Charu; Mattis, Joanna; Prakash, Rohit; Diester, Ilka; Goshen, Inbal; Thompson, Kimberly R.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gradinaru, Viviana; Mattis, Joanna; Prakash, Rohit] Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Ritter, Stefanie L/D-9312-2012; Macrae, Rhiannon/AAX-1536-2020; Goshen, Inbal/GQI-2230-2022; Diester, Ilka/D-4473-2011	Goshen, Inbal/0000-0001-7578-2615; Mattis, Joanna/0000-0003-0341-1270; Ramakrishnan, Charu/0000-0002-3474-6332	National Institutes of Health (NIH); Harvard Society; Stanford Medical Scientist Training Program; German Academic Exchange Service; Human Frontier Science Program; Machiah Foundation; Weizmann Institute; National Alliance for Research on Schizophrenia and Depression; Woo, Keck, Snyder, McKnight, Yu, and Coulter Foundations; California Institute of Regenerative Medicine; National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Society; Stanford Medical Scientist Training Program; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Human Frontier Science Program(Human Frontier Science Program); Machiah Foundation; Weizmann Institute; National Alliance for Research on Schizophrenia and Depression(NARSAD); Woo, Keck, Snyder, McKnight, Yu, and Coulter Foundations; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Science Foundation(National Science Foundation (NSF))	V. G. is supported by the Stanford Interdisciplinary Graduate Fellowship, F. Z. by the National Institutes of Health (NIH) and Harvard Society of Fellows, J. M. by the Stanford Medical Scientist Training Program, R. P. by the NIH, I. D. by the German Academic Exchange Service and the Human Frontier Science Program, I. G. by the Machiah Foundation and the Weizmann Institute, K. T. by the National Alliance for Research on Schizophrenia and Depression, and K. D. by the Woo, Keck, Snyder, McKnight, Yu, and Coulter Foundations, as well as by the California Institute of Regenerative Medicine, the National Science Foundation, and the NIH. We thank the entire Deisseroth lab for their support.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Colechio EM, 2009, BRAIN STRUCT FUNCT, V213, P423, DOI 10.1007/s00429-009-0215-7; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Han X, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.012.2009; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kalaidzidis IV, 1998, FEBS LETT, V427, P59, DOI 10.1016/S0014-5793(98)00394-9; Kissa K, 2002, MOL CELL NEUROSCI, V20, P627, DOI 10.1006/mcne.2002.1141; LANYI JK, 1982, J BIOL CHEM, V257, P2674; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; LOZIER RH, 1975, BIOPHYS J, V15, P955, DOI 10.1016/S0006-3495(75)85875-9; MARTI T, 1991, J BIOL CHEM, V266, P6919; Maskos U, 2002, P NATL ACAD SCI USA, V99, P10120, DOI 10.1073/pnas.152266799; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; Passini MA, 2005, MOL THER, V11, P754, DOI 10.1016/j.ymthe.2005.01.011; Paterna JC, 2004, J VIROL, V78, P6808, DOI 10.1128/JVI.78.13.6808-6817.2004; Perreault MC, 2006, NEUROSCIENCE, V141, P803, DOI 10.1016/j.neuroscience.2006.04.008; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Ratzliff ADH, 2004, J NEUROSCI, V24, P2259, DOI 10.1523/JNEUROSCI.5191-03.2004; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Sano H, 2007, GENESIS, V45, P123, DOI 10.1002/dvg.20273; Sato M, 2005, BIOCHEMISTRY-US, V44, P4775, DOI 10.1021/bi047500f; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Silberberg G, 2004, J PHYSIOL-LONDON, V556, P19, DOI 10.1113/jphysiol.2004.060962; Simon S M, 1993, Subcell Biochem, V21, P1; Sineshchekov OA, 2005, BIOPHYS J, V89, P4310, DOI 10.1529/biophysj.105.070920; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; STOECKENIUS W, 1982, ANNU REV BIOCHEM, V51, P587, DOI 10.1146/annurev.bi.51.070182.003103; Sugita M, 2005, SCIENCE, V309, P781, DOI 10.1126/science.1110787; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tengholm A, 2009, MOL CELL ENDOCRINOL, V297, P58, DOI 10.1016/j.mce.2008.07.009; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tsunoda SP, 2006, BIOPHYS J, V91, P1471, DOI 10.1529/biophysj.106.086421; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	77	662	731	4	252	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					154	165		10.1016/j.cell.2010.02.037	http://dx.doi.org/10.1016/j.cell.2010.02.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20303157	Green Accepted, Bronze			2022-12-24	WOS:000276211100020
J	Sfeir, A; Kabir, S; van Overbeek, M; Celli, GB; de Lange, T				Sfeir, Agnel; Kabir, Shaheen; van Overbeek, Megan; Celli, Giulia B.; de Lange, Titia			Loss of Rap1 Induces Telomere Recombination in the Absence of NHEJ or a DNA Damage Signal	SCIENCE			English	Article							HOMOLOGOUS RECOMBINATION; DYSFUNCTIONAL TELOMERES; CHROMOSOME ENDS; PROTECTION; POT1; COMPLEX; TRF2; TPP1; ATM	Shelterin is an essential telomeric protein complex that prevents DNA damage signaling and DNA repair at mammalian chromosome ends. Here we report on the role of the TRF2-interacting factor Rap1, a conserved shelterin subunit of unknown function. We removed Rap1 from mouse telomeres either through gene deletion or by replacing TRF2 with a mutant that does not bind Rap1. Rap1 was dispensable for the essential functions of TRF2-repression of ATM kinase signaling and nonhomologous end joining (NHEJ)-and mice lacking telomeric Rap1 were viable and fertile. However, Rap1 was critical for the repression of homology-directed repair (HDR), which can alter telomere length. The data reveal that HDR at telomeres can take place in the absence of DNA damage foci and underscore the functional compartmentalization within shelterin.	[Sfeir, Agnel; Kabir, Shaheen; van Overbeek, Megan; Celli, Giulia B.; de Lange, Titia] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	Women in Science Fellowship Program; The Leukemia & Lymphoma Society; NIH [AG016642, GM049046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049046, R37GM049046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER	Women in Science Fellowship Program; The Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	D. White, H. Takai, and the Rockefeller University Transgenics Facility are thanked for help in generating genetically modified mice. We thank L. Jovine for identifying the conserved helix in TRF2. A. S. is supported by Susan G. Komen for the Cure. G.B.C. was supported by the Women in Science Fellowship Program and The Leukemia & Lymphoma Society. Supported by NIH grants AG016642 and GM049046.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Cesare AJ, 2008, MOL CELL BIOL, V28, P20, DOI 10.1128/MCB.01122-07; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Hanaoka S, 2001, J MOL BIOL, V312, P167, DOI 10.1006/jmbi.2001.4924; Kibe T, 2010, MOL CELL BIOL, V30, P1059, DOI 10.1128/MCB.01498-09; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Li BB, 2003, MOL BIOL CELL, V14, P5060, DOI 10.1091/mbc.e03-06-0403; Marcand S, 2008, GENE DEV, V22, P1153, DOI 10.1101/gad.455108; Miller KM, 2005, EMBO J, V24, P3128, DOI 10.1038/sj.emboj.7600779; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Pardo B, 2005, EMBO J, V24, P3117, DOI 10.1038/sj.emboj.7600778; Sarthy J, 2009, EMBO J, V28, P3390, DOI 10.1038/emboj.2009.275; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tsai YL, 2002, MOL CELL BIOL, V22, P5679, DOI 10.1128/MCB.22.16.5679-5687.2002; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037	20	187	193	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1657	1661		10.1126/science.1185100	http://dx.doi.org/10.1126/science.1185100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339076	Green Accepted			2022-12-24	WOS:000275970600048
J	Lu, YH; Wu, KM; Jiang, YY; Xia, B; Li, P; Feng, HQ; Wyckhuys, KAG; Guo, YY				Lu, Yanhui; Wu, Kongming; Jiang, Yuying; Xia, Bing; Li, Ping; Feng, Hongqiang; Wyckhuys, Kris A. G.; Guo, Yuyuan			Mirid Bug Outbreaks in Multiple Crops Correlated with Wide-Scale Adoption of Bt Cotton in China	SCIENCE			English	Article							TRANSGENIC CROPS; PLANTS; BIOTECHNOLOGY; SUPPRESSION; BOLLWORM; POLLEN; IMPACT; RISKS; YIELD; IPM	Long-term ecological effects of transgenic Bacillus thuringiensis (Bt) crops on nontarget pests have received limited attention, more so in diverse small holder-based cropping systems of the developing world. Field trials conducted over 10 years in northern China show that mirid bugs (Heteroptera: Miridae) have progressively increased population sizes and acquired pest status in cotton and multiple other crops, in association with a regional increase in Bt cotton adoption. More specifically, our analyses show that Bt cotton has become a source of mirid bugs and that their population increases are related to drops in insecticide use in this crop. Hence, alterations of pest management regimes in Bt cotton could be responsible for the appearance and subsequent spread of nontarget pests at an agro-landscape level.	[Lu, Yanhui; Wu, Kongming; Feng, Hongqiang; Wyckhuys, Kris A. G.; Guo, Yuyuan] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Jiang, Yuying; Xia, Bing; Li, Ping] Natl Agrotech Extens & Serv Ctr, Beijing 100026, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wu, KM (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn	Wyckhuys, Kris/AAJ-4352-2020	Wyckhuys, Kris/0000-0003-0922-488X; Lu, Yanhui/0000-0002-6552-0248; Feng, Hongqiang/0000-0002-1171-248X	National Key Basic Research Program [2006CB102004]; National Natural Science Foundation of China [30625028]; Key Project for Breeding Genetically Modified Organisms [2008ZX08012-004]; Commonwealth Agricultural Scientific Research Project [200803011]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project for Breeding Genetically Modified Organisms; Commonwealth Agricultural Scientific Research Project	This work was supported by the National Key Basic Research Program (2006CB102004), the National Natural Science Foundation of China (30625028), the Key Project for Breeding Genetically Modified Organisms (2008ZX08012-004), and the Commonwealth Agricultural Scientific Research Project (200803011). We thank two anonymous reviewers for helpful comments and suggestions.	Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Cattaneo MG, 2006, P NATL ACAD SCI USA, V103, P7571, DOI 10.1073/pnas.0508312103; CHU H. F., 1958, ACTA ENT SINICA, V8, P97; Dale PJ, 2002, NAT BIOTECHNOL, V20, P567, DOI 10.1038/nbt0602-567; Dutcher J.D., 2007, GEN CONCEPTS INTEGRA, P27, DOI [10.1007/978-1-4020-6061-8_2, DOI 10.1007/978-1-4020-6061-8_2]; Fitt Gary P., 2008, V5, P303, DOI 10.1007/978-1-4020-8373-0_11; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Losey JE, 1999, NATURE, V399, P214, DOI 10.1038/20338; Lu Y., 2008, BIOL CONTROL COTTON; Lu YH, 2009, B ENTOMOL RES, V99, P543, DOI 10.1017/S000748530800655X; Lu YH, 2007, ENVIRON ENTOMOL, V36, P1007, DOI 10.1603/0046-225X(2007)36[1007:FPOLLM]2.0.CO;2; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Naranjo SE, 2005, ENVIRON ENTOMOL, V34, P1193, DOI 10.1603/0046-225X(2005)034[1193:LAOTEO]2.0.CO;2; Naranjon Steven E., 2008, V5, P159, DOI 10.1007/978-1-4020-8373-0_6; Qaim M, 2003, SCIENCE, V299, P900, DOI 10.1126/science.1080609; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Sears MK, 2001, P NATL ACAD SCI USA, V98, P11937, DOI 10.1073/pnas.211329998; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Storer Nicholas P., 2008, V5, P273, DOI 10.1007/978-1-4020-8373-0_10; TING Yen-chin, 1963, Acta Phytophylacica Sinica, Peking, V2, P285; Ting YQ, 1964, ACTA ENTOMOL SINICA, V13, P298; WILLIAMS MR, 2006, P BELTW COTT C NAT C, P1151; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088; Wu K., 1992, ACTA ECOL SIN, V12, P341; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2003, ENVIRON ENTOMOL, V32, P312, DOI 10.1603/0046-225X-32.2.312; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wu KongMing, 2007, Chinese Journal of Agricultural Biotechnology, V4, P93, DOI 10.1017/S1479236207001490	31	471	647	5	338	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1151	1154		10.1126/science.1187881	http://dx.doi.org/10.1126/science.1187881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20466880				2022-12-24	WOS:000278104700042
J	Kohler, A; Zimmerman, E; Schneider, M; Hurt, E; Zheng, N				Koehler, Alwin; Zimmerman, Erik; Schneider, Maren; Hurt, Ed; Zheng, Ning			Structural Basis for Assembly and Activation of the Heterotetrameric SAGA Histone H2B Deubiquitinase Module	CELL			English	Article							PROTEIN; UBIQUITIN; COMPLEX; DOMAIN; CHROMATIN; REVEALS; DEUBIQUITYLATION; ASSOCIATION; PROTEASOME; ENZYME	Deubiquitinating enzymes (DUBs) regulate diverse cellular functions by cleaving ubiquitin from specific protein substrates. How their activities are modulated in various cellular contexts remains poorly understood. The yeast deubiquitinase Ubp8 protein is recruited and activated by the SAGA complex and, together with Sgf11, Sus1, and Sgf73, forms a DUB module responsible for deubiquitinating histone H2B during gene expression. Here, we report the crystal structure of the complete SAGA DUB module, which features two functional lobes structurally coupled by Sgf73. In the "assembly lobe,'' a long Sgf11 N-terminal helix is clamped onto the Ubp8 ZnF-UBP domain by Sus1. In the "catalytic lobe,'' an Sgf11 C-terminal zinc-finger domain binds to the Ubp8 catalytic domain next to its active site. Our structural and functional analyses reveal a central role of Sgf11 and Sgf73 in activating Ubp8 for deubiquitinating histone H2B and demonstrate how a DUB can be allosterically regulated by its nonsubstrate partners.	[Zimmerman, Erik; Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Zimmerman, Erik; Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Koehler, Alwin; Schneider, Maren; Hurt, Ed] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Ruprecht Karls University Heidelberg	Kohler, A (corresponding author), Med Univ Vienna, Max F Perutz Labs, Dr Bohr Gasse 9-3, A-1030 Vienna, Austria.	alwin.koehler@mfpl.ac.at; nzheng@uw.edu	Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255	Howard Hughes Medical Institute; National Institutes of Health [CA107134]; Deutsche Forschungsgemeinschaft [SFB638/B3]; NATIONAL CANCER INSTITUTE [R01CA107134] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank ALS beamline staff for assistance and all members of the Zheng lab and Andrea Barta (MFPL) for invaluable discussions. This study is supported by the Howard Hughes Medical Institute and National Institutes of Health grant CA107134 to N.Z. and grants of the Deutsche Forschungsgemeinschaft (SFB638/B3) to A. K and E. H.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allen MD, 2007, PROTEIN SCI, V16, P2072, DOI 10.1110/ps.072967807; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; DeLano WL, 2002, PYMOL USERS MANUAL; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Jani DY, 2009, MOL CELL, V33, P727, DOI 10.1016/j.molcel.2009.01.033; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kao CF, 2003, METHODS, V31, P59, DOI 10.1016/S1046-2023(03)00088-4; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee KK, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-2; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Pai MT, 2007, J MOL BIOL, V370, P290, DOI 10.1016/j.jmb.2007.04.015; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Powell DW, 2004, MOL CELL BIOL, V24, P7249, DOI 10.1128/MCB.24.16.7249-7259.2004; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	53	139	143	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					606	617		10.1016/j.cell.2010.04.026	http://dx.doi.org/10.1016/j.cell.2010.04.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20434206	Green Accepted, Bronze			2022-12-24	WOS:000277623600014
J	Komiyama, T; Sato, TR; O'Connor, DH; Zhang, YX; Huber, D; Hooks, BM; Gabitto, M; Svoboda, K				Komiyama, Takaki; Sato, Takashi R.; O'Connor, Daniel H.; Zhang, Ying-Xin; Huber, Daniel; Hooks, Bryan M.; Gabitto, Mariano; Svoboda, Karel			Learning-related fine-scale specificity imaged in motor cortex circuits of behaving mice	NATURE			English	Article							IN-VIVO; CELLULAR RESOLUTION; PREFRONTAL CORTEX; CROSS-CORRELATION; TRANSGENIC MICE; RAT; ORGANIZATION; NEURONS; NETWORKS; CHANNELRHODOPSIN-2	Cortical neurons form specific circuits(1), but the functional structure of this microarchitecture and its relation to behaviour are poorly understood. Two-photon calcium imaging can monitor activity of spatially defined neuronal ensembles in the mammalian cortex(2-5). Here we applied this technique to the motor cortex of mice performing a choice behaviour. Head-fixed mice were trained to lick in response to one of two odours, and to withhold licking for the other odour(6,7). Mice routinely showed significant learning within the first behavioural session and across sessions. Microstimulation(8,9) and trans-synaptic tracing(10,11) identified two non-overlapping candidate tongue motor cortical areas. Inactivating either area impaired voluntary licking. Imaging in layer 2/3 showed neurons with diverse response types in both areas. Activity in approximately half of the imaged neurons distinguished trial types associated with different actions. Many neurons showed modulation coinciding with or preceding the action, consistent with their involvement in motor control. Neurons with different response types were spatially intermingled. Nearby neurons (within similar to 150 mm) showed pronounced coincident activity. These temporal correlations increased with learning within and across behavioural sessions, specifically for neuron pairs with similar response types. We propose that correlated activity in specific ensembles of functionally related neurons is a signature of learning-related circuit plasticity. Our findings reveal a fine-scale and dynamic organization of the frontal cortex that probably underlies flexible behaviour.	[Komiyama, Takaki; Sato, Takashi R.; O'Connor, Daniel H.; Zhang, Ying-Xin; Huber, Daniel; Hooks, Bryan M.; Svoboda, Karel] HHMI, Ashburn, VA 20147 USA; [Gabitto, Mariano] Univ Calif San Diego, HHMI, La Jolla, CA 92093 USA; [Gabitto, Mariano] Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA; [Gabitto, Mariano] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Komiyama, T (corresponding author), HHMI, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	komiyamat@janelia.hhmi.org	Huber, Daniel/C-2932-2013	Huber, Daniel/0000-0002-0744-7679; Komiyama, Takaki/0000-0001-9609-4600	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank D. Rinberg for help with experiments; F. Collman, D. Tank, C. Zuker, T. O'Connor and V. Iyer for help with analysis and imaging software; L. W. Enquist for pseudorabies vectors; W. Denk for help with mechanical design; D. Dombeck, M. Andermann, A. Kerlin and C. Reid for discussions about imaging awake mice; B. Shields, A. Hu and S. Michael for help with histology; A. Arnold for help with imaging; J. Osborne and S. Bassin for machining; L. Luo, Z. Mainen and D. Rinberg for comments on the manuscript; A. C. Gontang for illustration. Supported by Howard Hughes Medical Institute. T. K. is a Helen Hay Whitney Foundation postdoctoral fellow.	AERTSEN AMHJ, 1985, BRAIN RES, V340, P341, DOI 10.1016/0006-8993(85)90931-X; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Constantinidis C, 2001, J NEUROSCI, V21, P3646, DOI 10.1523/JNEUROSCI.21-10-03646.2001; DOBBINS EG, 1995, J COMP NEUROL, V357, P376, DOI 10.1002/cne.903570305; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Fay RA, 1997, BRAIN RES REV, V25, P291, DOI 10.1016/S0165-0173(97)00028-3; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; GEORGOPOULOS AP, 1993, SCIENCE, V260, P47, DOI 10.1126/science.8465199; Hira R, 2009, J NEUROSCI METH, V179, P258, DOI 10.1016/j.jneumeth.2009.02.001; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Slotnick B, 2005, CURR PROTOC NEUROSCI; Smith BN, 2000, P NATL ACAD SCI USA, V97, P9264, DOI 10.1073/pnas.97.16.9264; Song CK, 2005, VIRUS RES, V111, P235, DOI 10.1016/j.virusres.2005.04.012; Song J, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-13; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Travers JB, 1997, NEUROSCI BIOBEHAV R, V21, P631, DOI 10.1016/S0149-7634(96)00045-0; TSO DY, 1986, J NEUROSCI, V6, P1160; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Yaksi E, 2007, PLOS BIOL, V5, P1453, DOI 10.1371/journal.pbio.0050178; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	38	299	301	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2010	464	7292					1182	U99		10.1038/nature08897	http://dx.doi.org/10.1038/nature08897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20376005				2022-12-24	WOS:000276891100035
J	Rothwell, PM; Howard, SC; Dolan, E; O'Brien, E; Dobson, JE; Dahlof, B; Sever, PS; Poulter, NR				Rothwell, Peter M.; Howard, Sally C.; Dolan, Eamon; O'Brien, Eoin; Dobson, Joanna E.; Dahlof, Bjorn; Sever, Peter S.; Poulter, Neil R.			Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension	LANCET			English	Article							TRANSIENT ISCHEMIC ATTACK; SOCIETY-OF-HYPERTENSION; CARDIOVASCULAR EVENTS; ANTIHYPERTENSIVE TREATMENT; REGRESSION DILUTION; RISK-FACTOR; STROKE; TRIAL; PREDICTOR; MORTALITY	Background The mechanisms by which hypertension causes vascular events are unclear. Guidelines for diagnosis and treatment focus only on underlying mean blood pressure. We aimed to reliably establish the prognostic significance of visit-to-visit variability in blood pressure, maximum blood pressure reached, untreated episodic hypertension, and residual variability in treated patients. Methods We determined the risk of stroke in relation to visit-to-visit variability in blood pressure (expressed as standard deviation [SDI and parameters independent of mean blood pressure) and maximum blood pressure in patients with previous transient ischaemic attack (TIA; UK-TIA trial and three validation cohorts) and in patients with treated hypertension (Anglo-Scandinavian Cardiac Outcomes Trial Blood Pressure Lowering Arm [ASCOT-BPLA]). In ASCOT-BPLA, 24-h ambulatory blood-pressure monitoring (ABPM) was also studied. Findings In each TIA cohort, visit-to-visit variability in systolic blood pressure (SBP) was a strong predictor of subsequent stroke (eg, top-decile hazard ratio [HR] for SD SBP over seven visits in UK-TIA trial: 6.22, 95% CI 4.16-9.29, p<0.0001), independent of mean S BP, but dependent on precision of measurement (top-decile HR over ten visits: 12.08, 7.40-19.72, p<0.0001). Maximum SBP reached was also a strong predictor of stroke (HR for top-decile over seven visits: 15.01, 6.56-34.38, p<0.0001, after adjustment for mean SBP). In ASCOT-BPLA, residual visit-to-visit variability in SBP on treatment was also a strong predictor of stroke and coronary events (eg, top-decile HR for stroke: 3.25, 2.32-4.54, p<0.0001), independent of mean S BP in clinic or on ABPM. Variability on ABPM was a weaker predictor, but all measures of variability were most predictive in younger patients and at lower (<median) values of mean SBP in every cohort. Interpretation Visit-to-visit variability in SBP and maximum SBP are strong predictors of stroke, independent of mean SBP. Increased residual variability in SBP in patients with treated hypertension is associated with a high risk of vascular events.	[Rothwell, Peter M.; Howard, Sally C.] John Radcliffe Hosp, Stroke Prevent Res Unit, Univ Dept Clin Neurol, Oxford OX3 9DU, England; [Dolan, Eamon] Connolly Hosp, Stroke & Hypertens Unit, Dublin, Ireland; [O'Brien, Eoin] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Dobson, Joanna E.; Sever, Peter S.; Poulter, Neil R.] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England; [Dahlof, Bjorn] Univ Gothenburg, Dept Med, Gothenburg, Sweden	University of Oxford; University College Dublin; Imperial College London; University of Gothenburg	Rothwell, PM (corresponding author), John Radcliffe Hosp, Stroke Prevent Res Unit, Univ Dept Clin Neurol, Level 6,West Wing, Oxford OX3 9DU, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211	UK Medical Research Council; National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford, UK; Biomedical Research Centre Award; British Heart Foundation Centre for Excellence Award; Pfizer; Servier Research Group, Paris, France; Medical Research Council [G0500987] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10116] Funding Source: researchfish; MRC [G0500987] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford, UK(National Institute for Health Research (NIHR)); Biomedical Research Centre Award; British Heart Foundation Centre for Excellence Award; Pfizer(Pfizer); Servier Research Group, Paris, France; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the investigators of the UK-TIA aspirin trial, the European Stroke Prevention Study (ESPS-1), the Dutch TIA aspirin trial, and the ASCOT-BPLA study. We acknowledge the collaboration of the other ASCOT-BPLA ABPM substudy researchers: Alice V Stanton, Simon Thom, Mark Caulfield, Gordon McInnes, and David Collier. SCH was funded by the UK Medical Research Council and by the National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford, UK. NRP and PSS were supported by a Biomedical Research Centre Award to Imperial College NHS Health Care Trust, are in receipt of a British Heart Foundation Centre for Excellence Award, and along with PMR are recipients of NIHR Senior Investigator Awards. Pfizer was the major funding source of the main ASCOT trial with additional support provided by Servier Research Group, Paris, France.	[Anonymous], 1978, J Chronic Dis, V31, P651; [Anonymous], 1987, LANCET, V2, P1351; ARMITAGE P, 1966, CLIN SCI, V30, P337; Chalmers J, 1996, J HYPERTENS, V14, pS41; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLANDREA MA, 1970, CIRCULATION, V41, P239, DOI 10.1161/01.CIR.41.2.239; CUFFE RL, 2005, CEREBROVASC DIS, V19, P51; Cuffe RL, 2006, STROKE, V37, P2776, DOI 10.1161/01.STR.0000244761.62073.05; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dolan E, 2009, J HYPERTENS, V27, P876, DOI 10.1097/HJH.0b013e328322cd62; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Hata Y, 2002, J HUM HYPERTENS, V16, P141, DOI 10.1038/sj.jhh.1001301; Hata Y, 2000, HYPERTENS RES, V23, P553, DOI 10.1291/hypres.23.553; Havlik RJ, 2002, STROKE, V33, P26, DOI 10.1161/hs0102.101890; Howard SC, 2009, CEREBROVASC DIS, V28, P331, DOI 10.1159/000229551; Howard SC, 2003, J CLIN EPIDEMIOL, V56, P1084, DOI 10.1016/S0895-4356(03)00267-1; JANSEN PAF, 1986, AGE AGEING, V15, P129, DOI 10.1093/ageing/15.3.129; Keenan K, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1492; Kikuya M, 2008, HYPERTENSION, V52, P1045, DOI 10.1161/HYPERTENSIONAHA.107.104620; Klungel OH, 2000, J CLIN EPIDEMIOL, V53, P1158, DOI 10.1016/S0895-4356(00)00228-6; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Leenen FHH, 2004, CAN J CARDIOL, V20, p77B; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Marshall T, 2004, BMJ-BRIT MED J, V328, P933, DOI 10.1136/bmj.328.7445.933; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; O'Brien E, 2001, J HUM HYPERTENS, V15, pS47, DOI 10.1038/sj.jhh.1001076; OBRIEN E, 1994, J HYPERTENS, V12, P1089; OBRIEN E, 1991, J HYPERTENS, V9, P573, DOI 10.1097/00004872-199106000-00016; Parati G, 2008, J HYPERTENS, V26, P1505, DOI 10.1097/HJH.0b013e328308da66; Pickering TG, 2007, HYPERTENS RES, V30, P479, DOI 10.1291/hypres.30.479; Poulter NR, 2005, LANCET, V366, P907, DOI 10.1016/S0140-6736(05)67186-3; Pringle E, 2003, J HYPERTENS, V21, P2251, DOI 10.1097/00004872-200312000-00012; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Robinson T, 1997, CEREBROVASC DIS, V7, P214, DOI 10.1159/000108194; Rodgers A, 1996, BRIT MED J, V313, P147, DOI 10.1136/bmj.313.7050.147; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Toschke AM, 2009, CEREBROVASC DIS, V28, P105, DOI 10.1159/000223434; Tozawa M, 1999, NEPHROL DIAL TRANSPL, V14, P1976, DOI 10.1093/ndt/14.8.1976; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE; Turner MJ, 2008, AM J HYPERTENS, V21, P85, DOI 10.1038/ajh.2007.25; VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801; Verdecchia P, 2003, AM J HYPERTENS, V16, P87, DOI 10.1016/S0895-7061(02)03150-3; Warlow C, 2003, LANCET, V362, P1211, DOI 10.1016/S0140-6736(03)14544-8; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Whelton P K, 1989, Clin Geriatr Med, V5, P639; Williams B, 2008, LANCET, V371, P2219, DOI 10.1016/S0140-6736(08)60804-1; Zhang ZH, 2000, BRAIN RES, V863, P25, DOI 10.1016/S0006-8993(00)02068-0	51	1203	1363	3	97	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2010	375	9718					895	905		10.1016/S0140-6736(10)60308-X	http://dx.doi.org/10.1016/S0140-6736(10)60308-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	574NA	20226988				2022-12-24	WOS:000275995300029
J	Vegiopoulos, A; Muller-Decker, K; Strzoda, D; Schmitt, I; Chichelnitskiy, E; Ostertag, A; Diaz, MB; Rozman, J; de Angelis, MH; Nusing, RM; Meyer, CW; Wahli, W; Klingenspor, M; Herzig, S				Vegiopoulos, Alexandros; Mueller-Decker, Karin; Strzoda, Daniela; Schmitt, Iris; Chichelnitskiy, Evgeny; Ostertag, Anke; Diaz, Mauricio Berriel; Rozman, Jan; de Angelis, Martin Hrabe; Nuesing, Rolf M.; Meyer, Carola W.; Wahli, Walter; Klingenspor, Martin; Herzig, Stephan			Cyclooxygenase-2 Controls Energy Homeostasis in Mice by de Novo Recruitment of Brown Adipocytes	SCIENCE			English	Article							ADIPOSE-TISSUE; PPAR-GAMMA; IDENTIFICATION; RECEPTOR; FAT; CELECOXIB; OBESITY; PRDM16	Obesity results from chronic energy surplus and excess lipid storage in white adipose tissue (WAT). In contrast, brown adipose tissue (BAT) efficiently burns lipids through adaptive thermogenesis. Studying mouse models, we show that cyclooxygenase (COX)-2, a rate-limiting enzyme in prostaglandin (PG) synthesis, is a downstream effector of beta-adrenergic signaling in WAT and is required for the induction of BAT in WAT depots. PG shifted the differentiation of defined mesenchymal progenitors toward a brown adipocyte phenotype. Overexpression of COX-2 in WAT induced de novo BAT recruitment in WAT, increased systemic energy expenditure, and protected mice against high-fat diet-induced obesity. Thus, COX-2 appears integral to de novo BAT recruitment, which suggests that the PG pathway regulates systemic energy homeostasis.	[Vegiopoulos, Alexandros; Strzoda, Daniela; Schmitt, Iris; Chichelnitskiy, Evgeny; Ostertag, Anke; Diaz, Mauricio Berriel; Herzig, Stephan] German Canc Res Ctr DKFZ Heidelberg, Emmy Noether & Marie Curie Res Grp Mol Metab Cont, D-69120 Heidelberg, Germany; [Mueller-Decker, Karin] German Canc Res Ctr DKFZ Heidelberg, Core Facil Tumor Models, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany; [Rozman, Jan; de Angelis, Martin Hrabe] Helmholtz Ctr Munich, Inst Expt Genet, D-85764 Neuherberg, Germany; [Nuesing, Rolf M.] Goethe Univ Frankfurt, Inst Clin Pharmacol, D-60590 Frankfurt, Germany; [Meyer, Carola W.] Univ Marburg, Dept Anim Physiol, D-35043 Marburg, Germany; [Wahli, Walter] Univ Lausanne, Natl Res Ctr Frontiers Genet, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Klingenspor, Martin] Tech Univ Munich, Else Kroner Fresenius Ctr, D-85350 Freising Weihenstephan, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Goethe University Frankfurt; Philipps University Marburg; University of Lausanne; Technical University of Munich	Herzig, S (corresponding author), German Canc Res Ctr DKFZ Heidelberg, Emmy Noether & Marie Curie Res Grp Mol Metab Cont, D-69120 Heidelberg, Germany.	s.herzig@dkfz.de	Wahli, Walter/B-1398-2009; Rozman, Jan/A-2540-2010; Klingenspor, Martin/D-6930-2011; Klingenspor, Martin/K-5033-2019; de Angelis, Martin Hrabe/F-5531-2012; Diaz, Mauricio Berriel/AAF-8285-2021; Meyer, Carola/N-5874-2014; Wahli, Walter/I-3194-2019	Wahli, Walter/0000-0002-5966-9089; Rozman, Jan/0000-0002-8035-8904; Klingenspor, Martin/0000-0002-4502-6664; de Angelis, Martin Hrabe/0000-0002-7898-2353; Meyer, Carola/0000-0001-7959-1218; OSTERTAG, Agnes/0000-0002-1966-3213; Berriel Diaz, Mauricio/0000-0003-4670-919X; Chichelnitskiy, Evgeny/0000-0002-6341-4177; Herzig, Stephan/0000-0003-3950-3652	German National Genome Research Network [01GS0822, 01GS0869]; Deutsche Forschungsgemeinschaft [He3260/2-1]; Network Aging Research Heidelberg/Mannheim; Marie Curie Excellence Grant	German National Genome Research Network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Network Aging Research Heidelberg/Mannheim; Marie Curie Excellence Grant(European Commission)	We thank K. Hexel, A. Jones, D. Kucher, P. Kulozik, A. Lacher, F. Mattijssen, D. Metzger, A. Pohl-Arnold, A. Reimann, S. Schmitt, B. Steinbauer, M. Willershauser, and A. E. Schwarz for experimental support; A. Rose for comments on the manuscript; J. Masferrer (Pfizer, St. Louis, USA) for providing celecoxib; and S. Narumiya (Kyoto, Japan) for Ptgir knockout mice. This work was supported by the German National Genome Research Network (grants 01GS0822 to M. K. and 01GS0869 to M. K. and M. H.) and by the Deutsche Forschungsgemeinschaft He3260/2-1, the Network Aging Research Heidelberg/Mannheim, and a Marie Curie Excellence Grant to S. H.	Akunda JK, 2007, MOL CARCINOGEN, V46, P354, DOI 10.1002/mc.20290; Arch JRS, 2002, EUR J PHARMACOL, V440, P99, DOI 10.1016/S0014-2999(02)01421-8; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Celi FS, 2009, NEW ENGL J MED, V360, P1553, DOI 10.1056/NEJMe0900466; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Davis TW, 2004, J PHARMACOL EXP THER, V308, P929, DOI 10.1124/jpet.103.063099; Fain JN, 2001, PROSTAG OTH LIPID M, V65, P199, DOI 10.1016/S0090-6980(01)00136-8; Falcetti E, 2007, BIOCHEM BIOPH RES CO, V360, P821, DOI 10.1016/j.bbrc.2007.06.135; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gray SL, 2006, ENDOCRINOLOGY, V147, P5708, DOI 10.1210/en.2006-0684; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lundholm K, 2004, INT J ONCOL, V24, P505; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Neufang G, 2001, P NATL ACAD SCI USA, V98, P7629, DOI 10.1073/pnas.121574098; Palamara Kerri L, 2006, Cardiol Rev, V14, P238, DOI 10.1097/01.crd.0000233903.57946.fd; Penning TD, 1997, J MED CHEM, V40, P1347, DOI 10.1021/jm960803q; RICHELSEN B, 1987, BIOCHEM J, V247, P389, DOI 10.1042/bj2470389; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949	24	338	360	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1158	1161		10.1126/science.1186034	http://dx.doi.org/10.1126/science.1186034			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20448152				2022-12-24	WOS:000278104700044
J	Peleg, S; Sananbenesi, F; Zovoilis, A; Burkhardt, S; Bahari-Javan, S; Agis-Balboa, RC; Cota, P; Wittnam, JL; Gogol-Doering, A; Opitz, L; Salinas-Riester, G; Dettenhofer, M; Kang, H; Farinelli, L; Chen, W; Fischer, A				Peleg, Shahaf; Sananbenesi, Farahnaz; Zovoilis, Athanasios; Burkhardt, Susanne; Bahari-Javan, Sanaz; Agis-Balboa, Roberto Carlos; Cota, Perla; Wittnam, Jessica Lee; Gogol-Doering, Andreas; Opitz, Lennart; Salinas-Riester, Gabriella; Dettenhofer, Markus; Kang, Hui; Farinelli, Laurent; Chen, Wei; Fischer, Andre			Altered Histone Acetylation Is Associated with Age-Dependent Memory Impairment in Mice	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; SYNAPTIC PLASTICITY; CHIP-SEQ; BRAIN; FORMIN-2; PROTEIN; LTP	As the human life span increases, the number of people suffering from cognitive decline is rising dramatically. The mechanisms underlying age-associated memory impairment are, however, not understood. Here we show that memory disturbances in the aging brain of the mouse are associated with altered hippocampal chromatin plasticity. During learning, aged mice display a specific deregulation of histone H4 lysine 12 (H4K12) acetylation and fail to initiate a hippocampal gene expression program associated with memory consolidation. Restoration of physiological H4K12 acetylation reinstates the expression of learning-induced genes and leads to the recovery of cognitive abilities. Our data suggest that deregulated H4K12 acetylation may represent an early biomarker of an impaired genome-environment interaction in the aging mouse brain.	[Peleg, Shahaf; Sananbenesi, Farahnaz; Zovoilis, Athanasios; Burkhardt, Susanne; Bahari-Javan, Sanaz; Agis-Balboa, Roberto Carlos; Cota, Perla; Wittnam, Jessica Lee; Fischer, Andre] European Neurosci Inst, Lab Aging & Cognit Dis, D-37077 Gottingen, Germany; [Gogol-Doering, Andreas; Kang, Hui; Chen, Wei] Max Delbruck Ctr Mol Med, Inst Med Syst Biol, D-13125 Berlin, Germany; [Opitz, Lennart; Salinas-Riester, Gabriella] Univ Gottingen, DNA Microarray Facil, D-37073 Gottingen, Germany; [Dettenhofer, Markus] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Farinelli, Laurent] Fasteris SA, CH-1228 Plan Les Ouates, Switzerland	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Gottingen; Harvard University; Harvard Medical School	Fischer, A (corresponding author), European Neurosci Inst, Lab Aging & Cognit Dis, Grisebach Str 5, D-37077 Gottingen, Germany.	a.fischer@eni-g.de	Chen, Wei/C-1273-2011; Dettenhofer, Markus/ABB-9840-2021; Agís-Balboa, Roberto Carlos/K-5053-2014; Fischer, Andre/AAU-7487-2021	Dettenhofer, Markus/0000-0003-1972-7026; Agís-Balboa, Roberto Carlos/0000-0001-9899-9569; Fischer, Andre/0000-0001-8546-1161; Peleg, Shahaf/0000-0003-2646-3807; Zovoilis, Athanasios/0000-0001-6425-0402; Chen, Wei/0000-0003-3263-1627	European Science Foundation; Hans and Ilse Breuer Foundation; Schramm Foundation; European Research Area (ERA)-Net Neuron project Epitherapy; Minerva fellowship; Deutsche Forschungsgemeinschaft (German Research Foundation); German Academic Exchange Service (DAAD); European Molecular Biology Organization (EMBO); University Medicine Goettingen; Max Planck Society	European Science Foundation(European Science Foundation (ESF)European Commission); Hans and Ilse Breuer Foundation; Schramm Foundation; European Research Area (ERA)-Net Neuron project Epitherapy; Minerva fellowship; Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); University Medicine Goettingen; Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank J. Radulovic, S. Irniger, A Kranz, and W. Fischle for reading the manuscript and helpful comments. Microarray and ChIP-seq data are accessible through GEO Series accession number GSE20270 (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE20270) and Galaxy data-sharing platform (http://main.g2.bx.psu.edu/u/fischerlab/h/sm1186088; published history sm1186088). This work was partially supported by the following funds to A. F.: The EURYI award of the European Science Foundation, the Hans and Ilse Breuer Foundation, the Schramm Foundation, and the European Research Area (ERA)-Net Neuron project Epitherapy. S. P. is supported by a Minerva fellowship, F. S. is supported by the Deutsche Forschungsgemeinschaft (German Research Foundation), P. C. is supported by a German Academic Exchange Service (DAAD) fellowship, and R. C. A.-B. is supported by a European Molecular Biology Organization (EMBO) long-term fellowship. M. D is a Howard Hughes Medical Institute postdoctoral fellow, and L. F. is a founder and shareholder of Fasteris SA. The European Neuroscience Institute is jointly funded by the University Medicine Goettingen and the Max Planck Society.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jucker M, 1997, BEHAV BRAIN RES, V85, P1, DOI 10.1016/S0166-4328(96)02243-7; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Leader B, 2000, MECH DEVELOP, V93, P221, DOI 10.1016/S0925-4773(00)00276-8; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Liang N, 2008, J PROTEOME RES, V7, P3678, DOI 10.1021/pr800439b; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Mardis ER, 2007, NAT METHODS, V4, P613, DOI 10.1038/nmeth0807-613; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Xu X, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r234	24	681	709	1	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2010	328	5979					753	756		10.1126/science.1186088	http://dx.doi.org/10.1126/science.1186088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448184				2022-12-24	WOS:000277357100040
J	Karras, GI; Jentsch, S				Karras, Georgios I.; Jentsch, Stefan			The RAD6 DNA Damage Tolerance Pathway Operates Uncoupled from the Replication Fork and Is Functional Beyond S Phase	CELL			English	Article							UBIQUITIN-CONJUGATING-ENZYME; RADIATION-SENSITIVE STRAINS; SACCHAROMYCES-CEREVISIAE; POSTREPLICATION REPAIR; POLYMERASE-DELTA; TRANSLESION SYNTHESIS; RECQ HELICASE; HOMOLOGOUS RECOMBINATION; DISTINCT MECHANISMS; PCNA UBIQUITINATION	Damaged DNA templates provide an obstacle to the replication fork and can cause genome instability. In eukaryotes, tolerance to damaged DNA is mediated largely by the RAD6 pathway involving ubiquitylation of the DNA polymerase processivity factor PCNA. Whereas monoubiquitylation of PCNA mediates error-prone translesion synthesis (TLS), polyubiquitylation triggers an error-free pathway. Both branches of this pathway are believed to occur in S phase in order to ensure replication completion. However, we found that limiting TLS or the error-free pathway to the G2/M phase of the cell-cycle efficiently promote lesion tolerance. Thus, our findings indicate that both branches of the DNA damage tolerance pathway operate effectively after chromosomal replication, outside S phase. We therefore propose that the RAD6 pathway acts on single-stranded gaps left behind newly restarted replication forks.	[Karras, Georgios I.; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de		Karras, Georgios/0000-0003-2933-1535; Karras, Georgios/0000-0002-6169-5569	Max Planck Society; Deutsche Forschungsgemeinschaft; Fonds der chemischen Industrie; Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence	We thank M. Raghuraman and B. Brewer for generously hosting G. I. K. for experiments, W. Feng for demonstrating 2D gel analysis for replication intermediates, and G. Alvino and W. Feng for help with quantification. We also thank B. Le Tallec, S. Muller, I. Psakhye, M. Raschle, and Z. Storchova for comments on the manuscript, K. Schorpp and M. Schwarz for help with the robot-based screen, S. Moertl and B. Johansson for PFGE protocols, M. Kupiec for the cdc2-2 mutant strain, and A. Strasser for technical assistance. This work is supported (to S.J.) by the Max Planck Society, Deutsche Forschungsgemeinschaft, Fonds der chemischen Industrie, Center for Integrated Protein Science Munich, and RUBICON EU Network of Excellence.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Alvino GM, 2007, MOL CELL BIOL, V27, P6396, DOI 10.1128/MCB.00719-07; Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Barbour L, 2003, MUTAT RES-FUND MOL M, V532, P137, DOI 10.1016/j.mrfmmm.2003.08.014; Bi XH, 2006, MOL CELL BIOL, V26, P3527, DOI 10.1128/MCB.26.9.3527-3540.2006; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Branzei D, 2002, MOL GENET GENOMICS, V268, P371, DOI 10.1007/s00438-002-0757-3; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; BREWER BJ, 1980, P NATL ACAD SCI-BIOL, V77, P5380, DOI 10.1073/pnas.77.9.5380; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Frei C, 2000, GENE DEV, V14, P81; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Fukui T, 2004, GENES CELLS, V9, P179, DOI 10.1111/j.1356-9597.2004.00716.x; Gangavarapu V, 2007, MOL CELL BIOL, V27, P7758, DOI 10.1128/MCB.01331-07; Gangavarapu V, 2006, MOL CELL BIOL, V26, P7783, DOI 10.1128/MCB.01260-06; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Giot L, 1997, GENETICS, V146, P1239; HASTINGS PJ, 1976, NATURE, V264, P719, DOI 10.1038/264719a0; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hood JK, 2001, J CELL SCI, V114, P589; HOWARDFL.P, 1968, ANNU REV BIOCHEM, V37, P175, DOI 10.1146/annurev.bi.37.070168.001135; Huang ME, 1997, YEAST, V13, P1181, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1181::AID-YEA169>3.3.CO;2-F; Huang ME, 1999, MOL GEN GENET, V260, P541, DOI 10.1007/s004380050927; Huang ME, 2000, CURR GENET, V38, P178, DOI 10.1007/s002940000149; Jansen JG, 2009, DNA REPAIR, V8, P1444, DOI 10.1016/j.dnarep.2009.09.006; Jansen JG, 2009, MOL CELL BIOL, V29, P3113, DOI 10.1128/MCB.00071-09; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; JOHNSON RE, 1994, J BIOL CHEM, V269, P28259; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kunz BA, 2000, MUTAT RES-FUND MOL M, V451, P169, DOI 10.1016/S0027-5107(00)00048-8; LAWRENCE CW, 1974, J MOL BIOL, V85, P137, DOI 10.1016/0022-2836(74)90134-X; LAWRENCE CW, 1976, GENETICS, V82, P207; Leach CA, 2005, J CELL BIOL, V171, P947, DOI 10.1083/jcb.200508100; Lee KY, 2008, MOL CELLS, V26, P5; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Lehmann AR, 2006, DNA REPAIR, V5, P1495, DOI 10.1016/j.dnarep.2006.07.002; LEMONTT JF, 1971, GENETICS, V68, P21; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Ma WJ, 2009, MOL CELL BIOL, V29, P1212, DOI 10.1128/MCB.01499-08; McDonald JP, 1997, GENETICS, V147, P1557; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; MORRISON A, 1989, J BACTERIOL, V171, P5659, DOI 10.1128/jb.171.10.5659-5667.1989; Motlagh NDV, 2006, DNA REPAIR, V5, P1459, DOI 10.1016/j.dnarep.2006.07.006; Nakayama H, 2002, ONCOGENE, V21, P9008, DOI 10.1038/sj.onc.1205959; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Pages V, 2009, GENE DEV, V23, P1438, DOI 10.1101/gad.1793409; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Paulovich AG, 1998, GENETICS, V150, P75; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Sabbioneda S, 2005, J BIOL CHEM, V280, P38657, DOI 10.1074/jbc.M507638200; Sabbioneda S, 2007, DNA REPAIR, V6, P121, DOI 10.1016/j.dnarep.2006.09.002; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; Ward TR, 2000, MOL CELL BIOL, V20, P4948, DOI 10.1128/MCB.20.13.4948-4957.2000; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Waters LS, 2006, P NATL ACAD SCI USA, V103, P8971, DOI 10.1073/pnas.0510167103; Weinert T, 2007, SCIENCE, V315, P1374, DOI 10.1126/science.1140759; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yang XH, 2009, CELL CYCLE, V8, P191, DOI 10.4161/cc.8.2.7357; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102	87	226	228	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					255	267		10.1016/j.cell.2010.02.028	http://dx.doi.org/10.1016/j.cell.2010.02.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403322	Bronze			2022-12-24	WOS:000276738400016
J	Manier, MK; Belote, JM; Berben, KS; Novikov, D; Stuart, WT; Pitnick, S				Manier, Mollie K.; Belote, John M.; Berben, Kirstin S.; Novikov, David; Stuart, Will T.; Pitnick, Scott			Resolving Mechanisms of Competitive Fertilization Success in Drosophila melanogaster	SCIENCE			English	Article							SPERM DISPLACEMENT; MALES; EVOLUTION; STORAGE; FEMALES	Our understanding of postcopulatory sexual selection has been constrained by an inability to discriminate competing sperm of different males, coupled with challenges of directly observing live sperm inside the female reproductive tract. Real-time and spatiotemporal analyses of sperm movement, storage, and use within female Drosophila melanogaster inseminated by two transgenic males with, respectively, green and red sperm heads allowed us to unambiguously discriminate among hypothesized mechanisms underlying sperm precedence, including physical displacement and incapacitation of "resident" sperm by second males, female ejection of sperm, and biased use of competing sperm for fertilization. We find that competitive male fertilization success derives from a multivariate process involving ejaculate-female and ejaculate-ejaculate interactions, as well as complex sperm behavior in vivo.	[Manier, Mollie K.; Belote, John M.; Berben, Kirstin S.; Novikov, David; Stuart, Will T.; Pitnick, Scott] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Pitnick, S (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	sspitnic@syr.edu	Manier, Mollie K./I-2069-2019	Manier, Mollie K./0000-0001-9114-8649	NSF [DEB-9806649, DEB-0814732]	NSF(National Science Foundation (NSF))	Supported by the NSF (grants DEB-9806649 and DEB-0814732). We thank S. McClear for assistance with the protamine constructs and M. Wong for technical assistance.	Adams EM, 2007, J INSECT PHYSIOL, V53, P319, DOI 10.1016/j.jinsphys.2006.12.003; Birkhead TR, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P1; Birkhead TR, 1998, SPERM COMPETITION SE; Bjork A, 2007, P ROY SOC B-BIOL SCI, V274, P1779, DOI 10.1098/rspb.2007.0293; Bjork A, 2006, NATURE, V441, P742, DOI 10.1038/nature04683; Civetta A, 1999, CURR BIOL, V9, P841, DOI 10.1016/S0960-9822(99)80370-4; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; GILCHRIST AS, 1995, J INSECT PHYSIOL, V41, P1087, DOI 10.1016/0022-1910(95)00068-6; HARSHMAN LG, 1994, EVOLUTION, V48, P758, DOI [10.2307/2410484, 10.1111/j.1558-5646.1994.tb01359.x]; Holman L, 2009, FUNCT ECOL, V23, P180, DOI 10.1111/j.1365-2435.2008.01509.x; LEFEVRE G, 1962, GENETICS, V42, P1719; Miller GT, 2002, SCIENCE, V298, P1230, DOI 10.1126/science.1076968; Parker G.A., 1984, P1; Parker G.A., 1979, SEXUAL SELECTION REP, P123, DOI DOI 10.1016/B978-0-12-108750-0.50010-0; PARKER GA, 1991, P ROY SOC B-BIOL SCI, V246, P107, DOI 10.1098/rspb.1991.0131; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pattarini JA, 2006, EVOLUTION, V60, P2064, DOI 10.1111/j.0014-3820.2006.tb01844.x; Pitnick S, 1999, EVOLUTION, V53, P1804, DOI [10.2307/2640442, 10.1111/j.1558-5646.1999.tb04564.x]; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Price CSC, 1999, NATURE, V400, P449, DOI 10.1038/22755; Ram KR, 2007, INTEGR COMP BIOL, V47, P427, DOI 10.1093/icb/icm046; Snook RR, 2004, NATURE, V428, P939, DOI 10.1038/nature02455; Stewart AD, 2007, EVOLUTION, V61, P636, DOI 10.1111/j.1558-5646.2007.00056.x	23	234	235	2	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					354	357		10.1126/science.1187096	http://dx.doi.org/10.1126/science.1187096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20299550				2022-12-24	WOS:000276685000037
J	vonHoldt, BM; Pollinger, JP; Lohmueller, KE; Han, EJ; Parker, HG; Quignon, P; Degenhardt, JD; Boyko, AR; Earl, DA; Auton, A; Reynolds, A; Bryc, K; Brisbin, A; Knowles, JC; Mosher, DS; Spady, TC; Elkahloun, A; Geffen, E; Pilot, M; Jedrzejewski, W; Greco, C; Randi, E; Bannasch, D; Wilton, A; Shearman, J; Musiani, M; Cargill, M; Jones, PG; Qian, ZW; Huang, W; Ding, ZL; Zhang, YP; Bustamante, CD; Ostrander, EA; Novembre, J; Wayne, RK				vonHoldt, Bridgett M.; Pollinger, John P.; Lohmueller, Kirk E.; Han, Eunjung; Parker, Heidi G.; Quignon, Pascale; Degenhardt, Jeremiah D.; Boyko, Adam R.; Earl, Dent A.; Auton, Adam; Reynolds, Andy; Bryc, Kasia; Brisbin, Abra; Knowles, James C.; Mosher, Dana S.; Spady, Tyrone C.; Elkahloun, Abdel; Geffen, Eli; Pilot, Malgorzata; Jedrzejewski, Wlodzimierz; Greco, Claudia; Randi, Ettore; Bannasch, Danika; Wilton, Alan; Shearman, Jeremy; Musiani, Marco; Cargill, Michelle; Jones, Paul G.; Qian, Zuwei; Huang, Wei; Ding, Zhao-Li; Zhang, Ya-Ping; Bustamante, Carlos D.; Ostrander, Elaine A.; Novembre, John; Wayne, Robert K.			Genome-wide SNP and haplotype analyses reveal a rich history underlying dog domestication	NATURE			English	Article							LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; ANCIENT DNA; ORIGIN; WILD; SELECTION; GENOTYPE; DELETION	Advances in genome technology have facilitated a new understanding of the historical and genetic processes crucial to rapid phenotypic evolution under domestication(1,2). To understand the process of dog diversification better, we conducted an extensive genome-wide survey of more than 48,000 single nucleotide polymorphisms in dogs and their wild progenitor, the grey wolf. Here we show that dog breeds share a higher proportion of multi-locus haplotypes unique to grey wolves from the Middle East, indicating that they are a dominant source of genetic diversity for dogs rather than wolves from east Asia, as suggested by mitochondrial DNA sequence data(3). Furthermore, we find a surprising correspondence between genetic and phenotypic/functional breed groupings but there are exceptions that suggest phenotypic diversification depended in part on the repeated crossing of individuals with novel phenotypes. Our results show that Middle Eastern wolves were a critical source of genome diversity, although interbreeding with local wolf populations clearly occurred elsewhere in the early history of specific lineages. More recently, the evolution of modern dog breeds seems to have been an iterative process that drew on a limited genetic toolkit to create remarkable phenotypic diversity.	[vonHoldt, Bridgett M.; Pollinger, John P.; Knowles, James C.; Novembre, John; Wayne, Robert K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Lohmueller, Kirk E.; Degenhardt, Jeremiah D.; Boyko, Adam R.; Auton, Adam; Reynolds, Andy; Bryc, Kasia; Brisbin, Abra; Bustamante, Carlos D.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Han, Eunjung] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 14853 USA; [Parker, Heidi G.; Quignon, Pascale; Mosher, Dana S.; Spady, Tyrone C.; Elkahloun, Abdel; Ostrander, Elaine A.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Earl, Dent A.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Geffen, Eli] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Pilot, Malgorzata] Polish Acad Sci, Museum Zool, PL-00679 Warsaw, Poland; [Pilot, Malgorzata] Polish Acad Sci, Inst Zool, PL-00679 Warsaw, Poland; [Jedrzejewski, Wlodzimierz] Polish Acad Sci, Mammal Res Inst, PL-17230 Bialowieza, Poland; [Greco, Claudia; Randi, Ettore] ISPRA, I-40064 Ozzano Emilia B, Italy; [Bannasch, Danika] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Wilton, Alan; Shearman, Jeremy] Univ New S Wales, Clive & Vera Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia; [Wilton, Alan; Shearman, Jeremy] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Musiani, Marco] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada; [Cargill, Michelle] Affymetrix Corp, Santa Clara, CA 95051 USA; [Jones, Paul G.] WALTHAM Ctr Pet Nutr, Waltham On The Worlds LE14 4RT, Leics, England; [Qian, Zuwei; Huang, Wei] AZIA Ctr, Affymetrix Asia Pacific Sci Affairs & Collaborat, Shanghai 200120, Peoples R China; [Ding, Zhao-Li] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Peoples R China; [Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Novembre, John] Univ Calif Los Angeles, Interdepartmental Program Bioinformat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Cornell University; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Santa Cruz; Tel Aviv University; Polish Academy of Sciences; Polish Academy of Sciences; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Italian Institute for Environmental Protection & Research (ISPRA); University of California System; University of California Davis; University of New South Wales Sydney; University of New South Wales Sydney; University of Calgary; Affymetrix; Mars; WALTHAM Petcare Science Institute; Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology; University of California System; University of California Los Angeles	Wayne, RK (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, 621 Charles E Young Dr S, Los Angeles, CA 90095 USA.	rwayne@ucla.edu	Musiani, Marco/ABB-9387-2021; Wilton, Alan N/C-2430-2011; Shearman, Jeremy/F-1618-2010; Fiumefreddo, Andrea/T-2977-2019; Greco, Claudia/ABA-6030-2020; Bannasch, Danika/GZL-8044-2022; Novembre, John/G-1339-2011	Musiani, Marco/0000-0002-6097-5841; Pilot, Malgorzata/0000-0002-6057-5768; Parker, Heidi G./0000-0002-9707-6380; Bannasch, Danika/0000-0002-7614-7207; Greco, Claudia/0000-0002-8678-0890; Bustamante, Carlos D./0000-0002-4187-7920; Ostrander, Elaine/0000-0001-6075-9738	NSF; NIH; Polish Ministry of Science and Higher Education; European Nature Heritage Fund EURONATUR; National Basic Research Program of China; Chinese Academy of Sciences; Searle Scholars Program; National Human Genome Research Institute; Foundation for Polish Science; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365, T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083606] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Nature Heritage Fund EURONATUR; National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Searle Scholars Program; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grants from NSF and NIH (R. K. W.; C. D. B. and J.N.), the Polish Ministry of Science and Higher Education (M. P. and W.J.), European Nature Heritage Fund EURONATUR (W.J.), National Basic Research Program of China (Y.-p.Z.), and Chinese Academy of Sciences (Y.-p.Z.) supported this research. J.N. was supported by the Searle Scholars Program. B.M.vH. was supported by a NIH Training Grant in Genomic Analysis and Interpretation. K. E. L. was supported by a NSF Graduate Research Fellowship. E.A.O., D. S. M., T. C. S., A. E. and H. G. P. are supported by the intramural program of the National Human Genome Research Institute. M. P. was supported by the Foundation for Polish Science. Wolf samples from central and eastern Europe and Turkey were collected as a result of a continuing project on genetic differentiation in Eurasian wolves. We thank the project participants (B. Jedrzejewska, V. E. Sidorovich, M. Shkvyrya, I. Dikiy, E. Tsingarskaya and S. Nowak) for their permission to use 72 samples for this study. We acknowledge R. Hefner and the Zoological collection at Tel Aviv University for Israeli wolf samples. We thank the American Kennel Club (AKC) for the dog images reproduced in Fig. 1. We also gratefully acknowledge the dog owners who generously provided samples, the AKC Canine Health Foundation, and Affymetrix Corporation. We thank B. Van Valkenburgh, K.-P. Koepfli, D. Stahler and D. Smith for reviewing the manuscript.	American Kennel Club, 2006, COMPL DOG BOOK, Vtwentieth; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Balschun D, 1999, EMBO J, V18, P5264, DOI 10.1093/emboj/18.19.5264; Boyko AR, 2009, P NATL ACAD SCI USA, V106, P13903, DOI 10.1073/pnas.0902129106; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Cruz F, 2008, MOL BIOL EVOL, V25, P2331, DOI 10.1093/molbev/msn177; DAYAN T, 1994, J ARCHAEOL SCI, V21, P633, DOI 10.1006/jasc.1994.1062; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Germonpre M, 2009, J ARCHAEOL SCI, V36, P473, DOI 10.1016/j.jas.2008.09.033; Gray MM, 2009, GENETICS, V181, P1493, DOI 10.1534/genetics.108.098830; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Macdonald D., 1993, MAMMALS BRITAIN EURO; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Parker HG, 2007, GENOME RES, V17, P1562, DOI 10.1101/gr.6772807; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Verginelli F, 2005, MOL BIOL EVOL, V22, P2541, DOI 10.1093/molbev/msi248; Vila C, 2005, TRENDS GENET, V21, P214, DOI 10.1016/j.tig.2005.02.004; Vila C, 1999, J HERED, V90, P71, DOI 10.1093/jhered/90.1.71; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; Wilcox B, 1995, ATLAS DOG BREEDS WOR	37	509	521	10	516	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					898	U109		10.1038/nature08837	http://dx.doi.org/10.1038/nature08837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20237475	Green Accepted			2022-12-24	WOS:000276397300039
J	Hafner, M; Landthaler, M; Burger, L; Khorshid, M; Hausser, J; Berninger, P; Rothballer, A; Ascano, M; Jungkamp, AC; Munschauer, M; Ulrich, A; Wardle, GS; Dewell, S; Zavolan, M; Tuschl, T				Hafner, Markus; Landthaler, Markus; Burger, Lukas; Khorshid, Mohsen; Hausser, Jean; Berninger, Philipp; Rothballer, Andrea; Ascano, Manuel, Jr.; Jungkamp, Anna-Carina; Munschauer, Mathias; Ulrich, Alexander; Wardle, Greg S.; Dewell, Scott; Zavolan, Mihaela; Tuschl, Thomas			Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP	CELL			English	Article							HETEROGENEOUS NUCLEAR-RNA; MAMMALIAN MESSENGER-RNAS; CROSS-LINKING; RIBONUCLEOPROTEIN COMPLEXES; ULTRAVIOLET-LIGHT; GENE-EXPRESSION; C. ELEGANS; CELLS; TRANSLATION; FAMILY	RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.	[Burger, Lukas; Khorshid, Mohsen; Hausser, Jean; Berninger, Philipp; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Hafner, Markus; Landthaler, Markus; Rothballer, Andrea; Ascano, Manuel, Jr.; Jungkamp, Anna-Carina; Munschauer, Mathias; Ulrich, Alexander; Wardle, Greg S.; Tuschl, Thomas] Rockefeller Univ, Lab RNA Mol Biol, Howard Hughes Med Inst, New York, NY 10065 USA; [Burger, Lukas; Khorshid, Mohsen; Hausser, Jean; Berninger, Philipp; Zavolan, Mihaela] SIB, CH-4056 Basel, Switzerland; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA	University of Basel; Howard Hughes Medical Institute; Rockefeller University; Swiss Institute of Bioinformatics; Rockefeller University	Zavolan, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	mihaela.zavolan@unibas.ch; ttuschl@rockefeller.edu	Landthaler, Markus/A-1427-2010; Munschauer, Mathias/AAK-2789-2020; Hafner, Markus/O-7100-2018; Zavolan, Mihaela/S-3888-2016; Ascano, Manuel/ABA-3586-2020	Landthaler, Markus/0000-0002-1075-8734; Munschauer, Mathias/0000-0001-6143-4548; Hafner, Markus/0000-0002-4336-6518; Ascano, Manuel/0000-0002-9370-5493; Ulrich, Alexander Konstantin Christian/0000-0003-4255-4856; Hausser, Jean/0000-0002-3321-7199; Zavolan, Mihaela/0000-0002-8832-2041	Deutscher Akademischer Austauschdienst (DAAD); Swiss National Fund [3100A0-114001]; NIH [GM073047]; Starr Foundation [MH08442]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM073047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080442] Funding Source: NIH RePORTER	Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Swiss National Fund(Swiss National Science Foundation (SNSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank V. Hovestadt for his help with the analysis of the crosslinking positions within miRNAs. We are grateful to W. Zhang and C. Zhao (Genomics Resource Center) for mRNA array analysis and Solexa sequencing. We thank Millipore for the antibodies. We thank members of the Tuschl laboratory for comments on the manuscript. M. H. is supported by the Deutscher Akademischer Austauschdienst (DAAD). This work was supported by the Swiss National Fund Grant # 3100A0-114001 to M. Z.; T. T. is an HHMI investigator, and work in his laboratory was supported by NIH grants GM073047 and MH08442 and the Starr Foundation.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Chenard CA, 2008, J NEUROSCI RES, V86, P233, DOI 10.1002/jnr.21485; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Dimitriadis E, 2007, INT J CANCER, V121, P486, DOI 10.1002/ijc.22716; DREYFUSS G, 1984, MOL CELL BIOL, V4, P1104, DOI 10.1128/MCB.4.6.1104; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; FAVRE A, 1986, BIOCHEM BIOPH RES CO, V141, P847, DOI 10.1016/S0006-291X(86)80250-9; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; GREENBERG JR, 1979, NUCLEIC ACIDS RES, V6, P715, DOI 10.1093/nar/6.2.715; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kirino Y, 2008, RNA, V14, P2254, DOI 10.1261/rna.1133808; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; MAYRAND S, 1981, J CELL BIOL, V90, P380, DOI 10.1083/jcb.90.2.380; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Meisenheimer KM, 1997, CRIT REV BIOCHEM MOL, V32, P101, DOI 10.3109/10409239709108550; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; WAGENMAKERS AJM, 1980, EUR J BIOCHEM, V112, P323, DOI 10.1111/j.1432-1033.1980.tb07207.x; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	59	2020	2092	13	242	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					129	141		10.1016/j.cell.2010.03.009	http://dx.doi.org/10.1016/j.cell.2010.03.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371350	Green Accepted, Bronze			2022-12-24	WOS:000276211100018
J	Ito, T; Ando, H; Suzuki, T; Ogura, T; Hotta, K; Imamura, Y; Yamaguchi, Y; Handa, H				Ito, Takumi; Ando, Hideki; Suzuki, Takayuki; Ogura, Toshihiko; Hotta, Kentaro; Imamura, Yoshimasa; Yamaguchi, Yuki; Handa, Hiroshi			Identification of a Primary Target of Thalidomide Teratogenicity	SCIENCE			English	Article							UBIQUITIN LIGASE; MULTIPLE-MYELOMA; LIMB DEFECTS; DNA-DAMAGE; OUTGROWTH; EXPRESSION; ZEBRAFISH; PATHWAY; ORIGIN; CELLS	Half a century ago, thalidomide was widely prescribed to pregnant women as a sedative but was found to be teratogenic, causing multiple birth defects. Today, thalidomide is still used in the treatment of leprosy and multiple myeloma, although how it causes limb malformation and other developmental defects is unknown. Here, we identified cereblon (CRBN) as a thalidomide-binding protein. CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks. Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the associated ubiquitin ligase activity. This study reveals a basis for thalidomide teratogenicity and may contribute to the development of new thalidomide derivatives without teratogenic activity.	[Ito, Takumi; Handa, Hiroshi] Tokyo Inst Technol, Integrated Res Inst, Yokohama, Kanagawa 2268503, Japan; [Ando, Hideki; Hotta, Kentaro; Yamaguchi, Yuki; Handa, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Suzuki, Takayuki; Ogura, Toshihiko] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Suzuki, Takayuki] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Imamura, Yoshimasa] Astellas Pharma Inc, Drug Discovery Res, Tsukuba 3058585, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Tohoku University; Japan Science & Technology Agency (JST); Astellas Pharmaceuticals	Handa, H (corresponding author), Tokyo Inst Technol, Integrated Res Inst, Yokohama, Kanagawa 2268503, Japan.	handa.h.aa@m.titech.ac.jp	Yamaguchi, Yuki/B-9390-2015	Yamaguchi, Yuki/0000-0002-0197-614X; Ito, Takumi/0000-0002-9997-2664	JST; Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [20370084, 21770226]; New Energy and Technology Development Organization	JST(Japan Science & Technology Agency (JST)); Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Technology Development Organization	We thank T. Wada, S. Sakamoto, and S. Ishihara for discussions; P. Raychaudhuri, T. Matsunaga, S. Krauss, B. Thisse, A. Kawakami, S. Noji, J. Izpisua-Belmonte, K. Kawakami, and J. Yamauchi for valuable reagents; Y. Tsuboi for technical support; and P. Sharp and A. Berk for comments on this manuscript. This work was supported by Special Coordination Funds for Promoting Science and Technology from JST, by the Global COE (Center of Excellence) Program from the Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT), and by a grant for Research and Development Projects in Cooperation with Academic Institutions from the New Energy and Technology Development Organization (H. H. and H. A.). This work was also supported by grants-in-aid for Scientific Research (20370084 to T. O.) and for Young Scientists (21770226 to T. S.) from MEXT and by the Precursory Research for Embryonic Science and Technology program from JST (T. S.). T. I. was a Japan Society for the Promotion of Science Research Fellow. An application for a patent has been filed in the Japan Patent Office.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Cang Y, 2007, P NATL ACAD SCI USA, V104, P2733, DOI 10.1073/pnas.0611311104; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Chung F, 2004, CLIN CANCER RES, V10, P5949, DOI 10.1158/1078-0432.CCR-04-0421; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; Franks ME, 2004, LANCET, V363, P1802, DOI 10.1016/S0140-6736(04)16308-3; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Gupta D, 2001, LEUKEMIA, V15, P1950, DOI 10.1038/sj.leu.2402295; Hansen JM, 2002, DEV DYNAM, V225, P186, DOI 10.1002/dvdy.10150; HIGGINS JJ, 1927, NEUROLOGY, V63, P2004; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Knobloch J, 2008, CELL CYCLE, V7, P1121, DOI 10.4161/cc.7.9.5793; Knobloch J, 2007, FASEB J, V21, P1410, DOI 10.1096/fj.06-7603com; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Melchert M, 2007, INT J BIOCHEM CELL B, V39, P1489, DOI 10.1016/j.biocel.2007.01.022; Miller MT, 1999, TERATOLOGY, V60, P306, DOI 10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Parman T, 1999, NAT MED, V5, P582, DOI 10.1038/8466; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Sakamoto S, 2009, CHEM REC, V9, P66, DOI 10.1002/tcr.20170; SHESKIN J, 1965, CLIN PHARMACOL THER, V6, P303; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Streit A, 2001, J ANAT, V199, P99, DOI 10.1017/S0021878201008263; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Tanaka M, 2002, NATURE, V416, P527, DOI 10.1038/416527a; Therapontos C, 2009, P NATL ACAD SCI USA, V106, P8573, DOI 10.1073/pnas.0901505106; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; Yabu T, 2005, BLOOD, V106, P125, DOI 10.1182/blood-2004-09-3679; Zeldis JB, 1999, CLIN THER, V21, P319, DOI 10.1016/S0149-2918(00)88289-2	36	1164	1250	21	378	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1345	1350		10.1126/science.1177319	http://dx.doi.org/10.1126/science.1177319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223979				2022-12-24	WOS:000275418700032
J	Najafi-Shoushtari, SH; Kristo, F; Li, YX; Shioda, T; Cohen, DE; Gerszten, RE; Naar, AM				Najafi-Shoushtari, S. Hani; Kristo, Fjoralba; Li, Yingxia; Shioda, Toshi; Cohen, David E.; Gerszten, Robert E.; Naeaer, Anders M.			MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis	SCIENCE			English	Article							IN-VIVO; INTRONIC MICRORNAS; METABOLISM; ABCA1; ATHEROSCLEROSIS; COEXPRESSION; MECHANISM; TRANSPORT; EFFLUX; LIVER	Proper coordination of cholesterol biosynthesis and trafficking is essential to human health. The sterol regulatory element-binding proteins (SREBPs) are key transcription regulators of genes involved in cholesterol biosynthesis and uptake. We show here that microRNAs (miR-33a/b) embedded within introns of the SREBP genes target the adenosine triphosphate-binding cassette transporter A1 (ABCA1), an important regulator of high-density lipoprotein (HDL) synthesis and reverse cholesterol transport, for posttranscriptional repression. Antisense inhibition of miR-33 in mouse and human cell lines causes up-regulation of ABCA1 expression and increased cholesterol efflux, and injection of mice on a western-type diet with locked nucleic acid-antisense oligonucleotides results in elevated plasma HDL. Our findings indicate that miR-33 acts in concert with the SREBP host genes to control cholesterol homeostasis and suggest that miR-33 may represent a therapeutic target for ameliorating cardiometabolic diseases.	[Najafi-Shoushtari, S. Hani; Shioda, Toshi; Naeaer, Anders M.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Najafi-Shoushtari, S. Hani; Naeaer, Anders M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Kristo, Fjoralba; Gerszten, Robert E.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Li, Yingxia; Cohen, David E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Gastroenterol, Boston, MA 02115 USA; [Gerszten, Robert E.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Naar, AM (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	naar@helix.mgh.harvard.edu		Najafi-Shoushtari, Hani/0000-0002-7562-4083; Kristo, Fjoralba/0000-0002-8045-9756	NIH [R01GM071449, R21DK084459, R01DK56626, R01DK48873, P30 DK34854]; American Heart Association; Fondation Leducq; Massachusetts Biomedical Research Corporation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK084459, R01DK056626, P30DK034854, R37DK048873, R01DK048873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071449] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fondation Leducq(Leducq Foundation); Massachusetts Biomedical Research Corporation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Vasudevan and A. Walker for critical reading of the manuscript and K. Coser for technical assistance. This work was supported by the following funding sources: NIH R01GM071449 and R21DK084459 (A.M.N.), R01DK56626, R01DK48873, and P30 DK34854 (D. E. C.), American Heart Association Established Investigator Award (R. E. G.), the Fondation Leducq (R. E. G.), and Massachusetts Biomedical Research Corporation Tosteson Fellowship Award (S.H.N.-S.). A.M.N. and Massachusetts General Hospital have filed a patent application relating to the therapeutic use of antisense oligonucleotides directed against miR-33.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Wang D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004421; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942	29	733	787	0	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1566	1569		10.1126/science.1189123	http://dx.doi.org/10.1126/science.1189123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20466882	Green Accepted			2022-12-24	WOS:000278859200049
J	Nelson, KE; Weinstock, GM; Highlander, SK; Worley, KC; Creasy, HH; Wortman, JR; Rusch, DB; Mitreva, M; Sodergren, E; Chinwalla, AT; Feldgarden, M; Gevers, D; Haas, BJ; Madupu, R; Ward, DV; Birren, B; Gibbs, RA; Methe, B; Petrosino, JF; Strausberg, RL; Sutton, GG; White, OR; Wilson, RK; Durkin, S; Gujja, S; Howarth, C; Kodira, CD; Kyrpides, N; Madupu, R; Mehta, T; Mitreva, M; Muzny, DM; Pearson, M; Pepin, K; Pati, A; Qin, X; Yandava, C; Zeng, QD; Zhang, L; Berlin, AM; Chen, L; Hepburn, TA; Johnson, J; McCorrison, J; Miller, J; Minx, P; Nusbaum, C; Russ, C; Sutton, GG; Sykes, SM; Tomlinson, CM; Young, S; Warren, WC; Badger, J; Crabtree, J; Madupu, R; Markowitz, VM; Orvis, J; Rusch, DB; Sutton, GG; Cree, A; Ferriera, S; Gillis, M; Hemphill, LD; Joshi, V; Kovar, C; Wetterstrand, KA; Abouellleil, A; Wollam, AM; Buhay, CJ; Ding, Y; Dugan, S; Fulton, LL; Fulton, RS; Holder, M; Hostetler, J; Sutton, GG; Allen-Vercoe, E; Badger, J; Clifton, SW; Earl, AM; Farmer, CN; Giglio, MG; Liolios, K; Surette, MG; Sutton, GG; Torralba, M; Xu, Q; Pohl, C; Durkin, S; Sutton, GG; Wilczek-Boney, K; Zhu, DH				Nelson, Karen E.; Weinstock, George M.; Highlander, Sarah K.; Worley, Kim C.; Creasy, Heather Huot; Wortman, Jennifer Russo; Rusch, Douglas B.; Mitreva, Makedonka; Sodergren, Erica; Chinwalla, Asif T.; Feldgarden, Michael; Gevers, Dirk; Haas, Brian J.; Madupu, Ramana; Ward, Doyle V.; Birren, BruceW.; Gibbs, Richard A.; Methe, Barbara; Petrosino, Joseph F.; Strausberg, Robert L.; Sutton, Granger G.; White, Owen R.; Wilson, Richard K.; Durkin, Scott; Gujja, Sharvari; Howarth, Clint; Kodira, Chinnappa D.; Kyrpides, Nikos; Madupu, Ramana; Mehta, Teena; Mitreva, Makedonka; Muzny, Donna M.; Pearson, Matthew; Pepin, Kymberlie; Pati, Amrita; Qin, Xiang; Yandava, Chandri; Zeng, Qiandong; Zhang, Lan; Berlin, Aaron M.; Chen, Lei; Hepburn, Theresa A.; Johnson, Justin; McCorrison, Jamison; Miller, Jason; Minx, Pat; Nusbaum, Chad; Russ, Carsten; Sutton, Granger G.; Sykes, Sean M.; Tomlinson, Chad M.; Young, Sarah; Warren, Wesley C.; Badger, Jonathan; Crabtree, Jonathan; Madupu, Ramana; Markowitz, Victor M.; Orvis, Joshua; Rusch, Douglas B.; Sutton, Granger G.; Cree, Andrew; Ferriera, Steve; Gillis, Marcus; Hemphill, Lisa D.; Joshi, Vandita; Kovar, Christie; Wetterstrand, Kris A.; Abouellleil, Amr; Wollam, Aye M.; Buhay, Christian J.; Ding, Yan; Dugan, Shannon; Fulton, Lucinda L.; Fulton, Robert S.; Holder, Mike; Hostetler, Jessica; Sutton, Granger G.; Allen-Vercoe, Emma; Badger, Jonathan; Clifton, Sandra W.; Earl, Ashlee M.; Farmer, Candace N.; Giglio, Michelle Gwinn; Liolios, Konstantinos; Surette, Michael G.; Sutton, Granger G.; Torralba, Manolito; Xu, Qiang; Pohl, Craig; Durkin, Scott; Sutton, Granger G.; Wilczek-Boney, Katarzyna; Zhu, Dianhui		Human Microbiome Jumpstart	A Catalog of Reference Genomes from the Human Microbiome	SCIENCE			English	Article							GUT MICROBIOME; PAN-GENOME	The human microbiome refers to the community of microorganisms, including prokaryotes, viruses, and microbial eukaryotes, that populate the human body. The National Institutes of Health launched an initiative that focuses on describing the diversity of microbial species that are associated with health and disease. The first phase of this initiative includes the sequencing of hundreds of microbial reference genomes, coupled to metagenomic sequencing from multiple body sites. Here we present results from an initial reference genome sequencing of 178 microbial genomes. From 547,968 predicted polypeptides that correspond to the gene complement of these strains, previously unidentified ("novel") polypeptides that had both unmasked sequence length greater than 100 amino acids and no BLASTP match to any nonreference entry in the nonredundant subset were defined. This analysis resulted in a set of 30,867 polypeptides, of which 29,987 (similar to 97%) were unique. In addition, this set of microbial genomes allows for similar to 40% of random sequences from the microbiome of the gastrointestinal tract to be associated with organisms based on the match criteria used. Insights into pan-genome analysis suggest that we are still far from saturating microbial species genetic data sets. In addition, the associated metrics and standards used by our group for quality assurance are presented.	[Nelson, Karen E.; Rusch, Douglas B.; Methe, Barbara; Strausberg, Robert L.; Sutton, Granger G.; Durkin, Scott; Johnson, Justin; McCorrison, Jamison; Miller, Jason; Ferriera, Steve; Gillis, Marcus; Hostetler, Jessica; Torralba, Manolito] J Craig Venter Inst, Rockville, MD 20850 USA; [Weinstock, George M.; Mitreva, Makedonka; Sodergren, Erica; Chinwalla, Asif T.; Wilson, Richard K.; Pepin, Kymberlie; Chen, Lei; Minx, Pat; Tomlinson, Chad M.; Warren, Wesley C.; Wollam, Aye M.; Fulton, Lucinda L.; Fulton, Robert S.; Clifton, Sandra W.; Farmer, Candace N.; Pohl, Craig] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA; [Highlander, Sarah K.; Worley, Kim C.; Gibbs, Richard A.; Petrosino, Joseph F.; Muzny, Donna M.; Qin, Xiang; Zhang, Lan; Cree, Andrew; Hemphill, Lisa D.; Joshi, Vandita; Kovar, Christie; Buhay, Christian J.; Ding, Yan; Dugan, Shannon; Holder, Mike; Wilczek-Boney, Katarzyna; Zhu, Dianhui] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Highlander, Sarah K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Gibbs, Richard A.; Qin, Xiang; Zhang, Lan; Cree, Andrew; Hemphill, Lisa D.; Joshi, Vandita; Kovar, Christie; Buhay, Christian J.; Ding, Yan; Dugan, Shannon; Holder, Mike; Wilczek-Boney, Katarzyna; Zhu, Dianhui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Creasy, Heather Huot; Wortman, Jennifer Russo; White, Owen R.; Crabtree, Jonathan; Orvis, Joshua; Giglio, Michelle Gwinn] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Genet, Dept Med, Baltimore, MD 21201 USA; [Feldgarden, Michael; Gevers, Dirk; Haas, Brian J.; Ward, Doyle V.; Birren, BruceW.; Gujja, Sharvari; Howarth, Clint; Mehta, Teena; Mitreva, Makedonka; Pearson, Matthew; Yandava, Chandri; Zeng, Qiandong; Berlin, Aaron M.; Hepburn, Theresa A.; Nusbaum, Chad; Russ, Carsten; Sykes, Sean M.; Young, Sarah; Abouellleil, Amr; Earl, Ashlee M.] Broad Inst, Genome Sequencing & Anal Program, Cambridge, MA 02142 USA; Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; [Kodira, Chinnappa D.] Genome Sequencing & Anal Program, Branford, CT 06405 USA; [Kyrpides, Nikos; Pati, Amrita; Liolios, Konstantinos] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Badger, Jonathan] J Craig Venter Inst, La Jolla, CA 92121 USA; [Markowitz, Victor M.] Univ Calif Berkeley, Lawrence Berkeley Lab, Biol Data Management & Technol Ctr, Berkeley, CA 94720 USA; [Wetterstrand, Kris A.] NHGRI, Bethesda, MD 20892 USA; [Allen-Vercoe, Emma] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Surette, Michael G.] Univ Calgary, Calgary, AB T2N 4N1, Canada; [Xu, Qiang] Osel Inc, Santa Clara, CA 95054 USA	J. Craig Venter Institute; Washington University (WUSTL); Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Maryland; University of Maryland Baltimore; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; J. Craig Venter Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Guelph; University of Calgary	Nelson, KE (corresponding author), J Craig Venter Inst, 9704 Med Ctr Dr, Rockville, MD 20850 USA.	kenelson@jcvi.org	Gevers, Dirk/C-1451-2009; Weinstock, George M/C-6314-2013; Berlin, Aaron M/AFY-6549-2022; Wilson, Richard K./AAF-4139-2019; Kyrpides, Nikos C./A-6305-2014; Petrosino, Joseph F./AAF-1621-2019; Zeng, Qiandong/AAF-3305-2019; Surette, Michael G/AAE-8825-2020	Weinstock, George M/0000-0002-2997-4592; Berlin, Aaron M/0000-0002-0714-2808; Wilson, Richard K./0000-0002-1992-1358; Kyrpides, Nikos C./0000-0002-6131-0462; Chinwalla, Asif/0000-0001-7831-3996; Worley, Kim/0000-0002-0282-1000; Earl, Ashlee/0000-0001-7857-9145; Wortman, Jennifer/0000-0002-8713-1227; Mitreva, Makedonka/0000-0001-9572-3436	NIH [N01 AI 30071, U54-AI084844, U54-HG003079, U54-HG004968, U54-HG003273, U54-HG004973, HHSN272200900017C, U54-HG004969]; Crohn's and Colitis Foundation of Canada; Fund for Scientific Research, Flanders (Belgium); Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968, U54HG003273, U54HG004973, U54HG003067, U54HG004969, U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI084844] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of Canada; Fund for Scientific Research, Flanders (Belgium)(FWO); Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors gratefully acknowledge J. Warren, J. Zhang, R. G. Fowler, P. Pham, D. Haft, J. Selengut, T. Davidsen, P. Goetz, D. Harkins, S. Shrivastava, S. Koren, B. Walenz, L. Foster, I. Singh, Y.-h. Rogers, and the J. Craig Venter Institute Joint Technology Center. We thank J. Xu, S.-P. Yang, and S. Schobel for bioinformatics support; the Broad Genome Sequencing Platform, Y. Han, V. Korchina, M. Scheel, R. Thornton and the BCM-HGSC production team, L. Courntey, C. Fronick, O. Hall, M. O'Laughlin, M. Cunningham, D. O'Brien, B. Theising, and the GCWU production team for sequencing; J. Gordon, F. Dewhirst, B. Wilson, B. White, R. Mandrell, M. Blaser, R. H. Stevens, S. Hillier, Y. Liu, Z. Shen, D. Schauer, J. Fox, M. Allison, C. D. Sibley, D. M. Saulnier, and G. R. Gibson for providing strains; and M. Y. Giovanni, C. L. Baker, V. Bonazzi, C. D. Deal, S. Garges, R. W. Karp, R. W. Lunsford, J. Peterson, M. Wright, T. T. Belachew, and C. R. Wellington for funding agency management. We acknowledge NIH for funding this project with grants to the J. Craig Venter Institute (grants N01 AI 30071 and U54-AI084844), Washington University (grants U54-HG003079 and U54-HG004968), Baylor College of Medicine (grants U54-HG003273 and U54-HG004973), and the Broad Institute (grants HHSN272200900017C and U54-HG004969). Funding for E. A.-V. was from the Crohn's and Colitis Foundation of Canada; D. G. had secondary affiliation at the Laboratory of Microbiology (WE 10), Department of Biochemistry and Microbiology, Faculty of Sciences, Ghent University, KL Ledeganckstraat 35, 9000 Ghent, Belgium, and is indebted to the Fund for Scientific Research, Flanders (Belgium), for a postdoctoral fellowship and research funding for the duration of this project; M. S. acknowledges the Canadian Cystic Fibrosis Foundation and the Canadian Institutes of Health Research for funding of his research for this project.	Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; GIOVANNI MY, GENOME SEQUENCING CT; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Konstantinidis KT, 2006, APPL ENVIRON MICROB, V72, P7286, DOI 10.1128/AEM.01398-06; Li WZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003375; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656	15	467	481	1	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					994	999		10.1126/science.1183605	http://dx.doi.org/10.1126/science.1183605			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20489017	Green Accepted			2022-12-24	WOS:000277877100032
J	Shields, JD; Kourtis, IC; Tomei, AA; Roberts, JM; Swartz, MA				Shields, Jacqueline D.; Kourtis, Iraklis C.; Tomei, Alice A.; Roberts, Joanna M.; Swartz, Melody A.			Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21	SCIENCE			English	Article							ROR-GAMMA-T; LYMPH-NODES; CCR7; CANCER; HOMEOSTASIS; MODULATION; ONTOGENY; DISPLAY	Tumor manipulation of host immunity is important for tumor survival and invasion. Many cancers secrete CCL21, a chemoattractant for various leukocytes and lymphoid tissue inducer cells, which drive lymphoid neogenesis. CCL21 expression by melanoma tumors in mice was associated with an immunotolerant microenvironment, which included the induction of lymphoid-like reticular stromal networks, an altered cytokine milieu, and the recruitment of regulatory leukocyte populations. In contrast, CCL21-deficient tumors induced antigen-specific immunity. CCL21-mediated immune tolerance was dependent on host rather than tumor expression of the CCL21 receptor, CCR7, and could protect distant, coimplanted CCL21-deficient tumors and even nonsyngeneic allografts from rejection. We suggest that by altering the tumor microenvironment, CCL21-secreting tumors shift the host immune response from immunogenic to tolerogenic, which facilitates tumor progression.	[Shields, Jacqueline D.; Kourtis, Iraklis C.; Tomei, Alice A.; Roberts, Joanna M.; Swartz, Melody A.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Swartz, MA (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland.	melody.swartz@epfl.ch	Swartz, Melody/B-7633-2009; Swartz, Melody A./F-9563-2011	Roberts, Joanna/0000-0003-0679-8976; Tomei, Alice/0000-0002-5059-6303	Swiss Cancer League; Swiss National Science Foundation; European Research Council; U.S. Department of Defense Breast Cancer Research	Swiss Cancer League; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); U.S. Department of Defense Breast Cancer Research(United States Department of Defense)	We thank G. Eberl for Rorc(gamma t)+/GFP and Rorc(gamma t)<SUP>GFP/GFP</SUP> mice, S. Luther for CCR7<SUP>-/-</SUP> mice, D. Hanahan for beta tumor cells, and D. Trono for lentiviral vector plasmids; S. Pradervand, A. Paillusson, D. Foretay, M. Pasquier, V. Borel, B. Dixon, and A. Jimenez for technical assistance; and J. Hubbell and G. Eberl for critical reading of the manuscript. Funding was provided by the Swiss Cancer League, the Swiss National Science Foundation, the European Research Council, and the U.S. Department of Defense Breast Cancer Research Program to M. A. S. The authors (except J. M. R.) have filed a patent application	Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Britschgi MR, 2008, J IMMUNOL, V181, P7681, DOI 10.4049/jimmunol.181.11.7681; Davalos-Misslitz ACM, 2007, EUR J IMMUNOL, V37, P613, DOI 10.1002/eji.200636656; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Joyce JA, 2003, CANCER CELL, V4, P393, DOI 10.1016/S1535-6108(03)00271-X; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; Krautwald S, 2004, IMMUNOLOGY, V112, P301, DOI 10.1111/j.1365-2567.2004.01859.x; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Menning A, 2007, EUR J IMMUNOL, V37, P1575, DOI 10.1002/eji.200737201; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Ochando JC, 2005, J IMMUNOL, V174, P6993, DOI 10.4049/jimmunol.174.11.6993; Peduto L, 2009, J IMMUNOL, V182, P5789, DOI 10.4049/jimmunol.0803974; Prendergast GC, 2008, ONCOGENE, V27, P3889, DOI 10.1038/onc.2008.35; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Varela JC, 2008, CANCER RES, V68, P6734, DOI 10.1158/0008-5472.CAN-08-0502; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638; Ziegler E, 2006, J AM SOC NEPHROL, V17, P2521, DOI 10.1681/ASN.2005070782; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	27	346	360	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2010	328	5979					749	752		10.1126/science.1185837	http://dx.doi.org/10.1126/science.1185837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20339029	Green Published			2022-12-24	WOS:000277357100039
J	Rahl, PB; Lin, CY; Seila, AC; Flynn, RA; McCuine, S; Burge, CB; Sharp, PA; Young, RA				Rahl, Peter B.; Lin, Charles Y.; Seila, Amy C.; Flynn, Ryan A.; McCuine, Scott; Burge, Christopher B.; Sharp, Phillip A.; Young, Richard A.			c-Myc Regulates Transcriptional Pause Release	CELL			English	Article							RNA-POLYMERASE-II; EMBRYONIC STEM-CELLS; HEAT-SHOCK GENES; INHIBITS P-TEFB; IN-VIVO; TERMINAL DOMAIN; DROSOPHILA-MELANOGASTER; PRODUCTIVE ELONGATION; SELF-RENEWAL; PROCESSING FACTORS	Recruitment of the RNA polymerase II (Pol II) transcription initiation apparatus to promoters by specific DNA-binding transcription factors is well recognized as a key regulatory step in gene expression. We report here that promoter-proximal pausing is a general feature of transcription by Pol II in mammalian cells and thus an additional step where regulation of gene expression occurs. This suggests that some transcription factors recruit the transcription apparatus to promoters, whereas others effect promoter-proximal pause release. Indeed, we find that the transcription factor c-Myc, a key regulator of cellular proliferation, plays a major role in Pol II pause release rather than Pol II recruitment at its target genes. We discuss the implications of these results for the role of c-Myc amplification in human cancer.	[Rahl, Peter B.; Lin, Charles Y.; McCuine, Scott; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lin, Charles Y.; Burge, Christopher B.; Sharp, Phillip A.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Seila, Amy C.; Flynn, Ryan A.; Sharp, Phillip A.] MIT, Koch Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012; Burge, Christopher B./AAH-2177-2020	Young, Richard A/0000-0001-8855-8647; Flynn, Ryan/0000-0001-5013-0442	National Institutes of Health [RO1-HG002668, RO1-GM34277, RO1-CA133404, 5-F32-HD051190]; National Cancer Institute [PO1-CA42063, P30-CA14051]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD051190] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA133404, R01CA146445, P01CA042063] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Garrett Frampton for help with Solexa data analysis; David Price for antibodies and discussions; Hiroshi Handa for antibodies; Tom Volkert, Jennifer Love, Jeong-Ah Kwon, and Sumeet Gupta at the Whitehead Institute Sequencing Core for help with Solexa sequencing; and John Lis and members of the Young, Sharp, and Burge laboratories for helpful discussions. This work was supported by grants RO1-HG002668 (R.A.Y.), RO1-GM34277 (P.A.S.), RO1-CA133404 (P.A.S.) from the National Institutes of Health, PO1-CA42063 from the National Cancer Institute (P.A.S.), and Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute (P.A.S.). A.C.S. was supported by a National Institutes of Health postdoctoral fellowship 5-F32-HD051190.	Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gargano B, 2007, CELL CYCLE, V6, P2031, DOI 10.4161/cc.6.16.4554; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; Hanyu-Nakamura K, 2008, NATURE, V451, P730, DOI 10.1038/nature06498; Hochheimer A, 2003, GENE DEV, V17, P1309, DOI 10.1101/gad.1099903; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lis JT, 2000, GENE DEV, V14, P792; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OBRIEN T, 1991, MOL CELL BIOL, V11, P5285, DOI 10.1128/MCB.11.10.5285; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang F, 2003, GENE DEV, V17, P748, DOI 10.1101/gad.1068203; Zhou MS, 2006, J VIROL, V80, P4781, DOI 10.1128/JVI.80.10.4781-4791.2006; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	77	899	930	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					432	445		10.1016/j.cell.2010.03.030	http://dx.doi.org/10.1016/j.cell.2010.03.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434984	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000277180800015
J	Kosmrlj, A; Read, EL; Qi, Y; Allen, TM; Altfeld, M; Deeks, SG; Pereyra, F; Carrington, M; Walker, BD; Chakraborty, AK				Kosmrlj, Andrej; Read, Elizabeth L.; Qi, Ying; Allen, Todd M.; Altfeld, Marcus; Deeks, Steven G.; Pereyra, Florencia; Carrington, Mary; Walker, Bruce D.; Chakraborty, Arup K.			Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; RESPONSES; PEPTIDE; BINDING; MOLECULES; ANTIGEN; CD4(+); LYMPHOCYTES; DIVERSITY; EPITOPES	Without therapy, most people infected with human immunodeficiency virus (HIV) ultimately progress to AIDS. Rare individuals ('elite controllers') maintain very low levels of HIV RNA without therapy, thereby making disease progression and transmission unlikely. Certain HLA class I alleles are markedly enriched in elite controllers, with the highest association observed for HLA-B57 (ref. 1). Because HLA molecules present viral peptides that activate CD8(+) T cells, an immune-mediated mechanism is probably responsible for superior control of HIV. Here we describe how the peptide-binding characteristics of HLA-B57 molecules affect thymic development such that, compared to other HLA-restricted T cells, a larger fraction of the naive repertoire of B57-restricted clones recognizes a viral epitope, and these T cells are more cross-reactive to mutants of targeted epitopes. Our calculations predict that such a T-cell repertoire imposes strong immune pressure on immunodominant HIV epitopes and emergent mutants, thereby promoting efficient control of the virus. Supporting these predictions, in a large cohort of HLA-typed individuals, our experiments show that the relative ability of HLA-B alleles to control HIV correlates with their peptide-binding characteristics that affect thymic development. Our results provide a conceptual framework that unifies diverse empirical observations, and have implications for vaccination strategies.	[Kosmrlj, Andrej; Read, Elizabeth L.; Allen, Todd M.; Altfeld, Marcus; Pereyra, Florencia; Carrington, Mary; Walker, Bruce D.; Chakraborty, Arup K.] Ragon Inst MGH MIT & Harvard, Boston, MA 02114 USA; [Kosmrlj, Andrej] MIT, Dept Phys, Cambridge, MA 02139 USA; [Read, Elizabeth L.; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Read, Elizabeth L.; Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Qi, Ying; Carrington, Mary] NCI Frederick, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA; [Deeks, Steven G.] Univ Calif San Francisco, San Francisco, CA 94110 USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Chakraborty, AK (corresponding author), Ragon Inst MGH MIT & Harvard, Boston, MA 02114 USA.	bwalker@partners.org; arupc@mit.edu	Altfeld, Marcus/AAE-7306-2019; Allen, Todd/F-5473-2011	Altfeld, Marcus/0000-0001-5972-2997; Allen, Todd/0000-0002-6609-1318; Read, Elizabeth/0000-0002-9186-284X; Kosmrlj, Andrej/0000-0001-6137-9200	Mark and Lisa Schwartz Foundation; National Institutes of Health (NIH); Philip T and Susan M Ragon Foundation; Jane Coffin Childs Foundation; Bill and Melinda Gates Foundation; NIAID; National Cancer Institute, NIH [HHSN261200800001E]; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZICBC011237, ZIABC010791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030914, P30AI060354] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD001022] Funding Source: NIH RePORTER	Mark and Lisa Schwartz Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip T and Susan M Ragon Foundation; Jane Coffin Childs Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Financial support was provided by the Mark and Lisa Schwartz Foundation, the National Institutes of Health (NIH) Director's Pioneer award (A. K. C.), Philip T and Susan M Ragon Foundation, Jane Coffin Childs Foundation (E. L. R.), the Bill and Melinda Gates Foundation, and the NIAID (B. D. W., T. M. A. and M. A.). This project has been funded in whole or in part with federal funds from the National Cancer Institute, NIH, under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Althaus CL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000103; Bhalerao J, 1998, HUM MOL GENET, V7, P1537, DOI 10.1093/hmg/7.10.1537; Bowness P, 2002, RHEUMATOLOGY, V41, P857, DOI 10.1093/rheumatology/41.8.857; Cao JH, 2003, J IMMUNOL, V171, P3837, DOI 10.4049/jimmunol.171.7.3837; Chao DL, 2005, EUR J IMMUNOL, V35, P3452, DOI 10.1002/eji.200535098; Chessman D, 2008, IMMUNITY, V28, P822, DOI 10.1016/j.immuni.2008.04.020; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Gillespie GMA, 2002, AIDS, V16, P961, DOI 10.1097/00002030-200205030-00002; Gulukota K, 1997, J MOL BIOL, V267, P1258, DOI 10.1006/jmbi.1997.0937; HOSMER DW, 1989, BIOMETRICS, V45, P1265, DOI 10.2307/2531779; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kosmrlj A, 2008, P NATL ACAD SCI USA, V105, P16671, DOI 10.1073/pnas.0808081105; Kosmrlj A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.068103; de Castro JAL, 2007, IMMUNOL LETT, V108, P27, DOI 10.1016/j.imlet.2006.10.004; McKiernan SM, 2004, HEPATOLOGY, V40, P108, DOI 10.1002/hep.20261; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Naeher D, 2007, J EXP MED, V204, P2553, DOI 10.1084/jem.20070254; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; Parera M, 2007, MOL BIOL EVOL, V24, P382, DOI 10.1093/molbev/msl168; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Peters B, 2003, BIOINFORMATICS, V19, P1765, DOI 10.1093/bioinformatics/btg247; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127; Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Streeck H, 2009, J VIROL, V83, P7641, DOI 10.1128/JVI.00182-09; Thio CL, 2002, J VIROL, V76, P4792, DOI 10.1128/JVI.76.10.4792-4797.2002; Turnbull EL, 2006, J IMMUNOL, V176, P6130, DOI 10.4049/jimmunol.176.10.6130; Wodarz D, 2005, INT IMMUNOL, V17, P1269, DOI 10.1093/intimm/dxh303; Yu XG, 2007, J VIROL, V81, P1619, DOI 10.1128/JVI.01580-06	40	205	207	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2010	465	7296					350	U107		10.1038/nature08997	http://dx.doi.org/10.1038/nature08997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20445539	Green Accepted, Green Submitted			2022-12-24	WOS:000277829200041
J	Schwenk, J; Metz, M; Zolles, G; Turecek, R; Fritzius, T; Bildl, W; Tarusawa, E; Kulik, A; Unger, A; Ivankova, K; Seddik, R; Tiao, JY; Rajalu, M; Trojanova, J; Rohde, V; Gassmann, M; Schulte, U; Fakler, B; Bettler, B				Schwenk, Jochen; Metz, Michaela; Zolles, Gerd; Turecek, Rostislav; Fritzius, Thorsten; Bildl, Wolfgang; Tarusawa, Etsuko; Kulik, Akos; Unger, Andreas; Ivankova, Klara; Seddik, Riad; Tiao, Jim Y.; Rajalu, Mathieu; Trojanova, Johana; Rohde, Volker; Gassmann, Martin; Schulte, Uwe; Fakler, Bernd; Bettler, Bernhard			Native GABA(B) receptors are heteromultimers with a family of auxiliary subunits	NATURE			English	Article							K+ CHANNELS; AMPA RECEPTORS; CULTURED-CELLS; HCN CHANNELS; PROTEIN; RAT; EXPRESSION; RESPONSES; INHIBITION; COMPLEXES	GABA(B) receptors are the G-protein-coupled receptors for gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter in the brain. They are expressed in almost all neurons of the brain, where they regulate synaptic transmission and signal propagation by controlling the activity of voltage-gated calcium (Ca-v) and inward-rectifier potassium (K-ir) channels(1). Molecular cloning revealed that functional GABA(B) receptors are formed by the heteromeric assembly of GABA(B1) with GABA(B2) subunits(2-5). However, cloned GABA(B(1,2)) receptors failed to reproduce the functional diversity observed with native GABA(B) receptors(6-8). Here we show by functional proteomics that GABA(B) receptors in the brain are high-molecular-mass complexes of GABA(B1), GABA(B2) and members of a subfamily of the KCTD (potassium channel tetramerization domain-containing) proteins. KCTD proteins 8, 12, 12b and 16 show distinct expression profiles in the brain and associate tightly with the carboxy terminus of GABA(B2) as tetramers. This co-assembly changes the properties of the GABA(B(1,2)) core receptor: the KCTD proteins increase agonist potency and markedly alter the G-protein signalling of the receptors by accelerating onset and promoting desensitization in a KCTD-subtype-specific manner. Taken together, our results establish the KCTD proteins as auxiliary subunits of GABA(B) receptors that determine the pharmacology and kinetics of the receptor response.	[Schwenk, Jochen; Zolles, Gerd; Bildl, Wolfgang; Schulte, Uwe; Fakler, Bernd] Univ Freiburg, Inst Physiol 2, D-79108 Freiburg, Germany; [Metz, Michaela; Turecek, Rostislav; Fritzius, Thorsten; Ivankova, Klara; Seddik, Riad; Tiao, Jim Y.; Rajalu, Mathieu; Gassmann, Martin; Bettler, Bernhard] Univ Basel, Inst Physiol, Pharmazentrum, Dept Biomed, CH-4056 Basel, Switzerland; [Rohde, Volker; Schulte, Uwe] Logopharm GmbH, D-79108 Freiburg, Germany; [Tarusawa, Etsuko; Kulik, Akos; Unger, Andreas] Univ Freiburg, Inst Anat & Cell Biol, D-79104 Freiburg, Germany; [Fakler, Bernd] Ctr Biol Signaling Studies Bioss, D-79104 Freiburg, Germany; [Turecek, Rostislav; Trojanova, Johana] Acad Sci Czech Republic, Inst Expt Med, Prague 14220 4, Czech Republic	University of Freiburg; University of Basel; University of Freiburg; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Fakler, B (corresponding author), Univ Freiburg, Inst Physiol 2, Engesserstr 4, D-79108 Freiburg, Germany.	bernd.fakler@physiologie.uni-freiburg.de; bernhard.bettler@unibas.ch	Turecek, Rostislav/H-2706-2014; bettler, bernhard/AAO-8018-2020; Turecek, Rostislav/AAL-3523-2020	Turecek, Rostislav/0000-0003-4978-7556; Schwenk, Jochen/0000-0003-3664-9795; Bettler, Bernhard/0000-0003-0842-8207; Tiao, Jim/0000-0001-6692-9697; Gassmann, Martin/0000-0001-6201-3032	Deutsche Forschungsgemeinschaft [SFB 746/TP16, SFB 780/A3, EXC294, SFB 780/A2]; Wellcome Trust (ISRF); EU Synapse; GACR [309/06/1304]; Swiss Science Foundation [3100A0-117816]; Fridericus Stiftung; European Community [FP7/2007-2013, 201714]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust (ISRF)(Wellcome Trust); EU Synapse; GACR(Grant Agency of the Czech Republic); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Fridericus Stiftung; European Community(European Commission)	We thank J. P. Adelman and H. R. Brenner for discussions and critical reading of the manuscript, and A. Haupt and K. Kaupmann for help with bioinformatics and shRNA experiments, respectively. This work was supported by grants from the Deutsche Forschungsgemeinschaft to B. F. (SFB 746/TP16; SFB 780/A3; EXC294) and to A. K. (SFB 780/A2), by grants from the Wellcome Trust (ISRF), the EU Synapse and the GACR (309/06/1304) to R. T., and by grants from the Swiss Science Foundation (3100A0-117816), the Fridericus Stiftung and the European Community's 7th Framework Programme (FP7/2007-2013) under Grant Agreement 201714 to B. B.	Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; BONANNO G, 1993, TRENDS PHARMACOL SCI, V14, P259, DOI 10.1016/0165-6147(93)90124-3; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Deisz RA, 1997, SYNAPSE, V25, P62, DOI 10.1002/(SICI)1098-2396(199701)25:1<62::AID-SYN8>3.0.CO;2-D; Dittert I, 2006, J NEUROSCI METH, V151, P178, DOI 10.1016/j.jneumeth.2005.07.005; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Engle MP, 2006, NEUROSCIENCE, V138, P1277, DOI 10.1016/j.neuroscience.2005.11.064; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kulik A, 2006, J NEUROSCI, V26, P4289, DOI 10.1523/JNEUROSCI.4178-05.2006; Kulik A, 2003, J NEUROSCI, V23, P11026; Masugi-Tokita M, 2007, J NEUROSCI, V27, P2135, DOI 10.1523/JNEUROSCI.2861-06.2007; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Nicoll RA, 2004, BIOCHEM PHARMACOL, V68, P1667, DOI 10.1016/j.bcp.2004.07.024; OTIS TS, 1993, J PHYSIOL-LONDON, V463, P391, DOI 10.1113/jphysiol.1993.sp019600; Price CJ, 2008, J NEUROSCI, V28, P6974, DOI 10.1523/JNEUROSCI.4673-07.2008; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rivas G, 1999, METHODS, V19, P194, DOI 10.1006/meth.1999.0851; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wischmeyer E, 1997, MOL CELL NEUROSCI, V9, P194, DOI 10.1006/mcne.1997.0614; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	35	222	233	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2010	465	7295					231	U121		10.1038/nature08964	http://dx.doi.org/10.1038/nature08964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20400944				2022-12-24	WOS:000277558500038
J	Zhao, YF; Terry, D; Shi, L; Weinstein, H; Blanchard, SC; Javitch, JA				Zhao, Yongfang; Terry, Daniel; Shi, Lei; Weinstein, Harel; Blanchard, Scott C.; Javitch, Jonathan A.			Single-molecule dynamics of gating in a neurotransmitter transporter homologue	NATURE			English	Article							BACTERIAL HOMOLOG; LEUT; FLUORESCENCE; SUBSTRATE; BINDING; NA+; RNA; MECHANISM; REVEALS; PROTEIN	Neurotransmitter: Na+ symporters (NSS) remove neurotransmitters from the synapse in a reuptake process that is driven by the Na+ gradient. Drugs that interfere with this reuptake mechanism, such as cocaine and antidepressants, profoundly influence behaviour and mood. To probe the nature of the conformational changes that are associated with substrate binding and transport, we have developed a single-molecule fluorescence imaging assay and combined it with functional and computational studies of the prokaryotic NSS homologue LeuT. Here we show molecular details of the modulation of intracellular gating of LeuT by substrates and inhibitors, as well as by mutations that alter binding, transport or both. Our direct observations of single-molecule transitions, reflecting structural dynamics of the intracellular region of the transporter that might be masked by ensemble averaging or suppressed under crystallographic conditions, are interpreted in the context of an allosteric mechanism that couples ion and substrate binding to transport.	[Zhao, Yongfang; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Zhao, Yongfang; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Zhao, Yongfang; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Terry, Daniel; Shi, Lei; Weinstein, Harel; Blanchard, Scott C.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Shi, Lei; Weinstein, Harel] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute; Cornell University; Cornell University; Columbia University	Javitch, JA (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, 630 W 168th, New York, NY 10032 USA.	scb2005@med.cornell.edu; jaj2@columbia.edu	Shi, Lei/AAV-1321-2020; WEINSTEIN, HAREL/O-8245-2019; Zhao, Yongfang/B-5437-2010; Terry, Daniel/B-3521-2008; Blanchard, Scott C./A-5804-2009	Shi, Lei/0000-0002-4137-096X; WEINSTEIN, HAREL/0000-0003-3473-9818; Blanchard, Scott C./0000-0003-2717-9365; Terry, Daniel/0000-0001-9021-0084; Javitch, Jonathan/0000-0001-7395-2967	National Institutes of Health [DA17293, DA022413, DA12408, DA023694]; Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, P01DA012408, R01DA017293, K99DA023694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Altman for assistance with reagents for single-molecule experiments; F. Carvalho for the preparation of membranes; J. Munro for help measuring anisotropy; R. Dave for preliminary photobleaching optimization studies; and M. Quick for helpful discussion and comments on the manuscript. Molecular graphic figures and movies were prepared with PyMOL (DeLano Scientific; http://www.pymol.org). Computations were performed on Ranger at the Texas Advanced Computing Center (TG-MCB090022) and the David A. Cofrin computational infrastructure of the Institute for Computational Biomedicine at Weill Cornell Medical College. This work was supported in part by National Institutes of Health Grants DA17293 and DA022413 (J. A. J.), DA12408 (H. W.), and DA023694 (L. S.). D. S. T. is supported by the Tri-Institutional Training Program in Computational Biology and Medicine.	Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Blanchard SC, 2009, CURR OPIN STRUC BIOL, V19, P103, DOI 10.1016/j.sbi.2009.01.002; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Cornish PV, 2007, ACS CHEM BIOL, V2, P53, DOI 10.1021/cb600342a; Dave R, 2009, BIOPHYS J, V96, P2371, DOI 10.1016/j.bpj.2008.11.061; GU H, 1994, J BIOL CHEM, V269, P7124; Ha T, 2007, CELL, V129, P1249, DOI 10.1016/j.cell.2007.06.007; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Ishii Y, 2004, CURR PROTEIN PEPT SC, V5, P81, DOI 10.2174/1389203043486838; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; Jorgensen AM, 2007, CHEMMEDCHEM, V2, P827, DOI 10.1002/cmdc.200600243; KARSTENS T, 1980, J PHYS CHEM-US, V84, P1871, DOI 10.1021/j100451a030; Kinosita K Jr, 2000, Essays Biochem, V35, P3; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krause S, 2005, MOL PHARMACOL, V68, P1728, DOI 10.1124/mol.105.013870; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Majumdar DS, 2007, P NATL ACAD SCI USA, V104, P12640, DOI 10.1073/pnas.0700969104; MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Nie W, 2008, J MOL BIOL, V379, P695, DOI 10.1016/j.jmb.2008.04.015; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Park H, 2007, Q REV BIOPHYS, V40, P87, DOI 10.1017/S0033583507004611; Peterman EJG, 2004, ANNU REV PHYS CHEM, V55, P79, DOI 10.1146/annurev.physchem.55.091602.094340; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Rudnick G., 2002, MECH BIOGENIC AMINE; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sonders MS, 2005, CURR OPIN NEUROBIOL, V15, P296, DOI 10.1016/j.conb.2005.05.009; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; WILLIAMS ATR, 1983, ANALYST, V108, P1067, DOI 10.1039/an9830801067; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zhuang XW, 2005, ANNU REV BIOPH BIOM, V34, P399, DOI 10.1146/annurev.biophys.34.040204.144641	51	202	207	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					188	U73		10.1038/nature09057	http://dx.doi.org/10.1038/nature09057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463731	Green Accepted			2022-12-24	WOS:000277558500028
J	Kim, J; Lee, JE; Heynen-Genel, S; Suyama, E; Ono, K; Lee, K; Ideker, T; Aza-Blanc, P; Gleeson, JG				Kim, Joon; Lee, Ji Eun; Heynen-Genel, Susanne; Suyama, Eigo; Ono, Keiichiro; Lee, KiYoung; Ideker, Trey; Aza-Blanc, Pedro; Gleeson, Joseph G.			Functional genomic screen for modulators of ciliogenesis and cilium length	NATURE			English	Article							PHOSPHOLIPASE A(2); FIBROBLASTS; DISSECTION; MUTATIONS; PROTEINS; COMPLEX	Primary cilia are evolutionarily conserved cellular organelles that organize diverse signalling pathways(1,2). Defects in the formation or function of primary cilia are associated with a spectrum of human diseases and developmental abnormalities(3). Genetic screens in model organisms have discovered core machineries of cilium assembly and maintenance(4). However, regulatory molecules that coordinate the biogenesis of primary cilia with other cellular processes, including cytoskeletal organization, vesicle trafficking and cell-cell adhesion, remain to be identified. Here we report the results of a functional genomic screen using RNA interference (RNAi) to identify human genes involved in ciliogenesis control. The screen identified 36 positive and 13 negative ciliogenesis modulators, which include molecules involved in actin dynamics and vesicle trafficking. Further investigation demonstrated that blocking actin assembly facilitates ciliogenesis by stabilizing the pericentrosomal preciliary compartment (PPC), a previously uncharacterized compact vesiculotubular structure storing transmembrane proteins destined for cilia during the early phase of ciliogenesis. The PPC was labelled by recycling endosome markers. Moreover, knockdown of modulators that are involved in the endocytic recycling pathway affected the formation of the PPC as well as ciliogenesis. Our results uncover a critical regulatory step that couples actin dynamics and endocytic recycling with ciliogenesis, and also provides potential target molecules for future study.	[Kim, Joon; Lee, Ji Eun; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, Inst Genom Med, La Jolla, CA 92093 USA; [Kim, Joon; Lee, Ji Eun; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Pediat, Inst Genom Med, La Jolla, CA 92093 USA; [Heynen-Genel, Susanne; Suyama, Eigo; Aza-Blanc, Pedro] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Ono, Keiichiro; Lee, KiYoung; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ono, Keiichiro; Lee, KiYoung; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Lee, KiYoung] Ajou Univ, Sch Med, Dept Biomed Informat, Suwon 443749, South Korea	Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Ajou University	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, Inst Genom Med, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu	Kim, Joon/C-1833-2011	Ideker, Trey/0000-0002-1708-8454	UCSD Microscopy Core [P30 NS047101, P30 CA23100]; NARSAD; NINDS [RO1 NS052455]; NIH [GM070743]; Korea Food and Drug Administration [10182KFDA992]; Brain Research Center [M103KV010008-07K2201-00810]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096, R01NS052455, P30NS047101] Funding Source: NIH RePORTER	UCSD Microscopy Core; NARSAD(NARSAD); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); Brain Research Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The screen was performed at the Functional Genomics Core (LJINCC grant P30 NS057096 to S. Lipton) with technical assistance from A. Cortez and E. Sisman and with imaging support from the UCSD Microscopy Core (P30 NS047101 and P30 CA23100). We thank P. A. Beachy for the Smo-EGFP plasmid and J. F. Reiter for IFT88<SUP>orpk/orpk</SUP> MEFs. We thank C. Kintner, V. M. Fowler, S. J. Field and S. Ferro-Novick for discussion. This work was supported by grants from NARSAD (Young Investigator Award to J. K.), NINDS (RO1 NS052455 to J. G. G.), the NIH (GM070743 to T. I. and K. L.), the Korea Food and Drug Administration (10182KFDA992 to K. L.) and the Brain Research Center of the 21st Century Frontier Research Program (M103KV010008-07K2201-00810 to K. L.). J. G. G. is an investigator of the Howard Hughes Medical Institute.	ARCHER FL, 1971, J ANAT, V109, P277; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Christensen ST, 2008, CURR TOP DEV BIOL, V85, P261, DOI 10.1016/S0070-2153(08)00810-7; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Doyotte A, 2008, P NATL ACAD SCI USA, V105, P6308, DOI 10.1073/pnas.0707601105; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; HOPE WC, 1993, AGENTS ACTIONS, V39, pC39, DOI 10.1007/BF01972714; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Inoue H, 2008, MOL BIOL CELL, V19, P4224, DOI 10.1091/mbc.E08-03-0290; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sepulveda JL, 2006, CELL MOL LIFE SCI, V63, P25, DOI 10.1007/s00018-005-5355-1; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Valentin E, 2000, J BIOL CHEM, V275, P7492, DOI 10.1074/jbc.275.11.7492; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047	25	369	380	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1048	U114		10.1038/nature08895	http://dx.doi.org/10.1038/nature08895			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393563	Green Accepted, Green Published			2022-12-24	WOS:000276635000040
J	Krause, J; Fu, QM; Good, JM; Viola, B; Shunkov, MV; Derevianko, AP; Paabo, S				Krause, Johannes; Fu, Qiaomei; Good, Jeffrey M.; Viola, Bence; Shunkov, Michael V.; Derevianko, Anatoli P.; Paeaebo, Svante			The complete mitochondrial DNA genome of an unknown hominin from southern Siberia	NATURE			English	Article							SEQUENCE; ORIGIN; FLORES; AGE	With the exception of Neanderthals, from which DNA sequences of numerous individuals have now been determined(1), the number and genetic relationships of other hominin lineages are largely unknown. Here we report a complete mitochondrial (mt) DNA sequence retrieved from a bone excavated in 2008 in Denisova Cave in the Altai Mountains in southern Siberia. It represents a hitherto unknown type of hominin mtDNA that shares a common ancestor with anatomically modern human and Neanderthal mtDNAs about 1.0 million years ago. This indicates that it derives from a hominin migration out of Africa distinct from that of the ancestors of Neanderthals and of modern humans. The stratigraphy of the cave where the bone was found suggests that the Denisova hominin lived close in time and space with Neanderthals as well as with modern humans(2-4).	[Krause, Johannes; Fu, Qiaomei; Viola, Bence; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Good, Jeffrey M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Viola, Bence] Univ Vienna, Dept Anthropol, A-1090 Vienna, Austria; [Shunkov, Michael V.; Derevianko, Anatoli P.] Russian Acad Sci, Siberian Branch, Inst Archaeol & Ethnog, Paleolith Dept, RU-630090 Novosibirsk 17, Russia	Max Planck Society; University of Montana System; University of Montana; University of Vienna; Russian Academy of Sciences	Krause, J (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	krause@eva.mpg.de	Derevianko, Anatoly P./Q-5975-2016; Krause, Johannes/E-6640-2015; Shunkov, Mikhail V./Q-6576-2016; Viola, Bence/B-7390-2011; Krause, Johannes/AFP-2642-2022	Derevianko, Anatoly P./0000-0003-1156-8331; Krause, Johannes/0000-0001-5475-4690; Shunkov, Mikhail V./0000-0003-1388-2308; Krause, Johannes/0000-0001-9144-3920; Viola, Bence/0000-0001-8052-707X	Max Planck Society; NSF [OISE-0754461]	Max Planck Society(Max Planck SocietyFoundation CELLEX); NSF(National Science Foundation (NSF))	We thank A. W. Briggs, K. Finstermeier, R. E. Green, J.-J. Hublin, M. Kircher, A. I. Krivoshapkin, T. Maricic, M. Stoneking, A. Tsybonkov, L. Vigilant and V. Wiebe for comments, M. Meyer, the MPI-EVA sequencing group and M. Kircher for technical support, and the Presidential Innovation Fund of the Max Planck Society for financial support. J.M.G. was supported during this research by an NSF international postdoctoral fellowship (OISE-0754461).	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bermudez De Castro J. M., 1997, Science (Washington D C), V276, P1392, DOI 10.1126/science.276.5317.1392; Bolikhovskaya NS, 2006, PALEONTOL J+, V40, pS558, DOI 10.1134/S0031030106110025; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Caramelli D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002700; Derevianko AP, 2008, ARCHAEOL ETHNOL ANTH, V34, P13, DOI 10.1016/j.aeae.2008.07.002; Derevianko A.P., 1998, PALAEOLITHIC SIBERIA; Derevianko AP, 2000, ARCHAEOLOGY ETHNOLOG, V2, P33; Gabunia L, 2000, J HUM EVOL, V38, P785, DOI 10.1006/jhev.1999.0383; GOEBEL T, 1993, CURR ANTHROPOL, V34, P452, DOI 10.1086/204192; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Schoetensack O., 1908, UNTERKIEFER HOMOHEID; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; STRINGER C, 1997, R SOC ARTS J, V145, P111; Stringer CB, 1999, J HUM EVOL, V37, P873, DOI 10.1006/jhev.1999.0367; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; Tattersall I, 2009, P NATL ACAD SCI USA, V106, P16018, DOI 10.1073/pnas.0903207106; Viola TB, 2008, AM J PHYS ANTHROPOL, P214	29	457	495	14	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					894	897		10.1038/nature08976	http://dx.doi.org/10.1038/nature08976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20336068	hybrid			2022-12-24	WOS:000276397300038
J	Parekh, AK; Barton, MB				Parekh, Anand K.; Barton, Mary B.			The Challenge of Multiple Comorbidity for the US Health Care System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVALENCE; QUALITY		[Parekh, Anand K.] US Dept HHS, Off Assistant Secretary Hlth, Washington, DC 20201 USA; [Barton, Mary B.] US Dept HHS, Agcy Healthcare Res & Qual, Washington, DC 20201 USA	Agency for Healthcare Research & Quality	Parekh, AK (corresponding author), US Dept HHS, Off Assistant Secretary Hlth, 200 Independence Ave SW, Washington, DC 20201 USA.	anand.parekh@hhs.gov						Anderson G, CHRONIC CONDITIONS M; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Darer JD, 2004, ACAD MED, V79, P541, DOI 10.1097/00001888-200406000-00009; *DEP HLTH HUM SERV, OPT PREV HEALTHC MAN; Fortin M, 2006, ANN FAM MED, V4, P104, DOI 10.1370/afm.516; Lee TA, 2007, J GEN INTERN MED, V22, P403, DOI 10.1007/s11606-007-0277-2; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Warshaw G, 2006, GENERATIONS, V30, P5; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	10	169	170	2	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1303	1304		10.1001/jama.2010.381	http://dx.doi.org/10.1001/jama.2010.381			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579FM	20371790				2022-12-24	WOS:000276353700031
J	Lee, IM; Djousse, L; Sesso, HD; Wang, L; Buring, JE				Lee, I-Min; Djousse, Luc; Sesso, Howard D.; Wang, Lu; Buring, Julie E.			Physical Activity and Weight Gain Prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; LOW-DOSE ASPIRIN; WOMENS HEALTH; CARDIOVASCULAR-DISEASE; LOSS MAINTENANCE; EXERCISE; OBESITY; CANCER; ADULTS; FAT	Context The amount of physical activity needed to prevent long-term weight gain is unclear. In 2008, federal guidelines recommended at least 150 minutes per week (7.5 metabolic equivalent [MET] hours per week) of moderate-intensity activity for "substantial health benefits." Objective To examine the association of different amounts of physical activity with long-term weight changes among women consuming a usual diet. Design, Setting, and Participants A prospective cohort study involving 34 079 healthy US women (mean age, 54.2 years) from 1992-2007. At baseline and months 36, 72, 96, 120, 144, and 156, women reported their physical activity and body weight. Women were classified as expending less than 7.5, 7.5 to less than 21, and 21 or more MET hours per week of activity at each time. Repeated-measures regression prospectively examined physical activity and weight change over intervals averaging 3 years. Main Outcome Measure Change in weight. Results Women gained a mean of 2.6 kg throughout the study. A multivariate analysis comparing women expending 21 or more MET hours per week with those expending from 7.5 to less than 21 MET hours per week showed that the latter group gained a mean (SD) 0.11 kg (0.04 kg; P=.003) over a mean interval of 3 years, and those expending less than 7.5 MET hours per week gained 0.12 kg (0.04; P=.002). There was a significant interaction with body mass index (BMI), such that there was an inverse dose-response relation between activity levels and weight gain among women with a BMI of less than 25 (P for trend <.001) but no relation among women with a BMI from 25 to 29.9 (P for trend=.56) or with a BMI of 30.0 or higher (P for trend=.50). A total of 4540 women (13.3%) with a BMI lower than 25 at study start successfully maintained their weight by gaining less than 2.3 kg throughout. Their mean activity level over the study was 21.5 MET hours per week (approximate to 60 minutes a day of moderate-intensity activity). Conclusions Among women consuming a usual diet, physical activity was associated with less weight gain only among women whose BMI was lower than 25. Women successful in maintaining normal weight and gaining fewer than 2.3 kg over 13 years averaged approximately 60 minutes a day of moderate-intensity activity throughout the study. JAMA. 2010; 303(12): 1173-1179	[Lee, I-Min; Sesso, Howard D.; Wang, Lu; Buring, Julie E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med,Dept Med, Boston, MA 02215 USA; [Lee, I-Min; Buring, Julie E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; [Djousse, Luc] Boston Vet Affairs Healthcare Syst, Massachusetts Vet Epidemiol & Res Informat Ctr, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Lee, IM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med,Dept Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	ilee@rics.bwh.harvard.edu	Djousse, Luc/F-5033-2017; Lee, I-Min/ABD-5409-2021	Djousse, Luc/0000-0002-9902-3047; 	National Institutes of Health [CA047988, HL043851, HL080467, DK081141]; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851, R01HL080467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK081141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding/Support: This work was supported by grants CA047988, HL043851, HL080467, and DK081141 from the National Institutes of Health.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Blair SN, 2004, AM J CLIN NUTR, V79, P913; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Fogelholm M, 2000, Obes Rev, V1, P95, DOI 10.1046/j.1467-789x.2000.00016.x; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; He XXZ, 2004, AM J PREV MED, V27, P8, DOI 10.1016/j.amepre.2004.03.016; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Irwin ML, 2003, JAMA-J AM MED ASSOC, V289, P323, DOI 10.1001/jama.289.3.323; Jakicic JM, 2008, ARCH INTERN MED, V168, P1550, DOI 10.1001/archinte.168.14.1550; Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5; Katan MB, 2009, NEW ENGL J MED, V360, P923, DOI 10.1056/NEJMe0810291; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Lee I-M, 2009, EPIDEMIOLOGIC METHOD, P100; Lee IM, 2001, CANCER CAUSE CONTROL, V12, P137, DOI 10.1023/A:1008948125076; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lewis CE, 2000, AM J EPIDEMIOL, V151, P1172, DOI 10.1093/oxfordjournals.aje.a010167; McTiernan A, 2007, OBESITY, V15, P1496, DOI 10.1038/oby.2007.178; Mora S, 2006, JAMA-J AM MED ASSOC, V295, P1412, DOI 10.1001/jama.295.12.1412; Physical Activity Guidelines Committee, 2008, PHYS ACT GUID ADV CO; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x; Shaw K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003817.pub3; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Slentz CA, 2005, J APPL PHYSIOL, V99, P1613, DOI 10.1152/japplphysiol.00124.2005; StJeor ST, 1997, J AM DIET ASSOC, V97, P481, DOI 10.1016/S0002-8223(97)00126-0; Svetkey LP, 2008, JAMA-J AM MED ASSOC, V299, P1139, DOI 10.1001/jama.299.10.1139; Tataranni PA, 2003, INT J OBESITY, V27, P1578, DOI 10.1038/sj.ijo.0802469; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wareham NJ, 2005, P NUTR SOC, V64, P229, DOI 10.1079/PNS2005423; Weinstein AR, 2004, JAMA-J AM MED ASSOC, V292, P1188, DOI 10.1001/jama.292.10.1188; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	35	207	209	1	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2010	303	12					1173	1179		10.1001/jama.2010.312	http://dx.doi.org/10.1001/jama.2010.312			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573AC	20332403	Green Accepted, Bronze			2022-12-24	WOS:000275879600022
J	Hinde, CA; Johnstone, RA; Kilner, RM				Hinde, Camilla A.; Johnstone, Rufus A.; Kilner, Rebecca M.			Parent-Offspring Conflict and Coadaptation	SCIENCE			English	Article							MATERNAL TESTOSTERONE; HORMONES; GROWTH; EGGS; ECOLOGY; SIGNALS; BIRDS; YOLK	The evolution of family life has traditionally been studied in parallel by behavioral ecologists and quantitative geneticists. The former focus on parent-offspring conflict and whether parents or offspring control provisioning, whereas the latter concentrate on the coadaptation of parental supply and offspring demand. Here we show how prenatal effects on offspring begging can link the two different approaches. Using theoretical and experimental analyses, we show that when offspring control provisioning, prenatal effects primarily serve the parent's interests: Selection on parents drives coadaptation of parent and offspring traits. In contrast, when parents control provisioning, prenatal effects primarily serve the offspring's interests: Selection on the offspring drives coadaptation of parent and offspring traits. Parent-offspring conflict may thus be responsible for the selective forces that generate parent-offspring coadaptation.	[Hinde, Camilla A.; Johnstone, Rufus A.; Kilner, Rebecca M.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Hinde, CA (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.		Hinde, Camilla/G-4023-2012; Kilner, Rebecca/B-2867-2012; Hinde, Camilla/AAF-1597-2019	Hinde, Camilla/0000-0001-9376-4023; Kilner, Rebecca/0000-0003-1159-0758; Hinde, Camilla/0000-0001-9376-4023	Natural Environment Research Council (NERC); Magdalene College Cambridge; Wolfson Foundation; Royal Society; NERC [GR9/02650, GR9/04621, NER/A/S/2002/00776]; Isaac Newton Trust, Cambridge; Newnham College, Cambridge; Natural Environment Research Council [NER/A/S/2002/00776] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Magdalene College Cambridge; Wolfson Foundation; Royal Society(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Isaac Newton Trust, Cambridge; Newnham College, Cambridge; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	R. M. K. was supported by a Natural Environment Research Council (NERC) studentship, then a Junior Research Fellowship at Magdalene College Cambridge, a Royal Society Dorothy Hodgkin Research Fellowship (sponsored by the Wolfson Foundation), and finally a Royal Society University Research Fellowship. The experiments were funded by three NERC grants (GR9/02650, GR9/04621, and NER/A/S/2002/00776), which also supported C. A. H., and a Royal Society Equipment Grant. Additional funding for C. A. H. was provided by the Isaac Newton Trust, Cambridge, and a Junior Research Fellowship at Newnham College, Cambridge. We thank L. Barden, N. Bates, C. Donovan, P. Heavens, P. Hynes, I. Millar, J. Nightingale, and S. Shelton for their help in maintaining the birds and constructing equipment; T. Roberts, M. Wade, and J. Theaker for supplying the birds; and N. Davies, M. Clinchy, L. Zanette, and especially M. Klliker for comments on early drafts of the manuscript. R. M. K. conceived and designed the experiments, collected data, and wrote the paper. C. A. H. analyzed data and co- wrote the paper. R. A. J. contributed the theoretical analysis and co- wrote the paper.	Buchanan KL, 2007, HORM BEHAV, V52, P664, DOI 10.1016/j.yhbeh.2007.08.009; Drummond H, 2008, J AVIAN BIOL, V39, P139, DOI 10.1111/j.0908-8857.2008.04365.x; Falconer D. S, 1996, INTRO QUANTITATIVE G; Gebhardt-Henrich S., 1998, AVIAN GROWTH DEV, P324; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Hinde CA, 2009, P ROY SOC B-BIOL SCI, V276, P2787, DOI 10.1098/rspb.2009.0375; KILNER R, 1995, P ROY SOC B-BIOL SCI, V260, P343, DOI 10.1098/rspb.1995.0102; Kilner RM, 2008, ADV STUD BEHAV, V38, P283, DOI 10.1016/S0065-3454(08)00006-5; Kilner RM, 2001, P NATL ACAD SCI USA, V98, P11394, DOI 10.1073/pnas.191221798; Kilner RM, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P87, DOI 10.1007/0-306-47660-6_5; Kolliker M, 2005, AM NAT, V166, P506, DOI 10.1086/491687; Lock JE, 2004, AM NAT, V164, P13, DOI 10.1086/421444; Lock JE, 2007, AM NAT, V170, P709, DOI 10.1086/521963; Mock D. W., 1997, EVOLUTION SIBLING RI; Muller W, 2007, AM NAT, V169, pE84, DOI 10.1086/511962; Price T, 2007, SPECIATION BIRDS; Royle NJ, 2002, TRENDS ECOL EVOL, V17, P434, DOI 10.1016/S0169-5347(02)02565-X; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; Schwabl H, 1996, J EXP ZOOL, V276, P157, DOI 10.1002/(SICI)1097-010X(19961001)276:2<157::AID-JEZ9>3.3.CO;2-Y; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 1996, COMP BIOCHEM PHYS A, V114, P271, DOI 10.1016/0300-9629(96)00009-6; Smiseth PT, 2008, P ROY SOC B-BIOL SCI, V275, P1823, DOI 10.1098/rspb.2008.0199; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wolf JB, 1998, EVOLUTION, V52, P299, DOI [10.1111/j.1558-5646.1998.tb01632.x, 10.2307/2411068]	26	109	109	1	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	2010	327	5971					1373	1376		10.1126/science.1186056	http://dx.doi.org/10.1126/science.1186056			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223985				2022-12-24	WOS:000275418700040
J	Roesch, A; Fukunaga-Kalabis, M; Schmidt, EC; Zabierowski, SE; Brafford, PA; Vultur, A; Basu, D; Gimotty, P; Vogt, T; Herlyn, M				Roesch, Alexander; Fukunaga-Kalabis, Mizuho; Schmidt, Elizabeth C.; Zabierowski, Susan E.; Brafford, Patricia A.; Vultur, Adina; Basu, Devraj; Gimotty, Phyllis; Vogt, Thomas; Herlyn, Meenhard			A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth	CELL			English	Article							CANCER STEM-CELL; TRANSCRIPTIONAL REPRESSION; METASTATIC MELANOMA; GENE-EXPRESSION; BINDING; PLU-1; IDENTIFICATION; PROGRESSION; LEUKEMIA; REVEALS	Melanomas are highly heterogeneous tumors, but the biological significance of their different subpopulations is not clear. Using the H3K4 demethylase JARID1B (KDM5B/PLU-1/RBP2-H1) as a biomarker, we have characterized a small subpopulation of slow-cycling melanoma cells that cycle with doubling times of >4 weeks within the rapidly proliferating main population. Isolated JARID1B-positive melanoma cells give rise to a highly proliferative progeny. Knockdown of JARID1B leads to an initial acceleration of tumor growth followed by exhaustion which suggests that the JARID1B-positive subpopulation is essential for continuous tumor growth. Expression of JARID1B is dynamically regulated and does not follow a hierarchical cancer stem cell model because JARID1B-negative cells can become positive and even single melanoma cells irrespective of selection are tumorigenic. These results suggest a new understanding of melanoma heterogeneity with tumor maintenance as a dynamic process mediated by a temporarily distinct subpopulation.	[Roesch, Alexander; Fukunaga-Kalabis, Mizuho; Schmidt, Elizabeth C.; Zabierowski, Susan E.; Brafford, Patricia A.; Vultur, Adina; Basu, Devraj; Herlyn, Meenhard] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Basu, Devraj] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Gimotty, Phyllis] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Vogt, Thomas] Univ Regensburg, Med Ctr, Dept Dermatol, D-93053 Regensburg, Germany	The Wistar Institute; University of Pennsylvania; University of Pennsylvania; University of Regensburg	Herlyn, M (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	herlynm@wistar.org	Gimotty, Phyllis/GWZ-4136-2022; Hu, Ruogu/B-2203-2008	Gimotty, Phyllis/0000-0002-3850-9799; Vultur, Adina/0000-0003-0068-9496	NIH [P50 CA 093372, P01 CA 025874, R01 CA 047159, R01 CA 076674, P30 CA10815]; DFG [R3577/2-1]; NATIONAL CANCER INSTITUTE [R01CA076674, P50CA093372, R01CA047159, P30CA010815, P01CA025874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Hayden and F. Keeney (Wistar Microscopy Facility), D. C. Schultz (Wistar Protein Expression Facility), J. S. Faust, D. Ambrose, and D. Hussey (Wistar Flow Cytometry Facility) for technical support; L. Li, F. Raman, L. Kuenzel, T. Schifferstein, E. Herschberger, and A. Mueller for technical assistance, J. T. Lee for valuable discussion, and D. E. Elder (Hospital of the University of Pennsylvania) for providing patient material. The animals were housed at Wistar's Animal Facility. The research was funded by NIH grants P50 CA 093372, P01 CA 025874, R01 CA 047159, R01 CA 076674, P30 CA10815 and by the DFG grant R3577/ 2- 1.	Adams JM, 2008, CANCER RES, V68, P4018, DOI 10.1158/0008-5472.CAN-07-6334; Blagosklonny MV, 2005, CELL CYCLE, V4, P1693, DOI 10.4161/cc.4.12.2259; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dey BK, 2008, MOL CELL BIOL, V28, P5312, DOI 10.1128/MCB.00128-08; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Gogas HJ, 2007, CANCER-AM CANCER SOC, V109, P455, DOI 10.1002/cncr.22427; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grichnik JM, 2006, J INVEST DERMATOL, V126, P142, DOI 10.1038/sj.jid.5700017; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kageyama R, 2009, MOL CELLS, V27, P497, DOI 10.1007/s10059-009-0068-1; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roesch A, 2005, MODERN PATHOL, V18, P1249, DOI 10.1038/modpathol.3800413; Roesch A, 2008, INT J CANCER, V122, P1047, DOI 10.1002/ijc.23211; Roesch A, 2006, J INVEST DERMATOL, V126, P1850, DOI 10.1038/sj.jid.5700324; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Scibetta AG, 2007, MOL CELL BIOL, V27, P7220, DOI 10.1128/MCB.00274-07; Singh SK, 2003, CANCER RES, V63, P5821; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Vogt T, 1999, LAB INVEST, V79, P1615; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465	41	834	854	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					583	594		10.1016/j.cell.2010.04.020	http://dx.doi.org/10.1016/j.cell.2010.04.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478252	Bronze, Green Accepted			2022-12-24	WOS:000277623600012
J	Kolodkin-Gal, I; Romero, D; Cao, SG; Clardy, J; Kolter, R; Losick, R				Kolodkin-Gal, Ilana; Romero, Diego; Cao, Shugeng; Clardy, Jon; Kolter, Roberto; Losick, Richard			D-Amino Acids Trigger Biofilm Disassembly	SCIENCE			English	Article							BACILLUS-SUBTILIS	Bacteria form communities known as biofilms, which disassemble over time. In our studies outlined here, we found that, before biofilm disassembly, Bacillus subtilis produced a factor that prevented biofilm formation and could break down existing biofilms. The factor was shown to be a mixture of D-leucine, D-methionine, D-tyrosine, and D-tryptophan that could act at nanomolar concentrations. D-Amino acid treatment caused the release of amyloid fibers that linked cells in the biofilm together. Mutants able to form biofilms in the presence of D-Amino acids contained alterations in a protein (YqxM) required for the formation and anchoring of the fibers to the cell. D-Amino acids also prevented biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa. D-amino acids are produced by many bacteria and, thus, may be a widespread signal for biofilm disassembly.	[Kolodkin-Gal, Ilana; Losick, Richard] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Romero, Diego; Kolter, Roberto] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Cao, Shugeng; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Losick, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	losick@mcb.harvard.edu	Romero, Diego/D-3849-2013; Gal, Ilana Kolodkin/AFE-8494-2022	Romero, Diego/0000-0002-2052-6515; Gal, Ilana Kolodkin/0000-0002-8464-5660	NIH [GM58213, GM086258, CA24487, GM18546]; BASF; NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086258, R01GM058213, R01GM018568, F31GM018546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BASF(BASF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Norman for the analysis of table S2. I. K.-G. and D. R. are postdoctoral fellows of the Human Frontier Science Program and Fulbright/Ministerio de Educacion y Ciencia (Spain), respectively. This work was funded by NIH grants to R. K. (GM58213), J.C. (GM086258 and CA24487), and R. L. (GM18546), as well as grants from BASF to R. K. and R. L. Additionally, we have filed a patent application on the use of D-amino acids for biofilm disassembly.	Aguilar C, 2007, CURR OPIN MICROBIOL, V10, P638, DOI 10.1016/j.mib.2007.09.006; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; Yoshimura T, 2003, J BIOSCI BIOENG, V96, P103, DOI 10.1016/S1389-1723(03)90111-3	11	591	648	13	448	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					627	629		10.1126/science.1188628	http://dx.doi.org/10.1126/science.1188628			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431016	Green Accepted			2022-12-24	WOS:000277159800045
J	Rocks, O; Gerauer, M; Vartak, N; Koch, S; Huang, ZP; Pechlivanis, M; Kuhlmann, J; Brunsveld, L; Chandra, A; Ellinger, B; Waldmann, H; Bastiaens, PIH				Rocks, Oliver; Gerauer, Marc; Vartak, Nachiket; Koch, Sebastian; Huang, Zhi-Ping; Pechlivanis, Markos; Kuhlmann, Juergen; Brunsveld, Lucas; Chandra, Anchal; Ellinger, Bernhard; Waldmann, Herbert; Bastiaens, Philippe I. H.			The Palmitoylation Machinery Is a Spatially Organizing System for Peripheral Membrane Proteins	CELL			English	Article							CYSTEINE-RICH DOMAIN; PLASMA-MEMBRANE; STRUCTURAL DETERMINANTS; PALMITATE TURNOVER; H-RAS; GOLGI; TRAFFICKING; ACYLATION; PSD-95; FAMILY	Reversible S-palmitoylation of cysteine residues critically controls transient membrane tethering of peripheral membrane proteins. Little is known about how the palmitoylation machinery governs their defined localization and function. We monitored the spatially resolved reaction dynamics and substrate specificity of the core mammalian palmitoylation machinery using semisynthetic substrates. Palmitoylation is detectable only on the Golgi, whereas depalmitoylation occurs everywhere in the cell. The reactions are not stereoselective and lack any primary consensus sequence, demonstrating that substrate specificity is not essential for de-/repalmitoylation. Both palmitate attachment and removal require seconds to accomplish. This reaction topography and rapid kinetics allows the continuous redirection of mislocalized proteins via the post-Golgi sorting apparatus. Unidirectional secretion ensures the maintenance of a proper steady-state protein distribution between the Golgi and the plasma membrane, which are continuous with endosomes. This generic spatially organizing system differs from conventional receptor-mediated targeting mechanisms and efficiently counteracts entropy-driven redistribution of palmitoylated peripheral membrane proteins over all membranes.	[Gerauer, Marc; Koch, Sebastian; Huang, Zhi-Ping; Brunsveld, Lucas; Ellinger, Bernhard; Waldmann, Herbert] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44227 Dortmund, Germany; [Rocks, Oliver; Bastiaens, Philippe I. H.] European Mol Biol Lab, D-69118 Heidelberg, Germany; [Rocks, Oliver; Vartak, Nachiket; Chandra, Anchal; Bastiaens, Philippe I. H.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany; [Pechlivanis, Markos; Kuhlmann, Juergen] Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany; [Gerauer, Marc; Koch, Sebastian; Brunsveld, Lucas; Waldmann, Herbert; Bastiaens, Philippe I. H.] TU Dortmund, Fachbereich Chem, D-44227 Dortmund, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL); Max Planck Society; Max Planck Society; Dortmund University of Technology	Waldmann, H (corresponding author), Max Planck Inst Mol Physiol, Dept Biol Chem, Otto Hahn Str 11, D-44227 Dortmund, Germany.	herbert.waldmann@mpi-dortmund.mpg.de; philippe.bastiaens@mpi-dortmund.mpg.de	Vartak, Nachiket/A-2979-2009; Chandra, Anchal/AAT-5644-2021; Rocks, Oliver/ABG-3341-2020; Waldmann, Herbert/B-7406-2017; Rocks, Oliver/AFI-7418-2022	Vartak, Nachiket/0000-0002-2966-4631; Chandra, Anchal/0000-0003-4096-4771; Rocks, Oliver/0000-0001-6349-9193; Waldmann, Herbert/0000-0002-9606-7247; Brunsveld, Luc/0000-0001-5675-511X; Vartak, Nachiket/0000-0001-8813-4799; Ellinger, Bernhard/0000-0001-5703-3901	Human Frontier Science Program	Human Frontier Science Program(Human Frontier Science Program)	O.R. received funding from the Human Frontier Science Program (LT Fellowship). We are thankful to C. Nowak and J. Luig for technical support, J. Lippincott-Schwartz, R. Tsien, M. Frame, and M. Torti for providing plasmids, and J. Moffat and Y. Fedyshyn for providing lentiviruses.	Bader B, 2000, NATURE, V403, P223, DOI 10.1038/35003249; Baker TL, 2003, J BIOL CHEM, V278, P19292, DOI 10.1074/jbc.M206956200; Bano MC, 1998, BIOCHEM J, V330, P723, DOI 10.1042/bj3300723; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Bizzozero OA, 2001, BBA-PROTEIN STRUCT M, V1545, P278, DOI 10.1016/S0167-4838(00)00291-0; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Dighe SA, 2008, MOL BIOL CELL, V19, P4454, DOI 10.1091/mbc.E08-03-0252; DRAUZ K, 2002, ENZYME CATALYSIS ORG, V2; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fishburn CS, 1999, J BIOL CHEM, V274, P18793, DOI 10.1074/jbc.274.26.18793; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gerisch G, 2004, EUR J CELL BIOL, V83, P297, DOI 10.1078/0171-9335-00393; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Horton AC, 2003, J NEUROSCI, V23, P6188; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kawase K, 2006, DEV CELL, V11, P411, DOI 10.1016/j.devcel.2006.07.008; Kuhn K, 2001, J AM CHEM SOC, V123, P1023, DOI 10.1021/ja002723o; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; LU JY, 1995, J BIOL CHEM, V270, P7251, DOI 10.1074/jbc.270.13.7251; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Nadolski MJ, 2009, J BIOL CHEM, V284, P17720, DOI 10.1074/jbc.M109.005447; Navarro-Lerida I, 2002, J CELL SCI, V115, P3119; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Paganini S, 2006, BIOCHIMIE, V88, P285, DOI 10.1016/j.biochi.2005.08.007; Perez-Sala D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008117; QUESNEL S, 1994, BIOCHEMISTRY-US, V33, P13340, DOI 10.1021/bi00249a021; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2006, CURR OPIN CELL BIOL, V18, P351, DOI 10.1016/j.ceb.2006.06.007; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Seebach D, 2004, CHEM BIODIVERS, V1, P1111, DOI 10.1002/cbdv.200490087; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Smyth P, 1997, ADV NEUR IN, V9, P648; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329	53	312	316	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					458	471		10.1016/j.cell.2010.04.007	http://dx.doi.org/10.1016/j.cell.2010.04.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20416930	Bronze			2022-12-24	WOS:000277180800017
J	Adesnik, H; Scanziani, M				Adesnik, Hillel; Scanziani, Massimo			Lateral competition for cortical space by layer-specific horizontal circuits	NATURE			English	Article							PRIMARY VISUAL-CORTEX; SOMATOSENSORY BARREL CORTEX; ACTION-POTENTIAL INITIATION; PYRAMIDAL NEURONS; IN-VIVO; ORIENTATION SELECTIVITY; GABAERGIC INTERNEURONS; SYNAPTIC CONNECTIONS; SENSORY RESPONSES; STRIATE CORTEX	The cerebral cortex constructs a coherent representation of the world by integrating distinct features of the sensory environment. Although these features are processed vertically across cortical layers, horizontal projections interconnecting neighbouring cortical domains allow these features to be processed in a context-dependent manner. Despite the wealth of physiological and psychophysical studies addressing the function of horizontal projections, how they coordinate activity among cortical domains remains poorly understood. We addressed this question by selectively activating horizontal projection neurons in mouse somatosensory cortex, and determined how the resulting spatial pattern of excitation and inhibition affects cortical activity. We found that horizontal projections suppress superficial layers while simultaneously activating deeper cortical output layers. This layer-specific modulation does not result from a spatial separation of excitation and inhibition, but from a layer-specific ratio between these two opposing conductances. Through this mechanism, cortical domains exploit horizontal projections to compete for cortical space.	[Adesnik, Hillel; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA; [Adesnik, Hillel; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Scanziani, M (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA.	massimo@ucsd.edu			National Institute for Mental Health [R01 MH70058]; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070058] Funding Source: NIH RePORTER	National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Abelkop for immunohistochemical labelling, J. Isaacson and R. Malinow for critical reading of the manuscript and the members of the Scanziani and Isaacson laboratory for advice during the course of the study. We thank K. Svoboda for pCAGGS-ChR2-Venus (Addgene 15753), C. Cepko for pCAG-GFP (Addgene 11150) and K. Deisseroth for sharing reagents. This work was supported in part by a grant from the National Institute for Mental Health (R01 MH70058). H. A. was supported by the Helen Hay Whitney Foundation. M. S. is an investigator of the Howard Hughes Medical Institute.	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bosking WH, 1997, J NEUROSCI, V17, P2112; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carnevale NT, 2006, NEURON BOOK; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Douglas R, 1998, SYNAPTIC ORG BRAIN, V4th; Feldmeyer D, 2006, J PHYSIOL-LONDON, V575, P583, DOI 10.1113/jphysiol.2006.105106; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Fukuda T, 2006, J NEUROSCI, V26, P3434, DOI 10.1523/JNEUROSCI.4076-05.2006; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; Gottlieb JP, 1997, EXP BRAIN RES, V115, P47, DOI 10.1007/PL00005684; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Helmstaedter M, 2009, CEREB CORTEX, V19, P926, DOI 10.1093/cercor/bhn141; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Jones MS, 1997, BRAIN RES, V768, P167, DOI 10.1016/S0006-8993(97)00639-2; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; MOUNTCASTLE VB, 1959, B JOHNS HOPKINS HOSP, V105, P201; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nase G, 2003, J NEUROPHYSIOL, V90, P1115, DOI 10.1152/jn.00480.2002; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Shimegi S, 1999, J NEUROSCI, V19, P10164; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Tucker TR, 2003, J NEUROPHYSIOL, V89, P488, DOI 10.1152/jn.00869.2001	47	245	247	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1155	U71		10.1038/nature08935	http://dx.doi.org/10.1038/nature08935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20414303	Green Accepted			2022-12-24	WOS:000276891100029
J	Iwai, M; Takizawa, K; Tokutsu, R; Okamuro, A; Takahashi, Y; Minagawa, J				Iwai, Masakazu; Takizawa, Kenji; Tokutsu, Ryutaro; Okamuro, Akira; Takahashi, Yuichiro; Minagawa, Jun			Isolation of the elusive supercomplex that drives cyclic electron flow in photosynthesis	NATURE			English	Article							CYTOCHROME B(6)F COMPLEX; CHLAMYDOMONAS-REINHARDTII; PHOTOSYSTEM-I; STATE TRANSITIONS; TRANSPORT; ARABIDOPSIS; PLANTS; PHOTOPHOSPHORYLATION; PLASTOCYANIN; ACCLIMATION	Photosynthetic light reactions establish electron flow in the chloroplast's thylakoid membranes, leading to the production of the ATP and NADPH that participate in carbon fixation. Two modes of electron flow exist-linear electron flow (LEF) from water to NADP 1 via photosystem (PS) II and PSI in series(1) and cyclic electron flow (CEF) around PSI (ref. 2). Although CEF is essential for satisfying the varying demand for ATP, the exact molecule(s) and operational site are as yet unclear. In the green alga Chlamydomonas reinhardtii, the electron flow shifts from LEF to CEF on preferential excitation of PSII (ref. 3), which is brought about by an energy balancing mechanism between PSII and PSI (state transitions(4)). Here, we isolated a protein super-complex composed of PSI with its own light-harvesting complex (LHCI), the PSII light-harvesting complex (LHCII), the cytochrome b(6)f complex (Cyt bf), ferredoxin (Fd)-NADPH oxidoreductase (FNR), and the integral membrane protein PGRL1 (ref. 5) from C. reinhardtii cells under PSII-favouring conditions. Spectroscopic analyses indicated that on illumination, reducing equivalents from downstream of PSI were transferred to Cyt bf, whereas oxidised PSI was re-reduced by reducing equivalents from Cyt bf, indicating that this supercomplex is engaged in CEF (Supplementary Fig. 1). Thus, formation and dissociation of the PSI-LHCI-LHCII-FNR-Cyt bf-PGRL1 supercomplex not only controlled the energy balance of the two photosystems, but also switched the mode of photosynthetic electron flow.	[Iwai, Masakazu; Takizawa, Kenji; Tokutsu, Ryutaro; Minagawa, Jun] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Okamuro, Akira; Takahashi, Yuichiro] Okayama Univ, Fac Sci, Dept Biol, Okayama 7008530, Japan	Hokkaido University; Okayama University	Minagawa, J (corresponding author), Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan.	minagawa@lowtem.hokudai.ac.jp	Tokutsu, Ryutaro/V-7596-2019; Takahashi, Yuichiro/B-2062-2011; Tokutsu, Ryutaro/GRF-0208-2022	Tokutsu, Ryutaro/0000-0003-2037-255X; Takahashi, Yuichiro/0000-0001-6410-0447; Minagawa, Jun/0000-0002-3028-3203; Takizawa, Kenji/0000-0002-1060-5738; Iwai, Masakazu/0000-0002-0986-9015	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology [18GS0318, 2120006309, 2157003109]; Japan Science and Technology Agency; Natural Sciences by the Mitsubishi Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Natural Sciences by the Mitsubishi Foundation	We thank S. Ozawa and M. Kuwano for technical help with MS/ MS analysis, D. Kramer for valuable discussions, T. Shikanai, D. Leister and T. Hase for providing antibodies, and K. Redding for providing the PSI- His mutant. This study was supported by the Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science (M. I., R. T.), Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (Y. T., 18GS0318; J. M., 18GS0318, 2120006309, 2157003109), the Strategic International Cooperative Program by Japan Science and Technology Agency (J. M.), and a Research Grant in the Natural Sciences by the Mitsubishi Foundation (J. M.).	Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; ARNON DI, 1958, SCIENCE, V127, P1026, DOI 10.1126/science.127.3305.1026; ARNON DI, 1954, NATURE, V174, P394, DOI 10.1038/174394a0; Avenson TJ, 2004, P NATL ACAD SCI USA, V101, P5530, DOI 10.1073/pnas.0401269101; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; Breyton C, 2006, BIOCHEMISTRY-US, V45, P13465, DOI 10.1021/bi061439s; BULTE L, 1990, BIOCHIM BIOPHYS ACTA, V1020, P72, DOI 10.1016/0005-2728(90)90095-L; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Gulis G, 2008, PHOTOSYNTH RES, V96, P51, DOI 10.1007/s11120-007-9283-9; Hamel P, 2000, J BIOL CHEM, V275, P17072, DOI 10.1074/jbc.M001468200; Hippler M, 1997, BIOCHEMISTRY-US, V36, P6343, DOI 10.1021/bi970082c; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; Joliot P, 2002, P NATL ACAD SCI USA, V99, P10209, DOI 10.1073/pnas.102306999; Kramer DM, 2004, TRENDS PLANT SCI, V9, P349, DOI 10.1016/j.tplants.2004.05.001; LAISK A, 1993, P ROY SOC B-BIOL SCI, V251, P243, DOI 10.1098/rspb.1993.0036; LAM E, 1982, FEBS LETT, V141, P98, DOI 10.1016/0014-5793(82)80024-0; LEMAIRE C, 1986, BIOCHIM BIOPHYS ACTA, V851, P229, DOI 10.1016/0005-2728(86)90130-1; MARKWELL JP, 1980, BIOCHIM BIOPHYS ACTA, V591, P391, DOI 10.1016/0005-2728(80)90170-X; Metzger SU, 1997, BBA-BIOENERGETICS, V1319, P233, DOI 10.1016/S0005-2728(96)00164-8; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; OGAWA T, 1991, P NATL ACAD SCI USA, V88, P4275, DOI 10.1073/pnas.88.10.4275; Pesaresi P, 2009, PLANT CELL, V21, P2402, DOI 10.1105/tpc.108.064964; RICH PR, 1987, BIOCHIM BIOPHYS ACTA, V892, P138, DOI 10.1016/0005-2728(87)90256-8; Rochaix JD, 2007, FEBS LETT, V581, P2768, DOI 10.1016/j.febslet.2007.04.038; Sacksteder CA, 2001, PHOTOSYNTH RES, V70, P231, DOI 10.1023/A:1017906626288; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; TAGAWA K, 1963, P NATL ACAD SCI USA, V49, P567, DOI 10.1073/pnas.49.4.567; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; VALLON O, 1991, P NATL ACAD SCI USA, V88, P8262, DOI 10.1073/pnas.88.18.8262; Zhang HM, 2001, J BIOL CHEM, V276, P38159	32	315	329	2	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1210	U134		10.1038/nature08885	http://dx.doi.org/10.1038/nature08885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20364124				2022-12-24	WOS:000276891100041
J	Thorel, F; Nepote, V; Avril, I; Kohno, K; Desgraz, R; Chera, S; Herrera, PL				Thorel, Fabrizio; Nepote, Virginie; Avril, Isabelle; Kohno, Kenji; Desgraz, Renaud; Chera, Simona; Herrera, Pedro L.			Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss	NATURE			English	Article							DIPHTHERIA-TOXIN RECEPTOR; TRANSCRIPTION FACTOR; MOUSE PANCREAS; IN-VITRO; ECTOPIC EXPRESSION; GLUCAGON-SECRETION; ENDOCRINE PANCREAS; DIABETES-MELLITUS; PROGENITOR CELLS; REGENERATION	Pancreatic insulin-producing beta-cells have a long lifespan, such that in healthy conditions they replicate little during a lifetime. Nevertheless, they show increased self-duplication after increased metabolic demand or after injury (that is, beta-cell loss). It is not known whether adult mammals can differentiate (regenerate) new-beta-cells after extreme, total beta-cell loss, as in diabetes. This would indicate differentiation from precursors or another heterologous (non-beta-cell) source. Here we show beta-cell regeneration in a transgenicmodel of diphtheria-toxin-induced acute selective near-total beta-cell ablation. If given insulin, the mice survived and showed beta-cell mass augmentation with time. Lineage-tracing to label the glucagon-producing alpha-cells before beta-cell ablation tracked large fractions of regenerated beta-cells as deriving from alpha-cells, revealing a previously disregarded degree of pancreatic cell plasticity. Such inter-endocrine spontaneous adult cell conversion could be harnessed towards methods of producing beta-cells for diabetes therapies, either in differentiation settings in vitro or in induced regeneration.	[Thorel, Fabrizio; Nepote, Virginie; Avril, Isabelle; Desgraz, Renaud; Chera, Simona; Herrera, Pedro L.] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; [Kohno, Kenji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan	University of Geneva; Nara Institute of Science & Technology	Herrera, PL (corresponding author), Univ Geneva, Fac Med, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	pedro.herrera@unige.ch	Kohno, Kenji/AAZ-6573-2020; CHERA, Simona/N-3207-2014	Kohno, Kenji/0000-0002-3503-6551; CHERA, Simona/0000-0001-6310-3486; Herrera Merino, Pedro Luis/0000-0003-0771-9504	NIH/NIDDK; JDRF; Swiss National Science Foundation; EU; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072522] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JDRF(Juvenile Diabetes Research Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to P. Vassalli and C. V. E. Wright for their comments and support. We also thank R. Stein, S. Kim and A. Ruiz i Altaba for discussions, and G. Flores, C. Gysler, O. Fazio, G. Philippin and C. Vesin for their technical help. We thank D. Melton for the RIP-CreER transgenic strain, and B. Thorens and C. V. E. Wright for anti-Glut2 and anti-Pdx1 antibodies, respectively. Work was funded with grants from the NIH/NIDDK ('Beta Cell Biology Consortium'), JDRF (Juvenile Diabetes Research Foundation), Swiss National Science Foundation (and the NCCR 'Frontiers in Genetics'), and 6FP EU Integrated Project 'Beta Cell Therapy for Diabetes' to P. L. H.	Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Bonal C, 2008, INT J DEV BIOL, V52, P823, DOI 10.1387/ijdb.072444cb; Bonal C, 2009, GASTROENTEROLOGY, V136, P309, DOI 10.1053/j.gastro.2008.10.015; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Cano DA, 2008, DIABETES, V57, P958, DOI 10.2337/db07-0913; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Desgraz R, 2009, DEVELOPMENT, V136, P3567, DOI 10.1242/dev.039214; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Fodor A, 2007, DIABETOLOGIA, V50, P121, DOI 10.1007/s00125-006-0509-8; GERICH JE, 1975, JAMA-J AM MED ASSOC, V234, P159, DOI 10.1001/jama.234.2.159; Heimberg H, 1996, P NATL ACAD SCI USA, V93, P7036, DOI 10.1073/pnas.93.14.7036; HEIMBERG H, 1995, J BIOL CHEM, V270, P8971, DOI 10.1074/jbc.270.15.8971; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Herrera PL, 2000, DEVELOPMENT, V127, P2317; HERRERA PL, 1994, P NATL ACAD SCI USA, V91, P12999, DOI 10.1073/pnas.91.26.12999; Herrera PL, 2002, ENDOCRINE, V19, P267, DOI 10.1385/ENDO:19:3:267; Hogan B, 1994, MANIPULATING MOUSE E, P289; Karges B, 2004, DIABETES CARE, V27, P1207, DOI 10.2337/diacare.27.5.1207; Karges B, 2006, DIABETES-METAB RES, V22, P184, DOI 10.1002/dmrr.600; Li WC, 2005, MECH DEVELOP, V122, P835, DOI 10.1016/j.mod.2005.01.001; Matveyenko AV, 2008, DIABETES OBES METAB, V10, P23, DOI 10.1111/j.1463-1326.2008.00939.x; Meier JJ, 2006, DIABETOLOGIA, V49, P1838, DOI 10.1007/s00125-006-0308-2; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; NGUYEN VX, 1989, ANTIMICROB AGENTS CH, V33, P434, DOI 10.1128/AAC.33.4.434; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Quoix N, 2007, FEBS LETT, V581, P4235, DOI 10.1016/j.febslet.2007.07.068; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Ritz-Laser B, 2003, DIABETOLOGIA, V46, P810, DOI 10.1007/s00125-003-1115-7; Rorsman P, 2008, TRENDS ENDOCRIN MET, V19, P277, DOI 10.1016/j.tem.2008.07.003; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Trucco M, 2005, J CLIN INVEST, V115, P5, DOI 10.1172/JCI200523935; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; WANG RN, 1995, DIABETOLOGIA, V38, P1405, DOI 10.1007/BF00400600; Wang RN, 1996, DIABETOLOGIA, V39, P548, DOI 10.1007/BF00403301; Wang ZV, 2008, DIABETES, V57, P2137, DOI 10.2337/db07-1631; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	50	805	838	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1149	1154		10.1038/nature08894	http://dx.doi.org/10.1038/nature08894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20364121	Green Accepted			2022-12-24	WOS:000276891100028
J	Ferris, P; Olson, BJSC; De Hoff, PL; Douglass, S; Casero, D; Prochnik, S; Geng, S; Rai, R; Grimwood, J; Schmutz, J; Nishii, I; Hamaji, T; Nozaki, H; Pellegrini, M; Umen, JG				Ferris, Patrick; Olson, Bradley J. S. C.; De Hoff, Peter L.; Douglass, Stephen; Casero, David; Prochnik, Simon; Geng, Sa; Rai, Rhitu; Grimwood, Jane; Schmutz, Jeremy; Nishii, Ichiro; Hamaji, Takashi; Nozaki, Hisayoshi; Pellegrini, Matteo; Umen, James G.			Evolution of an Expanded Sex-Determining Locus in Volvox	SCIENCE			English	Article							MINUS-DOMINANCE GENE; MATING-TYPE LOCUS; CHLAMYDOMONAS-REINHARDTII; CHROMOSOME EVOLUTION; Y-CHROMOSOME; ORIGIN; IDENTIFICATION; DIMORPHISM; REVEALS	Although dimorphic sexes have evolved repeatedly in multicellular eukaryotes, their origins are unknown. The mating locus (MT) of the sexually dimorphic multicellular green alga Volvox carteri specifies the production of eggs and sperm and has undergone a remarkable expansion and divergence relative to MT from Chlamydomonas reinhardtii, which is a closely related unicellular species that has equal-sized gametes. Transcriptome analysis revealed a rewired gametic expression program for Volvox MT genes relative to Chlamydomonas and identified multiple gender-specific and sex-regulated transcripts. The retinoblastoma tumor suppressor homolog MAT3 is a Volvox MT gene that displays sexually regulated alternative splicing and evidence of gender-specific selection, both of which are indicative of cooption into the sexual cycle. Thus, sex-determining loci affect the evolution of both sex-related and non-sex-related genes.	[Ferris, Patrick; Olson, Bradley J. S. C.; De Hoff, Peter L.; Geng, Sa; Rai, Rhitu; Umen, James G.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Douglass, Stephen; Casero, David; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Douglass, Stephen; Casero, David; Pellegrini, Matteo] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Prochnik, Simon] US DOE, JGI, Walnut Creek, CA 95498 USA; [Rai, Rhitu] Indian Agr Res Inst, Lab Plant Microbe Interact, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Grimwood, Jane; Schmutz, Jeremy] Hudson Alpha Inst Biotechnol, Genome Sequencing Ctr, Huntsville, AL 35806 USA; [Nishii, Ichiro] Nara Womens Univ, Dept Biol Sci, Nara 6308506, Japan; [Hamaji, Takashi; Nozaki, Hisayoshi] Univ Tokyo, Dept Biol Sci, Tokyo 1130033, Japan	Salk Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Joint Genome Institute - JGI; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); Nara Womens University; University of Tokyo	Umen, JG (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	umen@salk.edu	Umen, James G/K-9120-2013; Casero, David/E-7365-2010; Grimwood, Jane/ABD-5737-2021; Olson, Bradley J S C/A-4532-2013; Schmutz, Jeremy/N-3173-2013; NOZAKI, HISAYOSHI/G-4926-2014	Umen, James G/0000-0003-4094-9045; Casero, David/0000-0002-7347-3330; Olson, Bradley J S C/0000-0002-4751-8347; Schmutz, Jeremy/0000-0001-8062-9172; Nozaki, Hisayoshi/0000-0002-9308-4498; Hamaji, Takashi/0000-0002-2801-2148; Pellegrini, Matteo/0000-0001-9355-9564	Coypu Foundation; NIH [R01 GM078376, F32 GM086037, T32-HG002536, DE-FC02-02ER63421]; Japan Society for the Promotion of Science [S05750/L06701]; Ministry of Education, Culture, Sports, Science and Technology, Japan [20247032]; AFOSR; DOE-JGI [776835]; DOE [DE-AC02-05CH11231]; DOE's Office of Science, Biological and Environmental Research; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078376, F32GM086037] Funding Source: NIH RePORTER	Coypu Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); DOE-JGI; DOE(United States Department of Energy (DOE)); DOE's Office of Science, Biological and Environmental Research; University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Kirk for DNA from Volvox mapping populations. We thank V. Lundblad and S. Merchant for advice on the manuscript. This work was supported by the Coypu Foundation and from grants NIH R01 GM078376 to J.G.U.; NIH F32 GM086037 to B.O.; Japan Society for the Promotion of Science grant S05750/L06701 to P. F.; Grant-in-Aid for Scientific Research (20247032) from the Ministry of Education, Culture, Sports, Science and Technology, Japan to H.N.; NIH grant T32-HG002536 to S. D.; and DE-FC02-02ER63421 and AFOSR to M. P. DOE-JGI provided sequencing and analyses for algal mating loci under the Community Sequencing Program (776835) supported by the Office of Science of DOE under contract DE-AC02-05CH11231. Sequencing of the V. carteri genome was performed under the auspices of DOE's Office of Science, Biological and Environmental Research Program and by the University of California, Lawrence Berkeley National Laboratory under contract DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344, and Los Alamos National Laboratory under contract DE-AC02-06NA25396. Sequences generated in this study have been deposited in GenBank under accession numbers GU814014, GU814015, GU784915, GU784916, and GU735444-GU735478. Materials used in this study will be made available upon request with the completion of a Materials Transfer Agreement from Salk Institute.	Bachtrog D, 2006, CURR OPIN GENET DEV, V16, P578, DOI 10.1016/j.gde.2006.10.007; BULL JJ, 1978, AM NAT, V112, P245, DOI 10.1086/283267; CHARLESWORTH B, 1978, J THEOR BIOL, V73, P347, DOI 10.1016/0022-5193(78)90195-9; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Fang SC, 2006, PLOS GENET, V2, P1565, DOI 10.1371/journal.pgen.0020167; Ferris PJ, 1997, GENETICS, V146, P859; Ferris PJ, 2002, GENETICS, V160, P181; Fraser JA, 2004, PLOS BIOL, V2, P2243, DOI 10.1371/journal.pbio.0020384; Goodenough U, 2007, SEMIN CELL DEV BIOL, V18, P350, DOI 10.1016/j.semcdb.2007.02.006; Hamaji T, 2008, GENETICS, V178, P283, DOI 10.1534/genetics.107.078618; Hamaji T, 2009, J PHYCOL, V45, P1310, DOI 10.1111/j.1529-8817.2009.00744.x; Herron MD, 2009, P NATL ACAD SCI USA, V106, P3254, DOI 10.1073/pnas.0811205106; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Idnurm A, 2008, NATURE, V451, P193, DOI 10.1038/nature06453; Kirk DL., 1998, VOLVOX MOL GENETIC O; KLIMAN RM, 1993, MOL BIOL EVOL, V10, P1239; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lin H, 2007, GENETICS, V176, P913, DOI 10.1534/genetics.106.066167; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Menkis A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000030; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Nozaki H, 1996, J PLANT RES, V109, P353, DOI 10.1007/BF02344484; Nozaki H, 2006, CURR BIOL, V16, pR1018, DOI 10.1016/j.cub.2006.11.019; PARKER GA, 1972, J THEOR BIOL, V36, P529, DOI 10.1016/0022-5193(72)90007-0; Umen JG, 2001, GENE DEV, V15, P1652, DOI 10.1101/gad.892101; Waters PD, 2007, SEMIN CELL DEV BIOL, V18, P389, DOI 10.1016/j.semcdb.2007.02.007; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687; Yamato KT, 2007, P NATL ACAD SCI USA, V104, P6472, DOI 10.1073/pnas.0609054104	28	115	119	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					351	354		10.1126/science.1186222	http://dx.doi.org/10.1126/science.1186222			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395508	Green Accepted			2022-12-24	WOS:000276685000036
J	Iess, L; Rappaport, NJ; Jacobson, RA; Racioppa, P; Stevenson, DJ; Tortora, P; Armstrong, JW; Asmar, SW				Iess, Luciano; Rappaport, Nicole J.; Jacobson, Robert A.; Racioppa, Paolo; Stevenson, David J.; Tortora, Paolo; Armstrong, John W.; Asmar, Sami W.			Gravity Field, Shape, and Moment of Inertia of Titan	SCIENCE			English	Article							AMMONIUM-SULFATE; SATELLITES	Precise radio tracking of the spacecraft Cassini has provided a determination of Titan's mass and gravity harmonics to degree 3. The quadrupole field is consistent with a hydrostatically relaxed body shaped by tidal and rotational effects. The inferred moment of inertia factor is about 0.34, implying incomplete differentiation, either in the sense of imperfect separation of rock from ice or a core in which a large amount of water remains chemically bound in silicates. The equilibrium figure is a triaxial ellipsoid whose semi-axes a, b, and c differ by 410 meters (a - c) and 103 meters (b - c). The nonhydrostatic geoid height variations (up to 19 meters) are small compared to the observed topographic anomalies of hundreds of meters, suggesting a high degree of compensation appropriate to a body that has warm ice at depth.	[Iess, Luciano; Racioppa, Paolo] Univ Roma La Sapienza, Dipartimento Ingn Aerospaziale & Astronaut, I-00184 Rome, Italy; [Rappaport, Nicole J.; Jacobson, Robert A.; Armstrong, John W.; Asmar, Sami W.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Stevenson, David J.] CALTECH, Pasadena, CA 91125 USA; [Tortora, Paolo] Univ Bologna, DIEM II Fac Ingn, I-47100 Forli, Italy	Sapienza University Rome; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; University of Bologna	Iess, L (corresponding author), Univ Roma La Sapienza, Dipartimento Ingn Aerospaziale & Astronaut, Via Eudossiana 18, I-00184 Rome, Italy.	luciano.iess@uniroma1.it	Tortora, Paolo/J-6191-2012; IESS, Luciano/F-4902-2011	Tortora, Paolo/0000-0001-9259-7673; IESS, Luciano/0000-0002-6230-5825	Italian Space Agency; NASA	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); NASA(National Aeronautics & Space Administration (NASA))	The work of L. I., P. R., and P. T. was funded in part by the Italian Space Agency. The work of N. J. R., R. A. J., J. W. A., and S. W. A. was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. D. J. S. acknowledges support from NASA's planetary geology and geophysics program.	Barr AC, 2008, ICARUS, V198, P163, DOI 10.1016/j.icarus.2008.07.004; Fortes AD, 2007, ICARUS, V188, P139, DOI 10.1016/j.icarus.2006.11.002; Grindrod PM, 2008, ICARUS, V197, P137, DOI 10.1016/j.icarus.2008.04.006; Heiskanen W., 1979, PHYS GEODESY; Jacobson RA, 2006, ASTRON J, V132, P2520, DOI 10.1086/508812; Kaula W.M., 1966, THEORY SATELLITE GEO; Lunine JI, 2009, ANNU REV EARTH PL SC, V37, P299, DOI 10.1146/annurev.earth.031208.100142; Murray C. D., 1999, SOLAR SYSTEM DYNAMIC; Rappaport N, 1997, ICARUS, V126, P313, DOI 10.1006/icar.1996.5661; Showman AP, 1999, SCIENCE, V286, P77, DOI 10.1126/science.286.5437.77; Sotin C, 2009, TITAN FROM CASSINI-HUYGENS, P61, DOI 10.1007/978-1-4020-9215-2_4; Zebker HA, 2009, SCIENCE, V324, P921, DOI 10.1126/science.1168905	12	149	149	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	2010	327	5971					1367	1369		10.1126/science.1182583	http://dx.doi.org/10.1126/science.1182583			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223984				2022-12-24	WOS:000275418700038
J	Yvan-Charvet, L; Pagler, T; Gautier, EL; Avagyan, S; Siry, RL; Han, S; Welch, CL; Wang, N; Randolph, GJ; Snoeck, HW; Tall, AR				Yvan-Charvet, Laurent; Pagler, Tamara; Gautier, Emmanuel L.; Avagyan, Serine; Siry, Read L.; Han, Seongah; Welch, Carrie L.; Wang, Nan; Randolph, Gwendalyn J.; Snoeck, Hans W.; Tall, Alan R.			ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation	SCIENCE			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; GENE-EXPRESSION; MACROPHAGE ABCA1; LIPID RAFTS; CHOLESTEROL; ATHEROSCLEROSIS; ACCUMULATION; MICE; ABCG1	Elevated leukocyte cell numbers (leukocytosis), and monocytes in particular, promote atherosclerosis; however, how they become increased is poorly understood. Mice deficient in the adenosine triphosphate-binding cassette (ABC) transporters ABCA1 and ABCG1, which promote cholesterol efflux from macrophages and suppress atherosclerosis in hypercholesterolemic mice, displayed leukocytosis, a transplantable myeloproliferative disorder, and a dramatic expansion of the stem and progenitor cell population containing Lin(-)Sca-1(+)Kit(+) (LSK) in the bone marrow. Transplantation of Abca1(-/-) Abcg1(-/-) bone marrow into apolipoprotein A-1 transgenic mice with elevated levels of high-density lipoprotein (HDL) suppressed the LSK population, reduced leukocytosis, reversed the myeloproliferative disorder, and accelerated atherosclerosis. The findings indicate that ABCA1, ABCG1, and HDL inhibit the proliferation of hematopoietic stem and multipotential progenitor cells and connect expansion of these populations with leukocytosis and accelerated atherosclerosis.	[Yvan-Charvet, Laurent; Pagler, Tamara; Siry, Read L.; Han, Seongah; Welch, Carrie L.; Wang, Nan; Tall, Alan R.] Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA; [Gautier, Emmanuel L.; Avagyan, Serine; Randolph, Gwendalyn J.; Snoeck, Hans W.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA	Columbia University; Icahn School of Medicine at Mount Sinai	Yvan-Charvet, L (corresponding author), Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA.	ly2159@columbia.edu	Gautier, Emmanuel L./E-2259-2017; Tall, Alan/AAT-8528-2021	Gautier, Emmanuel L./0000-0003-2976-7566; Yvan-Charvet, Laurent/0000-0002-7748-4942; , Ngobrolgame.com/0000-0001-6815-9112	NIH [HL54591, R01A1061741, R01AG016327]; American Heart Association [SDG2160053]; FWF Austrian Science Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073760, P01HL054591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049653, R01AI061741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016327, R01AG029626] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); FWF Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by a Program Project grant from the NIH to A. R. T. (HL54591) and a grant from the American Heart Association to L.Y.-C. (SDG2160053), by the FWF Austrian Science Fund (T. P.), and by NIH grants R01A1061741 (E. L. G. and G.J.R.) and R01AG016327 (H. W. S.). A. R. T. serves on scientific advisory boards for Merck and Arisaph Pharmaceuticals and provides paid consulting services to Roche, Merck, Arisaph Pharmaceuticals, and CSL Limited related to the development of drugs that would increase HDL levels.	Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; AVERILL LE, 1989, AM J PATHOL, V135, P369; Barter Philip J, 2007, Curr Cardiol Rep, V9, P493, DOI 10.1007/BF02938394; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Coller BS, 2005, ARTERIOSCL THROM VAS, V25, P658, DOI 10.1161/01.ATV.0000156877.94472.a5; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; de Grouw EPLM, 2006, LEUKEMIA, V20, P750, DOI 10.1038/sj.leu.2404131; Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Nichols BJ, 2003, CURR BIOL, V13, P686, DOI 10.1016/S0960-9822(03)00209-4; Out R, 2008, ARTERIOSCL THROM VAS, V28, P258, DOI 10.1161/ATVBAHA.107.156935; Out R, 2008, CIRC RES, V102, P113, DOI 10.1161/CIRCRESAHA.107.161711; Peeters SDPWM, 2006, EXP HEMATOL, V34, P622, DOI 10.1016/j.exphem.2006.01.020; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Testa U, 2004, LEUKEMIA, V18, P219, DOI 10.1038/sj.leu.2403224; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372	30	525	540	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1689	1693		10.1126/science.1189731	http://dx.doi.org/10.1126/science.1189731			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20488992	Green Accepted			2022-12-24	WOS:000279107400042
J	Wilson, CA; Tsuchida, MA; Allen, GM; Barnhart, EL; Applegate, KT; Yam, PT; Ji, L; Keren, K; Danuser, G; Theriot, JA				Wilson, Cyrus A.; Tsuchida, Mark A.; Allen, Greg M.; Barnhart, Erin L.; Applegate, Kathryn T.; Yam, Patricia T.; Ji, Lin; Keren, Kinneret; Danuser, Gaudenz; Theriot, Julie A.			Myosin II contributes to cell-scale actin network treadmilling through network disassembly	NATURE			English	Article							F-ACTIN; MIGRATING CELLS; MOTILITY; CYTOKINESIS; FILAMENTS; TURNOVER; DYNAMICS; BLEBBISTATIN; LOCALIZATION; PROTRUSION	Crawling locomotion of eukaryotic cells is achieved by a process dependent on the actin cytoskeleton(1): protrusion of the leading edge requires assembly of a network of actin filaments(2), which must be disassembled at the cell rear for sustained motility. Although ADF/cofilin proteins have been shown to contribute to actin disassembly(3), it is not clear how activity of these locally acting proteins could be coordinated over the distance scale of the whole cell. Here we show that non-muscle myosin II has a direct role in actin network disassembly in crawling cells. In fish keratocytes undergoing motility, myosin II is concentrated in regions at the rear with high rates of network disassembly. Activation of myosin II by ATP in detergent-extracted cytoskeletons results in rear-localized disassembly of the actin network. Inhibition of myosin II activity and stabilization of actin filaments synergistically impede cell motility, suggesting the existence of two disassembly pathways, one of which requires myosin II activity. Our results establish the importance of myosin II as an enzyme for actin network disassembly; we propose that gradual formation and reorganization of an actomyosin network provides an intrinsic destruction timer, enabling long-range coordination of actin network treadmilling in motile cells.	[Wilson, Cyrus A.; Tsuchida, Mark A.; Allen, Greg M.; Barnhart, Erin L.; Yam, Patricia T.; Keren, Kinneret; Theriot, Julie A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Wilson, Cyrus A.; Tsuchida, Mark A.; Allen, Greg M.; Barnhart, Erin L.; Yam, Patricia T.; Keren, Kinneret; Theriot, Julie A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Applegate, Kathryn T.; Ji, Lin; Danuser, Gaudenz] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Theriot, Julie A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Scripps Research Institute; Stanford University	Theriot, JA (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	theriot@stanford.edu	Theriot, Julie/HHN-2034-2022; Tsuchida, Mark/B-8180-2008	Tsuchida, Mark/0000-0003-4048-6220; Danuser, Gaudenz/0000-0001-8583-2014; Allen, Gregory/0000-0002-0032-8140; Theriot, Julie/0000-0002-2334-2535; Yam, Patricia/0000-0002-3631-3151; Keren, Kinneret/0000-0002-2962-6977	National Institutes of Health [R01AI067712, T32GM007276, U54GM64346, U01GM67230]; Stanford Medical Scientist Training Program; Howard Hughes Medical Institute; Stanford Graduate Fellowship; Skye International Foundation; National Science Foundation; Damon Runyon Cancer Research Foundation (DRG) [1854-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, T32GM007276, U01GM067230] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Medical Scientist Training Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Stanford Graduate Fellowship(Stanford University); Skye International Foundation; National Science Foundation(National Science Foundation (NSF)); Damon Runyon Cancer Research Foundation (DRG); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. J. Footer for the gift of purified GST-villin, A. Mogilner and S. Sivaramakrishnan for discussions, and Z. Pincus, N. Dye and T.Y.-C. Tsai for reading the manuscript. C. A. W. and J. A. T. were supported by National Institutes of Health grant R01AI067712 (J. A. T.). M. A. T. and E. L. B. were supported by National Institutes of Health grant T32GM007276. G. M. A. was supported by the Stanford Medical Scientist Training Program. P.T.Y. was supported by a Howard Hughes Medical Institute Predoctoral Fellowship, Stanford Graduate Fellowship and a Skye International Foundation Scholarship. K. T. A. was supported by a National Science Foundation Graduate Research Fellowship. K. K. was a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-#1854-05). K. T. A., L. J. and G. D. were supported by National Institutes of Health grants U54GM64346 and U01GM67230 (G. D.). J. A. T. was supported by the Howard Hughes Medical Institute.	ABERCROMBIE M, 1980, PROC R SOC SER B-BIO, V207, P129, DOI 10.1098/rspb.1980.0017; BRETSCHER A, 1980, CELL, V20, P839, DOI 10.1016/0092-8674(80)90330-X; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Doyle AD, 2005, J CELL SCI, V118, P369, DOI 10.1242/jcs.01590; EUTENEUER U, 1984, NATURE, V310, P58, DOI 10.1038/310058a0; GLENNEY JR, 1981, CELL, V24, P471, DOI 10.1016/0092-8674(81)90338-X; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Ji L, 2005, J MICROSC-OXFORD, V220, P150, DOI 10.1111/j.1365-2818.2005.01522.x; KELLER HU, 1993, CELL MOTIL CYTOSKEL, V25, P10, DOI 10.1002/cm.970250103; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Sai X, 2008, CURR BIOL, V18, P976, DOI 10.1016/j.cub.2008.05.049; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P584, DOI 10.1021/bi0483357; SMALL JV, 1994, J STRUCT BIOL, V113, P135, DOI 10.1006/jsbi.1994.1043; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Wilson CA, 2006, IEEE T IMAGE PROCESS, V15, P1939, DOI 10.1109/TIP.2006.873434; Yam PT, 2007, J CELL BIOL, V178, P1207, DOI 10.1083/jcb.200706012; YUMURA S, 1984, J CELL BIOL, V99, P894, DOI 10.1083/jcb.99.3.894	29	277	280	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2010	465	7296					373	U137		10.1038/nature08994	http://dx.doi.org/10.1038/nature08994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485438	Green Accepted			2022-12-24	WOS:000277829200046
J	Costello, EJ; Erkanli, A; Copeland, W; Angold, A				Costello, E. Jane; Erkanli, Alaattin; Copeland, William; Angold, Adrian			Association of Family Income Supplements in Adolescence With Development of Psychiatric and Substance Use Disorders in Adulthood Among an American Indian Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDRENS MENTAL-HEALTH; ASSESSMENT CAPA; CONDUCT DISORDER; TAX EXPERIMENT; POVERTY; AGE; COMMUNITY; PSYCHOPATHOLOGY; TRAJECTORIES; COMORBIDITY	Context In a natural experiment in which some families received income supplements, prevalence of adolescent behavioral symptoms decreased significantly. These adolescents are now young adults. Objective To examine the effects of income supplements in adolescence and adulthood on the prevalence of adult psychiatric disorders. Design Quasi-experimental, longitudinal. Population and Setting A representative sample of children aged 9, 11, or 13 years in 1993 (349 [25%] of whom are American Indian) were assessed for psychiatric and substance use disorders through age 21 years (1993-2006). Of the 1420 who participated in 1993, 1185 were interviewed as adults. From 1996, when a casino opened on the Indian reservation, every American Indian but no non-Indians received an annual income supplement that increased from $500 to around $9000. Main Outcome Measures Prevalence of adult psychiatric disorders and substance use disorders based on the Diagnostic and Statistical Manual of Mental Disorders in 3 age cohorts, adjusted for age, sex, length of time in the family home, and number of Indian parents. Results As adults, significantly fewer Indians than non-Indians had a psychiatric disorder (106 Indians [weighted 30.2%] vs 337 non-Indians [weighted 36.0%]; odds ratio [OR], 0.46; 95% confidence interval [CI], 0.30-0.72; P=.001), particularly alcohol and cannabis abuse, dependence, or both. The youngest age-cohort of Indian youth had the longest exposure to the family income. Interactions between race/ethnicity and age cohort were significant. Planned comparisons showed that fewer of the youngest Indian age-cohort had any psychiatric disorder (31.4%) than the Indian middle cohort (41.7%; OR, 0.43; 95% CI, 0.24-0.78; P=.005) or oldest cohort (41.3%; OR, 0.69; 95% CI, 0.51-0.94; P=.01) or the youngest non-Indian cohort (37.1%; OR, 0.66; 95% CI, 0.48-0.90; P=.008). Study hypotheses were not upheld for nicotine or other drugs, or emotional or behavioral disorders. The income supplement received in adulthood had no impact on adult psychopathology. Conclusion Lower prevalence of psychopathology in American Indian youth following a family income supplement, compared with the nonexposed, non-Indian population, persisted into adulthood. JAMA. 2010; 303(19): 1954-1960	[Costello, E. Jane] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; Duke Univ, Sch Med, Dev Epidemiol Program, Durham, NC 27710 USA	Duke University; Duke University	Costello, EJ (corresponding author), Duke Univ, Sch Med, Dept Psychiat & Behav Sci, POB 3454, Durham, NC 27710 USA.	jcostell@psych.duhs.duke.edu	Copeland, William E/N-5413-2014; Duran, Bonnie m/A-3029-2009	Copeland, William E/0000-0002-1348-7781; 	National Institute of Mental Health [MH63970, MH63671, MH48085]; National Institute on Drug Abuse [DA11301, DA023026]; National Alliance for Research on Schizophrenia and Depression; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048085, K23MH080230, R01MH063671, R01MH063970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA023026, R01DA011301] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Alliance for Research on Schizophrenia and Depression(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding/Support: The study was supported by grants MH63970, MH63671, and MH48085 from the National Institute of Mental Health, DA11301 and DA023026 from the National Institute on Drug Abuse, and National Alliance for Research on Schizophrenia and Depression. These institutions provided financial support for every aspect of the study.	Akee RKQ, 2010, AM ECON J-APPL ECON, V2, P86, DOI 10.1257/app.2.1.86; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; ANGOLD A, 1995, PSYCHOL MED, V25, P739, DOI 10.1017/S003329170003498X; ANGOLD A, 1995, PSYCHOL MED, V25, P755, DOI 10.1017/S0033291700034991; Angold A, 2000, J AM ACAD CHILD PSY, V39, P39, DOI 10.1097/00004583-200001000-00015; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Berger LM, 2009, CHILD YOUTH SERV REV, V31, P978, DOI 10.1016/j.childyouth.2009.04.013; BURNS BJ, 1995, HEALTH AFFAIR, V14, P147, DOI 10.1377/hlthaff.14.3.147; BURTLESS G, 1978, J POLIT ECON, V86, P1103, DOI 10.1086/260730; Conger RD, 1999, AM J COMMUN PSYCHOL, V27, P519, DOI 10.1023/A:1022133228206; Costello EJ, 2007, DRUG ALCOHOL DEPEN, V88, pS50, DOI 10.1016/j.drugalcdep.2006.12.009; Costello EJ, 2007, AM J PSYCHIAT, V164, P36, DOI 10.1176/appi.ajp.164.1.36; Costello EJ, 1996, ARCH GEN PSYCHIAT, V53, P1129; Costello EJ, 2003, JAMA-J AM MED ASSOC, V290, P2023, DOI 10.1001/jama.290.15.2023; Diggle PJ, 2002, ANAL LONGITUDINAL DA; DUNCAN GJ, 1988, J MARRIAGE FAM, V50, P1007, DOI 10.2307/352111; Elder GlenH., 1999, CHILDREN GREAT DEPRE; ELESH D, 1977, J HEALTH SOC BEHAV, V18, P391, DOI 10.2307/2955347; Epps SR, 2007, SOC SCI QUART, V88, P344, DOI 10.1111/j.1540-6237.2007.00461.x; Evans W. N., 2002, SOCIAL EC IMPACT NAT; Foster EM, 2005, AM J PUBLIC HEALTH, V95, P1767, DOI 10.2105/AJPH.2004.061424; Foster H, 2010, DEVIANT BEHAV, V31, P440, DOI 10.1080/01639620903231340; Gennetian LA, 2002, CHILD DEV, V73, P601, DOI 10.1111/1467-8624.00426; Gershoff ET, 2007, CHILD DEV, V78, P70, DOI 10.1111/j.1467-8624.2007.00986.x; Insel TR, 2005, JAMA-J AM MED ASSOC, V294, P2221, DOI 10.1001/jama.294.17.2221; Kellam SG, 2008, DRUG ALCOHOL DEPEN, V95, pS5, DOI 10.1016/j.drugalcdep.2008.01.004; Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P674, DOI 10.1001/archpsyc.65.6.674; Kessler RC, 2008, AM J PSYCHIAT, V165, P703, DOI 10.1176/appi.ajp.2008.08010126; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; McLeod JD, 1996, J HEALTH SOC BEHAV, V37, P207, DOI 10.2307/2137292; Perkonigg A, 2006, EUR ADDICT RES, V12, P187, DOI 10.1159/000094421; Rutter M, 2003, JAMA-J AM MED ASSOC, V290, P2063, DOI 10.1001/jama.290.15.2063; RUTTER M, 1989, INT J BEHAV DEV, V12, P1, DOI 10.1177/016502548901200101; *SAS I INC, 2004, SAS STAT SOFTW COMP; SCHAIE K W, 1965, Psychol Bull, V64, P92, DOI 10.1037/h0022371; Schweinhart LJ, 1997, EARLY CHILD RES Q, V12, P117, DOI 10.1016/S0885-2006(97)90009-0; Scott S, 2001, BRIT MED J, V323, P191, DOI 10.1136/bmj.323.7306.191; SPIEGELMAN RG, 1980, J HUM RESOUR, V15, P463, DOI 10.2307/145397; Sung MJ, 2004, DRUG ALCOHOL DEPEN, V75, P287, DOI 10.1016/j.drugalcdep.2004.03.013; von Sydow K, 2001, DRUG ALCOHOL DEPEN, V64, P347, DOI 10.1016/S0376-8716(01)00137-5; WRIGHT S, 1974, SOC FORCES, V53, P552	41	113	113	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2010	303	19					1954	1960		10.1001/jama.2010.621	http://dx.doi.org/10.1001/jama.2010.621			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	597NJ	20483972	Bronze, Green Accepted			2022-12-24	WOS:000277764500022
J	Zebaze, RMD; Ghasem-Zadeh, A; Bohte, A; Iuliano-Burns, S; Mirams, M; Price, RI; Mackie, EJ; Seeman, E				Zebaze, Roger M. D.; Ghasem-Zadeh, Ali; Bohte, Ann; Iuliano-Burns, Sandra; Mirams, Michiko; Price, Roger Ian; Mackie, Eleanor J.; Seeman, Ego			Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study	LANCET			English	Article							BONE-MINERAL DENSITY; CORTICAL BONE; FRACTURE; OSTEOPOROSIS; PROPORTION; MORPHOLOGY; STRENGTH; RISK	Background Osteoporosis research has focused on vertebral fractures and trabecular bone loss. However, non-vertebral fractures at predominantly cortical sites account for 80% of all fractures and most fracture-related morbidity and mortality in old age. We aimed to re-examine cortical bone as a source of bone loss in the appendicular skeleton. Methods In this cross-sectional study, we used high-resolution peripheral CT to quantify and compare cortical and trabecular bone loss from the distal radius of adult women, and measured porosity using scanning electron microscopy. Exclusion criteria were diseases or prescribed drugs affecting bone metabolism. We also measured bone mineral density of post-mortem hip specimens from female cadavers using densitometry. Age-related differences in total, cortical, and trabecular bone mass, trabecular bone of cortical origin, and cortical and trabecular densities were calculated. Findings We investigated 122 white women with a mean age of 62.8 (range 27-98) years. Between ages 50 and 80 years (n=89), 72.1 mg (95% CI 67.7-76.4) hydroxyapatite (68%) of 106.5 mg hydroxyapatite of bone lost at the distal radius was cortical and 34.3 mg (30.5-37.8) hydroxyapatite (32%) was trabecular; 17.1 mg (11-7-22.5) hydroxyapatite (16%) of total bone loss occurred between ages 50 and 64 years (n=34) and 89.4 mg (83.7-101.1) hydroxyapatite (84%) after age 65 years (n=55). Remodelling within cortex adjacent to the marrow accounted for 49.9 mg (45.4-53.7) hydroxyapatite (47%) of bone loss. Between ages 50-64 years (n=34) and 80 years and older (n=33), cortical density decreased by 127.8 mg (93.1-162.1) hydroxyapatite per cm(3) (15%, p<0.0001) before porosity trabecularising the cortex was included, but 374.3 mg (318.2-429.5) hydroxyapatite per cm(3) (43%, p<0.0001) after; trabecular density decreased by 18.2 mg (-1.4 to 38.2) hydroxyapatite per cm(3) (14%, p=0.06) before cortical remnants were excluded, but 68.7 mg (37.7-90.4) hydroxyapatite per cm(3) (52%, p<0.0001) after. Interpretation Accurate assessment of bone structure, especially porosity producing cortical remnants, could improve identification of individuals at high and low risk of fracture and therefore assist targeting of treatment.	[Zebaze, Roger M. D.; Ghasem-Zadeh, Ali; Bohte, Ann; Iuliano-Burns, Sandra; Seeman, Ego] Univ Melbourne, Dept Med, Austin Hlth, Melbourne, Vic, Australia; [Zebaze, Roger M. D.; Ghasem-Zadeh, Ali; Bohte, Ann; Iuliano-Burns, Sandra; Seeman, Ego] Univ Melbourne, Dept Endocrinol, Austin Hlth, Melbourne, Vic, Australia; [Price, Roger Ian] Univ Western Australia, Dept Med Technol & Phys, Perth, WA 6009, Australia; [Mirams, Michiko; Mackie, Eleanor J.] Univ Melbourne, Dept Vet Sci, Melbourne, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Western Australia; University of Melbourne	Zebaze, RMD (corresponding author), Austin Hlth, Dept Endocrinol, Centaur Bldg,Repatriat Campus,Waterdale Rd, Heidelberg, Vic 3084, Australia.	zebaze@unimelb.edu.au	Seeman, Ego/AAC-3656-2019; Mackie, Eleanor J/B-2045-2008	Seeman, Ego/0000-0002-9692-048X; Mackie, Eleanor J/0000-0002-8057-5407	Australia National Health and Medical Research Council [400139, 566916]	Australia National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the Australia National Health and Medical Research Council (project grants 400139 and 566916).	Albright F, 1941, J AMER MED ASSOC, V116, P2465, DOI 10.1001/jama.1941.02820220007002; BARTH RW, 1992, CLIN ORTHOP RELAT R, P178; Borah B, 2010, J BONE MINER RES, V25, P41, DOI 10.1359/jbmr.090711; BROCKSTEDT H, 1993, BONE, V14, P681, DOI 10.1016/8756-3282(93)90092-O; BURGHARDT AJ, 2009, J BONE MINER RES, DOI DOI 10.1359/JBMR.091104; De Geronimo S, 2006, EUR J ENDOCRINOL, V155, P415, DOI 10.1530/eje.1.02225; Delmas PD, 2002, LANCET, V359, P2018, DOI 10.1016/S0140-6736(02)08827-X; DEMPSTER DW, 1994, J CLIN ENDOCR METAB, V84, P1562; Diab T, 2005, BONE, V37, P96, DOI 10.1016/j.bone.2005.03.014; EASTELL R, 1990, J BONE MINER RES, V5, P1237; Eswaran SK, 2007, COMPUT METHOD APPL M, V196, P3025, DOI 10.1016/j.cma.2006.06.017; FOLDES J, 1991, J BONE MINER RES, V6, P759; Han ZH, 1996, J BONE MINER RES, V11, P1967; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P989, DOI 10.1007/s001980170006; Laib A, 1998, Technol Health Care, V6, P329; Martin RB., 1989, STRUCTURE FUNCTION; MAZESS RB, 1982, CLIN ORTHOP RELAT R, P239; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; NISHIYAMA KK, 2009, J BONE MINER RES, DOI DOI 10.1359/JBMR.091020; NOTTESTAD SY, 1987, J BONE MINER RES, V2, P221; Parfitt A. M., 1996, P315; PARFITT AM, 1989, CLIN DISORDERS BONE; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; RIGGS BL, 1981, J CLIN INVEST, V67, P328, DOI 10.1172/JCI110039; ROCKOFF SD, 1969, CALC TISS RES, V3, P163, DOI 10.1007/BF02058659; RUFF CB, 1993, AM J PHYS ANTHROPOL, V91, P21, DOI 10.1002/ajpa.1330910103; Seeman E, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P3; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815; Yeni YN, 1997, BONE, V21, P453, DOI 10.1016/S8756-3282(97)00173-7	30	573	601	1	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2010	375	9727					1729	1736		10.1016/S0140-6736(10)60320-0	http://dx.doi.org/10.1016/S0140-6736(10)60320-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599DK	20472174				2022-12-24	WOS:000277890200034
J	Hagan, CL; Kim, S; Kahne, D				Hagan, Christine L.; Kim, Seokhee; Kahne, Daniel			Reconstitution of Outer Membrane Protein Assembly from Purified Components	SCIENCE			English	Article							BETA-BARREL PROTEINS; ESCHERICHIA-COLI; YAET COMPLEX; IN-VITRO; TRANSLOCATION; SURA; PROTEOLIPOSOMES; IDENTIFICATION; BIOGENESIS; SECA	beta-barrel membrane proteins in Gram-negative bacteria, mitochondria, and chloroplasts are assembled by highly conserved multi-protein complexes. The mechanism by which these molecular machines fold and insert their substrates is poorly understood. It has not been possible to dissect the folding and insertion pathway because the process has not been reproduced in a biochemical system. We purified the components that fold and insert Escherichia coli outer membrane proteins and reconstituted beta-barrel protein assembly in proteoliposomes using the enzymatic activity of a protein substrate to report on its folding state. The assembly of this protein occurred without an energy source but required a soluble chaperone in addition to the multi-protein assembly complex.	[Hagan, Christine L.; Kim, Seokhee; Kahne, Daniel] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kahne, Daniel] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School	Kahne, D (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	kahne@chemistry.harvard.edu	Kim, Seokhee/C-2303-2018	Kim, Seokhee/0000-0003-0806-583X	NIH [AI081059]; NSF; Amherst College; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Amherst College; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Biophysics Resource of the Keck Facility at Yale University performed the size exclusion-light scattering analysis and amino acid analysis. This work is supported by NIH grant AI081059. C. L. H. is supported by a NSF Graduate Research Fellowship and a Kellogg fellowship from Amherst College.	AKIMARU J, 1991, P NATL ACAD SCI USA, V88, P6545, DOI 10.1073/pnas.88.15.6545; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Burgess NK, 2008, J BIOL CHEM, V283, P26748, DOI 10.1074/jbc.M802754200; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Eggert US, 2001, SCIENCE, V294, P361, DOI 10.1126/science.1063611; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Hennecke G, 2005, J BIOL CHEM, V280, P23540, DOI 10.1074/jbc.M413742200; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jansen C, 2000, EUR J BIOCHEM, V267, P3792, DOI 10.1046/j.1432-1327.2000.01417.x; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Kleinschmidt JH, 2006, CHEM PHYS LIPIDS, V141, P30, DOI 10.1016/j.chemphyslip.2006.02.004; Kramer RA, 2000, EUR J BIOCHEM, V267, P885, DOI 10.1046/j.1432-1327.2000.01073.x; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; NICCHITTA CV, 1990, CELL, V60, P259, DOI 10.1016/0092-8674(90)90741-V; Onufryk C, 2005, J BACTERIOL, V187, P4552, DOI 10.1128/JB.187.13.4552-4561.2005; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Reumann S, 1999, P NATL ACAD SCI USA, V96, P784, DOI 10.1073/pnas.96.2.784; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Ureta AR, 2007, J BACTERIOL, V189, P446, DOI 10.1128/JB.01103-06; Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Xu XH, 2007, J MOL BIOL, V373, P367, DOI 10.1016/j.jmb.2007.07.069; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635	31	195	205	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980					890	892		10.1126/science.1188919	http://dx.doi.org/10.1126/science.1188919			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20378773	Green Accepted			2022-12-24	WOS:000277618800048
J	Moran, NA; Jarvik, T				Moran, Nancy A.; Jarvik, Tyler			Lateral Transfer of Genes from Fungi Underlies Carotenoid Production in Aphids	SCIENCE			English	Article							ACYRTHOSIPHON-PISUM; PEA APHID; BIOSYNTHESIS; COLOR; ENDOSYMBIONT; RESISTANCE; PARASITISM; SYMBIONTS; EVOLUTION; PATTERNS	Carotenoids are colored compounds produced by plants, fungi, and microorganisms and are required in the diet of most animals for oxidation control or light detection. Pea aphids display a red-green color polymorphism, which influences their susceptibility to natural enemies, and the carotenoid torulene occurs only in red individuals. Unexpectedly, we found that the aphid genome itself encodes multiple enzymes for carotenoid biosynthesis. Phylogenetic analyses show that these aphid genes are derived from fungal genes, which have been integrated into the genome and duplicated. Red individuals have a 30-kilobase region, encoding a single carotenoid desaturase that is absent from green individuals. A mutation causing an amino acid replacement in this desaturase results in loss of torulene and of red body color. Thus, aphids are animals that make their own carotenoids.	[Moran, Nancy A.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Jarvik, Tyler] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Moran, NA (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, 1041 E Lowell St, Tucson, AZ 85721 USA.	nancy.moran@yale.edu	Moran, Nancy A/G-1591-2010		NSF [0626716]	NSF(National Science Foundation (NSF))	We are indebted to K. Vogel for samples of aphids, including crosses he performed for other experiments. We thank N. Craft and staff at Craft Technologies for high-performance liquid chromatography analyses of aphid samples, K. Hammond for care of pea aphid colonies, K. Hammond and H. Dunbar for noticing the mutant 5AY female, J. Russell and S. Via for aphid clones, B. Nankivell for preparation of figures and of the manuscript, H. Ochman for comments on the paper, members of the Ochman-Moran laboratory for comments on the project, and A. Badyaev for discussions of carotenoids in animals. This project was funded by NSF 0626716 to N. M. GenBank accession for the DNA sequence is GU456379.	ANDREWES AG, 1971, ACTA CHEM SCAND, V25, P3878, DOI 10.3891/acta.chem.scand.25-3878; Arrach N, 2001, P NATL ACAD SCI USA, V98, P1687, DOI 10.1073/pnas.021555298; Badyaev AV, 2007, EVOL BIOL, V34, P61, DOI 10.1007/s11692-007-9004-5; Brisson JA, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-22; BROWN KS, 1975, CHEM SOC REV, V4, P263, DOI 10.1039/cs9750400263; CZECZUGA B, 1976, Zoologica Poloniae, V25, P27; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; DEGNAN PH, ENV MICROBIOL; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; GOODWIN TW, 1986, ANNU REV NUTR, V6, P273, DOI 10.1146/annurev.nu.06.070186.001421; Harmon JP, 1998, OECOLOGIA, V115, P287, DOI 10.1007/s004420050518; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; HOUK EJ, 1974, J INSECT PHYSIOL, V20, P471, DOI 10.1016/0022-1910(74)90155-3; Jenkins RL, 1999, PHYSIOL ENTOMOL, V24, P171, DOI 10.1046/j.1365-3032.1999.00128.x; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Libbrecht R, 2007, J INSECT BEHAV, V20, P25, DOI 10.1007/s10905-006-9055-y; Linnemannstons P, 2002, MOL GENET GENOMICS, V267, P593, DOI 10.1007/s00438-002-0690-5; Losey JE, 1997, NATURE, V388, P269, DOI 10.1038/40849; MULLER F. P., 1962, Z. PflKrarikh., V69, P129; Muller F. P., 1961, Archiv des Vereins der Freunde der Naturgeschichte in Mecklenburg, V7, P228; Nikoh N, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-12; Nikoh N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000827; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Rodriguez-Saiz M, 2004, APPL ENVIRON MICROB, V70, P5589, DOI 10.1128/AEM.70.9.5589-5594.2004; Rothschild M., 1975, COEVOLUTION ANIMALS, P20; Rumpho ME, 2008, P NATL ACAD SCI USA, V105, P17867, DOI 10.1073/pnas.0804968105; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; TAKADA H, 1981, APPL ENTOMOL ZOOL, V16, P242, DOI 10.1303/aez.16.242; Umeno D, 2005, MICROBIOL MOL BIOL R, V69, P51, DOI 10.1128/MMBR.69.1.51-78.2005; Verdoes JC, 1999, MOL GEN GENET, V262, P453, DOI 10.1007/s004380051105; Verdoes JC, 2003, APPL ENVIRON MICROB, V69, P3728, DOI 10.1128/AEM.69.7.3728-3738.2003	33	401	427	13	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2010	328	5978					624	627		10.1126/science.1187113	http://dx.doi.org/10.1126/science.1187113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431015				2022-12-24	WOS:000277159800044
J	Xu, R; Ekiert, DC; Krause, JC; Hai, R; Crowe, JE; Wilson, IA				Xu, Rui; Ekiert, Damian C.; Krause, Jens C.; Hai, Rong; Crowe, James E., Jr.; Wilson, Ian A.			Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus	SCIENCE			English	Article							RECEPTOR-BINDING; HEMAGGLUTININ; ORIGIN; EMERGENCE	The 2009 H1N1 swine flu is the first influenza pandemic in decades. The crystal structure of the hemagglutinin from the A/California/04/2009 H1N1 virus shows that its antigenic structure, particularly within the Sa antigenic site, is extremely similar to those of human H1N1 viruses circulating early in the 20th century. The cocrystal structure of the 1918 hemagglutinin with 2D1, an antibody from a survivor of the 1918 Spanish flu that neutralizes both 1918 and 2009 H1N1 viruses, reveals an epitope that is conserved in both pandemic viruses. Thus, antigenic similarity between the 2009 and 1918-like viruses provides an explanation for the age-related immunity to the current influenza pandemic.	[Xu, Rui; Ekiert, Damian C.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Krause, Jens C.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Krause, Jens C.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Hai, Rong] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Vanderbilt University; Vanderbilt University; Icahn School of Medicine at Mount Sinai; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu	Xu, Rui/I-8098-2012; Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079; Ekiert, Damian/0000-0002-2570-0404	NIH [AI058113, AI057157, GM080209]; Achievement Rewards for College Scientists Foundation; Skaggs Institute for Chemical Biology; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; Pediatric Infectious Diseases Society Fellowship; MedImmune; AstraZeneca; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, P01AI058113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080209] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Rewards for College Scientists Foundation(General Electric); Skaggs Institute for Chemical Biology; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Pediatric Infectious Diseases Society Fellowship; MedImmune(AstraZenecaMedimmune); AstraZeneca(AstraZeneca); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported in part by NIH grants AI058113 (I. A. W., J.E.C., and P. Palese) and AI057157 (J.E.C.), predoctoral fellowships from the Achievement Rewards for College Scientists Foundation and the NIH Molecular Evolution Training Program GM080209 (D. C. E.), and the Skaggs Institute for Chemical Biology. X-ray diffraction data sets were collected at the Stanford Synchrotron Radiation Lightsource beamline 9-2 and at the Advanced Photon Source beamline 23ID-B (GM/CA-CAT). The GM/CA CAT 23-ID-B beamline has been funded in whole or in part with federal funds from National Cancer Institute (Y1-CO-1020) and National Institute of General Medical Sciences (Y1-GM-1104). Use of the Advanced Photon Source (APS) was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. We thank P. Palese (Mount Sinai School of Medicine) for providing the CA04 clone and helpful comments, X. Dai and M. A. Elsliger (Scripps Research Institute) and C.J. Huffman (Vanderbilt University) for expert technical assistance, H. Tien and D. Marciano of the Robotics Core at the Joint Center for Structural Genomics for automated crystal screening, and M. Becker and the staff of the APS GM/CA CAT 23-ID-B for beamline support. This is publication 20395 from the Scripps Research Institute. Coordinates and structure factors are deposited in the PDB [3LZG for CA04 HA (two trimers) and 3LZF for 1918 HA/2D1 complex]. Vanderbilt University has applied for a provisional patent covering the diagnostic and therapeutic use of antibodies described in this paper. J.E.C. Jr. is a founder of the vaccine company Corbeau Biotech LLC and has consulted for MedImmune, Novartis, Sanofi, and Immunobiosciences. J.C.K. is funded by a Pediatric Infectious Diseases Society Fellowship funded by MedImmune and AstraZeneca.	Brownlee GG, 2001, PHILOS T ROY SOC B, V356, P1871, DOI 10.1098/rstb.2001.1001; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; FISMAN DN, 2000, NEW ENGL J MED, V361, P2009; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gaydos JC, 2006, EMERG INFECT DIS, V12, P23, DOI 10.3201/eid1201.050965; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; HANCOCK K, 1945, NEW ENGL J MED, V361, P2009; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Krause JC, 2010, J VIROL, V84, P3127, DOI 10.1128/JVI.02184-09; Lin TW, 2009, VIROLOGY, V392, P73, DOI 10.1016/j.virol.2009.06.028; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Schulze Irene T., 1997, Journal of Infectious Diseases, V176, pS24, DOI 10.1086/514170; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; WEBB SA, 1925, NEW ENGL J MED, V361, P2009; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Xing Z, 2009, EMERG INFECT DIS, V15, P1847, DOI 10.3201/eid1511.090685; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	27	456	485	1	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					357	360		10.1126/science.1186430	http://dx.doi.org/10.1126/science.1186430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20339031	Green Submitted, Green Accepted			2022-12-24	WOS:000276685000038
J	Brousseau, DC; Owens, PL; Mosso, AL; Panepinto, JA; Steiner, CA				Brousseau, David C.; Owens, Pamela L.; Mosso, Andrew L.; Panepinto, Julie A.; Steiner, Claudia A.			Acute Care Utilization and Rehospitalizations for Sickle Cell Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; HOSPITAL READMISSION; VASOOCCLUSIVE CRISES; HEART-FAILURE; CHILDREN; QUALITY; LENGTH; STATE	Context Published rates of health care utilization and rehospitalization by people with sickle cell disease have had limited generalizability and are not population based. Objective To provide benchmark data for rates of acute care utilization and rehospitalizations for patients with sickle cell disease. Design Retrospective cohort of sickle cell disease-related emergency department (ED) visits and hospitalizations from select states in the 2005 and 2006 Healthcare Cost and Utilization Project (HCUP) State Inpatient Databases and State Emergency Department Databases. Setting Eight geographically dispersed states (Arizona, California, Florida, Massachusetts, Missouri, New York, South Carolina, and Tennessee) that provide encrypted identifiers and have sufficient numbers of patients with sickle cell disease; together these states have 33% of the US population with sickle cell disease. Patients A total of 21 112 patients with sickle cell-related treat-and-release ED visits or inpatient hospitalizations. Main Outcome Measures Rates of acute care utilization and rehospitalizations. Population-based utilization rates were also calculated. Results The 21 112 people with sickle cell disease had 109 344 encounters, a mean of 2.59 (95% confidence interval [CI], 2.53-2.65) encounters per patient per year, 1.52 (95% CI, 1.48-1.55) encounters for hospitalizations and 1.08 (95% CI, 1.04-1.11) for treat-and-release ED visits. Utilization was highest for 18- to 30-year-olds, 3.61 (95% CI, 3.47-3.75) encounters per patient per year, and those with public insurance, 3.22 (95% CI, 3.13-3.31) encounters per patient per year. Publicly insured 18- to 30-year-olds had 4.80 (95% CI, 4.58-5.02) encounters per patient per year. Approximately 29% of the population had no encounters while 16.9% had 3 or more encounters per year. The 30-day and 14-day rehospitalization rates were 33.4% (95% CI, 33.0%-33.8%) and 22.1% (95% CI, 21.8%-22.4%), respectively. The rehospitalization rate was highest for 18- to 30-year-olds, with 41.1% (95% CI, 40.5%-41.7%) rehospitalized within 30 days and 28.4% (95% CI, 27.8%-29.0%) within 14 days. Rehospitalizations were also highest for publicly insured patients. Conclusion Among patients with sickle cell disease, acute care encounters and rehospitalizations were frequent, particularly for 18- to 30-year-olds. JAMA. 2010; 303(13): 1288-1294	[Brousseau, David C.] Med Coll Wisconsin, Dept Pediat, Sect Emergency Med, Milwaukee, WI 53226 USA; [Panepinto, Julie A.] Med Coll Wisconsin, Sect Hematol Oncol Bone Marrow Transplant, Milwaukee, WI 53226 USA; [Owens, Pamela L.; Steiner, Claudia A.] Agcy Healthcare Res & Qual, Healthcare Cost & Utilizat Project, Rockville, MD USA; [Owens, Pamela L.; Steiner, Claudia A.] Agcy Healthcare Res & Qual, Ctr Delivery Org & Markets, Rockville, MD USA; [Owens, Pamela L.] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA; [Mosso, Andrew L.] Social & Sci Syst Inc, Silver Spring, MD USA; [Brousseau, David C.; Panepinto, Julie A.] Childrens Res Inst, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Agency for Healthcare Research & Quality; Agency for Healthcare Research & Quality; Washington University (WUSTL); Social & Scientific Systems	Brousseau, DC (corresponding author), Med Coll Wisconsin, Dept Pediat, Sect Emergency Med, 999 N 92nd St,CCC 550, Milwaukee, WI 53226 USA.	dbrousse@mcw.edu			Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Work on this study was funded in part by a Career Development Award (D.C.B.) from the Agency for Healthcare Research and Quality.	*AG HEALTHC RES QU, CLIN CALSS SOFTW CCS; Agency for Healthcare Research and Quality, OV STAT INP DAT SID; [Anonymous], OV STAT EM DEP DAT S; Ashley-Koch A, 2000, AM J EPIDEMIOL, V151, P839; Ballas SK, 2005, AM J HEMATOL, V79, P17, DOI 10.1002/ajh.20336; Basu J, 2007, MED CARE RES REV, V64, P544, DOI 10.1177/1077558707301955; Brousseau DC, 2010, AM J HEMATOL, V85, P77, DOI 10.1002/ajh.21570; CASTRO O, 1994, BLOOD, V84, P643, DOI 10.1182/blood.V84.2.643.643; *CTR MED MED SERV, 2007, MED SCHIP QUAL IMPR; Ellison AM, 2007, J NATL MED ASSOC, V99, P192; Fosdal Marian B, 2007, J Pediatr Nurs, V22, P342; Frei-Jones MJ, 2009, PEDIATR BLOOD CANCER, V52, P481, DOI 10.1002/pbc.21854; Guice KS, 2007, J TRAUMA, V63, pS68, DOI 10.1097/TA.0b013e31815acbb6; Harjai KJ, 2001, AM J CARDIOL, V87, P234, DOI 10.1016/S0002-9149(00)01328-X; Jasti H, 2008, CLIN INFECT DIS, V46, P550, DOI 10.1086/526526; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Johnson RW, 2000, HEALTH SERV RES, V35, P911; Lorey FW, 1996, GENET EPIDEMIOL, V13, P501, DOI 10.1002/(SICI)1098-2272(1996)13:5<501::AID-GEPI6>3.0.CO;2-4; Panepinto JA, 2005, PEDIATR BLOOD CANCER, V44, P182, DOI 10.1002/pbc.20180; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; Quinn CT, 2009, PEDIATR BLOOD CANCER, V52, P435, DOI 10.1002/pbc.21904; Reznik M, 2006, J ASTHMA, V43, P37, DOI 10.1080/02770900500446997; Robbins JM, 2006, MED CARE, V44, P292, DOI 10.1097/01.mlr.0000199639.20342.87; Ross JS, 2006, JAMA-J AM MED ASSOC, V295, P2027, DOI 10.1001/jama.295.17.2027; Scanlon DP, 2008, HEALTH SERV RES, V43, P1849, DOI 10.1111/j.1475-6773.2008.00889.x; Schwalenstocker E, 2009, PEDIATR BLOOD CANCER, V53, P1361, DOI 10.1002/pbc.22212; Shankar SM, 2005, AM J HEMATOL, V80, P262, DOI 10.1002/ajh.20485; Taylor A K, 2001, Health Serv Res, V36, P16; VanSuch M, 2006, QUAL SAF HEALTH CARE, V15, P414, DOI 10.1136/qshc.2005.017640	29	391	393	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1288	1294		10.1001/jama.2010.378	http://dx.doi.org/10.1001/jama.2010.378			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579FM	20371788	Bronze			2022-12-24	WOS:000276353700029
J	Pauwels, L; Barbero, GF; Geerinck, J; Tilleman, S; Grunewald, W; Perez, AC; Chico, JM; Vanden Bossche, R; Sewell, J; Gil, E; Garcia-Casado, G; Witters, E; Inze, D; Long, JA; De Jaeger, G; Solano, R; Goossens, A				Pauwels, Laurens; Barbero, Gemma Fernandez; Geerinck, Jan; Tilleman, Sofie; Grunewald, Wim; Perez, Amparo Cuellar; Chico, Jose Manuel; Vanden Bossche, Robin; Sewell, Jared; Gil, Eduardo; Garcia-Casado, Gloria; Witters, Erwin; Inze, Dirk; Long, Jeff A.; De Jaeger, Geert; Solano, Roberto; Goossens, Alain			NINJA connects the co-repressor TOPLESS to jasmonate signalling	NATURE			English	Article							TANDEM AFFINITY PURIFICATION; FUNCTIONAL GENOMICS; STRESS-RESPONSE; PROTEIN FAMILY; ARABIDOPSIS; DEGRADATION; DEFENSE; GENES; BIOSYNTHESIS; METABOLISM	Jasmonoyl-isoleucine (JA-Ile) is a plant hormone that regulates a broad array of plant defence and developmental processes(1-5). JA-Ile-responsive gene expression is regulated by the transcriptional activator MYC2 that interacts physically with the jasmonate ZIM-domain (JAZ) repressor proteins. On perception of JA-Ile, JAZ proteins are degraded and JA-Ile-dependent gene expression is activated(6,7). The molecular mechanisms by which JAZ proteins repress gene expression remain unknown. Here we show that the Arabidopsis JAZ proteins recruit the Groucho/Tup1-type corepressor TOPLESS (TPL)(8) and TPL-related proteins (TPRs) through a previously uncharacterized adaptor protein, designated Novel Interactor of JAZ (NINJA). NINJA acts as a transcriptional repressor whose activity is mediated by a functional TPL-binding EAR repression motif. Accordingly, both NINJA and TPL proteins function as negative regulators of jasmonate responses. Our results point to TPL proteins as general co-repressors that affect multiple signalling pathways through the interaction with specific adaptor proteins. This new insight reveals how stress-related and growth-related signalling cascades use common molecular mechanisms to regulate gene expression in plants.	[Pauwels, Laurens; Geerinck, Jan; Tilleman, Sofie; Grunewald, Wim; Perez, Amparo Cuellar; Vanden Bossche, Robin; Inze, Dirk; De Jaeger, Geert; Goossens, Alain] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Pauwels, Laurens; Geerinck, Jan; Tilleman, Sofie; Grunewald, Wim; Perez, Amparo Cuellar; Vanden Bossche, Robin; Inze, Dirk; De Jaeger, Geert; Goossens, Alain] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [Barbero, Gemma Fernandez; Chico, Jose Manuel; Solano, Roberto] Ctr Nacl Biotecnol CSIC, Dept Genet Mol Plantas, Madrid 28049, Spain; [Gil, Eduardo; Garcia-Casado, Gloria; Solano, Roberto] Ctr Nacl Biotecnol CSIC, Genom Unit, Madrid 28049, Spain; [Grunewald, Wim] Univ Ghent, Dept Mol Biotechnol, Fac Biosci Engn, B-9000 Ghent, Belgium; [Sewell, Jared; Long, Jeff A.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Witters, Erwin] Univ Antwerp, EBT CEPROMA, Dept Biol, B-2020 Antwerp, Belgium; [Witters, Erwin] VITO MANT, Flemish Inst Technol Res, B-2400 Mol, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Ghent University; Salk Institute; University of Antwerp; VITO	Goossens, A (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium.	alain.goossens@psb.vib-ugent.be	Inzé, Dirk/AAW-6381-2021; Solano, Roberto/O-5908-2017; Pauwels, Laurens/Y-4080-2019	Inzé, Dirk/0000-0002-3217-8407; Solano, Roberto/0000-0001-5459-2417; Pauwels, Laurens/0000-0002-0221-9052; Gil, Eduardo/0000-0002-0423-9794; Sewell, Jared/0000-0003-3229-2645; Goossens, Alain/0000-0002-1599-551X; De Jaeger, Geert/0000-0001-6558-5669	Research Foundation-Flanders; Agency for Innovation by Science and Technology in Flanders ('Generisch Basisonderzoek aan de Universiteiten'); Ghent University; National Institutes of Health; Spanish Ministerio de Ciencia y Tecnologia; Comunidad de Madrid; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072764] Funding Source: NIH RePORTER	Research Foundation-Flanders(FWO); Agency for Innovation by Science and Technology in Flanders ('Generisch Basisonderzoek aan de Universiteiten'); Ghent University(Ghent University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Lammertyn and all colleagues of the Functional Proteomics group at VIB and Ecophysiology-Biochemistry-Toxicology, Centre for Proteome Analysis and Mass Spectrometry (EBT-CEPROMA) at Antwerp University for technical assistance; M. I. Puga and J. Paz-Ares for providing the prey cDNA library for Y2H screens; V. Storme for help with statistical analysis; J. Van Leene and M. Karimi for discussions; and M. De Cock for help in preparing the manuscript. This work was supported by the Research Foundation-Flanders (predoctoral fellowship to L. P.), the Agency for Innovation by Science and Technology in Flanders ('Generisch Basisonderzoek aan de Universiteiten', and predoctoral fellowships to S. T. and J. G.), the Special Research Fund of Ghent University (postdoctoral fellowship to W. G.), the National Institutes of Health (to J. L.) and the Spanish Ministerio de Ciencia y Tecnologia and the Comunidad de Madrid (to R. S.).	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Browse J, 2008, PLANT PHYSIOL, V146, P832, DOI 10.1104/pp.107.115683; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Chico JM, 2008, CURR OPIN PLANT BIOL, V11, P486, DOI 10.1016/j.pbi.2008.06.003; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2009, PLANT J, V59, P77, DOI 10.1111/j.1365-313X.2009.03852.x; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Sutter V, 2005, PLANT J, V44, P1065, DOI 10.1111/j.1365-313X.2005.02586.x; Devoto A, 2002, PLANT J, V32, P457, DOI 10.1046/j.1365-313X.2002.01432.x; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Garcia ME, 2008, PLANT MOL BIOL, V67, P643, DOI 10.1007/s11103-008-9344-2; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Goossens A, 2003, P NATL ACAD SCI USA, V100, P8595, DOI 10.1073/pnas.1032967100; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Grunewald W, 2009, EMBO REP, V10, P923, DOI 10.1038/embor.2009.103; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karimi M, 2007, PLANT PHYSIOL, V145, P1144, DOI 10.1104/pp.107.106989; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kazan K, 2006, TRENDS PLANT SCI, V11, P109, DOI 10.1016/j.tplants.2006.01.004; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Long JA, 2002, DEVELOPMENT, V129, P2797; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Ohta M, 2000, PLANT J, V22, P29, DOI 10.1046/j.1365-313x.2000.00709.x; Pauwels L, 2009, TRENDS PLANT SCI, V14, P87, DOI 10.1016/j.tplants.2008.11.005; Pauwels L, 2008, P NATL ACAD SCI USA, V105, P1380, DOI 10.1073/pnas.0711203105; Salmon J, 2008, PLANT J, V54, P118, DOI 10.1111/j.1365-313X.2007.03396.x; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Van Leene J, 2008, TRENDS PLANT SCI, V13, P517, DOI 10.1016/j.tplants.2008.08.002; Van Leene J, 2007, MOL CELL PROTEOMICS, V6, P1226, DOI 10.1074/mcp.M700078-MCP200; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; White DWR, 2006, P NATL ACAD SCI USA, V103, P13238, DOI 10.1073/pnas.0604349103; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708	41	636	699	9	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					788	U169		10.1038/nature08854	http://dx.doi.org/10.1038/nature08854			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20360743	Green Accepted			2022-12-24	WOS:000276205000051
J	Rayner, KJ; Suarez, Y; Davalos, A; Parathath, S; Fitzgerald, ML; Tamehiro, N; Fisher, EA; Moore, KJ; Fernandez-Hernando, C				Rayner, Katey J.; Suarez, Yajaira; Davalos, Alberto; Parathath, Saj; Fitzgerald, Michael L.; Tamehiro, Norimasa; Fisher, Edward A.; Moore, Kathryn J.; Fernandez-Hernando, Carlos			MiR-33 Contributes to the Regulation of Cholesterol Homeostasis	SCIENCE			English	Article							CASSETTE TRANSPORTER 1; TANGIER-DISEASE; CELLULAR CHOLESTEROL; LIPID-METABOLISM; IN-VIVO; HDL; MUTATIONS	Cholesterol metabolism is tightly regulated at the cellular level. Here we show that miR-33, an intronic microRNA (miRNA) located within the gene encoding sterol-regulatory element-binding factor-2 (SREBF-2), a transcriptional regulator of cholesterol synthesis, modulates the expression of genes involved in cellular cholesterol transport. In mouse and human cells, miR-33 inhibits the expression of the adenosine triphosphate-binding cassette (ABC) transporter, ABCA1, thereby attenuating cholesterol efflux to apolipoprotein A1. In mouse macrophages, miR-33 also targets ABCG1, reducing cholesterol efflux to nascent high-density lipoprotein (HDL). Lentiviral delivery of miR-33 to mice represses ABCA1 expression in the liver, reducing circulating HDL levels. Conversely, silencing of miR-33 in vivo increases hepatic expression of ABCA1 and plasma HDL levels. Thus, miR-33 appears to regulate both HDL biogenesis in the liver and cellular cholesterol efflux.	[Rayner, Katey J.; Suarez, Yajaira; Davalos, Alberto; Parathath, Saj; Fisher, Edward A.; Moore, Kathryn J.; Fernandez-Hernando, Carlos] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Rayner, Katey J.; Suarez, Yajaira; Davalos, Alberto; Parathath, Saj; Fisher, Edward A.; Moore, Kathryn J.; Fernandez-Hernando, Carlos] NYU, Sch Med, Dept Cell Biol, Leon H Charney Div Cardiol, New York, NY 10016 USA; [Rayner, Katey J.; Suarez, Yajaira; Davalos, Alberto; Parathath, Saj; Fisher, Edward A.; Moore, Kathryn J.; Fernandez-Hernando, Carlos] NYU, Sch Med, Marc & Ruti Bell Vasc Biol & Dis Program, New York, NY 10016 USA; [Rayner, Katey J.; Fitzgerald, Michael L.; Tamehiro, Norimasa; Moore, Kathryn J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA	New York University; New York University; New York University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Moore, KJ (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.	kathryn.moore@nyumc.org; carlos.fernandez-hernando@nyumc.org	Fisher, Edward/ABE-7469-2020; Rayner, Katey/K-8914-2012; Parathath, Saj/ABE-2183-2021; Davalos, Alberto/AAA-9949-2021; Moore, Kathryn/ABE-6416-2020	Moore, Kathryn/0000-0003-2505-2547; Fisher, Edward/0000-0001-9802-143X; Suarez, Yajaira/0000-0003-4549-2953; Parathath, Sajesh/0000-0003-3431-297X; Davalos, Alberto/0000-0001-5709-6443; Rayner, Katey/0000-0001-6230-426X	American Heart Association [SDG-0835585D, SDG-0835481N, 09GRNT2260352]; NIH [R01AG02055, R01HL074136, R01HL084312, 1P30HL101270-01]; Heart and Stroke Foundation of Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074136, P30HL101270, R01HL084312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020255] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Hernando-Monje for assisting with lentiviral experiments and M. Freeman and L. Stuart for discussions. This work was supported by the American Heart Association (grant SDG-0835585D to C. F.-H., grant SDG-0835481N to Y.S., and grant 09GRNT2260352 to M. L. F.); NIH (grant R01AG02055 to K.J.M., grant R01HL074136 to M. L. F., grant R01HL084312 to E. A. F., and grant 1P30HL101270-01 to C. F.-H.); and the Heart and Stroke Foundation of Canada (K.J.R.). The authors (C. F.-H. and K.J.M) and New York University School of Medicine are preparing a patent application relating to the use of miR-33 as a therapeutic.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Ory DS, 2004, TRENDS CARDIOVAS MED, V14, P66, DOI 10.1016/j.tcm.2003.12.003; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421	14	933	1018	5	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1570	1573		10.1126/science.1189862	http://dx.doi.org/10.1126/science.1189862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20466885	Green Accepted			2022-12-24	WOS:000278859200050
J	Tormo-Mas, MA; Mir, I; Shrestha, A; Tallent, SM; Campoy, S; Lasa, I; Barbe, J; Novick, RP; Christie, GE; Penades, JR				Angeles Tormo-Mas, Maria; Mir, Ignacio; Shrestha, Archana; Tallent, Sandra M.; Campoy, Susana; Lasa, Inigo; Barbe, Jordi; Novick, Richard P.; Christie, Gail E.; Penades, Jose R.			Moonlighting bacteriophage proteins derepress staphylococcal pathogenicity islands	NATURE			English	Article							GRAM-POSITIVE BACTERIA; HELPER PHAGE; AUREUS; PARTICLES; DUTPASE; VECTOR; TOXIN	Staphylococcal superantigen-carrying pathogenicity islands (SaPIs) are discrete, chromosomally integrated units of similar to 15 kilobases that are induced by helper phages to excise and replicate. SaPI DNA is then efficiently encapsidated in phage-like infectious particles, leading to extremely high frequencies of intra-as well as intergeneric transfer(1-3). In the absence of helper phage lytic growth, the island is maintained in a quiescent prophage-like state by a global repressor, Stl, which controls expression of most of the SaPI genes(4). Here we show that SaPI derepression is effected by a specific, non-essential phage protein that binds to Stl, disrupting the Stl-DNA complex and thereby initiating the excision-replication-packaging cycle of the island. Because SaPIs require phage proteins to be packaged(5,6), this strategy assures that SaPIs will be transferred once induced. Several different SaPIs are induced by helper phage 80 alpha and, in each case, the SaPI commandeers a different non-essential phage protein for its derepression. The highly specific interactions between different SaPI repressors and helper-phage-encoded anti-repressors represent a remarkable evolutionary adaptation involved in pathogenicity island mobilization.	[Angeles Tormo-Mas, Maria; Mir, Ignacio; Penades, Jose R.] Inst Valenciano Invest Agr, CITA, Segorbe 12400, Castellon, Spain; [Shrestha, Archana; Tallent, Sandra M.; Christie, Gail E.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA; [Campoy, Susana; Barbe, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain; [Lasa, Inigo] Univ Publ Navarra, CSIC, Inst Agrobiotecnol, Navarra 31006, Spain; [Novick, Richard P.] NYU, Med Ctr, Skirball Inst Program Mol Pathogenesis, New York, NY 10016 USA; [Novick, Richard P.] NYU, Med Ctr, Dept Microbiol, New York, NY 10016 USA; [Novick, Richard P.] NYU, Med Ctr, Dept Med, New York, NY 10016 USA; [Penades, Jose R.] Univ Cardenal Herrera CEU, Dept Quim Bioquim & Biol Mol, Valencia 46113, Spain	Instituto Valenciano de Investigaciones Agrarias (IVIA); Virginia Commonwealth University; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; New York University; New York University; New York University; Universidad CEU Cardenal Herrera	Penades, JR (corresponding author), Inst Valenciano Invest Agr, CITA, Apdo 187, Segorbe 12400, Castellon, Spain.	penades_jos@gva.es	Mas, Maria Angeles Tormo/K-5085-2014; Campoy, Susana/C-7335-2008; Lasa, Iñigo/F-2947-2011; Barbe, Jordi/G-5212-2015; Tormo-Mas, María Ángeles/ABF-5881-2020; Mir Sanchis, Ignacio/L-6759-2016; campoy, susana/E-4346-2010; Penadés, José R/W-9685-2019	Mas, Maria Angeles Tormo/0000-0001-8928-2697; Campoy, Susana/0000-0003-1369-0197; Lasa, Iñigo/0000-0002-6625-9221; Barbe, Jordi/0000-0003-4408-013X; Tormo-Mas, María Ángeles/0000-0001-8928-2697; Mir Sanchis, Ignacio/0000-0002-6536-0045; campoy, susana/0000-0003-1369-0197; Penadés, José R/0000-0002-6439-5262; Novick, richard/0000-0003-4418-7893	Ministerio de Ciencia e Innovacion (MICINN) [CSD2009-00006, BIO2005-08399-C02-02, BIO2008-05284-C02-02, BIO2008-00642-E/C, BFU2008-01078]; Cardenal Herrera-CEU University [PRCEU-UCH25/08]; Conselleria de Agricultura, Pesca i Alimentacio (CAPiA); Generalitat Valenciana [ACOMP07/258]; Generalitat de Catalunya [2009SGR1106]; NIH [R21AI067654, R01AI022159-23A2]; A. D. Williams Trust; Baruch Foundation Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022159, R21AI067654] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cardenal Herrera-CEU University; Conselleria de Agricultura, Pesca i Alimentacio (CAPiA); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Generalitat de Catalunya(Generalitat de Catalunya); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A. D. Williams Trust; Baruch Foundation Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Casadesus and J. M. Ghigo for comments on the manuscript. This work was supported by grants Consolider-Ingenio CSD2009-00006, BIO2005-08399-C02-02, BIO2008-05284-C02-02 and BIO2008-00642-E/C from the Ministerio de Ciencia e Innovacion (MICINN), grants from the Cardenal Herrera-CEU University (PRCEU-UCH25/08 and Copernicus program), from the Conselleria de Agricultura, Pesca i Alimentacio (CAPiA) and from the Generalitat Valenciana (ACOMP07/258) to J. R. P.; grants BFU2008-01078 from the MICINN and 2009SGR1106 from the Generalitat de Catalunya to J. B.; NIH grant R21AI067654 and a grant-in-aid from the A. D. Williams Trust and the Baruch Foundation Trust to G. E. C.; and NIH grant R01AI022159-23A2 to R.P.N. Fellowship support for M. A. T.-M. from the Generalitat Valenciana is gratefully acknowledged.	Tormo MA, 2008, J BACTERIOL, V190, P2434, DOI 10.1128/JB.01349-07; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; AUSUBEL FM, 1990, CURRENT PROTOCOLS MO; Chan S, 2004, J MOL BIOL, V341, P503, DOI 10.1016/j.jmb.2004.06.028; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Chen J, 2009, SCIENCE, V323, P139, DOI 10.1126/science.1164783; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Liu J, 2004, NAT BIOTECHNOL, V22, P185, DOI 10.1038/nbt932; NOVICK RP, 2010, NATURE REV IN PRESS; Tallent SM, 2007, J BACTERIOL, V189, P7520, DOI 10.1128/JB.00738-07; Ubeda C, 2005, MOL MICROBIOL, V56, P836, DOI 10.1111/j.1365-2958.2005.04584.x; Ubeda C, 2008, MOL MICROBIOL, V67, P493, DOI 10.1111/j.1365-2958.2007.06027.x; Ubeda C, 2007, MOL MICROBIOL, V65, P41, DOI 10.1111/j.1365-2958.2007.05758.x; Varga B, 2008, BIOCHEM BIOPH RES CO, V373, P8, DOI 10.1016/j.bbrc.2008.05.130	15	124	127	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					779	U7		10.1038/nature09065	http://dx.doi.org/10.1038/nature09065			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20473284	Green Accepted, Green Submitted			2022-12-24	WOS:000278551800045
J	Gregor, T; Fujimoto, K; Masaki, N; Sawai, S				Gregor, Thomas; Fujimoto, Koichi; Masaki, Noritaka; Sawai, Satoshi			The Onset of Collective Behavior in Social Amoebae	SCIENCE			English	Article							DICTYOSTELIUM-DISCOIDEUM; CHEMICAL OSCILLATORS; SIGNAL PROPAGATION; QUORUM; SYNCHRONIZATION; POPULATIONS; DYNAMICS; CIRCUIT; CLOCKS; RELAY	In the social amoebae Dictyostelium discoideum, periodic synthesis and release of extracellular cyclic adenosine 3',5'-monophosphate (cAMP) guide cell aggregation and commitment to form fruiting bodies. It is unclear whether these oscillations are an intrinsic property of individual cells or if they exist only as a population-level phenomenon. Here, we showed by live-cell imaging of intact cell populations that pulses originate from a discrete location despite constant exchange of cells to and from the region. In a perfusion chamber, both isolated single cells and cell populations switched from quiescence to rhythmic activity depending on the concentration of extracellular cAMP. A quantitative analysis showed that stochastic pulsing of individual cells below the threshold concentration of extracellular cAMP plays a critical role in the onset of collective behavior.	[Gregor, Thomas; Sawai, Satoshi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1538902, Japan; [Fujimoto, Koichi; Masaki, Noritaka; Sawai, Satoshi] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO Complex Syst Bi, Tokyo 1538902, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Sawai, S (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1538902, Japan.	cssawai@mail.ecc.u-tokyo.ac.jp	Fujimoto, Koichi/J-8454-2013; Sawai, Satoshi/AAX-8536-2020	Fujimoto, Koichi/0000-0001-6473-7990; Gregor, Thomas/0000-0001-9460-139X; Sawai, Satoshi/0000-0003-3764-219X	Japan Society for the Promotion of Science (JSPS); ERATO-JST; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098407, P50GM071508] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22680024] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ERATO-JST(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank V. O. Nikolaev and M. J. Lohse for providing vector containing Epac1-camps; M. Kitahara and E. Hada for technical help, E. C. Cox, S. Ishihara, K. Kaneko, H. Kori, and J. Teramae for discussions and suggestions; and the Japan Society for the Promotion of Science (JSPS) postdoctoral fellowship (T. G.), K. Kaneko, and the ERATO-JST for support.	Bosgraaf L, 2008, J CELL SCI, V121, P3589, DOI 10.1242/jcs.031781; BUCK J, 1968, SCIENCE, V159, P1319, DOI 10.1126/science.159.3821.1319; Corner FI, 2005, CURR BIOL, V15, P134, DOI 10.1016/j.cub.2005.01.007; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; De Monte S, 2007, P NATL ACAD SCI USA, V104, P18377, DOI 10.1073/pnas.0706089104; DEVREOTES PN, 1979, J CELL BIOL, V80, P291, DOI 10.1083/jcb.80.2.291; DINAUER MC, 1980, J CELL BIOL, V86, P537, DOI 10.1083/jcb.86.2.537; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; GERISCH G, 1975, BIOCHEM BIOPH RES CO, V65, P364, DOI 10.1016/S0006-291X(75)80102-1; Goldbeter A., 1996, BIOCH OSCILLATIONS C; GROSS JD, 1976, J CELL SCI, V22, P645; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; JOHNSON RL, 1992, J BIOL CHEM, V267, P4600; Kim L, 2002, DEV CELL, V3, P523, DOI 10.1016/S1534-5807(02)00269-1; Kiss IZ, 2002, SCIENCE, V296, P1676, DOI 10.1126/science.1070757; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Sawai S, 2005, NATURE, V433, P323, DOI 10.1038/nature03228; SIEGERT F, 1989, J CELL SCI, V93, P325; Taylor AF, 2009, SCIENCE, V323, P614, DOI 10.1126/science.1166253; Thomason PA, 1998, EMBO J, V17, P2838, DOI 10.1093/emboj/17.10.2838; TOMCHIK KJ, 1981, SCIENCE, V212, P443, DOI 10.1126/science.6259734; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Wiesenfeld K, 1996, PHYS REV LETT, V76, P404, DOI 10.1103/PhysRevLett.76.404; WINFREE AT, 1980, BIOMATHEMATICS SERIE; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	28	215	216	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2010	328	5981					1021	1025		10.1126/science.1183415	http://dx.doi.org/10.1126/science.1183415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20413456	Green Accepted			2022-12-24	WOS:000277877100039
J	Barash, Y; Calarco, JA; Gao, WJ; Pan, Q; Wang, XC; Shai, O; Blencowe, BJ; Frey, BJ				Barash, Yoseph; Calarco, John A.; Gao, Weijun; Pan, Qun; Wang, Xinchen; Shai, Ofer; Blencowe, Benjamin J.; Frey, Brendan J.			Deciphering the splicing code	NATURE			English	Article							TRACT BINDING-PROTEIN; REGULATORY ELEMENTS; EXPORTIN 4; RNA; EXONS; IDENTIFICATION; EXPRESSION; EXCLUSION; INSIGHTS; PATHWAY	Alternative splicing has a crucial role in the generation of biological complexity, and its misregulation is often involved in human disease. Here we describe the assembly of a 'splicing code', which uses combinations of hundreds of RNA features to predict tissue-dependent changes in alternative splicing for thousands of exons. The code determines new classes of splicing patterns, identifies distinct regulatory programs in different tissues, and identifies mutation-verified regulatory sequences. Widespread regulatory strategies are revealed, including the use of unexpectedly large combinations of features, the establishment of low exon inclusion levels that are overcome by features in specific tissues, the appearance of features deeper into introns than previously appreciated, and the modulation of splice variant levels by transcript structure characteristics. The code detected a class of exons whose inclusion silences expression in adult tissues by activating nonsense-mediated messenger RNA decay, but whose exclusion promotes expression during embryogenesis. The code facilitates the discovery and detailed characterization of regulated alternative splicing events on a genome-wide scale.	[Barash, Yoseph; Gao, Weijun; Wang, Xinchen; Shai, Ofer; Frey, Brendan J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; [Barash, Yoseph; Calarco, John A.; Pan, Qun; Wang, Xinchen; Blencowe, Benjamin J.; Frey, Brendan J.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Barash, Yoseph; Calarco, John A.; Pan, Qun; Wang, Xinchen; Blencowe, Benjamin J.; Frey, Brendan J.] Univ Toronto, Donnelly Ctr, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Frey, Brendan J.] Microsoft Res, Cambridge, England	University of Toronto; University of Toronto; University of Toronto; Microsoft	Frey, BJ (corresponding author), Univ Toronto, Dept Elect & Comp Engn, 10 Kings Coll Rd, Toronto, ON M5S 3G4, Canada.	b.blencowe@utoronto.ca; frey@psi.toronto.edu	Gao, Weijun/A-6350-2011	Barash, Yoseph/0000-0003-3005-5048; Wang, Xinchen/0000-0002-5198-6581	Genome Canada through the OGI; NSERC/CFI/OIT CRC; CIHR; NCIC; NSERC EWR Steacie; Canadian Institute for Advanced Research	Genome Canada through the OGI(Genome Canada); NSERC/CFI/OIT CRC(Natural Sciences and Engineering Research Council of Canada (NSERC)Canada Foundation for Innovation); CIHR(Canadian Institutes of Health Research (CIHR)); NCIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSERC EWR Steacie; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	We thank D. L. Black, D. Botstein, S. E. Brenner, C. B. Burge, B. Chabot, R. Durbin, X.-D. Fu, B. R. Graveley, T. R. Hughes, N. Jojic, C. W. J. Smith, S. Tavazoie and members of our various laboratories for discussions or comments on the manuscript; D. D. Licatalosi and R. B. Darnell for communicating unpublished results; and S. Chaudhry for RT-PCR work. B. J. F. also thanks C. M. Bishop and D. J. C. MacKay for hosting him during his sabbatical in Cambridge. This research was funded by a grant from Genome Canada through the OGI to B. J. B., B. J. F. and others; an NSERC/CFI/OIT CRC grant to B. J. F.; CIHR grants to B. J. F. and B. J. B.; an NCIC grant to B. J. B.; and NSERC EWR Steacie and Canadian Institute for Advanced Research Fellowships to B. J. F.	Ashiya M, 1997, RNA, V3, P996; Bishop C.M., 2006, PATTERN RECOGNITION; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; Cote J, 2001, P NATL ACAD SCI USA, V98, P938, DOI 10.1073/pnas.031564098; Das D, 2007, NUCLEIC ACIDS RES, V35, P4845, DOI 10.1093/nar/gkm485; Fagnani M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r108; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Faustino NA, 2005, MOL CELL BIOL, V25, P879, DOI 10.1128/MCB.25.3.879-887.2005; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Gontan C, 2009, J CELL BIOL, V185, P27, DOI 10.1083/jcb.200810106; Gooding C, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r1; Hallegger M, 2010, FEBS J, V277, P856, DOI 10.1111/j.1742-4658.2009.07521.x; Hartmann B, 2009, CURR OPIN CELL BIOL, V21, P377, DOI 10.1016/j.ceb.2009.02.006; Hayakawa M, 2002, J BIOL CHEM, V277, P6974, DOI 10.1074/jbc.M110138200; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Kawamoto S, 1996, J BIOL CHEM, V271, P17613; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lim LP, 1998, MOL CELL BIOL, V18, P3900, DOI 10.1128/MCB.18.7.3900; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Minovitsky S, 2005, NUCLEIC ACIDS RES, V33, P714, DOI 10.1093/nar/gki210; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Perez I, 1997, RNA, V3, P764; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Shai O, 2006, BIOINFORMATICS, V22, P606, DOI 10.1093/bioinformatics/btk028; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shepard PJ, 2008, RNA, V14, P1463, DOI 10.1261/rna.1069408; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Stadler MB, 2006, PLOS GENET, V2, P1849, DOI 10.1371/journal.pgen.0020191; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wei N, 1997, RNA, V3, P1275; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Xiao XS, 2007, P NATL ACAD SCI USA, V104, P18583, DOI 10.1073/pnas.0707349104; Xie JY, 2005, RNA, V11, P1825, DOI 10.1261/rna.2171205; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304	50	560	587	0	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					53	59		10.1038/nature09000	http://dx.doi.org/10.1038/nature09000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20445623				2022-12-24	WOS:000277311900029
J	McClellan, J; King, MC				McClellan, Jon; King, Mary-Claire			Genetic Heterogeneity in Human Disease	CELL			English	Article							COLORECTAL-CANCER; ASSOCIATION; SCHIZOPHRENIA; AUTISM; VARIANTS; PATHWAYS; RISK; STRATIFICATION; DISORDERS; RS6983267		[McClellan, Jon] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Med, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McClellan, J (corresponding author), Univ Washington, Dept Psychiat, Seattle, WA 98195 USA.	drjack@uw.edu; mcking@uw.edu		King, Mary-Claire/0000-0001-9426-1743				Bird TD, 2005, NEW ENGL J MED, V352, P862, DOI 10.1056/NEJMp058027; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Fahmi S, 2008, HUM MOL GENET, V17, P2101, DOI 10.1093/hmg/ddn108; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Galton F., 1872, P R SOC LONDON, V20, P394, DOI DOI 10.1098/RSPL.1871.0075; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Gurwitz D, 2007, PHARMACOGENOMICS, V8, P1479, DOI 10.2217/14622416.8.11.1479; Kristiansson K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-109; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Nachman MW, 2000, GENETICS, V156, P297; OLSON MV, 1995, SCIENCE, V270, P394, DOI 10.1126/science.270.5235.394; Patrinos GR, 2005, HUM MUTAT, V26, P399, DOI 10.1002/humu.20225; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; RISCH N, 1996, SCIENCE, V273, P1517; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Serre D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001382; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Wright S, 1934, GENETICS, V19, P0537; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162	50	698	728	0	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 16	2010	141	2					210	217		10.1016/j.cell.2010.03.032	http://dx.doi.org/10.1016/j.cell.2010.03.032			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403315	Bronze			2022-12-24	WOS:000276738400008
J	Ashley, EA; Butte, AJ; Wheeler, MT; Chen, R; Klein, TE; Dewey, FE; Dudley, JT; Ormond, KE; Pavlovic, A; Morgan, AA; Pushkarev, D; Neff, NF; Hudgins, L; Gong, L; Hodges, LM; Berlin, DS; Thorn, CF; Sangkuhl, K; Hebert, JM; Woon, M; Sagreiya, H; Whaley, R; Knowles, JW; Chou, MF; Thakuria, JV; Rosenbaum, AM; Zaranek, AW; Church, GM; Greely, HT; Quake, SR; Altman, RB				Ashley, Euan A.; Butte, Atul J.; Wheeler, Matthew T.; Chen, Rong; Klein, Teri E.; Dewey, Frederick E.; Dudley, Joel T.; Ormond, Kelly E.; Pavlovic, Aleksandra; Morgan, Alexander A.; Pushkarev, Dmitry; Neff, Norma F.; Hudgins, Louanne; Gong, Li; Hodges, Laura M.; Berlin, Dorit S.; Thorn, Caroline F.; Sangkuhl, Katrin; Hebert, Joan M.; Woon, Mark; Sagreiya, Hersh; Whaley, Ryan; Knowles, Joshua W.; Chou, Michael F.; Thakuria, Joseph V.; Rosenbaum, Abraham M.; Zaranek, Alexander Wait; Church, George M.; Greely, Henry T.; Quake, Stephen R.; Altman, Russ B.			Clinical assessment incorporating a personal genome	LANCET			English	Article							HYPERTROPHIC CARDIOMYOPATHY; GENE; POLYMORPHISMS; MUTATIONS; ASSOCIATION; VARIANTS; DATABASE; GENOTYPE; APOLIPOPROTEIN(A); IDENTIFICATION	Background The cost of genomic information has fallen steeply, but the clinical translation of genetic risk estimates remains unclear. We aimed to undertake an integrated analysis of a complete human genome in a clinical context. Methods We assessed a patient with a family history of vascular disease and early sudden death. Clinical assessment included analysis of this patient's full genome sequence, risk prediction for coronary artery disease, screening for causes of sudden cardiac death, and genetic counselling. Genetic analysis included the development of novel methods for the integration of whole genome and clinical risk. Disease and risk analysis focused on prediction of genetic risk of variants associated with mendelian disease, recognised drug responses, and pathogenicity for novel variants. We queried disease-specific mutation databases and pharmacogenomics databases to identify genes and mutations with known associations with disease and drug response. We estimated post-test probabilities of disease by applying likelihood ratios derived from integration of multiple common variants to age-appropriate and sex-appropriate pretest probabilities. We also accounted for gene-environment interactions and conditionally dependent risks. Findings Analysis of 2.6 million single nucleotide polymorphisms and 752 copy number variations showed increased genetic risk for myocardial infarction, type 2 diabetes, and some cancers. We discovered rare variants in three genes that are clinically associated with sudden cardiac death-TMEM43, DSP, and MYBPC3. A variant in LPA was consistent with a family history of coronary artery disease. The patient had a heterozygous null mutation in CYP2C19 suggesting probable clopidogrel resistance, several variants associated with a positive response to lipid-lowering therapy, and variants in CYP4F2 and VKORC1 that suggest he might have a low initial dosing requirement for warfarin. Many variants of uncertain importance were reported. Interpretation Although challenges remain, our results suggest that whole-genome sequencing can yield useful and clinically relevant information for individual patients.	[Ashley, Euan A.; Wheeler, Matthew T.; Dewey, Frederick E.; Pavlovic, Aleksandra; Knowles, Joshua W.] Stanford Univ, Sch Med, Div Cardiovasc Med, Ctr Inherited Cardiovasc Dis, Stanford, CA 94305 USA; [Altman, Russ B.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Pushkarev, Dmitry; Neff, Norma F.; Quake, Stephen R.; Altman, Russ B.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Hudgins, Louanne] Stanford Univ, Sch Med, Div Med Genet, Stanford, CA 94305 USA; [Butte, Atul J.; Chen, Rong; Dudley, Joel T.; Morgan, Alexander A.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Pushkarev, Dmitry; Neff, Norma F.; Quake, Stephen R.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Klein, Teri E.; Ormond, Kelly E.; Gong, Li; Hodges, Laura M.; Berlin, Dorit S.; Thorn, Caroline F.; Sangkuhl, Katrin; Hebert, Joan M.; Woon, Mark; Sagreiya, Hersh; Whaley, Ryan; Altman, Russ B.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Greely, Henry T.] Stanford Univ, Sch Law, Ctr Law & Biosci, Stanford, CA 94305 USA; [Thakuria, Joseph V.] Massachusetts Gen Hosp, Div Clin & Biochem Genet, Boston, MA 02114 USA; [Chou, Michael F.; Thakuria, Joseph V.; Rosenbaum, Abraham M.; Zaranek, Alexander Wait; Church, George M.] Harvard Univ, Dept Genet, Boston, MA 02115 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Harvard University; Massachusetts General Hospital; Harvard University	Ashley, EA (corresponding author), Falk Cardiovasc Res Bldg,300 Pasteur Dr, Stanford, CA 94305 USA.	euan@stanford.edu	Dudley, Joel T/E-9283-2010; Ormond, Kelly E/I-5676-2019; Sagreiya, Hersh/Z-1641-2019	Ormond, Kelly E/0000-0002-1033-0818; Zaranek, Alexander (Sasha) Wait/0000-0002-0415-9655; Thorn, Caroline/0000-0001-5789-5747; Klein, Teri/0000-0001-5527-6475; Whaley, Ryan/0000-0002-8810-3893; church, george/0000-0001-6232-9969; Wheeler, Matthew/0000-0001-8721-3022	National Institute of General Medical Sciences; National Heart, Lung And Blood Institute; National Human Genome Research Institute; Howard Hughes Medical Institute; National Library of Medicine, Lucile Packard Foundation for Children's Health; Hewlett Packard Foundation; Breetwor Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL097462, K08HL083914, T32HL094274] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079719, U01GM061374, R24GM061374] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033, R01LM009719] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006511] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung And Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Library of Medicine, Lucile Packard Foundation for Children's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Hewlett Packard Foundation; Breetwor Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding National Institute of General Medical Sciences; National Heart, Lung And Blood Institute; National Human Genome Research Institute; Howard Hughes Medical Institute; National Library of Medicine, Lucile Packard Foundation for Children's Health; Hewlett Packard Foundation; Breetwor Family Foundation.	Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Chasman DI, 2009, ATHEROSCLEROSIS, V203, P371, DOI 10.1016/j.atherosclerosis.2008.07.019; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Couvert P, 2008, PHARMACOGENOMICS, V9, P1217, DOI 10.2217/14622416.9.9.1217; CUPPENS H, 1990, HUM GENET, V85, P402, DOI 10.1007/BF02428277; Evangelou E, 2009, ARTHRITIS RHEUM-US, V60, P1710, DOI 10.1002/art.24524; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hymes J, 2001, HUM MUTAT, V18, P375, DOI 10.1002/humu.1208; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Jegga AG, 2007, NUCLEIC ACIDS RES, V35, pD700, DOI 10.1093/nar/gkl826; Johnson JA, 2003, CLIN PHARMACOL THER, V74, P44, DOI 10.1016/S0009-9236(03)00068-7; Kamstrup PR, 2008, J CLIN ENDOCR METAB, V93, P3769, DOI 10.1210/jc.2008-0830; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kaye DM, 2003, PHARMACOGENETICS, V13, P379, DOI 10.1097/00008571-200307000-00002; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kivisto KT, 2007, PHARM RES-DORDR, V24, P239, DOI 10.1007/s11095-006-9159-2; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Lanfear DE, 2005, JAMA-J AM MED ASSOC, V294, P1526, DOI 10.1001/jama.294.12.1526; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Luke MM, 2007, ARTERIOSCL THROM VAS, V27, P2030, DOI 10.1161/ATVBAHA.107.141291; Maron BJ, 2001, J AM COLL CARDIOL, V38, P315, DOI 10.1016/S0735-1097(01)01386-9; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Merner ND, 2008, AM J HUM GENET, V82, P809, DOI 10.1016/j.ajhg.2008.01.010; Moore AF, 2008, DIABETES, V57, P2503, DOI 10.2337/db08-0284; Morner S, 2003, J MOL CELL CARDIOL, V35, P841, DOI 10.1016/S0022-2828(03)00146-9; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nishizato Y, 2003, CLIN PHARMACOL THER, V73, P554, DOI 10.1016/S0009-9236(03)00060-2; Pacanowski MA, 2008, CLIN PHARMACOL THER, V84, P715, DOI 10.1038/clpt.2008.139; Perez-Andreu V, 2009, BLOOD, V113, P4977, DOI 10.1182/blood-2008-09-176222; PULKKINEN L, 1994, GENOMICS, V24, P357, DOI 10.1006/geno.1994.1627; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rau T, 2009, CLIN PHARMACOL THER, V85, P269, DOI 10.1038/clpt.2008.218; Rossi A, 2001, HUM MUTAT, V17, P159, DOI 10.1002/humu.1; Shattuck TM, 2003, NEW ENGL J MED, V349, P1722, DOI 10.1056/NEJMoa031237; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002; Tomatsu S, 2003, P NATL ACAD SCI USA, V100, P15788, DOI 10.1073/pnas.2237037100; Tucker T, 2009, AM J HUM GENET, V85, P142, DOI 10.1016/j.ajhg.2009.06.022; van der Zwaag PA, 2009, HUM MUTAT, V30, P1278, DOI 10.1002/humu.21064; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6; Yuan HY, 2005, HUM MOL GENET, V14, P1745, DOI 10.1093/hmg/ddi180	54	489	507	1	204	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2010	375	9725					1525	1535		10.1016/S0140-6736(10)60452-7	http://dx.doi.org/10.1016/S0140-6736(10)60452-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AH	20435227	Green Accepted			2022-12-24	WOS:000277655100025
J	Zheng, W; Zhao, HY; Mancera, E; Steinmetz, LM; Snyder, M				Zheng, Wei; Zhao, Hongyu; Mancera, Eugenio; Steinmetz, Lars M.; Snyder, Michael			Genetic analysis of variation in transcription factor binding in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; EXPRESSION PROFILES; FILAMENTOUS GROWTH; BUDDING YEAST; OVEREXPRESSION; REGULATORS; SITES; MCM1; MAP	Variation in transcriptional regulation is thought to be a major cause of phenotypic diversity(1,2). Although widespread differences in gene expression among individuals of a species have been observed(3-8), studies to examine the variability of transcription factor binding on a global scale have not been performed, and thus the extent and underlying genetic basis of transcription factor binding diversity is unknown. By mapping differences in transcription factor binding among individuals, here we present the genetic basis of such variation on a genome-wide scale. Whole-genome Ste12-binding profiles were determined using chromatin immunoprecipitation coupled with DNA sequencing in pheromone-treated cells of 43 segregants of a cross between two highly diverged yeast strains and their parental lines. We identified extensive Ste12-binding variation among individuals, and mapped underlying cis- and trans-acting loci responsible for such variation. We showed that most transcription factor binding variation is cis- linked, and that many variations are associated with polymorphisms residing in the binding motifs of Ste12 as well as those of several proposed Ste12 cofactors. We also identified two transfactors, AMN1 and FLO8, that modulate Ste12 binding to promoters of more than ten genes under alpha-factor treatment. Neither of these two genes was previously known to regulate Ste12, and we suggest that they may be mediators of gene activity and phenotypic diversity. Ste12 binding strongly correlates with gene expression for more than 200 genes, indicating that binding variation is functional. Many of the variable-bound genes are involved in cell wall organization and biogenesis. Overall, these studies identified genetic regulators of molecular diversity among individuals and provide new insights into mechanisms of gene regulation.	[Zheng, Wei; Snyder, Michael] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Zhao, Hongyu] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Zhao, Hongyu] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; [Mancera, Eugenio; Steinmetz, Lars M.] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Yale University; Yale University; Yale University; European Molecular Biology Laboratory (EMBL); Stanford University	Snyder, M (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	mpsnyder@stanford.edu	Mancera, Eugenio/M-6334-2016	Mancera, Eugenio/0000-0003-0146-8732; Steinmetz, Lars/0000-0002-3962-2865; Snyder, Michael/0000-0003-0784-7987	National Institutes of Health (NIH) [RR19895]; NATIONAL CANCER INSTITUTE [R01CA077808] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068717, R01GM059507] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Gagneur for comments on data analysis, the Cornell Microarray Facility for helping with the gene expression experiments, A. Lin for preprocessing of microarray data, C. Yellman for technical help, and Yale University Biomedical High Performance Computing Center (NIH grant RR19895) for providing computation resources. Research was funded by National Institutes of Health (NIH) grants to M. S., H. Z. and L. M. S.	Aparicio Oscar, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1707s23; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; GIMENO CJ, 1994, MOL CELL BIOL, V14, P2100, DOI 10.1128/MCB.14.3.2100; Gordon DB, 2005, BIOINFORMATICS, V21, P3164, DOI 10.1093/bioinformatics/bti481; HWANGSHUM JJ, 1991, MOL GEN GENET, V227, P197, DOI 10.1007/BF00259671; Jin R, 2008, MOL BIOL CELL, V19, P284, DOI 10.1091/mbc.E07-05-0519; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kobayashi O, 1996, MOL GEN GENET, V251, P707, DOI 10.1007/s004380050220; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Liu HP, 1996, GENETICS, V144, P967; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Ni L, 2009, GENE DEV, V23, P1351, DOI 10.1101/gad.1781909; Pennisi E, 2004, SCIENCE, V306, P632, DOI 10.1126/science.306.5696.632; Pramila T, 2002, GENE DEV, V16, P3034, DOI 10.1101/gad.1034302; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	33	122	124	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1187	U106		10.1038/nature08934	http://dx.doi.org/10.1038/nature08934			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20237471	Green Accepted			2022-12-24	WOS:000276891100036
J	Wu, Y; Cain-Hom, C; Choy, L; Hagenbeek, TJ; de Leon, GP; Chen, YM; Finkle, D; Venook, R; Wu, XM; Ridgway, J; Schahin-Reed, D; Dow, GJ; Shelton, A; Stawicki, S; Watts, RJ; Zhang, J; Choy, R; Howard, P; Kadyk, L; Yan, MH; Zha, JP; Callahan, CA; Hymowitz, SG; Siebel, CW				Wu, Yan; Cain-Hom, Carol; Choy, Lisa; Hagenbeek, Thijs J.; de Leon, Gladys P.; Chen, Yongmei; Finkle, David; Venook, Rayna; Wu, Xiumin; Ridgway, John; Schahin-Reed, Dorreyah; Dow, Graham J.; Shelton, Amy; Stawicki, Scott; Watts, Ryan J.; Zhang, Jeff; Choy, Robert; Howard, Peter; Kadyk, Lisa; Yan, Minhong; Zha, Jiping; Callahan, Christopher A.; Hymowitz, Sarah G.; Siebel, Christian W.			Therapeutic antibody targeting of individual Notch receptors	NATURE			English	Article							INHIBITS TUMOR-GROWTH; GAMMA-SECRETASE; ANTI-P185HER2 ANTIBODY; MALIGNANT-MELANOMA; REGULATORY REGION; CANCER-THERAPY; B-CELLS; MUTATIONS; LEUKEMIA; ANGIOGENESIS	The four receptors of the Notch family are widely expressed transmembrane proteins that function as key conduits through which mammalian cells communicate to regulate cell fate and growth(1,2). Ligand binding triggers a conformational change in the receptor negative regulatory region (NRR) that enables ADAM protease cleavage(3,4) at a juxtamembrane site that otherwise lies buried within the quiescent NRR5,6. Subsequent intramembrane proteolysis catalysed by the c-secretase complex liberates the intracellular domain (ICD) to initiate the downstream Notch transcriptional program. Aberrant signalling through each receptor has been linked to numerous diseases, particularly cancer(7), making the Notch pathway a compelling target for new drugs. Although gamma-secretase inhibitors (GSIs) have progressed into the clinic(8), GSIs fail to distinguish individual Notch receptors, inhibit other signalling pathways(9) and cause intestinal toxicity(10), attributed to dual inhibition of Notch1 and 2 (ref. 11). To elucidate the discrete functions of Notch1 and Notch2 and develop clinically relevant inhibitors that reduce intestinal toxicity, we used phage display technology to generate highly specialized antibodies that specifically antagonize each receptor paralogue and yet cross-react with the human and mouse sequences, enabling the discrimination of Notch1 versus Notch2 function in human patients and rodent models. Our co-crystal structure shows that the inhibitory mechanism relies on stabilizing NRR quiescence. Selective blocking of Notch1 inhibits tumour growth in pre-clinical models through two mechanisms: inhibition of cancer cell growth and deregulation of angiogenesis. Whereas inhibition of Notch1 plus Notch2 causes severe intestinal toxicity, inhibition of either receptor alone reduces or avoids this effect, demonstrating a clear advantage over pan-Notch inhibitors. Our studies emphasize the value of paralogue-specific antagonists in dissecting the contributions of distinct Notch receptors to differentiation and disease and reveal the therapeutic promise in targeting Notch1 and Notch2 independently.	[Cain-Hom, Carol; Choy, Lisa; Hagenbeek, Thijs J.; Dow, Graham J.; Shelton, Amy; Siebel, Christian W.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Wu, Yan; Chen, Yongmei; Stawicki, Scott] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Zha, Jiping; Callahan, Christopher A.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Finkle, David; Venook, Rayna] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Wu, Xiumin; Ridgway, John; Yan, Minhong] Genentech Inc, Dept Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA; [Schahin-Reed, Dorreyah; Watts, Ryan J.] Genentech Inc, Dept Neurodegenerat, San Francisco, CA 94080 USA; [de Leon, Gladys P.; Hymowitz, Sarah G.] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Zhang, Jeff; Choy, Robert; Howard, Peter; Kadyk, Lisa] Exelixis Inc, San Francisco, CA 94083 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Exelixis, Inc.	Siebel, CW (corresponding author), Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA.	csiebel@gene.com	Kadyk, Lisa/W-5243-2019	Dow, Graham/0000-0003-2986-9677	Department of Energy, National Institutes of Health; National Institute of General Medical Sciences	Department of Energy, National Institutes of Health(United States Department of Energy (DOE)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the Notch scientists at Genentech and Exelixis for support throughout this project. In particular, we thank the following contributors at Exelixis: S.-H. Lin, L. Doukhan, S. Weiss, N. Benin and R. Mercer for protein production, purification and analysis, R. Funke for cloning and sequencing and D. Buckley and J. Greve for scientific discussions and guidance. We thank the Genentech protein expression group, R. Vij and J.-A. Hongo for help with antibody characterization, F. Bazan and C. Sanchez-Irizarry for stimulating discussions and critically reading the manuscript, J. Eastham-Anderson for morphometric analysis of the intestines, Y. Shang for making mutant Notch1 expression plasmids, S. Seshagiri for MT-3 sequencing, E. Quan for initial work with T-ALL lines, S. Chaudhuri for cloning and antibody characterization, and G. Plowman for insights and guidance. We appreciate the important contributions of F. de Sauvage, who helped initiate this collaborative project and provided guidance throughout. The Advanced Light Source and Berkeley Center for Structural Biology are supported by the Department of Energy, National Institutes of Health, and the National Institute of General Medical Sciences.	Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gordon WR, 2009, BLOOD, V113, P4381, DOI 10.1182/blood-2008-08-174748; Hagenbeek TJ, 2008, LEUKEMIA, V22, P608, DOI 10.1038/sj.leu.2405056; Hagenbeek TJ, 2004, J EXP MED, V200, P883, DOI 10.1084/jem.20040495; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Jonsson G, 2007, ONCOGENE, V26, P4738, DOI 10.1038/sj.onc.1210252; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Lee SY, 2009, CANCER SCI, V100, P920, DOI 10.1111/j.1349-7006.2009.01130.x; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Massi D, 2006, MODERN PATHOL, V19, P246, DOI 10.1038/modpathol.3800526; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Qin JZ, 2004, MOL CANCER THER, V3, P895; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; Troen G, 2008, HAEMATOL-HEMATOL J, V93, P1107, DOI 10.3324/haematol.11635; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Witt CM, 2003, J IMMUNOL, V171, P2783, DOI 10.4049/jimmunol.171.6.2783	38	537	604	3	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1052	U122		10.1038/nature08878	http://dx.doi.org/10.1038/nature08878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393564	Bronze			2022-12-24	WOS:000276635000041
J	Simonson, TS; Yang, YZ; Huff, CD; Yun, HX; Qin, G; Witherspoon, DJ; Bai, ZZ; Lorenzo, FR; Xing, JC; Jorde, LB; Prchal, JT; Ge, RL				Simonson, Tatum S.; Yang, Yingzhong; Huff, Chad D.; Yun, Haixia; Qin, Ga; Witherspoon, David J.; Bai, Zhenzhong; Lorenzo, Felipe R.; Xing, Jinchuan; Jorde, Lynn B.; Prchal, Josef T.; Ge, RiLi			Genetic Evidence for High-Altitude Adaptation in Tibet	SCIENCE			English	Article							CHRONIC MOUNTAIN-SICKNESS; POSITIVE SELECTION; EXERCISE PERFORMANCE; HAN RESIDENTS; HEMOGLOBIN; SEQUENCE; SIGNALS	Tibetans have lived at very high altitudes for thousands of years, and they have a distinctive suite of physiological traits that enable them to tolerate environmental hypoxia. These phenotypes are clearly the result of adaptation to this environment, but their genetic basis remains unknown. We report genome-wide scans that reveal positive selection in several regions that contain genes whose products are likely involved in high-altitude adaptation. Positively selected haplotypes of EGLN1 and PPARA were significantly associated with the decreased hemoglobin phenotype that is unique to this highland population. Identification of these genes provides support for previously hypothesized mechanisms of high-altitude adaptation and illuminates the complexity of hypoxia-response pathways in humans.	[Simonson, Tatum S.; Huff, Chad D.; Witherspoon, David J.; Xing, Jinchuan; Jorde, Lynn B.; Prchal, Josef T.] Univ Utah, Sch Med, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; [Yang, Yingzhong; Yun, Haixia; Qin, Ga; Bai, Zhenzhong; Ge, RiLi] Qinghai Univ, Sch Med, Res Ctr High Altitude Med, Xining 810001, Qinghai, Peoples R China; [Lorenzo, Felipe R.; Prchal, Josef T.] Univ Utah, Sch Med, Div Hematol, Salt Lake City, UT 84112 USA; [Lorenzo, Felipe R.; Prchal, Josef T.] Univ Utah, Sch Med, Dept Pathol ARUP, Salt Lake City, UT 84112 USA; [Lorenzo, Felipe R.; Prchal, Josef T.] VAH, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Qinghai University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs	Jorde, LB (corresponding author), Univ Utah, Sch Med, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA.	lbj@genetics.utah.edu; josef.prchal@hsc.utah.edu; geriligao@hotmail.com	Xing, Jinchuan/A-2489-2012		National Basic Research Program of China [2006CB504100]; National Natural Science Foundation of China [30393133]; University of Utah Research Foundation [51003402]; NIH [GM059290, T32]; NIH Heart, Lung, and Blood Institute [HL50077]; National Cancer Institute [1P01CA108671-01A2]; The Primary Children's Medical Digestive and Kidney Diseases [DK069513]; University of Luxembourg-Institute; NATIONAL CANCER INSTITUTE [P01CA108671] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050077] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG005846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK069513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Utah Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Primary Children's Medical Digestive and Kidney Diseases; University of Luxembourg-Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all participants of this study. We are grateful to A. R. Rogers, J. Seger, D. J. Grunwald, and W. S. Watkins, who provided helpful comments for the manuscript, and S. R. Woodward and J. E. Gomez (from the Sorenson Molecular Genealogy Foundation) for providing samples used for comparative analyses. This work was supported by the National Basic Research Program of China number 2006CB504100, the National Natural Science Foundation of China number 30393133, and the University of Utah Research Foundation Seed Grant number 51003402. Funding was also provided by GM059290 (NIH) to L. B. J., HL50077 (NIH Heart, Lung, and Blood Institute) and 1P01CA108671-01A2 (National Cancer Institute) Merit Review Award to J. T. P., and DK069513 (The Primary Children's Medical Digestive and Kidney Diseases) and The University of Luxembourg-Institute for Systems Biology Program to C. D. H. T. S. S. was supported by NIH Genetics Training Grant T32. All studies have been performed with informed consent approved by the Institutional Board of Qinghai Medical College of Qinghai University in Xining, Qinghai Province, People's Republic of China. All SNP genoptypes are deposited in Gene Expression Omnibus, with accession code GSE21661. These data, as well as phenotype data, are also available on our laboratory Web site, http://jorde-lab.genetics.utah.edu. Please contact R. L. G. for access to DNA samples.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Beall CM, 2001, NATURE, V414, P411, DOI 10.1038/35106641; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Bigham Abigail W., 2009, Human Genomics, V4, P79; Cai H, 2008, CARDIOVASC RES, V77, P30, DOI 10.1093/cvr/cvm010; Chen QH, 1997, J APPL PHYSIOL, V83, P661, DOI 10.1152/jappl.1997.83.2.661; GE RL, 1994, J APPL PHYSIOL, V77, P684, DOI 10.1152/jappl.1994.77.2.684; Ge RL, 2002, J APPL PHYSIOL, V92, P2361, DOI 10.1152/japplphysiol.00684.2001; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; GROVES BM, 1993, J APPL PHYSIOL, V74, P312, DOI 10.1152/jappl.1993.74.1.312; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; He JZ, 2010, J BIOL CHEM, V285, P9452, DOI 10.1074/jbc.M109.077230; Huff CD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-8; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Mejia OM, 2005, HAEMATOLOGICA, V90, P13; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; Narravula S, 2001, J IMMUNOL, V166, P7543, DOI 10.4049/jimmunol.166.12.7543; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Vargas EE, 2006, HIGH ALT MED BIOL, V7, P138, DOI 10.1089/ham.2006.7.138; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wilding John P H, 2007, Diab Vasc Dis Res, V4, P194; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Wu TY, 2005, J APPL PHYSIOL, V98, P598, DOI 10.1152/japplphysiol.01034.2002; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106; ZHUANG J, 1993, J APPL PHYSIOL, V74, P303, DOI 10.1152/jappl.1993.74.1.303; Zundel W, 2000, GENE DEV, V14, P391	32	745	813	15	356	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2010	329	5987					72	75		10.1126/science.1189406	http://dx.doi.org/10.1126/science.1189406			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20466884				2022-12-24	WOS:000279402700034
J	Butchart, SHM; Walpole, M; Collen, B; van Strien, A; Scharlemann, JPW; Almond, REA; Baillie, JEM; Bomhard, B; Brown, C; Bruno, J; Carpenter, KE; Carr, GM; Chanson, J; Chenery, AM; Csirke, J; Davidson, NC; Dentener, F; Foster, M; Galli, A; Galloway, JN; Genovesi, P; Gregory, RD; Hockings, M; Kapos, V; Lamarque, JF; Leverington, F; Loh, J; McGeoch, MA; McRae, L; Minasyan, A; Morcillo, MH; Oldfield, TEE; Pauly, D; Quader, S; Revenga, C; Sauer, JR; Skolnik, B; Spear, D; Stanwell-Smith, D; Stuart, SN; Symes, A; Tierney, M; Tyrrell, TD; Vie, JC; Watson, R				Butchart, Stuart H. M.; Walpole, Matt; Collen, Ben; van Strien, Arco; Scharlemann, Joern P. W.; Almond, Rosamunde E. A.; Baillie, Jonathan E. M.; Bomhard, Bastian; Brown, Claire; Bruno, John; Carpenter, Kent E.; Carr, Genevieve M.; Chanson, Janice; Chenery, Anna M.; Csirke, Jorge; Davidson, Nick C.; Dentener, Frank; Foster, Matt; Galli, Alessandro; Galloway, James N.; Genovesi, Piero; Gregory, Richard D.; Hockings, Marc; Kapos, Valerie; Lamarque, Jean-Francois; Leverington, Fiona; Loh, Jonathan; McGeoch, Melodie A.; McRae, Louise; Minasyan, Anahit; Morcillo, Monica Hernandez; Oldfield, Thomasina E. E.; Pauly, Daniel; Quader, Suhel; Revenga, Carmen; Sauer, John R.; Skolnik, Benjamin; Spear, Dian; Stanwell-Smith, Damon; Stuart, Simon N.; Symes, Andy; Tierney, Megan; Tyrrell, Tristan D.; Vie, Jean-Christophe; Watson, Reg			Global Biodiversity: Indicators of Recent Declines	SCIENCE			English	Article							CONSERVATION; FOREST; IMPACT; BIRDS	In 2002, world leaders committed, through the Convention on Biological Diversity, to achieve a significant reduction in the rate of biodiversity loss by 2010. We compiled 31 indicators to report on progress toward this target. Most indicators of the state of biodiversity (covering species' population trends, extinction risk, habitat extent and condition, and community composition) showed declines, with no significant recent reductions in rate, whereas indicators of pressures on biodiversity (including resource consumption, invasive alien species, nitrogen pollution, overexploitation, and climate change impacts) showed increases. Despite some local successes and increasing responses (including extent and biodiversity coverage of protected areas, sustainable forest management, policy responses to invasive alien species, and biodiversity-related aid), the rate of biodiversity loss does not appear to be slowing.	[Butchart, Stuart H. M.; Walpole, Matt; Scharlemann, Joern P. W.; Almond, Rosamunde E. A.; Chenery, Anna M.; Kapos, Valerie; Morcillo, Monica Hernandez; Stanwell-Smith, Damon; Stuart, Simon N.; Tierney, Megan; Tyrrell, Tristan D.] UN, Environm Programme, World Conservat Monitoring Ctr, Cambridge CB3 0DL, England; [Butchart, Stuart H. M.; Symes, Andy] BirdLife Int, Cambridge CB3 0NA, England; [Collen, Ben; Baillie, Jonathan E. M.; McRae, Louise] Zool Soc London, Inst Zool, London NW1 4RY, England; [van Strien, Arco] Stat Netherlands, NL-2490 HA The Hague, Netherlands; [Bruno, John] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA; [Carpenter, Kent E.] Old Dominion Univ, Norfolk, VA 23529 USA; [Carr, Genevieve M.] Natl Water Res Inst Branch, United Nations Environm Programme, Burlington, ON L7R 4A6, Canada; [Chanson, Janice] Conservat Int, Ctr Appl Biodivers Sci, Biodivers Assessment Unit, IUCN Species Survival Commiss, Arlington, VA 22202 USA; [Csirke, Jorge] UN, Food & Agr Org, Fisheries & Aquaculture Management Div, I-00153 Rome, Italy; [Davidson, Nick C.] Secretariat Ramsar Convent Wetlands, CH-1196 Gland, Switzerland; [Dentener, Frank] European Commiss, Joint Res Ctr, Inst Environm & Sustainabil, I-21027 Ispra, VA, Italy; [Galli, Alessandro] Global Footprint Network, Oakland, CA 94607 USA; [Galloway, James N.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Genovesi, Piero] Ist Super Protez & Ric Ambientale, I-00185 Rome, Italy; [Gregory, Richard D.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Hockings, Marc; Leverington, Fiona] Univ Queensland, Sch Integrat Syst, Brisbane, Qld 4067, Australia; [Kapos, Valerie] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Lamarque, Jean-Francois] Natl Ctr Atmospher Res, Boulder, CO 80301 USA; [Loh, Jonathan] World Wildlife Fund Int, CH-1196 Gland, Switzerland; [McGeoch, Melodie A.] S African Natl Pk, Ctr Invas Biol, ZA-7947 Steenberg, South Africa; [McGeoch, Melodie A.] S African Natl Pk, Global Invas Species Programme, ZA-7947 Steenberg, South Africa; [Minasyan, Anahit] United Nations Educ Sci & Cultural Org, F-75352 Paris, France; [Oldfield, Thomasina E. E.] TRAFFIC Int, Cambridge CB3 0DL, England; [Pauly, Daniel; Watson, Reg] Univ British Columbia, Fisheries Ctr, Sea Us Project, Vancouver, BC V6T 1Z4, Canada; [Quader, Suhel] Natl Ctr Biol Sci, Tata Inst Fundamental Res, Bangalore 560065, Karnataka, India; [Revenga, Carmen] Nature Conservancy, Arlington, VA 22203 USA; [Sauer, John R.] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD 20708 USA; [Skolnik, Benjamin] Amer Bird Conservancy, Washington, DC 20009 USA; [Spear, Dian] Univ Stellenbosch, Ctr Invas Biol, ZA-7602 Matieland, South Africa; [Stuart, Simon N.] Univ Bath, Dept Biol & Biochem, IUCN Species Survival Commiss, Bath BA2 7AY, Avon, England; [Stuart, Simon N.] Al Ain Wildlife Pk & Resort, Abu Dhabi, U Arab Emirates; [Vie, Jean-Christophe] IUCN, CH-1196 Gland, Switzerland	United Nations Environment Programme; BirdLife International; Zoological Society of London; University of North Carolina; University of North Carolina Chapel Hill; Old Dominion University; Environment & Climate Change Canada; National Water Research Institute; Conservation International; Food & Agriculture Organization of the United Nations (FAO); European Commission Joint Research Centre; EC JRC ISPRA Site; University of Virginia; Italian Institute for Environmental Protection & Research (ISPRA); Royal Society for Protection of Birds; University of Queensland; University of Cambridge; National Center Atmospheric Research (NCAR) - USA; World Wildlife Fund; University of British Columbia; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Nature Conservancy; United States Department of the Interior; United States Geological Survey; Stellenbosch University; University of Bath	Butchart, SHM (corresponding author), UN, Environm Programme, World Conservat Monitoring Ctr, 219 Huntingdon Rd, Cambridge CB3 0DL, England.	stuart.butchart@birdlife.org	Quader, Suhel/D-4454-2011; Lamarque, Jean-Francois/L-2313-2014; van Strien, Arco/AAG-1843-2020; Galloway, James N/C-2769-2013; Hockings, Marc/A-1283-2007; Carneiro, Fernanda/E-9513-2013; Butchart, Stuart/AAJ-1852-2021; Watson, Reg A/F-4850-2012; Spear, Dian/B-2469-2009; Collen, Ben/D-5055-2011; Pauly, Daniel Marc/AAY-2316-2021; Genovesi, Piero/Z-1571-2019; Collen, Ben/F-2543-2016; Davidson, Nicholas/AAA-9921-2019; Scharlemann, Jorn/A-4737-2008; Butchart, Stuart HM/Y-2711-2018; Bertzky, Bastian/I-6909-2013; Galli, Alessandro/AAV-5906-2020; Kapos, Valerie/G-3136-2010; McGeoch, Melodie A/F-8353-2011	Lamarque, Jean-Francois/0000-0002-4225-5074; Galloway, James N/0000-0001-7676-8698; Hockings, Marc/0000-0003-4419-8963; Carneiro, Fernanda/0000-0001-6389-4564; Butchart, Stuart/0000-0002-1140-4049; Watson, Reg A/0000-0001-7201-8865; Spear, Dian/0000-0002-2417-3980; Collen, Ben/0000-0003-2564-4243; Davidson, Nicholas/0000-0002-2466-0658; Scharlemann, Jorn/0000-0002-2834-6367; Bertzky, Bastian/0000-0001-7025-4733; Kapos, Valerie/0000-0002-5739-8262; McGeoch, Melodie A/0000-0003-3388-2241; Gregory, Richard/0000-0002-7419-5053; Csirke, Jorge/0000-0002-0253-3535; Galli, Alessandro/0000-0001-9503-4104; Pauly, Daniel/0000-0003-3756-4793	Global Environment Facility; Shell Foundation; European Commission; University of British Columbia/Pew Environment Group; Nature Conservancy; University of Queensland; New Hampshire Charitable Foundation; National Science Foundation (NSF)	Global Environment Facility; Shell Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); University of British Columbia/Pew Environment Group; Nature Conservancy; University of Queensland(University of Queensland); New Hampshire Charitable Foundation; National Science Foundation (NSF)(National Science Foundation (NSF))	We are grateful for comments, data, or help from R. Akcakaya, L. Alvarez-Filip, A. Angulo, L. Bennun, L. Coad, N. Cox, M. Dube, C. Estreguil, M. Evans, B. Galil, V. Gaveau, F. Gherardi, S. Goldfinger, R. Green, A. Grigg, P. Herkenrath, C. Hilton-Taylor, M. Hoffmann, E. Kleynhans, J. Lamoreux, S. Livingstone, E. Marais, P. Martin, I. May, A. Milam, K. Noonan-Mooney, H. Pavese, B. Polidoro, C. Pollock, D. Pritchard, J. Schipper, F. Schutyser, V. Shutte, S. Simons, J. Skorpilova, A. Stattersfield, P. Vorisek, R. Wright, M. Wackernagel, and M. Waycott. We acknowledge support from the Global Environment Facility to the 2010 Biodiversity Indicators Partnership; Shell Foundation; European Commission; the Sea Around Us Project (University of British Columbia/Pew Environment Group) to D. P. and R. W.; World Wildlife Fund, The Nature Conservancy, and the University of Queensland to M. H. and F. L.; T. Haas and the New Hampshire Charitable Foundation to K. E. C.; and the National Science Foundation (NSF) to J.-F.L. Opinions and findings expressed here do not necessarily reflect the views of the NSF or other funding bodies.	Balmford A, 2005, PHILOS T ROY SOC B, V360, P221, DOI 10.1098/rstb.2004.1599; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Butchart SHM, 2006, ORYX, V40, P266, DOI 10.1017/S0030605306000950; Chowdhury J. A., 2006, BETTER FOREST MANAGE; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Collen B, 2008, TROP CONSERV SCI, V1, P75, DOI 10.1177/194008290800100202; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Gilbert N, 2009, NATURE, V462, P263, DOI 10.1038/462263a; Gregory RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004678; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; McGeoch MA, 2010, DIVERS DISTRIB, V16, P95, DOI 10.1111/j.1472-4642.2009.00633.x; Mooney H, 2009, SCIENCE, V325, P1474, DOI 10.1126/science.1180935; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Sachs JD, 2009, SCIENCE, V325, P1502, DOI 10.1126/science.1175035; SCBD (SECRETARIAT OF THE CONVENTION ON BIOLOGICAL DIVERSITY), 2009, CONV BIOL DIV PLANT; Secretariat of the Convention on Biological Diversity, 2003, HDB CONV BIOL DIV; Soldaat L, 2007, J ORNITHOL, V148, pS351, DOI 10.1007/s10336-007-0176-7; United Nations, 2008, MILL DEV GOALS IND; Vie J.C., 2009, WILDLIFE CHANGING WO, DOI 10.2305/IUCN.CH.2009.17.en; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466	26	2903	3070	123	3844	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982					1164	1168		10.1126/science.1187512	http://dx.doi.org/10.1126/science.1187512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20430971	Green Published			2022-12-24	WOS:000278104700046
J	Maruyama, H; Morino, H; Ito, H; Izumi, Y; Kato, H; Watanabe, Y; Kinoshita, Y; Kamada, M; Nodera, H; Suzuki, H; Komure, O; Matsuura, S; Kobatake, K; Morimoto, N; Abe, K; Suzuki, N; Aoki, M; Kawata, A; Hirai, T; Kato, T; Ogasawara, K; Hirano, A; Takumi, T; Kusaka, H; Hagiwara, K; Kaji, R; Kawakami, H				Maruyama, Hirofumi; Morino, Hiroyuki; Ito, Hidefumi; Izumi, Yuishin; Kato, Hidemasa; Watanabe, Yasuhito; Kinoshita, Yoshimi; Kamada, Masaki; Nodera, Hiroyuki; Suzuki, Hidenori; Komure, Osamu; Matsuura, Shinya; Kobatake, Keitaro; Morimoto, Nobutoshi; Abe, Koji; Suzuki, Naoki; Aoki, Masashi; Kawata, Akihiro; Hirai, Takeshi; Kato, Takeo; Ogasawara, Kazumasa; Hirano, Asao; Takumi, Toru; Kusaka, Hirofumi; Hagiwara, Koichi; Kaji, Ryuji; Kawakami, Hideshi			Mutations of optineurin in amyotrophic lateral sclerosis	NATURE			English	Article							OPEN-ANGLE GLAUCOMA; MYOSIN-VI; PROTEIN; GENE; EXPRESSION; COMPLEX; NEMO	Amyotrophic lateral sclerosis (ALS) has its onset in middle age and is a progressive disorder characterized by degeneration of motor neurons of the primary motor cortex, brainstem and spinal cord(1). Most cases of ALS are sporadic, but about 10% are familial. Genes known to cause classic familial ALS (FALS) are superoxide dismutase 1 (SOD1)(2), ANG encoding angiogenin(3), TARDP encoding transactive response (TAR) DNA-binding protein TDP-43 (ref. 4) and fused in sarcoma/translated in liposarcoma (FUS, also known as TLS)(5,6). However, these genetic defects occur in only about 20-30% of cases of FALS, and most genes causing FALS are unknown. Here we show that there are mutations in the gene encoding optineurin (OPTN), earlier reported to be a causative gene of primary open-angle glaucoma (POAG)(7), in patients with ALS. We found three types of mutation of OPTN: a homozygous deletion of exon 5, a homozygous Q398X nonsense mutation and a heterozygous E478G missense mutation within its ubiquitin-binding domain. Analysis of cell transfection showed that the nonsense and missense mutations of OPTN abolished the inhibition of activation of nuclear factor kappa B (NF-kappa B), and the E478G mutation revealed a cytoplasmic distribution different from that of the wild type or a POAG mutation. A case with the E478G mutation showed OPTN-immunoreactive cytoplasmic inclusions. Furthermore, TDP-43- or SOD1-positive inclusions of sporadic and SOD1 cases of ALS were also noticeably immunolabelled by anti-OPTN antibodies. Our findings strongly suggest that OPTN is involved in the pathogenesis of ALS. They also indicate that NF-kB inhibitors could be used to treat ALS and that transgenic mice bearing various mutations of OPTN will be relevant in developing new drugs for this disorder.	[Maruyama, Hirofumi; Morino, Hiroyuki; Kamada, Masaki; Kawakami, Hideshi] Hiroshima Univ, Dept Epidemiol, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan; [Ito, Hidefumi; Kinoshita, Yoshimi; Kusaka, Hirofumi] Kansai Med Univ, Dept Neurol, Moriguchi, Osaka 5708506, Japan; [Izumi, Yuishin; Kamada, Masaki; Nodera, Hiroyuki; Kaji, Ryuji] Univ Tokushima, Grad Sch, Dept Clin Neurosci, Tokushima 7708503, Japan; [Kato, Hidemasa] Saitama Med Univ, Res Ctr Genom Med, Div Dev Biol, Saitama 3501241, Japan; [Watanabe, Yasuhito] Hiroshima Univ, Grad Sch Biomed Sci, Lab Integrat Biosci, Hiroshima 7348553, Japan; [Suzuki, Hidenori] Hiroshima Bunkyo Womens Univ, Fac Human Sci, Hiroshima 7310295, Japan; [Komure, Osamu] S Osaka Neurosurg Hosp, Osakasayama 5890011, Japan; [Matsuura, Shinya] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Genet & Cell Biol, Hiroshima 7348553, Japan; [Kobatake, Keitaro] Kobatake Hosp, Dept Neurol, Fukuyama, Hiroshima 7201142, Japan; [Morimoto, Nobutoshi; Abe, Koji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Okayama 7008558, Japan; [Suzuki, Naoki; Aoki, Masashi] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 9808574, Japan; [Kawata, Akihiro; Hirai, Takeshi] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Tokyo 1830042, Japan; [Kato, Takeo] Yamagata Univ, Fac Med, Dept Neurol Haematol Metab Endocrinol & Diabetol, Yamagata 9909585, Japan; [Ogasawara, Kazumasa] Shiga Univ Med Sci, Sch Med, Dept Pathol, Otsu, Shiga 5202192, Japan; [Hirano, Asao] Montefiore Med Ctr, Dept Pathol, Div Neuropathol, New York, NY 10467 USA; [Hagiwara, Koichi] Saitama Med Univ, Dept Resp Med, Saitama 3500495, Japan	Hiroshima University; Kansai Medical University; Tokushima University; Saitama Medical University; Hiroshima University; Hiroshima University; Okayama University; Tohoku University; Tokyo Metropolitan Institute for Neuroscience; Yamagata University; Shiga University of Medical Science; Montefiore Medical Center; Saitama Medical University	Kawakami, H (corresponding author), Hiroshima Univ, Dept Epidemiol, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan.	hkawakam@hiroshima-u.ac.jp	Maruyama, Hirofumi/B-9333-2011; Suzuki, Naoki/J-6331-2019; Kawakami, Hideshi/ABE-4077-2021; Morino, Hiroyuki/H-9583-2013; Matsuura, Shinya/U-4182-2017; Kawakami, Hideshi/A-2086-2009	Maruyama, Hirofumi/0000-0001-7613-8717; Suzuki, Naoki/0000-0001-8880-8554; Kawakami, Hideshi/0000-0002-1405-0901; Morino, Hiroyuki/0000-0002-5190-3547; Matsuura, Shinya/0000-0001-5294-081X; Kawakami, Hideshi/0000-0002-1405-0901	Ministry of Education, Science, and Culture of Japan; Smoking Research Foundation; Japan Science and Technology Agency, Core Research for Evolutional Science Technology	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation; Japan Science and Technology Agency, Core Research for Evolutional Science Technology(Japan Science & Technology Agency (JST))	This work was supported in part by grants-in-aid from the Ministry of Education, Science, and Culture of Japan, by a grant from the Smoking Research Foundation to H. Kawakami, and by the Japan Science and Technology Agency, Core Research for Evolutional Science & Technology to T. T. We thank E. Nakajima for technical support, K. Nakayama, H. W. Shin, M. Omi and H. Nakamura for conducting some of the experiments, and T. Miki and K. Noda for providing some DNA samples and clinical information. This paper is dedicated to the patients and families who contributed to this project.	Chalasani ML, 2008, EXP EYE RES, V87, P1, DOI 10.1016/j.exer.2007.10.021; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; Huqun, 2007, AM J RESP CRIT CARE, V175, P263, DOI 10.1164/rccm.200609-1274OC; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jiang YM, 2005, ANN NEUROL, V57, P236, DOI 10.1002/ana.20379; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Leigh P Nigel, 2007, Handb Clin Neurol, V82, P249, DOI 10.1016/S0072-9752(07)80016-9; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Mrowka R, 2008, FEBS J, V275, P3178, DOI 10.1111/j.1742-4658.2008.06471.x; Pizzi M, 2006, EUR J PHARMACOL, V545, P22, DOI 10.1016/j.ejphar.2006.06.027; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Schwamborn K, 2000, J BIOL CHEM, V275, P22780, DOI 10.1074/jbc.M001500200; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Takarada T, 2009, J NEUROCHEM, V110, P1457, DOI 10.1111/j.1471-4159.2009.06225.x; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	23	900	942	4	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					223	U109		10.1038/nature08971	http://dx.doi.org/10.1038/nature08971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20428114				2022-12-24	WOS:000277558500036
J	Srour, M; Riviere, JB; Pham, JMT; Dube, MP; Girard, S; Morin, S; Dion, PA; Asselin, G; Rochefort, D; Hince, P; Diab, S; Sharafaddinzadeh, N; Chouinard, S; Theoret, H; Charron, F; Rouleau, GA				Srour, Myriam; Riviere, Jean-Baptiste; Pham, Jessica M. T.; Dube, Marie-Pierre; Girard, Simon; Morin, Steves; Dion, Patrick A.; Asselin, Geraldine; Rochefort, Daniel; Hince, Pascale; Diab, Sabrina; Sharafaddinzadeh, Naser; Chouinard, Sylvain; Theoret, Hugo; Charron, Frederic; Rouleau, Guy A.			Mutations in DCC Cause Congenital Mirror Movements	SCIENCE			English	Article									[Srour, Myriam; Riviere, Jean-Baptiste; Dube, Marie-Pierre; Girard, Simon; Dion, Patrick A.; Rochefort, Daniel; Hince, Pascale; Diab, Sabrina; Chouinard, Sylvain; Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neur, Montreal, PQ H2L 2W5, Canada; [Pham, Jessica M. T.; Morin, Steves; Charron, Frederic] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Dube, Marie-Pierre; Asselin, Geraldine] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Sharafaddinzadeh, Naser] Jundishapour Univ Med Sci, Dept Neurol, Ahvaz, Iran; [Theoret, Hugo] Univ Montreal, Montreal, PQ H2V 2S9, Canada	Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Universite de Montreal	Rouleau, GA (corresponding author), Univ Montreal, Ctr Excellence Neur, Montreal, PQ H2L 2W5, Canada.	guy.rouleau@umontreal.ca	Charron, Frederic/D-2140-2009; Charron, Frederic/O-8017-2019; Dubé, Marie-Pierre/B-9364-2008	Charron, Frederic/0000-0003-3483-8672; Charron, Frederic/0000-0003-3483-8672; Dubé, Marie-Pierre/0000-0001-8442-4393; Girard, Simon/0000-0002-4089-2280; Theoret, Hugo/0000-0002-7458-8797				FARMER SF, 1990, J PHYSIOL-LONDON, V428, P467, DOI 10.1113/jphysiol.1990.sp018222; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Finger JH, 2002, J NEUROSCI, V22, P10346; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Sharafaddinzadeh N, 2008, NEUROL INDIA, V56, P482, DOI 10.4103/0028-3886.44813; Srour M, 2009, NEUROLOGY, V73, P729, DOI 10.1212/WNL.0b013e3181b59bda	7	115	117	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2010	328	5978					592	592		10.1126/science.1186463	http://dx.doi.org/10.1126/science.1186463			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431009				2022-12-24	WOS:000277159800034
J	Xavier, JB; Sander, C				Xavier, Joao B.; Sander, Chris			Principle of System Balance for Drug Interactions.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Xavier, Joao B.; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Xavier, JB (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, 1275 York Ave, New York, NY 10021 USA.		Xavier, Joao/H-5471-2011	Xavier, Joao/0000-0003-3592-1689				Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890	3	7	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2010	362	14					1339	1340		10.1056/NEJMcibr1001270	http://dx.doi.org/10.1056/NEJMcibr1001270			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579SN	20375413				2022-12-24	WOS:000276393700016
J	Lin, SC; Lo, YC; Wu, H				Lin, Su-Chang; Lo, Yu-Chih; Wu, Hao			Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling	NATURE			English	Article							PYOGENIC BACTERIAL-INFECTIONS; NF-KAPPA-B; DEATH DOMAIN; RECEPTOR SUPERFAMILY; SPLICE VARIANT; TOLL; INTERLEUKIN-1; MYD88; IRAK-4; MECHANISM	MyD88, IRAK4 and IRAK2 are critical signalling mediators of the TLR/IL1-R superfamily. Here we report the crystal structure of the MyD88-IRAK4-IRAK2 death domain (DD) complex, which surprisingly reveals a left-handed helical oligomer that consists of 6 MyD88, 4 IRAK4 and 4 IRAK2 DDs. Assembly of this helical signalling tower is hierarchical, in which MyD88 recruits IRAK4 and the MyD88-IRAK4 complex recruits the IRAK4 substrates IRAK2 or the related IRAK1. Formation of these Myddosome complexes brings the kinase domains of IRAKs into proximity for phosphorylation and activation. Composite binding sites are required for recruitment of the individual DDs in the complex, which are confirmed by mutagenesis and previously identified signalling mutations. Specificities in Myddosome formation are dictated by both molecular complementarity and correspondence of surface electrostatics. The MyD88-IRAK4-IRAK2 complex provides a template for Toll signalling in Drosophila and an elegant mechanism for versatile assembly and regulation of DD complexes in signal transduction.	[Lin, Su-Chang; Lo, Yu-Chih; Wu, Hao] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University	Wu, H (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA.	haowu@med.cornell.edu	Lin, Su-Chang/F-2899-2016	Lin, Su-Chang/0000-0003-0687-3139	NIH; Cancer Research Institute; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank K. Rajashankar, I. Kourinov and N. Sukumar for data collection and X. Ma for help with the manuscript. This work was supported by NIH (H. W.), the Cancer Research Institute (S.-C. L. and Y.-C.L.), and the American Heart Association (Y.-C.L.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; den Dekker WK, 2010, ATHEROSCLEROSIS, V209, P314, DOI 10.1016/j.atherosclerosis.2009.09.075; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Egelman EH, 2007, CURR OPIN STRUC BIOL, V17, P556, DOI 10.1016/j.sbi.2007.07.006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hardy MP, 2004, J BIOL CHEM, V279, P27699, DOI 10.1074/jbc.M403068200; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Horner AA, 2003, CURR OPIN IMMUNOL, V15, P614, DOI 10.1016/j.coi.2003.09.021; Janssens S, 2003, FEBS LETT, V548, P103, DOI 10.1016/S0014-5793(03)00747-6; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lasker MV, 2005, J IMMUNOL, V175, P4175, DOI 10.4049/jimmunol.175.7.4175; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Loiarro M, 2009, J BIOL CHEM, V284, P28093, DOI 10.1074/jbc.M109.004465; Marta M, 2009, AUTOIMMUN REV, V8, P506, DOI 10.1016/j.autrev.2009.01.006; Marx J, 2007, SCIENCE, V315, P33, DOI 10.1126/science.315.5808.33; Moncrieffe MC, 2008, J BIOL CHEM, V283, P33447, DOI 10.1074/jbc.M805427200; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; O'Neill LA, 2008, NAT CLIN PRACT RHEUM, V4, P319, DOI 10.1038/ncprheum0802; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Rao N, 2005, MOL CELL BIOL, V25, P6521, DOI 10.1128/MCB.25.15.6521-6532.2005; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Romero-Sandoval EA, 2008, CURR OPIN INVEST DR, V9, P726; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Sun HY, 2004, EMBO J, V23, P100, DOI 10.1038/sj.emboj.7600033; Sun HY, 2002, P NATL ACAD SCI USA, V99, P12871, DOI 10.1073/pnas.202396399; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Towb P, 2009, J INNATE IMMUN, V1, P309, DOI 10.1159/000200773; Verstak B, 2007, INFLAMM RES, V56, P1, DOI 10.1007/s00011-007-6093-7; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1	58	730	773	10	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					885	U2		10.1038/nature09121	http://dx.doi.org/10.1038/nature09121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20485341	Green Accepted			2022-12-24	WOS:000278804500029
J	McKenney, RJ; Vershinin, M; Kunwar, A; Vallee, RB; Gross, SP				McKenney, Richard J.; Vershinin, Michael; Kunwar, Ambarish; Vallee, Richard B.; Gross, Steven P.			LIS1 and NudE Induce a Persistent Dynein Force-Producing State	CELL			English	Article							MOTOR-BASED TRANSPORT; COILED-COIL DOMAIN; CYTOPLASMIC DYNEIN; MYOSIN-V; NEURONAL MIGRATION; HEAVY-CHAIN; ASPERGILLUS-NIDULANS; LISSENCEPHALY GENE; ATPASE ACTIVITY; PROTEIN	Cytoplasmic dynein is responsible for many aspects of cellular and subcellular movement. LIS1, NudE, and NudEL are dynein interactors initially implicated in brain developmental disease but now known to be required in cell migration, nuclear, centrosomal, and microtubule transport, mitosis, and growth cone motility. Identification of a specific role for these proteins in cytoplasmic dynein motor regulation has remained elusive. We find that NudE stably recruits LIS1 to the dynein holoenzyme molecule, where LIS1 interacts with the motor domain during the pre-powerstroke state of the dynein crossbridge cycle. NudE abrogates dynein force production, whereas LIS1 alone or with NudE induces a persistent-force dynein state that improves ensemble function of multiple dyneins for transport under high-load conditions. These results likely explain the requirement for LIS1 and NudE in the transport of nuclei, centrosomes, chromosomes, and the microtubule cytoskeleton as well as the particular sensitivity of migrating neurons to reduced LIS1 expression.	[McKenney, Richard J.; Vallee, Richard B.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Vershinin, Michael; Gross, Steven P.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Kunwar, Ambarish] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	Columbia University; University of California System; University of California Irvine; University of California System; University of California Davis	Vallee, RB (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	rv2025@columbia.edu; sgross@uci.edu	Kunwar, Ambarish/AAD-3618-2022	Kunwar, Ambarish/0000-0002-8671-7816; Vershinin, Michael/0000-0002-8207-1376	 [GM47434];  [HD40182];  [1RO1GM070676];  [GM079156];  [GM068952]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068952, R01GM070676, R01GM047434, R37GM047434, R01GM079156] Funding Source: NIH RePORTER	; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Drs. Jing Xu, Silvia Cermelli, and Peter Hook for helpful discussions and Shahrnaz Kemal, Kassandra Ori-McKenney, and Z. Shu for technical help. This work was supported by grants GM47434 and HD40182 to R. B. V. and grants 1RO1GM070676 and GM079156 to S. P. G. A. K. was supported by grant GM068952.	Bremner KH, 2009, CELL HOST MICROBE, V6, P523, DOI 10.1016/j.chom.2009.11.006; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Chen BY, 2007, STRUCTURE, V15, P429, DOI 10.1016/j.str.2007.02.007; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; Dietrich KA, 2008, P NATL ACAD SCI USA, V105, P8938, DOI 10.1073/pnas.0803575105; Dobyns W B, 1987, Birth Defects Orig Artic Ser, V23, P225; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Grabham PW, 2007, J NEUROSCI, V27, P5823, DOI 10.1523/JNEUROSCI.1135-07.2007; Guo J, 2006, MOL BIOL CELL, V17, P680, DOI 10.1091/mbc.E05-04-0360; Han GS, 2001, CURR BIOL, V11, P719, DOI 10.1016/S0960-9822(01)00200-7; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hook P, 2005, J BIOL CHEM, V280, P33045, DOI 10.1074/jbc.M504693200; Imamula K, 2007, P NATL ACAD SCI USA, V104, P16134, DOI 10.1073/pnas.0702370104; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Kunwar A, 2008, CURR BIOL, V18, P1173, DOI 10.1016/j.cub.2008.07.027; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Mesngon MT, 2006, J NEUROSCI, V26, P2132, DOI 10.1523/JNEUROSCI.5095-05.2006; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; SCHOLEY JM, 1980, NATURE, V287, P233, DOI 10.1038/287233a0; SCHROEDER HW, 2008, MOL BIOL CELL S, V19; Shen YD, 2008, DEV CELL, V14, P342, DOI 10.1016/j.devcel.2008.01.001; SHIMIZU T, 1983, J BIOL CHEM, V258, P3841; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Stock MF, 1999, J BIOL CHEM, V274, P14617, DOI 10.1074/jbc.274.21.14617; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Vershinin M, 2008, TRAFFIC, V9, P882, DOI 10.1111/j.1600-0854.2008.00741.x; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yan XM, 2003, MOL CELL BIOL, V23, P1239, DOI 10.1128/MCB.23.4.1239-1250.2003	60	255	256	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					304	314		10.1016/j.cell.2010.02.035	http://dx.doi.org/10.1016/j.cell.2010.02.035			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403325	Green Accepted, Bronze			2022-12-24	WOS:000276738400020
J	Nagy, M; Akos, Z; Biro, D; Vicsek, T				Nagy, Mate; Akos, Zsuzsa; Biro, Dora; Vicsek, Tamas			Hierarchical group dynamics in pigeon flocks	NATURE			English	Article							COLLECTIVE BEHAVIOR; LEADERSHIP; TRANSITION	Animals that travel together in groups display a variety of fascinating motion patterns thought to be the result of delicate local interactions among group members(1-3). Although the most informative way of investigating and interpreting collective movement phenomena would be afforded by the collection of high-resolution spatio-temporal data from moving individuals, such data are scarce(4-7) and are virtually non-existent for long-distance group motion within a natural setting because of the associated technological difficulties(8). Here we present results of experiments in which track logs of homing pigeons flying in flocks of up to 10 individuals have been obtained by high-resolution lightweight GPS devices and analysed using a variety of correlation functions inspired by approaches common in statistical physics. We find a well-defined hierarchy among flock members from data concerning leading roles in pairwise interactions, defined on the basis of characteristic delay times between birds' directional choices. The average spatial position of a pigeon within the flock strongly correlates with its place in the hierarchy, and birds respond more quickly to conspecifics perceived primarily through the left eye-both results revealing differential roles for birds that assume different positions with respect to flock-mates. From an evolutionary perspective, our results suggest that hierarchical organization of group flight may be more efficient than an egalitarian one, at least for those flock sizes that permit regular pairwise interactions among group members, during which leader-follower relationships are consistently manifested.	[Nagy, Mate; Akos, Zsuzsa; Vicsek, Tamas] Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary; [Biro, Dora] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Vicsek, Tamas] Hungarian Acad Sci, Stat & Biol Phys Res Grp, H-1117 Budapest, Hungary	Eotvos Lorand University; University of Oxford; Hungarian Academy of Sciences	Vicsek, T (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, Pazmany Peter Setany 1A, H-1117 Budapest, Hungary.	vicsek@hal.elte.hu	Nagy, Máté/B-3180-2011	Nagy, Máté/0000-0001-8817-087X; Biro, Dora/0000-0002-3408-6274	EU; Royal Society; Somerville College, Oxford	EU(European Commission); Royal Society(Royal Society of London); Somerville College, Oxford	We thank the Hungarian Racing Pigeon Sports Federation-in particular I. Bardos-for support. We are grateful to J. Pato for allowing his pigeons to participate in the present research, and for his technical help throughout the experiments. This research was partially supported by the EU ERC COLLMOT and the EU FP6 STARFLAG projects. D. B. was supported by a Royal Society University Research Fellowship and by Somerville College, Oxford.	Akos Z, 2008, P NATL ACAD SCI USA, V105, P4139, DOI 10.1073/pnas.0707711105; Bajec IL, 2009, ANIM BEHAV, V78, P777, DOI 10.1016/j.anbehav.2009.07.007; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Becco C, 2006, PHYSICA A, V367, P487, DOI 10.1016/j.physa.2005.11.041; Biro D, 2004, P NATL ACAD SCI USA, V101, P17440, DOI 10.1073/pnas.0406984101; Biro D, 2006, CURR BIOL, V16, P2123, DOI 10.1016/j.cub.2006.08.087; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; de Perera TB, 1999, ANIM BEHAV, V57, P715; Dell'Ariccia G, 2008, ANIM BEHAV, V76, P1165, DOI 10.1016/j.anbehav.2008.05.022; Dennis TE, 2007, P ROY SOC B-BIOL SCI, V274, P1153, DOI 10.1098/rspb.2007.3768; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Freeman R, 2009, J NAVIGATION, V62, P33, DOI 10.1017/S0373463308005080; Gregoire G, 2003, PHYSICA D, V181, P157, DOI 10.1016/S0167-2789(03)00102-7; Gunturkun O, 2009, LANGUAGE LATERALIZATION AND PSYCHOSIS, P19, DOI 10.1017/CBO9780511576744.003; Krause J, 2000, FISH FISH, V1, P82, DOI 10.1111/j.1467-2979.2000.tb00001.x; Lipp HP, 2004, CURR BIOL, V14, P1239, DOI 10.1016/j.cub.2004.07.024; Parrish J., 1997, ANIMAL GROUPS 3 DIME; PARTRIDGE BL, 1980, BEHAV ECOL SOCIOBIOL, V6, P277, DOI 10.1007/BF00292770; POMEROY H, 1977, ANIM BEHAV, V25, P720, DOI 10.1016/0003-3472(77)90121-X; Prior H, 2004, BEHAV BRAIN RES, V154, P301, DOI 10.1016/j.bbr.2004.02.018; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Tien JH, 2004, EVOL ECOL RES, V6, P555; VALLORTIGARA G, 1994, BEHAV PROCESS, V33, P41, DOI 10.1016/0376-6357(94)90059-0; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; WOLFER DP, 2005, 2005 C ROYAL I NAV R	30	634	661	8	293	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					890	U99		10.1038/nature08891	http://dx.doi.org/10.1038/nature08891			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20376149	Green Submitted			2022-12-24	WOS:000276397300037
J	Kinchen, JM; Ravichandran, KS				Kinchen, Jason M.; Ravichandran, Kodi S.			Identification of two evolutionarily conserved genes regulating processing of engulfed apoptotic cells	NATURE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; PHAGOSOME MATURATION; DEATH; DEGRADATION; RECEPTOR; ENDOCYTOSIS; MECHANISMS; PROTEINS; PATHWAY	Engulfment of apoptotic cells occurs throughout life in multicellular organisms. Impaired apoptotic cell clearance (due to defective recognition, internalization or degradation) results in autoimmune disease(1,2). One fundamental challenge in understanding how defects in corpse removal translate into diseased states is the identification of critical components orchestrating the different stages of engulfment. Here we use genetic, cell biological and molecular studies in Caenorhabditis elegans and mammalian cells to identify SAND-1 and its partner CCZ-1 as new factors in corpse removal. In worms deficient in either sand-1 or ccz-1, apoptotic cells are internalized and the phagosomes recruit the small GTPase RAB-5 but fail to progress to the subsequent RAB-7(+) stage. The mammalian orthologues of SAND-1, namely Mon1a and Mon1b, were similarly required for phagosome maturation. Mechanistically, Mon1 interacts with GTP-bound Rab5, identifying Mon1 as a previously unrecognized Rab5 effector. Moreover, a Mon1-Ccz1 complex (but not either protein alone) could bind Rab7 and could also influence Rab7 activation, suggesting Mon1-Ccz1 as an important link in progression from the Rab5-positive stage to the Rab7-positive stage of phagosome maturation. Taken together, these data identify SAND-1 (Mon1) and CCZ-1 (Ccz1) as critical and evolutionarily conserved components regulating the processing of ingested apoptotic cell corpses.	[Kinchen, Jason M.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Ravichandran, Kodi S.] Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Kinchen, Jason M.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA.	kinchen@virginia.edu; ravi@virginia.edu	Kinchen, Jason/ABC-5663-2021	Kinchen, Jason/0000-0001-8430-2265; Ravichandran, Kodi/0000-0001-9049-1410	NIH; American Heart Association; NIGMS/NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069998, R01GM064709] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIGMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Casanova, C. Grimsley and members of the Ravichandran laboratory for helpful conversations; the Caenorhabditis Genetics Consortium (CGC) for nematode strains; A. Wandinger-Ness for Rab7 expression constructs; and J. Redick and S. Guillot of the Advanced Microscopy Facility for the preparation of specimens for electron microscopy. This work was supported by a post-doctoral fellowship via an NIH T32 Immunology Training Grant and American Heart Association Award (to J. M. K.), and grants from the NIGMS/NIH (to K. S. R.). K. S. R. is a William Benter Senior Fellow of the American Asthma Foundation.	Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; BRENNER S, 1974, GENETICS, V77, P71; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Gengyo-Ando K, 2007, EMBO REP, V8, P152, DOI 10.1038/sj.embor.7400882; Grimsley CM, 2006, J BIOL CHEM, V281, P5928, DOI 10.1074/jbc.M510647200; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hackam DJ, 1997, J BIOL CHEM, V272, P29810, DOI 10.1074/jbc.272.47.29810; Hoeppner DJ, 2004, DEV BIOL, V274, P125, DOI 10.1016/j.ydbio.2004.06.022; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; KARNATH RS, 2003, NATURE, V421, P231; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Kinchen JM, 2005, CURR TOP DEV BIOL, V65, P1; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Lettre G, 2004, CELL DEATH DIFFER, V11, P1198, DOI 10.1038/sj.cdd.4401488; Li WD, 2009, DEVELOPMENT, V136, P2445, DOI 10.1242/dev.035949; Lu Q, 2008, DEVELOPMENT, V135, P1069, DOI 10.1242/dev.016063; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Sun J, 2007, J LEUKOCYTE BIOL, V82, P1437, DOI 10.1189/jlb.0507289; Tosello-Trampont AC, 2007, CELL DEATH DIFFER, V14, P963, DOI 10.1038/sj.cdd.4402094; Tosello-Trampont AC, 2001, J BIOL CHEM, V276, P13797, DOI 10.1074/jbc.M011238200; Wang CW, 2003, J CELL BIOL, V163, P973, DOI 10.1083/jcb.200308071; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	35	166	177	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					778	U157		10.1038/nature08853	http://dx.doi.org/10.1038/nature08853			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20305638	Green Accepted			2022-12-24	WOS:000276205000049
J	Lourido, S; Shuman, J; Zhang, C; Shokat, KM; Hui, R; Sibley, LD				Lourido, Sebastian; Shuman, Joel; Zhang, Chao; Shokat, Kevan M.; Hui, Raymond; Sibley, L. David			Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma	NATURE			English	Article							HOST-CELLS; APICOMPLEXAN PARASITES; MICRONEME DISCHARGE; GONDII; INVASION; SECRETION; TRANSFORMATION; GENETICS; MOTILITY; REVEALS	Calcium-regulated exocytosis is a ubiquitous process in eukaryotes, whereby secretory vesicles fuse with the plasma membrane and release their contents in response to an intracellular calcium surge(1). This process regulates various cellular functions such as plasma membrane repair in plants and animals(2,3), the discharge of defensive spikes in Paramecium 4, and the secretion of insulin from pancreatic cells, immune modulators from lymphocytes, and chemical transmitters from neurons(5). In animal cells, serine/threonine kinases including cAMP-dependent protein kinase, protein kinase C and calmodulin kinases have been implicated in calcium-signal transduction leading to regulated secretion(1,6,7). Although plants and protozoa also regulate secretion by means of intracellular calcium, the method by which these signals are relayed has not been explained. Here we show that the Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) is an essential regulator of calcium-dependent exocytosis in this opportunistic human pathogen. Conditional suppression of TgCDPK1 revealed that it controls calcium-dependent secretion of specialized organelles called micronemes, resulting in a block of essential phenotypes including parasite motility, host-cell invasion, and egress. These phenotypes were recapitulated by using a chemical biology approach in which pyrazolopyrimidine-derived compounds specifically inhibited TgCDPK1 and disrupted the parasite's life cycle at stages dependent on microneme secretion. Inhibition was specific to TgCDPK1, because expression of a resistant mutant kinase reversed sensitivity to the inhibitor. TgCDPK1 is conserved among apicomplexans and belongs to a family of kinases shared with plants and ciliates(8), suggesting that related CDPKs may have a function in calcium-regulated secretion in other organisms. Because this kinase family is absent from mammalian hosts, it represents a validated target that may be exploitable for chemotherapy against T. gondii and related apicomplexans.	[Lourido, Sebastian; Shuman, Joel; Sibley, L. David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Hui, Raymond] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada	Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Toronto; Structural Genomics Consortium	Sibley, LD (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	sibley@borcim.wustl.edu		Lourido, Sebastian/0000-0002-5237-1095	American Heart Association; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034036] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank O. Billker, G. Ward, S. Moreno and V. Carruthers for discussions; F. Dzierszinski for the DsRed plasmid; D. Soldati for the Tet-transactivator system; and K. Tang for technical assistance. This work was supported by a predoctoral fellowship from the American Heart Association (S. L.) and a grant from the National Institutes of Health (L. D. S.).	Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Barclay JW, 2005, CELL CALCIUM, V38, P343, DOI 10.1016/j.ceca.2005.06.012; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blair JA, 2007, NAT CHEM BIOL, V3, P229, DOI 10.1038/nchembio866; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Chieregatti E, 2005, NAT REV MOL CELL BIO, V6, P181, DOI 10.1038/nrm1572; Choi WS, 2002, ANN NY ACAD SCI, V968, P198, DOI 10.1111/j.1749-6632.2002.tb04336.x; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Easom RA, 1999, DIABETES, V48, P675, DOI 10.2337/diabetes.48.4.675; ENDO T, 1982, EXP PARASITOL, V53, P179, DOI 10.1016/0014-4894(82)90059-5; Gurnett AM, 2002, J BIOL CHEM, V277, P15913, DOI 10.1074/jbc.M108393200; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Kieschnick H, 2001, J BIOL CHEM, V276, P12369, DOI 10.1074/jbc.M011045200; KIM K, 1993, SCIENCE, V262, P911, DOI 10.1126/science.8235614; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; ROOS DS, 1994, METHOD CELL BIOL, V45, P28; Schapire AL, 2009, TRENDS PLANT SCI, V14, P645, DOI 10.1016/j.tplants.2009.09.004; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Starnes GL, 2009, CELL HOST MICROBE, V5, P353, DOI 10.1016/j.chom.2009.03.005; Sugi T, 2010, EUKARYOT CELL, V9, P667, DOI 10.1128/EC.00351-09; Vayssie L, 2000, BIOCHIMIE, V82, P269, DOI 10.1016/S0300-9084(00)00201-7; Wernimont AK, 2010, NAT STRUCT MOL BIOL, V17, P596, DOI 10.1038/nsmb.1795; Wiersma HI, 2004, INT J PARASITOL, V34, P369, DOI 10.1016/j.ijpara.2003.11.019	33	250	264	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2010	465	7296					359	U118		10.1038/nature09022	http://dx.doi.org/10.1038/nature09022			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485436	Green Accepted, Green Submitted			2022-12-24	WOS:000277829200043
J	Hagn, F; Eisoldt, L; Hardy, JG; Vendrely, C; Coles, M; Scheibel, T; Kessler, H				Hagn, Franz; Eisoldt, Lukas; Hardy, John G.; Vendrely, Charlotte; Coles, Murray; Scheibel, Thomas; Kessler, Horst			A conserved spider silk domain acts as a molecular switch that controls fibre assembly	NATURE			English	Article							TERMINAL DOMAIN; EXCHANGE-RATES; PROTEIN; DRAGLINE; ASSIGNMENT; STABILITY; MECHANISM; SEQUENCE; SHIFT	A huge variety of proteins are able to form fibrillar structures(1), especially at high protein concentrations. Hence, it is surprising that spider silk proteins can be stored in a soluble form at high concentrations and transformed into extremely stable fibres on demand(2,3). Silk proteins are reminiscent of amphiphilic block copolymers containing stretches of polyalanine and glycine-rich polar elements forming a repetitive core flanked by highly conserved non-repetitive amino-terminal(4,5) and carboxy-terminal(6) domains. The N-terminal domain comprises a secretion signal, but further functions remain unassigned. The C-terminal domain was implicated in the control of solubility and fibre formation(7) initiated by changes in ionic composition(8,9) and mechanical stimuli known to align the repetitive sequence elements and promote beta-sheet formation(10-14). However, despite recent structural data(15), little is known about this remarkable behaviour in molecular detail. Here we present the solution structure of the C-terminal domain of a spider dragline silk protein and provide evidence that the structural state of this domain is essential for controlled switching between the storage and assembly forms of silk proteins. In addition, the C-terminal domain also has a role in the alignment of secondary structural features formed by the repetitive elements in the backbone of spider silk proteins, which is known to be important for the mechanical properties of the fibre.	[Hagn, Franz; Kessler, Horst] Tech Univ Munich, Ctr Integrated Prot Sci CIPSM, D-85747 Garching, Germany; [Hagn, Franz; Kessler, Horst] Tech Univ Munich, Inst Adv Study, D-85747 Garching, Germany; [Eisoldt, Lukas; Hardy, John G.; Vendrely, Charlotte; Scheibel, Thomas] Univ Bayreuth, Fak Angew Nat Wissensch, Lehrstuhl Biomat, D-95440 Bayreuth, Germany; [Coles, Murray] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	Technical University of Munich; Technical University of Munich; University of Bayreuth; Max Planck Society	Kessler, H (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci CIPSM, D-85747 Garching, Germany.	thomas.scheibel@uni-bayreuth.de; horst.kessler@ch.tum.de	Hagn, Franz X/N-9553-2016; Hardy, John George/D-1501-2009; Scheibel, Thomas/I-1170-2014	Hagn, Franz X/0000-0002-1315-459X; Hardy, John George/0000-0003-0655-2167; Scheibel, Thomas/0000-0002-0457-2423	Center for Integrated Protein Science Munich (CIPS<SUP>M</SUP>); Deutsche Forschungsgemeinschaft [SCHE 603/4-3]; Elitenetzwerk Bayern, CompInt; Alexander von Humboldt Foundation	Center for Integrated Protein Science Munich (CIPS<SUP>M</SUP>); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elitenetzwerk Bayern, CompInt; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This paper is in memoriam of R. Rudolph who triggered spider silk research in the lab of T. S. We want to thank D. Hummerich and J. Exler for initial work on the project, S. Quedzuweit for sample preparation in early stages of the project, M. Heim and M. Suhre for cloning work, and H. Krause for mass spectrometry. This work was supported by the Center for Integrated Protein Science Munich (CIPS<SUP>M</SUP>) (to H. K. and T. S.) and the Deutsche Forschungsgemeinschaft SCHE 603/4-3 (to T. S.). F. H. was supported by the Elitenetzwerk Bayern, CompInt. J. G. H. was supported by the Alexander von Humboldt Foundation.	BROWM JC, 1995, INT ARCH ALLERGY IMM, V107, P484, DOI 10.1159/000237090; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Diercks T, 1999, J BIOMOL NMR, V15, P177, DOI 10.1023/A:1008367912535; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Exler JH, 2007, ANGEW CHEM INT EDIT, V46, P3559, DOI 10.1002/anie.200604718; GEMMECKER G, 1993, J AM CHEM SOC, V115, P11620, DOI 10.1021/ja00077a080; Gosline JM, 1999, J EXP BIOL, V202, P3295; Hardy JG, 2009, BIOCHEM SOC T, V37, P677, DOI 10.1042/BST0370677; Heim M, 2009, ANGEW CHEM INT EDIT, V48, P3584, DOI 10.1002/anie.200803341; Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q; IKURA M, 1991, Journal of Biomolecular NMR, V1, P299, DOI 10.1007/BF01875522; Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; KAY LE, 1990, J AM CHEM SOC, V112, P888, DOI 10.1021/ja00158a070; Knight DP, 1999, P ROY SOC B-BIOL SCI, V266, P519, DOI 10.1098/rspb.1999.0667; Knight DP, 2001, NATURWISSENSCHAFTEN, V88, P179, DOI 10.1007/s001140100220; Knight DP, 2000, INT J BIOL MACROMOL, V27, P205, DOI 10.1016/S0141-8130(00)00124-0; KOIDE S, 1995, J BIOMOL NMR, V6, P306; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; LEES JF, 1994, J BIOL CHEM, V269, P24354; Lefevre T, 2008, BIOMACROMOLECULES, V9, P2399, DOI 10.1021/bm800390j; Lin Z, 2009, P NATL ACAD SCI USA, V106, P8906, DOI 10.1073/pnas.0813255106; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b; PRIVALOV PL, 1979, ADV PROTEIN CHEM, V167, P241; Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105; Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x; Sacca B, 2002, J MOL BIOL, V324, P309, DOI 10.1016/S0022-2836(02)01065-3; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048; Truffault V, 2001, J MOL BIOL, V309, P949, DOI 10.1006/jmbi.2001.4683; Vezy C, 2009, BIOINTERPHASES, V4, P43, DOI 10.1116/1.3174930; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000	36	299	314	7	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					239	U131		10.1038/nature08936	http://dx.doi.org/10.1038/nature08936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463741	Green Accepted			2022-12-24	WOS:000277558500040
J	Mulder, DW; Boyd, ES; Sarma, R; Lange, RK; Endrizzi, JA; Broderick, JB; Peters, JW				Mulder, David W.; Boyd, Eric S.; Sarma, Ranjana; Lange, Rachel K.; Endrizzi, James A.; Broderick, Joan B.; Peters, John W.			Stepwise [FeFe]-hydrogenase H-cluster assembly revealed in the structure of HydA(Delta EFG)	NATURE			English	Article							HYDROGENASE; PROTEIN; MATURATION; BIOSYNTHESIS; EVOLUTION; INFERENCE; COFACTORS; ENZYMES; MRBAYES; LIGAND	Complex enzymes containing Fe-S clusters are ubiquitous in nature, where they are involved in a number of fundamental processes including carbon dioxide fixation, nitrogen fixation and hydrogen metabolism(1,2). Hydrogen metabolism is facilitated by the activity of three evolutionarily and structurally unrelated enzymes: the [NiFe]-hydrogenases, [FeFe]-hydrogenases and [Fe]-hydrogenases(3,4) (Hmd). The catalytic core of the [FeFe]-hydrogenase (HydA), termed the H-cluster, exists as a [4Fe-4S] subcluster linked by a cysteine thiolate to a modified 2Fe subcluster with unique non-protein ligands(5,6). The 2Fe subcluster and non-protein ligands are synthesized by the hydrogenase maturation enzymes HydE, HydF and HydG; however, the mechanism, synthesis and means of insertion of H-cluster components remain unclear(7-10). Here we show the structure of HydA(Delta EFG) (HydA expressed in a genetic background devoid of the active site H-cluster biosynthetic genes hydE, hydF and hydG) revealing the presence of a [4Fe-4S] cluster and an open pocket for the 2Fe subcluster. The structure indicates that H-cluster synthesis occurs in a stepwise manner, first with synthesis and insertion of the [4Fe-4S] subcluster by generalized host-cell machinery(11,12) and then with synthesis and insertion of the 2Fe subcluster by specialized hydE-, hydF- and hydG-encoded maturation machinery(7-10). Insertion of the 2Fe subcluster presumably occurs through a cationically charged channel that collapses following incorporation, as a result of conformational changes in two conserved loop regions. The structure, together with phylogenetic analysis, indicates that HydA emerged within bacteria most likely from a Nar1-like ancestor lacking the 2Fe subcluster, and that this was followed by acquisition in several unicellular eukaryotes.	[Mulder, David W.; Boyd, Eric S.; Sarma, Ranjana; Lange, Rachel K.; Endrizzi, James A.; Broderick, Joan B.; Peters, John W.] Montana State Univ, Astrobiol Biogeocatalysis Res Ctr, Bozeman, MT 59717 USA; [Mulder, David W.; Boyd, Eric S.; Sarma, Ranjana; Lange, Rachel K.; Endrizzi, James A.; Broderick, Joan B.; Peters, John W.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Peters, JW (corresponding author), Montana State Univ, Astrobiol Biogeocatalysis Res Ctr, Bozeman, MT 59717 USA.	john.peters@chemistry.montana.edu	Mulder, David/AHC-0138-2022	Mulder, David/0000-0003-0559-0145; Peters, John/0000-0001-9117-9568; Broderick, Joan/0000-0001-7057-9124; Spietz, Rachel/0000-0001-5277-0734	US Air Force Office of Scientific Research Multidisciplinary University Research Initiative [FA9550-05-01-0365]; NASA Astrobiology Institute (NAI) [NNA08C-N85A]; NAI; US Department of Energy, Office of Biological and Environmental Research; US National Institutes of Health, National Center for Research Resources; US National Institute of General Medical Sciences	US Air Force Office of Scientific Research Multidisciplinary University Research Initiative; NASA Astrobiology Institute (NAI); NAI; US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); US National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a US Air Force Office of Scientific Research Multidisciplinary University Research Initiative Award (FA9550-05-01-0365, J.W.P.) and the NASA Astrobiology Institute (NAI)-funded Astrobiology Biogeocatalysis Research Center (NNA08C-N85A, J.B.B. and J.W.P.). E. S. B. was supported by a NAI postdoctoral fellowship. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a national user facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology programme is supported by the US Department of Energy, Office of Biological and Environmental Research, the US National Institutes of Health, National Center for Research Resources, Biomedical Technology programme, and the US National Institute of General Medical Sciences.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL VIEWER; Drennan CL, 2003, CURR OPIN STRUC BIOL, V13, P220, DOI 10.1016/S0959-440X(03)00038-1; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fani R, 2000, J MOL EVOL, V51, P1; Fontecilla-Camps JC, 2009, NATURE, V460, P814, DOI 10.1038/nature08299; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hug LA, 2010, MOL BIOL EVOL, V27, P311, DOI 10.1093/molbev/msp237; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; McGlynn SE, 2009, DALTON T, P4274, DOI 10.1039/b821432h; Meyer J, 2007, CELL MOL LIFE SCI, V64, P1063, DOI 10.1007/s00018-007-6477-4; Mulder DW, 2009, BIOCHEMISTRY-US, V48, P6240, DOI 10.1021/bi9000563; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Peters JW, 2006, FEBS LETT, V580, P363, DOI 10.1016/j.febslet.2005.12.040; Pilet E, 2009, FEBS LETT, V583, P506, DOI 10.1016/j.febslet.2009.01.004; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Schmid B, 2002, SCIENCE, V296, P352, DOI 10.1126/science.1070010; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; Silakov A, 2009, PHYS CHEM CHEM PHYS, V11, P6592, DOI 10.1039/b905841a; TENEYCK LF, 1973, ACTA CRYSTALLOGR A, VA 29, P183, DOI 10.1107/S0567739473000458; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r	45	230	235	3	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					248	U143		10.1038/nature08993	http://dx.doi.org/10.1038/nature08993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20418861				2022-12-24	WOS:000277558500042
J	Dejnirattisai, W; Jumnainsong, A; Onsirisakul, N; Fitton, P; Vasanawathana, S; Limpitikul, W; Puttikhunt, C; Edwards, C; Duangchinda, T; Supasa, S; Chawansuntati, K; Malasit, P; Mongkolsapaya, J; Screaton, G				Dejnirattisai, Wanwisa; Jumnainsong, Amonrat; Onsirisakul, Naruthai; Fitton, Patricia; Vasanawathana, Sirijitt; Limpitikul, Wannee; Puttikhunt, Chunya; Edwards, Carolyn; Duangchinda, Thaneeya; Supasa, Sunpetchuda; Chawansuntati, Kriangkrai; Malasit, Prida; Mongkolsapaya, Juthathip; Screaton, Gavin			Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans	SCIENCE			English	Article							CONSERVED RESIDUES; ENVELOPE PROTEIN; FUSION-LOOP; MATURATION; FLAVIVIRUSES; VIRIONS; CELLS; CUBA	Dengue virus co-circulates as four serotypes, and sequential infections with more than one serotype are common. One hypothesis for the increased severity seen in secondary infections is antibody-dependent enhancement (ADE) leading to increased replication in Fc receptor-bearing cells. In this study, we have generated a panel of human monoclonal antibodies to dengue virus. Antibodies to the structural precursor-membrane protein (prM) form a major component of the response. These antibodies are highly cross-reactive among the dengue virus serotypes and, even at high concentrations, do not neutralize infection but potently promote ADE. We propose that the partial cleavage of prM from the viral surface reduces the density of antigen available for viral neutralization, leaving dengue viruses susceptible to ADE by antibody to prM, a finding that has implications for future vaccine design.	[Dejnirattisai, Wanwisa; Jumnainsong, Amonrat; Onsirisakul, Naruthai; Fitton, Patricia; Edwards, Carolyn; Chawansuntati, Kriangkrai; Mongkolsapaya, Juthathip; Screaton, Gavin] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W12 0NN, England; [Onsirisakul, Naruthai] Mahidol Univ, Fac Med Technol, Bangkok 10700, Thailand; [Vasanawathana, Sirijitt] Khon Kaen Hosp, Dept Pediat, Khon Kaen 4000, Thailand; [Limpitikul, Wannee] Songkhla Hosp, Dept Pediat, Songkhla 90100, Thailand; [Puttikhunt, Chunya; Duangchinda, Thaneeya; Malasit, Prida] NSTDA, BIOTEC, Phatumthani 12120, Thailand; [Supasa, Sunpetchuda; Malasit, Prida; Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok 10700, Thailand	Imperial College London; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Screaton, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, London W12 0NN, England.	j.mongkolsapaya@imperial.ac.uk; g.screaton@imperial.ac.uk	Puttikhunt, Chunya/E-1030-2011	Screaton, Gavin/0000-0002-3549-4309	Medical Research Council, UK; Wellcome Trust, UK; National Institute for Health Research Biomedical Research Centre; Thailand Tropical Disease Research Program T2; Thailand National Centre for Genetic Engineering and Biotechnology; MRC [G0400720, G0600000, G0801508] Funding Source: UKRI; Medical Research Council [G0600000] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust, UK(Wellcome Trust); National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Thailand Tropical Disease Research Program T2; Thailand National Centre for Genetic Engineering and Biotechnology; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank W. Supanchaimat, V. Jarupoonphol, S. Jinathongthai, K. Sriruksa, P. Wongsilarat, T. Suphachaiyakit, K. Ratarpa, Y. Sutvigit, and the staff of Khon Kaen and Songkhla hospitals for sample collection; L. Damrikarnlerd, P. Suriyapol, C. Komoltri, S. Udompunturak, N. Tangthawornchaikul, A. Jairangsri, K. Sae-Jang, and S. Supajitkasem for data and clinical database management and statistical analysis; N. Sittisombut and P. Keelapang from Chiang Mai University for sharing knowledge; and C. P. Simmons and B. Wills from the Oxford University Clinical Research Unit, Ho Chi Minh City for samples. This work was supported by the Medical Research Council, UK; the Wellcome Trust, UK; the National Institute for Health Research Biomedical Research Centre funding scheme; the Thailand Tropical Disease Research Program T2; and the Thailand National Centre for Genetic Engineering and Biotechnology.	Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; GUIRAKHOO F, 1991, J GEN VIROL, V72, P1323, DOI 10.1099/0022-1317-72-6-1323; Guzman MG, 2000, AM J EPIDEMIOL, V152, P804, DOI 10.1093/aje/152.9.804; Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; *WHO, 2008, 117 WHO; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0	17	618	658	3	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					745	748		10.1126/science.1185181	http://dx.doi.org/10.1126/science.1185181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448183	Green Accepted			2022-12-24	WOS:000277357100038
J	Morais-de-Sa, E; Mirouse, V; St Johnston, D				Morais-de-Sa, Eurico; Mirouse, Vincent; St Johnston, Daniel			aPKC Phosphorylation of Bazooka Defines the Apical/Lateral Border in Drosophila Epithelial Cells	CELL			English	Article							POLARITY PROTEIN PAR-3; ADHESION MOLECULE JAM; TIGHT-JUNCTION; CAENORHABDITIS-ELEGANS; ADHERENS JUNCTIONS; NEUROEPITHELIAL CELLS; SPINDLE ORIENTATION; APICAL DOMAIN; PDZ DOMAINS; KINASE-C	Bazooka (PAR-3), PAR-6, and aPKC form a complex that plays a key role in the polarization of many cell types. In epithelial cells, however, Bazooka localizes below PAR-6 and aPKC at the apical/lateral junction. Here, we show that Baz is excluded from the apical aPKC domain in epithelia by aPKC phosphorylation, which disrupts the Baz/aPKC interaction. Removal of Baz from the complex is epithelial-specific because it also requires the Crumbs complex, which prevents the Baz/PAR-6 interaction. In the absence of Crumbs or aPKC phosphorylation of Baz, mislocalized Baz recruits adherens junction components apically, leading to a loss of the apical domain and an expansion of lateral. Thus, apical exclusion of Baz by Crumbs and aPKC defines the apical/lateral border. Although Baz acts as an aPKC targeting and specificity factor in nonepithelial cells, our results reveal that it performs a complementary function in positioning the adherens junction in epithelia.	[Morais-de-Sa, Eurico; Mirouse, Vincent; St Johnston, Daniel] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Morais-de-Sa, Eurico; Mirouse, Vincent; St Johnston, Daniel] Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	d.stjohnston@gurdon.cam.ac.uk	St Johnston, Daniel/C-9568-2009; Morais-de-Sá, Eurico/I-2157-2013	Morais-de-Sá, Eurico/0000-0003-3525-8231; MIrouse, Vincent/0000-0001-5823-342X; St Johnston, Daniel/0000-0001-5582-3301	Wellcome Trust; Portuguese Foundation for Science and Technology	Wellcome Trust(Wellcome TrustEuropean Commission); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	We wish to thank Andreas Wodarz, David Bilder, Eli Knust, Jurgen Knoblich, Kate Beckingham, Ulrich Tepass, and the Bloomington stock centre for reagents, Benedicte Sanson for help with the movies of embryos, and Antonio Vega-Rioja for help with Kinase assays. This work was supported by a Wellcome Trust Principal Fellowship to D.StJ. E.M. received support from the Portuguese Foundation for Science and Technology as a student from the Graduate Program in Areas of Basic and Applied Biology.	Abdelilah-Seyfried S, 2003, DEVELOPMENT, V130, P1927, DOI 10.1242/dev.00420; Afonso C, 2006, J CELL SCI, V119, P4293, DOI 10.1242/jcs.03170; Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902; Atwood SX, 2009, CURR BIOL, V19, P723, DOI 10.1016/j.cub.2009.03.056; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Campbell K, 2009, J CELL SCI, V122, P2604, DOI 10.1242/jcs.047183; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Hung TJ, 1999, DEVELOPMENT, V126, P127; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Ito K, 1997, DEVELOPMENT, V124, P761; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kempkens O, 2006, EUR J CELL BIOL, V85, P753, DOI 10.1016/j.ejcb.2006.03.003; Kohjima M, 2002, BIOCHEM BIOPH RES CO, V299, P641, DOI 10.1016/S0006-291X(02)02698-0; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; McGill MA, 2009, J CELL BIOL, V185, P787, DOI 10.1083/jcb.200812146; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Satohisa S, 2005, EXP CELL RES, V310, P66, DOI 10.1016/j.yexcr.2005.06.025; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tian AG, 2008, DEVELOPMENT, V135, P463, DOI 10.1242/dev.016253; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Wang Q, 2004, J BIOL CHEM, V279, P30715, DOI 10.1074/jbc.M401930200; Wei SY, 2005, DEV CELL, V8, P493, DOI 10.1016/j.devcel.2005.03.015; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; XU T, 1993, DEVELOPMENT, V117, P1223; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	56	199	202	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					509	523		10.1016/j.cell.2010.02.040	http://dx.doi.org/10.1016/j.cell.2010.02.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434988	Green Published, hybrid			2022-12-24	WOS:000277180800021
J	Verhulst, EC; Beukeboom, LW; van de Zande, L				Verhulst, Eveline C.; Beukeboom, Leo W.; van de Zande, Louis			Maternal Control of Haplodiploid Sex Determination in the Wasp Nasonia	SCIENCE			English	Article							DOUBLESEX GENE; DROSOPHILA-MELANOGASTER; DETERMINATION PATHWAY; TRANSFORMER GENE; DETERMINING MECHANISMS; BACTROCERA-OLEAE; MUSCA-DOMESTICA; VITRIPENNIS; EVOLUTION; INSECTS	All insects in the order Hymenoptera have haplodiploid sex determination, in which males emerge from haploid unfertilized eggs and females are diploid. Sex determination in the honeybee Apis mellifera is controlled by the complementary sex determination (csd) locus, but the mechanisms controlling sex determination in other Hymenoptera without csd are unknown. We identified the sex-determination system of the parasitic wasp Nasonia, which has no csd locus. Instead, maternal input of Nasonia vitripennis transformer (Nvtra) messenger RNA, in combination with specific zygotic Nvtra transcription, in which Nvtra autoregulates female-specific splicing, is essential for female development. Our data indicate that males develop as a result of maternal imprinting that prevents zygotic transcription of the maternally derived Nvtra allele in unfertilized eggs. Upon fertilization, zygotic Nvtra transcription is initiated, which autoregulates the female-specific transcript, leading to female development.	[Verhulst, Eveline C.; Beukeboom, Leo W.; van de Zande, Louis] Univ Groningen, Ctr Ecol & Evolutionary Studies, NL-9700 AB Groningen, Netherlands	University of Groningen	van de Zande, L (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, NL-9700 AB Groningen, Netherlands.	louis.van.de.zande@rug.nl	Verhulst, Eveline/J-2641-2013; Beukeboom, L.W./D-1808-2012	Verhulst, Eveline/0000-0002-4781-535X; van de Zande, Louis/0000-0001-5687-3220	Netherlands Organization for Scientific Research (NWO) [ALW 833.02.003]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The authors thank the Werren lab (University of Rochester, United States), D. Bopp, M. H. Linskens, A. Rensink, and A. Kamping for technical assistance and discussions and four anonymous reviewers for helpful suggestions. This work was partly funded by Pioneer grant ALW 833.02.003 from the Netherlands Organization for Scientific Research (NWO).	BELOTE JM, 1989, DEV GENET, V10, P143, DOI 10.1002/dvg.1020100304; Bertossa RC, 2009, MOL BIOL EVOL, V26, P1557, DOI 10.1093/molbev/msp067; Beukeboom LW, 2007, SEMIN CELL DEV BIOL, V18, P371, DOI 10.1016/j.semcdb.2006.12.015; Beukeboom LW, 2007, SCIENCE, V315, P206, DOI 10.1126/science.1133388; Beukeboom LW, 2006, GENETICS, V172, P981, DOI 10.1534/genetics.105.044743; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Cho S, 2007, GENETICS, V177, P1733, DOI 10.1534/genetics.107.078980; Dubendorfer A, 2002, INT J DEV BIOL, V46, P75; Ruiz MF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001239; Gempe T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000222; Hasselmann M, 2008, NATURE, V454, P519, DOI 10.1038/nature07052; Hediger M, 2004, DEV GENES EVOL, V214, P29, DOI 10.1007/s00427-003-0372-2; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Kuhn S, 2000, GENOME, V43, P1011, DOI 10.1139/gen-43-6-1011; Lagos D, 2007, INSECT MOL BIOL, V16, P221, DOI 10.1111/j.1365-2583.2006.00717.x; Lagos D, 2005, GENE, V348, P111, DOI 10.1016/j.gene.2004.12.053; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Oliveira DCSG, 2009, INSECT MOL BIOL, V18, P315, DOI 10.1111/j.1365-2583.2009.00874.x; Pane A, 2005, GENETICS, V171, P615, DOI 10.1534/genetics.105.041004; Pane A, 2002, DEVELOPMENT, V129, P3715; Pultz MA, 2005, DEVELOPMENT, V132, P3705, DOI 10.1242/dev.01939; Rosenberg MI, 2009, BBA-GENE REGUL MECH, V1789, P333, DOI 10.1016/j.bbagrm.2008.09.007; Saccone G, 1996, P 1 RES COORD M ENH, P16; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Scali C, 2005, J EXP BIOL, V208, P3701, DOI 10.1242/jeb.01819; Shearman DCA, 1998, INSECT MOL BIOL, V7, P355, DOI 10.1046/j.1365-2583.1998.740355.x; van Wilgenburg Ellen, 2006, Frontiers in Zoology, V3, P1, DOI 10.1186/1742-9994-3-1; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; WILKINS AS, 1995, BIOESSAYS, V17, P71, DOI 10.1002/bies.950170113	30	138	148	8	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					620	623		10.1126/science.1185805	http://dx.doi.org/10.1126/science.1185805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431014	Green Submitted			2022-12-24	WOS:000277159800043
J	Proshkin, S; Rahmouni, AR; Mironov, A; Nudler, E				Proshkin, Sergey; Rahmouni, A. Rachid; Mironov, Alexander; Nudler, Evgeny			Cooperation Between Translating Ribosomes and RNA Polymerase in Transcription Elongation	SCIENCE			English	Article							CODON USAGE; ESCHERICHIA-COLI; EXPRESSION; MECHANISM; GROWTH; ATTENUATION; TERMINATION; GENOME; GENE; DNA	During transcription of protein-coding genes, bacterial RNA polymerase (RNAP) is closely followed by a ribosome that translates the newly synthesized transcript. Our in vivo measurements show that the overall elongation rate of transcription is tightly controlled by the rate of translation. Acceleration and deceleration of a ribosome result in corresponding changes in the speed of RNAP. Moreover, we found an inverse correlation between the number of rare codons in a gene, which delay ribosome progression, and the rate of transcription. The stimulating effect of a ribosome on RNAP is achieved by preventing its spontaneous backtracking, which enhances the pace and also facilitates readthrough of roadblocks in vivo. Such a cooperative mechanism ensures that the transcriptional yield is always adjusted to translational needs at different genes and under various growth conditions.	[Proshkin, Sergey; Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Proshkin, Sergey; Mironov, Alexander] State Res Inst Genet & Select Ind Microorganisms, Moscow 117545, Russia; [Rahmouni, A. Rachid] CNRS, Ctr Biophys Mol, F-45071 Orleans, France	New York University; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms; Centre National de la Recherche Scientifique (CNRS)	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.	evgeny.nudler@nyumc.org	Proshkin, Sergey/G-2733-2017; Mironov, Alexander/G-8531-2013	Proshkin, Sergey/0000-0002-6116-4637; Nudler, Evgeny/0000-0002-8811-3071; Mironov, Alexander/0000-0003-3914-1380	NIH; Dynasty Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dynasty Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Hughes for the CH184 (SmP) strain. This work was supported by grants from the NIH and Dynasty Foundation (E.N.).	ADHYA S, 1978, ANNU REV BIOCHEM, V47, P967, DOI 10.1146/annurev.bi.47.070178.004535; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; BOHMAN K, 1984, MOL GEN GENET, V198, P90, DOI 10.1007/BF00328706; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Depken M, 2009, BIOPHYS J, V96, P2189, DOI 10.1016/j.bpj.2008.12.3918; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; Jansen R, 2003, NUCLEIC ACIDS RES, V31, P2242, DOI 10.1093/nar/gkg306; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 2009, ANNU REV BIOCHEM, V78, P335, DOI 10.1146/annurev.biochem.76.052705.164655; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; RICHARDSON JP, 1991, CELL, V64, P1047, DOI 10.1016/0092-8674(91)90257-Y; RUUSALA T, 1984, EMBO J, V3, P2575, DOI 10.1002/j.1460-2075.1984.tb02176.x; Saeki H, 2009, MOL CELL, V35, P191, DOI 10.1016/j.molcel.2009.06.009; Steitz TA, 2008, NAT REV MOL CELL BIO, V9, P242, DOI 10.1038/nrm2352; Svetlov V, 2007, NUCLEIC ACIDS RES, V35, P5694, DOI 10.1093/nar/gkm600; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; YANOFSKY C, 1981, NATURE, V289, P751, DOI 10.1038/289751a0; Zhang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005036	27	355	358	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					504	508		10.1126/science.1184939	http://dx.doi.org/10.1126/science.1184939			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413502	Green Accepted			2022-12-24	WOS:000276952400044
J	Reyes-Lamothe, R; Sherratt, DJ; Leake, MC				Reyes-Lamothe, Rodrigo; Sherratt, David J.; Leake, Mark C.			Stoichiometry and Architecture of Active DNA Replication Machinery in Escherichia coli	SCIENCE			English	Article							CLAMP-LOADER COMPLEX; POLYMERASE-III; PLASMA-MEMBRANE; TWEEZERS ASSAY; IN-VIVO; SINGLE; REPLISOME; PROTEIN; ELASTICITY; DYNAMICS	The multiprotein replisome complex that replicates DNA has been extensively characterized in vitro, but its composition and architecture in vivo is unknown. Using millisecond single-molecule fluorescence microscopy in living cells expressing fluorescent derivatives of replisome components, we have examined replisome stoichiometry and architecture. Active Escherichia coli replisomes contain three molecules of the replicative polymerase, rather than the historically accepted two. These are associated with three molecules of tau, a clamp loader component that trimerizes polymerase. Only two of the three sliding clamps are always associated with the core replisome. Single-strand binding protein has a broader spatial distribution than the core components, with 5 to 11 tetramers per replisome. This in vivo technique could provide single-molecule insight into other molecular machines.	[Reyes-Lamothe, Rodrigo; Sherratt, David J.; Leake, Mark C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Leake, Mark C.] Univ Oxford, Dept Phys, Oxford OX1 3PU, England	University of Oxford; University of Oxford	Leake, MC (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	m.leake1@physics.ox.ac.uk	Leake, Mark/C-1245-2011	Leake, Mark/0000-0002-1715-1249	Wellcome Trust; Royal Society; Conacyt; Clarendon postgraduate award	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Clarendon postgraduate award	Supported by the Wellcome Trust and the Royal Society. M. C. L. is a Royal Society University Fellow and research fellow of Hertford College Oxford. R. R.-L. is a research fellow of New College Oxford and was supported by Conacyt and a Clarendon postgraduate award. We thank C. Possoz and C. Lesterlin for stimulating discussions, and we acknowledge National BioResource Project (NIG, Japan): E. coli for the provision of the holC and holD deletion strains.	ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; BLINKOVA A, 1993, J BACTERIOL, V175, P6018, DOI 10.1128/JB.175.18.6018-6027.1993; BLINKOWA AL, 1990, NUCLEIC ACIDS RES, V18, P1725, DOI 10.1093/nar/18.7.1725; CHUNG SH, 1991, J NEUROSCI METH, V40, P71, DOI 10.1016/0165-0270(91)90118-J; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kazmirski SL, 2004, P NATL ACAD SCI USA, V101, P16750, DOI 10.1073/pnas.0407904101; Lamers MH, 2006, CELL, V126, P881, DOI 10.1016/j.cell.2006.07.028; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Leake MC, 2004, BIOPHYS J, V87, P1112, DOI 10.1529/biophysj.103.033571; Leake MC, 2003, FEBS LETT, V535, P55, DOI 10.1016/S0014-5793(02)03857-7; Lenn T, 2008, BIOCHEM SOC T, V36, P1032, DOI 10.1042/BST0361032; Lenn T, 2008, MOL MICROBIOL, V70, P1397, DOI 10.1111/j.1365-2958.2008.06486.x; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; McInerney P, 2007, J BIOL CHEM, V282, P25903, DOI 10.1074/jbc.M703777200; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; Plank M, 2009, INTEGR BIOL-UK, V1, P602, DOI 10.1039/b907837a; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Smith DA, 1998, PHILOS T R SOC B, V353, P1969, DOI 10.1098/rstb.1998.0348; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Xie XS, 2006, SCIENCE, V312, P228, DOI 10.1126/science.1127566; Yao NY, 2009, P NATL ACAD SCI USA, V106, P13236, DOI 10.1073/pnas.0906157106; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X	27	259	265	2	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					498	501		10.1126/science.1185757	http://dx.doi.org/10.1126/science.1185757			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413500	Green Accepted			2022-12-24	WOS:000276952400042
J	Chapman, JA; Kirkness, EF; Simakov, O; Hampson, SE; Mitros, T; Weinmaier, T; Rattei, T; Balasubramanian, PG; Borman, J; Busam, D; Disbennett, K; Pfannkoch, C; Sumin, N; Sutton, GG; Viswanathan, LD; Walenz, B; Goodstein, DM; Hellsten, U; Kawashima, T; Prochnik, SE; Putnam, NH; Shu, SQ; Blumberg, B; Dana, CE; Gee, L; Kibler, DF; Law, L; Lindgens, D; Martinez, DE; Peng, JS; Wigge, PA; Bertulat, B; Guder, C; Nakamura, Y; Ozbek, S; Watanabe, H; Khalturin, K; Hemmrich, G; Franke, A; Augustin, R; Fraune, S; Hayakawa, E; Hayakawa, S; Hirose, M; Hwang, JS; Ikeo, K; Nishimiya-Fujisawa, C; Ogura, A; Takahashi, T; Steinmetz, PRH; Zhang, XM; Aufschnaiter, R; Eder, MK; Gorny, AK; Salvenmoser, W; Heimberg, AM; Wheeler, BM; Peterson, KJ; Boettger, A; Tischler, P; Wolf, A; Gojobori, T; Remington, KA; Strausberg, RL; Venter, JC; Technau, U; Hobmayer, B; Bosch, TCG; Holstein, TW; Fujisawa, T; Bode, HR; David, CN; Rokhsar, DS; Steele, RE				Chapman, Jarrod A.; Kirkness, Ewen F.; Simakov, Oleg; Hampson, Steven E.; Mitros, Therese; Weinmaier, Thomas; Rattei, Thomas; Balasubramanian, Prakash G.; Borman, Jon; Busam, Dana; Disbennett, Kathryn; Pfannkoch, Cynthia; Sumin, Nadezhda; Sutton, Granger G.; Viswanathan, Lakshmi Devi; Walenz, Brian; Goodstein, David M.; Hellsten, Uffe; Kawashima, Takeshi; Prochnik, Simon E.; Putnam, Nicholas H.; Shu, Shengquiang; Blumberg, Bruce; Dana, Catherine E.; Gee, Lydia; Kibler, Dennis F.; Law, Lee; Lindgens, Dirk; Martinez, Daniel E.; Peng, Jisong; Wigge, Philip A.; Bertulat, Bianca; Guder, Corina; Nakamura, Yukio; Ozbek, Suat; Watanabe, Hiroshi; Khalturin, Konstantin; Hemmrich, Georg; Franke, Andre; Augustin, Rene; Fraune, Sebastian; Hayakawa, Eisuke; Hayakawa, Shiho; Hirose, Mamiko; Hwang, Jung Shan; Ikeo, Kazuho; Nishimiya-Fujisawa, Chiemi; Ogura, Atshushi; Takahashi, Toshio; Steinmetz, Patrick R. H.; Zhang, Xiaoming; Aufschnaiter, Roland; Eder, Marie-Kristin; Gorny, Anne-Kathrin; Salvenmoser, Willi; Heimberg, Alysha M.; Wheeler, Benjamin M.; Peterson, Kevin J.; Boettger, Angelika; Tischler, Patrick; Wolf, Alexander; Gojobori, Takashi; Remington, Karin A.; Strausberg, Robert L.; Venter, J. Craig; Technau, Ulrich; Hobmayer, Bert; Bosch, Thomas C. G.; Holstein, Thomas W.; Fujisawa, Toshitaka; Bode, Hans R.; David, Charles N.; Rokhsar, Daniel S.; Steele, Robert E.			The dynamic genome of Hydra	NATURE			English	Article							TYROSINE KINASE; SEA-ANEMONE; STEM-CELLS; GENE; MOLECULES; MAINTENANCE; EXPRESSION; EVOLUTION; ORIGINS; CLUSTER	The freshwater cnidarian Hydra was first described in 1702(1) and has been the object of study for 300 years. Experimental studies of Hydra between 1736 and 1744 culminated in the discovery of asexual reproduction of an animal by budding, the first description of regeneration in an animal, and successful transplantation of tissue between animals(2). Today, Hydra is an important model for studies of axial patterning(3), stem cell biology(4) and regeneration(5). Here we report the genome of Hydra magnipapillata and compare it to the genomes of the anthozoan Nematostella vectensis(6) and other animals. The Hydra genome has been shaped by bursts of transposable element expansion, horizontal gene transfer, trans-splicing, and simplification of gene structure and gene content that parallel simplification of the Hydra life cycle. We also report the sequence of the genome of a novel bacterium stably associated with H. magnipapillata. Comparisons of the Hydra genome to the genomes of other animals shed light on the evolution of epithelia, contractile tissues, developmentally regulated transcription factors, the Spemann-Mangold organizer, pluripotency genes and the neuromuscular junction.	[Blumberg, Bruce; Dana, Catherine E.; Gee, Lydia; Law, Lee; Lindgens, Dirk; Peng, Jisong; Bode, Hans R.; Steele, Robert E.] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92717 USA; [Chapman, Jarrod A.; Goodstein, David M.; Hellsten, Uffe; Prochnik, Simon E.; Putnam, Nicholas H.; Shu, Shengquiang] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Kirkness, Ewen F.; Borman, Jon; Busam, Dana; Disbennett, Kathryn; Pfannkoch, Cynthia; Sumin, Nadezhda; Sutton, Granger G.; Viswanathan, Lakshmi Devi; Walenz, Brian; Remington, Karin A.; Strausberg, Robert L.; Venter, J. Craig] J Craig Venter Inst, Rockville, MD 20850 USA; [Simakov, Oleg; Balasubramanian, Prakash G.; Bertulat, Bianca; Guder, Corina; Nakamura, Yukio; Ozbek, Suat; Watanabe, Hiroshi; Holstein, Thomas W.] Heidelberg Univ, Dept Mol Evolut & Genom, Inst Zool, D-69120 Heidelberg, Germany; [Simakov, Oleg; Mitros, Therese; Kawashima, Takeshi; Putnam, Nicholas H.; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Hampson, Steven E.; Kibler, Dennis F.] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92697 USA; [Weinmaier, Thomas; Rattei, Thomas; Tischler, Patrick] Tech Univ Munich, Dept Genome Oriented Bioinformat, D-85354 Freising Weihenstephan, Germany; [Blumberg, Bruce; Gee, Lydia; Law, Lee; Lindgens, Dirk; Peng, Jisong; Bode, Hans R.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Dana, Catherine E.; Steele, Robert E.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Martinez, Daniel E.] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Wigge, Philip A.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Khalturin, Konstantin; Hemmrich, Georg; Franke, Andre; Augustin, Rene; Fraune, Sebastian; Bosch, Thomas C. G.] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Hayakawa, Eisuke; Hayakawa, Shiho; Hirose, Mamiko; Hwang, Jung Shan; Ikeo, Kazuho; Nishimiya-Fujisawa, Chiemi; Ogura, Atshushi; Gojobori, Takashi; Fujisawa, Toshitaka] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Takahashi, Toshio] Suntory Inst Bioorgan Res, Osaka 6188503, Japan; [Steinmetz, Patrick R. H.; Technau, Ulrich] Univ Vienna, Dept Mol Evolut & Dev, A-1090 Vienna, Austria; [Zhang, Xiaoming] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; [Aufschnaiter, Roland; Eder, Marie-Kristin; Gorny, Anne-Kathrin; Salvenmoser, Willi; Hobmayer, Bert] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Aufschnaiter, Roland; Eder, Marie-Kristin; Gorny, Anne-Kathrin; Salvenmoser, Willi; Hobmayer, Bert] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria; [Heimberg, Alysha M.; Peterson, Kevin J.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Wheeler, Benjamin M.] N Carolina State Univ, Dept Comp Sci, Raleigh, NC 27695 USA; [Boettger, Angelika; Wolf, Alexander; David, Charles N.] Univ Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany	University of California System; University of California Irvine; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; J. Craig Venter Institute; Ruprecht Karls University Heidelberg; University of California System; University of California Berkeley; University of California System; University of California Irvine; Technical University of Munich; University of California System; University of California Irvine; University of California System; University of California Irvine; Claremont Colleges; Pomona College; Salk Institute; University of Kiel; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Suntory Holdings Ltd; University of Vienna; University of Kansas; University of Kansas Medical Center; University of Innsbruck; University of Innsbruck; Dartmouth College; University of North Carolina; North Carolina State University; University of Munich	Steele, RE (corresponding author), Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92717 USA.	dsrokhsar@gmail.com; resteele@uci.edu	Putnam, Nicholas/B-9968-2008; Fraune, Sebastian/B-7970-2010; Guder, Corina/L-8413-2014; Bosch, Thomas C. G./D-5218-2011; Weinmaier, Thomas/K-5780-2013; Wigge, Philip Anthony/ABD-5113-2021; Rattei, Thomas/F-1366-2011; Bertulat, Bianca/F-5330-2012; Kawashima, Takeshi/M-4510-2015; Wolf, Alexander/K-2178-2013; Özbek, Suat/D-3701-2014; Hwang, Jung Shan/AAJ-3014-2020; Franke, Andre/B-2151-2010; Simakov, Oleg/AAV-2494-2020; Wigge, Philip/B-3333-2010; Peterson, Kevin J/A-2188-2009; Simakov, Oleg/G-4572-2015; Hemmrich-Stanisak, Georg/D-4319-2012; Watanabe, Hiroshi/GOP-0177-2022	Putnam, Nicholas/0000-0002-1315-782X; Fraune, Sebastian/0000-0002-6940-9571; Guder, Corina/0000-0002-8438-5168; Weinmaier, Thomas/0000-0002-9552-3220; Wigge, Philip Anthony/0000-0003-4822-361X; Rattei, Thomas/0000-0002-0592-7791; Hwang, Jung Shan/0000-0002-0908-2036; Franke, Andre/0000-0003-1530-5811; Simakov, Oleg/0000-0002-3585-4511; Simakov, Oleg/0000-0002-3585-4511; Hemmrich-Stanisak, Georg/0000-0002-2896-4691; Watanabe, Hiroshi/0000-0001-8887-5407; Technau, Ulrich/0000-0003-4472-8258; Dana, Catherine/0000-0003-3788-7955; Rokhsar, Daniel/0000-0002-8704-2224; Ozbek, Suat/0000-0003-2569-3942; Goodstein, David/0000-0001-6287-2697; Wolf, Alexander/0000-0003-0649-3363; Shu, Shengqiang/0000-0002-4336-8994; Steinmetz, Patrick/0000-0002-3705-2774; Bottger, Angelika/0000-0003-3273-9558; Hayakawa, Eisuke/0000-0003-1054-4266; Holstein, Thomas/0000-0003-0480-4674	National Science Foundation [IBN-0120591]; NSF [DEB-0716960]; Austrian Science Fund; Norwegian Research Council; Austrian Science Fund [FWF P16685, FWF P20734]; R. Melmon and the Gordon and Betty Moore Foundation; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Deutsche Forschungsgemeinschaft [SFB617-A1, SFB488-A12]; TOYOBO Biotechnology Foundation; Alexander von Humboldt Foundation; Austrian Science Fund (FWF) [P 20734, P 21108] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR015088] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Austrian Science Fund(Austrian Science Fund (FWF)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Austrian Science Fund(Austrian Science Fund (FWF)); R. Melmon and the Gordon and Betty Moore Foundation; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TOYOBO Biotechnology Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We are grateful to S. Clifton, R. Wilson and the EST sequencing group at the Genome Sequencing Center at the Washington University School of Medicine for their efforts in generating the Hydra ESTs and to the National Science Foundation for its support of the Hydra EST project (grant number IBN-0120591). Funding for the sequencing of the Hydra genome was provided by the National Human Genome Research Institute. We thank J. Gerhart who, as co-chair of the National Human Genome Research Institute Working Group on Comparative Genome Evolution, advocated sequencing of the Hydra genome. The septate junction electron micrograph in Fig. 3 was provided by G. Rieger. K. J. P. thanks N. Margulis for technical assistance and the NSF for support ( grant number DEB-0716960). U. T. was supported by the Austrian Science Fund and the Norwegian Research Council. B. H. was supported by Austrian Science Fund grants FWF P16685 and FWF P20734. D. S. R. was supported by R. Melmon and the Gordon and Betty Moore Foundation. Work at the US Department of Energy Joint Genome Institute was supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. T. F. and T. G. were supported by Grants-In-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. T. C. G. B. was supported by grants from the Deutsche Forschungsgemeinschaft ( DFG SFB617-A1) and from the DFG Cluster of Excellence programs 'The Future Ocean' and 'Inflammation at Interfaces'. T. W. H. was supported by grants from the Deutsche Forschungsgemeinschaft including SFB488-A12 and the DFG Cluster of Excellence program 'CellNetworks'. Support for H. W. was provided by the TOYOBO Biotechnology Foundation and the Alexander von Humboldt Foundation. Support for A. B., B. B., C. G., C. N. D., H. W., P. G. B., S. O., T. F. (Mercator Professor) and Y. N. was provided by the Deutsche Forschungsgemeinschaft.	Alexopoulos H, 2004, CURR BIOL, V14, pR879, DOI 10.1016/j.cub.2004.09.067; Bode HR, 1984, PATTERN FORMATION PR, V1, P213; Bridge DM, 2000, DEV BIOL, V220, P253, DOI 10.1006/dbio.2000.9653; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Browne EN, 1909, J EXP ZOOL, V7, P1, DOI 10.1002/jez.1400070102; Butts T, 2008, TRENDS GENET, V24, P259, DOI 10.1016/j.tig.2007.09.006; Chourrout D, 2006, NATURE, V442, P684, DOI 10.1038/nature04863; DAVID CN, 1977, DEV BIOL, V58, P372, DOI 10.1016/0012-1606(77)90098-7; Ding LX, 2004, INT J SYST EVOL MICR, V54, P2223, DOI 10.1099/ijs.0.02975-0; Douris V, 2010, MOL BIOL EVOL, V27, P684, DOI 10.1093/molbev/msp286; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Holstein TW, 2003, DEV DYNAM, V226, P257, DOI 10.1002/dvdy.10227; Jager M, 2006, MOL PHYLOGENET EVOL, V39, P468, DOI 10.1016/j.ympev.2005.12.005; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Mokady O, 1998, P NATL ACAD SCI USA, V95, P3673, DOI 10.1073/pnas.95.7.3673; Pace JK, 2008, P NATL ACAD SCI USA, V105, P17023, DOI 10.1073/pnas.0806548105; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reidling JC, 2000, J BIOL CHEM, V275, P10323, DOI 10.1074/jbc.275.14.10323; Ryan JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000153; Takahashi T, 1997, P NATL ACAD SCI USA, V94, P1241, DOI 10.1073/pnas.94.4.1241; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Trembley A., 1744, MEMOIRES SERVIR HIST; van Leeuwenhoek A., 1702, COLLECTED LETT A VAN, VXIV, P169; WESTFALL JA, 1971, J CELL BIOL, V51, P318, DOI 10.1083/jcb.51.1.318; Wittlieb J, 2006, P NATL ACAD SCI USA, V103, P6208, DOI 10.1073/pnas.0510163103; Yen MR, 2007, PROG BIOPHYS MOL BIO, V94, P5, DOI 10.1016/j.pbiomolbio.2007.03.006; Zacharias H, 2004, ZOOLOGY, V107, P219, DOI 10.1016/j.zool.2004.04.005	30	563	588	6	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					592	596		10.1038/nature08830	http://dx.doi.org/10.1038/nature08830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20228792	hybrid, Green Accepted			2022-12-24	WOS:000275974200048
J	Altschuler, SJ; Wu, LF				Altschuler, Steven J.; Wu, Lani F.			Cellular Heterogeneity: Do Differences Make a Difference?	CELL			English	Article							STOCHASTIC GENE-EXPRESSION; CONTEXT; NOISE; IDENTIFICATION; ARCHITECTURE; VARIABILITY; SWITCH; MODEL	A central challenge of biology is to understand how individual cells process information and respond to perturbations. Much of our knowledge is based on ensemble measurements. However, cell-to-cell differences are always present to some degree in any cell population, and the ensemble behaviors of a population may not represent the behaviors of any individual cell. Here, we discuss examples of when heterogeneity cannot be ignored and describe practical strategies for analyzing and interpreting cellular heterogeneity.	[Altschuler, Steven J.; Wu, Lani F.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Green Ctr Syst Biol, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Altschuler, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Green Ctr Syst Biol, Dept Pharmacol, Dallas, TX 75390 USA.	steven.altschuler@utsouthwestern.edu; lani.wu@utsouthwestern.edu			NIH [R01 GM081549, R01 GM085442]; Endowed Scholars program at UT Southwestern Medical Center; Welch Foundation [I-1619, I-1644]; Rita Allen Foundation; Mary Kay Ash Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085442, R01GM081549] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endowed Scholars program at UT Southwestern Medical Center; Welch Foundation(The Welch Foundation); Rita Allen Foundation; Mary Kay Ash Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Altschuler and Wu labs, Mike Brown, Nuno Lages, Tom Maniatis, David Mangelsdorf, Rama Ranganathan, and Gurol Suel for helpful feedback. This research was supported by NIH grants R01 GM081549 (L.F.W.) and R01 GM085442 (S.J.A.), the Endowed Scholars program at UT Southwestern Medical Center (L.F.W. and S.J.A.), the Welch Foundation I-1619 (S.J.A.) and I-1644 (L.F.W.), the Rita Allen Foundation (S.J.A.), and the Mary Kay Ash Charitable Foundation (S.J.A.).	Anselmetti D, 2009, SINGLE CELL ANAL TEC; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Boland MV, 2001, BIOINFORMATICS, V17, P1213, DOI 10.1093/bioinformatics/17.12.1213; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Duda R.O., 2006, PATTERN CLASSIFICATI; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; ELSASSER WM, 1984, P NATL ACAD SCI-BIOL, V81, P5126, DOI 10.1073/pnas.81.16.5126; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; HEPPNER GH, 1984, CANCER RES, V44, P2259; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; KIMURA M, 1964, GENETICS, V49, P561; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Loo LH, 2009, J CELL BIOL, V187, P375, DOI 10.1083/jcb.200904140; Loo LH, 2009, NAT METHODS, V6, P759, DOI [10.1038/NMETH.1375, 10.1038/nmeth.1375]; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Oved K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.15; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; RUBIN H, 1990, CANCER METAST REV, V9, P1, DOI 10.1007/BF00047585; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shinar G, 2010, SCIENCE, V327, P1389, DOI 10.1126/science.1183372; Singh DK, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.22; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Wang M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-32; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Yin Z, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-264	44	677	682	11	179	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					559	563		10.1016/j.cell.2010.04.033	http://dx.doi.org/10.1016/j.cell.2010.04.033			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478246	Green Accepted, Bronze			2022-12-24	WOS:000277623600006
J	Sinervo, B; Mendez-de-la-Cruz, F; Miles, DB; Heulin, B; Bastiaans, E; Cruz, MVS; Lara-Resendiz, R; Martinez-Mendez, N; Calderon-Espinosa, ML; Meza-Lazaro, RN; Gadsden, H; Avila, LJ; Morando, M; De la Riva, IJ; Sepulveda, PV; Rocha, CFD; Ibarguengoytia, N; Puntriano, CA; Massot, M; Lepetz, V; Oksanen, TA; Chapple, DG; Bauer, AM; Branch, WR; Clobert, J; Sites, JW				Sinervo, Barry; Mendez-de-la-Cruz, Fausto; Miles, Donald B.; Heulin, Benoit; Bastiaans, Elizabeth; Villagran-Santa Cruz, Maricela; Lara-Resendiz, Rafael; Martinez-Mendez, Norberto; Lucia Calderon-Espinosa, Martha; Nelsi Meza-Lazaro, Rubi; Gadsden, Hector; Javier Avila, Luciano; Morando, Mariana; De la Riva, Ignacio J.; Victoriano Sepulveda, Pedro; Duarte Rocha, Carlos Frederico; Ibargueengoytia, Nora; Aguilar Puntriano, Cesar; Massot, Manuel; Lepetz, Virginie; Oksanen, Tuula A.; Chapple, David G.; Bauer, Aaron M.; Branch, William R.; Clobert, Jean; Sites, Jack W., Jr.			Erosion of Lizard Diversity by Climate Change and Altered Thermal Niches	SCIENCE			English	Article							EXTINCTION RISK; EVOLUTION; UNCERTAINTY; ECOLOGY; TEMPERATURE; PREDICTIONS; ECTOTHERMS; PHYSIOLOGY; SELECTION; MODELS	It is predicted that climate change will cause species extinctions and distributional shifts in coming decades, but data to validate these predictions are relatively scarce. Here, we compare recent and historical surveys for 48 Mexican lizard species at 200 sites. Since 1975, 12% of local populations have gone extinct. We verified physiological models of extinction risk with observed local extinctions and extended projections worldwide. Since 1975, we estimate that 4% of local populations have gone extinct worldwide, but by 2080 local extinctions are projected to reach 39% worldwide, and species extinctions may reach 20%. Global extinction projections were validated with local extinctions observed from 1975 to 2009 for regional biotas on four other continents, suggesting that lizards have already crossed a threshold for extinctions caused by climate change.	[Sinervo, Barry; Bastiaans, Elizabeth] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Mendez-de-la-Cruz, Fausto; Lara-Resendiz, Rafael; Martinez-Mendez, Norberto; Nelsi Meza-Lazaro, Rubi] Univ Nacl Autonoma Mexico, Inst Biol, Lab Herpetol, Mexico City 04510, DF, Mexico; [Miles, Donald B.] Ohio Univ, Dept Biol, Athens, OH 45701 USA; [Heulin, Benoit] CNRS, UMR 6553, Stn Biol, F-35380 Paimpont, France; [Villagran-Santa Cruz, Maricela] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Biol Comparada, Lab Biol Reprod Anim, Mexico City 04510, DF, Mexico; [Lucia Calderon-Espinosa, Martha] Univ Nacl Colombia, Inst Ciencias Nat, Bogota, Colombia; [Gadsden, Hector] Inst Ecol AC, Chihuahua 31109, Mexico; [Javier Avila, Luciano; Morando, Mariana] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina; [De la Riva, Ignacio J.] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; [Victoriano Sepulveda, Pedro] Univ Concepcion, Dpto Zool, Concepcion, Chile; [Duarte Rocha, Carlos Frederico] Univ Estado Rio de Janeiro, Inst Biol, Dept Ecol, BR-20550019 Rio De Janeiro, Brazil; [Ibargueengoytia, Nora] Univ Nacl Comahue, Ctr Reg Univ Bariloche, Consejo Nacl Invest Cient & Tecn, INIBIOMA, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Aguilar Puntriano, Cesar] Univ Nacl Mayor San Marcos, Museo Hist Nat, Dept Herpetol, Lima 14, Peru; [Massot, Manuel] Univ UPMC, CNRS, UMR 7625, Lab Ecol Evolut, F-75005 Paris, France; [Lepetz, Virginie; Clobert, Jean] CNRS, USR 2936, Stat Ecol Expt, F-09200 Moulis, Saint Girons, France; [Oksanen, Tuula A.] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Evolutionary Res, FI-40014 Jyvaskyla, Finland; [Chapple, David G.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Bauer, Aaron M.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Branch, William R.] Bayworld, ZA-6013 Humewood, South Africa; [Sites, Jack W., Jr.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Sites, Jack W., Jr.] Brigham Young Univ, Bean Life Sci Museum, Provo, UT 84602 USA	University of California System; University of California Santa Cruz; Universidad Nacional Autonoma de Mexico; University System of Ohio; Ohio University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universidad Nacional Autonoma de Mexico; Universidad Nacional de Colombia; Instituto de Ecologia - Mexico; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universidad de Concepcion; Universidade do Estado do Rio de Janeiro; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Universidad Nacional Mayor de San Marcos; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); University of Jyvaskyla; Monash University; Villanova University; Brigham Young University; Brigham Young University	Sinervo, B (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	lizardrps@gmail.com	Mendez, Fausto/HGD-1205-2022; Mendez, Fausto R./O-3512-2018; Martínez-Méndez, Norberto/AAQ-5330-2021; Miles, Donald B./AFW-0480-2022; Gadsden, Hector/A-2066-2015; Aguilar, Cesar/Q-6148-2018; Rocha, Carlos Frederico D/A-6225-2013; Massot, Manuel/AGH-2703-2022; Martínez-Méndez, Norberto/AAB-2710-2021; Lara-Resendiz, Rafael A/K-3764-2013; Lara-Resendiz, Rafael A./AAG-5451-2021; Chapple, David/B-9073-2008	Mendez, Fausto R./0000-0002-5084-1276; Gadsden, Hector/0000-0002-1164-0578; Aguilar, Cesar/0000-0001-6372-7926; Rocha, Carlos Frederico D/0000-0003-3000-1242; Martínez-Méndez, Norberto/0000-0002-4029-4387; Lara-Resendiz, Rafael A/0000-0002-6922-0330; Lara-Resendiz, Rafael A./0000-0002-6922-0330; Miles, Donald/0000-0001-5768-179X; Avila, Luciano Javier/0000-0003-4641-6581; Massot, Manuel/0000-0002-2762-4417; Calderon Espinosa, Martha/0000-0002-3602-013X; Oksanen, Tuula/0000-0003-3481-6158; Chapple, David/0000-0002-7720-6280; Bastiaans, Elizabeth/0000-0002-7322-1088	National Geographic Society, UC Mexus; UCSC Committee-On-Research; NSF [DEB 0108577, IBN 0213179, LTREB DEB 051597, DEB 0515909, 0844523, OISE 0530267]; CNRS; Museum Nationale d'Histoire Naturelle, Universite Paris 6, Universite Paul Sabatier Toulouse III [PAPIIT-UNAM IN213405, 224208]; Universite Paul Sabatier Toulouse III; CONACYT [4171N, 52852Q]; CONACYT-SEP [43142-Q]; ANR Blanche; FONDYCET [1090664]; SMSI [CGL2005-03156, CLG2008-04164, APCT-PICT1086]; Universidad Nacional Autonoma de Mexico; American Museum of Natural History; Academy of Finland [108955]; Australian Research Council; PIRE-Patagonia; Brigham Young University; Direct For Biological Sciences [0844523] Funding Source: National Science Foundation	National Geographic Society, UC Mexus(National Geographic Society); UCSC Committee-On-Research; NSF(National Science Foundation (NSF)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Museum Nationale d'Histoire Naturelle, Universite Paris 6, Universite Paul Sabatier Toulouse III; Universite Paul Sabatier Toulouse III; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT-SEP(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ANR Blanche(French National Research Agency (ANR)); FONDYCET; SMSI; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); American Museum of Natural History; Academy of Finland(Academy of Finland); Australian Research Council(Australian Research Council); PIRE-Patagonia; Brigham Young University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Research of B. S. was funded by the National Geographic Society, UC Mexus, UCSC Committee-On-Research, NSF awards (DEB 0108577, IBN 0213179, LTREB DEB 051597), CNRS fellowships, and visiting professorships (Museum Nationale d'Histoire Naturelle, Universite Paris 6, Universite Paul Sabatier Toulouse III), PAPIIT-UNAM IN213405 and 224208 to F. M.-C., a Universite Paul Sabatier Toulouse III Visiting Professorship to D. B. M., CONACYT grants (4171N and 52852Q) to M.V.-S.C., grant CONACYT-SEP (43142-Q) to H. G., a CONACYT fellowship to R.N.M.-L., CNRS funding to B. H., and M. M., Biodivera: Tenlamas and from ANR Blanche: DIAME to J.C., CONICET grants to L.J.A. and M. M., FONDYCET 1090664 grants to P. V. S., CGL2005-03156 and CLG2008-04164 grant from SMSI to I.J.R., APCT-PICT1086 grant to N.I., scholarships and grants from Universidad Nacional Autonoma de Mexico and American Museum of Natural History to M.V.-S.C., Academy of Finland grant (108955) to T.A.O., Australian Research Council grants to D. G. C., NSF awards DEB 0515909 and 0844523 to A. M. B., NSF award OISE 0530267, PIRE-Patagonia grant to J.W.S., L.J.A., M. M., and P. V. S. and Brigham Young University funding (Biology Department, Kennedy Center for International Studies, Bean Life Science Museum) to J.W.S.	Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; BERGER PJ, 1975, J ANIM SCI, V40, P38, DOI 10.2527/jas1975.40138x; BEUCHAT CA, 1986, COPEIA, P971, DOI 10.2307/1445294; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dzialowski EM, 2005, J THERM BIOL, V30, P317, DOI 10.1016/j.jtherbio.2005.01.005; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; GUILLETTE LJ, 1993, BIOSCIENCE, V43, P742, DOI 10.2307/1312318; Hare B, 2006, CLIMATIC CHANGE, V75, P111, DOI 10.1007/s10584-005-9027-9; Harte John, 2004, Nature, V430, P33; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoekstra HE, 2001, P NATL ACAD SCI USA, V98, P9157, DOI 10.1073/pnas.161281098; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; HUEY RB, 1979, AM ZOOL, V19, P357; Huey RB, 2003, AM NAT, V161, P357, DOI 10.1086/346135; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Massot M, 2008, GLOBAL CHANGE BIOL, V14, P461, DOI 10.1111/j.1365-2486.2007.01514.x; PORTER WP, 1989, PHYSIOL ZOOL, V62, P286, DOI 10.1086/physzool.62.2.30156172; Pounds JA, 2004, NATURE, V427, P107, DOI 10.1038/427107a; Sinervo B, 1996, EVOLUTION, V50, P1314, DOI 10.1111/j.1558-5646.1996.tb02371.x; SINERVO B, 1990, OECOLOGIA, V83, P228, DOI 10.1007/BF00317757; Stainforth DA, 2005, NATURE, V433, P403, DOI 10.1038/nature03301; Stott PA, 2002, NATURE, V416, P723, DOI 10.1038/416723a; Swain DP, 2007, P ROY SOC B-BIOL SCI, V274, P1015, DOI 10.1098/rspb.2006.0275; TERBORGH J, 1973, AM NAT, V107, P481, DOI 10.1086/282852; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x	28	1178	1231	16	692	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					894	899		10.1126/science.1184695	http://dx.doi.org/10.1126/science.1184695			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466932				2022-12-24	WOS:000277618800050
J	Kennedy, MJ; Davison, IG; Robinson, CG; Ehlers, MD				Kennedy, Matthew J.; Davison, Ian G.; Robinson, Camenzind G.; Ehlers, Michael D.			Syntaxin-4 Defines a Domain for Activity-Dependent Exocytosis in Dendritic Spines	CELL			English	Article							LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; AMPA-RECEPTORS; RECYCLING ENDOSOMES; MEMBRANE-FUSION; POSTSYNAPTIC PLASTICITY; SYNAPTIC PLASTICITY; LATERAL DIFFUSION; PLASMA-MEMBRANE; ENDOCYTIC ZONES	Changes in postsynaptic membrane composition underlie many forms of learning-related synaptic plasticity in the brain. At excitatory glutamatergic synapses, fusion of intracellular vesicles at or near the postsynaptic plasma membrane is critical for dendritic spine morphology, retrograde synaptic signaling, and long-term synaptic plasticity. Whereas the molecular machinery for exocytosis in presynaptic terminals has been defined in detail, little is known about the location, kinetics, regulation, or molecules involved in postsynaptic exocytosis. Here, we show that an exocytic domain adjacent to the postsynaptic density (PSD) enables fusion of large, AMPA receptor-containing recycling compartments during elevated synaptic activity. Exocytosis occurs at microdomains enriched in the plasma membrane t-SNARE syntaxin 4 (Stx4), and disruption of Stx4 impairs both spine exocytosis and long-term potentiation (LTP) at hippocampal synapses. Thus, Stx4 defines an exocytic zone that directs membrane fusion for postsynaptic plasticity, revealing a novel specialization for local membrane traffic in dendritic spines.	[Kennedy, Matthew J.; Davison, Ian G.; Robinson, Camenzind G.; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Davison, Ian G.; Robinson, Camenzind G.; Ehlers, Michael D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Robinson, Camenzind G/O-5097-2018	Robinson, Camenzind G/0000-0002-7277-692X	NIMH; NINDS; NIA; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024492] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Marguerita Klein, Irina Lebedeva, and Haiwei Zhang for excellent technical assistance. We thank Ben Arenkiel, Cyril Hanus, Juliet Hernandez, Tom Newpher, Michael Patterson, Joel Schwartz, Chandra Tucker, Ryohei Yasuda, and Richard Weinberg for critical discussion and review of this manuscript. This work was supported by grants from NIMH, NINDS, and NIA to M.D.E. M.D.E. is an Investigator of the Howard Hughes Medical Institute.	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Gerges NZ, 2006, EMBO J, V25, P1623, DOI 10.1038/sj.emboj.7601065; Holcman D, 2006, BIOPHYS J, V91, P2405, DOI 10.1529/biophysj.106.081935; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Low SH, 2006, MOL BIOL CELL, V17, P977, DOI 10.1091/mbc.E05-05-0462; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6803; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; Ohara-Imaizumi M, 2004, J BIOL CHEM, V279, P8403, DOI 10.1074/jbc.M308954200; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Yang YL, 2008, J NEUROSCI, V28, P5740, DOI 10.1523/JNEUROSCI.3998-07.2008; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007	44	199	202	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					524	535		10.1016/j.cell.2010.02.042	http://dx.doi.org/10.1016/j.cell.2010.02.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434989	Green Accepted, Bronze			2022-12-24	WOS:000277180800022
J	Siston, AM; Rasmussen, SA; Honein, MA; Fry, AM; Seib, K; Callaghan, WM; Louie, J; Doyle, TJ; Crockett, M; Lynfield, R; Moore, Z; Wiedeman, C; Anand, M; Tabony, L; Nielsen, CF; Waller, K; Page, S; Thompson, JM; Avery, C; Springs, CB; Jones, T; Williams, JL; Newsome, K; Finelli, L; Jamieson, DJ				Siston, Alicia M.; Rasmussen, Sonja A.; Honein, Margaret A.; Fry, Alicia M.; Seib, Katherine; Callaghan, William M.; Louie, Janice; Doyle, Timothy J.; Crockett, Molly; Lynfield, Ruth; Moore, Zack; Wiedeman, Caleb; Anand, Madhu; Tabony, Laura; Nielsen, Carrie F.; Waller, Kirsten; Page, Shannon; Thompson, Jeannie M.; Avery, Catherine; Springs, Chasisity Brown; Jones, Timothy; Williams, Jennifer L.; Newsome, Kim; Finelli, Lyn; Jamieson, Denise J.		Pandemic H1N1 Influenza Pregnancy	Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							A H1N1 VIRUS; CRITICALLY-ILL PATIENTS; OSELTAMIVIR TREATMENT; ASIAN INFLUENZA; INFECTION; IMPACT; SAFETY; SENSITIVITY; VACCINATION; PREVENTION	Context Early data on pandemic 2009 influenza A(H1N1) suggest pregnant women are at increased risk of hospitalization and death. Objective To describe the severity of 2009 influenza A(H1N1) illness and the association with early antiviral treatment among pregnant women in the United States. Design, Setting, and Patients Surveillance of 2009 influenza A(H1N1) in pregnant women reported to the Centers for Disease Control and Prevention (CDC) with symptom onset from April through December 2009. Main Outcome Measures Severity of illness (hospitalizations, intensive care unit [ICU] admissions, and deaths) due to 2009 influenza A(H1N1) among pregnant women, stratified by timing of antiviral treatment and pregnancy trimester at symptom onset. Results We received reports on 788 pregnant women in the United States with 2009 influenza A(H1N1) with symptom onset from April through August 2009. Among those, 30 died (5% of all reported 2009 influenza A[ H1N1] influenza deaths in this period). Among 509 hospitalized women, 115 (22.6%) were admitted to an ICU. Pregnant women with treatment more than 4 days after symptom onset were more likely to be admitted to an ICU (56.9% vs 9.4%; relative risk [RR], 6.0; 95% confidence interval [CI], 3.5-10.6) than those treated within 2 days after symptom onset. Only 1 death occurred in a patient who received treatment within 2 days of symptom onset. Updating these data with the CDC's continued surveillance of ICU admissions and deaths among pregnant women with symptom onset through December 31, 2009, identified an additional 165 women for a total of 280 women who were admitted to ICUs, 56 of whom died. Among the deaths, 4 occurred in the first trimester (7.1%), 15 in the second (26.8%), and 36 in the third (64.3%); Conclusions Pregnant women had a disproportionately high risk of mortality due to 2009 influenza A(H1N1). Among pregnant women with 2009 influenza A(H1N1) influenza reported to the CDC, early antiviral treatment appeared to be associated with fewer admissions to an ICU and fewer deaths. JAMA. 2010;303(15):1517-1525 www.jama.com	[Rasmussen, Sonja A.; Honein, Margaret A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA; [Siston, Alicia M.; Nielsen, Carrie F.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Siston, Alicia M.; Fry, Alicia M.; Finelli, Lyn] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Callaghan, William M.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; [Louie, Janice] Calif Dept Publ Hlth, Richmond, CA USA; [Doyle, Timothy J.] Florida Dept Hlth, Tallahassee, FL USA; [Crockett, Molly] Massachusetts Dept Publ Hlth, Boston, MA USA; [Lynfield, Ruth] Minnesota Dept Hlth, St Paul, MN USA; [Moore, Zack] N Carolina Dept Hlth & Human Serv, Raleigh, NC USA; [Wiedeman, Caleb] Arizona Dept Hlth Serv, Phoenix, AZ 85007 USA; [Anand, Madhu] New York State Dept Hlth, Albany, NY 12237 USA; [Tabony, Laura] Texas Dept State Hlth Serv, Austin, TX USA; [Nielsen, Carrie F.] Wisconsin Dept Hlth Serv, Madison, WI USA; [Waller, Kirsten] Penn Dept Hlth, Harrisburg, PA 17108 USA; [Page, Shannon] Ohio Dept Hlth, Columbus, OH 43266 USA; [Thompson, Jeannie M.] Oklahoma Dept Hlth, Oklahoma City, OK USA; [Avery, Catherine] New Mexico Dept Hlth, Santa Fe, NM USA; [Springs, Chasisity Brown] S Carolina Dept Hlth & Environm Control, Columbia, SC 29201 USA; [Jones, Timothy] Tennessee Dept Hlth, Nashville, TN USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; California Department of Public Health; Florida Department of Health; Massachusetts Department of Public Health; Minnesota Department of Health (MHD); Arizona Department of Health Services; State University of New York (SUNY) System; Texas Department of State Health Services; New Mexico Department of Health; Tennessee Department Health	Honein, MA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 1600 Clifton Rd,MS E-86, Atlanta, GA 30333 USA.	mhonein@cdc.gov	Finelli, Lyn/AAK-2360-2020; Doyle, Timothy/AAM-3263-2021	Doyle, Timothy/0000-0002-4501-9157; Jamieson, Denise/0000-0003-2597-1201	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		ACOG Committee on Obstetric Practice, 2004, Obstet Gynecol, V104, P1125; Aoki FY, 2003, J ANTIMICROB CHEMOTH, V51, P123, DOI 10.1093/jac/dkg007; Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; *CDC HLTH AL NETW, REC EARL EMP ANT TRE; *CDCP, SEAS INFL FLUV; *CDCP, H1N1 FLU SWIN FLU RE; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P431; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1029; Chan KH, 2009, J CLIN VIROL, V45, P205, DOI 10.1016/j.jcv.2009.05.034; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Goodnight William H, 2005, Crit Care Med, V33, pS390, DOI 10.1097/01.CCM.0000182483.24836.66; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hamilton B. E., 2009, NATL VITAL STAT REP, V57, P1; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; HARDY JM, 1961, AM J PUBLIC HEALTH N, V51, P1182, DOI 10.2105/AJPH.51.8.1182; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Hurt AC, 2009, INFLUENZA OTHER RESP, V3, P171, DOI 10.1111/j.1750-2659.2009.00086.x; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; Kimura A. C., 2005, Morbidity and Mortality Weekly Report, V54, P196; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Langenegger E, 2009, SAMJ S AFR MED J, V99, P713; LIM ML, 2010, BJOG; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Lu PJ, 2008, VACCINE, V26, P1786, DOI 10.1016/j.vaccine.2008.01.040; Martinez Gustavo, 2009, Journal of Taphonomy, V7, P1; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Naleway AL, 2006, EPIDEMIOL REV, V28, P47, DOI 10.1093/epirev/mxj002; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Nuzum JW, 1918, J AMER MED ASSOC, V71, P1562, DOI 10.1001/jama.1918.26020450009011a; *PUBL HLTH AG CAN, 2009, FLU WATCH AUG 16 23; Rasmussen SA, 2009, AM J PUBLIC HEALTH, V99, pS248, DOI 10.2105/AJPH.2008.152900; Schrag SJ, 2003, OBSTET GYNECOL, V101, P704, DOI 10.1016/S0029-7844(03)00010-3; Singleton J. A., 2010, Morbidity and Mortality Weekly Report, V59, P44; Tamma PD, 2009, AM J OBSTET GYNECOL, V201, P547, DOI 10.1016/j.ajog.2009.09.034; Tanaka T, 2009, CAN MED ASSOC J, V181, P55, DOI 10.1503/cmaj.090866; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Woolston WJ, 1918, J AMER MED ASSOC, V71, P1898, DOI 10.1001/jama.1918.02600490030008; Zarocostas J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2425	53	638	683	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2010	303	15					1517	1525		10.1001/jama.2010.479	http://dx.doi.org/10.1001/jama.2010.479			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585SJ	20407061	Bronze, Green Accepted			2022-12-24	WOS:000276849000028
J	Gilbert, C; Schaack, S; Pace, JK; Brindley, PJ; Feschotte, C				Gilbert, Clement; Schaack, Sarah; Pace, John K., II; Brindley, Paul J.; Feschotte, Cedric			A role for host-parasite interactions in the horizontal transfer of transposons across phyla	NATURE			English	Article							GENE-TRANSFER; DNA TRANSPOSON; TRYPANOSOMA-RANGELI; LYMNAEA-STAGNALIS; DIVERGENCE TIMES; PHYLOGENY; MITOCHONDRIAL; RODENTS; MODEL; PHYLOGEOGRAPHY	Horizontal transfer (HT), or the passage of genetic material between non-mating species, is increasingly recognized as an important force in the evolution of eukaryotic genomes(1,2). Transposons, with their inherent ability to mobilize and amplify within genomes, may be especially prone to HT3-7. However, the means by which transposons can spread across widely diverged species remain elusive. Here we present evidence that host-parasite interactions have promoted the HT of four transposon families between invertebrates and vertebrates. We found that Rhodnius prolixus, a triatomine bug feeding on the blood of various tetrapods and vector of Chagas' disease in humans, carries in its genome four distinct transposon families that also invaded the genomes of a diverse, but overlapping, set of tetrapods. The bug transposons are similar to 98% identical and cluster phylogenetically with those of the opossum and squirrel monkey, two of its preferred mammalian hosts in South America. We also identified one of these transposon families in the pond snail Lymnaea stagnalis, a cosmopolitan vector of trematodes infecting diverse vertebrates, whose ancestral sequence is nearly identical and clusters with those found in Old World mammals. Together these data provide evidence for a previously hypothesized role of host-parasite interactions in facilitating HT among animals(3,7). Furthermore, the large amount of DNA generated by the amplification of the horizontally transferred transposons supports the idea that the exchange of genetic material between hosts and parasites influences their genomic evolution.	[Gilbert, Clement; Schaack, Sarah; Pace, John K., II; Feschotte, Cedric] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Brindley, Paul J.] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA	University of Texas System; University of Texas Arlington; George Washington University	Feschotte, C (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	cedric@uta.edu	Feschotte, Cedric/C-4048-2011; Gilbert, Clément/A-7538-2015	Gilbert, Clément/0000-0002-2131-7467; Brindley, Paul J./0000-0003-1765-0002	National Institutes of Health; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Betran, J. Demuth, T. Fondon, B. Koskella, J. Meik, E. Pritham, Q. Wang and members of the Feschotte laboratory for comments and suggestions during the preparation of the manuscript; M. Batzer, E. Dotson, S. Goodman, A. Prelat, T. Robinson, A. Ropiquet and the Grosell and Sanchez laboratories for the gifts of tissue samples used in this study; and J. Spieth and The Genome Center at Washington University School of Medicine in St Louis for permission to use the R. prolixus assembly before publication. C. F. is funded by the National Institutes of Health and S.S. by the National Science Foundation.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024; Da Silva FM, 2007, MOL ECOL, V16, P3361, DOI 10.1111/j.1365-294X.2007.03371.x; da Silva FM, 2009, ACTA TROP, V109, P199, DOI 10.1016/j.actatropica.2008.11.005; Davis CC, 2004, SCIENCE, V305, P676, DOI 10.1126/science.1100671; De Giorgi C, 2002, MOL BIOCHEM PARASIT, V124, P91, DOI 10.1016/S0166-6851(02)00161-5; Diao XM, 2006, PLOS BIOL, V4, P119, DOI 10.1371/journal.pbio.0040005; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; FRASER MJ, 1983, J VIROL, V47, P287, DOI 10.1128/JVI.47.2.287-300.1983; FRIESEN PD, 1990, MOL CELL BIOL, V10, P3067, DOI 10.1128/MCB.10.6.3067; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gebo DL, 2000, NATURE, V404, P276, DOI 10.1038/35005066; GENTLES AJ, 2005, REPBASE REPORT, V5, P10; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T., 2004, BIOEDIT VERSION 5 0; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Hecht MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009181; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; HOUCK MA, 1991, SCIENCE, V253, P1125, DOI 10.1126/science.1653453; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Jehle JA, 1998, J MOL EVOL, V46, P215, DOI 10.1007/PL00006296; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loreto ELS, 2008, HEREDITY, V100, P545, DOI 10.1038/sj.hdy.6801094; Loy C, 2001, PARASITOL RES, V87, P878, DOI 10.1007/s004360100462; MARSHALL LG, 1979, SCIENCE, V204, P272, DOI 10.1126/science.204.4390.272; Morgan JAT, 2001, PARASITOLOGY, V123, pS211; Mower JP, 2004, NATURE, V432, P165, DOI 10.1038/432165b; Novick P, 2010, GENE, V449, P85, DOI 10.1016/j.gene.2009.08.017; Pace JK, 2008, P NATL ACAD SCI USA, V105, P17023, DOI 10.1073/pnas.0806548105; Piskurek O, 2007, P NATL ACAD SCI USA, V104, P12046, DOI 10.1073/pnas.0700531104; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Ray DA, 2008, GENOME RES, V18, P717, DOI 10.1101/gr.071886.107; Ray DA, 2007, MOL BIOL EVOL, V24, P632, DOI 10.1093/molbev/msl192; Remigio EA, 2002, PARASITOL RES, V88, P687, DOI 10.1007/s00436-002-0658-8; Robertson Hugh M., 2002, P1093; Rogan MT, 2007, J HELMINTHOL, V81, P57, DOI 10.1017/S0022149X07214105; Rossie JB, 2006, P NATL ACAD SCI USA, V103, P4381, DOI 10.1073/pnas.0509424103; Roughgarden J., 1995, ANOLIS LIZARDS CARIB; Smit A, 1996, REPEATMASKER OPEN 30; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Steiner C, 2005, MOL PHYLOGENET EVOL, V35, P363, DOI 10.1016/j.ympev.2004.12.013; Steinke D, 2006, J MOL EVOL, V62, P772, DOI 10.1007/s00239-005-0170-8; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Wilson D.E., 2005, MAMMAL SPECIES WORLD; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122; Yoshiyama M, 2001, MOL BIOL EVOL, V18, P1952, DOI 10.1093/oxfordjournals.molbev.a003735; Zbikowska E, 2006, PARASITOL RES, V99, P434, DOI 10.1007/s00436-006-0178-z	62	173	185	2	76	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1347	U4		10.1038/nature08939	http://dx.doi.org/10.1038/nature08939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428170	Green Accepted			2022-12-24	WOS:000277149000046
J	Ye, SX; Zaitseva, E; Caltabiano, G; Schertler, GFX; Sakmar, TP; Deupi, X; Vogel, R				Ye, Shixin; Zaitseva, Ekaterina; Caltabiano, Gianluigi; Schertler, Gebhard F. X.; Sakmar, Thomas P.; Deupi, Xavier; Vogel, Reiner			Tracking G-protein-coupled receptor activation using genetically encoded infrared probes	NATURE			English	Article							INDUCED CONFORMATIONAL-CHANGES; BETA(2) ADRENERGIC-RECEPTOR; MECHANICAL CALCULATIONS; RHODOPSIN ACTIVATION; IONIC LOCK; CRYSTALLOGRAPHY; SPECTROSCOPY; DISCOVERY; SEGMENT-6; SWITCHES	Rhodopsin is a prototypical heptahelical family A G-protein-coupled receptor (GPCR) responsible for dim-light vision(1,2). Light isomerizes rhodopsin's retinal chromophore and triggers concerted movements of transmembrane helices, including an outward tilting of helix 6 (H6) and a smaller movement of H5, to create a site for G-protein binding and activation(3,4). However, the precise temporal sequence and mechanism underlying these helix rearrangements is unclear. We used site-directed non-natural amino acid mutagenesis to engineer rhodopsin with p-azido-L-phenylalanine residues incorporated at selected sites(5), and monitored the azido vibrational signatures using infrared spectroscopy as rhodopsin proceeded along its activation pathway. Here we report significant changes in electrostatic environments of the azido probes even in the inactive photoproduct Meta I, well before the active receptor state was formed. These early changes suggest a significant rotation of H6 and movement of the cytoplasmic part of H5 away from H3. Subsequently, a large outward tilt of H6 leads to opening of the cytoplasmic surface to form the active receptor photoproduct Meta II3. Thus, our results reveal early conformational changes that precede larger rigid-body helix movements, and provide a basis to interpret recent GPCR crystal structures(6,7) and to understand conformational sub-states observed during the activation of other GPCRs(8).	[Zaitseva, Ekaterina; Vogel, Reiner] Univ Freiburg, Inst Mol Med & Cell Res, Biophys Sect, D-79104 Freiburg, Germany; [Ye, Shixin; Sakmar, Thomas P.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA; [Caltabiano, Gianluigi; Deupi, Xavier] Univ Autonoma Barcelona, Unitat Bioestadist, Lab Med Computac, Bellaterra 08193, Catalunya, Spain; [Schertler, Gebhard F. X.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Schertler, Gebhard F. X.] Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland	University of Freiburg; Rockefeller University; Autonomous University of Barcelona; MRC Laboratory Molecular Biology; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Vogel, R (corresponding author), Univ Freiburg, Inst Mol Med & Cell Res, Biophys Sect, Hermann Herder Str 9, D-79104 Freiburg, Germany.	sakmar@mail.rockefeller.edu; xavier.deupi@uab.cat; reiner.vogel@biophysik.uni-freiburg.de	Schertler, Gebhard/M-9512-2014; Deupi, Xavier/B-2424-2009; Sakmar, Thomas P/D-1833-2015; Caltabiano, Gianluigi/F-4654-2010	Deupi, Xavier/0000-0003-4572-9316; Sakmar, Thomas P/0000-0002-2836-8953; Caltabiano, Gianluigi/0000-0002-2929-7069; Schertler, Gebhard F.X./0000-0002-5846-6810; Ye, Shixin/0000-0002-9254-9409	DFG [Vo 811/4-1, Za 566/2]; C. H. Li Memorial Scholar Award; NIH; Ministerio de Educacion y Ciencia; Instituto de Salud Carlos III	DFG(German Research Foundation (DFG)); C. H. Li Memorial Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Educacion y Ciencia(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by DFG grants (Vo 811/4-1 to R. V. and Za 566/2 to E. Z.), a C. H. Li Memorial Scholar Award ( to S. Y.), an NIH grant ( to T. P. S.), the Ministerio de Educacion y Ciencia (Ramon y Cajal Program) and the Instituto de Salud Carlos III ( to X. D.).	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; [Anonymous], 2008, AMBER 10; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bublitz GU, 1997, ANNU REV PHYS CHEM, V48, P213, DOI 10.1146/annurev.physchem.48.1.213; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESWAR XN, 2006, CURRENT PROTOCOLS S, V15, P20403; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Menon ST, 2001, PHYSIOL REV, V81, P1659, DOI 10.1152/physrev.2001.81.4.1659; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Oh KI, 2008, J PHYS CHEM B, V112, P10352, DOI 10.1021/jp801558k; Pieffet G, 2009, J MOL MODEL, V15, P1291, DOI 10.1007/s00894-009-0488-z; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Vogel R, 2005, BIOCHEMISTRY-US, V44, P11684, DOI 10.1021/bi0508587; Vogel R, 2005, BIOCHEMISTRY-US, V44, P12914, DOI 10.1021/bi058026w; Vogel R, 2003, BIOPOLYMERS, V72, P133, DOI 10.1002/bip.10407; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Vogel R, 2006, J AM CHEM SOC, V128, P10503, DOI 10.1021/ja0627848; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Ye SX, 2008, J BIOL CHEM, V283, P1525, DOI 10.1074/jbc.M707355200; Ye SX, 2009, NAT CHEM BIOL, V5, P397, DOI 10.1038/nchembio.167	41	202	203	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1386	U14		10.1038/nature08948	http://dx.doi.org/10.1038/nature08948			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20383122				2022-12-24	WOS:000277149000054
J	Tuller, T; Carmi, A; Vestsigian, K; Navon, S; Dorfan, Y; Zaborske, J; Pan, T; Dahan, O; Furman, I; Pilpel, Y				Tuller, Tamir; Carmi, Asaf; Vestsigian, Kalin; Navon, Sivan; Dorfan, Yuval; Zaborske, John; Pan, Tao; Dahan, Orna; Furman, Itay; Pilpel, Yitzhak			An Evolutionarily Conserved Mechanism for Controlling the Efficiency of Protein Translation	CELL			English	Article							GENOME-WIDE ANALYSIS; CODON USAGE BIAS; GENE-EXPRESSION; SELECTION	Recent years have seen intensive progress in measuring protein translation. However, the contributions of coding sequences to the efficiency of the process remain unclear. Here, we identify a universally conserved profile of translation efficiency along mRNAs computed based on adaptation between coding sequences and the tRNA pool. In this profile, the first similar to 30-50 codons are, on average, translated with a low efficiency. Additionally, in eukaryotes, the last similar to 50 codons show the highest efficiency over the full coding sequence. The profile accurately predicts position-dependent ribosomal density along yeast genes. These data suggest that translation speed and, as a consequence, ribosomal density are encoded by coding sequences and the tRNA pool. We suggest that the slow "ramp'' at the beginning of mRNAs serves as a late stage of translation initiation, forming an optimal and robust means to reduce ribosomal traffic jams, thus minimizing the cost of protein expression.	[Tuller, Tamir; Carmi, Asaf; Navon, Sivan; Dorfan, Yuval; Dahan, Orna; Furman, Itay; Pilpel, Yitzhak] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Tuller, Tamir] Weizmann Inst Sci, Fac Math & Comp Sci, IL-76100 Rehovot, Israel; [Vestsigian, Kalin] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Zaborske, John; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Weizmann Institute of Science; Weizmann Institute of Science; Harvard University; Harvard Medical School; University of Chicago	Pilpel, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	pilpel@weizmann.ac.il		Tuller, Tamir/0000-0003-4194-7068; Dorfan, Yuval/0000-0003-3236-0572	European Research Council; European Commission; FP6 Programme; Ben May Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); FP6 Programme(European Commission); Ben May Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Pilpel lab and Chaim Kahana, Ran Kafri, Ron Milo, Uri Alon, Michael Springer, Jeremy Gunawardena, Eytan Ruppin, and Martin Kupiec for stimulating discussions and Orna Man for critically reading the manuscript. We thank the "Ideas'' program of the European Research Council, EMBRACE Network of Excellence grant of the European Commission within its FP6 Programme, and the Ben May Charitable Trust for grant support. T. T. is a Koshland Scholar at the Weizmann Institute of Science.	Akashi H, 2003, GENETICS, V164, P1291; Alberts B, 2002, MOL BIOL CELL; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; GRAY NK, 1994, MOL BIOL REP, V19, P195, DOI 10.1007/BF00986961; Hirschman JE, 2006, NUCLEIC ACIDS RES, V34, pD442, DOI 10.1093/nar/gkj117; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; Li X, 2006, RNA, V12, P248, DOI 10.1261/rna.2212606; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Man O, 2007, NAT GENET, V39, P415, DOI 10.1038/ng1967; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; MILO R, 2009, NUCLEIC ACIDS RES, V23, P23; Pavon-Eternod M, 2010, RNA, V16, P267, DOI 10.1261/rna.1928110; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Qin H, 2004, GENETICS, V168, P2245, DOI 10.1534/genetics.104.030866; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SVOBODA K, 1994, P NATL ACAD SCI USA, V91, P11782, DOI 10.1073/pnas.91.25.11782; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Tuller T, 2007, PLOS COMPUT BIOL, V3, P2510, DOI 10.1371/journal.pcbi.0030248; Vetsigian K, 2009, P NATL ACAD SCI USA, V106, P215, DOI 10.1073/pnas.0810122106; Wang DY, 2007, GENOME RES, V17, P1161, DOI 10.1101/gr.6328907; Widmann M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-207; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877; ZHANG SP, 1994, J THEOR BIOL, V170, P339, DOI 10.1006/jtbi.1994.1196; Zhu J, 1997, J STRUCT BIOL, V118, P197, DOI 10.1006/jsbi.1997.3845	36	561	572	2	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					344	354		10.1016/j.cell.2010.03.031	http://dx.doi.org/10.1016/j.cell.2010.03.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403328	Bronze			2022-12-24	WOS:000276738400023
J	Salaita, K; Nair, PM; Petit, RS; Neve, RM; Das, D; Gray, JW; Groves, JT				Salaita, Khalid; Nair, Pradeep M.; Petit, Rebecca S.; Neve, Richard M.; Das, Debopriya; Gray, Joe W.; Groves, Jay T.			Restriction of Receptor Movement Alters Cellular Response: Physical Force Sensing by EphA2	SCIENCE			English	Article							IMMUNOLOGICAL SYNAPSE; BREAST-CANCER; LIGANDS; REORGANIZATION; RECOGNITION; MECHANISMS; MICROSCOPY; SUBSTRATE; EPHRIN-A5; MIGRATION	Activation of the EphA2 receptor tyrosine kinase by ephrin-A1 ligands presented on apposed cell surfaces plays important roles in development and exhibits poorly understood functional alterations in cancer. We reconstituted this intermembrane signaling geometry between live EphA2-expressing human breast cancer cells and supported membranes displaying laterally mobile ephrin-A1. Receptor-ligand binding, clustering, and subsequent lateral transport within this junction were observed. EphA2 transport can be blocked by physical barriers nanofabricated onto the underlying substrate. This physical reorganization of EphA2 alters the cellular response to ephrin-A1, as observed by changes in cytoskeleton morphology and recruitment of a disintegrin and metalloprotease 10. Quantitative analysis of receptor-ligand spatial organization across a library of 26 mammary epithelial cell lines reveals characteristic differences that strongly correlate with invasion potential. These observations reveal a mechanism for spatio-mechanical regulation of EphA2 signaling pathways.	[Salaita, Khalid; Nair, Pradeep M.; Petit, Rebecca S.; Groves, Jay T.] Univ Calif Berkeley, Dept Chem, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Salaita, Khalid; Nair, Pradeep M.; Petit, Rebecca S.; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Salaita, Khalid; Nair, Pradeep M.; Petit, Rebecca S.; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Neve, Richard M.; Das, Debopriya; Gray, Joe W.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Gray, Joe W.] Univ Calif San Francisco, Dept Lab Med & Radiat Oncol, San Francisco, CA 94143 USA; [Groves, Jay T.] Natl Univ Singapore, Res Ctr Excellence Mechanobiol, Singapore 117543, Singapore	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; National University of Singapore	Groves, JT (corresponding author), Univ Calif Berkeley, Dept Chem, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	jtgroves@lbl.gov	Gray, Joe/AAX-9549-2020; salaita, khalid/C-4414-2008		Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division; Materials Sciences and Engineering Division; U.S. Department of Energy (DOE) [DE-AC0205CH11231]; Office of Science, Office of Basic Energy Sciences, Scientific User Facilities Division, of the U.S. DOE [DE-AC02-05CH11231]; U.S. Army Medical Research Acquisition Activity [BC076701, W81XWH-08-1-0677]; National Cancer Institute (NCI) [U54 CA143836]; Office of Science, Office of Biological and Environmental Research, of the DOE [DE-AC02-05CH11231]; NIH [U54 CA 112970]; NCI [P50 CA 58207]; NATIONAL CANCER INSTITUTE [P50CA058207, U54CA112970, U54CA143836] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division(United States Department of Energy (DOE)); Materials Sciences and Engineering Division(United States Department of Energy (DOE)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, Scientific User Facilities Division, of the U.S. DOE(United States Department of Energy (DOE)); U.S. Army Medical Research Acquisition Activity; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Science, Office of Biological and Environmental Research, of the DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank N. Bayani for assistance in performing Western blotting, A. Smoligovets and C.-H. Yu for performing transfection and imaging with EGFP-actin-expressing MDA-MB-231 cells, and A. Bershadsky for helpful discussions. This work was supported by the Director, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division (K. S., P. M. N.; hybrid synthetic-live cell interfaces) and the Materials Sciences and Engineering Division (R. S. P.; supported membrane substrates) of the U.S. Department of Energy (DOE) under contract no. DE-AC0205CH11231. Patterned substrate fabrication was performed, in part, at the Molecular Foundry, Lawrence Berkeley National Laboratory (LBNL), and was supported by the Office of Science, Office of Basic Energy Sciences, Scientific User Facilities Division, of the U.S. DOE under contract no. DE-AC02-05CH11231. This work was also supported by the Laboratory Directed Research and Development Program of LBNL under U.S. DOE contract no. DE-AC02-05CH11231. Seed support for biomedical aspects of this work was provided by the U.S. Department of Defense Breast Cancer Research Program Concept Award BC076701 under U.S. Army Medical Research Acquisition Activity no. W81XWH-08-1-0677, with follow-on support provided by Award U54 CA143836 from the National Cancer Institute (NCI) beginning in 2009. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCI or the NIH. J. W. G. acknowledges support from the Director, Office of Science, Office of Biological and Environmental Research, of the DOE under conract no. DE-AC02-05CH11231; the NIH; NCI grant P50 CA 58207; and the NIH NCI Integrative Cancer Biology Program grant number U54 CA 112970 to J. W. G. (bioinformatics and cell lines). The Regents of the University of California have filed a related patent application through LBNL.	Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Day B, 2005, J BIOL CHEM, V280, P26526, DOI 10.1074/jbc.M504972200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Galush WJ, 2008, BIOPHYS J, V95, P2512, DOI 10.1529/biophysj.108.131540; Groves JT, 2006, CURR OPIN CHEM BIOL, V10, P544, DOI 10.1016/j.cbpa.2006.10.021; Groves JT, 2002, ACCOUNTS CHEM RES, V35, P149, DOI 10.1021/ar950039m; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Hartman NC, 2009, P NATL ACAD SCI USA, V106, P12729, DOI 10.1073/pnas.0902621106; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hurtley S, 2009, SCIENCE, V326, P1205, DOI 10.1126/science.326.5957.1205; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nam JM, 2006, CHEMBIOCHEM, V7, P436, DOI 10.1002/cbic.200500479; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Taddei ML, 2009, AM J PATHOL, V174, P1492, DOI 10.2353/ajpath.2009.080473; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; VERSCHUEREN H, 1985, J CELL SCI, V75, P279; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79	37	252	255	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1380	1385		10.1126/science.1181729	http://dx.doi.org/10.1126/science.1181729			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223987	Green Submitted, Green Accepted			2022-12-24	WOS:000275418700042
J	Papes, F; Logan, DW; Stowers, L				Papes, Fabio; Logan, Darren W.; Stowers, Lisa			The Vomeronasal Organ Mediates Interspecies Defensive Behaviors through Detection of Protein Pheromone Homologs	CELL			English	Article							MALE URINARY PROTEINS; OLFACTORY-BULB; FEMALE MICE; GENE; ODOR; NEURONS; SMELL; REPERTOIRES; PRIMATES; RODENTS	Potential predators emit uncharacterized chemosignals that warn receiving species of danger. Neurons that sense these stimuli remain unknown. Here we show that detection and processing of fear-evoking odors emitted from cat, rat, and snake require the function of sensory neurons in the vomeronasal organ. To investigate the molecular nature of the sensory cues emitted by predators, we isolated the salient ligands from two species using a combination of innate behavioral assays in naive receiving animals, calcium imaging, and c-Fos induction. Surprisingly, the defensive behavior-promoting activity released by other animals is encoded by species-specific ligands belonging to the major urinary protein (Mup) family, homologs of aggression-promoting mouse pheromones. We show that recombinant Mup proteins are sufficient to activate sensory neurons and initiate defensive behavior similarly to native odors. This co-option of existing sensory mechanisms provides a molecular solution to the difficult problem of evolving a variety of species-specific molecular detectors.	[Papes, Fabio; Logan, Darren W.; Stowers, Lisa] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Papes, Fabio] Univ Estadual Campinas, Dept Genet & Evolut, BR-13083970 Campinas, SP, Brazil	Scripps Research Institute; Universidade Estadual de Campinas	Stowers, L (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stowers@scripps.edu	Papes, Fabio/E-3774-2013; Stowers, Lisa/K-6137-2015; Logan, Darren/D-5629-2009	Papes, Fabio/0000-0001-5034-4088; Logan, Darren/0000-0003-1545-5510; Stowers, Lisa/0000-0002-4403-1269	FAPESP; Skaggs Foundation; NIH-NIDCD; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009413, R01DC006885] Funding Source: NIH RePORTER	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Skaggs Foundation; NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank F. Langone, G.A.G. Pereira, F.T.M. Costa, P. Arruda, A.T. Yamada, M.J. da Silva, M.G. Paniago, J.A. Yunes, and S.T.O. Saad for resources and K. Spencer, A. Roberts, C. Levy, K. Lloyd, T.S. Nakahara, F.B. Beato, E. Kiyota, and K.A. Flanagan for technical support. We also thank our volunteer cats Mitsy, Chewy, Cringer, Holiday, and Dolce. C. S. Zuker, A. Patapoutian, and K.K. Baldwin commented on the manuscript. This work was supported by a Young Investigator Grant from FAPESP (F.P.), the Skaggs Foundation (D.W.L. and L.S.), and NIH-NIDCD (L.S.). F.P. and L.S. initiated the study, F.P. and D.W.L. performed the experiments, and all authors wrote the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Buron G, 2007, BEHAV NEUROSCI, V121, P1063, DOI 10.1037/0735-7044.121.5.1063; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Cheetham SA, 2009, PHYSIOL BEHAV, V96, P253, DOI 10.1016/j.physbeh.2008.10.005; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Dielenberg RA, 2001, BRAIN RES, V897, P228, DOI 10.1016/S0006-8993(01)02227-2; Eilam D, 2005, NEUROSCI BIOBEHAV R, V29, P1181, DOI 10.1016/j.neubiorev.2005.03.027; Fendt M, 2006, J CHEM ECOL, V32, P2617, DOI 10.1007/s10886-006-9186-9; Flower DR, 1996, BIOCHEM J, V318, P1; HALPERN M, 1979, PHYSIOL BEHAV, V22, P1183, DOI 10.1016/0031-9384(79)90274-9; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Lane RP, 2002, P NATL ACAD SCI USA, V99, P291, DOI 10.1073/pnas.012608399; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; Mao Y, 1998, CHEM RES TOXICOL, V11, P953, DOI 10.1021/tx9800405; Marchlewska-Koj A, 2000, J CHEM ECOL, V26, P2355, DOI 10.1023/A:1005578911652; McLennan Deborah A., 2008, Evolution Education and Outreach, V1, P247, DOI 10.1007/s12052-008-0053-8; Miller LR, 1999, ANIM BEHAV, V58, P53, DOI 10.1006/anbe.1999.1126; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MUCIGNATCARETTA C, 1995, J PHYSIOL-LONDON, V486, P517, DOI 10.1113/jphysiol.1995.sp020830; Mudge JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r91; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; Rosen Jeffrey B, 2004, Behav Cogn Neurosci Rev, V3, P23, DOI 10.1177/1534582304265945; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; Shi P, 2007, GENOME RES, V17, P166, DOI 10.1101/gr.6040007; Smith W, 2004, CLIN EXP ALLERGY, V34, P1732, DOI 10.1111/j.1365-2222.2004.02090.x; STOWE MK, 1995, P NATL ACAD SCI USA, V92, P23, DOI 10.1073/pnas.92.1.23; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; SZOKA PR, 1978, GENETICS, V90, P597; Takahashi LK, 2005, NEUROSCI BIOBEHAV R, V29, P1157, DOI 10.1016/j.neubiorev.2005.04.008; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; Virtanen T, 1999, INT ARCH ALLERGY IMM, V120, P247, DOI 10.1159/000024277; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; WANG D, 1993, BRAIN BEHAV EVOLUT, V41, P246, DOI 10.1159/000113846; Young JM, 2007, TRENDS GENET, V23, P212, DOI 10.1016/j.tig.2007.03.004; Young JM, 2005, GENOME RES, V15, P231, DOI 10.1101/gr.3339905; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	45	223	229	3	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 14	2010	141	4					692	703		10.1016/j.cell.2010.03.037	http://dx.doi.org/10.1016/j.cell.2010.03.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478258	Green Accepted, Bronze			2022-12-24	WOS:000277623600021
J	Zeng, LY; Skinner, SO; Zong, CH; Sippy, J; Feiss, M; Golding, I				Zeng, Lanying; Skinner, Samuel O.; Zong, Chenghang; Sippy, Jean; Feiss, Michael; Golding, Ido			Decision Making at a Subcellular Level Determines the Outcome of Bacteriophage Infection	CELL			English	Article							TO-CELL VARIABILITY; GENE-EXPRESSION; ESCHERICHIA-COLI; KINETIC-ANALYSIS; LAMBDA; NOISE; MOLECULE; LYSOGENIZATION; STOCHASTICITY; DYNAMICS	When the process of cell-fate determination is examined at single-cell resolution, it is often observed that individual cells undergo different fates even when subject to identical conditions. This "noisy'' phenotype is usually attributed to the inherent stochasticity of chemical reactions in the cell. Here we demonstrate how the observed single-cell heterogeneity can be explained by a cascade of decisions occurring at the subcellular level. We follow the postinfection decision in bacteriophage lambda at single-virus resolution, and show that a choice between lysis and lysogeny is first made at the level of the individual virus. The decisions by all viruses infecting a single cell are then integrated in a precise (noise-free) way, such that only a unanimous vote by all viruses leads to the establishment of lysogeny. By detecting and integrating over the subcellular "hidden variables,'' we are able to predict the level of noise measured at the single-cell level.	[Zeng, Lanying; Skinner, Samuel O.; Zong, Chenghang; Golding, Ido] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Golding, Ido] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Golding, Ido] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Sippy, Jean; Feiss, Michael] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Baylor College of Medicine; University of Iowa	Golding, I (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	igolding@illinois.edu	Zong, Chenghang/F-3243-2013	Zeng, Lanying/0000-0002-8074-5824; Zong, Chenghang/0000-0002-8337-8038	National Institutes of Health [R01GM082837-01A1, GM-51611]; Human Frontier Science Program [RGY70/2008]; National Science Foundation [MCB-0717620]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082837, R01GM051611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to A. Campbell, D. Court, J. Cronan, I. Dodd, R. Edgar, M. Elowitz, D. Endy, R. Hendrix, J. Little, R. Moldovan, A. Rokney, F. St- Pierre, P. Thomen, and R. Y. Tsien for generous advice and for providing reagents. We thank members of the Golding, Feiss, and Selvin laboratories for providing help with experiments. We thank A. Arkin, R. Phillips, L. Weinberger, J. Weitz, R. Joh, D. Endy, and F. St- Pierre for commenting on earlier versions of the manuscript. Work in the Golding lab was supported by grants from the National Institutes of Health (R01GM082837-01A1) and Human Frontier Science Program (RGY70/2008). J. S. and M. F. were supported in part by National Institutes of Health grant GM-51611 and National Science Foundation grant MCB-0717620.	Alberts B, 2009, ESSENTIAL CELL BIOL; Alon U, 2007, INTRO SYSTEMS BIOL D; Alvarez LJ, 2007, BIOTECHNOL BIOENG, V96, P615, DOI 10.1002/bit.21110; Arkin A, 1998, GENETICS, V149, P1633; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Cohen J, 2007, SCIENCE, V317, P1315, DOI 10.1126/science.317.5843.1315; Court DL, 2007, J BACTERIOL, V189, P298, DOI 10.1128/JB.01215-06; Edgar R, 2008, MOL MICROBIOL, V68, P1107, DOI 10.1111/j.1365-2958.2008.06205.x; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Goldenfeld N., 1992, LECT PHASE TRANSITIO, DOI DOI 10.1201/9780429493492; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; HECHT MH, 1983, P NATL ACAD SCI-BIOL, V80, P2676, DOI 10.1073/pnas.80.9.2676; Hendrix R. W, 1983, LAMBDA, VII; Hershey A. D., 1971, BACTERIOPHAGE LAMBDA; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kobiler O, 2005, P NATL ACAD SCI USA, V102, P4470, DOI 10.1073/pnas.0500670102; Koster S, 2009, BIOPHYS J, V97, P1525, DOI 10.1016/j.bpj.2009.07.007; KOURILSKY P, 1973, MOL GEN GENET, V122, P183, DOI 10.1007/BF00435190; KOURILSKY P, 1974, BIOCHIMIE, V56, P1517; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Longo D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100110; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; MACKAY DJ, 1976, VIROLOGY, V72, P154, DOI 10.1016/0042-6822(76)90320-2; Michalowski CB, 2004, J BACTERIOL, V186, P7988, DOI 10.1128/JB.186.23.7988-7999.2004; Moldovan R, 2007, BIOPHYS J, V93, P303, DOI 10.1529/biophysj.106.102962; Munoz-Espin D, 2009, P NATL ACAD SCI USA, V106, P13347, DOI 10.1073/pnas.0906465106; Muzzey D, 2009, ANNU REV CELL DEV BI, V25, P301, DOI 10.1146/annurev.cellbio.042308.113408; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Ptashne M, 2004, GENETIC SWITCH PHAGE; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Russell JH, 2009, P NATL ACAD SCI USA, V106, P16405, DOI 10.1073/pnas.0904904106; Sambrook J, 2001, MOL CLONING LAB MANU; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; Singh A, 2009, CURR OPIN MICROBIOL, V12, P460, DOI 10.1016/j.mib.2009.06.016; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; SUNSHINE M, 1977, MOL GEN GENET, V151, P27, DOI 10.1007/BF00446909; Weitz JS, 2008, BIOPHYS J, V95, P2673, DOI 10.1529/biophysj.108.133694; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; YOCHEM J, 1978, MOL GEN GENET, V164, P9, DOI 10.1007/BF00267593; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zanghi CN, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni158	55	153	156	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					682	691		10.1016/j.cell.2010.03.034	http://dx.doi.org/10.1016/j.cell.2010.03.034			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478257	Green Accepted, Bronze			2022-12-24	WOS:000277623600020
J	Kim, TK; Hemberg, M; Gray, JM; Costa, AM; Bear, DM; Wu, J; Harmin, DA; Laptewicz, M; Barbara-Haley, K; Kuersten, S; Markenscoff-Papadimitriou, E; Kuhl, D; Bito, H; Worley, PF; Kreiman, G; Greenberg, ME				Kim, Tae-Kyung; Hemberg, Martin; Gray, Jesse M.; Costa, Allen M.; Bear, Daniel M.; Wu, Jing; Harmin, David A.; Laptewicz, Mike; Barbara-Haley, Kellie; Kuersten, Scott; Markenscoff-Papadimitriou, Eirene; Kuhl, Dietmar; Bito, Haruhiko; Worley, Paul F.; Kreiman, Gabriel; Greenberg, Michael E.			Widespread transcription at neuronal activity-regulated enhancers	NATURE			English	Article							RNA-POLYMERASE-II; CHIP-SEQ EXPERIMENTS; SYNAPSE DEVELOPMENT; GENE; ARC/ARG3.1; EXPRESSION; REVEALS; IDENTIFICATION; PLASTICITY; PROMOTERS	We used genome-wide sequencing methods to study stimulus-dependent enhancer function in mouse cortical neurons. We identified similar to 12,000 neuronal activity-regulated enhancers that are bound by the general transcriptional co-activator CBP in an activity-dependent manner. A function of CBP at enhancers may be to recruit RNA polymerase II (RNAPII), as we also observed activity-regulated RNAPII binding to thousands of enhancers. Notably, RNAPII at enhancers transcribes bi-directionally a novel class of enhancer RNAs (eRNAs) within enhancer domains defined by the presence of histone H3 monomethylated at lysine 4. The level of eRNA expression at neuronal enhancers positively correlates with the level of messenger RNA synthesis at nearby genes, suggesting that eRNA synthesis occurs specifically at enhancers that are actively engaged in promoting mRNA synthesis. These findings reveal that a widespread mechanism of enhancer activation involves RNAPII binding and eRNA synthesis.	[Kim, Tae-Kyung; Gray, Jesse M.; Costa, Allen M.; Bear, Daniel M.; Harmin, David A.; Laptewicz, Mike; Markenscoff-Papadimitriou, Eirene; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Hemberg, Martin; Kreiman, Gabriel] Harvard Univ, Childrens Hosp Boston, Dept Ophthalmol, Ctr Brain Sci, Boston, MA 02115 USA; [Hemberg, Martin; Kreiman, Gabriel] Harvard Univ, Swartz Ctr Theoret Neurosci, Boston, MA 02115 USA; [Wu, Jing; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Harmin, David A.] Harvard Mit Div Hlth Sci & Technol, Childrens Hosp Informat Program, Boston, MA 02115 USA; [Barbara-Haley, Kellie] Childrens Hosp, Mol Genet Core Facil, Boston, MA 02115 USA; [Kuersten, Scott] Epictr Biotechnol, Madison, WI 53713 USA; [Kuhl, Dietmar] Univ Med Ctr Hamburg Eppendorf UKE, Ctr Mol Neurobiol ZMNH, IMCC, D-20251 Hamburg, Germany; [Bito, Haruhiko] Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Johns Hopkins University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Tokyo	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	michael_greenberg@hms.harvard.edu	Kuhl, Dietmar/A-4689-2009; Kim, Tae-Kyung/AAX-4230-2020; Bito, Haruhiko/A-8635-2008	Kuhl, Dietmar/0000-0002-4772-6701; Kim, Tae-Kyung/0000-0001-5161-9864; Costa, Allen/0000-0002-4568-8449; Bito, Haruhiko/0000-0001-6315-9594	Nancy Lurie Marks Family Foundation; National Institutes of Health [NS028829, R21EY019710, DP2OD006461, MH-053608]; Lefler postdoctoral fellowship; Jane Coffin Childs Memorial Funds; Helen Hay Whitney postdoctoral fellowship; Children's Hospital Ophthalmology Foundation; Whitehall Foundation; Klingenstein Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY019710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028829, R01NS028829] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006461] Funding Source: NIH RePORTER	Nancy Lurie Marks Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lefler postdoctoral fellowship; Jane Coffin Childs Memorial Funds; Helen Hay Whitney postdoctoral fellowship; Children's Hospital Ophthalmology Foundation; Whitehall Foundation; Klingenstein Fund(Klingenstein Philanthropies); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Greenberg laboratory for discussions and for critical reading of the manuscript. We thank S. Vasquez for preparing dissociated mouse cortical neurons. We thank L. Hu for generating antibodies. We thank the Molecular Genetics Core Facility at Children's Hospital Boston, including H. Schneider and S. Burgess, for operation of their SOLiD 3.0 sequencer (I. D. D. R. C). We thank the support and R&D teams at Life Technologies including S. Ranade, R. David, J. Ni, C. Barbacioru, M. Barker, G. Costa and K. McKernan. M. E. G. acknowledges the support of the Nancy Lurie Marks Family Foundation. We thank M. Dehoff for technical support in the Arc knockout experiments. This work was supported by the National Institutes of Health grants NS028829 (M. E. G.), R21EY019710 (G. K.), DP2OD006461 (G. K.) and MH-053608 (P. F. W.). This work was also supported by The Lefler postdoctoral fellowship (T-K. K.) and The Jane Coffin Childs Memorial Funds (T-K. K.), The Helen Hay Whitney postdoctoral fellowship (J. M. G.), The Children's Hospital Ophthalmology Foundation (G. K.), The Whitehall Foundation (G. K.), and The Klingenstein Fund (G. K.)	Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brodsky AS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r64; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Efron B, 2008, STAT SCI, V23, P1, DOI 10.1214/07-STS236; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Kee BL, 1996, J BIOL CHEM, V271, P2373, DOI 10.1074/jbc.271.5.2373; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Koch F, 2008, TRENDS BIOCHEM SCI, V33, P265, DOI 10.1016/j.tibs.2008.04.006; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Ling JH, 2004, J BIOL CHEM, V279, P51704, DOI 10.1074/jbc.M404039200; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; SKELLAM JG, 1946, J ROY STAT SOC A STA, V109, P296, DOI 10.2307/2981372; Szutorisz H, 2005, TRENDS BIOCHEM SCI, V30, P593, DOI 10.1016/j.tibs.2005.08.006; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Zhao H, 2004, NUCLEIC ACIDS RES, V32, P4903, DOI 10.1093/nar/gkh832	37	1599	1655	2	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					182	U65		10.1038/nature09033	http://dx.doi.org/10.1038/nature09033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20393465	Green Accepted			2022-12-24	WOS:000277558500027
J	Sancak, Y; Bar-Peled, L; Zoncu, R; Markhard, AL; Nada, S; Sabatini, DM				Sancak, Yasemin; Bar-Peled, Liron; Zoncu, Roberto; Markhard, Andrew L.; Nada, Shigeyuki; Sabatini, David M.			Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids	CELL			English	Article							GTP-BINDING-PROTEINS; MEMBRANE LOCALIZATION; MAMMALIAN TARGET; RHEB; SCAFFOLD; MP1; AKT; PHOSPHORYLATION; PARTNER; PATHWAY	The mTORC1 kinase promotes growth in response to growth factors, energy levels, and amino acids, and its activity is often deregulated in disease. The Rag GTPases interact with mTORC1 and are proposed to activate it in response to amino acids by promoting mTORC1 translocation to a membrane-bound compartment that contains the mTORC1 activator, Rheb. We show that amino acids induce the movement of mTORC1 to lysosomal membranes, where the Rag proteins reside. A complex encoded by the MAPKSP1, ROBLD3, and c11orf59 genes, which we term Ragulator, interacts with the Rag GTPases, recruits them to lysosomes, and is essential for mTORC1 activation. Constitutive targeting of mTORC1 to the lysosomal surface is sufficient to render the mTORC1 pathway amino acid insensitive and independent of Rag and Ragulator, but not Rheb, function. Thus, Rag-Ragulator-mediated translocation of mTORC1 to lysosomal membranes is the key event in amino acid signaling to mTORC1.	[Sancak, Yasemin; Bar-Peled, Liron; Zoncu, Roberto; Markhard, Andrew L.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Sancak, Yasemin; Bar-Peled, Liron; Zoncu, Roberto; Markhard, Andrew L.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Sancak, Yasemin; Bar-Peled, Liron; Zoncu, Roberto; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Nada, Shigeyuki] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 5650871, Japan; [Sabatini, David M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Osaka University; Howard Hughes Medical Institute	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256	National Institutes of Health [CA103866, AI47389]; Department of Defense [W81XWH-07-0448]; W. M. Keck Foundation; LAM Foundation; Jane Coffin Childs Memorial Fund; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); W. M. Keck Foundation(W.M. Keck Foundation); LAM Foundation; Jane Coffin Childs Memorial Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all members of the Sabatini Lab for helpful suggestions and Eric Spooner for the mass spectrometric analysis of samples. We thank Lukas A. Huber for providing p14 null and control cells and Christoph Klein for providing patient-derived and healthy donor-derived cells. This work was supported by grants from the National Institutes of Health (CA103866 and AI47389) and Department of Defense (W81XWH-07-0448) to D. M. S., awards from the W. M. Keck Foundation and LAM Foundation to D. M. S, and fellowship support from the LAM Foundation and from the Jane Coffin Childs Memorial Fund for Medical Research to R.Z. D.M.S. is an investigator of the Howard Hughes Medical Institute.	Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Dard N, 2006, BIOESSAYS, V28, P146, DOI 10.1002/bies.20351; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hirose E, 1998, J CELL SCI, V111, P11; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Koonin EV, 2000, CURR BIOL, V10, pR774, DOI 10.1016/S0960-9822(00)00774-0; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Lunin VV, 2004, J BIOL CHEM, V279, P23422, DOI 10.1074/jbc.M401648200; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; PIZON V, 1994, J CELL SCI, V107, P1661; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Takahashi K, 2005, J BIOL CHEM, V280, P32768, DOI 10.1074/jbc.M506280200; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	35	1599	1660	3	126	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					290	303		10.1016/j.cell.2010.02.024	http://dx.doi.org/10.1016/j.cell.2010.02.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20381137	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000276738400019
J	Ravi, M; Chan, SWL				Ravi, Maruthachalam; Chan, Simon W. L.			Haploid plants produced by centromere-mediated genome elimination	NATURE			English	Article							CHROMOSOME ELIMINATION; MAIZE; MUTATION; WHEAT; GENE; INHERITANCE; ANTHERS; CULTURE	Production of haploid plants that inherit chromosomes from only one parent can greatly accelerate plant breeding(1-3). Haploids generated from a heterozygous individual and converted to diploid create instant homozygous lines, bypassing generations of inbreeding. Two methods are generally used to produce haploids. First, cultured gametophyte cells may be regenerated into haploid plants(4), but many species and genotypes are recalcitrant to this process(2,5). Second, haploids can be induced from rare interspecific crosses, in which one parental genome is eliminated after fertilization(6-11). The molecular basis for genome elimination is not understood, but one theory posits that centromeres from the two parent species interact unequally with the mitotic spindle, causing selective chromosome loss(12-14). Here we show that haploid Arabidopsis thaliana plants can be easily generated through seeds by manipulating a single centromere protein, the centromere-specific histone CENH3 (called CENP-A in human). When cenh3 null mutants expressing altered CENH3 proteins are crossed to wild type, chromosomes from the mutant are eliminated, producing haploid progeny. Haploids are spontaneously converted into fertile diploids through meiotic non-reduction, allowing their genotype to be perpetuated. Maternal and paternal haploids can be generated through reciprocal crosses. We have also exploited centromere-mediated genome elimination to convert a natural tetraploid Arabidopsis into a diploid, reducing its ploidy to simplify breeding. As CENH3 is universal in eukaryotes, our method may be extended to produce haploids in any plant species.	[Ravi, Maruthachalam; Chan, Simon W. L.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Chan, SWL (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	srchan@ucdavis.edu		Maruthachalam, Ravi/0000-0003-0036-3330	Hellman Family Foundation; University of California, Davis	Hellman Family Foundation; University of California, Davis(University of California System)	We thank L. Comai, D. Melters, J. Maloof and J. Ramahi for comments on the manuscript; and R. McNeilage, R. Clarke, P. Kwong and J. Stewart for technical assistance. This work was supported by a grant from the Hellman Family Foundation to S. W. L. C., and by the University of California, Davis.	AVETISOV VA, 1976, GENETIKA+, V12, P17; BAINS GS, 1950, NATURE, V166, P795, DOI 10.1038/166795a0; BARCLAY IR, 1975, NATURE, V256, P410, DOI 10.1038/256410a0; BENNETT MD, 1976, CHROMOSOMA, V54, P175, DOI 10.1007/BF00292839; BURK LG, 1979, SCIENCE, V206, P585, DOI 10.1126/science.206.4418.585; Bushell C, 2003, PLANT CELL, V15, P1430, DOI 10.1105/tpc.010496; CHASE SS, 1969, BOT REV, V35, P117, DOI 10.1007/BF02858912; Clausen RE, 1924, P NATL ACAD SCI USA, V10, P121, DOI 10.1073/pnas.10.4.121; COE EH, 1959, AM NAT, V93, P381, DOI 10.1086/282098; Comai L, 2006, PLANT J, V45, P684, DOI 10.1111/j.1365-313X.2006.02670.x; DUNWELL JM, PLANT BIOTE IN PRESS; Evans MMS, 2007, PLANT CELL, V19, P46, DOI 10.1105/tpc.106.047506; FINCH RA, 1983, CHROMOSOMA, V88, P386, DOI 10.1007/BF00285861; Forster BP, 2007, TRENDS PLANT SCI, V12, P368, DOI 10.1016/j.tplants.2007.06.007; Francis KE, 2006, PLANT PHYSIOL, V142, P1004, DOI 10.1104/pp.106.085274; FROSTER BP, 2005, PLANT BREEDING REV, P57; GUHA S, 1964, NATURE, V204, P497, DOI 10.1038/204497a0; HAGBERG A, 1980, HEREDITAS, V93, P341; Henikoff S, 2005, CURR OPIN GENET DEV, V15, P177, DOI 10.1016/j.gde.2005.01.004; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Henry IM, 2005, GENETICS, V170, P1979, DOI 10.1534/genetics.104.037788; HEPPICH S, 1982, THEOR APPL GENET, V61, P101, DOI 10.1007/BF00273874; HOUGAS RW, 1957, NATURE, V180, P1209, DOI 10.1038/1801209a0; Jauhar PP, 2000, CROP SCI, V40, P1742, DOI 10.2135/cropsci2000.4061742x; Jin WW, 2004, PLANT CELL, V16, P571, DOI 10.1105/tpc.018937; Josefsson C, 2006, CURR BIOL, V16, P1322, DOI 10.1016/j.cub.2006.05.045; Kasha K J, 1970, Nature, V225, P874, DOI 10.1038/225874a0; KERMICLE JL, 1969, SCIENCE, V166, P1422, DOI 10.1126/science.166.3911.1422; LAURIE DA, 1989, GENOME, V32, P953, DOI 10.1139/g89-537; Ori N, 2000, DEVELOPMENT, V127, P5523; PAUL W, 1992, PLANT MOL BIOL, V19, P611, DOI 10.1007/BF00026787; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; SCHOLL RL, 1980, Z PFLANZENPHYSIOL, V96, P407, DOI 10.1016/S0044-328X(80)80084-5; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Udall JA, 2006, CROP SCI, V46, pS3, DOI 10.2135/cropsci2006.07.0489tpg; Wedzony M, 2009, ADVANCES IN HAPLOID PRODUCTION IN HIGHER PLANTS, P1, DOI 10.1007/978-1-4020-8854-4_1	36	326	381	8	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					615	U180		10.1038/nature08842	http://dx.doi.org/10.1038/nature08842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336146				2022-12-24	WOS:000275974200053
J	Chappie, JS; Acharya, S; Leonard, M; Schmid, SL; Dyda, F				Chappie, Joshua S.; Acharya, Sharmistha; Leonard, Marilyn; Schmid, Sandra L.; Dyda, Fred			G domain dimerization controls dynamin's assembly-stimulated GTPase activity	NATURE			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; ISOMORPHOUS REPLACEMENT; CRYSTAL-STRUCTURE; PROTEINS; BINDING; CONSTRICTION; MECHANISM; MODEL; SUPERFAMILY; HYDROLYSIS	Dynamin is an atypical GTPase that catalyses membrane fission during clathrin-mediated endocytosis. The mechanisms of dynamin's basal and assembly-stimulated GTP hydrolysis are unknown, though both are indirectly influenced by the GTPase effector domain (GED). Here we present the 2.0 angstrom resolution crystal structure of a human dynamin 1-derived minimal GTPase-GED fusion protein, which was dimeric in the presence of the transition state mimic GDP.AlF4-. The structure reveals dynamin's catalytic machinery and explains how assembly-stimulated GTP hydrolysis is achieved through G domain dimerization. A sodium ion present in the active site suggests that dynamin uses a cation to compensate for the developing negative charge in the transition state in the absence of an arginine finger. Structural comparison to the rat dynamin G domain reveals key conformational changes that promote G domain dimerization and stimulated hydrolysis. The structure of the GTPase-GED fusion protein dimer provides insight into the mechanisms underlying dynamin-catalysed membrane fission.	[Chappie, Joshua S.; Acharya, Sharmistha; Leonard, Marilyn; Schmid, Sandra L.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Chappie, Joshua S.; Dyda, Fred] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Schmid, SL (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	slschmid@scripps.edu; dyda@helix.nih.gov	Chappie, Joshua S./AAV-6076-2021	Chappie, Joshua S./0000-0002-5733-7275; Schmid, Sandra/0000-0002-1690-7024	NIH [GM42455, MH61345]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH; NIMH [MH081419]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH081419, R01MH061345, R37MH061345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank V. Lukiyanchuk for assistance in cloning and purification; A. Hickman, J. Mindell and R. Ramachandran for discussions and technical advice; T. Pucadyil and R. Ramachandran for critical reading of the manuscript; J. Hinshaw and J. Mears for providing the unpublished coordinates for the GTPase docking model derived from their cryo-EM docking studies; and R. Stevens and I. Wilson for structural advice, guidance and the use of their laboratory facilities in the early stages of this work. This work was supported by NIH grants GM42455 and MH61345 (to S. L. S.) and the Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH. J. S. C. was supported by a Ruth Kirschstein individual predoctoral fellowship from the NIMH (MH081419) and by a postdoctoral Intramural Research Training Award from NIDDK. Data were collected at the SER-CAT 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the APS was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. W-31-109-Eng-38.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; *BRUK, 2001, BRUK AXS DAT PREP RE; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diederichs K, 2003, ACTA CRYSTALLOGR D, V59, P903, DOI 10.1107/S0907444903006516; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W., 2001, INT TABLES CRYSTALLO, VF; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Li GP, 2004, J MOL BIOL, V340, P921, DOI 10.1016/j.jmb.2004.06.007; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Narayanan R, 2005, J CELL BIOL, V169, P117, DOI 10.1083/jcb.200502042; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Sever S, 2006, EMBO J, V25, P4163, DOI 10.1038/sj.emboj.7601298; Sheldrick GM, 1998, NATO ADV SCI I C-MAT, V507, P401; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; Solomaha E, 2005, BIOCHEM J, V391, P601, DOI 10.1042/BJ20050707; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; Song BD, 2004, J BIOL CHEM, V279, P40431, DOI 10.1074/jbc.M407007200; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TERWILLIGER TC, 1994, ACTA CRYSTALLOGR D, V50, P17, DOI 10.1107/S0907444993008236; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; YAP K, INTERHLX; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	55	203	205	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2010	465	7297					435	U54		10.1038/nature09032	http://dx.doi.org/10.1038/nature09032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20428113	Green Accepted			2022-12-24	WOS:000278043700025
J	Gao, S; von der Malsburg, A; Paeschke, S; Behlke, J; Haller, O; Kochs, G; Daumke, O				Gao, Song; von der Malsburg, Alexander; Paeschke, Susann; Behlke, Joachim; Haller, Otto; Kochs, Georg; Daumke, Oliver			Structural basis of oligomerization in the stalk region of dynamin-like MxA	NATURE			English	Article							GTP-BINDING; PROTEIN; VIRUS; PROGRAM; SYSTEM; MODEL; VISUALIZATION; LOCALIZES; MECHANISM; COMPLEX	The interferon-inducible dynamin-like myxovirus resistance protein 1 (MxA; also called MX1) GTPase is a key mediator of cell-autonomous innate immunity against pathogens such as influenza viruses(1). MxA partially localizes to COPI-positive membranes of the smooth endoplasmic reticulum-Golgi intermediate compartment(2). At the point of infection, it redistributes to sites of viral replication and promotes missorting of essential viral constituents(3,4). It has been proposed that the middle domain and the GTPase effector domain of dynamin-like GTPases constitute a stalk that mediates oligomerization and transmits conformational changes from the G domain to the target structure(5-7); however, the molecular architecture of this stalk has remained elusive. Here we report the crystal structure of the stalk of human MxA, which folds into a four-helical bundle. This structure tightly oligomerizes in the crystal in a criss-cross pattern involving three distinct interfaces and one loop. Mutations in each of these interaction sites interfere with native assembly, oligomerization, membrane binding and antiviral activity of MxA. On the basis of these results, we propose a structural model for dynamin oligomerization and stimulated GTP hydrolysis that is consistent with previous structural predictions and has functional implications for all members of the dynamin family.	[Gao, Song; Paeschke, Susann; Behlke, Joachim; Daumke, Oliver] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Gao, Song] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [von der Malsburg, Alexander; Haller, Otto; Kochs, Georg] Univ Freiburg, Dept Virol, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany; [Daumke, Oliver] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; University of Freiburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Daumke, O (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	oliver.daumke@mdc-berlin.de		Gao, Song/0000-0001-7427-6681	Deutsche Forschungsgemeinschaft [SFB 740]; The International Human Frontier Science Program Organization; German-Israeli-Research foundation [GIF-841/04]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); The International Human Frontier Science Program Organization(Human Frontier Science Program); German-Israeli-Research foundation(German-Israeli Foundation for Scientific Research and Development)	This project was supported by a grant of the Deutsche Forschungsgemeinschaft (SFB 740-From Molecules to Modules) and by a Career Development Fellowship of 'The International Human Frontier Science Program Organization' to O. D., and by the German-Israeli-Research foundation (GIF-841/04) to G. K. and O.H. We are grateful to J. Hinshaw and J. Mears for providing the EM maps and model fittings of oligomerized dynamin. We would also like to acknowledge help and support of O. Ristau and K. Schilling/ Nanolytics (analytical ultracentrifugation), M. Dahte and H. Nikolenko (fluorescence measurements), A. Herrmann, T. Korte and P. Muller (stopped-flow analysis), G. Dittmar (mass spectrometry analysis), S. Werner and S. Gruber (technical assistance) and the BESSY staff at BL14.1 (data collection). This work was conducted by A. v. M. in partial fulfilment for a PhD degree from the Faculty of Biology at the University of Freiburg, Germany.	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; ARNHEITER H, 1988, EMBO J, V7, P1315, DOI 10.1002/j.1460-2075.1988.tb02946.x; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Behlke J, 1997, BIOCHEMISTRY-US, V36, P5149, DOI 10.1021/bi962755h; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Hefti HP, 1999, J VIROL, V73, P6984, DOI 10.1128/JVI.73.8.6984-6991.1999; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Klockow B, 2002, EMBO J, V21, P240, DOI 10.1093/emboj/21.3.240; Kochs G, 2002, J BIOL CHEM, V277, P14172, DOI 10.1074/jbc.M200244200; Kochs G, 2005, METHOD ENZYMOL, V404, P632, DOI 10.1016/S0076-6879(05)04055-3; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; MELEN K, 1994, J BIOL CHEM, V269, P2009; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Reichelt M, 2004, TRAFFIC, V5, P772, DOI 10.1111/j.1600-0854.2004.00219.x; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; RICHTER MF, 1995, J BIOL CHEM, V270, P13512, DOI 10.1074/jbc.270.22.13512; SCHWEMMLE M, 1995, J BIOL CHEM, V270, P13518, DOI 10.1074/jbc.270.22.13518; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Steinkellner G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-32; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; ZURCHER T, 1992, EMBO J, V11, P1657, DOI 10.1002/j.1460-2075.1992.tb05212.x	49	176	185	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2010	465	7297					502	U134		10.1038/nature08972	http://dx.doi.org/10.1038/nature08972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20428112	Green Accepted			2022-12-24	WOS:000278043700040
J	Zemach, A; McDaniel, IE; Silva, P; Zilberman, D				Zemach, Assaf; McDaniel, Ivy E.; Silva, Pedro; Zilberman, Daniel			Genome-Wide Evolutionary Analysis of Eukaryotic DNA Methylation	SCIENCE			English	Article								Eukaryotic cytosine methylation represses transcription but also occurs in the bodies of active genes, and the extent of methylation biology conservation is unclear. We quantified DNA methylation in 17 eukaryotic genomes and found that gene body methylation is conserved between plants and animals, whereas selective methylation of transposons is not. We show that methylation of plant transposons in the CHG context extends to green algae and that exclusion of histone H2A.Z from methylated DNA is conserved between plants and animals, and we present evidence for RNA-directed DNA methylation of fungal genes. Our data demonstrate that extant DNA methylation systems are mosaics of conserved and derived features, and indicate that gene body methylation is an ancient property of eukaryotic genomes.	[Zemach, Assaf; McDaniel, Ivy E.; Silva, Pedro; Zilberman, Daniel] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zilberman, D (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 211 Koshland Hall, Berkeley, CA 94720 USA.	danielz@berkeley.edu	Silva, Pedro/H-9497-2012	Silva, Pedro/0000-0002-9889-3075; Zilberman, Daniel/0000-0002-0123-8649; Zemach, Assaf/0000-0003-3282-4445				Bestor TH, 1999, GENETICA, V107, P289, DOI 10.1023/A:1003990818251; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Lewis ZA, 2009, GENOME RES, V19, P427, DOI 10.1101/gr.086231.108; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; PATEL CV, 1987, ANAL BIOCHEM, V164, P164, DOI 10.1016/0003-2697(87)90381-2; Simmen MW, 1999, SCIENCE, V283, P1164, DOI 10.1126/science.283.5405.1164; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	16	1120	1164	11	308	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					916	919		10.1126/science.1186366	http://dx.doi.org/10.1126/science.1186366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20395474				2022-12-24	WOS:000277618800056
J	Dowell, RD; Ryan, O; Jansen, A; Cheung, D; Agarwala, S; Danford, T; Bernstein, DA; Rolfe, PA; Heisler, LE; Chin, B; Nislow, C; Giaever, G; Phillips, PC; Fink, GR; Gifford, DK; Boone, C				Dowell, Robin D.; Ryan, Owen; Jansen, An; Cheung, Doris; Agarwala, Sudeep; Danford, Timothy; Bernstein, Douglas A.; Rolfe, P. Alexander; Heisler, Lawrence E.; Chin, Brian; Nislow, Corey; Giaever, Guri; Phillips, Patrick C.; Fink, Gerald R.; Gifford, David K.; Boone, Charles			Genotype to Phenotype: A Complex Problem	SCIENCE			English	Article							GENOME; CELL		[Dowell, Robin D.; Danford, Timothy; Rolfe, P. Alexander; Gifford, David K.] MIT, Dept Elect Engn & Comp Sci, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Ryan, Owen; Cheung, Doris; Heisler, Lawrence E.; Nislow, Corey; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Ryan, Owen; Cheung, Doris; Heisler, Lawrence E.; Nislow, Corey; Giaever, Guri; Boone, Charles] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Ryan, Owen; Cheung, Doris; Heisler, Lawrence E.; Nislow, Corey; Giaever, Guri; Boone, Charles] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Jansen, An; Agarwala, Sudeep; Bernstein, Douglas A.; Chin, Brian; Fink, Gerald R.; Gifford, David K.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Giaever, Guri] Univ Toronto, Dept Pharm, Toronto, ON M5S 3E1, Canada; [Phillips, Patrick C.] 5289 Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA; [Fink, Gerald R.; Gifford, David K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); University of Toronto; University of Toronto; University of Toronto; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Toronto; University of Oregon; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Gifford, DK (corresponding author), MIT, Dept Elect Engn & Comp Sci, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA.	gifford@mit.edu; charlie.boone@utoronto.ca	Young, Richard A/F-6495-2012; Jansen, An/T-9228-2018	Young, Richard A/0000-0001-8855-8647; Jansen, An/0000-0003-2412-0456; DOWELL, ROBIN/0000-0001-7665-9985; Heisler, Lawrence/0000-0002-1332-1802	NIH [DK076284, GM035010, GM069676, P01 NS055923, ACS PF-09-072-01-MBC]; NSF [DEB-0614588]; Ellison Medical Foundation; Natural Sciences and Engineering Research Council (NSERC) of Canada; Howard Hughes Medical Institute (HHMI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK076284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035010, R01GM069676, R37GM035010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055923] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Ellison Medical Foundation(Lawrence Ellison Foundation); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grants DK076284 (R. D. D.), GM035010 (G. R. F.), GM069676 (D. K. G.), P01 NS055923 (D. K. G.), ACS PF-09-072-01-MBC (D. A. B.); NSF grant DEB-0614588; a Senior Scholar Award in Aging from the Ellison Medical Foundation (P. C. P.); the Natural Sciences and Engineering Research Council (NSERC) of Canada; and Howard Hughes Medical Institute (HHMI) (C. B.). Sequence and assembly data has been deposited at DNA Data Bank of Japan/European Molecular Biology Laboratory/GenBank, project accession ACVY00000000.	Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484	6	273	274	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					469	469		10.1126/science.1189015	http://dx.doi.org/10.1126/science.1189015			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413493	Green Accepted			2022-12-24	WOS:000276952400033
J	Taylor, PG; Townsend, AR				Taylor, Philip G.; Townsend, Alan R.			Stoichiometric control of organic carbon-nitrate relationships from soils to the sea	NATURE			English	Article							N-P STOICHIOMETRY; GROWTH EFFICIENCY; NITROGEN; DENITRIFICATION; ECOSYSTEMS; TRENDS; RATIO; CYCLE; LAND; FATE	The production of artificial fertilizers, fossil fuel use and leguminous agriculture worldwide has increased the amount of reactive nitrogen in the natural environment by an order of magnitude since the Industrial Revolution(1). This reorganization of the nitrogen cycle has led to an increase in food production(2), but increasingly causes a number of environmental problems(1,3). One such problem is the accumulation of nitrate in both freshwater and coastal marine ecosystems. Here we establish that ecosystem nitrate accrual exhibits consistent and negative nonlinear correlations with organic carbon availability along a hydrologic continuum from soils, through freshwater systems and coastal margins, to the open ocean. The trend also prevails in ecosystems subject to substantial human alteration. Across this diversity of environments, we find evidence that resource stoichiometry ( organic carbon: nitrate) strongly influences nitrate accumulation by regulating a suite of microbial processes that couple dissolved organic carbon and nitrate cycling. With the help of a meta-analysis we show that heterotrophic microbes maintain low nitrate concentrations when organic carbon: nitrate ratios match the stoichiometric demands of microbial anabolism. When resource ratios drop below the minimum carbon: nitrogen ratio of microbial biomass(4), however, the onset of carbon limitation appears to drive rapid nitrate accrual, which may then be further enhanced by nitrification. At low organic carbon: nitrate ratios, denitrification appears to constrain the extent of nitrate accretion, once organic carbon and nitrate availability approach the 1: 1 stoichiometry(5) of this catabolic process. Collectively, these microbial processes express themselves on local to global scales by restricting the threshold ratios underlying nitrate accrual to a constrained stoichiometric window. Our findings indicate that ecological stoichiometry can help explain the fate of nitrate across disparate environments and in the face of human disturbance.	[Taylor, Philip G.; Townsend, Alan R.] Univ Colorado, INSTAAR, Boulder, CO 80309 USA; [Taylor, Philip G.; Townsend, Alan R.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Taylor, PG (corresponding author), Univ Colorado, INSTAAR, Boulder, CO 80309 USA.	philip.taylor@colorado.edu	Townsend, Alan/AAE-9602-2019					Allen AP, 2009, ECOL LETT, V12, P369, DOI 10.1111/j.1461-0248.2009.01302.x; Anderson TR, 2005, AM NAT, V165, P1, DOI 10.1086/426598; Apple JK, 2007, ISME J, V1, P729, DOI 10.1038/ismej.2007.86; Arango CP, 2008, J N AM BENTHOL SOC, V27, P90, DOI 10.1899/07-024.1; BARNES RT, ECOL APPL IN PRESS, DOI DOI 10.1890/08-1328; Bohlke JK, 2009, BIOGEOCHEMISTRY, V93, P117, DOI 10.1007/s10533-008-9282-8; Cebrian J, 1999, AM NAT, V154, P449, DOI 10.1086/303244; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Evans CD, 2006, ECOSYSTEMS, V9, P453, DOI 10.1007/s10021-006-0051-z; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Goodale CL, 2005, ECOSYSTEMS, V8, P334, DOI 10.1007/s10021-003-0162-8; Hedin LO, 1998, ECOLOGY, V79, P684, DOI 10.2307/176963; Hill AR, 2000, BIOGEOCHEMISTRY, V51, P193, DOI 10.1023/A:1006476514038; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; JAHNKE RA, 1995, LIMNOL OCEANOGR, V40, P436, DOI 10.4319/lo.1995.40.2.0436; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Mulholland MR, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P303, DOI 10.1016/B978-0-12-372522-6.00007-4; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Perakis SS, 2002, NATURE, V415, P416, DOI 10.1038/415416a; Raymond PA, 2001, ORG GEOCHEM, V32, P469, DOI 10.1016/S0146-6380(00)00190-X; Richards F. A., 1965, CHEM OCEANOGR, V1, P611; Sarmiento J.L., 2013, OCEAN BIOGEOCHEMICAL, DOI [DOI 10.2307/J.CTT3FGXQX, 10.1515/9781400849079, DOI 10.1515/9781400849079]; Smil V, 1999, GLOBAL BIOGEOCHEM CY, V13, P647, DOI 10.1029/1999GB900015; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; TEZUKA Y, 1990, MICROBIAL ECOL, V19, P227, DOI 10.1007/BF02017167; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	30	273	288	17	454	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1178	1181		10.1038/nature08985	http://dx.doi.org/10.1038/nature08985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20414306				2022-12-24	WOS:000276891100034
J	Shimomura, Y; Agalliu, D; Vonica, A; Luria, V; Wajid, M; Baumer, A; Belli, S; Petukhova, L; Schinzel, A; Brivanlou, AH; Barres, BA; Christiano, AM				Shimomura, Yutaka; Agalliu, Dritan; Vonica, Alin; Luria, Victor; Wajid, Muhammad; Baumer, Alessandra; Belli, Serena; Petukhova, Lynn; Schinzel, Albert; Brivanlou, Ali H.; Barres, Ben A.; Christiano, Angela M.			APCDD1 is a novel Wnt inhibitor mutated in hereditary hypotrichosis simplex	NATURE			English	Article							AUTOSOMAL DOMINANT INHERITANCE; PROTEIN-COUPLED RECEPTOR; HAIR-FOLLICLE; ANDROGENETIC ALOPECIA; SPEMANN ORGANIZER; DEPENDENT MANNER; NEURAL-TUBE; IN-VITRO; EXPRESSION; XENOPUS	Hereditary hypotrichosis simplex is a rare autosomal dominant form of hair loss characterized by hair follicle miniaturization(1,2). Using genetic linkage analysis, we mapped a new locus for the disease to chromosome 18p11.22, and identified a mutation (Leu9Arg) in the adenomatosis polyposis down-regulated 1 (APCDD1) gene in three families. We show that APCDD1 is a membrane-bound glycoprotein that is abundantly expressed in human hair follicles, and can interact in vitro with WNT3A and LRP5-two essential components of Wnt signalling. Functional studies show that APCDD1 inhibits Wnt signalling in a cell-autonomous manner and functions upstream of beta-catenin. Moreover, APCDD1 represses activation of Wnt reporters and target genes, and inhibits the biological effects of Wnt signalling during both the generation of neurons from progenitors in the developing chick nervous system, and axis specification in Xenopus laevis embryos. The mutation Leu9Arg is located in the signal peptide of APCDD1, and perturbs its translational processing from the endoplasmic reticulum to the plasma membrane. APCDD1(L9R) probably functions in a dominant-negative manner to inhibit the stability and membrane localization of the wild-type protein. These findings describe a novel inhibitor of the Wnt signalling pathway with an essential role in human hair growth. As APCDD1 is expressed in a broad repertoire of cell types(3), our findings indicate that APCDD1 may regulate a diversity of biological processes controlled by Wnt signalling.	[Shimomura, Yutaka; Luria, Victor; Wajid, Muhammad; Petukhova, Lynn; Christiano, Angela M.] Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA; [Luria, Victor; Christiano, Angela M.] Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; [Agalliu, Dritan; Barres, Ben A.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Vonica, Alin; Brivanlou, Ali H.] Rockefeller Univ, Lab Vertebrate Embryol, New York, NY 10065 USA; [Baumer, Alessandra; Schinzel, Albert] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; [Belli, Serena] Struttura Semplice Genet Med APSS, I-138100 Trento, Italy	Columbia University; Columbia University; Stanford University; Rockefeller University; University of Zurich	Christiano, AM (corresponding author), Columbia Univ Coll Phys & Surg, Dept Dermatol, 630 W 168th St,VC15 204A, New York, NY 10032 USA.	amc65@columbia.edu	Wajid, Muhammad/F-5087-2015; Petukhova, Lynn/W-6858-2019	Luria, Victor/0000-0003-0558-0983	USPHS NIH, NIH/NIAMS [R01AR44924]; Dermatology Foundation; Myelin Repair Foundation; National Multiple Sclerosis Society [RG 3936A7/1]; NIH [R01 HD032105, R03HD057334]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032105, R03HD057334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044924] Funding Source: NIH RePORTER	USPHS NIH, NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Dermatology Foundation; Myelin Repair Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to the family members for their participation in this study, and to H. Lam and M. Zhang for technical assistance. We appreciate the collaboration and discussions with R. M. Bernstein, R. M. Trueb and members of the A. M. C. laboratory. We thank S. Ishii and J. Miyazaki for supplying the pCXN2.1 vector. We thank C. Jahoda, A. Tomlinson, A. Salic, C. Extavour, L. Shapiro, B. Honig, D. Petrey, R. Vallee, G. Di Paolo and G. Karsenty for discussions and comments on the manuscript, and P. Ducy for sharing reagents. This work was supported in part by USPHS NIH grant R01AR44924 from NIH/NIAMS (A. M. C.). Y. S. is supported by a Research Career Development Award from the Dermatology Foundation. The work in B. A. B.'s laboratory (D. A. and B. A. B.) was supported by grants from the Myelin Repair Foundation and the National Multiple Sclerosis Society (grant RG 3936A7/1). The work in A. H. B.' s laboratory (A. V. and A. H. B.) was supported by NIH grants R01 HD032105 (A. H. B.) and R03HD057334 (A. V.).	Agalliu D, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-2; Aoki N, 2001, J INVEST DERMATOL, V116, P359, DOI 10.1046/j.1523-1747.2001.01226.x; Baumer A, 2000, EUR J HUM GENET, V8, P443, DOI 10.1038/sj.ejhg.5200506; Bazzi H, 2006, DIFFERENTIATION, V74, P129, DOI 10.1111/j.1432-0436.2006.00061.x; Bazzi H, 2007, DEV BIOL, V305, P498, DOI 10.1016/j.ydbio.2007.02.035; Betz RC, 2000, AM J HUM GENET, V66, P1979, DOI 10.1086/302934; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hillmer AM, 2008, AM J HUM GENET, V82, P737, DOI 10.1016/j.ajhg.2007.11.014; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; IBSEN HHW, 1991, ACTA DERM-VENEREOL, V71, P349; Jukkola T, 2004, GENE EXPR PATTERNS, V4, P755, DOI 10.1016/j.modgep.2004.03.006; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kishimoto J, 2000, GENE DEV, V14, P1181; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Luria V, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-13; Luria V, 2008, NEURON, V60, P1039, DOI 10.1016/j.neuron.2008.11.011; Martinez-Mir A, 2007, AM J HUM GENET, V80, P316, DOI 10.1086/511442; Megason SG, 2002, DEVELOPMENT, V129, P2087; Nakamura T, 2008, J CELL MOL MED, V12, P391, DOI 10.1111/j.1582-4934.2007.00201.x; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; O'Shaughnessy RFL, 2004, J INVEST DERMATOL, V123, P613, DOI 10.1111/j.0022-202X.2004.23410.x; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pidasheva S, 2005, HUM MOL GENET, V14, P1679, DOI 10.1093/hmg/ddi176; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shimomura Y, 2003, J DERMATOL SCI, V31, P43, DOI 10.1016/S0923-1811(02)00140-8; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Takahashi M, 2002, CANCER RES, V62, P5651; Taylor MF, 1996, J BIOL CHEM, V271, P17445, DOI 10.1074/jbc.271.29.17445; TORIBIO J, 1974, BRIT J DERMATOL, V91, P687, DOI 10.1111/j.1365-2133.1974.tb12455.x; Trueb RM, 2002, EXP GERONTOL, V37, P981, DOI 10.1016/S0531-5565(02)00093-1; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vonica A, 2002, DEV BIOL, V250, P112, DOI 10.1006/dbio.2002.0786; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; WILSON PA, 1994, CURR BIOL, V4, P676, DOI 10.1016/S0960-9822(00)00152-4; Yu WY, 2008, DEVELOPMENT, V135, P3687, DOI 10.1242/dev.021899	47	161	175	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1043	U109		10.1038/nature08875	http://dx.doi.org/10.1038/nature08875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393562	Green Accepted			2022-12-24	WOS:000276635000039
J	Patorno, E; Bohn, RL; Wahl, PM; Avorn, J; Patrick, AR; Liu, J; Schneeweiss, S				Patorno, Elisabetta; Bohn, Rhonda L.; Wahl, Peter M.; Avorn, Jerry; Patrick, Amanda R.; Liu, Jun; Schneeweiss, Sebastian			Anticonvulsant Medications and the Risk of Suicide, Attempted Suicide, or Violent Death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIEPILEPTIC DRUGS; AGGRESSIVE-BEHAVIOR; BIPOLAR DISORDER; EPILEPSY; LITHIUM; DIVALPROEX; GABAPENTIN; LAMOTRIGINE; DEPRESSION; MANAGEMENT	Context In 2008, the US Food and Drug Administration mandated warning labeling for anticonvulsant medications regarding the increased risk of suicidal thoughts and behaviors. The decision was based on a meta-analysis not sufficiently large to investigate individual drugs. Objective To evaluate the risk of suicidal acts and combined suicidal acts or violent death associated with individual anticonvulsants. Design A cohort study of the risk of suicidal acts and combined suicidal acts or violent death in patients beginning use of anticonvulsant medications compared with patients initiating a reference anticonvulsant drug. Setting and Patients Patients 15 years and older from the HealthCore Integrated Research Database (HIRD) who began taking an anticonvulsant between July 2001 and December 2006. Main Outcome Measures Cox proportional hazards models and propensity score-matched analyses were used to evaluate risk of attempted or completed suicide and combined suicidal acts or violent death, controlling for psychiatric comorbidities and other risk factors, among individual anticonvulsants compared with topiramate and secondarily carbamazepine. Results The study identified 26 completed suicides, 801 attempted suicides, and 41 violent deaths in 297 620 new episodes of treatment with an anticonvulsant (overall median follow-up, 60 days). The incidence of the composite outcomes of completed suicides, attempted suicides, and violent deaths for anticonvulsants used in at least 100 treatment episodes ranged from 6.2 per 1000 person-years for primidone to 34.3 per 1000 person-years for oxcarbazepine. The risk of suicidal acts was increased for gabapentin (hazard ratio [HR], 1.42; 95% confidence interval [CI], 1.11-1.80), lamotrigine (HR, 1.84; 95% CI, 1.43-2.37), oxcarbazepine (HR, 2.07; 95% CI, 1.522.80), tiagabine (HR, 2.41; 95% CI, 1.65-3.52), and valproate (HR, 1.65; 95% CI, 1.25-2.19), compared with topiramate. The analyses including violent death produced similar results. Gabapentin users had increased risk in subgroups of younger and older patients, patients with mood disorders, and patients with epilepsy or seizure when compared with carbamazepine. Conclusion This exploratory analysis suggests that the use of gabapentin, lamotrigine, oxcarbazepine, and tiagabine, compared with the use of topiramate, may be associated with an increased risk of suicidal acts or violent deaths. JAMA. 2010; 303(14): 1401-1409	[Patorno, Elisabetta; Bohn, Rhonda L.; Avorn, Jerry; Patrick, Amanda R.; Liu, Jun; Schneeweiss, Sebastian] Harvard Univ, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med,Med Sch, Boston, MA 02120 USA; [Bohn, Rhonda L.; Wahl, Peter M.] HealthCore Inc, Wilmington, DE USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; HealthCore, Inc	Patorno, E (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med,Med Sch, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	epatorno@partners.org	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X	HealthCore Fellowship in Pharmacoepidemiology; Harvard School of Public Health	HealthCore Fellowship in Pharmacoepidemiology; Harvard School of Public Health	Funding/Support: This study was supported by the HealthCore Fellowship in Pharmacoepidemiology and the Pharmacoepidemiology Research and Training Fund of the Harvard School of Public Health (Dr Patorno).	[Anonymous], 1989, PHYS CURR PROC TERM; Austin PC, 2009, PHARMACOEPIDEM DR S, V18, P469, DOI 10.1002/pds.1733; Avorn J, 2008, NEW ENGL J MED, V359, P991, DOI 10.1056/NEJMp0805922; BARABAS G, 1988, PEDIATRICS, V82, P284; Beran RG, 1998, EPILEPSIA, V39, P280, DOI 10.1111/j.1528-1157.1998.tb01373.x; Clark DE, 2004, J AM GERIATR SOC, V52, P2023, DOI 10.1111/j.1532-5415.2004.52560.x; Collins JC, 2008, J AFFECT DISORDERS, V107, P23, DOI 10.1016/j.jad.2007.07.014; CURRAN HV, 1993, EUR J CLIN PHARMACOL, V44, P529, DOI 10.1007/BF02440853; Elger CE, 2008, EPILEPSY BEHAV, V12, P501, DOI 10.1016/j.yebeh.2008.01.003; Ettinger AB, 1998, EPILEPSIA, V39, P874, DOI 10.1111/j.1528-1157.1998.tb01183.x; Ettinger AB, 2007, NEUROTHERAPEUTICS, V4, P75, DOI 10.1016/j.nurt.2006.10.003; Ettinger AB, 2006, NEUROLOGY, V67, P1916, DOI 10.1212/01.wnl.0000247045.85646.c0; *FDA PUBL HLTH ADV, SUIC THOUGHTS BEH AN; French JA, 2008, NEW ENGL J MED, V359, P166, DOI 10.1056/NEJMcp0801738; Goodwin FK, 2003, JAMA-J AM MED ASSOC, V290, P1467, DOI 10.1001/jama.290.11.1467; Grabowska-Grzyb A, 2006, EPILEPSY BEHAV, V8, P411, DOI 10.1016/j.yebeh.2005.12.005; Hamer Ann M, 2002, J Manag Care Pharm, V8, P266; Iribarren C, 2000, SOC PSYCH PSYCH EPID, V35, P288, DOI 10.1007/s001270050241; Kalinin VV, 2007, DRUG SAFETY, V30, P123, DOI 10.2165/00002018-200730020-00003; Ketter TA, 1999, NEUROLOGY, V53, pS53; Landmark CJ, 2008, CNS DRUGS, V22, P27; Lee DO, 1996, EPILEPSIA, V37, P87, DOI 10.1111/j.1528-1157.1996.tb00517.x; MOYER LA, 1989, AM J EPIDEMIOL, V130, P1024, DOI 10.1093/oxfordjournals.aje.a115403; Mula M, 2007, DRUG SAFETY, V30, P555, DOI 10.2165/00002018-200730070-00001; Ohberg A, 1998, ACTA PSYCHIAT SCAND, V98, P214, DOI 10.1111/j.1600-0447.1998.tb10069.x; Parsons LS, P 26 ANN SAS US GROU, DOI www2. sas. com/ proceedings/ sugi26/ p214- 26. pdf.; PATRICK AR, 2009, PHARMACOEPIDEM DR S, V18, pS1; PEREIRA J, 2002, COCHRANE DB SYST REV, V3; PHILLIPS DP, 1993, SUICIDE LIFE-THREAT, V23, P307; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Reijs R, 2004, EPILEPSY BEHAV, V5, pS66, DOI 10.1016/j.yebeh.2003.11.009; Rosenberg JM, 2007, CNS SPECTRUMS, V12, P831, DOI 10.1017/S1092852900015571; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Schmitz B, 2006, EPILEPSIA, V47, P28, DOI 10.1111/j.1528-1167.2006.00684.x; Schneeweiss S, 2009, EPIDEMIOLOGY, V20, P512, DOI 10.1097/EDE.0b013e3181a663cc; Spina E, 2004, EPILEPTIC DISORD, V6, P57; Tallian KB, 1996, EPILEPSIA, V37, P501, DOI 10.1111/j.1528-1157.1996.tb00598.x; U.S. Department of Health and Human Services Food and Drug Administration Center for Evaluation and Research, 2008, STAT REV EVALUATION; *US DEP HHS, 1988, INT CLASS DIS 9 REV; Vandenbroucke JP, 2008, PLOS MED, V5, P339, DOI 10.1371/journal.pmed.0050067; WOLF SM, 1995, EPILEPSIA, V36, P1203, DOI 10.1111/j.1528-1157.1995.tb01063.x; World Health Organization, 1992, INT STAT CLASS DIS 1; Yerevanian BI, 2007, J AFFECT DISORDERS, V103, P5, DOI 10.1016/j.jad.2007.05.019; 2008, JOINT M PER CENTR NE; UPDATE SUICIDAL BEHA	45	150	154	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2010	303	14					1401	1409		10.1001/jama.2010.410	http://dx.doi.org/10.1001/jama.2010.410			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582KX	20388896				2022-12-24	WOS:000276597300025
J	Wollert, T; Hurley, JH				Wollert, Thomas; Hurley, James H.			Molecular mechanism of multivesicular body biogenesis by ESCRT complexes	NATURE			English	Article							UBIQUITIN-BINDING DOMAINS; ENDOSOME-ASSOCIATED COMPLEX; III COMPLEX; IN-VITRO; MACHINERY; PROTEINS; ALIX; COMPARTMENT; CLATHRIN; BODIES	When internalized receptors and other cargo are destined for lysosomal degradation, they are ubiquitinated and sorted by the endosomal sorting complex required for transport (ESCRT) complexes 0, I, II and III into multivesicular bodies. Multivesicular bodies are formed when cargo-rich patches of the limiting membrane of endosomes bud inwards by an unknown mechanism and are then cleaved to yield cargo-bearing intralumenal vesicles. The biogenesis of multivesicular bodies was reconstituted and visualized using giant unilamellar vesicles, fluorescent ESCRT-0, -I, -II and -III complexes, and a membrane-tethered fluorescent ubiquitin fusion as a model cargo. Here we show that ESCRT-0 forms domains of clustered cargo but does not deform membranes. ESCRT-I and ESCRT-II in combination deform the membrane into buds, in which cargo is confined. ESCRT-I and ESCRT-II localize to the bud necks, and recruit ESCRT-0-ubiquitin domains to the buds. ESCRT-III subunits localize to the bud neck and efficiently cleave the buds to form intralumenal vesicles. Intralumenal vesicles produced in this reaction contain the model cargo but are devoid of ESCRTs. The observations explain how the ESCRTs direct membrane budding and scission from the cytoplasmic side of the bud without being consumed in the reaction.	[Wollert, Thomas; Hurley, James H.] NIDDK, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hurley, JH (corresponding author), NIDDK, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	hurley@helix.nih.gov		Wollert, Thomas/0000-0001-9732-4789	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Intramural AIDS Targeted Antiviral Program; EMBO; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036126, ZIADK036123, ZIADK036125] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural AIDS Targeted Antiviral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Boura for producing the CFP-Ub and GFP-Ub, J. Lippincott-Schwartz for microscope access, B. Wendland for a yeast strain and advice, and W. Prinz for comments on the manuscript. This work was funded by the Intramural Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases and Intramural AIDS Targeted Antiviral Program to J. H. H. and an EMBO long-term fellowship to T. W.	Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Bilodeau PS, 2003, J CELL BIOL, V163, P237, DOI 10.1083/jcb.200305007; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Doyotte A, 2005, J CELL SCI, V118, P3003, DOI 10.1242/jcs.02421; Falguieres T, 2008, MOL BIOL CELL, V19, P4942, DOI 10.1091/mbc.E08-03-0239; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Gill DJ, 2007, EMBO J, V26, P600, DOI 10.1038/sj.emboj.7601501; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hanson PI, 2009, CURR OPIN CELL BIOL, V21, P568, DOI 10.1016/j.ceb.2009.06.002; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lenz M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038101; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Murk JLAN, 2003, P NATL ACAD SCI USA, V100, P13332, DOI 10.1073/pnas.2232379100; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Rieder SE, 1996, MOL BIOL CELL, V7, P985, DOI 10.1091/mbc.7.6.985; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Samson RY, 2009, TRENDS MICROBIOL, V17, P507, DOI 10.1016/j.tim.2009.08.003; Shields SB, 2009, J CELL BIOL, V185, P213, DOI 10.1083/jcb.200811130; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Tran JH, 2009, P NATL ACAD SCI USA, V106, P17395, DOI 10.1073/pnas.0909473106; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	52	496	510	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					864	U73		10.1038/nature08849	http://dx.doi.org/10.1038/nature08849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20305637	Green Accepted			2022-12-24	WOS:000276397300031
J	Bloom, AJ; Burger, M; Rubio-Asensio, JS; Cousins, AB				Bloom, Arnold J.; Burger, Martin; Rubio-Asensio, Jose Salvador; Cousins, Asaph B.			Carbon Dioxide Enrichment Inhibits Nitrate Assimilation in Wheat and Arabidopsis	SCIENCE			English	Article							ELEVATED CO2; NITROGEN; RESPONSES; REDOX; PHOTOSYNTHESIS; CHLOROPLAST; METABOLISM; GRASSLAND; GROWTH; LEAVES	The concentration of carbon dioxide in Earth's atmosphere may double by the end of the 21st century. The response of higher plants to a carbon dioxide doubling often includes a decline in their nitrogen status, but the reasons for this decline have been uncertain. We used five independent methods with wheat and Arabidopsis to show that atmospheric carbon dioxide enrichment inhibited the assimilation of nitrate into organic nitrogen compounds. This inhibition may be largely responsible for carbon dioxide acclimation, the decrease in photosynthesis and growth of plants conducting C-3 carbon fixation after long exposures (days to years) to carbon dioxide enrichment. These results suggest that the relative availability of soil ammonium and nitrate to most plants will become increasingly important in determining their productivity as well as their quality as food.	[Bloom, Arnold J.; Burger, Martin; Rubio-Asensio, Jose Salvador; Cousins, Asaph B.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Bloom, AJ (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	ajbloom@ucdavis.edu	Rubio Asensio, Jose Salvador/E-3361-2010	Rubio Asensio, Jose Salvador/0000-0002-2813-601X	NSF [IBN-03-43127, IOS-08-18435]; National Research Initiative Competitive, U.S. Department of Agriculture National Institute of Food and Agriculture [2008-35100-04459]; Agencia Regional de Ciencia y Tecnologia, Region de Murcia, Spain; Direct For Biological Sciences [0818435] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); National Research Initiative Competitive, U.S. Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Agencia Regional de Ciencia y Tecnologia, Region de Murcia, Spain; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C. van Kessel, L. Jackson, and E. Carlisle for their review of the manuscript. This research was supported by NSF grants IBN-03-43127 and IOS-08-18435, by the National Research Initiative Competitive grant number 2008-35100-04459 from the U.S. Department of Agriculture National Institute of Food and Agriculture, and by a postdoctoral fellowship from Agencia Regional de Ciencia y Tecnologia, Region de Murcia, Spain to J.S.R.A. A.J.B. is a paid consultant to the Monsanto Corporation.	[Anonymous], 2005, MINERAL NUTR PLANTS; Backhausen JE, 2000, PHOTOSYNTH RES, V64, P1, DOI 10.1023/A:1026523809147; Backhausen JE, 1998, PLANTA, V207, P105, DOI 10.1007/s004250050461; BLOOM AJ, 1989, PLANT PHYSIOL, V91, P352, DOI 10.1104/pp.91.1.352; Bloom AJ, 2002, P NATL ACAD SCI USA, V99, P1730, DOI 10.1073/pnas.022627299; Cen YP, 2001, PLANT PHYSIOL, V126, P1555, DOI 10.1104/pp.126.4.1555; Cousins AB, 2003, PLANT CELL ENVIRON, V26, P1525, DOI 10.1046/j.1365-3040.2003.01075.x; CRAWFORD NM, 2002, ARABIDOPSIS BOOK; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Ellsworth DS, 2004, GLOBAL CHANGE BIOL, V10, P2121, DOI 10.1111/j.1365-2486.2004.00867.x; Erickson JE, 2007, GLOBAL CHANGE BIOL, V13, P202, DOI 10.1111/j.1365-2486.2006.01285.x; Foyer CH, 2009, ANNU REV PLANT BIOL, V60, P455, DOI 10.1146/annurev.arplant.043008.091948; Hogy P, 2009, PLANT BIOLOGY, V11, P60, DOI 10.1111/j.1438-8677.2009.00230.x; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Igamberdiev AU, 2001, PHYSIOL PLANTARUM, V111, P427, DOI 10.1034/j.1399-3054.2001.1110402.x; Kimball BA, 2001, NEW PHYTOL, V150, P295, DOI 10.1046/j.1469-8137.2001.00107.x; Knaff D.B., 1996, OXYGENIC PHOTOSYNTHE, V4, P333; Li PH, 2006, PLANT MOL BIOL, V62, P593, DOI 10.1007/s11103-006-9041-y; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Mariscal V, 2006, PROTIST, V157, P421, DOI 10.1016/j.protis.2006.06.003; Myers J., 1949, PHOTOSYNTHESIS PLANT, P349; Norby RJ, 2001, OECOLOGIA, V127, P153, DOI 10.1007/s004420000615; Quesada A, 2000, TRENDS PLANT SCI, V5, P463, DOI 10.1016/S1360-1385(00)01770-2; Rachmilevitch S, 2004, P NATL ACAD SCI USA, V101, P11506, DOI 10.1073/pnas.0404388101; Rasse DP, 2005, GLOBAL CHANGE BIOL, V11, P369, DOI 10.1111/j.1365-2486.2005.00913.x; RATHNAM CKM, 1976, PLANT PHYSIOL, V57, P881, DOI 10.1104/pp.57.6.881; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Robinson J. M., 1987, MODELS PLANT PHYSL B, P25; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; SCHULZE ED, 1984, PLANT PHYSIOL, V76, P827, DOI 10.1104/pp.76.3.827; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Tcherkez G, 2006, FUNCT PLANT BIOL, V33, P531, DOI 10.1071/FP05284; von Caemmerer S., 2000, BIOCH MODELS LEAF PH	33	383	405	10	336	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					899	903		10.1126/science.1186440	http://dx.doi.org/10.1126/science.1186440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466933				2022-12-24	WOS:000277618800051
J	Hailey, DW; Rambold, AS; Satpute-Krishnan, P; Mitra, K; Sougrat, R; Kim, PK; Lippincott-Schwartz, J				Hailey, Dale W.; Rambold, Angelika S.; Satpute-Krishnan, Prasanna; Mitra, Kasturi; Sougrat, Rachid; Kim, Peter K.; Lippincott-Schwartz, Jennifer			Mitochondria Supply Membranes for Autophagosome Biogenesis during Starvation	CELL			English	Article							ENDOPLASMIC-RETICULUM; PROTEIN; TRANSPORT; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPIDS; CYTOCHROME-B5; INTERACTS; MACHINERY; BECLIN-1	Starvation-induced autophagosomes engulf cytosol and/or organelles and deliver them to lysosomes for degradation, thereby resupplying depleted nutrients. Despite advances in understanding the molecular basis of this process, the membrane origin of autophagosomes remains unclear. Here, we demonstrate that, in starved cells, the outer membrane of mitochondria participates in autophagosome biogenesis. The early autophagosomal marker, Atg5, transiently localizes to punctae on mitochondria, followed by the late autophagosomal marker, LC3. The tail-anchor of an outer mitochondrial membrane protein also labels autophagosomes and is sufficient to deliver another outer mitochondrial membrane protein, Fis1, to autophagosomes. The fluorescent lipid NBD-PS (converted to NBD-phos-photidylethanolamine in mitochondria) transfers from mitochondria to autophagosomes. Photo-bleaching reveals membranes of mitochondria and autophagosomes are transiently shared. Disruption of mitochondria/ER connections by mitofusin2 depletion dramatically impairs starvation-induced autophagy. Mitochondria thus play a central role in starvation-induced autophagy, contributing membrane to autophagosomes.	[Hailey, Dale W.; Rambold, Angelika S.; Satpute-Krishnan, Prasanna; Mitra, Kasturi; Sougrat, Rachid; Lippincott-Schwartz, Jennifer] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD 20892 USA; [Kim, Peter K.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Lippincott-Schwartz, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, 18 Lib Dr, Bethesda, MD 20892 USA.	lippincj@mail.nih.gov	Satpute-Krishnan, Prasanna/ABE-5421-2020	Sougrat, Rachid/0000-0001-6476-1886	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA HD001609-16] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Borgese N, 2001, MOL BIOL CELL, V12, P2482, DOI 10.1091/mbc.12.8.2482; Bozidis P, 2008, J VIROL, V82, P2715, DOI 10.1128/JVI.02456-07; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; DARRIGO A, 1993, J BIOL CHEM, V268, P2802; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Fengsrud M, 2000, EUR J CELL BIOL, V79, P871, DOI 10.1078/0171-9335-00125; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Hailey DW, 2009, METHOD ENZYMOL, V452, P25, DOI 10.1016/S0076-6879(08)03603-3; HOYVIK H, 1991, J CELL BIOL, V113, P1305, DOI 10.1083/jcb.113.6.1305; Juhasz G, 2006, PLOS BIOL, V4, P161, DOI 10.1371/journal.pbio.0040036; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KOBAYASHI T, 1991, J CELL BIOL, V113, P235, DOI 10.1083/jcb.113.2.235; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; LEDERER F, 1983, EUR J BIOCHEM, V132, P95, DOI 10.1111/j.1432-1033.1983.tb07330.x; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Mijaljica D, 2007, AUTOPHAGY, V3, P4, DOI 10.4161/auto.3011; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Overbye A, 2007, AUTOPHAGY, V3, P300, DOI 10.4161/auto.3910; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840; Reggiori F, 2009, DEV CELL, V17, P747, DOI 10.1016/j.devcel.2009.12.004; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schmidt K, 2004, CURR BIOL, V14, P1002, DOI 10.1016/j.cub.2004.05.044; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Sneve ML, 2005, AUTOPHAGY, V1, P157, DOI 10.4161/auto.1.3.2037; Tadini-Buoninsegni F, 2008, MOL PHARMACOL, V73, P1134, DOI 10.1124/mol.107.043745; TAKAGAKI Y, 1983, J BIOL CHEM, V258, P9128; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3; THOMAS PD, 1989, BIOCHIM BIOPHYS ACTA, V978, P85, DOI 10.1016/0005-2736(89)90502-6; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; VERGERES G, 1995, BIOCHIMIE, V77, P604, DOI 10.1016/0300-9084(96)88176-4; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	57	982	1017	6	136	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					656	667		10.1016/j.cell.2010.04.009	http://dx.doi.org/10.1016/j.cell.2010.04.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478256	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000277623600018
J	Mucha, PJ; Richardson, T; Macon, K; Porter, MA; Onnela, JP				Mucha, Peter J.; Richardson, Thomas; Macon, Kevin; Porter, Mason A.; Onnela, Jukka-Pekka			Community Structure in Time-Dependent, Multiscale, and Multiplex Networks	SCIENCE			English	Article								Network science is an interdisciplinary endeavor, with methods and applications drawn from across the natural, social, and information sciences. A prominent problem in network science is the algorithmic detection of tightly connected groups of nodes known as communities. We developed a generalized framework of network quality functions that allowed us to study the community structure of arbitrary multislice networks, which are combinations of individual networks coupled through links that connect each node in one network slice to itself in other slices. This framework allows studies of community structure in a general setting encompassing networks that evolve over time, have multiple types of links (multiplexity), and have multiple scales.	[Mucha, Peter J.; Richardson, Thomas; Macon, Kevin] Univ N Carolina, Dept Math, Carolina Ctr Interdisciplinary Appl Math, Chapel Hill, NC 27599 USA; [Mucha, Peter J.] Univ N Carolina, Inst Adv Mat Nanosci & Technol, Chapel Hill, NC 27599 USA; [Richardson, Thomas] N Carolina State Univ, Raleigh, NC 27695 USA; [Porter, Mason A.] Univ Oxford, Math Inst, Oxford Ctr Ind & Appl Math, Oxford OX1 3LB, England; [Porter, Mason A.] Univ Oxford, CABDyN Complex Ctr, Oxford OX1 1HP, England; [Onnela, Jukka-Pekka] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Onnela, Jukka-Pekka] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of Oxford; University of Oxford; Harvard University; Harvard Medical School; Harvard University	Mucha, PJ (corresponding author), Univ N Carolina, Dept Math, Carolina Ctr Interdisciplinary Appl Math, Chapel Hill, NC 27599 USA.	mucha@unc.edu		Macon, Kevin/0000-0003-3589-2179; Richardson, Thomas/0000-0001-7767-452X	NSF [DMS-0645369]; James S. McDonnell Foundation [220020177]; Fulbright Program	NSF(National Science Foundation (NSF)); James S. McDonnell Foundation; Fulbright Program	We thank N. A. Christakis, L. Meneades, and K. Lewis for access to and helping with the "Tastes, Ties, and Time" data; S. Reid and A. L. Traud for help developing code; and A. Clauset, J.-C. Delvenne, S. Fortunato, M. Gould, and V. Traag for discussions. Congressional roll call data are from http://voteview.com (26). Supported by NSF grant DMS-0645369 (P.J.M.), James S. McDonnell Foundation grant 220020177 (M. A. P.), and the Fulbright Program (J.-P.O.).	[Anonymous], P 13 C KNOWL DISC DA, DOI DOI 10.1145/1281192.1281266; Arenas A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/176; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Berger-Wolf TY, 2006, P 12 ACM SIGKDD INT, P523, DOI [10.1145/1150402.1150462, DOI 10.1145/1150402.1150462]; Fenn DJ, 2009, CHAOS, V19, DOI 10.1063/1.3184538; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gomez S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016114; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Hopcroft J, 2004, P NATL ACAD SCI USA, V101, P5249, DOI 10.1073/pnas.0307750100; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Lewis K, 2008, SOC NETWORKS, V30, P330, DOI 10.1016/j.socnet.2008.07.002; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Porter MA., 2009, NOT AM MATH SOC, V56, P1082, DOI DOI 10.1103/PHYSREVE.69.066133; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Richardson T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036111; SELEE TM, 2007, CSRI SUMM P 2007, P87; Traag VA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036115; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	22	1212	1261	15	346	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					876	878		10.1126/science.1184819	http://dx.doi.org/10.1126/science.1184819			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466926	Green Submitted, Green Accepted, Green Published			2022-12-24	WOS:000277618800043
J	Lv, S; Dudek, DM; Cao, Y; Balamurali, MM; Gosline, J; Li, HB				Lv, Shanshan; Dudek, Daniel M.; Cao, Yi; Balamurali, M. M.; Gosline, John; Li, Hongbin			Designed biomaterials to mimic the mechanical properties of muscles	NATURE			English	Article							CARDIAC-MUSCLE; PROTEIN TITIN; ELASTIN; RESILIN; CONNECTIN/TITIN; MYOFIBRILS; MOLECULES; FILAMENTS; DOMAINS; TENSION	The passive elasticity of muscle is largely governed by the I-band part of the giantmuscle protein titin(1-4), a complex molecular spring composed of a series of individually folded immunoglobulin-like domains as well as largely unstructured unique sequences(5). These mechanical elements have distinct mechanical properties, and when combined, they provide the desired passive elastic properties of muscle(6-11), which are a unique combination of strength, extensibility and resilience. Single-molecule atomic force microscopy (AFM) studies demonstrated that the macroscopic behaviour of titin in intact myofibrils can be reconstituted by combining the mechanical properties of these mechanical elements measured at the single-molecule level(8). Here we report artificial elastomeric proteins that mimic the molecular architecture of titin through the combination of well-characterized protein domains GB1(12) and resilin(13). We show that these artificial elastomeric proteins can be photochemically crosslinked and cast into solid biomaterials. These biomaterials behave as rubber-like materials showing high resilience at low strain and as shock-absorber-like materials at high strain by effectively dissipating energy. These properties are comparable to the passive elastic properties of muscles within the physiological range of sarcomere length(14) and so these materials represent a new muscle-mimetic biomaterial. The mechanical properties of these biomaterials can be fine-tuned by adjusting the composition of the elastomeric proteins, providing the opportunity to develop biomaterials that are mimetic of different types of muscles. We anticipate that these biomaterials will find applications in tissue engineering(15) as scaffold and matrix for artificial muscles.	[Lv, Shanshan; Cao, Yi; Balamurali, M. M.; Li, Hongbin] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Dudek, Daniel M.; Gosline, John] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z1, Canada	University of British Columbia; University of British Columbia	Li, HB (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	gosline@zoology.ubc.ca; hongbin@chem.ubc.ca	Li, Hongbin/G-2949-2012; MM, Balamurali/ABG-9767-2020; Yi, Cao/A-4200-2011	Li, Hongbin/0000-0001-7813-1332; Yi, Cao/0000-0003-1493-7868; MM, Balamurali/0000-0001-7948-9950; Lv, Shanshan/0000-0002-6068-3048	Canadian Institutes of Health Research; Canada Research Chairs program; Canada Foundation for Innovation; Michael Smith Foundation for Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank M. Lillie and R. Shadwick for discussions. This work is supported by the Canadian Institutes of Health Research, the Canada Research Chairs program, the Canada Foundation for Innovation, the Michael Smith Foundation for Health Research, and the Natural Sciences and Engineering Research Council of Canada. H. L. is a Michael Smith Foundation for Health Research Career Investigator.	Amin AFMS, 2006, INT J PLASTICITY, V22, P1610, DOI 10.1016/j.ijplas.2005.09.005; ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2; Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512; Bochicchio B, 2005, MACROMOL BIOSCI, V5, P502, DOI 10.1002/mabi.200500007; Cao Y, 2007, NAT MATER, V6, P109, DOI 10.1038/nmat1825; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; DUDEK DM, 2009, ANN M SOC INT COMP B, pE50; Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; Helmes M, 1999, CIRC RES, V84, P1339, DOI 10.1161/01.RES.84.11.1339; Higuchi H, 1996, ADV BIOPHYS, V33, P159; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098; LILLIE MA, 1994, CONNECT TISSUE RES, V31, P23, DOI 10.3109/03008209409005632; LINKE WA, 1994, BIOPHYS J, V67, P782, DOI 10.1016/S0006-3495(94)80538-7; Linke WA, 1999, J CELL BIOL, V146, P631, DOI 10.1083/jcb.146.3.631; Maruyama K, 1997, FASEB J, V11, P341, DOI 10.1096/fasebj.11.5.9141500; Minajeva A, 2001, BIOPHYS J, V80, P1442, DOI 10.1016/S0006-3495(01)76116-4; Nagapudi K, 2005, MACROMOLECULES, V38, P345, DOI 10.1021/ma0491199; Nairn KM, 2008, BIOPHYS J, V95, P3358, DOI 10.1529/biophysj.107.119107; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023; Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x; Wang K, 1996, ADV BIOPHYS, V33, P123; Watanabe K, 2002, J BIOL CHEM, V277, P11549, DOI 10.1074/jbc.M200356200; Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914	33	398	403	9	468	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 6	2010	465	7294					69	73		10.1038/nature09024	http://dx.doi.org/10.1038/nature09024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20445626				2022-12-24	WOS:000277311900032
J	Ribet, D; Hamon, M; Gouin, E; Nahori, MA; Impens, F; Neyret-Kahn, H; Gevaert, K; Vandekerckhove, J; Dejean, A; Cossart, P				Ribet, David; Hamon, Melanie; Gouin, Edith; Nahori, Marie-Anne; Impens, Francis; Neyret-Kahn, Helene; Gevaert, Kris; Vandekerckhove, Joel; Dejean, Anne; Cossart, Pascale			Listeria monocytogenes impairs SUMOylation for efficient infection	NATURE			English	Article							GROWTH-FACTOR-BETA; HISTONE MODIFICATIONS; SUMO PATHWAY; PROTEIN; CELLS; HOST; PROTEOMICS; FAMILY; ENTRY; MICE	During infection, pathogenic bacteria manipulate the host cell in various ways to allow their own replication, propagation and escape from host immune responses. Post-translational modifications are unique mechanisms that allow cells to rapidly, locally and specifically modify activity or interactions of key proteins. Some of these modifications, including phosphorylation and ubiquitylation(1,2), can be induced by pathogens. However, the effects of pathogenic bacteria on SUMOylation, an essential post-translational modification in eukaryotic cells(3), remain largely unknown. Here we show that infection with Listeria monocytogenes leads to a decrease in the levels of cellular SUMO-conjugated proteins. This event is triggered by the bacterial virulence factor listeriolysin O (LLO), which induces a proteasome-independent degradation of Ubc9, an essential enzyme of the SUMOylation machinery, and a proteasome-dependent degradation of some SUMOylated proteins. The effect of LLO on Ubc9 is dependent on the pore-forming capacity of the toxin and is shared by other bacterial pore-forming toxins like perfringolysin O(PFO) and pneumolysin (PLY). Ubc9 degradation was also observed in vivo in infected mice. Furthermore, we show that SUMO overexpression impairs bacterial infection. Together, our results reveal that Listeria, and probably other pathogens, dampen the host response by decreasing the SUMOylation level of proteins critical for infection.	[Ribet, David; Hamon, Melanie; Gouin, Edith; Nahori, Marie-Anne; Cossart, Pascale] Inst Pasteur, Dept Biol Cellulaire & Infect, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Ribet, David; Hamon, Melanie; Gouin, Edith; Nahori, Marie-Anne; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France; [Ribet, David; Hamon, Melanie; Gouin, Edith; Nahori, Marie-Anne; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Impens, Francis; Gevaert, Kris; Vandekerckhove, Joel] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Impens, Francis; Gevaert, Kris; Vandekerckhove, Joel] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Neyret-Kahn, Helene; Dejean, Anne] Inst Pasteur, Dept Biol Cellulaire & Infect, Unite Org Nucl & Oncogenese, F-75015 Paris, France; [Neyret-Kahn, Helene; Dejean, Anne] INSERM, U579, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Flanders Institute for Biotechnology (VIB); Ghent University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Cossart, P (corresponding author), Inst Pasteur, Dept Biol Cellulaire & Infect, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pascale.cossart@pasteur.fr	Hamon, Melanie/B-3501-2013; Gevaert, Kris/AAE-4212-2019; Gevaert, Kris/H-3637-2013; Ribet, David/AAA-6659-2020; Impens, Francis/C-3335-2009; Dejean, Anne/L-5145-2018; Gevaert, Kris/D-6489-2017	Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Ribet, David/0000-0003-1175-6471; Gevaert, Kris/0000-0002-4237-0283; Hamon, Melanie/0000-0001-5078-4083; Marie-Anne, Nahori/0000-0002-4066-4528; Impens, Francis/0000-0003-2886-9616; NEYRET-KAHN, Helene/0000-0002-5660-4941	Institut Pasteur; INSERM; INRA; European Research Council (ERC) [233348]; Fund for Scientific Research Flanders (Belgium) [G.0042.07]; Concerted Research Actions [BOF07/GOA/012]; Ghent University; Inter University Attraction Poles [IUAP06]; Association pour la Recherche sur le Cancer; Research Assistant of the Research Foundation - Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen)	Institut Pasteur(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; European Research Council (ERC)(European Research Council (ERC)European Commission); Fund for Scientific Research Flanders (Belgium)(FWO); Concerted Research Actions; Ghent University(Ghent University); Inter University Attraction Poles(Belgian Federal Science Policy Office); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Research Assistant of the Research Foundation - Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen)(FWO)	We thank V. Villiers for technical assistance. Work in the P. C. laboratory received financial support from Institut Pasteur, INSERM, INRA and European Research Council (ERC, Advanced Grant 233348). We further acknowledge support by research grants from the Fund for Scientific Research Flanders (Belgium) (project number G.0042.07), the Concerted Research Actions (project BOF07/GOA/012) from Ghent University and the Inter University Attraction Poles (IUAP06). D. R. is supported by a fellowship from the Association pour la Recherche sur le Cancer, F. I. is a Research Assistant of the Research Foundation - Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen) and P. C. is an international research scholar of the Howard Hughes Medical Institute.	Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Boggio R, 2007, J BIOL CHEM, V282, P15376, DOI 10.1074/jbc.M700889200; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; Bonazzi M, 2008, CELL MICROBIOL, V10, P2208, DOI 10.1111/j.1462-5822.2008.01200.x; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Dramsi S, 2003, INFECT IMMUN, V71, P3614, DOI 10.1128/IAI.71.6.3614-3618.2003; Fitzpatrick DR, 1999, TRENDS MICROBIOL, V7, P232, DOI 10.1016/S0966-842X(99)01498-5; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gevaert K, 2008, PROTEOMICS, V8, P4873, DOI 10.1002/pmic.200800421; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Hamon MA, 2007, P NATL ACAD SCI USA, V104, P13467, DOI 10.1073/pnas.0702729104; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Kang JS, 2008, NAT CELL BIOL, V10, P654, DOI 10.1038/ncb1728; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MICHEL E, 1990, MOL MICROBIOL, V4, P2167, DOI 10.1111/j.1365-2958.1990.tb00578.x; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nakane A, 1996, INFECT IMMUN, V64, P3901, DOI 10.1128/IAI.64.9.3901-3904.1996; NATO F, 1991, INFECT IMMUN, V59, P4641, DOI 10.1128/IAI.59.12.4641-4646.1991; Rytkonen A, 2007, CELL HOST MICROBE, V1, P13, DOI 10.1016/j.chom.2007.02.003; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Tang P, 1996, INFECT IMMUN, V64, P2359, DOI 10.1128/IAI.64.6.2359-2361.1996; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	32	147	153	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1192	U111		10.1038/nature08963	http://dx.doi.org/10.1038/nature08963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20414307	Green Accepted			2022-12-24	WOS:000276891100037
J	Hudson, TJ; Anderson, W; Aretz, A; Barker, AD; Bell, C; Bernabe, RR; Bhan, MK; Calvo, F; Eerola, I; Gerhard, DS; Guttmacher, A; Guyer, M; Hemsley, FM; Jennings, JL; Kerr, D; Klatt, P; Kolar, P; Kusuda, J; Lane, DP; Laplace, F; Lu, YY; Nettekoven, G; Ozenberger, B; Peterson, J; Rao, TS; Remacle, J; Schafer, AJ; Shibata, T; Stratton, MR; Vockley, JG; Watanabe, K; Yang, HM; Yuen, MMF; Knoppers, M; Bobrow, M; Cambon-Thomsen, A; Dressler, LG; Dyke, SOM; Joly, Y; Kato, K; Kennedy, KL; Nicolas, P; Parker, MJ; Rial-Sebbag, E; Romeo-Casabona, CM; Shaw, KM; Wallace, S; Wiesner, GL; Zeps, N; Lichter, P; Biankin, AV; Chabannon, C; Chin, L; Clement, B; de Alava, E; Degos, F; Ferguson, ML; Geary, P; Hayes, DN; Johns, AL; Nakagawa, H; Penny, R; Piris, MA; Sarin, R; Scarpa, A; van de Vijver, M; Futreal, PA; Aburatani, H; Bayes, M; Bowtell, DDL; Campbell, PJ; Estivill, X; Grimmond, SM; Gut, I; Hirst, M; Lopez-Otin, C; Majumder, P; Marra, M; Ning, ZM; Puente, XS; Ruan, YJ; Stunnenberg, HG; Swerdlow, H; Velculescu, VE; Wilson, RK; Xue, HH; Yang, L; Spellman, PT; Bader, GD; Boutros, PC; Flicek, P; Getz, G; Guigo, R; Guo, GW; Haussler, D; Heath, S; Hubbard, TJ; Jiang, T; Jones, SM; Li, QB; Lopez-Bigas, N; Luo, RB; Pearson, JV; Quesada, V; Raphael, BJ; Sander, C; Speed, TP; Stuart, JM; Teague, JW; Totoki, Y; Tsunoda, T; Valencia, A; Wheeler, DA; Wu, HL; Zhao, SC; Zhou, GY; Stein, LD; Lathrop, M; Ouellette, BFF; Thomas, G; Yoshida, T; Axton, M; Gunter, C; McPherson, JD; Miller, LJ; Kasprzyk, A; Zhang, JJ; Haider, SA; Wang, JX; Yung, CK; Cross, A; Liang, Y; Gnaneshan, S; Guberman, J; Hsu, J; Chalmers, DRC; Hasel, KW; Kaan, TSH; Knoppers, BM; Lowrance, WW; Masui, T; Rodriguez, LL; Vergely, C; Cloonan, N; Defazio, A; Eshleman, JR; Etemadmoghadam, D; Gardiner, BA; Kench, JG; Sutherland, RL; Tempero, MA; Waddell, NJ; Wilson, PJ; Gallinger, S; Tsao, MS; Shaw, PA; Petersen, GM; Mukhopadhyay, D; DePinho, RA; Thayer, S; Muthuswamy, L; Shazand, K; Beck, T; Sam, M; Timms, L; Ballin, V; Ji, JF; Zhang, XQ; Chen, F; Hu, XD; Yang, Q; Tian, G; Zhang, LH; Xing, XF; Li, XH; Zhu, ZG; Yu, YY; Yu, J; Tost, J; Brennan, P; Holcatova, I; Zaridze, D; Brazma, A; Egevad, L; Prokhortchouk, E; Banks, RE; Uhlen, M; Viksna, J; Ponten, F; Skryabin, K; Birney, E; Borg, A; Borresen-Dale, AL; Caldas, C; Foekens, JA; Martin, S; Reis-Filho, JS; Richardson, AL; Sotiriou, C; van't Veer, L; Birnbaum, D; Blanche, H; Boucher, P; Boyault, S; Masson-Jacquemier, JD; Pauporte, I; Pivot, X; Vincent-Salomon, A; Tabone, E; Theillet, C; Treilleux, I; Bioulac-Sage, P; Decaens, T; Franco, D; Gut, M; Samuel, D; Zucman-Rossi, J; Eils, R; Brors, B; Korbel, JO; Korshunov, A; Landgraf, P; Lehrach, H; Pfister, S; Radlwimmer, B; Reifenberger, G; Taylor, MD; von Kalle, C; Majumder, PP; Pederzoli, P; Lawlor, RT; Delledonne, M; Bardelli, A; Gress, T; Klimstra, D; Zamboni, G; Nakamura, Y; Miyano, S; Fujimoto, A; Campo, E; de Sanjose, S; Montserrat, E; Gonzalez-Diaz, M; Jares, P; Himmelbaue, H; Bea, S; Aparicio, S; Easton, DF; Collins, FS; Compton, CC; Lander, ES; Burke, W; Green, AR; Hamilton, SR; Kallioniemi, OP; Ley, TJ; Liu, ET; Wainwright, BJ				Hudson, Thomas J.; Anderson, Warwick; Aretz, Axel; Barker, Anna D.; Bell, Cindy; Bernabe, Rosa R.; Bhan, M. K.; Calvo, Fabien; Eerola, Iiro; Gerhard, Daniela S.; Guttmacher, Alan; Guyer, Mark; Hemsley, Fiona M.; Jennings, Jennifer L.; Kerr, David; Klatt, Peter; Kolar, Patrik; Kusuda, Jun; Lane, David P.; Laplace, Frank; Lu, Youyong; Nettekoven, Gerd; Ozenberger, Brad; Peterson, Jane; Rao, T. S.; Remacle, Jacques; Schafer, Alan J.; Shibata, Tatsuhiro; Stratton, Michael R.; Vockley, Joseph G.; Watanabe, Koichi; Yang, Huanming; Yuen, Matthew M. F.; Knoppers, M.; Bobrow, Martin; Cambon-Thomsen, Anne; Dressler, Lynn G.; Dyke, Stephanie O. M.; Joly, Yann; Kato, Kazuto; Kennedy, Karen L.; Nicolas, Pilar; Parker, Michael J.; Rial-Sebbag, Emmanuelle; Romeo-Casabona, Carlos M.; Shaw, Kenna M.; Wallace, Susan; Wiesner, Georgia L.; Zeps, Nikolajs; Lichter, Peter; Biankin, Andrew V.; Chabannon, Christian; Chin, Lynda; Clement, Bruno; de Alava, Enrique; Degos, Francoise; Ferguson, Martin L.; Geary, Peter; Hayes, D. Neil; Johns, Amber L.; Nakagawa, Hidewaki; Penny, Robert; Piris, Miguel A.; Sarin, Rajiv; Scarpa, Aldo; van de Vijver, Marc; Futreal, P. Andrew; Aburatani, Hiroyuki; Bayes, Monica; Bowtell, David D. L.; Campbell, Peter J.; Estivill, Xavier; Grimmond, Sean M.; Gut, Ivo; Hirst, Martin; Lopez-Otin, Carlos; Majumder, Partha; Marra, Marco; Ning, Zemin; Puente, Xose S.; Ruan, Yijun; Stunnenberg, Hendrik G.; Swerdlow, Harold; Velculescu, Victor E.; Wilson, Richard K.; Xue, Hong H.; Yang, Liu; Spellman, Paul T.; Bader, Gary D.; Boutros, Paul C.; Flicek, Paul; Getz, Gad; Guigo, Roderic; Guo, Guangwu; Haussler, David; Heath, Simon; Hubbard, Tim J.; Jiang, Tao; Jones, Steven M.; Li, Qibin; Lopez-Bigas, Nuria; Luo, Ruibang; Pearson, John V.; Quesada, Victor; Raphael, Benjamin J.; Sander, Chris; Speed, Terence P.; Stuart, Joshua M.; Teague, Jon W.; Totoki, Yasushi; Tsunoda, Tatsuhiko; Valencia, Alfonso; Wheeler, David A.; Wu, Honglong; Zhao, Shancen; Zhou, Guangyu; Stein, Lincoln D.; Lathrop, Mark; Ouellette, B. F. Francis; Thomas, Gilles; Yoshida, Teruhiko; Axton, Myles; Gunter, Chris; McPherson, John D.; Miller, Linda J.; Kasprzyk, Arek; Zhang, Junjun; Haider, Syed A.; Wang, Jianxin; Yung, Christina K.; Cross, Anthony; Liang, Yong; Gnaneshan, Saravanamuttu; Guberman, Jonathan; Hsu, Jack; Chalmers, Don R. C.; Hasel, Karl W.; Kaan, Terry S. H.; Knoppers, Bartha M.; Lowrance, William W.; Masui, Tohru; Rodriguez, Laura Lyman; Vergely, Catherine; Cloonan, Nicole; Defazio, Anna; Eshleman, James R.; Etemadmoghadam, Dariush; Gardiner, Brooke A.; Kench, James G.; Sutherland, Robert L.; Tempero, Margaret A.; Waddell, Nicola J.; Wilson, Peter J.; Gallinger, Steve; Tsao, Ming-Sound; Shaw, Patricia A.; Petersen, Gloria M.; Mukhopadhyay, Debabrata; DePinho, Ronald A.; Thayer, Sarah; Muthuswamy, Lakshmi; Shazand, Kamran; Beck, Timothy; Sam, Michelle; Timms, Lee; Ballin, Vanessa; Ji, Jiafu; Zhang, Xiuqing; Chen, Feng; Hu, Xueda; Yang, Qi; Tian, Geng; Zhang, Lianhai; Xing, Xiaofang; Li, Xianghong; Zhu, Zhenggang; Yu, Yingyan; Yu, Jun; Tost, Joerg; Brennan, Paul; Holcatova, Ivana; Zaridze, David; Brazma, Alvis; Egevad, Lars; Prokhortchouk, Egor; Banks, Rosamonde Elizabeth; Uhlen, Mathias; Viksna, Juris; Ponten, Fredrik; Skryabin, Konstantin; Birney, Ewan; Borg, Ake; Borresen-Dale, Anne-Lise; Caldas, Carlos; Foekens, John A.; Martin, Sancha; Reis-Filho, Jorge S.; Richardson, Andrea L.; Sotiriou, Christos; van't Veer, Laura; Birnbaum, Daniel; Blanche, Helene; Boucher, Pascal; Boyault, Sandrine; Masson-Jacquemier, Jocelyne D.; Pauporte, Iris; Pivot, Xavier; Vincent-Salomon, Anne; Tabone, Eric; Theillet, Charles; Treilleux, Isabelle; Bioulac-Sage, Paulette; Decaens, Thomas; Franco, Dominique; Gut, Marta; Samuel, Didier; Zucman-Rossi, Jessica; Eils, Roland; Brors, Benedikt; Korbel, Jan O.; Korshunov, Andrey; Landgraf, Pablo; Lehrach, Hans; Pfister, Stefan; Radlwimmer, Bernhard; Reifenberger, Guido; Taylor, Michael D.; von Kalle, Christof; Majumder, Partha P.; Pederzoli, Paolo; Lawlor, Rita T.; Delledonne, Massimo; Bardelli, Alberto; Gress, Thomas; Klimstra, David; Zamboni, Giuseppe; Nakamura, Yusuke; Miyano, Satoru; Fujimoto, Akihiro; Campo, Elias; de Sanjose, Silvia; Montserrat, Emili; Gonzalez-Diaz, Marcos; Jares, Pedro; Himmelbaue, Heinz; Bea, Silvia; Aparicio, Samuel; Easton, Douglas F.; Collins, Francis S.; Compton, Carolyn C.; Lander, Eric S.; Burke, Wylie; Green, Anthony R.; Hamilton, Stanley R.; Kallioniemi, Olli P.; Ley, Timothy J.; Liu, Edison T.; Wainwright, Brandon J.		Int Canc Genome Consortium	International network of cancer genome projects	NATURE			English	Article							SOMATIC MUTATIONS; MYELOID-LEUKEMIA; BREAST-CANCER; GENE; PATHWAYS; LANDSCAPES	The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumours from 50 different cancer types and/or subtypes that are of clinical and societal importance across the globe. Systematic studies of more than 25,000 cancer genomes at the genomic, epigenomic and transcriptomic levels will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies.	[Jennings, Jennifer L.; Boutros, Paul C.; Stein, Lincoln D.; Ouellette, B. F. Francis; McPherson, John D.; Kasprzyk, Arek; Zhang, Junjun; Wang, Jianxin; Yung, Christina K.; Cross, Anthony; Liang, Yong; Gnaneshan, Saravanamuttu; Guberman, Jonathan; Hsu, Jack; Muthuswamy, Lakshmi; Shazand, Kamran; Beck, Timothy; Sam, Michelle; Timms, Lee; Ballin, Vanessa] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Hudson, Thomas J.; Anderson, Warwick] Natl Hlth & Med Res Council, Canberra, ACT 2601, Australia; [Aretz, Axel] German Aerosp Ctr DLR, Project Management Agcy, D-53175 Bonn, Germany; [Barker, Anna D.; Gerhard, Daniela S.; Vockley, Joseph G.; Shaw, Kenna M.; Compton, Carolyn C.] NCI, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Bell, Cindy; Hasel, Karl W.] Genome Canada, Ottawa, ON K2P 1P1, Canada; [Bernabe, Rosa R.; Klatt, Peter] Minist Sci & Innovat, Secretariat State Res, Madrid 28027, Spain; [Bhan, M. K.; Rao, T. S.] Govt India, Minist Sci & Technol, Dept Biotechnol, New Delhi 110003, India; [Calvo, Fabien; Chabannon, Christian; Boucher, Pascal; Pauporte, Iris] Natl Canc Inst, F-92513 Boulogne, France; [Eerola, Iiro; Kolar, Patrik; Remacle, Jacques] European Commiss, Hlth Res Directorate, Genom & Syst Biol Unit, B-1049 Brussels, Belgium; [Guttmacher, Alan] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Guyer, Mark; Ozenberger, Brad; Peterson, Jane; Rodriguez, Laura Lyman] NHGRI, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Hemsley, Fiona M.; Lane, David P.] Canc Res UK, London WC2A 3PX, England; [Kerr, David] Qatar Fdn, Sidra Med & Res Ctr, Doha, Qatar; Univ Oxford, Dept Clin Pharmacol, Oxford OX2 6HE, England; [Kusuda, Jun; Masui, Tohru] Natl Inst Biomed Innovat, Osaka 5670085, Japan; [Laplace, Frank] Fed Minist Educ & Res, Div Mol Life Sci, D-11055 Berlin, Germany; [Lu, Youyong; Ji, Jiafu; Chen, Feng; Zhang, Lianhai; Xing, Xiaofang; Li, Xianghong] Peking Univ, Sch Oncol, Beijing Canc Inst & Hosp, Beijing 100142, Peoples R China; [Nettekoven, Gerd] German Canc Aid, D-53113 Bonn, Germany; [Schafer, Alan J.] Wellcome Trust Res Labs, London NW1 2BE, England; [Shibata, Tatsuhiro; Totoki, Yasushi; Yoshida, Teruhiko; Zaridze, David] Natl Canc Ctr, Chuo Ku, Tokyo 1040045, Japan; [Stratton, Michael R.; Dyke, Stephanie O. M.; Kennedy, Karen L.; Futreal, P. Andrew; Campbell, Peter J.; Ning, Zemin; Swerdlow, Harold; Hubbard, Tim J.; Teague, Jon W.; Martin, Sancha] Hinxton, Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Watanabe, Koichi] RIKEN, Yokohama Inst, Kanagawa, Japan; [Yang, Huanming; Guo, Guangwu; Jiang, Tao; Li, Qibin; Luo, Ruibang; Wu, Honglong; Zhao, Shancen; Zhou, Guangyu; Zhang, Xiuqing; Hu, Xueda; Yang, Qi; Tian, Geng] BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China; [Yuen, Matthew M. F.] Hong Kong Univ Sci & Technol, Hong Kong, Hong Kong, Peoples R China; [Knoppers, M.; Joly, Yann; Wallace, Susan; Knoppers, Bartha M.] McGill Univ, Ctr Genom & Policy, Montreal, PQ H3A 1A4, Canada; [Knoppers, M.; Wallace, Susan] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Bobrow, Martin] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Cambon-Thomsen, Anne; Rial-Sebbag, Emmanuelle] Fac Med Toulouse, INSERM, U558, F-31073 Toulouse, France; [Dressler, Lynn G.] Univ N Carolina, Sch Pharm, Div Pharmaceut Outcomes & Policy, Inst Pharmacogen & Individualized Therapy, Chapel Hill, NC 27599 USA; [Kato, Kazuto] Kyoto Univ, Grad Sch Biostudies, Inst Integrated Cell Mat Sci, Inst Res Humanities, Kyoto 6068501, Japan; [Nicolas, Pilar; Romeo-Casabona, Carlos M.] Univ Deusto, Interuniv Chair Law & Human Genome, Bizkaia 48007, Spain; [Parker, Michael J.] Univ Oxford, Ethox Ctr, Oxford OX3 7LF, England; [Wiesner, Georgia L.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Wiesner, Georgia L.] Univ Hosp Cleveland, Case Med Ctr, Ctr Human Genet, Cleveland, OH 44106 USA; St John God Pathol, Subiaco, WA 6008, Australia; Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Zeps, Nikolajs] Univ Western Australia, Sch Surg, Nedlands, WA 6009, Australia; [Lichter, Peter; Eils, Roland; Brors, Benedikt; Pfister, Stefan; Radlwimmer, Bernhard] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Biankin, Andrew V.; Johns, Amber L.; Kench, James G.; Sutherland, Robert L.] Univ New S Wales, Garvan Inst Med Res, Sydney, NSW 2010, Australia; Bankstown Hosp, Dept Surg, Sydney, NSW 2200, Australia; [Birnbaum, Daniel; Masson-Jacquemier, Jocelyne D.] Inst J Paoli I Calmettes, F-13273 Marseille, France; [Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Clement, Bruno] INSERM, U991, F-35043 Rennes, France; [de Alava, Enrique; Gonzalez-Diaz, Marcos] Univ Salamanca, Ctr Invest Canc, Univ Hosp, Dept Hematol, Salamanca 37007, Spain; [Degos, Francoise] Hop Beaujon, F-92110 Clichy, France; [Ferguson, Martin L.] MLF Consulting, Arlington, MA 02474 USA; [Geary, Peter] Canadian Tumour Repository Network, Winnipeg, MB R3M 0V5, Canada; [Hayes, D. Neil] Univ N Carolina, Div Med Oncol, Lineberger Comprehens Canc Ctr, Dept Internal Med, Chapel Hill, NC 27599 USA; [Nakagawa, Hidewaki; Tsunoda, Tatsuhiko; Nakamura, Yusuke; Fujimoto, Akihiro] RIKEN, Ctr Genom Med, Kanagawa 2300045, Japan; [Penny, Robert] Int Genom Consortium, Phoenix, AZ 85004 USA; [Piris, Miguel A.] Spanish Natl Canc Res Ctr, Mol Pathol Programme, Madrid 28029, Spain; [Sarin, Rajiv] Tata Mem Hosp, Adv Ctr Treatment, Res & Educ Canc, Navi Mumbai 41021, Maharashtra, India; [Scarpa, Aldo; Zamboni, Giuseppe] Univ Verona, Dept Pathol, I-37134 Verona, Italy; [Scarpa, Aldo; Lawlor, Rita T.] Verona Univ Hosp, Ctr Appl Res Canc ARC NET, I-37134 Verona, Italy; [van de Vijver, Marc; van't Veer, Laura] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [van de Vijver, Marc] Acad Med Ctr, NL-1015 AZ Amsterdam, Netherlands; [Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Bayes, Monica; Estivill, Xavier; Himmelbaue, Heinz] Pompeu Fabra Univ, Ctr Genom Regulat, Barcelona 08003, Spain; [Bayes, Monica] Biomed Res Ctr CIBERESP, Publ Hlth & Epidemiol Network, Barcelona 08003, Catalonia, Spain; [Bowtell, David D. L.; Etemadmoghadam, Dariush] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; [Etemadmoghadam, Dariush] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England; [Grimmond, Sean M.; Pearson, John V.; Cloonan, Nicole; Gardiner, Brooke A.; Waddell, Nicola J.] Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld 4067, Australia; [Gut, Ivo; Heath, Simon; Lathrop, Mark; Tost, Joerg] CEA, DSV, IG Ctr Natl Genotypage, F-91057 Evry, France; [Hirst, Martin; Marra, Marco; Jones, Steven M.] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Lopez-Otin, Carlos; Puente, Xose S.; Quesada, Victor] Univ Oviedo, Inst Univ Oncol, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Majumder, Partha; Majumder, Partha P.] Natl Inst Biomed Genom, Kalyani 741251, W Bengal, India; [McPherson, John D.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; [Ruan, Yijun; Liu, Edison T.] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore; [Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Velculescu, Victor E.] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [Wilson, Richard K.; Ley, Timothy J.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA; Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63108 USA; [Xue, Hong H.] HKUST, Appl Genom Ctr, Fok Ying Grad Sch, Hong Kong, Hong Kong, Peoples R China; [Xue, Hong H.] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Yang, Liu] Zhejiang Univ, Inst Canc, Hangzhou 310009, Zhejiang, Peoples R China; [Spellman, Paul T.] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94510 USA; [Bader, Gary D.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Bader, Gary D.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Flicek, Paul; Brazma, Alvis; Birney, Ewan; Korbel, Jan O.] Hinxton, European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Getz, Gad; Lander, Eric S.] MIT, Cambridge, MA 02142 USA; [Getz, Gad] Broad Inst Harvard, Cambridge, MA 02142 USA; [Guigo, Roderic] Univ Pompeu Fabra, Spanish Natl Bioinformat Inst, Barcelona 08003, Spain; Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona 08003, Spain; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Lopez-Bigas, Nuria] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona 08003, Spain; [Raphael, Benjamin J.] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA; [Raphael, Benjamin J.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Speed, Terence P.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Speed, Terence P.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Stuart, Joshua M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Valencia, Alfonso] Spanish Natl Canc Res Ctr CNIO, Spanish Natl Bioinformat Inst, Madrid 28029, Spain; [Valencia, Alfonso] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomputing Programme, Madrid 28029, Spain; [Wheeler, David A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Blanche, Helene; Gut, Marta] Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, F-75010 Paris, France; [Thomas, Gilles] Univ Lyon 1, F-69622 Villeurbanne, France; Fdn Synergie Lyon Canc, F-69008 Lyon, France; [Axton, Myles] Natl Genet, New York, NY 10013 USA; [Gunter, Chris] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Miller, Linda J.] Nat & Nat Res Journals, New York, NY 10013 USA; [Haider, Syed A.] Univ Cambridge, Comp Lab, Cambridge CB3 0FD, England; [Chalmers, Don R. C.] Univ Tasmania, Fac Law, Hobart, Tas 7001, Australia; [Kaan, Terry S. H.] Natl Univ Singapore, Fac Law, Singapore 259776, Singapore; [Lowrance, William W.] Consultant Hlth Res Eth & Policy, F-34280 La Grande Motte, France; [Vergely, Catherine] Inst Gustave Roussy, ISIS 39, F-94805 Villejuif, France; [Defazio, Anna] Westmead Hosp, Dept Gynaecol Oncol, Westmead, NSW 2145, Australia; [Defazio, Anna] Univ Sydney, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; [Eshleman, James R.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21231 USA; [Kench, James G.] Univ Sydney, Royal Prince Alfred Hosp, Dept Anat Pathol, Sydney, NSW 2050, Australia; [Tempero, Margaret A.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA; [Gallinger, Steve] Toronto Gen Hosp, Dept Gen Surg, Toronto, ON M5G 2C4, Canada; [Gallinger, Steve] Samuel Lunenfeld Res Inst, Toronto, ON M5S 1A1, Canada; [Tsao, Ming-Sound] Ontario Canc Inst, Univ Hlth Network, Toronto, ON M5G 2M9, Canada; [Tsao, Ming-Sound] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada; [Shaw, Patricia A.] Univ Hlth Network, Dept Pathol, Toronto, ON M5G 2C4, Canada; [Petersen, Gloria M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Mukhopadhyay, Debabrata] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med & Genet, Boston, MA 02115 USA; [Thayer, Sarah] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Zhu, Zhenggang; Yu, Yingyan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Shanghai 200025, Peoples R China; [Yu, Jun] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Holcatova, Ivana] Charles Univ Prague, Fac Med 1, Inst Hyg & Epidemiol, Prague 12108, Czech Republic; [Zaridze, David] NN Blokhin Russian Canc Res Ctr, Dept Epidemiol & Prevent, Moscow 115478, Russia; [Egevad, Lars] Karolinska Univ Hosp, Karolinska Inst, SE-17176 Stockholm, Sweden; [Prokhortchouk, Egor] Russian Acad Sci, Ctr Bioengn, Moscow 117312, Russia; [Banks, Rosamonde Elizabeth] St James Univ Hosp, Leeds Inst Mol Med, Canc Res UK Ctr, Leeds LS9 7TF, W Yorkshire, England; [Uhlen, Mathias] KTH Royal Inst Technol, Sci Life Lab, SE-10044 Stockholm, Sweden; [Viksna, Juris] Univ Latvia, Inst Math & Comp Sci, LV-1459 Riga, Latvia; [Ponten, Fredrik] Uppsala Univ, SE-75105 Uppsala, Sweden; [Skryabin, Konstantin] Kurchatov Sci Ctr, Moscow 123182, Russia; [Borg, Ake] Lund Univ, Dept Oncol, SE-22185 Lund, Sweden; [Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Radiumhosp, Inst Canc Res, N-0310 Oslo, Norway; [Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, N-0316 Oslo, Norway; [Caldas, Carlos] Univ Cambridge, Dept Oncol, Cambridge CB2 0RE, England; [Caldas, Carlos] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge CB2 0RE, England; [Foekens, John A.] Josephine Nefkens Inst, Erasmus MC Rotterdam, Dept Med Oncol, NL-3015 CE Rotterdam, Netherlands; [Foekens, John A.] Canc Genom Ctr, NL-3015 CE Rotterdam, Netherlands; [Reis-Filho, Jorge S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Richardson, Andrea L.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Boyault, Sandrine; Tabone, Eric; Treilleux, Isabelle] Ctr Leon Berard, F-69373 Lyon, France; [Sotiriou, Christos] Inst Jules Bordet, B-1000 Brussels, Belgium; [Pivot, Xavier] Hop Jean Minjoz, F-25030 Besancon, France; [Vincent-Salomon, Anne] Inst Curie, F-75231 Paris, France; [Theillet, Charles] Ctr Val Aurelle, F-34298 Montpellier, France; [Bioulac-Sage, Paulette] Hop Pellegrin, F-33076 Bordeaux, France; [Decaens, Thomas] Hop Henri Mondor, F-94010 Creteil, France; [Decaens, Thomas] INSERM, U955, F-94000 Creteil, France; [Franco, Dominique] Hop Antoine Beclere, F-92141 Clamart, France; [Samuel, Didier] Hop Paul Brousse, AP HP, Ctr Hepatobilaire, F-94800 Villejuif, France; [Samuel, Didier] INSERM, U785, F-94800 Villejuif, France; [Zucman-Rossi, Jessica] INSERM, U674, F-75010 Paris, France; [Eils, Roland] Heidelberg Univ, D-69120 Heidelberg, Germany; [Korbel, Jan O.] European Mol Biol Lab, Genome Biol Unit, D-69126 Heidelberg, Germany; [Korshunov, Andrey] Univ Heidelberg Hosp, Dept Neuropathol, D-69120 Heidelberg, Germany; [Landgraf, Pablo] Univ Dusseldorf, Clin Pediat Oncol Hematol & Immunol, D-40225 Dusseldorf, Germany; [Lehrach, Hans] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Pfister, Stefan] Univ Heidelberg Hosp, Dept Pediat Hematol & Oncol, D-69120 Heidelberg, Germany; [Reifenberger, Guido] Univ Dusseldorf, Inst Neuropathol, D-40001 Dusseldorf, Germany; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [von Kalle, Christof] Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [von Kalle, Christof] German Canc Res Ctr, Div Translat Oncol, D-69120 Heidelberg, Germany; [Pederzoli, Paolo] Univ Hosp Trust Verona, Dept Surg, I-37134 Verona, Italy; [Delledonne, Massimo] Univ Verona, Dept Biotechnol, Funct Genom Ctr, I-37134 Verona, Italy; [Bardelli, Alberto] Univ Torino, Inst Canc Res & Treatment, Mol Genet Lab, I-10060 Turin, Italy; [Bardelli, Alberto] FIRC Inst Mol Oncol, I-20139 Milan, Italy; [Gress, Thomas] Univ Marburg, Dept Gastroenterol Endocrinol Metab & Infectiol, D-35043 Marburg, Germany; [Klimstra, David] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Nakamura, Yusuke; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo 1088639, Japan; Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain; [Wilson, Peter J.; de Sanjose, Silvia] Hosp Llobregat, Inst Catala Oncol IDIBELL, Unit Infect & Canc,CIBER Epidemiol & Salud Publ, Canc Epidemiol Res Programme, Lhospitalet De Llobregat 08907, Spain; [Aparicio, Samuel] British Columbia Canc Agcy, BC Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Easton, Douglas F.] Univ Cambridge, Dept Primary Care & Oncol, Dept Publ Hlth, Cambridge CB1 8RN, England; [Collins, Francis S.] US Natl Inst Hlth, Bethesda, MD 20892 USA; [Burke, Wylie] Univ Washington, Dept Bioeth & Humanities, Seattle, WA 98195 USA; [Green, Anthony R.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England; [Green, Anthony R.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England; [Hamilton, Stanley R.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Kallioniemi, Olli P.] Univ Helsinki, Inst Mol Med Finland, FIN-00290 Helsinki, Finland; [Ley, Timothy J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Ley, Timothy J.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Wainwright, Brandon J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; Helmholtz Association; German Aerospace Centre (DLR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Department of Biotechnology (DBT) India; Institut National du Cancer (INCA) France; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Cancer Research UK; Qatar Foundation (QF); Sidra Medical & Research Center; University of Oxford; National Institute of Health Sciences - Japan; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking University; National Cancer Center - Japan; Wellcome Trust Sanger Institute; RIKEN; Beijing Genomics Institute (BGI); Hong Kong University of Science & Technology; McGill University; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); University of North Carolina; University of North Carolina Chapel Hill; Kyoto University; University of Deusto; University of Oxford; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; St John of God Health Care; University of Western Australia; University of Western Australia; Helmholtz Association; German Cancer Research Center (DKFZ); Garvan Institute of Medical Research; University of New South Wales Sydney; UNICANCER; Institut Paoli-Calmette (IPC); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; University of North Carolina; University of North Carolina Chapel Hill; RIKEN; International Genomics Consortium; Centro Nacional de Investigaciones Oncologicas (CNIO); Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; University of Verona; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Tokyo; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Peter Maccallum Cancer Center; University of Melbourne; University of Cambridge; University of Queensland; CEA; British Columbia Cancer Agency; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); University of Toronto; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Radboud University Nijmegen; Johns Hopkins University; Johns Hopkins Medicine; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Zhejiang University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Toronto; University of Toronto; European Molecular Biology Laboratory (EMBL); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Pompeu Fabra University; Brown University; Brown University; Memorial Sloan Kettering Cancer Center; Walter & Eliza Hall Institute; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Baylor College of Medicine; Baylor College of Medicine; Foundation Jean Dausset-CEPH; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; HudsonAlpha Institute for Biotechnology; University of Cambridge; University of Tasmania; National University of Singapore; UNICANCER; Gustave Roussy; University of Sydney; University of Sydney; Westmead Institute for Medical Research; Johns Hopkins University; Johns Hopkins Medicine; University of Sydney; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Mayo Clinic; Mayo Clinic; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Shanghai Jiao Tong University; Chinese University of Hong Kong; World Health Organization; International Agency for Research on Cancer (IARC); Charles University Prague; N.N. Blokhin Russian Cancer Research Center; Karolinska Institutet; Karolinska University Hospital; Research Center of Biotechnology RAS; Russian Academy of Sciences; Cancer Research UK; Saint James's University Hospital; University of Leeds; Royal Institute of Technology; University of Latvia; Uppsala University; National Research Centre - Kurchatov Institute; Lund University; University of Oslo; University of Oslo; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; Erasmus University Rotterdam; Erasmus MC; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; UNICANCER; Centre Leon Berard; Institut Jules Bordet; Universite de Franche-Comte; CHU Besancon; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Heinrich Heine University Dusseldorf; Max Planck Society; Ruprecht Karls University Heidelberg; Heinrich Heine University Dusseldorf; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Turin; IFOM - FIRC Institute of Molecular Oncology; Philipps University Marburg; Memorial Sloan Kettering Cancer Center; University of Tokyo; University of Barcelona; Hospital Clinic de Barcelona; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); British Columbia Cancer Agency; University of Cambridge; National Institutes of Health (NIH) - USA; University of Washington; University of Washington Seattle; University of Cambridge; University of Cambridge; University of Texas System; UTMD Anderson Cancer Center; University of Helsinki; Washington University (WUSTL); Washington University (WUSTL); University of Queensland	Hudson, TJ (corresponding author), Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada.	tom.hudson@oicr.on.ca	Chalmers, Don R/J-7658-2014; Zeps, Nikolajs/C-4180-2013; Tsao, Ming Sound/AFQ-7332-2022; Viksna, Juris/ABD-2482-2021; Cloonan, Nicole/B-5272-2008; Piris, Miguel A/B-7067-2008; IBSAL, Secretaría/H-3719-2011; Lopez-Bigas, Nuria/F-6193-2011; de Sanjosé Llongueras, Silvia/H-6339-2014; Campo, Elias/AAC-5593-2019; Brors, Benedikt/E-5620-2013; Yuen, Matthew M.F./E-5621-2011; Grimmond, Sean/K-3246-2019; Caldas, Carlos/U-7250-2019; Eils, Roland/B-6121-2009; Grimmond, Sean M/J-5304-2016; DeFazio, Anna/O-2385-2019; Korbel, Jan O/G-6470-2012; Stunnenberg, Hendrik G./D-6875-2012; Reifenberger, Guido/AAE-3599-2019; Velculescu, Victor/ABF-4846-2020; Radlwimmer, Bernhard F/I-3229-2013; Clement, Bruno/E-5546-2016; Sutherland, Robert L/A-8378-2008; Theillet, Charles/O-7634-2018; Zaridze, David/K-5605-2013; Gill, Anthony/D-4215-2015; Gasull, Martina/J-4076-2019; Sander, Chris/H-1452-2011; Marra, Marco A/B-5987-2008; Hirst, Martin/B-7684-2016; Pfister, Stefan M/F-6860-2013; yang, liu/GVU-8760-2022; Wheeler, David A/M-9740-2018; Delledonne, Massimo/O-8685-2017; Prokhortchouk, Egor/I-9108-2014; Gnaneshan, Saravanamuttu/D-2305-2012; Hubbard, Tim J/C-2567-2008; deFazio, Anna/D-3939-2013; Tuluc, Petronel/C-2527-2011; scarpa, aldo/K-6832-2016; Tsunoda, Tatsuhiko/K-2061-2014; Axton, Myles/AAZ-4093-2020; Uhlen, Mathias/AAV-8746-2021; Gunter, Chris/AHA-7271-2022; wei, jiang/GRX-7907-2022; Pearson, John/AAT-4211-2020; Speed, Terence P/B-8085-2009; Tsao, Ming-Sound/M-3503-2017; Ouellette, Francis/G-1684-2010; j, zucman-rossi/AAV-3594-2021; Estivill, Xavier/E-2957-2012; de Alava, Enrique/GOH-0368-2022; Waddell, Nicola/H-4929-2015; Pearson, John V/F-2249-2011; zucman-rossi, Jessica/B-5098-2009; Jones, Steven J/C-3621-2009; Guigo, Roderic/D-1303-2010; Giuseppe, Zamboni/L-6029-2019; Gut, Ivo/ABF-3188-2020; Gallinger, Steven/E-4575-2013; Caldas, Carlos/A-7543-2008; Shibata, Tatsuhiro/AAO-1278-2021; Gardiner, Brooke B/C-7773-2011; López-Otín, Carlos/AAB-2106-2020; Holcatova, Ivana/C-8327-2017; Yu, Jun/D-8569-2015; Kallioniemi, Olli P/H-5111-2011; Zeps, Nikolajs/AAF-3186-2021; Valencia, Alfonso/I-3127-2015; Liu, Edison/C-4141-2008; Uhlen, Mathias/B-3262-2016; McPherson, John D/D-2633-2017; Piris, Miguel A/AAP-1445-2020; Quesada, Víctor/B-6557-2014; Bowtell, David/H-1007-2016; Ning, Zemin/D-2411-2013; Estivill, Xavier/A-3125-2013; Wilson, Richard K./AAF-4139-2019; Tost, Joerg/H-7129-2019; bea, silvia/K-7699-2014; Decaens, Thomas/L-9483-2013; Heath, Simon C/J-4138-2012; IBIS, SARCOMAS/O-1893-2015; Shibata, Tatsuhiro/ABA-8234-2020; Puente, Xosé S./ADB-0672-2022; Hubbard, Tim J.P./AAT-4571-2020; Jares, Pedro/T-3778-2019; BARDELLI, Alberto/J-9721-2018; Bader, Gary/C-1176-2009	Chalmers, Don R/0000-0002-7925-8818; Zeps, Nikolajs/0000-0002-6404-6839; Tsao, Ming Sound/0000-0002-9160-5405; Cloonan, Nicole/0000-0001-7802-6647; Piris, Miguel A/0000-0001-5839-3634; Lopez-Bigas, Nuria/0000-0003-4925-8988; Campo, Elias/0000-0001-9850-9793; Brors, Benedikt/0000-0001-5940-3101; Yuen, Matthew M.F./0000-0002-6773-328X; Grimmond, Sean/0000-0002-8102-7998; Caldas, Carlos/0000-0003-3547-1489; Eils, Roland/0000-0002-0034-4036; Grimmond, Sean M/0000-0002-8102-7998; DeFazio, Anna/0000-0003-0057-4744; Korbel, Jan O/0000-0002-2798-3794; Stunnenberg, Hendrik G./0000-0002-0066-1576; Velculescu, Victor/0000-0003-1195-438X; Radlwimmer, Bernhard F/0000-0002-4553-7800; Clement, Bruno/0000-0001-8827-146X; Gill, Anthony/0000-0002-9447-1967; Sander, Chris/0000-0001-6059-6270; Marra, Marco A/0000-0001-7146-7175; Pfister, Stefan M/0000-0002-5447-5322; Wheeler, David A/0000-0002-9056-6299; Gnaneshan, Saravanamuttu/0000-0002-0455-8701; Hubbard, Tim J/0000-0002-1767-9318; deFazio, Anna/0000-0003-0057-4744; scarpa, aldo/0000-0003-1678-739X; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Axton, Myles/0000-0002-8042-4131; Speed, Terence P/0000-0002-5403-7998; j, zucman-rossi/0000-0002-5687-0334; de Alava, Enrique/0000-0001-8400-046X; Waddell, Nicola/0000-0002-3950-2476; Pearson, John V/0000-0003-0904-4598; zucman-rossi, Jessica/0000-0002-5687-0334; Jones, Steven J/0000-0003-3394-2208; Guigo, Roderic/0000-0002-5738-4477; Giuseppe, Zamboni/0000-0001-7428-4673; Gut, Ivo/0000-0001-7219-632X; Gardiner, Brooke B/0000-0003-3740-3244; López-Otín, Carlos/0000-0001-6964-1904; Holcatova, Ivana/0000-0002-1366-0337; Yu, Jun/0000-0001-5008-2153; Kallioniemi, Olli P/0000-0002-3231-0332; Zeps, Nikolajs/0000-0002-6404-6839; Valencia, Alfonso/0000-0002-8937-6789; Uhlen, Mathias/0000-0002-4858-8056; McPherson, John D/0000-0001-8049-9347; Piris, Miguel A/0000-0001-5839-3634; Quesada, Víctor/0000-0002-8398-3457; Bowtell, David/0000-0001-9089-7525; Estivill, Xavier/0000-0002-0723-2256; Wilson, Richard K./0000-0002-1992-1358; Tost, Joerg/0000-0002-2683-0817; bea, silvia/0000-0001-7192-2385; Decaens, Thomas/0000-0003-0928-0048; Heath, Simon C/0000-0002-9550-0897; Puente, Xosé S./0000-0001-9525-1483; Hubbard, Tim J.P./0000-0002-1767-9318; Xue, Hong/0000-0002-8133-9828; JI, JIAFU/0000-0001-6878-5543; Flicek, Paul/0000-0002-3897-7955; Swerdlow, Harold/0000-0002-9510-160X; Sarin, Rajiv/0000-0002-6405-8282; BARDELLI, Alberto/0000-0003-1647-5070; NICOLAS JIMENEZ, MARIA PILAR/0000-0003-4166-5941; Aparicio, Samuel/0000-0002-0487-9599; Birnbaum, Daniel/0000-0001-7920-9883; Hayes, D. Neil/0000-0001-6203-7771; Martin, Sancha/0000-0001-6213-5259; Stuart, Joshua/0000-0002-2171-565X; Biankin, Andrew/0000-0002-0362-5597; Birney, Ewan/0000-0001-8314-8497; JARES, PEDRO/0000-0002-8401-579X; calvo, fabien/0000-0002-0298-7633; Egevad, Lars/0000-0001-8531-222X; Banks, Rosamonde/0000-0002-0042-8715; Viksna, Juris/0000-0003-2283-2978; Taylor, Michael/0000-0001-7009-3466; Yung, Christina/0000-0003-2958-150X; Himmelbauer, Heinz/0000-0001-8897-2928; Kench, James Geoffrey/0000-0001-8687-4988; Gress, Thomas/0000-0002-9333-5461; Gunter, Chris/0000-0001-9369-7537; Bader, Gary/0000-0003-0185-8861; Brazma, Alvis/0000-0001-5988-7409; Anderson, Warwick Peter/0000-0002-7130-3530; Lane, David/0000-0003-0551-3545; Miyano, Satoru/0000-0002-1753-6616; Ning, Zemin/0000-0003-4359-776X; Beck, Timothy/0000-0003-0145-3557; Wainwright, Brandon/0000-0003-0406-2092; Ouellette, B. F. Francis/0000-0003-4676-675X; DePinho, Ronald/0000-0002-5625-577X; Theillet, Charles/0000-0001-5555-2759; Green, Anthony/0000-0002-9795-0218; Delledonne, Massimo/0000-0002-7100-4581; Kato, Kazuto/0000-0001-9006-9551; lawlor, Rita/0000-0003-3160-0634; Luo, Ruibang/0000-0001-9711-6533; Gonzalez Diaz, Marcos/0000-0001-6637-1072; Boutros, Paul/0000-0003-0553-7520	NCI NIH HHS [P50 CA102701-08, P01 CA117969-04S1, P01 CA117969-05, P50 CA127003, P50 CA127003-04, R21 CA094510, P01 CA117969, P50 CA102701, P50 CA127003-05] Funding Source: Medline; NHGRI NIH HHS [R01 HG001806-02] Funding Source: Medline; NIDDK NIH HHS [K08 DK071329, K08 DK071329-05, K08 DK071329-04] Funding Source: Medline; Wellcome Trust [093867, 077198, 088340] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA117969, P50CA127003, R21CA094510, P50CA102701] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK071329] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dickson D, 1999, NATURE, V401, P729, DOI 10.1038/44413; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; DRUKER BJ, 2001, NEW ENGL J MED, V344, P1037; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Toronto Int Data Release Workshop, 2009, NATURE, V461, P168, DOI 10.1038/461168a; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	35	1513	1537	7	359	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					993	998		10.1038/nature08987	http://dx.doi.org/10.1038/nature08987			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393554	Green Accepted, Bronze, Green Published, Green Submitted			2022-12-24	WOS:000276635000029
J	Thomson, JP; Skene, PJ; Selfridge, J; Clouaire, T; Guy, J; Webb, S; Kerr, ARW; Deaton, A; Andrews, R; James, KD; Turner, DJ; Illingworth, R; Bird, A				Thomson, John P.; Skene, Peter J.; Selfridge, Jim; Clouaire, Thomas; Guy, Jacky; Webb, Shaun; Kerr, Alastair R. W.; Deaton, Aimee; Andrews, Rob; James, Keith D.; Turner, Daniel J.; Illingworth, Robert; Bird, Adrian			CpG islands influence chromatin structure via the CpG-binding protein Cfp1	NATURE			English	Article							H3-LYS(4) METHYLTRANSFERASE COMPLEX; EMBRYONIC STEM-CELLS; DE-NOVO METHYLATION; DNA METHYLATION; HUMAN TRITHORAX; HISTONE H3; GENOME; MECP2; IDENTIFICATION; DOMAIN	CpG islands (CGIs) are prominent in the mammalian genome owing to their GC-rich base composition and high density of CpG dinucleotides(1,2). Most human gene promoters are embedded within CGIs that lack DNA methylation and coincide with sites of histone H3 lysine 4 trimethylation (H3K4me3), irrespective of transcriptional activity(3,4). In spite of these intriguing correlations, the functional significance of non-methylated CGI sequences with respect to chromatin structure and transcription is unknown. By performing a search for proteins that are common to all CGIs, here we show high enrichment for Cfp1, which selectively binds to nonmethylated CpGs in vitro(5,6). Chromatin immunoprecipitation of a mono-allelically methylated CGI confirmed that Cfp1 specifically associates with non-methylated CpG sites in vivo. High throughput sequencing of Cfp1-bound chromatin identified a notable concordance with non-methylated CGIs and sites of H3K4me3 in the mouse brain. Levels of H3K4me3 at CGIs were markedly reduced in Cfp1-depleted cells, consistent with the finding that Cfp1 associates with the H3K4 methyltransferase Setd1 (refs 7, 8). To test whether non-methylated CpG-dense sequences are sufficient to establish domains of H3K4me3, we analysed artificial CpG clusters that were integrated into the mouse genome. Despite the absence of promoters, the insertions recruited Cfp1 and created new peaks of H3K4me3. The data indicate that a primary function of non-methylated CGIs is to genetically influence the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.	[Thomson, John P.; Skene, Peter J.; Selfridge, Jim; Clouaire, Thomas; Guy, Jacky; Webb, Shaun; Kerr, Alastair R. W.; Deaton, Aimee; Illingworth, Robert; Bird, Adrian] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Andrews, Rob; James, Keith D.; Turner, Daniel J.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Edinburgh; Wellcome Trust Sanger Institute	Bird, A (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Michael Swann Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	a.bird@ed.ac.uk	CLOUAIRE, THOMAS/L-7396-2017; Kerr, Alastair/B-3272-2010	CLOUAIRE, THOMAS/0000-0003-3238-1496; Bird, Adrian/0000-0002-8600-0372; SELFRIDGE, JIM/0000-0003-2473-4386; Kerr, Alastair/0000-0001-9207-6050; Guy, Jacky/0000-0002-8440-5667; Illingworth, Rob/0000-0001-9275-1933; Deaton, Aimee/0000-0003-0365-3077	Cancer Research UK studentship; Wellcome Trust; Medical Research Council; European Union; Medical Research Council [G0800026] Funding Source: researchfish; MRC [G0800026] Funding Source: UKRI	Cancer Research UK studentship(Cancer Research UK); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to D. Skalnik for the gift of a Cfp1 antibody, I. Chambers for the T beta C44 ES cell line, R. Klose for discussions, E. Sheridan for testing the DNA sequencing protocol, and K. Auger and J. Parkhill for coordinating the DNA sequencing. We also thank R. Ekiert and J. Connelly for comments on the manuscript. This work was funded by a Cancer Research UK studentship to J. P. T. and by grants from the Wellcome Trust, the Medical Research Council and the European Union 'Epigenome' Network of Excellence.	Araki K, 1997, NUCLEIC ACIDS RES, V25, P868, DOI 10.1093/nar/25.4.868; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Klose RJ, 2004, J BIOL CHEM, V279, P46490, DOI 10.1074/jbc.M408284200; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee JH, 2002, J BIOL CHEM, V277, P42259, DOI 10.1074/jbc.M205054200; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Lorincz MC, 2001, MOL CELL BIOL, V21, P7913, DOI 10.1128/MCB.21.23.7913-7922.2001; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; McDonald LE, 1998, GENOMICS, V54, P379, DOI 10.1006/geno.1998.5570; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nan XS, 1996, MOL CELL BIOL, V16, P414; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592	33	464	469	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1082	U162		10.1038/nature08924	http://dx.doi.org/10.1038/nature08924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393567	Green Accepted			2022-12-24	WOS:000276635000047
J	Ishiyama, N; Lee, SH; Liu, S; Li, GY; Smith, MJ; Reichardt, LF; Ikura, M				Ishiyama, Noboru; Lee, Seung-Hye; Liu, Shuang; Li, Guang-Yao; Smith, Matthew J.; Reichardt, Louis F.; Ikura, Mitsuhiko			Dynamic and Static Interactions between p120 Catenin and E-Cadherin Regulate the Stability of Cell-Cell Adhesion	CELL			English	Article							TYROSINE-KINASE FER; BETA-CATENIN; CYTOPLASMIC DOMAIN; ALPHA-CATENIN; ADHERENS JUNCTIONS; ENDOTHELIAL-CELLS; DILEUCINE MOTIF; COMPLEX; P120-CATENIN; BINDING	The association of p120 catenin (p120) with the juxta-membrane domain (JMD) of the cadherin cytoplasmic tail is critical for the surface stability of cadherin-catenin cell-cell adhesion complexes. Here, we present the crystal structure of p120 isoform 4A in complex with the JMD core region (JMD(core)) of E-cadherin. The p120 armadillo repeat domain contains modular binding pockets that are complementary to electrostatic and hydrophobic properties of the JMD(core). Single-residue mutations within the JMD(core)-binding site of p120 abolished its interaction with E-and N-cadherins in vitro and in cultured cells. These mutations of p120 enabled us to clearly differentiate between N-cadherin-dependent and -independent steps of neuronal dendritic spine morphogenesis crucial for synapse development. NMR studies revealed that p120 regulates the stability of cadherin-mediated cell-cell adhesion by associating with the majority of the JMD, including residues implicated in clathrin-mediated endocytosis and Hakai-dependent ubiquitination of E-cadherin, through its discrete "dynamic" and "static" binding sites.	[Ishiyama, Noboru; Liu, Shuang; Li, Guang-Yao; Smith, Matthew J.; Ikura, Mitsuhiko] Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada; [Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Lee, Seung-Hye; Reichardt, Louis F.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of California System; University of California San Francisco	Ikura, M (corresponding author), Ontario Canc Inst, Div Signaling Biol, MaRS Toronto Med Discovery Tower,Room 4-804,101 C, Toronto, ON M5G 1L7, Canada.	mikura@uhnres.utoronto.ca	Smith, Matthew J/AAI-8060-2020	Smith, Matthew J/0000-0003-2896-9350; Ishiyama, Noboru/0000-0002-1426-6083	Canadian Cancer Society; Simons Foundation; Canadian Institutes of Health; Larry L. Hillblom Foundation	Canadian Cancer Society(Canadian Cancer Society (CCS)); Simons Foundation; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Larry L. Hillblom Foundation	We are grateful to M. Takeichi for valuable discussion and encouragement. We thank P. B. Stathopulos for assistance with circular dichroism spectroscopy and fluorescence microscopy and for critical reading of the manuscript. We thank S. Oliveri for assistance with crystallization. We are grateful to P. L. Howell and Y. Lobsanov for assistance with crystal screening. We are grateful to the staff of the APS beamline 19BM for help with data collection. We thank S. Ng for assistance with site-directed mutagenesis and biochemical experiments in 293T cells. This work was supported by the grants from the Canadian Cancer Society (M. I.) and the Simons Foundation (L. F. R.). N. I. is a recipient of a Canadian Institutes of Health Research postdoctoral fellowship. S.-H. L. was supported by a Larry L. Hillblom Foundation fellowship. M. I. holds a Canada Research Chair in Cancer Structural Biology.	Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Chen HY, 1997, J CELL SCI, V110, P345; Choi HJ, 2005, J MOL BIOL, V346, P367, DOI 10.1016/j.jmb.2004.11.048; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Lampugnani MG, 1997, J CELL SCI, V110, P2065; Lee SH, 2008, J CELL BIOL, V183, P893, DOI 10.1083/jcb.200807188; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Miyashita Y, 2007, J CELL SCI, V120, P4395, DOI 10.1242/jcs.03489; Miyashita Y, 2007, J BIOL CHEM, V282, P11540, DOI 10.1074/jbc.M608351200; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Myster SH, 2003, J CELL BIOL, V160, P433, DOI 10.1083/jcb.200211083; Nishimura T, 2009, CURR TOP DEV BIOL, V89, P33, DOI 10.1016/S0070-2153(09)89002-9; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peifer M, 2003, J CELL BIOL, V163, P437, DOI 10.1083/jcb.200310090; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; REYNOLDS AB, 1992, ONCOGENE, V7, P2439; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Thoreson MA, 2002, DIFFERENTIATION, V70, P583, DOI 10.1046/j.1432-0436.2002.700911.x; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xu G, 2004, J CELL SCI, V117, P3207, DOI 10.1242/jcs.01174; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, ANNU REV BIOCHEM, V76, P267, DOI 10.1146/annurev.biochem.75.103004.142811; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0	45	228	238	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					117	128		10.1016/j.cell.2010.01.017	http://dx.doi.org/10.1016/j.cell.2010.01.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371349	Bronze			2022-12-24	WOS:000276211100017
J	Red-Horse, K; Ueno, H; Weissman, IL; Krasnow, MA				Red-Horse, Kristy; Ueno, Hiroo; Weissman, Irving L.; Krasnow, Mark A.			Coronary arteries form by developmental reprogramming of venous cells	NATURE			English	Article							SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; SAPHENOUS-VEIN; GROWTH-FACTOR; HEART; ANGIOGENESIS; EMBRYO; MOUSE; SYSTEM; DIFFERENTIATION	Coronary artery disease is the leading cause of death worldwide. Determining the coronary artery developmental program could aid understanding of the disease and lead to new treatments, but many aspects of the process, including their developmental origin, remain obscure. Here we show, using histological and clonal analysis in mice and cardiac organ culture, that coronary vessels arise from angiogenic sprouts of the sinus venosus-the vein that returns blood to the embryonic heart. Sprouting venous endothelial cells dedifferentiate as they migrate over and invade the myocardium. Invading cells differentiate into arteries and capillaries; cells on the surface redifferentiate into veins. These results show that some differentiated venous cells retain developmental plasticity, and indicate that position-specific cardiac signals trigger their dedifferentiation and conversion into coronary arteries, capillaries and veins. Understanding this new reprogramming process and identifying the endogenous signals should suggest more natural ways of engineering coronary bypass grafts and revascularizing the heart.	[Red-Horse, Kristy; Krasnow, Mark A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Red-Horse, Kristy; Krasnow, Mark A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Ueno, Hiroo; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Krasnow, MA (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	krasnow@stanford.edu			National Institutes of Health [2T32HD007249]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007249] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999, U01HL099995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank T. Quertermous, L. Iruela-Arispe and S. M. Evans for mouse strains, Krasnow laboratory members for input and comments, especially M. Kumar for guidance on clonal analysis, and C. Breitweiser and M. Petersen for help preparing figures. K. R.-H. was supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award (2T32HD007249). M. A. K. is an investigator of the Howard Hughes Medical Institute.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Bennett HS, 1936, AM J ANAT, V60, P27, DOI 10.1002/aja.1000600103; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Goldman S, 2004, J AM COLL CARDIOL, V44, P2149, DOI 10.1016/j.jacc.2004.08.064; GRANT R. T., 1926, HEART, V13, P261; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; HIRUMA T, 1989, AM J ANAT, V184, P129, DOI 10.1002/aja.1001840204; HUTCHINS GM, 1988, CIRCULATION, V77, P1250, DOI 10.1161/01.CIR.77.6.1250; Kattan J, 2004, DEV DYNAM, V230, P34, DOI 10.1002/dvdy.20022; Kidoya H, 2008, EMBO J, V27, P522, DOI 10.1038/sj.emboj.7601982; Kirby M. L., 2007, CARDIAC DEV; Kudo FA, 2007, ARTERIOSCL THROM VAS, V27, P1562, DOI 10.1161/ATVBAHA.107.143032; Lavine KJ, 2008, DEVELOPMENT, V135, P3161, DOI 10.1242/dev.019919; Lavine KJ, 2006, GENE DEV, V20, P1651, DOI 10.1101/gad.1411406; Lavine KJ, 2009, CIRC RES, V104, P159, DOI 10.1161/CIRCRESAHA.108.191239; le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lewis FT, 1904, ANAT ANZEIGER, V25, P261; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Majesky MW, 2004, CURR TOP DEV BIOL, V62, P225; Manner J, 1999, ANAT RECORD, V255, P212; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Moyon D, 2001, DEVELOPMENT, V128, P3359; Othman-Hassan K, 2001, DEV BIOL, V237, P398, DOI 10.1006/dbio.2001.0383; Perez-Pomares JM, 2002, INT J DEV BIOL, V46, P1005; POELMANN RE, 1993, CIRC RES, V73, P559, DOI 10.1161/01.RES.73.3.559; Sabik JF, 2005, ANN THORAC SURG, V79, P544, DOI 10.1016/j.athoracsur.2004.07.047; Sheikh AY, 2008, AM J PHYSIOL-HEART C, V294, pH88, DOI 10.1152/ajpheart.00935.2007; Smart N, 2009, INT J EXP PATHOL, V90, P262, DOI 10.1111/j.1365-2613.2009.00646.x; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; World Health Organization, 2004, GLOB BURD DIS 2004 U; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	45	364	372	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					549	U100		10.1038/nature08873	http://dx.doi.org/10.1038/nature08873			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336138	Green Accepted			2022-12-24	WOS:000275974200039
J	Lee, JH; Durand, R; Gradinaru, V; Zhang, F; Goshen, I; Kim, DS; Fenno, LE; Ramakrishnan, C; Deisseroth, K				Lee, Jin Hyung; Durand, Remy; Gradinaru, Viviana; Zhang, Feng; Goshen, Inbal; Kim, Dae-Shik; Fenno, Lief E.; Ramakrishnan, Charu; Deisseroth, Karl			Global and local fMRI signals driven by neurons defined optogenetically by type and wiring	NATURE			English	Article							OPTICAL TECHNOLOGIES; NEURAL CIRCUITRY; CORTEX; INTERROGATION; PROJECTIONS; SYSTEMS; BOLD; RAT	Despite a rapidly-growing scientific and clinical brain imaging literature based on functional magnetic resonance imaging (fMRI) using blood oxygenation level-dependent (BOLD)(1) signals, it remains controversial whether BOLD signals in a particular region can be caused by activation of local excitatory neurons(2). This difficult question is central to the interpretation and utility of BOLD, with major significance for fMRI studies in basic research and clinical applications(3). Using a novel integrated technology unifying optogenetic(4-13) control of inputs with high-field fMRI signal readouts, we show here that specific stimulation of local CaMKII alpha-expressing excitatory neurons, either in the neocortex or thalamus, elicits positive BOLD signals at the stimulus location with classical kinetics. We also show that optogenetic fMRI (ofMRI) allows visualization of the causal effects of specific cell types defined not only by genetic identity and cell body location, but also by axonal projection target. Finally, we show that ofMRI within the living and intact mammalian brain reveals BOLD signals in downstream targets distant from the stimulus, indicating that this approach can be used to map the global effects of controlling a local cell population. In this respect, unlike both conventional fMRI studies based on correlations 14 and fMRI with electrical stimulation that will also directly drive afferent and nearby axons, this ofMRI approach provides causal information about the global circuits recruited by defined local neuronal activity patterns. Together these findings provide an empirical foundation for the widely-used fMRI BOLD signal, and the features of ofMRI define a potent tool that may be suitable for functional circuit analysis as well as global phenotyping of dysfunctional circuitry.	[Lee, Jin Hyung] Univ Calif Los Angeles, Dept Elect Engn Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Lee, Jin Hyung; Durand, Remy; Gradinaru, Viviana; Zhang, Feng; Goshen, Inbal; Fenno, Lief E.; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kim, Dae-Shik] Korea Adv Inst Sci & Technol, Dept Elect Engn, Taejon 305701, South Korea; [Kim, Dae-Shik] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	University of California System; University of California Los Angeles; Stanford University; Korea Advanced Institute of Science & Technology (KAIST); Boston University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Lee, JH (corresponding author), Univ Calif Los Angeles, Dept Elect Engn Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.	ljinhy@gmail.com; deissero@stanford.edu	Bullmore, Ed/C-1706-2012; Fenno, Lief/AAK-2924-2020; Fenno, Lief/AAF-9638-2019; Goshen, Inbal/GQI-2230-2022; Macrae, Rhiannon/AAX-1536-2020; Kim, Dae-Shik/C-2071-2011	Bullmore, Ed/0000-0002-8955-8283; Goshen, Inbal/0000-0001-7578-2615; Ramakrishnan, Charu/0000-0002-3474-6332	NIH [(K99/R00) 1K99EB008738]; NSF; SGF; SIGF; Deisseroth laboratory; Keck Foundation; Snyder Foundation; Woo Foundation; Yu Foundation; McKnight Foundation; Coulter Foundation; CIRM; NIMH; NIDA; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R00EB008738, K99EB008738] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); SGF; SIGF; Deisseroth laboratory; Keck Foundation(W.M. Keck Foundation); Snyder Foundation; Woo Foundation; Yu Foundation; McKnight Foundation; Coulter Foundation; CIRM(California Institute for Regenerative Medicine); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	J.H.L. is supported by NIH pathway to independence grant (K99/R00) 1K99EB008738. R. D. is supported by an NSF Graduate Research Fellowship. V. G. is supported by SGF and SIGF (Stanford Graduate Fellowships). We acknowledge G. H. Glover, J. M. Pauly and D. G. Nishimura for generous support and advice, and C. Pacharinsak for assistance with rat intubation. We would also like to thank the entire Deisseroth laboratory for discussions and support, and Lee laboratory students, V. Karasev, Z. Fang and C. Jones for help with histological quantification and fMRI data analysis. K. D. is supported by the Keck, Snyder, Woo, Yu, McKnight, and Coulter Foundations, as well as by CIRM, NIMH, NIDA and the NIH Director's Pioneer Award.	Alloway KD, 2008, J COMP NEUROL, V510, P100, DOI 10.1002/cne.21782; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Cohen JD, 2002, NEURON, V36, P193, DOI 10.1016/S0896-6273(02)00973-X; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Donahue MJ, 2006, MAGN RESON MED, V56, P1261, DOI 10.1002/mrm.21072; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; GLOVER GH, 1995, MAGNET RESON MED, V33, P624, DOI 10.1002/mrm.1910330507; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Kuramoto E, 2009, CEREB CORTEX, V19, P2065, DOI 10.1093/cercor/bhn231; Lauritzen M, 2005, NAT REV NEUROSCI, V6, P77, DOI 10.1038/nrn1589; Lee JH, 2003, MAGN RESON MED, V50, P1276, DOI 10.1002/mrm.10644; Lee JH, 2008, MAGN RESON MED, V59, P1099, DOI 10.1002/mrm.21576; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; Nir Y, 2008, NAT NEUROSCI, V11, P523, DOI 10.1038/nn0508-523; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Ugurbil K, 1999, PHILOS T R SOC B, V354, P1195, DOI 10.1098/rstb.1999.0474; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang Guang Lan, 2006, Immunome Res, V2, P3, DOI 10.1186/1745-7580-2-3	30	430	444	5	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					788	792		10.1038/nature09108	http://dx.doi.org/10.1038/nature09108			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20473285	Green Accepted			2022-12-24	WOS:000278551800047
J	Zachariah, MA; Cyster, JG				Zachariah, Marcus A.; Cyster, Jason G.			Neural Crest-Derived Pericytes Promote Egress of Mature Thymocytes at the Corticomedullary Junction	SCIENCE			English	Article							LYMPHOCYTE EGRESS; T-CELLS; LYMPHATIC VESSELS; THYMIC EMIGRATION; MOUSE THYMUS; BLOOD; MIGRATION; RETENTION; EMIGRANTS; S1P(1)	T cell egress from the thymus is essential for adaptive immunity, yet the requirements for and sites of egress are incompletely understood. We have shown that transgenic expression of sphingosine-1-phosphate receptor-1 (S1P1) in immature thymocytes leads to their perivascular accumulation and premature release into circulation. Using an intravascular procedure to label emigrating cells, we found that mature thymocytes exit via blood vessels at the corticomedullary junction. By deleting sphingosine kinases in neural crest-derived pericytes, we provide evidence that these specialized vessel-ensheathing cells contribute to the S1P that promotes thymic egress. Lymphatic endothelial cell-derived S1P was not required. These studies identify the major thymic egress route and suggest a role for pericytes in promoting reverse transmigration of cells across blood vessel endothelium.	[Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave,HSE1001, San Francisco, CA 94143 USA.	Jason.Cyster@ucsf.edu			UCSF; NIH [AI74847]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074847] Funding Source: NIH RePORTER	UCSF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Lingrel for making KLF2<SUP>f/f</SUP> mice available and K. Hogquist for sending these mice; S. Coughlin for Sphk1<SUP>f/-</SUP>2<SUP>-/-</SUP> mice; T. Nakayama for CD69<SUP>-/-</SUP>; B. Black for providing Wnt1-Cre mice; T. Pham, Y. Xu, and J. An for technical help; F. Schaufele of the Diabetes Endocrinology Research Center Imaging Core for help with the confocal microscope core; N. Killeen for help generating the S1P1 transgenic mice; and O. Bannard, S. Coughlin, M. Anderson, and A. Weiss for comments on the manuscript. M.A.Z. was supported by the UCSF Medical Scientist Training Program. J. G. C. is an investigator of the Howard Hughes Medical Institute. This work was supported in part by NIH grant AI74847.	BEARMAN RM, 1975, ANAT REC, V183, P485, DOI 10.1002/ar.1091830402; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chai Y, 2000, DEVELOPMENT, V127, P1671; Drumea-Mirancea M, 2006, J CELL SCI, V119, P1396, DOI 10.1242/jcs.02840; Foster K, 2008, J IMMUNOL, V180, P3183, DOI 10.4049/jimmunol.180.5.3183; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Ji RC, 2006, ANAT SCI INT, V81, P201, DOI 10.1111/j.1447-073x.2006.00145.x; Kato S, 1997, MICROSC RES TECHNIQ, V38, P287, DOI 10.1002/(SICI)1097-0029(19970801)38:3<287::AID-JEMT9>3.0.CO;2-J; KATO S, 1988, CELL TISSUE RES, V253, P181; Komatsu N, 2007, P NATL ACAD SCI USA, V104, P8959, DOI 10.1073/pnas.0702004104; KOTANI M, 1967, Okajimas Folia Anatomica Japonica, V43, P61; Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898; Kuwata N, 1999, J IMMUNOL, V163, P6355; Lauzurica P, 2000, BLOOD, V95, P2312, DOI 10.1182/blood.V95.7.2312.007k16_2312_2320; Le Borgne M, 2009, NAT IMMUNOL, V10, P823, DOI 10.1038/ni.1761; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; McGettrick HM, 2009, J LEUKOCYTE BIOL, V85, P98, DOI 10.1189/jlb.0508301; MIYASAKA M, 1990, THYMUS, V16, P29; Mori K, 2007, INT IMMUNOL, V19, P745, DOI 10.1093/intimm/dxm041; Muller SM, 2008, J IMMUNOL, V180, P5344, DOI 10.4049/jimmunol.180.8.5344; Murata K, 2003, INT IMMUNOL, V15, P987, DOI 10.1093/intimm/dxg102; Odaka C, 2006, CELL TISSUE RES, V325, P13, DOI 10.1007/s00441-005-0139-3; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; RAVIOLA E, 1972, J EXP MED, V136, P466, DOI 10.1084/jem.136.3.466; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; SAINTEMARIE G, 1964, BLOOD, V23, P275, DOI 10.1182/blood.V23.3.275.275; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; SMITH ME, 1983, IMMUNOLOGY, V49, P83; TORO I, 1967, J ULTRA MOL STRUCT R, V17, P439, DOI 10.1016/S0022-5320(67)80134-5; USHIKI T, 1986, CELL TISSUE RES, V244, P285; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Weinreich MA, 2008, J IMMUNOL, V181, P2265, DOI 10.4049/jimmunol.181.4.2265; Zachariah Marcus A, 2009, F1000 Biol Rep, V1, P60, DOI 10.3410/B1-60	40	151	158	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982					1129	1135		10.1126/science.1188222	http://dx.doi.org/10.1126/science.1188222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20413455	Green Accepted			2022-12-24	WOS:000278104700036
J	Wijeysundera, HC; Machado, M; Farahati, F; Wang, XS; Witteman, W; van der Velde, G; Tu, JV; Lee, DS; Goodman, SG; Petrella, R; O'Flaherty, M; Krahn, M; Capewell, S				Wijeysundera, Harindra C.; Machado, Marcio; Farahati, Farah; Wang, Xuesong; Witteman, William; van der Velde, Gabrielle; Tu, Jack V.; Lee, Douglas S.; Goodman, Shaun G.; Petrella, Robert; O'Flaherty, Martin; Krahn, Murray; Capewell, Simon			Association of Temporal Trends in Risk Factors and Treatment Uptake With Coronary Heart Disease Mortality, 1994-2005	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOCARDIAL-INFARCTION; VASCULAR MORTALITY; INDIVIDUAL DATA; BLOOD-PRESSURE; DECREASE; DECLINE; METAANALYSIS; DEATHS; RATES; AGE	Context Coronary heart disease (CHD) mortality has declined substantially in Canada since 1994. Objective To determine what proportion of this decline was associated with temporal trends in CHD risk factors and advancements in medical treatments. Design, Setting, and Patients Prospective analytic study of the Ontario, Canada, population aged 25 to 84 years between 1994 and 2005, using an updated version of the validated IMPACT model, which integrates data on population size, CHD mortality, risk factors, and treatment uptake changes. Relative risks and regression coefficients from the published literature quantified the relationship between CHD mortality and (1) evidence-based therapies in 8 distinct CHD subpopulations (acute myocardial infarction [AMI], acute coronary syndromes, secondary prevention post-AMI, chronic coronary artery disease, heart failure in the hospital vs in the community, and primary prevention for hyperlipidemia or hypertension) and (2) population trends in 6 risk factors (smoking, diabetes mellitus, systolic blood pressure, plasma cholesterol level, exercise, and obesity). Main Outcome Measures The number of deaths prevented or delayed in 2005; secondary outcome measures were improvements in medical treatments and trends in risk factors. Results Between 1994 and 2005, the age-adjusted CHD mortality rate in Ontario decreased by 35% from 191 to 125 deaths per 100 000 inhabitants, translating to an estimated 7585 fewer CHD deaths in 2005. Improvements in medical and surgical treatments were associated with 43% (range, 11% to 124%) of the total mortality decrease, most notably in AMI (8%; range, -5% to 40%), chronic stable coronary artery disease (17%; range, 7% to 35%), and heart failure occurring while in the community (10%; range, 6% to 31%). Trends in risk factors accounted for 3660 fewer CHD deaths prevented or delayed (48% of total; range, 28% to 64%), specifically, reductions in total cholesterol (23%; range, 10% to 33%) and systolic blood pressure (20%; range, 13% to 26%). Increasing diabetes prevalence and body mass index had an inverse relationship associated with higher CHD mortality of 6% (range, 4% to 8%) and 2% (range, 1% to 4%), respectively. Conclusion Between 1994 and 2005, there was a decrease in CHD mortality rates in Ontario that was associated primarily with trends in risk factors and improvements in medical treatments, each explaining about half of the decrease. JAMA. 2010;303(18):1841-1847 www.jama.com	[Wijeysundera, Harindra C.; Tu, Jack V.] Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Div Cardiol, Toronto, ON M4N 3M5, Canada; [Wijeysundera, Harindra C.; Machado, Marcio; Farahati, Farah; Witteman, William; van der Velde, Gabrielle; Krahn, Murray] Toronto Hlth Econ & Technol Assessment Collaborat, Toronto, ON, Canada; [Wijeysundera, Harindra C.; Lee, Douglas S.; Goodman, Shaun G.; Krahn, Murray] Univ Toronto, Dept Med, Toronto, ON, Canada; [Krahn, Murray] Univ Toronto, Fac Pharm, Toronto, ON, Canada; [Wang, Xuesong; Tu, Jack V.; Lee, Douglas S.] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [van der Velde, Gabrielle] Inst Work & Hlth, Toronto, ON, Canada; [Lee, Douglas S.; Krahn, Murray] Toronto Gen Hosp, Univ Hlth Network, Toronto, ON, Canada; [Goodman, Shaun G.] Toronto Gen Hosp, Univ Hlth Network, Toronto, ON, Canada; [Goodman, Shaun G.] St Michaels Hosp, Div Cardiol, Toronto, ON M5B 1W8, Canada; [Petrella, Robert] Univ Western Ontario, Dept Family Med, London, ON, Canada; [O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Div Publ Hlth, Liverpool L69 3BX, Merseyside, England	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; Institute for Work & Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Western University (University of Western Ontario); University of Liverpool	Wijeysundera, HC (corresponding author), 2075 Bayview Ave,Ste A209D, Toronto, ON M4N 3M5, Canada.	wijeysundera@gmail.com	Petrella, Robert J/G-6557-2018; Wijeysundera, Harindra/AAA-6058-2020	Krahn, Murray/0000-0001-5836-397X; Lee, Douglas/0000-0001-7078-745X; O'Flaherty, Martin/0000-0001-8944-4131; Wijeysundera, Harindra/0000-0001-8464-1080; Tu, Jack/0000-0003-0111-722X	Canadian Institute of Health Research [MOP 82747]; Canadian Institute of Health Research Team; Ministry of Health and Long-Term Care of Ontario; Tier 1 Canada Research Chair in Health Services Research; Heart and Stroke Foundation of Ontario; UK Medical Research Council; Medical Research Council [G0900847] Funding Source: researchfish; MRC [G0900847] Funding Source: UKRI	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institute of Health Research Team(Canadian Institutes of Health Research (CIHR)); Ministry of Health and Long-Term Care of Ontario(Ministry of Health and Long-Term Care, Ontario); Tier 1 Canada Research Chair in Health Services Research; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The analysis of this study was funded in part by operating grant MOP 82747 from the Canadian Institute of Health Research and a Canadian Institute of Health Research Team grant in cardiovascular outcomes research. The Toronto Health Economics and Technology Assessment Collaborative and the Institute for Clinical Evaluative Sciences are funded in part by the Ministry of Health and Long-Term Care of Ontario. Dr Wijeysundera is supported by a research fellowship award from the Canadian Institute of Health Research. Dr van der Velde is supported by a postdoctoral fellowship and a Bisby award provided by the Canadian Institute of Health Research. Dr Tu is supported by a Tier 1 Canada Research Chair in Health Services Research and a career investigator award from the Heart and Stroke Foundation of Ontario. Dr Lee is supported by a Clinician Scientist Award from Canadian Institute of Health Research. Dr O'Flaherty was partly funded by the UK Medical Research Council. Dr Krahn holds the F. Norman Hughes Chair in Pharmacoeconomics at the Faculty of Pharmacy, University of Toronto.	Bennett K, 2006, J EPIDEMIOL COMMUN H, V60, P322, DOI 10.1136/jech.2005.038638; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; Capewell S, 2008, HEART, V94, P1105, DOI 10.1136/hrt.2008.149930; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; Nichol G, 1999, ACAD EMERG MED, V6, P95, DOI 10.1111/j.1553-2712.1999.tb01044.x; Palmieri L, 2010, AM J PUBLIC HEALTH, V100, P684, DOI 10.2105/AJPH.2008.147173; *POL RES DIV STRAT, EC BURD ILLN CAN 199; Rodriguez T, 2006, HEART, V92, P453, DOI 10.1136/hrt.2004.059295; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; World Health Organization, GLOB BURD COR HEART; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	17	204	213	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2010	303	18					1841	1847		10.1001/jama.2010.580	http://dx.doi.org/10.1001/jama.2010.580			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594DK	20460623	Bronze			2022-12-24	WOS:000277513900025
J	Sarwar, N; Sandhu, MS; Ricketts, SL; Butterworth, AS; Di Angelantonio, E; Boelcholdt, SM; Ouwehand, W; Watkins, H; Samani, NJ; Saleheen, D; Lawlor, D; Reilly, MP; Hingorani, AD; Talmud, PJ; Danesh, J; Braund, PS; Hall, AS; Thompson, J; Marz, W; Sivapalaratnam, S; Soranzo, N; Trip, M; Casas, JP; Ebrahim, S; Arsenault, BJ; Boekholdt, SM; Khaw, KT; Wareham, NJ; Grallert, H; Illig, T; Humphries, SE; Rader, DJ; He, J; Clarke, R; Hamsten, R; Hopewell, JC; Frossard, P; Deloukas, P; Ye, S; Simpson, JA; Onat, A; Komurcu-Bayrak, E; Martinelli, N; Olivieri, O; Girelli, D; Kivimaki, M; Kumari, M; Aouizerat, BE; Baum, L; Campos, H; Chaaba, R; Chen, BS; Cho, EY; Evans, D; Hill, J; Hsu, LA; Hubacek, JA; Lai, CQ; Lee, JH; Klos, K; Liu, H; Masana, L; Melegh, B; Nabika, T; Ribalta, J; Ruiz-Narvaez, E; Thomas, GN; Tomlinson, B; Szalai, C; Vaverkova, H; Yamada, Y; Yang, Y; Tipping, RW; Ford, CE; Pressel, SL; Ballantyne, C; Brautbar, A; Knuiman, M; Winchup, PH; Wannamethee, SG; Morris, RW; Kiechl, S; Willeit, J; Santer, P; Mayr, A; Wald, N; Yarnell, JWG; Gallacher, J; Casiglia, E; Tikhonoff, V; Cushman, M; Psaty, BM; Tracy, RP; Tybjaerg-Hansen, A; Nordestgaard, BG; Benn, M; Frikke-Schmidt, R; Giampaoli, S; Palmieri, L; Panico, S; Vanuzzo, D; Pilotto, L; de la Camara, AG; Gomez-Gerique, JA; Simons, L; McCallum, J; Friedlander, Y; Fowkes, FGR; Lee, AJ; Taylor, J; Guralnik, JM; Phillips, CL; Wallace, WR; Blazer, DG; Brenner, H; Raum, E; Muller, H; Rothenbacher, D; Jansson, JH; Wennberg, P; Nissinen, A; Donfrancesco, C; Salomaa, V; Harald, K; Pencina, MJ; Vartiainen, E; D'Agostino, RB; Vasan, RS; Bladbjerg, EM; Jorgensen, T; Moller, L; Jespersen, J; Dankner, R; Chetrit, A; Lubin, F; Bjorkelund, C; Lissner, L; Bengtsson, C; Cremer, P; Nagel, D; Rodriguez, B; Dekker, JM; Nijpels, G; Stehouwer, CDA; Sato, S; Iso, H; Kitamura, A; Noda, H; Salonen, JT; Nyssonen, K; Tuimainen, TP; Voutilainen, S; Meade, TW; Cooper, JA; Kuller, LH; Grandits, G; Gillum, R; Mussolino, M; Rimm, E; Hankinson, S; Manson, JAE; Pai, JK; Bauer, KA; Naito, Y; Amouyel, P; Arveiler, D; Evans, A; Ferrieres, J; Schulte, H; Assmann, G; Packard, CJ; Sattar, N; Westendorp, RG; Buckley, BM; Cantin, B; Lamarche, B; Despres, JP; Dagenais, GR; Barrett-Connor, E; Wingard, DL; Bettencourt, R; Gudnason, V; Aspelund, T; Sigurdsson, G; Thorsson, B; Trevisan, M; Tunstall-Pedoe, H; Tavendale, R; Lowe, GDO; Woodward, M; Howard, BV; Zhang, Y; Best, L; Umans, J; Ben-Shlomo, Y; Davey-Smith, G; Njolstad, I; Mathiesen, EB; Lochen, ML; Wilsgaard, T; Ingelsson, E; Lind, I; Giedraitis, V; Michaelsson, K; Brunner, E; Shipley, M; Ridker, P; Buring, J; Shepherd, J; Cobbe, SM; Ford, I; Robertson, M; Ibanez, AM; Feskens, EJM; Kromhout, D; Walker, M; Watson, S; Collins, R; Kaptoge, S; Perry, PL; Sarwar, N; Thompson, A; Thompson, SG; White, IR; Wood, AM				Sarwar, Nadeem; Sandhu, Manjinder S.; Ricketts, Sally L.; Butterworth, Adam S.; Di Angelantonio, Emanuele; Boelcholdt, S. Matthijs; Ouwehand, Willem; Watkins, Hugh; Samani, Nilesh J.; Saleheen, Danish; Lawlor, Debbie; Reilly, Muredach P.; Hingorani, Aroon D.; Talmud, Philippa J.; Danesh, John; Braund, P. S.; Hall, A. S.; Thompson, J.; Marz, W.; Sivapalaratnam, S.; Soranzo, N.; Trip, M.; Casas, J. P.; Ebrahim, S.; Arsenault, B. J.; Boekholdt, S. M.; Khaw, K. T.; Wareham, N. J.; Grallert, H.; Illig, T.; Humphries, S. E.; Rader, D. J.; He, J.; Clarke, R.; Hamsten, R.; Hopewell, J. C.; Frossard, P.; Deloukas, P.; Ye, S.; Simpson, J. A.; Onat, A.; Komurcu-Bayrak, E.; Martinelli, N.; Olivieri, O.; Girelli, D.; Kivimaki, M.; Kumari, M.; Aouizerat, B. E.; Baum, L.; Campos, H.; Chaaba, R.; Chen, B. S.; Cho, E. Y.; Evans, D.; Hill, J.; Hsu, L. A.; Hubacek, J. A.; Lai, C. Q.; Lee, J. H.; Klos, K.; Liu, H.; Masana, L.; Melegh, B.; Nabika, T.; Ribalta, J.; Ruiz-Narvaez, E.; Thomas, G. N.; Tomlinson, B.; Szalai, C.; Vaverkova, H.; Yamada, Y.; Yang, Y.; Tipping, R. W.; Ford, C. E.; Pressel, S. L.; Ballantyne, C.; Brautbar, A.; Knuiman, M.; Winchup, P. H.; Wannamethee, S. G.; Morris, R. W.; Kiechl, S.; Willeit, J.; Santer, P.; Mayr, A.; Wald, N.; Yarnell, J. W. G.; Gallacher, J.; Casiglia, E.; Tikhonoff, V.; Cushman, M.; Psaty, B. M.; Tracy, R. P.; Tybjaerg-Hansen, A.; Nordestgaard, B. G.; Benn, M.; Frikke-Schmidt, R.; Giampaoli, S.; Palmieri, L.; Panico, S.; Vanuzzo, D.; Pilotto, L.; Gomez de la Camara, A.; Gomez-Gerique, J. A.; Simons, L.; McCallum, J.; Friedlander, Y.; Fowkes, F. G. R.; Lee, A. J.; Taylor, J.; Guralnik, J. M.; Phillips, C. L.; Wallace, W. R.; Blazer, D. G.; Brenner, H.; Raum, E.; Mueller, H.; Rothenbacher, D.; Jansson, J. H.; Wennberg, P.; Nissinen, A.; Donfrancesco, C.; Salomaa, V.; Harald, K.; Pencina, M. J.; Vartiainen, E.; D'Agostino, R. B.; Vasan, R. S.; Bladbjerg, E. M.; Jorgensen, T.; Moller, L.; Jespersen, J.; Dankner, R.; Chetrit, A.; Lubin, F.; Bjoerkelund, C.; Lissner, L.; Bengtsson, C.; Cremer, P.; Nagel, D.; Rodriguez, B.; Dekker, J. M.; Nijpels, G.; Stehouwer, C. D. A.; Sato, S.; Iso, H.; Kitamura, A.; Noda, H.; Salonen, J. T.; Nyssoenen, K.; Tuimainen, T. -P.; Voutilainen, S.; Meade, T. W.; Cooper, J. A.; Kuller, L. H.; Grandits, G.; Gillum, R.; Mussolino, M.; Rimm, E.; Hankinson, S.; Manson, J. A. E.; Pai, J. K.; Bauer, K. A.; Naito, Y.; Amouyel, P.; Arveiler, D.; Evans, A.; Ferrieres, J.; Schulte, H.; Assmann, G.; Packard, C. J.; Sattar, N.; Westendorp, R. G.; Buckley, B. M.; Cantin, B.; Lamarche, B.; Despres, J. -P.; Dagenais, G. R.; Barrett-Connor, E.; Wingard, D. L.; Bettencourt, R.; Gudnason, V.; Aspelund, T.; Sigurdsson, G.; Thorsson, B.; Trevisan, M.; Tunstall-Pedoe, H.; Tavendale, R.; Lowe, G. D. O.; Woodward, M.; Howard, B. V.; Zhang, Y.; Best, L.; Umans, J.; Ben-Shlomo, Y.; Davey-Smith, G.; Njolstad, I.; Mathiesen, E. B.; Lochen, M. L.; Wilsgaard, T.; Ingelsson, E.; Lind, I.; Giedraitis, V.; Michaeelsson, K.; Brunner, E.; Shipley, M.; Ridker, P.; Buring, J.; Shepherd, J.; Cobbe, S. M.; Ford, I.; Robertson, M.; Marin Ibanez, A.; Feskens, E. J. M.; Kromhout, D.; Walker, M.; Watson, S.; Collins, R.; Kaptoge, S.; Perry, P. L.; Sarwar, N.; Thompson, A.; Thompson, S. G.; White, I. R.; Wood, A. M.		Triglyceride Coronary Dis Genetics	Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies	LANCET			English	Article							APOLIPOPROTEIN-A-V; HEART-DISEASE; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; RICH LIPOPROTEINS; RISK; ASSOCIATION; RECEPTOR; SNP; MEN	Background Whether triglyceride-mediated pathways are causally relevant to coronary heart disease is uncertain. We studied a genetic variant that regulates triglyceride concentration to help judge likelihood of causality. Methods We assessed the -1131T>C (rs662799) promoter polymorphism of the apolipoprotein A5 (APOA5) gene in relation to triglyceride concentration, several other risk factors, and risk of coronary heart disease. We compared disease risk for genetically-raised triglyceride concentration (20 842 patients with coronary heart disease, 35 206 controls) with that recorded for equivalent differences in circulating triglyceride concentration in prospective studies (302 430 participants with no history of cardiovascular disease; 12 785 incident cases of coronary heart disease during 2.79 million person-years at risk). We analysed -1131T>C in 1795 people without a history of cardiovascular disease who had information about lipoprotein concentration and diameter obtained by nuclear magnetic resonance spectroscopy. Findings The minor allele frequency of -1131T>C was 8% (95% CI 7-9). -1131T>C was not significantly associated with several non-lipid risk factors or LDL cholesterol, and it was modestly associated with lower HDL cholesterol (mean difference per C allele 3.5% [95% CI 2.6-4.6]; 0.053 mmol/L [0.039-0.068]), lower apolipoprotein AI (1.3% [0.3-2.3]; 0.023 g/L [0.005-0.041]), and higher apolipoprotein B (3.2% [1.3-5.1]; 0.027 g/L [0.011-0.043]). By contrast, for every C allele inherited, mean triglyceride concentration was 16.0% (95% CI 12.9-18.7), or 0.25 mmol/L (0.20-0.29), higher (p=4.4x10(-24)). The odds ratio for coronary heart disease was 1.18 (95% CI 1.11-1.26; p=2.6x10(-7)) per C allele, which was concordant with the hazard ratio of 1.10 (95% CI 1.08-1.12) per 16% higher triglyceride concentration recorded in prospective studies. -1131T>C was significantly associated with higher VLDL particle concentration (mean difference per C allele 12.2 nmol/L [95% CI 7.7-16.7]; p=9.3x10(-8)) and smaller HDL particle size (0.14 nm [0.08-0.20]; p=7.0x10(-5)), factors that could mediate the effects of triglyceride. Interpretation These data are consistent with a causal association between triglyceride-mediated pathways and coronary heart disease.	[Sarwar, Nadeem] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Worts Causeway, Cambridge CB1 8RN, England; [Boelcholdt, S. Matthijs] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Watkins, Hugh] Univ Oxford, Oxford, England; [Samani, Nilesh J.] Univ Leicester, Leicester, Leics, England; [Lawlor, Debbie] Univ Bristol, Bristol, Avon, England; [Reilly, Muredach P.] Univ Penn, Philadelphia, PA 19104 USA; [Hingorani, Aroon D.; Talmud, Philippa J.] UCL, London, England	University of Cambridge; University of Amsterdam; Academic Medical Center Amsterdam; University of Oxford; University of Leicester; University of Bristol; University of Pennsylvania; University of London; University College London	Sarwar, N (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Worts Causeway, Cambridge CB1 8RN, England.	nadeem.sarwar@phpc.cam.ac.uk	Feskens, Edith JM/A-3757-2012; Dankner, Rachel/Q-5245-2019; Aspelund, Thor/C-5983-2008; Knuiman, Matthew W/I-5549-2013; Girelli, Domenico/B-1183-2008; Benn, Marianne/O-4164-2019; Thomas, G. Neil/A-1879-2013; Ye, Shu/C-4067-2009; Aspelund, Thor/F-4826-2011; de la Camara, Agustin Gomez/S-7123-2018; Watson, Stephen P/Q-6292-2016; Gudnason, Vilmundur/K-6885-2015; Brunner, Eric/H-2114-2011; DiAngelantonio, Emanuele/ABE-6852-2020; Ford, Ian/ABE-6145-2020; Tomlinson, Brian/AAD-9404-2019; Hall, Alistair/K-1953-2019; Njolstad, Inger/X-3784-2019; Boekholdt, Matthijs S.M./G-7562-2014; Nordestgaard, Borge Gronne/ABF-1310-2020; MASANA, LUIS/M-7002-2019; Deloukas, Panos/B-2922-2013; Tikhonoff, Valerie/AAC-3728-2019; Blazer, Dan G/D-6675-2012; Olivieri, Oliviero/A-9126-2008; Kivimaki, Mika/B-3607-2012; Grallert, Harald/B-3424-2013; Lamarche, Benoit/ABA-4785-2021; Stehouwer, Coen/AAB-3435-2021; Tomlinson, Brian/P-5365-2015; Ballantyne, Christie/A-6599-2008; Kromhout, Daan/A-8566-2014; Aspelund, Thor/K-7022-2019; Gudnason, Vilmundur/AAE-7126-2019; He, Jing/E-5316-2012; Komurcu Bayrak, Evrim/B-2271-2014; PALMIERI, LUIGI/O-1845-2017; Feskens, Edith/ABI-1446-2020; Ramachandran, Vasan/Y-2527-2019; Brenner, Hermann/ABE-6383-2020; Hubacek, Jaroslav Alois/AAN-6134-2021; Ribalta, Josep/AAD-4859-2020; Ye, Shu/R-6384-2017; Davey Smith, George/A-7407-2013; Khaw, Kay-Tee/AAZ-3209-2021; Lennon, Lucy/ABB-9433-2020; Woodward, Mark/L-6817-2017; Michaelsson, Karl/AAM-9094-2021; donfrancesco, chiara/K-1460-2016; Ferrieres, Jean/S-7993-2016	Dankner, Rachel/0000-0001-6454-6000; Aspelund, Thor/0000-0002-7998-5433; Girelli, Domenico/0000-0001-9684-1899; Benn, Marianne/0000-0002-1701-595X; Thomas, G. Neil/0000-0002-2777-1847; Watson, Stephen P/0000-0002-7846-7423; Gudnason, Vilmundur/0000-0001-5696-0084; Brunner, Eric/0000-0002-0595-4474; Tomlinson, Brian/0000-0001-6717-5444; MASANA, LUIS/0000-0002-0789-4954; Deloukas, Panos/0000-0001-9251-070X; Tikhonoff, Valerie/0000-0001-7846-0101; Olivieri, Oliviero/0000-0001-8209-9056; Kivimaki, Mika/0000-0002-4699-5627; Lamarche, Benoit/0000-0002-4443-5378; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Komurcu Bayrak, Evrim/0000-0003-1271-1208; PALMIERI, LUIGI/0000-0002-4298-2642; Feskens, Edith/0000-0001-5819-2488; Ramachandran, Vasan/0000-0001-7357-5970; Brenner, Hermann/0000-0002-6129-1572; Hubacek, Jaroslav Alois/0000-0001-6537-1353; Ribalta, Josep/0000-0002-8879-4719; Ye, Shu/0000-0002-4126-4278; Davey Smith, George/0000-0002-1407-8314; Lennon, Lucy/0000-0002-1738-1351; Morris, Richard/0000-0001-7240-4563; Lawlor, Debbie A/0000-0002-6793-2262; Humphries, Stephen E/0000-0002-8221-6547; Lai, Chao-Qiang/0000-0003-1107-8375; Boekholdt, Matthijs/0000-0002-0861-0765; Butterworth, Adam/0000-0002-6915-9015; Ricketts, Sally/0000-0002-5644-7958; Kumari, Meena/0000-0001-9716-1035; s, hema/0000-0002-3440-9475; Nordestgaard, Borge/0000-0002-1954-7220; Michaelsson, Karl/0000-0003-2815-1217; Ballantyne, Christie/0000-0002-6432-1730; Whincup, Peter/0000-0002-5589-4107; Hopewell, Jemma/0000-0002-3870-8018; Jespersen, Jorgen/0000-0002-3059-2356; Ouwehand, Willem/0000-0002-7744-1790; Amouyel, Philippe/0000-0001-9088-234X; Gomez de la Camara, Agustin/0000-0001-6827-6319; Lochen, Maja-Lisa/0000-0002-8532-6573; Hingorani, Aroon/0000-0001-8365-0081; Di Angelantonio, Emanuele/0000-0001-8776-6719; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Bladbjerg, Else Marie/0000-0003-0912-2437; donfrancesco, chiara/0000-0002-8040-5571; Hsu, Lung-An/0000-0002-0012-2804; Reilly, Muredach/0000-0002-3035-9386; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Hall, Alistair/0000-0003-0306-7887; Stehouwer, Coen/0000-0001-8752-3223; Woodward, Mark/0000-0001-9800-5296; Cushman, Mary/0000-0002-7871-6143; Watkins, Hugh/0000-0002-5287-9016; Talmud, Philippa/0000-0002-5560-1933; Ferrieres, Jean/0000-0001-6144-1297; Rothenbacher, Dietrich/0000-0002-3563-2791; Jorgensen, Torben/0000-0001-9453-2830; Ruiz-Narvaez, Edward/0000-0002-0339-5824	British Heart Foundation; UK Medical Research Council; Novartis; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [MC_U137686857, G0701863, MC_U105260792, G0801566, G0501792] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067, RG/08/008/25291, RG/08/013/25942] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [MC_U105260792, G0801566, G0401527, G0600705, MC_U137686857, G0501792, G0701863] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novartis(Novartis); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The coordinating centre was supported by the British Heart Foundation, the UK Medical Research Council, and Novartis. A variety of sources have supported investigators, recruitment, follow-up, and laboratory measurements in the studies contributing to this report. Investigators of several of these studies have contributed to a list naming some of these funding sources, which can be found at http://www.phpc.cam.ac.uk/ceu/. S Shah assisted with provision of tabular data.	Ansell BJ, 2007, CURR OPIN LIPIDOL, V18, P427, DOI 10.1097/MOL.0b013e3282364a17; Barter P, 2008, AM J CARDIOL, V102, P1040, DOI 10.1016/j.amjcard.2008.05.056; Brunzell JD, 2007, NEW ENGL J MED, V357, P1009, DOI 10.1056/NEJMcp070061; Cardona F, 2009, ATHEROSCLEROSIS, V206, P148, DOI 10.1016/j.atherosclerosis.2009.02.024; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Dichlberger A, 2007, J LIPID RES, V48, P1451, DOI 10.1194/jlr.C600026-JLR200; El Harchaoui K, 2007, J AM COLL CARDIOL, V49, P547, DOI 10.1016/j.jacc.2006.09.043; *EM RISK FACT COLL, INT J EPIDE IN PRESS; Gaddi A, 2007, VASC HEALTH RISK MAN, V3, P877; Garg A, 2007, J CLIN ENDOCR METAB, V92, P1581, DOI 10.1210/jc.2007-0275; Ginsberg HN, 2002, CIRCULATION, V106, P2137, DOI 10.1161/01.CIR.0000035280.64322.31; Hegele RA, 2007, ARTERIOSCL THROM VAS, V27, P1224, DOI 10.1161/ATVBAHA.107.144980; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hubacek JA, 2009, PHARMACOGENOMICS, V10, P945, DOI 10.2217/PGS.09.17; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P572, DOI 10.1097/MOL.0b013e328312707c; Joy TR, 2008, NAT CLIN PRACT CARD, V5, P506, DOI 10.1038/ncpcardio1251; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Ladenson PW, 2010, NEW ENGL J MED, V362, P906, DOI 10.1056/NEJMoa0905633; Matsuda D, 2007, CURR OPIN INVEST DR, V8, P836; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Nilsson SK, 2008, J BIOL CHEM, V283, P25920, DOI 10.1074/jbc.M802721200; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Packard CJ, 2003, BIOCHEM SOC T, V31, P1066; Palmen J, 2008, BBA-MOL BASIS DIS, V1782, P447, DOI 10.1016/j.bbadis.2008.03.003; PHILLIPS AN, 1991, J CLIN EPIDEMIOL, V44, P1223, DOI 10.1016/0895-4356(91)90155-3; Preiss D, 2009, CLIN ENDOCRINOL, V70, P815, DOI 10.1111/j.1365-2265.2008.03490.x; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Sarwar N, 2009, CURR OPIN LIPIDOL, V20, P275, DOI 10.1097/MOL.0b013e32832dd4dc; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; SMITH GD, 2008, ANN MED, V12, P524; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Wong K, 2007, CURR OPIN LIPIDOL, V18, P319, DOI 10.1097/MOL.0b013e328133856c; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530	36	517	524	1	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2010	375	9726					1634	1639						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597CX	20452521	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000277734700029
J	Poteryaev, D; Datta, S; Ackema, K; Zerial, M; Spang, A				Poteryaev, Dmitry; Datta, Sunando; Ackema, Karin; Zerial, Marino; Spang, Anne			Identification of the Switch in Early-to-Late Endosome Transition	CELL			English	Article							CAENORHABDITIS-ELEGANS; YEAST; PROTEINS; COMPLEX; RABEX-5; SPECIFICITY; ENDOCYTOSIS; MATURATION; CASCADE; VPS21	Sequential transport from early to late endosomes requires the coordinated activities of the small GTPases Rab5 and Rab7. The transition between early and late endosomes could be mediated either through transport carriers or by Rab conversion, a process in which the loss of Rab5 from an endosome occurs concomitantly to the acquisition of Rab7. We demonstrate that Rab conversion is the mechanism by which proteins pass from early to late endosomes in Caenorhabditis elegans coelomocytes. Moreover, we identified SAND-1/Mon1 as the critical switch for Rab conversion in metazoa. SAND-1 serves a dual role in this process. First, it interrupts the positive feedback loop of RAB-5 activation by displacing RABX-5 from endosomal membranes; second, it times the recruitment of RAB-7, probably through interaction with the HOPS complex to the same membranes. SAND-1/Mon1 thus acts as a switch by controlling the localization of RAB-5 and RAB-7 GEFs.	[Poteryaev, Dmitry; Ackema, Karin; Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Datta, Sunando; Zerial, Marino] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of Basel; Max Planck Society	Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	anne.spang@unibas.ch	Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019	Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203; Poteryaev, Dmitry/0000-0003-2695-8869	University Basel; Swiss National Science Foundation; Max Planck Society	University Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank H. Fares, N. Andrews, and J. Hegemann for reagents and I.G. Macara and M. Labouesse for critical reading of the manuscript. L. Bermudo and I. G. Macara are acknowledged for fruitful discussions, and B. Grant is thanked for providing information about the RABX-5 ORF. This work was supported by the University Basel, the Swiss National Science Foundation (A.S.), and the Max Planck Society (M.Z.).	Allan RB, 1999, SCIENCE, V285, P63, DOI 10.1126/science.285.5424.63; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; BRENNER S, 1974, GENETICS, V77, P71; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; de Wit H, 2001, MOL BIOL CELL, V12, P3703, DOI 10.1091/mbc.12.11.3703; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Gerrard SR, 2000, MOL BIOL CELL, V11, P613, DOI 10.1091/mbc.11.2.613; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Golemis E A, 1997, Methods Mol Biol, V63, P197; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Mattera R, 2008, EMBO J, V27, P2484, DOI 10.1038/emboj.2008.177; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Poteryaev D, 2005, BIOCHEM SOC T, V33, P606, DOI 10.1042/BST0330606; Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Spang A, 2009, BIOL CHEM, V390, P753, DOI 10.1515/BC.2009.056; STENMARK H, 1994, EMBO J, V13, P575, DOI 10.1002/j.1460-2075.1994.tb06295.x; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wang CW, 2002, J BIOL CHEM, V277, P47917, DOI 10.1074/jbc.M208191200; Xiao QF, 2009, ELECTRON J LINEAR AL, V18, P21; Zhang YH, 2001, MOL BIOL CELL, V12, P2011, DOI 10.1091/mbc.12.7.2011; Zhu HP, 2007, MOL BIOL CELL, V18, P4119, DOI 10.1091/mbc.E07-02-0100	32	449	469	2	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					497	508		10.1016/j.cell.2010.03.011	http://dx.doi.org/10.1016/j.cell.2010.03.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434987	Bronze			2022-12-24	WOS:000277180800020
J	Buonocore, S; Ahern, PP; Uhlig, HH; Ivanov, II; Littman, DR; Maloy, KJ; Powrie, F				Buonocore, Sofia; Ahern, Philip P.; Uhlig, Holm H.; Ivanov, Ivaylo I.; Littman, Dan R.; Maloy, Kevin J.; Powrie, Fiona			Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology	NATURE			English	Article							ROR-GAMMA-T; DIFFERENTIATION; MUCOSAL; IL-23; MICE; POPULATIONS	The key role of interleukin (IL)-23 in the pathogenesis of autoimmune and chronic inflammatory disorders is supported by the identification of IL-23 receptor (IL-23R) susceptibility alleles associated with inflammatory bowel disease, psoriasis and ankylosing spondylitis. IL-23-driven inflammation has primarily been linked to the actions of T-helper type 17 (T(H)17) cells(1). Somewhat overlooked, IL-23 also has inflammatory effects on innate immune cells(2) and can drive T-cell-independent colitis. However, the downstream cellular and molecular pathways involved in this innate intestinal inflammatory response are poorly characterized. Here we show that bacteria-driven innate colitis is associated with an increased production of IL-17 and interferon-gamma in the colon. Stimulation of colonic leukocytes with IL-23 induced the production of IL-17 and interferon-gamma exclusively by innate lymphoid cells expressing Thy1, stem cell antigen 1 (SCA-1), retinoic-acid-related orphan receptor (ROR)-gamma t and IL-23R, and these cells markedly accumulated in the inflamed colon. IL-23-responsive innate intestinal cells are also a feature of T-cell-dependent models of colitis. The transcription factor ROR-gamma t, which controls IL-23R expression, has a functional role, because Rag(-/-) Rorc(-/-) mice failed to develop innate colitis. Last, depletion of Thy1(+) innate lymphoid cells completely abrogated acute and chronic innate colitis. These results identify a previously unrecognized IL-23-responsive innate lymphoid population that mediates intestinal immune pathology and may therefore represent a target in inflammatory bowel disease.	[Buonocore, Sofia; Ahern, Philip P.; Maloy, Kevin J.; Powrie, Fiona] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Powrie, Fiona] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Translat Gastroenterol Unit, Oxford OX3 9DU, England; [Uhlig, Holm H.] Univ Childrens Hosp, D-04317 Leipzig, Germany; [Ivanov, Ivaylo I.; Littman, Dan R.] NYU, Sch Med, Kimmel Ctr Biol & Med,Skirball Inst, Mol Pathogenesis Program,Howard Hughes Med Inst, New York, NY 10016 USA	University of Oxford; University of Oxford; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Howard Hughes Medical Institute; New York University	Powrie, F (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	kevin.maloy@path.ox.ac.uk; fiona.powrie@path.ox.ac.uk		Maloy, Kevin/0000-0001-5795-7688; Uhlig, Holm/0000-0002-6111-7355	Wellcome Trust; Marie-Curie Network [MRTN-CT2004-006532]; Philippe Wiener-Maurice Anspach; European Crohn's & Colitis Organisation (ECCO); European Commission [223151]; Howard Hughes Medical Institute Exchange Programme; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK085329] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Marie-Curie Network(European Commission); Philippe Wiener-Maurice Anspach; European Crohn's & Colitis Organisation (ECCO); European Commission(European CommissionEuropean Commission Joint Research Centre); Howard Hughes Medical Institute Exchange Programme; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Rust for cell sorting; R. Stillion and M. Ziegler for histology; J. Langhorne for providing the AN18 hybridoma; S. Cobbold and H. Waldmann for the gift of the depleting anti-Thy1 and isotype control antibodies; UCB Celltech for providing the blocking anti-IL-17 and isotype control antibodies; O. Boulard and S. Kirchberger for technical assistance; and C. Arancibia for critically reading the manuscript. This work was supported by the Wellcome Trust (F. P. and K. J. M.), the Marie-Curie Network fellowship (IMDEMI, MRTN-CT2004-006532) (S. B., P. A.), the Philippe Wiener-Maurice Anspach foundation (S. B.), European Crohn's & Colitis Organisation (ECCO) (S. B.), the European Commission research programme INFLA-CARE (EC contract no. 223151) (S. B. and P. A.) and a Wellcome Trust and Howard Hughes Medical Institute Exchange Programme grant (P. A., F. P. and D. R. L.).	Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Finke D, 2005, CURR OPIN IMMUNOL, V17, P144, DOI 10.1016/j.coi.2005.01.006; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaiserling E, 2001, LYMPHOLOGY, V34, P22; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Marchesi F, 2009, MUCOSAL IMMUNOL, V2, P486, DOI 10.1038/mi.2009.113; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Yeung MMW, 2000, GUT, V47, P215, DOI 10.1136/gut.47.2.215; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	27	822	872	0	106	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1371	1375		10.1038/nature08949	http://dx.doi.org/10.1038/nature08949			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20393462	Green Accepted			2022-12-24	WOS:000277149000051
J	Rivkin, AS; Emery, JP				Rivkin, Andrew S.; Emery, Joshua P.			Detection of ice and organics on an asteroidal surface	NATURE			English	Article							OPTICAL-CONSTANTS; SPECTROSCOPY; SPECTROGRAPH; TELESCOPE; MODEL; BELT; SPEX	Recent observations, including the discovery(1) in typical asteroidal orbits of objects with cometary characteristics (main-belt comets, or MBCs), have blurred the line between comets and asteroids, although so far neither ice nor organic material has been detected on the surface of an asteroid or directly proven to be an asteroidal constituent. Here we report the spectroscopic detection of water ice and organic material on the asteroid 24 Themis, a detection that has been independently confirmed(2). 24 Themis belongs to the same dynamical family as three of the five known MBCs, and the presence of ice on 24 Themis is strong evidence that it also is present in the MBCs. We conclude that water ice is more common on asteroids than was previously thought and may be widespread in asteroidal interiors at much smaller heliocentric distances than was previously expected.	[Rivkin, Andrew S.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Emery, Joshua P.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Tennessee System; University of Tennessee Knoxville	Rivkin, AS (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	andy.rivkin@jhuapl.edu	Rivkin, Andrew S/B-7744-2016	Rivkin, Andrew S/0000-0002-9939-9976	NASA	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by the NASA Planetary Astronomy programme. A.S.R. is a visiting astronomer at the IRTF, which is operated by the University of Hawaii under cooperative agreement no. NNX-08AE38A with NASA, Science Mission Directorate, Planetary Astronomy programme. All the observations used in this publication were obtained at the IRTF. We would like to thank the telescope operators of the IRTF for their efforts.	Cohen BA, 2000, ICARUS, V145, P369, DOI 10.1006/icar.2000.6329; COLANGELI L, 1992, ASTROPHYS J, V396, P369, DOI 10.1086/171723; Cushing MC, 2004, PUBL ASTRON SOC PAC, V116, P362, DOI 10.1086/382907; DORSCHNER J, 1995, ASTRON ASTROPHYS, V300, P503; Emery JP, 2006, ICARUS, V182, P496, DOI 10.1016/j.icarus.2006.01.011; Hsieh HH, 2006, SCIENCE, V312, P561, DOI 10.1126/science.1125150; JONES TD, 1988, THESIS U ARIZONA; KHARE BN, 1993, ICARUS, V103, P290, DOI 10.1006/icar.1993.1071; LEBOFSKY LA, 1986, ICARUS, V68, P239, DOI 10.1016/0019-1035(86)90021-7; Mastrapa RM, 2009, ASTROPHYS J, V701, P1347, DOI 10.1088/0004-637X/701/2/1347; Moroz LV, 1998, ICARUS, V134, P253, DOI 10.1006/icar.1998.5955; Rayner JT, 2003, PUBL ASTRON SOC PAC, V115, P362, DOI 10.1086/367745; Schorghofer N, 2008, ASTROPHYS J, V682, P697, DOI 10.1086/588633; Shkuratov Y, 1999, ICARUS, V137, P235, DOI 10.1006/icar.1998.6035	14	238	240	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 29	2010	464	7293					1322	1323		10.1038/nature09028	http://dx.doi.org/10.1038/nature09028			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428165				2022-12-24	WOS:000277149000040
J	Han, ZF; Niu, TH; Chang, JB; Lei, XG; Zhao, MY; Wang, Q; Cheng, W; Wang, JJ; Feng, Y; Chai, JJ				Han, Zhifu; Niu, Tianhui; Chang, Junbiao; Lei, Xiaoguang; Zhao, Mingyan; Wang, Qiang; Cheng, Wei; Wang, Jinjing; Feng, Yi; Chai, Jijie			Crystal structure of the FTO protein reveals basis for its substrate specificity	NATURE			English	Article							URACIL-DNA GLYCOSYLASE; REPAIR ENZYME ALKB; OXIDATIVE DEMETHYLATION; ESCHERICHIA-COLI; ALKYLATION DAMAGE; ADULT OBESITY; RNA; GENE; METHYLATION; MITOCHONDRIAL	Recent studies(1-5) have unequivocally associated the fat mass and obesity-associated (FTO) gene with the risk of obesity. In vitro FTO protein is an AlkB-like DNA/RNA demethylase with a strong preference for 3-methylthymidine (3-meT) in single-stranded DNA or 3-methyluracil (3-meU) in single-stranded RNA(6-8). Here we report the crystal structure of FTO in complex with the mononucleotide 3-meT. FTO comprises an amino-terminal AlkB-like domain and a carboxy-terminal domain with a novel fold. Biochemical assays show that these two domains interact with each other, which is required for FTO catalytic activity. In contrast with the structures of other AlkB members, FTO possesses an extra loop covering one side of the conserved jelly-roll motif. Structural comparison shows that this loop selectively competes with the unmethylated strand of the DNA duplex for binding to FTO, suggesting that it has an important role in FTO selection against double-stranded nucleic acids. The ability of FTO to distinguish 3-meT or 3-meU from other nucleotides is conferred by its hydrogen-bonding interaction with the two carbonyl oxygen atoms in 3-meT or 3-meU. Taken together, these results provide a structural basis for understanding FTO substrate-specificity, and serve as a foundation for the rational design of FTO inhibitors.	[Han, Zhifu; Niu, Tianhui; Lei, Xiaoguang; Zhao, Mingyan; Cheng, Wei; Wang, Jinjing; Feng, Yi; Chai, Jijie] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Niu, Tianhui] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Chang, Junbiao; Wang, Qiang] Zhengzhou Univ, Dept Chem, Zhengzhou 450001, Peoples R China; [Lei, Xiaoguang] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China; [Chai, Jijie] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China	National Institute of Biological Sciences, Beijing; China Agricultural University; Zhengzhou University; Tianjin University; Tsinghua University	Chai, JJ (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd, Beijing 102206, Peoples R China.	chaijijie@nibs.ac.cn	chang, junbiao/P-1095-2014	chang, junbiao/0000-0001-6236-1256; Chai, Jijie/0000-0001-7591-3873; Wang, Qiang/0000-0002-7366-5674	Chinese Ministry of Science and Technology [2008AA022305, 2006CB806704, 2008AA022317]; National Natural Science Foundation of China [30825043]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Y. Yamada at Photon Factory of Japan for assistance with data collection. This research was funded by Chinese Ministry of Science and Technology '863' grant no. 2008AA022305 and '973' grant no. 2006CB806704 to J. Chai, '863' grant no. 2008AA022317 to X. L. and the National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China grant no. 30825043 to J. Chang.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Fan JS, 2003, NUCLEIC ACIDS RES, V31, P769, DOI 10.1093/nar/gkg144; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; KLAGSBRUN M, 1973, J BIOL CHEM, V248, P2606; Koivisto P, 2003, J BIOL CHEM, V278, P44348, DOI 10.1074/jbc.M307361200; Meyre D, 2010, DIABETES, V59, P311, DOI 10.2337/db09-0703; Micura R, 2001, NUCLEIC ACIDS RES, V29, P3997, DOI 10.1093/nar/29.19.3997; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; NEGRE D, 1989, P NATL ACAD SCI USA, V86, P4902, DOI 10.1073/pnas.86.13.4902; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Sundheim O, 2008, DNA REPAIR, V7, P1916, DOI 10.1016/j.dnarep.2008.07.015; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Yu B, 2009, P NATL ACAD SCI USA, V106, P14315, DOI 10.1073/pnas.0812938106	30	272	287	7	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1205	U129		10.1038/nature08921	http://dx.doi.org/10.1038/nature08921			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20376003				2022-12-24	WOS:000276891100040
J	Stuart, SN; Wilson, EO; McNeely, JA; Mittermeier, RA; Rodriguez, JP				Stuart, S. N.; Wilson, E. O.; McNeely, J. A.; Mittermeier, R. A.; Rodriguez, J. P.			The Barometer of Life	SCIENCE			English	Editorial Material							IUCN RED LIST		[Stuart, S. N.] IUCN, Species Survival Commiss, CH-1196 Gland, Switzerland; [Stuart, S. N.] UN Environm Program, World Conservat Monitoring Ctr, Al Ain, U Arab Emirates; [Stuart, S. N.] Univ Bath, Dept Chem & Biol Chem, Bath BA2 7AY, Avon, England; [Wilson, E. O.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Mittermeier, R. A.] Conservat Int, Arlington, VA 22202 USA; [Rodriguez, J. P.] Inst Venezolano Invest Cient, Ctr Ecol, Caracas 1020A, Venezuela; [Rodriguez, J. P.] Provita, Caracas 1040A, Venezuela	United Nations Environment Programme; University of Bath; Harvard University; Conservation International; Venezuelan Institute Science Research	Stuart, SN (corresponding author), IUCN, Species Survival Commiss, CH-1196 Gland, Switzerland.	simon.stuart@iucn.org	Rodriguez, Jon P/G-7224-2012; Rodriguez, Jon P/A-1491-2009	Rodriguez, Jon P/0000-0001-5019-2870				BISBY FA, 2009, CATALOGUE LIFE 2009; CHAPMAN AD, 2009, NUMBERS LIVING SPECI; Mace G., 2005, ECOSYSTEMS HUMAN WEL, V1, P77; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodriguez Jon Paul, 2008, Endangered Species Research, V6, P193, DOI 10.3354/esr006193; Vie J-C, 2009, WILDLIFE CHANGING WO; VIE JC, COMMUNICATION; Wheeler QD, 2004, SCIENCE, V303, P285, DOI 10.1126/science.303.5656.285; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; ZAMIN TJ, CONSERV BIO IN PRESS	10	110	117	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2010	328	5975					177	177		10.1126/science.1188606	http://dx.doi.org/10.1126/science.1188606			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20378803				2022-12-24	WOS:000276459600027
J	Sigurdsson, T; Stark, KL; Karayiorgou, M; Gogos, JA; Gordon, JA				Sigurdsson, Torfi; Stark, Kimberly L.; Karayiorgou, Maria; Gogos, Joseph A.; Gordon, Joshua A.			Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia	NATURE			English	Article							22Q11 DELETION SYNDROME; FUNCTIONAL CONNECTIVITY; WORKING-MEMORY; DEFICITS; CONTRIBUTES; MECHANISMS; CHILDREN; CORTEX; RISK	Abnormalities in functional connectivity between brain areas have been postulated as an important pathophysiological mechanism underlying schizophrenia(1,2). In particular, macroscopic measurements of brain activity in patients suggest that functional connectivity between the frontal and temporal lobes may be altered(3,4). However, it remains unclear whether such dysconnectivity relates to the aetiology of the illness, and how it is manifested in the activity of neural circuits. Because schizophrenia has a strong genetic component(5), animal models of genetic risk factors are likely to aid our understanding of the pathogenesis and pathophysiology of the disease. Here we study Df(16)A(+/-) mice, which model a microdeletion on human chromosome 22 (22q11.2) that constitutes one of the largest known genetic risk factors for schizophrenia(6). To examine functional connectivity in these mice, we measured the synchronization of neural activity between the hippocampus and the prefrontal cortex during the performance of a task requiring working memory, which is one of the cognitive functions disrupted in the disease. In wild-type mice, hippocampal-prefrontal synchrony increased during working memory performance, consistent with previous reports in rats(7). Df(16)A(+/-) mice, which are impaired in the acquisition of the task, showed drastically reduced synchrony, measured both by phase-locking of prefrontal cells to hippocampal theta oscillations and by coherence of prefrontal and hippocampal local field potentials. Furthermore, the magnitude of hippocampal-prefrontal coherence at the onset of training could be used to predict the time it took the Df(16)A(+/-) mice to learn the task and increased more slowly during task acquisition. These data suggest how the deficits in functional connectivity observed in patients with schizophrenia may be realized at the single-neuron level. Our findings further suggest that impaired long-range synchrony of neural activity is one consequence of the 22q11.2 deletion and may be a fundamental component of the pathophysiology underlying schizophrenia.	[Sigurdsson, Torfi; Stark, Kimberly L.; Karayiorgou, Maria; Gordon, Joshua A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Stark, Kimberly L.; Gogos, Joseph A.] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Gogos, Joseph A.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Karayiorgou, Maria; Gordon, Joshua A.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Gordon, JA (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA.	jag90@columbia.edu; jg343@columbia.edu	Gordon, Joshua A/E-6778-2012	Gordon, Joshua A/0000-0002-5488-8266	Simons Foundation; US National Institute of Mental Health [MH67068, MH081968]; Lieber Center for Schizophrenia Research and Treatment; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067068, R01MH081968] Funding Source: NIH RePORTER	Simons Foundation; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lieber Center for Schizophrenia Research and Treatment; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank M. Topiwala, A. Adhikari and Y. Sun for technical assistance. We also thank A. Adhikari, L. Drew and A. Arguello for comments on the manuscript. This work was supported by the Simons Foundation (J. A. Gogos), US National Institute of Mental Health grants MH67068 (M. K. and J. A. Gogos) and MH081968 (J. A. Gordon), and the Lieber Center for Schizophrenia Research and Treatment.	Bertolino A, 2006, BIOL PSYCHIAT, V60, P1250, DOI 10.1016/j.biopsych.2006.03.078; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Floresco SB, 1997, J NEUROSCI, V17, P1880; Forbes NF, 2009, PSYCHOL MED, V39, P889, DOI 10.1017/S0033291708004558; Ford JM, 2002, BIOL PSYCHIAT, V51, P485, DOI 10.1016/S0006-3223(01)01335-X; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Karayiorgou M, 2004, MOL BRAIN RES, V132, P95, DOI 10.1016/j.molbrainres.2004.09.029; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kates WR, 2007, NEUROPSYCHOLOGIA, V45, P2863, DOI 10.1016/j.neuropsychologia.2007.05.007; Kelly RC, 2007, J NEUROSCI, V27, P261, DOI 10.1523/JNEUROSCI.4906-06.2007; Lawrie SM, 2002, BIOL PSYCHIAT, V51, P1008, DOI 10.1016/S0006-3223(02)01316-1; Lewandowski KE, 2007, AM J MED GENET B, V144B, P27, DOI 10.1002/ajmg.b.30379; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Raux G, 2007, HUM MOL GENET, V16, P83, DOI 10.1093/hmg/ddl443; Schroll S, 2005, REGUL PEPTIDES, V131, P1, DOI 10.1016/j.regpep.2005.03.001; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sobin C, 2005, CHILD NEUROPSYCHOL, V11, P39, DOI 10.1080/09297040590911167; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; WERNICKE C, 1906, GRUNDRISSE PSYCHIAT; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yavich L, 2007, J NEUROSCI, V27, P10196, DOI 10.1523/JNEUROSCI.0665-07.2007	30	463	468	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					763	U139		10.1038/nature08855	http://dx.doi.org/10.1038/nature08855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20360742	Green Accepted			2022-12-24	WOS:000276205000046
J	Korner, C; Basler, D				Koerner, Christian; Basler, David			Phenology Under Global Warming	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; BUDBURST; PHOTOPERIODISM; RESPONSES		[Koerner, Christian; Basler, David] Univ Basel, Inst Bot, CH-4056 Basel, Switzerland	University of Basel	Korner, C (corresponding author), Univ Basel, Inst Bot, Hebelstr 1, CH-4056 Basel, Switzerland.	ch.koerner@unibas.ch; david.basler@unibas.ch	Körner, Christian/B-6592-2014	Körner, Christian/0000-0001-7768-7638; Basler, David/0000-0002-4068-8319				Borchert R, 2005, INT J BIOMETEOROL, V50, P57, DOI 10.1007/s00484-005-0261-7; Chuine I, 1999, NEW PHYTOL, V143, P339, DOI 10.1046/j.1469-8137.1999.00445.x; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Defila C, 2001, INT J BIOMETEOROL, V45, P203, DOI 10.1007/s004840100101; HAY RKM, 1990, NEW PHYTOL, V116, P233, DOI 10.1111/j.1469-8137.1990.tb04711.x; HEIDE OM, 1993, PHYSIOL PLANTARUM, V88, P531, DOI 10.1111/j.1399-3054.1993.tb01368.x; Jackson SD, 2009, NEW PHYTOL, V181, P517, DOI 10.1111/j.1469-8137.2008.02681.x; K/rner C., 2006, PLANT GROWTH CLIMATE, P48, DOI [10.1002/9780470988695.ch3, DOI 10.1002/9780470988695.CH3]; Keller F, 2003, ARCT ANTARCT ALP RES, V35, P361, DOI 10.1657/1523-0430(2003)035[0361:TROPIA]2.0.CO;2; Keskitalo J, 2005, PLANT PHYSIOL, V139, P1635, DOI 10.1104/pp.105.066845; Khanduri V. P., 2008, Environmentalist, V28, P143, DOI 10.1007/s10669-007-9153-1; LANGLET O, 1971, Taxon, V20, P653, DOI 10.2307/1218596; LARCHER W, 2007, SITZBER ANZEIGER MN, V212, P3; Li CY, 2003, PHYSIOL PLANTARUM, V117, P206, DOI 10.1034/j.1399-3054.2003.00002.x; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Morin X, 2009, GLOBAL CHANGE BIOL, V15, P961, DOI 10.1111/j.1365-2486.2008.01735.x; Moser L, 2010, TREE PHYSIOL, V30, P225, DOI 10.1093/treephys/tpp108; MURRAY MB, 1989, J APPL ECOL, V26, P693, DOI 10.2307/2404093; Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; WAREING PF, 1956, ANNU REV PLANT PHYS, V7, P191, DOI 10.1146/annurev.pp.07.060156.001203	20	665	719	40	603	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1461	1462		10.1126/science.1186473	http://dx.doi.org/10.1126/science.1186473			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299580				2022-12-24	WOS:000275715200031
J	Walker, MM; Diebel, CE; Haugh, CV; Pankhurst, PM; Montgomery, JC; Green, CR				Walker, MM; Diebel, CE; Haugh, CV; Pankhurst, PM; Montgomery, JC; Green, CR			Structure and function of the vertebrate magnetic sense	NATURE			English	Article							GEOMAGNETIC-FIELD; HOMING PIGEONS; BEHAVIORAL EVIDENCE; BIOGENIC MAGNETITE; ATMOSPHERIC ODORS; MIGRATORY BIRDS; SOCKEYE SALMON; HONEYBEES; MAGNETORECEPTION; DISCRIMINATION	Some vertebrates can navigate over long distances using the Earth's magnetic field, but the sensory system that they use to do so has remained a mystery. Here we describe the key components of a magnetic sense underpinning this navigational ability in a single species, the rainbow trout (Oncorhynchus mykiss), We report behavioural and electrophysiological responses to magnetic fields and identify an area in the nose of the trout where candidate magnetoreceptor cells are located. We have tracked the sensory pathway from these newly identified candidate magnetoreceptor cells to the brain and associated the system with a learned response to magnetic fields.	UNIV AUCKLAND,SCH MED,DEPT ANAT RADIOL,AUCKLAND,NEW ZEALAND	University of Auckland	Walker, MM (corresponding author), UNIV AUCKLAND,SCH BIOL SCI,EXPT BIOL RES GRP,PRIVATE BAG 92019,AUCKLAND 1,NEW ZEALAND.		Green, Colin R/B-5663-2012; Montgomery, John C/D-4310-2009	Green, Colin R/0000-0003-3459-6298; Montgomery, John C/0000-0002-7451-3541; Walker, Michael/0000-0001-9631-9128				BEASON RC, 1995, J EXP BIOL, V198, P141; Beason RC, 1996, J EXP BIOL, V199, P1241; BENVENUTI S, 1985, J COMP PHYSIOL A, V156, P737, DOI 10.1007/BF00610827; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; CARMAN GJ, 1987, ANIM LEARN BEHAV, V15, P124, DOI 10.3758/BF03204957; GOULD JL, 1978, SCIENCE, V201, P1026, DOI 10.1126/science.201.4360.1026; KALMIJN AJ, 1981, IEEE T MAGN, V17, P1113, DOI 10.1109/TMAG.1981.1061156; KIRSCHVINK JL, 1989, BIOELECTROMAGNETICS, V10, P239, DOI 10.1002/bem.2250100304; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; KIRSCHVINK JL, 1986, J EXP BIOL, V120, P1; KIRSCHVINK JL, 1985, MAGNETITE BIOMINERAL, P243; KREITHEN ML, 1974, J COMP PHYSIOL, V91, P355, DOI 10.1007/BF00694466; LEASK MJM, 1977, NATURE, V267, P144, DOI 10.1038/267144a0; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; LOHMANN KJ, 1995, J EXP BIOL, V198, P2041; MANN S, 1988, J EXP BIOL, V140, P35; MOENCH TT, 1978, ARCH MICROBIOL, V119, P203, DOI 10.1007/BF00964274; MOORE A, 1990, PHILOS T ROY SOC B, V329, P11, DOI 10.1098/rstb.1990.0145; PAPI F, 1989, ETHOL ECOL EVOL, V1, P219, DOI 10.1080/08927014.1989.9525511; PHILLIPS JB, 1992, NATURE, V359, P142, DOI 10.1038/359142a0; PUZDROWSKI RL, 1988, J MORPHOL, V198, P131, DOI 10.1002/jmor.1051980202; QUINN TP, 1981, J EXP ZOOL, V217, P137, DOI 10.1002/jez.1402170114; SEMM P, 1990, BRAIN RES BULL, V25, P735, DOI 10.1016/0361-9230(90)90051-Z; Sidman M., 1960, TACTICS SCI RES; WALCOTT C, 1979, SCIENCE, V205, P1027, DOI 10.1126/science.472725; WALCOTT C, 1980, IEEE T MAGN, V16, P1008, DOI 10.1109/TMAG.1980.1060868; WALKER MM, 1989, J COMP PSYCHOL, V103, P62; WALKER MM, 1984, J COMP PHYSIOL, V155, P673, DOI 10.1007/BF00610853; WALKER MM, 1989, J EXP BIOL, V145, P489; WALKER MM, 1992, J EXP BIOL, V171, P67; WALKER MM, 1985, J COMP PHYSIOL A, V157, P67, DOI 10.1007/BF00611096; WALKER MM, 1989, J EXP BIOL, V141, P447; WALLRAFF HG, 1983, COMP BIOCHEM PHYS A, V76, P643, DOI 10.1016/0300-9629(83)90126-3; Wiltschko R., 1995, TIEROSYCHOL; WILTSCHKO W, 1994, EXPERIENTIA, V50, P697, DOI 10.1007/BF01952877; WOODARD WT, 1974, BEHAV RES METH INSTR, V6, P389, DOI 10.3758/BF03200385; YORKE ED, 1979, J THEOR BIOL, V89, P533	37	316	330	4	171	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 27	1997	390	6658					371	376		10.1038/37057	http://dx.doi.org/10.1038/37057			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YH549	20358649				2022-12-24	WOS:A1997YH54900053
J	Guiguemde, WA; Shelat, AA; Bouck, D; Duffy, S; Crowther, GJ; Davis, PH; Smithson, DC; Connelly, M; Clark, J; Zhu, FY; Jimenez-Diaz, MB; Martinez, MS; Wilson, EB; Tripathi, AK; Gut, J; Sharlow, ER; Bathurst, I; El Mazouni, F; Fowble, JW; Forquer, I; McGinley, PL; Castro, S; Angulo-Barturen, I; Ferrer, S; Rosenthal, PJ; DeRisi, JL; Sullivan, DJ; Lazo, JS; Roos, DS; Riscoe, MK; Phillips, MA; Rathod, PK; Van Voorhis, WC; Avery, VM; Guy, RK				Guiguemde, W. Armand; Shelat, Anang A.; Bouck, David; Duffy, Sandra; Crowther, Gregory J.; Davis, Paul H.; Smithson, David C.; Connelly, Michele; Clark, Julie; Zhu, Fangyi; Jimenez-Diaz, Maria B.; Martinez, Maria S.; Wilson, Emily B.; Tripathi, Abhai K.; Gut, Jiri; Sharlow, Elizabeth R.; Bathurst, Ian; El Mazouni, Farah; Fowble, Joseph W.; Forquer, Isaac; McGinley, Paula L.; Castro, Steve; Angulo-Barturen, Inigo; Ferrer, Santiago; Rosenthal, Philip J.; DeRisi, Joseph L.; Sullivan, David J., Jr.; Lazo, John S.; Roos, David S.; Riscoe, Michael K.; Phillips, Margaret A.; Rathod, Pradipsinh K.; Van Voorhis, Wesley C.; Avery, Vicky M.; Guy, R. Kiplin			Chemical genetics of Plasmodium falciparum	NATURE			English	Article							MALARIA; IDENTIFICATION; DISRUPTION; RESISTANCE; SURVIVAL; GROWTH	Malaria caused by Plasmodium falciparum is a disease that is responsible for 880,000 deaths per year worldwide. Vaccine development has proved difficult and resistance has emerged for most antimalarial drugs. To discover new antimalarial chemotypes, we have used a phenotypic forward chemical genetic approach to assay 309,474 chemicals. Here we disclose structures and biological activity of the entire library-many of which showed potent in vitro activity against drug-resistant P. falciparum strains-and detailed profiling of 172 representative candidates. A reverse chemical genetic study identified 19 new inhibitors of 4 validated drug targets and 15 novel binders among 61 malarial proteins. Phylochemogenetic profiling in several organisms revealed similarities between Toxoplasma gondii and mammalian cell lines and dissimilarities between P. falciparum and related protozoans. One exemplar compound displayed efficacy in a murine model. Our findings provide the scientific community with new starting points for malaria drug discovery.	[Guiguemde, W. Armand; Shelat, Anang A.; Bouck, David; Smithson, David C.; Connelly, Michele; Clark, Julie; Zhu, Fangyi; Guy, R. Kiplin] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Duffy, Sandra; Avery, Vicky M.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Crowther, Gregory J.; Van Voorhis, Wesley C.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Davis, Paul H.; Roos, David S.] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Davis, Paul H.; Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Jimenez-Diaz, Maria B.; Martinez, Maria S.; Angulo-Barturen, Inigo; Ferrer, Santiago] GlaxoSmithKline, Dis Developing World, Tres Cantos 28760, Spain; [Wilson, Emily B.; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Tripathi, Abhai K.; Sullivan, David J., Jr.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Gut, Jiri; Rosenthal, Philip J.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA; [Sharlow, Elizabeth R.; Lazo, John S.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Bathurst, Ian] Med Malaria Venture, CH-1215 Geneva, Switzerland; [El Mazouni, Farah; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Fowble, Joseph W.; Rathod, Pradipsinh K.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Forquer, Isaac; Riscoe, Michael K.] Portland VA Med Ctr, Expt Chemotherapy Lab, Portland, OR 97239 USA; [McGinley, Paula L.; Castro, Steve] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA	St Jude Children's Research Hospital; Griffith University; University of Washington; University of Washington Seattle; University of Pennsylvania; University of Pennsylvania; GlaxoSmithKline; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Rutgers State University New Brunswick	Guy, RK (corresponding author), St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA.	kip.guy@stjude.org	Avery, Vicky M/A-5449-2010; Ferrer-Bazaga, Santiago/AAA-7749-2021; duffy, sandra/AAX-7527-2021; Davis, Paul H/J-6141-2012; Shelat, Anang/J-4995-2013; Guy, Rodney/J-7107-2013; duffy, sandra/B-8479-2017	Avery, Vicky M/0000-0003-4914-2299; Ferrer-Bazaga, Santiago/0000-0002-6672-551X; duffy, sandra/0000-0002-2814-1193; Davis, Paul H/0000-0002-0526-3841; Shelat, Anang/0000-0002-6266-2910; Guy, Rodney/0000-0002-9638-2060; duffy, sandra/0000-0002-2814-1193; Roos, David Siker/0000-0001-6725-4089; Bouck, David/0000-0002-6281-2544; Tripathi, Abhai/0000-0001-9848-0142; Crowther, Gregory/0000-0003-0530-9130	American Lebanese Syrian Associated Charities (ALSAC); St Jude Children's Research Hospital (SJCRH); Medicines for Malaria Venture; National Institute of Allergy and Infectious Diseases [AI772682, AI075517, AI067921, AI080625, AI28724, AI53862, AI35707, AI053680, AI075594, AI082617, AI045774]; National Cancer Institute [CA78039]; Welch Foundation [I-1257]; Doris Duke Charitable Foundation; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [P01CA078039] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI082617, R56AI053680, R01AI045774, U01AI053862, R01AI028724, P01AI067921, R37AI028724, R21AI053680, U01AI075517, U01AI075594, R01AI080625, F32AI077268, R01AI053680, P01AI035707] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); St Jude Children's Research Hospital (SJCRH); Medicines for Malaria Venture; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Welch Foundation(The Welch Foundation); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the American Lebanese Syrian Associated Charities (ALSAC) and St Jude Children's Research Hospital (SJCRH, R. K. G.), the Medicines for Malaria Venture (W. C. V. V. and V. M. A.), National Institute of Allergy and Infectious Diseases (AI772682 (P. H. D.), AI075517 (R. K. G.), AI067921 (W. C. V. V.) and AI080625 (W. C. V. V.), AI28724 (D. S. R.), AI53862 (J.L.D.), AI35707 (P.J.R.), AI053680 (M. A. P. and P. K. R.), AI075594 (M. A. P., P. K. R. and I. B.), AI082617 (P. K. R.) and AI045774 (D.J.S.)), the National Cancer Institute (CA78039 (J.S.L.)), the Welch Foundation (I-1257 (M. A. P.)), the Doris Duke Charitable Foundation (P.J.R.), and the Ellison Medical Foundation (D. S. R.). We acknowledge A. B. Vaidya for providing the parasite strain D10_yDHOD. We acknowledge M. Sigal for assistance in the early leads project coordination, the SJCRH High Throughput Screening Center, particularly J. Cui; the SJCRH Lead Discovery Informatics Center, and the SJCRH High Throughput Analytical Chemistry Center, particularly C. Nelson and A. Lemoff; at UW, F. Buckner, W. Hol and A. Napuli (AI067921, W. Hol); S. Wei and W. Hao in the UT Southwestern HTS Center; and the Australian Red Cross Blood Service for the provision of O+ erythrocytes to Griffith University.	Baniecki ML, 2007, ANTIMICROB AGENTS CH, V51, P716, DOI 10.1128/AAC.01144-06; Cibulskis RE, 2007, AM J TROP MED HYG, V77, P133; Crowther GJ, 2009, J BIOMOL SCREEN, V14, P700, DOI 10.1177/1087057109335749; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Gujjar R, 2009, J MED CHEM, V52, P1864, DOI 10.1021/jm801343r; Kissinger JC, 2002, NATURE, V419, P490, DOI 10.1038/419490a; Krnajski Z, 2002, J BIOL CHEM, V277, P25970, DOI 10.1074/jbc.M203539200; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; McFadden GI, 1999, TRENDS MICROBIOL, V7, P328, DOI 10.1016/S0966-842X(99)01547-4; Munos B, 2006, NAT REV DRUG DISCOV, V5, P723, DOI 10.1038/nrd2131; Patel V, 2008, J BIOL CHEM, V283, P35078, DOI 10.1074/jbc.M804990200; Pisciotta JM, 2007, BIOCHEM J, V402, P197, DOI 10.1042/BJ20060986; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Reynolds MG, 1998, J BIOL CHEM, V273, P3461, DOI 10.1074/jbc.273.6.3461; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; Ritz C, 2005, J STAT SOFTW, V12, P1; Shelat AA, 2007, NAT CHEM BIOL, V3, P442, DOI 10.1038/nchembio0807-442; Shelat AA, 2007, CURR OPIN CHEM BIOL, V11, P244, DOI 10.1016/j.cbpa.2007.05.003; Shenai BR, 2003, ANTIMICROB AGENTS CH, V47, P154, DOI 10.1128/AAC.47.1.154-160.2003; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; Weissbuch I, 2008, CHEM REV, V108, P4899, DOI 10.1021/cr078274t; Wells TNC, 2009, NAT REV DRUG DISCOV, V8, P879, DOI 10.1038/nrd2972; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601	27	427	435	1	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2010	465	7296					311	315		10.1038/nature09099	http://dx.doi.org/10.1038/nature09099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485428	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-24	WOS:000277829200032
J	Peisajovich, SG; Garbarino, JE; Wei, P; Lim, WA				Peisajovich, Sergio G.; Garbarino, Joan E.; Wei, Ping; Lim, Wendell A.			Rapid Diversification of Cell Signaling Phenotypes by Modular Domain Recombination	SCIENCE			English	Article							PHEROMONE RESPONSE; KINASE CASCADE; PATHWAY; YEAST; PROTEINS; TRANSDUCTION; EVOLUTION; PRINCIPLES	Cell signaling proteins are often modular, containing distinct catalytic and regulatory domains. Recombination of such biological modules has been proposed to be a major source of evolutionary innovation. We systematically analyzed the phenotypic diversity of a signaling response that results from domain recombination by using 11 proteins in the yeast mating pathway to construct a library of 66 chimeric domain recombinants. Domain recombination resulted in greater diversity in pathway response dynamics than did duplication of genes, of single domains, or of two unlinked domains. Domain recombination also led to changes in mating phenotype, including recombinants with increased mating efficiency over the wild type. Thus, novel linkages between preexisting domains may have a major role in the evolution of protein networks and novel phenotypic behaviors.	[Peisajovich, Sergio G.; Garbarino, Joan E.; Wei, Ping; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Garbarino, Joan E.; Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Wei, Ping] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Peking University	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu	Peisajovich, Sergio/C-6641-2011	Wei, Ping/0000-0002-1275-7145	Howard Hughes Medical Institute; Packard Foundation; NIH; NIH Nanomedicine Development Centers; Human Frontier Science Program; Li Foundation; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Packard Foundation(The David & Lucile Packard Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Nanomedicine Development Centers; Human Frontier Science Program(Human Frontier Science Program); Li Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Chau for help with Matlab, N. Helman and J. Walter for help with fluorescence microscopy, and members of the Lim laboratory for critical reading of this manuscript and assistance. This work was supported by grants from the Howard Hughes Medical Institute, the Packard Foundation, the NIH, and the NIH Nanomedicine Development Centers (W. A. L.). S. G. P. was supported by a Long-Term Postdoctoral Fellowship from the Human Frontier Science Program. P. W. was supported by the Li Foundation. S. G. P. and W. A. L. conceived the project. S. G. P. and J. G. performed the experiments. P. W. assisted with initial experiments. S. G. P., J. G., and W. A. L. analyzed the results. S. G. P. and W. A. L. wrote the manuscript. The authors declare no competing financial interests.	Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bashton M, 2007, STRUCTURE, V15, P85, DOI 10.1016/j.str.2006.11.009; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DUEBER JE, 1904, SCIENCE, V301, P2003; Gerhart J, 2007, P NATL ACAD SCI USA, V104, P8582, DOI 10.1073/pnas.0701035104; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Howard PL, 2003, P NATL ACAD SCI USA, V100, P11267, DOI 10.1073/pnas.1934711100; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Lynch M, 2000, GENETICS, V154, P459; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; MARSH L, 1991, ANNU REV CELL BIOL, V7, P699, DOI 10.1146/annurev.cellbio.7.1.699; Pawson T, 2007, ONCOGENE, V26, P1268, DOI 10.1038/sj.onc.1210255; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Rogers RL, 2009, GENETICS, V181, P313, DOI 10.1534/genetics.108.091538; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; Takahashi S, 2008, CURR BIOL, V18, P1184, DOI 10.1016/j.cub.2008.07.050; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Voigt CA, 2002, NAT STRUCT BIOL, V9, P553, DOI 10.1038/nsb805; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851	25	118	122	4	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					368	372		10.1126/science.1182376	http://dx.doi.org/10.1126/science.1182376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395511	Green Accepted			2022-12-24	WOS:000276685000041
J	Gupta, RA; Shah, N; Wang, KC; Kim, J; Horlings, HM; Wong, DJ; Tsai, MC; Hung, T; Argani, P; Rinn, JL; Wang, YL; Brzoska, P; Kong, B; Li, R; West, RB; van de Vijver, MJ; Sukumar, S; Chang, HY				Gupta, Rajnish A.; Shah, Nilay; Wang, Kevin C.; Kim, Jeewon; Horlings, Hugo M.; Wong, David J.; Tsai, Miao-Chih; Hung, Tiffany; Argani, Pedram; Rinn, John L.; Wang, Yulei; Brzoska, Pius; Kong, Benjamin; Li, Rui; West, Robert B.; van de Vijver, Marc J.; Sukumar, Saraswati; Chang, Howard Y.			Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis	NATURE			English	Article							AGGRESSIVE BREAST-CANCER; EPITHELIAL-CELLS; GENE-EXPRESSION; CARCINOMA; INVASION; GENOME; SIGNATURE; PATTERNS; SURVIVAL; GROWTH	Large intervening non-coding RNAs (lincRNAs) are pervasively transcribed in the genome(1-3) yet their potential involvement in human disease is not well understood(4,5). Recent studies of dosage compensation, imprinting, and homeotic gene expression suggest that individual lincRNAs can function as the interface between DNA and specific chromatin remodelling activities(6-8). Here we show that lincRNAs in the HOX loci become systematically dys-regulated during breast cancer progression. The lincRNA termed HOTAIR is increased in expression in primary breast tumours and metastases, and HOTAIR expression level in primary tumours is a powerful predictor of eventual metastasis and death. Enforced expression of HOTAIR in epithelial cancer cells induced genome-wide re-targeting of Polycomb repressive complex 2 (PRC2) to an occupancy pattern more resembling embryonic fibroblasts, leading to altered histone H3 lysine 27 methylation, gene expression, and increased cancer invasiveness and metastasis in a manner dependent on PRC2. Conversely, loss of HOTAIR can inhibit cancer invasiveness, particularly in cells that possess excessive PRC2 activity. These findings indicate that lincRNAs have active roles in modulating the cancer epigenome and may be important targets for cancer diagnosis and therapy.	[Gupta, Rajnish A.; Wang, Kevin C.; Wong, David J.; Tsai, Miao-Chih; Hung, Tiffany; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Gupta, Rajnish A.; Wang, Kevin C.; Wong, David J.; Tsai, Miao-Chih; Hung, Tiffany; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Kim, Jeewon] Stanford Univ, Sch Med, Stanford Canc Ctr, Stanford, CA 94305 USA; [Kim, Jeewon] Stanford Univ, Sch Med, Transgenic Mouse Res Ctr, Stanford, CA 94305 USA; [Li, Rui; West, Robert B.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Shah, Nilay; Sukumar, Saraswati] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Argani, Pedram] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; [Horlings, Hugo M.; van de Vijver, Marc J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Rinn, John L.] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Rinn, John L.] MIT, Cambridge, MA 02142 USA; [Wang, Yulei; Brzoska, Pius; Kong, Benjamin] Appl Biosyst Inc, Foster City, CA 94404 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Thermo Fisher Scientific; Applied Biosystems	Chang, HY (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	howchang@stanford.edu	乐驰, 叶/H-3399-2011; Shah, Nilay/H-9988-2013; Shah, Nilay/E-4925-2015	Kim, Jeewon/0000-0002-1063-0239; van de Vijver, Marc/0000-0002-0385-4787; Tsai, Miao-Chih/0000-0003-4471-4825; Wang, Kevin/0000-0002-5305-6791; Shah, Nilay/0000-0002-8906-6844; Wang, Yulei/0000-0002-9057-9786; Rinn, John/0000-0002-7231-7539; West, Robert/0000-0002-8330-8283	National Institutes of Health (NIH); Emerald Foundation; American Cancer Society; Dermatology Foundation; Susan Komen Foundation; NSF; Department of Defense BCRP; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA118750] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; American Cancer Society(American Cancer Society); Dermatology Foundation; Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); NSF(National Science Foundation (NSF)); Department of Defense BCRP(United States Department of Defense); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Y. Chen-Tsai, M. Guttman, G. Sen, T. Ridky, P. Khavari, V. Band and Y. Kang for advice and reagents. Supported by National Institutes of Health (NIH), Emerald Foundation, and American Cancer Society (H. Y. C.), Dermatology Foundation (R. A. G., K. C. W. and D. J. W.), Susan Komen Foundation (M.-C. T.), NSF (T. H.), and Department of Defense BCRP (S. S.). H. Y. C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BERGSTRAESSER LM, 1993, CANCER RES, V53, P2644; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Herath NI, 2009, BRIT J CANCER, V100, P1095, DOI 10.1038/sj.bjc.6604970; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Naik MU, 2008, CANCER RES, V68, P2194, DOI 10.1158/0008-5472.CAN-07-3057; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Olmeda D, 2007, CANCER RES, V67, P11721, DOI 10.1158/0008-5472.CAN-07-2318; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wu JM, 2008, CLIN CANCER RES, V14, P1938, DOI 10.1158/1078-0432.CCR-07-4082; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	30	3955	4245	19	743	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1071	U148		10.1038/nature08975	http://dx.doi.org/10.1038/nature08975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393566	Green Accepted			2022-12-24	WOS:000276635000045
J	Gibson, DG; Glass, JI; Lartigue, C; Noskov, VN; Chuang, RY; Algire, MA; Benders, GA; Montague, MG; Ma, L; Moodie, MM; Merryman, C; Vashee, S; Krishnakumar, R; Assad-Garcia, N; Andrews-Pfannkoch, C; Denisova, EA; Young, L; Qi, ZQ; Segall-Shapiro, TH; Calvey, CH; Parmar, PP; Hutchison, CA; Smith, HO; Venter, JC				Gibson, Daniel G.; Glass, John I.; Lartigue, Carole; Noskov, Vladimir N.; Chuang, Ray-Yuan; Algire, Mikkel A.; Benders, Gwynedd A.; Montague, Michael G.; Ma, Li; Moodie, Monzia M.; Merryman, Chuck; Vashee, Sanjay; Krishnakumar, Radha; Assad-Garcia, Nacyra; Andrews-Pfannkoch, Cynthia; Denisova, Evgeniya A.; Young, Lei; Qi, Zhi-Qing; Segall-Shapiro, Thomas H.; Calvey, Christopher H.; Parmar, Prashanth P.; Hutchison, Clyde A., III; Smith, Hamilton O.; Venter, J. Craig			Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome	SCIENCE			English	Article							MYCOPLASMA-GENITALIUM GENOME; MINIMAL GENOME; DNA FRAGMENTS; YEAST; CLONING; GENES	We report the design, synthesis, and assembly of the 1.08-mega-base pair Mycoplasma mycoides JCVI-syn1.0 genome starting from digitized genome sequence information and its transplantation into a M. capricolum recipient cell to create new M. mycoides cells that are controlled only by the synthetic chromosome. The only DNA in the cells is the designed synthetic DNA sequence, including "watermark" sequences and other designed gene deletions and polymorphisms, and mutations acquired during the building process. The new cells have expected phenotypic properties and are capable of continuous self-replication.	[Gibson, Daniel G.; Glass, John I.; Lartigue, Carole; Noskov, Vladimir N.; Chuang, Ray-Yuan; Algire, Mikkel A.; Montague, Michael G.; Ma, Li; Moodie, Monzia M.; Merryman, Chuck; Vashee, Sanjay; Krishnakumar, Radha; Assad-Garcia, Nacyra; Andrews-Pfannkoch, Cynthia; Denisova, Evgeniya A.; Young, Lei; Qi, Zhi-Qing; Segall-Shapiro, Thomas H.; Calvey, Christopher H.; Parmar, Prashanth P.; Venter, J. Craig] J Craig Venter Inst, Rockville, MD 20850 USA; [Benders, Gwynedd A.; Hutchison, Clyde A., III; Smith, Hamilton O.; Venter, J. Craig] J Craig Venter Inst, San Diego, CA 92121 USA	J. Craig Venter Institute; J. Craig Venter Institute	Venter, JC (corresponding author), J Craig Venter Inst, 9704 Med Ctr Dr, Rockville, MD 20850 USA.	jcventer@jcvi.org	Lartigue, Carole/GQP-4896-2022; lartigue, carole/I-1576-2013; Glass, John/A-6572-2015	Lartigue, Carole/0000-0001-5550-7579; Segall-Shapiro, Thomas/0000-0001-9364-6537; Glass, John/0000-0002-3784-5301; Calvey, Christopher/0000-0002-7330-4983	Synthetic Genomics, Inc.; National Center for Microscopy and Imaging Research at the University of California at San Diego	Synthetic Genomics, Inc.; National Center for Microscopy and Imaging Research at the University of California at San Diego	We thank Synthetic Genomics, Inc. for generous funding of this work. We thank J. B. Hostetler, D. Radune, N. B. Fedorova, M. D. Kim, B. J. Szczypinski, I. K. Singh, J. R. Miller, S. Kaushal, R. M. Friedman, and J. Mulligan for their contributions to this work. Electron micrographs were generously provided by T. Deerinck and M. Ellisman of the National Center for Microscopy and Imaging Research at the University of California at San Diego. J. C. V. is chief executive officer and co-chief scientific officer of SGI. H.O.S. is co-chief scientific officer and on the Board of Directors of SGI. C. A. H. is chairman of the SGI Scientific Advisory Board. All three of these authors and JCVI hold SGI stock. JCVI has filed patent applications on some of the techniques described in this paper.	Benders GA, 2010, NUCLEIC ACIDS RES, V38, P2558, DOI 10.1093/nar/gkq119; Cho MK, 1999, SCIENCE, V286, P2087, DOI 10.1126/science.286.5447.2087; Chun JY, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm051; DEAN WW, 1973, ANAL BIOCHEM, V56, P417, DOI 10.1016/0003-2697(73)90207-8; DEVENISH RJ, 1982, GENE, V18, P277, DOI 10.1016/0378-1119(82)90166-4; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Garfinkel MS, 2007, BIOSECUR BIOTERROR, V5, P359, DOI 10.1089/bsp.2007.0923; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; ITAYA M, 1995, FEBS LETT, V362, P257, DOI 10.1016/0014-5793(95)00233-Y; Itaya M, 2005, P NATL ACAD SCI USA, V102, P15971, DOI 10.1073/pnas.0503868102; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Lartigue C, 2009, SCIENCE, V325, P1693, DOI 10.1126/science.1173759; Leem SH, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng029; Mizoguchi H, 2007, BIOTECHNOL APPL BIOC, V46, P157, DOI 10.1042/BA200650107; Noskov VN, 2010, NUCLEIC ACIDS RES, V38, P2570, DOI 10.1093/nar/gkq099; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; SMITH HO, 2008, ACCESSING UNCULTIVAT, P320; Venter JC, 2010, NATURE, V464, P676, DOI 10.1038/464676a; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187	25	1430	1658	28	862	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					52	56		10.1126/science.1190719	http://dx.doi.org/10.1126/science.1190719			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20488990				2022-12-24	WOS:000279402700028
J	Sprinzak, D; Lakhanpal, A; LeBon, L; Santat, LA; Fontes, ME; Anderson, GA; Garcia-Ojalvo, J; Elowitz, MB				Sprinzak, David; Lakhanpal, Amit; LeBon, Lauren; Santat, Leah A.; Fontes, Michelle E.; Anderson, Graham A.; Garcia-Ojalvo, Jordi; Elowitz, Michael B.			Cis-interactions between Notch and Delta generate mutually exclusive signalling states	NATURE			English	Article							PATTERN-FORMATION; CELL FATE; DROSOPHILA; EXPRESSION; INDUCTION; FEEDBACK; TRANSACTIVATION; ACTIVATION; LIGANDS; DOMAIN	The Notch-Delta signalling pathway allows communication between neighbouring cells during development(1). It has a critical role in the formation of 'fine-grained' patterns, generating distinct cell fates among groups of initially equivalent neighbouring cells and sharply delineating neighbouring regions in developing tissues(2-5). The Delta ligand has been shown to have two activities: it transactivates Notch in neighbouring cells and cis-inhibits Notch in its own cell. However, it remains unclear how Notch integrates these two activities and how the resulting system facilitates pattern formation. Here we report the development of a quantitative time-lapse microscopy platform for analysing Notch-Delta signalling dynamics in individual mammalian cells, with the aim of addressing these issues. By controlling both cis- and trans-Delta concentrations, and monitoring the dynamics of a Notch reporter, we measured the combined cis-trans input-output relationship in the Notch-Delta system. The data revealed a striking difference between the responses of Notch to trans-and cis-Delta: whereas the response to trans-Delta is graded, the response to cis-Delta is sharp and occurs at a fixed threshold, independent of trans-Delta. We developed a simple mathematical model that shows how these behaviours emerge from the mutual inactivation of Notch and Delta proteins in the same cell. This interaction generates an ultrasensitive switch between mutually exclusive sending ( high Delta/low Notch) and receiving (high Notch/low Delta) signalling states. At the multicellular level, this switch can amplify small differences between neighbouring cells even without transcription-mediated feedback. This Notch-Delta signalling switch facilitates the formation of sharp boundaries and lateral-inhibition patterns in models of development, and provides insight into previously unexplained mutant behaviours.	[Sprinzak, David; Lakhanpal, Amit; LeBon, Lauren; Santat, Leah A.; Fontes, Michelle E.; Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA; [Sprinzak, David; Lakhanpal, Amit; LeBon, Lauren; Santat, Leah A.; Fontes, Michelle E.; Elowitz, Michael B.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Anderson, Graham A.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Garcia-Ojalvo, Jordi] Univ Politecn Cataluna, Dept Fis & Engn Nucl, E-08222 Terrassa, Spain	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Stanford University; Universitat Politecnica de Catalunya	Elowitz, MB (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	melowitz@caltech.edu	Garcia-Ojalvo, Jordi/A-4574-2009	Garcia-Ojalvo, Jordi/0000-0002-3716-7520; Sprinzak, David/0000-0001-6776-6957; LeBon, Lauren/0000-0003-3205-1948	US National Institutes of Health [F32GM77014, GM08042]; Caltech Center for Biological Circuit Design; Packard Foundation; Fannie and John Hertz Foundation; Ministerio de Ciencia e Innovacion (Spain) [FIS2009-13360]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042, F32GM077014] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech Center for Biological Circuit Design; Packard Foundation(The David & Lucile Packard Foundation); Fannie and John Hertz Foundation; Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank I. Bernstein for the IgG-Delta<SUP>ext</SUP>, U. Lendahl for the 12xCSL reporter construct, J. Aster for human NOTCH1 and other constructs, and G. Weinmaster for the rat DLL1 construct and advice. We also thank R. Tsien and K. Thorn for mCherry, S. Megason and S. Fraser for H2B- citrine and other constructs, R. Diamond and D. Perez for assistance with FACS, and F. Tan and J. Yong for help with cloning some of the constructs. We thank A. Eldar, J. Locke, G. Seelig, R. Kishony, B. Shraiman, A. C. Oates and members of the Elowitz laboratory for discussions and advice. This work was supported by the US National Institutes of Health Fellowship F32GM77014 (D. S.), the Caltech Center for Biological Circuit Design and the Packard Foundation. A. L. acknowledges support from the Fannie and John Hertz Foundation and the UCLA/Caltech Medical Scientist Training Program (NIH GM08042). J. G. O. acknowledges support from the Ministerio de Ciencia e Innovacion (Spain, project FIS2009-13360 and the I3 programme).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; de Celis JF, 2000, DEVELOPMENT, V127, P1291; deCelis JF, 1997, DEVELOPMENT, V124, P1919; deCelis JF, 1997, DEVELOPMENT, V124, P3241; Goodyear R, 1997, J NEUROSCI, V17, P6289; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Huppert SS, 1997, DEVELOPMENT, V124, P3283; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; KAKIDANI H, 1988, CELL, V52, P161, DOI 10.1016/0092-8674(88)90504-1; Klein T, 1997, DEV BIOL, V189, P123, DOI 10.1006/dbio.1997.8564; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Matsuda M, 2009, DEVELOPMENT, V136, P197, DOI 10.1242/dev.027938; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Miller AC, 2009, CURR BIOL, V19, P1378, DOI 10.1016/j.cub.2009.06.042; Plahte E, 2001, J MATH BIOL, V43, P411, DOI 10.1007/s002850100105; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Shaye DD, 2005, DEVELOPMENT, V132, P5081, DOI 10.1242/dev.02076; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614	29	406	416	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					86	U95		10.1038/nature08959	http://dx.doi.org/10.1038/nature08959			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20418862	Green Accepted			2022-12-24	WOS:000277311900036
J	Kikuchi, K; Holdway, JE; Werdich, AA; Anderson, RM; Fang, Y; Egnaczyk, GF; Evans, T; MacRae, CA; Stainier, DYR; Poss, KD				Kikuchi, Kazu; Holdway, Jennifer E.; Werdich, Andreas A.; Anderson, Ryan M.; Fang, Yi; Egnaczyk, Gregory F.; Evans, Todd; MacRae, Calum A.; Stainier, Didier Y. R.; Poss, Kenneth D.			Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes	NATURE			English	Article							ADULT MAMMALIAN CARDIOMYOCYTES; CELL-BASED THERAPY; VENTRAL MORPHOGENESIS; TRANSCRIPTION FACTOR; TUBE FORMATION; GROWTH; DIFFERENTIATION; PROLIFERATION; INJURY; EXPRESSION	Recent studies indicate that mammals, including humans, maintain some capacity to renew cardiomyocytes throughout postnatal life(1,2). Yet, there is little or no significant cardiac muscle regeneration after an injury such as acute myocardial infarction(3). By contrast, zebrafish efficiently regenerate lost cardiac muscle, providing a model for understanding how natural heart regeneration may be blocked or enhanced(4,5). In the absence of lineage-tracing technology applicable to adult zebrafish, the cellular origins of newly regenerated cardiac muscle have remained unclear. Using new genetic fate-mapping approaches, here we identify a population of cardiomyocytes that become activated after resection of the ventricular apex and contribute prominently to cardiac muscle regeneration. Through the use of a transgenic reporter strain, we found that cardiomyocytes throughout the subepicardial ventricular layer trigger expression of the embryonic cardiogenesis gene gata4 within a week of trauma, before expression localizes to proliferating cardiomyocytes surrounding and within the injury site. Cre-recombinase-based lineage-tracing of cells expressing gata4 before evident regeneration, or of cells expressing the contractile gene cmlc2 before injury, each labelled most cardiac muscle in the ensuing regenerate. By optical voltage mapping of surface myocardium in whole ventricles, we found that electrical conduction is re-established between existing and regenerated cardiomyocytes between 2 and 4 weeks post-injury. After injury and prolonged fibroblast growth factor receptor inhibition to arrest cardiac regeneration and enable scar formation, experimental release of the signalling block led to gata4 expression and morphological improvement of the injured ventricular wall without loss of scar tissue. Our results indicate that electrically coupled cardiac muscle regenerates after resection injury, primarily through activation and expansion of cardiomyocyte populations. These findings have implications for promoting regeneration of the injured human heart.	[Kikuchi, Kazu; Holdway, Jennifer E.; Fang, Yi; Egnaczyk, Gregory F.; Poss, Kenneth D.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Kikuchi, Kazu; Holdway, Jennifer E.; Fang, Yi; Egnaczyk, Gregory F.; Poss, Kenneth D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Egnaczyk, Gregory F.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Werdich, Andreas A.; MacRae, Calum A.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Anderson, Ryan M.; Stainier, Didier Y. R.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Evans, Todd] Cornell Univ, Dept Surg, Weill Cornell Med Coll, New York, NY 10021 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco; Cornell University	Poss, KD (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	k.poss@cellbio.duke.edu	Kikuchi, Kazu/A-4097-2017	Kikuchi, Kazu/0000-0002-4681-4275; Stainier, Didier/0000-0002-0382-0026; Werdich, Andreas/0000-0002-1222-1180; Poss, Kenneth/0000-0002-6743-5709	AHA; JDRF; JSPS; NIH at Massachusetts General Hospital [HL007208]; NIH at Duke University Medical Center [HL007101]; NHLBI [HL064282, HL054737, HL081674]; NIGMS [GM075846]; March of Dimes; Pew Charitable Trusts; Whitehead Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054737, T32HL007208, R01HL109264, T32HL007101, R01HL064282, R01HL081674, K08HL068711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM075946] Funding Source: NIH RePORTER	AHA(American Heart Association); JDRF(Juvenile Diabetes Research Foundation); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH at Massachusetts General Hospital; NIH at Duke University Medical Center; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); March of Dimes(March of Dimes); Pew Charitable Trusts; Whitehead Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Burris and A. Eastes for zebrafish care, X. Meng and the Developmental Studies Hybridoma Bank for antibodies, M. Gignac for help with electron microscopy, laboratory members for comments on the manuscript, and G. Burns, P. Chambon and G. Felsenfeld for plasmids. This work was supported by postdoctoral fellowships from AHA ( K. K. and Y.F.), JDRF ( R. M. A.), and JSPS ( K. K.); NIH training grants HL007208 at Massachusetts General Hospital ( A. A. W.) and HL007101 at Duke University Medical Center ( G. F. E.); grants from NHLBI (HL064282 to T. E., HL054737 to D. Y. R. S., and HL081674 to K. D. P.), NIGMS (GM075846 to C. A. M.), and March of Dimes ( C. A. M.); and grants from AHA, Pew Charitable Trusts and Whitehead Foundation (K. D. P.).	Bayly PV, 1998, IEEE T BIO-MED ENG, V45, P563, DOI 10.1109/10.668746; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Brette F, 2008, BIOCHEM BIOPH RES CO, V374, P143, DOI 10.1016/j.bbrc.2008.06.109; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; FAST VG, 1995, CARDIOVASC RES, V29, P697, DOI 10.1016/S0008-6363(96)88643-3; Heicklen-Klein A, 2004, DEV BIOL, V267, P490, DOI 10.1016/j.ydbio.2003.09.042; Holtzinger A, 2005, DEVELOPMENT, V132, P4005, DOI 10.1242/dev.01978; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Laflamme MA, 2007, ANNU REV PATHOL-MECH, V2, P307, DOI 10.1146/annurev.pathol.2.010506.092038; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Meilhac SM, 2003, DEVELOPMENT, V130, P3877, DOI 10.1242/dev.00580; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Pu WT, 2004, DEV BIOL, V275, P235, DOI 10.1016/j.ydbio.2004.08.008; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Sidorov VY, 2008, BASIC RES CARDIOL, V103, P537, DOI 10.1007/s00395-008-0740-1; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Waxman JS, 2008, DEV CELL, V15, P923, DOI 10.1016/j.devcel.2008.09.009; Wills AA, 2008, DEVELOPMENT, V135, P183, DOI 10.1242/dev.010363; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	36	739	767	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 25	2010	464	7288					601	U162		10.1038/nature08804	http://dx.doi.org/10.1038/nature08804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336144	Green Accepted			2022-12-24	WOS:000275974200050
J	Sawamiphak, S; Seidel, S; Essmann, CL; Wilkinson, GA; Pitulescu, ME; Acker, T; Acker-Palmer, A				Sawamiphak, Suphansa; Seidel, Sascha; Essmann, Clara L.; Wilkinson, George A.; Pitulescu, Mara E.; Acker, Till; Acker-Palmer, Amparo			Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis	NATURE			English	Article							VASCULAR MORPHOGENESIS; RECEPTORS; GUIDANCE; PHOSPHORYLATION; ASTROCYTES; PTP	The formation and guidance of specialized endothelial tip cells is essential for both developmental and pathological angiogenesis(1). Notch-1 signalling regulates the generation of tip cells, which respond to gradients of vascular endothelial growth factor (VEGF-A)(2). The molecular cues and signalling pathways that control the guidance of tip cells are poorly understood. Bidirectional signalling by Eph receptors and ephrin ligands represents one of the most important guidance cues involved in axon path finding(3). Here we show that ephrin-B2 reverse signalling involving PDZ interactions regulates endothelial tip cell guidance to control angiogenic sprouting and branching in physiological and pathological angiogenesis. In vivo, ephrin-B2 PDZ-signalling-deficient mice (ephrin-B2DV) exhibit a reduced number of tip cells with fewer filopodial extensions at the vascular front in the mouse retina. In pathological settings, impaired PDZ signalling decreases tumour vascularization and growth. Mechanistically, we show that ephrin-B2 controls VEGF receptor (VEGFR)-2 internalization and signalling. Importantly, internalization of VEGFR2 is necessary for activation and downstream signalling of the receptor and is required for VEGF-induced tip cell filopodial extension. Together, our results suggest that ephrin-B2 at the tip cell filopodia regulates the proper spatial activation of VEGFR2 endocytosis and signalling to direct filopodial extension. Blocking ephrin-B2 reverse signalling may be an attractive alternative or combinatorial anti-angiogenic therapy strategy to disrupt VEGFR2 function in tumour angiogenesis.	[Sawamiphak, Suphansa; Essmann, Clara L.; Acker-Palmer, Amparo] Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci, D-60438 Frankfurt, Germany; [Sawamiphak, Suphansa; Essmann, Clara L.; Acker-Palmer, Amparo] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, D-60438 Frankfurt, Germany; [Seidel, Sascha; Acker, Till] Univ Giessen, Inst Neuropathol, D-35392 Giessen, Germany; [Wilkinson, George A.] Med Coll Wisconsin, Dev Vasc Biol Program, Milwaukee, WI 53226 USA; [Pitulescu, Mara E.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Pitulescu, Mara E.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Justus Liebig University Giessen; Medical College of Wisconsin; University of Munster; Max Planck Society	Acker-Palmer, A (corresponding author), Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci, Max von Laue Str 9, D-60438 Frankfurt, Germany.	Acker-Palmer@bio.uni-frankfurt.de		Seidel, Sascha/0000-0001-9411-8795; Acker, Till/0000-0001-6357-7227; Pitulescu, Mara E/0000-0001-5322-8146	Deutsche Forschungsgemeinschaft [AC110/3-1, 3-2, AC180/3-1, 3-2]; Deutsche Krebshilfe [107231]; Clusters of Excellence 'Macromolecular Complexes (CEF)' at University Frankfurt [EXC 115]; 'Cardio-Pulmonary System (ECCPS)' at the Universities of Giessen and Frankfurt [EXC 147]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Clusters of Excellence 'Macromolecular Complexes (CEF)' at University Frankfurt; 'Cardio-Pulmonary System (ECCPS)' at the Universities of Giessen and Frankfurt	We thank R. Klein for the ephrin-B2<SUP>lox/lox</SUP> mice, A. Filosa, F. Finkelmeier and H. zum Buttel for technical support, A. Filosa and B. Garvalov for comments on the manuscript and R. Adams for scientific input and reading the manuscript. We acknowledge the Max Planck Institute of Neurobiology in Martinsried (Germany) and the Edinger Institute at Frankfurt University (Germany) for support and the use of equipment and animal facilities in the early stages of this project. This work was supported by grants from the Deutsche Forschungsgemeinschaft within the SPP1190 (AC110/3-1, 3-2 to T. A. and AC180/3-1, 3-2 to A.A.-P.), the Deutsche Krebshilfe (107231 to T. A.) and the Clusters of Excellence 'Macromolecular Complexes (CEF)' (EXC 115) at the University Frankfurt and 'Cardio-Pulmonary System (ECCPS)' (EXC 147) at the Universities of Giessen and Frankfurt.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Bhattacharya R, 2005, FASEB J, V19, P1692, DOI 10.1096/fj.05-3889fje; Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Dorrell MI, 2006, PROG RETIN EYE RES, V25, P277, DOI 10.1016/j.preteyeres.2006.01.001; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Essmann CL, 2008, NAT NEUROSCI, V11, P1035, DOI 10.1038/nn.2171; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Gariano RF, 1996, INVEST OPHTH VIS SCI, V37, P2367; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Lauterbach J, 2006, J NEUROSCI, V26, P11575, DOI 10.1523/JNEUROSCI.2697-06.2006; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Padera TP, 2008, DEV CELL, V15, P178, DOI 10.1016/j.devcel.2008.07.014; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; Wilkinson GA, 2008, DEV DYNAM, V237, P2220, DOI 10.1002/dvdy.21643; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	32	391	408	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2010	465	7297					487	U115		10.1038/nature08995	http://dx.doi.org/10.1038/nature08995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20445540				2022-12-24	WOS:000278043700037
J	Duan, Z; Andronescu, M; Schutz, K; McIlwain, S; Kim, YJ; Lee, C; Shendure, J; Fields, S; Blau, CA; Noble, WS				Duan, Zhijun; Andronescu, Mirela; Schutz, Kevin; McIlwain, Sean; Kim, Yoo Jung; Lee, Choli; Shendure, Jay; Fields, Stanley; Blau, C. Anthony; Noble, William S.			A three-dimensional model of the yeast genome	NATURE			English	Article							SPATIAL-ORGANIZATION; CHROMATIN; GENES; ARCHITECTURE; PRINCIPLES; DYNAMICS; NUCLEI	Layered on top of information conveyed by DNA sequence and chromatin are higher order structures that encompass portions of chromosomes, entire chromosomes, and even whole genomes(1-3). Interphase chromosomes are not positioned randomly within the nucleus, but instead adopt preferred conformations(4-7). Disparate DNA elements co-localize into functionally defined aggregates or 'factories' for transcription(8) and DNA replication(9). In budding yeast, Drosophila and many other eukaryotes, chromosomes adopt a Rabl configuration, with arms extending from centromeres adjacent to the spindle pole body to telomeres that abut the nuclear envelope(10-12). Nonetheless, the topologies and spatial relationships of chromosomes remain poorly understood. Here we developed a method to globally capture intra-and inter-chromosomal interactions, and applied it to generate a map at kilobase resolution of the haploid genome of Saccharomyces cerevisiae. The map recapitulates known features of genome organization, thereby validating the method, and identifies new features. Extensive regional and higher order folding of individual chromosomes is observed. Chromosome XII exhibits a striking conformation that implicates the nucleolus as a formidable barrier to interaction between DNA sequences at either end. Inter-chromosomal contacts are anchored by centromeres and include interactions among transfer RNA genes, among origins of early DNA replication and among sites where chromosomal breakpoints occur. Finally, we constructed a three-dimensional model of the yeast genome. Our findings provide a glimpse of the interface between the form and function of a eukaryotic genome.	[Duan, Zhijun; Kim, Yoo Jung; Blau, C. Anthony] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Duan, Zhijun; Kim, Yoo Jung; Fields, Stanley; Blau, C. Anthony] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Andronescu, Mirela; McIlwain, Sean; Lee, Choli; Shendure, Jay; Fields, Stanley; Blau, C. Anthony; Noble, William S.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Schutz, Kevin] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Fields, Stanley] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Blau, CA (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.	tblau@u.washington.edu; william-noble@u.washington.edu	Shendure, Jay/AAU-3684-2021	Kim, Yoo Jung/0000-0003-4589-5875; Shendure, Jay/0000-0002-1516-1865	NIH [P01GM081619, P41RR0011823]; Natural Sciences and Engineering Research Council of Canada; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We appreciate the advice and assistance of M. Dorschner, the comments of S. Di Rienzi, B. Brewer and B. Byers, and the assistance of L. Zhang and G. Schroth (Illumina Inc.) in performing sequencing. We thank A. Brown for help with the 3D model. Supported by NIH grants P01GM081619, P41RR0011823, a post-doctoral fellowship (to M. A.) from the Natural Sciences and Engineering Research Council of Canada, and the Howard Hughes Medical Institute.	Berger AB, 2008, NAT METHODS, V5, P1031, DOI 10.1038/nmeth.1266; Bystricky K, 2005, J CELL BIOL, V168, P375, DOI 10.1083/jcb.200409091; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Di Rienzi SC, 2009, GENOME BIOL EVOL, V1, P350, DOI 10.1093/gbe/evp034; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Fullwood MJ, 2009, J CELL BIOCHEM, V107, P30, DOI 10.1002/jcb.22116; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Haeusler RA, 2008, GENE DEV, V22, P2204, DOI 10.1101/gad.1675908; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Jin QW, 1998, J CELL BIOL, V141, P21, DOI 10.1083/jcb.141.1.21; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lorenz A, 2002, J CELL SCI, V115, P3829, DOI 10.1242/jcs.00066; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Schober H, 2008, GENOME RES, V18, P261, DOI 10.1101/gr.6687808; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Stone EM, 2000, CURR BIOL, V10, P373, DOI 10.1016/S0960-9822(00)00413-9; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Zhao YF, 2009, J FLUORESC, V19, P179, DOI 10.1007/s10895-008-0401-7; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	30	667	693	3	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2010	465	7296					363	367		10.1038/nature08973	http://dx.doi.org/10.1038/nature08973			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20436457	Green Accepted			2022-12-24	WOS:000277829200044
J	Dvorin, JD; Martyn, DC; Patel, SD; Grimley, JS; Collins, CR; Hopp, CS; Bright, AT; Westenberger, S; Winzeler, E; Blackman, MJ; Baker, DA; Wandless, TJ; Duraisingh, MT				Dvorin, Jeffrey D.; Martyn, Derek C.; Patel, Saurabh D.; Grimley, Joshua S.; Collins, Christine R.; Hopp, Christine S.; Bright, A. Taylor; Westenberger, Scott; Winzeler, Elizabeth; Blackman, Michael J.; Baker, David A.; Wandless, Thomas J.; Duraisingh, Manoj T.			A Plant-Like Kinase in Plasmodium falciparum Regulates Parasite Egress from Erythrocytes	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; MALARIA PARASITE; HOST-CELLS; TOXOPLASMA-GONDII; CALCIUM; EXPRESSION	Clinical malaria is associated with the proliferation of Plasmodium parasites in human erythrocytes. The coordinated processes of parasite egress from and invasion into erythrocytes are rapid and tightly regulated. We have found that the plant-like calcium-dependent protein kinase PfCDPK5, which is expressed in invasive merozoite forms of Plasmodium falciparum, was critical for egress. Parasites deficient in PfCDPK5 arrested as mature schizonts with intact membranes, despite normal maturation of egress proteases and invasion ligands. Merozoites physically released from stalled schizonts were capable of invading new erythrocytes, separating the pathways of egress and invasion. The arrest was downstream of cyclic guanosine monophosphate-dependent protein kinase (PfPKG) function and independent of protease processing. Thus, PfCDPK5 plays an essential role during the blood stage of malaria replication.	[Dvorin, Jeffrey D.; Patel, Saurabh D.; Duraisingh, Manoj T.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Dvorin, Jeffrey D.] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Patel, Saurabh D.] Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Martyn, Derek C.] Broad Inst, Cambridge, MA 02142 USA; [Grimley, Joshua S.; Wandless, Thomas J.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Collins, Christine R.; Blackman, Michael J.] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England; [Hopp, Christine S.; Baker, David A.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Bright, A. Taylor; Westenberger, Scott; Winzeler, Elizabeth] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Winzeler, Elizabeth] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; MRC National Institute for Medical Research; University of London; London School of Hygiene & Tropical Medicine; Scripps Research Institute; Novartis	Duraisingh, MT (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	mduraisi@hsph.harvard.edu	Winzeler, Elizabeth/AAP-6752-2020	Winzeler, Elizabeth/0000-0002-4049-2113; Hopp, Christine/0000-0002-0528-9531; Dvorin, Jeffrey/0000-0002-5883-7271; Baker, David/0000-0002-5490-8933	Pediatric Scientist Development Program [K12-HD000850]; National Institutes of Health [R01AI057919]; Burroughs Wellcome Fund; MRC UK [U117532063]; Wellcome Trust [086550]; NIH [GM073046]; EU [MALSIG 223044]; MRC [MC_U117532063] Funding Source: UKRI; Medical Research Council [MC_U117532063] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI087874, R01AI057919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073046] Funding Source: NIH RePORTER	Pediatric Scientist Development Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Kettleborough, S. Osborne, and colleagues at Medical Research Council (MRC) Technology for provision of compound 1, S. Badrinath, E. Duraisingh, C. Merrick, and B. Coleman for critical reading of the manuscript, and D. Wirth for essential guidance and support. This work was supported by Pediatric Scientist Development Program Fellowship awards K12-HD000850 (J.D.D. and S.D.P.), National Institutes of Health R01 grant R01AI057919 (M.T.D.), a Burroughs Wellcome Fund New Investigator in the Pathogenesis of Infectious Diseases Fellowship (M.T.D.), the MRC UK U117532063 (M.J.B.), a Wellcome Trust Project grant 086550 (C.R.C.), the NIH GM073046 (T.J.W.), and an EU FP7 grant MALSIG 223044 (D.A.B.).	Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Chandramohanadas R, 2009, SCIENCE, V324, P794, DOI 10.1126/science.1171085; Chu BW, 2008, BIOORG MED CHEM LETT, V18, P5941, DOI 10.1016/j.bmcl.2008.09.043; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; Farber PM, 1997, MOL BIOCHEM PARASIT, V87, P211, DOI 10.1016/S0166-6851(97)00052-2; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Kieschnick H, 2001, J BIOL CHEM, V276, P12369, DOI 10.1074/jbc.M011045200; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Moskes C, 2004, MOL MICROBIOL, V54, P676, DOI 10.1111/j.1365-2958.2004.04313.x; Russo I, 2009, P NATL ACAD SCI USA, V106, P1554, DOI 10.1073/pnas.0806926106; Taylor HM, 2010, EUKARYOT CELL, V9, P37, DOI 10.1128/EC.00186-09; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; ZHAO Y, 1993, J BIOL CHEM, V268, P4347	22	220	230	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980					910	912		10.1126/science.1188191	http://dx.doi.org/10.1126/science.1188191			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466936	Green Accepted			2022-12-24	WOS:000277618800054
J	Pastor, F; Kolonias, D; Giangrande, PH; Gilboa, E				Pastor, Fernando; Kolonias, Despina; Giangrande, Paloma H.; Gilboa, Eli			Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay	NATURE			English	Article							COMBINATION IMMUNOTHERAPY; T-CELLS; EXPRESSION; RECOGNITION; REJECTION; APTAMERS	The main reason why tumours are not controlled by the immune system is that, unlike pathogens, they do not express potent tumour rejection antigens (TRAs). Tumour vaccination aims at stimulating a systemic immune response targeted to, mostly weak, antigens expressed in the disseminated tumour lesions. Main challenges in developing effective vaccination protocols are the identification of potent and broadly expressed TRAs1-3 and effective adjuvants to stimulate a robust and durable immune response(4-6). Here we describe an alternative approach in which the expression of new, and thereby potent, antigens are induced in tumour cells by inhibiting nonsense-mediated messenger RNA decay (NMD)(7-10). Small interfering RNA (siRNA)-mediated inhibition of NMD in tumour cells led to the expression of new antigenic determinants and their immune-mediated rejection. In subcutaneous and metastatic tumour models, tumour-targeted delivery of NMD factor-specific siRNAs conjugated to oligonucleotide aptamer ligands led to significant inhibition of tumour growth that was superior to that of vaccination with granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing irradiated tumour cells(11), and could be further enhanced by co-stimulation. Tumour-targeted NMD inhibition forms the basis of a simple, broadly useful, and clinically feasible approach to enhance the antigenicity of disseminated tumours leading to their immune recognition and rejection. The cell-free chemically synthesized oligonucleotide backbone of aptamer-siRNAs reduces the risk of immunogenicity and enhances the feasibility of generating reagents suitable for clinical use.	[Pastor, Fernando; Kolonias, Despina; Gilboa, Eli] Univ Miami, Miller Sch Med Miami, Dodson Interdisciplinary Immunotherapy Inst, Dept Microbiol & Immunol, Miami, FL 33134 USA; [Giangrande, Paloma H.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Giangrande, Paloma H.] Univ Iowa, Dept Radiat Oncol, Mol & Cellular Biol Program, Iowa City, IA 52242 USA	University of Miami; University of Iowa; University of Iowa	Gilboa, E (corresponding author), Univ Miami, Miller Sch Med Miami, Dodson Interdisciplinary Immunotherapy Inst, Dept Microbiol & Immunol, Miami, FL 33134 USA.	egilboa@med.miami.edu	Pastor, Fernando/T-6239-2017	Pastor, Fernando/0000-0003-0432-3133	Dodson foundation; Sylvester Comprehensive Cancer Center (Medical School, University of Miami); NATIONAL CANCER INSTITUTE [R01CA151857, R01CA138503] Funding Source: NIH RePORTER	Dodson foundation; Sylvester Comprehensive Cancer Center (Medical School, University of Miami); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Zhang for assistance in the mouse studies, A.-M. Jegg for technical assistance in characterizing Smg1 siRNAs, J. Rossi for advising in the design of aptamer-siRNA conjugates, and S. Nair and D. Boczkowski for advice in performing T-cell assays. This work was supported by the Dodson foundation and the Sylvester Comprehensive Cancer Center (Medical School, University of Miami).	Aagaard L, 2007, MOL THER, V15, P938, DOI 10.1038/sj.mt.6300118; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Behm-Ansmant I, 2007, FEBS LETT, V581, P2845, DOI 10.1016/j.febslet.2007.05.027; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Duval A, 2002, CANCER RES, V62, P2447; El-Bchiri J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002583; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gilboa E, 1999, IMMUNITY, V11, P263, DOI 10.1016/S1074-7613(00)80101-6; Gilboa E, 2004, NAT REV CANCER, V4, P401, DOI 10.1038/nrc1359; GOLD L, 1995, J BIOL CHEM, V270, P13581, DOI 10.1074/jbc.270.23.13581; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Jinushi M, 2008, IMMUNOL REV, V222, P287, DOI 10.1111/j.1600-065X.2008.00618.x; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Li MJ, 2005, METHOD ENZYMOL, V392, P218, DOI 10.1016/S0076-6879(04)92013-7; Lupold SE, 2002, CANCER RES, V62, P4029; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; McNamara JO, 2008, J CLIN INVEST, V118, P376, DOI 10.1172/JCI33365; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Muhlemann O, 2008, BBA-GENE REGUL MECH, V1779, P538, DOI 10.1016/j.bbagrm.2008.06.012; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Novellino L, 2005, CANCER IMMUNOL IMMUN, V54, P187, DOI 10.1007/s00262-004-0560-6; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Schietinger A, 2008, SEMIN IMMUNOL, V20, P276, DOI 10.1016/j.smim.2008.07.001; Usuki F, 2006, MOL THER, V14, P351, DOI 10.1016/j.ymthe.2006.04.011; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006	30	186	204	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					227	U114		10.1038/nature08999	http://dx.doi.org/10.1038/nature08999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463739	Green Accepted			2022-12-24	WOS:000277558500037
J	Hernandez, AF; Greiner, MA; Fonarow, GC; Hammill, BG; Heidenreich, PA; Yancy, CW; Peterson, ED; Curtis, LH				Hernandez, Adrian F.; Greiner, Melissa A.; Fonarow, Gregg C.; Hammill, Bradley G.; Heidenreich, Paul A.; Yancy, Clyde W.; Peterson, Eric D.; Curtis, Lesley H.			Relationship Between Early Physician Follow-up and 30-Day Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; TRANSITIONAL CARE; OPTIMIZE-HF; INPATIENT; OPPORTUNITIES; CHALLENGES; OUTPATIENT; PROGRAM	Context Readmission after hospitalization for heart failure is common. Early outpatient follow-up after hospitalization has been proposed as a means of reducing readmission rates. However, there are limited data describing patterns of follow-up after heart failure hospitalization and its association with readmission rates. Objective To examine associations between outpatient follow-up within 7 days after discharge from a heart failure hospitalization and readmission within 30 days. Design, Setting, and Patients Observational analysis of patients 65 years or older with heart failure and discharged to home from hospitals participating in the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure and the Get With the Guidelines-Heart Failure quality improvement program from January 1, 2003, through December 31, 2006. Main Outcome Measure All-cause readmission within 30 days after discharge. Results The study population included 30 136 patients from 225 hospitals. Median length of stay was 4 days (interquartile range, 2-6) and 21.3% of patients were readmitted within 30 days. At the hospital level, the median percentage of patients who had early follow-up after discharge from the index hospitalization was 38.3% (interquartile range, 32.4%-44.5%). Compared with patients whose index admission was in a hospital in the lowest quartile of early follow-up (30-day readmission rate, 23.3%), the rates of 30-day readmission were 20.5% among patients in the second quartile (riskadjusted hazard ratio [HR], 0.85; 95% confidence interval [CI], 0.78-0.93), 20.5% among patients in the third quartile (risk-adjusted HR, 0.87; 95% CI, 0.78-0.96), and 20.9% among patients in the fourth quartile (risk-adjusted HR, 0.91; 95% CI, 0.83-1.00). Conclusions Among patients who are hospitalized for heart failure, substantial variation exists in hospital-level rates of early outpatient follow-up after discharge. Patients who are discharged from hospitals that have higher early follow-up rates have a lower risk of 30-day readmission.	[Hernandez, Adrian F.; Greiner, Melissa A.; Hammill, Bradley G.; Peterson, Eric D.; Curtis, Lesley H.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27715 USA; [Hernandez, Adrian F.; Peterson, Eric D.; Curtis, Lesley H.] Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA; [Heidenreich, Paul A.] Palo Alto VA Med Ctr, Palo Alto, CA USA; [Fonarow, Gregg C.] Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA; [Yancy, Clyde W.] Baylor Heart & Vasc Inst, Dallas, TX USA	Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Hernandez, AF (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	adrian.hernandez@duke.edu	Peterson, Eric David/ABF-5033-2021; Heidenreich, Paul/AAU-6864-2021; Hernandez, Adrian F/A-7818-2016; Fonarow, Gregg C/D-5988-2014	Heidenreich, Paul/0000-0001-7730-8490; Hernandez, Adrian F/0000-0003-3387-9616; Fonarow, Gregg C/0000-0002-3192-8093	GlaxoSmithKline; Medtronic; American Heart Association Pharmaceutical Round-table Outcomes Center [087512N]; American Heart Association Pharmaceutical Roundtable [0675060N]; Agency for Healthcare Research and Quality [U18HS016964]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016964] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Medtronic(Medtronic); American Heart Association Pharmaceutical Round-table Outcomes Center; American Heart Association Pharmaceutical Roundtable(American Heart Association); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Get With the Guidelines-Heart Failure is a program of the American Heart Association and is supported in part by an unrestricted educational grant from GlaxoSmithKline and Medtronic. OPTIMIZE-HF was supported by GlaxoSmithKline. This study was supported by American Heart Association Pharmaceutical Round-table Outcomes Center grant 087512N. Dr Hernandez was supported by American Heart Association Pharmaceutical Roundtable grant 0675060N. Drs Peterson and Curtis were supported by grant U18HS016964 from the Agency for Healthcare Research and Quality.	Adams KF, 2006, J CARD FAIL, V12, P10, DOI 10.1016/j.cardfail.2005.12.001; *AM COLL CARD I HE, HOSP HOM H2H; *AM HOSP ASS, 2008, AHA ANN SURV DAT 200; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; *CTR MED MED SERV, 2007, CTR MED MED SERV M S; Curtis LH, 2009, CIRC-CARDIOVASC QUAL, V2, P377, DOI 10.1161/CIRCOUTCOMES.108.822692; Ezekowitz JA, 2005, CAN MED ASSOC J, V172, P189, DOI 10.1503/cmaj.1032017; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859; *JOINT COMM, 2006, JOINT COMM SPEC MAN; Jong P, 2003, CIRCULATION, V108, P184, DOI 10.1161/01.CIR.0000080290.39027.48; Kuo Y, 2009, NEW ENGL J MED, V360, P1102, DOI 10.1056/NEJMsa0802381; Leendertse AJ, 2008, ARCH INTERN MED, V168, P1890, DOI 10.1001/archinternmed.2008.3; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Pham HH, 2008, HEALTH AFFAIR, V27, P1315, DOI 10.1377/hlthaff.27.5.1315; Romano PS, 2005, NEW ENGL J MED, V353, P302, DOI 10.1056/NEJMe058150; Sharma G, 2009, JAMA-J AM MED ASSOC, V301, P1671, DOI 10.1001/jama.2009.517	22	722	731	2	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2010	303	17					1716	1722		10.1001/jama.2010.533	http://dx.doi.org/10.1001/jama.2010.533			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591CR	20442387	Bronze			2022-12-24	WOS:000277276600024
J	Hutchins, JRA; Toyoda, Y; Hegemann, B; Poser, I; Heriche, JK; Sykora, MM; Augsburg, M; Hudecz, O; Buschhorn, BA; Bulkescher, J; Conrad, C; Comartin, D; Schleiffer, A; Sarov, M; Pozniakovsky, A; Slabicki, MM; Schloissnig, S; Steinmacher, I; Leuschner, M; Ssykor, A; Lawo, S; Pelletier, L; Stark, H; Nasmyth, K; Ellenberg, J; Durbin, R; Buchholz, F; Mechtler, K; Hyman, AA; Peters, JM				Hutchins, James R. A.; Toyoda, Yusuke; Hegemann, Bjoern; Poser, Ina; Heriche, Jean-Karim; Sykora, Martina M.; Augsburg, Martina; Hudecz, Otto; Buschhorn, Bettina A.; Bulkescher, Jutta; Conrad, Christian; Comartin, David; Schleiffer, Alexander; Sarov, Mihail; Pozniakovsky, Andrei; Slabicki, Mikolaj Michal; Schloissnig, Siegfried; Steinmacher, Ines; Leuschner, Marit; Ssykor, Andrea; Lawo, Steffen; Pelletier, Laurence; Stark, Holger; Nasmyth, Kim; Ellenberg, Jan; Durbin, Richard; Buchholz, Frank; Mechtler, Karl; Hyman, Anthony A.; Peters, Jan-Michael			Systematic Analysis of Human Protein Complexes Identifies Chromosome Segregation Proteins	SCIENCE			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; MAMMALIAN-CELL DIVISION; TISSUE-CULTURE CELLS; CAENORHABDITIS-ELEGANS; MICROTUBULE GENERATION; GLOBAL ANALYSIS; SPINDLE; GENOME; RNAI; CENTROSOME	Chromosome segregation and cell division are essential, highly ordered processes that depend on numerous protein complexes. Results from recent RNA interference screens indicate that the identity and composition of these protein complexes is incompletely understood. Using gene tagging on bacterial artificial chromosomes, protein localization, and tandem-affinity purification-mass spectrometry, the MitoCheck consortium has analyzed about 100 human protein complexes, many of which had not or had only incompletely been characterized. This work has led to the discovery of previously unknown, evolutionarily conserved subunits of the anaphase-promoting complex and the g-tubulin ring complex-large complexes that are essential for spindle assembly and chromosome segregation. The approaches we describe here are generally applicable to high-throughput follow-up analyses of phenotypic screens in mammalian cells.	[Toyoda, Yusuke; Poser, Ina; Augsburg, Martina; Sarov, Mihail; Pozniakovsky, Andrei; Slabicki, Mikolaj Michal; Schloissnig, Siegfried; Leuschner, Marit; Ssykor, Andrea; Buchholz, Frank; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Hutchins, James R. A.; Hegemann, Bjoern; Sykora, Martina M.; Hudecz, Otto; Buschhorn, Bettina A.; Schleiffer, Alexander; Steinmacher, Ines; Nasmyth, Kim; Mechtler, Karl; Peters, Jan-Michael] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Heriche, Jean-Karim; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Heriche, Jean-Karim; Bulkescher, Jutta; Conrad, Christian; Ellenberg, Jan] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Comartin, David; Lawo, Steffen; Pelletier, Laurence] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Comartin, David; Lawo, Steffen; Pelletier, Laurence] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Schloissnig, Siegfried] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Stark, Holger] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society	Hyman, AA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	hyman@mpi-cbg.de; peters@imp.univie.ac.at	Mechtler, Karl/AAF-2717-2019; Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Durbin, Richard/AAE-7178-2019; Ellenberg, Jan/I-4688-2014; Pelletier, Laurence/F-8858-2013; Hegemann, Björn/A-8761-2015; Buchholz, Frank/B-4700-2017	Mechtler, Karl/0000-0002-3392-9946; Hyman, Anthony A/0000-0003-3664-154X; Durbin, Richard/0000-0002-9130-1006; Ellenberg, Jan/0000-0001-5909-701X; Hegemann, Björn/0000-0002-1009-2952; Buchholz, Frank/0000-0002-4577-3344; Schloissnig, Siegfried/0000-0003-4574-8330; Schleiffer, Alexander/0000-0001-6251-2747; Toyoda, Yusuke/0000-0003-0534-6898; Holger, Stark/0000-0002-6161-1118; Heriche, Jean-Karim/0000-0001-6867-9425; Lawo, Steffen/0000-0002-9659-7416; Nasmyth, Kim/0000-0001-7030-4403	European Commission [LSHG-CT-2004-503464]; Boehringer Ingelheim; Vienna Spots of Excellence Programme; Austrian Science Fund Special Research Programme "Chromosome Dynamics"; Genome Research in Austria Programme; Max Planck Society; Bundesministerium fur Bildung und Forschung [NGFN-2 SMP-RNAi (01GR0402), NGFN-Plus (01GS0859)]; Natural Science and Engineering Research Council of Canada [RGPIN-355644-2008]; National Cancer Institute of Canada [019562]; Human Frontier Science Program [CDA0044/200]; Japan Society for the Promotion of Science	European Commission(European CommissionEuropean Commission Joint Research Centre); Boehringer Ingelheim(Boehringer Ingelheim); Vienna Spots of Excellence Programme; Austrian Science Fund Special Research Programme "Chromosome Dynamics"(Austrian Science Fund (FWF)); Genome Research in Austria Programme; Max Planck Society(Max Planck SocietyFoundation CELLEX); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Human Frontier Science Program(Human Frontier Science Program); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to the following colleagues for their excellent assistance: E. Kreidl, M. Mazanek, M. Madalinski, G. Mitulovic, M. Novatchkova, C. Stingl, Y. Sun (IMP and Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna); A. Bird, K. Kozak, D. Krastev, Z. Maliga, D. Richter, M. Theis, M. Toyoda (MPI, Dresden); P. Dube (MPI, Gottingen); and N. Kraut (Boehringer Ingelheim, Vienna). This work was funded in the most part by the European Commission via the Sixth Framework Programme Integrated Project MitoCheck (LSHG-CT-2004-503464). Work in the laboratories of J.-M.P. and K. M. received support from Boehringer Ingelheim, the Vienna Spots of Excellence Programme, the Austrian Science Fund Special Research Programme "Chromosome Dynamics," and the Genome Research in Austria Programme. Work in the laboratories of A. A. H. and F. B. received support from the Max Planck Society and from Bundesministerium fur Bildung und Forschung grants NGFN-2 SMP-RNAi (01GR0402) and NGFN-Plus (01GS0859). Work in the laboratory of L. P. was supported by operating grants from the Natural Science and Engineering Research Council of Canada (RGPIN-355644-2008), the National Cancer Institute of Canada (019562), and the Human Frontier Science Program (CDA0044/200). L. P. holds a Canada Research Chair in Centrosome Biogenesis and Function. Y. T. was supported by a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; CHEESEMAN IM, 2005, SCI STKE, pPL1, DOI DOI 10.1126/STKE.2662005PL1; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Kittler R, 2008, CELL CYCLE, V7, P2123, DOI 10.4161/cc.7.14.6322; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Patel U, 2002, CURR BIOL, V12, pR408, DOI 10.1016/S0960-9822(02)00908-9; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Somma MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000126; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Theis M, 2009, EMBO J, V28, P1453, DOI 10.1038/emboj.2009.114; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	29	384	396	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					593	599		10.1126/science.1181348	http://dx.doi.org/10.1126/science.1181348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20360068	Green Accepted			2022-12-24	WOS:000277159800035
J	Shimamura, T; Weyand, S; Beckstein, O; Rutherford, NG; Hadden, JM; Sharples, D; Sansom, MSP; Iwata, S; Henderson, PJF; Cameron, AD				Shimamura, Tatsuro; Weyand, Simone; Beckstein, Oliver; Rutherford, Nicholas G.; Hadden, Jonathan M.; Sharples, David; Sansom, Mark S. P.; Iwata, So; Henderson, Peter J. F.; Cameron, Alexander D.			Molecular Basis of Alternating Access Membrane Transport by the Sodium-Hydantoin Transporter Mhp1	SCIENCE			English	Article							AMINO-ACID ANTIPORTER; NEUROTRANSMITTER TRANSPORTERS; MICROBACTERIUM-LIQUEFACIENS; CRYSTAL-STRUCTURE; MECHANISM; MODEL	The structure of the sodium-benzylhydantoin transport protein Mhp1 from Microbacterium liquefaciens comprises a five-helix inverted repeat, which is widespread among secondary transporters. Here, we report the crystal structure of an inward-facing conformation of Mhp1 at 3.8 angstroms resolution, complementing its previously described structures in outward-facing and occluded states. From analyses of the three structures and molecular dynamics simulations, we propose a mechanism for the transport cycle in Mhp1. Switching from the outward-to the inward-facing state, to effect the inward release of sodium and benzylhydantoin, is primarily achieved by a rigid body movement of transmembrane helices 3, 4, 8, and 9 relative to the rest of the protein. This forms the basis of an alternating access mechanism applicable to many transporters of this emerging superfamily.	[Shimamura, Tatsuro; Weyand, Simone; Iwata, So; Cameron, Alexander D.] Univ London Imperial Coll Sci Technol & Med, Membrane Prot Crystallog Grp, Div Mol Biosci, London SW7 2AZ, England; [Shimamura, Tatsuro; Weyand, Simone; Iwata, So; Cameron, Alexander D.] Japan Sci & Technol Agcy, Human Receptor Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Shimamura, Tatsuro; Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Weyand, Simone; Iwata, So; Cameron, Alexander D.] Diamond Light Source, Membrane Prot Lab, Didcot OX11 0DE, Oxon, England; [Beckstein, Oliver; Sansom, Mark S. P.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Rutherford, Nicholas G.; Hadden, Jonathan M.; Sharples, David; Henderson, Peter J. F.] Univ Leeds, Inst Membrane & Syst Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Iwata, So] RIKEN, Syst & Struct Biol Ctr, Tsurumi ku, Kanagawa 2300045, Japan	Imperial College London; Japan Science & Technology Agency (JST); Kyoto University; Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Oxford; University of Leeds; RIKEN	Iwata, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Membrane Prot Crystallog Grp, Div Mol Biosci, London SW7 2AZ, England.	s.iwata@imperial.ac.uk; p.j.f.henderson@leeds.ac.uk; a.cameron@imperial.ac.uk	Cameron, Alexander/L-7288-2013; Sansom, Mark S.P./C-5157-2009; Beckstein, Oliver/C-9095-2009; Henderson, Peter JF/Q-1907-2018	Sansom, Mark S.P./0000-0001-6360-7959; Beckstein, Oliver/0000-0003-1340-0831; Henderson, Peter/0000-0002-9187-0938; Cameron, Alexander/0000-0001-8776-3518	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C51725]; European Union [LSHG-CT-2004-504601, 201924]; Wellcome Trust [062164/Z/00/Z]; Leverhulme Trust; European Molecular Biology Organization; BBSRC MPSi [BBS/B/14418]; S. Suzuki and Ajinomoto Company Incorporated; Japan Science and Technology Agency; MEXT, Japan;  [21370043]; BBSRC [BB/H000267/1, BB/G023425/1, BB/G020043/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/14418, B19456, BBS/B/16011, BEP17032, BB/H000267/1, BB/G023425/1, BB/C51725X/1, BB/G020043/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); BBSRC MPSi(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); S. Suzuki and Ajinomoto Company Incorporated; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (grant no. BB/C51725) and the European Union (EMeP grant, LSHG-CT-2004-504601, and EDICT grant 201924). The authors are grateful for the use of the Membrane Protein Laboratory funded by the Wellcome Trust (grant 062164/Z/00/Z) at the Diamond Light Source Limited. P.J.F.H. received personal funding from the Leverhulme Trust, S. W. from a European Molecular Biology Organization long-term fellowship, T. S. from a Grant-in-Aid for Scientific Research (B) (grant 21370043) and J.H. from the BBSRC MPSi (grant BBS/B/14418). We appreciate the additional support of S. Suzuki and Ajinomoto Company Incorporated. A part of this work was also supported by a grant from the ERATO IWATA Human Receptor Crystallography Project from the Japan Science and Technology Agency and by the Targeted Proteins Research Program of MEXT, Japan. Data were collected at the European Synchrotron Radiation Facility, and further experiments were carried out at Diamond Light Source. We are grateful to D. Drew for critical reading of the manuscript. The coordinates and the structure factors for Mhp1 have been deposited in the Protein Data Bank (entry 2X79).	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Beckstein O, 2009, J MOL BIOL, V394, P160, DOI 10.1016/j.jmb.2009.09.009; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; CRANE RK, 1961, MEMBRANE TRANSPORT M, P439; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Harada N, 2000, ACTA HAEMATOL-BASEL, V103, P144, DOI 10.1159/000041037; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Leonard GA, 2009, J APPL CRYSTALLOGR, V42, P333, DOI 10.1107/S0021889809001721; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Loo DDF, 2006, J GEN PHYSIOL, V128, P701, DOI 10.1085/jgp.200609643; MITCHELL P, 1967, ADV ENZYMOL RAMB, V29, P33; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shimamura T, 2008, ACTA CRYSTALLOGR F, V64, P1172, DOI 10.1107/S1744309108036920; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Suzuki S, 2006, J BACTERIOL, V188, P3329, DOI 10.1128/JB.188.9.3329-3336.2006; TANFORD C, 1983, P NATL ACAD SCI-BIOL, V80, P3701, DOI 10.1073/pnas.80.12.3701; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4	30	220	226	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2010	328	5977					470	473		10.1126/science.1186303	http://dx.doi.org/10.1126/science.1186303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413494	Green Accepted			2022-12-24	WOS:000276952400034
J	Kahn, R; Alperin, P; Eddy, D; Borch-Johnsen, K; Buse, J; Feigelman, J; Gregg, E; Holman, RR; Kirkman, MS; Stern, M; Tuomilehto, J; Wareham, NJ				Kahn, Richard; Alperin, Peter; Eddy, David; Borch-Johnsen, Knut; Buse, John; Feigelman, Justin; Gregg, Edward; Holman, Rury R.; Kirkman, M. Sue; Stern, Michael; Tuomilehto, Jaakko; Wareham, Nick J.			Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis	LANCET			English	Article							PREVENTION; ARCHIMEDES; HEALTH; MODEL; POPULATION; STRATEGIES; MELLITUS; GLUCOSE; ADULTS; IMPACT	Background No clinical trials have assessed the effects or cost-effectiveness of sequential screening strategies to detect new cases of type 2 diabetes. We used a mathematical model to estimate the cost-effectiveness of several screening strategies. Methods We used person-specific data from a representative sample of the US population to create a simulated population of 325 000 people aged 30 years without diabetes. We used the Archimedes model to compare eight simulated screening strategies for type 2 diabetes with a no-screening control strategy. Strategies differed in terms of age at initiation and frequency of screening. Once diagnosed, diabetes treatment was simulated in a standard manner. We calculated the effects of each strategy on the incidence of type 2 diabetes, myocardial infarction, stroke, and microvascular complications in addition to quality of life, costs, and cost per quality-adjusted life-year (QALY). Findings Compared with no screening, all simulated screening strategies reduced the incidence of myocardial infarction (3-9 events prevented per 1000 people screened) and diabetes-related microvascular complications (3-9 events prevented per 1000 people), and increased the number of QALYs (93-194 undiscounted QALYs) added over 50 years. Most strategies prevented a significant number of simulated deaths (2-5 events per 1000 people). There was little or no effect of screening on incidence of stroke (0-1 event prevented per 1000 people). Five screening strategies had costs per QALY of about US$10 500 or less, whereas costs were much higher for screening started at 45 years of age and repeated every year ($15 509), screening started at 60 years of age and repeated every 3 years ($25738), or a maximum screening strategy (screening started at 30 years of age and repeated every 6 months; $40 778). Several strategies differed substantially in the number of QALYs gained. Costs per QALY were sensitive to the disutility assigned to the state of having diabetes diagnosed with or without symptoms. Interpretation In the US population, screening for type 2 diabetes is cost effective when started between the ages of 30 years and 45 years, with screening repeated every 3-5 years.	[Kahn, Richard; Kirkman, M. Sue] Amer Diabet Assoc, Alexandria, VA USA; [Alperin, Peter; Eddy, David; Feigelman, Justin] Archimedes, San Francisco, CA USA; [Borch-Johnsen, Knut] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Buse, John] Univ N Carolina, Sch Med, Dept Med, Div Endocrinol, Chapel Hill, NC USA; [Gregg, Edward] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA; [Holman, Rury R.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trials Unit, Oxford, England; [Stern, Michael] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Tuomilehto, Jaakko] Univ Helsinki, Hjelt Inst, Helsinki, Finland; [Wareham, Nick J.] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England	American Diabetes Association; Steno Diabetes Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Centers for Disease Control & Prevention - USA; University of Oxford; University of Texas System; University of Texas Health San Antonio; University of Helsinki; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Kahn, R (corresponding author), 1701 N Beauregard St, Alexandria, VA 22311 USA.	rak6200@gmail.com	Buse, John Bernard/J-9742-2019	Buse, John Bernard/0000-0002-9723-3876; Gregg, Edward/0000-0003-2381-6822	Novo Nordisk; Bayer HealthCare; Pfizer; Medical Research Council [MC_U106179471] Funding Source: researchfish	Novo Nordisk(Novo Nordisk); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Novo Nordisk, Bayer HealthCare, and Pfizer.	*AM DIAB ASS, 2004, DIABETES CARE S1, V27, pS11, DOI DOI 10.2337/DIACARE.27.2007.S11; [Anonymous], MED EXP PAN SURV; *ARCH, ARCH MOD; Calonge N, 2008, ANN INTERN MED, V148, P846, DOI 10.7326/0003-4819-148-11-200806030-00007; Centers for Disease Control and Prevention (CDC), NAT HLTH NUTR EX SUR; Centers for Medicare and Medicaid Services, MEDPAR; Chen THH, 2001, DIABETES RES CLIN PR, V54, pS37; Cherry Donald K, 2008, Natl Health Stat Report, P1; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coffey JT, 2002, DIABETES CARE, V25, P2238, DOI 10.2337/diacare.25.12.2238; Colagiuri S, 2002, DIABETES CARE, V25, P1378, DOI 10.2337/diacare.25.8.1378; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; *CTR MED MED SERV, HOSP OUTP REG NOT; *CTR MED MED SERV, EXTR SUMM SYST BES B; *CTR MED MED SERV, STAND AN FIL LDS; Eddy DM, 2003, DIABETES CARE, V26, P3102, DOI 10.2337/diacare.26.11.3102; Eddy DM, 2003, DIABETES CARE, V26, P3093, DOI 10.2337/diacare.26.11.3093; Eddy DM, 2005, ANN INTERN MED, V143, P251, DOI 10.7326/0003-4819-143-4-200508160-00006; Edelman D, 2002, DIABETES CARE, V25, P1022, DOI 10.2337/diacare.25.6.1022; Engelgau MM, 1998, JAMA-J AM MED ASSOC, V280, P1757; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Glumer C, 2006, DIABETOLOGIA, V49, P1536, DOI 10.1007/s00125-006-0248-x; Goyder EC, 2000, DIABETIC MED, V17, P469, DOI 10.1046/j.1464-5491.2000.00308.x; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hoerger TJ, 2004, ANN INTERN MED, V140, P689, DOI 10.7326/0003-4819-140-9-200405040-00008; Hofer TP, 2000, INT J TECHNOL ASSESS, V16, P822, DOI 10.1017/S0266462300102090; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Icks A, 2004, DIABETES CARE, V27, P2120, DOI 10.2337/diacare.27.9.2120; Kahn R, 2008, DIABETES CARE, V31, P1686, DOI 10.2337/dc08-9022; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Palmer AJ, 2007, DIABETES CARE, V30, P1638, DOI 10.2337/dc07-9919; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; PATERSON KR, 1993, DIABETIC MED, V10, P777, DOI 10.1111/j.1464-5491.1993.tb00164.x; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Schlessinger L, 2002, J BIOMED INFORM, V35, P37, DOI 10.1016/S1532-0464(02)00006-0; Spijkerman AMW, 2003, DIABETES CARE, V26, P2604, DOI 10.2337/diacare.26.9.2604; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UK Prospective Diabetes Study Grp, 1999, DIABETES CARE, V22, P1125; UNCOMMON DRUGSTORE	45	175	179	3	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2010	375	9723					1365	1374		10.1016/S0140-6736(09)62162-0	http://dx.doi.org/10.1016/S0140-6736(09)62162-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588GW	20356621				2022-12-24	WOS:000277057800027
J	Shinar, G; Feinberg, M				Shinar, Guy; Feinberg, Martin			Structural Sources of Robustness in Biochemical Reaction Networks	SCIENCE			English	Article							CHEMICAL-REACTION NETWORKS; BACTERIAL CHEMOTAXIS; PHOSPHATASE-ACTIVITY; PHOSPHORYLATION; DEPHOSPHORYLATION; ADAPTATION; GRADIENT; SENSOR; ENVZ	In vivo variations in the concentrations of biomolecular species are inevitable. These variations in turn propagate along networks of chemical reactions and modify the concentrations of still other species, which influence biological activity. Because excessive variations in the amounts of certain active species might hamper cell function, regulation systems have evolved that act to maintain concentrations within tight bounds. We identify simple yet subtle structural attributes that impart concentration robustness to any mass-action network possessing them. We thereby describe a large class of robustness-inducing networks that already embraces two quite different biochemical modules for which concentration robustness has been observed experimentally: the Escherichia coli osmoregulation system EnvZ-OmpR and the glyoxylate bypass control system isocitrate dehydrogenase kinase-phosphatase-isocitrate dehydrogenase. The structural attributes identified here might confer robustness far more broadly.	[Feinberg, Martin] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Koffolt Labs 125, Columbus, OH 43210 USA; [Shinar, Guy] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Feinberg, Martin] Ohio State Univ, Dept Math, Koffolt Labs 125, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Weizmann Institute of Science; University System of Ohio; Ohio State University	Feinberg, M (corresponding author), Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Koffolt Labs 125, 140 W 19th Ave, Columbus, OH 43210 USA.	feinberg@chbmeng.ohio-state.edu			NSF [BES-0425459]; NIH [1R01GM086881-01]; Kahn Family Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086881] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kahn Family Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to U. Alon for comments, insight, and support; E. Eden for writing the software implementation of the theorem; and A. Cohen, G. Enciso, R. Kishony, D. Koster, M. Laub, A. Mayo, R. Milo, and J. Rabinowitz for their help. Supported by NSF grant BES-0425459, NIH grant 1R01GM086881-01, and the Kahn Family Foundation.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Craciun G, 2006, P NATL ACAD SCI USA, V103, P8697, DOI 10.1073/pnas.0602767103; Csikasz-Nagy A, 2008, J R SOC INTERFACE, V5, pS41, DOI 10.1098/rsif.2008.0099.focus; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; EDEN E, 2009, REACTION NETWORK ANA; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; FEINBERG M, 1987, CHEM ENG SCI, V42, P2229, DOI 10.1016/0009-2509(87)80099-4; Feinberg M, 1995, ARCH RATION MECH AN, V132, P311, DOI 10.1007/BF00375614; FEINBERG M, 1979, LECT CHEM REACT NETW; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; IGO MM, 1989, GENE DEV, V3, P1725, DOI 10.1101/gad.3.11.1725; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; LAPORTE DC, 1985, J BIOL CHEM, V260, P563; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; Pratt L., 1995, 2 COMPONENT SIGNAL T, P105; Sanowar S, 2005, BIOCHEM J, V390, P769, DOI 10.1042/BJ20050060; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; Shinar G, 2009, SIAM J APPL MATH, V69, P977, DOI 10.1137/080719820; Shinar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000297; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; Zhu Y, 2000, P NATL ACAD SCI USA, V97, P7808, DOI 10.1073/pnas.97.14.7808	24	236	238	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1389	1391		10.1126/science.1183372	http://dx.doi.org/10.1126/science.1183372			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223989				2022-12-24	WOS:000275418700044
J	Gandhi, NR; Nunn, P; Dheda, K; Schaaf, HS; Zignol, M; van Soolingen, D; Jensen, P; Bayona, J				Gandhi, Neel R.; Nunn, Paul; Dheda, Keertan; Schaaf, H. Simon; Zignol, Matteo; van Soolingen, Dick; Jensen, Paul; Bayona, Jaime			Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis	LANCET			English	Article							HIV-INFECTED PATIENTS; NEW-YORK-CITY; COMMUNITY-BASED THERAPY; MYCOBACTERIUM-TUBERCULOSIS; XDR-TB; PULMONARY TUBERCULOSIS; NOSOCOMIAL TRANSMISSION; TREATMENT OUTCOMES; CLINICAL-FEATURES; WESTERN-CAPE	Although progress has been made to reduce global incidence of drug-susceptible tuberculosis, the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis during the past decade threatens to undermine these advances. However, countries are responding far too slowly. Of the estimated 440000 cases of MDR tuberculosis that occurred in 2008, only 7% were identified and reported to WHO. Of these cases, only a fifth were treated according to WHO standards. Although treatment of MDR and XDR tuberculosis is possible with currently available diagnostic techniques and drugs, the treatment course is substantially more costly and laborious than for drug-susceptible tuberculosis, with higher rates of treatment failure and mortality. Nonetheless, a few countries provide examples of how existing technologies can be used to reverse the epidemic of MDR tuberculosis within a decade. Major improvements in laboratory capacity, infection control, performance of tuberculosis control programmes, and treatment regimens for both drug-susceptible and drug-resistant disease will be needed, together with a massive scale-up in diagnosis and treatment of MDR and XDR tuberculosis to prevent drug-resistant strains from becoming the dominant form of tuberculosis. New diagnostic tests and drugs are likely to become available during the next few years and should accelerate control of MDR and XDR tuberculosis. Equally important, especially in the highest-burden countries of India, China, and Russia, will be a commitment to tuberculosis control including improvements in national policies and health systems that remove financial barriers to treatment, encourage rational drug use, and create the infrastructure necessary to manage MDR tuberculosis on a national scale.	[Gandhi, Neel R.] Albert Einstein Coll Med, Dept Med, New York, NY 10467 USA; [Gandhi, Neel R.] Montefiore Med Ctr, Div Gen Internal Med, New York, NY 10467 USA; [Gandhi, Neel R.] Tugela Ferry Care & Res Collaborat TF CARES, Tugela Ferry, South Africa; [Nunn, Paul; Zignol, Matteo] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland; [Dheda, Keertan] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] UCL, Dept Infect, London, England; [Schaaf, H. Simon] Univ Stellenbosch, Dept Pediat & Child Hlth, Cape Town, South Africa; [van Soolingen, Dick] Natl Inst Publ Hlth & Environm, TB Reference Lab, NL-3720 BA Bilthoven, Netherlands; [Jensen, Paul] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Bayona, Jaime] Socios Salud & Partners Hlth, Lima, Peru	Yeshiva University; Montefiore Medical Center; World Health Organization; University of Cape Town; University of Cape Town; University of London; University College London; Stellenbosch University; Netherlands National Institute for Public Health & the Environment; Centers for Disease Control & Prevention - USA	Gandhi, NR (corresponding author), Albert Einstein Coll Med, Dept Med, 111 E 210 St, New York, NY 10467 USA.	neelgandhi@alumni.williams.edu		Schaaf, Hendrik Simon/0000-0001-5755-4133	Doris Duke Charitable Foundation; South African Research Chair Initiative; MRC; European Union; EDCTP; South African Medical Research Council; National Research Foundation	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); South African Research Chair Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); EDCTP; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation	NRG is the recipient of the Doris Duke Charitable Foundation Clinical Scientist Development Award. KD is supported by a South African Research Chair Initiative award, a MRC Career Development Fellowship, the European Union (FW7-TBsusgent), and the EDCTP (TESA and TB-NEAT). HSS is supported by the South African Medical Research Council and National Research Foundation for MDR TB studies.	ALLAN WGL, 1977, AM REV RESPIR DIS, V115, P727; ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; [Anonymous], 2008, GUID PROGR MAN DRUG; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; BATEMAN C, 2007, S AFR MED J, V97, P1028; BATEMAN C, 2007, S AFR MED J, V97, P1030; Bateman Chris, 2007, S Afr Med J, V97, P1030; Bayona J, 2003, INT J TUBERC LUNG D, V7, pS501; Ben Amor Y, 2008, EMERG INFECT DIS, V14, P1345, DOI 10.3201/eid1409.061524; Bernardo J, 2009, AM J RESP CRIT CARE, V180, P288, DOI 10.1164/rccm.200906-0863ED; Blomberg B, 2001, B WORLD HEALTH ORGAN, V79, P61; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Borgdorff MW, 2009, LANCET, V373, P1822, DOI 10.1016/S0140-6736(09)60557-2; Burman WJ, 1997, CHEST, V112, P57, DOI 10.1378/chest.112.1.57; Bwanga F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-67; Caminero JA, 2006, INT J TUBERC LUNG D, V10, P829; Cato A, 1998, CLIN PHARMACOL THER, V63, P414, DOI 10.1016/S0009-9236(98)90036-4; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; *CDCP, 1991, JAMA-J AM MED ASSOC, V266, P1483; Chideya S, 2009, CLIN INFECT DIS, V48, P1685, DOI 10.1086/599040; CHIRENDA J, 2009, INT J TUBERC LUNG S1, V13, pS3; Churchyard GJ, 2009, CLIN CHEST MED, V30, P769, DOI 10.1016/j.ccm.2009.08.009; Cohen T, 2008, AM J RESP CRIT CARE, V177, P1302, DOI 10.1164/rccm.200801-175PP; COMBS DL, 1990, ANN INTERN MED, V112, P397, DOI 10.7326/0003-4819-76-3-112-6-397; Cox HS, 2007, CLIN INFECT DIS, V44, P1421, DOI 10.1086/517536; DAVID HL, 1970, APPL MICROBIOL, V20, P810, DOI 10.1128/AEM.20.5.810-814.1970; Devasia RA, 2009, AM J RESP CRIT CARE, V180, P365, DOI 10.1164/rccm.200901-0146OC; Devaux I, 2009, EMERG INFECT DIS, V15, P1052, DOI 10.3201/eid1507.080994; DHEDA K, LANCET IN PRESS; DHEDA K, 2009, TUBERCULOSIS COMPREH, P746; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Drobac PC, 2006, PEDIATRICS, V117, P2022, DOI 10.1542/peds.2005-2235; Dubrovina I, 2008, INT J TUBERC LUNG D, V12, P756; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Dye C, 2009, NAT REV MICROBIOL, V7, P81, DOI 10.1038/nrmicro2048; Dye C, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000346; EAST AFRICAN /BRITISH MEDICAL RESEARCH COUNCILS, 1973, Lancet, P1331; Eker B, 2008, EMERG INFECT DIS, V14, P1700, DOI 10.3201/eid1411.080729; ESCOMBE A, 2007, PLOS MED, V4, pE63; Escombe AR, 2007, CLIN INFECT DIS, V44, P1349, DOI 10.1086/515397; Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043; Espinal M, 2009, INT J TUBERC LUNG D, V13, P1; Feja K, 2008, PEDIATR INFECT DIS J, V27, P907, DOI 10.1097/INF.0b013e3181783aca; FLOYD K, 2006, TB COMPREHENSIVE INT, P649; Forsythe CT, 2007, CAN J EMERG MED, V9, P459; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; FRIEDEN TR, 1993, NEW ENGL J MED, V328, P521, DOI 10.1056/NEJM199302253280801; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gagneux S, 2009, CLIN MICROBIOL INFEC, V15, P66, DOI 10.1111/j.1469-0691.2008.02685.x; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Garcia-Garcia MD, 2000, ARCH INTERN MED, V160, P630, DOI 10.1001/archinte.160.5.630; Grandjean L, 2008, CURR OPIN INFECT DIS, V21, P454, DOI 10.1097/QCO.0b013e32830ce783; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Katiyar SK, 2008, INT J TUBERC LUNG D, V12, P139; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Kobaidze K, 2009, INTERDISCIP PERSPECT, V2009; Laserson KF, 2001, INT J TUBERC LUNG D, V5, P448; Laszlo A, 2002, INT J TUBERC LUNG D, V6, P748; Legrand J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002100; Lienhardt C, 2010, CURR OPIN PULM MED, V16, P186, DOI 10.1097/MCP.0b013e328337580c; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2000, INT J TUBERC LUNG D, V4, P1052; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Marais BJ, 2006, CLIN INFECT DIS, V42, pE69, DOI 10.1086/502652; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Migliori GB, 2009, EUR RESPIR J, V34, P387, DOI 10.1183/09031936.00009509; Migliori GB, 2007, EUROSURVEILLANCE, V12, P5, DOI DOI 10.2807/ESW.12.20.03194-EN; Migliori GB, 2007, EMERG INFECT DIS, V13, P780, DOI 10.3201/eid1305.070200; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Mitnick CD, 2007, PLOS MED, V4, P1730, DOI 10.1371/journal.pmed.0040292; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; MOLL A, 2009, 40 UN WORLD C LUNG H; MPHAHLELE M, 2009, 40 UN WORLD C LUNG H; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; Nelson LJ, 2005, LANCET, V366, P488, DOI 10.1016/S0140-6736(05)67062-6; Nkengasong JN, 2009, AM J CLIN PATHOL, V131, P852, DOI 10.1309/AJCPC51BLOBBPAKC; Nunes EA, 2005, INT J TUBERC LUNG D, V9, P494; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; ODONNELL MR, 2009, 5 INT AIDS SOC C HIV; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pai M, 2009, CLIN CHEST MED, V30, P701, DOI 10.1016/j.ccm.2009.08.016; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Perez-Guzman C, 2002, INT J TUBERC LUNG D, V6, P1102; Perkins MD, 2006, LANCET, V367, P942, DOI 10.1016/S0140-6736(06)68386-4; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Post FA, 2004, J INFECT DIS, V190, P99, DOI 10.1086/421501; Raviglione M, 2008, HARRISONS PRINCIPLES, P1006; Raviglione M, 2006, INT J TUBERC LUNG D, V10, P1185; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; RILEY RL, 1989, AM REV RESPIR DIS, V139, P1286, DOI 10.1164/ajrccm/139.5.1286; RILEY RL, 1959, AM J HYG, V70, P185, DOI 10.1093/oxfordjournals.aje.a120069; Ritacco V, 1997, J INFECT DIS, V176, P637, DOI 10.1086/514084; Rullan JV, 1996, EMERG INFECT DIS, V2, P125, DOI 10.3201/eid0202.960208; Sahai J, 1997, ANN INTERN MED, V127, P289, DOI 10.7326/0003-4819-127-4-199708150-00006; Scano F, 2008, INT J TUBERC LUNG D, V12, P1370; Schaaf HS, 2009, CLIN CHEST MED, V30, P667, DOI 10.1016/j.ccm.2009.08.019; Schaaf HS, 2009, PEDIATR INFECT DIS J, V28, P748, DOI 10.1097/INF.0b013e31819bc491; Schaaf HS, 2002, PEDIATRICS, V109, P765, DOI 10.1542/peds.109.5.765; Schaaf HS, 2003, ARCH DIS CHILD, V88, P1106, DOI 10.1136/adc.88.12.1106; Schluger NW, 1996, PEDIATR PULM, V21, P138, DOI 10.1002/(SICI)1099-0496(199602)21:2<138::AID-PPUL9>3.0.CO;2-N; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; SHAH N, 2009, 40 UN WORLD C LUNG H; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0; Shiraishi Y, 2009, J THORAC CARDIOV SUR, V138, P1180, DOI 10.1016/j.jtcvs.2009.07.018; Singh JA, 2007, PLOS MED, V4, P19, DOI 10.1371/journal.pmed.0040050; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Soeters M, 2005, SAMJ S AFR MED J, V95, P602; Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008; Story A, 2007, THORAX, V62, P667, DOI 10.1136/thx.2006.065409; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; THOMAS T, INT J TUBER IN PRESS; Toungoussova OS, 2004, FEMS IMMUNOL MED MIC, V42, P281, DOI 10.1016/j.femsim.2004.05.012; Tsiouris Simon J, 2007, MedGenMed, V9, P62, DOI 10.1186/1758-2652-9-3-62; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; Upshur R, 2009, B WORLD HEALTH ORGAN, V87, P481, DOI 10.2471/BLT.08.051698; van Doorn HR, 2006, CLIN MICROBIOL INFEC, V12, P769, DOI 10.1111/j.1469-0691.2006.01495.x; van Rie A, 2005, AM J RESP CRIT CARE, V172, P636, DOI 10.1164/rccm.200503-449OC; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Victor TC, 2007, INT J TUBERC LUNG D, V11, P195; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; Weiner M, 2005, CLIN INFECT DIS, V41, P1343, DOI 10.1086/496980; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2010, MULT EXT DRUG RES TU; *WHO, 2009, 62 WORLD HLTH ASS PR; *WHO, 2009, GLOB TUB CONTR SHORT; *WHO, 2007, GLOB MDR TB XFR TB R; WHO, 2009, WHOHTMTB2009422; *WHO, 2009, COUNTR HAD REP LEAST; *WHO, 2008, WHOHTMTB2008394; WHO, 2006, WORLD HLTH REPORT 20; *WHO STOP TB PARTN, 2006, WHOHTMSTB200635 STOP; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Yew WW, 2000, CHEST, V117, P744, DOI 10.1378/chest.118.3.744; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370; Zumla A, 2009, CLIN CHEST MED, V30, pXIII, DOI 10.1016/j.ccm.2009.08.020	151	756	791	4	237	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2010	375	9728					1830	1843		10.1016/S0140-6736(10)60410-2	http://dx.doi.org/10.1016/S0140-6736(10)60410-2			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603NY	20488523				2022-12-24	WOS:000278216500034
J	Askarieh, G; Hedhammar, M; Nordling, K; Saenz, A; Casals, C; Rising, A; Johansson, J; Knight, SD				Askarieh, Glareh; Hedhammar, My; Nordling, Kerstin; Saenz, Alejandra; Casals, Cristina; Rising, Anna; Johansson, Jan; Knight, Stefan D.			Self-assembly of spider silk proteins is controlled by a pH-sensitive relay	NATURE			English	Article							DRAGLINE; FIBROIN; DOMAIN; PHENIX	Nature's high-performance polymer, spider silk, consists of specific proteins, spidroins, with repetitive segments flanked by conserved non-repetitive domains(1,2). Spidroins are stored as a highly concentrated fluid dope. On silk formation, intermolecular interactions between repeat regions are established that provide strength and elasticity(3,4). How spiders manage to avoid premature spidroin aggregation before self-assembly is not yet established. A pH drop to 6.3 along the spider's spinning apparatus, altered salt composition and shear forces are believed to trigger the conversion to solid silk, but no molecular details are known. Miniature spidroins consisting of a few repetitive spidroin segments capped by the carboxy-terminal domain form metre-long silk-like fibres irrespective of pH(5). We discovered that incorporation of the amino-terminal domain of major ampullate spidroin 1 from the dragline of the nursery web spider Euprosthenops australis (NT) into mini-spidroins enables immediate, charge-dependent self-assembly at pH values around 6.3, but delays aggregation above pH7. The X-ray structure of NT, determined to 1.7 angstrom resolution, shows a homodimer of dipolar, antiparallel five-helix bundle subunits that lack homologues. The overall dimeric structure and observed charge distribution of NT is expected to be conserved through spider evolution and in all types of spidroins. Our results indicate a relay-like mechanism through which the N-terminal domain regulates spidroin assembly by inhibiting precocious aggregation during storage, and accelerating and directing self-assembly as the pH is lowered along the spider's silk extrusion duct.	[Askarieh, Glareh; Knight, Stefan D.] SLU, Biomed Ctr, Uppsala BioCtr, Dept Mol Biol, SE-75124 Uppsala, Sweden; [Askarieh, Glareh] Univ Oslo, Dept Chem, N-0315 Oslo, Norway; [Hedhammar, My; Nordling, Kerstin; Rising, Anna; Johansson, Jan] SLU, Biomed Ctr, Dept Anat Physiol & Biochem, SE-75123 Uppsala, Sweden; [Saenz, Alejandra; Casals, Cristina] Univ Complutense Madrid, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Saenz, Alejandra; Casals, Cristina] Univ Complutense Madrid, CIBER Enfermedades Resp, E-28040 Madrid, Spain	Swedish University of Agricultural Sciences; University of Oslo; Swedish University of Agricultural Sciences; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Complutense University of Madrid	Knight, SD (corresponding author), SLU, Biomed Ctr, Uppsala BioCtr, Dept Mol Biol, SE-75124 Uppsala, Sweden.	jan.johansson@afb.slu.se; stefan.knight@molbio.slu.se	Casals, Cristina/H-4658-2015; Rising, Anna/ABE-8822-2020; Saenz, Alejandra/G-7275-2015; Knight, Stefan/D-4315-2015	Casals, Cristina/0000-0003-2696-0918; Rising, Anna/0000-0002-1872-1207; Saenz, Alejandra/0000-0001-8439-2985; Knight, Stefan/0000-0002-7180-8758; Johansson, Jan/0000-0002-8719-4703	Swedish Research Council; FORMAS	Swedish Research Council(Swedish Research CouncilEuropean Commission); FORMAS(Swedish Research Council Formas)	This work was supported by grants (to J.J., M. H. and S. D. K.) from the Swedish Research Council and FORMAS. We thank E. Andersson, K. Tars and D. Ericsson for collecting the high resolution wild-type X-ray diffraction data set, H. Bramfeldt and C. Aulin for help with collecting scanning electron microscopy images, L. Serpell, I. Andersson, A. Zavialov and T. Hard for comments on the manuscript, and a number of other colleagues for discussions. We thank the ESRF (Grenoble, France) beamline staff for help during data collection.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; CANDELAS GC, 1981, J EXP ZOOL, V216, P1, DOI 10.1002/jez.1402160102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans W, 1997, CHEM BRIT, V33, P22; FLOCCO MW, 1995, J MOL BIOL, V254, P96, DOI 10.1006/jmbi.1995.0602; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Gosline JM, 1999, J EXP BIOL, V202, P3295; Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; LESLIE AGW, 1992, JOINT CCP4 ESF EACBM; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lin Z, 2009, P NATL ACAD SCI USA, V106, P8906, DOI 10.1073/pnas.0813255106; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y; Weeks CM, 2003, METHOD ENZYMOL, V374, P37, DOI 10.1016/S0076-6879(03)74003-8; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	27	311	329	14	281	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					236	U125		10.1038/nature08962	http://dx.doi.org/10.1038/nature08962			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463740				2022-12-24	WOS:000277558500039
J	Werner, T; Koshikawa, S; Williams, TM; Carroll, SB				Werner, Thomas; Koshikawa, Shigeyuki; Williams, Thomas M.; Carroll, Sean B.			Generation of a novel wing colour pattern by the Wingless morphogen	NATURE			English	Article							SEGMENT-POLARITY GENE; PIGMENT PATTERNS; NEURAL CREST; YELLOW GENE; DROSOPHILA; ZEBRAFISH; EVOLUTION; ELEMENTS; SPECIFICATION; EXPRESSION	The complex, geometric colour patterns of many animal bodies have important roles in behaviour and ecology. The generation of certain patterns has been the subject of considerable theoretical exploration, however, very little is known about the actual mechanisms underlying colour pattern formation or evolution. Here we have investigated the generation and evolution of the complex, spotted wing pattern of Drosophila guttifera. We show that wing spots are induced by the Wingless morphogen, which is expressed at many discrete sites that are specified by pre-existing positional information that governs the development of wing structures. Furthermore, we demonstrate that the elaborate spot pattern evolved from simpler schemes by co-option of Wingless expression at new sites. This example of a complex design developing and evolving by the layering of new patterns on pre-patterns is likely to be a general theme in other animals.	[Werner, Thomas; Koshikawa, Shigeyuki; Williams, Thomas M.; Carroll, Sean B.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Werner, Thomas; Koshikawa, Shigeyuki; Williams, Thomas M.; Carroll, Sean B.] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@wisc.edu	Koshikawa, Shigeyuki/D-3052-2012	Koshikawa, Shigeyuki/0000-0003-2831-555X	Human Frontiers Science Program Fellowship [LT00640/2005-L]; JSPS; National Institutes of Health [GM076935]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076935] Funding Source: NIH RePORTER	Human Frontiers Science Program Fellowship(Human Frontier Science Program); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Blair and E. Bier for suggesting Wingless as a candidate inducer; E. Wimmer for the piggyBac, mariner, Hermes and Minos transposon vectors; E. Hare and M. Eisen for the D. guttifera genomic library; M. Rebeiz, K. Vaccaro, V. Kassner, J. Selegue and B. Prud'homme for technical advice; A. Martinez-Arias for discussions; J. Jaenike for D. nigromaculata flies; H. Krause and L. Baev for the UAS-wg construct; B. Prud'homme, H. Dufour, M. Rebeiz, H. Chung and T. Shirangi for comments on the manuscript; and L. Olds for help with the artwork. This work was supported by a Human Frontiers Science Program Fellowship (LT00640/2005-L) to T. W., a JSPS Postdoctoral Fellowship for Research Abroad to S. K., a National Institutes of Health Postdoctoral fellowship (GM076935) to T. M. W., and the Howard Hughes Medical Institute ( S. B. C.).	Ashburner M., 1989, DROSOPHILA LAB HDB; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; BAKER NE, 1988, DEVELOPMENT, V102, P489; BAKER NE, 1988, DEV BIOL, V125, P96, DOI 10.1016/0012-1606(88)90062-0; BARD JBL, 1981, J THEOR BIOL, V93, P363, DOI 10.1016/0022-5193(81)90109-0; BLAIR SS, 1994, DEV BIOL, V162, P229, DOI 10.1006/dbio.1994.1081; CAMPBELL G, 1993, CELL, V74, P1113, DOI 10.1016/0092-8674(93)90732-6; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Cott H.B., 1940, ADAPTIVE COLORATION; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; GOMEZSKARMETA JL, 1995, GENE DEV, V9, P1869, DOI 10.1101/gad.9.15.1869; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; GOTO T, 1989, CELL, V57, P413, DOI 10.1016/0092-8674(89)90916-1; HARDING K, 1989, EMBO J, V8, P1205, DOI 10.1002/j.1460-2075.1989.tb03493.x; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kondo S, 2009, SEMIN CELL DEV BIOL, V20, P82, DOI 10.1016/j.semcdb.2008.10.008; Lawrence PA, 2001, CURR BIOL, V11, pR638, DOI 10.1016/S0960-9822(01)00380-3; Liu RT, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011914; Markow T. A., 2006, DROSOPHILA GUIDE SPE; MEINHARDT H, 1981, FORTS ZOOL, V26, P163; Meinhardt H., 1982, MODELS BIOL PATTERN; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; Nijhout H. F., 1991, DEV EVOLUTION BUTTER; NOORDERMEER J, 1992, DEVELOPMENT, V116, P711; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Parichy DM, 2003, DEV BIOL, V256, P221, DOI 10.1016/S0012-1606(03)00016-2; Parichy DM, 2000, DEV BIOL, V227, P294, DOI 10.1006/dbio.2000.9899; Perlman SJ, 2003, MOL ECOL, V12, P237, DOI 10.1046/j.1365-294X.2003.01721.x; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Rebeiz M, 2004, DEV BIOL, V271, P431, DOI 10.1016/j.ydbio.2004.04.011; Simmonds AJ, 2001, CELL, V105, P197, DOI 10.1016/S0092-8674(01)00311-7; Simpson P, 1999, DEVELOPMENT, V126, P1349; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; Tanaka R, 2007, DEV BIOL, V304, P53, DOI 10.1016/j.ydbio.2006.12.018; Turing A. M., 1952, PHILOS T R SOC B, V237, P37; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; WALTER MF, 1991, DEV BIOL, V147, P32, DOI 10.1016/S0012-1606(05)80005-3; Watanabe M, 2006, EMBO REP, V7, P893, DOI 10.1038/sj.embor.7400757; Wheeler M.R., 1965, DROS INFORM SERV, V40, P98; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; Yamaguchi M, 2007, P NATL ACAD SCI USA, V104, P4790, DOI 10.1073/pnas.0607790104; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	49	152	156	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1143	U57		10.1038/nature08896	http://dx.doi.org/10.1038/nature08896			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20376004				2022-12-24	WOS:000276891100027
J	Chen, L; Yang, SY; Jakoncic, J; Zhang, JJ; Huang, XY				Chen, Lin; Yang, Shengyu; Jakoncic, Jean; Zhang, J. Jillian; Huang, Xin-Yun			Migrastatin analogues target fascin to block tumour metastasis	NATURE			English	Article							CELL-MIGRATION INHIBITORS; NEGATIVE BREAST-CANCER; ACTIN-BUNDLING PROTEIN; EXPRESSION; CARCINOMA; MOTILITY; GENE; DISCOVERY; FILOPODIA; ROLES	Tumour metastasis is the primary cause of death of cancer patients. Development of new therapeutics preventing tumour metastasis is urgently needed. Migrastatin is a natural product secreted by Streptomyces(1,2), and synthesized migrastatin analogues such as macroketone are potent inhibitors of metastatic tumour cell migration, invasion and metastasis(3-6). Here we show that these migrastatin analogues target the actin-bundling protein fascin to inhibit its activity. X-ray crystal structural studies reveal that migrastatin analogues bind to one of the actin-binding sites on fascin. Our data demonstrate that actin cytoskeletal proteins such as fascin can be explored as new molecular targets for cancer treatment, in a similar manner to the microtubule protein tubulin.	[Chen, Lin; Yang, Shengyu; Zhang, J. Jillian; Huang, Xin-Yun] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10065 USA; [Jakoncic, Jean] Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA	Cornell University; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory	Huang, XY (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10065 USA.	xyhuang@med.cornell.edu	Yang, Shengyu/I-9531-2012	Yang, Shengyu/0000-0002-7933-6118; Jakoncic, Jean/0000-0002-6315-0933	National Institutes of Health [CA136837]; Department of Defense [W81XWH-06-1-0362]; NATIONAL CANCER INSTITUTE [R01CA136837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J. J. Z. and X. Y. H. dedicate this paper to the memory of Yonghong Zhang, who died of cancer on 12 September 2009. We are grateful to W. Gerald (deceased) at Memorial Sloan-Kettering Cancer Center for letting us examine his DNA microarray data on human breast tumour samples for the fascin expression. We thank S. Almo for the fascin plasmid; S. Danishefsky and colleagues for the biotin-conjugated macroketone used in the initial exploration of the conditions for protein purification; members of the J. Massague laboratory for teaching the use of the IVIS Imaging system; the personnel at the beamlines X6A and X4C of the National Synchrotron Light Source for the beamtime and for assistance; and D. Eliezer, T. Maack, L. Palmer, H. Wu and members of our laboratory for critically reading the manuscript. We thank S. Almo and his colleagues, H. Wu and J. Wu, for help with the crystallization experiments. This work was supported by grants from the National Institutes of Health (CA136837) and the Department of Defense (W81XWH-06-1-0362).	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; BRYAN J, 1978, J MOL BIOL, V125, P207, DOI 10.1016/0022-2836(78)90345-5; Cant K, 1996, GENETICS, V143, P249; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaul C, 2004, J AM CHEM SOC, V126, P11326, DOI 10.1021/ja048779q; Grothey A, 2000, BRIT J CANCER, V83, P870, DOI 10.1054/bjoc.2000.1395; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Hashimoto Y, 2004, ONCOLOGY-BASEL, V67, P262, DOI 10.1159/000081327; Hashimoto Y, 2007, MOL BIOL CELL, V18, P4591, DOI 10.1091/mbc.E07-02-0157; Ju JH, 2008, BIOORG MED CHEM LETT, V18, P5951, DOI 10.1016/j.bmcl.2008.07.072; Maitra A, 2002, AM J CLIN PATHOL, V118, P52; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; MOSIALOS G, 1994, J VIROL, V68, P7320, DOI 10.1128/JVI.68.11.7320-7328.1994; Nakae K, 2000, J ANTIBIOT, V53, P1228, DOI 10.7164/antibiotics.53.1228; Njardarson JT, 2004, J AM CHEM SOC, V126, P1038, DOI 10.1021/ja039714a; Ono S, 1997, J BIOL CHEM, V272, P2527; OTTO JJ, 1979, CELL, V17, P285, DOI 10.1016/0092-8674(79)90154-5; Pelosi G, 2003, LUNG CANCER-J IASLC, V42, P203, DOI 10.1016/S0169-5002(03)00294-0; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Woo EJ, 2002, J ANTIBIOT, V55, P141, DOI 10.7164/antibiotics.55.141; Wu JM, 2008, CLIN CANCER RES, V14, P1938, DOI 10.1158/1078-0432.CCR-07-4082; YAMASHIROMATSUMURA S, 1985, J BIOL CHEM, V260, P5087; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Yoder BJ, 2005, CLIN CANCER RES, V11, P186; Zigeuner R, 2006, UROLOGY, V68, P518, DOI 10.1016/j.urology.2006.03.032	36	202	213	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1062	U135		10.1038/nature08978	http://dx.doi.org/10.1038/nature08978			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393565	Green Accepted			2022-12-24	WOS:000276635000043
J	Huang, J; Zarnitsyna, VI; Liu, BY; Edwards, LJ; Jiang, N; Evavold, BD; Zhu, C				Huang, Jun; Zarnitsyna, Veronika I.; Liu, Baoyu; Edwards, Lindsay J.; Jiang, Ning; Evavold, Brian D.; Zhu, Cheng			The kinetics of two-dimensional TCR and pMHC interactions determine T-cell responsiveness	NATURE			English	Article							LIGAND BINDING-KINETICS; P-SELECTIN; RECEPTOR MICROCLUSTERS; IMPACT; AFFINITY; MICROTOPOLOGY; RECOGNITION; ACTIVATION; THRESHOLD; SURFACES	The T-cell receptor (TCR) interacts with peptide-major histocompatibility complexes (pMHC) to discriminate pathogens from self-antigens and trigger adaptive immune responses. Direct physical contact is required between the T cell and the antigen-presenting cell for cross-junctional binding where the TCR and pMHC are anchored on two-dimensional (2D) membranes of the apposing cells(1). Despite their 2D nature, TCR-pMHC binding kinetics have only been analysed three-dimensionally (3D) with a varying degree of correlation with the T-cell responsiveness(2-4). Here we use two mechanical assays(5,6) to show high 2D affinities between a TCR and its antigenic pMHC driven by rapid on-rates. Compared to their 3D counterparts, 2D affinities and on-rates of the TCR for a panel of pMHC ligands possess far broader dynamic ranges that match that of their corresponding T-cell responses. The best 3D predictor of response is the off-rate, with agonist pMHC dissociating the slowest(2-4). In contrast, 2D off-rates are up to 8,300-fold faster, with the agonist pMHC dissociating the fastest. Our 2D data suggest rapid antigen sampling by T cells and serial engagement of a few agonist pMHCs by TCRs in a large self pMHC background. Thus, the cellular environment amplifies the intrinsic TCR-pMHC binding to generate broad affinities and rapid kinetics that determine T-cell responsiveness.	[Huang, Jun; Zarnitsyna, Veronika I.; Liu, Baoyu; Jiang, Ning; Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Edwards, Lindsay J.; Evavold, Brian D.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Zhu, C (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	bevavol@emory.edu; cheng.zhu@bme.gatech.edu	Zhu, Cheng/A-5724-2011; Huang, Jun/E-8472-2010; Liu, Baoyu/C-4911-2009; Jiang, Ning/M-5448-2017	Liu, Baoyu/0000-0002-0798-6314; Jiang, Ning/0000-0003-1103-5922; Evavold, Brian/0000-0002-3561-3494; Zarnitsyna, Veronika/0000-0003-3096-3695	NIH [AI38282, AI060799]; National Multiple Sclerosis Society [RG4047-A-3];  [NS062358]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI038282, R29AI038282, R01AI060799, R01AI056017, R01AI038282, R56AI060799, R21AI056017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062358, R01NS071518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the NIH Tetramer Core Facility at Emory University for providing MHC monomers, J. Altman for providing the H-2K<SUP>b</SUP> mutant construct, G. Bao for providing the divalent streptavidin, as well as M. Davis and H.-T. He for commenting on the manuscript. This work was supported by NIH grants AI38282 and AI060799 (to C.Z.) and NS062358, and National Multiple Sclerosis Society Grant RG4047-A-3 (to B. D. E.).	Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Evans E, 2005, BIOPHYS J, V88, P2288, DOI 10.1529/biophysj.104.051698; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; GASCOIGNE NR, 2001, EXPERT REV MOL MED, P1; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Hochmuth R., 1987, HDB BIOENGINEERING; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200; Huang J, 2007, J IMMUNOL, V179, P7653, DOI 10.4049/jimmunol.179.11.7653; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Mehta P, 1998, J BIOL CHEM, V273, P32506, DOI 10.1074/jbc.273.49.32506; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Sabatino JJ, 2008, J IMMUNOL, V180, P4451, DOI 10.4049/jimmunol.180.7.4451; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Williams TE, 2000, BIOPHYS J, V79, P1858, DOI 10.1016/S0006-3495(00)76435-6; Williams TE, 2001, J BIOL CHEM, V276, P13283, DOI 10.1074/jbc.M010427200; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wu L, 2007, J BIOL CHEM, V282, P9846, DOI 10.1074/jbc.M609219200; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zarnitsyna VI, 2007, P NATL ACAD SCI USA, V104, P18037, DOI 10.1073/pnas.0704811104; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhu C, 2002, ANN BIOMED ENG, V30, P305, DOI 10.1114/1.1467923; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	39	352	360	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					932	U156		10.1038/nature08944	http://dx.doi.org/10.1038/nature08944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20357766	Green Accepted			2022-12-24	WOS:000276397300046
J	Weinert, S; Jabs, S; Supanchart, C; Schweizer, M; Gimber, N; Richter, M; Rademann, J; Stauber, T; Kornak, U; Jentsch, TJ				Weinert, Stefanie; Jabs, Sabrina; Supanchart, Chayarop; Schweizer, Michaela; Gimber, Niclas; Richter, Martin; Rademann, Joerg; Stauber, Tobias; Kornak, Uwe; Jentsch, Thomas J.			Lysosomal Pathology and Osteopetrosis upon Loss of H+-Driven Lysosomal Cl- Accumulation	SCIENCE			English	Article							STORAGE DISEASE; CHLORIDE; ACIDIFICATION; ENDOSOMES; CLC-7; PROTEINS; PATHWAY; MOUSE; LEADS	During lysosomal acidification, proton-pump currents are thought to be shunted by a chloride ion (Cl-) channel, tentatively identified as ClC-7. Surprisingly, recent data suggest that ClC-7 instead mediates Cl-/proton (H+) exchange. We generated mice carrying a point mutation converting ClC-7 into an uncoupled (unc) Cl- conductor. Despite maintaining lysosomal conductance and normal lysosomal pH, these Clcn7(unc/unc) mice showed lysosomal storage disease like mice lacking ClC-7. However, their osteopetrosis was milder, and they lacked a coat color phenotype. Thus, only some roles of ClC-7 Cl-/H+ exchange can be taken over by a Cl- conductance. This conductance was even deleterious in Clcn7(+/unc) mice. Clcn7(-/-) and Clcn7(unc/unc) mice accumulated less Cl- in lysosomes than did wild-type mice. Thus, lowered lysosomal chloride may underlie their common phenotypes.	[Weinert, Stefanie; Jabs, Sabrina; Gimber, Niclas; Rademann, Joerg; Stauber, Tobias; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Weinert, Stefanie; Jabs, Sabrina; Gimber, Niclas; Stauber, Tobias; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Supanchart, Chayarop; Kornak, Uwe] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Schweizer, Michaela] Univ Hamburg, ZMNH, D-20251 Hamburg, Germany; [Kornak, Uwe] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Jabs, Sabrina; Richter, Martin; Rademann, Joerg] Free Univ Berlin, D-14195 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; Max Planck Society; Free University of Berlin	Jentsch, TJ (corresponding author), Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany.	jentsch@fmp-berlin.de	Jabs, Sabrina/F-9026-2019; Stauber, Tobias/E-4005-2010; Weinert, Stefanie/AAR-1481-2021; Rademann, Jörg/F-4893-2017	Jabs, Sabrina/0000-0001-8065-8002; Stauber, Tobias/0000-0003-0727-6109; Rademann, Jörg/0000-0001-6678-3165; Jentsch, Thomas/0000-0002-3509-2553; Gimber, Niclas/0000-0001-9456-3063; Weinert, Stefanie/0000-0003-3036-1440	Deutsche Forschungsgemeinschaft [Je164/7, SFB740 (C5), SFB765(Ra895/6)]; Bundesministerium fur Bildung und Forschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	We thank I. Freyert, A. von Bock, and P. Goritz for technical assistance; M. Falcke for help with modeling; and S. Grinstein for suggesting protonophore pretreatment of lysosomes. Support was provided by the Deutsche Forschungsgemeinschaft [grants Je164/7 and SFB740 (C5)] to T.J.J., SFB765(Ra895/6) to J.R., and the OSTEOPETR E-Rare grant (Bundesministerium fur Bildung und Forschung) to UK	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; FUCHS R, 1989, J BIOL CHEM, V264, P2212; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Novarino G, 2010, SCIENCE, V328, P1398, DOI 10.1126/science.1188070; OHKUMA S, 1983, J BIOCHEM, V94, P1935, DOI 10.1093/oxfordjournals.jbchem.a134547; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Steinberg BE, 2007, P NATL ACAD SCI USA, V104, P9523, DOI 10.1073/pnas.0700783104; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; VANDYKE RW, 1993, AM J PHYSIOL, V265, pC901, DOI 10.1152/ajpcell.1993.265.4.C901; Wartosch L, 2009, FASEB J, V23, P4056, DOI 10.1096/fj.09-130880	22	164	167	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1401	1403		10.1126/science.1188072	http://dx.doi.org/10.1126/science.1188072			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20430974				2022-12-24	WOS:000278598400040
J	Atwell, S; Huang, YS; Vilhjalmsson, BJ; Willems, G; Horton, M; Li, Y; Meng, DZ; Platt, A; Tarone, AM; Hu, TT; Jiang, R; Muliyati, NW; Zhang, X; Amer, MA; Baxter, I; Brachi, B; Chory, J; Dean, C; Debieu, M; de Meaux, J; Ecker, JR; Faure, N; Kniskern, JM; Jones, JDG; Michael, T; Nemri, A; Roux, F; Salt, DE; Tang, CL; Todesco, M; Traw, MB; Weigel, D; Marjoram, P; Borevitz, JO; Bergelson, J; Nordborg, M				Atwell, Susanna; Huang, Yu S.; Vilhjalmsson, Bjarni J.; Willems, Glenda; Horton, Matthew; Li, Yan; Meng, Dazhe; Platt, Alexander; Tarone, Aaron M.; Hu, Tina T.; Jiang, Rong; Muliyati, N. Wayan; Zhang, Xu; Amer, Muhammad Ali; Baxter, Ivan; Brachi, Benjamin; Chory, Joanne; Dean, Caroline; Debieu, Marilyne; de Meaux, Juliette; Ecker, Joseph R.; Faure, Nathalie; Kniskern, Joel M.; Jones, Jonathan D. G.; Michael, Todd; Nemri, Adnane; Roux, Fabrice; Salt, David E.; Tang, Chunlao; Todesco, Marco; Traw, M. Brian; Weigel, Detlef; Marjoram, Paul; Borevitz, Justin O.; Bergelson, Joy; Nordborg, Magnus			Genome-wide association study of 107 phenotypes in Arabidopsis thaliana inbred lines	NATURE			English	Article							FLOWERING-LOCUS-C; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; MODEL; DISEASES; PROTEIN; FRIGIDA; TIME	Although pioneered by human geneticists as a potential solution to the challenging problem of finding the genetic basis of common human diseases(1,2), genome-wide association (GWA) studies have, owing to advances in genotyping and sequencing technology, become an obvious general approach for studying the genetics of natural variation and traits of agricultural importance. They are particularly useful when inbred lines are available, because once these lines have been genotyped they can be phenotyped multiple times, making it possible (as well as extremely cost effective) to study many different traits in many different environments, while replicating the phenotypic measurements to reduce environmental noise. Here we demonstrate the power of this approach by carrying out a GWA study of 107 phenotypes in Arabidopsis thaliana, a widely distributed, predominantly self-fertilizing model plant known to harbour considerable genetic variation for many adaptively important traits(3). Our results are dramatically different from those of human GWA studies, in that we identify many common alleles of major effect, but they are also, in many cases, harder to interpret because confounding by complex genetics and population structure make it difficult to distinguish true associations from false. However, a-priori candidates are significantly over-represented among these associations as well, making many of them excellent candidates for follow-up experiments. Our study demonstrates the feasibility of GWA studies in A. thaliana and suggests that the approach will be appropriate for many other organisms.	[Marjoram, Paul; Nordborg, Magnus] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; [Horton, Matthew; Li, Yan; Muliyati, N. Wayan; Zhang, Xu; Kniskern, Joel M.; Roux, Fabrice; Traw, M. Brian; Borevitz, Justin O.; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Baxter, Ivan] Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Salt, David E.] Purdue Univ, W Lafayette, IN 47907 USA; [Brachi, Benjamin; Faure, Nathalie; Roux, Fabrice] Univ Sci & Technol Lille 1, CNRS, UMR 8016, Lab Genet & Evolut Populat Vegetales, F-59655 Villeneuve Dascq, France; [Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Chory, Joanne; Ecker, Joseph R.; Michael, Todd] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Dean, Caroline] John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Debieu, Marilyne; de Meaux, Juliette] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Jones, Jonathan D. G.; Nemri, Adnane] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Todesco, Marco; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Nordborg, Magnus] Gregor Mendel Inst, A-1030 Vienna, Austria	University of Southern California; University of Chicago; Purdue University System; Purdue University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Howard Hughes Medical Institute; Salk Institute; Salk Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Max Planck Society; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Nordborg, M (corresponding author), Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA.	magnus.nordborg@gmi.oeaw.ac.at	Vilhjálmsson, Bjarni/ABC-1369-2020; Borevitz, Justin/B-5423-2012; Vilhjalmsson, Bjarni/K-3971-2014; Nemri, Adnane/I-3830-2012; Traw, Milton Brian/ABD-3275-2020; Roux, Fabrice/A-1718-2009; Tang, Chunlao/F-9203-2010; Tarone, Aaron/I-6483-2012; Jones, Jonathan DG/J-5129-2012; Li, Yan/AAF-5886-2019; Weigel, Detlef/AAR-3312-2021; Faure, Nathalie/B-4485-2009; Todesco, Marco/HCH-3494-2022; Weigel, Detlef/GSJ-0799-2022; Baxter, Ivan R/A-1052-2009; Weigel, Detlef/C-1418-2008; Huang, Yu/C-2789-2011; Atwell, Susanna/H-8630-2016; Ecker, Joseph R/B-9144-2008	Vilhjálmsson, Bjarni/0000-0003-2277-9249; Borevitz, Justin/0000-0001-8408-3699; Vilhjalmsson, Bjarni/0000-0003-2277-9249; Traw, Milton Brian/0000-0002-3148-2108; Jones, Jonathan DG/0000-0002-4953-261X; Li, Yan/0000-0002-1627-7763; Weigel, Detlef/0000-0002-2114-7963; Baxter, Ivan R/0000-0001-6680-1722; Weigel, Detlef/0000-0002-2114-7963; Atwell, Susanna/0000-0001-8680-9721; Ecker, Joseph R/0000-0001-5799-5895; Fabrice, Roux/0000-0001-8059-5638; Bergelson, Joy/0000-0001-7893-7387; de Meaux, Juliette/0000-0002-2942-4750; Michael, Todd/0000-0001-6272-2875; Nordborg, Magnus/0000-0001-7178-9748; Todesco, Marco/0000-0002-6227-4096; Horton, Matthew/0000-0002-7537-0730; Platt, Alexander/0000-0003-3783-4781; Tarone, Aaron/0000-0003-0965-7634	US National Science Foundation (NSF) [DEB-0519961, DEB-0723935, MCB-0603515]; US National Institutes of Health (NIH) [GM073822, GM057994, GM078536, P42ES007373, GM62932]; Dropkin Foundation; Max Planck Society; Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft (DFG) [SFB 680]; Marie Curie [220833]; BBSRC [BBS/E/J/000CA355] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA355] Funding Source: researchfish; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057994, R01GM062932, R01GM073822, R01GM078536] Funding Source: NIH RePORTER	US National Science Foundation (NSF)(National Science Foundation (NSF)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dropkin Foundation; Max Planck Society(Max Planck SocietyFoundation CELLEX); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Marie Curie(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Carvalho for his advice on how to modify the OLIGO package. This work was primarily supported by US National Science Foundation (NSF) grant DEB-0519961 (J.B., M.N.), US National Institutes of Health (NIH) grant GM073822 (J.O.B.), and NSF grant DEB-0723935 (M.N.). Additional support was provided by the Dropkin Foundation, NIH grant GM057994 and NSF grant MCB-0603515 (J.B.), the Max Planck Society (D.W., M.T.), the Austrian Academy of Sciences (M.N.), the University of Lille 1 (F. R.), NIH grant GM078536 and NIH grant P42ES007373 (D. E. S.), NIH grant GM62932 (J.C., D. W.), the Howard Hughes Medical Institute (J.C.), the Deutsche Forschungsgemeinschaft (DFG) SFB 680 (J.d.M.), a Marie Curie International Outgoing Fellowship 'ANAVACO' (project number 220833; G. W.), and a Gottfried Wilhelm Leibniz Award of the DFG (D. W.). The project would not have been possible without the existence of The Arabidopsis Information Resource (http://arabidopsis.org).	Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Bentsink L, 2006, P NATL ACAD SCI USA, V103, P17042, DOI 10.1073/pnas.0607877103; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Hischer J, 2009, CURR BIOL, V19, P1747, DOI 10.1016/j.cub.2009.08.057; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Lu H, 2003, PLANT CELL, V15, P2408, DOI 10.1105/tpc.015412; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Rosenberg NA, 2006, GENETICS, V173, P1665, DOI 10.1534/genetics.105.055335; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Toomajian C, 2006, PLOS BIOL, V4, P732, DOI 10.1371/journal.pbio.0040137; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	28	1169	1219	9	495	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					627	631		10.1038/nature08800	http://dx.doi.org/10.1038/nature08800			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20336072	Green Published, Green Accepted			2022-12-24	WOS:000278249000044
J	Khor, CC; Vannberg, FO; Chapman, SJ; Guo, HY; Wong, SH; Walley, AJ; Vukcevic, D; Rautanen, A; Mills, TC; Chang, KC; Kam, KM; Crampin, AC; Ngwira, B; Leung, CC; Tam, CM; Chan, CY; Sung, JJY; Yew, WW; Toh, KY; Tay, SKH; Kwiatkowski, D; Lienhardt, C; Hien, TT; Day, NP; Peshu, N; Marsh, K; Maitland, K; Scott, JA; Williams, TN; Berkley, JA; Floyd, S; Tang, NLS; Fine, PEM; Goh, DLM; Hill, AVS				Khor, Chiea C.; Vannberg, Fredrik O.; Chapman, Stephen J.; Guo, Haiyan; Wong, Sunny H.; Walley, Andrew J.; Vukcevic, Damjan; Rautanen, Anna; Mills, Tara C.; Chang, Kwok-Chiu; Kam, Kai-Man; Crampin, Amelia C.; Ngwira, Bagrey; Leung, Chi-Chiu; Tam, Cheuk-Ming; Chan, Chiu-Yeung; Sung, Joseph J. Y.; Yew, Wing-Wai; Toh, Kai-Yee; Tay, Stacey K. H.; Kwiatkowski, Dominic; Lienhardt, Christian; Hien, Tran-Tinh; Day, Nicholas P.; Peshu, Nobert; Marsh, Kevin; Maitland, Kathryn; Scott, J. Anthony; Williams, Thomas N.; Berkley, James A.; Floyd, Sian; Tang, Nelson L. S.; Fine, Paul E. M.; Goh, Denise L. M.; Hill, Adrian V. S.			CISH and Susceptibility to Infectious Diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SIGNALING PATHWAYS; T-CELLS; INTERLEUKIN-2; TUBERCULOSIS; PROTEIN; RECEPTOR; MALARIA; CHILDREN; STAT5	BACKGROUND The interleukin-2-mediated immune response is critical for host defense against infectious pathogens. Cytokine-inducible SRC homology 2 (SH2) domain protein (CISH), a suppressor of cytokine signaling, controls interleukin-2 signaling. METHODS Using a case-control design, we tested for an association between CISH polymorphisms and susceptibility to major infectious diseases (bacteremia, tuberculosis, and severe malaria) in blood samples from 8402 persons in Gambia, Hong Kong, Kenya, Malawi, and Vietnam. We had previously tested 20 other immune-related genes in one or more of these sample collections. RESULTS We observed associations between variant alleles of multiple CISH polymorphisms and increased susceptibility to each infectious disease in each of the study populations. When all five single-nucleotide polymorphisms (SNPs) (at positions -639, -292, -163, +1320, and +3415 [all relative to CISH]) within the CISH-associated locus were considered together in a multiple-SNP score, we found an association between CISH genetic variants and susceptibility to bacteremia, malaria, and tuberculosis (P = 3.8x10(-11) for all comparisons), with -292 accounting for most of the association signal (P = 4.58x10(-7)). Peripheral-blood mononuclear cells obtained from adult subjects carrying the -292 variant, as compared with wild-type cells, showed a muted response to the stimulation of interleukin-2 production-that is, 25 to 40% less CISH expression. CONCLUSIONS Variants of CISH are associated with susceptibility to diseases caused by diverse infectious pathogens, suggesting that negative regulators of cytokine signaling have a role in immunity against various infectious diseases. The overall risk of one of these infectious diseases was increased by at least 18% among persons carrying the variant CISH alleles.	[Khor, Chiea C.; Vannberg, Fredrik O.; Chapman, Stephen J.; Wong, Sunny H.; Vukcevic, Damjan; Rautanen, Anna; Mills, Tara C.; Kwiatkowski, Dominic; Hill, Adrian V. S.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Scott, J. Anthony; Williams, Thomas N.; Berkley, James A.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Khor, Chiea C.; Guo, Haiyan; Toh, Kai-Yee; Goh, Denise L. M.] Agcy Sci Technol & Res, Host Susceptibil Infect Program, Singapore Inst Clin Sci, Singapore, Singapore; [Tay, Stacey K. H.; Goh, Denise L. M.] Natl Univ Hlth Syst, Univ Childrens Med Inst, Dept Paediat, Singapore, Singapore; [Tay, Stacey K. H.; Goh, Denise L. M.] Natl Univ Singapore, Singapore 117548, Singapore; [Walley, Andrew J.] Hammersmith Hosp, Imperial Coll, Sect Genom Med, London, England; [Marsh, Kevin; Maitland, Kathryn] Univ London Imperial Coll Sci Technol & Med, Fac Med, Wellcome Trust Ctr, Clin Trop Med, London SW7 2AZ, England; [Marsh, Kevin; Maitland, Kathryn] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London SW7 2AZ, England; [Floyd, Sian; Fine, Paul E. M.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Infect Dis Epidemiol Unit, London, England; [Chang, Kwok-Chiu; Leung, Chi-Chiu; Tam, Cheuk-Ming] Chinese Univ Hong Kong, TB & Chest Serv, Dept Hlth, Hong Kong, Hong Kong, Peoples R China; [Kam, Kai-Man] Chinese Univ Hong Kong, Publ Hlth Lab, Dept Hlth, Hong Kong, Hong Kong, Peoples R China; [Chan, Chiu-Yeung] Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Sung, Joseph J. Y.] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Tang, Nelson L. S.] Chinese Univ Hong Kong, Dept Chem Pathol, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Tang, Nelson L. S.] Chinese Univ Hong Kong, Lab Genet Dis Susceptibil, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Yew, Wing-Wai] Grantham Hosp, Hosp Author, TB & Chest Unit, Hong Kong, Hong Kong, Peoples R China; [Crampin, Amelia C.; Ngwira, Bagrey] Karonga Prevent Study, Chilumba, Malawi; [Lienhardt, Christian] Inst Rech Dev, Dakar, Senegal; [Hien, Tran-Tinh; Day, Nicholas P.] Cho Quan Hosp, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Hien, Tran-Tinh; Day, Nicholas P.] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Peshu, Nobert; Marsh, Kevin; Maitland, Kathryn; Scott, J. Anthony; Williams, Thomas N.; Berkley, James A.] Kilifi Dist Hosp, Ctr Geog Med Res, Wellcome Trust Programme, Kilifi, Kenya; [Peshu, Nobert; Marsh, Kevin; Maitland, Kathryn; Scott, J. Anthony; Williams, Thomas N.; Berkley, James A.] Kenya Govt Med Res Ctr, Kilifi, Kenya	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; National University of Singapore; Imperial College London; Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Malawi Epidemiology and Intervention Research Unit; Institut de Recherche pour le Developpement (IRD); Kenya Medical Research Institute	Khor, CC (corresponding author), Genome Inst Singapore, Div Infect Dis, 60 Biopolis St, Singapore, Singapore.	khorcc@gis.a-star.edu.sg; adrian.hill@well.ox.ac.uk	Lienhardt, Christian/AAU-4969-2021; Chan, Raphael Chiu Yeung/J-9649-2013; Tay, Stacey/E-7029-2015; SUNG, Joseph J Y/R-3203-2018; Tang, Nelson/P-5018-2017	Lienhardt, Christian/0000-0003-0233-893X; Tay, Stacey/0000-0002-3077-4184; Walley, Andrew/0000-0001-7707-7549; Kwiatkowski, Dominic/0000-0002-5023-0176; Vukcevic, Damjan/0000-0001-7780-9586; SUNG, Joseph J Y/0000-0003-3125-5199; Berkley, James/0000-0002-1236-849X; Crampin, Amelia/0000-0002-1513-4330; Maitland, Kathryn/0000-0002-0007-0645; Tang, Nelson/0000-0002-3607-5819; Khor, Chiea Chuen/0000-0002-1128-4729; Toh, Kai Yee/0000-0001-9763-1762; Wong, Sunny/0000-0002-3354-9310	Wellcome Trust; Agency for Science, Technology and Research, Singapore; MRC [G19/9] Funding Source: UKRI; Medical Research Council [G19/9, G0600718B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants (to Drs. Khor, Goh, and Hill) and clinical research fellowships (to Drs. Chapman, Williams, Scott, and Berkley) from the Wellcome Trust and the Agency for Science, Technology and Research, Singapore; and by the Wellcome Trust Kenya Major Overseas Programme.	Aman MJ, 1999, J BIOL CHEM, V274, P30266, DOI 10.1074/jbc.274.42.30266; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Chistiakov DA, 2008, IMMUNOL LETT, V118, P1, DOI 10.1016/j.imlet.2008.03.002; CLAYTON D, 2003, HDB STAT GENETICS, P519; Crampin AC, 2001, T ROY SOC TROP MED H, V95, P481, DOI 10.1016/S0035-9203(01)90009-4; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; FAUCI AS, 1999, 39 INT C ANT AG CHEM; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hoyer KK, 2008, IMMUNOL REV, V226, P19, DOI 10.1111/j.1600-065X.2008.00697.x; Jin P, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-26; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kovacs JA, 1996, NEW ENGL J MED, V335, P1350, DOI 10.1056/NEJM199610313351803; KOVACS JA, 1995, NEW ENGL J MED, V332, P567, DOI 10.1056/NEJM199503023320904; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Lienhardt C, 2002, AM J EPIDEMIOL, V155, P1066, DOI 10.1093/aje/155.11.1066; Lin Jian-Xin, 1997, Cytokine and Growth Factor Reviews, V8, P313; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; McDermott DF, 2007, CLIN CANCER RES, V13, p716S, DOI 10.1158/1078-0432.CCR-06-1872; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Summerfield JA, 1997, BRIT MED J, V314, P1229, DOI 10.1136/bmj.314.7089.1229; Tang NLS, 2009, CLIN CHIM ACTA, V406, P98, DOI 10.1016/j.cca.2009.06.006; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Uchida K, 1997, CYTOGENET CELL GENET, V78, P209, DOI 10.1159/000134658; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x	41	91	98	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2010	362	22					2092	2101		10.1056/NEJMoa0905606	http://dx.doi.org/10.1056/NEJMoa0905606			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603XU	20484391	Green Accepted			2022-12-24	WOS:000278242200008
J	Carlsbecker, A; Lee, JY; Roberts, CJ; Dettmer, J; Lehesranta, S; Zhou, J; Lindgren, O; Moreno-Risueno, MA; Vaten, A; Thitamadee, S; Campilho, A; Sebastian, J; Bowman, JL; Helariutta, Y; Benfey, PN				Carlsbecker, Annelie; Lee, Ji-Young; Roberts, Christina J.; Dettmer, Jan; Lehesranta, Satu; Zhou, Jing; Lindgren, Ove; Moreno-Risueno, Miguel A.; Vaten, Anne; Thitamadee, Siripong; Campilho, Ana; Sebastian, Jose; Bowman, John L.; Helariutta, Yka; Benfey, Philip N.			Cell signalling by microRNA165/6 directs gene dose-dependent root cell fate	NATURE			English	Article							BINDING-PROTEIN HYL1; CLASS IIIHD-ZIP; ARABIDOPSIS ROOT; TRANSCRIPTION FACTOR; INTERCELLULAR MOVEMENT; VASCULAR DEVELOPMENT; APICAL MERISTEM; KANADI GENES; EXPRESSION; PLANTS	A key question in developmental biology is how cells exchange positional information for proper patterning during organ development. In plant roots the radial tissue organization is highly conserved with a central vascular cylinder in which two water conducting cell types, protoxylem and metaxylem, are patterned centripetally. We show that this patterning occurs through crosstalk between the vascular cylinder and the surrounding endodermis mediated by cell-to-cell movement of a transcription factor in one direction and microRNAs in the other. SHORT ROOT, produced in the vascular cylinder, moves into the endodermis to activate SCARECROW. Together these transcription factors activate MIR165a and MIR166b. Endodermally produced microRNA165/6 then acts to degrade its target mRNAs encoding class III homeodomain-leucine zipper transcription factors in the endodermis and stele periphery. The resulting differential distribution of target mRNA in the vascular cylinder determines xylem cell types in a dosage-dependent manner.	[Carlsbecker, Annelie; Dettmer, Jan; Lehesranta, Satu; Lindgren, Ove; Vaten, Anne; Thitamadee, Siripong; Campilho, Ana; Helariutta, Yka] Univ Helsinki, Inst Biotechnol, Dept Biosci, FIN-00014 Helsinki, Finland; [Carlsbecker, Annelie; Roberts, Christina J.] Uppsala Univ, Evolutionary Biol Ctr, Dept Physiol Bot, SE-75236 Uppsala, Sweden; [Lee, Ji-Young; Zhou, Jing; Sebastian, Jose] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Lee, Ji-Young; Zhou, Jing] Cornell Univ, Grad Field Plant Biol, Ithaca, NY 14853 USA; [Lindgren, Ove] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia; [Moreno-Risueno, Miguel A.; Benfey, Philip N.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Moreno-Risueno, Miguel A.; Benfey, Philip N.] Duke Univ, IGSP Ctr Syst Biol, Durham, NC 27708 USA; [Bowman, John L.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia	University of Helsinki; Uppsala University; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; University of Tartu; Duke University; Duke University; Monash University	Helariutta, Y (corresponding author), Univ Helsinki, Inst Biotechnol, Dept Biosci, FIN-00014 Helsinki, Finland.	yrjo.helariutta@helsinki.fi; philip.benfey@duke.edu	Campilho, Ana/U-8263-2019; Campilho, Ana/H-8790-2013; Mueller, Christina Joy/Y-1210-2019; Lee, Ji-Young/E-2196-2012; MORENO-RISUENO, MIGUEL ANGEL/J-8832-2016; Lee, Ji-Young/F-7455-2013; Helariutta, Yrjo/AAE-8149-2020	Campilho, Ana/0000-0002-3470-1943; Campilho, Ana/0000-0002-3470-1943; Mueller, Christina Joy/0000-0002-8116-0705; MORENO-RISUENO, MIGUEL ANGEL/0000-0002-9794-1450; Helariutta, Yrjo/0000-0002-7287-8459; Bowman, John/0000-0001-7347-3691; Lee, Ji-Young/0000-0002-7631-5127; Vaten, Anne/0000-0003-1788-5127; Carlsbecker, Annelie/0000-0002-8450-3718	Boyce Thompson Institute; NSF [IOS0818071, NSF DBI-0618969]; Cornell Presidential Life Science Fellowship; NIH [RO1-GM043778]; MICINN, Spanish Government; Academy of Finland; Tekes; ESF; European Molecular Biology Organisation (EMBO) [ALTF 450-2007]; Estonian funding agencies [ETF7361, SF0180071s07]; Nilsson-Ehle Foundation; FORMAS; Carl Trygger's Foundation for Scientific Research; Triad Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043778] Funding Source: NIH RePORTER	Boyce Thompson Institute; NSF(National Science Foundation (NSF)); Cornell Presidential Life Science Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MICINN, Spanish Government(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Academy of Finland(Academy of Finland); Tekes(Finnish Funding Agency for Technology & Innovation (TEKES)); ESF(European Commission); European Molecular Biology Organisation (EMBO)(European Molecular Biology Organization (EMBO)); Estonian funding agencies; Nilsson-Ehle Foundation; FORMAS(Swedish Research Council Formas); Carl Trygger's Foundation for Scientific Research; Triad Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Kainulainen, M. Herpola, G.-B. Berglund and J. Jung for technical assistance; M. Prigge, S. Clark, C. Bellini, N. Sauer, J. Colinas, T. Vernoux, K. Gallagher, A. P. Mahonen, A. Bishopp, M. Bonke, N. Fedoroff, J. C. Fletcher, B. J. Reinhart, I. Pekker, ABRC and NASC for materials, and E. Richards and M. Harrison for comments on the manuscript; M. Tsiantis for sharing results before publication. This work was supported by the Boyce Thompson Institute and NSF IOS0818071 to J.-Y.L., Cornell Presidential Life Science Fellowship to J.Z., grants from the NIH (RO1-GM043778) and from the NSF ARABIDOPSIS 2010 programme to P. N. B., a fellowship from the MICINN, Spanish Government to M.A.M.-R., grants by the Academy of Finland, Tekes and ESF to Y.H., S. L. and A. V., European Molecular Biology Organisation (EMBO, ALTF 450-2007) to J. D., Estonian funding agencies (ETF7361 and SF0180071s07) to O.L., Nilsson-Ehle Foundation to C. J. R, and FORMAS and Carl Trygger's Foundation for Scientific Research to A. C. Imaging at Boyce Thompson Institute was supported by NSF (NSF DBI-0618969) and Triad Foundation.	Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Boyce C. Kevin, 2005, P479; Chitwood DH, 2009, GENE DEV, V23, P549, DOI 10.1101/gad.1770009; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Du TG, 2007, SEMIN CELL DEV BIOL, V18, P171, DOI 10.1016/j.semcdb.2007.01.010; Dunoyer P, 2007, NAT GENET, V39, P848, DOI 10.1038/ng2081; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Esau K., 1977, ANATOMY SEED PLANTS; Floyd SK, 2007, INT J PLANT SCI, V168, P1, DOI 10.1086/509079; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Gallagher KL, 2009, PLANT J, V57, P785, DOI 10.1111/j.1365-313X.2008.03735.x; Gallagher KL, 2004, CURR BIOL, V14, P1847, DOI 10.1016/j.cub.2004.09.081; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Hawker NP, 2004, PLANT PHYSIOL, V135, P2261, DOI 10.1104/pp.104.040196; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Jung JH, 2007, PLANTA, V225, P1327, DOI 10.1007/s00425-006-0439-1; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Levine E, 2007, PLOS COMPUT BIOL, V3, P2356, DOI 10.1371/journal.pcbi.0030233; Lin SI, 2008, PLANT PHYSIOL, V147, P732, DOI 10.1104/pp.108.116269; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Muniz L, 2008, DEVELOPMENT, V135, P2573, DOI 10.1242/dev.019349; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Nogueira FTS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000320; Ohashi-Ito K, 2005, PLANT CELL PHYSIOL, V46, P1646, DOI 10.1093/pcp/pci180; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Pryer KM, 2004, ASSEMBLING THE TREE OF LIFE, P138; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tretter EM, 2008, PLANT PHYSIOL, V147, P58, DOI 10.1104/pp.108.117119; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Zhou GK, 2007, PLANT CELL PHYSIOL, V48, P391, DOI 10.1093/pcp/pcm008	40	588	634	8	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2010	465	7296					316	321		10.1038/nature08977	http://dx.doi.org/10.1038/nature08977			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20410882	Green Accepted			2022-12-24	WOS:000277829200033
J	Dixit, E; Boulant, S; Zhang, YJ; Lee, ASY; Odendall, C; Shum, B; Hacohen, N; Chen, ZJ; Whelan, SP; Fransen, M; Nibert, ML; Superti-Furga, G; Kagan, JC				Dixit, Evelyn; Boulant, Steeve; Zhang, Yijing; Lee, Amy S. Y.; Odendall, Charlotte; Shum, Bennett; Hacohen, Nir; Chen, Zhijian J.; Whelan, Sean P.; Fransen, Marc; Nibert, Max L.; Superti-Furga, Giulio; Kagan, Jonathan C.			Peroxisomes Are Signaling Platforms for Antiviral Innate Immunity	CELL			English	Article							RIG-I; MAMMALIAN-CELLS; TRANSCRIPTION FACTORS; MEMBRANE-PROTEINS; GENE-EXPRESSION; POTENTIAL ROLE; RNA VIRUSES; MITOCHONDRIAL; RESPONSES; RECOGNITION	Peroxisomes have long been established to play a central role in regulating various metabolic activities in mammalian cells. These organelles act in concert with mitochondria to control the metabolism of lipids and reactive oxygen species. However, while mitochondria have emerged as an important site of antiviral signal transduction, a role for peroxisomes in immune defense is unknown. Here, we report that the RIG-I-like receptor (RLR) adaptor protein MAVS is located on peroxisomes and mitochondria. We find that peroxisomal and mitochondrial MAVS act sequentially to create an antiviral cellular state. Upon viral infection, peroxisomal MAVS induces the rapid interferon-independent expression of defense factors that provide short-term protection, whereas mitochondrial MAVS activates an interferon-dependent signaling pathway with delayed kinetics, which amplifies and stabilizes the antiviral response. The interferon regulatory factor IRF1 plays a crucial role in regulating MAVS-dependent signaling from peroxisomes. These results establish that peroxisomes are an important site of antiviral signal transduction.	[Boulant, Steeve; Lee, Amy S. Y.; Whelan, Sean P.; Nibert, Max L.; Kagan, Jonathan C.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Dixit, Evelyn; Zhang, Yijing; Odendall, Charlotte; Kagan, Jonathan C.] Childrens Hosp Boston, Div Gastroenterol, Boston, MA 02115 USA; [Dixit, Evelyn; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Lee, Amy S. Y.; Whelan, Sean P.; Nibert, Max L.] Harvard Univ, Div Med Sci, Training Program Virol, Boston, MA 02115 USA; [Shum, Bennett; Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Fransen, Marc] Katholieke Univ Leuven, Fac Geneeskunde, Dept Mol Celbiol, LIPIT, B-3000 Leuven, Belgium	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; KU Leuven	Kagan, JC (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu	Superti-Furga, Giulio/F-4755-2015; Boulant, Steeve/W-3754-2019; Fransen, Marc/C-6262-2008; Chen, Zhijian/C-6039-2012; Superti-Furga, Giulio/AAE-5681-2019; Fransen, Marc/ADL-0723-2022	Superti-Furga, Giulio/0000-0002-0570-1768; Boulant, Steeve/0000-0001-8614-4993; Fransen, Marc/0000-0001-9284-1197; Chen, Zhijian/0000-0002-8475-8251; Shum, Bennett/0000-0001-6150-7233; Zhang, Yijing/0000-0001-9568-9389; Whelan, Sean/0000-0003-1564-8590	Children's Hospital; Austrian Science Fund (FWF) [DK CCHD W1205]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G.0754.09]; Bijzonder Onderzoeksfonds of the K.U. Leuven [OT/09/045]; National Institutes of Health [AI059371]; Bill and Melinda Gates Foundation; National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI059371, R01AI059371] Funding Source: NIH RePORTER	Children's Hospital(Tehran University of Medical Sciences); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Bijzonder Onderzoeksfonds of the K.U. Leuven; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank B. Boush (FACS), J. Wagner (microscopy), and C. Brees (cell fractionation) for expert help. We would like to thank S. Brubaker, C. Glanemann, L.R. Marek, M. Schneider, and I. Zanoni for helpful discussions. This work has been supported by the following sources: Children's Hospital Boston Career Development Fellowship (J. K.), Austrian Science Fund (FWF; DK CCHD W1205) (E.D.), Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (G.0754.09) and the Bijzonder Onderzoeksfonds of the K.U. Leuven (OT/09/045) (M.F.), the National Institutes of Health (AI059371 to S.P.W.); the Bill and Melinda Gates Foundation (S.B. and M.L.N., through a Vaccine Discovery Consortium grant to the International AIDS Vaccine Initiative), and the National Defense Science and Engineering Graduate Fellowship (A.S.Y. L.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Balachandran S, 2007, J IMMUNOL, V178, P2429, DOI 10.4049/jimmunol.178.4.2429; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Ferran MC, 1997, J VIROL, V71, P371, DOI 10.1128/JVI.71.1.371-377.1997; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fransen M, 2004, J BIOL CHEM, V279, P12615, DOI 10.1074/jbc.M304941200; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hettema EH, 2009, J CELL SCI, V122, P2331, DOI 10.1242/jcs.034363; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Ingelmo-Torres M, 2009, TRAFFIC, V10, P1785, DOI 10.1111/j.1600-0854.2009.00994.x; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Middleton JK, 2007, VIROLOGY, V361, P412, DOI 10.1016/j.virol.2006.11.024; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Nemoto Y, 1999, EMBO J, V18, P2991, DOI 10.1093/emboj/18.11.2991; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Vastiau IMK, 2006, CELL MOL LIFE SCI, V63, P1686, DOI 10.1007/s00018-006-6110-y; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200	45	554	568	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					668	681		10.1016/j.cell.2010.04.018	http://dx.doi.org/10.1016/j.cell.2010.04.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20451243	Bronze, Green Accepted			2022-12-24	WOS:000277623600019
J	Craven, L; Tuppen, HA; Greggains, GD; Harbottle, SJ; Murphy, JL; Cree, LM; Murdoch, AP; Chinnery, PF; Taylor, RW; Lightowlers, RN; Herbert, M; Turnbull, DM				Craven, Lyndsey; Tuppen, Helen A.; Greggains, Gareth D.; Harbottle, Stephen J.; Murphy, Julie L.; Cree, Lynsey M.; Murdoch, Alison P.; Chinnery, Patrick F.; Taylor, Robert W.; Lightowlers, Robert N.; Herbert, Mary; Turnbull, Douglass M.			Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease	NATURE			English	Article							REAL-TIME PCR; 1555A-GREATER-THAN-G MUTATION; PREVALENCE; MOUSE; MTDNA; QUANTIFICATION; SEGREGATION; DISORDERS; DELETIONS; INSIGHTS	Mutations in mitochondrial DNA ( mtDNA) are a common cause of genetic disease. Pathogenic mutations in mtDNA are detected in approximately 1 in 250 live births(1-3) and at least 1 in 10,000 adults in the UK are affected by mtDNA disease(4). Treatment options for patients with mtDNA disease are extremely limited and are predominantly supportive in nature. Mitochondrial DNA is transmitted maternally and it has been proposed that nuclear transfer techniques may be an approach for the prevention of transmission of human mtDNA disease(5,6). Here we show that transfer of pronuclei between abnormally fertilized human zygotes results in minimal carry-over of donor zygote mtDNA and is compatible with onward development to the blastocyst stage in vitro. By optimizing the procedure we found the average level of carry-over after transfer of two pronuclei is less than 2.0%, with many of the embryos containing no detectable donor mtDNA. We believe that pronuclear transfer between zygotes, as well as the recently described metaphase II spindle transfer, has the potential to prevent the transmission of mtDNA disease in humans.	[Greggains, Gareth D.; Harbottle, Stephen J.; Murdoch, Alison P.; Herbert, Mary] Newcastle Univ, Int Ctr Life, Newcastle Fertil Ctr, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England; [Craven, Lyndsey; Tuppen, Helen A.; Murphy, Julie L.; Cree, Lynsey M.; Chinnery, Patrick F.; Taylor, Robert W.; Lightowlers, Robert N.; Turnbull, Douglass M.] Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Turnbull, Douglass M.] Newcastle Univ, Ctr Brain Ageing & Vital, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Murdoch, Alison P.; Herbert, Mary; Turnbull, Douglass M.] Newcastle Univ, Int Ctr Life, Biosci Ctr, NE England Stem Cell Inst NESCI, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England; [Greggains, Gareth D.; Herbert, Mary] Newcastle Univ, Int Ctr Life, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Herbert, M (corresponding author), Newcastle Univ, Int Ctr Life, Newcastle Fertil Ctr, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England.	mary.herbert@ncl.ac.uk; d.m.turnbull@ncl.ac.uk		Cree, Lynsey/0000-0003-2090-1589; Greggains, Gareth/0000-0003-2424-4694; Chinnery, Patrick/0000-0002-7065-6617; Turnbull, Doug/0000-0002-8878-9901; Herbert, Mary/0000-0002-8488-2770; Tuppen, Helen/0000-0001-8762-0824	Muscular Dystrophy Campaign; Wellcome Trust [074454/Z/04/Z]; Medical Research Council [G0601157, G0601943, G0700718]; UK National Institute for Health Research Biomedical Research Centre for Ageing and Age-related Disease; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Medical Research Council [G0800674, G0601943B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10011] Funding Source: researchfish; MRC [G0800674, G0700718, G0601943, G0601157] Funding Source: UKRI	Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research Biomedical Research Centre for Ageing and Age-related Disease; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Nesbitt, L. Burgess and S. Byerley for help with embryo donation and collection, and V. Wilson and S. Abbs for help with the nuclear genotyping. We thank the patients and staff at Newcastle Fertility Centre, and J. Lawford-Davies, K. Stern, Sir John Burn and Lord Walton of Detchant for helping us to obtain a Human Fertilisation and Embryology Authority research licence and guidance with the legislation. This work was funded by the Muscular Dystrophy Campaign, the Wellcome Trust (074454/Z/04/Z), the Medical Research Council (G0601157, G0601943), One North East, the UK National Institute for Health Research Biomedical Research Centre for Ageing and Age-related Disease and the Newcastle University Centre for Brain Ageing and Vitality supported by the Biotechnology and Biological Sciences Research Council, the Engineering and Physical Sciences Research Council, the Economic and Social Research Council and the Medical Research Council (G0700718). P. F. C. is a Wellcome Trust Senior Fellow in Clinical Science.	Almeida PA, 1995, ZYGOTE, V3, P357, DOI 10.1017/S0967199400002793; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Barritt J A, 2002, Reprod Biomed Online, V4, P243; Battaglia DE, 1996, HUM REPROD, V11, P2217; Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396; Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1; Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Feenan Katie, 2006, Hum Fertil (Camb), V9, P157, DOI 10.1080/14647270600636269; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024; Lin DPC, 2004, FERTIL STERIL, V81, P73, DOI 10.1016/j.fertnstert.2003.05.005; Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015; McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004; McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819; Meirelles FV, 1997, GENETICS, V145, P445; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930; REIK W, 1993, DEVELOPMENT, V119, P933; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Tajima H, 2007, J ASSIST REPROD GEN, V24, P227, DOI 10.1007/s10815-007-9114-0; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0; Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74; Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955	30	312	327	0	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					82	U89		10.1038/nature08958	http://dx.doi.org/10.1038/nature08958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20393463	Green Accepted			2022-12-24	WOS:000277311900035
J	Floer, M; Wang, X; Prabhu, V; Berrozpe, G; Narayan, S; Spagna, D; Alvarez, D; Kendall, J; Krasnitz, A; Stepansky, A; Hicks, J; Bryant, GO; Ptashne, M				Floer, Monique; Wang, Xin; Prabhu, Vidya; Berrozpe, Georgina; Narayan, Santosh; Spagna, Dan; Alvarez, David; Kendall, Jude; Krasnitz, Alexander; Stepansky, Asya; Hicks, James; Bryant, Gene O.; Ptashne, Mark			A RSC/Nucleosome Complex Determines Chromatin Architecture and Facilitates Activator Binding	CELL			English	Article							NUCLEOSOME OCCUPANCY; TRANSCRIPTION FACTOR; RSC; ORGANIZATION; LOCATION; PROMOTER; GENES; REPRESSION; TURNOVER; SEQUENCE	How is chromatin architecture established and what role does it play in transcription? We show that the yeast regulatory locus UASg bears, in addition to binding sites for the activator Gal4, sites bound by the RSC complex. RSC positions a nucleosome, evidently partially unwound, in a structure that facilitates Gal4 binding to its sites. The complex comprises a barrier that imposes characteristic features of chromatin architecture. In the absence of RSC, ordinary nucleosomes encroach over the UASg and compete with Gal4 for binding. Taken with our previous work, the results show that both prior to and following induction, specific DNA-binding proteins are the predominant determinants of chromatin architecture at the GAL1/10 genes. RSC/nucleosome complexes are also found scattered around the yeast genome. Higher eukaryotic RSC lacks the specific DNA-binding determinants found on yeast RSC, and evidently Gal4 works in those organisms despite whatever obstacle broadly positioned nucleosomes present.	[Floer, Monique; Wang, Xin; Prabhu, Vidya; Berrozpe, Georgina; Narayan, Santosh; Spagna, Dan; Alvarez, David; Bryant, Gene O.; Ptashne, Mark] Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; [Kendall, Jude; Krasnitz, Alexander; Stepansky, Asya; Hicks, James] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory	Ptashne, M (corresponding author), Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	m-ptashne@mskcc.org			NIH [R01GM032308]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032308] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Francisco Asturias for preparing the space filling model of the RSC/nucleosome complex bound to the UASg together with two Gal4 DNA-binding domain dimers. We would also like to thank Timothy Hughes, Brad Cairns, TomKodadek, Francesc Posas, and David Allis for yeast strains and plasmids, Hiten Madhani for the antibody against H2A.Z, and Alex Gann for helpful comments on the manuscript. This work was supported by a grant (R01GM032308) from the NIH to M.P.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Asturias FJ, 2002, P NATL ACAD SCI USA, V99, P13477, DOI 10.1073/pnas.162504299; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bryan WW, 2003, AMYOTROPH LATERAL SC, V4, P11, DOI 10.1080/14660820310006661; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; CAVALLI G, 1993, EMBO J, V12, P4603, DOI 10.1002/j.1460-2075.1993.tb06149.x; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Du J, 1998, GENETICS, V150, P987; FEDOR MJ, 1989, MOL CELL BIOL, V9, P1721, DOI 10.1128/MCB.9.4.1721; FEDOR MJ, 1988, J MOL BIOL, V204, P109, DOI 10.1016/0022-2836(88)90603-1; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hong MQ, 2008, STRUCTURE, V16, P1019, DOI 10.1016/j.str.2008.03.015; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Korber P, 2004, J BIOL CHEM, V279, P35113, DOI 10.1074/jbc.M405446200; KORNBERG R, 1981, NATURE, V292, P579, DOI 10.1038/292579a0; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Linger J, 2006, EUKARYOT CELL, V5, P1780, DOI 10.1128/EC.00202-06; LOHR D, 1993, P NATL ACAD SCI USA, V90, P10628, DOI 10.1073/pnas.90.22.10628; LOHR D, 1984, NUCLEIC ACIDS RES, V12, P8457, DOI 10.1093/nar/12.22.8457; Lorch Y, 2001, MOL CELL, V7, P89, DOI 10.1016/S1097-2765(01)00157-5; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Parnell TJ, 2008, EMBO J, V27, P100, DOI 10.1038/sj.emboj.7601946; RAINBOW M, 1989, BIOCHEMISTRY-US, V28, P7486, DOI 10.1021/bi00444a048; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Reagan MS, 1998, MOL GEN GENET, V259, P142, DOI 10.1007/s004380050799; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Terrell AR, 2002, J BIOL CHEM, V277, P31038, DOI 10.1074/jbc.M204662200; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625	36	135	135	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					407	418		10.1016/j.cell.2010.03.048	http://dx.doi.org/10.1016/j.cell.2010.03.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434983	Green Accepted, Bronze			2022-12-24	WOS:000277180800013
J	Martin, F; Kohler, A; Murat, C; Balestrini, R; Coutinho, PM; Jaillon, O; Montanini, B; Morin, E; Noel, B; Percudani, R; Porcel, B; Rubini, A; Amicucci, A; Amselem, J; Anthouard, V; Arcioni, S; Artiguenave, F; Aury, JM; Ballario, P; Bolchi, A; Brenna, A; Brun, A; Buee, M; Cantarel, B; Chevalier, G; Couloux, A; Da Silva, C; Denoeud, F; Duplessis, S; Ghignone, S; Hilselberger, B; Iotti, M; Marcais, B; Mello, A; Miranda, M; Pacioni, G; Quesneville, H; Riccioni, C; Ruotolo, R; Splivallo, R; Stocchi, V; Tisserant, E; Viscomi, AR; Zambonelli, A; Zampieri, E; Henrissat, B; Lebrun, MH; Paolocci, F; Bonfante, P; Ottonello, S; Wincker, P				Martin, Francis; Kohler, Annegret; Murat, Claude; Balestrini, Raffaella; Coutinho, Pedro M.; Jaillon, Olivier; Montanini, Barbara; Morin, Emmanuelle; Noel, Benjamin; Percudani, Riccardo; Porcel, Bettina; Rubini, Andrea; Amicucci, Antonella; Amselem, Joelle; Anthouard, Veronique; Arcioni, Sergio; Artiguenave, Francois; Aury, Jean-Marc; Ballario, Paola; Bolchi, Angelo; Brenna, Andrea; Brun, Annick; Buee, Marc; Cantarel, Brandi; Chevalier, Gerard; Couloux, Arnaud; Da Silva, Corinne; Denoeud, France; Duplessis, Sebastien; Ghignone, Stefano; Hilselberger, Benoit; Iotti, Mirco; Marcais, Benoit; Mello, Antonietta; Miranda, Michele; Pacioni, Giovanni; Quesneville, Hadi; Riccioni, Claudia; Ruotolo, Roberta; Splivallo, Richard; Stocchi, Vilberto; Tisserant, Emilie; Viscomi, Arturo Roberto; Zambonelli, Alessandra; Zampieri, Elisa; Henrissat, Bernard; Lebrun, Marc-Henri; Paolocci, Francesco; Bonfante, Paola; Ottonello, Simone; Wincker, Patrick			Perigord black truffle genome uncovers evolutionary origins and mechanisms of symbiosis	NATURE			English	Article							FUNGAL; INSIGHTS	The Perigord black truffle (Tuber melanosporum Vittad.) and the Piedmont white truffle dominate today's truffle market(1,2). The hypogeous fruiting body of T. melanosporum is a gastronomic delicacy produced by an ectomycorrhizal symbiont(3) endemic to calcareous soils in southern Europe. The worldwide demand for this truffle has fuelled intense efforts at cultivation. Identification of processes that condition and trigger fruit body and symbiosis formation, ultimately leading to efficient crop production, will be facilitated by a thorough analysis of truffle genomic traits. In the ectomycorrhizal Laccaria bicolor, the expansion of gene families may have acted as a 'symbiosis toolbox'(4). This feature may however reflect evolution of this particular taxon and not a general trait shared by all ectomycorrhizal species(5). To get a better understanding of the biology and evolution of the ectomycorrhizal symbiosis, we report here the sequence of the haploid genome of T. melanosporum, which at similar to 125 megabases is the largest and most complex fungal genome sequenced so far. This expansion results from a proliferation of transposable elements accounting for similar to 58% of the genome. In contrast, this genome only contains similar to 7,500 protein-coding genes with very rare multigene families. It lacks large sets of carbohydrate cleaving enzymes, but a few of them involved in degradation of plant cell walls are induced in symbiotic tissues. The latter feature and the upregulation of genes encoding for lipases and multicopper oxidases suggest that T. melanosporum degrades its host cell walls during colonization. Symbiosis induces an increased expression of carbohydrate and amino acid transporters in both L. bicolor and T. melanosporum, but the comparison of genomic traits in the two ectomycorrhizal fungi showed that genetic predispositions for symbiosis-'the symbiosis toolbox'-evolved along different ways in ascomycetes and basidiomycetes.	[Martin, Francis; Kohler, Annegret; Murat, Claude; Morin, Emmanuelle; Brun, Annick; Buee, Marc; Duplessis, Sebastien; Marcais, Benoit; Tisserant, Emilie] Nancy Univ, UMR 1136, INRA, F-54280 Champenoux, France; [Balestrini, Raffaella; Ghignone, Stefano; Mello, Antonietta; Zampieri, Elisa; Bonfante, Paola] Univ Turin, Dipartimento Biol Vegetale, I-10125 Turin, Italy; [Balestrini, Raffaella; Ghignone, Stefano; Mello, Antonietta; Zampieri, Elisa; Bonfante, Paola] Univ Turin, CNR, Ist Protez Piante, Sez Torino, I-10125 Turin, Italy; [Coutinho, Pedro M.; Cantarel, Brandi; Henrissat, Bernard] Univ Aix Marseille 1, CNRS, UMR6098, F-13288 Marseille, France; [Coutinho, Pedro M.; Cantarel, Brandi; Henrissat, Bernard] Univ Aix Marseille 2, CNRS, UMR6098, F-13288 Marseille, France; [Jaillon, Olivier; Noel, Benjamin; Porcel, Bettina; Anthouard, Veronique; Artiguenave, Francois; Aury, Jean-Marc; Couloux, Arnaud; Da Silva, Corinne; Denoeud, France; Wincker, Patrick] CEA, IG, F-91057 Evry, France; [Jaillon, Olivier; Noel, Benjamin; Porcel, Bettina; Anthouard, Veronique; Artiguenave, Francois; Aury, Jean-Marc; Couloux, Arnaud; Da Silva, Corinne; Denoeud, France; Wincker, Patrick] CNRS, UMR 8030, F-91057 Evry, France; [Jaillon, Olivier; Noel, Benjamin; Porcel, Bettina; Anthouard, Veronique; Artiguenave, Francois; Aury, Jean-Marc; Couloux, Arnaud; Da Silva, Corinne; Denoeud, France; Wincker, Patrick] Univ Evry, F-91057 Evry, France; [Montanini, Barbara; Percudani, Riccardo; Bolchi, Angelo; Ruotolo, Roberta; Viscomi, Arturo Roberto; Ottonello, Simone] Univ Parma, Dipartmento Biochim & Biol Mol, I-43100 Parma, Italy; [Rubini, Andrea; Arcioni, Sergio; Riccioni, Claudia; Paolocci, Francesco] CNR, IGV, Unita Organizzat Supporto Perugia, I-06128 Perugia, Italy; [Amicucci, Antonella] Univ Urbino, Dipartimento Sci Biomol, I-61029 Urbino, PU, Italy; [Amselem, Joelle; Hilselberger, Benoit; Quesneville, Hadi] INRA, Unite Rech Genom Info, F-78000 Versailles, France; [Ballario, Paola; Brenna, Andrea] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; [Ballario, Paola; Brenna, Andrea] Univ Roma La Sapienza, CNR, IBPM, I-00185 Rome, Italy; [Chevalier, Gerard] Univ Blaise Pascal, INRA Clermont Theix, INRA, UMR Ameliorat & Sante Plantes, F-63122 St Genes Champanelle, France; [Iotti, Mirco; Zambonelli, Alessandra] Univ Bologna, Dipartimento Protez Valorizzaz Agroalimentare, I-40126 Bologna, Italy; [Miranda, Michele] Univ Aquila, Dipartimento Biol Base & Applicata, I-67100 Laquila, Italy; [Pacioni, Giovanni] Univ Aquila, Dipartimento Sci Ambientali, I-67100 Laquila, Italy; [Splivallo, Richard] Univ Gottingen, D-37077 Gottingen, Germany; [Lebrun, Marc-Henri] INRA Grignon, INRA, UMR BIOGER CPP, F-78850 Thiverval Grignon, France	INRAE; Universite de Lorraine; University of Turin; Consiglio Nazionale delle Ricerche (CNR); University of Turin; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Parma; Consiglio Nazionale delle Ricerche (CNR); University of Urbino; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; INRAE; Universite Clermont Auvergne (UCA); University of Bologna; University of L'Aquila; University of L'Aquila; University of Gottingen; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Martin, F (corresponding author), Nancy Univ, UMR 1136, INRA, F-54280 Champenoux, France.	fmartin@nancy.inra.fr	Bolchi, Angelo/GOJ-9730-2022; Paolocci, Francesco/AAD-9484-2019; Mello, Antonietta/B-9101-2015; Cantarel, Brandi/ABF-5756-2020; Pacioni, Giovanni/O-7646-2015; Iotti, Mirco/M-1750-2015; percudani, riccardo/B-4872-2011; Rubini, Andrea/AAB-3036-2021; Balestrini, Raffaella/Q-1106-2015; Quesneville, Hadi/AAG-1048-2020; Rubini, Andrea/AAE-2217-2022; Jaillon, Olivier/GRY-6287-2022; Kohler, Annegret/AAD-1876-2019; Murat, Claude/AAA-5226-2020; morin, emmanuelle/AAA-1246-2019; Zambonelli, Alessandra/AAF-3581-2019; Balestrini, Raffaella/D-1975-2010; Ghignone, Stefano/B-8288-2008; Zampieri, Elisa/G-6516-2011; Henrissat, Bernard/J-2475-2012; Aury, Jean-Marc/N-1621-2019; Riccioni, Claudia/AAX-1878-2020; Bonfante, Paola/ABE-6733-2020; Marcais, Benoit/O-5049-2019; , DUPLESSIS/G-4150-2011; Mello, Antonietta/AFX-6601-2022	Paolocci, Francesco/0000-0002-9394-876X; Mello, Antonietta/0000-0002-6311-377X; Cantarel, Brandi/0000-0003-4126-4478; Pacioni, Giovanni/0000-0002-0201-5789; Iotti, Mirco/0000-0003-2705-0385; percudani, riccardo/0000-0001-8452-1062; Balestrini, Raffaella/0000-0001-7958-7681; Quesneville, Hadi/0000-0003-3001-4908; Rubini, Andrea/0000-0003-3988-6294; Murat, Claude/0000-0003-0685-7307; morin, emmanuelle/0000-0002-7268-972X; Balestrini, Raffaella/0000-0001-7958-7681; Ghignone, Stefano/0000-0002-2033-2286; Henrissat, Bernard/0000-0002-3434-8588; Aury, Jean-Marc/0000-0003-1718-3010; Riccioni, Claudia/0000-0003-1069-8943; Marcais, Benoit/0000-0002-8107-644X; , DUPLESSIS/0000-0002-2072-2989; Mello, Antonietta/0000-0002-6311-377X; Splivallo, Richard/0000-0002-7567-6553; Porcel, Betina/0000-0003-0169-5302; Brenna, Andrea/0000-0002-8542-9855; Noel, Benjamin/0000-0002-5830-3253; LEBRUN, marc-henri/0000-0003-1562-1902; Denoeud, France/0000-0001-8819-7634; Brun-Jacob, Annick/0000-0002-0299-2766; ZAMPIERI, Elisa/0000-0003-4623-1747; Bonfante, Paola/0000-0003-3576-8530; Montanini, Barbara/0000-0002-5419-7975; DA SILVA, Corinne/0000-0002-7618-7831; Amselem, Joelle/0000-0001-7124-3454; Couloux, Arnaud/0000-0003-2356-0062; Buee, Marc/0000-0001-8614-3886	Genoscope, Institut de Genomique, CEA; Agence Nationale de la Recherche (ANR); European FP6 Network of Excellence EVOLTREE, Region Lorraine; Fondazione Cariparma, Compagnia di San Paolo-Torino; Italian Ministry of Education, University and Research (MIUR), Regione Umbria; Instituto Pasteur Fondazione Cenci Bolognetti	Genoscope, Institut de Genomique, CEA(French Atomic Energy Commission); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European FP6 Network of Excellence EVOLTREE, Region Lorraine(Region Grand-Est); Fondazione Cariparma, Compagnia di San Paolo-Torino(Compagnia di San Paolo); Italian Ministry of Education, University and Research (MIUR), Regione Umbria(Ministry of Education, Universities and Research (MIUR)); Instituto Pasteur Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	We thank the late L. Riousset and C. Dupre for providing the Mel28 isolate, and acknowledge F. Le Tacon and J. Weissenbach for continuous support. The genome sequencing of T. melanosporum was funded by the Genoscope, Institut de Genomique, CEA, and Agence Nationale de la Recherche (ANR). Genome annotation and transcriptome analysis were supported by INRA, the European FP6 Network of Excellence EVOLTREE, Region Lorraine, the ANR FungEffector project, Fondazione Cariparma, Compagnia di San Paolo-Torino, the Italian Ministry of Education, University and Research (MIUR), Regione Umbria and Instituto Pasteur Fondazione Cenci Bolognetti. We thank D. Hibbett and J. Heitman for comments on an early draft of the manuscript, and J. Plett for a critical reading of the paper.	Bertault G, 1998, NATURE, V394, P734, DOI 10.1038/29428; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Fraser JA, 2004, MOL MICROBIOL, V51, P299, DOI 10.1046/j.1365-2958.2003.03874.x; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; HALL IR, 2007, TAMING TRUFFLE HIST; Hibbett DS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-13; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Liu M, 2008, APPL ENVIRON MICROB, V74, P4590, DOI 10.1128/AEM.00150-08; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martin F, 2008, NEW PHYTOL, V180, P296, DOI 10.1111/j.1469-8137.2008.02613.x; MASER C, 2008, TRUFFLES BEASTS; Mello A, 2006, FEMS MICROBIOL LETT, V260, P1, DOI 10.1111/j.1574-6968.2006.00252.x; Murat C, 2004, NEW PHYTOL, V164, P401, DOI 10.1111/j.1469-8137.2004.01189.x; Riccioni C, 2008, NEW PHYTOL, V180, P466, DOI 10.1111/j.1469-8137.2008.02560.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Soanes DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002300; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838	19	478	514	7	165	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1033	1038		10.1038/nature08867	http://dx.doi.org/10.1038/nature08867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20348908	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000276635000037
J	Bzymek, M; Thayer, NH; Oh, SD; Kleckner, N; Hunter, N				Bzymek, Malgorzata; Thayer, Nathaniel H.; Oh, Steve D.; Kleckner, Nancy; Hunter, Neil			Double Holliday junctions are intermediates of DNA break repair	NATURE			English	Article							DOUBLE-STRAND-BREAK; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; MEIOTIC RECOMBINATION; GENE CONVERSION; CROSSING-OVER; CELL-CYCLE; ENDONUCLEASE; TRANSITION; HELICASE	Repair of DNA double-strand breaks (DSBs) by homologous recombination is crucial for cell proliferation and tumour suppression. However, despite its importance, the molecular intermediates of mitotic DSB repair remain undefined. The double Holliday junction (DHJ), presupposed to be the central intermediate for more than 25 years(1), has only been identified during meiotic recombination(2). Moreover, evidence has accumulated for alternative, DHJ-independent mechanisms(3-6), raising the possibility that DHJs are not formed during DSB repair in mitotically cycling cells. Here we identify intermediates of DSB repair by using a budding-yeast assay system designed to mimic physiological DSB repair. This system uses diploid cells and provides the possibility for allelic recombination either between sister chromatids or between homologues, as well as direct comparison with meiotic recombination at the same locus. In mitotically cycling cells, we detect inter-homologue joint molecule (JM) intermediates whose strand composition and size are identical to those of the canonical DHJ structures observed in meiosis(2). However, in contrast to meiosis, JMs between sister chromatids form in preference to those between homologues. Moreover, JMs seem to represent a minor pathway of DSB repair in mitotic cells, being detected at about tenfold lower levels (per DSB) than during meiotic recombination. Thus, although DHJs are identified as intermediates of DSB-promoted recombination in both mitotic and meiotic cells, their formation is distinctly regulated according to the specific dictates of the two cellular programs.	[Bzymek, Malgorzata; Hunter, Neil] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Hunter, Neil] Univ Calif Davis, Howard Hughes Med Inst, Davis, CA 95616 USA; [Hunter, Neil] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Thayer, Nathaniel H.] Univ Washington, Mol & Cellular Biol PhD Program, Seattle, WA 98195 USA; [Oh, Steve D.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Oh, Steve D.] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of California System; University of California Davis; Howard Hughes Medical Institute; University of California System; University of California Davis; University of California System; University of California Davis; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Harvard University	Hunter, N (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	nhunter@ucdavis.edu			National Institutes of Health (NIH) National Institute of General Medical Sciences [GM025326, GM074223]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025326, R01GM074223, R01GM025326] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Schiestl for plasmid pWY203, and W. Heyer for critical reading of the manuscript. This work was supported by National Institutes of Health (NIH) National Institute of General Medical Sciences grants GM025326 to N.K. and GM074223 to N.H.	Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; BELL L, 1983, ANAL BIOCHEM, V130, P527, DOI 10.1016/0003-2697(83)90628-0; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; FABRE F, 1984, MOL GEN GENET, V195, P139, DOI 10.1007/BF00332736; Galli A, 1998, GENETICS, V149, P1235; Haber JE, 2002, METHOD ENZYMOL, V350, P141, DOI 10.1016/S0076-6879(02)50961-7; Heyer WD, 2003, TRENDS BIOCHEM SCI, V28, P548, DOI 10.1016/j.tibs.2003.08.011; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jessop L, 2005, GENETICS, V169, P1353, DOI 10.1534/genetics.104.036509; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; KADYK LC, 1992, GENETICS, V132, P387; Lee PS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000410; Liu Y, 2008, GENE DEV, V22, P2737, DOI 10.1101/gad.1732808; McMahill MS, 2007, PLOS BIOL, V5, P2589, DOI 10.1371/journal.pbio.0050299; MONTEILHET C, 1990, NUCLEIC ACIDS RES, V18, P1407, DOI 10.1093/nar/18.6.1407; Mullen JR, 2000, GENETICS, V154, P1101; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Oh SD, 2009, METHODS MOL BIOL, V557, P209, DOI 10.1007/978-1-59745-527-5_14; RESNICK MA, 1976, J THEOR BIOL, V59, P97, DOI 10.1016/S0022-5193(76)80025-2; ROMAN H, 1983, P NATL ACAD SCI-BIOL, V80, P6912, DOI 10.1073/pnas.80.22.6912; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Wu L, 2005, EMBO J, V24, P2679, DOI 10.1038/sj.emboj.7600740; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	30	153	153	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					937	U162		10.1038/nature08868	http://dx.doi.org/10.1038/nature08868			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20348905	Green Accepted			2022-12-24	WOS:000276397300047
J	Davoli, T; Denchi, EL; de Lange, T				Davoli, Teresa; Denchi, Eros Lazzerini; de Lange, Titia			Persistent Telomere Damage Induces Bypass of Mitosis and Tetraploidy	CELL			English	Article							CELL-CYCLE PROGRESSION; GENOMIC INSTABILITY; S-PHASE; BARRETTS-ESOPHAGUS; COLORECTAL-CANCER; BREAST-CANCER; FISSION YEAST; DNA; ANEUPLOIDY; MICE	Tetraploidization has been proposed as an intermediate step toward aneuploidy in human cancer but a general mechanism for the induction of tetraploidy during tumorigenesis is lacking. We report that tetraploidization occurs in p53-deficient cells experiencing a prolonged DNA damage signal due to persistent telomere dysfunction. Live-cell imaging revealed that these cells have an extended G2 due to ATM/ATR-and Chk1/Chk2-mediated inhibition of Cdk1/CyclinB and eventually bypass mitosis. Despite their lack of mitosis, the cells showed APC/Cdh1-dependent degradation of the replication inhibitor geminin, followed by accumulation of Cdt1, which is required for origin licensing. Cells then entered a second S phase resulting in whole-genome reduplication and tetraploidy. Upon restoration of telomere protection, these tetraploid cells resumed cell division cycles and proliferated. These observations suggest a general mechanism for the induction of tetraploidization in the early stages of tumorigenesis when telomere dysfunction can result from excessive telomere shortening.	[Davoli, Teresa; Denchi, Eros Lazzerini; de Lange, Titia] Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10065 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10065 USA.	delange@mail.rockefeller.edu	lazzerini denchi, eros/F-7913-2010; Denchi, Eros Lazzerini/AAD-8208-2020; de Lange, Titia/B-8263-2011	lazzerini denchi, eros/0000-0001-5378-4644; de Lange, Titia/0000-0002-9267-367X; Davoli, Teresa/0000-0003-4116-9745	Breast Cancer Research Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000379] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Devon White for expert mouse husbandry. Antibodies, DNA constructs, and protocols were generously provided by Drs. A. Ballabeni, J. Pines, A. Miyawaki, and O. Fernandez-Capetillo. We are grateful to Dr. A. Musacchio, Dr. D. Morgan, and members of the de Lange lab for advice and discussion. A. North (RU Bio-imaging RC) and S. Mazel (RU Flow Cytometry RC) are thanked for expert assistance. This work was supported by the Breast Cancer Research Foundation.	Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; CARDER P, 1993, ONCOGENE, V8, P1397; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; DANES BS, 1978, CANCER-AM CANCER SOC, V41, P2330, DOI 10.1002/1097-0142(197806)41:6<2330::AID-CNCR2820410635>3.0.CO;2-X; de Lange T, 1999, CELL, V98, P273, DOI 10.1016/S0092-8674(00)81955-8; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Duelli DM, 2007, CURR BIOL, V17, P431, DOI 10.1016/j.cub.2007.01.049; DUTRILLAUX B, 1991, BREAST CANCER RES TR, V19, P245, DOI 10.1007/BF01961161; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HAYLES J, 1994, CELL, V78, P813, DOI 10.1016/S0092-8674(94)90542-8; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258; Kiang L, 2009, MOL CELL BIOL, V29, P4025, DOI 10.1128/MCB.00185-09; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; LEVINE DS, 1991, GASTROENTEROLOGY, V101, P1198, DOI 10.1016/0016-5085(91)90068-V; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Narbonne-Reveau K, 2008, DEVELOPMENT, V135, P1451, DOI 10.1242/dev.016295; Pantic M, 2006, ONCOGENE, V25, P4413, DOI 10.1038/sj.onc.1209486; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; RABINOVITCH PS, 1989, LAB INVEST, V60, P65; Reina-San-Martin B, 2005, P NATL ACAD SCI USA, V102, P1590, DOI 10.1073/pnas.0406289102; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wang X, 2003, GENE DEV, V17, P965, DOI 10.1101/gad.1065103; Weaver BAA, 2006, NATURE, V442, pE9, DOI 10.1038/nature05139; Yoshihara T, 2004, EMBO J, V23, P670, DOI 10.1038/sj.emboj.7600087; Zielke N, 2008, GENE DEV, V22, P1690, DOI 10.1101/gad.469108	52	195	199	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					81	93		10.1016/j.cell.2010.01.031	http://dx.doi.org/10.1016/j.cell.2010.01.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371347	Bronze, Green Accepted			2022-12-24	WOS:000276211100014
J	Jopling, C; Sleep, E; Raya, M; Marti, M; Raya, A; Belmonte, JCI				Jopling, Chris; Sleep, Eduard; Raya, Marina; Marti, Merce; Raya, Angel; Izpisua Belmonte, Juan Carlos			Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation	NATURE			English	Article							CELL-CYCLE; INJURY; MYOCARDIUM; EXPRESSION	Although mammalian hearts show almost no ability to regenerate, there is a growing initiative to determine whether existing cardiomyocytes or progenitor cells can be coaxed into eliciting a regenerative response. In contrast to mammals, several non-mammalian vertebrate species are able to regenerate their hearts(1-3), including the zebrafish(4,5), which can fully regenerate its heart after amputation of up to 20% of the ventricle. To address directly the source of newly formed cardiomyocytes during zebrafish heart regeneration, we first established a genetic strategy to trace the lineage of cardiomyocytes in the adult fish, on the basis of the Cre/lox system widely used in the mouse(6). Here we use this system to show that regenerated heart muscle cells are derived from the proliferation of differentiated cardiomyocytes. Furthermore, we show that proliferating cardiomyocytes undergo limited dedifferentiation characterized by the disassembly of their sarcomeric structure, detachment from one another and the expression of regulators of cell-cycle progression. Specifically, we show that the gene product of polo-like kinase 1 (plk1) is an essential component of cardiomyocyte proliferation during heart regeneration. Our data provide the first direct evidence for the source of proliferating cardiomyocytes during zebrafish heart regeneration and indicate that stem or progenitor cells are not significantly involved in this process.	[Jopling, Chris; Sleep, Eduard; Raya, Marina; Marti, Merce; Raya, Angel; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Sleep, Eduard; Raya, Angel; Izpisua Belmonte, Juan Carlos] Networking Ctr Biomed Res Bioengn Biomat & Nanome, Barcelona 08003, Spain; [Raya, Angel] ICREA, Barcelona 08010, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; ICREA; Salk Institute	Belmonte, JCI (corresponding author), Ctr Regenerat Med Barcelona, Dr Aiguader St 88, Barcelona 08003, Spain.	belmonte@salk.edu	Raya, Angel/E-6205-2010; Jopling, Chris/D-1728-2019	Raya, Angel/0000-0003-2189-9775; jopling, chris/0000-0003-0950-0063	Ministry of Innovation, Universities and Enterprise (DIUE), Generalitat de Catalunya; Fundacion Cellex; Ipsen Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis; Ministry of Science and Innovation (MICINN); CIBER; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL088293] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Ministry of Innovation, Universities and Enterprise (DIUE), Generalitat de Catalunya(Generalitat de Catalunya); Fundacion Cellex(Foundation CELLEX); Ipsen Foundation(Ipsen); G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis(Sanofi-Aventis); Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBER; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ICREA(ICREA)	We thank M. C. Fabregat, C. Rodriguez Esteban and I. Dubova for technical assistance, and A. Faucherre for constructive criticism of the manuscript. E. S. was the recipient of a pre-doctoral fellowship from the Ministry of Innovation, Universities and Enterprise (DIUE), Generalitat de Catalunya. This work was supported by grants from Fundacion Cellex, the Ipsen Foundation, the G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi-Aventis, the Ministry of Science and Innovation (MICINN), CIBER, and the National Institutes of Health.	Abbate A, 2007, INT J CARDIOL, V114, P118, DOI 10.1016/j.ijcard.2005.11.025; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006; Boniface EJ, 2009, GENESIS, V47, P484, DOI 10.1002/dvg.20526; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Cheville NF, 1994, ULTRASTRUCTURAL PATH; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Dispersyn GD, 2001, CARDIOVASC RES, V51, P230, DOI 10.1016/S0008-6363(01)00326-1; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Flink IL, 2002, ANAT EMBRYOL, V205, P235, DOI 10.1007/s00429-002-0249-6; Glauert A.M., 1975, PRACTICAL METHODS EL, V3, P44; Hans S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004640; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Laube F, 2006, J CELL SCI, V119, P4719, DOI 10.1242/jcs.03252; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Neff AW, 1996, INT J DEV BIOL, V40, P719; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Sleep E, 2010, J CARDIOVASC MED, V11, P369, DOI 10.2459/JCM.0b013e3283375900; Wijns W, 1998, NEW ENGL J MED, V339, P173, DOI 10.1056/NEJM199807163390307	25	889	926	2	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					606	U168		10.1038/nature08899	http://dx.doi.org/10.1038/nature08899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336145	Green Accepted			2022-12-24	WOS:000275974200051
J	Daigaku, Y; Davies, AA; Ulrich, HD				Daigaku, Yasukazu; Davies, Adelina A.; Ulrich, Helle D.			Ubiquitin-dependent DNA damage bypass is separable from genome replication	NATURE			English	Article							CELL NUCLEAR ANTIGEN; SACCHAROMYCES-CEREVISIAE; POSTREPLICATION REPAIR; TRANSLESION SYNTHESIS; ULTRAVIOLET-LIGHT; POLYMERASE-ETA; BUDDING YEAST; ERROR-FREE; POL-ETA; S-PHASE	Post-replication repair (PRR) is a pathway that allows cells to bypass or overcome lesions during DNA replication(1). In eukaryotes, damage bypass is activated by ubiquitylation of the replication clamp PCNA through components of the RAD6 pathway(2). Whereas monoubiquitylation of PCNA allows mutagenic translesion synthesis by damage-tolerant DNA polymerases(3-5), polyubiquitylation is required for an error-free pathway that probably involves a template switch to the undamaged sister chromatid(6). Both the timing of PRR events during the cell cycle and their location relative to replication forks, as well as the factors required downstream of PCNA ubiquitylation, have remained poorly characterized. Here we demonstrate that the RAD6 pathway normally operates during S phase. However, using an inducible system of DNA damage bypass in budding yeast (Saccharomyces cerevisiae), we show that the process is separable in time and space from genome replication, thus allowing direct visualization and quantification of productive PRR tracts. We found that both during and after S phase ultraviolet-radiation-induced lesions are bypassed predominantly via translesion synthesis, whereas the error-free pathway functions as a backup system. Our approach has revealed the distribution of PRR tracts in a synchronized cell population. It will allow an in-depth mechanistic analysis of how cells manage the processing of lesions to their genomes during and after replication.	[Daigaku, Yasukazu; Davies, Adelina A.; Ulrich, Helle D.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Ulrich, HD (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Blanche Lane, S Mimms EN6 3LD, Herts, England.	helle.ulrich@cancer.org.uk		Ulrich, Helle D./0000-0003-0431-2223; Daigaku, Yasukazu/0000-0002-8404-7492	Cancer Research UK	Cancer Research UK(Cancer Research UK)	We thank O. Aparicio for plasmid p306-BrdU-Inc and the laboratory of V. Costanzo for advice on DNA fibre analysis. This work was funded by Cancer Research UK.	Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Bresson A, 2002, EMBO J, V21, P3881, DOI 10.1093/emboj/cdf363; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; DICAPRIO L, 1981, MUTAT RES, V82, P69, DOI 10.1016/0027-5107(81)90139-1; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Haracska L, 2006, P NATL ACAD SCI USA, V103, P6477, DOI 10.1073/pnas.0510924103; Hishida T, 2009, NATURE, V457, P612, DOI 10.1038/nature07580; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; LAWRENCE C, 1994, BIOESSAYS, V16, P253, DOI 10.1002/bies.950160408; LEHMANN AR, 1972, J MOL BIOL, V66, P319, DOI 10.1016/0022-2836(72)90418-4; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; MacAlpine D, 2005, CHROMOSOME RES, V13, P309, DOI 10.1007/s10577-005-1508-1; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Parker JL, 2007, NUCLEIC ACIDS RES, V35, P881, DOI 10.1093/nar/gkl1102; PRAKASH L, 1981, MOL GEN GENET, V184, P471, DOI 10.1007/BF00352525; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; RESNICK MA, 1972, J BACTERIOL, V109, P979, DOI 10.1128/JB.109.3.979-986.1972; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; UNRAU P, 1973, BIOCHIM BIOPHYS ACTA, V312, P626, DOI 10.1016/0005-2787(73)90065-8; Viggiani CJ, 2006, YEAST, V23, P1045, DOI 10.1002/yea.1406; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Waters LS, 2006, P NATL ACAD SCI USA, V103, P8971, DOI 10.1073/pnas.0510167103; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102	30	198	200	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					951	U13		10.1038/nature09097	http://dx.doi.org/10.1038/nature09097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20453836	Green Accepted			2022-12-24	WOS:000278804500043
J	Cotter, L; Ozcelik, M; Jacob, C; Pereira, JA; Locher, V; Baumann, R; Relvas, JB; Suter, U; Tricaud, N				Cotter, Laurent; Ozcelik, Murat; Jacob, Claire; Pereira, Jorge A.; Locher, Veronica; Baumann, Reto; Relvas, Joao B.; Suter, Ueli; Tricaud, Nicolas			Dlg1-PTEN Interaction Regulates Myelin Thickness to Prevent Damaging Peripheral Nerve Overmyelination	SCIENCE			English	Article							NEUREGULIN-1; POLARITY; PHOSPHORYLATION; BINDING; SHEATH; PTEN	The thickness of the myelin sheath that insulates axons is fitted for optimal nerve conduction velocity. Here, we show that, in Schwann cells, mammalian disks large homolog 1 (Dlg1) interacts with PTEN (phosphatase and tensin homolog deleted on chromosome 10) to inhibit axonal stimulation of myelination. This mechanism limits myelin sheath thickness and prevents overmyelination in mouse sciatic nerves. Removing this brake results also in myelin outfoldings and demyelination, characteristics of some peripheral neuropathies. Indeed, the Dlg1 brake is no longer functional in a mouse model of Charcot-Marie-Tooth disease. Therefore, negative regulation of myelination appears to be essential for optimization of nerve conduction velocity and myelin maintenance.	[Cotter, Laurent; Ozcelik, Murat; Jacob, Claire; Pereira, Jorge A.; Locher, Veronica; Baumann, Reto; Relvas, Joao B.; Suter, Ueli; Tricaud, Nicolas] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Relvas, Joao B.] Univ Porto, IBMC, P-4150180 Oporto, Portugal	Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidade do Porto	Tricaud, N (corresponding author), ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland.	nicolas.tricaud@cell.biol.ethz.ch	Suter, Ueli/A-1624-2010; Relvas, Joao B/A-1142-2008; Jacob, Claire/C-1485-2012	Relvas, Joao B/0000-0001-7636-0924; Jacob, Claire/0000-0001-9567-3950; Tricaud, Nicolas/0000-0002-1620-4046	Swiss National Science Foundation; National Centre of Competence in Research; ETH Zurich (ETHIIRA)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre of Competence in Research; ETH Zurich (ETHIIRA)(ETH Zurich)	We thank J. Salzer for his help with cocultures, N. Mantei, C. Perrin-Tricaud for critically reading the manuscript, and the Light Microscopy Center and Electron Microscopy Center at ETH facilities of the ETHZ for technical help. Supported by the Swiss National Science Foundation (N. T. and U. S.), the National Centre of Competence in Research "Neural Plasticity and Repair," and ETH Zurich (ETHIIRA).	Adey NB, 2000, CANCER RES, V60, P35; Bolis A, 2005, J NEUROSCI, V25, P8567, DOI 10.1523/JNEUROSCI.2493-05.2005; Bolis A, 2009, J NEUROSCI, V29, P8858, DOI 10.1523/JNEUROSCI.1423-09.2009; Bonneick S, 2005, HUM MOL GENET, V14, P3685, DOI 10.1093/hmg/ddi400; Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Contreras-Paredes A, 2009, VIROLOGY, V383, P78, DOI 10.1016/j.virol.2008.09.040; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Ogata T, 2006, MOL NEUROBIOL, V33, P51, DOI 10.1385/MN:33:1:051; Ozcelik M, 2010, J NEUROSCI, V30, P4120, DOI 10.1523/JNEUROSCI.5185-09.2010; Pegtel DM, 2007, CURR BIOL, V17, P1623, DOI 10.1016/j.cub.2007.08.035; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; STAHL N, 1990, MOL BRAIN RES, V8, P209, DOI 10.1016/0169-328X(90)90018-9; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; Waxman SG, 1997, CURR BIOL, V7, pR406, DOI 10.1016/S0960-9822(06)00203-X; Yamanaka T, 2008, FRONT BIOSCI-LANDMRK, V13, P6693, DOI 10.2741/3182	24	137	139	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1415	1418		10.1126/science.1187735	http://dx.doi.org/10.1126/science.1187735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20448149				2022-12-24	WOS:000278598400044
J	Sugahara, KN; Teesalu, T; Karmali, PP; Kotamraju, VR; Agemy, L; Greenwald, DR; Ruoslahti, E				Sugahara, Kazuki N.; Teesalu, Tambet; Karmali, Priya Prakash; Kotamraju, Venkata Ramana; Agemy, Lilach; Greenwald, Daniel R.; Ruoslahti, Erkki			Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs	SCIENCE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; PHAGE DISPLAY; MOUSE MODEL; IN-VIVO; NANOPARTICLES; DOXORUBICIN; CELL; INTEGRINS; DELIVERY	Poor penetration of anticancer drugs into tumors can be an important factor limiting their efficacy. We studied mouse tumor models to show that a previously characterized tumor-penetrating peptide, iRGD, increased vascular and tissue permeability in a tumor-specific and neuropilin-1-dependent manner, allowing coadministered drugs to penetrate into extravascular tumor tissue. Importantly, this effect did not require the drugs to be chemically conjugated to the peptide. Systemic injection with iRGD improved the therapeutic index of drugs of various compositions, including a small molecule (doxorubicin), nanoparticles (nab-paclitaxel and doxorubicin liposomes), and a monoclonal antibody (trastuzumab). Thus, coadministration of iRGD may be a valuable way to enhance the efficacy of anticancer drugs while reducing their side effects, a primary goal of cancer therapy research.	[Sugahara, Kazuki N.; Teesalu, Tambet; Kotamraju, Venkata Ramana; Agemy, Lilach; Ruoslahti, Erkki] Univ Calif Santa Barbara, Vasc Mapping Lab, Ctr Nanomed, Sanford Burnham Med Res Inst, Santa Barbara, CA 93106 USA; [Karmali, Priya Prakash; Ruoslahti, Erkki] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA; [Greenwald, Daniel R.] Canc Ctr Santa Barbara, Santa Barbara Hematol Oncol Med Grp, Santa Barbara, CA 93105 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Santa Barbara; Sanford Burnham Prebys Medical Discovery Institute	Ruoslahti, E (corresponding author), Univ Calif Santa Barbara, Vasc Mapping Lab, Ctr Nanomed, Sanford Burnham Med Res Inst, Biol 2 Bldg, Santa Barbara, CA 93106 USA.	ruoslahti@burnham.org	Teesalu, Tambet/J-1802-2015		National Cancer Institute of the NIH [CA104898, CA119414, CA119335, CA124427, CA115410, CA30199]; U.S. Department of Defense [BC076050, BC08544]; NATIONAL CANCER INSTITUTE [R01CA115410, P01CA104898, R01CA124427, U54CA119335, R01CA119414, P30CA030199] Funding Source: NIH RePORTER	National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Hanahan for transgenic mice, R. M. Hoffman for the GFP-PC-3 cell line, M. J. Sailor and J.-H. Park for advice on the synthesis of iron oxide nanoworms, and E. Engvall for comments on the manuscript. This work was supported by grants CA104898, CA119414, CA119335, CA124427, CA115410, and CA30199 from the National Cancer Institute of the NIH and grants BC076050 and BC08544 from the U.S. Department of Defense. The authors and their institutions have patents on methods and compositions related to peptides and proteins with C-terminal elements and related to internalizing RGD peptides.	Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Arola OJ, 2000, CANCER RES, V60, P1789; Black Keith L, 2004, Cancer Control, V11, P165; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; FENDLY BM, 1990, CANCER RES, V50, P1550; Hambley TW, 2009, CANCER RES, V69, P1259, DOI 10.1158/0008-5472.CAN-08-3786; Hoffman JA, 2003, CANCER CELL, V4, P383, DOI 10.1016/S1535-6108(03)00273-3; Jia HY, 2006, J BIOL CHEM, V281, P13493, DOI 10.1074/jbc.M512121200; Joyce JA, 2003, CANCER CELL, V4, P393, DOI 10.1016/S1535-6108(03)00271-X; Karmali PP, 2009, NANOMED-NANOTECHNOL, V5, P73, DOI 10.1016/j.nano.2008.07.007; KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205; KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265; Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Monsky WL, 1999, CANCER RES, V59, P4129; Murohara T, 1998, CIRCULATION, V97, P99, DOI 10.1161/01.CIR.97.1.99; Murphy EA, 2008, P NATL ACAD SCI USA, V105, P9343, DOI 10.1073/pnas.0803728105; Park JH, 2009, SMALL, V5, P694, DOI 10.1002/smll.200801789; Pastorino F, 2008, CLIN CANCER RES, V14, P7320, DOI 10.1158/1078-0432.CCR-08-0804; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Petrioli R, 2008, CANCER TREAT REV, V34, P710, DOI 10.1016/j.ctrv.2008.05.004; Porkka K, 2002, P NATL ACAD SCI USA, V99, P7444, DOI 10.1073/pnas.062189599; Primeau T, 2005, IMMUNOL RES, V32, P109, DOI 10.1385/IR:32:1-3:109; Ruoslahti E, 2002, NAT REV CANCER, V2, P83, DOI 10.1038/nrc724; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Tagle Danilo A., 1992, Human Molecular Genetics, V1, P121, DOI 10.1093/hmg/1.2.121; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; YUAN F, 1995, CANCER RES, V55, P3752	32	816	861	14	566	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					1031	1035		10.1126/science.1183057	http://dx.doi.org/10.1126/science.1183057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20378772	Green Accepted			2022-12-24	WOS:000277877100042
J	Burbano, HA; Hodges, E; Green, RE; Briggs, AW; Krause, J; Meyer, M; Good, JM; Maricic, T; Johnson, PLF; Xuan, ZY; Rooks, M; Bhattacharjee, A; Brizuela, L; Albert, FW; de la Rasilla, M; Fortea, J; Rosas, A; Lachmann, M; Hannon, GJ; Paabo, S				Burbano, Hernan A.; Hodges, Emily; Green, Richard E.; Briggs, Adrian W.; Krause, Johannes; Meyer, Matthias; Good, Jeffrey M.; Maricic, Tomislav; Johnson, Philip L. F.; Xuan, Zhenyu; Rooks, Michelle; Bhattacharjee, Arindam; Brizuela, Leonardo; Albert, Frank W.; de la Rasilla, Marco; Fortea, Javier; Rosas, Antonio; Lachmann, Michael; Hannon, Gregory J.; Paeaebo, Svante			Targeted Investigation of the Neandertal Genome by Array-Based Sequence Capture	SCIENCE			English	Article							SELECTION; FOXP2; EVOLUTION; SPEECH; HUMANS	It is now possible to perform whole-genome shotgun sequencing as well as capture of specific genomic regions for extinct organisms. However, targeted resequencing of large parts of nuclear genomes has yet to be demonstrated for ancient DNA. Here we show that hybridization capture on microarrays can successfully recover more than a megabase of target regions from Neandertal DNA even in the presence of similar to 99.8% microbial DNA. Using this approach, we have sequenced similar to 14,000 protein-coding positions inferred to have changed on the human lineage since the last common ancestor shared with chimpanzees. By generating the sequence of one Neandertal and 50 present-day humans at these positions, we have identified 88 amino acid substitutions that have become fixed in humans since our divergence from the Neandertals.	[Burbano, Hernan A.; Green, Richard E.; Briggs, Adrian W.; Krause, Johannes; Meyer, Matthias; Good, Jeffrey M.; Maricic, Tomislav; Albert, Frank W.; Lachmann, Michael; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Hodges, Emily; Xuan, Zhenyu; Rooks, Michelle; Hannon, Gregory J.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Hodges, Emily; Rooks, Michelle; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Good, Jeffrey M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Johnson, Philip L. F.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Bhattacharjee, Arindam; Brizuela, Leonardo] Agilent Technol, Life Sci Grp, Santa Clara, CA 95051 USA; [de la Rasilla, Marco; Fortea, Javier] Univ Oviedo, Dept Hist, Area Prehist, Oviedo, Spain; [Rosas, Antonio] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain	Max Planck Society; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Montana System; University of Montana; Emory University; Agilent Technologies; University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Burbano, HA (corresponding author), Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany.		Krause, Johannes/E-6640-2015; Rosas, Antonio/D-9742-2016; Burbano, Hernán/F-2952-2010; Krause, Johannes/AFP-2642-2022; Hannon, Gregory/AAB-3568-2019	Krause, Johannes/0000-0001-5475-4690; Rosas, Antonio/0000-0002-5829-9952; Krause, Johannes/0000-0001-9144-3920; Albert, Frank/0000-0002-1380-8063; Green, Richard/0000-0003-0516-5827; Hodges, Emily/0000-0001-6513-610X; Xuan, Zhenyu/0000-0001-9344-8493; Burbano, Hernan A./0000-0003-3433-719X; de la RASILLA, Marco/0000-0002-5505-0625	NSF [OISE-0754461]; NIH; Max Planck Society; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C. S. Burbano, C. de Filippo, J. Kelso, and D. Reich for helpful comments; M. Kircher, K. Pruefer, and U. Stenzel for technical support; C. D. Bustamante and K. E. Lohmueller for access to human resequencing databases; D. L. Goode and A. Sidow for providing conservation scores; J. M. Akey for providing coordinates of genome-wide scans for selection; I. Gut for human genotyping; E. Leproust and M. Srinivasan for providing early access to the 1 Million feature Agilent microarrays; and the Genome Center at Washington University for pre-publication use of the orangutan genome assembly (http://genome.wustl.edu/genomes/view/pongo_abelii/). The government of the Principado de Asturias funded excavations at the Sidron site. J. M. G. was supported by an NSF international postdoctoral fellowship (OISE-0754461) and E. H. by a postdoctoral training grant from the NIH and by a gift from the Stanley Foundation. G. J. H. is an investigator of the Howard Hughes Medical Institute, which together with the Presidential Innovation Fund of the Max Planck Society provided generous financial support. DNA sequences are deposited in the European Bioinformatics Institute short read archive, with accession number ERP000125. The array capture technologies used in this study are the subject of pending patent filings U. S. 60/478, 382 (filed 2003) and U. S. 61/205, 834 (filed 2009), on which G. J. H. and E. H. are listed as inventors.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cann HM, 2002, SCIENCE, V296, P261; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; de Torres T, 2010, ARCHAEOMETRY, V52, P680, DOI 10.1111/j.1475-4754.2009.00491.x; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Wu HH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-192	24	197	211	1	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2010	328	5979					723	725		10.1126/science.1188046	http://dx.doi.org/10.1126/science.1188046			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448179	Green Accepted			2022-12-24	WOS:000277357100031
J	de Calignon, A; Fox, LM; Pitstick, R; Carlson, GA; Bacskai, BJ; Spires-Jones, TL; Hyman, BT				de Calignon, Alix; Fox, Leora M.; Pitstick, Rose; Carlson, George A.; Bacskai, Brian J.; Spires-Jones, Tara L.; Hyman, Bradley T.			Caspase activation precedes and leads to tangles	NATURE			English	Article							MOUSE MODEL; NEUROFIBRILLARY TANGLES; NEURONAL LOSS; TAU-PHOSPHORYLATION; CONGO RED; CLEAVAGE; AGGREGATION; TRUNCATION; DISSOCIATION; EXPRESSION	Studies of post-mortem tissue have shown that the location of fibrillar tau deposits, called neurofibrillary tangles (NFT), matches closely with regions of massive neuronal death(1,2), severe cytological abnormalities(3), and markers of caspase activation and apoptosis(4-6), leading to the idea that tangles cause neurodegeneration in Alzheimer's disease and tau-related frontotemporal dementia. However, using in vivo multiphoton imaging to observe tangles and activation of executioner caspases in living tau transgenic mice (Tg4510 strain), we find the opposite: caspase activation occurs first, and precedes tangle formation by hours to days. New tangles form within a day. After a new tangle forms, the neuron remains alive and caspase activity seems to be suppressed. Similarly, introduction of wild-type 4-repeat tau (tau-4R) into wild-type animals triggered caspase activation, tau truncation and tau aggregation. Adeno-associated virus-mediated expression of a construct mimicking caspase-cleaved tau into wild-type mice led to the appearance of intracellular aggregates, tangle-related conformational-and phospho-epitopes, and the recruitment of full-length endogenous tau to the aggregates. On the basis of these data, we propose a new model in which caspase activation cleaves tau to initiate tangle formation, then truncated tau recruits normal tau to misfold and form tangles. Because tangle-bearing neurons are long-lived, we suggest that tangles are 'off pathway' to acute neuronal death. Soluble tau species, rather than fibrillar tau, may be the critical toxic moiety underlying neurodegeneration.	[de Calignon, Alix; Fox, Leora M.; Bacskai, Brian J.; Spires-Jones, Tara L.; Hyman, Bradley T.] Harvard Univ, Alzheimers Dis Res Lab, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis,Dept Neurol,Med S, Charlestown, MA 02129 USA; [de Calignon, Alix] Univ Paris 06, F-75005 Paris, France; [Pitstick, Rose; Carlson, George A.] McLaughlin Res Inst, Great Falls, MT 59401 USA	Harvard University; Massachusetts General Hospital; UDICE-French Research Universities; Sorbonne Universite; McLaughlin Research Institute for Biomedical Sciences, Inc.	Hyman, BT (corresponding author), Harvard Univ, Alzheimers Dis Res Lab, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis,Dept Neurol,Med S, Charlestown, MA 02129 USA.	bhyman@partners.org	Spires-Jones, Tara/AAR-7697-2020; Bacskai, Brian/AAE-9583-2021	Spires-Jones, Tara/0000-0003-2530-0598; 	Alzheimer's disease Drug Discovery Foundation; Harvard Medical School Shore Award;  [AG08487];  [AG 026249];  [K99 AG033670-01A1]; NATIONAL INSTITUTE ON AGING [P50AG005134, K99AG033670, R01AG008487, R01AG026249, R29AG008487] Funding Source: NIH RePORTER	Alzheimer's disease Drug Discovery Foundation; Harvard Medical School Shore Award; ; ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by AG08487, AG 026249, K99 AG033670-01A1, Alzheimer's disease Drug Discovery Foundation, Harvard Medical School Shore Award. We thank W. E. Klunk for his generous gift of compound X-34. A. d. C. is a student in the B2M programme (Universite Pierre and Marie Curie, Paris, France) and the results in this manuscript will be presented in her thesis.	Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Basurto-Islas G, 2008, J NEUROPATH EXP NEUR, V67, P470, DOI 10.1097/NEN.0b013e31817275c7; de Calignon A, 2009, J NEUROPATH EXP NEUR, V68, P757, DOI 10.1097/NEN.0b013e3181a9fc66; Delobel P, 2008, AM J PATHOL, V172, P123, DOI 10.2353/ajpath.2008.070627; Ding HP, 2006, J BIOL CHEM, V281, P19107, DOI 10.1074/jbc.M511697200; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Guillozet-Bongaarts AL, 2006, J NEUROCHEM, V97, P1005, DOI 10.1111/j.1471-4159.2006.03784.x; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Horowitz PM, 2004, J NEUROSCI, V24, P7895, DOI 10.1523/JNEUROSCI.1988-04.2004; Jaworski T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007280; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Mocanu MM, 2008, J NEUROSCI, V28, P737, DOI 10.1523/JNEUROSCI.2824-07.2008; Park SY, 2007, NEUROSCIENCE, V144, P119, DOI 10.1016/j.neuroscience.2006.09.012; Ramalho RM, 2008, MOL MED, V14, P309, DOI 10.2119/2007-00133.Ramalho; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Rohn TT, 2001, AM J PATHOL, V158, P189, DOI 10.1016/S0002-9440(10)63957-0; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Skoch Jesse, 2004, V299, P349; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008; Styren SC, 2000, J HISTOCHEM CYTOCHEM, V48, P1223, DOI 10.1177/002215540004800906; Velasco A, 2008, FEBS LETT, V582, P901, DOI 10.1016/j.febslet.2008.02.025; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Yin HS, 2006, FEBS LETT, V580, P211, DOI 10.1016/j.febslet.2005.11.077; Zhang QP, 2009, ACTA NEUROPATHOL, V117, P687, DOI 10.1007/s00401-009-0491-6	30	374	393	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1201	U123		10.1038/nature08890	http://dx.doi.org/10.1038/nature08890			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20357768	Green Accepted			2022-12-24	WOS:000276891100039
J	Skibbe, DS; Doehlemann, G; Fernandes, J; Walbot, V				Skibbe, David S.; Doehlemann, Gunther; Fernandes, John; Walbot, Virginia			Maize Tumors Caused by Ustilago maydis Require Organ-Specific Genes in Host and Pathogen	SCIENCE			English	Article							TRANSCRIPTOME; EFFECTORS; GENOME	Infection of maize by corn smut (Ustilago maydis) provides an agronomically important model of biotrophic host-pathogen interactions. After penetration of the maize epidermis, fungal colonization of host tissue induces tumor formation on all aerial maize organs. We hypothesized that transformation of different primordia into plant tumors would require organ-specific gene expression by both host and pathogen and documented these differences by transcriptome profiling. Phenotypic screening of U. maydis mutants deleted for genes encoding secreted proteins and maize mutants with organ-specific defects confirmed organ-restricted tumorigenesis. This is the foundation for exploring how individual pathogen effectors, deployed in an organ-specific pattern, interact with host factors to reprogram normal ontogeny into a tumor pathway.	[Skibbe, David S.; Fernandes, John; Walbot, Virginia] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Doehlemann, Gunther] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Stanford University; Max Planck Society	Walbot, V (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	walbot@stanford.edu	Doehlemann, Gunther/C-1777-2008	Walbot, Virginia/0000-0002-1596-7279; Doehlemann, Gunther/0000-0002-7353-8456	NSF [IOS-0852788]; Savitzky Fund; European Molecular Biology Organization; Deutsche Forschungsgemeinschaft [FOR 666]	NSF(National Science Foundation (NSF)); Savitzky Fund; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Research was supported by NSF grant IOS-0852788 (V. W.), the Savitzky Fund (D. S. S.), European Molecular Biology Organization STF program (G. D.), and Deutsche Forschungsgemeinschaft priority program FOR 666. We thank R. Kahmann for U. maydis strains. We appreciate critical comments on this manuscript by R. Kahmann, R. Fisher, and M. Barnett. Microarray data have been deposited in Gene Expression Omnibus (GEO) under accession GSE20130.	Banuett F, 2002, MYCOLOGY S, V15, P349; Barazesh S, 2008, TRENDS PLANT SCI, V13, P656, DOI 10.1016/j.tplants.2008.09.007; Bolduc N, 2009, PLANT CELL, V21, P1647, DOI 10.1105/tpc.109.068221; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; CALLOW JA, 1975, NEW PHYTOL, V75, P253, DOI 10.1111/j.1469-8137.1975.tb01394.x; Dodds PN, 2009, NEW PHYTOL, V183, P993, DOI 10.1111/j.1469-8137.2009.02922.x; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Fernandes J, 2008, PLANT BIOTECHNOL J, V6, P782, DOI 10.1111/j.1467-7652.2008.00360.x; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Ma J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r22; Martinez-Espinoza AD, 2002, FUNGAL GENET BIOL, V35, P1, DOI 10.1006/fgbi.2001.1301; Mueller O, 2008, FUNGAL GENET BIOL, V45, pS63, DOI 10.1016/j.fgb.2008.03.012; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Skibbe DS, 2009, PLANT J, V59, P622, DOI 10.1111/j.1365-313X.2009.03901.x; SMITH LG, 1992, DEVELOPMENT, V116, P21; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Walbot V, 2010, SEX PLANT REPROD, V23, P1, DOI 10.1007/s00497-009-0109-0	19	145	151	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					89	92		10.1126/science.1185775	http://dx.doi.org/10.1126/science.1185775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360107				2022-12-24	WOS:000276202200041
J	Metzger, E; Imhof, A; Patel, D; Kahl, P; Hoffmeyer, K; Friedrichs, N; Muller, JM; Greschik, H; Kirfel, J; Ji, S; Kunowska, N; Beisenherz-Huss, C; Gunther, T; Buettner, R; Schule, R				Metzger, Eric; Imhof, Axel; Patel, Dharmeshkumar; Kahl, Philip; Hoffmeyer, Katrin; Friedrichs, Nicolaus; Mueller, Judith M.; Greschik, Holger; Kirfel, Jutta; Ji, Sujuan; Kunowska, Natalia; Beisenherz-Huss, Christian; Guenther, Thomas; Buettner, Reinhard; Schuele, Roland			Phosphorylation of histone H3T6 by PKC beta(I) controls demethylation at histone H3K4	NATURE			English	Article							DOMAIN-CONTAINING PROTEINS; ANDROGEN-RECEPTOR; PROSTATE-CANCER; TRANSCRIPTIONAL REGULATION; STRUCTURAL BASIS; LSD1; COMPLEX; GENE	Demethylation at distinct lysine residues in histone H3 by lysine-specific demethylase 1 (LSD1) causes either gene repression or activation(1,2). As a component of co-repressor complexes, LSD1 contributes to target gene repression by removing mono-and dimethyl marks from lysine 4 of histone H3 (H3K4)(1,3). In contrast, during androgen receptor (AR)-activated gene expression, LSD1 removes mono-and dimethyl marks from lysine 9 of histone H3 (H3K9)(2). Yet, the mechanisms that control this dual specificity of demethylation are unknown. Here we show that phosphorylation of histone H3 at threonine 6 (H3T6) by protein kinase C beta I (PKC beta(I), also known as PRKCb beta) is the key event that prevents LSD1 from demethylating H3K4 during AR-dependent gene activation. In vitro, histone H3 peptides methylated at lysine 4 and phosphorylated at threonine 6 are no longer LSD1 substrates. In vivo, PKC beta(I) co-localizes with AR and LSD1 on target gene promoters and phosphorylates H3T6 after androgen-induced gene expression. RNA interference (RNAi)-mediated knockdown of PKC beta(I) abrogates H3T6 phosphorylation, enhances demethylation at H3K4, and inhibits AR-dependent transcription. Activation of PKC beta(I) requires androgen-dependent recruitment of the gatekeeper kinase protein kinase C (PKC)-related kinase 1 (PRK1)(4). Notably, increased levels of PKC beta(I) and phosphorylated H3T6 (H3T6ph) positively correlate with high Gleason scores of prostate carcinomas, and inhibition of PKC beta(I) blocks AR-induced tumour cell proliferation in vitro and cancer progression of tumour xeno-grafts in vivo. Together, our data establish that androgen-dependent kinase signalling leads to the writing of the new chromatin mark H3T6ph, which in consequence prevents removal of active methyl marks from H3K4 during AR-stimulated gene expression.	[Metzger, Eric; Patel, Dharmeshkumar; Hoffmeyer, Katrin; Friedrichs, Nicolaus; Mueller, Judith M.; Greschik, Holger; Ji, Sujuan; Kunowska, Natalia; Guenther, Thomas; Schuele, Roland] Univ Freiburg Klinikum, Urol Klin, Frauenklin, D-79106 Freiburg, Germany; [Metzger, Eric; Patel, Dharmeshkumar; Hoffmeyer, Katrin; Friedrichs, Nicolaus; Mueller, Judith M.; Greschik, Holger; Ji, Sujuan; Kunowska, Natalia; Guenther, Thomas; Schuele, Roland] Univ Freiburg Klinikum, Zent Klin Forsch, D-79106 Freiburg, Germany; [Beisenherz-Huss, Christian] ProQinase, D-79106 Freiburg, Germany; [Imhof, Axel] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Imhof, Axel] Univ Munich, Munich CIPS, D-80336 Munich, Germany; [Kahl, Philip; Kirfel, Jutta; Buettner, Reinhard] Univ Klinikum Bonn, Inst Pathol, D-53127 Bonn, Germany	University of Freiburg; University of Freiburg; University of Munich; University of Munich; University of Bonn	Schule, R (corresponding author), Univ Freiburg Klinikum, Urol Klin, Frauenklin, Breisacherstr 66, D-79106 Freiburg, Germany.	roland.schuele@uniklinik-freiburg.de	Imhof, Axel/AAU-5313-2021	Imhof, Axel/0000-0003-2993-8249; Gunther, Thomas/0000-0003-3903-9490	Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft [SFB 746/P2, Schu 688/9-1, SFB 832/Z1]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank U. Elsasser-Beile, K. Alt, U. Wetterauer, W. Schulze-Seelmann, R. Schneider, T. Waldmann, L. Heukamp, J. M. G. Higgins and N. Potier for providing reagents. We are obliged to A. Rieder, F. Pfefferle, L. Walz, L. Spady and J. Lauterwasser for technical assistance. This work was supported by grants of the Deutsche Krebshilfe and the Deutsche Forschungsgemeinschaft (Reinhart Koselleck-Projekt, SFB 746/P2, Schu 688/9-1, Dr. Hans Messner Stiftung, Dr. Oetker-Stiftung and SFB 832/Z1) to R. S. and R. B.	Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;60::AID-IJC11&gt;3.0.CO;2-B; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Makkonen H, 2008, ONCOGENE, V27, P4865, DOI 10.1038/onc.2008.125; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Metzger E, 2007, NAT STRUCT MOL BIOL, V14, P252, DOI 10.1038/nsmb0407-252; ONEILL TE, 1992, J MOL BIOL, V223, P67, DOI 10.1016/0022-2836(92)90716-W; SCHRODER FH, 1992, PROSTATE, P129; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang MJ, 2007, NAT STRUCT MOL BIOL, V14, P535, DOI 10.1038/nsmb1255	23	208	222	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	2010	464	7289					792	U175		10.1038/nature08839	http://dx.doi.org/10.1038/nature08839			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20228790				2022-12-24	WOS:000276205000052
J	Neumann, B; Walter, T; Heriche, JK; Bulkescher, J; Erfle, H; Conrad, C; Rogers, P; Poser, I; Held, M; Liebel, U; Cetin, C; Sieckmann, F; Pau, G; Kabbe, R; Wunsche, A; Satagopam, V; Schmitz, MHA; Chapuis, C; Gerlich, DW; Schneider, R; Eils, R; Huber, W; Peters, JM; Hyman, AA; Durbin, R; Pepperkok, R; Ellenberg, J				Neumann, Beate; Walter, Thomas; Heriche, Jean-Karim; Bulkescher, Jutta; Erfle, Holger; Conrad, Christian; Rogers, Phill; Poser, Ina; Held, Michael; Liebel, Urban; Cetin, Cihan; Sieckmann, Frank; Pau, Gregoire; Kabbe, Rolf; Wuensche, Annelie; Satagopam, Venkata; Schmitz, Michael H. A.; Chapuis, Catherine; Gerlich, Daniel W.; Schneider, Reinhard; Eils, Roland; Huber, Wolfgang; Peters, Jan-Michael; Hyman, Anthony A.; Durbin, Richard; Pepperkok, Rainer; Ellenberg, Jan			Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes	NATURE			English	Article							TISSUE-CULTURE CELLS; RNA INTERFERENCE; IDENTIFICATION; ORGANIZATION; ARRAYS	Despite our rapidly growing knowledge about the human genome, we do not know all of the genes required for some of the most basic functions of life. To start to fill this gap we developed a high-throughput phenotypic screening platform combining potent gene silencing by RNA interference, time-lapse microscopy and computational image processing. We carried out a genome-wide phenotypic profiling of each of the similar to 21,000 human protein-coding genes by two-day live imaging of fluorescently labelled chromosomes. Phenotypes were scored quantitatively by computational image processing, which allowed us to identify hundreds of human genes involved in diverse biological functions including cell division, migration and survival. As part of the Mitocheck consortium, this study provides an in-depth analysis of cell division phenotypes and makes the entire high-content data set available as a resource to the community.	[Wuensche, Annelie; Ellenberg, Jan] European Mol Biol Lab, Gene Express Unit, D-69117 Heidelberg, Germany; [Neumann, Beate; Walter, Thomas; Bulkescher, Jutta; Erfle, Holger; Conrad, Christian; Rogers, Phill; Held, Michael; Liebel, Urban] European Mol Biol Lab, MitoCheck Project Grp, D-69117 Heidelberg, Germany; [Erfle, Holger; Conrad, Christian; Cetin, Cihan; Chapuis, Catherine; Pepperkok, Rainer] European Mol Biol Lab, Cell Biol Biophys Unit, D-69117 Heidelberg, Germany; [Satagopam, Venkata; Schneider, Reinhard] European Mol Biol Lab, Computat Biol Unit, D-69117 Heidelberg, Germany; [Heriche, Jean-Karim; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Poser, Ina; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Schmitz, Michael H. A.; Gerlich, Daniel W.] Swiss Fed Inst Technol Zurich ETHZ, Inst Biochem, CH-8093 Zurich, Switzerland; [Sieckmann, Frank] Leica Microsyst CMS GmbH, D-68165 Mannheim, Germany; [Pau, Gregoire; Huber, Wolfgang] European Mol Biol Lab, European Bioinformat Inst, Cambridge CB10 1SD, England; [Kabbe, Rolf; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Peters, Jan-Michael] Inst Mol Pathol, A-1030 Vienna, Austria	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Ellenberg, J (corresponding author), European Mol Biol Lab, Gene Express Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jan.ellenberg@embl.de	Gerlich, Daniel Wolfram W/A-6991-2016; Liebel, Urban/D-8519-2011; Durbin, Richard/AAE-7178-2019; Hyman, Tony/F-1923-2011; Schneider, Reinhard/C-5441-2009; chapuis, catherine/AAH-4617-2019; Eils, Roland/B-6121-2009; Ellenberg, Jan/I-4688-2014; Hyman, Anthony A/B-3917-2017; Walter, Thomas/B-9079-2015	Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Durbin, Richard/0000-0002-9130-1006; Schneider, Reinhard/0000-0002-8278-1618; chapuis, catherine/0000-0002-3765-0969; Eils, Roland/0000-0002-0034-4036; Ellenberg, Jan/0000-0001-5909-701X; Hyman, Anthony A/0000-0003-3664-154X; Heriche, Jean-Karim/0000-0001-6867-9425; Walter, Thomas/0000-0001-7419-7879; Neumann, Beate/0000-0002-6899-502X; Satagopam, Venkata/0000-0002-6532-5880; Huber, Wolfgang/0000-0002-0474-2218; Pepperkok, Rainer/0000-0002-9762-3583	European Commission [LSHG-CT-2004-503464]; Federal Ministry of Education and Research (BMBF) [FKZ01GR0403, FKZ01GR0423]; Wellcome Trust	European Commission(European CommissionEuropean Commission Joint Research Centre); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank J. Gagneur for suggestions on data processing; S. Berthoumieux for assistance in computation; Y. Sun for coordination support in Mitocheck; U. Ringeisen for help in preparing the figures; S. Winkler and L. Burger and EMBL's electronic and mechanical workshops for support in microscope development; Olympus Soft Imaging Solutions (OSIS) and Olympus Europe for collaboration; Leica Microsystems for collaboration; Applied Biosystems for providing unpublished validation data of the siRNA library; and all our colleagues in the Mitocheck consortium for collaboration. This project was funded by grants to J. E. (within the Mitocheck consortium by the European Commission (LSHG-CT-2004-503464) as well as by the Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN) (NGFN-2 SMP-RNAi, FKZ01GR0403)), to R. P. (BMBF NGFN2 SMP-Cell, FKZ01GR0423) as well as to J. E. and R. P. by the Landesstiftung Baden Wuerttemberg in the framework of the research programme 'RNS/RNAi'. R. D. is supported by the Wellcome Trust.	Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Boland MV, 1998, CYTOMETRY, V33, P366; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Conrad C, 2004, GENOME RES, V14, P1130, DOI 10.1101/gr.2383804; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; Glory E, 2007, DEV CELL, V12, P7, DOI 10.1016/j.devcel.2006.12.007; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Grus F H, 2002, BMC Ophthalmol, V2, P4, DOI 10.1186/1471-2415-2-4; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Liebel U, 2003, FEBS LETT, V554, P394, DOI 10.1016/S0014-5793(03)01197-9; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; WALTER T, J STRUCT BI IN PRESS, P93901; Wang M, 2008, BIOINFORMATICS, V24, P94, DOI 10.1093/bioinformatics/btm530; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	22	617	626	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					721	727		10.1038/nature08869	http://dx.doi.org/10.1038/nature08869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20360735	Green Accepted, Green Published			2022-12-24	WOS:000276205000037
J	Roch, S				Roch, Sebastien			Toward Extracting All Phylogenetic Information from Matrices of Evolutionary Distances	SCIENCE			English	Article							GENERALIZED LEAST-SQUARES; SEQUENCE DATA; TREES; RECONSTRUCTION; MODEL; PERFORMANCE	The matrix of evolutionary distances is a model-based statistic, derived from molecular sequences, summarizing the pairwise phylogenetic relations between a collection of species. Phylogenetic tree reconstruction methods relying on this matrix are relatively fast and thus widely used in molecular systematics. However, because of their intrinsic reliance on summary statistics, distance-matrix methods are assumed to be less accurate than likelihood-based approaches. In this paper, pairwise sequence comparisons are shown to be more powerful than previously hypothesized. A statistical analysis of certain distance-based techniques indicates that their data requirement for large evolutionary trees essentially matches the conjectured performance of maximum likelihood methods-challenging the idea that summary statistics lead to suboptimal analyses. On the basis of a connection between ancestral state reconstruction and distance averaging, the critical role played by the covariances of the distance matrix is identified.	Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Roch, S (corresponding author), Univ Calif Los Angeles, Dept Math, 520 Portola Plaza, Los Angeles, CA 90095 USA.	roch@math.ucla.edu						Atteson K, 1999, ALGORITHMICA, V25, P251, DOI 10.1007/PL00008277; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; BULMER M, 1991, MOL BIOL EVOL, V8, P868; Chor B, 2006, J ACM, V53, P722, DOI 10.1145/1183907.1183909; Daskalakis C., 2006, STOC'06. Proceedings of the 38th Annual ACM Symposium on Theory of Computing, P159, DOI 10.1145/1132516.1132540; Daskalakis C, 2011, PROBAB THEORY REL, V149, P149, DOI 10.1007/s00440-009-0246-2; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Erdos PL, 1999, RANDOM STRUCT ALGOR, V14, P153, DOI 10.1002/(SICI)1098-2418(199903)14:2<153::AID-RSA3>3.0.CO;2-R; Evans W, 2000, ANN APPL PROBAB, V10, P410; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; GRAHAM RL, 1982, MATH BIOSCI, V60, P133, DOI 10.1016/0025-5564(82)90125-0; HUSON DH, 1999, WAE 99, P271; Kim J, 1998, SYST BIOL, V47, P43, DOI 10.1080/106351598261021; Lacey MR, 2006, MATH BIOSCI, V199, P188, DOI 10.1016/j.mbs.2005.11.003; MIHAESCU R, 2008, THESIS U CALIFORNIA; Mihaescu R, 2008, P NATL ACAD SCI USA, V105, P13206, DOI 10.1073/pnas.0802089105; Mossel E, 2004, T AM MATH SOC, V356, P2379, DOI 10.1090/S0002-9947-03-03382-8; Mossel E, 2001, ANN APPL PROBAB, V11, P285, DOI 10.1214/aoap/998926994; MOSSEL E, COMMUNICATION; Roch S., 2008, FOCS, P729; Rzhetsky A, 1996, MOL BIOL EVOL, V13, P1255, DOI 10.1093/oxfordjournals.molbev.a025691; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schervish M J., 1995, THEORY STAT; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Sokal RR, 1963, PRINCIPLES NUMERICAL; Steel MA, 2002, SIAM J DISCRETE MATH, V15, P562, DOI 10.1137/S089548010138790X; STEEL MA, 1988, NATURE, V336, P118, DOI 10.1038/336118a0; Steel M, 2009, J THEOR BIOL, V256, P467, DOI 10.1016/j.jtbi.2008.10.010; Susko E, 2003, MOL BIOL EVOL, V20, P862, DOI 10.1093/molbev/msg093; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023	34	35	36	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	2010	327	5971					1376	1379		10.1126/science.1182300	http://dx.doi.org/10.1126/science.1182300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223986				2022-12-24	WOS:000275418700041
J	Samara, NL; Datta, AB; Berndsen, CE; Zhang, XB; Yao, TT; Cohen, RE; Wolberger, C				Samara, Nadine L.; Datta, Ajit B.; Berndsen, Christopher E.; Zhang, Xiangbin; Yao, Tingting; Cohen, Robert E.; Wolberger, Cynthia			Structural Insights into the Assembly and Function of the SAGA Deubiquitinating Module	SCIENCE			English	Article							MESSENGER-RNA EXPORT; NUCLEAR-PORE; UBIQUITIN; CHROMATIN; COMPLEX; SUS1; DEUBIQUITYLATION; ASSOCIATION; DOMAIN; UBP8	SAGA is a transcriptional coactivator complex that is conserved across eukaryotes and performs multiple functions during transcriptional activation and elongation. One role is deubiquitination of histone H2B, and this activity resides in a distinct subcomplex called the deubiquitinating module (DUBm), which contains the ubiquitin-specific protease Ubp8, bound to Sgf11, Sus1, and Sgf73. The deubiquitinating activity depends on the presence of all four DUBm proteins. We report here the 1.90 angstrom resolution crystal structure of the DUBm bound to ubiquitin aldehyde, as well as the 2.45 angstrom resolution structure of the uncomplexed DUBm. The structure reveals an arrangement of protein domains that gives rise to a highly interconnected complex, which is stabilized by eight structural zinc atoms that are critical for enzymatic activity. The structure suggests a model for how interactions with the other DUBm proteins activate Ubp8 and allows us to speculate about how the DUBm binds to monoubiquitinated histone H2B in nucleosomes.	[Samara, Nadine L.; Datta, Ajit B.; Berndsen, Christopher E.; Zhang, Xiangbin; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Datta, Ajit B.; Berndsen, Christopher E.; Zhang, Xiangbin; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Yao, Tingting; Cohen, Robert E.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Colorado State University	Wolberger, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	cwolberg@jhmi.edu	Samara, Nadine/AAT-2720-2020	Wolberger, Cynthia/0000-0001-8578-2969; Berndsen, Christopher/0000-0002-4285-4341	National Institute of General Medical Science, NIH [F32GM089037, Y1-GM-1104]; National Cancer Institute [Y1-CO-1020]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM089037, R01GM095822] Funding Source: NIH RePORTER	National Institute of General Medical Science, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. DiBello for helping with the ubiquitin aldehyde synthesis, E. Hurt for providing the Sus1 clone, S. Corcoran at the General Medicine and Cancer Institutes Collaborative Access Team (GM/CA-CAT) beamline at the Advanced Photon Source for assistance with data collection and processing, and M. Bianchet for advice and discussions. C. E. B. is supported by a Ruth Kirchstein Fellowship from the National Institute of General Medical Science, NIH (F32GM089037), and T.Y. is a Special Fellow of the Leukemia and Lymphoma Society. GM/CA-CAT has been funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104), NIH. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 3MHS (DUBm bound to Ubal) and 3MHH (apo DUBm).	Allen MD, 2007, PROTEIN SCI, V16, P2072, DOI 10.1110/ps.072967807; Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Bonnet J, 2008, TRENDS BIOCHEM SCI, V33, P369, DOI 10.1016/j.tibs.2008.05.005; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Ellisdon AM, 2010, J BIOL CHEM, V285, P3850, DOI 10.1074/jbc.M109.070839; Helmlinger D, 2006, TRENDS GENET, V22, P562, DOI 10.1016/j.tig.2006.07.010; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Jani DY, 2009, MOL CELL, V33, P727, DOI 10.1016/j.molcel.2009.01.033; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; KOUTELOU E, 2010, CURR OPIN CELL BIOL; Latouche M, 2006, MOL CELL NEUROSCI, V31, P438, DOI 10.1016/j.mcn.2005.10.013; Lee HJ, 2006, GENE EXPR PATTERNS, V6, P277, DOI 10.1016/j.modgep.2005.07.007; Lee KK, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-2; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Lindblad K, 1996, GENOME RES, V6, P965, DOI 10.1101/gr.6.10.965; Luthra R, 2007, J BIOL CHEM, V282, P3042, DOI 10.1074/jbc.M608741200; Pascual-Garcia P, 2008, GENE DEV, V22, P2811, DOI 10.1101/gad.483308; PICKART CM, 1986, J BIOL CHEM, V261, P210; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Rodriguez-Navarro S, 2009, EMBO REP, V10, P843, DOI 10.1038/embor.2009.168; Weake VM, 2008, EMBO J, V27, P394, DOI 10.1038/sj.emboj.7601966; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Ye Y, 2009, MOL BIOSYST, V5, P1797, DOI 10.1039/b907669g	29	159	163	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					1025	1029		10.1126/science.1190049	http://dx.doi.org/10.1126/science.1190049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20395473	Green Accepted			2022-12-24	WOS:000277877100040
J	Scheuermann, JC; Alonso, AGD; Oktaba, K; Ly-Hartig, N; McGinty, RK; Fraterman, S; Wilm, M; Muir, TW; Muller, J				Scheuermann, Johanna C.; Alonso, Andres Gaytan de Ayala; Oktaba, Katarzyna; Ly-Hartig, Nga; McGinty, Robert K.; Fraterman, Sven; Wilm, Matthias; Muir, Tom W.; Mueller, Juerg			Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB	NATURE			English	Article							GROUP PROTEIN COMPLEXES; BITHORAX COMPLEX; DROSOPHILA; GENES; MECHANISMS; CORE; TRIMETHYLATION; UBIQUITINATION; UBIQUITYLATION; HYDROLASES	Polycomb group (PcG) proteins are transcriptional repressors that control processes ranging from the maintenance of cell fate decisions and stem cell pluripotency in animals to the control of flowering time in plants(1-6). In Drosophila, genetic studies identified more than 15 different PcG proteins that are required to repress homeotic (HOX) and other developmental regulator genes in cells where they must stay inactive(1,7,8). Biochemical analyses established that these PcG proteins exist in distinct multiprotein complexes that bind to and modify chromatin of target genes(1-4). Among those, Polycomb repressive complex 1 (PRC1) and the related dRing-associated factors (dRAF) complex contain an E3 ligase activity for monoubiquitination of histone H2A (refs 1-4). Here we show that the uncharacterized Drosophila PcG gene calypso encodes the ubiquitin carboxy-terminal hydrolase BAP1. Biochemically purified Calypso exists in a complex with the PcG protein ASX, and this complex, named Polycomb repressive deubiquitinase (PR-DUB), is bound at PcG target genes in Drosophila. Reconstituted recombinant Drosophila and human PR-DUB complexes remove monoubiquitin from H2A but not from H2B in nucleosomes. Drosophila mutants lacking PR-DUB show a strong increase in the levels of monoubiquitinated H2A. A mutation that disrupts the catalytic activity of Calypso, or absence of the ASX subunit abolishes H2A deubiquitination in vitro and HOX gene repression in vivo. Polycomb gene silencing may thus entail adynamic balance between H2A ubiquitination by PRC1 and dRAF, and H2A deubiquitination by PR-DUB.	[Scheuermann, Johanna C.; Alonso, Andres Gaytan de Ayala; Oktaba, Katarzyna; Ly-Hartig, Nga; Fraterman, Sven; Wilm, Matthias; Mueller, Juerg] European Mol Biol Lab, D-69117 Heidelberg, Germany; [McGinty, Robert K.; Muir, Tom W.] Rockefeller Univ, New York, NY 10065 USA	European Molecular Biology Laboratory (EMBL); Rockefeller University	Muller, J (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	juerg.mueller@embl.de	Ferris, Laura/I-7689-2012; Müller, Jürg/ABB-3007-2020; Oktaba, Katarzyna/A-7737-2018; Muir, Tom/AHD-0860-2022	Müller, Jürg/0000-0003-2391-4641; Oktaba, Katarzyna/0000-0002-3950-5626; Muir, Tom/0000-0001-9635-0344; Wilm, Matthias/0000-0002-5461-6834	NIH [RC2CA148354]; EMBL; DFG; NATIONAL CANCER INSTITUTE [RC2CA148354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086868, T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBL; DFG(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Sixma and G. Buchwald for the gift of proteins, H. W. Brock, R. E. Kingston, B. Korn and B. Turner for plasmids, baculoviruses and antibodies, V. Benes, J. de Graaf, S. Muller and A. Riddell for technical support, and W. Huber and J. Gagneur for discussions. T. W. M. is supported by NIH grant RC2CA148354. J. C. S., A. G. A. A., K.O., N.L.-H. and J. M. are supported by EMBL and by grants from the DFG.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Beuchle D, 2001, DEVELOPMENT, V128, P993; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; CELNIKER SE, 1990, EMBO J, V9, P4277, DOI 10.1002/j.1460-2075.1990.tb07876.x; Alonso AGD, 2007, GENETICS, V176, P2099, DOI 10.1534/genetics.107.075739; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Fraterman S, 2007, MOL CELL PROTEOMICS, V6, P728, DOI 10.1074/mcp.M600345-MCP200; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Henderson IR, 2004, DEVELOPMENT, V131, P3829, DOI 10.1242/dev.01294; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; JURGENS G, 1985, NATURE, V316, P153, DOI 10.1038/316153a0; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Larsen CN, 1996, BIOCHEMISTRY-US, V35, P6735, DOI 10.1021/bi960099f; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mason DE, 2004, BIOCHEMISTRY-US, V43, P6535, DOI 10.1021/bi049722j; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; McGinty RK, 2009, ACS CHEM BIOL, V4, P958, DOI 10.1021/cb9002255; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sinclair DAR, 1998, DEVELOPMENT, V125, P1207; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; VASSILEV AP, 1995, J CELL SCI, V108, P1205; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2	40	546	563	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2010	465	7295					243	U138		10.1038/nature08966	http://dx.doi.org/10.1038/nature08966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20436459	Green Published, Green Accepted			2022-12-24	WOS:000277558500041
J	Cameron, P; Hiroi, M; Ngai, J; Scott, K				Cameron, Peter; Hiroi, Makoto; Ngai, John; Scott, Kristin			The molecular basis for water taste in Drosophila	NATURE			English	Article							GUSTATORY RECEPTOR NEURONS; POX-NEURO; CHANNELS; BEHAVIOR; PROTEIN; SYSTEM; BRAIN	The detection of water and the regulation of water intake are essential for animals to maintain proper osmotic homeostasis(1). Drosophila and other insects have gustatory sensory neurons that mediate the recognition of external water sources(2-4), but little is known about the underlying molecular mechanism for water taste detection. Here we identify a member of the degenerin/epithelial sodium channel family(5), PPK28, as an osmosensitive ion channel that mediates the cellular and behavioural response to water. We use molecular, cellular, calcium imaging and electrophysiological approaches to show that ppk28 is expressed in water-sensing neurons, and that loss of ppk28 abolishes water sensitivity. Moreover, ectopic expression of ppk28 confers water sensitivity to bitter-sensing gustatory neurons in the fly and sensitivity to hypoosmotic solutions when expressed in heterologous cells. These studies link an osmosensitive ion channel to water taste detection and drinking behaviour, providing the framework for examining the molecular basis for water detection in other animals.	[Scott, Kristin] Univ Calif Berkeley, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Ngai, John] Univ Calif Berkeley, Funct Genom Lab, Berkeley, CA 94720 USA; [Scott, Kristin] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Scott, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, 229 Stanley Hall, Berkeley, CA 94720 USA.	kscott@berkeley.edu	Hiroi, Makoto/B-6834-2008	Hiroi, Makoto/0000-0002-0136-5891; Cameron, Peter/0000-0002-1443-557X	NIH (NIDCD); Burroughs-Wellcome CAREER Award; John Merck Award; NIH; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006252] Funding Source: NIH RePORTER	NIH (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Burroughs-Wellcome CAREER Award(Burroughs Wellcome Fund); John Merck Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank K. Vranizan for assistance with microarray analyses. K. Gerhold and D. Bautista provided the TRPV4 construct, protocols and advice for HEK293 experiments; the Roelink laboratory provided tissue culture facilities and advice. G. Agarwaal generated heat map images in Matlab for data presentation. W. Fischler generated the NP1017 G-CaMP data in Supplementary Information. We are grateful to C. Zuker and members of the Scott laboratory for comments on the manuscript. This work was supported by a grant from the NIH (NIDCD), a Burroughs-Wellcome CAREER Award and a John Merck Award to K. S. and a NIH predoctoral fellowship to P. C. K. S. is an HHMI Early Career Scientist.	Awasaki T, 1997, J NEUROBIOL, V32, P707, DOI 10.1002/(SICI)1097-4695(19970620)32:7<707::AID-NEU6>3.0.CO;2-8; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Colbert HA, 1997, J NEUROSCI, V17, P8259; EVANS DR, 1962, J GEN PHYSIOL, V45, P487, DOI 10.1085/jgp.45.3.487; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Gilbertson TA, 2002, CHEM SENSES, V27, P383, DOI 10.1093/chemse/27.4.383; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Inoshita T, 2006, P NATL ACAD SCI USA, V103, P1094, DOI 10.1073/pnas.0502376103; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Meunier N, 2000, CURR BIOL, V10, P1583, DOI 10.1016/S0960-9822(00)00860-5; Meunier N, 2009, CHEM SENSES, V34, P441, DOI 10.1093/chemse/bjp019; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Werner-Reiss U, 1999, J INSECT PHYSIOL, V45, P485, DOI 10.1016/S0022-1910(98)00151-6; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001	27	170	175	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					91	U101		10.1038/nature09011	http://dx.doi.org/10.1038/nature09011			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20364123	Green Accepted, Green Submitted			2022-12-24	WOS:000277311900037
J	Jin, Y; Birlea, SA; Fain, PR; Gowan, K; Riccardi, SL; Holland, PJ; Mailloux, CM; Sufit, AJD; Hutton, SM; Amadi-Myers, A; Bennett, DC; Wallace, MR; McCormack, WT; Kemp, EH; Gawkrodger, DJ; Weetman, AP; Picardo, M; Leone, G; Taieb, A; Jouary, T; Ezzedine, K; van Geel, N; Lambert, J; Overbeck, A; Spritz, RA				Jin, Ying; Birlea, Stanca A.; Fain, Pamela R.; Gowan, Katherine; Riccardi, Sheri L.; Holland, Paulene J.; Mailloux, Christina M.; Sufit, Alexandra J. D.; Hutton, Saunie M.; Amadi-Myers, Anita; Bennett, Dorothy C.; Wallace, Margaret R.; McCormack, Wayne T.; Kemp, E. Helen; Gawkrodger, David J.; Weetman, Anthony P.; Picardo, Mauro; Leone, Giovanni; Taieb, Alain; Jouary, Thomas; Ezzedine, Khaled; van Geel, Nanny; Lambert, Jo; Overbeck, Andreas; Spritz, Richard A.			Variant of TYR and Autoimmunity Susceptibility Loci in Generalized Vitiligo.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; HAPLOTYPE MAP; GRANZYME-B; DISEASE; RISK; GENE; PIGMENTATION; TYROSINASE; HLA	Background: Generalized vitiligo is an autoimmune disease characterized by melanocyte loss, which results in patchy depigmentation of skin and hair, and is associated with an elevated risk of other autoimmune diseases. Methods: To identify generalized vitiligo susceptibility loci, we conducted a genomewide association study. We genotyped 579,146 single-nucleotide polymorphisms (SNPs) in 1514 patients with generalized vitiligo who were of European-derived white (CEU) ancestry and compared the genotypes with publicly available control genotypes from 2813 CEU persons. We then tested 50 SNPs in two replication sets, one comprising 677 independent CEU patients and 1106 CEU controls and the other comprising 183 CEU simplex trios with generalized vitiligo and 332 CEU multiplex families. Results: We detected significant associations between generalized vitiligo and SNPs at several loci previously associated with other autoimmune diseases. These included genes encoding major-histocompatibility-complex class I molecules (P=9.05 x 10(sup -23)) and class II molecules (P=4.50 x 10(sup -34)), PTPN22 (P=1.31 x 10(sup -7)), LPP (P=1.01 x 10(sup -11)), IL2RA (P=2.78 x 10(sup -9)), UBASH3A (P=1.26 x 10(sup -9)), and C1QTNF6 (P=2.21 x 10(sup -16)). We also detected associations between generalized vitiligo and SNPs in two additional immune-related loci, RERE (P=7.07 x 10(sup -15)) and GZMB (P=3.44 x 10(sup -8)), and in a locus containing TYR (P=1.60 x 10(sup -18)), encoding tyrosinase. Conclusions: We observed associations between generalized vitiligo and markers implicating multiple genes, some associated with other autoimmune diseases and one (TYR) that may mediate target-cell specificity and indicate a mutually exclusive relationship between susceptibility to vitiligo and susceptibility to melanoma. N Engl J Med 2010;362:1686-97.	[Jin, Ying; Birlea, Stanca A.; Fain, Pamela R.; Gowan, Katherine; Riccardi, Sheri L.; Holland, Paulene J.; Mailloux, Christina M.; Sufit, Alexandra J. D.; Hutton, Saunie M.; Spritz, Richard A.] Univ Colorado, Sch Med, Human Med Genet Program, Aurora, CO 80045 USA; [Fain, Pamela R.] Univ Colorado, Sch Med, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA; [Birlea, Stanca A.] Univ Colorado, Sch Med, Dept Dermatol, Aurora, CO 80045 USA; [Jin, Ying; Fain, Pamela R.; Spritz, Richard A.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Fain, Pamela R.] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA; [Amadi-Myers, Anita; Bennett, Dorothy C.] Univ London, Div Basic Med Sci, London, England; [Wallace, Margaret R.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [McCormack, Wayne T.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Kemp, E. Helen; Weetman, Anthony P.] Univ Sheffield, Sch Med, Dept Human Metab, Sheffield, S Yorkshire, England; [Gawkrodger, David J.] Royal Hallamshire Hosp, Dept Dermatol, Sheffield S10 2JF, S Yorkshire, England; [Picardo, Mauro; Leone, Giovanni] Ist Dermatol S Maria & S Gallicano, Lab Fisiopatol Cutanea, Rome, Italy; [Taieb, Alain; Jouary, Thomas; Ezzedine, Khaled] Hop St Andre, Dept Dermatol, Ctr Reference Malad Rares Peau, Bordeaux, France; [van Geel, Nanny; Lambert, Jo] Ghent Univ Hosp, Dept Dermatol, B-9000 Ghent, Belgium; [Overbeck, Andreas] Lumiderm, Madrid, Spain	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of London; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Sheffield; University of Sheffield; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); CHU Bordeaux; Ghent University; Ghent University Hospital	Spritz, RA (corresponding author), Univ Colorado, Sch Med, Human Med Genet Program, POB 6511,Mailstop 8300, Aurora, CO 80045 USA.	richard.spritz@ucdenver.edu	Bennett, Dorothy C/C-2418-2008; Leone, Giovanni/AAW-7785-2021; TAIEB, ALAIN/AAB-1085-2021; Kemp, Elizabeth Helen/D-1665-2011; Ezzedine, Khaled/A-3072-2009; Jo, Lambert LW/AAG-4880-2021; Jo, Lambert LW/ABD-3264-2021; Ezzedine, Khaled/F-2716-2017; Picardo, Mauro/A-6978-2011; GAWKRODGER, DAVID J./AFO-6373-2022	Bennett, Dorothy C/0000-0002-3639-7527; Leone, Giovanni/0000-0001-6120-2712; Kemp, Elizabeth Helen/0000-0002-0313-8916; Ezzedine, Khaled/0000-0002-5468-4589; Picardo, Mauro/0000-0003-4899-6639; GAWKRODGER, DAVID J./0000-0002-6863-7011; Lambert, Jo/0000-0001-5303-9310; McCormack, Wayne/0000-0002-2117-8727	National Institutes of Health [AR45584, AR056292]; Anna and John Sie Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045584, R01AR056292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anna and John Sie Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by grants (AR45584 and AR056292) from the National Institutes of Health and a grant from the Anna and John Sie Foundation.	Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Carr EJ, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-22; Coenen MJH, 2009, HUM MOL GENET, V18, P4195, DOI 10.1093/hmg/ddp365; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Devadas S, 2006, IMMUNITY, V25, P237, DOI 10.1016/j.immuni.2006.06.011; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Fain PR, 2006, PIGM CELL RES, V19, P51, DOI 10.1111/j.1600-0749.2005.00279.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gregersen PK, 2006, SEMIN IMMUNOL, V18, P214, DOI 10.1016/j.smim.2006.03.009; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hinks A, 2009, ARTHRITIS RHEUM, V60, P251, DOI 10.1002/art.24187; Hondo Yoshihide, 1997, Journal of Dermatology (Tokyo), V24, P561; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Liu JB, 2007, J EUR ACAD DERMATOL, V21, P205, DOI 10.1111/j.1468-3083.2006.01899.x; Lotz C, 2004, INT J CANCER, V108, P571, DOI 10.1002/ijc.11602; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Majumder PA., 2000, VITILIGO MONOGRAPH B; Ostankovitch M, 2009, J IMMUNOL, V182, P4830, DOI 10.4049/jimmunol.0802902; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rezaei N, 2007, J EUR ACAD DERMATOL, V21, P865, DOI 10.1111/j.1468-3083.2007.02228.x; Spritz RA, 2003, CURR OPIN GENET DEV, V13, P284, DOI 10.1016/S0959-437X(03)00059-5; Spritz Richard A., 2008, V10, P244, DOI 10.1159/000131501; Stromberg S, 2008, PIGM CELL MELANOMA R, V21, P162, DOI 10.1111/j.1755-148X.2007.00429.x; Taieb A, 2007, PIGM CELL RES, V20, P27, DOI 10.1111/j.1600-0749.2006.00355.x; Toyofuku K, 2001, BIOCHEM J, V355, P259, DOI 10.1042/0264-6021:3550259; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; TRIPATHI RK, 1991, GENE EXPRESSION, V1, P103; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Waerner T, 2001, CELL GROWTH DIFFER, V12, P201; Wallis RH, 2009, DIABETES, V58, P1007, DOI 10.2337/db08-1215; Wang JG, 2009, SEMIN IMMUNOL, V21, P363, DOI 10.1016/j.smim.2009.04.004; Wang Lei, 2008, Nucl Recept Signal, V6, pe009, DOI 10.1621/nrs.06009	41	261	276	2	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					1686	1697		10.1056/NEJMoa0908547	http://dx.doi.org/10.1056/NEJMoa0908547			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591OQ	20410501	Green Accepted			2022-12-24	WOS:000277311200006
J	Vastenhouw, NL; Zhang, Y; Woods, IG; Imam, F; Regev, A; Liu, XS; Rinn, J; Schier, AF				Vastenhouw, Nadine L.; Zhang, Yong; Woods, Ian G.; Imam, Farhad; Regev, Aviv; Liu, X. Shirley; Rinn, John; Schier, Alexander F.			Chromatin signature of embryonic pluripotency is established during genome activation	NATURE			English	Article							RNA-POLYMERASE; ZYGOTIC TRANSITION; GENES; POLYCOMB	After fertilization the embryonic genome is inactive until transcription is initiated during the maternal-zygotic transition(1-3). This transition coincides with the formation of pluripotent cells, which in mammals can be used to generate embryonic stem cells. To study the changes in chromatin structure that accompany pluripotency and genome activation, we mapped the genomic locations of histone H3 molecules bearing lysine trimethylation modifications before and after the maternal-zygotic transition in zebrafish. Histone H3 lysine 27 trimethylation (H3K27me3), which is repressive, and H3K4me3, which is activating, were not detected before the transition. After genome activation, more than 80% of genes were marked by H3K4me3, including many inactive developmental regulatory genes that were also marked by H3K27me3. Sequential chromatin immunoprecipitation demonstrated that the same promoter regions had both trimethylation marks. Such bivalent chromatin domains also exist in embryonic stem cells and are thought to poise genes for activation while keeping them repressed(4-8). Furthermore, we found many inactive genes that were uniquely marked by H3K4me3. Despite this activating modification, these monovalent genes were neither expressed nor stably bound by RNA polymerase II. Inspection of published data sets revealed similar monovalent domains in embryonic stem cells. Moreover, H3K4me3 marks could form in the absence of both sequence-specific transcriptional activators and stable association of RNA polymerase II, as indicated by the analysis of an inducible transgene. These results indicate that bivalent and monovalent domains might poise embryonic genes for activation and that the chromatin profile associated with pluripotency is established during the maternal-zygotic transition.	[Zhang, Yong; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Vastenhouw, Nadine L.; Woods, Ian G.; Imam, Farhad; Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Zhang, Yong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Regev, Aviv; Rinn, John; Schier, Alexander F.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Regev, Aviv; Rinn, John; Schier, Alexander F.] Harvard Univ, Cambridge, MA 02142 USA; [Rinn, John] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Schier, Alexander F.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Schier, Alexander F.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Tongji University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University	Liu, XS (corresponding author), Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.	xsliu@jimmy.harvard.edu; schier@fas.harvard.edu	Zhang, Yong/B-4838-2011	Zhang, Yong/0000-0001-6316-2734; Schier, Alexander Franz/0000-0001-7645-5325; Rinn, John/0000-0002-7231-7539; Liu, Xiaole/0000-0003-4736-7339; Imam, Farhad/0000-0003-2854-2568	NIH [1R01 HG004069, 5R01 GM56211]; EMBO [LT-00090/2007]; HFSP [LT-00090/2007]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056211] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Schier laboratory for help and advice; H. G. Shin, L. Taing and Z. J. Wufor computational analysis and discussions; N. Follmer and B. Lilley for technical advice; and J. Dubrulle, N. Francis, R. Losick, S. Mango, T. van Opijnen and W. Talbot for discussions and critical reading of the manuscript. This work was supported by NIH grants to X. S. L. (1R01 HG004069) and A. F. S. (5R01 GM56211), and by EMBO and HFSP (LT-00090/2007) fellowships to N. L. V.	Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Boyer, 2009, CHROMATIN SIGNATURE, DOI [10.3824/stembook.1.45.1, DOI 10.3824/STEMBOOK.1.45.1]; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dreijerink KMA, 2006, CANCER RES, V66, P4929, DOI 10.1158/0008-5472.CAN-05-4461; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Stockard J, 2007, JUDGM DECIS MAK, V2, P9; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	35	275	284	3	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					922	U143		10.1038/nature08866	http://dx.doi.org/10.1038/nature08866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20336069	Green Accepted, Green Submitted			2022-12-24	WOS:000276397300044
J	Magen, D; Berger, L; Coady, MJ; Ilivitzki, A; Militianu, D; Tieder, M; Selig, S; Lapointe, JY; Zelikovic, I; Skorecki, K				Magen, Daniella; Berger, Liron; Coady, Michael J.; Ilivitzki, Anat; Militianu, Daniela; Tieder, Martin; Selig, Sara; Lapointe, Jean Yves; Zelikovic, Israel; Skorecki, Karl			BRIEF REPORT A Loss-of-Function Mutation in NaPi-IIa and Renal Fanconi's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SODIUM-PHOSPHATE COTRANSPORTER; HEREDITARY HYPOPHOSPHATEMIC RICKETS; MICE; HYPERCALCIURIA; NEPHROLITHIASIS; HOMEOSTASIS; METABOLISM; ALBUMIN; SLC34A3; NPT2A	We describe two siblings from a consanguineous family with autosomal recessive Fanconi's syndrome and hypophosphatemic rickets. Genetic analysis revealed a homozygous in-frame duplication of 21 bp in SLC34A1, which encodes the renal sodium-inorganic phosphate cotransporter NaPi-IIa, as the causative mutation. Functional studies in Xenopus laevis oocytes and in opossum kidney cells indicated complete loss of function of the mutant NaPi-IIa, resulting from failure of the transporter to reach the plasma membrane. These findings show that disruption of the human NaPi-IIa profoundly impairs overall renal phosphate reabsorption and proximal-tubule function and provide evidence of the critical role of NaPi-IIa in human renal phosphate handling.	[Magen, Daniella; Zelikovic, Israel] Pediat Nephrol Unit, Haifa, Israel; [Magen, Daniella; Zelikovic, Israel; Skorecki, Karl] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Magen, Daniella; Zelikovic, Israel; Skorecki, Karl] Technion Israel Inst Technol, Res Inst, Haifa, Israel; [Zelikovic, Israel] Technion Israel Inst Technol, Lab Dev Nephrol, Haifa, Israel; [Tieder, Martin] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Tieder, Martin] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dana Childrens Hosp, Sect Pediat Nephrol,Dept Pediat, IL-69978 Tel Aviv, Israel; [Coady, Michael J.; Lapointe, Jean Yves] Univ Montreal, Dept Phys, Grp Etud Prot Membranaires, Montreal, PQ H3C 3J7, Canada	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Universite de Montreal	Magen, D (corresponding author), Pediat Nephrol Unit, Rambam Hlth Care Campus, Haifa, Israel.	danmag@tx.technion.ac.il			Israel Science Foundation [1735/08]; Rappaport Family Institute for Research in the Medical Sciences; Veronique Elek Fund of the Canadian Technion Society; Rosalinde and Arthur Gilbert Foundation of the American Technion Society; Canadian Institutes of Health Research [MOP-10580]; Eshaghian Estate Fund of the American Technion Society	Israel Science Foundation(Israel Science Foundation); Rappaport Family Institute for Research in the Medical Sciences; Veronique Elek Fund of the Canadian Technion Society; Rosalinde and Arthur Gilbert Foundation of the American Technion Society; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Eshaghian Estate Fund of the American Technion Society	Supported by grants from the Morasha program of the Israel Science Foundation (1735/08), the Rappaport Family Institute for Research in the Medical Sciences, the Veronique Elek Fund of the Canadian Technion Society, the Rosalinde and Arthur Gilbert Foundation of the American Technion Society, the Canadian Institutes of Health Research (MOP-10580), and the Eshaghian Estate Fund of the American Technion Society.	Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Biber J, 2009, PFLUG ARCH EUR J PHY, V458, P39, DOI 10.1007/s00424-008-0580-8; Chau H, 2003, J BONE MINER RES, V18, P644, DOI 10.1359/jbmr.2003.18.4.644; Hryciw DH, 2006, INT J BIOCHEM CELL B, V38, P1036, DOI 10.1016/j.biocel.2005.09.009; Iwaki T, 2008, J AM SOC NEPHROL, V19, P1753, DOI 10.1681/ASN.2007121360; Khan SR, 2008, AM J PHYSIOL-RENAL, V294, pF1109, DOI 10.1152/ajprenal.00620.2007; Kremke B, 2009, EXP CLIN ENDOCR DIAB, V117, P49, DOI 10.1055/s-2008-1076716; Lapointe JY, 2006, KIDNEY INT, V69, P2261, DOI 10.1038/sj.ki.5000437; Lorenz-Depiereux B, 2006, AM J HUM GENET, V78, P193, DOI 10.1086/499410; Marshansky V, 2002, CURR OPIN NEPHROL HY, V11, P527, DOI 10.1097/00041552-200209000-00009; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Norden AGW, 2001, KIDNEY INT, V60, P1885, DOI 10.1046/j.1523-1755.2001.00016.x; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Russo LM, 2002, AM J KIDNEY DIS, V39, P899, DOI 10.1053/ajkd.2002.32764; Segawa H, 2009, AM J PHYSIOL-RENAL, V297, pF671, DOI 10.1152/ajprenal.00156.2009; Segawa H, 2009, J AM SOC NEPHROL, V20, P104, DOI 10.1681/ASN.2008020177; TIEDER M, 1988, NEW ENGL J MED, V319, P845, DOI 10.1056/NEJM198809293191307; Virkki LV, 2003, J BONE MINER RES, V18, P2135, DOI 10.1359/jbmr.2003.18.12.2135; Wagner CA, 2008, J AM SOC NEPHROL, V19, P1625, DOI 10.1681/ASN.2008060611	20	127	130	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1102	1109		10.1056/NEJMoa0905647	http://dx.doi.org/10.1056/NEJMoa0905647			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335586	Bronze			2022-12-24	WOS:000275894600007
J	Hemmelgarn, BR; Zhang, JG; Manns, BJ; James, MT; Quinn, RR; Ravani, P; Klarenbach, SW; Culleton, BF; Krause, R; Thorlacius, L; Jain, AK; Tonelli, M				Hemmelgarn, Brenda R.; Zhang, Jianguo; Manns, Braden J.; James, Matthew T.; Quinn, Robert R.; Ravani, Pietro; Klarenbach, Scott W.; Culleton, Bruce F.; Krause, Richard; Thorlacius, Laurel; Jain, Arsh K.; Tonelli, Marcello		Alberta Kidney Dis Network	Nephrology Visits and Health Care Resource Use Before and After Reporting Estimated Glomerular Filtration Rate	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC KIDNEY-DISEASE; CONVERTING ENZYME-INHIBITORS; SERUM CREATININE; RENAL-DISEASE; CARDIOVASCULAR OUTCOMES; ESTIMATED GFR; IMPACT; GUIDELINES; TIME; INTERVENTION	Context Laboratory reporting of estimated glomerular filtration rate (GFR) has been widely implemented, with limited evaluation. Objective To examine trends in nephrologist visits and health care resource use before and after estimated GFR reporting. Design, Setting, and Patients Community-based cohort study (N=1 135 968) with time-series analysis. Participants were identified from a laboratory registry in Alberta, Canada, and followed up from May 15, 2003, to March 14, 2007 (with estimated GFR reporting implemented October 15, 2004). Main Outcome Measure Nephrologist visits and patient management. Results Following estimated GFR reporting, the rate of first outpatient visits to a nephrologist for patients with chronic kidney disease (CKD; estimated GFR <60 mL/min/1.73 m(2)) increased by 17.5 (95% confidence interval [CI], 16.5-18.6) visits per 10 000 CKD patients per month, corresponding to a relative increase from baseline of 68.4% (95% CI, 65.7%-71.2%). There was no association between estimated GFR reporting and rate of first nephrologist visit among patients without CKD. Among patients with an estimated GFR of less than 30 mL/min/1.73 m2, the rate of first nephrologist visits increased by 134.4 (95% CI, 60.0-208.7) visits per 10 000 patients per month. This increase was predominantly seen in women, patients aged 46 to 65 years as well as those aged 86 years or older, and those with hypertension, diabetes, and comorbidity. Reporting of estimated GFR was not associated with increased rates of internal medicine or general practitioner visits or increased use of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers among patients with CKD and proteinuria or the subgroup limited to patients with diabetes. Conclusions Reporting of estimated GFR was associated with an increase in first nephrologist visits, particularly among patients with more severe kidney dysfunction, women, middle-aged and very elderly patients, and those with comorbidities. Any effect on outcomes remains to be shown. JAMA. 2010; 303(12): 1151-1158	[Hemmelgarn, Brenda R.; Zhang, Jianguo; Manns, Braden J.; James, Matthew T.; Quinn, Robert R.; Ravani, Pietro; Culleton, Bruce F.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Hemmelgarn, Brenda R.; Manns, Braden J.; James, Matthew T.; Ravani, Pietro] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Krause, Richard] Calgary Lab Serv, Calgary, AB, Canada; [Klarenbach, Scott W.; Tonelli, Marcello] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Thorlacius, Laurel] Diagnost Serv Manitoba, Winnipeg, MB, Canada; [Jain, Arsh K.] Univ Western Ontario, Dept Med, London, ON, Canada	University of Calgary; University of Calgary; University of Calgary; University of Alberta; Western University (University of Western Ontario)	Hemmelgarn, BR (corresponding author), Foothills Med Ctr, Div Nephrol, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.	Brenda.Hemmelgarn@albertahealthservices.ca	Ravani, Pietro/J-3050-2015; Hug, Balthasar L./G-1568-2010; Tonelli, Marcello/B-3028-2009; Hemmelgarn, Brenda R./I-6894-2012; Manns, Braden J/I-8942-2012; Quinn, Robert R/E-7017-2011; Jain, Arsh/G-3308-2011	Ravani, Pietro/0000-0001-6973-8570; Tonelli, Marcello/0000-0002-0846-3187; MacRae, Jennifer/0000-0002-4711-1440	Alberta Heritage Foundation for Medical Research (AHFMR); Kidney Foundation of Canada; Canadian Institutes of Health Research; KRESCENT	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Kidney Foundation of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); KRESCENT	Funding/Support: This study was funded by the Alberta Heritage Foundation for Medical Research (AHFMR) Interdisciplinary Team Grants Program and by the Kidney Foundation of Canada. Drs Hemmelgarn, Manns, and Tonelli were supported by awards from the Canadian Institutes of Health Research. Drs Hemmelgarn, Klarenbach, and Tonelli were supported by awards from the AHFMR. Dr James was supported by a KRESCENT and AHFMR Fellowship.	Aghaie-Jaladerany H, 2007, SCOT MED J, V52, P28, DOI 10.1258/rsmsmj.52.4.28; Akbari A, 2004, ARCH INTERN MED, V164, P1788, DOI 10.1001/archinte.164.16.1788; *ALB HLTH WELLN, 2008, PREM ASS PROGR PREM; Anavekar N, 2005, MED J AUSTRALIA, V183, P138, DOI 10.5694/j.1326-5377.2005.tb06958.x; Bauer C, 2008, J AM SOC NEPHROL, V19, P844, DOI 10.1681/ASN.2008010110; Bertoni AG, 2009, ARCH INTERN MED, V169, P678, DOI 10.1001/archinternmed.2009.44; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Clase CM, 2004, BMJ-BRIT MED J, V329, P912, DOI 10.1136/bmj.329.7471.912; Cook T.C., 1979, QUASIEXPERIMENTATION; *CTR CLIN EP BIOST, 2001, PHARM BEH CULT THEM; Davis D, 2009, CHEST, V135, p42S, DOI 10.1378/chest.08-2517; den Hartog JR, 2009, CLIN J AM SOC NEPHRO, V4, P419, DOI 10.2215/CJN.04080808; Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; Duncan L, 2001, NEPHROL DIAL TRANSPL, V16, P1042, DOI 10.1093/ndt/16.5.1042; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Glassock RJ, 2008, CLIN J AM SOC NEPHRO, V3, P1563, DOI 10.2215/CJN.00960208; Glassock RJ, 2009, KIDNEY INT, V75, P1001, DOI 10.1038/ki.2009.38; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hemmelgarn BR, 2007, J AM SOC NEPHROL, V18, P993, DOI 10.1681/ASN.2006080860; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Huisman RM, 2004, NEPHROL DIAL TRANSPL, V19, P2175, DOI 10.1093/ndt/gfh409; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; Jain AK, 2009, KIDNEY INT, V76, P318, DOI 10.1038/ki.2009.158; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Manns BJ, 2001, CLIN INVEST MED, V24, P164; Miller WG, 2008, AM J KIDNEY DIS, V52, P645, DOI 10.1053/j.ajkd.2008.07.032; *NAT KIDN DIS ED P, 2004, LAB PROF; Noble E, 2008, NEPHROL DIAL TRANSPL, V23, P3845, DOI 10.1093/ndt/gfn385; O'Hare AM, 2009, ANN INTERN MED, V150, P717, DOI 10.7326/0003-4819-150-10-200905190-00010; Ornstein S, 2004, ANN INTERN MED, V141, P523, DOI 10.7326/0003-4819-141-7-200410050-00008; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Rainey PM, 2006, CLIN CHEM, V52, P2184, DOI 10.1373/clinchem.2006.069732; Statistics Canada, ETHN PORTR CAN HIGHL; Swedko P, 2003, ARCH INTERN MED, V163, P356, DOI 10.1001/archinte.163.3.356; Tseng CL, 2008, ARCH INTERN MED, V168, P55, DOI 10.1001/archinternmed.2007.9; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Wyatt C, 2007, AM J KIDNEY DIS, V49, P634, DOI 10.1053/j.ajkd.2007.02.258	47	117	119	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2010	303	12					1151	1158		10.1001/jama.2010.303	http://dx.doi.org/10.1001/jama.2010.303			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573AC	20332400	Bronze			2022-12-24	WOS:000275879600019
J	Angers, RC; Kang, HE; Napier, D; Browning, S; Seward, T; Mathiason, C; Balachandran, A; McKenzie, D; Castilla, J; Soto, C; Jewell, J; Graham, C; Hoover, EA; Telling, GC				Angers, Rachel C.; Kang, Hae-Eun; Napier, Dana; Browning, Shawn; Seward, Tanya; Mathiason, Candace; Balachandran, Aru; McKenzie, Debbie; Castilla, Joaquin; Soto, Claudio; Jewell, Jean; Graham, Catherine; Hoover, Edward A.; Telling, Glenn C.			Prion Strain Mutation Determined by Prion Protein Conformational Compatibility and Primary Structure	SCIENCE			English	Article							CHRONIC WASTING DISEASE; CREUTZFELDT-JAKOB-DISEASE; TRANSGENIC MICE; VARIANT CJD; SCRAPIE; ELK; DEER; TRANSMISSION; PRP; ADAPTATION	Prions are infectious proteins composed of the abnormal disease-causing isoform PrP(Sc), which induces conformational conversion of the host-encoded normal cellular prion protein PrP(C) to additional PrP(Sc). The mechanism underlying prion strain mutation in the absence of nucleic acids remains unresolved. Additionally, the frequency of strains causing chronic wasting disease (CWD), a burgeoning prion epidemic of cervids, is unknown. Using susceptible transgenic mice, we identified two prevalent CWD strains with divergent biological properties but composed of PrP(Sc) with indistinguishable biochemical characteristics. Although CWD transmissions indicated stable, independent strain propagation by elk PrP(C), strain coexistence in the brains of deer and transgenic mice demonstrated unstable strain propagation by deer PrP(C). The primary structures of deer and elk prion proteins differ at residue 226, which, in concert with PrP(Sc) conformational compatibility, determines prion strain mutation in these cervids.	[Angers, Rachel C.; Browning, Shawn; Telling, Glenn C.] Univ Kentucky, Med Ctr, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40536 USA; [Kang, Hae-Eun; Napier, Dana; Seward, Tanya; Telling, Glenn C.] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Telling, Glenn C.] Univ Kentucky, Dept Neurol, Med Ctr, Lexington, KY 40536 USA; [Mathiason, Candace; Hoover, Edward A.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Balachandran, Aru] Canadian Food Inspect Agcy, Ottawa, ON K2H 8P9, Canada; [McKenzie, Debbie] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB T6G 2M8, Canada; [Castilla, Joaquin] Basque Fdn Sci, CIC bioGUNE & IKERBasque, Derio 48992, Bizkaia, Spain; [Castilla, Joaquin] Basque Fdn Sci, CIC bioGUNE & IKERBasque, Bilbao 48011, Bizkaia, Spain; [Soto, Claudio] Univ Texas Med Sch Houston, Houston, TX 77030 USA; [Jewell, Jean] Univ Wyoming, Dept Vet Sci, Laramie, WY 82070 USA; [Graham, Catherine] Canadian Food Inspect Agcy, Lethbridge, AB T1J 3Z4, Canada	University of Kentucky; University of Kentucky; University of Kentucky; Colorado State University; Canadian Food Inspection Agency; University of Alberta; Basque Foundation for Science; CIC bioGUNE; Basque Foundation for Science; University of Texas System; University of Texas Health Science Center Houston; University of Wyoming; Canadian Food Inspection Agency	Telling, GC (corresponding author), Univ Kentucky, Med Ctr, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40536 USA.	gtell2@uky.edu	Mathiason, Candace K/E-7843-2017; Castilla, Joaquín/J-8414-2019; Telling, Glenn C/G-1217-2019; Castilla, Joaquin/E-6952-2012; Mathiason, Candace/H-9769-2017; Castilla, Joaquin/D-5261-2011; McKenzie, Debbie/G-4459-2015	Mathiason, Candace K/0000-0002-5920-4556; Castilla, Joaquín/0000-0002-2216-1361; Telling, Glenn C/0000-0002-6294-1805; Mathiason, Candace/0000-0002-5920-4556; Castilla, Joaquin/0000-0002-2216-1361; McKenzie, Debbie/0000-0002-9291-6977	National Institute of Neurological Disorders and Stroke [2RO1 NS040334-04]; National Institute of Allergy and Infectious Diseases [N01-AI-25491, 1P01AI077774-01]; U.S. Department of Defense [V180003]; National Institute on Drug Abuse [T32 DA022738, T32 AI49795]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025491, T32AI049795, P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040334, R01NS049173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA022738] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Department of Defense(United States Department of Defense); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Prionics for mAb 6H4, V. Saylor for technical help, A. Aguzzi for mAb POM2, P. Nelson for neuropathological expertise, R. Kryscio and J. Marcum for biostatistical advice, and C. Ryou for reading the manuscript. C. S. is currently Founder and Chief Scientific Officer of Amprion Inc., a privately held company focusing on exploiting PMCA for sensitive detection of prions and early disease diagnosis. These studies were supported by grant 2RO1 NS040334-04 from the National Institute of Neurological Disorders and Stroke, grants N01-AI-25491 and 1P01AI077774-01 from the National Institute of Allergy and Infectious Diseases, and grant V180003 from the U.S. Department of Defense. R. C. A. and S. B. were supported by T32 DA022738 and T32 AI49795 Training Programs from the National Institute on Drug Abuse and the National Institute of Allergy and Infectious Diseases, respectively.	Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Bartz JC, 1998, VIROLOGY, V251, P297, DOI 10.1006/viro.1998.9427; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; BRUCE ME, 1982, ACTA NEUROPATHOL, V58, P133, DOI 10.1007/BF00691654; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; BRUCE ME, 1989, NEUROSCI LETT, V102, P1, DOI 10.1016/0304-3940(89)90298-X; Bruce ME, 1979, SLOW TRANSMISSIBLE D, V2, P71; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; DICKINSON AG, 1971, MOL GEN GENET, V112, P73, DOI 10.1007/BF00266934; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Green KM, 2008, J GEN VIROL, V89, P598, DOI 10.1099/vir.0.83168-0; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Johnson C, 2006, J GEN VIROL, V87, P2109, DOI 10.1099/vir.0.81615-0; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; LaFauci G, 2006, J GEN VIROL, V87, P3773, DOI 10.1099/vir.0.82137-0; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Raymond GJ, 2007, J VIROL, V81, P4305, DOI 10.1128/JVI.02474-06; Sigurdson CJ, 2006, J VIROL, V80, P12303, DOI 10.1128/JVI.01120-06; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932	30	162	163	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1154	1158		10.1126/science.1187107	http://dx.doi.org/10.1126/science.1187107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20466881	Green Accepted			2022-12-24	WOS:000278104700043
J	Lengner, CJ; Gimelbrant, AA; Erwin, JA; Cheng, AW; Guenther, MG; Welstead, GG; Alagappan, R; Frampton, GM; Xu, P; Muffat, J; Santagata, S; Powers, D; Barrett, CB; Young, RA; Lee, JT; Jaenisch, R; Mitalipova, M				Lengner, Christopher J.; Gimelbrant, Alexander A.; Erwin, Jennifer A.; Cheng, Albert Wu; Guenther, Matthew G.; Welstead, G. Grant; Alagappan, Raaji; Frampton, Garrett M.; Xu, Ping; Muffat, Julien; Santagata, Sandro; Powers, Doug; Barrett, C. Brent; Young, Richard A.; Lee, Jeannie T.; Jaenisch, Rudolf; Mitalipova, Maisam			Derivation of Pre-X Inactivation Human Embryonic Stem Cells under Physiological Oxygen Concentrations	CELL			English	Article							EARLY MOUSE EMBRYOS; CHROMOSOME INACTIVATION; IN-VITRO; HUMAN BLASTOCYSTS; HISTONE H3; XIST RNA; SELF-RENEWAL; LINES; DIFFERENTIATION; METHYLATION	The presence of two active X chromosomes (XaXa) is a hallmark of the ground state of pluripotency specific to murine embryonic stem cells (ESCs). Human ESCs (hESCs) invariably exhibit signs of X chromosome inactivation (XCI) and are considered developmentally more advanced than their murine counterparts. We describe the establishment of XaXa hESCs derived under physiological oxygen concentrations. Using these cell lines, we demonstrate that (1) differentiation of hESCs induces random XCI in a manner similar to murine ESCs, (2) chronic exposure to atmospheric oxygen is sufficient to induce irreversible XCI with minor changes of the transcriptome, (3) the Xa exhibits heavy methylation of the XIST promoter region, and (4) XCI is associated with demethylation and transcriptional activation of XIST along with H3K27-me3 deposition across the Xi. These findings indicate that the human blastocyst contains pre-X-inactivation cells and that this state is preserved in vitro through culture under physiological oxygen.	[Lengner, Christopher J.; Cheng, Albert Wu; Guenther, Matthew G.; Welstead, G. Grant; Alagappan, Raaji; Frampton, Garrett M.; Xu, Ping; Muffat, Julien; Santagata, Sandro; Young, Richard A.; Jaenisch, Rudolf; Mitalipova, Maisam] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Frampton, Garrett M.; Young, Richard A.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Cheng, Albert Wu] MIT, Dept Computat & Syst Biol, Cambridge, MA 02139 USA; [Gimelbrant, Alexander A.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gimelbrant, Alexander A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02114 USA; [Erwin, Jennifer A.; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Erwin, Jennifer A.; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Erwin, Jennifer A.; Lee, Jeannie T.] Howard Hughes Med Inst, Ann Arbor, MI 48108 USA; [Powers, Doug] Incept Biosyst, Ann Arbor, MI 48108 USA; [Barrett, C. Brent] Waltham Ctr, Boston IVF, Waltham, MA 02451 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu; mitalipo@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Santagata, Sandro/0000-0002-7528-9668; Muffat, Julien/0000-0003-1889-7023; Gimelbrant, Alexander/0000-0001-6986-0285; Erwin, Jennifer/0000-0002-6784-9290; Cheng, Albert/0000-0003-2653-5743; Frampton, Garrett/0000-0002-2361-2750; Lengner, Christopher/0000-0002-0574-5189	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BATT PA, 1991, REPROD FERT DEVELOP, V3, P601, DOI 10.1071/RD9910601; Bernardi ML, 1996, J REPROD FERTIL, V106, P161, DOI 10.1530/jrf.0.1060161; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Chen HF, 2009, HUM REPROD, V24, P71, DOI 10.1093/humrep/den345; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; FISCHER B, 1993, J REPROD FERTIL, V99, P673, DOI 10.1530/jrf.0.0990673; Forsyth NR, 2008, REGEN MED, V3, P817, DOI 10.2217/17460751.3.6.817; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gimelbrant AA, 2006, GENOME RES, V16, P723, DOI 10.1101/gr.5023706; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; HARLOW GM, 1979, AUST J BIOL SCI, V32, P363; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Karja NWK, 2004, THERIOGENOLOGY, V62, P1585, DOI 10.1016/j.theriogenology.2004.03.012; Kikuchi K, 2002, BIOL REPROD, V66, P1033, DOI 10.1095/biolreprod66.4.1033; Kitagawa Y, 2004, THERIOGENOLOGY, V62, P1186, DOI 10.1016/j.theriogenology.2004.01.011; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mermoud JE, 2002, CURR BIOL, V12, P247, DOI 10.1016/S0960-9822(02)00660-7; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Nesterova TB, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-2; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Prasad SM, 2009, CELL PROLIFERAT, V42, P63, DOI 10.1111/j.1365-2184.2008.00571.x; QUINN P, 1978, J EXP ZOOL, V206, P73, DOI 10.1002/jez.1402060108; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; THOMPSON JGE, 1990, J REPROD FERTIL, V89, P573, DOI 10.1530/jrf.0.0890573; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van den Berg IM, 2009, AM J HUM GENET, V84, P771, DOI 10.1016/j.ajhg.2009.05.003; Wang FN, 2006, CLONING STEM CELLS, V8, P108, DOI 10.1089/clo.2006.8.108; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036	54	271	285	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					872	883		10.1016/j.cell.2010.04.010	http://dx.doi.org/10.1016/j.cell.2010.04.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20471072	Bronze, Green Published			2022-12-24	WOS:000278132900021
J	Krol, J; Busskamp, V; Markiewicz, I; Stadler, MB; Ribi, S; Richter, J; Duebel, J; Bicker, S; Fehling, HJ; Schubeler, D; Oertner, TG; Schratt, G; Bibel, M; Roska, B; Filipowicz, W				Krol, Jacek; Busskamp, Volker; Markiewicz, Ilona; Stadler, Michael B.; Ribi, Sebastian; Richter, Jens; Duebel, Jens; Bicker, Silvia; Fehling, Hans Joerg; Schuebeler, Dirk; Oertner, Thomas G.; Schratt, Gerhard; Bibel, Miriam; Roska, Botond; Filipowicz, Witold			Characterizing Light-Regulated Retinal MicroRNAs Reveals Rapid Turnover as a Common Property of Neuronal MicroRNAs	CELL			English	Article							GLUTAMATE TRANSPORTERS; EXPRESSION; MECHANISMS; CELLS; IDENTIFICATION; PLASTICITY; TARGET; ACID; RNAS	Adaptation to different levels of illumination is central to the function of the retina. Here, we demonstrate that levels of the miR-183/96/182 cluster, miR-204, and miR-211 are regulated by different light levels in the mouse retina. Concentrations of these microRNAs were downregulated during dark adaptation and upregulated in light-adapted retinas, with rapid decay and increased transcription being responsible for the respective changes. We identified the voltage-dependent glutamate transporter Slc1a1 as one of the miR-183/96/182 targets in photoreceptor cells. We found that microRNAs in retinal neurons decay much faster than microRNAs in nonneuronal cells. The high turnover is also characteristic of microRNAs in hippocampal and cortical neurons, and neurons differentiated from ES cells in vitro. Blocking activity reduced turnover of microRNAs in neuronal cells while stimulation with glutamate accelerated it. Our results demonstrate that microRNA metabolism in neurons is higher than in most other cells types and linked to neuronal activity.	[Krol, Jacek; Busskamp, Volker; Markiewicz, Ilona; Stadler, Michael B.; Ribi, Sebastian; Duebel, Jens; Schuebeler, Dirk; Oertner, Thomas G.; Roska, Botond; Filipowicz, Witold] Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland; [Richter, Jens; Bibel, Miriam] Novartis Inst Biomed Res, Neurodegenerat Dept, CH-4002 Basel, Switzerland; [Bicker, Silvia; Schratt, Gerhard] Univ Klinikum Heidelberg, Inst Neuroanat, Heidelberg, Germany; [Bicker, Silvia; Schratt, Gerhard] Heidelberg Univ, Interdisziplinares Zentrum Neurowissensch, Heidelberg, Germany; [Fehling, Hans Joerg] Univ Clin Ulm, Inst Immunol, Ulm, Germany	Friedrich Miescher Institute for Biomedical Research; Novartis; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ulm University	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, POB 2543, CH-4002 Basel, Switzerland.	botond.roska@fmi.ch; witold.filipowicz@fmi.ch	Oertner, Thomas/F-2214-2010; Roska, Botond/AAD-7268-2021; Busskamp, Volker/E-6339-2015; Ribi, Sebastian/J-4927-2014	Oertner, Thomas/0000-0002-2312-7528; Busskamp, Volker/0000-0001-7517-8944; Ribi, Sebastian/0000-0003-0242-1362; Duebel, Jens/0000-0002-9906-5597	EC FP6 Program; EMBO; National Centers of Competence in Research, Frontiers in Genetics; Novartis Research Foundation	EC FP6 Program; EMBO(European Molecular Biology Organization (EMBO)); National Centers of Competence in Research, Frontiers in Genetics; Novartis Research Foundation	We thank K. J. Sweadner and N. Sonenberg for antibodies; B. Gross Scherf, S. Djaffer, D. Gerosa Erni, and T. Wust for excellent technical help; E. Oakeley for array analysis; and E. Cabuy, H. Kohler, and K. Jacobeit for help with LCM, FASC, and sequencing. We also thank members of W. F. and B. R. groups for valuable discussions. The work done in the laboratory of W. F. is supported by the EC FP6 Program "Sirocco.'' J. K. is the recipient of an EMBO Fellowship. V. B. and B. R. are supported by a fellowship and grant, respectively, from National Centers of Competence in Research, Frontiers in Genetics. The Friedrich Miescher Institute is supported by the Novartis Research Foundation.	Arora A, 2007, INVEST OPHTH VIS SCI, V48, P3962, DOI 10.1167/iovs.06-1221; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; COPENHAGEN DR, 1989, NATURE, V341, P536, DOI 10.1038/341536a0; Demb JB, 2008, J PHYSIOL-LONDON, V586, P4377, DOI 10.1113/jphysiol.2008.156638; Ding XC, 2009, TRENDS BIOTECHNOL, V27, P27, DOI 10.1016/j.tibtech.2008.09.006; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Gaal L, 1998, J NEUROPHYSIOL, V79, P190, DOI 10.1152/jn.1998.79.1.190; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Hasegawa J, 2006, NEURON, V50, P63, DOI 10.1016/j.neuron.2006.02.022; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Kugler P, 2003, HISTOCHEM CELL BIOL, V120, P199, DOI 10.1007/s00418-003-0555-y; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Nieoullon A, 2006, J NEUROCHEM, V98, P1007, DOI 10.1111/j.1471-4159.2006.03978.x; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Ryan D, 2006, MOL VIS, V12, P1175; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Weiler R, 1998, P NATL ACAD SCI USA, V95, P7139, DOI 10.1073/pnas.95.12.7139; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200	41	357	369	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					618	631		10.1016/j.cell.2010.03.039	http://dx.doi.org/10.1016/j.cell.2010.03.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478254	Bronze			2022-12-24	WOS:000277623600015
J	Lorincz, A; Nusser, Z				Lorincz, Andrea; Nusser, Zoltan			Molecular Identity of Dendritic Voltage-Gated Sodium Channels	SCIENCE			English	Article							ACTIVITY-DEPENDENT ATTENUATION; ACTION-POTENTIAL INITIATION; NA+ CHANNELS; ION CHANNELS; CELL-TYPE; HIPPOCAMPAL; SUBUNITS; LOCALIZATION; RECEPTORS; DENSITY	Active invasion of the dendritic tree by action potentials (APs) generated in the axon is essential for associative synaptic plasticity and neuronal ensemble formation. In cortical pyramidal cells (PCs), this AP back-propagation is supported by dendritic voltage-gated Na+ (Nav) channels, whose molecular identity is unknown. Using a highly sensitive electron microscopic immunogold technique, we revealed the presence of the Nav1.6 subunit in hippocampal CA1 PC proximal and distal dendrites. Here, the subunit density is lower by a factor of 35 to 80 than that found in axon initial segments. A gradual decrease in Nav1.6 density along the proximodistal axis of the dendritic tree was also detected without any labeling in dendritic spines. Our results reveal the characteristic subcellular distribution of the Nav1.6 subunit, identifying this molecule as a key substrate enabling dendritic excitability.	[Lorincz, Andrea; Nusser, Zoltan] Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, H-1083 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Lorincz, A (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, H-1083 Budapest, Hungary.	lorincz@koki.hu; nusser@koki.hu	Nusser, Zoltan/K-8587-2014	Nusser, Zoltan/0000-0001-7004-4111	Hungarian Academy of Sciences; European Young Investigator Award; Wellcome Trust	Hungarian Academy of Sciences(Hungarian Academy of Sciences); European Young Investigator Award; Wellcome Trust(Wellcome TrustEuropean Commission)	A.L. is the recipient of a Janos Bolyai Scholarship of the Hungarian Academy of Sciences. Z.N. is the recipient of a European Young Investigator Award (www.esf.org/euryi) and Wellcome Trust Project and Equipment grants. We thank D. Ronaszeki and E. Dobai for their excellent technical help, W. Sieghart and J.-M. Fritschy for antibodies to the GABA<INF>A</INF> receptors, and M. Eyre and M. Farrant for their comments on the manuscript.	BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; Boiko T, 2003, J NEUROSCI, V23, P2306; Colbert CM, 1998, J NEUROPHYSIOL, V79, P491, DOI 10.1152/jn.1998.79.1.491; Colbert CM, 1997, J NEUROSCI, V17, P6512; Fritschy JM, 1998, J COMP NEUROL, V390, P194; FUJIMOTO K, 1995, J CELL SCI, V108, P3443; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Gasparini S, 2002, J PHYSIOL-LONDON, V541, P665, DOI 10.1113/jphysiol.2002.020503; Gong B, 1999, J COMP NEUROL, V412, P342; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kole MHP, 2008, NAT NEUROSCI, V11, P1253, DOI 10.1038/nn.2203; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 2007, J NEUROSCI, V27, P8999, DOI 10.1523/JNEUROSCI.1717-07.2007; Lorincz A, 2008, J NEUROSCI, V28, P9083, DOI 10.1523/JNEUROSCI.2494-08.2008; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Masugi-Tokita M, 2007, CURR OPIN NEUROBIOL, V17, P387, DOI 10.1016/j.conb.2007.04.012; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Tanaka J, 2005, J NEUROSCI, V25, P799, DOI 10.1523/JNEUROSCI.4256-04.2005; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Xu J, 2005, J NEUROSCI, V25, P1750, DOI 10.1523/JNEUROSCI.4217-04.2005	32	195	197	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					906	909		10.1126/science.1187958	http://dx.doi.org/10.1126/science.1187958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466935	Green Accepted			2022-12-24	WOS:000277618800053
J	Molnar, A; Melnyk, CW; Bassett, A; Hardcastle, TJ; Dunn, R; Baulcombe, DC				Molnar, Attila; Melnyk, Charles W.; Bassett, Andrew; Hardcastle, Thomas J.; Dunn, Ruth; Baulcombe, David C.			Small Silencing RNAs in Plants Are Mobile and Direct Epigenetic Modification in Recipient Cells	SCIENCE			English	Review							POTATO-VIRUS-X; DNA-METHYLATION; POLYMERASE-IV; ARABIDOPSIS-THALIANA; INTERFERING RNA; SIGNAL; EXPRESSION; SEQUENCE; SIRNAS; PHLOEM	A silencing signal in plants with an RNA specificity determinant moves through plasmodesmata and the phloem. To identify the mobile RNA, we grafted Arabidopsis thaliana shoots to roots that would be a recipient for the silencing signal. Using mutants that block small RNA (sRNA) biogenesis in either source or recipient tissue, we found that transgene-derived sRNA as well as a substantial proportion of the endogenous sRNA had moved across the graft union, and we provide evidence that 24-nucleotide mobile sRNAs direct epigenetic modifications in the genome of the recipient cells. Mobile sRNA thus represents a mechanism for transmitting the specification of epigenetic modification and could affect genome defense and responses to external stimuli that have persistent effects in plants.	[Molnar, Attila; Melnyk, Charles W.; Bassett, Andrew; Hardcastle, Thomas J.; Dunn, Ruth; Baulcombe, David C.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Cambridge	Baulcombe, DC (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England.	dcb40@cam.ac.uk	Melnyk, Charles W/R-2846-2017; Molnar, Attila/F-5833-2011	Melnyk, Charles W/0000-0003-3251-800X; Molnar, Attila/0000-0002-1044-6327; Baulcombe, David/0000-0003-0780-6878; Bassett, Andrew/0000-0003-1632-9137; Hardcastle, Thomas/0000-0002-9328-5011	Commonwealth scholarship [CACR 2006-115]; Natural Sciences and Engineering Research Council of Canada [PGS D2 358506-2008]; Royal Society; Gatsby Charitable Foundation; European Union [LSHG-CT-2006-037900]; European Research Council [233325 REVOLUTION]	Commonwealth scholarship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Royal Society(Royal Society of London); Gatsby Charitable Foundation; European Union(European Commission); European Research Council(European Research Council (ERC)European Commission)	We thank K. Rutherford for data assembly and the Genomics and Bioinformatics core facilities (CRUK Cambridge Research Institute) for Illumina sequencing. Supported by Commonwealth scholarship CACR 2006-115 and Natural Sciences and Engineering Research Council of Canada scholarship PGS D2 358506-2008 (C. W. M.), a Royal Society research professorship (D. C. B.), the Gatsby Charitable Foundation, the European Union Sixth Framework Programme Integrated Project SIROCCO (grant LSHG-CT-2006-037900), and European Research Council advanced investigator grant 233325 REVOLUTION. RNA sequencing raw data are available from Gene Expression Omnibus (GSE20663).	Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Brosnan CA, 2007, P NATL ACAD SCI USA, V104, P14741, DOI 10.1073/pnas.0706701104; Buhtz A, 2008, PLANT J, V53, P739, DOI 10.1111/j.1365-313X.2007.03368.x; Dalmay T, 2000, PLANT CELL, V12, P369, DOI 10.1105/tpc.12.3.369; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; LEISNER SM, 1993, PLANT CELL, V5, P191, DOI 10.1105/tpc.5.2.191; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Melquist S, 1999, GENETICS, V153, P401; Melquist S, 2003, GENE DEV, V17, P2036, DOI 10.1101/gad.1081603; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	29	500	565	8	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					872	875		10.1126/science.1187959	http://dx.doi.org/10.1126/science.1187959			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20413459				2022-12-24	WOS:000277618800042
J	Berger, LR; de Ruiter, DJ; Churchill, SE; Schmid, P; Carlson, KJ; Dirks, PHGM; Kibii, JM				Berger, Lee R.; de Ruiter, Darryl J.; Churchill, Steven E.; Schmid, Peter; Carlson, Kristian J.; Dirks, Paul H. G. M.; Kibii, Job M.			Australopithecus sediba: A New Species of Homo-Like Australopith from South Africa	SCIENCE			English	Article							OLDUVAI-GORGE; PLIOPLEISTOCENE HOMINID; SYSTEMATIC ASSESSMENT; LAKE TURKANA; EAST; STERKFONTEIN; CRANIA; GENUS; TANZANIA; ETHIOPIA	Despite a rich African Plio-Pleistocene hominin fossil record, the ancestry of Homo and its relation to earlier australopithecines remain unresolved. Here we report on two partial skeletons with an age of 1.95 to 1.78 million years. The fossils were encased in cave deposits at the Malapa site in South Africa. The skeletons were found close together and are directly associated with craniodental remains. Together they represent a new species of Australopithecus that is probably descended from Australopithecus africanus. Combined craniodental and postcranial evidence demonstrates that this new species shares more derived features with early Homo than any other australopith species and thus might help reveal the ancestor of that genus.	[Berger, Lee R.; de Ruiter, Darryl J.; Churchill, Steven E.; Schmid, Peter; Carlson, Kristian J.; Kibii, Job M.] Univ Witwatersrand, Inst Human Evolut, ZA-2050 Wits, South Africa; [Berger, Lee R.; Dirks, Paul H. G. M.] Univ Witwatersrand, Sch Geosci, ZA-2050 Wits, South Africa; [de Ruiter, Darryl J.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [Churchill, Steven E.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Schmid, Peter] Univ Zurich, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland; [Carlson, Kristian J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Dirks, Paul H. G. M.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia	University of Witwatersrand; University of Witwatersrand; Texas A&M University System; Texas A&M University College Station; Duke University; University of Zurich; Indiana University System; Indiana University Bloomington; James Cook University	Berger, LR (corresponding author), Univ Witwatersrand, Inst Human Evolut, Private Bag 3, ZA-2050 Wits, South Africa.	profleeberger@yahoo.com	Berger, Lee Rogers/AAC-3484-2020; Churchill, Steven/AAA-9386-2022	Berger, Lee Rogers/0000-0002-0367-7629; de Ruiter, Darryl/0000-0003-1183-0352	South African Department of Science and Technology; South African National Research Foundation; Institute for Human Evolution; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; AfricaArray Program; U.S. Diplomatic Mission to South Africa	South African Department of Science and Technology; South African National Research Foundation(National Research Foundation - South Africa); Institute for Human Evolution; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; AfricaArray Program; U.S. Diplomatic Mission to South Africa	We thank the South African Heritage Resources Agency for the permits to work at the Malapa site; the Nash family for granting access to the Malapa site and continued support of research on their reserve; the South African Department of Science and Technology, the South African National Research Foundation, the Institute for Human Evolution, the Palaeontological Scientific Trust, the Andrew W. Mellon Foundation, the AfricaArray Program, the U.S. Diplomatic Mission to South Africa, and Sir Richard Branson for funding; the University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology for support and facilities; the Gauteng Government, Gauteng Department of Agriculture, Conservation and Environment and the Cradle of Humankind Management Authority; E. Mbua, P. Kiura, V. Iminjili, and the National Museums of Kenya for access to comparative specimens; Optech and Optron; Duke University; the Ray A. Rothrock Fellowship of Texas A&M University; and the University of Zurich 2009 Field School. Numerous individuals have been involved in the ongoing preparation and excavation of these fossils, including C. Dube, B. Eloff, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi, M. Ngcamphalala, S. Jirah, S. Tshabalala, and C. Yates. Other individuals who have given significant support to this project include B. de Klerk, C. Steininger, B. Kuhn, L. Pollarolo, B. Zipfel, J. Kretzen, D. Conforti, J. McCaffery, C. Dlamini, H. Visser, R. McCrae-Samuel, B. Nkosi, B. Louw, L. Backwell, F. Thackeray, and M. Peltier. T. Stidham helped construct the cladogram in fig. S3. J. Smilg facilitated computed tomography scanning of the specimens. R. Clarke and F. Kirera provided valuable discussions on these and other hominin fossils in Africa.	Aiello L, 1990, INTRO HUMAN EVOLUTIO; Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; BRAIN C K, 1974, Annals of the Transvaal Museum, V29, P55; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Clarke RJ, 2008, S AFR J SCI, V104, P443, DOI 10.1590/s0038-23532008000600015; Collard M, 2000, P NATL ACAD SCI USA, V97, P5003, DOI 10.1073/pnas.97.9.5003; Curnoe D, 2006, J HUM EVOL, V50, P36, DOI 10.1016/j.jhevol.2005.07.008; Dart RA, 1925, NATURE, V115, P195, DOI 10.1038/115195a0; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; GABUNIA L, 1995, NATURE, V373, P509, DOI 10.1038/373509a0; Grine FE, 1996, J HUM EVOL, V30, P189, DOI 10.1006/jhev.1996.0019; HUGHES AR, 1977, NATURE, V265, P310, DOI 10.1038/265310a0; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; JOHANSON DC, 1979, SCIENCE, V203, P321, DOI 10.1126/science.104384; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Lague MR, 1996, AM J PHYS ANTHROPOL, V101, P401, DOI 10.1002/(SICI)1096-8644(199611)101:3<401::AID-AJPA8>3.3.CO;2-9; Leakey MG, 2001, NATURE, V410, P433, DOI 10.1038/35068500; Leakey R.E., 1989, P167; Lieberman DE, 2001, NATURE, V410, P419, DOI 10.1038/35068648; Lovejoy CO, 2005, GAIT POSTURE, V21, P113, DOI 10.1016/j.gaitpost.2004.06.010; Rak Y., 1983, AUSTRALOPITHECINE FA, DOI [10.1016/B978-0-12-576280-9.50006-7, DOI 10.1016/B978-0-12-576280-9.50006-7]; RIGHTMIRE GP, 1993, AM J PHYS ANTHROPOL, V90, P1, DOI 10.1002/ajpa.1330900102; ROSE MD, 1984, AM J PHYS ANTHROPOL, V63, P371, DOI 10.1002/ajpa.1330630404; Ruff C, 2009, AM J PHYS ANTHROPOL, V138, P90, DOI 10.1002/ajpa.20907; SKELTON RR, 1992, J HUM EVOL, V23, P309, DOI 10.1016/0047-2484(92)90070-P; Smith HF, 2008, J HUM EVOL, V54, P684, DOI 10.1016/j.jhevol.2007.10.012; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; Tobias PV, 1971, BRAIN HOMINID EVOLUT; Tobias PV, 1991, OLDUVAI GORGE, V4; Walker Alan, 1993, P221; White TD, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P369; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Wood B., 1991, HOMINID CRANIAL REMA, V4	36	349	373	1	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2010	328	5975					195	204		10.1126/science.1184944	http://dx.doi.org/10.1126/science.1184944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580OU	20378811	Green Submitted			2022-12-24	WOS:000276459600035
J	Hehemann, JH; Correc, G; Barbeyron, T; Helbert, W; Czjzek, M; Michel, G				Hehemann, Jan-Hendrik; Correc, Gaelle; Barbeyron, Tristan; Helbert, William; Czjzek, Mirjam; Michel, Gurvan			Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota	NATURE			English	Article							GLYCOSIDE HYDROLASES; MAXIMUM-LIKELIHOOD; KAPPA-CARRAGEENASE; SEQUENCE ALIGNMENT; DIFFRACTION DATA; BETA-AGARASES; SP-NOV; POLYSACCHARIDE; EVOLUTION; CLASSIFICATION	Gut microbes supply the human body with energy from dietary polysaccharides through carbohydrate active enzymes, or CAZymes(1), which are absent in the human genome. These enzymes target polysaccharides from terrestrial plants that dominated diet throughout human evolution(2). The array of CAZymes in gut microbes is highly diverse, exemplified by the human gut symbiont Bacteroides thetaiotaomicron(3), which contains 261 glycoside hydrolases and polysaccharide lyases, as well as 208 homologues of susC and susD-genes coding for two outer membrane proteins involved in starch utilization(1,4). A fundamental question that, to our knowledge, has yet to be addressed is how this diversity evolved by acquiring new genes from microbes living outside the gut. Here we characterize the first porphyranases from a member of the marine Bacteroidetes, Zobellia galactanivorans, active on the sulphated polysaccharide porphyran from marine red algae of the genus Porphyra. Furthermore, we show that genes coding for these porphyranases, agarases and associated proteins have been transferred to the gut bacterium Bacteroides plebeius isolated from Japanese individuals(5). Our comparative gut metagenome analyses show that porphyranases and agarases are frequent in the Japanese population(6) and that they are absent in metagenome data(7) from North American individuals. Seaweeds make an important contribution to the daily diet in Japan (14.2 g per person per day)(8), and Porphyra spp. (nori) is the most important nutritional seaweed, traditionally used to prepare sushi(9,10). This indicates that seaweeds with associated marine bacteria may have been the route by which these novel CAZymes were acquired in human gut bacteria, and that contact with non-sterile food may be a general factor in CAZyme diversity in human gut microbes.	[Hehemann, Jan-Hendrik; Correc, Gaelle; Barbeyron, Tristan; Helbert, William; Czjzek, Mirjam; Michel, Gurvan] Univ Paris 06, F-29682 Roscoff, France; [Hehemann, Jan-Hendrik; Correc, Gaelle; Barbeyron, Tristan; Helbert, William; Czjzek, Mirjam; Michel, Gurvan] CNRS, Stn Biol Roscoff, Vegetaux Marins & Biomol UMR 7139, F-29682 Roscoff, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Czjzek, M (corresponding author), Univ Paris 06, F-29682 Roscoff, France.	czjzek@sb-roscoff.fr; gurvan@sb-roscoff.fr	MICHEL, Gurvan/B-3490-2008	Hehemann, Jan-Hendrik/0000-0002-8700-2564; MICHEL, Gurvan/0000-0002-3009-6205	French national research centre (Centre National de la Recherche Scientifique); University Marie Curie; European Marie Curie PhD grant; Region Bretagne; GIS 'Genomique Marine'; French Research Ministry	French national research centre (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); University Marie Curie; European Marie Curie PhD grant; Region Bretagne(Region Bretagne); GIS 'Genomique Marine'; French Research Ministry(Ministry of Research, France)	We thank B. Kloareg and C. de Vargas for critical discussions and reading of the manuscript and M. Jam, A. Jeudy and D. Freudenreich for technical assistance. The 'Marine Plants and Biomolecules' laboratory is funded by the French national research centre (Centre National de la Recherche Scientifique) and the University Marie Curie; J.-H.H. was supported by a European Marie Curie PhD grant; this work was also funded by the 'Region Bretagne' through the program Marine 3D. G. M. was supported by the GIS 'Genomique Marine' and the French Research Ministry (ACI Young Researcher). We thank the beamline scientists and staff at the European Synchrotron Radiation Facilities for technical support during data collections, the NMR Service, University Bretagne Occidentale, for access to the Bruker NMR spectrometer and Genoscope for sequencing the Z. galactanivorans genome.	Allouch J, 2003, J BIOL CHEM, V278, P47171, DOI 10.1074/jbc.M308313200; ANDERSON NS, 1965, J CHEM SOC, P5880, DOI 10.1039/jr9650005880; Barbeyron T, 1998, MOL BIOL EVOL, V15, P528, DOI 10.1093/oxfordjournals.molbev.a025952; Barbeyron T, 2001, INT J SYST EVOL MICR, V51, P985, DOI 10.1099/00207713-51-3-985; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fukuda S, 2007, EUR J CLIN NUTR, V61, P99, DOI 10.1038/sj.ejcn.1602505; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ishihara K, 2005, BIOSCI BIOTECH BIOCH, V69, P1824, DOI 10.1271/bbb.69.1824; Jam M, 2005, BIOCHEM J, V385, P703, DOI 10.1042/BJ20041044; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIDBY DK, 1973, ANAL BIOCHEM, V55, P321, DOI 10.1016/0003-2697(73)90323-0; Kitahara M, 2005, INT J SYST EVOL MICR, V55, P2143, DOI 10.1099/ijs.0.63788-0; KLOAREG B., 1988, OCEANOGR MAR BIOL, V26, P259; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kuo CH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-35; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Maciel JS, 2008, CARBOHYD POLYM, V71, P559, DOI 10.1016/j.carbpol.2007.06.026; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mc Hugh D.J., 2003, 441 FAO; Michel G, 2001, STRUCTURE, V9, P513, DOI 10.1016/S0969-2126(01)00612-8; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISIZAWA K, 1987, HYDROBIOLOGIA, V151, P5, DOI 10.1007/BF00046102; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Starr CM, 1996, J CHROMATOGR A, V720, P295, DOI 10.1016/0021-9673(95)00749-0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; TURVEY JR, 1961, NATURE, V189, P831, DOI 10.1038/189831a0; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Zhong ZP, 2001, APPL ENVIRON MICROB, V67, P5771, DOI 10.1128/AEM.67.12.5771-5779.2001	41	676	717	19	439	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					908	U123		10.1038/nature08937	http://dx.doi.org/10.1038/nature08937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20376150				2022-12-24	WOS:000276397300041
J	Sharma, SV; Lee, DY; Li, BH; Quinlan, MP; Takahashi, F; Maheswaran, S; McDermott, U; Azizian, N; Zou, L; Fischbach, MA; Wong, KK; Brandstetter, K; Wittner, B; Ramaswamy, S; Classon, M; Settleman, J				Sharma, Sreenath V.; Lee, Diana Y.; Li, Bihua; Quinlan, Margaret P.; Takahashi, Fumiyuki; Maheswaran, Shyamala; McDermott, Ultan; Azizian, Nancy; Zou, Lee; Fischbach, Michael A.; Wong, Kwok-Kin; Brandstetter, Kathleyn; Wittner, Ben; Ramaswamy, Sridhar; Classon, Marie; Settleman, Jeff			A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations	CELL			English	Article							STEM-CELLS; THERAPEUTIC RESISTANCE; HISTONE MODIFICATION; GROWTH; INSULIN; MECHANISMS; SENSITIVITY; RETREATMENT; INHIBITORS; DISEASE	Accumulating evidence implicates heterogeneity within cancer cell populations in the response to stressful exposures, including drug treatments. While modeling the acute response to various anticancer agents in drug-sensitive human tumor cell lines, we consistently detected a small subpopulation of reversibly "drug-tolerant" cells. These cells demonstrate >100-fold reduced drug sensitivity and maintain viability via engagement of IGF-1 receptor signaling and an altered chromatin state that requires the histone demethylase RBP2/KDM5A/Jarid1A. This drug-tolerant phenotype is transiently acquired and relinquished at low frequency by individual cells within the population, implicating the dynamic regulation of phenotypic heterogeneity in drug tolerance. The drug-tolerant subpopulation can be selectively ablated by treatment with IGF-1 receptor inhibitors or chromatin-modifying agents, potentially yielding a therapeutic opportunity. Together, these findings suggest that cancer cell populations employ a dynamic survival strategy in which individual cells transiently assume a reversibly drug-tolerant state to protect the population from eradication by potentially lethal exposures.	[Sharma, Sreenath V.; Lee, Diana Y.; Li, Bihua; Quinlan, Margaret P.; Takahashi, Fumiyuki; Maheswaran, Shyamala; McDermott, Ultan; Azizian, Nancy; Zou, Lee; Fischbach, Michael A.; Wittner, Ben; Ramaswamy, Sridhar; Classon, Marie; Settleman, Jeff] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Wong, Kwok-Kin; Brandstetter, Kathleyn] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute	Classon, M (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 149 13th St, Charlestown, MA 02129 USA.	classon@helix.mgh.harvard.edu; settleman@helix.mgh.harvard.edu	Hu, Ruogu/B-2203-2008	McDermott, Ultan/0000-0001-9032-4700; wong, kwok kin/0000-0001-6323-235X; Fischbach, Michael/0000-0003-3079-8247; azizian, nancy/0000-0002-1158-0608	LUNGevity Foundation; Goldman Philanthropic; NIH [RO1CA115830, P20 CA090578]; NATIONAL CANCER INSTITUTE [P20CA090578, P50CA090578, R01CA115830] Funding Source: NIH RePORTER	LUNGevity Foundation; Goldman Philanthropic; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the Settleman laboratory, Luisa Di Stefano, Daniel Haber, and Kurt Isselbacher for helpful discussions through the course of these studies. We also thank Lisa Drew and Jeff Hanke (AstraZeneca) for providing AZ628; James Christensen (Pfizer) for providing PF-2341066; Robert Schlegel (Novartis) for providing AEW541; Jeff Engelman for providing the drug-resistant HCC827 cells; and Toshi Shioda for providing shRNA plasmids and performing gene expression array analysis. This work was supported by an award from the LUNGevity Foundation and Goldman Philanthropic Partnerships to S. V. S. and NIH RO1CA115830 and NIH P20 CA090578 to J. S.	Ahmed S, 2004, MOL CELL BIOL, V24, P3660, DOI 10.1128/MCB.24.9.3660-3669.2004; Baege AC, 2004, J VIROL, V78, P5720, DOI 10.1128/JVI.78.11.5720-5727.2004; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Buck E, 2008, CANCER RES, V68, P8322, DOI 10.1158/0008-5472.CAN-07-6720; Cara S, 2001, ANN ONCOL, V12, P23, DOI 10.1023/A:1008389706725; Casa AJ, 2008, FRONT BIOSCI-LANDMRK, V13, P3273, DOI 10.2741/2925; Chakravarti A, 2002, CANCER RES, V62, P200; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Eot-Houllier G, 2009, CANCER LETT, V274, P169, DOI 10.1016/j.canlet.2008.06.005; ERNST M, 1990, ENDOCRINOLOGY, V127, P807, DOI 10.1210/endo-127-2-807; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; FATTAEY AR, 1993, ONCOGENE, V8, P3149; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Glasspool RM, 2006, BRIT J CANCER, V94, P1087, DOI 10.1038/sj.bjc.6603024; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Kang MK, 2007, STEM CELLS DEV, V16, P837, DOI 10.1089/scd.2007.0006; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kurata T, 2004, ANN ONCOL, V15, P173, DOI 10.1093/annonc/mdh006; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Quinlan MP, 2008, MOL CELL BIOL, V28, P2659, DOI 10.1128/MCB.01661-07; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070; Rothenberg SM, 2008, P NATL ACAD SCI USA, V105, P12480, DOI 10.1073/pnas.0803217105; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Trumpp A, 2008, NAT CLIN PRACT ONCOL, V5, P337, DOI 10.1038/ncponc1110; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Yano S, 2005, ONCOL RES, V15, P107, DOI 10.3727/096504005775082020	42	1583	1641	3	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					69	80		10.1016/j.cell.2010.02.027	http://dx.doi.org/10.1016/j.cell.2010.02.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371346	Green Accepted, Bronze			2022-12-24	WOS:000276211100013
J	Ettwig, KF; Butler, MK; Le Paslier, D; Pelletier, E; Mangenot, S; Kuypers, MMM; Schreiber, F; Dutilh, BE; Zedelius, J; de Beer, D; Gloerich, J; Wessels, HJCT; van Alen, T; Luesken, F; Wu, ML; van de Pas-Schoonen, KT; den Camp, HJMO; Janssen-Megens, EM; Francoijs, KJ; Stunnenberg, H; Weissenbach, J; Jetten, MSM; Strous, M				Ettwig, Katharina F.; Butler, Margaret K.; Le Paslier, Denis; Pelletier, Eric; Mangenot, Sophie; Kuypers, Marcel M. M.; Schreiber, Frank; Dutilh, Bas E.; Zedelius, Johannes; de Beer, Dirk; Gloerich, Jolein; Wessels, Hans J. C. T.; van Alen, Theo; Luesken, Francisca; Wu, Ming L.; van de Pas-Schoonen, Katinka T.; den Camp, Huub J. M. Op; Janssen-Megens, Eva M.; Francoijs, Kees-Jan; Stunnenberg, Henk; Weissenbach, Jean; Jetten, Mike S. M.; Strous, Marc			Nitrite-driven anaerobic methane oxidation by oxygenic bacteria	NATURE			English	Article							CHLORITE DISMUTASE; NITROUS-OXIDE; GENOME; MICROSENSOR; TRANSFORMATION; MONOOXYGENASE; ENRICHMENT; ATMOSPHERE; SOILS; N2O	Only three biological pathways are known to produce oxygen: photosynthesis, chlorate respiration and the detoxification of reactive oxygen species. Here we present evidence for a fourth pathway, possibly of considerable geochemical and evolutionary importance. The pathway was discovered after metagenomic sequencing of an enrichment culture that couples anaerobic oxidation of methane with the reduction of nitrite to dinitrogen. The complete genome of the dominant bacterium, named 'Candidatus Methylomirabilis oxyfera', was assembled. This apparently anaerobic, denitrifying bacterium encoded, transcribed and expressed the well-established aerobic pathway for methane oxidation, whereas it lacked known genes for dinitrogen production. Subsequent isotopic labelling indicated that 'M. oxyfera' bypassed the denitrification intermediate nitrous oxide by the conversion of two nitric oxidemolecules to dinitrogen and oxygen, which was used to oxidize methane. These results extend our understanding of hydrocarbon degradation under anoxic conditions and explain the biochemical mechanism of a poorly understood freshwater methane sink. Because nitrogen oxides were already present on early Earth, our finding opens up the possibility that oxygen was available to microbial metabolism before the evolution of oxygenic photosynthesis.	[Ettwig, Katharina F.; Butler, Margaret K.; van Alen, Theo; Luesken, Francisca; Wu, Ming L.; van de Pas-Schoonen, Katinka T.; den Camp, Huub J. M. Op; Jetten, Mike S. M.; Strous, Marc] Radboud Univ Nijmegen, IWWR, Dept Microbiol, NL-6525 AJ Nijmegen, Netherlands; [Le Paslier, Denis; Pelletier, Eric; Mangenot, Sophie; Weissenbach, Jean] CEA Genoscope, F-91057 Evry, France; [Le Paslier, Denis; Pelletier, Eric; Weissenbach, Jean] CNRS, UMR 8030, F-91057 Evry, France; [Le Paslier, Denis; Pelletier, Eric; Weissenbach, Jean] Univ Evry Val Essonne, F-91057 Evry, France; [Kuypers, Marcel M. M.; Schreiber, Frank; Zedelius, Johannes; de Beer, Dirk; Strous, Marc] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; [Dutilh, Bas E.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Gloerich, Jolein; Wessels, Hans J. C. T.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Prote Facil, Dept Lab Med,Lab Genet Endocrine & Metab Dis, NL-6525 GA Nijmegen, Netherlands; [Janssen-Megens, Eva M.; Francoijs, Kees-Jan; Stunnenberg, Henk] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Strous, Marc] Univ Bielefeld, Ctr Biotechnol, D-33501 Bielefeld, Germany	Radboud University Nijmegen; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Max Planck Society; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Bielefeld	Ettwig, KF (corresponding author), Radboud Univ Nijmegen, IWWR, Dept Microbiol, Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	k.ettwig@science.ru.nl; mstrous@mpi-bremen.de	Jetten, Mike/B-8834-2011; Schreiber, Frank/I-9182-2012; Gloerich, Jolein/L-4327-2015; Wessels, Hans J/P-6248-2015; de Beer, Dirk/L-4840-2013; Dutilh, Bas E./B-9719-2011; Camp, Huub J.M. Op den/F-5114-2011; Stunnenberg, Hendrik G./D-6875-2012; Ettwig, Katharina F/B-9395-2011; Strous, Marc/B-4064-2017	Jetten, Mike/0000-0002-4691-7039; Schreiber, Frank/0000-0003-1957-6328; Gloerich, Jolein/0000-0001-5976-8426; Wessels, Hans J/0000-0001-5957-3127; de Beer, Dirk/0000-0001-5274-1781; Dutilh, Bas E./0000-0003-2329-7890; Camp, Huub J.M. Op den/0000-0003-1990-9030; Stunnenberg, Hendrik G./0000-0002-0066-1576; Strous, Marc/0000-0001-9600-3828; Le Paslier, Denis/0000-0003-4335-9956; Pelletier, Eric/0000-0003-4228-1712	Max Planck Society; European Research Council [232937]; Netherlands Organisation for Scientific Research (NWO) [050-71-058]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	We thank F. Stams and N. Tan for sharing their ideas on NO decomposition; D. Speth and L. Russ for pilot experiments; N. Kip for providing M. acidophilus cultures; A. Pierik for electron paramagnetic resonance analysis; G. Klockgether and G. Lavik for technical assistance; and B. Kartal, J. Keltjens, A. Pol, J. van de Vossenberg and F. Widdel for helpful discussions. M. M. M. K., F. S., J. Z. and D. d. B. were supported by the Max Planck Society, M. S. M. J. by European Research Council grant 232937, M. S., K. F. E. and M. K. B. by a Vidi grant to M. S. from the Netherlands Organisation for Scientific Research (NWO), and M. L. W. and B. D. by a Horizon grant (050-71-058) from NWO.	ALLEN MB, 1952, J BACTERIOL, V64, P397, DOI 10.1128/JB.64.3.397-412.1952; Andersen K, 2001, SENSOR ACTUAT B-CHEM, V81, P42, DOI 10.1016/S0925-4005(01)00924-8; Bab-Dinitz E, 2006, BIOINFORMATICS, V22, P671, DOI 10.1093/bioinformatics/btk043; Bodelier PLE, 2004, FEMS MICROBIOL ECOL, V47, P265, DOI 10.1016/S0168-6496(03)00304-0; BRODA E, 1975, J MOL EVOL, V7, P87, DOI 10.1007/BF01732182; Castresana J, 2004, ADV PHOTO RESPIRAT, V15, P1; CHAPMAN DJ, 1983, BIOL BIOCH EFFECTS D; Chistoserdova L, 2005, ASM NEWS, V71, P521; Daniels F., 1958, J PHYS CHEM, V62, P360, DOI [10.1021/j150561a030, DOI 10.1021/J150561A030]; Demicheli V, 2007, FREE RADICAL BIO MED, V42, P1359, DOI 10.1016/j.freeradbiomed.2007.01.034; Ducluzeau AL, 2009, TRENDS BIOCHEM SCI, V34, P9, DOI 10.1016/j.tibs.2008.10.005; Dutilh BE, 2009, BIOINFORMATICS, V25, P2878, DOI 10.1093/bioinformatics/btp377; Ettwig KF, 2008, ENVIRON MICROBIOL, V10, P3164, DOI 10.1111/j.1462-2920.2008.01724.x; Ettwig KF, 2009, APPL ENVIRON MICROB, V75, P3656, DOI 10.1128/AEM.00067-09; Farrer RA, 2009, FEMS MICROBIOL LETT, V291, P103, DOI 10.1111/j.1574-6968.2008.01441.x; Fenchel T., 2002, ORIGIN EARLY EVOLUTI; FRIEDMAN SH, 1986, J BIOL CHEM, V261, P538; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; Hayes JM., 1983, EARTHS EARLIEST BIOS, P291; Heider J, 2007, CURR OPIN CHEM BIOL, V11, P188, DOI 10.1016/j.cbpa.2007.02.027; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Hu SH, 2009, ENV MICROBIOL REP, V1, P377, DOI 10.1111/j.1758-2229.2009.00083.x; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kool DM, 2007, RAPID COMMUN MASS SP, V21, P3569, DOI 10.1002/rcm.3249; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McIlvin MR, 2005, ANAL CHEM, V77, P5589, DOI 10.1021/ac050528s; Parvulescu VI, 1998, CATAL TODAY, V46, P233, DOI 10.1016/S0920-5861(98)00399-X; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; PRIOR SD, 1985, FEMS MICROBIOL LETT, V29, P105; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; RAGHOEBARSING AA, 2006, THESIS RADBOUD U NIJ; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Schreiber F, 2008, ANAL CHEM, V80, P1152, DOI 10.1021/ac071563x; Stoecker K, 2006, P NATL ACAD SCI USA, V103, P2363, DOI 10.1073/pnas.0506361103; Thauer RK, 2008, ANN NY ACAD SCI, V1125, P158, DOI 10.1196/annals.1419.000; Trotsenko YA, 2008, ADV APPL MICROBIOL, V63, P183, DOI 10.1016/S0065-2164(07)00005-6; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; vanGlinkel CG, 1996, ARCH MICROBIOL, V166, P321, DOI 10.1007/s002030050390; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wilmes P, 2009, FEMS MICROBIOL REV, V33, P109, DOI 10.1111/j.1574-6976.2008.00144.x; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996; Zumft WG, 2007, ADV MICROB PHYSIOL, V52, P107, DOI 10.1016/S0065-2911(06)52003-X; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997; Zumft WG, 2005, J INORG BIOCHEM, V99, P194, DOI 10.1016/j.jinorgbio.2004.09.024	51	1113	1216	50	1176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					543	+		10.1038/nature08883	http://dx.doi.org/10.1038/nature08883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336137	Green Published			2022-12-24	WOS:000275974200038
J	Andersen, CBF; Madsen, M; Storm, T; Moestrup, SK; Andersen, GR				Andersen, Christian Brix Folsted; Madsen, Mette; Storm, Tina; Moestrup, Soren K.; Andersen, Gregers R.			Structural basis for receptor recognition of vitamin-B-12-intrinsic factor complexes	NATURE			English	Article							FACTOR-VITAMIN B-12; HUMAN INTRINSIC-FACTOR; ELECTRON-DENSITY MAPS; MANNAN-BINDING LECTIN; X-RAY-STRUCTURE; LIGAND RECOGNITION; CRYSTAL-STRUCTURE; CUBILIN; PROTEIN; IDENTIFICATION	Cobalamin (Cbl, vitamin B-12) is a bacterial organic compound and an essential coenzyme in mammals, which take it up from the diet. This occurs by the combined action of the gastric intrinsic factor (IF) and the ileal endocytic cubam receptor formed by the 460-kilodalton (kDa) protein cubilin and the 45-kDa transmembrane protein amnionless(1,2). Loss of function of any of these proteins ultimately leads to Cbl deficiency in man(3,4). Here we present the crystal structure of the complex between IF-Cbl and the cubilin IF-Cbl-binding-region (CUB5-8)(5) determined at 3.3 angstrom resolution. The structure provides insight into how several CUB (for 'complement C1r/C1s, Uegf, Bmp1') domains collectively function as modular ligand-binding regions, and how two distant CUB domains embrace the Cbl molecule by binding the two IF domains in a Ca2+-dependent manner. This dual-point model provides a probable explanation of how Cbl indirectly induces ligand-receptor coupling. Finally, the comparison of Ca2+-binding CUB domains and the low-density lipoprotein (LDL) receptor-type A modules suggests that the electrostatic pairing of a basic ligand arginine/lysine residue with Ca2+-coordinating acidic aspartates/glutamates is a common theme of Ca2+-dependent ligand-receptor interactions.	[Andersen, Christian Brix Folsted; Madsen, Mette; Storm, Tina; Moestrup, Soren K.] Aarhus Univ, Dept Med Biochem, DK-8000 Aarhus C, Denmark; [Andersen, Christian Brix Folsted; Andersen, Gregers R.] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Moestrup, SK (corresponding author), Aarhus Univ, Dept Med Biochem, DK-8000 Aarhus C, Denmark.	skm@biokemi.au.dk	Moestrup, Søren Kragh/AAD-1735-2019; Moestrup, Søren Kragh/A-1403-2014; Andersen, Christian/G-9954-2011	Moestrup, Søren Kragh/0000-0003-3862-2107; Storm, Tina/0000-0001-6550-4072; Andersen, Gregers Rom/0000-0001-6292-3319; Madsen, Mette/0000-0001-7241-6505	Lundbeck foundation; Danish Science Research Council; Novo Nordisk Foundation; Lundbeck Foundation [R7-2006-752] Funding Source: researchfish	Lundbeck foundation(Lundbeckfonden); Danish Science Research Council(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden)	We are grateful to G. Biller, G. Ratz and G. Hartvigsen for technical assistance, the staff at MAX-lab and SLS beamlines for help with data collection, and S. Fedosov for advice on expression. The study was essentially supported by a grant to S. K. M. from the Lundbeck foundation. G. R. A. was supported by the Danish Science Research Council and a Hallas-Moller stipend from the Novo-Nordisk foundation. M. M. was supported by the Novo Nordisk Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aminoff M, 1999, NAT GENET, V21, P309, DOI 10.1038/6831; Appleton BA, 2007, EMBO J, V26, P4902, DOI 10.1038/sj.emboj.7601906; Bally I, 2009, J BIOL CHEM, V284, P19340, DOI 10.1074/jbc.M109.004473; Bates PA, 2001, PROTEINS, P39; Birn H, 1997, J BIOL CHEM, V272, P26497, DOI 10.1074/jbc.272.42.26497; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fedosov SN, 2004, BIOCHEMISTRY-US, V43, P15095, DOI 10.1021/bi048924c; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Fyfe JC, 2004, BLOOD, V103, P1573, DOI 10.1182/blood-2003-08-2852; GORDON MM, 1991, AM J PHYSIOL, V260, pG736, DOI 10.1152/ajpgi.1991.260.5.G736; Gregory LA, 2004, J BIOL CHEM, V279, P29391, DOI 10.1074/jbc.M402687200; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; KLEYWEGT GJ, HALLOWEEN MASKS BONE; Kozyraki R, 1998, BLOOD, V91, P3593; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristiansen M, 2000, BLOOD, V96, P405; Kristiansen M, 1999, J BIOL CHEM, V274, P20540, DOI 10.1074/jbc.274.29.20540; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindblom A, 1999, J BIOL CHEM, V274, P6374, DOI 10.1074/jbc.274.10.6374; Mathews FS, 2007, P NATL ACAD SCI USA, V104, P17311, DOI 10.1073/pnas.0703228104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Tanner SM, 2005, P NATL ACAD SCI USA, V102, P4130, DOI 10.1073/pnas.0500517102; Tanner SM, 2004, HUM MUTAT, V23, P327, DOI 10.1002/humu.20014; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200	34	82	88	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					445	U147		10.1038/nature08874	http://dx.doi.org/10.1038/nature08874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20237569				2022-12-24	WOS:000275657100054
